<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37700297</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Prevention of cardiac surgery-associated acute kidney injury: a systematic review and meta-analysis of non-pharmacological interventions.</ArticleTitle><Pagination><StartPage>354</StartPage><MedlinePgn>354</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">354</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-023-04640-1</ELocationID><Abstract><AbstractText Label="BACKGROUND">Cardiac surgery-associated acute kidney injury (CSA-AKI) is frequent. While two network meta-analyses assessed the impact of pharmacological interventions to prevent CSA-AKI, none focused on non-pharmacological interventions. We aim to assess the effectiveness of non-pharmacological interventions to reduce the incidence of CSA-AKI.</AbstractText><AbstractText Label="METHODS">We searched PubMed, Embase, Central and clinical trial registries from January 1, 2004 (first consensus definition of AKI) to July 1, 2023. Additionally, we conducted manual screening of abstracts of major anesthesia and intensive care conferences over the last 5 years and reference lists of relevant studies. We selected all randomized controlled trials (RCTs) assessing a non-pharmacological intervention to reduce the incidence of CSA-AKI, without language restriction. We excluded RCTs of heart transplantation or involving a pediatric population. The primary outcome variable was CSA-AKI. Two reviewers independently identified trials, extracted data and assessed risk of bias. Random-effects meta-analyses were conducted to calculate risk ratios (RRs) with 95% confidence intervals (CIs). We used the Grading of Recommendations Assessment, Development, and Evaluation to assess the quality of evidence.</AbstractText><AbstractText Label="RESULTS">We included 86 trials (25,855 patients) evaluating 10 non-pharmacological interventions to reduce the incidence of CSA-AKI. No intervention had high-quality evidence to reduce CSA-AKI. Two interventions were associated with a significant reduction in CSA-AKI incidence, with moderate quality of evidence: goal-directed perfusion (RR, 0.55 [95% CI 0.40-0.76], I<sup>2</sup>&#x2009;=&#x2009;0%; P<sub>het</sub>&#x2009;=&#x2009;0.44) and remote ischemic preconditioning (RR, 0.86 [0.78-0.95]; I<sup>2</sup>&#x2009;=&#x2009;23%; P<sub>het</sub>&#x2009;=&#x2009;0.07). Pulsatile flow during cardiopulmonary bypass was associated with a significant reduction in CSA-AKI incidence but with very low quality of evidence (RR&#x2009;=&#x2009;0.69 [0.48; 0.99]; I<sup>2</sup>&#x2009;=&#x2009;53%; P<sub>het</sub>&#x2009;&lt;&#x2009;0.01). We found high quality of evidence for lack of effect of restrictive transfusion strategy (RR, 1.02 [95% CI 0.92; 1.12; P<sub>het</sub>&#x2009;=&#x2009;0.67; I<sup>2</sup>&#x2009;=&#x2009;3%) and tight glycemic control (RR, 0.86 [95% CI 0.55; 1.35]; P<sub>het</sub>&#x2009;=&#x2009;0.25; I<sup>2</sup>&#x2009;=&#x2009;26%).</AbstractText><AbstractText Label="CONCLUSIONS">Two non-pharmacological interventions are likely to reduce CSA-AKI incidence, with moderate quality of evidence: goal-directed perfusion and remote ischemic preconditioning.</AbstractText><CopyrightInformation>&#xa9; 2023. BioMed Central Ltd., part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hariri</LastName><ForeName>Geoffroy</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de Sant&#xe9; Publique, UMR-S 1136, AP-HP, INSERM, Institut Pierre Louis d'Epid&#xe9;miologie et de Sant&#xe9; Publique, H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, Paris, France. geoffroy.hariri@aphp.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement d'anesth&#xe9;sie et r&#xe9;animation, GRC 29, DMU DREAM, Institut de Cardiologie, Assistance Publique-H&#xf4;pitaux de Paris (AP-HP), H&#xf4;pital La Piti&#xe9;-Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, 75013, Paris, France. geoffroy.hariri@aphp.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collet</LastName><ForeName>Lucie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de Sant&#xe9; Publique, UMR-S 1136, AP-HP, INSERM, Institut Pierre Louis d'Epid&#xe9;miologie et de Sant&#xe9; Publique, H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte</LastName><ForeName>Lucie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>D&#xe9;partement d'anesth&#xe9;sie et r&#xe9;animation, GRC 29, DMU DREAM, Institut de Cardiologie, Assistance Publique-H&#xf4;pitaux de Paris (AP-HP), H&#xf4;pital La Piti&#xe9;-Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, 75013, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Guillaume L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de Sant&#xe9; Publique, UMR-S 1136, AP-HP, INSERM, Institut Pierre Louis d'Epid&#xe9;miologie et de Sant&#xe9; Publique, H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Resche-Rigon</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>ECSTRRA - CRESS UMR1153, INSERM and SBIM, AP-HP, H&#xf4;pital Saint-Louis, Universit&#xe9; de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lebreton</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>AP-HP, Service de Chirurgie Cardiaque, Institut de Cardiologie, H&#xf4;pital La Piti&#xe9;-Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, 75013, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bougl&#xe9;</LastName><ForeName>Adrien</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>D&#xe9;partement d'anesth&#xe9;sie et r&#xe9;animation, GRC 29, DMU DREAM, Institut de Cardiologie, Assistance Publique-H&#xf4;pitaux de Paris (AP-HP), H&#xf4;pital La Piti&#xe9;-Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, 75013, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dechartres</LastName><ForeName>Agn&#xe8;s</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de Sant&#xe9; Publique, UMR-S 1136, AP-HP, INSERM, Institut Pierre Louis d'Epid&#xe9;miologie et de Sant&#xe9; Publique, H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="Y">Anesthesia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000776" MajorTopicYN="Y">Anesthesiology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Non-pharmacological interventions</Keyword><Keyword MajorTopicYN="N">Prevention</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>13</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>12</Day><Hour>23</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37700297</ArticleId><ArticleId IdType="pmc">PMC10498585</ArticleId><ArticleId IdType="doi">10.1186/s13054-023-04640-1</ArticleId><ArticleId IdType="pii">10.1186/s13054-023-04640-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mao H, Katz N, Ariyanon W, Blanca-Martos L, Ad&#xfd;belli Z, Giuliani A, et al. Cardiac surgery-associated acute kidney injury. Cardiorenal Med. 2013;3:178&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3884176</ArticleId><ArticleId IdType="pubmed">24454314</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EA, Cruz DN, Davenport A, Mehta RL, Piccinni P, Tetta C, et al. The epidemiology of cardiac surgery-associated acute kidney injury. Int J Artif Organs. 2008;31:158&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">18311732</ArticleId></ArticleIdList></Reference><Reference><Citation>Karkouti K, Wijeysundera DN, Yau TM, Callum JL, Cheng DC, Crowther M, et al. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation. 2009;119:495&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pubmed">19153273</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Delgado JC, Esteve F, Torrado H, Rodr&#xed;guez-Castro D, Carrio ML, Farrero E, et al. Influence of acute kidney injury on short- and long-term outcomes in patients undergoing cardiac surgery: risk factors and prognostic value of a modified RIFLE classification. Crit Care. 2013;17:R293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4056889</ArticleId><ArticleId IdType="pubmed">24330769</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Q, Hong L, Mu X, Zhang C, Chen X. Meta-analysis for outcomes of acute kidney injury after cardiac surgery. Medicine (Baltimore) 2016;95:e5558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5266033</ArticleId><ArticleId IdType="pubmed">27930561</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasta JF, Kane-Gill SL, Durtschi AJ, Pathak DS, Kellum JA. Costs and outcomes of acute kidney injury (AKI) following cardiac surgery. Nephrol Dial Transpl. 2008;23:1970&#x2013;1974.</Citation><ArticleIdList><ArticleId IdType="pubmed">18178605</ArticleId></ArticleIdList></Reference><Reference><Citation>Newsome BB, Warnock DG, McClellan WM, Herzog CA, Kiefe CI, Eggers PW, et al. Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med. 2008;168:609&#x2013;616.</Citation><ArticleIdList><ArticleId IdType="pubmed">18362253</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson CE, Yavas S, Segal MS, Schold JD, Tribble CG, Layon AJ, et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation. 2009;119:2444&#x2013;2453.</Citation><ArticleIdList><ArticleId IdType="pubmed">19398670</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomivorotov VV, Efremov SM, Kirov MY, Fominskiy EV, Karaskov AM. Low-cardiac-output syndrome after cardiac surgery. J Cardiothorac Vasc Anesth. 2017;31:291&#x2013;308.</Citation><ArticleIdList><ArticleId IdType="pubmed">27671216</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy GJ, Reeves BC, Rogers CA, Rizvi SIA, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116:2544&#x2013;2552.</Citation><ArticleIdList><ArticleId IdType="pubmed">17998460</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald CI, Fraser JF, Coombes JS, Fung YL. Oxidative stress during extracorporeal circulation. Eur J Cardiothorac Surg. 2014;46:937&#x2013;943.</Citation><ArticleIdList><ArticleId IdType="pubmed">24482384</ArticleId></ArticleIdList></Reference><Reference><Citation>Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005;293:1653&#x2013;1662.</Citation><ArticleIdList><ArticleId IdType="pubmed">15811985</ArticleId></ArticleIdList></Reference><Reference><Citation>Harky A, Joshi M, Gupta S, Teoh WY, Gatta F, Snosi M. Acute kidney injury associated with cardiac surgery: a comprehensive literature review. Braz J Cardiovasc Surg. 2020;35:211&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7199993</ArticleId><ArticleId IdType="pubmed">32369303</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin SR, Kim WH, Kim DJ, Shin I-W, Sohn J-T. Prediction and prevention of acute kidney injury after cardiac surgery. Biomed Res Int. 2016;2016:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4935903</ArticleId><ArticleId IdType="pubmed">27419130</ArticleId></ArticleIdList></Reference><Reference><Citation>Romagnoli S, Ricci Z, Ronco C. Perioperative acute kidney injury: prevention, early recognition, and supportive measures. NEF. 2018;140:105&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pubmed">29945154</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob KA, Leaf DE. Prevention of cardiac surgery-associated acute kidney injury: a review of current strategies. Anesthesiol Clin. 2019;37:729.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7644277</ArticleId><ArticleId IdType="pubmed">31677688</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim WH, Hur M, Park S-K, Jung DE, Kang P, Yoo S, et al. Pharmacological interventions for protecting renal function after cardiac surgery: a Bayesian network meta-analysis of comparative effectiveness. Anaesthesia. 2018;73:1019&#x2013;1031.</Citation><ArticleIdList><ArticleId IdType="pubmed">29682727</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Huang T, Cao X, Xu G. Comparative efficacy of drugs for preventing acute kidney injury after cardiac surgery: a network meta-analysis. Am J Cardiovasc Drugs. 2018;18:49&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">28819767</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative workgroup Acute renal failure&#x2014;definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (ADQI) group. Crit Care. 2004;8:204&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC522841</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>20190822_RoB_2.0_guidance_parallel_trial.pdf [Internet]. Google Docs. [cited 2021 Feb 9]. https://drive.google.com/file/d/19R9savfPdCHC8XLz2iiMvL_71lPJERWK/view?usp=drive_open&amp;usp=embed_facebook</Citation></Reference><Reference><Citation>Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539&#x2013;1558. doi: 10.1002/sim.1186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629&#x2013;634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Team RC. R: A language and environment for statistical computing. Vienna, Austria: R foundation for statistical computing. See https://wwwR-project.org. 2017</Citation></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924&#x2013;926.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>de Somer F, Mulholland JW, Bryan MR, Aloisio T, Van Nooten GJ, Ranucci M. O2 delivery and CO2 production during cardiopulmonary bypass as determinants of acute kidney injury: Time for a goal-directed perfusion management? Crit Care. 2011;15:R192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3387634</ArticleId><ArticleId IdType="pubmed">21831302</ArticleId></ArticleIdList></Reference><Reference><Citation>Dijoy L, Dean JS, Bistrick C, Sistino JJ. The history of goal-directed therapy and relevance to cardiopulmonary bypass. J Extra Corpor Technol. 2015;47:90&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4557555</ArticleId><ArticleId IdType="pubmed">26405356</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukaida H, Matsushita S, Yamamoto T, Minami Y, Sato G, Asai T, et al. Oxygen delivery-guided perfusion for the prevention of acute kidney injury: a randomized controlled trial. J Thorac Cardiovasc Surg. 2021;S0022&#x2013;5223(21):00511.</Citation><ArticleIdList><ArticleId IdType="pubmed">33840474</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranucci M, Johnson I, Willcox T, Baker R, Boer C, Baumann A, et al. Goal-directed perfusion to reduce acute kidney injury: a randomized trial. J Thorac Cardiovasc Surg. 2018;156:1918&#x2013;1927.e2.</Citation><ArticleIdList><ArticleId IdType="pubmed">29778331</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P, Liu J, Zhang P, Bai L, Jin Y, Li Y. Goal-directed perfusion for reducing acute kidney injury in cardiac surgery: a systematic review and meta-analysis. Perfusion. 2022;38(3):591&#x2013;599.</Citation><ArticleIdList><ArticleId IdType="pubmed">35125028</ArticleId></ArticleIdList></Reference><Reference><Citation>Hausenloy DJ, Candilio L, Evans R, Ariti C, Jenkins DP, Kolvekar S, et al. Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA study): a multicentre double-blind randomised controlled clinical trial. Southampton (UK) NIHR J Library; 2016.</Citation><ArticleIdList><ArticleId IdType="pubmed">27359023</ArticleId></ArticleIdList></Reference><Reference><Citation>Meybohm P, Bein B, Brosteanu O, Cremer J, Gruenewald M, Stoppe C, et al. A multicenter trial of remote ischemic preconditioning for heart surgery. N Engl J Med. 2015;373:1397&#x2013;1407.</Citation><ArticleIdList><ArticleId IdType="pubmed">26436208</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Egger M, Smith GD. Investigating and dealing with publication and other biases in meta-analysis. BMJ. 2001;323:101&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1120714</ArticleId><ArticleId IdType="pubmed">11451790</ArticleId></ArticleIdList></Reference><Reference><Citation>Kottenberg E, Musiolik J, Thielmann M, Jakob H, Peters J, Heusch G. Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischemic preconditioning during coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2014;147:376&#x2013;382.</Citation><ArticleIdList><ArticleId IdType="pubmed">23465551</ArticleId></ArticleIdList></Reference><Reference><Citation>Loukogeorgakis SP, Williams R, Panagiotidou AT, Kolvekar SK, Donald A, Cole TJ, et al. Transient limb ischemia induces remote preconditioning and remote postconditioning in humans by a KATP channel-dependent mechanism. Circulation. 2007;116:1386&#x2013;1395.</Citation><ArticleIdList><ArticleId IdType="pubmed">17724264</ArticleId></ArticleIdList></Reference><Reference><Citation>Long Y-Q, Feng X-M, Shan X-S, Chen Q-C, Xia Z, Ji F-H, et al. Remote ischemic preconditioning reduces acute kidney injury after cardiac surgery: a systematic review and meta-analysis of randomized controlled trials. Anesth Analg. 2021;134(3):592&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pubmed">34748518</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Zhao Y, Lei M, Zhao G, Li D, Sun R, et al. Remote ischemic preconditioning to prevent acute kidney injury after cardiac surgery: a meta-analysis of randomized controlled trials. Front Cardiovasc Med. 2021;8:601470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8012491</ArticleId><ArticleId IdType="pubmed">33816572</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JR, Baker RA, Shore-Lesserson L, Fox AA, Mongero LB, Lobdell KW, et al. The society of thoracic surgeons/society of cardiovascular anesthesiologists/American society of extracorporeal technology clinical practice guidelines for the prevention of adult cardiac surgery-associated acute kidney injury. Ann Thorac Surg. 2023;115:34&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">36549802</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2018;t Hart DC, van der Vlag J, Nijenhuis T. Laminar flow substantially affects the morphology and functional phenotype of glomerular endothelial cells. PLoS ONE. 2021;16:e0251129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8099128</ArticleId><ArticleId IdType="pubmed">33951113</ArticleId></ArticleIdList></Reference><Reference><Citation>Hathcock JJ. Flow effects on coagulation and thrombosis. Arterioscler Thromb Vasc Biol. 2006;26:1729&#x2013;1737.</Citation><ArticleIdList><ArticleId IdType="pubmed">16741150</ArticleId></ArticleIdList></Reference><Reference><Citation>Koning NJ, Vonk ABA, van Barneveld LJ, Beishuizen A, Atasever B, van den Brom CE, et al. Pulsatile flow during cardiopulmonary bypass preserves postoperative microcirculatory perfusion irrespective of systemic hemodynamics. J Appl Physiol. 2012;112:1727&#x2013;1734.</Citation><ArticleIdList><ArticleId IdType="pubmed">22403352</ArticleId></ArticleIdList></Reference><Reference><Citation>Poswal P, Mehta Y, Juneja R, Khanna S, Meharwal ZS, Trehan N. Comparative study of pulsatile and nonpulsatile flow during cardio-pulmonary bypass. Ann Card Anaesth. 2004;7:44&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">17827561</ArticleId></ArticleIdList></Reference><Reference><Citation>Parissis H, Soo A, Al-Alao B. Intra aortic balloon pump: literature review of risk factors related to complications of the intraaortic balloon pump. J Cardiothorac Surg. 2011;6:147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3216865</ArticleId><ArticleId IdType="pubmed">22047038</ArticleId></ArticleIdList></Reference><Reference><Citation>Nam J, Lee E, Choi D, Hahm K, Sim J, Choi I. Impact of the preceding time of coronary angiography on acute kidney injury after elective off-pump coronary artery bypass surgery. Appl Cardiopulm Pathophysiol. 2014;17:215&#x2013;216.</Citation></Reference><Reference><Citation>Sievert A, Sistino J. A meta-analysis of renal benefits to pulsatile perfusion in cardiac surgery. J Extra Corpor Technol. 2012;44:10&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4557433</ArticleId><ArticleId IdType="pubmed">22730858</ArticleId></ArticleIdList></Reference><Reference><Citation>Shehata N, Mistry N, da Costa BR, Pereira TV, Whitlock R, Curley GF, et al. Restrictive compared with liberal red cell transfusion strategies in cardiac surgery: a meta-analysis. Eur Heart J. 2019;40:1081&#x2013;1088.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6441852</ArticleId><ArticleId IdType="pubmed">30107514</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheiri B, Abdalla A, Osman M, Haykal T, Chintalapati S, Cranford J, et al. Restrictive versus liberal red blood cell transfusion for cardiac surgery: a systematic review and meta-analysis of randomized controlled trials. J Thromb Thrombolysis. 2019;47:179&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">30511259</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol. 2017;13:697&#x2013;711.</Citation><ArticleIdList><ArticleId IdType="pubmed">28869251</ArticleId></ArticleIdList></Reference><Reference><Citation>Pahwa S, Bernabei A, Schaff H, Stulak J, Greason K, Pochettino A, et al. Impact of postoperative complications after cardiac surgery on long-term survival. J Card Surg. 2021;36:2045&#x2013;2052.</Citation><ArticleIdList><ArticleId IdType="pubmed">33686738</ArticleId></ArticleIdList></Reference><Reference><Citation>Benstoem C, Moza A, Meybohm P, Stoppe C, Autschbach R, Devane D, et al. A core outcome set for adult cardiac surgery trials: a consensus study. PLoS ONE. 2017 doi: 10.1371/journal.pone.0186772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0186772</ArticleId><ArticleId IdType="pmc">PMC5667757</ArticleId><ArticleId IdType="pubmed">29095881</ArticleId></ArticleIdList></Reference><Reference><Citation>Legrand M, Bagshaw SM, Koyner JL, Schulman IH, Mathis MR, Bernholz J, et al. Optimizing the design and analysis of future AKI trials. J Am Soc Nephrol. 2022;33:1459&#x2013;1470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9342638</ArticleId><ArticleId IdType="pubmed">35831022</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiari P, Desebbe O, Durand M, Fischer M-O, Lena-Quintard D, Palao J-C, et al. A multimodal cardioprotection strategy during cardiac surgery: the ProCCard study. J Cardiothorac Vasc Anesth. 2023;37:1368&#x2013;1376.</Citation><ArticleIdList><ArticleId IdType="pubmed">37202231</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, K&#xfc;llmar M, Ostermann M, Lucchese G, Baig K, Cennamo A, et al. Prevention of cardiac surgery-associated acute kidney injury by implementing the KDIGO guidelines in high-risk patients identified by biomarkers: the PrevAKI-multicenter randomized controlled trial. Anesth Analg. 2021;133(2):292&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pubmed">33684086</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28577069</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1238</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>6</Issue><PubDate><Year>2017</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Intensive care medicine</Title><ISOAbbreviation>Intensive Care Med</ISOAbbreviation></Journal><ArticleTitle>Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017 : Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine.</ArticleTitle><Pagination><StartPage>730</StartPage><EndPage>749</EndPage><MedlinePgn>730-749</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00134-017-4832-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute kidney injury (AKI) in the intensive care unit is associated with significant mortality and morbidity.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To determine and update previous recommendations for the prevention of AKI, specifically the role of fluids, diuretics, inotropes, vasopressors/vasodilators, hormonal and nutritional interventions, sedatives, statins, remote ischaemic preconditioning and care bundles.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">A systematic search of the literature was performed for studies published between 1966 and March 2017 using these potential protective strategies in adult patients at risk of AKI. The following clinical conditions were considered: major surgery, critical illness, sepsis, shock, exposure to potentially nephrotoxic drugs and radiocontrast. Clinical endpoints included incidence or grade of AKI, the need for renal replacement therapy and mortality. Studies were graded according to the international GRADE system.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We formulated 12 recommendations, 13 suggestions and seven best practice statements. The few strong recommendations with high-level evidence are mostly against the intervention in question (starches, low-dose dopamine, statins in cardiac surgery). Strong recommendations with lower-level evidence include controlled fluid resuscitation with crystalloids, avoiding fluid overload, titration of norepinephrine to a target MAP of 65-70&#xa0;mmHg (unless chronic hypertension) and not using diuretics or levosimendan for kidney protection solely.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results of recent randomised controlled trials have allowed the formulation of new recommendations and/or increase the strength of previous recommendations. On the other hand, in many domains the available evidence remains insufficient, resulting from the limited quality of the clinical trials and the poor reporting of kidney outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Joannidis</LastName><ForeName>M</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6996-0881</Identifier><AffiliationInfo><Affiliation>Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck, Anichstasse 35, 6020, Innsbruck, Austria. michael.joannidis@i-med.ac.at.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Druml</LastName><ForeName>W</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine III, University Hospital Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forni</LastName><ForeName>L G</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Department of Clinical and Experimental Medicine, Faculty of Health and Medical Sciences, University of Surrey and Surrey Perioperative Anaesthesia and Critical Care Collaborative Research Group (SPACeR), Intensive Care Unit, Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford, GU2 7XX, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Groeneveld</LastName><ForeName>A B J</ForeName><Initials>ABJ</Initials></Author><Author ValidYN="Y"><LastName>Honore</LastName><ForeName>P M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoste</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Ghent University Hospital, Ghent University, De Pintelaan 185, 9000, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostermann</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Critical Care and Nephrology, Guy's and St Thomas' Hospital, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oudemans-van Straaten</LastName><ForeName>H M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Adult Intensive Care, VU University Medical Centre, De Boelelaan 1118, 1081 HZ, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schetz</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Department and Laboratory of Intensive Care Medicine, Division of Cellular and Molecular Medicine, KU Leuven University, Leuven, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Intensive Care Med</MedlineTA><NlmUniqueID>7704851</NlmUniqueID><ISSNLinking>0342-4642</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N">Europe</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="Y">Practice Guidelines as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Prevention</Keyword><Keyword MajorTopicYN="N">Recommendations</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword><Keyword MajorTopicYN="N">Vasopressors</Keyword><Keyword MajorTopicYN="N">Volume expansion</Keyword></KeywordList><CoiStatement>MJ has received honoraria or research support from Baxter Healthcare Corp, AM-Pharma, CLS Behring, Fresenius and Astute Medical. WD declares no conflicts of interest. LF has received honoraria and research support from Astute Medical, Fresenius, Baxter Gambro Renal and Orthoclinical Diagnostics. PH had received research grants from Baxter, AM Pharma, Bellco, and Pfizer EH received speaker&#x2019;s fees from Alexion and Astute Medical, and a research grant from Bellco. MO has received honoraria and research funding from Fresenius Medical Care and Baxter Gambro. HO has financial congress support from Dirinco (Netherlands) and speaker&#x2019;s honoraria from Fresenius and Gambro/Baxter. MS declares no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>6</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28577069</ArticleId><ArticleId IdType="pmc">PMC5487598</ArticleId><ArticleId IdType="doi">10.1007/s00134-017-4832-y</ArticleId><ArticleId IdType="pii">10.1007/s00134-017-4832-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chertow GM, Burdick E, Honour M. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16:3365&#x2013;3370. doi: 10.1681/ASN.2004090740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2004090740</ArticleId><ArticleId IdType="pubmed">16177006</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1&#x2013;138. doi: 10.1038/kisup.2012.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/kisup.2012.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Kane-Gill SL, Sileanu FE, Murugan R, Trietley GS, Handler SM, Kellum JA. Risk factors for acute kidney injury in older adults with critical illness: a retrospective cohort study. Am J Kidney Dis. 2015;65:860&#x2013;869. doi: 10.1053/j.ajkd.2014.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2014.10.018</ArticleId><ArticleId IdType="pmc">PMC4442750</ArticleId><ArticleId IdType="pubmed">25488106</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirwan CJ, Blunden MJ, Dobbie H, James A, Nedungadi A, Prowle JR. Critically ill patients requiring acute renal replacement therapy are at an increased risk of long-term renal dysfunction, but rarely receive specialist nephrology follow-up. Nephron. 2015;129:164&#x2013;170. doi: 10.1159/000371448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000371448</ArticleId><ArticleId IdType="pubmed">25765730</ArticleId></ArticleIdList></Reference><Reference><Citation>Joannidis M, Metnitz B, Bauer P, Schusterschitz N, Moreno R, Druml W, Metnitz PG. Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med. 2009;35:1692&#x2013;1702. doi: 10.1007/s00134-009-1530-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-009-1530-4</ArticleId><ArticleId IdType="pubmed">19547955</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, Honore PM, Joannes-Boyau O, Joannidis M, Korhonen AM, Lavrentieva A, Mehta RL, Palevsky P, Roessler E, Ronco C, Uchino S, Vazquez JA, Vidal Andrade E, Webb S, Kellum JA. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41:1411&#x2013;1423. doi: 10.1007/s00134-015-3934-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3934-7</ArticleId><ArticleId IdType="pubmed">26162677</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccinni P, Cruz DN, Gramaticopolo S, Garzotto F, Dal Santo M, Aneloni G, Rocco M, Alessandri E, Giunta F, Michetti V, Iannuzzi M, Belluomo Anello C, Brienza N, Carlini M, Pelaia P, Gabbanelli V, Ronco C, Investigators N. Prospective multicenter study on epidemiology of acute kidney injury in the ICU: a critical care nephrology Italian collaborative effort (NEFROINT) Minerva Anestesiol. 2011;77:1072&#x2013;1083.</Citation><ArticleIdList><ArticleId IdType="pubmed">21597441</ArticleId></ArticleIdList></Reference><Reference><Citation>Srisawat N, Sileanu FE, Murugan R, Bellomod R, Calzavacca P, Cartin-Ceba R, Cruz D, Finn J, Hoste EE, Kashani K, Ronco C, Webb S, Kellum JA, Acute Kidney Injury-6 Study Group Variation in risk and mortality of acute kidney injury in critically ill patients: a multicenter study. Am J Nephrol. 2015;41:81&#x2013;88. doi: 10.1159/000371748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000371748</ArticleId><ArticleId IdType="pubmed">25677982</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell S, Dekker FW, Vadiveloo T, Marwick C, Deshmukh H, Donnan PT, Van Diepen M. Risk of postoperative acute kidney injury in patients undergoing orthopaedic surgery&#x2013;development and validation of a risk score and effect of acute kidney injury on survival: observational cohort study. BMJ. 2015;351:h5639. doi: 10.1136/bmj.h5639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h5639</ArticleId><ArticleId IdType="pmc">PMC4641433</ArticleId><ArticleId IdType="pubmed">26561522</ArticleId></ArticleIdList></Reference><Reference><Citation>Joannidis M, Druml W, Forni LG, Groeneveld AB, Honore P, Oudemans-van Straaten HM, Ronco C, Schetz MR, Woittiez AJ, Critical Care Nephrology Working Group of the European Society of Intensive Care Medicine Prevention of acute kidney injury and protection of renal function in the intensive care unit. Expert opinion of the Working Group for Nephrology, ESICM. Intensive Care Med. 2010;36:392&#x2013;411. doi: 10.1007/s00134-009-1678-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-009-1678-y</ArticleId><ArticleId IdType="pubmed">19921152</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichai C, Vinsonneau C, Souweine B, Armando F, Canet E, Clec&#x2019;h C, Constantin JM, Darmon M, Duranteau J, Gaillot T, Garnier A, Jacob L, Joannes-Boyau O, Juillard L, Journois D, Lautrette A, Muller L, Legrand M, Lerolle N, Rimmele T, Rondeau E, Tamion F, Walrave Y, Velly L, Soci&#xe9;t&#xe9; fran&#xe7;aise d&#x2019;anesth&#xe9;sie et de r&#xe9;animation (Sfar) Soci&#xe9;t&#xe9; de r&#xe9;animation de langue fran&#xe7;aise (SRLF) Groupe francophone de r&#xe9;animation et urgences p&#xe9;diatriques (GFRUP) Soci&#xe9;t&#xe9; fran&#xe7;aise de n&#xe9;phrologie (SFN) Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies) Ann Intensive Care. 2016;6:48. doi: 10.1186/s13613-016-0145-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-016-0145-5</ArticleId><ArticleId IdType="pmc">PMC4882312</ArticleId><ArticleId IdType="pubmed">27230984</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schunemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924&#x2013;926. doi: 10.1136/bmj.39489.470347.AD.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, Alderson P, Glasziou P, Falck-Ytter Y, Schunemann HJ. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. 2011;64:395&#x2013;400. doi: 10.1016/j.jclinepi.2010.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.09.012</ArticleId><ArticleId IdType="pubmed">21194891</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Schunemann HJ, Djulbegovic B, Akl EA. Guideline panels should not GRADE good practice statements. J Clin Epidemiol. 2015;68:597&#x2013;600. doi: 10.1016/j.jclinepi.2014.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2014.12.011</ArticleId><ArticleId IdType="pubmed">25660962</ArticleId></ArticleIdList></Reference><Reference><Citation>de Mendonca A, Vincent JL, Suter PM, Moreno R, Dearden NM, Antonelli M, Takala J, Sprung C, Cantraine F. Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med. 2000;26:915&#x2013;921. doi: 10.1007/s001340051281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001340051281</ArticleId><ArticleId IdType="pubmed">10990106</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerin C, Girard R, Selli JM, Perdrix JP, Ayzac L. Initial versus delayed acute renal failure in the intensive care unit. A multicenter prospective epidemiological study. Rhone-Alpes Area Study Group on Acute Renal Failure. Am J Respir Crit Care Med. 2000;161:872&#x2013;879. doi: 10.1164/ajrccm.161.3.9809066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.161.3.9809066</ArticleId><ArticleId IdType="pubmed">10712336</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwilk B, Wiedeck H, Stein B, Reinelt H, Treiber H, Bothner U. Epidemiology of acute renal failure and outcome of haemodiafiltration in intensive care. Intensive Care Med. 1997;23:1204&#x2013;1211. doi: 10.1007/s001340050487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001340050487</ArticleId><ArticleId IdType="pubmed">9470074</ArticleId></ArticleIdList></Reference><Reference><Citation>Himmelfarb J, Joannidis M, Molitoris B, Schietz M, Okusa MD, Warnock D, Laghi F, Goldstein SL, Prielipp R, Parikh CR, Pannu N, Lobo SM, Shah S, D&#x2019;Intini V, Kellum JA. Evaluation and initial management of acute kidney injury. Clin J Am Soc Nephrol. 2008;3:962&#x2013;967. doi: 10.2215/CJN.04971107.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.04971107</ArticleId><ArticleId IdType="pmc">PMC2440262</ArticleId><ArticleId IdType="pubmed">18354074</ArticleId></ArticleIdList></Reference><Reference><Citation>Joannidis M. Drug-induced renal failure in the ICU. Int J Artif Organs. 2004;27:1034&#x2013;1042.</Citation><ArticleIdList><ArticleId IdType="pubmed">15645613</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43:304&#x2013;377. doi: 10.1007/s00134-017-4683-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-4683-6</ArticleId><ArticleId IdType="pubmed">28101605</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Kirwan CJ, Bellomo R. Fluid management for the prevention and attenuation of acute kidney injury. Nat Rev Nephrol. 2014;10:37&#x2013;47. doi: 10.1038/nrneph.2013.232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2013.232</ArticleId><ArticleId IdType="pubmed">24217464</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostermann M, Straaten HM, Forni LG. Fluid overload and acute kidney injury: cause or consequence? Crit Care. 2015;19:443. doi: 10.1186/s13054-015-1163-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-1163-7</ArticleId><ArticleId IdType="pmc">PMC4699346</ArticleId><ArticleId IdType="pubmed">26707872</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Chawla LS, Keener C, Singbartl K, Palevsky PM, Pike FL, Yealy DM, Huang DT, Angus DC, ProCESS and ProGReSS-AKI Investigators The effects of alternative resuscitation strategies on acute kidney injury in patients with septic shock. Am J Respir Crit Care Med. 2016;193:281&#x2013;287. doi: 10.1164/rccm.201505-0995OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201505-0995OC</ArticleId><ArticleId IdType="pmc">PMC4803059</ArticleId><ArticleId IdType="pubmed">26398704</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and Plasma-lyte&#xae; 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2012;256:18&#x2013;24. doi: 10.1097/SLA.0b013e318256be72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e318256be72</ArticleId><ArticleId IdType="pubmed">22580944</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkes NJ, Woolf R, Mutch M, Mallett SV, Peachey T, Stephens R, Mythen MG. The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg. 2001;93:811&#x2013;816. doi: 10.1097/00000539-200110000-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-200110000-00003</ArticleId><ArticleId IdType="pubmed">11574338</ArticleId></ArticleIdList></Reference><Reference><Citation>Alphonsus CS, Rodseth RN. The endothelial glycocalyx: a review of the vascular barrier. Anaesthesia. 2014;69:777&#x2013;784. doi: 10.1111/anae.12661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.12661</ArticleId><ArticleId IdType="pubmed">24773303</ArticleId></ArticleIdList></Reference><Reference><Citation>Chappell D, Jacob M. Role of the glycocalyx in fluid management: small things matter. Best Pract Res Clin Anaesthesiol. 2014;28:227&#x2013;234. doi: 10.1016/j.bpa.2014.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2014.06.003</ArticleId><ArticleId IdType="pubmed">25208958</ArticleId></ArticleIdList></Reference><Reference><Citation>Perner A, Prowle JR, Joannidis M, Young P, Hjortrup PB, Pettil&#xe4; V (2017) Fluid management in acute kidney injury. Intensive Care Med. doi:10.1007/s00134-017-4817-x</Citation><ArticleIdList><ArticleId IdType="pubmed">28470347</ArticleId></ArticleIdList></Reference><Reference><Citation>Horgan KJ, Ottaviano YL, Watson AJ. Acute renal-failure due to mannitol intoxication. Am J Nephrol. 1989;9:106&#x2013;109. doi: 10.1159/000167946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000167946</ArticleId><ArticleId IdType="pubmed">2500855</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozich JD, Paul RV. Acute renal failure precipitated by elevated colloid osmotic pressure. Am J Med. 1989;87:359&#x2013;360. doi: 10.1016/S0002-9343(89)80171-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(89)80171-8</ArticleId><ArticleId IdType="pubmed">2773975</ArticleId></ArticleIdList></Reference><Reference><Citation>Legendre C, Thervet E, Page B, Percheron A, Noel LH, Kreis H. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet. 1993;342:248&#x2013;249. doi: 10.1016/0140-6736(93)92345-T.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0140-6736(93)92345-T</ArticleId><ArticleId IdType="pubmed">7686994</ArticleId></ArticleIdList></Reference><Reference><Citation>Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet. 1996;348:1620&#x2013;1622. doi: 10.1016/S0140-6736(96)07588-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(96)07588-5</ArticleId><ArticleId IdType="pubmed">8961992</ArticleId></ArticleIdList></Reference><Reference><Citation>Skinsnes OK. Gelatin nephrosis; renal tissue changes in man resulting from the intravenous administration of gelatin. Surg Gynecol Obstetri. 1947;85:563&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pubmed">20266769</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyer R, Harmening U, Rittmeyer O, Zielmann S, Mielck F, Kazmaier S, Kettler D. Use of modified fluid gelatin and hydroxyethyl starch for colloidal volume replacement in major orthopaedic surgery. Brit J Anaesth. 1997;78:44&#x2013;50. doi: 10.1093/bja/78.1.44.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/78.1.44</ArticleId><ArticleId IdType="pubmed">9059203</ArticleId></ArticleIdList></Reference><Reference><Citation>Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet. 2001;357:911&#x2013;916. doi: 10.1016/S0140-6736(00)04211-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(00)04211-2</ArticleId><ArticleId IdType="pubmed">11289347</ArticleId></ArticleIdList></Reference><Reference><Citation>Mardel SN, Saunders FM, Allen H, Menezes G, Edwards CM, Ollerenshaw L, Baddeley D, Kennedy A, Ibbotson RM. Reduced quality of clot formation with gelatin-based plasma substitutes. Br J Anaesth. 1998;80:204&#x2013;207. doi: 10.1093/bja/80.2.204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/80.2.204</ArticleId><ArticleId IdType="pubmed">9602586</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabuchi N, deHaan J, Huet RCGG, Boonstra PW, vanOeveren W. Gelatin use impairs platelet adhesion during cardiac surgery. Thromb Haemostasis. 1995;74:1447&#x2013;1451.</Citation><ArticleIdList><ArticleId IdType="pubmed">8772218</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurnik BR, Singer F, Groh WC. Case report: dextran-induced acute anuric renal failure. Am J Med Sci. 1991;302:28&#x2013;30. doi: 10.1097/00000441-199107000-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000441-199107000-00007</ArticleId><ArticleId IdType="pubmed">1712152</ArticleId></ArticleIdList></Reference><Reference><Citation>Laxenaire MC, Charpentier C, Feldman L. Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study. Ann Fr Anesth Reanim. 1994;13:301&#x2013;310. doi: 10.1016/S0750-7658(94)80038-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0750-7658(94)80038-3</ArticleId><ArticleId IdType="pubmed">7992937</ArticleId></ArticleIdList></Reference><Reference><Citation>Mailloux L, Swartz CD, Capizzi R, Kim KE, Onesti G, Ramirez O, Brest AN. Acute renal failure after administration of low-molecular weight dextran. N Engl J Med. 1967;277:1113&#x2013;1118. doi: 10.1056/NEJM196711232772103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM196711232772103</ArticleId><ArticleId IdType="pubmed">6054998</ArticleId></ArticleIdList></Reference><Reference><Citation>Messmer KFW. The use of plasma substitutes with special attention to their side-effects. World J Surg. 1987;11:69&#x2013;74. doi: 10.1007/BF01658463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01658463</ArticleId><ArticleId IdType="pubmed">3544523</ArticleId></ArticleIdList></Reference><Reference><Citation>Fliser D, Zurbruggen I, Mutschler E, Bischoff I, Nussberger J, Franek E, Ritz E. Coadministration of albumin and furosemide in patients with the nephrotic syndrome. Kidney Int. 1999;55:629&#x2013;634. doi: 10.1046/j.1523-1755.1999.00298.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1523-1755.1999.00298.x</ArticleId><ArticleId IdType="pubmed">9987087</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue M, Okajima K, Itoh K, Ando Y, Watanabe N, Yasaka T, Nagase S, Morino Y. Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients. Kidney Int. 1987;32(2):198&#x2013;203. doi: 10.1038/ki.1987.192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.1987.192</ArticleId><ArticleId IdType="pubmed">3656933</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedermann CJ, Dunzendorfer S, Gaioni LU, Zaraca F, Joannidis M. Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials. Crit Care. 2010;14:R191. doi: 10.1186/cc9308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9308</ArticleId><ArticleId IdType="pmc">PMC3219298</ArticleId><ArticleId IdType="pubmed">21029460</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedermann CJ, Joannidis M. Nephroprotective potential of human albumin infusion: a narrative review. Gastroenterol Res Pract. 2015;2015:912839. doi: 10.1155/2015/912839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/912839</ArticleId><ArticleId IdType="pmc">PMC4475554</ArticleId><ArticleId IdType="pubmed">26136776</ArticleId></ArticleIdList></Reference><Reference><Citation>Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R, SAFE Study Investigators A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247&#x2013;2256. doi: 10.1056/NEJMoa040232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa040232</ArticleId><ArticleId IdType="pubmed">15163774</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, Early Goal-Directed Therapy Collaborative Group Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368&#x2013;1377. doi: 10.1056/NEJMoa010307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa010307</ArticleId><ArticleId IdType="pubmed">11794169</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano AB, Candela-Toha AM, Zamora J, Vera J, Muriel A, Del Rey JM, Liano F. Preoperative hydration with 0.9% normal saline to prevent acute kidney injury after major elective open abdominal surgery: a randomised controlled trial. Eur J Anaesthesiol. 2016;33:436&#x2013;443. doi: 10.1097/EJA.0000000000000421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000421</ArticleId><ArticleId IdType="pubmed">26825017</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjortrup PB, Haase N, Bundgaard H, Thomsen SL, Winding R, Pettila V, Aaen A, Lodahl D, Berthelsen RE, Christensen H, Madsen MB, Winkel P, Wetterslev J, Perner A, CLASSIC Trial Group. Scandinavian Critical Care Trials Group Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial. Intensive Care Med. 2016;42:1695&#x2013;1705. doi: 10.1007/s00134-016-4500-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4500-7</ArticleId><ArticleId IdType="pubmed">27686349</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012;308:1566&#x2013;1572. doi: 10.1001/jama.2012.13356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.13356</ArticleId><ArticleId IdType="pubmed">23073953</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw AD, Raghunathan K, Peyerl FW, Munson SH, Paluszkiewicz SM, Schermer CR. Association between intravenous chloride load during resuscitation and in-hospital mortality among patients with SIRS. Intensive Care Med. 2014;40:1897&#x2013;1905. doi: 10.1007/s00134-014-3505-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-014-3505-3</ArticleId><ArticleId IdType="pmc">PMC4239799</ArticleId><ArticleId IdType="pubmed">25293535</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Lameire N, KDIGO AKI Guideline Work Group Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1) Crit Care. 2013;17:204. doi: 10.1186/cc11454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11454</ArticleId><ArticleId IdType="pmc">PMC4057151</ArticleId><ArticleId IdType="pubmed">23394211</ArticleId></ArticleIdList></Reference><Reference><Citation>Young P, Bailey M, Beasley R, Henderson S, Mackle D, McArthur C, McGuinness S, Mehrtens J, Myburgh J, Psirides A, Reddy S, Bellomo R. Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the SPLIT randomized clinical trial. JAMA. 2015;314:1701&#x2013;1710. doi: 10.1001/jama.2015.12334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.12334</ArticleId><ArticleId IdType="pubmed">26444692</ArticleId></ArticleIdList></Reference><Reference><Citation>Joannidis M, Forni LG. Acute kidney injury: buffered crystalloids or saline in the ICU&#x2014;a SPLIT decision. Nat Rev Nephrol. 2016;12:6&#x2013;8. doi: 10.1038/nrneph.2015.190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2015.190</ArticleId><ArticleId IdType="pubmed">26592191</ArticleId></ArticleIdList></Reference><Reference><Citation>Semler MW, Wanderer JP, Ehrenfeld JM, Stollings JL, Self WH, Siew ED, Wang L, Byrne DW, Shaw AD, Bernard GR, Rice TW, SALT Investigators and the Pragmatic Critical Care Research Group (2017) Balanced crystalloids versus saline in the intensive care unit: the SALT randomized trial. Am J Respir Crit Care Med. doi: 10.1164/rccm.201607-1345OC</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5443900</ArticleId><ArticleId IdType="pubmed">27749094</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase M, Haase-Fielitz A, Bellomo R, Devarajan P, Story D, Matalanis G, Reade MC, Bagshaw SM, Seevanayagam N, Seevanayagam S, Doolan L, Buxton B, Dragun D. Sodium bicarbonate to prevent increases in serum creatinine after cardiac surgery: a pilot double-blind, randomized controlled trial. Crit Care Med. 2009;37:39&#x2013;47. doi: 10.1097/CCM.0b013e318193216f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318193216f</ArticleId><ArticleId IdType="pubmed">19112278</ArticleId></ArticleIdList></Reference><Reference><Citation>McGuinness SP, Parke RL, Bellomo R, Van Haren FM, Bailey M. Sodium bicarbonate infusion to reduce cardiac surgery-associated acute kidney injury: a phase II multicenter double-blind randomized controlled trial. Crit Care Med. 2013;41:1599&#x2013;1607. doi: 10.1097/CCM.0b013e31828a3f99.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31828a3f99</ArticleId><ArticleId IdType="pubmed">23685640</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristeller JL, Zavorsky GS, Prior JE, Keating DA, Brady MA, Romaldini TA, Hickman TL, Stahl RF. Lack of effectiveness of sodium bicarbonate in preventing kidney injury in patients undergoing cardiac surgery: a randomized controlled trial. Pharmacotherapy. 2013;33:710&#x2013;717. doi: 10.1002/phar.1262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/phar.1262</ArticleId><ArticleId IdType="pubmed">23553549</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase M, Haase-Fielitz A, Plass M, Kuppe H, Hetzer R, Hannon C, Murray PT, Bailey MJ, Bellomo R, Bagshaw SM. Prophylactic perioperative sodium bicarbonate to prevent acute kidney injury following open heart surgery: a multicenter double-blinded randomized controlled trial. PLoS Med. 2013;10:e1001426. doi: 10.1371/journal.pmed.1001426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001426</ArticleId><ArticleId IdType="pmc">PMC3627643</ArticleId><ArticleId IdType="pubmed">23610561</ArticleId></ArticleIdList></Reference><Reference><Citation>Tie HT, Luo MZ, Luo MJ, Zhang M, Wu QC, Wan JY. Sodium bicarbonate in the prevention of cardiac surgery-associated acute kidney injury: a systematic review and meta-analysis. Crit Care. 2014;18:517. doi: 10.1186/s13054-014-0517-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0517-x</ArticleId><ArticleId IdType="pmc">PMC4177432</ArticleId><ArticleId IdType="pubmed">25212718</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian ML, Hu Y, Yuan J, Zha Y. Efficacy and safety of perioperative sodium bicarbonate therapy for cardiac surgery-associated acute kidney injury: a meta-analysis. J Cardiovasc Pharmacol. 2015;65:130&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pubmed">25264756</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JH, Kim HJ, Kim JY, Ahn H, Ahn IM, Choe WJ, Lim CH. Meta-analysis of sodium bicarbonate therapy for prevention of cardiac surgery-associated acute kidney injury. J Cardiothorac Vasc Anesth. 2015;29:1248&#x2013;1256. doi: 10.1053/j.jvca.2015.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2015.03.007</ArticleId><ArticleId IdType="pubmed">26119410</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey M, McGuinness S, Haase M, Haase-Fielitz A, Parke R, Hodgson CL, Forbes A, Bagshaw SM, Bellomo R. Sodium bicarbonate and renal function after cardiac surgery: a prospectively planned individual patient meta-analysis. Anesthesiology. 2015;122:294&#x2013;306. doi: 10.1097/ALN.0000000000000547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000547</ArticleId><ArticleId IdType="pubmed">25501691</ArticleId></ArticleIdList></Reference><Reference><Citation>Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SA, CHEST Investigators. Australian and New Zealand Intensive Care Society Clinical Trials Group Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901&#x2013;1911. doi: 10.1056/NEJMoa1209759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1209759</ArticleId><ArticleId IdType="pubmed">23075127</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, German Competence Network Sepsis (SepNet) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125&#x2013;139. doi: 10.1056/NEJMoa070716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa070716</ArticleId><ArticleId IdType="pubmed">18184958</ArticleId></ArticleIdList></Reference><Reference><Citation>Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Aneman A, Madsen KR, Moller MH, Elkjaer JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Soe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjaeldgaard AL, Fabritius ML, Mondrup F, Pott FC, Moller TP, Winkel P, Wetterslev J, 6S Trial Group. Scandinavian Critical Care Trials Group Hydroxyethyl starch 130/0.42 versus Ringer&#x2019;s acetate in severe sepsis. N Engl J Med. 2012;367:124&#x2013;134. doi: 10.1056/NEJMoa1204242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1204242</ArticleId><ArticleId IdType="pubmed">22738085</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattas DJ, Dan A, Myburgh J, Billot L, Lo S, Finfer S, CHEST Management Committee Fluid resuscitation with 6% hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Med. 2013;39:558&#x2013;568. doi: 10.1007/s00134-013-2840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-013-2840-0</ArticleId><ArticleId IdType="pubmed">23407978</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarychanski R, Abou-Setta AM, Turgeon AF, Houston BL, McIntyre L, Marshall JC, Fergusson DA. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA. 2013;309:678&#x2013;688. doi: 10.1001/jama.2013.430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.430</ArticleId><ArticleId IdType="pubmed">23423413</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochwerg B, Alhazzani W, Gibson A, Ribic CM, Sindi A, Heels-Ansdell D, Thabane L, Fox-Robichaud A, Mbuagbaw L, Szczeklik W, Alshamsi F, Altayyar S, Ip W, Li G, Wang M, Wludarczyk A, Zhou Q, Annane D, Cook DJ, Jaeschke R, Guyatt GH. Fluid type and the use of renal replacement therapy in sepsis: a systematic review and network meta-analysis. Intensive Care Med. 2015;41:1561&#x2013;1571. doi: 10.1007/s00134-015-3794-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3794-1</ArticleId><ArticleId IdType="pubmed">25904181</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase N, Perner A, Hennings LI, Siegemund M, Lauridsen B, Wetterslev M, Wetterslev J. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ. 2013;346:f839. doi: 10.1136/bmj.f839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.f839</ArticleId><ArticleId IdType="pmc">PMC3573769</ArticleId><ArticleId IdType="pubmed">23418281</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutter TC, Ruth CA, Dart AB (2013) Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 7:CD007594. doi:10.1002/14651858.CD007594.pub3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11561698</ArticleId><ArticleId IdType="pubmed">23881659</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhart K, Perner A, Sprung CL, Jaeschke R, Schortgen F, Johan Groeneveld AB, Beale R, Hartog CS, European Society of Intensive Care Medicine Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med. 2012;38:368&#x2013;383. doi: 10.1007/s00134-012-2472-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-012-2472-9</ArticleId><ArticleId IdType="pubmed">22323076</ArticleId></ArticleIdList></Reference><Reference><Citation>Moeller C, Fleischmann C, Thomas-Rueddel D, Vlasakov V, Rochwerg B, Theurer P, Gattinoni L, Reinhart K, Hartog CS. How safe is gelatin? A systematic review and meta-analysis of gelatin-containing plasma expanders vs crystalloids and albumin. J Crit Care. 2016;35:75&#x2013;83. doi: 10.1016/j.jcrc.2016.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2016.04.011</ArticleId><ArticleId IdType="pubmed">27481739</ArticleId></ArticleIdList></Reference><Reference><Citation>Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, Fanizza C, Caspani L, Faenza S, Grasselli G, Iapichino G, Antonelli M, Parrini V, Fiore G, Latini R, Gattinoni L, ALBIOS Study Investigators Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370:1412&#x2013;1421. doi: 10.1056/NEJMoa1305727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1305727</ArticleId><ArticleId IdType="pubmed">24635772</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois MJ, Orellana-Jimenez C, Melot C, De Backer D, Berre J, Leeman M, Brimioulle S, Appoloni O, Creteur J, Vincent JL. Albumin administration improves organ function in critically ill hypoalbuminemic patients: a prospective, randomized, controlled, pilot study. Crit Care Med. 2006;34:2536&#x2013;2540. doi: 10.1097/01.CCM.0000239119.57544.0C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000239119.57544.0C</ArticleId><ArticleId IdType="pubmed">16915107</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedermann CJ, Joannidis M. Albumin replacement in severe sepsis or septic shock. N Engl J Med. 2014;371:83. doi: 10.1056/NEJMc1405675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1405675</ArticleId><ArticleId IdType="pubmed">24988572</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A, Laffan MA, Waheed U, Brett SJ. Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality. BMJ. 2014;349:g4561. doi: 10.1136/bmj.g4561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.g4561</ArticleId><ArticleId IdType="pmc">PMC4106199</ArticleId><ArticleId IdType="pubmed">25099709</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EH, Kim WJ, Kim JY, Chin JH, Choi DK, Sim JY, Choo SJ, Chung CH, Lee JW, Choi IC. Effect of exogenous albumin on the incidence of postoperative acute kidney injury in patients undergoing off-pump coronary artery bypass surgery with a preoperative albumin level of less than 4.0&#xa0;g/dl. Anesthesiology. 2016;124:1001&#x2013;1011. doi: 10.1097/ALN.0000000000001051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001051</ArticleId><ArticleId IdType="pubmed">26891150</ArticleId></ArticleIdList></Reference><Reference><Citation>Pannu N, Nadim MK. An overview of drug-induced acute kidney injury. Crit Care Med. 2008;36:S216&#x2013;223. doi: 10.1097/CCM.0b013e318168e375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318168e375</ArticleId><ArticleId IdType="pubmed">18382197</ArticleId></ArticleIdList></Reference><Reference><Citation>Perazella MA, Luciano RL. Review of select causes of drug-induced AKI. Expert Rev Clin Pharmacol. 2015;8(4):367&#x2013;371. doi: 10.1586/17512433.2015.1045489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/17512433.2015.1045489</ArticleId><ArticleId IdType="pubmed">26109096</ArticleId></ArticleIdList></Reference><Reference><Citation>Branch RA. Prevention of amphotericin-B induced renal impairment. A review on the use of sodium supplementation. Arch Intern Med. 1988;148:2389&#x2013;2394. doi: 10.1001/archinte.1988.00380110049010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.1988.00380110049010</ArticleId><ArticleId IdType="pubmed">3056312</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung TW, Jayaweera DT, Pearce D, Benson P, Nahass R, Olson C, Wool GM. Safety of oral versus intravenous hydration during induction therapy with intravenous foscarnet in AIDS patients with cytomegalovirus infections. Int J STD AIDS. 2000;11:640&#x2013;647. doi: 10.1258/0956462001914995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/0956462001914995</ArticleId><ArticleId IdType="pubmed">11057934</ArticleId></ArticleIdList></Reference><Reference><Citation>Safrin S, Cherrington J, Jaffe HS. Cidofovir. Review of current and potential clinical uses. Adv Exp Med Biol. 1999;458:111&#x2013;120. doi: 10.1007/978-1-4615-4743-3_10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4615-4743-3_10</ArticleId><ArticleId IdType="pubmed">10549383</ArticleId></ArticleIdList></Reference><Reference><Citation>Perazella MA. Crystal-induced acute renal failure. Am J Med. 1999;106:459&#x2013;465. doi: 10.1016/S0002-9343(99)00041-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(99)00041-8</ArticleId><ArticleId IdType="pubmed">10225250</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon R, Werner C, Mann D, D&#x2019;Elia J, Silva P. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 1994;331:1416&#x2013;1420. doi: 10.1056/NEJM199411243312104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199411243312104</ArticleId><ArticleId IdType="pubmed">7969280</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, Marsch S, Roskamm H. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med. 2002;162:329&#x2013;336. doi: 10.1001/archinte.162.3.329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.162.3.329</ArticleId><ArticleId IdType="pubmed">11822926</ArticleId></ArticleIdList></Reference><Reference><Citation>Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, Bersin RM, Van Moore A, Simonton CA, 3rd, Rittase RA, Norton HJ, Kennedy TP. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA. 2004;291:2328&#x2013;2334. doi: 10.1001/jama.291.19.2328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.291.19.2328</ArticleId><ArticleId IdType="pubmed">15150204</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozcan EE, Guneri S, Akdeniz B, Akyildiz IZ, Senaslan O, Baris N, Aslan O, Badak O. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. Am Heart J. 2007;154:539&#x2013;544. doi: 10.1016/j.ahj.2007.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2007.05.012</ArticleId><ArticleId IdType="pubmed">17719303</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda M, Yamada T, Mine T, Morita T, Tamaki S, Tsukamoto Y, Okuda K, Iwasaki Y, Hori M, Fukunami M. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure. Am J Cardiol. 2007;100:781&#x2013;786. doi: 10.1016/j.amjcard.2007.03.098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2007.03.098</ArticleId><ArticleId IdType="pubmed">17719320</ArticleId></ArticleIdList></Reference><Reference><Citation>Briguori C, Airoldi F, D&#x2019;Andrea D, Bonizzoni E, Morici N, Focaccio A, Michev I, Montorfano M, Carlino M, Cosgrave J, Ricciardelli B, Colombo A. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation. 2007;115:1211&#x2013;1217.</Citation><ArticleIdList><ArticleId IdType="pubmed">17309916</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen EC, Rennenberg RJ, Nelemans PJ, Essers BA, Janssen MM, Vermeeren MA, Ommen VV, Wildberger JE. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet. 2017;389:1312&#x2013;1322. doi: 10.1016/S0140-6736(17)30057-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)30057-0</ArticleId><ArticleId IdType="pubmed">28233565</ArticleId></ArticleIdList></Reference><Reference><Citation>Newhouse JH, Kho D, Rao QA, Starren J. Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol. 2008;191:376&#x2013;382. doi: 10.2214/AJR.07.3280.</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/AJR.07.3280</ArticleId><ArticleId IdType="pubmed">18647905</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilhelm-Leen E, Montez-Rath ME, Chertow G. Estimating the risk of radiocontrast-associated nephropathy. J Am Soc Nephrol. 2017;28:653&#x2013;659. doi: 10.1681/ASN.2016010021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2016010021</ArticleId><ArticleId IdType="pmc">PMC5280012</ArticleId><ArticleId IdType="pubmed">27688297</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EA, Doom S, De Waele J, Delrue LJ, Defreyne L, Benoit DD, Decruyenaere J. Epidemiology of contrast-associated acute kidney injury in ICU patients: a retrospective cohort analysis. Intensive Care Med. 2011;37:1921&#x2013;1931. doi: 10.1007/s00134-011-2389-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-011-2389-8</ArticleId><ArticleId IdType="pubmed">22048719</ArticleId></ArticleIdList></Reference><Reference><Citation>Cely CM, Schein RM, Quartin AA. Risk of contrast induced nephropathy in the critically ill: a prospective, case matched study. Crit Care. 2012;16:R67. doi: 10.1186/cc11317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11317</ArticleId><ArticleId IdType="pmc">PMC3681396</ArticleId><ArticleId IdType="pubmed">22534554</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrmann S, Badin J, Savath L, Pajot O, Garot D, Pham T, Capdevila X, Perrotin D, Lakhal K. Acute kidney injury in the critically ill: is iodinated contrast medium really harmful? Crit Care Med. 2013;41:1017&#x2013;1026. doi: 10.1097/CCM.0b013e318275871a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318275871a</ArticleId><ArticleId IdType="pubmed">23324952</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald JS, McDonald RJ, Williamson EE, Kallmes DF, Kashani K (2017) Post-contrast acute kidney injury in intensive care unit patients: a propensity score-adjusted study. Intensive Care Med. doi:10.1007/s00134-017-4699-y</Citation><ArticleIdList><ArticleId IdType="pubmed">28213620</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinson JS, Ehmann MR, Fine DM, Fishman EK, Toerper MF, Rothman RE, Klein EY (2017) Risk of acute kidney injury after intravenous contrast media administration. Ann Emerg Med 69:577&#x2013;586.e4</Citation><ArticleIdList><ArticleId IdType="pubmed">28131489</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrmann S, Quartin A, Hobbs BP, Robert-Edan V, Cely C, Bell C, Lyons G, Pham T, Schein R, Geng Y, Lakhal K, Ng CS (2017) Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis. Intensive Care Med. doi:10.1007/s00134-017-4700-9</Citation><ArticleIdList><ArticleId IdType="pubmed">28197679</ArticleId></ArticleIdList></Reference><Reference><Citation>Valette X, Desmeulles I, Savary B, Masson R, Seguin A, Sauneuf B, Brunet J, Verrier P, Pottier V, Orabona M, Samba D, Viquesnel G, Lermuzeaux M, Hazera P, Dutheil JJ, Hanouz JL, Parienti JJ, du Cheyron D. Sodium bicarbonate versus sodium chloride for preventing contrast-associated acute kidney injury in critically ill patients: a randomized controlled trial. Crit Care Med. 2017;45:637&#x2013;644. doi: 10.1097/CCM.0000000000002267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002267</ArticleId><ArticleId IdType="pubmed">28181941</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Li H, Chen S, Chen J, Tan N, Zhou Y, Liu Y, Ye P, Ran P, Duan C, Chen P (2016) Excessively high hydration volume may not be associated with decreased risk of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with renal insufficiency. J Am Heart Assoc. doi:10.1161/JAHA.115.003171</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4937263</ArticleId><ArticleId IdType="pubmed">27233298</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagshaw SM, Delaney A, Jones D, Ronco C, Bellomo R. Diuretics in the management of acute kidney injury: a multinational survey. Contrib Nephrol. 2007;156:236&#x2013;249. doi: 10.1159/000102089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000102089</ArticleId><ArticleId IdType="pubmed">17464133</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayati A, Nygren K, Kallskog O, Wolgast M. The effect of loop diuretics on the long-term outcome of post-ischaemic acute renal failure in the rat. Acta Physiol Scand. 1990;139:271&#x2013;279. doi: 10.1111/j.1748-1716.1990.tb08924.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1748-1716.1990.tb08924.x</ArticleId><ArticleId IdType="pubmed">2368616</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyman SN, Rosen S, Epstein FH, Spokes K, Brezis ML. Loop diuretics reduce hypoxic damage to proximal tubules of the isolated perfused rat kidney. Kidney Int. 1994;45:981&#x2013;985. doi: 10.1038/ki.1994.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.1994.132</ArticleId><ArticleId IdType="pubmed">8007601</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer HJ, Schuurmann J, Wassermann C, Dusing R. Prostaglandin-independent protection by furosemide from oliguric ischemic renal failure in conscious rats. Kidney Int. 1980;17:455&#x2013;464. doi: 10.1038/ki.1980.53.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.1980.53</ArticleId><ArticleId IdType="pubmed">7392420</ArticleId></ArticleIdList></Reference><Reference><Citation>Legrand M, Dupuis C, Simon C, Gayat E, Mateo J, Lukaszewicz AC, Payen D. Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: a retrospective observational study. Crit Care. 2013;17:R278. doi: 10.1186/cc13133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13133</ArticleId><ArticleId IdType="pmc">PMC4056656</ArticleId><ArticleId IdType="pubmed">24289206</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen KP, Cavender S, Lee J, Feng M, Mark RG, Celi LA, Mukamal KJ, Danziger J. Peripheral edema, central venous pressure, and risk of AKI in critical illness. Clinic J Am Soc Nephrol. 2016;11:602&#x2013;608. doi: 10.2215/CJN.08080715.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.08080715</ArticleId><ArticleId IdType="pmc">PMC4822669</ArticleId><ArticleId IdType="pubmed">26787777</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu YF, Zheng YP, Zhang N, Liu H, Zheng QX, Yang FT, Wu YF. Study on the correlation between the changes in intra-abdominal pressure and renal functional in the patients with abdominal compartment syndrome. Eur Rev Med Pharmacol Sci. 2015;19:3682&#x2013;3687.</Citation><ArticleIdList><ArticleId IdType="pubmed">26502858</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordemans C, De Laet I, Van Regenmortel N, Schoonheydt K, Dits H, Huber W, Malbrain ML. Fluid management in critically ill patients: the role of extravascular lung water, abdominal hypertension, capillary leak, and fluid balance. Ann Intensive Care. 2012;2:S1. doi: 10.1186/2110-5820-2-S1-S1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2110-5820-2-S1-S1</ArticleId><ArticleId IdType="pmc">PMC3390304</ArticleId><ArticleId IdType="pubmed">22873410</ArticleId></ArticleIdList></Reference><Reference><Citation>Chawla LS, Davison DL, Brasha-Mitchell E, Koyner JL, Arthur JM, Shaw AD, Tumlin JA, Trevino SA, Kimmel PL, Seneff MG. Development and standardization of a furosemide stress test to predict the severity of acute kidney injury. Crit Care. 2013;17:R207. doi: 10.1186/cc13015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13015</ArticleId><ArticleId IdType="pmc">PMC4057505</ArticleId><ArticleId IdType="pubmed">24053972</ArticleId></ArticleIdList></Reference><Reference><Citation>National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF, Jr, Hite RD, Harabin AL. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354:2564&#x2013;2575. doi: 10.1056/NEJMoa062200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa062200</ArticleId><ArticleId IdType="pubmed">16714767</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol. 2000;11:97&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">10616845</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown CB, Ogg CS, Cameron JS. High dose frusemide in acute renal failure: a controlled trial. Clin Nephrol. 1981;15:90&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">7011622</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho KM, Power BM. Benefits and risks of furosemide in acute kidney injury. Anaesthesia. 2010;65:283&#x2013;293. doi: 10.1111/j.1365-2044.2009.06228.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2009.06228.x</ArticleId><ArticleId IdType="pubmed">20085566</ArticleId></ArticleIdList></Reference><Reference><Citation>Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO, Anstrom KJ, Hernandez AF, McNulty SE, Velazquez EJ, Kfoury AG, Chen HH, Givertz MM, Semigran MJ, Bart BA, Mascette AM, Braunwald E, O&#x2019;Connor CM, NHLBI Heart Failure Clinical Research Network Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011;364:797&#x2013;805. doi: 10.1056/NEJMoa1005419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1005419</ArticleId><ArticleId IdType="pmc">PMC3412356</ArticleId><ArticleId IdType="pubmed">21366472</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotter G, Weissgarten J, Metzkor E, Moshkovitz Y, Litinski I, Tavori U, Perry C, Zaidenstein R, Golik A. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure. Clin Pharmacol Ther. 1997;62:187&#x2013;193. doi: 10.1016/S0009-9236(97)90067-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0009-9236(97)90067-9</ArticleId><ArticleId IdType="pubmed">9284855</ArticleId></ArticleIdList></Reference><Reference><Citation>Hager B, Betschart M, Krapf R. Effect of postoperative intravenous loop diuretic on renal function after major surgery. Schweiz Med Wochenschr. 1996;126:666&#x2013;673.</Citation><ArticleIdList><ArticleId IdType="pubmed">8658094</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Voort PHJ, Boerma EC, Koopmans M, Zandberg M, de Ruiter J, Gerritsen RT, Egbers PH, Kingma WP, Kuiper MA. Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: a double blind randomized controlled trial. Crit Care Med. 2009;37:533&#x2013;538. doi: 10.1097/CCM.0b013e318195424d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318195424d</ArticleId><ArticleId IdType="pubmed">19114909</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahsan N, Palmer BF, Wheeler D, Greenlee RG, Jr, Toto RD. Intravenous immunoglobulin-induced osmotic nephrosis. Arch Intern Med. 1994;154:1985&#x2013;1987. doi: 10.1001/archinte.154.17.1985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.154.17.1985</ArticleId><ArticleId IdType="pubmed">8074604</ArticleId></ArticleIdList></Reference><Reference><Citation>Shilliday IR, Quinn KJ, Allison ME. Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-controlled, randomized study. Nephrol Dial Transplant. 1997;12:2592&#x2013;2596. doi: 10.1093/ndt/12.12.2592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/12.12.2592</ArticleId><ArticleId IdType="pubmed">9430857</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirivella S, Gielchinsky I, Parsonnet V. Mannitol, furosemide, and dopamine infusion in postoperative renal failure complicating cardiac surgery. Ann Thorac Surg. 2000;69:501&#x2013;506. doi: 10.1016/S0003-4975(99)01298-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-4975(99)01298-9</ArticleId><ArticleId IdType="pubmed">10735688</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho KM, Sheridan DJ. Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ. 2006;333:420. doi: 10.1136/bmj.38902.605347.7C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38902.605347.7C</ArticleId><ArticleId IdType="pmc">PMC1553510</ArticleId><ArticleId IdType="pubmed">16861256</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagshaw SM, Delaney A, Haase M, Ghali WA, Bellomo R. Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis. Crit Care Resusc. 2007;9:60&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">17352669</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampath S, Moran JL, Graham PL, Rockliff S, Bersten AD, Abrams KR. The efficacy of loop diuretics in acute renal failure: assessment using Bayesian evidence synthesis techniques. Crit Care Med. 2007;35:2516&#x2013;2524. doi: 10.1097/01.CCM.0000284503.88148.6F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000284503.88148.6F</ArticleId><ArticleId IdType="pubmed">18084840</ArticleId></ArticleIdList></Reference><Reference><Citation>Asfar P, Meziani F, Hamel JF, Grelon F, Megarbane B, Anguel N, Mira JP, Dequin PF, Gergaud S, Weiss N, Legay F, Le Tulzo Y, Conrad M, Robert R, Gonzalez F, Guitton C, Tamion F, Tonnelier JM, Guezennec P, Van Der Linden T, Vieillard-Baron A, Mariotte E, Pradel G, Lesieur O, Ricard JD, Herve F, du Cheyron D, Guerin C, Mercat A, Teboul JL, Radermacher P, Investigators S. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370:1583&#x2013;1593. doi: 10.1056/NEJMoa1312173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1312173</ArticleId><ArticleId IdType="pubmed">24635770</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi AI, Palesch YY, Suarez JI. Intensive blood-pressure lowering in cerebral hemorrhage. N Eng J Med. 2016;375:e48. doi: 10.1056/NEJMoa1603460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1603460</ArticleId><ArticleId IdType="pubmed">27959682</ArticleId></ArticleIdList></Reference><Reference><Citation>De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL, SOAP II Investigators Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362:779&#x2013;789. doi: 10.1056/NEJMoa0907118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0907118</ArticleId><ArticleId IdType="pubmed">20200382</ArticleId></ArticleIdList></Reference><Reference><Citation>Serpa Neto A, Nassar AP, Cardoso SO, Manetta JA, Pereira VG, Esposito DC, Damasceno MC, Russell JA. Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials. Crit Care. 2012;16:R154. doi: 10.1186/cc11469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11469</ArticleId><ArticleId IdType="pmc">PMC3580743</ArticleId><ArticleId IdType="pubmed">22889256</ArticleId></ArticleIdList></Reference><Reference><Citation>Bragadottir G, Redfors B, Nygren A, Sellgren J, Ricksten SE. Low-dose vasopressin increases glomerular filtration rate, but impairs renal oxygenation in post-cardiac surgery patients. Acta Anaesthesiol Scand. 2009;53:1052&#x2013;1059. doi: 10.1111/j.1399-6576.2009.02037.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.2009.02037.x</ArticleId><ArticleId IdType="pubmed">19572935</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell JA, Walley KR, Singer J, Gordon AC, Hebert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D, VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877&#x2013;887. doi: 10.1056/NEJMoa067373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa067373</ArticleId><ArticleId IdType="pubmed">18305265</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon AC, Russell JA, Walley KR, Singer J, Ayers D, Storms MM, Holmes CL, Hebert PC, Cooper DJ, Mehta S, Granton JT, Cook DJ, Presneill JJ. The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Med. 2010;36:83&#x2013;91. doi: 10.1007/s00134-009-1687-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-009-1687-x</ArticleId><ArticleId IdType="pubmed">19841897</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, Pogson DG, Aya HD, Anjum A, Frazier GJ, Santhakumaran S, Ashby D, Brett SJ, VANISH Investigators Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA. 2016;316:509&#x2013;518. doi: 10.1001/jama.2016.10485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.10485</ArticleId><ArticleId IdType="pubmed">27483065</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajjar LA, Vincent JL, Barbosa Gomes Galas FR, Rhodes A, Landoni G, Osawa EA, Melo RR, Sundin MR, Grande SM, Gaiotto FA, Pomerantzeff PM, Dallan LO, Franco RA, Nakamura RE, Lisboa LA, de Almeida JP, Gerent AM, Souza DH, Gaiane MA, Fukushima JT, Park CL, Zambolim C, Rocha Ferreira GS, Strabelli TM, Fernandes FL, Camara L, Zeferino S, Santos VG, Piccioni MA, Jatene FB, Costa Auler JO, Jr, Filho RK. Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: the VANCS randomized controlled trial. Anesthesiology. 2017;126:85&#x2013;93. doi: 10.1097/ALN.0000000000001434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001434</ArticleId><ArticleId IdType="pubmed">27841822</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramaswamy D, Corrigan G, Polhemus C, Boothroyd D, Scandling J, Sommer FG, Alfrey E, Higgins J, Deen WM, Olshen R, Myers BD. Maintenance and recovery stages of postischemic acute renal failure in humans. Am J Physiol Renal Physiol. 2002;282:F271&#x2013;F280. doi: 10.1152/ajprenal.0068.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.0068.2001</ArticleId><ArticleId IdType="pubmed">11788441</ArticleId></ArticleIdList></Reference><Reference><Citation>Conger J, Robinette J, Villar A, Raij L, Shultz P. Increased nitric oxide synthase activity despite lack of response to endothelium-dependent vasodilators in postischemic acute renal failure in rats. J Clin Invest. 1995;96:631&#x2013;638. doi: 10.1172/JCI118078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI118078</ArticleId><ArticleId IdType="pmc">PMC185238</ArticleId><ArticleId IdType="pubmed">7542287</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan L, Bagshaw SM, Langenberg C, Saotome T, May C, Bellomo R. Pathophysiology of septic acute kidney injury: what do we really know? Crit Care Med. 2008;36:S198&#x2013;S203. doi: 10.1097/CCM.0b013e318168ccd5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318168ccd5</ArticleId><ArticleId IdType="pubmed">18382194</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa K, May CN, Gobe G, Langenberg C, Bellomo R. Pathophysiology of septic acute kidney injury: a different view of tubular injury. Contrib Nephrol. 2010;165:18&#x2013;27. doi: 10.1159/000313740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000313740</ArticleId><ArticleId IdType="pubmed">20427951</ArticleId></ArticleIdList></Reference><Reference><Citation>Legrand M, Bezemer R, Kandil A, Demirci C, Payen D, Ince C. The role of renal hypoperfusion in development of renal microcirculatory dysfunction in endotoxemic rats. Intensive Care Med. 2011;37:1534&#x2013;1542. doi: 10.1007/s00134-011-2267-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-011-2267-4</ArticleId><ArticleId IdType="pmc">PMC3155675</ArticleId><ArticleId IdType="pubmed">21695476</ArticleId></ArticleIdList></Reference><Reference><Citation>Molitoris BA, Sutton TA. Endothelial injury and dysfunction: role in the extension phase of acute renal failure. Kidney Int. 2004;66:496&#x2013;499. doi: 10.1111/j.1523-1755.2004.761_5.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-1755.2004.761_5.x</ArticleId><ArticleId IdType="pubmed">15253696</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauschke A, Teichgraber UKM, Frei U, Eckardt KU. &#x2018;Low-dose&#x2019; dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int. 2006;69:1669&#x2013;1674. doi: 10.1038/sj.ki.5000310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ki.5000310</ArticleId><ArticleId IdType="pubmed">16572117</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedrich JO, Adhikari N, Herridge MS, Beyene J. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med. 2005;142:510&#x2013;524. doi: 10.7326/0003-4819-142-7-200504050-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-142-7-200504050-00010</ArticleId><ArticleId IdType="pubmed">15809463</ArticleId></ArticleIdList></Reference><Reference><Citation>Karthik S, Lisbon A. Low-dose dopamine in the intensive care unit. Semin Dial. 2006;19:465&#x2013;471. doi: 10.1111/j.1525-139X.2006.00208.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1525-139X.2006.00208.x</ArticleId><ArticleId IdType="pubmed">17150046</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes CL, Walley KR. Bad medicine: low-dose dopamine in the ICU. Chest. 2003;123:1266&#x2013;1275. doi: 10.1378/chest.123.4.1266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.123.4.1266</ArticleId><ArticleId IdType="pubmed">12684320</ArticleId></ArticleIdList></Reference><Reference><Citation>Landoni G, Biondi-Zoccai GG, Tumlin JA, Bove T, De Luca M, Calabro MG, Ranucci M, Zangrillo A. Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. Am J Kidney Dis. 2007;49:56&#x2013;68. doi: 10.1053/j.ajkd.2006.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2006.10.013</ArticleId><ArticleId IdType="pubmed">17185146</ArticleId></ArticleIdList></Reference><Reference><Citation>Zangrillo A, Biondi-Zoccai GG, Frati E, Covello RD, Cabrini L, Guarracino F, Ruggeri L, Bove T, Bignami E, Landoni G. Fenoldopam and acute renal failure in cardiac surgery: a meta-analysis of randomized placebo-controlled trials. J Cardiothorac Vasc Anesth. 2012;26:407&#x2013;413. doi: 10.1053/j.jvca.2012.01.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2012.01.038</ArticleId><ArticleId IdType="pubmed">22459931</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillies MA, Kakar V, Parker RJ, Honore PM, Ostermann M. Fenoldopam to prevent acute kidney injury after major surgery-a systematic review and meta-analysis. Crit Care. 2015;19:449. doi: 10.1186/s13054-015-1166-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-1166-4</ArticleId><ArticleId IdType="pmc">PMC4699343</ArticleId><ArticleId IdType="pubmed">26703329</ArticleId></ArticleIdList></Reference><Reference><Citation>Bove T, Zangrillo A, Guarracino F, Alvaro G, Persi B, Maglioni E, Galdieri N, Comis M, Caramelli F, Pasero DC, Pala G, Renzini M, Conte M, Paternoster G, Martinez B, Pinelli F, Frontini M, Zucchetti MC, Pappalardo F, Amantea B, Camata A, Pisano A, Verdecchia C, Dal CE, Cariello C, Faita L, Baldassarri R, Scandroglio AM, Saleh O, Lembo R, Calabro MG, Bellomo R, Landoni G. Effect of fenoldopam on use of renal replacement therapy among patients with acute kidney injury after cardiac surgery: a randomized clinical trial. JAMA. 2014;312:2244&#x2013;2253. doi: 10.1001/jama.2014.13573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.13573</ArticleId><ArticleId IdType="pubmed">25265449</ArticleId></ArticleIdList></Reference><Reference><Citation>Sward K, Valson F, Ricksten SE. Long-term infusion of atrial natriuretic peptide (ANP) improves renal blood flow and glomerular filtration rate in clinical acute renal failure. Acta Anaesthesiol Scand. 2001;45:536&#x2013;542. doi: 10.1034/j.1399-6576.2001.045005536.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1399-6576.2001.045005536.x</ArticleId><ArticleId IdType="pubmed">11309000</ArticleId></ArticleIdList></Reference><Reference><Citation>Sward K, Valsson F, Sellgren J, Ricksten SE. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans. Intensive Care Med. 2005;31:79&#x2013;85. doi: 10.1007/s00134-004-2490-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-004-2490-3</ArticleId><ArticleId IdType="pubmed">15565364</ArticleId></ArticleIdList></Reference><Reference><Citation>Houben AJ, van der Zander K, de Leeuw PW. Vascular and renal actions of brain natriuretic peptide in man: physiology and pharmacology. Fundam Clin Pharmacol. 2005;19:411&#x2013;419. doi: 10.1111/j.1472-8206.2005.00336.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1472-8206.2005.00336.x</ArticleId><ArticleId IdType="pubmed">16011727</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn M. Endothelial actions of atrial and B-type natriuretic peptides. Br J Pharmacol. 2012;166:522&#x2013;531. doi: 10.1111/j.1476-5381.2012.01827.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.2012.01827.x</ArticleId><ArticleId IdType="pmc">PMC3417485</ArticleId><ArticleId IdType="pubmed">22220582</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitaka C, Kudo T, Haraguchi G, Tomita M. Cardiovascular and renal effects of carperitide and nesiritide in cardiovascular surgery patients: a systematic review and meta-analysis. Crit Care. 2011;15:R258. doi: 10.1186/cc10519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10519</ArticleId><ArticleId IdType="pmc">PMC3334809</ArticleId><ArticleId IdType="pubmed">22032777</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel NN, Rogers CA, Angelini GD, Murphy GJ. Pharmacological therapies for the prevention of acute kidney injury following cardiac surgery: a systematic review. Heart Fail Rev. 2011;16:553&#x2013;567. doi: 10.1007/s10741-011-9235-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10741-011-9235-5</ArticleId><ArticleId IdType="pubmed">21400231</ArticleId></ArticleIdList></Reference><Reference><Citation>Nigwekar SU, Navaneethan SD, Parikh CR, Hix JK (2009) Atrial natriuretic peptide for preventing and treating acute kidney injury. Cochrane Database Syst Rev CD006028. doi:10.1002/14651858.CD006028.pub2</Citation><ArticleIdList><ArticleId IdType="pubmed">19821351</ArticleId></ArticleIdList></Reference><Reference><Citation>Sezai A, Nakata K, Iida M, Yoshitake I, Wakui S, Hata H, Shiono M. Results of low-dose carperitide infusion in high-risk patients undergoing coronary artery bypass grafting. Ann Thorac Surg. 2013;96:119&#x2013;126. doi: 10.1016/j.athoracsur.2013.03.090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2013.03.090</ArticleId><ArticleId IdType="pubmed">23702231</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori Y, Kamada T, Ochiai R. Reduction in the incidence of acute kidney injury after aortic arch surgery with low-dose atrial natriuretic peptide: a randomised controlled trial. Eur J Anaesthesiol. 2014;31:381&#x2013;387. doi: 10.1097/EJA.0000000000000035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000035</ArticleId><ArticleId IdType="pubmed">24384584</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong B, Wang C, Yao Y, Huang Y, Tan J, Cao Y, Zou Y, Huang J. The dose-dependent effect of nesiritide on renal function in patients with acute decompensated heart failure: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2015;10:e0131326. doi: 10.1371/journal.pone.0131326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0131326</ArticleId><ArticleId IdType="pmc">PMC4479574</ArticleId><ArticleId IdType="pubmed">26107522</ArticleId></ArticleIdList></Reference><Reference><Citation>Papp Z, Edes I, Fruhwald S, De Hert SG, Salmenpera M, Leppikangas H, Mebazaa A, Landoni G, Grossini E, Caimmi P, Morelli A, Guarracino F, Schwinger RH, Meyer S, Algotsson L, Wikstrom BG, Jorgensen K, Filippatos G, Parissis JT, Gonzalez MJ, Parkhomenko A, Yilmaz MB, Kivikko M, Pollesello P, Follath F. Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan. Int J Cardiol. 2012;159:82&#x2013;87. doi: 10.1016/j.ijcard.2011.07.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2011.07.022</ArticleId><ArticleId IdType="pubmed">21784540</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasslacher J, Bijuklic K, Bertocchi C, Kountchev J, Bellmann R, Dunzendorfer S, Joannidis M. Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: a prospective observational study. Crit Care. 2011;15:R166. doi: 10.1186/cc10307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10307</ArticleId><ArticleId IdType="pmc">PMC3387603</ArticleId><ArticleId IdType="pubmed">21749676</ArticleId></ArticleIdList></Reference><Reference><Citation>Bove T, Matteazzi A, Belletti A, Paternoster G, Saleh O, Taddeo D, Dossi R, Greco T, Bradic N, Husedzinovic I, Nigro Neto C, Lomivorotov VV, Calabro MG. Beneficial impact of levosimendan in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. Heart Lung Vessel. 2015;7:35&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4381821</ArticleId><ArticleId IdType="pubmed">25861589</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou C, Gong J, Chen D, Wang W, Liu M, Liu B. Levosimendan for prevention of acute kidney injury after cardiac surgery: a meta-analysis of randomized controlled trials. Am J Kidney Dis. 2016;67:408&#x2013;416. doi: 10.1053/j.ajkd.2015.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2015.09.015</ArticleId><ArticleId IdType="pubmed">26518388</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon AC, Perkins GD, Singer M, McAuley DF, Orme RM, Santhakumaran S, Mason AJ, Cross M, Al-Beidh F, Best-Lane J, Brealey D, Nutt CL, McNamee JJ, Reschreiter H, Breen A, Liu KD, Ashby D. Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med. 2016;375:1638&#x2013;1648. doi: 10.1056/NEJMoa1609409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1609409</ArticleId><ArticleId IdType="pubmed">27705084</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RH, Leimberger JD, van Diepen S, Meza J, Wang A, Jankowich R, Harrison RW, Hay D, Fremes S, Duncan A, Soltesz EG, Luber J, Park S, Argenziano M, Murphy E, Marcel R, Kalavrouziotis D, Nagpal D, Bozinovski J, Toller W, Heringlake M, Goodman SG, Levy JH, Harrington RA, Anstrom KJ, Alexander JH, LEVO-CTS Investigators (2017) Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery. N Engl J Med. doi:10.1056/NEJMoa1616218</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Landoni G, Lomivorotov VV, Alvaro G, Lobreglio R, Pisano A, Guarracino F, Calabro MG, Grigoryev EV, Likhvantsev VV, Salgado-Filho MF, Bianchi A, Pasyuga VV, Baiocchi M, Pappalardo F, Monaco F, Boboshko VA, Abubakirov MN, Amantea B, Lembo R, Brazzi L, Verniero L, Bertini P, Scandroglio AM, Bove T, Belletti A, Michienzi MG, Shukevich DL, Zabelina TS, Bellomo R, Zangrillo A, CHEETAH Study Group (2017) Levosimendan for hemodynamic support after cardiac surgery. N Engl J Med. doi:10.1056/NEJMoa1616325</Citation><ArticleIdList><ArticleId IdType="pubmed">28320259</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo C, Yuan D, Li X, Yao W, Luo G, Chi X, Li H, Irwin MG, Xia Z, Hei Z. Propofol attenuated acute kidney injury after orthotopic liver transplantation via inhibiting gap junction composed of connexin 32. Anesthesiology. 2015;122:72&#x2013;86. doi: 10.1097/ALN.0000000000000448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000448</ArticleId><ArticleId IdType="pubmed">25254904</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsing CH, Chou W, Wang JJ, Chen HW, Yeh CH. Propofol increases bone morphogenetic protein-7 and decreases oxidative stress in sepsis-induced acute kidney injury. Nephrol Dial Transplant. 2011;26:1162&#x2013;1172. doi: 10.1093/ndt/gfq572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfq572</ArticleId><ArticleId IdType="pubmed">20864551</ArticleId></ArticleIdList></Reference><Reference><Citation>Villela NR, Nascimento Junior P, Carvalho LR, Teixeira A. Effects of dexmedetomidine on renal system and on vasopressin plasma levels. Experimental study in dogs. Rev Bras Anestesiol. 2005;55:429&#x2013;440. doi: 10.1590/S0034-70942005000400007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0034-70942005000400007</ArticleId><ArticleId IdType="pubmed">19468631</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FT, Chen SW, Kim M, Park SW, Song JH, Wang S, Herman J, D&#x2019;Agati V, Lee HT. alpha2-Adrenergic agonists protect against radiocontrast-induced nephropathy in mice. Am J Physiol Renal Physiol. 2008;295:F741&#x2013;748. doi: 10.1152/ajprenal.90244.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.90244.2008</ArticleId><ArticleId IdType="pubmed">18579700</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsing CH, Lin CF, So E, Sun DP, Chen TC, Li CF, Yeh CH. alpha2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5. Am J Physiol Renal Physiol. 2012;303:F1443&#x2013;F1453. doi: 10.1152/ajprenal.00143.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00143.2012</ArticleId><ArticleId IdType="pubmed">22933299</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan F, Chen Y, Yuan D, Gong C, Li X, Zhou S. Dexmedetomidine protects against acute kidney injury through downregulating inflammatory reactions in endotoxemia rats. Biomed Rep. 2015;3:365&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4467244</ArticleId><ArticleId IdType="pubmed">26137237</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao H, Chi X, Jin Y, Wang Y, Huang P, Wu S, Xia Z, Cai J. Dexmedetomidine inhibits TLR4/NF-kappaB activation and reduces acute kidney injury after orthotopic autologous liver transplantation in rats. Sci Rep. 2015;5:16849. doi: 10.1038/srep16849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep16849</ArticleId><ArticleId IdType="pmc">PMC4653646</ArticleId><ArticleId IdType="pubmed">26585410</ArticleId></ArticleIdList></Reference><Reference><Citation>Reade MC, Finfer S. Sedation and delirium in the intensive care unit. N Engl J Med. 2014;370:444&#x2013;454. doi: 10.1056/NEJMra1208705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1208705</ArticleId><ArticleId IdType="pubmed">24476433</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirrakhimov AE, Voore P, Halytskyy O, Khan M, Ali AM. Propofol infusion syndrome in adults: a clinical update. Crit Care Res Pract. 2015;2015:260385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4410753</ArticleId><ArticleId IdType="pubmed">25954513</ArticleId></ArticleIdList></Reference><Reference><Citation>Krajcova A, Waldauf P, Andel M, Duska F. Propofol infusion syndrome: a structured review of experimental studies and 153 published case reports. Crit Care. 2015;19:398. doi: 10.1186/s13054-015-1112-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-1112-5</ArticleId><ArticleId IdType="pmc">PMC4642662</ArticleId><ArticleId IdType="pubmed">26558513</ArticleId></ArticleIdList></Reference><Reference><Citation>Cremer OL, Moons KG, Bouman EA, Kruijswijk JE, de Smet AM, Kalkman CJ. Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet. 2001;357:117&#x2013;118. doi: 10.1016/S0140-6736(00)03547-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(00)03547-9</ArticleId><ArticleId IdType="pubmed">11197401</ArticleId></ArticleIdList></Reference><Reference><Citation>Leite TT, Macedo E, Martins Ida S, Neves FM, Liborio AB. Renal outcomes in critically ill patients receiving propofol or midazolam. Clin J Am Soc Nephrol. 2015;10:1937&#x2013;1945. doi: 10.2215/CJN.02330315.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.02330315</ArticleId><ArticleId IdType="pmc">PMC4633782</ArticleId><ArticleId IdType="pubmed">26342046</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo YC, Shim JK, Song Y, Yang SY, Kwak YL. Anesthetics influence the incidence of acute kidney injury following valvular heart surgery. Kidney Int. 2014;86:414&#x2013;422. doi: 10.1038/ki.2013.532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2013.532</ArticleId><ArticleId IdType="pubmed">24429400</ArticleId></ArticleIdList></Reference><Reference><Citation>Menting TP, Wever KE, Ozdemir-van Brunschot DM, Van der Vliet DJ, Rovers MM, Warle MC. Ischaemic preconditioning for the reduction of renal ischaemia reperfusion injury. Cochrane Database Syst Rev. 2017;3:Cd010777.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6464274</ArticleId><ArticleId IdType="pubmed">28258686</ArticleId></ArticleIdList></Reference><Reference><Citation>Pichot C, Longrois D, Ghignone M, Quintin L. Dexmedetomidine and clonidine: a review of their pharmacodynamy to define their role for sedation in intensive care patients. Ann Fr Anesth Reanim. 2012;31:876&#x2013;896. doi: 10.1016/j.annfar.2012.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annfar.2012.07.018</ArticleId><ArticleId IdType="pubmed">23089375</ArticleId></ArticleIdList></Reference><Reference><Citation>Leino K, Hynynen M, Jalonen J, Salmenpera M, Scheinin H, Aantaa R, Dexmedetomidine in Cardiac Surgery Study Group Renal effects of dexmedetomidine during coronary artery bypass surgery: a randomized placebo-controlled study. BMC Anesthesiol. 2011;11:9. doi: 10.1186/1471-2253-11-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2253-11-9</ArticleId><ArticleId IdType="pmc">PMC3123640</ArticleId><ArticleId IdType="pubmed">21605394</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji F, Li Z, Young JN, Yeranossian A, Liu H. Post-bypass dexmedetomidine use and postoperative acute kidney injury in patients undergoing cardiac surgery with cardiopulmonary bypass. PLoS One. 2013;8:e77446. doi: 10.1371/journal.pone.0077446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0077446</ArticleId><ArticleId IdType="pmc">PMC3795046</ArticleId><ArticleId IdType="pubmed">24130886</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon T, Tsai JY, Vachhani S, Peng SP, Feng L, Vaporciyan AA, Cata JP. The use of intraoperative dexmedetomidine is not associated with a reduction in acute kidney injury after lung cancer surgery. J Cardiothorac Vasc Anesth. 2016;30:51&#x2013;55. doi: 10.1053/j.jvca.2015.03.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2015.03.025</ArticleId><ArticleId IdType="pubmed">26260907</ArticleId></ArticleIdList></Reference><Reference><Citation>Balkanay OO, Goksedef D, Omeroglu SN, Ipek G. The dose-related effects of dexmedetomidine on renal functions and serum neutrophil gelatinase-associated lipocalin values after coronary artery bypass grafting: a randomized, triple-blind, placebo-controlled study. Interact Cardiovasc Thorac Surg. 2015;20:209&#x2013;214. doi: 10.1093/icvts/ivu367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivu367</ArticleId><ArticleId IdType="pubmed">25392341</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho JS, Shim JK, Soh S, Kim MK, Kwak YL. Perioperative dexmedetomidine reduces the incidence and severity of acute kidney injury following valvular heart surgery. Kidney Int. 2016;89:693&#x2013;700. doi: 10.1038/ki.2015.306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2015.306</ArticleId><ArticleId IdType="pubmed">26444030</ArticleId></ArticleIdList></Reference><Reference><Citation>Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978&#x2013;982. doi: 10.1210/jcem.87.3.8341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jcem.87.3.8341</ArticleId><ArticleId IdType="pubmed">11889147</ArticleId></ArticleIdList></Reference><Reference><Citation>Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78:1471&#x2013;1478. doi: 10.4065/78.12.1471.</Citation><ArticleIdList><ArticleId IdType="doi">10.4065/78.12.1471</ArticleId><ArticleId IdType="pubmed">14661676</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359&#x2013;1367. doi: 10.1056/NEJMoa011300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa011300</ArticleId><ArticleId IdType="pubmed">11794168</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449&#x2013;461. doi: 10.1056/NEJMoa052521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa052521</ArticleId><ArticleId IdType="pubmed">16452557</ArticleId></ArticleIdList></Reference><Reference><Citation>Schetz M, Vanhorebeek I, Wouters PJ, Wilmer A, van den Berghe G (2008) Tight blood glucose control is renoprotective in critically ill patients. J Am Soc Nephrol 19: 571&#x2013;578</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2391044</ArticleId><ArticleId IdType="pubmed">18235100</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabi YM, Dabbagh OC, Tamim HM, Al-Shimemeri AA, Memish ZA, Haddad SH, Syed SJ, Giridhar HR, Rishu AH, Al-Daker MO, Kahoul SH, Britts RJ, Sakkijha MH. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med. 2008;36:3190&#x2013;3197. doi: 10.1097/CCM.0b013e31818f21aa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31818f21aa</ArticleId><ArticleId IdType="pubmed">18936702</ArticleId></ArticleIdList></Reference><Reference><Citation>Investigators N-SS, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hebert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283&#x2013;1297. doi: 10.1056/NEJMoa0810625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0810625</ArticleId><ArticleId IdType="pubmed">19318384</ArticleId></ArticleIdList></Reference><Reference><Citation>Preiser JC, Devos P, Ruiz-Santana S, Melot C, Annane D, Groeneveld J, Iapichino G, Leverve X, Nitenberg G, Singer P, Wernerman J, Joannidis M, Stecher A, Chiolero R. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009;35:1738&#x2013;1748. doi: 10.1007/s00134-009-1585-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-009-1585-2</ArticleId><ArticleId IdType="pubmed">19636533</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabi YM, Tamim HM, Dhar GS, Al-Dawood A, Al-Sultan M, Sakkijha MH, Kahoul SH, Brits R. Permissive underfeeding and intensive insulin therapy in critically ill patients: a randomized controlled trial. Am J Clin Nutr. 2011;93:569&#x2013;577. doi: 10.3945/ajcn.110.005074.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.110.005074</ArticleId><ArticleId IdType="pubmed">21270385</ArticleId></ArticleIdList></Reference><Reference><Citation>De La Rosa GC, Donado JH, Restrepo AH, Quintero AM, Gonzalez LG, Saldarriaga NE, Bedoya M, Toro JM, Velasquez JB, Valencia JC, Arango CM, Aleman PH, Vasquez EM, Chavarriaga JC, Yepes A, Pulido W, Cadavid CA. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care. 2008;12:R120. doi: 10.1186/cc7017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc7017</ArticleId><ArticleId IdType="pmc">PMC2592751</ArticleId><ArticleId IdType="pubmed">18799004</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Berghe G, Schetz M, Vlasselaers D, Hermans G, Wilmer A, Bouillon R, Mesotten D. Clinical review: intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? J Clin Endocrinol Metab. 2009;94:3163&#x2013;3170. doi: 10.1210/jc.2009-0663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2009-0663</ArticleId><ArticleId IdType="pubmed">19531590</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling Y, Li X, Gao X. Intensive versus conventional glucose control in critically ill patients: a meta-analysis of randomized controlled trials. Eur J Intern Med. 2012;23:564&#x2013;574. doi: 10.1016/j.ejim.2012.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2012.02.013</ArticleId><ArticleId IdType="pubmed">22863436</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickerson RN, Hamilton LA, Connor KA, Maish GO, 3rd, Croce MA, Minard G, Brown RO. Increased hypoglycemia associated with renal failure during continuous intravenous insulin infusion and specialized nutritional support. Nutrition. 2011;27:766&#x2013;772. doi: 10.1016/j.nut.2010.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2010.08.009</ArticleId><ArticleId IdType="pubmed">20971617</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosiborod M, Inzucchi SE, Goyal A, Krumholz HM, Masoudi FA, Xiao L, Spertus JA. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA. 2009;301:1556&#x2013;1564. doi: 10.1001/jama.2009.496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.496</ArticleId><ArticleId IdType="pubmed">19366775</ArticleId></ArticleIdList></Reference><Reference><Citation>Mowery NT, Guillamondegui OD, Gunter OL, Diaz JJ, Jr, Collier BR, Dossett LA, Dortch MJ, May AK. Severe hypoglycemia while on intensive insulin therapy is not an independent predictor of death after trauma. J Trauma. 2010;68:342&#x2013;347. doi: 10.1097/TA.0b013e3181c825f2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e3181c825f2</ArticleId><ArticleId IdType="pubmed">20154546</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE-SUGAR Study Investigators. Finfer S, Liu B, Chittock DR, Norton R, Myburgh JA, McArthur C, Mitchell I, Foster D, Dhingra V, Henderson WR, Ronco JJ, Bellomo R, Cook D, McDonald E, Dodek P, Hebert PC, Heyland DK, Robinson BG. Hypoglycemia and risk of death in critically ill patients. N Engl J Med. 2012;367:1108&#x2013;1118. doi: 10.1056/NEJMoa1204942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1204942</ArticleId><ArticleId IdType="pubmed">22992074</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. EndocrPract. 2009;15:353&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pubmed">19454396</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Berghe G (2013) What&#x2019;s new in glucose control in the ICU? Intensive Care Med 39:823&#x2013;825</Citation><ArticleIdList><ArticleId IdType="pubmed">23460140</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieleman JM, Nierich AP, Rosseel PM, van der Maaten JM, Hofland J, Diephuis JC, Schepp RM, Boer C, Moons KG, van Herwerden LA, Tijssen JG, Numan SC, Kalkman CJ, van Dijk D, Dexamethasone for Cardiac Surgery Study Group Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. JAMA. 2012;308:1761&#x2013;1767. doi: 10.1001/jama.2012.14144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.14144</ArticleId><ArticleId IdType="pubmed">23117776</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob KA, Leaf DE, Dieleman JM, van Dijk D, Nierich AP, Rosseel PM, van der Maaten JM, Hofland J, Diephuis JC, de Lange F, Boer C, Kluin J, Waikar SS, Dexamethasone for Cardiac Surgery Study Group Intraoperative high-dose dexamethasone and severe AKI after cardiac surgery. J Am Soc Nephrol. 2015;26:2947&#x2013;2951. doi: 10.1681/ASN.2014080840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2014080840</ArticleId><ArticleId IdType="pmc">PMC4657835</ArticleId><ArticleId IdType="pubmed">25952257</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitlock RP, Devereaux PJ, Teoh KH, Lamy A, Vincent J, Pogue J, Paparella D, Sessler DI, Karthikeyan G, Villar JC, Zuo Y, Avezum A, Quantz M, Tagarakis GI, Shah PJ, Abbasi SH, Zheng H, Pettit S, Chrolavicius S, Yusuf S. Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial. Lancet. 2015;386:1243&#x2013;1253. doi: 10.1016/S0140-6736(15)00273-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)00273-1</ArticleId><ArticleId IdType="pubmed">26460660</ArticleId></ArticleIdList></Reference><Reference><Citation>Song YR, Lee T, You SJ, Chin HJ, Chae DW, Lim C, Park KH, Han S, Kim JH, Na KY. Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: a pilot study. Am J Nephrol. 2009;30:253&#x2013;260. doi: 10.1159/000223229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000223229</ArticleId><ArticleId IdType="pubmed">19494484</ArticleId></ArticleIdList></Reference><Reference><Citation>de Seigneux S, Ponte B, Weiss L, Pugin J, Romand JA, Martin PY, Saudan P. Epoetin administrated after cardiac surgery: effects on renal function and inflammation in a randomized controlled study. BMC Nephrol. 2012;13:132. doi: 10.1186/1471-2369-13-132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2369-13-132</ArticleId><ArticleId IdType="pmc">PMC3506492</ArticleId><ArticleId IdType="pubmed">23033926</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo YC, Shim JK, Kim JC, Jo YY, Lee JH, Kwak YL. Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. Anesthesiology. 2011;115:929&#x2013;937. doi: 10.1097/ALN.0b013e318232004b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318232004b</ArticleId><ArticleId IdType="pubmed">22027622</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JH, Shim JK, Song JW, Song Y, Kim HB, Kwak YL. Effect of erythropoietin on the incidence of acute kidney injury following complex valvular heart surgery: a double blind, randomized clinical trial of efficacy and safety. Crit Care. 2013;17:R254. doi: 10.1186/cc13081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13081</ArticleId><ArticleId IdType="pmc">PMC4056185</ArticleId><ArticleId IdType="pubmed">24156702</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasanarong A, Duangchana S, Sumransurp S, Homvises B, Satdhabudha O. Prophylaxis with erythropoietin versus placebo reduces acute kidney injury and neutrophil gelatinase-associated lipocalin in patients undergoing cardiac surgery: a randomized, double-blind controlled trial. BMC Nephrol. 2013;14:136. doi: 10.1186/1471-2369-14-136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2369-14-136</ArticleId><ArticleId IdType="pmc">PMC3704968</ArticleId><ArticleId IdType="pubmed">23829828</ArticleId></ArticleIdList></Reference><Reference><Citation>Tie HT, Luo MZ, Lin D, Zhang M, Wan JY, Wu QC. Erythropoietin administration for prevention of cardiac surgery-associated acute kidney injury: a meta-analysis of randomized controlled trials. Eur J Cardiothorac Surg. 2015;48:32&#x2013;39. doi: 10.1093/ejcts/ezu378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezu378</ArticleId><ArticleId IdType="pubmed">25312524</ArticleId></ArticleIdList></Reference><Reference><Citation>Penny-Dimri JC, Cochrane AD, Perry LA, Smith JA. Characterising the role of perioperative erythropoietin for preventing acute kidney injury after cardiac surgery: systematic review and meta-analysis. Heart Lung Circ. 2016;25:1067&#x2013;1076. doi: 10.1016/j.hlc.2016.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2016.04.016</ArticleId><ArticleId IdType="pubmed">27523464</ArticleId></ArticleIdList></Reference><Reference><Citation>Dardashti A, Ederoth P, Algotsson L, Bronden B, Grins E, Larsson M, Nozohoor S, Zinko G, Bjursten H. Erythropoietin and protection of renal function in cardiac surgery (the EPRICS Trial) Anesthesiology. 2014;121:582&#x2013;590. doi: 10.1097/ALN.0000000000000321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000321</ArticleId><ArticleId IdType="pubmed">25225746</ArticleId></ArticleIdList></Reference><Reference><Citation>Endre ZH, Walker RJ, Pickering JW, Shaw GM, Frampton CM, Henderson SJ, Hutchison R, Mehrtens JE, Robinson JM, Schollum JB, Westhuyzen J, Celi LA, McGinley RJ, Campbell IJ, George PM. Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial) Kidney Int. 2010;77:1020&#x2013;1030. doi: 10.1038/ki.2010.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2010.25</ArticleId><ArticleId IdType="pubmed">20164823</ArticleId></ArticleIdList></Reference><Reference><Citation>Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Shapiro MJ, Corwin MJ, Colton T, EPO Critical Care Trials Group Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA. 2002;288:2827&#x2013;2835. doi: 10.1001/jama.288.22.2827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.288.22.2827</ArticleId><ArticleId IdType="pubmed">12472324</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C, Lin Z, Luo Q, Xia X, Yu X, Huang F. Efficacy and safety of erythropoietin to prevent acute kidney injury in patients with critical illness or perioperative care: a systematic review and meta-analysis of randomized controlled trials. J Cardiovasc Pharmacol. 2015;65:593&#x2013;600. doi: 10.1097/FJC.0000000000000229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FJC.0000000000000229</ArticleId><ArticleId IdType="pmc">PMC4461384</ArticleId><ArticleId IdType="pubmed">26065644</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JE, Song SW, Kim JY, Lee HJ, Chung KH, Shim YH. Effect of a single bolus of erythropoietin on renoprotection in patients undergoing thoracic aortic surgery with moderate hypothermic circulatory arrest. Ann Thorac Surg. 2016;101:690&#x2013;696. doi: 10.1016/j.athoracsur.2015.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2015.08.007</ArticleId><ArticleId IdType="pubmed">26576750</ArticleId></ArticleIdList></Reference><Reference><Citation>Shema-Didi L, Kristal B, Eizenberg S, Marzuq N, Sussan M, Feldman-Idov Y, Ofir P, Atar S. Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: a randomized controlled trial. Nephrology (Carlton) 2016;21:295&#x2013;300. doi: 10.1111/nep.12609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nep.12609</ArticleId><ArticleId IdType="pubmed">26370061</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons M, Plante I, LeBrun M, Gourde P, Simard M, Grenier L, Thibault L, Labrecque G, Beauchamp D. Protein-rich diet attenuates cyclosporin a-induced renal tubular damage in rats. J Ren Nutr. 2003;13:84&#x2013;92. doi: 10.1053/jren.2003.50027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jren.2003.50027</ArticleId><ArticleId IdType="pubmed">12671830</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts PR, Black KW, Zaloga GP. Enteral feeding improves outcome and protects against glycerol-induced acute renal failure in the rat. Am J Respir Crit Care Med. 1997;156:1265&#x2013;1269. doi: 10.1164/ajrccm.156.4.9607003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.156.4.9607003</ArticleId><ArticleId IdType="pubmed">9351632</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouser JF, Hak EB, Kuhl DA, Dickerson RN, Gaber LW, Hak LJ. Recovery from ischemic acute renal failure is improved with enteral compared with parenteral nutrition. Crit Care Med. 1997;25:1748&#x2013;1754. doi: 10.1097/00003246-199710000-00028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199710000-00028</ArticleId><ArticleId IdType="pubmed">9377893</ArticleId></ArticleIdList></Reference><Reference><Citation>Zager RA. Amino acid hyperalimentation in acute renal failure: a potential therapeutic paradox. Kidney Int Suppl. 1987;22:S72&#x2013;S75.</Citation><ArticleIdList><ArticleId IdType="pubmed">3123764</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyland DK, Elke G, Cook D, Berger MM, Wischmeyer PE, Albert M, Muscedere J, Jones G, Day AG. Glutamine and antioxidants in the critically ill patient: a post hoc analysis of a large-scale randomized trial. JPEN J Parenter Enteral Nutr. 2015;39:401&#x2013;409. doi: 10.1177/0148607114529994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0148607114529994</ArticleId><ArticleId IdType="pmc">PMC6800175</ArticleId><ArticleId IdType="pubmed">24803474</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell JR, Verweij M, Brand K, van de Ven M, Goemaere N, van den Engel S, Chu T, Forrer F, Muller C, de Jong M, van IJcken W, IJzermans JN, Hoeijmakers JH, de Bruin RW (2010) Short-term dietary restriction and fasting precondition against ischemia reperfusion injury in mice. Aging Cell 9:40&#x2013;53</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3412229</ArticleId><ArticleId IdType="pubmed">19878145</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel RM, Beck CH, Jr, Abbott WM, Ryan JA, Jr, Barnett GO, Fischer JE. Improved survival from acute renal failure after treatment with intravenous essential l-amino acids and glucose. Results of a prospective, double-blind study. N Engl J Med. 1973;288:695&#x2013;699. doi: 10.1056/NEJM197304052881401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM197304052881401</ArticleId><ArticleId IdType="pubmed">4631743</ArticleId></ArticleIdList></Reference><Reference><Citation>Doig GS, Simpson F, Bellomo R, Heighes PT, Sweetman EA, Chesher D, Pollock C, Davies A, Botha J, Harrigan P, Reade MC. Intravenous amino acid therapy for kidney function in critically ill patients: a randomized controlled trial. Intensive Care Med. 2015;41:1197&#x2013;1208. doi: 10.1007/s00134-015-3827-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3827-9</ArticleId><ArticleId IdType="pubmed">25925203</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunst J, Vanhorebeek I, Casaer MP, Hermans G, Wouters PJ, Dubois J, Claes K, Schetz M, Van den Berghe G. Impact of early parenteral nutrition on metabolism and kidney injury. J Am Soc Nephrol. 2013;24:995&#x2013;1005. doi: 10.1681/ASN.2012070732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2012070732</ArticleId><ArticleId IdType="pmc">PMC3665391</ArticleId><ArticleId IdType="pubmed">23539756</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Dorzi HM, Albarrak A, Ferwana M, Murad MH, Arabi YM. Lower versus higher dose of enteral caloric intake in adult critically ill patients: a systematic review and meta-analysis. Crit Care. 2016;20:358. doi: 10.1186/s13054-016-1539-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1539-3</ArticleId><ArticleId IdType="pmc">PMC5097427</ArticleId><ArticleId IdType="pubmed">27814776</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzales DA, Norsworthy KJ, Kern SJ, Banks S, Sieving PC, Star RA, Natanson C, Danner RL. A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity. BMC Med. 2007;5:32. doi: 10.1186/1741-7015-5-32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7015-5-32</ArticleId><ArticleId IdType="pmc">PMC2200657</ArticleId><ArticleId IdType="pubmed">18001477</ArticleId></ArticleIdList></Reference><Reference><Citation>Zagler A, Azadpour M, Mercado C, Hennekens CH. N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials. Am Heart J. 2006;151:140&#x2013;145. doi: 10.1016/j.ahj.2005.01.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2005.01.055</ArticleId><ArticleId IdType="pubmed">16368307</ArticleId></ArticleIdList></Reference><Reference><Citation>Duong MH, MacKenzie TA, Malenka DJ. N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis. Catheter Cardiovasc Interv. 2005;64:471&#x2013;479. doi: 10.1002/ccd.20342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.20342</ArticleId><ArticleId IdType="pubmed">15789388</ArticleId></ArticleIdList></Reference><Reference><Citation>Pannu N, Manns B, Lee H, Tonelli M. Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int. 2004;65:1366&#x2013;1374. doi: 10.1111/j.1523-1755.2004.00516.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-1755.2004.00516.x</ArticleId><ArticleId IdType="pubmed">15086476</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso A, Lau J, Jaber BL, Weintraub A, Sarnak MJ. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. Am J Kidney Dis. 2004;43:1&#x2013;9. doi: 10.1053/j.ajkd.2003.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2003.09.009</ArticleId><ArticleId IdType="pubmed">14712421</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med. 2008;148:284&#x2013;294. doi: 10.7326/0003-4819-148-4-200802190-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-148-4-200802190-00007</ArticleId><ArticleId IdType="pubmed">18283206</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao SJ, Zhong ZS, Qi GX, Tian W. The efficacy of N-acetylcysteine plus sodium bicarbonate in the prevention of contrast-induced nephropathy after cardiac catheterization and percutaneous coronary intervention: a meta-analysis of randomized controlled trials. Int J Cardiol. 2016;221:251&#x2013;259. doi: 10.1016/j.ijcard.2016.07.086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2016.07.086</ArticleId><ArticleId IdType="pubmed">27404685</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang N, Qian P, Kumar S, Yan TD, Phan K. The effect of N-acetylcysteine on the incidence of contrast-induced kidney injury: a systematic review and trial sequential analysis. Int J Cardiol. 2016;209:319&#x2013;327. doi: 10.1016/j.ijcard.2016.02.083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2016.02.083</ArticleId><ArticleId IdType="pubmed">26922293</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang X, Hu DY, Li CB, Ai ZS, Peng A. N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with pre-existing renal insufficiency or diabetes: a systematic review and meta-analysis. Ren Fail. 2015;37(10):297&#x2013;303. doi: 10.3109/0886022X.2015.1012985.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/0886022X.2015.1012985</ArticleId><ArticleId IdType="pubmed">26458505</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z, Fu Q, Cao L, Jin W, Cheng L, Li Z (2013) Intravenous N-acetylcysteine for prevention of contrast-induced nephropathy: a meta-analysis of randomized, controlled trials. PLoS One 8:e55124</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3559541</ArticleId><ArticleId IdType="pubmed">23383076</ArticleId></ArticleIdList></Reference><Reference><Citation>ACT Investigators Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT) Circulation. 2011;124:1250&#x2013;1259. doi: 10.1161/CIRCULATIONAHA.111.038943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.111.038943</ArticleId><ArticleId IdType="pubmed">21859972</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns KE, Chu MW, Novick RJ, Fox SA, Gallo K, Martin CM, Stitt LW, Heidenheim AP, Myers ML, Moist L. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing CABG surgery: a randomized controlled trial. JAMA. 2005;294:342&#x2013;350. doi: 10.1001/jama.294.3.342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.294.3.342</ArticleId><ArticleId IdType="pubmed">16030279</ArticleId></ArticleIdList></Reference><Reference><Citation>Macedo E, Abdulkader R, Castro I, Sobrinho AC, Yu L, Vieira JM., Jr Lack of protection of N-acetylcysteine (NAC) in acute renal failure related to elective aortic aneurysm repair-a randomized controlled trial. Nephrol Dial Transplant. 2006;21:1863&#x2013;1869. doi: 10.1093/ndt/gfl079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfl079</ArticleId><ArticleId IdType="pubmed">16522657</ArticleId></ArticleIdList></Reference><Reference><Citation>Komisarof JA, Gilkey GM, Peters DM, Koudelka CW, Meyer MM, Smith SM. N-acetylcysteine for patients with prolonged hypotension as prophylaxis for acute renal failure (NEPHRON) Crit Care Med. 2007;35:435&#x2013;441. doi: 10.1097/01.CCM.0000253816.83011.DB.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000253816.83011.DB</ArticleId><ArticleId IdType="pubmed">17205018</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisillo E, Ceriani R, Bortone F, Juliano G, Salvi L, Veglia F, Fiorentini C, Marenzi G. N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial. Crit Care Med. 2008;36:81&#x2013;86. doi: 10.1097/01.CCM.0000295305.22281.1D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000295305.22281.1D</ArticleId><ArticleId IdType="pubmed">18090169</ArticleId></ArticleIdList></Reference><Reference><Citation>Adabag AS, Ishani A, Koneswaran S, Johnson DJ, Kelly RF, Ward HB, McFalls EO, Bloomfield HE, Chandrashekhar Y. Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: a randomized controlled trial. Am Heart J. 2008;155:1143&#x2013;1149. doi: 10.1016/j.ahj.2008.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2008.01.013</ArticleId><ArticleId IdType="pubmed">18513531</ArticleId></ArticleIdList></Reference><Reference><Citation>Song JW, Shim JK, Soh S, Jang J, Kwak YL. Double-blinded, randomized controlled trial of N-acetylcysteine for prevention of acute kidney injury in high risk patients undergoing off-pump coronary artery bypass. Nephrology (Carlton) 2015;20:96&#x2013;102. doi: 10.1111/nep.12361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nep.12361</ArticleId><ArticleId IdType="pubmed">25384603</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeysundera DN, Beattie WS, Rao V, Granton JT, Chan CT. N-acetylcysteine for preventing acute kidney injury in cardiac surgery patients with pre-existing moderate renal insufficiency. Can J Anaesth. 2007;54:872&#x2013;881. doi: 10.1007/BF03026790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03026790</ArticleId><ArticleId IdType="pubmed">17975231</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandilands EA, Bateman DN. Adverse reactions associated with acetylcysteine. Clin Toxicol (Phila) 2009;47:81&#x2013;88. doi: 10.1080/15563650802665587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15563650802665587</ArticleId><ArticleId IdType="pubmed">19280424</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar Z, Shearer E, Lowe D. N-Acetylcysteine treatment to prevent the progression of multisystem organ failure: a prospective, randomized, placebo-controlled study. Crit Care Med. 1999;27:1100&#x2013;1104. doi: 10.1097/00003246-199906000-00028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199906000-00028</ArticleId><ArticleId IdType="pubmed">10397212</ArticleId></ArticleIdList></Reference><Reference><Citation>Peake SL, Moran JL, Leppard PI. N-acetyl-l-cysteine depresses cardiac performance in patients with septic shock. Crit Care Med. 1996;24:1302&#x2013;1310. doi: 10.1097/00003246-199608000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199608000-00006</ArticleId><ArticleId IdType="pubmed">8706483</ArticleId></ArticleIdList></Reference><Reference><Citation>Angstwurm MW, Schottdorf J, Schopohl J, Gaertner R. Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Crit Care Med. 1999;27:1807&#x2013;1813. doi: 10.1097/00003246-199909000-00017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199909000-00017</ArticleId><ArticleId IdType="pubmed">10507602</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra V, Baines M, Perry SE, McLaughlin PJ, Carson J, Wenstone R, Shenkin A. Effect of selenium supplementation on biochemical markers and outcome in critically ill patients. Clin Nutr. 2007;26:41&#x2013;50. doi: 10.1016/j.clnu.2006.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2006.10.003</ArticleId><ArticleId IdType="pubmed">17174015</ArticleId></ArticleIdList></Reference><Reference><Citation>Angstwurm MW, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, Strauss R, Meier-Hellmann A, Insel R, Radke J, Schuttler J, Gartner R. Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med. 2007;35:118&#x2013;126. doi: 10.1097/01.CCM.0000251124.83436.0E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000251124.83436.0E</ArticleId><ArticleId IdType="pubmed">17095947</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloos F, Trips E, Nierhaus A, Briegel J, Heyland DK, Jaschinski U, Moerer O, Weyland A, Marx G, Grundling M, Kluge S, Kaufmann I, Ott K, Quintel M, Jelschen F, Meybohm P, Rademacher S, Meier-Hellmann A, Utzolino S, Kaisers UX, Putensen C, Elke G, Ragaller M, Gerlach H, Ludewig K, Kiehntopf M, Bogatsch H, Engel C, Brunkhorst FM, Loeffler M, Reinhart K, for SepNet Critical Care Trials G (2016) Effect of sodium selenite administration and procalcitonin-guided therapy on mortality in patients with severe sepsis or septic shock: a randomized clinical trial. JAMA intern med 176: 1266-1276</Citation><ArticleIdList><ArticleId IdType="pubmed">27428731</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavalipati N, Shah J, Ramakrishan A, Vasnawala H. Pleiotropic effects of statins. Indian J Endocrinol Metab. 2015;19:554&#x2013;562. doi: 10.4103/2230-8210.163106.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2230-8210.163106</ArticleId><ArticleId IdType="pmc">PMC4566334</ArticleId><ArticleId IdType="pubmed">26425463</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y, Zhu G, Han L, Hou F, Huang W, Liu H, Gan J, Jiang T, Li X, Wang W, Ding S, Jia S, Shen W, Wang D, Sun L, Qiu J, Wang X, Li Y, Deng J, Li J, Xu K, Xu B, Mehran R, Huo Y. Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease. J Am Coll Cardiol. 2014;63:62&#x2013;70. doi: 10.1016/j.jacc.2013.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2013.09.017</ArticleId><ArticleId IdType="pubmed">24076297</ArticleId></ArticleIdList></Reference><Reference><Citation>Leoncini M, Toso A, Maioli M, Tropeano F, Villani S, Bellandi F. Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: results from the PRATO-ACS Study (Protective EFFECT of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome) J Am Coll Cardiol. 2014;63:71&#x2013;79. doi: 10.1016/j.jacc.2013.04.105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2013.04.105</ArticleId><ArticleId IdType="pubmed">24076283</ArticleId></ArticleIdList></Reference><Reference><Citation>Quintavalle C, Fiore D, De Micco F, Visconti G, Focaccio A, Golia B, Ricciardelli B, Donnarumma E, Bianco A, Zabatta MA, Troncone G, Colombo A, Briguori C, Condorelli G. Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury. Circulation. 2012;126:3008&#x2013;3016. doi: 10.1161/CIRCULATIONAHA.112.103317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.112.103317</ArticleId><ArticleId IdType="pubmed">23147173</ArticleId></ArticleIdList></Reference><Reference><Citation>Shehata M, Hamza M. Impact of high loading dose of atorvastatin in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention: a randomized controlled trial. Cardiovasc Ther. 2015;33:35&#x2013;41. doi: 10.1111/1755-5922.12108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1755-5922.12108</ArticleId><ArticleId IdType="pubmed">25677920</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Li Y, Xu B, Jia G, Guo T, Wang D, Xu K, Deng J, Han Y. Short-term rosuvastatin therapy prevents contrast-induced acute kidney injury in female patients with diabetes and chronic kidney disease: a subgroup analysis of the TRACK-D study. J Thorac Dis. 2016;8:1000&#x2013;1006. doi: 10.21037/jtd.2016.03.26.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2016.03.26</ArticleId><ArticleId IdType="pmc">PMC4842819</ArticleId><ArticleId IdType="pubmed">27162677</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbieri L, Verdoia M, Schaffer A, Nardin M, Marino P, De Luca G. The role of statins in the prevention of contrast induced nephropathy: a meta-analysis of 8 randomized trials. J Thromb Thrombolysis. 2014;38:493&#x2013;502. doi: 10.1007/s11239-014-1076-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-014-1076-3</ArticleId><ArticleId IdType="pubmed">24705677</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JM, Park J, Jeon KH, Jung JH, Lee SE, Han JK, Kim HL, Yang HM, Park KW, Kang HJ, Koo BK, Jo SH, Kim HS. Efficacy of short-term high-dose statin pretreatment in prevention of contrast-induced acute kidney injury: updated study-level meta-analysis of 13 randomized controlled trials. PLoS One. 2014;9:e111397. doi: 10.1371/journal.pone.0111397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0111397</ArticleId><ArticleId IdType="pmc">PMC4219719</ArticleId><ArticleId IdType="pubmed">25369120</ArticleId></ArticleIdList></Reference><Reference><Citation>Ukaigwe A, Karmacharya P, Mahmood M, Pathak R, Aryal MR, Jalota L, Donato AA. Meta-analysis on efficacy of statins for prevention of contrast-induced acute kidney injury in patients undergoing coronary angiography. Am J Cardiol. 2014;114:1295&#x2013;1302. doi: 10.1016/j.amjcard.2014.07.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2014.07.059</ArticleId><ArticleId IdType="pubmed">25239829</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh N, Lee JZ, Huang JJ, Low SW, Howe C, Pandit A, Suryanarayana P, Lee KS. Benefit of statin pretreatment in prevention of contrast-induced nephropathy in different adult patient population: systematic review and meta-analysis. Open Heart. 2014;1:e000127. doi: 10.1136/openhrt-2014-000127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/openhrt-2014-000127</ArticleId><ArticleId IdType="pmc">PMC4189228</ArticleId><ArticleId IdType="pubmed">25332824</ArticleId></ArticleIdList></Reference><Reference><Citation>Marenzi G, Cosentino N, Werba JP, Tedesco CC, Veglia F, Bartorelli AL. A meta-analysis of randomized controlled trials on statins for the prevention of contrast-induced acute kidney injury in patients with and without acute coronary syndromes. Int J Cardiol. 2015;183:47&#x2013;53. doi: 10.1016/j.ijcard.2015.01.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2015.01.046</ArticleId><ArticleId IdType="pubmed">25662053</ArticleId></ArticleIdList></Reference><Reference><Citation>Liakopoulos OJ, Choi YH, Haldenwang PL, Strauch J, Wittwer T, Dorge H, Stamm C, Wassmer G, Wahlers T. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients. Eur Heart J. 2008;29:1548&#x2013;1559. doi: 10.1093/eurheartj/ehn198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehn198</ArticleId><ArticleId IdType="pubmed">18506053</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Gu C, Gao M, Yu W, Yu Y. Preoperative statin therapy and renal outcomes after cardiac surgery: a meta-analysis and meta-regression of 59,771 patients. Can J Cardiol. 2015;31:1051&#x2013;1060. doi: 10.1016/j.cjca.2015.02.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2015.02.034</ArticleId><ArticleId IdType="pubmed">26081692</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewicki M, Ng I, Schneider AG. HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass. Cochrane Database Syst Rev. 2015;3:CD010480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10788137</ArticleId><ArticleId IdType="pubmed">25758322</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FT, Hendricks PA, Schildcrout JS, Shi Y, Petracek MR, Byrne JG, Brown NJ. High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial. JAMA. 2016;315:877&#x2013;888. doi: 10.1001/jama.2016.0548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0548</ArticleId><ArticleId IdType="pmc">PMC4843765</ArticleId><ArticleId IdType="pubmed">26906014</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JH, Shim JK, Song JW, Soh S, Kwak YL. Effect of atorvastatin on the incidence of acute kidney injury following valvular heart surgery: a randomized, placebo-controlled trial. Intensive Care Med. 2016;42:1398&#x2013;1407. doi: 10.1007/s00134-016-4358-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4358-8</ArticleId><ArticleId IdType="pubmed">27120082</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z, Jayaram R, Jiang L, Emberson J, Zhao Y, Li Q, Du J, Guarguagli S, Hill M, Chen Z, Collins R, Casadei B. Perioperative rosuvastatin in cardiac surgery. N Engl J Med. 2016;374:1744&#x2013;1753. doi: 10.1056/NEJMoa1507750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1507750</ArticleId><ArticleId IdType="pubmed">27144849</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, Schmidt C, Van Aken H, Wempe C, Martens S, Zahn PK, Wolf B, Goebel U, Schwer CI, Rosenberger P, Haeberle H, Gorlich D, Kellum JA, Meersch M, Renal RI. Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA. 2015;313:2133&#x2013;2141. doi: 10.1001/jama.2015.4189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.4189</ArticleId><ArticleId IdType="pubmed">26024502</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmerman RF, Ezeanuna PU, Kane JC, Cleland CD, Kempananjappa TJ, Lucas FL, Kramer RS. Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery. Kidney Int. 2011;80:861&#x2013;867. doi: 10.1038/ki.2011.156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2011.156</ArticleId><ArticleId IdType="pubmed">21677633</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim TK, Min JJ, Cho YJ, Hausenloy DJ, Ahn H, Kim KH, Hwang HY, Hong DM, Jeon Y. Effects of delayed remote ischemic preconditioning on peri-operative myocardial injury in patients undergoing cardiac surgery&#x2014;a randomized controlled trial. Int J Cardiol. 2017;227:511&#x2013;515. doi: 10.1016/j.ijcard.2016.10.111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2016.10.111</ArticleId><ArticleId IdType="pubmed">27839807</ArticleId></ArticleIdList></Reference><Reference><Citation>Meybohm P, Bein B, Brosteanu O, Cremer J, Gruenewald M, Stoppe C, Coburn M, Schaelte G, Boning A, Niemann B, Roesner J, Kletzin F, Strouhal U, Reyher C, Laufenberg-Feldmann R, Ferner M, Brandes IF, Bauer M, Stehr SN, Kortgen A, Wittmann M, Baumgarten G, Meyer-Treschan T, Kienbaum P, Heringlake M, Schon J, Sander M, Treskatsch S, Smul T, Wolwender E, Schilling T, Fuernau G, Hasenclever D, Zacharowski K. A multicenter trial of remote ischemic preconditioning for heart surgery. N Engl J Med. 2015;373:1397&#x2013;1407. doi: 10.1056/NEJMoa1413579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1413579</ArticleId><ArticleId IdType="pubmed">26436208</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong DM, Lee EH, Kim HJ, Min JJ, Chin JH, Choi DK, Bahk JH, Sim JY, Choi IC, Jeon Y. Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote Ischaemic Preconditioning with Postconditioning Outcome Trial. Eur Heart J. 2014;35:176&#x2013;183. doi: 10.1093/eurheartj/eht346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/eht346</ArticleId><ArticleId IdType="pubmed">24014392</ArticleId></ArticleIdList></Reference><Reference><Citation>Hausenloy DJ, Candilio L, Evans R, Ariti C, Jenkins DP, Kolvekar S, Knight R, Kunst G, Laing C, Nicholas J, Pepper J, Robertson S, Xenou M, Clayton T, Yellon DM, ERICCA Trial Investigators Remote ischemic preconditioning and outcomes of cardiac surgery. N Engl J Med. 2015;373:1408&#x2013;1417. doi: 10.1056/NEJMoa1413534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1413534</ArticleId><ArticleId IdType="pubmed">26436207</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh M, Whitlock R, Garg AX, Legare JF, Duncan AE, Zimmerman R, Miller S, Fremes S, Kieser T, Karthikeyan G, Chan M, Ho A, Nasr V, Vincent J, Ali I, Lavi R, Sessler DI, Kramer R, Gardner J, Syed S, VanHelder T, Guyatt G, Rao-Melacini P, Thabane L, Devereaux PJ, Remote IMPACT Investigators Effects of remote ischemic preconditioning in high-risk patients undergoing cardiac surgery (Remote IMPACT): a randomized controlled trial. CMAJ. 2016;188:329&#x2013;336. doi: 10.1503/cmaj.150632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.150632</ArticleId><ArticleId IdType="pmc">PMC4786386</ArticleId><ArticleId IdType="pubmed">26668200</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Diao Y, Chen G, Tanaka A, Eastwood GM, Bellomo R. Remote ischemic conditioning for kidney protection: a meta-analysis. J Crit Care. 2016;33:224&#x2013;232. doi: 10.1016/j.jcrc.2016.01.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2016.01.026</ArticleId><ArticleId IdType="pubmed">26936039</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou C, Jeon Y, Meybohm P, Zarbock A, Young PJ, Li L, Hausenloy DJ. Renoprotection by remote ischemic conditioning during elective coronary revascularization: a systematic review and meta-analysis of randomized controlled trials. Int J Cardiol. 2016;222:295&#x2013;302. doi: 10.1016/j.ijcard.2016.07.176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2016.07.176</ArticleId><ArticleId IdType="pubmed">27498373</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Lang XB, Zhang P, Lv R, Wang YF, Chen JH. Remote ischemic preconditioning for prevention of acute kidney injury: a meta-analysis of randomized controlled trials. Am J Kidney Dis. 2014;64:574&#x2013;583. doi: 10.1053/j.ajkd.2014.04.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2014.04.029</ArticleId><ArticleId IdType="pubmed">24954246</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Lang X, Cao L, Wang Y, Lu Y, Feng S, Yang Y, Chen J, Jiang H. Effect of remote ischemic preconditioning on postoperative acute kidney injury among patients undergoing cardiac and vascular interventions: a meta-analysis. J Nephrol. 2017;30:19&#x2013;33. doi: 10.1007/s40620-016-0301-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40620-016-0301-x</ArticleId><ArticleId IdType="pmc">PMC5316401</ArticleId><ArticleId IdType="pubmed">27091767</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J, Liu S, Jia P, Xu X, Song N, Zhang T, Chen R, Ding X. Protection of remote ischemic preconditioning against acute kidney injury: a systematic review and meta-analysis. Crit Care. 2016;20:111. doi: 10.1186/s13054-016-1272-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1272-y</ArticleId><ArticleId IdType="pmc">PMC4837562</ArticleId><ArticleId IdType="pubmed">27095379</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce B, Bole I, Patel V, Brown DL (2017) Clinical outcomes of remote ischemic preconditioning prior to cardiac surgery: a meta-analysis of randomized controlled trials. J Am Heart Assoc. doi:10.1161/JAHA.116.004666</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5523764</ArticleId><ArticleId IdType="pubmed">28219918</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi B, Chen X, Shi H, Lin T, Lin H, Xu Y, Rong J (2017) Remote ischaemic preconditioning reduces acute kidney injury in adult patients undergoing cardiac surgery with cardiopulmonary bypass: a meta-analysis. Eur J Cardiothorac Surg 51:616&#x2013;623</Citation><ArticleIdList><ArticleId IdType="pubmed">28329336</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou C, Bulluck H, Fang N, Li L, Hausenloy DJ. Age and surgical complexity impact on renoprotection by remote ischemic preconditioning during adult cardiac surgery: a meta analysis. Sci Rep. 2017;7:215. doi: 10.1038/s41598-017-00308-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-00308-3</ArticleId><ArticleId IdType="pmc">PMC5428278</ArticleId><ArticleId IdType="pubmed">28303021</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Zhang X, Chi D, Wang S, Wei H, Yu H, Li Q, Liu B. Remote ischemic preconditioning for prevention of acute kidney injury in patients undergoing on-pump cardiac surgery: a systematic review and meta-analysis. Medicine. 2016;95:e3465. doi: 10.1097/MD.0000000000003465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000003465</ArticleId><ArticleId IdType="pmc">PMC5402542</ArticleId><ArticleId IdType="pubmed">27631199</ArticleId></ArticleIdList></Reference><Reference><Citation>Pei H, Wu Y, Wei Y, Yang Y, Teng S, Zhang H. Remote ischemic preconditioning reduces perioperative cardiac and renal events in patients undergoing elective coronary intervention: a meta-analysis of 11 randomized trials. PLoS One. 2014;9:e115500. doi: 10.1371/journal.pone.0115500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0115500</ArticleId><ArticleId IdType="pmc">PMC4281209</ArticleId><ArticleId IdType="pubmed">25551671</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Li G, Yu C, Li Y. The role of remote ischemic preconditioning on postoperative kidney injury in patients undergoing cardiac and vascular interventions: a meta-analysis. J Cardiothorac Surg. 2013;8:43. doi: 10.1186/1749-8090-8-43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-8090-8-43</ArticleId><ArticleId IdType="pmc">PMC3639828</ArticleId><ArticleId IdType="pubmed">23497625</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukkar L, Hong D, Wong MG, Badve SV, Rogers K, Perkovic V, Walsh M, Yu X, Hillis GS, Gallagher M, Jardine M. Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: systematic review and meta-analysis. BMJ. 2016;355:i5599. doi: 10.1136/bmj.i5599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i5599</ArticleId><ArticleId IdType="pmc">PMC5098417</ArticleId><ArticleId IdType="pubmed">27821641</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou CC, Ge YZ, Yao WT, Wu R, Xin H, Lu TZ, Li MH, Song KW, Wang M, Zhu YP, Zhu M, Geng LG, Gao XF, Zhou LH, Zhang SL, Zhu JG, Jia RP. Limited clinical utility of remote ischemic conditioning in renal transplantation: a meta-analysis of randomized controlled trials. PLoS One. 2017;12:e0170729. doi: 10.1371/journal.pone.0170729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0170729</ArticleId><ArticleId IdType="pmc">PMC5271340</ArticleId><ArticleId IdType="pubmed">28129389</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolhe NV, Reilly T, Leung J, Fluck RJ, Swinscoe KE, Selby NM, Taal MW. A simple care bundle for use in acute kidney injury: a propensity score-matched cohort study. Nephrol Dial Transplant. 2016;31:1846&#x2013;1854. doi: 10.1093/ndt/gfw087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfw087</ArticleId><ArticleId IdType="pubmed">27190331</ArticleId></ArticleIdList></Reference><Reference><Citation>Joslin J, Wilson H, Zubli D, Gauge N, Kinirons M, Hopper A, Pile T, Ostermann M. Recognition and management of acute kidney injury in hospitalised patients can be partially improved with the use of a care bundle. Clinic Med (Lond) 2015;15:431&#x2013;436. doi: 10.7861/clinmedicine.15-5-431.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmedicine.15-5-431</ArticleId><ArticleId IdType="pmc">PMC4953226</ArticleId><ArticleId IdType="pubmed">26430180</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhagwanani A, Carpenter R, Yusuf A (2014) Improving the management of acute kidney injury in a district general hospital: introduction of the DONUT bundle. BMJ Qual Improv Rep. doi:10.1136/bmjquality.u202650.w1235</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4663825</ArticleId><ArticleId IdType="pubmed">26734238</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M, Schmidt C, Hoffmeier A, Van Aken H, Wempe C, Gerss J, Zarbock A (2017) Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med. doi:10.1007/s00134-016-4670-3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5633630</ArticleId><ArticleId IdType="pubmed">28110412</ArticleId></ArticleIdList></Reference><Reference><Citation>Angus DC, Barnato AE, Bell D, Bellomo R, Chong CR, Coats TJ, Davies A, Delaney A, Harrison DA, Holdgate A, Howe B, Huang DT, Iwashyna T, Kellum JA, Peake SL, Pike F, Reade MC, Rowan KM, Singer M, Webb SA, Weissfeld LA, Yealy DM, Young JD. A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe investigators. Intensive Care Med. 2015;41:1549&#x2013;1560. doi: 10.1007/s00134-015-3822-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3822-1</ArticleId><ArticleId IdType="pubmed">25952825</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative workgroup Acute renal failure&#x2014;definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204&#x2013;R212. doi: 10.1186/cc2872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc2872</ArticleId><ArticleId IdType="pmc">PMC522841</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. Acute Kidney Injury Network (AKIN): report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31. doi: 10.1186/cc5713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc5713</ArticleId><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35544772</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>135</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Society of Cardiovascular Anesthesiologists Clinical Practice Update for Management of Acute Kidney Injury Associated With Cardiac Surgery.</ArticleTitle><Pagination><StartPage>744</StartPage><EndPage>756</EndPage><MedlinePgn>744-756</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000006068</ELocationID><Abstract><AbstractText>Cardiac surgery-associated acute kidney injury (CS-AKI) is common and is associated with increased risk for postoperative morbidity and mortality. Our recent survey of the Society of Cardiovascular Anesthesiologists (SCA) membership showed 6 potentially renoprotective strategies for which clinicians would most value an evidence-based review (ie, intraoperative target blood pressure, choice of specific vasopressor agent, erythrocyte transfusion threshold, use of alpha-2 agonists, goal-directed oxygen delivery on cardiopulmonary bypass [CPB], and the "Kidney Disease Improving Global Outcomes [KDIGO] bundle of care"). Thus, the SCA's Continuing Practice Improvement Acute Kidney Injury Working Group aimed to provide a practice update for each of these strategies in cardiac surgical patients based on the evidence from randomized controlled trials (RCTs). PubMed, EMBASE, and Cochrane library databases were comprehensively searched for eligible studies from inception through February 2021, with search results updated in August 2021. A total of 15 RCTs investigating the effects of the above-mentioned strategies on CS-AKI were included for meta-analysis. For each strategy, the level of evidence was assessed using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology. Across the 6 potentially renoprotective strategies evaluated, current evidence for their use was rated as "moderate," "low," or "very low." Based on eligible RCTs, our analysis suggested using goal-directed oxygen delivery on CPB and the "KDIGO bundle of care" in high-risk patients to prevent CS-AKI (moderate level of GRADE evidence). Our results suggested considering the use of vasopressin in vasoplegic shock patients to reduce CS-AKI (low level of GRADE evidence). The decision to use a restrictive versus liberal strategy for perioperative red cell transfusion should not be based on concerns for renal protection (a moderate level of GRADE evidence). In addition, targeting a higher mean arterial pressure during CPB, perioperative use of dopamine, and use of dexmedetomidine did not reduce CS-AKI (a low or very low level of GRADE evidence). This review will help clinicians provide evidence-based care, targeting improved renal outcomes in adult patients undergoing cardiac surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 International Anesthesia Research Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Ke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology and Pain Medicine, University of California Davis Health, Sacramento, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>First Affiliated Hospital of Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McIlroy</LastName><ForeName>David R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bollen</LastName><ForeName>Bruce A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The International Heart Institute of Montana, Missoula, Montana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Billings</LastName><ForeName>Frederic T</ForeName><Initials>FT</Initials><Suffix>4th</Suffix><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zarbock</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital of Muenster, Muenster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Popescu</LastName><ForeName>Wanda M</ForeName><Initials>WM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Yale University School of Medicine, Easton, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fox</LastName><ForeName>Amanda A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center, Dallas, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shore-Lesserson</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Northwell Health, Manhasset, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Shaofeng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Texas Medical School, Sugar Land, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geube</LastName><ForeName>Mariya A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anesthesiology, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Fuhai</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>First Affiliated Hospital of Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhatia</LastName><ForeName>Meena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of North Carolina, Chapel Hill, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwann</LastName><ForeName>Nanette M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Lehigh Valley Health Network, Allentown, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Andrew D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Intensive Care and Resuscitation, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology and Pain Medicine, University of California Davis Health, Sacramento, California.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical><Chemical><RegistryNumber>VTD58H1Z2X</RegistryNumber><NameOfSubstance UI="D004298">Dopamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072080" MajorTopicYN="N">Anesthesiologists</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="Y">Dexmedetomidine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004298" MajorTopicYN="N">Dopamine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="N">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>11</Day><Hour>17</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35544772</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000006068</ArticleId><ArticleId IdType="pii">00000539-202210000-00017</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Meersch M, Zarbock A. Prevention of cardiac surgery-associated acute kidney injury. Curr Opin Anaesthesiol. 2017;30:76&#x2013;83.</Citation></Reference><Reference><Citation>Wang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol. 2017;13:697&#x2013;711.</Citation></Reference><Reference><Citation>Ricci Z, Cruz DN, Ronco C. Classification and staging of acute kidney injury: beyond the RIFLE and AKIN criteria. Nat Rev Nephrol. 2011;7:201&#x2013;208.</Citation></Reference><Reference><Citation>Thomas ME, Blaine C, Dawnay A, et al. The definition of acute kidney injury and its use in practice. Kidney Int. 2015;87:62&#x2013;73.</Citation></Reference><Reference><Citation>Sutherland L, Hittesdorf E, Yoh N, Lai T, Mechling A, Wagener G. Acute kidney injury after cardiac surgery: a comparison of different definitions. Nephrology (Carlton). 2020;25:212&#x2013;218.</Citation></Reference><Reference><Citation>Massoth C, Zarbock A, Meersch M. Risk stratification for targeted AKI prevention after surgery: biomarkers and bundled interventions. Semin Nephrol. 2019;39:454&#x2013;461.</Citation></Reference><Reference><Citation>McIlroy DR, Roman B, Billings FT IV, . Potential renoprotective strategies in adult cardiac surgery: a survey of Society of Cardiovascular Anesthesiologists members to explore the rationale and beliefs driving current clinical decision-making. J Cardiothorac Vasc Anesth. 2021;35:2043&#x2013;2051.</Citation></Reference><Reference><Citation>Peng K, Li D, Applegate RL II, Lubarsky DA, Ji FH, Liu H. Effect of dexmedetomidine on cardiac surgery-associated acute kidney injury: a meta-analysis with trial sequential analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2020;34:603&#x2013;613.</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557&#x2013;560.</Citation></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, et al.; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924&#x2013;926.</Citation></Reference><Reference><Citation>Azau A, Markowicz P, Corbeau JJ, et al. Increasing mean arterial pressure during cardiac surgery does not reduce the rate of postoperative acute kidney injury. Perfusion. 2014;29:496&#x2013;504.</Citation></Reference><Reference><Citation>Kandler K, Nilsson JC, Oturai P, et al. Higher arterial pressure during cardiopulmonary bypass may not reduce the risk of acute kidney injury. J Cardiothorac Surg. 2019;14:107.</Citation></Reference><Reference><Citation>Vedel AG, Holmgaard F, Rasmussen LS, et al. High-target versus low-target blood pressure management during cardiopulmonary bypass to prevent cerebral injury in cardiac surgery patients: a randomized controlled trial. Circulation. 2018;137:1770&#x2013;1780.</Citation></Reference><Reference><Citation>Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol. 2000;11:97&#x2013;104.</Citation></Reference><Reference><Citation>Hajjar LA, Vincent JL, Barbosa Gomes Galas FR, et al. Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: the VANCS randomized controlled trial. Anesthesiology. 2017;126:85&#x2013;93.</Citation></Reference><Reference><Citation>Garg AX, Badner N, Bagshaw SM, et al.; TRICS Investigators and Perioperative Anesthesia Clinical Trials Group. Safety of a restrictive versus liberal approach to red blood cell transfusion on the outcome of AKI in patients undergoing cardiac surgery: a randomized clinical trial. J Am Soc Nephrol. 2019;30:1294&#x2013;1304.</Citation></Reference><Reference><Citation>Hajjar LA, Vincent JL, Galas FR, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA. 2010;304:1559&#x2013;1567.</Citation></Reference><Reference><Citation>Cho JS, Shim JK, Soh S, Kim MK, Kwak YL. Perioperative dexmedetomidine reduces the incidence and severity of acute kidney injury following valvular heart surgery. Kidney Int. 2016;89:693&#x2013;700.</Citation></Reference><Reference><Citation>Li X, Yang J, Nie XL, et al. Impact of dexmedetomidine on the incidence of delirium in elderly patients after cardiac surgery: a randomized controlled trial. PLoS One. 2017;12:e0170757.</Citation></Reference><Reference><Citation>Soh S, Shim JK, Song JW, et al. Effect of dexmedetomidine on acute kidney injury after aortic surgery: a single-centre, placebo-controlled, randomised controlled trial. Br J Anaesth. 2020; S0007-0912(20)30001-5. doi:10.1016/j.bja.2019.12.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2019.12.036</ArticleId></ArticleIdList></Reference><Reference><Citation>Turan A, Duncan A, Leung S, et al.; DECADE Study Group. Dexmedetomidine for reduction of atrial fibrillation and delirium after cardiac surgery (DECADE): a randomised placebo-controlled trial. Lancet. 2020;396:177&#x2013;185.</Citation></Reference><Reference><Citation>Ranucci M, Johnson I, Willcox T, et al. Goal-directed perfusion to reduce acute kidney injury: a randomized trial. J Thorac Cardiovasc Surg. 2018;156:1918&#x2013;1927.e2.</Citation></Reference><Reference><Citation>Mukaida H, Matsushita S, Yamamoto T, et al. Oxygen delivery-guided perfusion for the prevention of acute kidney injury: a randomized controlled trial. J Thorac Cardiovasc Surg. 2021;S0022-5223(21)00511-0. doi:10.1016/j.jtcvs.2021.03.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2021.03.032</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M, Schmidt C, Hoffmeier A, et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med. 2017;43:1551&#x2013;1561.</Citation></Reference><Reference><Citation>Zarbock A, K&#xfc;llmar M, Ostermann M, et al. Prevention of cardiac surgery-associated acute kidney injury by implementing the KDIGO guidelines in high-risk patients identified by biomarkers: the PrevAKI-multicenter randomized controlled trial. Anesth Analg. 2021;133:292&#x2013;302.</Citation></Reference><Reference><Citation>Ngu JMC, Jabagi H, Chung AM, et al. Defining an intraoperative hypotension threshold in association with de novo renal replacement therapy after cardiac surgery. Anesthesiology. 2020;132:1447&#x2013;1457.</Citation></Reference><Reference><Citation>Guyton AC, Hall JE. Textbook of Medical Physiology. Elsevier Saunders, 2006:323.</Citation></Reference><Reference><Citation>James A, Amour J. Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: a discussion of the level of evidence. Anesthesiology. 2018;128:228.</Citation></Reference><Reference><Citation>Nadim MK, Forni LG, Bihorac A, et al. Cardiac and vascular surgery-associated acute kidney injury: the 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) Group. J Am Heart Assoc. 2018;7:e008834.</Citation></Reference><Reference><Citation>Khanna A, English SW, Wang XS, et al.; ATHOS-3 Investigators. Angiotensin II for the treatment of vasodilatory shock. N Engl J Med. 2017;377:419&#x2013;430.</Citation></Reference><Reference><Citation>Delaney M, Wendel S, Bercovitz RS, et al.; Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Transfusion reactions: prevention, diagnosis, and treatment. Lancet. 2016;388:2825&#x2013;2836.</Citation></Reference><Reference><Citation>Miceli A, Romeo F, Glauber M, de Siena PM, Caputo M, Angelini GD. Preoperative anemia increases mortality and postoperative morbidity after cardiac surgery. J Cardiothorac Surg. 2014;9:137.</Citation></Reference><Reference><Citation>Chen QH, Wang HL, Liu L, Shao J, Yu J, Zheng RQ. Effects of restrictive red blood cell transfusion on the prognoses of adult patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials. Crit Care. 2018;22:142.</Citation></Reference><Reference><Citation>Liu Y, Sheng B, Wang S, Lu F, Zhen J, Chen W. Dexmedetomidine prevents acute kidney injury after adult cardiac surgery: a meta-analysis of randomized controlled trials. BMC Anesthesiol. 2018;18:7.</Citation></Reference><Reference><Citation>Magruder JT, Dungan SP, Grimm JC, et al. Nadir oxygen delivery on bypass and hypotension increase acute kidney injury risk after cardiac operations. Ann Thorac Surg. 2015;100:1697&#x2013;1703.</Citation></Reference><Reference><Citation>Ranucci M, Romitti F, Isgr&#xf2; G, et al. Oxygen delivery during cardiopulmonary bypass and acute renal failure after coronary operations. Ann Thorac Surg. 2005;80:2213&#x2013;2220.</Citation></Reference><Reference><Citation>de Somer F, Mulholland JW, Bryan MR, Aloisio T, Van Nooten GJ, Ranucci M. O 2 delivery and CO 2 production during cardiopulmonary bypass as determinants of acute kidney injury: time for a goal-directed perfusion management? Crit Care. 2011;15:R192.</Citation></Reference><Reference><Citation>McGuinness SP, Parke RL, Drummond K, et al.; SO-COOL investigators. A multicenter, randomized, controlled phase IIb trial of avoidance of hyperoxemia during cardiopulmonary bypass. Anesthesiology. 2016;125:465&#x2013;473.</Citation></Reference><Reference><Citation>Engelman DT, Lother S, George I, et al.; Society of Thoracic Surgeons COVID-19 Task Force. Adult cardiac surgery and the COVID-19 pandemic: aggressive infection mitigation strategies are necessary in the operating room and surgical recovery. J Thorac Cardiovasc Surg. 2020;160:447&#x2013;451.</Citation></Reference><Reference><Citation>Pathak S, Olivieri G, Mohamed W, et al. Pharmacological interventions for the prevention of renal injury in surgical patients: a systematic literature review and meta-analysis. Br J Anaesth. 2021;126:131&#x2013;138.</Citation></Reference><Reference><Citation>McIlroy DR, Bellomo R, Billings FT IV, . Systematic review and consensus definitions for the Standardised Endpoints in Perioperative Medicine (StEP) initiative: renal endpoints. Br J Anaesth. 2018;121:1013&#x2013;1024.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38954672</PMID><DateCompleted><Year>2025</Year><Month>03</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-9159</ISSN><JournalIssue CitedMedium="Internet"><Volume>111</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of surgery (London, England)</Title><ISOAbbreviation>Int J Surg</ISOAbbreviation></Journal><ArticleTitle>Association between frailty and acute kidney injury after cardiac surgery: unraveling the moderation effect of body fat through an international, retrospective, multicohort study.</ArticleTitle><Pagination><StartPage>761</StartPage><EndPage>770</EndPage><MedlinePgn>761-770</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/JS9.0000000000001861</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute kidney injury (AKI) is a common and serious complication after cardiac surgery that significantly affects patient outcomes. Given the limited treatment options available, identifying modifiable risk factors is critical. Frailty and obesity, two heterogeneous physiological states, have significant implications for identifying and preventing AKI. Our study investigated the interplay among frailty, body composition, and AKI risk after cardiac surgery to inform patient management strategies.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">This retrospective cohort study included three international cohorts. Primary analysis was conducted on adult patients who underwent cardiac surgery between 2014 and 2019 at Wuhan Union Hospital, China. We tested the generalizability of our findings with data from two independent international cohorts, the Medical Information Mart for Intensive Care IV (MIMIC-IV) and the eICU Collaborative Research Database. Frailty was assessed using a clinical lab-based frailty index (FI-LAB), while total body fat percentage (BF%) was calculated based on a formula accounting for BMI, sex, and age. Logistic regression models were used to analyze the associations between frailty, body fat, and AKI, adjusting for pertinent covariates.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 8785 patients across three international cohorts were included in the study. In the primary analysis of 3569 patients from Wuhan Union Hospital, moderate and severe frailty were associated with an increased AKI risk after cardiac surgery. Moreover, a nonlinear relationship was observed between BF% and AKI risk. When stratified by the degree of frailty, lower body fat correlated with a decreased incidence of AKI. Extended analyses using the MIMIC-IV and eICU cohorts ( n =3951 and n =1265, respectively) validated these findings and demonstrated that a lower total BF% was associated with decreased AKI incidence. Moderation analysis revealed that the effect of frailty on AKI risk was moderated by the BF%. Sensitivity analyses demonstrated results consistent with the main analyses.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Higher degrees of frailty were associated with an elevated risk of AKI following cardiac surgery, and total BF% moderated this relationship. This research underscores the significance of integrating frailty and body fat assessments into routine cardiovascular care to identify high-risk patients for AKI and implement personalized interventions to improve patient outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Yun-Xiao</ForeName><Initials>YX</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Anesthesiology and Resuscitation (Huazhong University of Science and Technology), Ministry of Education, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zi-Hao</ForeName><Initials>ZH</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Anesthesiology and Resuscitation (Huazhong University of Science and Technology), Ministry of Education, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Anesthesiology and Resuscitation (Huazhong University of Science and Technology), Ministry of Education, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Zhen-Zhen</ForeName><Initials>ZZ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Anesthesiology and Resuscitation (Huazhong University of Science and Technology), Ministry of Education, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Yi-Qi</ForeName><Initials>YQ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Anesthesiology and Resuscitation (Huazhong University of Science and Technology), Ministry of Education, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Guo-Yang</ForeName><Initials>GY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Anesthesiology and Resuscitation (Huazhong University of Science and Technology), Ministry of Education, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Ping</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yan-Ting</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Anesthesiology and Resuscitation (Huazhong University of Science and Technology), Ministry of Education, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Nian-Guo</ForeName><Initials>NG</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Qing-Ping</ForeName><Initials>QP</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Anesthesiology and Resuscitation (Huazhong University of Science and Technology), Ministry of Education, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>01</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Surg</MedlineTA><NlmUniqueID>101228232</NlmUniqueID><ISSNLinking>1743-9159</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073496" MajorTopicYN="Y">Frailty</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000273" MajorTopicYN="Y">Adipose Tissue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The author(s) have no potential conflicts of interest to disclose. Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>7</Day><Hour>18</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>2</Day><Hour>21</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>2</Day><Hour>14</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>1</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38954672</ArticleId><ArticleId IdType="pmc">PMC11745703</ArticleId><ArticleId IdType="doi">10.1097/JS9.0000000000001861</ArticleId><ArticleId IdType="pii">01279778-990000000-01754</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol 2017;13:697&#x2013;711.</Citation><ArticleIdList><ArticleId IdType="pubmed">28869251</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Gao Y, Tian Y, et al. . Prediction of acute kidney injury after cardiac surgery from preoperative N-terminal pro-B-type natriuretic peptide. Br J Anaesth 2021;127:862&#x2013;870.</Citation><ArticleIdList><ArticleId IdType="pubmed">34561052</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernardi MH, Schmidlin D, Ristl R, et al. . Serum creatinine back-estimation in cardiac surgery patients: misclassification of AKI using existing formulae and a data-driven model. Clin J Am Soc Nephrol 2016;11:395&#x2013;404.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4791819</ArticleId><ArticleId IdType="pubmed">26801479</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao H, Katz N, Ariyanon W, et al. . Cardiac surgery-associated acute kidney injury. Cardiorenal Med 2013;3:178&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3884176</ArticleId><ArticleId IdType="pubmed">24454314</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson CE, Yavas S, Segal MS, et al. . Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation 2009;119:2444&#x2013;2453.</Citation><ArticleIdList><ArticleId IdType="pubmed">19398670</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EAJ, Bagshaw SM, Bellomo R, et al. . Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intens Care Med 2015;41:1411&#x2013;1423.</Citation><ArticleIdList><ArticleId IdType="pubmed">26162677</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Levy EM, Hammermeister KE, et al. . Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 1998;104:343&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pubmed">9576407</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco C, Bellomo R, Kellum JA. Acute kidney injury. Lancet 2019;394:1949&#x2013;1964.</Citation><ArticleIdList><ArticleId IdType="pubmed">31777389</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickkers P, Darmon M, Hoste E, et al. . Acute kidney injury in the critically ill: an updated review on pathophysiology and management. Intens Care Med 2021;47:835&#x2013;850.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8249842</ArticleId><ArticleId IdType="pubmed">34213593</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoogendijk EO, Afilalo J, Ensrud KE, et al. . Frailty: implications for clinical practice and public health. Lancet 2019;394:1365&#x2013;1375.</Citation><ArticleIdList><ArticleId IdType="pubmed">31609228</ArticleId></ArticleIdList></Reference><Reference><Citation>Dent E, Martin FC, Bergman H, et al. . Management of frailty: opportunities, challenges, and future directions. Lancet 2019;394:1376&#x2013;1386.</Citation><ArticleIdList><ArticleId IdType="pubmed">31609229</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Lup&#xf3;n J, Vid&#xe1;n MT, et al. . Impact of frailty on mortality and hospitalization in chronic heart failure: a systematic review and meta-analysis. J Am Heart Assoc 2018;7:e008251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6405567</ArticleId><ArticleId IdType="pubmed">30571603</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeiren S, Vella-Azzopardi R, Beckw&#xe9;e D, et al. . Frailty and the prediction of negative health outcomes: a meta-analysis. J Am Med Dir Assoc 2016;17:1163.e1&#x2013;1163.e17.</Citation><ArticleIdList><ArticleId IdType="pubmed">27886869</ArticleId></ArticleIdList></Reference><Reference><Citation>Clegg A, Young J, Iliffe S, et al. . Frailty in elderly people. Lancet 2013;381:752&#x2013;762.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4098658</ArticleId><ArticleId IdType="pubmed">23395245</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace LMK, Theou O, Godin J, et al. . Investigation of frailty as a moderator of the relationship between neuropathology and dementia in Alzheimer&#x2019;s disease: a cross-sectional analysis of data from the Rush Memory and Aging Project. Lancet Neurol 2019;18:177&#x2013;184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11062500</ArticleId><ArticleId IdType="pubmed">30663607</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanlon P, Nicholl BI, Jani BD, et al. . Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493&#x2008;737 UK Biobank participants. Lancet Public Health 2018;3:e323&#x2013;e332.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6028743</ArticleId><ArticleId IdType="pubmed">29908859</ArticleId></ArticleIdList></Reference><Reference><Citation>Tutor AW, Lavie CJ, Kachur S, et al. . Updates on obesity and the obesity paradox in cardiovascular diseases. Prog Cardiovasc Dis 2023;78:2&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">36481212</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianchettin RG, Lavie CJ, Lopez-Jimenez F. Challenges in cardiovascular evaluation and management of obese patients: JACC state-of-the-art review. J Am Coll Cardiol 2023;81:490&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pubmed">36725178</ArticleId></ArticleIdList></Reference><Reference><Citation>Despr&#xe9;s JP, Carpentier AC, Tchernof A, et al. . Management of obesity in cardiovascular practice: JACC focus seminar. J Am Coll Cardiol 2021;78:513&#x2013;531.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8609918</ArticleId><ArticleId IdType="pubmed">34325840</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew G, Agha R, Albrecht J, et al. . STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. Int J Surg 2021;96:106165.</Citation><ArticleIdList><ArticleId IdType="pubmed">34774726</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson AEW, Bulgarelli L, Shen L, et al. . MIMIC-IV, a freely accessible electronic health record dataset. Sci Data 2023;10:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9810617</ArticleId><ArticleId IdType="pubmed">36596836</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollard TJ, Johnson AEW, Raffa JD, et al. . The eICU Collaborative Research Database, a freely available multi-center database for critical care research. Sci Data 2018;5:180178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6132188</ArticleId><ArticleId IdType="pubmed">30204154</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012;120:c179&#x2013;c184.</Citation><ArticleIdList><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Howlett SE, Rockwood MR, Mitnitski A, et al. . Standard laboratory tests to identify older adults at increased risk of death. BMC Med 2014;12:171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4190374</ArticleId><ArticleId IdType="pubmed">25288274</ArticleId></ArticleIdList></Reference><Reference><Citation>Blodgett JM, Theou O, Howlett SE, et al. . A frailty index from common clinical and laboratory tests predicts increased risk of death across the life course. Geroscience 2017;39:447&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5636769</ArticleId><ArticleId IdType="pubmed">28866737</ArticleId></ArticleIdList></Reference><Reference><Citation>Deurenberg P, Weststrate JA, Seidell JC. Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. Br J Nutr 1991;65:105&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pubmed">2043597</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaskirbayeva D, West R, Jaafari H, et al. . Progression of frailty as measured by a cumulative deficit index: a systematic review. Ageing Res Rev 2023;84:101789.</Citation><ArticleIdList><ArticleId IdType="pubmed">36396032</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng S, Chen X, Bai K, et al. . Association of the cl&#xed;nica universidad de navarra-body adiposity estimator with type 2 diabetes: a retrospective cohort study. Int J Public Health 2023;68:1606063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10551821</ArticleId><ArticleId IdType="pubmed">37810434</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiesisibieke ZL, Tung TH, Xu QY, et al. . Association of acute kidney injury with frailty in elderly population: a systematic review and meta-analysis. Ren Fail 2019;41:1021&#x2013;1027.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6913666</ArticleId><ArticleId IdType="pubmed">31809623</ArticleId></ArticleIdList></Reference><Reference><Citation>Aykut A, Salman N. Poor nutritional status and frailty associated with acute kidney injury after cardiac surgery: A retrospective observational study. J Card Surg 2022;37:4755&#x2013;4761.</Citation><ArticleIdList><ArticleId IdType="pubmed">36352787</ArticleId></ArticleIdList></Reference><Reference><Citation>Tirupakuzhi Vijayaraghavan BK, Rashan A, Ranganathan L, et al. . Prevalence of frailty and association with patient centered outcomes: a prospective registry-embedded cohort study from India. J Crit Care 2024;80:154509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10830405</ArticleId><ArticleId IdType="pubmed">38134715</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol 2018;15:505&#x2013;522.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6146930</ArticleId><ArticleId IdType="pubmed">30065258</ArticleId></ArticleIdList></Reference><Reference><Citation>Vives M, Hernandez A, Parramon F, et al. . Acute kidney injury after cardiac surgery: prevalence, impact and management challenges. Int J Nephrol Renovasc Dis 2019;12:153&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6612286</ArticleId><ArticleId IdType="pubmed">31303781</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu CY, McCulloch CE, Iribarren C, et al. . Body mass index and risk for end-stage renal disease. Ann Intern Med 2006;144:21&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">16389251</ArticleId></ArticleIdList></Reference><Reference><Citation>Berthoux F, Mariat C, Maillard N. Overweight/obesity revisited as a predictive risk factor in primary IgA nephropathy. Nephrol Dial Transplant 2013;28(suppl 4):iv160&#x2013;iv166.</Citation><ArticleIdList><ArticleId IdType="pubmed">24026246</ArticleId></ArticleIdList></Reference><Reference><Citation>Curran SP, Famure O, Li Y, et al. . Increased recipient body mass index is associated with acute rejection and other adverse outcomes after kidney transplantation. Transplantation 2014;97:64&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">24056619</ArticleId></ArticleIdList></Reference><Reference><Citation>Gross ML, Amann K, Ritz E. Nephron number and renal risk in hypertension and diabetes. J Am Soc Nephrol 2005;16(Suppl 1):S27&#x2013;S29.</Citation><ArticleIdList><ArticleId IdType="pubmed">15938029</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">7678183</ArticleId></ArticleIdList></Reference><Reference><Citation>Clemente-Su&#xe1;rez VJ, Redondo-Fl&#xf3;rez L, Beltr&#xe1;n-Velasco AI, et al. . The Role of Adipokines in Health and Disease. Biomedicines 2023;11:1290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10216288</ArticleId><ArticleId IdType="pubmed">37238961</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser M, Bouter LM, McQuillan GM, et al. . Elevated C-reactive protein levels in overweight and obese adults. Jama 1999;282:2131&#x2013;2135.</Citation><ArticleIdList><ArticleId IdType="pubmed">10591334</ArticleId></ArticleIdList></Reference><Reference><Citation>Basile DP, Anderson MD, Sutton TA. Pathophysiology of acute kidney injury. Compr Physiol 2012;2:1303&#x2013;1353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3919808</ArticleId><ArticleId IdType="pubmed">23798302</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinsey GR, McHowat J, Patrick KS, et al. . Role of Ca2+-independent phospholipase A2gamma in Ca2+-induced mitochondrial permeability transition. J Pharmacol Exp Ther 2007;321:707&#x2013;715.</Citation><ArticleIdList><ArticleId IdType="pubmed">17312185</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldkamp T, Park JS, Pasupulati R, et al. . Regulation of the mitochondrial permeability transition in kidney proximal tubules and its alteration during hypoxia-reoxygenation. Am J Physiol Renal Physiol 2009;297:F1632&#x2013;F1646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2801335</ArticleId><ArticleId IdType="pubmed">19741014</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh SW, Ahn SY, Jianwei X, et al. . Relationship between changes in body fat and a decline of renal function in the elderly. PLoS One 2014;9:e84052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3894176</ArticleId><ArticleId IdType="pubmed">24454716</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma C, Avenell A, Bolland M, et al. . Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis. Bmj 2017;359:j4849.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5682593</ArticleId><ArticleId IdType="pubmed">29138133</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin M, Wu S, Deng X, et al. . Visceral fat and its dynamic change are associated with renal damage: Evidence from two cohorts. Clin Exp Hypertens 2023;45:2271187.</Citation><ArticleIdList><ArticleId IdType="pubmed">37871163</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Gindan YY, Hankey CR, Govan L, et al. . Derivation and validation of simple anthropometric equations to predict adipose tissue mass and total fat mass with MRI as the reference method. Br J Nutr 2015;114:1852&#x2013;1867.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5276707</ArticleId><ArticleId IdType="pubmed">26435103</ArticleId></ArticleIdList></Reference><Reference><Citation>Vel&#xe1;zquez-Alva MC, Irigoyen-Camacho ME, Zepeda-Zepeda MA, et al. . Comparison of body fat percentage assessments by bioelectrical impedance analysis, anthropometrical prediction equations, and dual-energy X-ray absorptiometry in older women. Front Nutr 2022;9:978971.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9812576</ArticleId><ArticleId IdType="pubmed">36618693</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29381513</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>127</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>A Systematic Review of Outcomes Associated With Withholding or Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Before Noncardiac Surgery.</ArticleTitle><Pagination><StartPage>678</StartPage><EndPage>687</EndPage><MedlinePgn>678-687</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000002837</ELocationID><Abstract><AbstractText Label="BACKGROUND">The global rate of major noncardiac surgical procedures is increasing annually, and of those patients presenting for surgery, increasing numbers are taking either an angiotensin-converting enzyme inhibitor (ACE-I) or an angiotensin receptor blocker (ARB). The current recommendations of whether to continue or withhold ACE-I and ARB in the perioperative period are conflicting. Previous meta-analyses have linked preoperative ACE-I/ARB therapy to the increased incidence of postinduction hypotension; however, they have failed to correlate this with adverse patient outcomes. The aim of this meta-analysis was to determine whether continuation or withholding ACE-I or ARB therapy in the perioperative period is associated with mortality and major morbidity.</AbstractText><AbstractText Label="METHODS">This meta-analysis was prospectively registered on PROSPERO (CRD42017055291). A comprehensive search of MEDLINE (PubMed), CINAHL (EBSCO host), ProQuest, Cochrane database, Scopus, and Web of Science was conducted on December 6, 2016. We included adult patients &gt;18 years of age on chronic ACE-I or ARB therapy who underwent noncardiac surgery in which ACE-I or ARB was either withheld or continued on the morning of surgery. Primary outcomes included all-cause mortality and major cardiac events (MACE). Secondary outcomes included the risk of congestive heart failure, acute kidney injury, stroke, intraoperative/postoperative hypotension, and the length of hospital stay.</AbstractText><AbstractText Label="RESULTS">After abstract review, the full text of 25 studies was retrieved, of which 9 fulfilled the inclusion criteria: 5 were randomized control trials, and 4 were cohort studies. These studies included a total of 6022 patients on chronic ACE-I/ARB therapy before noncardiac surgery. A total of 1816 patients withheld treatment the morning of surgery and 4206 continued their ACE-I/ARB. Preoperative demographics were similar between the 2 groups. Withholding ACE-I/ARB therapy was not associated with a difference in mortality (odds ratio [OR], 0.97; 95% confidence interval [CI], 0.62-1.52; I = 0%) or MACE (OR, 1.12; 95% CI, 0.82-1.52; I = 0%). However, withholding therapy was associated with significantly less intraoperative hypotension (OR, 0.63; 95% CI, 0.47-0.85; I = 71%). No effect estimate could be pooled concerning length of hospital stay and congestive heart failure.</AbstractText><AbstractText Label="CONCLUSIONS">This meta-analysis did not demonstrate an association between perioperative administration of ACE-I/ARB and mortality or MACE. It did, however, confirm the current observation that perioperative continuation of ACE-I/ARBs is associated with an increased incidence of intraoperative hypotension. A large randomized control trial is necessary to determine the appropriate perioperative management of ACE-I and ARBs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hollmann</LastName><ForeName>Caryl</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>From the Department of Anaesthesia and Perioperative Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandes</LastName><ForeName>Nicole L</ForeName><Initials>NL</Initials></Author><Author ValidYN="Y"><LastName>Biccard</LastName><ForeName>Bruce M</ForeName><Initials>BM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047228">Angiotensin II Type 1 Receptor Blockers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000806">Angiotensin-Converting Enzyme Inhibitors</NameOfSubstance></Chemical></ChemicalList><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Anesth Analg. 2018 Sep;127(3):598-600. doi: 10.1213/ANE.0000000000003516.</RefSource><PMID Version="1">30113975</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D047228" MajorTopicYN="N">Angiotensin II Type 1 Receptor Blockers</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000806" MajorTopicYN="N">Angiotensin-Converting Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29381513</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000002837</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38527923</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>133</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Preoperative risk prediction models for acute kidney injury after noncardiac surgery: an independent external validation cohort study.</ArticleTitle><Pagination><StartPage>508</StartPage><EndPage>518</EndPage><MedlinePgn>508-518</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2024.02.018</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(24)00097-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Numerous models have been developed to predict acute kidney injury (AKI) after noncardiac surgery, yet there is a lack of independent validation and comparison among them.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a systematic literature search to review published risk prediction models for AKI after noncardiac surgery. An independent external validation was performed using a retrospective surgical cohort at a large Chinese hospital from January 2019 to October 2022. The cohort included patients undergoing a wide range of noncardiac surgeries with perioperative creatinine measurements. Postoperative AKI was defined according to the Kidney Disease Improving Global Outcomes creatinine criteria. Model performance was assessed in terms of discrimination (area under the receiver operating characteristic curve, AUROC), calibration (calibration plot), and clinical utility (net benefit), before and after model recalibration through intercept and slope updates. A sensitivity analysis was conducted by including patients without postoperative creatinine measurements in the validation cohort and categorising them as non-AKI cases.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Nine prediction models were evaluated, each with varying clinical and methodological characteristics, including the types of surgical cohorts used for model development, AKI definitions, and predictors. In the validation cohort involving 13,186 patients, 650 (4.9%) developed AKI. Three models demonstrated fair discrimination (AUROC between 0.71 and 0.75); other models had poor or failed discrimination. All models exhibited some miscalibration; five of the nine models were well-calibrated after intercept and slope updates. Decision curve analysis indicated that the three models with fair discrimination consistently provided a positive net benefit after recalibration. The results were confirmed in the sensitivity analysis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We identified three models with fair discrimination and potential clinical utility after recalibration for assessing the risk of acute kidney injury after noncardiac surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhuo</LastName><ForeName>Xiao-Yu</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, China; Guangdong Provincial Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Shao-Hui</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, China; Guangdong Provincial Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection, Guangzhou, China; College of Anaesthesiology, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Lan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, China; Department of Biostatistics, Lejiu Healthcare Technology Co., Ltd, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Ya-Wen</ForeName><Initials>YW</Initials><AffiliationInfo><Affiliation>College of Anaesthesiology, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jiao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>College of Anaesthesiology, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Yong-Jia</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>College of Anaesthesiology, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ke-Xuan</ForeName><Initials>KX</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, China; Guangdong Provincial Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection, Guangzhou, China; College of Anaesthesiology, Southern Medical University, Guangzhou, China; Outcomes Research Consortium, Cleveland, OH, USA. Electronic address: liukexuan705@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Wei-Feng</ForeName><Initials>WF</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, China; Guangdong Provincial Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection, Guangzhou, China; College of Anaesthesiology, Southern Medical University, Guangzhou, China. Electronic address: sglwfeng01@21cn.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Bing-Cheng</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, China; Guangdong Provincial Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection, Guangzhou, China; College of Anaesthesiology, Southern Medical University, Guangzhou, China; Outcomes Research Consortium, Cleveland, OH, USA. Electronic address: zhaobch@mail2.sysu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">clinical prediction model</Keyword><Keyword MajorTopicYN="N">noncardiac surgery</Keyword><Keyword MajorTopicYN="N">perioperative care</Keyword><Keyword MajorTopicYN="N">validation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>11</Day><Hour>4</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>26</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>25</Day><Hour>22</Hour><Minute>56</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38527923</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2024.02.018</ArticleId><ArticleId IdType="pii">S0007-0912(24)00097-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31351590</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>26</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>123</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Anaesthetic care of patients undergoing primary hip and knee arthroplasty: consensus recommendations from the International Consensus on Anaesthesia-Related Outcomes after Surgery group (ICAROS) based on a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>269</StartPage><EndPage>287</EndPage><MedlinePgn>269-287</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2019.05.042</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(19)30497-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Evidence-based international expert consensus regarding anaesthetic practice in hip/knee arthroplasty surgery is needed for improved healthcare outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The International Consensus on Anaesthesia-Related Outcomes after Surgery group (ICAROS) systematic review, including randomised controlled and observational studies comparing neuraxial to general anaesthesia regarding major complications, including mortality, cardiac, pulmonary, gastrointestinal, renal, genitourinary, thromboembolic, neurological, infectious, and bleeding complications. Medline, PubMed, Embase, and Cochrane Library including Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, NHS Economic Evaluation Database, from 1946 to May 17, 2018 were queried. Meta-analysis and Grading of Recommendations Assessment, Development and Evaluation approach was utilised to assess evidence quality and to develop recommendations.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The analysis of 94 studies revealed that neuraxial anaesthesia was associated with lower odds or no difference in virtually all reported complications, except for urinary retention. Excerpt of complications for neuraxial vs general anaesthesia in hip/knee arthroplasty, respectively: mortality odds ratio (OR): 0.67, 95% confidence interval (CI): 0.57-0.80/OR: 0.83, 95% CI: 0.60-1.15; pulmonary OR: 0.65, 95% CI: 0.52-0.80/OR: 0.69, 95% CI: 0.58-0.81; acute renal failure OR: 0.69, 95% CI: 0.59-0.81/OR: 0.73, 95% CI: 0.65-0.82; deep venous thrombosis OR: 0.52, 95% CI: 0.42-0.65/OR: 0.77, 95% CI: 0.64-0.93; infections OR: 0.73, 95% CI: 0.67-0.79/OR: 0.80, 95% CI: 0.76-0.85; and blood transfusion OR: 0.85, 95% CI: 0.82-0.89/OR: 0.84, 95% CI: 0.82-0.87.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Recommendation: primary neuraxial anaesthesia is preferred for knee arthroplasty, given several positive postoperative outcome benefits; evidence level: low, weak recommendation.</AbstractText><AbstractText Label="RECOMMENDATION" NlmCategory="CONCLUSIONS">neuraxial anaesthesia is recommended for hip arthroplasty given associated outcome benefits; evidence level: moderate-low, strong recommendation. Based on current evidence, the consensus group recommends neuraxial over general anaesthesia for hip/knee arthroplasty.</AbstractText><AbstractText Label="TRIAL REGISTRY NUMBER" NlmCategory="UNASSIGNED">PROSPERO CRD42018099935.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Memtsoudis</LastName><ForeName>Stavros G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Pain Management, Hospital for Special Surgery and Department of Anesthesiology, Weill Cornell Medical College, New York, NY, USA; Department of Anesthesiology, Perioperative Medicine and Intensive Care Medicine, Paracelsus Medical University, Salzburg, Austria. Electronic address: memtsoudiss@hss.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cozowicz</LastName><ForeName>Crispiana</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Pain Management, Hospital for Special Surgery and Department of Anesthesiology, Weill Cornell Medical College, New York, NY, USA; Department of Anesthesiology, Perioperative Medicine and Intensive Care Medicine, Paracelsus Medical University, Salzburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bekeris</LastName><ForeName>Janis</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Pain Management, Hospital for Special Surgery and Department of Anesthesiology, Weill Cornell Medical College, New York, NY, USA; Department of Anesthesiology, Perioperative Medicine and Intensive Care Medicine, Paracelsus Medical University, Salzburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bekere</LastName><ForeName>Dace</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Pain Management, Hospital for Special Surgery and Department of Anesthesiology, Weill Cornell Medical College, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jiabin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Pain Management, Hospital for Special Surgery and Department of Anesthesiology, Weill Cornell Medical College, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soffin</LastName><ForeName>Ellen M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Pain Management, Hospital for Special Surgery and Department of Anesthesiology, Weill Cornell Medical College, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mariano</LastName><ForeName>Edward R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Rebecca L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hargett</LastName><ForeName>Mary J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Pain Management, Hospital for Special Surgery and Department of Anesthesiology, Weill Cornell Medical College, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Bradley H</ForeName><Initials>BH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Pain Management, Hospital for Special Surgery and Department of Anesthesiology, Weill Cornell Medical College, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wendel</LastName><ForeName>Pamela</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Pain Management, Hospital for Special Surgery and Department of Anesthesiology, Weill Cornell Medical College, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brouillette</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Pain Management, Hospital for Special Surgery and Department of Anesthesiology, Weill Cornell Medical College, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Go</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Pain Management, Hospital for Special Surgery and Department of Anesthesiology, Weill Cornell Medical College, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sang J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Pain Management, Hospital for Special Surgery and Department of Anesthesiology, Weill Cornell Medical College, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baaklini</LastName><ForeName>Lila</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Pain Management, Hospital for Special Surgery and Department of Anesthesiology, Weill Cornell Medical College, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wetmore</LastName><ForeName>Douglas</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Pain Management, Hospital for Special Surgery and Department of Anesthesiology, Weill Cornell Medical College, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Genewoo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Pain Management, Hospital for Special Surgery and Department of Anesthesiology, Weill Cornell Medical College, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goto</LastName><ForeName>Rie</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Kim Barrett Memorial Library, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jivanelli</LastName><ForeName>Bridget</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Kim Barrett Memorial Library, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Argyra</LastName><ForeName>Eriphyli</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Pain and Palliative Care, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrington</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Medicine &amp; Radiology, The University of Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borgeat</LastName><ForeName>Alain</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Universit&#xe4;t Z&#xfc;rich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Andres</LastName><ForeName>Jose</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Anesthesia Unit- Surgical Specialties Department, Valencia University Medical School, Spain; Anesthesia, Critical Care, and Pain Management Department, General University Hospital, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elkassabany</LastName><ForeName>Nabil M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gautier</LastName><ForeName>Philippe E</ForeName><Initials>PE</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Clinique Ste-Anne St-Remi, Anderlecht, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerner</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative Medicine and Intensive Care Medicine, Paracelsus Medical University, Salzburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez Della Valle</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Pain Management, Hospital for Special Surgery and Department of Anesthesiology, Weill Cornell Medical College, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goytizolo</LastName><ForeName>Enrique</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Pain Management, Hospital for Special Surgery and Department of Anesthesiology, Weill Cornell Medical College, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kessler</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care and Pain Medicine, Orthopedic University Hospital, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kopp</LastName><ForeName>Sandra L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lavand'Homme</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacLean</LastName><ForeName>Catherine H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Value Management Office, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mantilla</LastName><ForeName>Carlos B</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacIsaac</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McLawhorn</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Hip and Knee Replacement, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neal</LastName><ForeName>Joseph M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Virginia Mason Medical Center, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parks</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Hip and Knee Replacement, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parvizi</LastName><ForeName>Javad</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Rothman Orthopaedic Institute, Bensalem, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pichler</LastName><ForeName>Lukas</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative Medicine and Intensive Care Medicine, Paracelsus Medical University, Salzburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poeran</LastName><ForeName>Jashvant</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, Institute for Healthcare Delivery Science, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poultsides</LastName><ForeName>Lazaros A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, New York Langone Orthopaedic Hospital, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sites</LastName><ForeName>Brian D</ForeName><Initials>BD</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Dartmouth College Geisel School of Medicine, Hanover, NH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stundner</LastName><ForeName>Otto</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative Medicine and Intensive Care Medicine, Paracelsus Medical University, Salzburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Eric C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viscusi</LastName><ForeName>Eugene R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Pain Center, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Votta-Velis</LastName><ForeName>Effrossyni G</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Illinois Hospital and Health Sciences System, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Christopher L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Pain Management, Hospital for Special Surgery and Department of Anesthesiology, Weill Cornell Medical College, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ya Deau</LastName><ForeName>Jacques T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Pain Management, Hospital for Special Surgery and Department of Anesthesiology, Weill Cornell Medical College, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharrock</LastName><ForeName>Nigel E</ForeName><Initials>NE</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Pain Management, Hospital for Special Surgery and Department of Anesthesiology, Weill Cornell Medical College, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K08 DA042314</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016446">Consensus Development Conference</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000767" MajorTopicYN="N">Anesthesia, Epidural</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000775" MajorTopicYN="N">Anesthesia, Spinal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019644" MajorTopicYN="N">Arthroplasty, Replacement, Hip</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="N">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019317" MajorTopicYN="N">Evidence-Based Medicine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anaesthesia</Keyword><Keyword MajorTopicYN="N">arthroplasty</Keyword><Keyword MajorTopicYN="N">assessment</Keyword><Keyword MajorTopicYN="N">epidural</Keyword><Keyword MajorTopicYN="N">general</Keyword><Keyword MajorTopicYN="N">hip</Keyword><Keyword MajorTopicYN="N">knee</Keyword><Keyword MajorTopicYN="N">outcomes</Keyword><Keyword MajorTopicYN="N">replacement</Keyword><Keyword MajorTopicYN="N">spinal</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31351590</ArticleId><ArticleId IdType="pmc">PMC7678169</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2019.05.042</ArticleId><ArticleId IdType="pii">S0007-0912(19)30497-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pabinger C., Geissler A. Utilization rates of hip arthroplasty in OECD countries. Osteoarthritis Cartilage. 2014;22:734&#x2013;741.</Citation><ArticleIdList><ArticleId IdType="pubmed">24780823</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurtz S., Ong K., Lau E., Mowat F., Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J&#xa0;Bone Jt Surg Am. 2007;89:780&#x2013;785.</Citation><ArticleIdList><ArticleId IdType="pubmed">17403800</ArticleId></ArticleIdList></Reference><Reference><Citation>Ethgen O., Bruyere O., Richy F., Dardennes C., Reginster J.Y. Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature. J&#xa0;Bone Jt Surg Am. 2004;86:963&#x2013;974.</Citation><ArticleIdList><ArticleId IdType="pubmed">15118039</ArticleId></ArticleIdList></Reference><Reference><Citation>Memtsoudis S.G., Ma Y., Gonzalez Della Valle A. Demographics, outcomes, and risk factors for adverse events associated with primary and revision total hip arthroplasties in the United States. Am J Orthop. 2010;39:E72&#x2013;E77.</Citation><ArticleIdList><ArticleId IdType="pubmed">20882208</ArticleId></ArticleIdList></Reference><Reference><Citation>Memtsoudis S.G., Sun X., Chiu Y.L. Perioperative comparative effectiveness of anesthetic technique in orthopedic patients. Anesthesiology. 2013;118:1046&#x2013;1058.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3956038</ArticleId><ArticleId IdType="pubmed">23612126</ArticleId></ArticleIdList></Reference><Reference><Citation>Pugely A.J., Martin C.T., Gao Y., Mendoza-Lattes S., Callaghan J.J. Differences in short-term complications between spinal and general anesthesia for primary total knee arthroplasty. J&#xa0;Bone Jt Surg Am. 2013;95:193&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pubmed">23269359</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauermann W.J., Shilling A.M., Zuo Z. A&#xa0;comparison of neuraxial block versus general anesthesia for elective total hip replacement: a meta-analysis. Anesth Analg. 2006;103:1018&#x2013;1025.</Citation><ArticleIdList><ArticleId IdType="pubmed">17000823</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson R., Kopp S., Burkle C. Neuraxial vs general anaesthesia for total hip and total knee arthroplasty: a systematic review of comparative-effectiveness research. Br J Anaesth. 2016;116:163&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pubmed">26787787</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Quality Ontario &amp; Ministry of Health and Long-Term Care . 2014. Quality-based procedures: clinical handbook for primary hip and knee replacement.http://www.health.gov.on.ca/en/pro/programs/ecfa/docs/qbp_prihipknee.pdf 1&#x2013;95.</Citation></Reference><Reference><Citation>Memtsoudis S.G., Poeran J., Zubizarreta N. Do hospitals performing frequent neuraxial anesthesia for hip and knee replacements have better outcomes? Anesthesiology. 2018;129:428&#x2013;439.</Citation><ArticleIdList><ArticleId IdType="pubmed">29878899</ArticleId></ArticleIdList></Reference><Reference><Citation>Memtsoudis S.G., Poeran J., Zubizarreta N., Rasul R., Opperer M., Mazumdar M. Anesthetic care for orthopedic patients: is there a potential for differences in care? Anesthesiology. 2016;124:608&#x2013;623.</Citation><ArticleIdList><ArticleId IdType="pubmed">26771909</ArticleId></ArticleIdList></Reference><Reference><Citation>Memtsoudis S.G., Rasul R., Suzuki S. Does the impact of the type of anesthesia on outcomes differ by patient age and comorbidity burden? Reg Anesth Pain Med. 2014;39:112&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">24509423</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozowicz C., Poeran J., Memtsoudis S.G. Epidemiology, trends, and disparities in regional anaesthesia for orthopaedic surgery. Br J Anaesth. 2015;115 ii57&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">26658202</ArticleId></ArticleIdList></Reference><Reference><Citation>International Prospective Register of Systematic Reviews. https://www.crd.york.ac.uk/prospero/</Citation></Reference><Reference><Citation>Guyatt G.H., Oxman A.D., Vist G.E. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924&#x2013;926.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Balshem H., Helfand M., Sch&#xfc;nemann H.J. GRADE guidelines: 3. Rating the quality of evidence. J&#xa0;Clin Epidemiol. 2011;64:401&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">21208779</ArticleId></ArticleIdList></Reference><Reference><Citation>Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia. Available at www.covidence.org (please see https://support.covidence.org/help/how-can-i-cite-covidence)</Citation></Reference><Reference><Citation>Guyatt G.H., Oxman A.D., Vist G. GRADE guidelines: 4. Rating the quality of evidence&#x2014;study limitations (risk of bias) J&#xa0;Clin Epidemiol. 2011;64:407&#x2013;415.</Citation><ArticleIdList><ArticleId IdType="pubmed">21247734</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann I., Santesso N., Akl E.A. A&#xa0;guide for health professionals to interpret and use recommendations in guidelines developed with the GRADE approach. J&#xa0;Clin Epidemiol. 2016;72:45&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">26772609</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Community. RevMan 5. https://community.cochrane.org/help/tools-and-software/revman-5</Citation></Reference><Reference><Citation>Guyatt G., Oxman A.D., Akl E.A. GRADE guidelines: 1. Introduction&#x2014;GRADE evidence profiles and summary of findings tables. J&#xa0;Clin Epidemiol. 2011;64:383&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pubmed">21195583</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt G.H., Oxman A.D., Sultan S. GRADE guidelines: 9. Rating up the quality of evidence. J&#xa0;Clin Epidemiol. 2011;64:1311&#x2013;1316.</Citation><ArticleIdList><ArticleId IdType="pubmed">21802902</ArticleId></ArticleIdList></Reference><Reference><Citation>McMaster University . 2015. GRADEpro GDT: GRADEpro Guideline Development Tool [software]https://gradepro.org/</Citation></Reference><Reference><Citation>Woolf S.H., Grol R., Hutchinson A., Eccles M., Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999;318:527&#x2013;530.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1114973</ArticleId><ArticleId IdType="pubmed">10024268</ArticleId></ArticleIdList></Reference><Reference><Citation>La Colla L., Albertin A., La Colla G. No adjustment vs. adjustment formula as input weight for propofol target-controlled infusion in morbidly obese patients. Eur J Anaesthesiol. 2009;26:362&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pubmed">19307972</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones J., Hunter D. Consensus methods for medical and health services research. BMJ. 1995;311:376&#x2013;380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2550437</ArticleId><ArticleId IdType="pubmed">7640549</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabriel R.A., Kaye A.D., Jones M.R., Dutton R.P., Urman R.D. Practice variations in anesthetic care and its effect on clinical outcomes for primary total hip arthroplasties. J&#xa0;Arthroplasty. 2016;31:918&#x2013;922.</Citation><ArticleIdList><ArticleId IdType="pubmed">26410553</ArticleId></ArticleIdList></Reference><Reference><Citation>Helwani M.A., Avidan M.S., Ben Abdallah A. Effects of regional versus general anesthesia on outcomes after total hip arthroplasty: a retrospective propensity-matched cohort study. J&#xa0;Bone Jt Surg Am. 2015;97:186&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pubmed">25653318</ArticleId></ArticleIdList></Reference><Reference><Citation>Aynardi M., Jacovides C.L., Huang R., Mortazavi S.M., Parvizi J. Risk factors for early mortality following modern total hip arthroplasty. J&#xa0;Arthroplasty. 2013;28:517&#x2013;520.</Citation><ArticleIdList><ArticleId IdType="pubmed">23142452</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinker M.R., Reuben J.D., Mull J.R., Cox D.D., Daum W.J., Parker J.R. Comparison of general and epidural anesthesia in patients undergoing primary unilateral THR. Orthopedics. 1997;20:109&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pubmed">9048387</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W.H., Hung K.C., Tan P.H., Shi H.Y. Neuraxial anesthesia improves long-term survival after total joint replacement: a retrospective nationwide population-based study in Taiwan. Can J Anaesth. 2015;62:369&#x2013;376.</Citation><ArticleIdList><ArticleId IdType="pubmed">25608641</ArticleId></ArticleIdList></Reference><Reference><Citation>Harsten A., Kehlet H., Ljung P., Toksvig-Larsen S. Total intravenous general anaesthesia vs. spinal anaesthesia for total hip arthroplasty: a randomised, controlled trial. Acta Anaesthesiol Scand. 2015;59:298&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">25522681</ArticleId></ArticleIdList></Reference><Reference><Citation>Haughom B.D., Schairer W.W., Nwachukwu B.U., Hellman M.D., Levine B.R. Does neuraxial anesthesia decrease transfusion rates following total hip arthroplasty? J&#xa0;Arthroplasty. 2015;30:116&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pubmed">26077150</ArticleId></ArticleIdList></Reference><Reference><Citation>Hole A., Terjesen T., Breivik H. Epidural versus general anaesthesia for total hip arthroplasty in elderly patients. Acta Anaesthesiol Scand. 1980;24:279&#x2013;287.</Citation><ArticleIdList><ArticleId IdType="pubmed">7468115</ArticleId></ArticleIdList></Reference><Reference><Citation>Khatod M., Inacio M.C., Bini S.A., Paxton E.W. Prophylaxis against pulmonary embolism in patients undergoing total hip arthroplasty. J&#xa0;Bone Jt Surg Am. 2011;93:1767&#x2013;1772.</Citation><ArticleIdList><ArticleId IdType="pubmed">22005861</ArticleId></ArticleIdList></Reference><Reference><Citation>Modig J., Maripuu E., Sahlstedt B. Thromboembolism following total hip replacement: a prospective investigation of 94 patients with emphasis on the efficacy of lumbar epidural anesthesia in prophylaxis. Reg Anesth Pain Med. 1986;11:72&#x2013;79.</Citation></Reference><Reference><Citation>Liang C., Wei J., Cai X., Lin W., Fan Y., Yang F. Efficacy and safety of 3 different anesthesia techniques used in total hip arthroplasty. Med Sci Monit. 2017;23:3752&#x2013;3759.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5549712</ArticleId><ArticleId IdType="pubmed">28767640</ArticleId></ArticleIdList></Reference><Reference><Citation>Dauphin A., Raymer K.E., Stanton E.B., Fuller H.D. Comparison of general anesthesia with and without lumbar epidural for total hip arthroplasty: effects of epidural block on hip arthroplasty. J&#xa0;Clin Anesth. 1997;9:200&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pubmed">9172026</ArticleId></ArticleIdList></Reference><Reference><Citation>Walton J.K., Robinson R.G. Some observations on urinary retention and deep hip sepsis following total hip replacement. Aust N Z J Surg. 1982;52:130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">6805454</ArticleId></ArticleIdList></Reference><Reference><Citation>Walts L.F., Kaufman R.D., Moreland J.R., Weiskopf M. Total hip arthroplasty. An investigation of factors related to postoperative urinary retention. Clin Orthop Relat Res. 1985;194:280&#x2013;282.</Citation><ArticleIdList><ArticleId IdType="pubmed">3978926</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis F.M., Laurenson V.G., Gillespie W.J., Wells J.E., Foate J., Newman E. Deep vein thrombosis after total hip replacement. A comparison between spinal and general anaesthesia. J&#xa0;Bone Jt Surg Br. 1989;71:181&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">2925731</ArticleId></ArticleIdList></Reference><Reference><Citation>Harsten A., Kehlet H., Toksvig-Larsen S. Recovery after total intravenous general anaesthesia or spinal anaesthesia for total knee arthroplasty: a randomized trial. Br J Anaesth. 2013;111:391&#x2013;399.</Citation><ArticleIdList><ArticleId IdType="pubmed">23578860</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorburn J., Louden J., Vallance R. Spinal and general anaesthesia in total hip replacement: frequency of deep vein thrombosis. Br J Anaesth. 1980;52:1117&#x2013;1121.</Citation><ArticleIdList><ArticleId IdType="pubmed">7426216</ArticleId></ArticleIdList></Reference><Reference><Citation>Macdowell A.D., Robinson A.H., Hill D.J., Villar R.N. Is epidural anaesthesia acceptable at total hip arthroplasty? A study of the rates of urinary catheterisation. J&#xa0;Bone Jt Surg Br. 2004;86:1115&#x2013;1117.</Citation><ArticleIdList><ArticleId IdType="pubmed">15568522</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams A., Price N., Willett K. Epidural anaesthesia and urinary dysfunction: the risks in total hip replacement. J&#xa0;R Soc Med. 1995;88:699&#x2013;701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1295420</ArticleId><ArticleId IdType="pubmed">8786593</ArticleId></ArticleIdList></Reference><Reference><Citation>Feller J.A., Parkin J.D., Phillips G.W., Hannon P.J., Hennessy O., Huggins R.M. Prophylaxis against venous thrombosis after total hip arthroplasty. Aust N Z J Surg. 1992;62:606&#x2013;610.</Citation><ArticleIdList><ArticleId IdType="pubmed">1642580</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas S., Holberg G., Kreutz R. The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery&#x2014;subgroup analyses from 17,701 patients in the XAMOS study. Vasc Health Risk Manag. 2016;12:209&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4876074</ArticleId><ArticleId IdType="pubmed">27274266</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarmiento A., Goswami A. Thromboembolic disease prophylaxis in total hip arthroplasty. Clin Orthop Relat Res. 2005;436:138&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pubmed">15995432</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalldorf P.G., Perkins F.M., Totterman S., Pellegrini V.D., Jr. Deep venous thrombosis following total hip arthroplasty. Effects of prolonged postoperative epidural anesthesia. J&#xa0;Arthroplasty. 1994;9:611&#x2013;616.</Citation><ArticleIdList><ArticleId IdType="pubmed">7699373</ArticleId></ArticleIdList></Reference><Reference><Citation>Fredin H., Rosberg B. Anaesthetic techniques and thromboembolism in total hip arthroplasty. Eur J Anaesthesiol. 1986;3:273&#x2013;281.</Citation><ArticleIdList><ArticleId IdType="pubmed">2429834</ArticleId></ArticleIdList></Reference><Reference><Citation>Modig J., Hjelmstedt A., Sahlstedt B., Maripuu E. Comparative influences of epidural and general anaesthesia on deep venous thrombosis and pulmonary embolism after total hip replacement. Acta Chir Scand. 1981;147:125&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pubmed">7324741</ArticleId></ArticleIdList></Reference><Reference><Citation>Modig J., Borg T., Karlstrom G., Maripuu E., Sahlstedt B. Thromboembolism after total hip replacement: role of epidural and general anesthesia. Anesth Analg. 1983;62:174&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pubmed">6829920</ArticleId></ArticleIdList></Reference><Reference><Citation>Wille-Jorgensen P., Christensen S.W., Bjerg-Nielsen A., Stadeager C., Kjaer L. Prevention of thromboembolism following elective hip surgery. The value of regional anesthesia and graded compression stockings. Clin Orthop Relat Res. 1989;247:163&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pubmed">2791385</ArticleId></ArticleIdList></Reference><Reference><Citation>Basques B.A., Toy J.O., Bohl D.D., Golinvaux N.S., Grauer J.N. General compared with spinal anesthesia for total hip arthroplasty. J&#xa0;Bone Jt Surg Am. 2015;97:455&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4357526</ArticleId><ArticleId IdType="pubmed">25788301</ArticleId></ArticleIdList></Reference><Reference><Citation>Brueckner S., Reinke U., Roth-Isigkeit A., Eleftheriadis S., Schmucker P., Siemens H.J. Comparison of general and spinal anesthesia and their influence on hemostatic markers in patients undergoing total hip arthroplasty. J&#xa0;Clin Anesth. 2003;15:433&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pubmed">14652120</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell D., Friedman R.J., Baker J.D., 3rd, Cooke J.E., Darcy M.D., Miller M.C., 3rd Prevention of thromboembolic disease following total knee arthroplasty. Epidural versus general anesthesia. Clin Orthop Relat Res. 1991;269:109&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">1864027</ArticleId></ArticleIdList></Reference><Reference><Citation>Park Y.B., Chae W.S., Park S.H., Yu J.S., Lee S.G., Yim S.J. Comparison of short-term complications of general and spinal anesthesia for primary unilateral total knee arthroplasty. Knee Surg Relat Res. 2017;29:96&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5450584</ArticleId><ArticleId IdType="pubmed">28545173</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi H.J., Xue X.H., Wang Y.L., Zhang W.S., Wang Z.S., Yu A.L. Effects of different anesthesia methods on cognitive dysfunction after hip replacement operation in elder patients. Int J Clin Exp Med. 2015;8:3883&#x2013;3888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4443122</ArticleId><ArticleId IdType="pubmed">26064288</ArticleId></ArticleIdList></Reference><Reference><Citation>Kita T., Maki N., Song Y.S., Arai F., Nakai T. Caudal epidural anesthesia administered intraoperatively provides for effective postoperative analgesia after total hip arthroplasty. J&#xa0;Clin Anesth. 2007;19:204&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">17531729</ArticleId></ArticleIdList></Reference><Reference><Citation>Benson M., Hartmann B., Junger A., Dietrich G., B&#xf6;ttger S., Hempelmann G. Causes of higher blood loss during general anesthesia compared to spinal anesthesia in total hip replacement&#x2014;a retrospective analysis of data collected online. Transfus Med Hemother. 2000;27:311&#x2013;316.</Citation></Reference><Reference><Citation>Borghi B., Casati A., Iuorio S. Frequency of hypotension and bradycardia during general anesthesia, epidural anesthesia, or integrated epidural-general anesthesia for total hip replacement. J&#xa0;Clin Anesth. 2002;14:102&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">11943521</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis F.M., McDermott E., Hickton C. Influence of spinal and general anaesthesia on haemostasis during total hip arthroplasty. Br J Anaesth. 1987;59:561&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pubmed">3107600</ArticleId></ArticleIdList></Reference><Reference><Citation>Eroglu A., Uzunlar H., Erciyes N. Comparison of hypotensive epidural anesthesia and hypotensive total intravenous anesthesia on intraoperative blood loss during total hip replacement. J&#xa0;Clin Anesth. 2005;17:420&#x2013;425.</Citation><ArticleIdList><ArticleId IdType="pubmed">16171661</ArticleId></ArticleIdList></Reference><Reference><Citation>Flordal P.A., Neander G. Blood loss in total hip replacement. A retrospective study. Arch Orthop Trauma Surg. 1991;111:34&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">1772723</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton H., Jamieson J. Deep infection in total hip arthroplasty. Can J Surg. 2008;51:111&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2386332</ArticleId><ArticleId IdType="pubmed">18377751</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann B., Junger A., Benson M. Comparison of blood loss using fluorescein flow cytometry during total hip replacement under general or spinal anesthesia. Transfus Med Hemother. 2003;30:20&#x2013;26.</Citation></Reference><Reference><Citation>Jones M.J., Piggott S.E., Vaughan R.S. Cognitive and functional competence after anaesthesia in patients aged over 60: controlled trial of general and regional anaesthesia for elective hip or knee replacement. BMJ. 1990;300:1683&#x2013;1687.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1663336</ArticleId><ArticleId IdType="pubmed">2390547</ArticleId></ArticleIdList></Reference><Reference><Citation>Keith I. Anaesthesia and blood loss in total hip replacement. Anaesthesia. 1977;32:444&#x2013;450.</Citation><ArticleIdList><ArticleId IdType="pubmed">869143</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong S., Tang H., de Steiger R. Blood management in total hip replacement: an analysis of factors associated with allogenic blood transfusion. ANZ J Surg. 2015;85:461&#x2013;465.</Citation><ArticleIdList><ArticleId IdType="pubmed">25781570</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob A.K., Mantilla C.B., Sviggum H.P., Schroeder D.R., Pagnano M.W., Hebl J.R. Perioperative nerve injury after total knee arthroplasty: regional anesthesia risk during a 20-year cohort study. Anesthesiology. 2011;114:311&#x2013;317.</Citation><ArticleIdList><ArticleId IdType="pubmed">21239974</ArticleId></ArticleIdList></Reference><Reference><Citation>Memtsoudis S.G., Danninger T., Rasul R. Inpatient falls after total knee arthroplasty: the role of anesthesia type and peripheral nerve blocks. Anesthesiology. 2014;120:551&#x2013;563.</Citation><ArticleIdList><ArticleId IdType="pubmed">24534855</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendri&#x161;i&#x107; M., &#x160;urbatovi&#x107; M., &#x110;or&#x111;evi&#x107; D., Trifunovi&#x107; B., Jev&#x111;i&#x107; J. Analgesic efficacy and safety of four different anesthesia/postoperative analgesia protocols in patients following total hip arthroplasty. Vojnosanit Pregl. 2017;74:814&#x2013;820.</Citation></Reference><Reference><Citation>Bonnet F., Harari A., Thibonnier M., Viars P. Suppression of antidiuretic hormone hypersecretion during surgery by extradural anaesthesia. Br J Anaesth. 1982;54:29&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">7055526</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghi B., Casati A., Iuorio S. Effect of different anesthesia techniques on red blood cell endogenous recovery in hip arthroplasty. J&#xa0;Clin Anesth. 2005;17:96&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">15809124</ArticleId></ArticleIdList></Reference><Reference><Citation>Modig J., Malmberg P., Karlstrom G. Effect of epidural versus general anaesthesia on calf blood flow. Acta Anaesthesiol Scand. 1980;24:305&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">7468118</ArticleId></ArticleIdList></Reference><Reference><Citation>Modig J., Borg T., Bagge L., Saldeen T. Role of extradural and of general anaesthesia in fibrinolysis and coagulation after total hip replacement. Br J Anaesth. 1983;55:625&#x2013;629.</Citation><ArticleIdList><ArticleId IdType="pubmed">6409135</ArticleId></ArticleIdList></Reference><Reference><Citation>Modig J., Karlstrom G. Intra- and post-operative blood loss and haemodynamics in total hip replacement when performed under lumbar epidural versus general anaesthesia. Eur J Anaesthesiol. 1987;4:345&#x2013;355.</Citation><ArticleIdList><ArticleId IdType="pubmed">3322824</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Ambrosio A., Borghi B., Damato A., D&#x2019;Amato G., Antonacci D., Valeri F. Reducing perioperative blood loss in patients undergoing total hip arthroplasty. Int J Artif Organs. 1999;22:47&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">10098585</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin S.P., Abou-Madi M.N., Eurin B., Witvoet J., Montagne J. Blood loss in total hip replacement: extradural v. phenoperidine analgesia. Br J Anaesth. 1982;54:491&#x2013;495.</Citation><ArticleIdList><ArticleId IdType="pubmed">7073917</ArticleId></ArticleIdList></Reference><Reference><Citation>Wulf H., Biscoping J., Beland B., Bachmann-Mennenga B., Motsch J. Ropivacaine epidural anesthesia and analgesia versus general anesthesia and intravenous patient-controlled analgesia with morphine in the perioperative management of hip replacement. Ropivacaine Hip Replacement Multicenter Study Group. Anesth Analg. 1999;89:111&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pubmed">10389787</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams-Russo P., Sharrock N.E., Mattis S., Szatrowski T.P., Charlson M.E. Cognitive effects after epidural vs general anesthesia in older adults. A randomized trial. JAMA. 1995;274:44&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">7791257</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams-Russo P, Sharrock NE, Haas SB Randomized trial of epidural versus general anesthesia: outcomes after primary total knee replacement. Clin Orthop Relat Res. 1996;331:199&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">8895639</ArticleId></ArticleIdList></Reference><Reference><Citation>Bugada D., Allegri M., Gemma M. Effects of anaesthesia and analgesia on long-term outcome after total knee replacement: a prospective, observational, multicentre study. Eur J Anaesthesiol. 2017;34:665&#x2013;672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5588609</ArticleId><ArticleId IdType="pubmed">28767456</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh J.Y., Lin H.W. Less incidence of coronary artery disease in general anesthesia compared to spinal-epidural anesthesia after total knee replacement: 90-day follow-up period by a population-based dataset. Eur J Orthop Surg Traumatol. 2015;25:927&#x2013;932.</Citation><ArticleIdList><ArticleId IdType="pubmed">25761988</ArticleId></ArticleIdList></Reference><Reference><Citation>Chelly J.E., Greger J., Gebhard R. Continuous femoral blocks improve recovery and outcome of patients undergoing total knee arthroplasty. J&#xa0;Arthroplasty. 2001;16:436&#x2013;445.</Citation><ArticleIdList><ArticleId IdType="pubmed">11402405</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu C.P., Yap J.C., Chen P.P., Hung H.H. Postoperative outcome in Chinese patients having primary total knee arthroplasty under general anaesthesia/intravenous patient-controlled analgesia compared to spinal-epidural anaesthesia/analgesia. Hong Kong Med J. 2006;12:442&#x2013;447.</Citation><ArticleIdList><ArticleId IdType="pubmed">17148797</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Ma C., Elkassabany N., Fleisher L.A., Neuman M.D. Neuraxial anesthesia decreases postoperative systemic infection risk compared with general anesthesia in knee arthroplasty. Anesth Analg. 2013;117:1010&#x2013;1016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3800057</ArticleId><ArticleId IdType="pubmed">24023024</ArticleId></ArticleIdList></Reference><Reference><Citation>Lingaraj K., Ruben M., Chan Y., Das S.D. Identification of risk factors for urinary retention following total knee arthroplasty: a Singapore hospital experience. Singapore Med J. 2007;48:213.</Citation><ArticleIdList><ArticleId IdType="pubmed">17342289</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas S.B. Effects of epidural anesthesia on incidence of venous thromboembolism following joint replacement. Orthopedics. 1994;17:18&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">7937384</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorgensen L.N., Rasmussen L.S., Nielsen P.T., Leffers A., Albrecht-Beste E. Antithrombotic efficacy of continuous extradural analgesia after knee replacement. Br J Anaesth. 1991;66:8&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">1997063</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen P.T., Jorgensen L.N., Albrecht-Beste E., Leffers A.M., Rasmussen L.S. Lower thrombosis risk with epidural blockade in knee arthroplasty. Acta Orthop Scand. 1990;61:29&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">2186591</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishii Y., Noguchi H., Sato J., Takayama S., Okada Y., Toyabe S.I. Impact of anesthesia modality and mechanical venous thromboembolism prophylaxis on the incidence of symptomatic deep venous thrombosis after TKA. J&#xa0;Clin Orthop Trauma. 2018;9:142&#x2013;145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5995002</ArticleId><ArticleId IdType="pubmed">29896017</ArticleId></ArticleIdList></Reference><Reference><Citation>Nathan S., Aleem M.A., Thiagarajan P., Das De S. The incidence of proximal deep vein thrombosis following total knee arthroplasty in an Asian population: a Doppler ultrasound study. J&#xa0;Orthop Surg (Hong Kong) 2003;11:184&#x2013;189.</Citation><ArticleIdList><ArticleId IdType="pubmed">14676345</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharrock N.E., Haas S.B., Hargett M.J., Urquhart B., Insall J.N., Scuderi G. Effects of epidural anesthesia on the incidence of deep-vein thrombosis after total knee arthroplasty. J&#xa0;Bone Jt Surg Am. 1991;73:502&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pubmed">2013588</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L.Y., Gu W., Liu Y., Ma Z.L. Effects of inhalation anesthesia vs. total intravenous anesthesia (TIVA) vs. spinal-epidural anesthesia on deep vein thrombosis after total knee arthroplasty. Med Sci Monit. 2018;24:67&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5764483</ArticleId><ArticleId IdType="pubmed">29300003</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudoh A., Takase H., Takazawa T. A&#xa0;comparison of anesthetic quality in propofol-spinal anesthesia and propofol-fentanyl anesthesia for total knee arthroplasty in elderly patients. J&#xa0;Clin Anesth. 2004;16:405&#x2013;410.</Citation><ArticleIdList><ArticleId IdType="pubmed">15567642</ArticleId></ArticleIdList></Reference><Reference><Citation>Belmont P.J., Jr., Goodman G.P., Rodriguez M., Bader J.O., Waterman B.R., Schoenfeld A.J. Predictors of hospital readmission following revision total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2016;24:3329&#x2013;3338.</Citation><ArticleIdList><ArticleId IdType="pubmed">26387125</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayupov E., Okroj K., Young A.C. Continuous adductor canal blocks provide superior ambulation and pain control compared to epidural analgesia for primary knee arthroplasty: a randomized, controlled trial. J&#xa0;Arthroplasty. 2018;33:1040&#x2013;1044.e1.</Citation><ArticleIdList><ArticleId IdType="pubmed">29233569</ArticleId></ArticleIdList></Reference><Reference><Citation>Napier D.E., Bass S.S. Postoperative benefits of intrathecal injection for patients undergoing total knee arthroplasty. Orthop Nurs. 2007;26:374&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pubmed">18046213</ArticleId></ArticleIdList></Reference><Reference><Citation>Pope D., El-Othmani M.M., Manning B.T., Sepula M., Markwell S.J., Saleh K.J. Impact of age, gender and anesthesia modality on post-operative pain in total knee arthroplasty patients. Iowa Orthop J. 2015;35:92&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4492143</ArticleId><ArticleId IdType="pubmed">26361449</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrie C.M., Ong A.C., Hernandez V.H., Rosas S., Post Z.D., Orozco F.R. Incidence and risk factors for postoperative urinary retention in total hip arthroplasty performed under spinal anesthesia. J&#xa0;Arthroplasty. 2017;32:3748&#x2013;3751.</Citation><ArticleIdList><ArticleId IdType="pubmed">28781015</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams M.R., McKeown A., Dexter F. Efficacy outcome measures for procedural sedation clinical trials in adults: an ACTTION systematic review. Anesth Analg. 2016;122:152&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pubmed">26678470</ArticleId></ArticleIdList></Reference><Reference><Citation>Kehlet H. The stress response to surgery: release mechanisms and the modifying effect of pain relief. Acta Chir Scand Suppl. 1989;550:22&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">2652970</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36925330</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>130</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Norepinephrine versus phenylephrine for treating hypotension during general anaesthesia in adult patients undergoing major noncardiac surgery: a multicentre, open-label, cluster-randomised, crossover, feasibility, and pilot trial.</ArticleTitle><Pagination><StartPage>519</StartPage><EndPage>527</EndPage><MedlinePgn>519-527</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2023.02.004</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(23)00062-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">Intraoperative hypotension is associated with postoperative complications. The use of vasopressors is often required to correct hypotension but the best vasopressor is unknown.</AbstractText><AbstractText Label="METHODS">A multicentre, cluster-randomised, crossover, feasibility and pilot trial was conducted across five hospitals in California. Phenylephrine (PE) vs norepinephrine (NE) infusion as the first-line vasopressor in patients under general anaesthesia alternated monthly at each hospital for 6 months. The primary endpoint was first-line vasopressor administration compliance of 80% or higher. Secondary endpoints were acute kidney injury (AKI), 30-day mortality, myocardial injury after noncardiac surgery (MINS), hospital length of stay, and rehospitalisation within 30 days.</AbstractText><AbstractText Label="RESULTS">A total of 3626 patients were enrolled over 6 months; 1809 patients were randomised in the NE group, 1817 in the PE group. Overall, 88.2% received the assigned first-line vasopressor. No drug infiltrations requiring treatment were reported in either group. Patients were median 63 yr old, 50% female, and 58% white. Randomisation in the NE group vs PE group did not reduce readmission within 30 days (adjusted odds ratio=0.92; 95% confidence interval, 0.6-1.39), 30-day mortality (1.01; 0.48-2.09), AKI (1.1; 0.92-1.31), or MINS (1.63; 0.84-3.16).</AbstractText><AbstractText Label="CONCLUSIONS">A large and diverse population undergoing major surgery under general anaesthesia was successfully enrolled and randomised to receive NE or PE infusion. This pilot and feasibility trial was not powered for adverse postoperative outcomes and a follow-up multicentre effectiveness trial is planned.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION">NCT04789330 (ClinicalTrials.gov).</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Legrand</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA; INI-CRCT Network, Nancy, France. Electronic address: Matthieu.Legrand@ucsf.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kothari</LastName><ForeName>Rishi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA; Department of Anesthesiology and Perioperative Medicine, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fong</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA; School of Medicine, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palaniappa</LastName><ForeName>Nandini</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boldt</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, Los Angeles, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lee-Lynn</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurien</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabel</LastName><ForeName>Eilon</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, Los Angeles, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sturgess-DaPrato</LastName><ForeName>Jillene</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harhay</LastName><ForeName>Michael O</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pirracchio</LastName><ForeName>Romain</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bokoch</LastName><ForeName>Michael P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>VEGA-1 trial investigators</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04789330</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>1WS297W6MV</RegistryNumber><NameOfSubstance UI="D010656">Phenylephrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber><NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010656" MajorTopicYN="N">Phenylephrine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009638" MajorTopicYN="N">Norepinephrine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="N">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cluster-randomised crossover trial</Keyword><Keyword MajorTopicYN="N">intraoperative hypotension</Keyword><Keyword MajorTopicYN="N">noncardiac surgery</Keyword><Keyword MajorTopicYN="N">norepinephrine</Keyword><Keyword MajorTopicYN="N">phenylephrine</Keyword><Keyword MajorTopicYN="N">postoperative outcomes</Keyword><Keyword MajorTopicYN="N">vasopressor</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>16</Day><Hour>23</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36925330</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2023.02.004</ArticleId><ArticleId IdType="pii">S0007-0912(23)00062-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38445452</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-9159</ISSN><JournalIssue CitedMedium="Internet"><Volume>110</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of surgery (London, England)</Title><ISOAbbreviation>Int J Surg</ISOAbbreviation></Journal><ArticleTitle>Development of interpretable machine learning models for prediction of acute kidney injury after noncardiac surgery: a retrospective cohort study.</ArticleTitle><Pagination><StartPage>2950</StartPage><EndPage>2962</EndPage><MedlinePgn>2950-2962</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/JS9.0000000000001237</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Early identification of patients at high-risk of postoperative acute kidney injury (AKI) can facilitate the development of preventive approaches. This study aimed to develop prediction models for postoperative AKI in noncardiac surgery using machine learning algorithms. The authors also evaluated the predictive performance of models that included only preoperative variables or only important predictors.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Adult patients undergoing noncardiac surgery were retrospectively included in the study (76&#xa0;457 patients in the discovery cohort and 11&#xa0;910 patients in the validation cohort). AKI was determined using the KDIGO criteria. The prediction model was developed using 87 variables (56 preoperative variables and 31 intraoperative variables). A variety of machine learning algorithms were employed to develop the model, including logistic regression, random forest, extreme gradient boosting, and gradient boosting decision trees. The performance of different models was compared using the area under the receiver operating characteristic curve (AUROC). Shapley Additive Explanations (SHAP) analysis was employed for model interpretation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The patients in the discovery cohort had a median age of 52 years (IQR: 42-61 years), and 1179 patients (1.5%) developed AKI after surgery. The gradient boosting decision trees algorithm showed the best predictive performance using all available variables, or only preoperative variables. The AUROCs were 0.849 (95% CI: 0.835-0.863) and 0.828 (95% CI: 0.813-0.843), respectively. The SHAP analysis showed that age, surgical duration, preoperative serum creatinine, and gamma-glutamyltransferase, as well as American Society of Anesthesiologists physical status III were the most important five features. When gradually reducing the features, the AUROCs decreased from 0.852 (including the top 40 features) to 0.839 (including the top 10 features). In the validation cohort, the authors observed a similar pattern regarding the models' predictive performance.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The machine learning models the authors developed had satisfactory predictive performance for identifying high-risk postoperative AKI patients. Furthermore, the authors found that model performance was only slightly affected when only preoperative variables or only the most important predictive features were included.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Rao</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shiyong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Yuna</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Yidu Cloud Technology Inc, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Liu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Health Management Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Qiaoqiao</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhan</LastName><ForeName>Gaofeng</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Yuqin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Yidu Cloud Technology Inc, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xinhua</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Ailin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Zhiqiang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT06146829</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Surg</MedlineTA><NlmUniqueID>101228232</NlmUniqueID><ISSNLinking>1743-9159</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>15</Day><Hour>23</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>6</Day><Hour>4</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38445452</ArticleId><ArticleId IdType="pmc">PMC11093510</ArticleId><ArticleId IdType="doi">10.1097/JS9.0000000000001237</ArticleId><ArticleId IdType="pii">01279778-202405000-00050</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pang Z, Liang S, Xing M, et al. . The correlation of intraoperative oliguria with acute kidney injury after noncardiac surgery: a systematic review and meta-analysis. Int J Surg 2023;109:449&#x2013;457.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10389605</ArticleId><ArticleId IdType="pubmed">36912515</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun R, Zhou Z, Li X, et al. . Prognostic significance of preoperative nutritional status for postoperative acute kidney injury in older patients undergoing major abdominal surgery: a retrospective cohort study. Int J Surg 2024;110:873&#x2013;883.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10871641</ArticleId><ArticleId IdType="pubmed">37921644</ArticleId></ArticleIdList></Reference><Reference><Citation>French WB, Shah PR, Fatani YI, et al. . Mortality and costs associated with acute kidney injury following major elective, non-cardiac surgery. J Clin Anesth 2022;82:110933.</Citation><ArticleIdList><ArticleId IdType="pubmed">35933842</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok V, Nixon J, Hu J, et al. . The impact of perioperative acute kidney injury/failure on short and long surgical outcomes. Anesthesiol Perioperat Sci 2023;1:9.</Citation></Reference><Reference><Citation>Hoste EA, Bagshaw SM, Bellomo R, et al. . Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 2015;41:1411&#x2013;1423.</Citation><ArticleIdList><ArticleId IdType="pubmed">26162677</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamout F, Zhu T, Clifton DA. Machine learning for clinical outcome prediction. IEEE Rev Biomed Eng 2021;14:116&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pubmed">32746368</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngiam KY, Khor IW. Big data and machine learning algorithms for health-care delivery. Lancet Oncol 2019;20:e262&#x2013;e273.</Citation><ArticleIdList><ArticleId IdType="pubmed">31044724</ArticleId></ArticleIdList></Reference><Reference><Citation>Nohara Y, Matsumoto K, Soejima H, et al. . Explanation of machine learning models using shapley additive explanation and application for real data in hospital. Comput Methods Programs Biomed 2022;214:106584.</Citation><ArticleIdList><ArticleId IdType="pubmed">34942412</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Y, Loftus TJ, Datta S, et al. . Performance of a machine learning algorithm using electronic health record data to predict postoperative complications and report on a mobile platform. JAMA Netw Open 2022;5:e2211973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9112066</ArticleId><ArticleId IdType="pubmed">35576007</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue B, Li D, Lu C, et al. . Use of machine learning to develop and evaluate models using preoperative and intraoperative data to identify risks of postoperative complications. JAMA Netw Open 2021;4:e212240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010590</ArticleId><ArticleId IdType="pubmed">33783520</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofer IS, Lee C, Gabel E, et al. . Development and validation of a deep neural network model to predict postoperative mortality, acute kidney injury, and reintubation using a single feature set. NPJ Digit Med 2020;3:58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7170922</ArticleId><ArticleId IdType="pubmed">32352036</ArticleId></ArticleIdList></Reference><Reference><Citation>Satapathy P, Pradhan KB, Rustagi S, et al. . Application of machine learning in surgery research: current uses and future directions - editorial. Int J Surg 2023, 109:1550&#x2013;1551.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10389442</ArticleId><ArticleId IdType="pubmed">37094825</ArticleId></ArticleIdList></Reference><Reference><Citation>Fransvea P, Fransvea G, Liuzzi P, et al. . Study and validation of an explainable machine learning-based mortality prediction following emergency surgery in the elderly: a prospective observational study. Int J Surg 2022;107:106954.</Citation><ArticleIdList><ArticleId IdType="pubmed">36229017</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei VJ, Luong T, Shan E, et al. . Risk stratification for postoperative acute kidney injury in major noncardiac surgery using preoperative and intraoperative data. JAMA Netw Open 2019;2:e1916921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6902769</ArticleId><ArticleId IdType="pubmed">31808922</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng PY, Chen YT, Wang CH, et al. . Prediction of the development of acute kidney injury following cardiac surgery by machine learning. Crit Care 2020;24:478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7395374</ArticleId><ArticleId IdType="pubmed">32736589</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Chen L, Yao G, et al. . Novel blood cytokine-based model for predicting severe acute kidney injury and poor outcomes after cardiac surgery. J Am Heart Assoc 2020;9:e018004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7763725</ArticleId><ArticleId IdType="pubmed">33131359</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HC, Yoon HK, Nam K, et al. . Derivation and validation of machine learning approaches to predict acute kidney injury after cardiac surgery. J Clin Med 2018;7:322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6210196</ArticleId><ArticleId IdType="pubmed">30282956</ArticleId></ArticleIdList></Reference><Reference><Citation>Thongprayoon C, Pattharanitima P, Kattah AG, et al. . Explainable preoperative automated machine learning prediction model for cardiac surgery-associated acute kidney injury. J Clin Med 2022;11:6264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9656700</ArticleId><ArticleId IdType="pubmed">36362493</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikkinen O, Kolehmainen T, Aaltonen T, et al. . Developing a supervised machine learning model for predicting perioperative acute kidney injury in arthroplasty patients. Comput Biol Med 2022;144:105351.</Citation><ArticleIdList><ArticleId IdType="pubmed">35286890</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HC, Yoon S, Yang SM, et al. . Prediction of acute kidney injury after liver transplantation: machine learning approaches vs. logistic regression model. J Clin Med 2018;7:428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6262324</ArticleId><ArticleId IdType="pubmed">30413107</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu M, Jiang X, Du K, et al. . Ensemble machine learning algorithm for predicting acute kidney injury in patients admitted to the neurointensive care unit following brain surgery. Sci Rep 2023;13:6705.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10130041</ArticleId><ArticleId IdType="pubmed">37185782</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew G, Agha R, Albrecht J, et al. . STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. Int J Surg 2021;96:106165.</Citation><ArticleIdList><ArticleId IdType="pubmed">34774726</ArticleId></ArticleIdList></Reference><Reference><Citation>Lameire NH, Levin A, Kellum JA, et al. . Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int 2021;100:516&#x2013;526.</Citation><ArticleIdList><ArticleId IdType="pubmed">34252450</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkharusi H. Categorical variables in regression analysis: a comparison of dummy and effect coding. Int J Educat 2012;4:202&#x2013;210.</Citation></Reference><Reference><Citation>Bihorac A, Ozrazgat-Baslanti T, Ebadi A, et al. . MySurgeryRisk: development and validation of a machine-learning risk algorithm for major complications and death after surgery. Ann Surg 2019;269:652&#x2013;662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6110979</ArticleId><ArticleId IdType="pubmed">29489489</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinlay J, Tyson E, Forni LG. Renal complications of anaesthesia. Anaesthesia 2018;73(suppl 1):85&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">29313905</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Forni LG, Bell M, et al. . Postoperative acute kidney injury in adult non-cardiac surgery: joint consensus report of the Acute Disease Quality Initiative and PeriOperative Quality Initiative. Nat Rev Nephrol 2021;17:605&#x2013;618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8367817</ArticleId><ArticleId IdType="pubmed">33976395</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaara ST, Bellomo R. Postoperative renal dysfunction after noncardiac surgery. Curr Opin Crit Care 2017;23:440&#x2013;446.</Citation><ArticleIdList><ArticleId IdType="pubmed">28820797</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyigun M, Aykut G, Tosun M, et al. . Perioperative risk factors of acute kidney injury after non-cardiac surgery: a multicenter, prospective, observational study in patients with low grade American Society of Anesthesiologists physical status. Am J Surg 2019;218:457&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pubmed">30739741</ArticleId></ArticleIdList></Reference><Reference><Citation>Grams ME, Sang Y, Coresh J, et al. . Acute kidney injury after major surgery: a retrospective analysis of veterans health administration data. Am J Kidney Dis 2016;67:872&#x2013;880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4775458</ArticleId><ArticleId IdType="pubmed">26337133</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun K, Li F, Lin D, et al. . Serum gamma - glutamyltransferase is associated with albuminuria: a population-based study. PLoS One 2014;9:e114970.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4263709</ArticleId><ArticleId IdType="pubmed">25500578</ArticleId></ArticleIdList></Reference><Reference><Citation>Yilmaz MI, Turgut F, Kanbay M, et al. . Serum gamma-glutamyltransferase levels are inversely related to endothelial function in chronic kidney disease. Int Urol Nephrol 2013;45:1071&#x2013;1078.</Citation><ArticleIdList><ArticleId IdType="pubmed">23242503</ArticleId></ArticleIdList></Reference><Reference><Citation>Javid M, Mirdamadi A, Javid M, et al. . Gamma glutamyl transferase as a biomarker to predict contrast-induced nephropathy among patients with acute coronary syndrome undergoing coronary interventions: a meta-analysis. Ann Med Surg (Lond) 2023;85:4033&#x2013;4040.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10406001</ArticleId><ArticleId IdType="pubmed">37554858</ArticleId></ArticleIdList></Reference><Reference><Citation>Limaye K, Yang JD, Hinduja A. Role of admission serum albumin levels in patients with intracerebral hemorrhage. Acta Neurol Belg 2016;116:27&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">26133948</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N, Qiao H, Guo JF, et al. . Preoperative hypoalbuminemia was associated with acute kidney injury in high-risk patients following non-cardiac surgery: a retrospective cohort study. BMC Anesthesiol 2019;19:171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6719349</ArticleId><ArticleId IdType="pubmed">31477030</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EH, Baek SH, Chin JH, et al. . Preoperative hypoalbuminemia is a major risk factor for acute kidney injury following off-pump coronary artery bypass surgery. Intensive Care Med 2012;38:1478&#x2013;1486.</Citation><ArticleIdList><ArticleId IdType="pubmed">22618092</ArticleId></ArticleIdList></Reference><Reference><Citation>Kertai MD, Zhou S, Karhausen JA, et al. . Platelet counts, acute kidney injury, and mortality after coronary artery bypass grafting surgery. Anesthesiology 2016;124:339&#x2013;352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5040517</ArticleId><ArticleId IdType="pubmed">26599400</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghdaii N, Ferasatkish R, Mohammadzadeh Jouryabi A, et al. . Significance of preoperative total lymphocyte count as a prognostic criterion in adult cardiac surgery. Anesth Pain Med 2014;4:e20331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4183084</ArticleId><ArticleId IdType="pubmed">25289377</ArticleId></ArticleIdList></Reference><Reference><Citation>Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 2006;17:17&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">16291837</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Chen J, Luo C, et al. . Predicting the risk of postoperative acute kidney injury: development and assessment of a novel predictive nomogram. J Int Med Res 2021;49:3000605211032838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8366143</ArticleId><ArticleId IdType="pubmed">34382465</ArticleId></ArticleIdList></Reference><Reference><Citation>De Rosa S, Greco M, Rauseo M, et al. . The good, the bad, and the serum creatinine: exploring the effect of muscle mass and nutrition. Blood Purif 2023;52:775&#x2013;785.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10623400</ArticleId><ArticleId IdType="pubmed">37742621</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang JY, Jun IG, Lee JB, et al. . Impact of sarcopenia on acute kidney injury after infrarenal abdominal aortic aneurysm surgery: a propensity matching analysis. Nutrients 2021;13:2212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8308481</ArticleId><ArticleId IdType="pubmed">34199110</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR Croal B Abbott TEF et al. . investigators Ms . Cystatin C or creatinine for pre-operative assessment of kidney function and risk of post-operative acute kidney injury: a secondary analysis of the METS cohort study. Clin Kidney J 2024;17:sfae004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10807905</ArticleId><ArticleId IdType="pubmed">38269033</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanda E, Muneyuki T, Kanno Y, et al. . Uric acid level has a U-shaped association with loss of kidney function in healthy people: a prospective cohort study. PLoS One 2015;10:e0118031.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4320097</ArticleId><ArticleId IdType="pubmed">25658588</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JH, Jo YI, Lee JH. Renal effects of uric acid: hyperuricemia and hypouricemia. Korean J Intern Med 2020;35:1291&#x2013;1304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652664</ArticleId><ArticleId IdType="pubmed">32872730</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez CE, Der Mesropian PJ, Mathew RO, et al. . Hyperglycemia and acute kidney injury during the perioperative period. Curr Diab Rep 2016;16:10.</Citation><ArticleIdList><ArticleId IdType="pubmed">26792142</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J, Li S, Zhao Y, et al. . Intensive glucose control during the perioperative period for diabetic patients undergoing surgery: an updated systematic review and meta-analysis. J Clin Anesth 2021;75:110504.</Citation><ArticleIdList><ArticleId IdType="pubmed">34509960</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YL, Chen BK, Lin KD, et al. . The impact of severe hypoglycemia on renal impairment in type 2 diabetes. Diabetes Res Clin Pract 2015;108:448&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pubmed">25779866</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun JS, Park YM, Han K, et al. . Severe hypoglycemia and the risk of end stage renal disease in type 2 diabetes. Sci Rep 2021;11:4305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7900096</ArticleId><ArticleId IdType="pubmed">33619302</ArticleId></ArticleIdList></Reference><Reference><Citation>Boon AC, Bulmer AC, Coombes JS, et al. . Circulating bilirubin and defense against kidney disease and cardiovascular mortality: mechanisms contributing to protection in clinical investigations. Am J Physiol Renal Physiol 2014;307:F123&#x2013;F136.</Citation><ArticleIdList><ArticleId IdType="pubmed">24761005</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Pant P, Basu S, et al. . Oxidative stress in neonatal hyperbilirubinemia. J Trop Pediatr 2007;53:69&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">17158814</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu YH, Wu CY, Cheng CY, et al. . Severe hyperbilirubinemia is associated with higher risk of contrast-related acute kidney injury following contrast-enhanced computed tomography. PLoS One 2020;15:e0231264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159198</ArticleId><ArticleId IdType="pubmed">32294106</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, Weiss R, Albert F, et al. . Epidemiology of surgery associated acute kidney injury (EPIS-AKI): a prospective international observational multi-center clinical study. Intensive Care Med 2023;49:1441&#x2013;1455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10709241</ArticleId><ArticleId IdType="pubmed">37505258</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu C, Fong N, Lazzareschi D, et al. . Fluids, vasopressors, and acute kidney injury after major abdominal surgery between 2015 and 2019: a multicentre retrospective analysis. Br J Anaesth 2022;129:317&#x2013;326.</Citation><ArticleIdList><ArticleId IdType="pubmed">35688657</ArticleId></ArticleIdList></Reference><Reference><Citation>Karkouti K, Grocott HP, Hall R, et al. . Interrelationship of preoperative anemia, intraoperative anemia, and red blood cell transfusion as potentially modifiable risk factors for acute kidney injury in cardiac surgery: a historical multicentre cohort study. Can J Anaesth 2015;62:377&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pubmed">25537735</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu S, Lu P, Liu Z, et al. . Longitudinal hemoglobin trajectories and acute kidney injury in patients undergoing cardiac surgery: a retrospective cohort study. Front Cardiovasc Med 2023;10:1181617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10229827</ArticleId><ArticleId IdType="pubmed">37265564</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Liu S. Threshold heterogeneity of perioperative hemoglobin drop for acute kidney injury after noncardiac surgery: a propensity score weighting analysis. BMC Nephrol 2022;23:206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9188693</ArticleId><ArticleId IdType="pubmed">35690725</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36794753</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1522-1466</ISSN><JournalIssue CitedMedium="Internet"><Volume>324</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>American journal of physiology. Renal physiology</Title><ISOAbbreviation>Am J Physiol Renal Physiol</ISOAbbreviation></Journal><ArticleTitle>Postoperative acute kidney injury after volatile or intravenous anesthesia: a meta-analysis.</ArticleTitle><Pagination><StartPage>F329</StartPage><EndPage>F334</EndPage><MedlinePgn>F329-F334</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1152/ajprenal.00316.2022</ELocationID><Abstract><AbstractText>Postoperative acute kidney injury (AKI) is a common complication after surgery. The pathophysiology of postoperative AKI is complex. One potentially important factor is anesthetic modality. We, therefore, conducted a meta-analysis of the available literature regarding anesthetic modality and incidence of postoperative AKI. Records were retrieved until January 17, 2023, with the search terms ("propofol" OR "intravenous") AND ("sevoflurane" OR "desflurane" OR "isoflurane" OR "volatile" OR "inhalational") AND ("acute kidney injury" OR "AKI"). A meta-analysis for common effects and random effects was performed after exclusion assessment. Eight records were included in the meta-analysis with a total of 15,140 patients (<i>n</i> = 7,542 propofol and <i>n</i> = 7,598 volatile). The common and random effects model revealed that propofol was associated with a lower incidence of postoperative AKI compared with volatile anesthesia [odds ratio: 0.63 (95% confidence interval: 0.56-0.72) and 0.49 (95% confidence interval: 0.33-0.73), respectively]. In conclusion, the meta-analysis revealed that propofol anesthesia is associated with a lower incidence of postoperative AKI compared with volatile anesthesia. This may motivate choosing propofol-based anesthesia in patients with increased risk of postoperative AKI due to preexisting renal impairment or surgery with a high risk of renal ischemia.<b>NEW &amp; NOTEWORTHY</b> This study analyzed the available literature on anesthetic modality and incidence of postoperative AKI. The meta-analysis revealed that propofol is associated with lower incidence of AKI compared with volatile anesthesia. It might therefore be considerable to use propofol anesthesia in surgeries with increased susceptibility for developing renal injuries such as cardiopulmonary bypass and major abdominal surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Franz&#xe9;n</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5003-2508</Identifier><AffiliationInfo><Affiliation>Department of Surgical Sciences, Anesthesiology and Intensive Care, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frithiof</LastName><ForeName>Robert</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-2278-7951</Identifier><AffiliationInfo><Affiliation>Department of Surgical Sciences, Anesthesiology and Intensive Care, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hultstr&#xf6;m</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4675-1099</Identifier><AffiliationInfo><Affiliation>Department of Surgical Sciences, Anesthesiology and Intensive Care, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Cell Biology, Integrative Physiology, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Physiol Renal Physiol</MedlineTA><NlmUniqueID>100901990</NlmUniqueID><ISSNLinking>1522-1466</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018686">Anesthetics, Intravenous</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018685">Anesthetics, Inhalation</NameOfSubstance></Chemical><Chemical><RegistryNumber>YI7VU623SF</RegistryNumber><NameOfSubstance UI="D015742">Propofol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018686" MajorTopicYN="N">Anesthetics, Intravenous</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018685" MajorTopicYN="Y">Anesthetics, Inhalation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000771" MajorTopicYN="N">Anesthesia, Intravenous</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015742" MajorTopicYN="Y">Propofol</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">isoflurane</Keyword><Keyword MajorTopicYN="N">propofol</Keyword><Keyword MajorTopicYN="N">sevoflurane</Keyword><Keyword MajorTopicYN="N">volatile</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>16</Day><Hour>7</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36794753</ArticleId><ArticleId IdType="doi">10.1152/ajprenal.00316.2022</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40696938</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1743-9159</ISSN><JournalIssue CitedMedium="Internet"><Volume>111</Volume><Issue>9</Issue><PubDate><Year>2025</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of surgery (London, England)</Title><ISOAbbreviation>Int J Surg</ISOAbbreviation></Journal><ArticleTitle>Risk factors for acute kidney injury following radical cystectomy: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>6330</StartPage><EndPage>6342</EndPage><MedlinePgn>6330-6342</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/JS9.0000000000002537</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The factors contributing to acute kidney injury (AKI) after radical cystectomy (RC) remain uncertain. This study aimed to determine the risk factors for AKI following RC and guide clinicians in implementing effective interventions for high-risk groups.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Three English databases were searched for relevant articles published until November 2024. The odds ratio (OR), 95% confidence interval (CI), and P value were determined for each study using univariate or multivariate analysis. Random effects models were applied for high heterogeneity ( I2 &#xa0;&#x2265;&#xa0;50% or P &lt; 0.05) instead of fixed effects models. Moreover, descriptive analysis was performed when meta-analysis was unfeasible. We investigated heterogeneity by performing subgroup and sensitivity analyses. A funnel plot was used to test for publication bias when the number of included studies was &gt;10.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Nine studies were included in the meta-analysis. The meta-analysis revealed that older age (OR&#xa0;=&#xa0;1.02, 95% CI&#xa0;= [1.00, 1.03], P =&#xa0;0.008), operative route (robot versus open, OR&#xa0;=&#xa0;2.41, 95% CI&#xa0;= [1.35, 4.31], P =&#xa0;0.003), and nonsteroidal anti-inflammatory drug use (OR&#xa0;=&#xa0;1.50, 95% CI&#xa0;= [1.01, 2.23], P =&#xa0;0.05) were risk factors for postoperative AKI. Female gender (OR&#xa0;=&#xa0;0.55, 95% CI&#xa0;= [0.35, 0.88], P =&#xa0;0.01) was identified as a protective factor against postoperative AKI. Body mass index (OR&#xa0;=&#xa0;1.02, 95% CI&#xa0;= [1.00, 1.04], P =&#xa0;0.06), diabetes (OR&#xa0;=&#xa0;1.00, 95% CI&#xa0;= [0.65, 1.53], P =&#xa0;0.98), hypertension (OR&#xa0;=&#xa0;1.76, 95% CI&#xa0;= [0.79, 3.93], P =&#xa0;0.17), smoking (OR&#xa0;=&#xa0;1.01, 95% CI&#xa0;= [0.74, 1.39], P =&#xa0;0.94), cardiovascular disease (OR&#xa0;=&#xa0;1.37, 95% CI&#xa0;= [0.70, 2.68], P =&#xa0;0.35), estimated glomerular filtration rate (OR&#xa0;=&#xa0;1.00, 95% CI&#xa0;= [0.98, 1.02], P =&#xa0;0.89), neoadjuvant chemotherapy (OR&#xa0;=&#xa0;1.23, 95% CI&#xa0;= [0.69, 2.20], P =&#xa0;0.49), operation time (OR&#xa0;=&#xa0;1.00, 95% CI&#xa0;= [0.99, 1.01], P =&#xa0;0.87), intraoperative bleeding volume (OR&#xa0;=&#xa0;1.00, 95% CI&#xa0;= [1.00, 1.00], P =&#xa0;0.73), blood transfusion (OR&#xa0;=&#xa0;1.46, 95% CI&#xa0;= [0.79, 2.72], P =&#xa0;0.23), enhanced recovery after surgery program (OR&#xa0;=&#xa0;1.35, 95% CI&#xa0;= [0.65, 2.78], P =&#xa0;0.42), and urinary diversion (OR&#xa0;=&#xa0;1.03, 95% CI&#xa0;= [0.45, 2.39], P =&#xa0;0.94) were not associated with increased risk of AKI after RC.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Obvious risk factors for AKI include one patient-related risk factor, such as older age, and two therapy-related risk factors, such as robot surgery and the use of nonsteroidal anti-inflammatory drugs. Moreover, obvious protective factors for AKI include one patient-related factor, such as the female gender. However, these findings should be approached carefully, as most of these risk factors exhibited minimal effect sizes. Nonetheless, they could aid clinicians in identifying high-risk patients for better prognosis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Liang</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-1372-4596</Identifier><AffiliationInfo><Affiliation>Department of Urology department, Chongqing Emergency Medical Center, Chongqing University Central Hospital, Chongqing University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jing-Po</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Urology, Hebei General Hospital, Shijiazhuang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Li-Xia</ForeName><Initials>LX</Initials><AffiliationInfo><Affiliation>Department of Geriatrics and Cardiovascular Medicine, Hebei General Hospital, Shijiazhuang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>An</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Affiliated Hospital of Hebei University, Hebei Key Laboratory of Cancer Radiotherapy and Chemotherapy, Baoding, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Dong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Urology, Hebei General Hospital, Shijiazhuang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qiang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Urology, Baoding No.1 Central Hospital, Baoding, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Ji</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Surg</MedlineTA><NlmUniqueID>101228232</NlmUniqueID><ISSNLinking>1743-9159</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015653" MajorTopicYN="Y">Cystectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001749" MajorTopicYN="Y">Urinary Bladder Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">radical cystectomy</Keyword><Keyword MajorTopicYN="N">risk factor</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>16</Day><Hour>18</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>23</Day><Hour>11</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>23</Day><Hour>3</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40696938</ArticleId><ArticleId IdType="pmc">PMC12430789</ArticleId><ArticleId IdType="doi">10.1097/JS9.0000000000002537</ArticleId><ArticleId IdType="pii">01279778-990000000-02849</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: an overview. Int, J, Cancer 2021;149:778&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">33818764</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfred Witjes J, Max Bruins H, Carri&#xf3;n A, et al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: summary of the 2023 guidelines. Eur Urol 2023;85:17&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">37858453</ArticleId></ArticleIdList></Reference><Reference><Citation>Powles T, Bellmunt J, Comperat E, et al. Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. ANN ONCOL 2021;33:244&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">34861372</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyllested E, Vejlgaard M, Stroomberg HV, et al. Acute kidney injury within 90Days of radical cystectomy for bladder cancer: incidence and risk factors. Urology 2023;182:181&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">37742849</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobhani S, Alsyouf M, Ahmadi H, et al. Association between early postradical cystectomy kidney injury and perioperative outcome in enhanced recovery era. Urol Oncol-Semin Ori 2023;41:389.e15&#x2013;389.e20.</Citation><ArticleIdList><ArticleId IdType="pubmed">36967251</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;ffel LM, Bachmann KF, Furrer MA, et al. Impact of intraoperative hypotension on early postoperative acute kidney injury in cystectomy patients - A retrospective cohort analysis. J Clin Anesth 2020;66:109906.</Citation><ArticleIdList><ArticleId IdType="pubmed">32615512</ArticleId></ArticleIdList></Reference><Reference><Citation>Joung KW, Choi SS, Kong YG, et al. Incidence and risk factors of acute kidney injury after radical cystectomy: importance of preoperative serum uric acid level. Int J Med Sci 2015;12:599&#x2013;604.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4532964</ArticleId><ArticleId IdType="pubmed">26283877</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012;120:c179&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Zacharias M, Mugawar M, Herbison GP, et al. Interventions for protecting renal function in the perioperative period. Cochrane Database Syst Rev 2013;9:CD003590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7154582</ArticleId><ArticleId IdType="pubmed">24027097</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques M, Tezier M, Tourret M, et al. Risk factors for postoperative acute kidney injury after radical cystectomy for bladder cancer in the era of ERAS protocols: a retrospective observational study. PLoS One 2024;19:e0309549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11478916</ArticleId><ArticleId IdType="pubmed">39405326</ArticleId></ArticleIdList></Reference><Reference><Citation>Lone Z, Campbell RA, Corrigan D, et al. Ability of the surgical Apgar score to predict acute kidney injury following radical cystectomy. UROL ONCOL-SEMIN ORI 2021;40:194.e1&#x2013;194.e6.</Citation><ArticleIdList><ArticleId IdType="pubmed">34654645</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishiyama Y, Kondo T, Ishihara H, et al. Association between ureteral clamping time and acute kidney injury during robot-assisted radical cystectomy. Curr Oncol 2021;28:4986&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8700330</ArticleId><ArticleId IdType="pubmed">34940057</ArticleId></ArticleIdList></Reference><Reference><Citation>Furrer MA, Schneider MP, Burkhard FC, et al. Incidence and perioperative risk factors for early acute kidney injury after radical cystectomy and urinary diversion. Urol Oncol-Semin Ori 2018;36:306.e17&#x2013;306.e23.</Citation><ArticleIdList><ArticleId IdType="pubmed">29550095</ArticleId></ArticleIdList></Reference><Reference><Citation>Osman Y, Harraz AM, El-Halwagy S, et al. Acute kidney injury following radical cystectomy and urinary diversion: predictors and associated morbidity. Int Braz J Urol 2018;44:726&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6092670</ArticleId><ArticleId IdType="pubmed">29757568</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikehata Y, Tanaka T, Ichihara K, et al. Incidence and risk factors for acute kidney injury after radical cystectomy. Int J Urol 2016;23:558&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">27168129</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Jama-J Am Med Assoc 2000;283:2008&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg 2021;88:105906.</Citation><ArticleIdList><ArticleId IdType="pubmed">33789826</ArticleId></ArticleIdList></Reference><Reference><Citation>Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ 2017;358:j4008.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5833365</ArticleId><ArticleId IdType="pubmed">28935701</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25:603&#x2013;05.</Citation><ArticleIdList><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo M, Cao Q, Wang D, et al. The impact of diabetes on postoperative outcomes following spine surgery: a meta-analysis of 40 cohort studies with 2.9 million participants. Int J Surg 2022;104:106789.</Citation><ArticleIdList><ArticleId IdType="pubmed">35918006</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna PT, Peterson M, Albersheim J, et al. Acute kidney injury following enhanced recovery after surgery in patients undergoing radical cystectomy. J Urol 2020;204:982&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">32469268</ArticleId></ArticleIdList></Reference><Reference><Citation>Lone Z, Zhang A, Benidir T, et al. The role of enhanced recovery after surgery protocols in the development of acute kidney injury following radical cystectomy. Urol Oncol-Semin Ori 2022;40:453.e1&#x2013;453.e7.</Citation><ArticleIdList><ArticleId IdType="pubmed">35953395</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J, Park J-Y, Ha S, et al. C-reactive protein/albumin ratio and acute kidney injury after radical cystectomy among elderly patients: a propensity score-matched analysis. Dis Markers 2020;2020:8818445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7641682</ArticleId><ArticleId IdType="pubmed">33193910</ArticleId></ArticleIdList></Reference><Reference><Citation>Denic A, Glassock RJ, Rule AD. Structural and functional changes with the aging kidney. Adv Chronic Kidney Dis 2016;23:19&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4693148</ArticleId><ArticleId IdType="pubmed">26709059</ArticleId></ArticleIdList></Reference><Reference><Citation>Rule AD, Semret MH, Amer H, et al. Association of kidney function and metabolic risk factors with density of glomeruli on renal biopsy samples from living donors. Mayo Clin Proc 2011;86:282&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3068887</ArticleId><ArticleId IdType="pubmed">21454731</ArticleId></ArticleIdList></Reference><Reference><Citation>Naganuma T, Takemoto Y, Maeda S, et al. Chronic kidney disease in patients with ileal conduit urinary diversion. Exp Ther Med 2012;4:962&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3494134</ArticleId><ArticleId IdType="pubmed">23226756</ArticleId></ArticleIdList></Reference><Reference><Citation>Todenh&#xf6;fer T, Stenzl A, Schwentner C. Optimal use and outcomes of orthotopic neobladder reconstruction in men and women. Curr Opin Urol 2013;23:479&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">23851385</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang KP, Lee JE, Lee AS, et al. Effect of gender differences on the regulation of renal ischemia-reperfusion-induced inflammation in mice. Mol Med Rep 2014;9:2061&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4055478</ArticleId><ArticleId IdType="pubmed">24682292</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh AP, Singh N, Bedi PMS. Estradiol mitigates ischemia reperfusion-induced acute renal failure through NMDA receptor antagonism in rats. Mol Cell Biochem 2017;434:33&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">28432550</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishi Y, Satoh M, Nagasu H, et al. Selective estrogen receptor modulation attenuates proteinuria-induced renal tubular damage by modulating mitochondrial oxidative status. Kidney Int 2013;83:662&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">23344476</ArticleId></ArticleIdList></Reference><Reference><Citation>Aufhauser DD, Wang Z, Murken DR, et al. Improved renal ischemia tolerance in females influences kidney transplantation outcomes. J Clin Invest 2016;126:1968&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4855926</ArticleId><ArticleId IdType="pubmed">27088798</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed ML, Blackwell T, Neugarten J, et al. Raloxifene, a selective estrogen receptor modulator, is renoprotective: a post-hoc analysis. Kidney Int 2011;79:389.e15&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">20927038</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Heung M, et al. Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set. Anesthesiology 2009;110:505&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">19212261</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira C, Rosa R, Rodrigues N, et al. Acute kidney injury after major abdominal surgery: a retrospective cohort analysis. Crit Care Res Pract 2014;2014:132175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3955689</ArticleId><ArticleId IdType="pubmed">24719758</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno JA, Gomez-Guerrero C, Mas S, et al. Targeting inflammation in diabetic nephropathy: a tale of hope. Expert Opin Invest Drugs 2018;27:917&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">30334635</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Hou J-G, Liu Z, et al. Alleviative effects of 20(R)-Rg3 on HFD/STZ-induced diabetic nephropathy via MAPK/NF-&#x3ba;B signaling pathways in C57BL/6 mice. J Ethnopharmacol 2021;267:113500.</Citation><ArticleIdList><ArticleId IdType="pubmed">33091499</ArticleId></ArticleIdList></Reference><Reference><Citation>McPartlin A, Grimaldo C, Lyons J, et al. Successful delivery of chemotherapy to treat small-cell prostate cancer in a patient undergoing haemodialysis. Clin Kidney J 2014;7:593&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4389136</ArticleId><ArticleId IdType="pubmed">25859378</ArticleId></ArticleIdList></Reference><Reference><Citation>Joung K-W, Kong Y-G, Yoon S-H, et al. Comparison of postoperative acute kidney injury between ileal conduit and neobladder urinary diversions after radical cystectomy: a propensity score matching analysis. Medicine 2016;95:e4838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5023924</ArticleId><ArticleId IdType="pubmed">27603401</ArticleId></ArticleIdList></Reference><Reference><Citation>Furrer MA, Schneider MP, L&#xf6;ffel LM, et al. Impact of intra-operative fluid and noradrenaline administration on early postoperative renal function after cystectomy and urinary diversion: a retrospective observational cohort study. Eur J Anaesth 2018;35:641&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">29652680</ArticleId></ArticleIdList></Reference><Reference><Citation>Jerlstr&#xf6;m T, G&#xe5;rdmark T, Carringer M, et al. Urinary bladder cancer treated with radical cystectomy: perioperative parameters and early complications prospectively registered in a national population-based database. Scand J Urol 2014;48:334&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">24844275</ArticleId></ArticleIdList></Reference><Reference><Citation>Licker M, Cartier V, Robert J, et al. Risk factors of acute kidney injury according to RIFLE criteria after lung cancer surgery. Ann Thorac Surg 2011;91:844&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">21353011</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D, Li Y, Li Q, et al. Risk factors and a nomogram model establishment for postoperative delirium in elderly patients undergoing arthroplasty surgery: a single-center retrospective study. Biomed Res Int 2021;2021:6607386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8660191</ArticleId><ArticleId IdType="pubmed">34901277</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y, Chen J, Wang Z. Meta-analysis of factors which influence delirium following cardiac surgery. J Card Surg 2012;27:481&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">22784203</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenberg MS, Thompson RH, Frank I, et al. Long-term renal function outcomes after radical cystectomy. J Urol 2013;191:619&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">24036234</ArticleId></ArticleIdList></Reference><Reference><Citation>Harraz AM, Mosbah A, Abdel-Latif M, et al. Impact of the type of ureteroileal anastomosis on renal function measured by diuretic scintigraphy: long-term results of a prospective randomized study. BJU Int 2014;114:202&#x2013;09.</Citation><ArticleIdList><ArticleId IdType="pubmed">24128168</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabbab ILN, Manalo RVM. Anti-inflammatory drugs and the renin-angiotensin-aldosterone system: current knowledge and potential effects on early SARS-CoV-2 infection. VIRUS RES 2021;291:198190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543703</ArticleId><ArticleId IdType="pubmed">33039544</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy HJ, Thomas B, Van Wyk B, et al. Nephrotoxic medications and acute kidney injury risk factors in the neonatal intensive care unit: clinical challenges for neonatologists and nephrologists. Pediatr Nephrol 2020;35:2077&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">31605211</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Zhang C, Zhang F, et al. Development and validation of a risk nomogram for postoperative acute kidney injury in older patients undergoing liver resection: a pilot study. BMC Anesthesiol 2022;22:22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8756684</ArticleId><ArticleId IdType="pubmed">35026992</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34620647</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>03</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1555-905X</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>10</Issue><PubDate><Year>2021</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Clinical journal of the American Society of Nephrology : CJASN</Title><ISOAbbreviation>Clin J Am Soc Nephrol</ISOAbbreviation></Journal><ArticleTitle>Strategies to Prevent Acute Kidney Injury after Pediatric Cardiac Surgery: A Network Meta-Analysis.</ArticleTitle><Pagination><StartPage>1480</StartPage><EndPage>1490</EndPage><MedlinePgn>1480-1490</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2215/CJN.05800421</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES">AKI is a common complication after pediatric cardiac surgery and has been associated with higher morbidity and mortality. We aimed to compare the efficacy of available pharmacologic and nonpharmacologic strategies to prevent AKI after pediatric cardiac surgery.</AbstractText><AbstractText Label="DESIGN, SETTING, PARTICIPANTS, &amp; MEASUREMENTS">PubMed/MEDLINE, Embase, Cochrane Controlled Trials Register, and reference lists of relevant articles were searched for randomized controlled trials from inception until August 2020. Random effects traditional pairwise, Bayesian network meta-analyses, and trial sequential analyses were performed.</AbstractText><AbstractText Label="RESULTS">Twenty randomized controlled trials including 2339 patients and 11 preventive strategies met the eligibility criteria. No overall significant differences were observed compared with control for corticosteroids, fenoldopam, hydroxyethyl starch, or remote ischemic preconditioning in traditional pairwise meta-analysis. In contrast, trial sequential analysis suggested a 80% relative risk reduction with dexmedetomidine and evidence of &lt;57% relative risk reduction with remote ischemic preconditioning. Nonetheless, the network meta-analysis was unable to demonstrate any significant differences among the examined treatments, including also acetaminophen, aminophylline, levosimendan, milrinone, and normothermic cardiopulmonary bypass. Surface under the cumulative ranking curve probabilities showed that milrinone (76%) was most likely to result in the lowest risk of AKI, followed by dexmedetomidine (70%), levosimendan (70%), aminophylline (59%), normothermic cardiopulmonary bypass (57%), and remote ischemic preconditioning (55%), although all showing important overlap.</AbstractText><AbstractText Label="CONCLUSIONS">Current evidence from randomized controlled trials does not support the efficacy of most strategies to prevent AKI in the pediatric population, apart from limited evidence for dexmedetomidine and remote ischemic preconditioning.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 by the American Society of Nephrology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Van den Eynde</LastName><ForeName>Jef</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-5606-376</Identifier><AffiliationInfo><Affiliation>Helen B. Taussig Heart Center, The Johns Hopkins Hospital and School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cloet</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Lerberghe</LastName><ForeName>Robin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;</LastName><ForeName>Michel Pompeu B O</ForeName><Initials>MPBO</Initials><Identifier Source="ORCID">0000-0001-5356-2996</Identifier><AffiliationInfo><Affiliation>Division of Cardiovascular Surgery of Pronto Socorro Cardiol&#xf3;gico de Pernambuco-PROCAPE, University of Pernambuco-UPE, Recife, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vlasselaers</LastName><ForeName>Dirk</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toelen</LastName><ForeName>Jaan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Woman and Child, Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Development and Regeneration, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verbakel</LastName><ForeName>Jan Y</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Budts</LastName><ForeName>Werner</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Congenital and Structural Cardiology, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gewillig</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Cardiology, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kutty</LastName><ForeName>Shelby</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Helen B. Taussig Heart Center, The Johns Hopkins Hospital and School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pottel</LastName><ForeName>Hans</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Public Health and Primary Care, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mekahli</LastName><ForeName>Djalila</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pediatric Nephrology, University Hospitals of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>PKD Research Group, GPURE, Department of Development and Regeneration, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D000099094">Network Meta-Analysis</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin J Am Soc Nephrol</MedlineTA><NlmUniqueID>101271570</NlmUniqueID><ISSNLinking>1555-9041</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058647">Adrenergic alpha-2 Receptor Agonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Clin J Am Soc Nephrol. 2021 Oct;16(10):1459-1461. doi: 10.2215/CJN.11000821.</RefSource><PMID Version="1">34620643</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058647" MajorTopicYN="N">Adrenergic alpha-2 Receptor Agonists</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="N">Dexmedetomidine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019194" MajorTopicYN="Y">Ischemic Preconditioning</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">acute renal failure</Keyword><Keyword MajorTopicYN="N">cardiac surgical procedures</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">congenital heart disease</Keyword><Keyword MajorTopicYN="N">heart</Keyword><Keyword MajorTopicYN="N">network meta-analysis</Keyword><Keyword MajorTopicYN="N">specialties</Keyword><Keyword MajorTopicYN="N">surgical</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>8</Day><Hour>6</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34620647</ArticleId><ArticleId IdType="pmc">PMC8498996</ArticleId><ArticleId IdType="doi">10.2215/CJN.05800421</ArticleId><ArticleId IdType="pii">01277230-202110000-00007</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Van den Eynde J, Rotbi H, Gewillig M, Kutty S, Allegaert K, Mekahli D: In-hospital outcomes of acute kidney injury after pediatric cardiac surgery: A meta-analysis. Front Pediatr 9: 733&#x2013;744, 2021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8446539</ArticleId><ArticleId IdType="pubmed">34540775</ArticleId></ArticleIdList></Reference><Reference><Citation>Zappitelli M, Bernier PL, Saczkowski RS, Tchervenkov CI, Gottesman R, Dancea A, Hyder A, Alkandari O: A small post-operative rise in serum creatinine predicts acute kidney injury in children undergoing cardiac surgery. Kidney Int 76: 885&#x2013;892, 2009</Citation><ArticleIdList><ArticleId IdType="pubmed">19641482</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan C, Al-Aklabi M, Garcia Guerra G: Chronic kidney disease in congenital heart disease patients: A narrative review of evidence. Can J Kidney Health Dis 2: 27, 2015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4531493</ArticleId><ArticleId IdType="pubmed">26266042</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SH, Kim SJ, Kim HJ, Son JS, Lee R, Yoon TG: Acute kidney injury following cardiopulmonary bypass in children &#x2013; Risk factors and outcomes. Circ J 81: 1522&#x2013;1527, 2017</Citation><ArticleIdList><ArticleId IdType="pubmed">28515370</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan S-M: Acute kidney injury after pediatric cardiac surgery. Pediatr Neonatol 60: 3&#x2013;11, 2019</Citation><ArticleIdList><ArticleId IdType="pubmed">29891225</ArticleId></ArticleIdList></Reference><Reference><Citation>Selewski DT, Askenazi DJ, Kashani K, Basu RK, Gist KM, Harer MW, Jetton JG, Sutherland SM, Zappitelli M, Ronco C, Goldstein SL, Mottes TA: Quality improvement goals for pediatric acute kidney injury: Pediatric applications of the 22nd Acute Disease Quality Initiative (ADQI) conference. Pediatr Nephrol 36: 733&#x2013;746, 2021</Citation><ArticleIdList><ArticleId IdType="pubmed">33433708</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group : Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med 151: 264&#x2013;269, W64, 2009</Citation><ArticleIdList><ArticleId IdType="pubmed">19622511</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Savovi&#x107; J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng H-Y, Corbett MS, Eldridge SM, Emberson JR, Hern&#xe1;n MA, Hopewell S, Hr&#xf3;bjartsson A, Junqueira DR, J&#xfc;ni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT: RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ 366: l4898, 2019</Citation><ArticleIdList><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ 327: 557&#x2013;560, 2003</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Macaskill P, Walter SD, Irwig L: A comparison of methods to detect publication bias in meta-analysis. Stat Med 20: 641&#x2013;654, 2001</Citation><ArticleIdList><ArticleId IdType="pubmed">11223905</ArticleId></ArticleIdList></Reference><Reference><Citation>Wetterslev J, Thorlund K, Brok J, Gluud C: Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol 61: 64&#x2013;75, 2008</Citation><ArticleIdList><ArticleId IdType="pubmed">18083463</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaimani A, Caldwell D, Li T, Higgins J, Salanti G: Chapter 11: Undertaking network meta-analyses. In: Cochrane Handbook for Systematic Reviews of Interventions, edited by Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, 2021. Available at: www.training.cochrane.org/handbook</Citation></Reference><Reference><Citation>Higgins JPT, Jackson D, Barrett JK, Lu G, Ades AE, White IR: Consistency and inconsistency in network meta-analysis: Concepts and models for multi-arm studies. Res Synth Methods 3: 98&#x2013;110, 2012</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4433772</ArticleId><ArticleId IdType="pubmed">26062084</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson SA, Zaccagni H, Bichell DP, Christian KG, Mettler BA, Donahue BS, Roberts LJ 2nd, Pretorius M: Acetaminophen attenuates lipid peroxidation in children undergoing cardiopulmonary bypass. Pediatr Crit Care Med 15: 503&#x2013;510, 2014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4087071</ArticleId><ArticleId IdType="pubmed">24732290</ArticleId></ArticleIdList></Reference><Reference><Citation>Axelrod DM, Sutherland SM, Anglemyer A, Grimm PC, Roth SJ: A double-blinded, randomized, placebo-controlled clinical trial of aminophylline to prevent acute kidney injury in children following congenital heart surgery with cardiopulmonary bypass. Pediatr Crit Care Med 17: 135&#x2013;143, 2016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4740222</ArticleId><ArticleId IdType="pubmed">26669642</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang A, Cui C, Fan Y, Zi J, Zhang J, Wang G, Wang F, Wang J, Tan Q: Prophylactic use of levosimendan in pediatric patients undergoing cardiac surgery: A prospective randomized controlled trial. Crit Care 23: 428, 2019</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6937718</ArticleId><ArticleId IdType="pubmed">31888711</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorlacius EM, Suominen PK, Wa^&#xe5;hlander H, Keski-Nisula J, Vistnes M, Ricksten SE, Synnergren M, Romlin BS, Castellheim A: The effect of levosimendan versus milrinone on the occurrence rate of acute kidney injury following congenital heart surgery in infants: A randomized clinical trial. Pediatr Crit Care Med 20: 947&#x2013;956, 2019</Citation><ArticleIdList><ArticleId IdType="pubmed">31274775</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahnukainen T, Keski-Nisula J, Tainio J, Valkonen H, P&#xe4;til&#xe4; T, Jalanko H, Suominen P: Efficacy of corticosteroids in prevention of acute kidney injury in neonates undergoing cardiac surgery&#x2014;A randomized controlled trial. Acta Anaesthesiol Scand 62: 1072&#x2013;1079, 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">29667173</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EM, Martin RH, Buckley JR, Zyblewski SC, Kavarana MN, Bradley SM, Alsoufi B, Mahle WT, Hassid M, Atz AM: Corticosteroid therapy in neonates undergoing cardiopulmonary bypass: Randomized controlled trial. J Am Coll Cardiol 74: 659&#x2013;668, 2019</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6684326</ArticleId><ArticleId IdType="pubmed">31370958</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesonen EJ, Suominen PK, Keski-Nisula J, Mattila IP, Rautiainen P, Jahnukainen T: The effect of methylprednisolone on plasma concentrations of neutrophil gelatinase-associated lipocalin in pediatric heart surgery. Pediatr Crit Care Med 17: 121&#x2013;127, 2016</Citation><ArticleIdList><ArticleId IdType="pubmed">26509817</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalili M, Vesal A, Tabib A, Khani-Tafti L, Hosseini S, Totonchi Z: Single dose corticosteroid therapy after surgical repair of Fallot&#x2019;s tetralogy: A randomized controlled clinical trial. Res Cardiovasc Med 4: e25500, 2015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4350157</ArticleId><ArticleId IdType="pubmed">25789260</ArticleId></ArticleIdList></Reference><Reference><Citation>Caputo M, Patel N, Angelini GD, de Siena P, Stoica S, Parry AJ, Rogers CA: Effect of normothermic cardiopulmonary bypass on renal injury in pediatric cardiac surgery: A randomized controlled trial. J Thorac Cardiovasc Surg 142: 1114&#x2013;1121, 2011</Citation><ArticleIdList><ArticleId IdType="pubmed">21872282</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen KR, Ravn HB, Povlsen JV, Schmidt MR, Erlandsen EJ, Hjortdal VE: Failure of remote ischemic preconditioning to reduce the risk of postoperative acute kidney injury in children undergoing operation for complex congenital heart disease: A randomized single-center study. J Thorac Cardiovasc Surg 143: 576&#x2013;583, 2012</Citation><ArticleIdList><ArticleId IdType="pubmed">21955475</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q, Wang T, Chen S, Zhou Q, Li H, Hu N, Feng Y, Dong N, Yao S, Xia Z: Cardiac protective effects of remote ischaemic preconditioning in children undergoing tetralogy of fallot repair surgery: A randomized controlled trial. Eur Heart J 39: 1028&#x2013;1037, 2018</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6018784</ArticleId><ArticleId IdType="pubmed">28329231</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang Z, Li Z, Huang P, Luo J, Liu P, Wang Y, Xia T, Zhou Y: Remote ischemic preconditioning upregulates microRNA-21 to protect the kidney in children with congenital heart disease undergoing cardiopulmonary bypass. Pediatr Nephrol 33: 911&#x2013;919, 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">29197999</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomivorotov V, Kornilov I, Boboshko V, Shmyrev V, Bondarenko I, Soynov I, Voytov A, Polyanskih S, Strunin O, Bogachev-Prokophiev A, Landoni G, Nigro Neto C, Oliveira Nicolau G, Saurith Izquierdo L, Nogueira Nascimento V, Wen Z, Renjie H, Haibo Z, Bazylev V, Evdokimov M, Sulejmanov S, Chernogrivov A, Ponomarev D: Effect of intraoperative dexamethasone on major complications and mortality among infants undergoing cardiac surgery: The DECISION Randomized Clinical Trial. JAMA 323: 2485&#x2013;2492, 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7312411</ArticleId><ArticleId IdType="pubmed">32573670</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronicki RA, Backer CL, Baden HP, Mavroudis C, Crawford SE, Green TP: Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg 69: 1490&#x2013;1495, 2000</Citation><ArticleIdList><ArticleId IdType="pubmed">10881828</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo YY, Kim JY, Lee JY, Choi CH, Chang YJ, Kwak HJ: The effect of intraoperative dexmedetomidine on acute kidney injury after pediatric congenital heart surgery: A prospective randomized trial. Medicine (Baltimore) 96: e7480, 2017</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5515761</ArticleId><ArticleId IdType="pubmed">28700489</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci Z, Stazi GV, Di Chiara L, Morelli S, Vitale V, Giorni C, Ronco C, Picardo S: Fenoldopam in newborn patients undergoing cardiopulmonary bypass: Controlled clinical trial. Interact Cardiovasc Thorac Surg 7: 1049&#x2013;1053, 2008</Citation><ArticleIdList><ArticleId IdType="pubmed">18782787</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci Z, Luciano R, Favia I, Garisto C, Muraca M, Morelli S, Di Chiara L, Cogo P, Picardo S: High-dose fenoldopam reduces postoperative neutrophil gelatinase-associated lipocaline and cystatin C levels in pediatric cardiac surgery. Crit Care 15: R160, 2011</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3219034</ArticleId><ArticleId IdType="pubmed">21714857</ArticleId></ArticleIdList></Reference><Reference><Citation>Akkucuk FG, Kanbak M, Ayhan B, Celebioglu B, Aypar U: The effect of HES (130/0.4) usage as the priming solution on renal function in children undergoing cardiac surgery. Ren Fail 35: 210&#x2013;215, 2013</Citation><ArticleIdList><ArticleId IdType="pubmed">23228215</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh HW, Lee JH, Kim HC, Kim EH, Song IK, Kim HS, Kim JT: The effect of 6% hydroxyethyl starch (130/0.4) on acute kidney injury in paediatric cardiac surgery: A prospective, randomised trial. Anaesthesia 73: 205&#x2013;215, 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">29150842</ArticleId></ArticleIdList></Reference><Reference><Citation>Robert SM, Borasino S, Dabal RJ, Cleveland DC, Hock KM, Alten JA: Postoperative hydrocortisone infusion reduces the prevalence of low cardiac output syndrome after neonatal cardiopulmonary bypass. Pediatr Crit Care Med 16: 629&#x2013;636, 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">25901540</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group: KDIGO Clinical Practice Guideline for Acute Kidney Injury. Available at: https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2012-AKI-Guideline-English.pdf. Accessed June 21, 2021</Citation></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative Workgroup : Acute renal failure &#x2013; definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit. Care 8: R204&#x2013;R212, 2004</Citation><ArticleIdList><ArticleId IdType="pmc">PMC522841</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>Akcan-Arikan A, Zappitelli M, Loftis LL, Washburn KK, Jefferson LS, Goldstein SL: Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 71: 1028&#x2013;1035, 2007</Citation><ArticleIdList><ArticleId IdType="pubmed">17396113</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A; Acute Kidney Injury Network : Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care 11: R31, 2007</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellos I, Iliopoulos DC, Perrea DN: Pharmacological interventions for the prevention of acute kidney injury after pediatric cardiac surgery: A network meta-analysis. Clin Exp Nephrol 23: 782&#x2013;791, 2019</Citation><ArticleIdList><ArticleId IdType="pubmed">30734166</ArticleId></ArticleIdList></Reference><Reference><Citation>Springate JE, Christensen SL, Feld LG: Serum creatinine level and renal function in children. Am J Dis Child 146: 1232&#x2013;1235, 1992</Citation><ArticleIdList><ArticleId IdType="pubmed">1415055</ArticleId></ArticleIdList></Reference><Reference><Citation>Lex DJ, T&#xf3;th R, Cser&#xe9;p Z, Alexander SI, Breuer T, S&#xe1;pi E, Szatm&#xe1;ri A, Sz&#xe9;kely E, G&#xe1;l J, Sz&#xe9;kely A: A comparison of the systems for the identification of postoperative acute kidney injury in pediatric cardiac patients. Ann Thorac Surg 97: 202&#x2013;210, 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">24206964</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodgson LE, Selby N, Huang TM, Forni LG: The role of risk prediction models in prevention and management of AKI. Semin Nephrol 39: 421&#x2013;430, 2019</Citation><ArticleIdList><ArticleId IdType="pubmed">31514906</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosseini MM, Zargoush M, Alemi F, Kheirbek RE: Leveraging machine learning and big data for optimizing medication prescriptions in complex diseases: A case study in diabetes management. J Big Data 7: 26, 2020</Citation></Reference><Reference><Citation>Katzman JL, Shaham U, Cloninger A, Bates J, Jiang T, Kluger Y: DeepSurv: Personalized treatment recommender system using a Cox proportional hazards deep neural network. BMC Med Res Methodol 18: 24, 2018</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5828433</ArticleId><ArticleId IdType="pubmed">29482517</ArticleId></ArticleIdList></Reference><Reference><Citation>Balasubramanian G, Al-Aly Z, Moiz A, Rauchman M, Zhang Z, Gopalakrishnan R, Balasubramanian S, El-Achkar TM: Early nephrologist involvement in hospital-acquired acute kidney injury: A pilot study. Am J Kidney Dis 57: 228&#x2013;234, 2011</Citation><ArticleIdList><ArticleId IdType="pubmed">21195518</ArticleId></ArticleIdList></Reference><Reference><Citation>Rank N, Pfahringer B, Kempfert J, Stamm C, K&#xfc;hne T, Schoenrath F, Falk V, Eickhoff C, Meyer A: Deep-learning-based real-time prediction of acute kidney injury outperforms human predictive performance. NPJ Digit Med 3: 1&#x2013;12, 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7588492</ArticleId><ArticleId IdType="pubmed">33134556</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S, Fan J, Shu Q: Early prediction of acute kidney injury in neonates with cardiac surgery. World J Pediatr Surg 3: e000107, 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9716980</ArticleId><ArticleId IdType="pubmed">36474915</ArticleId></ArticleIdList></Reference><Reference><Citation>Desanti De Oliveira B, Xu K, Shen TH, Callahan M, Kiryluk K, D&#x2019;Agati VD, Tatonetti NP, Barasch J, Devarajan P: Molecular nephrology: Types of acute tubular injury. Nat Rev Nephrol 15: 599&#x2013;612, 2019</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7303545</ArticleId><ArticleId IdType="pubmed">31439924</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36870304</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-8673</ISSN><JournalIssue CitedMedium="Internet"><Volume>287</Volume><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>The Journal of surgical research</Title><ISOAbbreviation>J Surg Res</ISOAbbreviation></Journal><ArticleTitle>Acute Kidney Injury After General Thoracic Surgery: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>72</StartPage><EndPage>81</EndPage><MedlinePgn>72-81</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jss.2023.01.011</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-4804(23)00031-8</ELocationID><Abstract><AbstractText Label="INTRODUCTION">The clinical importance of postoperative acute kidney injury (AKI) in patients undergoing general thoracic surgery is unclear. We aimed to systematically review the incidence, risk factors, and prognostic implications of AKI as a complication after general thoracic surgery.</AbstractText><AbstractText Label="METHODS">We searched PubMed, EMBASE, and the Cochrane Library from January 2004 to September 2021. Observational or interventional studies that enrolled &#x2265;50 patients undergoing general thoracic surgery and reported postoperative AKI defined using contemporary consensus criteria were included for meta-analysis.</AbstractText><AbstractText Label="RESULTS">Thirty-seven articles reporting 35 unique cohorts were eligible. In 29 studies that enrolled 58,140 consecutive patients, the pooled incidence of postoperative AKI was 8.0% (95% confidence interval [CI]: 6.2-10.0). The incidence was 3.8 (2.0-6.2) % after sublobar resection, 6.7 (4.1-9.9) % after lobectomy, 12.1 (8.1-16.6) % after bilobectomy/pneumonectomy, and 10.5 (5.6-16.7) % after esophagectomy. Considerable heterogeneity in reported incidences of AKI was observed across studies. Short-term mortality was higher (unadjusted risk ratio: 5.07, 95% CI: 2.99-8.60) and length of hospital stay was longer (weighted mean difference: 3.53, 95% CI: 2.56-4.49, d) in patients with postoperative AKI (11 studies, 28,480 patients). Several risk factors for AKI after thoracic surgery were identified.</AbstractText><AbstractText Label="CONCLUSIONS">AKI occurs frequently after general thoracic surgery and is associated with increased short-term mortality and length of hospital stay. For patients undergoing general&#xa0;thoracic surgery, AKI may be an important postoperative complication that needs early risk evaluation and mitigation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Shao-Hui</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Gao-Feng</ForeName><Initials>GF</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fujian Medical University Union Hospital, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Bing-Cheng</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Shi-Da</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ke-Xuan</ForeName><Initials>KX</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, China. Electronic address: liukexuan705@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Surg Res</MedlineTA><NlmUniqueID>0376340</NlmUniqueID><ISSNLinking>0022-4804</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013903" MajorTopicYN="Y">Thoracic Surgery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019616" MajorTopicYN="Y">Thoracic Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011013" MajorTopicYN="N">Pneumonectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">General thoracic surgery</Keyword><Keyword MajorTopicYN="N">Length of hospital stay</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Quality improvement</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>4</Day><Hour>18</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36870304</ArticleId><ArticleId IdType="doi">10.1016/j.jss.2023.01.011</ArticleId><ArticleId IdType="pii">S0022-4804(23)00031-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37341357</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2245-1919</ISSN><JournalIssue CitedMedium="Internet"><Volume>70</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>03</Day></PubDate></JournalIssue><Title>Danish medical journal</Title><ISOAbbreviation>Dan Med J</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury after gynaecological surgery - a systematic review and meta-analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">A11220733</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Acute kidney injury (AKI) is an abruptly occurring loss of renal function, which includes both kidney injury and kidney impairment. It is associated with mortality and morbidity due to the increased risk of developing chronic kidney disease. The aim of this systematic review and meta-analysis was to determine the incidence of post-operative AKI in gynaecological patients without pre-existing kidney injury.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Systematic searches were made for studies examining the association between AKI and gynaecological surgery published between 2004 and March 2021. The primary outcome was to compare two subgroups of studies; a screening group where AKI was diagnosed by systematic clinical screening and a non-screening group where AKI was diagnosed randomly.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the 1,410 records screened, 23 studies met the inclusion criteria, reporting AKI in 224,713 patients. The pooled incidence for post-operative AKI after gynaecological surgery in the screening subgroup was 7% (95% confidence interval (CI): 0.04-0.12). The overall pooled result for post-operative AKI after gynaecological surgery in the non-screening subgroup was 0% (95% CI: 0.00-0.01).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We found a 7% overall risk of post-operative AKI after gynaecological surgery. We found a higher incidence of AKI in the studies screening for kidney injury, illustrating that the condition is underdiagnosed when not screened for. An important risk exists of healthy women developing severe renal damage as AKI is a common post-operative complication with a potentially severe outcome that may be prevented in early diagnosis.</AbstractText><CopyrightInformation>Articles published in the DMJ are &#x201c;open access&#x201d;. This means that the articles are distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reza</LastName><ForeName>Cani</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Gynecology and Obstetrics, Copenhagen University Hospital - Herlev Hospital, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klarskov</LastName><ForeName>Niels</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Gynecology and Obstetrics, Copenhagen University Hospital - Herlev Hospital, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amirian</LastName><ForeName>Ilda</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Gynecology and Obstetrics, Copenhagen University Hospital - Herlev Hospital, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Dan Med J</MedlineTA><NlmUniqueID>101576205</NlmUniqueID><ISSNLinking>2245-1919</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013509" MajorTopicYN="N">Gynecologic Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006176" MajorTopicYN="Y">Gynecology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006304" MajorTopicYN="N">Health Status</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>21</Day><Hour>13</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>21</Day><Hour>7</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37341357</ArticleId><ArticleId IdType="pii">A11220733</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33656736</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0065-2598</ISSN><JournalIssue CitedMedium="Print"><Volume>1321</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Advances in experimental medicine and biology</Title><ISOAbbreviation>Adv Exp Med Biol</ISOAbbreviation></Journal><ArticleTitle>Acute Kidney Injury and Covid-19: A Scoping Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>309</StartPage><EndPage>324</EndPage><MedlinePgn>309-324</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/978-3-030-59261-5_28</ELocationID><Abstract><AbstractText>Acute kidney injury (AKI) is a fatal complication of the new severe acute respiratory syndrome coronavirus (SARS-CoV-2) which causes COVID-19 disease. Here, we performed a scoping review and meta-analysis including clinical studies on patients with SARS-CoV-2 infection with data on AKI assessment and characteristics, and the overall prevalence of AKI was estimated using a random-effects model. We identified 21 articles which passed the search criteria. All were quantitative observational studies which used a cross-sectional, retrospective, case report, or cohort methodology. This showed that aging, diabetes, cardiovascular disease, previous chronic disease, and other comorbidities were risk factors of AKI. Although the prevalence of proteinuria, hematuria, and increased serum creatinine was reported for up to 60% of the patients with COVID-19, the overall prevalence of AKI was estimated to be 8%. We conclude that although approximately two-thirds of patients with COVID-19 had symptoms of kidney damage, most of these did not meet the diagnostic criteria for AKI. Further studies should be performed to validate biomarkers for improved AKI diagnosis in COVID-19 patients and new treatment options are required to reduce the rate of mortality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jafari-Oori</LastName><ForeName>Mehdi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Trauma Research Center, Nursing Faculty, Baqiyatallah University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fiorentino</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Emergency and Organ Transplantation, Nephrology Dialysis and Transplantation Unit, "Aldo Moro" University, Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castellano</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Nephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Science, University of Foggia, Foggia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebadi</LastName><ForeName>Abbas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Behavioral Sciences Research Center, Life style institute, Nursing Faculty, Baqiyatallah University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahimi-Bashar</LastName><ForeName>Farshid</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Anesthesia and Critical Care Department, Hamadan University of Medical Sciences, Hamadan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guest</LastName><ForeName>Paul C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Laboratory of Neuroproteomics, Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas (UNICAMP), Campinas, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vahedian-Azimi</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Trauma Research Center, Nursing Faculty, Baqiyatallah University of Medical Sciences, Tehran, Iran. amirvahedian63@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahebkar</LastName><ForeName>Amirhossein</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. sahebkara@mums.ac.ir.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. sahebkara@mums.ac.ir.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland. sahebkara@mums.ac.ir.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Halal Research Center of IRI, FDA, Tehran, Iran. sahebkara@mums.ac.ir.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000098583">Scoping Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Adv Exp Med Biol</MedlineTA><NlmUniqueID>0121103</NlmUniqueID><ISSNLinking>0065-2598</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Scoping review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>3</Day><Hour>12</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33656736</ArticleId><ArticleId IdType="doi">10.1007/978-3-030-59261-5_28</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lu H, Stratton CW, Tang YW (2020) Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol 92(4):401&#x2013;402</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25678</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (2020) Novel coronavirus (2019-nCoV) situation report&#xa0;&#x2013; 1, 21 Jan 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf?sfvrsn=20a99c10_4</Citation></Reference><Reference><Citation>Chu KH, Tsang WK, Tang CS, Lam MF, Lai FM, To KF et al (2005) Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney Int 67(2):698&#x2013;705</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-1755.2005.67130.x</ArticleId></ArticleIdList></Reference><Reference><Citation>ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E et al (2012) Acute respiratory distress syndrome: the Berlin Definition. JAMA 307(23):2526&#x2013;2533</Citation></Reference><Reference><Citation>Perico L, Benigni A, Remuzzi G (2020) Should COVID-19 concern nephrologists? Why and to what extent? The emerging impasse of angiotensin blockade. Nephron 144(5):213&#x2013;221</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000507305</ArticleId></ArticleIdList></Reference><Reference><Citation>Rismanbaf A, Zarei S (2020) Liver and kidney injuries in COVID-19 and their effects on drug therapy; a letter to editor. Arch Acad Emerg Med 8:e17</Citation><ArticleIdList><ArticleId IdType="pubmed">32185369</ArticleId><ArticleId IdType="pmc">7075271</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L et al (2020) Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 97(5):829&#x2013;838</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2020.03.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease Improving Global Outcomes (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:1&#x2013;138. https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2012-AKI-Guideline-English.pdf</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/kisup.2012.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorentino M, Castellano G, Kellum JA (2017) Differences in acute kidney injury ascertainment for clinical and preclinical studies. Nephrol Dial Transplant 32:1789&#x2013;1805. https://doi.org/10.1093/ndt/gfx002</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfx002</ArticleId><ArticleId IdType="pubmed">28371878</ArticleId></ArticleIdList></Reference><Reference><Citation>Naicker S, Yang CW, Hwang SJ, Liu BC, Chen JH, Jha V (2020) The novel coronavirus 2019 epidemic and kidneys. Kidney Int 97(5):824&#x2013;828</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2020.03.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Li X, Chen H, Yan S, Li D, Li Y et al (2020) Coronavirus disease 19 infection does not result in acute kidney injury: an analysis of 116 hospitalized patients from Wuhan, China. Am J Nephrol 51(5):343&#x2013;348</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000507471</ArticleId></ArticleIdList></Reference><Reference><Citation>Levac D, Colquhoun H, O&#x2019;Brien KK (2010) Scoping studies: advancing the methodology. Implement Sci 5:69. https://doi.org/10.1186/1748-5908-5-69</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1748-5908-5-69</ArticleId><ArticleId IdType="pubmed">20854677</ArticleId><ArticleId IdType="pmc">2954944</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4(1):1. https://doi.org/10.1186/2046-4053-4-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId><ArticleId IdType="pmc">4320440</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung C, McKenna L, Cooper SJ (2020) Patients&#x2019; experiences of acute deterioration: a scoping review. Int J Nurs Stud 101:103404. https://doi.org/10.1016/j.ijnurstu.2019.103404</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnurstu.2019.103404</ArticleId><ArticleId IdType="pubmed">31670222</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, Mulrow C, G&#xf8;tzsche PC, Ioannidis JP et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6(7):e1000100. https://doi.org/10.1371/journal.pmed.1000100</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000100</ArticleId><ArticleId IdType="pubmed">19621070</ArticleId><ArticleId IdType="pmc">2707010</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoodin F, Weber S (2003) A systematic review of psychosocial factors affecting survival after bone marrow transplantation. Psychosomatics 44(3):181&#x2013;195. https://doi.org/10.1176/appi.psy.44.3.181</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.psy.44.3.181</ArticleId><ArticleId IdType="pubmed">12724499</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman MK, Kopf AW, Grin CM, Bart RS, Levenstein MJ (1991) Recurrence rates of treated basal cell carcinomas. Part 2: curettage-electrodesiccation. J Dermatol Surg Oncol 17(9):720&#x2013;726</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1524-4725.1991.tb03425.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafari Oori M, Mohammadi F, Norouzi-Tabrizi K, Fallahi-Khoshknab M, Ebadi A (2019) Prevalence of medication adherence in patients with hypertension in Iran: a systematic review and meta-analysis of studies published in 2000-2018. ARYA Atheroscler 15(2):82&#x2013;92</Citation><ArticleIdList><ArticleId IdType="pubmed">31440290</ArticleId><ArticleId IdType="pmc">6679658</ArticleId></ArticleIdList></Reference><Reference><Citation>Oori MJ, Mohammadi F, Norozi K, Fallahi-Khoshknab M, Ebadi A, Gheshlagh RG (2019) Prevalence of HTN in Iran: meta-analysis of published studies in 2004&#x2013;2018. Curr Hypertens Rev 15(2):113&#x2013;122</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1573402115666190118142818</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun V, Clarke V (2012) Thematic analysis. In: Cooper H, Camic PM, Long DL, Panter AT, Rindskopf D, Sher KJ (eds) APA handbook of research methods in psychology, Vol 2: research designs: quantitative, qualitative, neuropsychological, and biological. American Psychological Association, Washington, DC, pp 57&#x2013;71</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/13620-004</ArticleId></ArticleIdList></Reference><Reference><Citation>Princess Margaret Hospital SARS Study Group, Choi KW, Chau TN, Tsang O, Tso E, Chiu MC et al (2003) Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med 139(9):715&#x2013;723</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-139-9-200311040-00005</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen LL, Hsu CW, Tian YC, Fang JT (2005) Rhabdomyolysis associated with acute renal failure in patients with severe acute respiratory syndrome. Int J Clin Pract 59(10):1162&#x2013;1166</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1368-5031.2005.00540.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Volunteers A-2019-nCoV; Li Z, Wu M, Yao J, Guo J, Liao X et al (2020) Caution on Kidney Dysfunctions of 2019-nCoV Patients. medRxiv. https://doi.org/10.1101/2020.02.08.20021212</Citation></Reference><Reference><Citation>Al Ghamdi M, Mushtaq F, Awn N, Shalhoub S (2015) MERS CoV infection in two renal transplant recipients: case report. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg 15:1101&#x2013;1104. https://doi.org/10.1111/ajt.13085</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.13085</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Y, Liu W, Liu K et al (2020) Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study. Chin Med J (Engl). https://doi.org/10.1097/CM9.0000000000000824</Citation></Reference><Reference><Citation>Lin W, Hu L, Zhang Y, Ooi JD, Meng T, Jin P et al (2020) Single-cell analysis of ACE2 expression in human kidneys and bladders reveals a potential route of 2019-nCoV infection. bioRxiv. https://doi.org/10.1101/2020.02.08.939892</Citation></Reference><Reference><Citation>Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323(11):1061&#x2013;1069</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382(18):1708&#x2013;1720</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId></ArticleIdList></Reference><Reference><Citation>Drosten C, Seilmaier M, Corman VM, Hartmann W, Scheible G, Sack S et al (2013) Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis 13(9):745&#x2013;751</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70154-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (London, England) 395(10223):507&#x2013;513</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Guery B, Poissy J, el Mansouf L, S&#xe9;journ&#xe9; C, Ettahar N, Lemaire X et al (2013) Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission. Lancet 381(9885):2265&#x2013;2272</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)60982-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L et al (2020) Kidney impairment is associated with in-hospital death of COVID-19 patients. medRxiv. https://doi.org/10.1101/2020.02.18.20023242</Citation></Reference><Reference><Citation>Chen T, Wu D, Chen H, Yan W, Yang D, Chen G et al (2020) Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 368:m1091. https://doi.org/10.1136/bmj.m1091</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1091</ArticleId><ArticleId IdType="pubmed">32217556</ArticleId><ArticleId IdType="pmc">7190011</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H et al (2020) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 8(5):475&#x2013;481</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30079-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan X-W, Xu D, Zhang H, Zhou W, Wang LH, Cui XG (2020) Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. Intensive Care Med 46(6):1114&#x2013;1116</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06026-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Diao B, Wang C, Wang R, Feng Z, Tan Y, Wang H et al (2020) Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. medRxiv. https://doi.org/10.1101/2020.03.04.20031120</Citation></Reference><Reference><Citation>Yeung ML, Yao Y, Jia L, Chan JF, Chan KH, Cheung KF et al (2016) MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2. Nat Microbiol 1(3):16004. https://doi.org/10.1038/nmicrobiol.2016.4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmicrobiol.2016.4</ArticleId><ArticleId IdType="pubmed">27572168</ArticleId><ArticleId IdType="pmc">7097571</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacciarini F, Ghezzi S, Canducci F, Sims A, Sampaolo M, Ferioli E et al (2008) Persistent replication of severe acute respiratory syndrome coronavirus in human tubular kidney cells selects for adaptive mutations in the membrane protein. J Virol 82(11):5137&#x2013;5144</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00096-08</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497&#x2013;506</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou X, Chen K, Zou J, Han P, Hao J, Han Z et al (2020) Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med 14(2):185&#x2013;192</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11684-020-0754-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA et al (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426(6965):450&#x2013;454</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02145</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj VS, Mou H, Smits SL, Dekkers DH, M&#xfc;ller MA, Dijkman R et al (2013) Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495(7440):251&#x2013;254</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12005</ArticleId></ArticleIdList></Reference><Reference><Citation>Peiris JSM, Chu CM, Cheng VCC, Chan KS, Hung IF, Poon LL et al (2003) Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361(9371):1767&#x2013;1772</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(03)13412-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J et al (2004) Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol 203(2):622&#x2013;630</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1560</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang KJ, Su IJ, Theron M, Wu YC, Lai SK, Liu CC et al (2005) An interferon-gamma-related cytokine storm in SARS patients. J Med Virol 75(2):185&#x2013;194</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20255</ArticleId></ArticleIdList></Reference><Reference><Citation>Perazella MA, Shirali AC (2018) Nephrotoxicity of Cancer immunotherapies: past, present and future. J Am Soc Nephrol 29(8):2039&#x2013;2052</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2018050488</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanelli V, Fiorentino M, Cantaluppi V, Gesualdo L, Stallone G, Ronco C et al (2020) Acute kidney injury in SARS-CoV-2 infected patients. Crit Care 24(1):155. https://doi.org/10.1186/s13054-020-02872-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02872-z</ArticleId><ArticleId IdType="pubmed">32299479</ArticleId><ArticleId IdType="pmc">7161433</ArticleId></ArticleIdList></Reference><Reference><Citation>Pike F, Murugan R, Keener C, Palevsky PM, Vijayan A, Unruh M et al (2015) Biomarker enhanced risk prediction for adverse outcomes in critically ill patients receiving RRT. Clin J Am Soc Nephrol 10(8):1332&#x2013;1339</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.09911014</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M et al (2013) Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 17(1):R25. https://doi.org/10.1186/cc12503</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc12503</ArticleId><ArticleId IdType="pubmed">23388612</ArticleId><ArticleId IdType="pmc">4057242</ArticleId></ArticleIdList></Reference><Reference><Citation>Bihorac A, Chawla LS, Shaw AD, Al-Khafaji A, Davison DL, Demuth GE et al (2014) Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med 189(8):932&#x2013;939</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201401-0077OC</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirsch JS, Ng JH, Ross DW, Sharma P, Shah HH; Northwell Nephrology COVID-19 Research Consortium (2020) Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. May 16:S0085-2538(20)30532-9. https://doi.org/10.1016/j.kint.2020.05.006 . Online ahead of print</Citation></Reference><Reference><Citation>No authors listed (News in Brief) (2020) Biggest COVID-19 trial tests repurposed drugs first. Nat Biotech 38:510. https://doi.org/10.1038/s41587-020-0528-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-020-0528-x</ArticleId></ArticleIdList></Reference><Reference><Citation>BBC News (2020) Coronavirus: what is dexamethasone and how does it work? https://www.bbc.co.uk/news/health-53077879</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26602784</PMID><DateCompleted><Year>2017</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1238</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>4</Issue><PubDate><Year>2016</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Intensive care medicine</Title><ISOAbbreviation>Intensive Care Med</ISOAbbreviation></Journal><ArticleTitle>Incidence and associations of acute kidney injury after major abdominal surgery.</ArticleTitle><Pagination><StartPage>521</StartPage><EndPage>530</EndPage><MedlinePgn>521-530</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00134-015-4157-7</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Acute kidney injury (AKI) is a recognised risk factor for adverse outcomes in critical illness and hospitalised patients in general. To understand the incidence and associations of AKI as a peri-operative complication of major abdominal surgery, we conducted a systematic literature review and meta-analysis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Using a systematic strategy, we searched the electronic reference databases for articles describing post-operative renal outcomes using consensus criteria for AKI diagnosis (RIFLE, AKIN or KDIGO) in the setting of major abdominal surgery. Pooled incidence of AKI and, where reported, pooled relative risk of death after post-operative AKI were estimated using random effects models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">From 4287 screened titles, 19 articles met our inclusion criteria describing AKI outcomes in 82,514 patients undergoing abdominal surgery. Pooled incidence of AKI was 13.4% (95% CI 10.9-16.4%). In eight studies that reported the short-term mortality, relative risk of death in the presence of post-operative AKI was 12.6 fold (95% CI, 6.8-23.4). Where reported, length of stay was greater and non-renal post-operative complications were also more frequent in patients experiencing AKI.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Using modern consensus definitions, AKI is a common complication of major abdominal surgery that is associated with adverse patient outcomes including death. While a causative role for AKI cannot be concluded from this analysis, as an important signal of peri-operative harm, AKI should be regarded as an important surgical outcome measure and potential target for clinical interventions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>O'Connor</LastName><ForeName>M E</ForeName><Initials>ME</Initials><Identifier Source="ORCID">0000-0002-3446-1070</Identifier><AffiliationInfo><Affiliation>Adult Critical Care Unit, The Royal London Hospital, Barts Health NHS Trust, Whitechapel Road, London, E1 1BB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>William Harvey Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirwan</LastName><ForeName>C J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Adult Critical Care Unit, The Royal London Hospital, Barts Health NHS Trust, Whitechapel Road, London, E1 1BB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>William Harvey Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Renal Medicine and Transplantation, The Royal London Hospital, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pearse</LastName><ForeName>R M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Adult Critical Care Unit, The Royal London Hospital, Barts Health NHS Trust, Whitechapel Road, London, E1 1BB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>William Harvey Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prowle</LastName><ForeName>J R</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0002-5002-2721</Identifier><AffiliationInfo><Affiliation>Adult Critical Care Unit, The Royal London Hospital, Barts Health NHS Trust, Whitechapel Road, London, E1 1BB, UK. j.prowle@qmul.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>William Harvey Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK. j.prowle@qmul.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Renal Medicine and Transplantation, The Royal London Hospital, Barts Health NHS Trust, London, UK. j.prowle@qmul.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RP_2014-04-022</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>11</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Intensive Care Med</MedlineTA><NlmUniqueID>7704851</NlmUniqueID><ISSNLinking>0342-4642</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="N">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Abdominal surgery</Keyword><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Incidence</Keyword><Keyword MajorTopicYN="N">Perioperative</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26602784</ArticleId><ArticleId IdType="doi">10.1007/s00134-015-4157-7</ArticleId><ArticleId IdType="pii">10.1007/s00134-015-4157-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Crit Care. 2011;15(1):R16</Citation><ArticleIdList><ArticleId IdType="pubmed">21232094</ArticleId></ArticleIdList></Reference><Reference><Citation>BJOG. 2015 Sep;122(10):1340-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25134440</ArticleId></ArticleIdList></Reference><Reference><Citation>Perfusion. 2008 Nov;23(6):323-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19454560</ArticleId></ArticleIdList></Reference><Reference><Citation>J Trauma. 2007 Nov;63(5):987-93</Citation><ArticleIdList><ArticleId IdType="pubmed">17993940</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Nephrol. 2014 Oct 23;15:169</Citation><ArticleIdList><ArticleId IdType="pubmed">25342079</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2007;11(2):R31</Citation><ArticleIdList><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Soc Nephrol. 2005 Nov;16(11):3365-70</Citation><ArticleIdList><ArticleId IdType="pubmed">16177006</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 2000 Jan;43(1):83-91</Citation><ArticleIdList><ArticleId IdType="pubmed">10813129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2009 May;249(5):851-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19387314</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 2009 Mar;110(3):505-15</Citation><ArticleIdList><ArticleId IdType="pubmed">19212261</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gastrointest Surg. 2014 Mar;18(3):605-12</Citation><ArticleIdList><ArticleId IdType="pubmed">24241964</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2006 Jul;34(7):1913-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16715038</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 2014 Jan;207(1):53-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24050540</ArticleId></ArticleIdList></Reference><Reference><Citation>Syst Rev. 2015 Jan 01;4:1</Citation><ArticleIdList><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2010 Nov;78(9):926-33</Citation><ArticleIdList><ArticleId IdType="pubmed">20686452</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2013 Jul;258(1):169-77</Citation><ArticleIdList><ArticleId IdType="pubmed">23478526</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin J Am Soc Nephrol. 2010 Oct;5(10):1734-44</Citation><ArticleIdList><ArticleId IdType="pubmed">20671222</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin J Am Soc Nephrol. 2013 Sep;8(9):1482-93</Citation><ArticleIdList><ArticleId IdType="pubmed">23744003</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 2015 Sep;123(3):515-23</Citation><ArticleIdList><ArticleId IdType="pubmed">26181335</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Res Pract. 2014;2014:132175</Citation><ArticleIdList><ArticleId IdType="pubmed">24719758</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Kidney Dis. 2012 Mar;59(3):382-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22206745</ArticleId></ArticleIdList></Reference><Reference><Citation>J Surg Res. 2011 Sep;170(1):32-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21601222</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2009;13(3):R79</Citation><ArticleIdList><ArticleId IdType="pubmed">19463152</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med. 2012 Dec;125(12):1195-1204.e3</Citation><ArticleIdList><ArticleId IdType="pubmed">23062398</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Kidney Dis. 2016 Jun;67(6):872-80</Citation><ArticleIdList><ArticleId IdType="pubmed">26337133</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2008 May;36(5):1397-403</Citation><ArticleIdList><ArticleId IdType="pubmed">18434915</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2012 Jan;93(1):337-47</Citation><ArticleIdList><ArticleId IdType="pubmed">22186469</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2011 Jul;80(1):17-28</Citation><ArticleIdList><ArticleId IdType="pubmed">21150873</ArticleId></ArticleIdList></Reference><Reference><Citation>HPB (Oxford). 2015 Mar;17(3):258-64</Citation><ArticleIdList><ArticleId IdType="pubmed">25387727</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2009 Nov;250(5):720-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19809295</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2012 Sep 22;380(9847):1059-65</Citation><ArticleIdList><ArticleId IdType="pubmed">22998715</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2004 Aug;8(4):R204-12</Citation><ArticleIdList><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiothorac Vasc Anesth. 2014 Aug;28(4):936-42</Citation><ArticleIdList><ArticleId IdType="pubmed">24680132</ArticleId></ArticleIdList></Reference><Reference><Citation>J Heart Valve Dis. 2010 Jan;19(1):139-47; discussion 148</Citation><ArticleIdList><ArticleId IdType="pubmed">20329500</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1996 May 15;275(19):1489-94</Citation><ArticleIdList><ArticleId IdType="pubmed">8622223</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2008 Jul;86(1):4-11</Citation><ArticleIdList><ArticleId IdType="pubmed">18573389</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2015 Jun;102(7):805-12</Citation><ArticleIdList><ArticleId IdType="pubmed">25877255</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Anaesth. 2015 Jul;62(7):753-61</Citation><ArticleIdList><ArticleId IdType="pubmed">25925634</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Surg. 2013 Aug;217(2):240-50</Citation><ArticleIdList><ArticleId IdType="pubmed">23870218</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2012 Feb;93(2):584-91</Citation><ArticleIdList><ArticleId IdType="pubmed">22269725</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Dec 09;8(12):e82289</Citation><ArticleIdList><ArticleId IdType="pubmed">24349249</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2005 Aug 17;294(7):813-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16106006</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Soc Nephrol. 2014 Nov;25(11):2625-32</Citation><ArticleIdList><ArticleId IdType="pubmed">24876113</ArticleId></ArticleIdList></Reference><Reference><Citation>J Vasc Surg. 1993 Feb;17(2):357-68; discussion 368-70</Citation><ArticleIdList><ArticleId IdType="pubmed">8433431</ArticleId></ArticleIdList></Reference><Reference><Citation>HPB (Oxford). 2009 Dec;11(8):622-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20495629</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32785846</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1436-2813</ISSN><JournalIssue CitedMedium="Internet"><Volume>51</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Surgery today</Title><ISOAbbreviation>Surg Today</ISOAbbreviation></Journal><ArticleTitle>Risk factors for acute kidney injury in an enhanced recovery pathway for colorectal surgery.</ArticleTitle><Pagination><StartPage>537</StartPage><EndPage>544</EndPage><MedlinePgn>537-544</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00595-020-02107-2</ELocationID><Abstract><AbstractText Label="PURPOSES" NlmCategory="OBJECTIVE">Enhanced recovery pathways (ERPs) have been disseminated worldwide to improve the perioperative patient outcomes while lowering direct healthcare costs. Recent evidence has revealed a potential association between ERPs for colorectal surgery and acute kidney injury (AKI). We, therefore, sought to identify the risk factors associated with postoperative AKI among patients in an ERP for colorectal surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We analyzed the data resulting from a large multicenter, prospective cohort study of patients in an ERP for colorectal surgery. A multivariable analysis was performed to identify factors independently associated with postoperative AKI. The receiver operating characteristic (ROC) curves and contour representations were plotted for the diagnostic prediction analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among those patients included in the analysis (n&#x2009;=&#x2009;1652), the overall incidence of postoperative AKI was 7.7% (95% CI 6.5-9.1%). After adjustment, the independent risk factors for AKI included age&#x2009;&gt;&#x2009;60 (OR 1.03, 95% CI 1.01-1.05), male gender (OR 2.33, 95% CI 1.36-4.02), ASA III-IV (OR 2.43, 95% CI 1.39-4.26), CKD (OR 2.45, 95% CI 1.42-4.23), open surgical approach (OR 2.62, 95% CI 1.63-4.21) and serum albumin&#x2009;&lt;&#x2009;3.5&#xa0;g/dL (OR 1.68, 95% CI 1.02-2.79). An ROC analysis revealed that the composite of albumin, creatinine and age was a strong predictor of postoperative AKI [area under the curve (AUC) 0.756; 95% CI 0.705-0.808].</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Postoperative AKI is common in the setting of ERPs for colorectal surgery and it is associated with a poor clinical outcome. Of those characteristics associated with postoperative AKI, one modifiable factor is a low preoperative albumin level. Screening for malnourished patients or optimizing the nutritional status may be a useful preoperative intervention to prevent postoperative AKI and associated complications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zorrilla-Vaca</LastName><ForeName>Andr&#xe9;s</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8140-8486</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, University of Texas, MD Anderson Cancer Center, Houston, TX, USA. azorrilla@mdanderson.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mena</LastName><ForeName>Gabriel E</ForeName><Initials>GE</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, University of Texas, MD Anderson Cancer Center, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ripolles-Melchor</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care, Infanta Leonor University Hospital, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorente</LastName><ForeName>Juan Victor</ForeName><Initials>JV</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Hospital Juan Ramon Jimenez, Huelva, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramirez-Rodriguez</LastName><ForeName>Juan Jos&#xe9; M</ForeName><Initials>JJM</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Lozano Blesa University Hospital Zaragoza Spain, Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grant</LastName><ForeName>Michael C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Surg Today</MedlineTA><NlmUniqueID>9204360</NlmUniqueID><ISSNLinking>0941-1291</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012709">Serum Albumin</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003106" MajorTopicYN="N">Colon</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013505" MajorTopicYN="N">Digestive System Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000080482" MajorTopicYN="Y">Enhanced Recovery After Surgery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044342" MajorTopicYN="N">Malnutrition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009752" MajorTopicYN="N">Nutritional Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012007" MajorTopicYN="N">Rectum</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012709" MajorTopicYN="N">Serum Albumin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Albumin</Keyword><Keyword MajorTopicYN="N">Colorectal surgery</Keyword><Keyword MajorTopicYN="N">Enhanced recovery pathways</Keyword><Keyword MajorTopicYN="N">Perioperative medicine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32785846</ArticleId><ArticleId IdType="doi">10.1007/s00595-020-02107-2</ArticleId><ArticleId IdType="pii">10.1007/s00595-020-02107-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Feldheiser A, Aziz O, Baldini G, Cox BP, Fearon KC, Feldman LS, et al. Enhanced recovery after surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice. Acta Anaesthesiol Scand. 2016;60:289&#x2013;334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.12651</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott MJ, Baldini G, Fearon KC, Feldheiser A, Feldman LS, Gan TJ, et al. Enhanced recovery after surgery (ERAS) for gastrointestinal surgery, part 1: pathophysiological considerations. Acta Anaesthesiol Scand. 2015;59:1212&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.12601</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafsson UO, Scott MJ, Hubner M, Nygren J, Demartines N, Francis N, et al. Guidelines for perioperative care in elective colorectal surgery: enhanced recovery after surgery (ERAS<sup>&#xae;</sup>) society recommendations: 2018. World J Surg. 2019;43:659&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-018-4844-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiele RH, Raghunathan K, Brudney CS, Lobo DN, Martin D, Senagore A, et al. American society for enhanced recovery (ASER) and perioperative quality initiative (POQI) joint consensus statement on perioperative fluid management within an enhanced recovery pathway for colorectal surgery. Perioper Med (Lond). 2016;5:24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13741-016-0049-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant MC, Hanna A, Benson A, Hobson D, Wu CL, Yuan CT, et al. Dedicated operating room teams and clinical outcomes in an enhanced recovery after surgery pathway for colorectal surgery. J Am Coll Surg. 2018;226:267&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2017.12.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant MC, Isada T, Ruzankin P, Whitman G, Lawton JS, Dodd OJ, et al. Results from an enhanced recovery program for cardiac surgery. J Thorac Cardiovasc Surg. 2020;159(1393&#x2013;1402):e1397.</Citation></Reference><Reference><Citation>Grant MC, Pio Roda CM, Canner JK, Sommer P, Galante D, Hobson D, et al. The impact of anesthesia-influenced process measure compliance on length of stay: results from an enhanced recovery after surgery for colorectal surgery cohort. Anesth Analg. 2019;128:68&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000003458</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollis RH, Kennedy GD. Postoperative complications after colorectal surgery: where are we in the era of enhanced recovery? Curr Gastroenterol Rep. 2020;22:26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11894-020-00763-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Koerner CP, Lopez-Aguiar AG, Zaidi M, Speegle S, Balch G, Shaffer VO, et al. Caution: increased acute kidney injury in enhanced recovery after surgery (ERAS) protocols. Am Surg. 2019;85:156&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000313481908500221</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcotte JH, Patel K, Desai R, Gaughan JP, Rattigan D, Cahill KW, et al. Acute kidney injury following implementation of an enhanced recovery after surgery (ERAS) protocol in colorectal surgery. Int J Colorectal Dis. 2018;33:1259&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00384-018-3084-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiener JGD, Goss L, Wahl TS, Terry MA, Burge KG, Chu DI, et al. The association of enhanced recovery pathway and acute kidney injury in patients undergoing colorectal surgery. Dis Colon Rectum. 2020;63:233&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/DCR.0000000000001528</ArticleId></ArticleIdList></Reference><Reference><Citation>Slagelse C, Gammelager H, Iversen LH, Sorensen HT, Christiansen CF. Acute kidney injury and 1-year mortality after colorectal cancer surgery: a population-based cohort study. BMJ Open. 2019;9:e024817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-024817</ArticleId></ArticleIdList></Reference><Reference><Citation>Turan A, Cohen B, Adegboye J, Makarova N, Liu L, Mascha EJ, et al. Mild acute kidney injury after noncardiac surgery is associated with long-term renal dysfunction: a retrospective cohort study. Anesthesiology. 2020;132:1053&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003109</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripolles-Melchor J, Ramirez-Rodriguez JM, Casans-Frances R, Aldecoa C, Abad-Motos A, Logrono-Egea M, et al. Association between use of enhanced recovery after surgery protocol and postoperative complications in colorectal surgery: the postoperative outcomes within enhanced recovery after surgery protocol (POWER) study. JAMA Surg. 2019;154(8):725&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2019.0995</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripoll&#xe9;s-Melchor J, Fuenmayor Varela M, Camargo S, Jerez Fern&#xe1;ndez P, Contreras del Barrio A, Mart&#xed;nez-Hurtado E, et al. Enhanced recovery after surgery protocol versus conventional perioperative care in colorectal surgery. A single center cohort study. Rev Bras Anestesiol. 2018;68:358&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjan.2018.01.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: Improving global outcomes (KDIGO). Kidney Int. 2005;67:2089&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-1755.2005.00365.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Masoomi H, Carmichael JC, Dolich M, Mills S, Ketana N, Pigazzi A, et al. Predictive factors of acute renal failure in colon and rectal surgery. Am Surg. 2012;78:1019&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000313481207801001</ArticleId></ArticleIdList></Reference><Reference><Citation>Grass F, Lovely JK, Crippa J, Mathis KL, Hubner M, Larson DW. Early acute kidney injury within an established enhanced recovery pathway: uncommon and transitory. World J Surg. 2019;43:1207&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-019-04923-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Frenette AJ, Bouchard J, Bernier P, Charbonneau A, Nguyen LT, Rioux JP, et al. Albumin administration is associated with acute kidney injury in cardiac surgery: a propensity score analysis. Crit Care. 2014;18:602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0602-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksoy R, Adademir T, Yilmaz E, Cevirme D, Sengor M, Koksal C, et al. Is hypoalbuminemia a predictor for acute kidney injury after coronary bypass grafting in diabetes mellitus patients? Braz J Cardiovasc Surg. 2019;34:565&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">31165612</ArticleId><ArticleId IdType="pmc">6852450</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang JY, Kim SO, Kim SG, Song JG, Kang J, Kim JW, et al. Impact of the serum albumin level on acute kidney injury after cerebral artery aneurysm clipping. PLoS ONE. 2018;13:e0206731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0206731</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K, Bang JY, Kim SO, Kim S, Kim JU, Song JG. Association of preoperative hypoalbuminemia with postoperative acute kidney injury in patients undergoing brain tumor surgery: a retrospective study. J Neurosurg. 2018;128:1115&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2016.11.JNS162237</ArticleId></ArticleIdList></Reference><Reference><Citation>Kee YK, Kim H, Jhee JH, Han SH, Yoo TH, Kang SW, et al. Incidence of and risk factors for delayed acute kidney injury in patients undergoing colorectal surgery. Am J Surg. 2019;218:907&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2019.03.027</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung SE, Hilkewich L, Gillis C, Heine JA, Fenton TR. Protein intakes are associated with reduced length of stay: a comparison between enhanced recovery after surgery (ERAS) and conventional care after elective colorectal surgery. Am J Clin Nutr. 2017;106:44&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">28468890</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EH, Kim WJ, Kim JY, Chin JH, Choi DK, Sim JY, et al. Effect of exogenous albumin on the incidence of postoperative acute kidney injury in patients undergoing off-pump coronary artery bypass surgery with a preoperative albumin level of less than 4.0 g/dl. Anesthesiology. 2016;124:1001&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001051</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40448205</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2047-783X</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>May</Month><Day>31</Day></PubDate></JournalIssue><Title>European journal of medical research</Title><ISOAbbreviation>Eur J Med Res</ISOAbbreviation></Journal><ArticleTitle>Risk factors and mortality of postoperative acute kidney injury (AKI) in newborns across geographical regions, surgical type, and national economic levels: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>433</StartPage><MedlinePgn>433</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">433</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40001-025-02719-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">It is noted that postoperative acute kidney injury (AKI) in neonates is known to be associated with adverse outcomes, yet its incidence and risk factors remain incompletely elucidated. The current study aims to improve the understanding of postoperative AKI in neonates by systematically evaluating its incidence, diagnostic criteria, risk factors, and clinical outcomes, with particular attention to variations across geographic regions, surgical types, the span of time, and national economic statuses.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A comprehensive search of Pubmed, Embase, OVID, Web of Science (WOS), Medline, and Cochrane Controlled Register of Trials (CENTRAL) was conducted from inception to 30 September 2024. Studies meeting all the following inclusion criteria were enrolled: 1) Population: neonates aged &#x2264; 30 days; 2) Disease: postoperative AKI diagnosed per KDIGO, pRIFLE, AKIN, nKDIGO, or others; 3) Study design: prospective/retrospective cohort studies or case-control studies; 4) Reporting data on postoperative incidence of AKI. The pooled proportion (along with 95% confidence intervals [CI]) of postoperative AKI was calculated. We also calculated pooled odds ratios (95% CI) for all-cause mortality in neonates with postoperative AKI when compared with those without AKI.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 69 studies (10,519 cases) were included in the meta-analysis. The pooled incidence of postoperative AKI in neonates was 37% (95%CI 32-42, I<sup>2</sup> = 96.4%, P&lt;0.01), with a wide variability ranging from 0.0% to 74.8%. Several risk factors were identified, including lower preoperative or intraoperative urinary output, lower preoperative serum creatinine (SCr)/higher maximum postoperative SCr, elevated vasoactive inotrope score (VIS)/hypotension, younger corrected gestational age, prolonged cardiopulmonary bypass (CPB) duration, hypothermia, sepsis, and preoperative ventilation. Furthermore, 28 studies involving 6714 patients reported data on AKI-associated mortality with an overall incidence of 8.2%. Neonates who developed postoperative AKI had 3.3 times higher odds of mortality as compared to those without this complication.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Postoperative AKI affects one-third of neonates, and AKI-associated mortality remains high. Future efforts should focus on developing earlier and more sensitive detection methods.</AbstractText><AbstractText Label="SYSTEMATIC REVIEW REGISTRATION NUMBER" NlmCategory="UNASSIGNED">This meta-analysis was registered on https://www.crd.york.ac.uk/prospero/ with the registration number CRD 42024602820 on October 29, 2024.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Cui</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, The Affiliated Hospital, UESTC Chengdu Women's and Children's Central Hospital, No.1617, Riyue Avenue, Qingyang District, Chengdu, 610091, China. cuiyu19831001@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Luo</LastName><ForeName>Yifei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, The Affiliated Hospital, UESTC Chengdu Women's and Children's Central Hospital, No.1617, Riyue Avenue, Qingyang District, Chengdu, 610091, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Diwei</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, The Affiliated Hospital, UESTC Chengdu Women's and Children's Central Hospital, No.1617, Riyue Avenue, Qingyang District, Chengdu, 610091, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Qianqian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, The Affiliated Hospital, UESTC Chengdu Women's and Children's Central Hospital, No.1617, Riyue Avenue, Qingyang District, Chengdu, 610091, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Qinghua</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, The Affiliated Hospital, UESTC Chengdu Women's and Children's Central Hospital, No.1617, Riyue Avenue, Qingyang District, Chengdu, 610091, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Tianqing</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, The Affiliated Hospital, UESTC Chengdu Women's and Children's Central Hospital, No.1617, Riyue Avenue, Qingyang District, Chengdu, 610091, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2023NSFSC1626</GrantID><Agency>Science &amp; Technology Department of Sichuan Province</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Med Res</MedlineTA><NlmUniqueID>9517857</NlmUniqueID><ISSNLinking>0949-2321</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury (AKI)</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Neonates</Keyword><Keyword MajorTopicYN="N">Postoperative</Keyword><Keyword MajorTopicYN="N">Risk factors</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Conflicts of interest: The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>31</Day><Hour>22</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>31</Day><Hour>0</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>30</Day><Hour>23</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40448205</ArticleId><ArticleId IdType="pmc">PMC12125791</ArticleId><ArticleId IdType="doi">10.1186/s40001-025-02719-9</ArticleId><ArticleId IdType="pii">10.1186/s40001-025-02719-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Duong MD, Kwak S, Bagrodia N, Basalely A. Acute kidney injury post-abdominal surgery in infants: implications for prevention and management. Front Pediatr. 2023. 10.3389/fped.2023.1162863.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10160454</ArticleId><ArticleId IdType="pubmed">37152314</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang SJ, Fang TF, Lin MY, et al. Risk factors for acute kidney injury in preterm neonates after noncardiac surgery: a single-center retrospective cohort study. Sci Reports. 2024;14(1):17965.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11297254</ArticleId><ArticleId IdType="pubmed">39095375</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y, Cao R, Deng L. Inadvertent hypothermia and acute kidney injury (AKI) in neonates undergoing gastrointestinal surgeries: a retrospective study. J Perinatol&#x202f;: Off J California Perinatal Assoc. 2022;42(2):247&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">34413460</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkins J, Mpody C, Corridore M, Cambier G, Tobias JD, Nafiu OO. Risk Factors and Consequences of Acute Kidney Injury After Noncardiac Surgery in Children. Anesth Analges. 2022;135:625.</Citation><ArticleIdList><ArticleId IdType="pubmed">35086116</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang XZT, Zhou H, et al. Acute kidney injury as an independent predicting factor for stage 3 or higher chronic kidney disease after nephrectomy. Urol Oncol. 2023;41(3):149.e141-149.e149.</Citation><ArticleIdList><ArticleId IdType="pubmed">36463084</ArticleId></ArticleIdList></Reference><Reference><Citation>Wingert T, Grogan T, Cannesson M, Sapru A, Ren W, Hofer I. Acute Kidney Injury and Outcomes in Children Undergoing Noncardiac Surgery: A Propensity-Matched Analysis. Anesth Analges. 2020;132(2):332&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7855789</ArticleId><ArticleId IdType="pubmed">32739953</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Wang H, Pei J, Jiang X, Tang J. Acute kidney injury in premature and low birth weight neonates: a systematic review and meta-analysis. Pediatr Nephrol (Berlin, Germany). 2022;37(2):275&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">34529137</ArticleId></ArticleIdList></Reference><Reference><Citation>Harer MW, Selewski DT, Kashani K, et al. Improving the quality of neonatal acute kidney injury care: neonatal-specific response to the 22nd Acute Disease Quality Initiative (ADQI) conference. J Perinatol. 2020;41(2):185&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">32892210</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu C, Lian J, Cao Z, Chen L, Liang J, Wang S. Comparing the pRIFLE, AKIN, KDIGO, and modified KDIGO criteria in neonates after cardiac surgery. Pediatr Nephrol (Berlin, Germany). 2022;37(6):1399&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pubmed">34716482</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayenew AA, Mol BW, Bradford B, Abeje G. Prevalence of female genital mutilation and associated factors among women and girls in Africa: a systematic review and meta-analysis. Syst Rev. 2024;13(1):26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10785359</ArticleId><ArticleId IdType="pubmed">38217004</ArticleId></ArticleIdList></Reference><Reference><Citation>Dettori JR, Norvell DC, Chapman JR. Fixed-Effect vs Random-Effects Models for Meta-Analysis: 3 Points to Consider. Global Spine J. 2022;12(7):1624&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9393987</ArticleId><ArticleId IdType="pubmed">35723546</ArticleId></ArticleIdList></Reference><Reference><Citation>The World Bank. Accessed Oct 30. WDI &#x2013; the world by income and region Available at: https://datatopicsworldbankorg/world-developmentindicators/the-world-by-income-and-regionhtml. Accessed Oct 30, 2024.</Citation></Reference><Reference><Citation>Ricci Z, Stazi GV, Di Chiara L, et al. Fenoldopam in newborn patients undergoing cardiopulmonary bypass: controlled clinical trial. Int Cardiovas Thorac Sur. 2008;7(6):1049&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">18782787</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajagopal SK, Emani SM, Roy N, Westgate L, Bacha EA. Acute kidney injury and regional abdominal perfusion during neonatal aortic arch reconstruction. J Thorac Cardiovas Sur. 2010;140(2):453&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20447657</ArticleId></ArticleIdList></Reference><Reference><Citation>Krawczeski CD, Woo JG, Wang Y, Bennett MR, Ma Q, Devarajan P. Neutrophil gelatinase-associated lipocalin concentrations predict development of acute kidney injury in neonates and children after cardiopulmonary bypass. J Pediatr. 2011;158(6):1009-1015.e1001.</Citation><ArticleIdList><ArticleId IdType="pubmed">21300375</ArticleId></ArticleIdList></Reference><Reference><Citation>Alabbas A, Campbell A, Skippen P, Human D, Matsell D, Mammen C. Epidemiology of cardiac surgery-associated acute kidney injury in neonates: a retrospective study. Pediatr Nephrol (Berlin, Germany). 2013;28(7):1127&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">23519522</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan CJ, Zappitelli M, Robertson CM, et al. Risk factors for and outcomes of acute kidney injury in neonates undergoing complex cardiac surgery. J Pediatr. 2013;162(1):120-127.e121.</Citation><ArticleIdList><ArticleId IdType="pubmed">22878115</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmody JB, Seckeler MD, Ballengee CR, Conaway M, Jayakumar KA, Charlton JR. Pre-operative renal volume predicts peak creatinine after congenital heart surgery in neonates. Cardiol Young. 2014;24(5):831&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24229479</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonseca E, Georgiev SG, Gorenflo M, Loukanov TS. Patent ductus arteriosus in preterm infants: benefits of early surgical closure. Asian Cardiovas Thorac Ann. 2014;22(4):391&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">24771725</ArticleId></ArticleIdList></Reference><Reference><Citation>Jolley M, Yarlagadda VV, Rajagopal SK, Almodovar MC, Rycus PT, Thiagarajan RR. Extracorporeal membrane oxygenation-supported cardiopulmonary resuscitation following stage 1 palliation for hypoplastic left heart syndrome. Pediatr Crit Care Med&#x202f;: J Soc Crit Care Med World Feder Pediatr Intens Crit Care Soc. 2014;15(6):538&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">24797720</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehmood A, Ismail SR, Kabbani MS, Abu-Sulaiman RM, Najm HK. Outcome of low body weight (&lt;22kg) infants undergoing cardiac surgery. J Saudi Heart Assoc. 2014;26(3):132&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4062764</ArticleId><ArticleId IdType="pubmed">24954985</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh SP, Chauhan S, Choudhury M, et al. Modified Blalock Taussig shunt: Comparison between neonates, infants and older children. Ann Cardiac Anaesth. 2014;17(3):191&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">24994729</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CY, Shuhaiber JH, Loyola H, et al. The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery. PloS One. 2015;10(5):e012514.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4425500</ArticleId><ArticleId IdType="pubmed">25954976</ArticleId></ArticleIdList></Reference><Reference><Citation>Piggott KD, Soni M, Decampli WM, et al. Acute Kidney Injury and Fluid Overload in Neonates Following Surgery for Congenital Heart Disease. World J Pediatr Cong Heart Sur. 2015;6(3):401&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">26180155</ArticleId></ArticleIdList></Reference><Reference><Citation>Robert SM, Borasino S, Dabal RJ, Cleveland DC, Hock KM, Alten JA. Postoperative hydrocortisone infusion reduces the prevalence of low cardiac output syndrome after neonatal cardiopulmonary bypass. Pediat Crit Care Med. 2015;16(7):629&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">25901540</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang P, Luo J, Liu J, Yang X, Peng X, Liu P. Safety of surgical therapy for neonate aortic coarctation combined with ventricular septal defect. Zhong nan da xue xue bao Yi xue ban = J Central South Univ Med Sci. 2016;41(7):696&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">27592573</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-de-Toledo J, Perez-Ortiz A, Gil L, et al. Early Initiation of Renal Replacement Therapy in Pediatric Heart Surgery Is Associated with Lower Mortality. Pediatr Cardiol. 2016;37(4):623&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26687178</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong JH, Selewski DT, Yu S, et al. Severe Acute Kidney Injury Following Stage 1 Norwood Palliation: Effect on Outcomes and Risk of Severe Acute Kidney Injury at Subsequent Surgical Stages. Pediatr Crit Care Med&#x202f;: J Soc Crit Care Med World Feder Pediatr Intens Crit Care Soc. 2016;17(7):615&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">27099973</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlo WF, Clark ST, Borasino S, Alten JA. Impact of contrast exposure from computed tomography angiography on acute kidney injury after neonatal cardiopulmonary bypass surgery. Cong Heart Dis. 2017;12(4):540&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">28557332</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenzie JM, Scodellaro T, d&#x2019;Udekem Y, Chiletti R, Butt W, Namachivayam SP. Late-Term Gestation Is Associated With Improved Survival in Neonates With Congenital Heart Disease Following Postoperative Extracorporeal Life Support. Pediatr Crit Care Med&#x202f;: J Soc Crit Care Med World Feder Pediatr Intens Crit Care Soc. 2017;18(9):876&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">28658196</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahnukainen T, Keski-Nisula J, Tainio J, et al. Efficacy of corticosteroids in prevention of acute kidney injury in neonates undergoing cardiac surgery-A randomized controlled trial. Acta Anaesthesiol Scandin. 2018;62(8):1072&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29667173</ArticleId></ArticleIdList></Reference><Reference><Citation>Mah KE, Hao S, Sutherland SM, et al. Fluid overload independent of acute kidney injury predicts poor outcomes in neonates following congenital heart surgery. Pediatr Nephrol (Berlin, Germany). 2018;33(3):511&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">29128923</ArticleId></ArticleIdList></Reference><Reference><Citation>Piggott KD, Liu A, Monczka J, et al. Inadequate preoperative nutrition might be associated with acute kidney injury and greater illness severity postoperatively. J Thorac Cardiovas Sur. 2018;155(5):2104&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29366566</ArticleId></ArticleIdList></Reference><Reference><Citation>SooHoo MM, Patel SS, Jaggers J, Faubel S, Gist KM. Acute Kidney Injury Defined by Fluid Corrected Creatinine in Neonates After the Norwood Procedure. World J Pediatr Cong Heart Sur. 2018;9(5):513&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">30157730</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayg&#xfc;n A, Poryo M, Wagenpfeil G, et al. Birth weight, Apgar scores and gentamicin were associated with acute kidney injuries in VLBW neonates requiring treatment for patent ductus arteriosus. Acta Paediatr. 2019;108(4):645&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">30178614</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EM, Martin RH, Buckley JR, et al. Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass: Randomized Controlled Trial. J Am College Cardiol. 2019;74(5):659&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6684326</ArticleId><ArticleId IdType="pubmed">31370958</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeder LW, Buckley JR, Stroud RE, et al. Plasma Neutrophil Gelatinase-Associated Lipocalin Is Associated With Acute Kidney Injury and Clinical Outcomes in Neonates Undergoing Cardiopulmonary Bypass. Pediatr Crit Med&#x202f;: J Soc Crit Care Med World Feder Pediatr Intens Crit Care Soc. 2019;20(10):957&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6776671</ArticleId><ArticleId IdType="pubmed">31206501</ArticleId></ArticleIdList></Reference><Reference><Citation>Yum SK, Seo YM, Youn YA, Sung IK. Preoperative metabolic acidosis and acute kidney injury after open laparotomy in the neonatal intensive care unit. Pediatr Int&#x202f;: Off J Japan Pediatr Soc. 2019;61(10):994&#x2013;1000.</Citation><ArticleIdList><ArticleId IdType="pubmed">31267596</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennan KG, Parravicini E, Lorenz JM, Bateman DA. Patterns of Urinary Neutrophil Gelatinase-Associated Lipocalin and Acute Kidney Injury in Neonates Receiving Cardiopulmonary Bypass. Child (Basel, Switzerland). 2020;7(9):132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7552644</ArticleId><ArticleId IdType="pubmed">32916929</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubbard R, Edmonds K, Rydalch E, Pawelek O, Griffin E, Gautam N. Anesthetic management of catheter-based patent ductus arteriosus closure in neonates weighing &lt;3 kg: A Retrospective Observational Study. Paediatr Anaesth. 2020;30(4):506&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">32040230</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh L, Rodriguez-Lopez S, Benisty K, et al. Follow-up after neonatal heart disease repair: watch out for chronic kidney disease and hypertension! Pediatr Nephrol (Berlin, Germany). 2020;35(11):2137&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7515960</ArticleId><ArticleId IdType="pubmed">32500246</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Lopez S, Huynh L, Benisty K, et al. Paucity of renal follow-up by school age after neonatal cardiac surgery. Cardiol Young. 2020;30(6):822&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">32425142</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueno K, Shiokawa N, Takahashi Y, et al. Kidney Disease: Improving Global Outcomes in neonates with acute kidney injury after cardiac surgery. Clin Exp Nephrol. 2020;24(2):167&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">31677063</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Hua X, Yang G, Xiang B, Jiang X. Incidence, risk factors, and outcomes of acute kidney injury in neonates after surgical procedures. Pediatr Nephrol (Berlin, Germany). 2020;35(7):1341&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">32232634</ArticleId></ArticleIdList></Reference><Reference><Citation>Alten JA, Cooper DS, Blinder JJ, et al. Epidemiology of Acute Kidney Injury After Neonatal Cardiac Surgery: A Report From the Multicenter Neonatal and Pediatric Heart and Renal Outcomes Network. Crit Care Med. 2021;49(10):e941&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">34166288</ArticleId></ArticleIdList></Reference><Reference><Citation>Beken S, Akbulut BB, Albayrak E, et al. Evaluation of neonatal acute kidney injury after critical congenital heart disease surgery. Pediatr Nephrol (Berlin, Germany). 2021;36(7):1923&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">33492453</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchert E, de la Fuente R, Guzman AM, et al. Biomarkers as predictors of renal damage in neonates undergoing cardiac surgery. Perfusion. 2021;36(8):825&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">33140691</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;ttcher W, Weixler V, Redlin M, et al. Acute Kidney Injury After Neonatal Aortic Arch Surgery: Deep Hypothermic Circulatory Arrest Versus Moderate Hypothermia With Distal Aortic Perfusion. World J Pediatr Cong Heart Sur. 2021;12(5):573&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">34597201</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham TW, Tan Y, Krawczeski CD, et al. Incidence and impact of acute kidney injury in patients with hypoplastic left heart syndrome following the hybrid stage 1 palliation. Cardiol Young. 2021;31(3):414&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">33261689</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahnukainen T, Rautiainen P, Tainio J, P&#xe4;til&#xe4; T, Salminen J, Keski-Nisula J. Renal function and inflammatory response in neonates undergoing cardiac surgery with or without antegrade cerebral perfusion - A post hoc analysis. Ann Card Anaesth. 2021;24(4):434&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8617397</ArticleId><ArticleId IdType="pubmed">34747750</ArticleId></ArticleIdList></Reference><Reference><Citation>Slagle CL, Goldstein SL, Gavigan HW, et al. Association between Elevated Urine Neutrophil Gelatinase-Associated Lipocalin and Postoperative Acute Kidney Injury in Neonates. J Pediatr. 2021;238:193-201.e192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8551040</ArticleId><ArticleId IdType="pubmed">34371091</ArticleId></ArticleIdList></Reference><Reference><Citation>Uygur &#xd6;, K&#xf6;ro&#x11f;lu &#xd6;A, Levent RE, et al. Can urinary biomarkers predict acute kidney injury in newborns with critical congenital heart disease? Turkish J Med Sci. 2021;51(1):175&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7991857</ArticleId><ArticleId IdType="pubmed">33021763</ArticleId></ArticleIdList></Reference><Reference><Citation>Arattu Thodika FMS, Dassios T, Deep A, Greenough A. Acute kidney injury in infants with congenital diaphragmatic hernia. J Perinatol&#x202f;: Off J California Perinatal Assoc. 2022;42(7):925&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9259479</ArticleId><ArticleId IdType="pubmed">35393531</ArticleId></ArticleIdList></Reference><Reference><Citation>Boettcher W, O&#x2019;Brien B, Photiadis J, Habazettl H, Eggert-Doktor D. Acute Kidney Injury With a Miniaturized Extracorporeal Circuit for Neonatal Cardiopulmonary Bypass. J Cardiothorac Vas Anesth. 2022;36(11):4045&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">36008209</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y, Fang X, Li J, Deng L. Evaluation of neonatal acute kidney injury (AKI) after emergency gastrointestinal surgery. Asian J Sur. 2023;46(5):1924&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">36089435</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg PM, Paschal JL, Zhang M, et al. Brain injury in preterm infants with surgical necrotizing enterocolitis: clinical and bowel pathological correlates. Pediatr Res. 2022;91(5):1182&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10308193</ArticleId><ArticleId IdType="pubmed">34103675</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg PM, Paschal JL, Zhang M, et al. Clinical impact of severe acute kidney injury on post-operative and brain injury outcomes in preterm infants following surgical necrotizing enterocolitis. J Maternal-fetal Neonat Med&#x202f;: Off J Eur Assoc Perinat Med, Feder Asia Ocean Perinat Soc, Int Soc Perinat Obstet. 2022;35(25):10124&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10986639</ArticleId><ArticleId IdType="pubmed">36093832</ArticleId></ArticleIdList></Reference><Reference><Citation>Gist KM, Borasino S, SooHoo M, et al. Transient and persistent acute kidney injury phenotypes following the Norwood operation: a retrospective study. Cardiol Young. 2022;32(4):564&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8741883</ArticleId><ArticleId IdType="pubmed">34233781</ArticleId></ArticleIdList></Reference><Reference><Citation>Grabski DF, Vavolizza RD, Roecker Z, et al. Reduction of post-operative opioid use in neonates following open congenital diaphragmatic hernia repairs: A quality improvement initiative. J Pediatr Sur. 2022;57(1):45&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">34686379</ArticleId></ArticleIdList></Reference><Reference><Citation>Heibel J, Graham EM, Mahle WT, et al. Perioperative Metabolites Are Associated With Adverse Neonatal Congenital Heart Disease Surgical Outcomes. J Am Heart Assoc. 2022;11(16):e024996.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9496308</ArticleId><ArticleId IdType="pubmed">35946448</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;ktener Anuk E, Erdo&#x11f;an &#x130;, &#xd6;zkan M, Baskin E, Varan B, Tokel NK. Evaluation of acute kidney injury after surgery for congenital heart disease in neonates: a tertiary hospital experience. J Maternal-fetal Neonat Med&#x202f;: Off J Eur Assoc Perinat Med, Feder Asia Ocean Perinat Soc, Int Soc Perinat Obstet. 2022;35(25):9496&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pubmed">35382696</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram&#xed;rez M, Chakravarti S, Busovsky-McNeal M, et al. Elevated Levels of Urinary Biomarkers TIMP-2 and IGFBP-7 Predict Acute Kidney Injury in Neonates after Congenital Heart Surgery. J Pediatr Intens Care. 2022;11(2):153&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9208843</ArticleId><ArticleId IdType="pubmed">35734207</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Tong Y, Yuan D, et al. Association of high-sensitivity C-reactive protein and anemia with acute kidney injury in neonates. Front Pediatr. 2022;10:882739.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9666738</ArticleId><ArticleId IdType="pubmed">36405830</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezirganoglu H, Okur N, Ozdemir F, Gul O, Aldudak B. Comparison of Three Different Multiple Organ Dysfunction Scores for Predicting Mortality after Neonatal Cardiac Surgery. Children. 2023;10(8):1333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10453477</ArticleId><ArticleId IdType="pubmed">37628332</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg PM, Rebentisch A, Zhang M, et al. Clinical impact of analgesic-sedative agents and peri-operative clinical status on white matter brain injury in preterm infants following surgical NEC. J Neonat-Perinat Med. 2023;16(3):527&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10615724</ArticleId><ArticleId IdType="pubmed">37742664</ArticleId></ArticleIdList></Reference><Reference><Citation>Navaratnam M, Mendoza JM, Zhang S, et al. Activated 4-Factor Prothrombin Complex Concentrate as a Hemostatic Adjunct for Neonatal Cardiac Surgery: A Propensity Score-Matched Cohort Study. Anesth Analges. 2023;136(3):473&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">36729967</ArticleId></ArticleIdList></Reference><Reference><Citation>Niknafs N, Kuan MTY, Mammen C, Skarsgard E, Ting JY. Fluid overload in newborns undergoing abdominal surgery: a retrospective study. J Maternal-fetal Neonat Med&#x202f;: Off J Eur Assoc Perinat Med, Feder Asia Ocean Perinat Soc, Int Soc Perinat Obstet. 2023;36(1):2206940.</Citation><ArticleIdList><ArticleId IdType="pubmed">37121907</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;zt&#xfc;rk DY, &#xd6;zt&#xfc;rk E, Dlkmen RT, et al. Evaluation of perfusion index and left ventricular output changes in low cardiac output syndrome after arterial switch operation. Cardiol Young. 2023;33(11):2196&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">36606506</ArticleId></ArticleIdList></Reference><Reference><Citation>Puzanov A, Tkachuk V, Maksymenko A. Acute kidney injury after arterial switch operation: incidence, risk factors, clinical impact - a retrospective single-center study. Renal Fail. 2023;45(1):2167661.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9879166</ArticleId><ArticleId IdType="pubmed">36692196</ArticleId></ArticleIdList></Reference><Reference><Citation>Alghamdi FA, Bin Mahfooz MA, Almutairi HF, et al. Incidence, Risk Factors and Outcomes of Acute Kidney Injury in Neonates Undergoing Open-heart Surgeries: Single Center Experience. J Saudi Heart Assoc. 2024;36(2):70&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11195661</ArticleId><ArticleId IdType="pubmed">38919507</ArticleId></ArticleIdList></Reference><Reference><Citation>Condit PE, Gorski DP, Lasarev MR, Al-Subu AM, Harer MW. Decreased Intraoperative Renal Tissue Oxygenation after Cardiopulmonary Bypass Predicts Cardiac Surgery-Associated Acute Kidney Injury in Neonates. Children (Basel, Switzerland). 2024;11(3):315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10969573</ArticleId><ArticleId IdType="pubmed">38539350</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg PM, Pippin M, Zhang M, et al. Clinical Correlates of Moderate-to-Severe Bronchopulmonary Dysplasia in Preterm Infants following Surgical Necrotizing Enterocolitis. Am J Perinatol. 2024;41(10):1348&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10278056</ArticleId><ArticleId IdType="pubmed">35858647</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg PM, Riddick RA, Ansari MAY, et al. Clinical and Growth Correlates of Retinopathy of Prematurity in Preterm Infants with Surgical Necrotizing Enterocolitis and Intestinal Perforation. Am J Perinatol. 2024;364:255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11496023</ArticleId><ArticleId IdType="pubmed">38565196</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi RK, Joshi R, Aggarwal N, et al. Comparison of Levosimendan Versus Milrinone After the Arterial Switch Operation for Infants &#x2264;3 kg. World J Pediatr Cong Heart Sur. 2024;15:588.</Citation><ArticleIdList><ArticleId IdType="pubmed">38766718</ArticleId></ArticleIdList></Reference><Reference><Citation>Lembo C, Meot M, Mellul K, et al. Renal function after ductus arteriosus transcatheter closure with or without angiography in very preterm infants. Acta Paediatr. 2024;113(5):955&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">38180109</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang S, Du L, Geng N, et al. Neurodevelopmental impairment following surgical necrotizing enterocolitis with gestational age &#x2265; 28 weeks: who is at risk? Pediatr Sur Int. 2024;40(1):41.</Citation><ArticleIdList><ArticleId IdType="pubmed">38286871</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson EJ, Zimmerman KO, Gonzalez D, et al. Population Pharmacokinetics of Caffeine in Neonates with Congenital Heart Disease and Associations with Acute Kidney Injury. J Clin Pharmacol. 2024;64(3):300&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10898646</ArticleId><ArticleId IdType="pubmed">37933788</ArticleId></ArticleIdList></Reference><Reference><Citation>de Melo T, Bezerra Gir&#xe3;o A, de Melo T, Bezerra Cavalcante C, Pereira Castello Branco KM, de Oliveira C, Teles A, Lib&#xf3;rio AB. Urine Output and Acute Kidney Injury in Neonates/Younger Children: A Prospective Study of Cardiac Surgery Patients with Indwelling Urinary Catheters. Clin J Am Soc Nephrol&#x202f;: CJASN. 2024;19:1230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11469780</ArticleId><ArticleId IdType="pubmed">39058926</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Eynde J, Schuermans A, Verbakel JY, et al. Biomarkers of acute kidney injury after pediatric cardiac surgery: a meta-analysis of diagnostic test accuracy. Eur J Pediatr. 2022;181(5):1909&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">35039910</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Jiang L, Wang B, Xi X. Epidemiological characteristics of and risk factors for patients with postoperative acute kidney injury: a multicenter prospective study in 30 Chinese intensive care units. Int Urol Nephrol. 2018;50(7):1319&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">29480442</ArticleId></ArticleIdList></Reference><Reference><Citation>Meena J, Kumar J, Kocharlakota JP, et al. Acute Kidney Injury in Neonates: A Meta-Analysis. Pediatrics. 2024. 10.1542/peds.2023-065182.</Citation><ArticleIdList><ArticleId IdType="pubmed">38872621</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadav YS, Surendrasingh C, Proshad NE, Xuan P, Liu L, Dongsheng Y, Praneeta CR, Peter S, Daniel IS. Intraoperative Hypotension and Acute Kidney Injury. Anesthesiology. 2022;136(1):93&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">34843618</ArticleId></ArticleIdList></Reference><Reference><Citation>Nada A, Bonachea EM, Askenazi DJ. Acute kidney injury in the fetus and neonate. Sem Fetal Neonat Med. 2017;22(2):90&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5373985</ArticleId><ArticleId IdType="pubmed">28034548</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory A, Stapelfeldt WH, Khanna AK, et al. Intraoperative Hypotension Is Associated With Adverse Clinical Outcomes After Noncardiac Surgery. Anesthes Analges. 2020;132(6):1654&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8115733</ArticleId><ArticleId IdType="pubmed">33177322</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaddourah A, Basu RK, Bagshaw SM, Goldstein SL. Epidemiology of Acute Kidney Injury in Critically Ill Children and Young Adults. New England J Med. 2017;376(1):11&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5322803</ArticleId><ArticleId IdType="pubmed">27959707</ArticleId></ArticleIdList></Reference><Reference><Citation>Ely DMDA. Infant Mortality in the United States, 2022: Data From the Period Linked Birth/Infant Death File. Natl Vital Stat Rep. 2024. 10.15620/cdc/157006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11513748</ArticleId><ArticleId IdType="pubmed">39412861</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31623901</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>26</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0267</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>12</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Injury</Title><ISOAbbreviation>Injury</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury following hip fracture.</ArticleTitle><Pagination><StartPage>2268</StartPage><EndPage>2271</EndPage><MedlinePgn>2268-2271</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.injury.2019.10.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0020-1383(19)30589-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hip fracture causes disability and excess mortality in the aging population. Acute kidney injury (AKI), is known to diminish survival of critically ill and trauma patients. AKI is also a common perioperative complication among surgical patients. We examined the effect of AKI on the survival of hip fracture patients in a Finnish hip fracture population and the risk factors for AKI in a prospective study.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study cohort constituted of 486 consecutive low-energy trauma hip fracture patients referred to Satakunta Central Hospital (Pori, Finland) and Turku University Hospital (Turku, Finland). The patients underwent standard diagnostics and treatment in the emergency department (ER) and were operated according to the local treatment protocol. Serum creatinine (sCr) was analyzed daily pre- and post-operatively during the hospital stay. Patients were divided into groups; AKI and non-AKI based on Kidney Disease: Improving Global Outcomes (KDIGO) criteria.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The incidence of AKI in the study cohort was 8.4% (40/475). Eleven patients were excluded due to missing sCr data. The baseline characteristics of AKI and non-AKI groups differed significantly concerning baseline sCr but were otherwise similar. At 90-day follow-up, the overall mortality was 14.4%. Patients with AKI had a significantly higher mortality (35.0%) than those with no AKI (12.7%) (p&#xa0;&lt;&#xa0;0.001). Dementia, preoperative sCr and any stage of AKI were independent predictors for mortality. Dementia and preoperative sCr were independently associated with post-operative AKI.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In this study AKI was a significant factor associated with a 3 -fold mortality during the first three months after surgery for low-energy trauma hip fracture.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rantalaiho</LastName><ForeName>Ida</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics and Traumatology, Turku University Hospital and University of Turku, P.O. Box 28, FIN-20701, Turku, Finland. Electronic address: ida.rantalaiho@tyks.fi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gunn</LastName><ForeName>Jarmo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Heart Center, Turku University Hospital, Turku, Finland; Department of Surgery, University of Turku, Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kukkonen</LastName><ForeName>Juha</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Orthopaedic and Trauma Surgery, Satakunta Central Hospital, Pori, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaipia</LastName><ForeName>Antti</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Urology, Tampere University Hospital and University of Tampere, Tampere, Finland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Injury</MedlineTA><NlmUniqueID>0226040</NlmUniqueID><ISSNLinking>0020-1383</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Injury. 2020 Jun;51(6):1406-1407. doi: 10.1016/j.injury.2020.03.060.</RefSource><PMID Version="1">32327230</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005387" MajorTopicYN="N" Type="Geographic">Finland</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="Y">Hip Fractures</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007677" MajorTopicYN="N">Kidney Function Tests</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010043" MajorTopicYN="N">Outcome and Process Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AKI</Keyword><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Hip fracture</Keyword><Keyword MajorTopicYN="N">Incidence</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31623901</ArticleId><ArticleId IdType="doi">10.1016/j.injury.2019.10.008</ArticleId><ArticleId IdType="pii">S0020-1383(19)30589-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39384419</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>12</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Amino Acid Infusion for Perioperative Functional Renal Protection: A Meta-analysis.</ArticleTitle><Pagination><StartPage>3076</StartPage><EndPage>3085</EndPage><MedlinePgn>3076-3085</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2024.08.033</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(24)00572-X</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Acute kidney injury (AKI) is a common perioperative complication. To date, no single intervention has been proven effective for AKI prevention in this setting. However, intravenous amino acids (AA) administration may recruit renal functional reserve and, thereby, attenuate the perioperative loss of the glomerular filtration rate.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">We performed a meta-analysis to assess the efficacy of AA infusion for perioperative renal functional protection.</AbstractText><AbstractText Label="SETTING AND PARTICIPANTS" NlmCategory="METHODS">We performed a meta-analysis of controlled studies in perioperative patients evaluating intravenous AA infusion versus any comparator.</AbstractText><AbstractText Label="MEASUREMENTS" NlmCategory="METHODS">The primary outcome was AKI at longest follow-up. We performed a random effects meta-analysis on the relative risk (RR) scale to assess the effect of AA infusion. We used a Bayesian approach to estimate the probability of benefit (RR &lt; 1) for the primary outcome. Secondary outcomes included renal replacement therapy, serum creatinine, and estimated glomerular filtration rate. Tertiary outcomes included mechanical ventilation duration, intensive care unit and hospital length of stay and mortality (PROSPERO: CRD42024547225).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 15 studies (14 randomized controlled trials and 1 prospective before-after study) reporting at least one outcome of interest (4,544 patients), with 6 studies (4,084 patients) reporting the primary outcome. AKI occurred 504 of 2,041 (24.7%) in AA patients versus 614 of 2,041 (30.1%) in controls (RR, 0.66; 95% confidence interval, 0.47-0.94; I<sup>2</sup> = 50%; p = 0.02), which corresponded with a 99.1% probability of AKI reduction with AA. Moreover, consistent with these findings, AA decreased serum creatinine and hospital length of stay and increased the estimated glomerular filtration rate.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This meta-analysis suggests that AA administration likely decreased the perioperative incidence of AKI.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pruna</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Losiggio</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy; School of Medicine, Vita-Salute San Raffaele University, Milan, Italy. Electronic address: landoni.giovanni@hsr.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotani</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Redaelli</LastName><ForeName>Martina Baiardo</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veneziano</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Todd C</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zangrillo</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy; School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaudino</LastName><ForeName>Mario F L</ForeName><Initials>MFL</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, USA; Department of Critical Care, The University of Melbourne, Melbourne, Australia; Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia; Data Analytics Research and Evaluation Centre, Austin Hospital, Melbourne, Australia; Department of Intensive Care, Austin Hospital, Melbourne, Australia; Department of Intensive Care, Royal Melbourne Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>for Protection Study group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000596">Amino Acids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="Y">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000596" MajorTopicYN="Y">Amino Acids</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007262" MajorTopicYN="N">Infusions, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="N">Glomerular Filtration Rate</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">amino acids</Keyword><Keyword MajorTopicYN="N">anesthesia</Keyword><Keyword MajorTopicYN="N">perioperative</Keyword><Keyword MajorTopicYN="N">renal protection</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Monaco</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Belletti</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nisi</LastName><ForeName>Francesco Giuseppe</ForeName><Initials>FG</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Fominskiy</LastName><ForeName>Evgeny</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>24</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>21</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39384419</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2024.08.033</ArticleId><ArticleId IdType="pii">S1053-0770(24)00572-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27029658</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>06</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0310-057X</ISSN><JournalIssue CitedMedium="Print"><Volume>44</Volume><Issue>2</Issue><PubDate><Year>2016</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Anaesthesia and intensive care</Title><ISOAbbreviation>Anaesth Intensive Care</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury following liver transplantation: a systematic review of published predictive models.</ArticleTitle><Pagination><StartPage>251</StartPage><EndPage>261</EndPage><MedlinePgn>251-61</MedlinePgn></Pagination><Abstract><AbstractText>Acute kidney injury is a frequent postoperative complication amongst liver transplant recipients and is associated with increased morbidity and mortality. This systematic review analysed the existing predictive models, in order to solidify current understanding. Articles were selected for inclusion if they described the primary development of a clinical prediction model (either an algorithm or risk score) to predict AKI post liver transplantation. The database search yielded a total of seven studies describing the primary development of a prediction model or risk score for the development of AKI following liver transplantation. The models span thirteen years of clinical research and highlight a gradual change in the definitions of AKI, emphasising the need to employ standardised definitions for subsequent studies. Collectively, the models identify a diverse range of predictive factors with several common trends. They emphasise the impact of preoperative renal dysfunction, liver disease severity and aetiology, metabolic risk factors as well as intraoperative variables including measures of haemodynamic instability and graft quality. Although several of the models address postoperative parameters, their utility in predictive modelling seems to be of questionable relevance. The common risk factors identified within this systematic review provide a minimum list of variables, which future studies should address. Research in this area would benefit from prospective, multi-site studies with larger cohorts as well as the subsequent internal and external validation of predictive models. Ultimately, the ability to identify patients at high risk of post-transplant AKI may enable early intervention and perhaps prevention.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Caragata</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Princess Alexandra Hospital, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wyssusek</LastName><ForeName>K H</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Princess Alexandra Hospital, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kruger</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Princess Alexandra Hospital, Queensland, Australia, The University of Queensland, School of Medicine, Herston Rd, 4006 Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anaesth Intensive Care</MedlineTA><NlmUniqueID>0342017</NlmUniqueID><ISSNLinking>0310-057X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Anaesth Intensive Care. 2016 Sep;44(5):641-2.</RefSource><PMID Version="1">27608353</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008107" MajorTopicYN="N">Liver Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016031" MajorTopicYN="N">Liver Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">liver transplantation</Keyword><Keyword MajorTopicYN="N">prediction model</Keyword><Keyword MajorTopicYN="N">risk score</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27029658</ArticleId><ArticleId IdType="doi">10.1177/0310057X1604400212</ArticleId><ArticleId IdType="pii">20150419</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27919293</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Dec</Month><Day>05</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Perioperative statin therapy in cardiac surgery: a meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>395</StartPage><MedlinePgn>395</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">395</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Several studies suggest beneficial effects of perioperative statin therapy on postoperative outcome after cardiac surgery. However, recent randomized controlled trials (RCTs) show potential detrimental effects. The objective of this systematic review is to examine the association between perioperative statin therapy and clinical outcomes in cardiac surgery patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Electronic databases were searched up to 1 November 2016 for RCTs of preoperative statin therapy versus placebo or no treatment in adult cardiac surgery. Postoperative outcomes were acute kidney injury, atrial fibrillation, myocardial infarction, stroke, infections, and mortality. We calculated odds ratios (ORs) and 95% confidence intervals (CIs) using fixed-effects meta-analyses. Primary analysis was restricted to trials with low risk of bias according to Cochrane methodology, and sensitivity analyses examined whether the risk of bias of included studies was associated with different results. We performed trial sequential analysis (TSA) to test the strength of the results.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included data from 23 RCTs involving 5102 patients. Meta-analysis of trials with low risk of bias showed that statin therapy was associated with an increase in acute kidney injury (314 of 1318 (23.82%) with statins versus 262 of 1319 (19.86%) with placebo; OR 1.26 (95%CI 1.05 to 1.52); p&#x2009;=&#x2009;0.01); these results were supported by TSA. No difference in postoperative atrial fibrillation, myocardial infarction, stroke, infections, or mortality was present. On sensitivity analysis, statin therapy was associated with a slight increase in hospital mortality. Meta-analysis&#xa0;including also trials with high or unclear risk of bias showed no beneficial effects of statin therapy on any postoperative outcomes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There is no evidence that statin therapy in the days prior to cardiac surgery is beneficial for patients' outcomes. Particularly, statins are not protective against postoperative atrial fibrillation, myocardial infarction, stroke, or infections. Statins are associated with a possible increased risk of acute kidney injury and a detrimental effect on hospital survival could not be excluded. Future RCTs should further evaluate the safety profile of this therapy in relation to patients' outcomes and assess the more appropriate time point for discontinuation of statins before cardiac surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Putzu</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, Cardiocentro Ticino, Via Tesserete 48, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capelli</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, Cardiocentro Ticino, Via Tesserete 48, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belletti</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cassina</LastName><ForeName>Tiziano</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, Cardiocentro Ticino, Via Tesserete 48, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrari</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Cardiocentro Ticino, Via Tesserete 48, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallo</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Cardiocentro Ticino, Via Tesserete 48, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casso</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, Cardiocentro Ticino, Via Tesserete 48, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, Milano, Italy. landoni.giovanni@hsr.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vita-Salute San Raffaele University, Via Olgettina 58, Milano, Italy. landoni.giovanni@hsr.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001860</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019161">Hydroxymethylglutaryl-CoA Reductase Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019161" MajorTopicYN="N">Hydroxymethylglutaryl-CoA Reductase Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Atrial fibrillation</Keyword><Keyword MajorTopicYN="N">Cardiac anesthesia</Keyword><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Intensive care</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Myocardial infarction</Keyword><Keyword MajorTopicYN="N">Statins</Keyword><Keyword MajorTopicYN="N">Stroke</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>12</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27919293</ArticleId><ArticleId IdType="mid">NIHMS1054800</ArticleId><ArticleId IdType="pmc">PMC5139027</ArticleId><ArticleId IdType="doi">10.1186/s13054-016-1560-6</ArticleId><ArticleId IdType="pii">10.1186/s13054-016-1560-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>LaPar DJ, Crosby IK, Rich JB, Fonner E, Kron IL, Ailawadi G, et al. A contemporary cost analysis of postoperative morbidity after coronary artery bypass grafting with and without concomitant aortic valve replacement to improve patient quality and cost-effective care. Ann Thorac Surg. 2013;96:1621&#x2013;7. doi: 10.1016/j.athoracsur.2013.05.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2013.05.050</ArticleId><ArticleId IdType="pubmed">23972932</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim LK, Looser P, Swaminathan RV, Minutello RM, Wong SC, Girardi L, et al. Outcomes in patients undergoing coronary artery bypass graft surgery in the United States based on hospital volume, 2007 to 2011. J Thorac Cardiovasc Surg. 2016;151:1686&#x2013;92. doi: 10.1016/j.jtcvs.2016.01.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2016.01.050</ArticleId><ArticleId IdType="pubmed">26964912</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckmann A, Funkat A-K, Lewandowski J, Frie M, Ernst M, Hekmat K, et al. Cardiac surgery in Germany during 2014: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg. 2015;63:258&#x2013;69. doi: 10.1055/s-0035-1544425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0035-1544425</ArticleId><ArticleId IdType="pubmed">26011675</ArticleId></ArticleIdList></Reference><Reference><Citation>Karkouti K, Wijeysundera DN, Yau TM, Callum JL, Cheng DC, Crowther M, et al. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation. 2009;119:495&#x2013;502. doi: 10.1161/CIRCULATIONAHA.108.786913.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.786913</ArticleId><ArticleId IdType="pubmed">19153273</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1:19&#x2013;32. doi: 10.2215/CJN.00240605.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.00240605</ArticleId><ArticleId IdType="pubmed">17699187</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillinov AM, Bagiella E, Moskowitz AJ, Raiten JM, Groh MA, Bowdish ME, et al. Rate control versus rhythm control for atrial fibrillation after cardiac surgery. N Engl J Med. 2016;374:1911&#x2013;21. doi: 10.1056/NEJMoa1602002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1602002</ArticleId><ArticleId IdType="pmc">PMC4908812</ArticleId><ArticleId IdType="pubmed">27043047</ArticleId></ArticleIdList></Reference><Reference><Citation>Helgadottir S, Sigurdsson MI, Ingvarsdottir IL, Arnar DO, Gudbjartsson T, Almassi G, et al. Atrial fibrillation following cardiac surgery: risk analysis and long-term survival. J Cardiothorac Surg. 2012;7:87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3515503</ArticleId><ArticleId IdType="pubmed">22992266</ArticleId></ArticleIdList></Reference><Reference><Citation>Svircevic V, Nierich AP, Moons KGM, Brandon Bravo Bruinsma GJ, Kalkman CJ, van Dijk D. Fast-track anesthesia and cardiac surgery: a retrospective cohort study of 7989 patients. Anesth Analg. 2009;108:727&#x2013;33. doi: 10.1213/ane.0b013e318193c423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e318193c423</ArticleId><ArticleId IdType="pubmed">19224776</ArticleId></ArticleIdList></Reference><Reference><Citation>Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2012;143:4&#x2013;34. doi: 10.1016/j.jtcvs.2011.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2011.10.015</ArticleId><ArticleId IdType="pubmed">22172748</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulik A, Levin R, Ruel M, Mesana TG, Solomon DH, Choudhry NK. Patterns and predictors of statin use after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg. 2007;134:932&#x2013;8. doi: 10.1016/j.jtcvs.2007.05.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2007.05.039</ArticleId><ArticleId IdType="pubmed">17903510</ArticleId></ArticleIdList></Reference><Reference><Citation>Mihos CG, Salas MJ, Santana O. The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in cardiovascular disease: a comprehensive review. Cardiol Rev. 18:298&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">20926939</ArticleId></ArticleIdList></Reference><Reference><Citation>Sodha NR, Sellke FW. The effect of statins on perioperative inflammation in cardiac and thoracic surgery. J Thorac Cardiovasc Surg. 2015;149:1495&#x2013;501. doi: 10.1016/j.jtcvs.2015.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2015.02.005</ArticleId><ArticleId IdType="pubmed">25791954</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotani MI, Morise AP, Haque R, Jain AC, Gupta N, Gibson CM. Association between short-term simvastatin therapy before coronary artery bypass grafting and postoperative myocardial blood flow as assessed by positron emission tomography. Am J Cardiol. 2003;91:1107&#x2013;9. doi: 10.1016/S0002-9149(03)00158-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9149(03)00158-9</ArticleId><ArticleId IdType="pubmed">12714156</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan W, Pintar T, Anton J, Lee V-V, Vaughn WK, Collard CD. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation. 2004;110:II45&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15364837</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascual DA, Arribas JM, Tornel PL, Mar&#xed;n F, Oliver C, Ahumada M, et al. Preoperative statin therapy and troponin T predict early complications of coronary artery surgery. Ann Thorac Surg. 2006;81:78&#x2013;83. doi: 10.1016/j.athoracsur.2005.07.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2005.07.038</ArticleId><ArticleId IdType="pubmed">16368340</ArticleId></ArticleIdList></Reference><Reference><Citation>Liakopoulos OJ, Choi Y-H, Haldenwang PL, Strauch J, Wittwer T, D&#xf6;rge H, et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients. Eur Heart J. 2008;29:1548&#x2013;59. doi: 10.1093/eurheartj/ehn198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehn198</ArticleId><ArticleId IdType="pubmed">18506053</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn EW, Liakopoulos OJ, Stange S, Deppe A-C, Slottosch I, Choi Y-H, et al. Preoperative statin therapy in cardiac surgery: a meta-analysis of 90,000 patients. Eur J Cardiothorac Surg. 2014;45:17&#x2013;26. doi: 10.1093/ejcts/ezt181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezt181</ArticleId><ArticleId IdType="pubmed">23562936</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar&#xed;n F, Pascual DA, Rold&#xe1;n V, Arribas JM, Ahumada M, Tornel PL, et al. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol. 2006;97:55&#x2013;60. doi: 10.1016/j.amjcard.2005.07.124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2005.07.124</ArticleId><ArticleId IdType="pubmed">16377284</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabata M, Khalpey Z, Pirundini PA, Byrne ML, Cohn LH, Rawn JD. Renoprotective effect of preoperative statins in coronary artery bypass grafting. Am J Cardiol. 2007;100:442&#x2013;4. doi: 10.1016/j.amjcard.2007.03.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2007.03.071</ArticleId><ArticleId IdType="pubmed">17659925</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman CI, Lucek DM, Hammond J, White CM. Preoperative statins and infectious complications following cardiac surgery. Curr Med Res Opin. 2007;23:1783&#x2013;90. doi: 10.1185/030079907X210570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1185/030079907X210570</ArticleId><ArticleId IdType="pubmed">17597556</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FT, Hendricks PA, Schildcrout JS, Shi Y, Petracek MR, Byrne JG, et al. High-dose perioperative Atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial. JAMA. 2016;315:877&#x2013;88. doi: 10.1001/jama.2016.0548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0548</ArticleId><ArticleId IdType="pmc">PMC4843765</ArticleId><ArticleId IdType="pubmed">26906014</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z, Jayaram R, Jiang L, Emberson J, Zhao Y, Li Q, et al. Perioperative Rosuvastatin in cardiac surgery. N Engl J Med. 2016;374:1744&#x2013;53. doi: 10.1056/NEJMoa1507750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1507750</ArticleId><ArticleId IdType="pubmed">27144849</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Green S (editors).&#xa0;Cochrane Handbook for Systematic Reviews of Interventions&#xa0;Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org.</Citation></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, Mulrow C, G&#xf8;tzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. doi: 10.1136/bmj.b2700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2700</ArticleId><ArticleId IdType="pmc">PMC2714672</ArticleId><ArticleId IdType="pubmed">19622552</ArticleId></ArticleIdList></Reference><Reference><Citation>Landoni G, Putzu A, Capelli B, Belletti A. Perioperative statin therapy in cardiac surgery: a meta-analysis of randomized controlled trials [Internet]. Available from: http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42016039509. Accessed 23 Nov 2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5139027</ArticleId><ArticleId IdType="pubmed">27919293</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Altman DG, G&#xf8;tzsche PC, J&#xfc;ni P, Moher D, Oxman AD, et al. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi: 10.1136/bmj.d5928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924&#x2013;6. doi: 10.1136/bmj.39489.470347.AD.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol. 2008;61:64&#x2013;75. doi: 10.1016/j.jclinepi.2007.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2007.03.013</ArticleId><ArticleId IdType="pubmed">18083463</ArticleId></ArticleIdList></Reference><Reference><Citation>Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol. 2008;61:763&#x2013;9. doi: 10.1016/j.jclinepi.2007.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2007.10.007</ArticleId><ArticleId IdType="pubmed">18411040</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JPA, Thabane L, et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? Int J Epidemiol. 2009;38:276&#x2013;86. doi: 10.1093/ije/dyn179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyn179</ArticleId><ArticleId IdType="pubmed">18824467</ArticleId></ArticleIdList></Reference><Reference><Citation>Almansob MAS, Xu B, Zhou L, Hu X-X, Chen W, Chang F-J, et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: a randomized controlled trial. Arterioscler Thromb Vasc Biol. 2012;32:2304&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">22796581</ArticleId></ArticleIdList></Reference><Reference><Citation>Baran &#xc7;, Durdu S, Dalva K, Zaim &#xc7;, Dogan A, Ocakoglu G, et al. Effects of preoperative short term use of atorvastatin on endothelial progenitor cells after coronary surgery: a randomized, controlled trial. Stem Cell Rev. 2012;8:963&#x2013;71. doi: 10.1007/s12015-011-9321-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-011-9321-z</ArticleId><ArticleId IdType="pubmed">22076751</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkan O, Katrancioglu N, Ozker E, Ozerdem G, Bakici Z, Yilmaz MB. Reduced P-selectin in hearts pretreated with fluvastatin: a novel benefit for patients undergoing open heart surgery. Thorac Cardiovasc Surg. 2009;57:91&#x2013;5. doi: 10.1055/s-2008-1039107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2008-1039107</ArticleId><ArticleId IdType="pubmed">19241310</ArticleId></ArticleIdList></Reference><Reference><Citation>Caorsi C, Pineda F, Munoz C. Pravastatin immunomodulates IL-6 and C-reactive protein, but not IL-1 and TNF-alpha, in cardio-pulmonary bypass. Eur Cytokine Netw. 2008;19:99&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">18632424</ArticleId></ArticleIdList></Reference><Reference><Citation>Casta&#xf1;o M, Gonz&#xe1;lez-Santos JM, L&#xf3;pez J, Garc&#xed;a B, Centeno JE, Aparicio B, et al. Effect of preoperative oral pravastatin reload in systemic inflammatory response and myocardial damage after coronary artery bypass grafting. A pilot double-blind placebo-controlled study. J Cardiovasc Surg (Torino) 2015;56:617&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">25968407</ArticleId></ArticleIdList></Reference><Reference><Citation>Chello M, Patti G, Candura D, Mastrobuoni S, Di Sciascio G, Agr&#xf2; F, et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit Care Med. 2006;34:660&#x2013;7. doi: 10.1097/01.CCM.0000201407.89977.EA.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000201407.89977.EA</ArticleId><ArticleId IdType="pubmed">16505650</ArticleId></ArticleIdList></Reference><Reference><Citation>Christenson JT. Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. Eur J Cardiothorac Surg. 1999;15:394&#x2013;9. doi: 10.1016/S1010-7940(99)00034-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1010-7940(99)00034-2</ArticleId><ArticleId IdType="pubmed">10371111</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehghani MR, Kasianzadeh M, Rezaei Y, Sepehrvand N. Atorvastatin reduces the incidence of postoperative atrial fibrillation in statin-naive patients undergoing isolated heart valve surgery: a double-blind, placebo-controlled randomized trial. J Cardiovasc Pharmacol Ther. 2015;20:465&#x2013;72. doi: 10.1177/1074248414564869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1074248414564869</ArticleId><ArticleId IdType="pubmed">25540059</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji Q, Mei Y, Wang X, Sun Y, Feng J, Cai J, et al. Effect of preoperative atorvastatin therapy on atrial fibrillation following off-pump coronary artery bypass grafting. Circ J. 2009;73:2244&#x2013;9. doi: 10.1253/circj.CJ-09-0352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-09-0352</ArticleId><ArticleId IdType="pubmed">19822977</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannacio VA, Iorio D, De Amicis V, Di Lello F, Musumeci F. Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. J Thorac Cardiovasc Surg. 2008;136:1541&#x2013;8. doi: 10.1016/j.jtcvs.2008.06.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2008.06.038</ArticleId><ArticleId IdType="pubmed">19114204</ArticleId></ArticleIdList></Reference><Reference><Citation>Melina G, Angeloni E, Di Nucci G, Benedetto U, Fiorani B, Sclafani G, et al. Preoperative HMG-CoA reductase inhibitors and atrial fibrillation in patients undergoing CABG: a prospective randomised trial. Eur Hear J. 2009;30:32.</Citation></Reference><Reference><Citation>Park JH, Shim J-K, Song J-W, Soh S, Kwak Y-L. Effect of atorvastatin on the incidence of acute kidney injury following valvular heart surgery: a randomized, placebo-controlled trial. Intensive Care Med. 2016;42:1398&#x2013;407. doi: 10.1007/s00134-016-4358-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4358-8</ArticleId><ArticleId IdType="pubmed">27120082</ArticleId></ArticleIdList></Reference><Reference><Citation>Patti G, Chello M, Candura D, Pasceri V, D&#x2019;Ambrosio A, Covino E, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation. 2006;114:1455&#x2013;61. doi: 10.1161/CIRCULATIONAHA.106.621763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.621763</ArticleId><ArticleId IdType="pubmed">17000910</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Calzavacca P, Licari E, Ligabo EV, Echeverri JE, Haase M, et al. Pilot double-blind, randomized controlled trial of short-term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology (Carlton) 2012;17:215&#x2013;24. doi: 10.1111/j.1440-1797.2011.01546.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1797.2011.01546.x</ArticleId><ArticleId IdType="pubmed">22117606</ArticleId></ArticleIdList></Reference><Reference><Citation>Bin SY, On YK, Kim JH, Shin D-H, Kim JS, Sung J, et al. The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery. Am Heart J. 2008;156:373.</Citation><ArticleIdList><ArticleId IdType="pubmed">18657672</ArticleId></ArticleIdList></Reference><Reference><Citation>Spadaccio C, Pollari F, Casacalenda A, Alfano G, Genovese J, Covino E, et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. J Cardiovasc Pharmacol. 2010;55:30&#x2013;8. doi: 10.1097/FJC.0b013e3181c37d4d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FJC.0b013e3181c37d4d</ArticleId><ArticleId IdType="pubmed">19834333</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Ji Q, Mei Y, Wang X, Feng J, Cai J, et al. Role of preoperative atorvastatin administration in protection against postoperative atrial fibrillation following conventional coronary artery bypass grafting. Int Heart J. 2011;52:7&#x2013;11. doi: 10.1536/ihj.52.7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1536/ihj.52.7</ArticleId><ArticleId IdType="pubmed">21321461</ArticleId></ArticleIdList></Reference><Reference><Citation>Vukovic PM, Maravic-Stojkovic VR, Peric MS, Jovic MD, Cirkovic MV, Gradinac SD, et al. Steroids and statins: an old and a new anti-inflammatory strategy compared. Perfusion. 2011;26:31&#x2013;7. doi: 10.1177/0267659110385607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0267659110385607</ArticleId><ArticleId IdType="pubmed">20921085</ArticleId></ArticleIdList></Reference><Reference><Citation>Youn Y-N, Park S-Y, Hwang Y, Joo H-C, Yoo K-J. Impact of high-dose statin pretreatment in patients with stable angina during off-pump coronary artery bypass. Korean J Thorac Cardiovasc Surg. 2011;44:208&#x2013;14. doi: 10.5090/kjtcs.2011.44.3.208.</Citation><ArticleIdList><ArticleId IdType="doi">10.5090/kjtcs.2011.44.3.208</ArticleId><ArticleId IdType="pmc">PMC3249304</ArticleId><ArticleId IdType="pubmed">22263153</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamayo E, Alvarez FJ, Alonso O, Bustamante R, Castrodeza J, Soria S, et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. J Cardiovasc Surg (Torino) 2009;50:687&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">19741581</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrascal Y, Arnold RJ, De la Fuente L, Revilla A, Sevilla T, Arce N, et al. Efficacy of atorvastatin in prevention of atrial fibrillation after heart valve surgery in the PROFACE trial (PROphylaxis of postoperative atrial Fibrillation After Cardiac surgEry). J Arrhythm Elsevier. 2016;32:191&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4913150</ArticleId><ArticleId IdType="pubmed">27354864</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016;0:2152&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">27616593</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulik A, Ruel M, Jneid H, Ferguson TB, Hiratzka LF, Ikonomidis JS, et al. Secondary prevention after coronary artery bypass graft surgery. Circulation. 2015;131:927-964.</Citation><ArticleIdList><ArticleId IdType="pubmed">25679302</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R. Perioperative statins in cardiac surgery and acute kidney injury. JAMA. 2016;315:873&#x2013;4. doi: 10.1001/jama.2016.0245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0245</ArticleId><ArticleId IdType="pubmed">26905755</ArticleId></ArticleIdList></Reference><Reference><Citation>Layton JB, Hansen MK, Jakobsen C-J, Kshirsagar AV, Andreasen JJ, Hjortdal VE, et al. Statin initiation and acute kidney injury following elective cardiovascular surgery: a population cohort study in Denmark&#x2020;. Eur J Cardiothorac Surg. 2016;49:995&#x2013;1000. doi: 10.1093/ejcts/ezv246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezv246</ArticleId><ArticleId IdType="pubmed">26188012</ArticleId></ArticleIdList></Reference><Reference><Citation>Layton JB, Kshirsagar AV, Simpson RJ, Pate V, Jonsson Funk M, St&#xfc;rmer T, et al. Effect of statin use on acute kidney injury risk following coronary artery bypass grafting. Am J Cardiol. 2013;111:823&#x2013;8. doi: 10.1016/j.amjcard.2012.11.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2012.11.047</ArticleId><ArticleId IdType="pmc">PMC3637989</ArticleId><ArticleId IdType="pubmed">23273532</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar AO, Parikh CR, Coca SG, Thiessen-Philbrook H, Koyner JL, Shlipak MG, et al. Association between preoperative statin use and acute kidney injury biomarkers in cardiac surgical procedures. Ann Thorac Surg. 2014;97:2081&#x2013;7. doi: 10.1016/j.athoracsur.2014.02.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2014.02.033</ArticleId><ArticleId IdType="pmc">PMC4068122</ArticleId><ArticleId IdType="pubmed">24725831</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Gu C, Gao M, Yu W, Yu Y. Preoperative statin therapy and renal outcomes after cardiac surgery: a meta-analysis and meta-regression of 59,771 patients. Can J Cardiol. 2015;31:1051&#x2013;60. doi: 10.1016/j.cjca.2015.02.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2015.02.034</ArticleId><ArticleId IdType="pubmed">26081692</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunelli SM, Waikar SS, Bateman BT, Chang TI, Lii J, Garg AX, et al. Preoperative statin use and postoperative acute kidney injury. Am J Med. 2012;125:1195&#x2013;204. doi: 10.1016/j.amjmed.2012.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2012.06.021</ArticleId><ArticleId IdType="pmc">PMC3597342</ArticleId><ArticleId IdType="pubmed">23062398</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn EW, Slottosch I, Wahlers T, Liakopoulos OJ. Preoperative statin therapy for patients undergoing cardiac surgery. Cochrane Database Syst Rev. 2015;13:CD008493.</Citation><ArticleIdList><ArticleId IdType="pubmed">26270008</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewicki M, Ng I, Schneider AG. HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass. Cochrane Database Syst Rev. 2015;11:CD010480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10788137</ArticleId><ArticleId IdType="pubmed">25758322</ArticleId></ArticleIdList></Reference><Reference><Citation>Golomb BA, Evans MA. Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism. Am J Cardiovasc Drugs. 2008;8:373&#x2013;418. doi: 10.2165/0129784-200808060-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/0129784-200808060-00004</ArticleId><ArticleId IdType="pmc">PMC2849981</ArticleId><ArticleId IdType="pubmed">19159124</ArticleId></ArticleIdList></Reference><Reference><Citation>Kain V, Kapadia B, Misra P, Saxena U, Mol MJ, Erkelens DW, et al. Simvastatin may induce insulin resistance through a novel fatty acid mediated cholesterol independent mechanism. Sci Rep. 2015;5:13823. doi: 10.1038/srep13823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep13823</ArticleId><ArticleId IdType="pmc">PMC4561915</ArticleId><ArticleId IdType="pubmed">26345110</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniades C, Bakogiannis C, Tousoulis D, Reilly S, Zhang M-H, Paschalis A, et al. Preoperative atorvastatin treatment in CABG patients rapidly improves vein graft redox state by inhibition of Rac1 and NADPH-oxidase activity. Circulation. 2010;122:S66&#x2013;73. doi: 10.1161/CIRCULATIONAHA.109.927376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.109.927376</ArticleId><ArticleId IdType="pubmed">20837928</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezaei Y, Gholami-Fesharaki M, Dehghani MR, Arya A, Haghjoo M, Arjmand N. Statin antiarrhythmic effect on atrial fibrillation in statin-naive patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials. J Cardiovasc Pharmacol Ther. 2016;21:167&#x2013;76. doi: 10.1177/1074248415602557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1074248415602557</ArticleId><ArticleId IdType="pubmed">26333596</ArticleId></ArticleIdList></Reference><Reference><Citation>Trezzi M, Blackstone EH, Sun Z, Li L, Sabik JF, Lytle BW, et al. Statin therapy is associated with fewer infections after cardiac operations. Ann Thorac Surg. 2013;95:892&#x2013;900.</Citation><ArticleIdList><ArticleId IdType="pubmed">23380476</ArticleId></ArticleIdList></Reference><Reference><Citation>National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Truwit JD, Bernard GR, Steingrub J, Matthay MA, Liu KD, et al. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N Engl J Med. 2014;370:2191&#x2013;200. doi: 10.1056/NEJMoa1401520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1401520</ArticleId><ArticleId IdType="pmc">PMC4241052</ArticleId><ArticleId IdType="pubmed">24835849</ArticleId></ArticleIdList></Reference><Reference><Citation>Papazian L, Roch A, Charles P-E, Penot-Ragon C, Perrin G, Roulier P, et al. Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial. JAMA. 2013;310:1692&#x2013;700. doi: 10.1001/jama.2013.280031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.280031</ArticleId><ArticleId IdType="pubmed">24108510</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark LL, Ikonomidis JS, Crawford FA, Crumbley A, Kratz JM, Stroud MR, et al. Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: an 8-year retrospective cohort study. J Thorac Cardiovasc Surg. 2006;131:679&#x2013;85. doi: 10.1016/j.jtcvs.2005.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2005.11.006</ArticleId><ArticleId IdType="pubmed">16515923</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Xu X, Ni H. Small studies may overestimate the effect sizes in critical care meta-analyses: a meta-epidemiological study. Crit Care. 2013;17:R2. doi: 10.1186/cc11919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11919</ArticleId><ArticleId IdType="pmc">PMC4056100</ArticleId><ArticleId IdType="pubmed">23302257</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopewell S, Loudon K, Clarke MJ, Oxman AD, Dickersin K. Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database Syst Rev. 2009;(1):MR000006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8276556</ArticleId><ArticleId IdType="pubmed">19160345</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormuth CR, Hemmelgarn BR, Paterson JM, James MT, Teare GF, Raymond CB, et al. Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases. BMJ. 2013;346:f880. doi: 10.1136/bmj.f880.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.f880</ArticleId><ArticleId IdType="pubmed">23511950</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26642777</PMID><DateCompleted><Year>2016</Year><Month>12</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1873-4286</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>13</Issue><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>Current pharmaceutical design</Title><ISOAbbreviation>Curr Pharm Des</ISOAbbreviation></Journal><ArticleTitle>General or Local Anesthesia for TAVI? A Systematic Review of the Literature and Meta-Analysis.</ArticleTitle><Pagination><StartPage>1868</StartPage><EndPage>1878</EndPage><MedlinePgn>1868-78</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Transcatheter aortic valve implantation (TAVI) is becoming a valuable alternative to surgical aortic valve replacement in patients with severe aortic stenosis that are at high surgical risk or deemed inoperable. The optimal anesthesia technique for TAVI is still undecided. We performed a systematic review and metaanalysis to compare the safety of locoregional anesthesia (LRA) with or without conscious sedation and general anesthesia (GA) for the TAVI-procedure.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched PUBMED, MEDLINE, EMBASE and the Cochrane central register of controlled trials from January 1st 2002 to February 15th 2015. The primary outcome parameters searched were 30-days mortality, hospital length of stay, procedure time, use of adrenergic support, stroke rate, incidence of myocardial infarction, incidence of acute kidney injury, rate of procedural succes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Ten studies, including 5919 patients, fulfilled the inclusion criteria. None of these studies was randomized resulting in a considerable risk of bias. The choice for a specific anesthesia technique did neither affect the average 30-day mortality rate [RR 0.91 (95% CI: 0.53 to 1.56), p=0.72] nor a wide variety of safety endpoints. LRA for TAVI was associated with a significantly shorter procedure time when compared to GA, and a reduction in hospital length of stay. However, LRA significantly increased the risk for implantation of a permanent pacemaker (RR 1.23, p=0.02) and for paravalvular leakage (RR 1.31, p=0.006.).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Neither mortality nor the incidence of major adverse cardiac and cerebrovascular events after TAVI is affected by the choice for either LRA or GA.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maas</LastName><ForeName>E H A</ForeName><Initials>EH</Initials></Author><Author ValidYN="Y"><LastName>Pieters</LastName><ForeName>B M A</ForeName><Initials>BM</Initials></Author><Author ValidYN="Y"><LastName>Van de Velde</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Rex</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, UZ Leuven, Herestraat 9, 3000 Leuven, Belgium. steffen.rex@uzleuven.be.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United Arab Emirates</Country><MedlineTA>Curr Pharm Des</MedlineTA><NlmUniqueID>9602487</NlmUniqueID><ISSNLinking>1381-6128</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000772" MajorTopicYN="Y">Anesthesia, Local</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="N">Aortic Valve Stenosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065467" MajorTopicYN="Y">Transcatheter Aortic Valve Replacement</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26642777</ArticleId><ArticleId IdType="doi">10.2174/1381612822666151208121825</ArticleId><ArticleId IdType="pii">CPD-EPUB-72334</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39216462</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>30</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2157</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>12</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</Title><ISOAbbreviation>Eur J Surg Oncol</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy - A systematic review.</ArticleTitle><Pagination><StartPage>108622</StartPage><MedlinePgn>108622</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejso.2024.108622</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0748-7983(24)00674-7</ELocationID><Abstract><AbstractText>The use of nephrotoxic chemotherapeutic agents during hyperthermic intraperitoneal chemotherapy (HIPEC), carries the risk of postoperative acute kidney injury (AKI). The available evidence on this subject is sparse with variability in the reported incidence of AKI. In this systematic review, the aim was to analyse the incidence, risk factors, and preventive measures for AKI after cytoreductive surgery and HIPEC. A systematic literature search was conducted using the terms 'Acute kidney injury', 'Acute kidney failure', 'Acute renal failure', 'Acute renal impairment', 'HIPEC Surgery', 'Cytoreductive Surgery', 'Heated Chemotherapy' on PubMed, Scopus, clinical trial.gov, POPLINE and Google Scholar. Randomized controlled trials, cohort studies and observational studies published from January 2000-December 2020 were included. The systematic review was registered in the International Prospective Register of Systematic Reviews (PROSPERO) (CRD42021247781). Data from 16 articles, which included 1622 patients, was included. The incidence AKI by any definition, was 23.36&#xa0;%. The highest incidence of AKI (45.45&#xa0;%) was reported after paclitaxel-HIPEC. The incidence of AKI after cisplatin-HIPEC was 34.7&#xa0;%. Cisplatin HIPEC was the most common factor associated with AKI in 7/16 studies followed by pre-existing comorbidities and low intraoperative diuresis in 4 and 3 studies respectively. The perioperative use of sodium thiosulfate and amifostine led to a significant reduction in the incidence of AKI. The reported incidence of AKI after CRS-HIPEC is high. Identifying preoperative risk factors, optimising comorbidities, maintaining perioperative haemodynamic stability, perioperative use of sodium thiosulfate, maintaining adequate diuresis could reduce the incidence of AKI.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Solanki</LastName><ForeName>Sohan Lal</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Critical Care and Pain, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India. Electronic address: me_sohans@yahoo.co.in.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salunke</LastName><ForeName>Bindiya</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Critical Care and Pain, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gangakhedkar</LastName><ForeName>Gauri</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Critical Care and Pain, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi-Mumbai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ambulkar</LastName><ForeName>Reshma</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Critical Care and Pain, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi-Mumbai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuberkar</LastName><ForeName>Deepali V</ForeName><Initials>DV</Initials><AffiliationInfo><Affiliation>Department of Library Science, Digital Library, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhatt</LastName><ForeName>Aditi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgical Oncology, KD Hospital, Ahmedabad, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Surg Oncol</MedlineTA><NlmUniqueID>8504356</NlmUniqueID><ISSNLinking>0748-7983</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013885">Thiosulfates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>Q20Q21Q62J</RegistryNumber><NameOfSubstance UI="D002945">Cisplatin</NameOfSubstance></Chemical><Chemical><RegistryNumber>HX1032V43M</RegistryNumber><NameOfSubstance UI="C017717">sodium thiosulfate</NameOfSubstance></Chemical><Chemical><RegistryNumber>M487QF2F4V</RegistryNumber><NameOfSubstance UI="D004999">Amifostine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000084262" MajorTopicYN="Y">Hyperthermic Intraperitoneal Chemotherapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065426" MajorTopicYN="Y">Cytoreduction Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010534" MajorTopicYN="N">Peritoneal Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013885" MajorTopicYN="N">Thiosulfates</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002945" MajorTopicYN="N">Cisplatin</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004999" MajorTopicYN="N">Amifostine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Cytoreductive surgery</Keyword><Keyword MajorTopicYN="N">HIPEC</Keyword><Keyword MajorTopicYN="N">Heated chemotherapy</Keyword></KeywordList><CoiStatement>Declaration of competing interest All the authors have no disclosures. All the authors have no conflicts of interest. None of authors received any funding for this study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>1</Day><Hour>15</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>1</Day><Hour>16</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>18</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39216462</ArticleId><ArticleId IdType="doi">10.1016/j.ejso.2024.108622</ArticleId><ArticleId IdType="pii">S0748-7983(24)00674-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34732600</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2186-1005</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>20</Day></PubDate></JournalIssue><Title>Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia</Title><ISOAbbreviation>Ann Thorac Cardiovasc Surg</ISOAbbreviation></Journal><ArticleTitle>N-Acetylcysteine's Renoprotective Effect in Cardiac Surgery: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>138</StartPage><EndPage>145</EndPage><MedlinePgn>138-145</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5761/atcs.oa.21-00132</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To examine N-acetylcysteine's (NAC's) renoprotective effect in adult cardiac surgeryMethods: PubMed, Ovid Medline, and Embase were searched for randomized controlled trials published between January 1990 and May 2021 that investigated the effect of NAC in preventing acute kidney injury (AKI) in patients undergoing cardiac surgery. The inclusion criterion was studies that assessed the effect of NAC in comparison to placebo by measuring the incidence of AKI.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall meta-analytic estimates of all 10 included trials showed that NAC did not have a significant effect (odds ratio [OR]: 0.84, 95% confidence interval [CI]: 0.64-1.10) on AKI. Further subgroup analysis did not show a significant benefit of NAC in preventing AKI.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This meta-analysis suggests that NAC does not have a significant effect in reducing the incidence of AKI. However, there is notable heterogeneity among the included studies that could possibly account for the non-significant effect observed. It is worth noting that only one trial administered NAC high dosages perioperatively, and it is the only included trial to show a significant benefit in reducing the incidence of AKI (OR: 0.30, 95% CI: 0.11-0.81). Further studies on this dosage and duration of administration should be conducted to best elucidate the effect of administering NAC.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Ying Kiat</ForeName><Initials>YK</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Yong Loo Lin School of Medicine, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>HaiDong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiac Thoracic &amp; Vascular Surgery, National University Heart Centre, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Giap Swee</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Department of Cardiac Thoracic &amp; Vascular Surgery, National University Heart Centre, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teoh</LastName><ForeName>Kristine Lk</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Department of Cardiac Thoracic &amp; Vascular Surgery, National University Heart Centre, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kofidis</LastName><ForeName>Theo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiac Thoracic &amp; Vascular Surgery, National University Heart Centre, Singapore, Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Ann Thorac Cardiovasc Surg</MedlineTA><NlmUniqueID>9703158</NlmUniqueID><ISSNLinking>1341-1098</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>WYQ7N0BPYC</RegistryNumber><NameOfSubstance UI="D000111">Acetylcysteine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000111" MajorTopicYN="N">Acetylcysteine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">N-acetylcysteine</Keyword><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>4</Day><Hour>5</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34732600</ArticleId><ArticleId IdType="pmc">PMC9081465</ArticleId><ArticleId IdType="doi">10.5761/atcs.oa.21-00132</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lee SH, Kim SJ, Kim HJ, et al. . Acute kidney injury following cardiopulmonary bypass in children-risk factors and outcomes. Circ J 2017; 81: 1522&#x2013; 7.</Citation><ArticleIdList><ArticleId IdType="pubmed">28515370</ArticleId></ArticleIdList></Reference><Reference><Citation>Schopka S, Diez C, Camboni D, et al. . Impact of cardiopulmonary bypass on acute kidney injury following coronary artery bypass grafting: a matched pair analysis. J Cardiothorac Surg 2014; 9: 20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3922736</ArticleId><ArticleId IdType="pubmed">24438155</ArticleId></ArticleIdList></Reference><Reference><Citation>Waikar SS, Bonventre JV. Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol 2009; 20: 672&#x2013; 9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2653692</ArticleId><ArticleId IdType="pubmed">19244578</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar AB, Suneja M. Response: role of true cardiopulmonary bypass time and acute kidney injury after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2012; 26: E19&#x2013; 20.</Citation><ArticleIdList><ArticleId IdType="pubmed">21924633</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadim MK, Forni LG, Bihorac A, et al. . Cardiac and vascular surgery-associated acute kidney injury: The 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) Group. J Am Heart Assoc 2018; 7: e008834.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6015369</ArticleId><ArticleId IdType="pubmed">29858368</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinning C, Westermann D, Clemmensen P. Oxidative stress in ischemia and reperfusion: current concepts, novel ideas and future perspectives. Biomark Med 2017; 11: 11031&#x2013; 40.</Citation><ArticleIdList><ArticleId IdType="pubmed">29039206</ArticleId></ArticleIdList></Reference><Reference><Citation>Ates B, Abraham L, Ercal N. Antioxidant and free radical scavenging properties of N-acetylcysteine amide (NACA) and comparison with N-acetylcysteine (NAC). Free Radic Res 2008; 42: 372&#x2013; 7.</Citation><ArticleIdList><ArticleId IdType="pubmed">18404536</ArticleId></ArticleIdList></Reference><Reference><Citation>Nigwekar SU, Kandula P. N-Acetylcysteine in cardiovascular-surgery-associated renal failure: a meta-analysis. Ann Thorac Surg 2009; 87: 139&#x2013; 47.</Citation><ArticleIdList><ArticleId IdType="pubmed">19101287</ArticleId></ArticleIdList></Reference><Reference><Citation>Savluk OF, Guzelmeric F, Yavuz Y, et al. . N-acetylcysteine versus dopamine to prevent acute kidney injury after cardiac surgery in patients with preexisting moderate renal insufficiency. Braz J Cardiovasc Surg 2017; 32: 8&#x2013; 14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5382906</ArticleId><ArticleId IdType="pubmed">28423123</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A, Banakal S, Muralidhar K. N-acetylcysteine does not prevent renal dysfunction after off-pump coronary artery bypass surgery. Eur J Anaesthesiol 2010; 27: 973&#x2013; 7.</Citation><ArticleIdList><ArticleId IdType="pubmed">20299984</ArticleId></ArticleIdList></Reference><Reference><Citation>Santana-Santos E, Gowdak LH, Gaiotto FA, et al. . High dose of N-acetylcystein prevents acute kidney injury in chronic kidney disease patients undergoing myocardial revascularization. Ann Thorac Surg 2014; 97: 1617&#x2013; 23.</Citation><ArticleIdList><ArticleId IdType="pubmed">24657033</ArticleId></ArticleIdList></Reference><Reference><Citation>Ristikankare A, Kuitunen T, Kuitunen A, et al. . Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery. Br J Anaesth 2006; 97: 611&#x2013; 6.</Citation><ArticleIdList><ArticleId IdType="pubmed">16914459</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase M, Haase-Fielitz A, Bagshaw SM, et al. . Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients. Crit Care Med 2007; 35: 1324&#x2013; 31.</Citation><ArticleIdList><ArticleId IdType="pubmed">17414730</ArticleId></ArticleIdList></Reference><Reference><Citation>Song JW, Shim JK, Soh S, et al. . Double-blinded, randomized controlled trial of N-acetylcysteine for prevention of acute kidney injury in high risk patients undergoing off-pump coronary artery bypass. Nephrology (Carlton) 2015; 20: 96&#x2013; 102.</Citation><ArticleIdList><ArticleId IdType="pubmed">25384603</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldemir M, Koca HB, Baki ED, et al. . Effects of N-acetyl cysteine on renal functions evaluated by blood neutrophil gelatinase-associated lipocalin levels in geriatric patients undergoing coronary artery bypass grafting. Anatol J Cardiol 2016; 16: 504&#x2013; 11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5331398</ArticleId><ArticleId IdType="pubmed">27004703</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns K, Chu M, Novick R. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing CABG surgery: a randomized controlled trial. JAMA 2005; 294: 342&#x2013; 50.</Citation><ArticleIdList><ArticleId IdType="pubmed">16030279</ArticleId></ArticleIdList></Reference><Reference><Citation>Adabag AS, Ishani A, Koneswaran S, et al. . Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: a randomized controlled trial. Am Heart J 2008; 155: 1143&#x2013; 9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18513531</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisillo E, Ceriani R, Bortone F, et al. . N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial. Crit Care Med 2008; 36: 81&#x2013; 6.</Citation><ArticleIdList><ArticleId IdType="pubmed">18090169</ArticleId></ArticleIdList></Reference><Reference><Citation>Amini S, Robabi HN, Tashnizi MA, et al. . Selenium, vitamin C and N-acetylcysteine do not reduce the risk of acute kidney injury after off-pump CABG: a randomized clinical trial. Braz J Cardiovasc Surg 2018; 33: 129&#x2013; 34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5985838</ArticleId><ArticleId IdType="pubmed">29898141</ArticleId></ArticleIdList></Reference><Reference><Citation>
Cochrane handbook for systematic reviews of interventions . 
Cochrane Training. Trusted evidence. Informed decision. 
Better health. 
n.d.. 
https://training.cochrane.org/handbook/current</Citation></Reference><Reference><Citation>Xu R, Tao A, Bai Y, et al. . Effectiveness of N-acetylcysteine for the prevention of contrast-induced nephropathy: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc 2016; 5: e003968.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5079043</ArticleId><ArticleId IdType="pubmed">27663415</ArticleId></ArticleIdList></Reference><Reference><Citation>Sucu N, Cinel I, Unlu A, et al. . N-acetylcysteine for preventing pump-induced oxidoinflammatory response during cardiopulmonary bypass. Surg Today 2004; 34: 237&#x2013; 42.</Citation><ArticleIdList><ArticleId IdType="pubmed">14999536</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu X, Li Q, Wang X, et al. . N-acetylcysteine attenuates cardiopulmonary bypass-induced lung injury in dogs. J Cardiothorac Surg 2013; 8: 107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3639066</ArticleId><ArticleId IdType="pubmed">23607780</ArticleId></ArticleIdList></Reference><Reference><Citation>Fishbane S. N-acetylcysteine in the prevention of contrast-induced nephropathy. Clin J Am Soc Nephrol 2008; 3: 281&#x2013; 7.</Citation><ArticleIdList><ArticleId IdType="pubmed">18003766</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo SH. N-acetylcysteine for prevention of contrast-induced nephropathy: a narrative review. Korean Circ J 2011; 41: 695&#x2013; 702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3257451</ArticleId><ArticleId IdType="pubmed">22259598</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozaydin M, Peker T, Akcay S, et al. . Addition of N-acetyl cysteine to carvedilol decreases the incidence of acute renal injury after cardiac surgery. Clin Cardiol 2014; 37: 108&#x2013; 14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6649511</ArticleId><ArticleId IdType="pubmed">24672814</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira JEG, El Dib R, Braz LG, et al. . N-acetylcysteine use among patients undergoing cardiac surgery: a systematic review and meta-analysis of randomized trials. PLoS One 2019; 14: e0213862.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6508704</ArticleId><ArticleId IdType="pubmed">31071081</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27797892</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1555-905X</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>12</Issue><PubDate><Year>2016</Year><Month>Dec</Month><Day>07</Day></PubDate></JournalIssue><Title>Clinical journal of the American Society of Nephrology : CJASN</Title><ISOAbbreviation>Clin J Am Soc Nephrol</ISOAbbreviation></Journal><ArticleTitle>Sex and the Risk of AKI Following Cardio-thoracic Surgery: A Meta-Analysis.</ArticleTitle><Pagination><StartPage>2113</StartPage><EndPage>2122</EndPage><MedlinePgn>2113-2122</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2215/CJN.03340316</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES">Being a woman is a well established risk factor for the development of cardiothoracic surgery-associated AKI. In striking contrast, women are less likely to develop AKI associated with noncardiac surgical procedures than men. In an attempt to ascertain why being a woman might be protective for ischemic AKI after general surgery but deleterious in patients undergoing cardiothoracic surgery, we examined cardiothoracic surgery-associated AKI in greater detail.</AbstractText><AbstractText Label="DESIGN, SETTING, PARTICIPANTS, &amp; MEASUREMENTS">We performed a systematic review and meta-analysis of cardiothoracic surgery-associated AKI studies published between January of 1978 and December of 2015 to further explore the relationship between sex and cardiothoracic surgery-associated AKI.</AbstractText><AbstractText Label="RESULTS">Sixty-four studies were identified that provided sex-specific data regarding the incidence of cardiothoracic surgery-associated AKI among 1,057,412 subjects. Using univariate analysis, women were more likely than men to develop AKI postoperatively (odds ratio, 1.21; 95% confidence interval, 1.09 to 1.33; P&lt;0.001). However, when the analysis was restricted to the 120,464 subjects reported in 29 studies that used the Acute Kidney Injury Network criteria, the RIFLE criteria, or the Kidney Disease Improving Global Outcomes criteria to define AKI, there was no significant sex-related difference in risk. Seventeen studies used multivariate analysis to assess risk factors for cardiothoracic surgery-associated AKI and provided sex-specific odd ratios. Among the 1,587,181 individuals included in these studies, the risk of developing cardiothoracic surgery-associated AKI was not significantly associated with sex (odds ratio, 1.04; 95% confidence interval, 0.92 to 1.19; P=0.51). However, when the analysis was restricted to the 5106 subjects reported in four studies that used the Acute Kidney Injury Network criteria to define AKI, the risk of developing AKI was significantly lower in women compared with in men (odds ratio, 0.75; 95% confidence interval, 0.65 to 0.87; P&lt;0.001).</AbstractText><AbstractText Label="CONCLUSIONS">Our systematic review and meta-analysis contradict the generally held consensus that being a woman is an independent risk factor for the development of cardiothoracic surgery-associated AKI.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 by the American Society of Nephrology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Neugarten</LastName><ForeName>Joel</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Nephrology Division, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandilya</LastName><ForeName>Sandipani</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Beenu</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Golestaneh</LastName><ForeName>Ladan</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>10</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin J Am Soc Nephrol</MedlineTA><NlmUniqueID>101271570</NlmUniqueID><ISSNLinking>1555-9041</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019616" MajorTopicYN="Y">Thoracic Surgical Procedures</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac Surgical Procedures</Keyword><Keyword MajorTopicYN="N">Consensus</Keyword><Keyword MajorTopicYN="N">Incidence</Keyword><Keyword MajorTopicYN="N">Multivariate Analysis</Keyword><Keyword MajorTopicYN="N">Specialties, Surgical</Keyword><Keyword MajorTopicYN="N">Thoracic Surgery</Keyword><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">acute renal failure</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">female</Keyword><Keyword MajorTopicYN="N">humans</Keyword><Keyword MajorTopicYN="N">male</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword><Keyword MajorTopicYN="N">sex</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>12</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27797892</ArticleId><ArticleId IdType="pmc">PMC5142065</ArticleId><ArticleId IdType="doi">10.2215/CJN.03340316</ArticleId><ArticleId IdType="pii">01277230-201612000-00006</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Neugarten J, Golestaneh L: Gender and the prevalence and progression of renal disease. Adv Chronic Kidney Dis 20: 390&#x2013;395, 2013</Citation><ArticleIdList><ArticleId IdType="pubmed">23978543</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchens MP, Dunlap J, Hurn PD, Jarnberg PO: Renal ischemia: Does sex matter? Anesth Analg 107: 239&#x2013;249, 2008</Citation><ArticleIdList><ArticleId IdType="pubmed">18635495</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell S, Dekker FW, Vadiveloo T, Marwick C, Deshmukh H, Donnan PT, Van Diepen M: Risk of postoperative acute kidney injury in patients undergoing orthopaedic surgery--development and validation of a risk score and effect of acute kidney injury on survival: Observational cohort study. BMJ 351: h5639, 2015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4641433</ArticleId><ArticleId IdType="pubmed">26561522</ArticleId></ArticleIdList></Reference><Reference><Citation>Grams ME, Sang Y, Coresh J, Ballew S, Matsushita K, Molnar MZ, Szabo Z, Kalantar-Zadeh K, Kovesdy CP: Acute kidney injury after major surgery: A retrospective analysis of Veterans Health Administration data. Am J Kidney Dis 67: 872&#x2013;880, 2016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4775458</ArticleId><ArticleId IdType="pubmed">26337133</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Heung M, Rosenberg AL, Englesbe M, Shanks AM, Campbell DA Jr.: Development and validation of an acute kidney injury risk index for patients undergoing general surgery: Results from a national data set. Anesthesiology 110: 505&#x2013;515, 2009</Citation><ArticleIdList><ArticleId IdType="pubmed">19212261</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora P, Kolli H, Nainani N, Nader N, Lohr J: Preventable risk factors for acute kidney injury in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth 26: 687&#x2013;697, 2012</Citation><ArticleIdList><ArticleId IdType="pubmed">22516466</ArticleId></ArticleIdList></Reference><Reference><Citation>Ihle BU: Acute renal dysfunction after cardiac surgery: Still a big problem! Heart Lung Circ 16[Suppl 3]: S39&#x2013;S44, 2007</Citation><ArticleIdList><ArticleId IdType="pubmed">17616436</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar AB, Suneja M: Cardiopulmonary bypass-associated acute kidney injury. Anesthesiology 114: 964&#x2013;970, 2011</Citation><ArticleIdList><ArticleId IdType="pubmed">21394005</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao H, Katz N, Ariyanon W, Blanca-Martos L, Ad&#xfd;belli Z, Giuliani A, Danesi TH, Kim JC, Nayak A, Neri M, Virzi GM, Brocca A, Scalzotto E, Salvador L, Ronco C: Cardiac surgery-associated acute kidney injury. Blood Purif 37[Suppl 2]: 34&#x2013;50, 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">25196567</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariscalco G, Lorusso R, Dominici C, Renzulli A, Sala A: Acute kidney injury: A relevant complication after cardiac surgery. Ann Thorac Surg 92: 1539&#x2013;1547, 2011</Citation><ArticleIdList><ArticleId IdType="pubmed">21872837</ArticleId></ArticleIdList></Reference><Reference><Citation>Najjar M, Salna M, George I: Acute kidney injury after aortic valve replacement: Incidence, risk factors and outcomes. Expert Rev Cardiovasc Ther 13: 301&#x2013;316, 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">25592763</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivero JJ, Olivero JJ, Nguyen PT, Kagan A: Acute kidney injury after cardiovascular surgery: An overview. Methodist DeBakey Cardiovasc J 8: 31&#x2013;36, 2012</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3487575</ArticleId><ArticleId IdType="pubmed">23227284</ArticleId></ArticleIdList></Reference><Reference><Citation>Parida S, Badhe AS: Cardiac surgery-associated acute kidney injury. J Anesth 27: 433&#x2013;446, 2013</Citation><ArticleIdList><ArticleId IdType="pubmed">23179740</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranucci M: Perioperative renal failure: Hypoperfusion during cardiopulmonary bypass? Semin Cardiothorac Vasc Anesth 11: 265&#x2013;268, 2007</Citation><ArticleIdList><ArticleId IdType="pubmed">18270190</ArticleId></ArticleIdList></Reference><Reference><Citation>Romagnoli S, Ricci Z: Postoperative acute kidney injury. Minerva Anestesiol 81: 684&#x2013;696, 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">25057935</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosner MH, Okusa MD: Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 1: 19&#x2013;32, 2006</Citation><ArticleIdList><ArticleId IdType="pubmed">17699187</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosner MH, Portilla D, Okusa MD: Cardiac surgery as a cause of acute kidney injury: Pathogenesis and potential therapies. J Intensive Care Med 23: 3&#x2013;18, 2008</Citation><ArticleIdList><ArticleId IdType="pubmed">18230632</ArticleId></ArticleIdList></Reference><Reference><Citation>Stafford-Smith M, Patel UD, Phillips-Bute BG, Shaw AD, Swaminathan M: Acute kidney injury and chronic kidney disease after cardiac surgery. Adv Chronic Kidney Dis 15: 257&#x2013;277, 2008</Citation><ArticleIdList><ArticleId IdType="pubmed">18565477</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakar CV: Perioperative acute kidney injury. Adv Chronic Kidney Dis 20: 67&#x2013;75, 2013</Citation><ArticleIdList><ArticleId IdType="pubmed">23265598</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiele RH, Isbell JM, Rosner MH: AKI associated with cardiac surgery. Clin J Am Soc Nephrol 10: 500&#x2013;514, 2015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4348689</ArticleId><ArticleId IdType="pubmed">25376763</ArticleId></ArticleIdList></Reference><Reference><Citation>Vives M, Wijeysundera D, Marczin N, Monedero P, Rao V: Cardiac surgery-associated acute kidney injury. Interact Cardiovasc Thorac Surg 18: 637&#x2013;645, 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">24535092</ArticleId></ArticleIdList></Reference><Reference><Citation>KDIGO : KDIGO clinical practice guidelines for acute kidney injury. Kidney Int 2[Suppl 1]: 1&#x2013;138, Online Appendices A&#x2013;F, 2012. Accessed September 1, 2016</Citation></Reference><Reference><Citation>Brown JR, Cochran RP, Leavitt BJ, Dacey LJ, Ross CS, MacKenzie TA, Kunzelman KS, Kramer RS, Hernandez F Jr., Helm RE, Westbrook BM, Dunton RF, Malenka DJ, O&#x2019;Connor GT; Northern New England Cardiovascular Disease Study Group : Multivariable prediction of renal insufficiency developing after cardiac surgery. Circulation 116[Suppl]: I139&#x2013;I143, 2007</Citation><ArticleIdList><ArticleId IdType="pubmed">17846294</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakar CV, Liangos O, Yared JP, Nelson DA, Hariachar S, Paganini EP: Predicting acute renal failure after cardiac surgery: Validation and re-definition of a risk-stratification algorithm. Hemodial Int 7: 143&#x2013;147, 2003</Citation><ArticleIdList><ArticleId IdType="pubmed">19379354</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng SY, Sanagou M, Wolfe R, Cochrane A, Smith JA, Reid CM: Prediction of acute kidney injury within 30 days of cardiac surgery. J Thorac Cardiovasc Surg 147: 1875&#x2013;1883.e1, 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">23993316</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JP, Straus S, Thorlund K, Jansen JP, Mulrow C, Catal&#xe1;-L&#xf3;pez F, G&#xf8;tzsche PC, Dickersin K, Boutron I, Altman DG, Moher D: The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: Checklist and explanations. Ann Intern Med 162: 777&#x2013;784, 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">26030634</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A; Acute Kidney Injury Network : Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care 11: R31, 2007</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative workgroup : Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8: R204&#x2013;R212, 2004</Citation><ArticleIdList><ArticleId IdType="pmc">PMC522841</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells GASB, O&#x2019;Connell D, Peterson J, Welch V, Losos M, Tugwell P: The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Available at: http://wwwohrica/programsclinical_epidemiology/oxfordasp. Accessed September 1, 2016</Citation></Reference><Reference><Citation>Andersson LG, Ekroth R, Bratteby LE, Hallhagen S, Wessl&#xe9;n O: Acute renal failure after coronary surgery--a study of incidence and risk factors in 2009 consecutive patients. Thorac Cardiovasc Surg 41: 237&#x2013;241, 1993</Citation><ArticleIdList><ArticleId IdType="pubmed">8211928</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora P, Rajagopalam S, Ranjan R, Kolli H, Singh M, Venuto R, Lohr J: Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clin J Am Soc Nephrol 3: 1266&#x2013;1273, 2008</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2518804</ArticleId><ArticleId IdType="pubmed">18667735</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahar I, Akgul A, Ozatik MA, Vural KM, Demirbag AE, Boran M, Tasdemir O: Acute renal failure following open heart surgery: Risk factors and prognosis. Perfusion 20: 317&#x2013;322, 2005</Citation><ArticleIdList><ArticleId IdType="pubmed">16363316</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetto U, Angeloni E, Luciani R, Refice S, Stefanelli M, Comito C, Roscitano A, Sinatra R: Acute kidney injury after coronary artery bypass grafting: Does rhabdomyolysis play a role? J Thorac Cardiovasc Surg 140: 464&#x2013;470, 2010</Citation><ArticleIdList><ArticleId IdType="pubmed">20416892</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg KS, Stenseth R, Wahba A, Pleym H, Videm V: How can we best predict acute kidney injury following cardiac surgery?: A prospective observational study. Eur J Anaesthesiol 30: 704&#x2013;712, 2013</Citation><ArticleIdList><ArticleId IdType="pubmed">24067536</ArticleId></ArticleIdList></Reference><Reference><Citation>Birnie K, Verheyden V, Pagano D, Bhabra M, Tilling K, Sterne JA, Murphy GJ; UK AKI in Cardiac Surgery Collaborators : Predictive models for kidney disease: Improving global outcomes (KDIGO) defined acute kidney injury in UK cardiac surgery. Crit Care 18: 606, 2014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4258283</ArticleId><ArticleId IdType="pubmed">25673427</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JR, Cochran RP, Dacey LJ, Ross CS, Kunzelman KS, Dunton RF, Braxton JH, Charlesworth DC, Clough RA, Helm RE, Leavitt BJ, Mackenzie TA, O&#x2019;Connor GT; Northern New England Cardiovascular Disease Study Group : Perioperative increases in serum creatinine are predictive of increased 90-day mortality after coronary artery bypass graft surgery. Circulation 114[Suppl]: I409&#x2013;I413, 2006</Citation><ArticleIdList><ArticleId IdType="pubmed">16820609</ArticleId></ArticleIdList></Reference><Reference><Citation>Candela-Toha A, El&#xed;as-Mart&#xed;n E, Abraira V, Tenorio MT, Parise D, de Pablo A, Centella T, Lia&#xf1;o F: Predicting acute renal failure after cardiac surgery: External validation of two new clinical scores. Clin J Am Soc Nephrol 3: 1260&#x2013;1265, 2008</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2518781</ArticleId><ArticleId IdType="pubmed">18463173</ArticleId></ArticleIdList></Reference><Reference><Citation>Che M, Li Y, Liang X, Xie B, Xue S, Qian J, Ni Z, Axelsson J, Yan Y: Prevalence of acute kidney injury following cardiac surgery and related risk factors in Chinese patients. Nephron Clin Pract 117: c305&#x2013;c311, 2011</Citation><ArticleIdList><ArticleId IdType="pubmed">20861652</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon PJ, Stafford-Smith M, White WD, Newman MF, King S, Winn MP, Landolfo K: Acute renal failure following cardiac surgery. Nephrol Dial Transplant 14: 1158&#x2013;1162, 1999</Citation><ArticleIdList><ArticleId IdType="pubmed">10344355</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Duca D, Iqbal S, Rahme E, Goldberg P, de Varennes B: Renal failure after cardiac surgery: Timing of cardiac catheterization and other perioperative risk factors. Ann Thorac Surg 84: 1264&#x2013;1271, 2007</Citation><ArticleIdList><ArticleId IdType="pubmed">17888981</ArticleId></ArticleIdList></Reference><Reference><Citation>Dietrich W, Busley R, Boulesteix AL: Effects of aprotinin dosage on renal function: An analysis of 8,548 cardiac surgical patients treated with different dosages of aprotinin. Anesthesiology 108: 189&#x2013;198, 2008</Citation><ArticleIdList><ArticleId IdType="pubmed">18212563</ArticleId></ArticleIdList></Reference><Reference><Citation>Doddakula K, Al-Sarraf N, Gately K, Hughes A, Tolan M, Young V, McGovern E: Predictors of acute renal failure requiring renal replacement therapy post cardiac surgery in patients with preoperatively normal renal function. Interact Cardiovasc Thorac Surg 6: 314&#x2013;318, 2007</Citation><ArticleIdList><ArticleId IdType="pubmed">17669854</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Onofrio A, Cruz D, Bolgan I, Auriemma S, Cresce GD, Fabbri A, Ronco C: RIFLE criteria for cardiac surgery-associated acute kidney injury: Risk factors and outcomes. Congest Heart Fail 16[Suppl 1]: S32&#x2013;S36, 2010</Citation><ArticleIdList><ArticleId IdType="pubmed">20653709</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis MC, Paugh TA, Dickinson TA, Fuller J, Chores J, Paone G, Heung M, Fliegner K, Pruitt AL, Patel HJ, Zhang M, Prager RL, Likosky DS; PERForm Registry and the Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative : Nadir hematocrit on bypass and rates of acute kidney injury: Does sex matter? Ann Thorac Surg 100: 1549&#x2013;1554, 2015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6817808</ArticleId><ArticleId IdType="pubmed">26296273</ArticleId></ArticleIdList></Reference><Reference><Citation>Englberger L, Suri RM, Connolly HM, Li Z, Abel MD, Greason KL, Dearani JA, Schaff HV: Increased risk of acute kidney injury in patients undergoing tricuspid valve surgery. Eur J Cardiothorac Surg 43: 993&#x2013;999, 2013</Citation><ArticleIdList><ArticleId IdType="pubmed">23002188</ArticleId></ArticleIdList></Reference><Reference><Citation>Englberger L, Suri RM, Greason KL, Burkhart HM, Sundt TM 3rd, Daly RC, Schaff HV: Deep hypothermic circulatory arrest is not a risk factor for acute kidney injury in thoracic aortic surgery. J Thorac Cardiovasc Surg 141: 552&#x2013;558, 2011</Citation><ArticleIdList><ArticleId IdType="pubmed">20392457</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortescue EB, Bates DW, Chertow GM: Predicting acute renal failure after coronary bypass surgery: Cross-validation of two risk-stratification algorithms. Kidney Int 57: 2594&#x2013;2602, 2000</Citation><ArticleIdList><ArticleId IdType="pubmed">10844629</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaudino M, Luciani N, Giungi S, Caradonna E, Nasso G, Schiavello R, Luciani G, Possati G: Different profiles of patients who require dialysis after cardiac surgery. Ann Thorac Surg 79: 825&#x2013;829, 2005</Citation><ArticleIdList><ArticleId IdType="pubmed">15734386</ArticleId></ArticleIdList></Reference><Reference><Citation>Grayson AD, Khater M, Jackson M, Fox MA: Valvular heart operation is an independent risk factor for acute renal failure. Ann Thorac Surg 75: 1829&#x2013;1835, 2003</Citation><ArticleIdList><ArticleId IdType="pubmed">12822624</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase M, Bellomo R, Story D, Letis A, Klemz K, Matalanis G, Seevanayagam S, Dragun D, Seeliger E, Mertens PR, Haase-Fielitz A: Effect of mean arterial pressure, haemoglobin and blood transfusion during cardiopulmonary bypass on post-operative acute kidney injury. Nephrol Dial Transplant 27: 153&#x2013;160, 2012</Citation><ArticleIdList><ArticleId IdType="pubmed">21677302</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen MK, Gammelager H, Jacobsen CJ, Hjortdal VE, Layton JB, Rasmussen BS, Andreasen JJ, Johnsen SP, Christiansen CF: Acute kidney injury and long-term risk of cardiovascular events after cardiac surgery: A population-based cohort study. J Cardiothorac Vasc Anesth 29: 617&#x2013;625, 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">25575408</ArticleId></ArticleIdList></Reference><Reference><Citation>Heringlake M, Nowak Y, Sch&#xf6;n J, Trautmann J, Berggreen AE, Charitos EI, Paarmann H: Postoperative intubation time is associated with acute kidney injury in cardiac surgical patients. Crit Care 18: 547, 2014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4209080</ArticleId><ArticleId IdType="pubmed">25277725</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson CE, Yavas S, Segal MS, Schold JD, Tribble CG, Layon AJ, Bihorac A: Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation 119: 2444&#x2013;2453, 2009</Citation><ArticleIdList><ArticleId IdType="pubmed">19398670</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen DP, Noyez L, van Druten JA, Skotnicki SH, Lacquet LK: Predictors of nephrological morbidity after coronary artery bypass surgery. Cardiovasc Surg 10: 222&#x2013;227, 2002</Citation><ArticleIdList><ArticleId IdType="pubmed">12044429</ArticleId></ArticleIdList></Reference><Reference><Citation>Kajimoto K, Miyauchi K, Kasai T, Yanagisawa N, Yamamoto T, Kikuchi K, Nakatomi T, Iwamura H, Daida H, Amano A: Metabolic syndrome is an independent risk factor for stroke and acute renal failure after coronary artery bypass grafting. J Thorac Cardiovasc Surg 137: 658&#x2013;663, 2009</Citation><ArticleIdList><ArticleId IdType="pubmed">19258085</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandler K, Jensen ME, Nilsson JC, M&#xf8;ller CH, Steinbr&#xfc;chel DA: Acute kidney injury is independently associated with higher mortality after cardiac surgery. J Cardiothorac Vasc Anesth 28: 1448&#x2013;1452, 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">25440657</ArticleId></ArticleIdList></Reference><Reference><Citation>Karkouti K, Grocott HP, Hall R, Jessen ME, Kruger C, Lerner AB, MacAdams C, Mazer CD, de Medicis &#xc9;, Myles P, Ralley F, Rheault MR, Rochon A, Slaughter MS, Sternlicht A, Syed S, Waters T: Interrelationship of preoperative anemia, intraoperative anemia, and red blood cell transfusion as potentially modifiable risk factors for acute kidney injury in cardiac surgery: A historical multicentre cohort study. Can J Anaesth 62: 377&#x2013;384, 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">25537735</ArticleId></ArticleIdList></Reference><Reference><Citation>Karkouti K, Wijeysundera DN, Yau TM, Callum JL, Cheng DC, Crowther M, Dupuis JY, Fremes SE, Kent B, Laflamme C, Lamy A, Legare JF, Mazer CD, McCluskey SA, Rubens FD, Sawchuk C, Beattie WS: Acute kidney injury after cardiac surgery: Focus on modifiable risk factors. Circulation 119: 495&#x2013;502, 2009</Citation><ArticleIdList><ArticleId IdType="pubmed">19153273</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiers HD, van den Boogaard M, Schoenmakers MC, van der Hoeven JG, van Swieten HA, Heemskerk S, Pickkers P: Comparison and clinical suitability of eight prediction models for cardiac surgery-related acute kidney injury. Nephrol Dial Transplant 28: 345&#x2013;351, 2013</Citation><ArticleIdList><ArticleId IdType="pubmed">23222415</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim WH, Park JY, Ok SH, Shin IW, Sohn JT: Association between the neutrophil/lymphocyte ratio and acute kidney injury after cardiovascular surgery: A retrospective observational study. Medicine (Baltimore) 94: e1867, 2015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4985412</ArticleId><ArticleId IdType="pubmed">26512598</ArticleId></ArticleIdList></Reference><Reference><Citation>Kincaid EH, Ashburn DA, Hoyle JR, Reichert MG, Hammon JW, Kon ND: Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery? Ann Thorac Surg 80: 1388&#x2013;1393, 2005</Citation><ArticleIdList><ArticleId IdType="pubmed">16181876</ArticleId></ArticleIdList></Reference><Reference><Citation>Kourliouros A, Valencia O, Phillips SD, Collinson PO, van Besouw JP, Jahangiri M: Low cardiopulmonary bypass perfusion temperatures are associated with acute kidney injury following coronary artery bypass surgery. Eur J Cardiothorac Surg 37: 704&#x2013;709, 2010</Citation><ArticleIdList><ArticleId IdType="pubmed">19767217</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristovic D, Horvatic I, Husedzinovic I, Sutlic Z, Rudez I, Baric D, Unic D, Blazekovic R, Crnogorac M: Cardiac surgery-associated acute kidney injury: Risk factors analysis and comparison of prediction models. Interact Cardiovasc Thorac Surg 21: 366&#x2013;373, 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">26091696</ArticleId></ArticleIdList></Reference><Reference><Citation>Landoni G, Zangrillo A, Franco A, Aletti G, Roberti A, Calabr&#xf2; MG, Slaviero G, Bignami E, Marino G: Long-term outcome of patients who require renal replacement therapy after cardiac surgery. Eur J Anaesthesiol 23: 17&#x2013;22, 2006</Citation><ArticleIdList><ArticleId IdType="pubmed">16390560</ArticleId></ArticleIdList></Reference><Reference><Citation>Loef BG, Epema AH, Smilde TD, Henning RH, Ebels T, Navis G, Stegeman CA: Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol 16: 195&#x2013;200, 2005</Citation><ArticleIdList><ArticleId IdType="pubmed">15563558</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Delgado JC, Esteve F, Torrado H, Rodr&#xed;guez-Castro D, Carrio ML, Farrero E, Javierre C, Ventura JL, Manez R: Influence of acute kidney injury on short- and long-term outcomes in patients undergoing cardiac surgery: Risk factors and prognostic value of a modified RIFLE classification. Crit Care 17: R293, 2013</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4056889</ArticleId><ArticleId IdType="pubmed">24330769</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangos GJ, Brown MA, Chan WY, Horton D, Trew P, Whitworth JA: Acute renal failure following cardiac surgery: Incidence, outcomes and risk factors. Aust N Z J Med 25: 284&#x2013;289, 1995</Citation><ArticleIdList><ArticleId IdType="pubmed">8540867</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariscalco G, Cottini M, Dominici C, Banach M, Piffaretti G, Borsani P, Bruno VD, Corazzari C, Gherli R, Beghi C: The effect of timing of cardiac catheterization on acute kidney injury after cardiac surgery is influenced by the type of operation. Int J Cardiol 173: 46&#x2013;54, 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">24602318</ArticleId></ArticleIdList></Reference><Reference><Citation>McIlroy DR, Epi MC, Argenziano M, Farkas D, Umann T: Acute kidney injury after cardiac surgery: Does the time interval from contrast administration to surgery matter? J Cardiothorac Vasc Anesth 26: 804&#x2013;812, 2012</Citation><ArticleIdList><ArticleId IdType="pubmed">22521404</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirmohammad-Sadeghi M, Naghiloo A, Najarzadegan MR: Evaluating the relative frequency and predicting factors of acute renal failure following coronary artery bypass grafting. ARYA Atheroscler 9: 287&#x2013;292, 2013</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3845695</ArticleId><ArticleId IdType="pubmed">24302937</ArticleId></ArticleIdList></Reference><Reference><Citation>Newland RF, Tully PJ, Baker RA: Hyperthermic perfusion during cardiopulmonary bypass and postoperative temperature are independent predictors of acute kidney injury following cardiac surgery. Perfusion 28: 223&#x2013;231, 2013</Citation><ArticleIdList><ArticleId IdType="pubmed">23314194</ArticleId></ArticleIdList></Reference><Reference><Citation>Palomba H, de Castro I, Neto AL, Lage S, Yu L: Acute kidney injury prediction following elective cardiac surgery: AKICS Score. Kidney Int 72: 624&#x2013;631, 2007</Citation><ArticleIdList><ArticleId IdType="pubmed">17622275</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Valdivieso JR, Monedero P, Vives M, Garcia-Fernandez N, Bes-Rastrollo M; GEDRCC (Grupo Espa&#xf1;ol de Disfunci&#xf3;n Renal en Cirug&#xed;a Cardiaca) : Cardiac-surgery associated acute kidney injury requiring renal replacement therapy. A Spanish retrospective case-cohort study. BMC Nephrol 10: 27, 2009</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2759914</ArticleId><ArticleId IdType="pubmed">19772621</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry TE, Muehlschlegel JD, Liu KY, Fox AA, Collard CD, Shernan SK, Body SC; CABG Genomics Investigators : Plasma neutrophil gelatinase-associated lipocalin and acute postoperative kidney injury in adult cardiac surgical patients. Anesth Analg 110: 1541&#x2013;1547, 2010</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2999841</ArticleId><ArticleId IdType="pubmed">20435938</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmanian PB, Filsoufi F, Castillo JG, Zaku B, Chikwe J, Carpentier A, Adams DH: Predicting postoperative renal failure requiring dialysis, and an analysis of long-term outcome in patients undergoing valve surgery. J Heart Valve Dis 17: 657&#x2013;665, 2008</Citation><ArticleIdList><ArticleId IdType="pubmed">19137798</ArticleId></ArticleIdList></Reference><Reference><Citation>Ried M, Lunz D, Kobuch R, Rupprecht L, Keyser A, Hilker M, Schmid C, Diez C: Gender&#x2019;s impact on outcome in coronary surgery with minimized extracorporeal circulation. Clin Res Cardiol 101: 437&#x2013;444, 2012</Citation><ArticleIdList><ArticleId IdType="pubmed">22228145</ArticleId></ArticleIdList></Reference><Reference><Citation>Rioux JP, Lessard M, De Bortoli B, Roy P, Albert M, Verdant C, Madore F, Troyanov S: Pentastarch 10% (250 kDa/0.45) is an independent risk factor of acute kidney injury following cardiac surgery. Crit Care Med 37: 1293&#x2013;1298, 2009</Citation><ArticleIdList><ArticleId IdType="pubmed">19242349</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryckwaert F, Boccara G, Frappier JM, Colson PH: Incidence, risk factors, and prognosis of a moderate increase in plasma creatinine early after cardiac surgery. Crit Care Med 30: 1495&#x2013;1498, 2002</Citation><ArticleIdList><ArticleId IdType="pubmed">12130968</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryd&#xe9;n L, Sartipy U, Evans M, Holzmann MJ: Acute kidney injury after coronary artery bypass grafting and long-term risk of end-stage renal disease. Circulation 130: 2005&#x2013;2011, 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">25239439</ArticleId></ArticleIdList></Reference><Reference><Citation>van Straten AH, Hamad MA, van Zundert AA, Martens EJ, Sch&#xf6;nberger JP, de Wolf AM: Risk factors for deterioration of renal function after coronary artery bypass grafting. Eur J Cardiothorac Surg 37: 106&#x2013;111, 2010</Citation><ArticleIdList><ArticleId IdType="pubmed">19699103</ArticleId></ArticleIdList></Reference><Reference><Citation>Vellinga S, Verbrugghe W, De Paep R, Verpooten GA, Janssen van Doorn K: Identification of modifiable risk factors for acute kidney injury after cardiac surgery. Neth J Med 70: 450&#x2013;454, 2012</Citation><ArticleIdList><ArticleId IdType="pubmed">23230014</ArticleId></ArticleIdList></Reference><Reference><Citation>Vives M, Monedero P, Perez-Valdivieso JR, Garcia-Fernandez N, Lavilla J, Herreros J, Bes-Rastrollo M; Spanish Renal Dysfunction in Cardiac Surgery Group : External validation and comparison of three scores to predict renal replacement therapy after cardiac surgery: A multicenter cohort. Int J Artif Organs 34: 329&#x2013;338, 2011</Citation><ArticleIdList><ArticleId IdType="pubmed">21534243</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeysundera DN, Karkouti K, Dupuis JY, Rao V, Chan CT, Granton JT, Beattie WS: Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. JAMA 297: 1801&#x2013;1809, 2007</Citation><ArticleIdList><ArticleId IdType="pubmed">17456822</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu JR, Zhu JM, Jiang J, Ding XQ, Fang Y, Shen B, Liu ZH, Zou JZ, Liu L, Wang CS, Ronco C, Liu H, Teng J: Risk factors for long-term mortality and progressive chronic kidney disease associated with acute kidney injury after cardiac surgery. Medicine (Baltimore) 94: e2025, 2015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4912299</ArticleId><ArticleId IdType="pubmed">26559305</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanardo G, Michielon P, Paccagnella A, Rosi P, Cal&#xf3; M, Salandin V, Da Ros A, Michieletto F, Simini G: Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg 107: 1489&#x2013;1495, 1994</Citation><ArticleIdList><ArticleId IdType="pubmed">8196394</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang WF, Gu TX, Diao C, Zhang YH, Wang C, Fang Q, Wang HL: Comparison of transient changes in renal function between off-pump and on-pump coronary artery bypass grafting. Chin Med J (Engl) 121: 1537&#x2013;1542, 2008</Citation><ArticleIdList><ArticleId IdType="pubmed">18982864</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado MN, Nakazone MA, Maia LN: Prognostic value of acute kidney injury after cardiac surgery according to kidney disease: Improving global outcomes definition and staging (KDIGO) criteria. PLoS One 9: e98028, 2014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4020924</ArticleId><ArticleId IdType="pubmed">24826910</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RH, Castelvecchio S, Ballotta A, Frigiola A, Bossone E, Ranucci M: Association of gender and lowest hematocrit on cardiopulmonary bypass with acute kidney injury and operative mortality in patients undergoing cardiac surgery. Ann Thorac Surg 96: 133&#x2013;140, 2013</Citation><ArticleIdList><ArticleId IdType="pubmed">23673070</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahian DM, O&#x2019;Brien SM, Filardo G, Ferraris VA, Haan CK, Rich JB, Normand SL, DeLong ER, Shewan CM, Dokholyan RS, Peterson ED, Edwards FH, Anderson RP; Society of Thoracic Surgeons Quality Measurement Task Force : The Society of Thoracic Surgeons 2008 cardiac surgery risk models: Part 1--coronary artery bypass grafting surgery. Ann Thorac Surg 88[Suppl]: S2&#x2013;S22, 2009</Citation><ArticleIdList><ArticleId IdType="pubmed">19559822</ArticleId></ArticleIdList></Reference><Reference><Citation>Antunes PE, de Oliveira JF, Antunes MJ: Risk-prediction for postoperative major morbidity in coronary surgery. Eur J Cardiothorac Surg 35: 760&#x2013;766, 2009</Citation><ArticleIdList><ArticleId IdType="pubmed">19243970</ArticleId></ArticleIdList></Reference><Reference><Citation>Hein OV, Birnbaum J, Wernecke KD, Konertz W, Jain U, Spies C: Three-year survival after four major post-cardiac operative complications. Crit Care Med 34: 2729&#x2013;2737, 2006</Citation><ArticleIdList><ArticleId IdType="pubmed">16971859</ArticleId></ArticleIdList></Reference><Reference><Citation>Noyez L: Influence of the definition of acute renal failure post-cardiac surgery on incidence, patient identification, and identification of risk factors. Eur J Cardiothorac Surg 39: e8&#x2013;e12, 2011</Citation><ArticleIdList><ArticleId IdType="pubmed">21167730</ArticleId></ArticleIdList></Reference><Reference><Citation>Parolari A, Pesce LL, Pacini D, Mazzanti V, Salis S, Sciacovelli C, Rossi F, Alamanni F; Monzino Research Group on Cardiac Surgery Outcomes : Risk factors for perioperative acute kidney injury after adult cardiac surgery: Role of perioperative management. Ann Thorac Surg 93: 584&#x2013;591, 2012</Citation><ArticleIdList><ArticleId IdType="pubmed">22269725</ArticleId></ArticleIdList></Reference><Reference><Citation>Stallwood MI, Grayson AD, Mills K, Scawn ND: Acute renal failure in coronary artery bypass surgery: Independent effect of cardiopulmonary bypass. Ann Thorac Surg 77: 968&#x2013;972, 2004</Citation><ArticleIdList><ArticleId IdType="pubmed">14992908</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG, Jammalamadaka D, Sint K, Thiessen Philbrook H, Shlipak MG, Zappitelli M, Devarajan P, Hashim S, Garg AX, Parikh CR; Translational Research Investigating Biomarker Endpoints in Acute Kidney Injury Consortium : Preoperative proteinuria predicts acute kidney injury in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 143: 495&#x2013;502, 2012</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3341084</ArticleId><ArticleId IdType="pubmed">22050987</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S, Youn YN, Yoo KJ: Metabolic syndrome as a risk factor for postoperative kidney injury after off-pump coronary artery bypass surgery. Circ J 74: 1121&#x2013;1126, 2010</Citation><ArticleIdList><ArticleId IdType="pubmed">20410619</ArticleId></ArticleIdList></Reference><Reference><Citation>Li SY, Chuang CL, Yang WC, Lin SJ: Proteinuria predicts postcardiotomy acute kidney injury in patients with preserved glomerular filtration rate. J Thorac Cardiovasc Surg 149: 894&#x2013;899, 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">25433643</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien SM, Shahian DM, Filardo G, Ferraris VA, Haan CK, Rich JB, Normand SL, DeLong ER, Shewan CM, Dokholyan RS, Peterson ED, Edwards FH, Anderson RP; Society of Thoracic Surgeons Quality Measurement Task Force : The Society of Thoracic Surgeons 2008 cardiac surgery risk models: Part 2--isolated valve surgery. Ann Thorac Surg 88[Suppl]: S23&#x2013;S42, 2009</Citation><ArticleIdList><ArticleId IdType="pubmed">19559823</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahian DM, O&#x2019;Brien SM, Filardo G, Ferraris VA, Haan CK, Rich JB, Normand SL, DeLong ER, Shewan CM, Dokholyan RS, Peterson ED, Edwards FH, Anderson RP; Society of Thoracic Surgeons Quality Measurement Task Force : The Society of Thoracic Surgeons 2008 cardiac surgery risk models: Part 3--valve plus coronary artery bypass grafting surgery. Ann Thorac Surg 88[Suppl]: S43&#x2013;S62, 2009</Citation><ArticleIdList><ArticleId IdType="pubmed">19559824</ArticleId></ArticleIdList></Reference><Reference><Citation>Shroyer AL, Coombs LP, Peterson ED, Eiken MC, DeLong ER, Chen A, Ferguson TB Jr, Grover FL, Edwards FH; Society of Thoracic Surgeons: The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg 75: 1856&#x2013;1864, 2003</Citation><ArticleIdList><ArticleId IdType="pubmed">12822628</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonini M, Lanzani C, Bignami E, Casamassima N, Frati E, Meroni R, Messaggio E, Alfieri O, Hamlyn J, Body SC, Collard CD, Zangrillo A, Manunta P; CABG Genomics Investigators : A new clinical multivariable model that predicts postoperative acute kidney injury: Impact of endogenous ouabain. Nephrol Dial Transplant 29: 1696&#x2013;1701, 2014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4200038</ArticleId><ArticleId IdType="pubmed">24920842</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakar CV, Liangos O, Yared JP, Nelson D, Piedmonte MR, Hariachar S, Paganini EP: ARF after open-heart surgery: Influence of gender and race. Am J Kidney Dis 41: 742&#x2013;751, 2003</Citation><ArticleIdList><ArticleId IdType="pubmed">12666060</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, Himmelfarb J, Collins AJ: Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 17: 1135&#x2013;1142, 2006</Citation><ArticleIdList><ArticleId IdType="pubmed">16495381</ArticleId></ArticleIdList></Reference><Reference><Citation>Nash K, Hafeez A, Hou S: Hospital-acquired renal insufficiency. Am J Kidney Dis 39: 930&#x2013;936, 2002</Citation><ArticleIdList><ArticleId IdType="pubmed">11979336</ArticleId></ArticleIdList></Reference><Reference><Citation>Liangos O, Wald R, O&#x2019;Bell JW, Price L, Pereira BJ, Jaber BL: Epidemiology and outcomes of acute renal failure in hospitalized patients: A national survey. Clin J Am Soc Nephrol 1: 43&#x2013;51, 2006</Citation><ArticleIdList><ArticleId IdType="pubmed">17699189</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu RK, McCulloch CE, Dudley RA, Lo LJ, Hsu CY: Temporal changes in incidence of dialysis-requiring AKI. J Am Soc Nephrol 24: 37&#x2013;42, 2013</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3537221</ArticleId><ArticleId IdType="pubmed">23222124</ArticleId></ArticleIdList></Reference><Reference><Citation>Karkouti K, Beattie WS, Wijeysundera DN, Rao V, Chan C, Dattilo KM, Djaiani G, Ivanov J, Karski J, David TE: Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery. J Thorac Cardiovasc Surg 129: 391&#x2013;400, 2005</Citation><ArticleIdList><ArticleId IdType="pubmed">15678051</ArticleId></ArticleIdList></Reference><Reference><Citation>DeFoe GR, Ross CS, Olmstead EM, Surgenor SD, Fillinger MP, Groom RC, Forest RJ, Pieroni JW, Warren CS, Bogosian ME, Krumholz CF, Clark C, Clough RA, Weldner PW, Lahey SJ, Leavitt BJ, Marrin CA, Charlesworth DC, Marshall P, O&#x2019;Connor GT; Northern New England Cardiovascular Disease Study Group : Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Ann Thorac Surg 71: 769&#x2013;776, 2001</Citation><ArticleIdList><ArticleId IdType="pubmed">11269449</ArticleId></ArticleIdList></Reference><Reference><Citation>Swaminathan M, Phillips-Bute BG, Conlon PJ, Smith PK, Newman MF, Stafford-Smith M: The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery. Ann Thorac Surg 76: 784&#x2013;791, 2003</Citation><ArticleIdList><ArticleId IdType="pubmed">12963200</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray PT, Thakar CV: Acute kidney injury and critical care. Nephrol Self Assess Program 14: 97&#x2013;169, 2015</Citation></Reference><Reference><Citation>Mehta RH, Grab JD, O&#x2019;Brien SM, Bridges CR, Gammie JS, Haan CK, Ferguson TB, Peterson ED; Society of Thoracic Surgeons National Cardiac Surgery Database Investigators : Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation 114: 2208&#x2013;2216, 2006</Citation><ArticleIdList><ArticleId IdType="pubmed">17088458</ArticleId></ArticleIdList></Reference><Reference><Citation>Englberger L, Suri RM, Li Z, Dearani JA, Park SJ, Sundt TM 3rd , Schaff HV: Validation of clinical scores predicting severe acute kidney injury after cardiac surgery. Am J Kidney Dis 56: 623&#x2013;631, 2010</Citation><ArticleIdList><ArticleId IdType="pubmed">20630639</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson FP, Yang W, Machado CA, Mariani LH, Borovskiy Y, Berns JS, Feldman HI: Dialysis versus nondialysis in patients with AKI: A propensity-matched cohort study. Clin J Am Soc Nephrol 9: 673&#x2013;681, 2014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3974360</ArticleId><ArticleId IdType="pubmed">24651073</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards FH, Carey JS, Grover FL, Bero JW, Hartz RS: Impact of gender on coronary bypass operative mortality. Ann Thorac Surg 66: 125&#x2013;131, 1998</Citation><ArticleIdList><ArticleId IdType="pubmed">9692451</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogue CW Jr., Barzilai B, Pieper KS, Coombs LP, DeLong ER, Kouchoukos NT, D&#xe1;vila-Rom&#xe1;n VG: Sex differences in neurological outcomes and mortality after cardiac surgery: A society of thoracic surgery national database report. Circulation 103: 2133&#x2013;2137, 2001</Citation><ArticleIdList><ArticleId IdType="pubmed">11331252</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch CG, Weng YS, Zhou SX, Savino JS, Mathew JP, Hsu PH, Saidman LJ, Mangano DT; Ischemia Research and Education Foundation; Multicenter Study of Perioperative Ischemia Research Group : Prevalence of risk factors, and not gender per se, determines short- and long-term survival after coronary artery bypass surgery. J Cardiothorac Vasc Anesth 17: 585&#x2013;593, 2003</Citation><ArticleIdList><ArticleId IdType="pubmed">14579211</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitter N, Shah A, Yuh D, Dodd-O J, Thompson RE, Cameron D, Hogue CW: Renal injury is associated with operative mortality after cardiac surgery for women and men. J Thorac Cardiovasc Surg 140: 1367&#x2013;1373, 2010</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2904436</ArticleId><ArticleId IdType="pubmed">20381074</ArticleId></ArticleIdList></Reference><Reference><Citation>Karkouti K: Transfusion and risk of acute kidney injury in cardiac surgery. Br J Anaesth 109[Suppl 1]: i29&#x2013;i38, 2012</Citation><ArticleIdList><ArticleId IdType="pubmed">23242748</ArticleId></ArticleIdList></Reference><Reference><Citation>Macedo E, Bouchard J, Soroko SH, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL; Program to Improve Care in Acute Renal Disease Study : Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients. Crit Care 14: R82, 2010</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2911707</ArticleId><ArticleId IdType="pubmed">20459609</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39668054</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>134</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Feb</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Intraoperative dexmedetomidine and acute kidney injury in paediatric noncardiac surgery: a retrospective propensity score-matched analysis.</ArticleTitle><Pagination><StartPage>453</StartPage><EndPage>460</EndPage><MedlinePgn>453-460</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2024.10.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(24)00647-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Paediatric acute kidney injury (AKI) is common and linked to longer hospitalisation and mortality. We investigated whether a continuous intraoperative infusion of dexmedetomidine, which increases renal blood flow, was associated with a lower risk of postoperative AKI in paediatric patients undergoing noncardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective cohort study included paediatric patients undergoing noncardiac surgery between January 2019 and July 2021. Propensity score matching, based on the participants' baseline characteristics, was used to minimise the potential bias. The primary outcome was AKI within 7 days after surgery. The secondary outcomes included ICU admission, in-hospital mortality, length of hospitalisation, intraoperative bradycardia, and hypotension. The exposure of interest was continuous intraoperative infusion of dexmedetomidine at any dosage or duration. Multivariable logistic regression and linear regression analyses were further used to adjust for residual imbalanced intraoperative factors in the matched cohort.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">After propensity score matching, we identified 1858/4091 paediatric patients who had received intraoperative dexmedetomidine infusion. Intraoperative dexmedetomidine infusion was associated with a lower risk of AKI (1.4% vs 3.2%; odds ratio 0.43, 95% confidence interval 0.27-0.66; P&lt;0.001), postoperative ICU admission (odds ratio 0.35, 95% confidence interval 0.30-0.42; P&lt;0.001), and shorter hospitalisation (7 [5-10] vs 9 [6-13] days; P&lt;0.001). Intraoperative bradycardia, hypotension, and in-hospital mortality were similar between the matched groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This retrospective analysis of a single-centre paediatric noncardiac surgery cohort suggests that intraoperative dexmedetomidine infusion was associated with a lower incidence of AKI within 7 days after surgery.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION" NlmCategory="BACKGROUND">ChiCTR2300069115.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Rong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, West China Hospital, Sichuan University, Chengdu, China; Laboratory of Anaesthesia and Critical Care Medicine, National-Local Joint Engineering Research Center of Translational Medicine of Anaesthesiology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Haibei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>Xiaoya</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Xiaojun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, West China Hospital, Sichuan University, Chengdu, China; Laboratory of Anaesthesia and Critical Care Medicine, National-Local Joint Engineering Research Center of Translational Medicine of Anaesthesiology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xuehan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuo</LastName><ForeName>Yunxia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, West China Hospital, Sichuan University, Chengdu, China. Electronic address: zuoyunxia@scu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006993">Hypnotics and Sedatives</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="Y">Dexmedetomidine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006993" MajorTopicYN="Y">Hypnotics and Sedatives</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="Y">Intraoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="Y">Surgical Procedures, Operative</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">dexmedetomidine</Keyword><Keyword MajorTopicYN="N">intraoperative dexmedetomidine</Keyword><Keyword MajorTopicYN="N">noncardiac surgery</Keyword><Keyword MajorTopicYN="N">paediatric patients</Keyword></KeywordList><CoiStatement>Declaration of interest The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>30</Day><Hour>0</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>13</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>12</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39668054</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2024.10.016</ArticleId><ArticleId IdType="pii">S0007-0912(24)00647-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38383166</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1883</ISSN><JournalIssue CitedMedium="Internet"><Volume>232</Volume><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>American journal of surgery</Title><ISOAbbreviation>Am J Surg</ISOAbbreviation></Journal><ArticleTitle>Intraoperative hypotension and postoperative acute kidney injury: A systematic review.</ArticleTitle><Pagination><StartPage>45</StartPage><EndPage>53</EndPage><MedlinePgn>45-53</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amjsurg.2024.02.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0002-9610(24)00062-X</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There is no consensus regarding safe intraoperative blood pressure thresholds that protect against postoperative acute kidney injury (AKI). This review aims to examine the existing literature to delineate safe intraoperative hypotension (IOH) parameters to prevent postoperative AKI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed, Cochrane Central, and Web of Science were systematically searched for articles published between 2015 and 2022 relating the effects of IOH on postoperative AKI.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our search yielded 19 articles. IOH risk thresholds ranged from &lt;50 to &lt;75&#xa0;&#x200b;mmHg for mean arterial pressure (MAP) and from &lt;70 to &lt;100&#xa0;&#x200b;mmHg for systolic blood pressure (SBP). MAP below 65&#xa0;&#x200b;mmHg for over 5&#xa0;&#x200b;min was the most cited threshold (N&#xa0;&#x200b;=&#xa0;&#x200b;13) consistently associated with increased postoperative AKI. Greater magnitude and duration of MAP and SBP below the thresholds were generally associated with a dose-dependent increase in postoperative AKI incidence.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">While a consistent definition for IOH remains elusive, the evidence suggests that MAP below 65&#xa0;&#x200b;mmHg for over 5&#xa0;&#x200b;min is strongly associated with postoperative AKI, with the risk increasing with the magnitude and duration of IOH.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Penev</LastName><ForeName>Yordan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Florida, Gainesville, FL, USA; Intelligent Clinical Care Center, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruppert</LastName><ForeName>Matthew M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Florida, Gainesville, FL, USA; Intelligent Clinical Care Center, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bilgili</LastName><ForeName>Ahmet</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Florida, Gainesville, FL, USA; Intelligent Clinical Care Center, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Youlei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Habib</LastName><ForeName>Raiya</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dozic</LastName><ForeName>Abdul-Vehab</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Small</LastName><ForeName>Coulter</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Intelligent Clinical Care Center, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adiyeke</LastName><ForeName>Esra</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Intelligent Clinical Care Center, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ozrazgat-Baslanti</LastName><ForeName>Tezcan</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Intelligent Clinical Care Center, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loftus</LastName><ForeName>Tyler J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Florida, Gainesville, FL, USA; Intelligent Clinical Care Center, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giordano</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bihorac</LastName><ForeName>Azra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Florida, Gainesville, FL, USA; Intelligent Clinical Care Center, University of Florida, Gainesville, FL, USA. Electronic address: abihorac@ufl.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Surg</MedlineTA><NlmUniqueID>0370473</NlmUniqueID><ISSNLinking>0002-9610</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="Y">Intraoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AKI</Keyword><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Intraoperative hemodynamics</Keyword><Keyword MajorTopicYN="N">Intraoperative hypotension</Keyword><Keyword MajorTopicYN="N">Postoperative complications</Keyword><Keyword MajorTopicYN="N">Surgery complications</Keyword></KeywordList><CoiStatement>Declaration of competing interest This work is supported by NIH/NIGMS RO1 GM-110240 (MR, AB), Davis Foundation &#x2013; University of Florida (MR), NIH/NIGMS P50 GM111152 (AB), and NIH/NIBIB 1R21EB027344-01 (AB). The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>14</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>22</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>21</Day><Hour>21</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38383166</ArticleId><ArticleId IdType="doi">10.1016/j.amjsurg.2024.02.001</ArticleId><ArticleId IdType="pii">S0002-9610(24)00062-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25445101</PMID><DateCompleted><Year>2015</Year><Month>03</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1523-6838</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>2</Issue><PubDate><Year>2015</Year><Month>Feb</Month></PubDate></JournalIssue><Title>American journal of kidney diseases : the official journal of the National Kidney Foundation</Title><ISOAbbreviation>Am J Kidney Dis</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury and prognosis after cardiopulmonary bypass: a meta-analysis of cohort studies.</ArticleTitle><Pagination><StartPage>283</StartPage><EndPage>293</EndPage><MedlinePgn>283-93</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.ajkd.2014.09.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0272-6386(14)01252-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Robust estimates and sources of variation in risks of clinical outcomes for cardiopulmonary bypass (CPB)-associated acute kidney injury (AKI) are needed to inform clinical practice and policy. We aimed to assess whether the methods for defining acute kidney disease modify the estimated association of AKI with CPB.</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Systematic review and meta-analysis.</AbstractText><AbstractText Label="SETTING &amp; POPULATION" NlmCategory="METHODS">Adults undergoing CPB.</AbstractText><AbstractText Label="SELECTION CRITERIA FOR STUDIES" NlmCategory="METHODS">Cohort studies reporting adjusted associations between CPB-associated AKI and early mortality, later mortality, stroke, myocardial infarction, congestive heart failure, all-cause hospitalization, chronic kidney disease, end-stage kidney disease, bleeding complications, or perioperative infection.</AbstractText><AbstractText Label="PREDICTORS" NlmCategory="METHODS">CPB-associated AKI and renal replacement therapy.</AbstractText><AbstractText Label="OUTCOMES" NlmCategory="RESULTS">The primary outcome was early mortality (in-hospital or within 90 days of surgery) in studies reporting adjusted associations and secondary outcomes including total and cardiovascular mortality, major adverse cardiovascular events, rehospitalization, end-stage kidney disease, bleeding, and perioperative infection.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">46 studies with 47 unique cohorts comprising 242,388 participants were included. The pooled rate of CPB-associated AKI was 18.2%, and of renal replacement therapy, 2.1%. CPB-associated AKI was associated with early mortality (risk ratio [RR], 4.0; 95% CI, 3.1-5.2; crude mortality with CPB-associated AKI, 4.6%; without CPB-AKI, 1.5%) with considerable heterogeneity between studies (I(2)=87%). The AKI definition did not modify prognostic estimates (P for subgroup analysis&#xa0;= 0.9). When heterogeneity was fully accounted for using credibility ceilings, risks of early mortality were attenuated (RR, 2.2; 95% CI, 1.8-2.8) but remained high. Renal replacement therapy also was associated with early mortality (RR, 5.3; 95% CI, 3.4-8.1). CPB-associated AKI also was associated with long-term mortality (RR, 2.0; 95% CI, 1.7-2.3) and stroke (RR, 2.2; 95% CI, 1.1-4.5). No other outcomes were reported in more than 3 studies.</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Unclear attrition from follow-up in most studies and variable adjustment for confounders across studies.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">CPB-associated AKI is associated with a more than 2-fold increase in early mortality regardless of AKI definition.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pickering</LastName><ForeName>John W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand. Electronic address: john.pickering@otago.ac.nz.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>James</LastName><ForeName>Matthew T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palmer</LastName><ForeName>Suetonia C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Kidney Dis</MedlineTA><NlmUniqueID>8110075</NlmUniqueID><ISSNLinking>0272-6386</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiopulmonary bypass (CBP)</Keyword><Keyword MajorTopicYN="N">acute kidney injury (AKI)</Keyword><Keyword MajorTopicYN="N">acute renal failure (ARF)</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">coronary artery bypass graft</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">stroke</Keyword><Keyword MajorTopicYN="N">valve surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25445101</ArticleId><ArticleId IdType="doi">10.1053/j.ajkd.2014.09.008</ArticleId><ArticleId IdType="pii">S0272-6386(14)01252-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40185666</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>134</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>May</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Remote ischaemic preconditioning and survival in noncardiac surgery: a meta-analysis of randomised trials.</ArticleTitle><Pagination><StartPage>1373</StartPage><EndPage>1384</EndPage><MedlinePgn>1373-1384</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2025.02.023</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(25)00144-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Remote ischaemic preconditioning (RIPC) is an intervention involving brief periods of limb ischaemia to protect remote organs from subsequent ischaemic injury. Although evidence exists on the beneficial effects of RIPC on biomarkers, its effect on survival is unknown. We performed a meta-analysis of randomised controlled trials (RCTs) to evaluate whether RIPC improves survival in noncardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched several electronic databases for randomised trials comparing RIPC vs a control group in adult noncardiac surgical settings. The primary outcome was mortality at the longest follow-up available. We conducted a random-effects meta-analysis to calculate the risk ratio (RR) and 95% confidence intervals (CIs). Bayesian statistics were used to estimate the probability of mortality benefit (RR &lt;1).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 72 RCTs, which included 7457 subjects. Mortality was reported in 28 RCTs and was lower in the RIPC group compared with the control group (88/2122 [4.1%] vs 102/1767 [5.8%]; RR 0.74, 95% CI 0.57-0.98, P=0.03; I<sup>2</sup>=0%; moderate certainty; number needed to treat&#xa0;= 67), corresponding to a 97.0% probability of any reduction in mortality. RIPC was also associated with a reduced incidence of postoperative stroke (moderate certainty) and with a shorter duration of hospital stay (low certainty).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Remote ischaemic preconditioning was associated with improved survival and reduced postoperative stroke and hospital stay in noncardiac surgery. These findings warrant careful considerations of the benefits of RIPC and support the need for a large, multicentre RCT to confirm these promising results.</AbstractText><AbstractText Label="SYSTEMATIC REVIEW PROTOCOL" NlmCategory="UNASSIGNED">CRD42024588358 (PROSPERO).</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fresilli</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Labanca</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turi</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casuale</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vietri</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lombardi</LastName><ForeName>Gaetano</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Covello</LastName><ForeName>Remo Daniel</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Unit, Emergency Department, Busto Arsizio Hospital, ASST Valle Olona, Busto Arsizio, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Todd Campbell</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy; School of Medicine, Vita-Salute San Raffaele University, Milan, Italy. Electronic address: landoni.giovanni@hsr.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greco</LastName><ForeName>Massimiliano</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy; Department of Anesthesiology and Intensive Care, IRCCS Humanitas Research Hospital, Rozzano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>RIPC group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019194" MajorTopicYN="Y">Ischemic Preconditioning</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="Y">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">anaesthesia</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">noncardiac surgery</Keyword><Keyword MajorTopicYN="N">organ protection</Keyword><Keyword MajorTopicYN="N">remote ischaemic preconditioning (RIPC)</Keyword></KeywordList><CoiStatement>Declaration of interest The authors declare that they have no conflict of interest.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Lembo</LastName><ForeName>Rosalba</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Giardina</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nakhnoukh</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Oliva</LastName><ForeName>Federico Mattia</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pontillo</LastName><ForeName>Domenico</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Brusasco</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Anaesthesia and Intensive Care Unit, E.O. Ospedali Galliera, Genoa, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Roasio</LastName><ForeName>Agostino</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Anaesthesia and Intensive Care Unit, Cardinal Massaia Hospital, Asti, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Konkayev</LastName><ForeName>Aidos</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Astana Medical University, Astana, Kazakhstan; National Scientific Center of Traumatology and Orthopedia named acad NBatpenov, Astana Medical University, Astana, Kazakhstan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lei</LastName><ForeName>Chong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Perioperative Medicine, Xijing Hospital, Xi'an, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Yavorovskiy</LastName><ForeName>Andrey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care, I.M. Sechenov First Moscow State Medical University of the Russian Ministry of Health, Moscow, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Likhvantsev</LastName><ForeName>Valery</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>V. Negovsky Reanimatology Research Institute, Moscow, Russia.</Affiliation></AffiliationInfo></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>1</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>5</Day><Hour>15</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>4</Day><Hour>21</Hour><Minute>59</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40185666</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2025.02.023</ArticleId><ArticleId IdType="pii">S0007-0912(25)00144-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31078413</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>06</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2165</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Jul</Month></PubDate></JournalIssue><Title>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</Title><ISOAbbreviation>Eur J Vasc Endovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Mannitol for the Prevention of Peri-Operative Acute Kidney Injury: A&#xa0;Systematic Review.</ArticleTitle><Pagination><StartPage>130</StartPage><EndPage>140</EndPage><MedlinePgn>130-140</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejvs.2019.02.003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1078-5884(19)30100-5</ELocationID><Abstract><AbstractText Label="OBJECTIVE/BACKGROUND" NlmCategory="OBJECTIVE">Post-operative acute kidney injury (AKI) is a frequent peri-operative complication that negatively affects morbidity and mortality. Mannitol is frequently used peri-operatively for renal protection, although evidence for its use is ambiguous. A systematic review was conducted to clarify whether there is evidence supporting peri-operative mannitol administration for the prevention of post-operative AKI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic literature search was performed in MEDLINE/Pubmed, Embase, the Cochrane Library, Clinical Trials registry, and the Cochrane Central Register of Controlled Trials (CENTRAL). Eligibility criteria were (i) population (studies involving adult patients undergoing surgery or a related intervention); (ii) intervention (intravenous mannitol administered in either the pre- or intra-operative period with comparison to controls); and (iii) predefined outcomes (post-operative AKI or respective renal end points/surrogates).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 1,538 articles published between January 1990 and October 2018 were identified. After checking for eligibility, 22 studies, including 17 prospective and/or randomised controlled trials and five retrospective studies, were included. The investigations involved various fields of surgery, such as aortic surgery, cardiac surgery with cardiopulmonary bypass, and urological procedures, including partial nephrectomy. Significant heterogeneity, limited sample size, and mostly short follow up periods were noted.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Given the available evidence, the peri-operative use of mannitol to prevent AKI cannot be considered an evidence based intervention in cardiac surgery, partial nephrectomy, and/or other major surgery. Further research is required with a focus on patients at high risk of post-operative AKI.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Waskowski</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Department of Anaesthesiology and Pain Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address: jan.waskowski@insel.ch.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfortmueller</LastName><ForeName>Carmen A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erdoes</LastName><ForeName>Gabor</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Pain Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buehlmann</LastName><ForeName>Roman</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messmer</LastName><ForeName>Anna S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luedi</LastName><ForeName>Markus M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Pain Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidli</LastName><ForeName>J&#xfc;rg</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schefold</LastName><ForeName>Joerg C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Vasc Endovasc Surg</MedlineTA><NlmUniqueID>9512728</NlmUniqueID><ISSNLinking>1078-5884</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004234">Diuretics, Osmotic</NameOfSubstance></Chemical><Chemical><RegistryNumber>3OWL53L36A</RegistryNumber><NameOfSubstance UI="D008353">Mannitol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004234" MajorTopicYN="N">Diuretics, Osmotic</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008353" MajorTopicYN="N">Mannitol</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009392" MajorTopicYN="N">Nephrectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AKI</Keyword><Keyword MajorTopicYN="N">AKI prevention</Keyword><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Aortic surgery</Keyword><Keyword MajorTopicYN="N">Mannitol</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31078413</ArticleId><ArticleId IdType="doi">10.1016/j.ejvs.2019.02.003</ArticleId><ArticleId IdType="pii">S1078-5884(19)30100-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38599161</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Processed electroencephalography-guided general anesthesia and norepinephrine requirements: A randomized trial in patients having vascular surgery.</ArticleTitle><Pagination><StartPage>111459</StartPage><MedlinePgn>111459</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2024.111459</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(24)00088-6</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVE">Processed electroencephalography (pEEG) may help clinicians optimize depth of general anesthesia. Avoiding excessive depth of anesthesia may reduce intraoperative hypotension and the need for vasopressors. We tested the hypothesis that pEEG-guided - compared to non-pEEG-guided - general anesthesia reduces the amount of norepinephrine needed to keep intraoperative mean arterial pressure above 65&#xa0;mmHg in patients having vascular surgery.</AbstractText><AbstractText Label="DESIGN">Randomized controlled clinical trial.</AbstractText><AbstractText Label="SETTING">University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</AbstractText><AbstractText Label="PATIENTS">110 patients having vascular surgery.</AbstractText><AbstractText Label="INTERVENTIONS">pEEG-guided general anesthesia.</AbstractText><AbstractText Label="MEASUREMENTS">Our primary endpoint was the average norepinephrine infusion rate from the beginning of induction of anesthesia until the end of surgery.</AbstractText><AbstractText Label="MAIN RESULT">96 patients were analyzed. The mean&#xa0;&#xb1;&#xa0;standard deviation average norepinephrine infusion rate was 0.08&#xa0;&#xb1;&#xa0;0.04&#xa0;&#x3bc;g&#xa0;kg<sup>-1</sup>&#xa0;min<sup>-1</sup> in patients assigned to pEEG-guided and 0.12&#xa0;&#xb1;&#xa0;0.09&#xa0;&#x3bc;g&#xa0;kg<sup>-1</sup>&#xa0;min<sup>-1</sup> in patients assigned to non-pEEG-guided general anesthesia (mean difference 0.04&#xa0;&#x3bc;g&#xa0;kg<sup>-1</sup>&#xa0;min<sup>-1</sup>, 95% confidence interval 0.01 to 0.07&#xa0;&#x3bc;g&#xa0;kg<sup>-1</sup>&#xa0;min<sup>-1</sup>, p&#xa0;=&#xa0;0.004). Patients assigned to pEEG-guided versus non-pEEG-guided general anesthesia, had a median time-weighted minimum alveolar concentration of 0.7 (0.6, 0.8) versus 0.8 (0.7, 0.8) (p&#xa0;=&#xa0;0.006) and a median percentage of time Patient State Index was &lt;25 of 12 (1, 41) % versus 23 (3, 49) % (p&#xa0;=&#xa0;0.279).</AbstractText><AbstractText Label="CONCLUSION">pEEG-guided - compared to non-pEEG-guided - general anesthesia reduced the amount of norepinephrine needed to keep mean arterial pressure above 65&#xa0;mmHg by about a third in patients having vascular surgery. Whether reduced intraoperative norepinephrine requirements resulting from pEEG-guided general anesthesia translate into improved patient-centered outcomes remains to be determined in larger trials.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thomsen</LastName><ForeName>Kristen K</ForeName><Initials>KK</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: science.thomsen@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>OutcomesResearch Consortium, Department of Anesthesiology, Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krause</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoppe</LastName><ForeName>Phillip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Opitz</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kessler</LastName><ForeName>Till</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chindris</LastName><ForeName>Viorel</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bergholz</LastName><ForeName>Alina</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flick</LastName><ForeName>Moritz</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kouz</LastName><ForeName>Karim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; OutcomesResearch Consortium, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Z&#xf6;llner</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulte-Uentrop</LastName><ForeName>Leonie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saugel</LastName><ForeName>Bernd</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; OutcomesResearch Consortium, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05293288</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber><NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009638" MajorTopicYN="Y">Norepinephrine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004569" MajorTopicYN="Y">Electroencephalography</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014656" MajorTopicYN="Y">Vascular Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="Y">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062186" MajorTopicYN="N">Arterial Pressure</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="N">Monitoring, Intraoperative</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Anesthesia</Keyword><Keyword MajorTopicYN="N">Blood pressure</Keyword><Keyword MajorTopicYN="N">Electroencephalography</Keyword><Keyword MajorTopicYN="N">Hemodynamic monitoring</Keyword><Keyword MajorTopicYN="N">Hypotension</Keyword><Keyword MajorTopicYN="N">Patient state index</Keyword><Keyword MajorTopicYN="N">Vasopressor</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: KKT has no conflicts of interest to declare. DIS has received research funding from Edwards Lifesciences; he also is an advisor and has equity interest in Perceptive Medical (Newport Beach, CA, USA). LK has no conflicts of interest to declare. PH has no conflicts of interest to declare. BO has no conflicts of interest to declare. TK has no conflicts of interest to declare. VC has no conflicts of interest to declare. AB has no conflicts of interest to declare. MF is a consultant for Edwards Lifesciences (Irvine, CA, USA) and has received honoraria for consulting and giving lectures from CNSystems Medizintechnik (Graz, Austria). KK is a consultant for and has received honoraria for giving lectures from Edwards Lifesciences (Irvine, CA, USA). KK is a consultand for Vygon (Aachen, Germany). CZ has no conflict of interest to declare. LS-U has no conflicts of interest to declare. BS has received honoraria for giving lectures from Masimo (Neuch&#xe2;tel, Switzerland). BS is a consultant for and has received institutional restricted research grants and honoraria for giving lectures from Edwards Lifesciences (Irvine, CA, USA). BS is a consultant for Philips North America (Cambridge, MA, USA) and has received honoraria for giving lectures from Philips Medizin Systeme B&#xf6;blingen (B&#xf6;blingen, Germany). BS has received institutional restricted research grants and honoraria for giving lectures from Baxter (Deerfield, IL, USA). BS is a consultant for and has received institutional restricted research grants and honoraria for giving lectures from GE Healthcare (Chicago, IL, USA). BS has received institutional restricted research grants and honoraria for giving lectures from CNSystems Medizintechnik (Graz, Austria). BS is a consultant for Maquet Critical Care (Solna, Sweden). BS has received honoraria for giving lectures from Getinge (Gothenburg, Sweden). BS is a consultant for and has received institutional restricted research grants and honoraria for giving lectures from Pulsion Medical Systems (Feldkirchen, Germany). BS is a consultant for and has received institutional restricted research grants and honoraria for giving lectures from Vygon (Aachen, Germany). BS is a consultant for and has received institutional restricted research grants from Retia Medical (Valhalla, NY, USA). BS is a consultant for Dynocardia (Cambridge, MA, USA). BS has received institutional restricted research grants from Osypka Medical (Berlin, Germany). BS was a consultant for and has received institutional restricted research grants from Tensys Medical (San Diego, CA, USA). BS is an Editor of the British Journal of Anesthesia.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>28</Day><Hour>7</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>11</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>10</Day><Hour>18</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38599161</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2024.111459</ArticleId><ArticleId IdType="pii">S0952-8180(24)00088-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29203473</PMID><DateCompleted><Year>2019</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1533-3450</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of the American Society of Nephrology : JASN</Title><ISOAbbreviation>J Am Soc Nephrol</ISOAbbreviation></Journal><ArticleTitle>Perioperative THR-184 and AKI after Cardiac Surgery.</ArticleTitle><Pagination><StartPage>670</StartPage><EndPage>679</EndPage><MedlinePgn>670-679</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1681/ASN.2017020217</ELocationID><Abstract><AbstractText>AKI after cardiac surgery is associated with mortality, prolonged hospital length of stay, use of dialysis, and subsequent CKD. We evaluated the effects of THR-184, a bone morphogenetic protein-7 agonist, in patients at high risk for AKI after cardiac surgery. We conducted a randomized, double-blind, placebo-controlled, multidose comparison of the safety and efficacy of perioperative THR-184 using a two-stage seamless adaptive design in 452 patients between 18 and 85 years of age who were scheduled for nonemergent cardiac surgery requiring cardiopulmonary bypass and had recognized risk factors for AKI. The primary efficacy end point was the proportion of patients who developed AKI according to Kidney Disease Improving Global Outcomes (KDIGO) criteria. The proportion of patients who developed AKI within 7 days of surgery was similar in THR-184 treatment groups and placebo groups (range, 74%-79%; <i>P</i>=0.43). Prespecified secondary end point analysis did not show significant differences in the severity of AKI stage (<i>P</i>=0.53) or the total duration of AKI (<i>P</i>=0.44). A composite of death, dialysis, or sustained impaired renal function by day 30 after surgery did not differ between groups (range, 11%-20%; <i>P</i>=0.46). Safety-related outcomes were similar across all treatment groups. In conclusion, compared with placebo, administration of perioperative THR-184 through a range of dose exposures failed to reduce the incidence, severity, or duration of AKI after cardiac surgery in high-risk patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 by the American Society of Nephrology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Himmelfarb</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine, Kidney Research Institute, University of Washington, Seattle, Washington; Jhimmelfarb@nephrology.washington.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chertow</LastName><ForeName>Glenn M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>School of Medicine, Stanford University, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCullough</LastName><ForeName>Peter A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Baylor University Medical Center, Dallas, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mesana</LastName><ForeName>Thierry</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University of Ottawa Heart Institute, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Andrew D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sundt</LastName><ForeName>Thoralf M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Craig</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, New Brunswick Heart Centre, Saint John, New Brunswick, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cortville</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Cardiac and Vascular Research Center, McLaren Northern Michigan, Petoskey, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dagenais</LastName><ForeName>Fran&#xe7;ois</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Institut Universitaire de Cardiologie et de Pneumologie, Quebec City, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Varennes</LastName><ForeName>Benoit</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Surgery, McGill University Health Centre, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fontes</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Yale University School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossert</LastName><ForeName>Jerome</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Thrasos Therapeutics, Inc., Boston, Massachusetts; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tardif</LastName><ForeName>Jean-Claude</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Medicine, Montreal Heart Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001863</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000076362">Adaptive Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Soc Nephrol</MedlineTA><NlmUniqueID>9013836</NlmUniqueID><ISSNLinking>1046-6673</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C525819">BMP7 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D055419">Bone Morphogenetic Protein 7</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009842">Oligopeptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000632227">THR-184</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055419" MajorTopicYN="N">Bone Morphogenetic Protein 7</DescriptorName><QualifierName UI="Q000819" MajorTopicYN="Y">agonists</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009842" MajorTopicYN="N">Oligopeptides</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059035" MajorTopicYN="N">Perioperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017211" MajorTopicYN="N">Treatment Failure</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute renal failure</Keyword><Keyword MajorTopicYN="N">bone morphogenetic protein</Keyword><Keyword MajorTopicYN="N">randomized controlled trials</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29203473</ArticleId><ArticleId IdType="pmc">PMC5791058</ArticleId><ArticleId IdType="doi">10.1681/ASN.2017020217</ArticleId><ArticleId IdType="pii">ASN.2017020217</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bellomo R, Kellum JA, Ronco C: Acute kidney injury. Lancet 380: 756&#x2013;766, 2012</Citation><ArticleIdList><ArticleId IdType="pubmed">22617274</ArticleId></ArticleIdList></Reference><Reference><Citation>Chawla LS, Eggers PW, Star RA, Kimmel PL: Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 371: 58&#x2013;66, 2014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9720902</ArticleId><ArticleId IdType="pubmed">24988558</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu CY, McCulloch CE, Fan D, Ordo&#xf1;ez JD, Chertow GM, Go AS: Community-based incidence of acute renal failure. Kidney Int 72: 208&#x2013;212, 2007</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2673495</ArticleId><ArticleId IdType="pubmed">17507907</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiele RH, Isbell JM, Rosner MH: AKI associated with cardiac surgery. Clin J Am Soc Nephrol 10: 500&#x2013;514, 2015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4348689</ArticleId><ArticleId IdType="pubmed">25376763</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators : Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA 294: 813&#x2013;818, 2005</Citation><ArticleIdList><ArticleId IdType="pubmed">16106006</ArticleId></ArticleIdList></Reference><Reference><Citation>McCullough PA, Bennett-Guerrero E, Chawla LS, Beaver T, Mehta RL, Molitoris BA, Eldred A, Ball G, Lee HJ, Houser MT, Khan S: ABT-719 for the prevention of acute kidney injury in patients undergoing high-risk cardiac surgery: A randomized phase 2b clinical trial. J Am Heart Assoc 5: e003549, 2016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5015281</ArticleId><ArticleId IdType="pubmed">27543797</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase M, Bellomo R, Matalanis G, Calzavacca P, Dragun D, Haase-Fielitz A: A comparison of the RIFLE and Acute Kidney Injury Network classifications for cardiac surgery-associated acute kidney injury: A prospective cohort study. J Thorac Cardiovasc Surg 138: 1370&#x2013;1376, 2009</Citation><ArticleIdList><ArticleId IdType="pubmed">19733864</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuitunen A, Vento A, Suojaranta-Ylinen R, Pettil&#xe4; V: Acute renal failure after cardiac surgery: Evaluation of the RIFLE classification. Ann Thorac Surg 81: 542&#x2013;546, 2006</Citation><ArticleIdList><ArticleId IdType="pubmed">16427848</ArticleId></ArticleIdList></Reference><Reference><Citation>Robert AM, Kramer RS, Dacey LJ, Charlesworth DC, Leavitt BJ, Helm RE, Hernandez F, Sardella GL, Frumiento C, Likosky DS, Brown JR; Northern New England Cardiovascular Disease Study Group : Cardiac surgery-associated acute kidney injury: A comparison of two consensus criteria. Ann Thorac Surg 90: 1939&#x2013;1943, 2010</Citation><ArticleIdList><ArticleId IdType="pubmed">21095340</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanardo G, Michielon P, Paccagnella A, Rosi P, Cal&#xf3; M, Salandin V, Da Ros A, Michieletto F, Simini G: Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg 107: 1489&#x2013;1495, 1994</Citation><ArticleIdList><ArticleId IdType="pubmed">8196394</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryd&#xe9;n L, Sartipy U, Evans M, Holzmann MJ: Acute kidney injury after coronary artery bypass grafting and long-term risk of end-stage renal disease. Circulation 130: 2005&#x2013;2011, 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">25239439</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng XM, Chung AC, Lan HY: Role of the TGF-&#x3b2;/BMP-7/Smad pathways in renal diseases. Clin Sci (Lond) 124: 243&#x2013;254, 2013</Citation><ArticleIdList><ArticleId IdType="pubmed">23126427</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D, Zhao M, Mundy GR: Bone morphogenetic proteins. Growth Factors 22: 233&#x2013;241, 2004</Citation><ArticleIdList><ArticleId IdType="pubmed">15621726</ArticleId></ArticleIdList></Reference><Reference><Citation>Vukicevic S, Basic V, Rogic D, Basic N, Shih MS, Shepard A, Jin D, Dattatreyamurty B, Jones W, Dorai H, Ryan S, Griffiths D, Maliakal J, Jelic M, Pastorcic M, Stavljenic A, Sampath TK: Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. J Clin Invest 102: 202&#x2013;214, 1998</Citation><ArticleIdList><ArticleId IdType="pmc">PMC509082</ArticleId><ArticleId IdType="pubmed">9649574</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould SE, Day M, Jones SS, Dorai H: BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int 61: 51&#x2013;60, 2002</Citation><ArticleIdList><ArticleId IdType="pubmed">11786084</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffith DL, Keck PC, Sampath TK, Rueger DC, Carlson WD: Three-dimensional structure of recombinant human osteogenic protein 1: Structural paradigm for the transforming growth factor beta superfamily. Proc Natl Acad Sci U S A 93: 878&#x2013;883, 1996</Citation><ArticleIdList><ArticleId IdType="pmc">PMC40151</ArticleId><ArticleId IdType="pubmed">8570652</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugimoto H, LeBleu VS, Bosukonda D, Keck P, Taduri G, Bechtel W, Okada H, Carlson W Jr, Bey P, Rusckowski M, Tampe B, Tampe D, Kanasaki K, Zeisberg M, Kalluri R: Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis. Nat Med 18: 396&#x2013;404, 2012</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3998727</ArticleId><ArticleId IdType="pubmed">22306733</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeisberg M, Bottiglio C, Kumar N, Maeshima Y, Strutz F, M&#xfc;ller GA, Kalluri R: Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol Renal Physiol 285: F1060&#x2013;F1067, 2003</Citation><ArticleIdList><ArticleId IdType="pubmed">12915382</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R: BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9: 964&#x2013;968, 2003</Citation><ArticleIdList><ArticleId IdType="pubmed">12808448</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob KA, Leaf DE, Dieleman JM, van Dijk D, Nierich AP, Rosseel PM, van der Maaten JM, Hofland J, Diephuis JC, de Lange F, Boer C, Kluin J, Waikar SS; Dexamethasone for Cardiac Surgery (DECS) Study Group : Intraoperative high-dose dexamethasone and severe AKI after cardiac surgery. J Am Soc Nephrol 26: 2947&#x2013;2951, 2015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4657835</ArticleId><ArticleId IdType="pubmed">25952257</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FT IV, Hendricks PA, Schildcrout JS, Shi Y, Petracek MR, Byrne JG, Brown NJ: High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: A randomized clinical trial. JAMA 315: 877&#x2013;888, 2016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4843765</ArticleId><ArticleId IdType="pubmed">26906014</ArticleId></ArticleIdList></Reference><Reference><Citation>ClinicalTrials.gov: A Study to Evaluate the Safety and Efficacy of AC607 for the Treatment of Kidney Injury in Cardiac Surgery Subjects (ACT-AKI). NCT01602328. 2012, 2016. Available at: http://clinicaltrials.gov/ct2/show/NCT01602328. Accessed August 8, 2016</Citation></Reference><Reference><Citation>Choi YS, Shim JK, Kim JC, Kang KS, Seo YH, Ahn KR, Kwak YL: Effect of remote ischemic preconditioning on renal dysfunction after complex valvular heart surgery: A randomized controlled trial. J Thorac Cardiovasc Surg 142: 148&#x2013;154, 2011</Citation><ArticleIdList><ArticleId IdType="pubmed">21272897</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher SM, Jones DA, Kapur A, Wragg A, Harwood SM, Mathur R, Archbold RA, Uppal R, Yaqoob MM: Remote ischemic preconditioning has a neutral effect on the incidence of kidney injury after coronary artery bypass graft surgery. Kidney Int 87: 473&#x2013;481, 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">25075773</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmerman RF, Ezeanuna PU, Kane JC, Cleland CD, Kempananjappa TJ, Lucas FL, Kramer RS: Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery. Kidney Int 80: 861&#x2013;867, 2011</Citation><ArticleIdList><ArticleId IdType="pubmed">21677633</ArticleId></ArticleIdList></Reference><Reference><Citation>Meybohm P, Bein B, Brosteanu O, Cremer J, Gruenewald M, Stoppe C, Coburn M, Schaelte G, B&#xf6;ning A, Niemann B, Roesner J, Kletzin F, Strouhal U, Reyher C, Laufenberg-Feldmann R, Ferner M, Brandes IF, Bauer M, Stehr SN, Kortgen A, Wittmann M, Baumgarten G, Meyer-Treschan T, Kienbaum P, Heringlake M, Sch&#xf6;n J, Sander M, Treskatsch S, Smul T, Wolwender E, Schilling T, Fuernau G, Hasenclever D, Zacharowski K; RIPHeart Study Collaborators : A multicenter trial of remote ischemic preconditioning for heart surgery. N Engl J Med 373: 1397&#x2013;1407, 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">26436208</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, O&#x2019;Brien PC, Johnson MG, Williams AR, Cutshall SM, Mundy LM, Rizza RA, McMahon MM: Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: A randomized trial. Ann Intern Med 146: 233&#x2013;243, 2007</Citation><ArticleIdList><ArticleId IdType="pubmed">17310047</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, Fukushima J, Kalil Filho R, Sierra DB, Lopes NH, Mauad T, Roquim AC, Sundin MR, Le&#xe3;o WC, Almeida JP, Pomerantzeff PM, Dallan LO, Jatene FB, Stolf NA, Auler JO Jr.: Transfusion requirements after cardiac surgery: The TRACS randomized controlled trial. JAMA 304: 1559&#x2013;1567, 2010</Citation><ArticleIdList><ArticleId IdType="pubmed">20940381</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow SC, Corey R: Benefits, challenges and obstacles of adaptive clinical trial designs. Orphanet J Rare Dis 6: 79, 2011</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3248853</ArticleId><ArticleId IdType="pubmed">22129361</ArticleId></ArticleIdList></Reference><Reference><Citation>Coffey CS, Levin B, Clark C, Timmerman C, Wittes J, Gilbert P, Harris S: Overview, hurdles, and future work in adaptive designs: Perspectives from a National Institutes of Health-funded workshop. Clin Trials 9: 671&#x2013;680, 2012</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5570450</ArticleId><ArticleId IdType="pubmed">23250942</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt DL, Mehta C: Adaptive designs for clinical trials. N Engl J Med 375: 65&#x2013;74, 2016</Citation><ArticleIdList><ArticleId IdType="pubmed">27406349</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group : KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2: 1&#x2013;138, 2012</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36512724</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>138</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Postoperative Acute Kidney Injury by Age and Sex: A Retrospective Cohort Association Study.</ArticleTitle><Pagination><StartPage>184</StartPage><EndPage>194</EndPage><MedlinePgn>184-194</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0000000000004436</ELocationID><Abstract><AbstractText Label="BACKGROUND">Acute kidney injury (AKI) after noncardiac surgery is common and has substantial health impact. Preclinical and clinical studies examining the influence of sex on AKI have yielded conflicting results, although they typically do not account for age-related changes. The objective of the study was to determine the association of age and sex groups on postoperative AKI. The authors hypothesized that younger females would display lower risk of postoperative AKI than males of similar age, and the protection would be lost in older females.</AbstractText><AbstractText Label="METHODS">This was a multicenter retrospective cohort study across 46 institutions between 2013 and 2019. Participants included adult inpatients without pre-existing end-stage kidney disease undergoing index major noncardiac, nonkidney/urologic surgeries. The authors' primary exposure was age and sex groups defined as females 50 yr or younger, females older than 50 yr, males 50 yr or younger, and males older than 50 yr. The authors' primary outcome was development of AKI by Kidney Disease-Improving Global Outcomes serum creatinine criteria. Exploratory analyses included associations of ascending age groups and hormone replacement therapy home medications with postoperative AKI.</AbstractText><AbstractText Label="RESULTS">Among 390,382 patients, 25,809 (6.6%) developed postoperative AKI (females 50 yr or younger: 2,190 of 58,585 [3.7%]; females older than 50 yr: 9,320 of 14,4047 [6.5%]; males 50 yr or younger: 3,289 of 55,503 [5.9%]; males older than 50 yr: 11,010 of 132,447 [8.3%]). When adjusted for AKI risk factors, compared to females younger than 50 yr (odds ratio, 1), the odds of AKI were higher in females older than 50 yr (odds ratio, 1.51; 95% CI, 1.43 to 1.59), males younger than 50 yr (odds ratio, 1.90; 95% CI, 1.79 to 2.01), and males older than 50 yr (odds ratio, 2.06; 95% CI, 1.96 to 2.17).</AbstractText><AbstractText Label="CONCLUSIONS">Younger females display a lower odds of postoperative AKI that gradually increases with age. These results suggest that age-related changes in women should be further studied as modifiers of postoperative AKI risk after noncardiac surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022, the American Society of Anesthesiologists. All Rights Reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Privratsky</LastName><ForeName>Jamie R</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0003-3598-4911</Identifier><AffiliationInfo><Affiliation>Critical Care and Perioperative Population Health Research Unit, Department of Anesthesiology, and Center for Perioperative Organ Protection, Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuller</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Population Health Research Unit, Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raghunathan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Population Health Research Unit, Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina; and Durham Veterans Administration Medical Center, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohnuma</LastName><ForeName>Tetsu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Population Health Research Unit, Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartz</LastName><ForeName>Raquel R</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Population Health Research Unit, Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schroeder</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Population Health Research Unit, Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina; and Durham Veterans Administration Medical Center, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Price</LastName><ForeName>Thomas M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Population Health Research Unit, Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sigurdsson</LastName><ForeName>Martin I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Division of Anesthesia and Intensive Care Medicine, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland; and University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathis</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Michigan, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naik</LastName><ForeName>Bhiken</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Virginia, Charlottesville, Virginia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krishnamoorthy</LastName><ForeName>Vijay</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Population Health Research Unit, Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K01 HL141701</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K08 GM132689</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK131065</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK133226</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007676" MajorTopicYN="Y">Kidney Failure, Chronic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Conflicts of Interest: The authors declare no competing interests. The authors report the following not related to the present manuscript: K08-GM132689 from NIH-NIGMS and R01-DK131065 from NIH-NIDDK (JRP); past financial relationship with American Board of Obstetrics (TMP); and K01-HL141701 from NIH-NHLBI and R01-DK133226 award from NIH-NIDDK (MRM).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>13</Day><Hour>15</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36512724</ArticleId><ArticleId IdType="mid">NIHMS1922848</ArticleId><ArticleId IdType="pmc">PMC10439699</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000004436</ArticleId><ArticleId IdType="pii">137235</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kork F, Balzer F, Spies CD, Wernecke KD, Ginde AA, Jankowski J, Eltzschig HK: Minor Postoperative Increases of Creatinine Are Associated with Higher Mortality and Longer Hospital Length of Stay in Surgical Patients. Anesthesiology 2015; 123: 1301&#x2013;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4679549</ArticleId><ArticleId IdType="pubmed">26492475</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor ME, Hewson RW, Kirwan CJ, Ackland GL, Pearse RM, Prowle JR: Acute kidney injury and mortality 1 year after major non-cardiac surgery. Br J Surg 2017; 104: 868&#x2013;876</Citation><ArticleIdList><ArticleId IdType="pubmed">28218392</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, Koyner JL, Hoste EAJ, Kellum JA: Update on Perioperative Acute Kidney Injury. Anesth Analg 2018; 127: 1236&#x2013;1245</Citation><ArticleIdList><ArticleId IdType="pubmed">30138176</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris DG, McCrone MP, Koo G, Weltz AS, Chiu WC, Scalea TM, Diaz JJ, Lissauer ME: Epidemiology and outcomes of acute kidney injury in critically ill surgical patients. J Crit Care 2015; 30: 102&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pubmed">25171816</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P, Hiesmayr M: Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 2004; 15: 1597&#x2013;605</Citation><ArticleIdList><ArticleId IdType="pubmed">15153571</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson CE, Yavas S, Segal MS, Schold JD, Tribble CG, Layon AJ, Bihorac A: Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation 2009; 119: 2444&#x2013;53</Citation><ArticleIdList><ArticleId IdType="pubmed">19398670</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA, Collins AJ: Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 2009; 20: 223&#x2013;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2615732</ArticleId><ArticleId IdType="pubmed">19020007</ArticleId></ArticleIdList></Reference><Reference><Citation>Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C-yY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296&#x2013;1305</Citation><ArticleIdList><ArticleId IdType="pubmed">15385656</ArticleId></ArticleIdList></Reference><Reference><Citation>Doi K, Rabb H: Impact of acute kidney injury on distant organ function: recent findings and potential therapeutic targets. Kidney Int 2016; 89: 555&#x2013;564</Citation><ArticleIdList><ArticleId IdType="pubmed">26880452</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, Honor&#xe9; PM, Joannes-Boyau O, Joannidis M, Korhonen A-MM, Lavrentieva A, Mehta RL, Palevsky P, Roessler E, Ronco C, Uchino S, Vazquez JA, Vidal Andrade E, Webb S, Kellum JA: Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 2015; 41: 1411&#x2013;1423</Citation><ArticleIdList><ArticleId IdType="pubmed">26162677</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson C, Lysak N, Huber M, Scali S, Bihorac A: Epidemiology, outcomes, and management of acute kidney injury in the vascular surgery patient. Journal of vascular surgery 2018; 68: 916&#x2013;928</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6236681</ArticleId><ArticleId IdType="pubmed">30146038</ArticleId></ArticleIdList></Reference><Reference><Citation>Loftus TJ, Bihorac A, Ozrazgat-Baslanti T, Jordan JR, Croft CA, Smith RS, Efron PA, Moore FA, Mohr AM, Brakenridge SC: Acute Kidney Injury Following Exploratory Laparotomy and Temporary Abdominal Closure. Shock (Augusta, Ga.) 2017; 48: 5&#x2013;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5468485</ArticleId><ArticleId IdType="pubmed">28009772</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaught AJ, Ozrazgat-Baslanti T, Javed A, Morgan L, Hobson CE, Bihorac A: Acute kidney injury in major gynaecological surgery: an observational study. BJOG : an international journal of obstetrics and gynaecology 2015; 122: 1340&#x2013;1348</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4334755</ArticleId><ArticleId IdType="pubmed">25134440</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis MR, Naik BI, Freundlich RE, Shanks AM, Heung M, Kim M, Burns ML, Colquhoun DA, Rangrass G, Janda A, Engoren MC, Saager L, Tremper KK, Kheterpal S, Aziz MF, Coffman T, Durieux ME, Levy WJ, Schonberger RB, Soto R, Wilczak J, Berman MF, Berris J, Biggs DA, Coles P, Craft RM, Cummings KC, Ellis TA 2nd, Fleishut PM, Helsten DL, Jameson LC, van Klei WA, Kooij F, LaGorio J, Lins S, Miller SA, Molina, Nair B, Paganelli WC, Peterson W, Tom S, Wanderer JP, Wedeven C, Multicenter Perioperative Outcomes Group I: Preoperative Risk and the Association between Hypotension and Postoperative Acute Kidney Injury. Anesthesiology 2020; 132: 461&#x2013;475</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7015776</ArticleId><ArticleId IdType="pubmed">31794513</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchens MP, Fujiyoshi T, Komers R, Herson PS, Anderson S: Estrogen protects renal endothelial barrier function from ischemia-reperfusion in vitro and in vivo. Am J Physiol Renal Physiol 2012; 303: F377&#x2013;85</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3774263</ArticleId><ArticleId IdType="pubmed">22622457</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang KP, Lee JE, Lee AS, Jung YJ, Kim D, Lee S, Hwang HP, Kim W, Park SK: Effect of gender differences on the regulation of renal ischemia-reperfusion-induced inflammation in mice. Mol Med Rep 2014; 9: 2061&#x2013;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4055478</ArticleId><ArticleId IdType="pubmed">24682292</ArticleId></ArticleIdList></Reference><Reference><Citation>Satake A, Takaoka M, Nishikawa M, Yuba M, Shibata Y, Okumura K, Kitano K, Tsutsui H, Fujii K, Kobuchi S, Ohkita M, Matsumura Y: Protective effect of 17beta-estradiol on ischemic acute renal failure through the PI3K/Akt/eNOS pathway. Kidney Int 2008; 73: 308&#x2013;17</Citation><ArticleIdList><ArticleId IdType="pubmed">18004295</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka R, Tsutsui H, Kobuchi S, Sugiura T, Yamagata M, Ohkita M, Takaoka M, Yukimura T, Matsumura Y: Protective effect of 17beta-estradiol on ischemic acute kidney injury through the renal sympathetic nervous system. Eur J Pharmacol 2012; 683: 270&#x2013;5</Citation><ArticleIdList><ArticleId IdType="pubmed">22426161</ArticleId></ArticleIdList></Reference><Reference><Citation>Kher A, Meldrum KK, Wang M, Tsai BM, Pitcher JM, Meldrum DR: Cellular and molecular mechanisms of sex differences in renal ischemia-reperfusion injury. Cardiovasc Res 2005; 67: 594&#x2013;603</Citation><ArticleIdList><ArticleId IdType="pubmed">15950202</ArticleId></ArticleIdList></Reference><Reference><Citation>Park KM, Kim JI, Ahn Y, Bonventre AJ, Bonventre JV: Testosterone is responsible for enhanced susceptibility of males to ischemic renal injury. J Biol Chem 2004; 279: 52282&#x2013;92</Citation><ArticleIdList><ArticleId IdType="pubmed">15358759</ArticleId></ArticleIdList></Reference><Reference><Citation>Palevsky PM, Liu KD, Brophy PD, Chawla LS, Parikh CR, Thakar CV, Tolwani AJ, Waikar SS, Weisbord SD: KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. American journal of kidney diseases : the official journal of the National Kidney Foundation 2013; 61: 649&#x2013;672</Citation><ArticleIdList><ArticleId IdType="pubmed">23499048</ArticleId></ArticleIdList></Reference><Reference><Citation>Neugarten J, Golestaneh L: Female sex reduces the risk of hospital-associated acute kidney injury: a meta-analysis. BMC Nephrol 2018; 19: 314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6225636</ArticleId><ArticleId IdType="pubmed">30409132</ArticleId></ArticleIdList></Reference><Reference><Citation>Colquhoun DA, Shanks AM, Kapeles SR, Shah N, Saager L, Vaughn MT, Buehler K, Burns ML, Tremper KK, Freundlich RE, Aziz M, Kheterpal S, Mathis MR: Considerations for Integration of Perioperative Electronic Health Records Across Institutions for Research and Quality Improvement: The Approach Taken by the Multicenter Perioperative Outcomes Group. Anesth Analg 2020; 130: 1133&#x2013;1146</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7663856</ArticleId><ArticleId IdType="pubmed">32287121</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Vaughn MT, Dubovoy TZ, Shah NJ, Bash LD, Colquhoun DA, Shanks AM, Mathis MR, Soto RG, Bardia A, Bartels K, McCormick PJ, Schonberger RB, Saager L: Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis. Anesthesiology 2020; 132: 1371&#x2013;1381</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7864000</ArticleId><ArticleId IdType="pubmed">32282427</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun E, Mello MM, Rishel CA, Vaughn MT, Kheterpal S, Saager L, Fleisher LA, Damrose EJ, Kadry B, Jena AB, Multicenter Perioperative Outcomes G: Association of Overlapping Surgery With Perioperative Outcomes. JAMA 2019; 321: 762&#x2013;772</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6439866</ArticleId><ArticleId IdType="pubmed">30806696</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G: A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004; 44: 1393&#x2013;9</Citation><ArticleIdList><ArticleId IdType="pubmed">15464318</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore RD, Smith CR, Lipsky JJ, Mellits ED, Lietman PS: Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med 1984; 100: 352&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pubmed">6364908</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon GM, Zeng X, Waikar SS: A risk prediction score for kidney failure or mortality in rhabdomyolysis. JAMA Intern Med 2013; 173: 1821&#x2013;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5152583</ArticleId><ArticleId IdType="pubmed">24000014</ArticleId></ArticleIdList></Reference><Reference><Citation>Neugarten J, Sandilya S, Singh B, Golestaneh L: Sex and the Risk of AKI Following Cardio-thoracic Surgery: A Meta-Analysis. Clin J Am Soc Nephrol 2016; 11: 2113&#x2013;2122</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5142065</ArticleId><ArticleId IdType="pubmed">27797892</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris DG, Koo G, McCrone MP, Weltz AS, Chiu WC, Sarkar R, Scalea TM, Diaz JJ, Lissauer ME, Crawford RS: Acute Kidney Injury in Critically Ill Vascular Surgery Patients is Common and Associated with Increased Mortality. Frontiers in surgery 2014; 2: 8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4353172</ArticleId><ArticleId IdType="pubmed">25806372</ArticleId></ArticleIdList></Reference><Reference><Citation>Neugarten J, Golestaneh L, Kolhe NV: Sex differences in acute kidney injury requiring dialysis. BMC Nephrol 2018; 19: 131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5994053</ArticleId><ArticleId IdType="pubmed">29884141</ArticleId></ArticleIdList></Reference><Reference><Citation>George RL, McGwin G Jr., Windham ST, Melton SM, Metzger J, Chaudry IH, Rue LW 3rd: Age-related gender differential in outcome after blunt or penetrating trauma. Shock 2003; 19: 28&#x2013;32</Citation><ArticleIdList><ArticleId IdType="pubmed">12558140</ArticleId></ArticleIdList></Reference><Reference><Citation>Zangrillo A, Morselli F, Biagioni E, Stella RD, Coloretti I, Moizo E, Plumari VP, Monti G, Borghi G, Salonia A, Almirante G, Maraggia D, Zambon M, Langiano N, Roasio A, Pasin L, Mucci M, Beccaria PF, Pasculli N, Redaelli MB, Pallanch O, Gallo G, Real G, Nava M, Venturelli S, Tosi M, Munari E, Visconti MG, Perno S, Girardis M, Landoni G: Sex-related mortality differences in young adult septic shock patients. Signa Vitae 2022; doi:10.22514/sv.2022.017</Citation><ArticleIdList><ArticleId IdType="doi">10.22514/sv.2022.017</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckenrode HE, Gutierrez OM, Osis G, Agarwal A, Curtis LM: Kidney Disease Prevalence in Transgender Individuals. Clin J Am Soc Nephrol 2021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8823938</ArticleId><ArticleId IdType="pubmed">34872973</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer KE, Riddle NC : Sex Differences in Aging: Genomic Instability. J Gerontol A Biol Sci Med Sci 2018; 73: 166&#x2013;174</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5861920</ArticleId><ArticleId IdType="pubmed">28575157</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagg S, Jylhava J: Sex differences in biological aging with a focus on human studies. Elife 2021; 10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8118651</ArticleId><ArticleId IdType="pubmed">33982659</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampathkumar NK, Bravo JI, Chen Y, Danthi PS, Donahue EK, Lai RW, Lu R, Randall LT, Vinson N, Benayoun BA: Widespread sex dimorphism in aging and age-related diseases. Hum Genet 2020; 139: 333&#x2013;356</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7031050</ArticleId><ArticleId IdType="pubmed">31677133</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33079777</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1473-5687</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>12</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>European journal of gastroenterology &amp; hepatology</Title><ISOAbbreviation>Eur J Gastroenterol Hepatol</ISOAbbreviation></Journal><ArticleTitle>Intraoperative systemic biomarkers predict post-liver transplantation acute kidney injury.</ArticleTitle><Pagination><StartPage>1556</StartPage><EndPage>1563</EndPage><MedlinePgn>1556-1563</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MEG.0000000000001892</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Liver transplant (LT) is a definitive therapeutic option for patients with chronic liver disease. However, acute kidney injury after LT (post-LT AKI) is a frequent complication that may lead to graft dysfunction and decrease life expectancy. Delay in AKI detection by traditional biomarkers boosted research with new biomarkers for post-LT AKI as neutrophil gelatinase-associated lipocalin (NGAL) and syndecan-1. We aim to evaluate associations of intraoperative systemic NGAL and syndecan-1 levels with post-LT AKI.</AbstractText><AbstractText Label="METHODS">This is a prospective study conducted in 46 patients selected for LT. Patients were evaluated preoperatively and blood samples were collected intraoperatively: T1 (after induction of anesthesia), T2 (anhepatic phase) and T3 (2 h after reperfusion of the graft).</AbstractText><AbstractText Label="RESULTS">The mean age was 54 &#xb1; 12 years and 60% were male. Post-LT AKI was observed in 24 (52%) patients of which 12% needed dialysis. Serum NGAL and syndecan-1 increased along surgical phases. Mostly, increment values of serum NGAL of T2 to T3 and syndecan-1 at T3 were importantly associated with post-LT AKI. Into a multivariate model with model for end-stage liver disease score, age, gender, warm ischemia, cold ischemia and surgery time, syndecan-1 levels at T3 remains capable to predict post-LT AKI. Serum NGAL had significance only with increment values calculated by the ratio of 'T3/T2'. Finally, serum syndecan-1 at T3 had a better diagnostic performance in receiver operating characteristic curve analysis.</AbstractText><AbstractText Label="CONCLUSION">Serum syndecan-1 levels in 2 h after reperfusion were most useful in early post-LT AKI diagnosis and may be used to construct new risk groups in this context.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cezar</LastName><ForeName>Lia Cavalcante</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Medical Surgery Science Post-Graduate Program, Department of Surgery.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meneses</LastName><ForeName>Gdayllon Cavalcante</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Medical Sciences Post-Graduate Program, School of Medicine, Federal University of Cear&#xe1;, Universidade de Fortaleza- UNIFOR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva Junior</LastName><ForeName>Geraldo Bezerra</ForeName><Initials>GB</Initials><AffiliationInfo><Affiliation>School of Medicine, Health Sciences Center, University of Fortaleza.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bezerra</LastName><ForeName>Gabriela Freire</ForeName><Initials>GF</Initials><AffiliationInfo><Affiliation>Department of Physiology and Pharmacology, School of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>Alice Maria Costa</ForeName><Initials>AMC</Initials><AffiliationInfo><Affiliation>Clinical and Toxicological Analysis Department, School of Pharmacy, Federal University of Cear&#xe1;, Cear&#xe1;, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lib&#xf3;rio</LastName><ForeName>Alexandre Braga</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Medical Sciences Post-Graduate Program, School of Medicine, Federal University of Cear&#xe1;, Universidade de Fortaleza- UNIFOR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daher</LastName><ForeName>Elizabeth De Francesco</ForeName><Initials>EF</Initials><AffiliationInfo><Affiliation>Medical Sciences Post-Graduate Program, School of Medicine, Federal University of Cear&#xe1;, Universidade de Fortaleza- UNIFOR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>Jos&#xe9; Huygens Parente</ForeName><Initials>JHP</Initials><AffiliationInfo><Affiliation>Medical Surgery Science Post-Graduate Program, Department of Surgery.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Gastroenterol Hepatol</MedlineTA><NlmUniqueID>9000874</NlmUniqueID><ISSNLinking>0954-691X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000209">Acute-Phase Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054834">Lipocalins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011518">Proto-Oncogene Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000209" MajorTopicYN="N">Acute-Phase Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058625" MajorTopicYN="Y">End Stage Liver Disease</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054834" MajorTopicYN="N">Lipocalins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016031" MajorTopicYN="Y">Liver Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011518" MajorTopicYN="N">Proto-Oncogene Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>20</Day><Hour>17</Hour><Minute>9</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33079777</ArticleId><ArticleId IdType="doi">10.1097/MEG.0000000000001892</ArticleId><ArticleId IdType="pii">00042737-202112000-00015</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gallegos-Orozco JF, Vargas HE. Liver transplantation: from Child to MELD. Med Clin North Am 2009; 93:931&#x2013;50, ix.</Citation></Reference><Reference><Citation>Carrion AF, Aye L, Martin P. Patient selection for liver transplantation. Expert Rev Gastroenterol Hepatol 2013; 7:571&#x2013;9.</Citation></Reference><Reference><Citation>Alqahtani SA. Update in liver transplantation. Curr Opin Gastroenterol 2012; 28:230&#x2013;238.</Citation></Reference><Reference><Citation>Magalh&#xe3;es CBA, Lima JMC, Viana CFG, Pereira EDB. Risk factors for acute kidney injury and 30-day mortality after liver transplantation. Ann Hepatol 2015; 14:688&#x2013;694.</Citation></Reference><Reference><Citation>Thongprayoon C, Kaewput W, Thamcharoen N, Bathini T, Watthanasuntorn K, Lertjitbanjong P, et al. Incidence and impact of acute kidney injury after liver transplantation: a meta-analysis. J Clin Med 2019; 8:372.</Citation></Reference><Reference><Citation>Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet 2005; 365:417&#x2013;430.</Citation></Reference><Reference><Citation>Kellum JA, Lameire N; KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 2013; 17:204</Citation></Reference><Reference><Citation>Parikh CR, Mansour SG. Perspective on clinical application of biomarkers in AKI. J Am Soc Nephrol 2017; 28:1677&#x2013;1685.</Citation></Reference><Reference><Citation>Yeung ACY, Morozov A, Robertson FP, Fuller BJ, Davidson BR. Neutrophil Gelatinase-Associated Lipocalin (NGAL) in predicting acute kidney injury following orthotopic liver transplantation: a systematic review. Int J Surg 2018; 59:48&#x2013;54.</Citation></Reference><Reference><Citation>Kohan DE, Inscho EW, Wesson D, Pollock DM. Physiology of endothelin and the kidney. Compr Physiol 2011; 1:883&#x2013;919.</Citation></Reference><Reference><Citation>Dane MJ, Khairoun M, Lee DH, van den Berg BM, Eskens BJ, Boels MG, et al. Association of kidney function with changes in the endothelial surface layer. Clin J Am Soc Nephrol 2014; 9:698&#x2013;704.</Citation></Reference><Reference><Citation>Vlahu CA, Lemkes BA, Struijk DG, Koopman MG, Krediet RT, Vink H. Damage of the endothelial glycocalyx in dialysis patients. J Am Soc Nephrol 2012; 23:1900&#x2013;1908.</Citation></Reference><Reference><Citation>Padberg JS, Wiesinger A, di Marco GS, Reuter S, Grabner A, Kentrup D, et al. Damage of the endothelial glycocalyx in chronic kidney disease. Atherosclerosis 2014; 234:335&#x2013;343.</Citation></Reference><Reference><Citation>Thiago F, Salmito S, Macedo F, Neves DO, Cavalcante G. Glycocalyx injury in adults with nephrotic syndrome: association with endothelial function. Clin Chim Acta 2015; 447:55&#x2013;58.</Citation></Reference><Reference><Citation>Neves FM, Meneses GC, Sousa NE, Menezes RR, Parahyba MC, Martins AM, Lib&#xf3;rio AB. Syndecan-1 in acute decompensated heart failure&#x2013;association with renal function and mortality. Circ J 2015; 79:1511&#x2013;1519.</Citation></Reference><Reference><Citation>de Melo Bezerra Cavalcante CT, Castelo Branco KM, Pinto J&#xfa;nior VC, Meneses GC, de Oliveira Neves FM, de Souza NM, et al. Syndecan-1 improves severe acute kidney injury prediction after pediatric cardiac surgery. J Thorac Cardiovasc Surg 2016; 152:178&#x2013;186.e2.</Citation></Reference><Reference><Citation>Shenoda B, Boselli J. Vascular syndromes in liver cirrhosis. Clin J Gastroenterol 2019; 12:387&#x2013;397.</Citation></Reference><Reference><Citation>Schiefer J, Lebherz-Eichinger D, Erdoes G, Berlakovich G, Bacher A, Krenn CG, Faybik P. Alterations of endothelial glycocalyx during orthotopic liver transplantation in patients with end-stage liver disease. Transplantation 2015; 99:2118&#x2013;2123.</Citation></Reference><Reference><Citation>Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 2014; 63:713&#x2013;735.</Citation></Reference><Reference><Citation>Hosein Shokouh-Amiri M, Osama Gaber A, Bagous WA, Grewal HP, Hathaway DK, Vera SR, et al. Choice of surgical technique influences perioperative outcomes in liver transplantation. Ann Surg 2000; 231:814&#x2013;823.</Citation></Reference><Reference><Citation>Hoo ZH, Candlish J, Teare D. What is an ROC curve? Emerg Med J 2017; 34:357&#x2013;359.</Citation></Reference><Reference><Citation>Zongyi Y, Baifeng L, Funian Z, Hao L, Xin W. Risk factors of acute kidney injury after orthotopic liver transplantation in China. Sci Rep 2017; 7:41555.</Citation></Reference><Reference><Citation>Durand F, Francoz C, Asrani SK, Khemichian S, Pham TA, Sung RS, et al. Acute kidney injury after liver transplantation. Transplantation 2018; 102:1636&#x2013;1649.</Citation></Reference><Reference><Citation>Sanchez EQ, Gonwa TA, Levy MF, Goldstein RM, Mai ML, Hays SR, et al. Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation. Transplantation 2004; 78:1048&#x2013;1054.</Citation></Reference><Reference><Citation>Schiefer J, Lebherz-Eichinger D, Erdoes G, Berlakovich G, Bacher A, Krenn CG, Faybik P. Alterations of endothelial glycocalyx during orthotopic liver transplantation in patients with end-stage liver disease. Transplantation 2015; 99:2118&#x2013;2123.</Citation></Reference><Reference><Citation>Robertson FP, Yeung AC, Male V, Rahman S, Mallett S, Fuller BJ, Davidson BR. Urinary neutrophil gelatinase associated lipocalins (NGALs) predict acute kidney injury post liver transplant. HPB (Oxford) 2019; 21:473&#x2013;481.</Citation></Reference><Reference><Citation>Buonafine M, Martinez-Martinez E, Jaisser F. More than a simple biomarker: the role of NGAL in cardiovascular and renal diseases. Clin Sci (Lond) 2018; 132:909&#x2013;923.</Citation></Reference><Reference><Citation>Kuwabara T, Mori K, Mukoyama M, Kasahara M, Yokoi H, Saito Y, et al. Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. Kidney Int 2009; 75:285&#x2013;294.</Citation></Reference><Reference><Citation>Hryniewiecka E, Gala K, Krawczyk M, P&#x105;czek L. Is neutrophil gelatinase-associated lipocalin an optimal marker of renal function and injury in liver transplant recipients? Transplant Proc 2014; 46:2782&#x2013;2785.</Citation></Reference><Reference><Citation>Aljumah AA, Tamim H, Saeed M, Tamimi W, Alfawaz H, Al Qurashi S, et al. The role of urinary neutrophil gelatinase-associated lipocalin in predicting acute kidney dysfunction in patients with liver cirrhosis. J Clin Med Res 2018; 10:419&#x2013;428.</Citation></Reference><Reference><Citation>Jeong TD, Kim S, Lee W, Song GW, Kim YK, Chun S, et al. Neutrophil gelatinase-associated lipocalin as an early biomarker of acute kidney injury in liver transplantation. Clin Transplant 2012; 26:775&#x2013;781.</Citation></Reference><Reference><Citation>Ijtsma AJ, van der Hilst CS, de Boer MT, de Jong KP, Peeters PM, Porte RJ, Slooff MJ. The clinical relevance of the anhepatic phase during liver transplantation. Liver Transpl 2009; 15:1050&#x2013;1055.</Citation></Reference><Reference><Citation>Iwakiri Y, Shah V, Rockey DC. Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions. J Hepatol 2014; 61:912&#x2013;924.</Citation></Reference><Reference><Citation>Gupta TK, Toruner M, Chung MK, Groszmann RJ. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Hepatology 1998; 28:926&#x2013;931.</Citation></Reference><Reference><Citation>Ikeda M, Matsumoto H, Ogura H, Hirose T, Shimizu K, Yamamoto K, et al. Circulating syndecan-1 predicts the development of disseminated intravascular coagulation in patients with sepsis. J Crit Care 2018; 43:48&#x2013;53.</Citation></Reference><Reference><Citation>Post EH, Kellum JA, Bellomo R, Vincent JL. Renal perfusion in sepsis: from macro- to microcirculation. Kidney Int 2017; 91:45&#x2013;60.</Citation></Reference><Reference><Citation>Rehm M, Bruegger D, Christ F, Conzen P, Thiel M, Jacob M, et al. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 2007; 116:1896&#x2013;1906.</Citation></Reference><Reference><Citation>Svennevig K, Hoel T, Thiara A, Kolset S, Castelheim A, Mollnes T, et al. Syndecan-1 plasma levels during coronary artery bypass surgery with and without cardiopulmonary bypass. Perfusion 2008; 23:165&#x2013;171.</Citation></Reference><Reference><Citation>Meneses GC, Cavalcante MG, da Silva Junior GB, Martins AMC, Neto RDJP, Lib&#xf3;rio AB, De Francesco Daher E. Endothelial glycocalyx damage and renal dysfunction in HIV patients receiving combined antiretroviral therapy. AIDS Res Hum Retroviruses 2017; 33:703&#x2013;710.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39922732</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>How Would We Prevent Our Own Acute Kidney Injury After Cardiac Surgery?</ArticleTitle><Pagination><StartPage>1123</StartPage><EndPage>1134</EndPage><MedlinePgn>1123-1134</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2025.01.019</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(25)00048-5</ELocationID><Abstract><AbstractText>Acute Kidney Injury (AKI) is a common complication after cardiac surgery affecting up to 40% leading to increased morbidity and mortality. To date, there is no specific treatment for AKI, thus, clinical research efforts are focused on preventive measures. The only pharmacological preventive intervention that has demonstrated a beneficial effect on AKI in a high-quality, double-blind, randomized controlled trial is a short perioperative infusion of a balanced mixture of amino acid solution. Amino acid infusion reduced the incidence of AKI by recruiting renal functional reserve and, therefore, increasing the glomerular filtration rate. The beneficial effect of amino acids was further confirmed for severe AKI and applied to patients with chronic kidney disease. Among non-pharmacological interventions, international guidelines on AKI suggest the implementation of a bundle of good clinical practice measures to reduce the incidence of perioperative AKI or to improve renal function whenever AKI occurs. The Kidney Disease Improving Global Outcomes (KDIGO) bundle includes the discontinuation of nephrotoxic agents, volume status and perfusion pressure assessment, renal functional hemodynamic monitoring, serum creatine, and urine output monitoring, and the avoidance of hyperglycemia and radiocontrast procedures. However, pooled data from a meta-analysis did not find a significant reduction in AKI. The aim of this review is to delineate the most appropriate evidence-based approach to prevent AKI in cardiac surgery patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pruna</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monaco</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asiller</LastName><ForeName>&#xd6;zg&#xfc;n &#xd6;mer</ForeName><Initials>&#xd6;&#xd6;</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Ankara University Faculty of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delrio</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yavorovskiy</LastName><ForeName>Andrey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>I.M. Sechenov First Moscow State Medical University of the Russian Ministry of Health, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Critical Care, The University of Melbourne, Melbourne, Australia; Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia; Data Analytics Research and Evaluation Centre, Austin Hospital, Melbourne, Australia; Department of Intensive Care, Austin Hospital, Melbourne, Australia; Department of Intensive Care, Royal Melbourne Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy; School of Medicine, Vita-Salute San Raffaele University, Milan, Italy. Electronic address: landoni.giovanni@hsr.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>01</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">perioperative</Keyword><Keyword MajorTopicYN="N">prevention</Keyword><Keyword MajorTopicYN="N">renal function</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors have disclosed that they do not have any conflicts of interest. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>13</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>8</Day><Hour>21</Hour><Minute>56</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39922732</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2025.01.019</ArticleId><ArticleId IdType="pii">S1053-0770(25)00048-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36983722</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4426</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>17</Day></PubDate></JournalIssue><Title>Journal of personalized medicine</Title><ISOAbbreviation>J Pers Med</ISOAbbreviation></Journal><ArticleTitle>Intraoperative Hypertension Is Associated with Postoperative Acute Kidney Injury after Laparoscopic Surgery.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">541</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jpm13030541</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">It is well demonstrated that intraoperative blood pressure is associated with postoperative acute kidney injury (AKI); however, the association between severity and duration of abnormal intraoperative blood pressure (BP) with AKI in patients undergoing laparoscopic surgery remains unknown.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective cohort study included 12,414 patients aged &#x2265; 18 years who underwent a single elective laparoscopic abdominal surgery during hospitalization between October 2011 and April 2017. Multivariate stepwise logistic regressions were applied to determine the correlation between the severity and duration of intraoperative mean arterial pressure (MAP, (systolic BP + 2 &#xd7; diastolic BP)/3), acute intraoperative hypertension (IOTH) and postoperative AKI, in different periods of surgery.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 482 hospitalized patients (3.9%) developed surgery-related AKI. Compared with those without IOTH or with preoperative mean MAP (80-85 mmHg), acute elevated IOTH (odds ratio, OR, 1.4, 95% CI, 1.1 to 1.7), mean MAP 95-100 mmHg (OR, 1.8; 95% CI, 1.3 to 2.7), MAP 100-105 mmHg (OR, 2.4; 95% CI, 1.6 to 3.8), and more than 105 mmHg (OR, 1.9; 95% CI, 1.1 to 3.3) were independent of other risk factors in a diverse cohort undergoing laparoscopic surgery. In addition, the risk of postoperative AKI appeared to result from long exposure (&#x2265;20 min) to IOTH (OR, 1.9; 95% CI, 1.5 to 2.5) and MAP &#x2265; 115 mmHg (OR, 2.2; 95% CI, 1.6 to 3.0). Intraoperative hypotension was not found to be associated with AKI in laparoscopic surgery patients.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Postoperative AKI correlates positively with intraoperative hypertension in patients undergoing laparoscopic surgery. These findings provide an intraoperative evaluation criterion to predict the occurrence of postoperative AKI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Yongzhong</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-3746-360X</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, The Third Xiangya Hospital, Central South University, Changsha 410013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Operation Center, The Third Xiangya Hospital, Central South University, Changsha 410013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ouyang</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Third Xiangya Hospital, Central South University, Changsha 410013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Guiping</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Third Xiangya Hospital, Central South University, Changsha 410013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Hongjia</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Third Xiangya Hospital, Central South University, Changsha 410013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Third Xiangya Hospital, Central South University, Changsha 410013, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>81901842</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>YLGX-WS-202000</GrantID><Agency>China Primary Health Care Foundation</Agency><Country/></Grant><Grant><GrantID>2021JJ40936</GrantID><Agency>Natural Science Foundation of Hunan Province</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Pers Med</MedlineTA><NlmUniqueID>101602269</NlmUniqueID><ISSNLinking>2075-4426</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">exposure time</Keyword><Keyword MajorTopicYN="N">intraoperative hypertension</Keyword><Keyword MajorTopicYN="N">laparoscopic surgery</Keyword><Keyword MajorTopicYN="N">mean arterial pressure</Keyword></KeywordList><CoiStatement>The authors declare no conflict to interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>1</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36983722</ArticleId><ArticleId IdType="pmc">PMC10058414</ArticleId><ArticleId IdType="doi">10.3390/jpm13030541</ArticleId><ArticleId IdType="pii">jpm13030541</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Silverstein A., Costas-Chavarri A., Gakwaya M.R., Lule J., Mukhopadhyay S., Meara J.G., Shrime M.G. Laparoscopic versus open cholecystectomy: A cost-effectiveness analysis at rwanda military hospital. World J. Surg. 2017;41:1225&#x2013;1233. doi: 10.1007/s00268-016-3851-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-016-3851-0</ArticleId><ArticleId IdType="pubmed">27905020</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox T.C., Huntington C.R., Blair L.J., Prasad T., Lincourt A.E., Augenstein V.A., Heniford B.T. Laparoscopic appendectomy and cholecystectomy versus open: A study in 1999 pregnant patients. Surg. Endosc. 2016;30:593&#x2013;602. doi: 10.1007/s00464-015-4244-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-015-4244-4</ArticleId><ArticleId IdType="pubmed">26091987</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn M.D., McDougall E.M. Renal physiology. Laparoscopic considerations. Urol. Clin. N. Am. 2000;27:609&#x2013;614. doi: 10.1016/S0094-0143(05)70110-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0094-0143(05)70110-5</ArticleId><ArticleId IdType="pubmed">11098759</ArticleId></ArticleIdList></Reference><Reference><Citation>de Seigneux S., Klopfenstein C.E., Iselin C., Martin P.Y. The risk of acute kidney injury following laparoscopic surgery in a chronic kidney disease patient. NDT Plus. 2011;4:339&#x2013;341. doi: 10.1093/ndtplus/sfr071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndtplus/sfr071</ArticleId><ArticleId IdType="pmc">PMC4421741</ArticleId><ArticleId IdType="pubmed">25984183</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdullah H.R., Tan T.P., Vaez M., Deb C., Farag N., Jackson T.D., Wong D.T. Predictors of perioperative acute kidney injury in obese patients undergoing laparoscopic bariatric surgery: A single-centre retrospective cohort study. Obes. Surg. 2016;26:1493&#x2013;1499. doi: 10.1007/s11695-015-1938-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11695-015-1938-6</ArticleId><ArticleId IdType="pubmed">26482165</ArticleId></ArticleIdList></Reference><Reference><Citation>Gameiro J., Fonseca J.A., Marques F., Lopes J.A. Management of acute kidney injury following major abdominal surgery: A contemporary review. J. Clin. Med. 2020;9:2679. doi: 10.3390/jcm9082679.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9082679</ArticleId><ArticleId IdType="pmc">PMC7463962</ArticleId><ArticleId IdType="pubmed">32824854</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A., Koyner J.L., Hoste E.A.J., Kellum J.A. Update on perioperative acute kidney injury. Anesth. Analg. 2018;127:1236&#x2013;1245. doi: 10.1213/ANE.0000000000003741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000003741</ArticleId><ArticleId IdType="pubmed">30138176</ArticleId></ArticleIdList></Reference><Reference><Citation>Corredor C., Thomson R., Al-Subaie N. Long-term consequences of acute kidney injury after cardiac surgery: A systematic review and meta-analysis. J. Cardiothorac. Vasc. Anesth. 2016;30:69&#x2013;75. doi: 10.1053/j.jvca.2015.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2015.07.013</ArticleId><ArticleId IdType="pubmed">26482483</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucaloiu I.D., Kirchner H.L., Norfolk E.R., Hartle J.E., Perkins R.M. Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury. Kidney Int. 2012;81:477&#x2013;485. doi: 10.1038/ki.2011.405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2011.405</ArticleId><ArticleId IdType="pubmed">22157656</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Wen D., Zou Y.F., Shen P.Y., Xu Y.W., Shi H., Xu J., Chen X.N., Chen N. One-year survival and renal function recovery of acute kidney injury patients with chronic heart failure. Cardiorenal Med. 2015;5:40&#x2013;47. doi: 10.1159/000369834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000369834</ArticleId><ArticleId IdType="pmc">PMC4327335</ArticleId><ArticleId IdType="pubmed">25759699</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore P.K., Hsu R.K., Liu K.D. Management of acute kidney injury: Core curriculum 2018. Am. J. Kidney Dis. 2018;72:136&#x2013;148. doi: 10.1053/j.ajkd.2017.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2017.11.021</ArticleId><ArticleId IdType="pubmed">29478864</ArticleId></ArticleIdList></Reference><Reference><Citation>Sessler D.I., Bloomstone J.A., Aronson S., Berry C., Gan T.J., Kellum J.A., Plumb J., Mythen M.G., Grocott M.P.W., Edwards M.R., et al. Perioperative quality initiative consensus statement on intraoperative blood pressure, risk and outcomes for elective surgery. Br. J. Anaesth. 2019;122:563&#x2013;574. doi: 10.1016/j.bja.2019.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2019.01.013</ArticleId><ArticleId IdType="pubmed">30916004</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu N., Long Q., He T., Liu X., Dai H., Lu Y., Wen J., Wu Q., Yuan H. Association between preoperative renin-angiotensin system inhibitor use and postoperative acute kidney injury risk in patients with hypertension. Clin. Nephrol. 2018;89:403&#x2013;414. doi: 10.5414/CN109319.</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/CN109319</ArticleId><ArticleId IdType="pubmed">29578401</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X.Y., Wu Q.Y., Chen Z.H., Yan G.Y., Lu Y., Dai H.J., Li Y., Yang P.T., Yuan H. Elevated triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio increased risk of hyperuricemia: A 4-year cohort study in China. Endocrine. 2020;68:71&#x2013;80. doi: 10.1007/s12020-019-02176-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-019-02176-5</ArticleId><ArticleId IdType="pubmed">31940133</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen J., Guo C.X., Lu M.G., Lu Y., Huang Y., Liu X., Li Y., Huang Z.J., Zhang Y.P., Yuan H. Gender-specific association between metabolic syndrome and decreased glomerular filtration rate in elderly population. Int. Urol. Nephrol. 2016;48:389&#x2013;397. doi: 10.1007/s11255-015-1172-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11255-015-1172-0</ArticleId><ArticleId IdType="pubmed">26725076</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Ye Y., Mi Q., Huang W., He T., Huang P., Xu N., Wu Q., Wang A., Li Y., et al. A predictive model for assessing surgery-related acute kidney injury risk in hypertensive patients: A retrospective cohort study. PLoS ONE. 2016;11:e0165280. doi: 10.1371/journal.pone.0165280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0165280</ArticleId><ArticleId IdType="pmc">PMC5089779</ArticleId><ArticleId IdType="pubmed">27802302</ArticleId></ArticleIdList></Reference><Reference><Citation>He P., Wei M., Yao H. Shanghai hierarchical management experience in the evaluation of maturity levels in health information interoperability standardization. Chin. Health Inform. Manag. 2016;4:338&#x2013;341.</Citation></Reference><Reference><Citation>Chinese Society of Cardiothoracic Anesthesia. Beijing Association of Hypertension Prevention and Treatment Experts&#x2019; consensus on perioperative hypertension management. J. Clin. Anesthesiol. 2016;32:295&#x2013;297.</Citation></Reference><Reference><Citation>Bijker J.B., van Klei W.A., Kappen T.H., van Wolfswinkel L., Moons K.G., Kalkman C.J. Incidence of intraoperative hypotension as a function of the chosen definition: Literature definitions applied to a retrospective cohort using automated data collection. Anesthesiology. 2007;107:213&#x2013;220. doi: 10.1097/01.anes.0000270724.40897.8e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.anes.0000270724.40897.8e</ArticleId><ArticleId IdType="pubmed">17667564</ArticleId></ArticleIdList></Reference><Reference><Citation>Derby S.A. Opioid conversion guidelines for managing adult cancer pain. Am. J. Nurs. 1999;99:62&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">10542852</ArticleId></ArticleIdList></Reference><Reference><Citation>Palevsky P.M., Liu K.D., Brophy P.D., Chawla L.S., Parikh C.R., Thakar C.V., Tolwani A.J., Waikar S.S., Weisbord S.D. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am. J. Kidney Dis. 2013;61:649&#x2013;672. doi: 10.1053/j.ajkd.2013.02.349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2013.02.349</ArticleId><ArticleId IdType="pubmed">23499048</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsushita K., Mahmoodi B.K., Woodward M., Emberson J.R., Jafar T.H., Jee S.H., Polkinghorne K.R., Shankar A., Smith D.H., Tonelli M., et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA. 2012;307:1941&#x2013;1951. doi: 10.1001/jama.2012.3954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.3954</ArticleId><ArticleId IdType="pmc">PMC3837430</ArticleId><ArticleId IdType="pubmed">22570462</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y., Chen Y., Wang Y., Liu M. Comparison of methods dealing with category variables with missing data. Chin. J. Health Stat. 2016;33:186&#x2013;189.</Citation></Reference><Reference><Citation>Huang W.W., Zhu W.Z., Mu D.L., Ji X.Q., Li X.Y., Ma D., Wang D.X. Intraoperative hypotension is associated with shortened overall survival after lung cancer surgery. BMC Anesthesiol. 2020;20:160. doi: 10.1186/s12871-020-01062-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-020-01062-2</ArticleId><ArticleId IdType="pmc">PMC7322881</ArticleId><ArticleId IdType="pubmed">32600326</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh M., Devereaux P.J., Garg A.X., Kurz A., Turan A., Rodseth R.N., Cywinski J., Thabane L., Sessler D.I. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: Toward an empirical definition of hypotension. Anesthesiology. 2013;119:507&#x2013;515. doi: 10.1097/ALN.0b013e3182a10e26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3182a10e26</ArticleId><ArticleId IdType="pubmed">23835589</ArticleId></ArticleIdList></Reference><Reference><Citation>Monk T.G., Bronsert M.R., Henderson W.G., Mangione M.P., Sum-Ping S.T., Bentt D.R., Nguyen J.D., Richman J.S., Meguid R.A., Hammermeister K.E. Association between intraoperative hypotension and hypertension and 30-day postoperative mortality in noncardiac surgery. Anesthesiology. 2015;123:307&#x2013;319. doi: 10.1097/ALN.0000000000000756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000756</ArticleId><ArticleId IdType="pubmed">26083768</ArticleId></ArticleIdList></Reference><Reference><Citation>Maheshwari K., Turan A., Mao G., Yang D., Niazi A.K., Agarwal D., Sessler D.I., Kurz A. The association of hypotension during non-cardiac surgery, before and after skin incision, with postoperative acute kidney injury: A retrospective cohort analysis. Anaesthesia. 2018;73:1223&#x2013;1228. doi: 10.1111/anae.14416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.14416</ArticleId><ArticleId IdType="pubmed">30144029</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Jiang Z., Ying J., Han Y., Chen Z. Optimal blood pressure decreases acute kidney injury after gastrointestinal surgery in elderly hypertensive patients: A randomized study: Optimal blood pressure reduces acute kidney injury. J. Clin. Anesth. 2017;43:77&#x2013;83. doi: 10.1016/j.jclinane.2017.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2017.09.004</ArticleId><ArticleId IdType="pubmed">29055803</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito S., Uchino S., Takinami M., Uezono S., Bellomo R. Postoperative blood pressure deficit and acute kidney injury progression in vasopressor-dependent cardiovascular surgery patients. Crit. Care. 2016;20:74. doi: 10.1186/s13054-016-1253-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1253-1</ArticleId><ArticleId IdType="pmc">PMC4806486</ArticleId><ArticleId IdType="pubmed">27013056</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfsthal S.D. Is blood pressure control necessary before surgery? Med. Clin. N. Am. 1993;77:349&#x2013;363. doi: 10.1016/S0025-7125(16)30256-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0025-7125(16)30256-5</ArticleId><ArticleId IdType="pubmed">8441300</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang D., Zhou J., Su D., Yu W., Chen J. Variations of perioperative baroreflex sensitivity in hypertensive and normotensive patients. Clin. Exp. Hypertens. 2017;39:74&#x2013;79. doi: 10.1080/10641963.2016.1210624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10641963.2016.1210624</ArticleId><ArticleId IdType="pubmed">28060537</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos L.P.J., Araujo R.B., Castro M., Ramos M., Cunha E.S.J.A., Iglesias A.C. Hemodynamic evaluation of elderly patients during laparoscopic cholecystectomy. Rev. Col&#xe9;gio Bras. Cir. 2018;45:e1659. doi: 10.1590/0100-6991e-20181659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0100-6991e-20181659</ArticleId><ArticleId IdType="pubmed">29846461</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalmar A.F., Foubert L., Hendrickx J.F., Mottrie A., Absalom A., Mortier E.P., Struys M.M. Influence of steep Trendelenburg position and CO2 pneumoperitoneum on cardiovascular, cerebrovascular, and respiratory homeostasis during robotic prostatectomy. Br. J. Anaesth. 2010;104:433&#x2013;439. doi: 10.1093/bja/aeq018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeq018</ArticleId><ArticleId IdType="pubmed">20167583</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono N., Nakahira J., Nakano S., Sawai T., Minami T. Changes in cardiac function and hemodynamics during robot-assisted laparoscopic prostatectomy with steep head-down tilt: A prospective observational study. BMC Res. Notes. 2017;10:341. doi: 10.1186/s13104-017-2672-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13104-017-2672-z</ArticleId><ArticleId IdType="pmc">PMC5534046</ArticleId><ArticleId IdType="pubmed">28754145</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Jiang Z., Chen Z. Intraoperative mean arterial pressure: What is the magic level really favorable for renal function? J. Clin. Anesth. 2018;47:45&#x2013;46. doi: 10.1016/j.jclinane.2018.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2018.03.011</ArticleId><ArticleId IdType="pubmed">29550621</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostermann M., Liu K. Pathophysiology of AKI. Best Pract. Res. Clin. Anaesthesiol. 2017;31:305&#x2013;314. doi: 10.1016/j.bpa.2017.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2017.09.001</ArticleId><ArticleId IdType="pubmed">29248138</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkinson T.M., Giraud G.D., Togioka B.M., Jones D.B., Cigarroa J.E. Cardiovascular and ventilatory consequences of laparoscopic surgery. Circulation. 2017;135:700&#x2013;710. doi: 10.1161/CIRCULATIONAHA.116.023262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.116.023262</ArticleId><ArticleId IdType="pubmed">28193800</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen N.T., Cronan M., Braley S., Rivers R., Wolfe B.M. Duplex ultrasound assessment of femoral venous flow during laparoscopic and open gastric bypass. Surg. Endosc. 2003;17:285&#x2013;290. doi: 10.1007/s00464-002-8812-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-002-8812-z</ArticleId><ArticleId IdType="pubmed">12364988</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuto K., Kitano S., Yoshida T., Bandoh T., Mitarai Y., Kobayashi M. Hemodynamic and arterial blood gas changes during carbon dioxide and helium pneumoperitoneum in pigs. Surg. Endosc. 1995;9:1173&#x2013;1178. doi: 10.1007/BF00210922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00210922</ArticleId><ArticleId IdType="pubmed">8553228</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali N.A., Eubanks W.S., Stamler J.S., Gow A.J., Lagoo-Deenadayalan S.A., Villegas L., El-Moalem H.E., Reynolds J.D. A method to attenuate pneumoperitoneum-induced reductions in splanchnic blood flow. Ann. Surg. 2005;241:256&#x2013;261. doi: 10.1097/01.sla.0000153034.54128.5e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.sla.0000153034.54128.5e</ArticleId><ArticleId IdType="pmc">PMC1356910</ArticleId><ArticleId IdType="pubmed">15650635</ArticleId></ArticleIdList></Reference><Reference><Citation>Miki Y., Iwase K., Kamiike W., Taniguchi E., Sakaguchi K., Sumimura J., Matsuda H., Nagai I. Laparoscopic cholecystectomy and time-course changes in renal function. The effect of the retraction method on renal function. Surg. Endosc. 1997;11:838&#x2013;841. doi: 10.1007/s004649900466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004649900466</ArticleId><ArticleId IdType="pubmed">9266647</ArticleId></ArticleIdList></Reference><Reference><Citation>Srisawat N., Kongwibulwut M., Laoveeravat P., Lumplertgul N., Chatkaew P., Saeyub P., Latthaprecha K., Peerapornratana S., Tiranathanagul K., Eiam-Ong S., et al. The role of intraoperative parameters on predicting laparoscopic abdominal surgery associated acute kidney injury. BMC Nephrol. 2018;19:289. doi: 10.1186/s12882-018-1081-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-018-1081-4</ArticleId><ArticleId IdType="pmc">PMC6198484</ArticleId><ArticleId IdType="pubmed">30348111</ArticleId></ArticleIdList></Reference><Reference><Citation>Huen S.C., Parikh C.R. Predicting acute kidney injury after cardiac surgery: A systematic review. Ann. Thorac. Surg. 2012;93:337&#x2013;347. doi: 10.1016/j.athoracsur.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3286599</ArticleId><ArticleId IdType="pubmed">22186469</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38471194</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Postoperative haemoglobin and anaemia-associated ischaemic events after major noncardiac surgery: A sex-stratified cohort study.</ArticleTitle><Pagination><StartPage>111439</StartPage><MedlinePgn>111439</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2024.111439</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(24)00068-0</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVE">To determine the sex-specific associations between postoperative haemoglobin and mortality or complications reflecting ischaemia or inadequate oxygen supply after major noncardiac surgery.</AbstractText><AbstractText Label="DESIGN">A retrospective cohort study with prospective validation.</AbstractText><AbstractText Label="SETTING">A large university hospital health system in China.</AbstractText><AbstractText Label="PATIENTS">Men and women undergoing elective major noncardiac surgery.</AbstractText><AbstractText Label="INTERVENTIONS AND MEASUREMENTS">The primary exposure was nadir haemoglobin within 48&#xa0;h after surgery. The outcome of interest was a composite of postoperative mortality or ischaemic events including myocardial injury, acute kidney injury and stroke within hospitalisation.</AbstractText><AbstractText Label="MAIN RESULTS">The study included 26,049 patients (15,757 men and 10,292 women). Low postoperative haemoglobin was a strong predictor of the composite outcome in both sexes, with the risk progressively increasing as the nadir haemoglobin concentration dropped below 130&#xa0;g&#xa0;l<sup>-1</sup> in men and 120&#xa0;g&#xa0;l<sup>-1</sup> in women (adjusted odds ratio [OR] 1.43, 95% CI 1.37-1.50 in men, and OR 1.45, 95% CI 1.35-1.55 in women, per 10&#xa0;g&#xa0;l<sup>-1</sup> decrease in postoperative nadir haemoglobin). Above these sex-specific thresholds, the change of nadir haemoglobin was no longer associated with odds of the composite outcome in either men or women. There was no significant interaction between patient sex and the association between postoperative haemoglobin and the composite outcome (Pinteraction&#xa0;=&#xa0;0.673). Validation in an external prospective cohort (n&#xa0;=&#xa0;2120) with systematic postoperative troponin and creatinine measurement confirmed our findings.</AbstractText><AbstractText Label="CONCLUSIONS">Postoperative haemoglobin levels following major noncardiac surgery were nonlinearly associated with ischaemic complications or mortality, without any clinically important interaction with patient sex.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Bing-Cheng</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Yi-Shan</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Wen-Chi</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Shao-Hui</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jia-Ming</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Ye-Hong</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Wei-Feng</ForeName><Initials>WF</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China. Electronic address: sglwfeng01@21cn.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ke-Xuan</ForeName><Initials>KX</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China. Electronic address: liukexuan705@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006454" MajorTopicYN="Y">Hemoglobins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000740" MajorTopicYN="Y">Anemia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007511" MajorTopicYN="N">Ischemia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anaemia</Keyword><Keyword MajorTopicYN="N">Haemoglobin</Keyword><Keyword MajorTopicYN="N">Noncardiac surgery</Keyword><Keyword MajorTopicYN="N">Patient blood management</Keyword><Keyword MajorTopicYN="N">Sex</Keyword></KeywordList><CoiStatement>Declaration of competing interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>28</Day><Hour>7</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>13</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>12</Day><Hour>19</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38471194</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2024.111439</ArticleId><ArticleId IdType="pii">S0952-8180(24)00068-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38567745</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1478-596X</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>The international journal of medical robotics + computer assisted surgery : MRCAS</Title><ISOAbbreviation>Int J Med Robot</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury after robot-assisted laparoscopic prostatectomy: A meta-analysis.</ArticleTitle><Pagination><StartPage>e2630</StartPage><MedlinePgn>e2630</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/rcs.2630</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">We investigated the rates of acute kidney injury (AKI) post robot-assisted laparoscopic prostatectomy (RALP).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A comprehensive search was conducted to identify studies that reported the rates of AKI post-RALP. A random effects model was used, and the pooled rates of AKI were calculated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 10 studies with 60,937 patients to be included. The mean age was 65.1&#xa0;years. The mean anaesthesia time was 234.3&#xa0;min (95% CI: 177.8-290.9). The mean operation time was 212.2&#xa0;min (95% CI: 188.7-235.6). The mean estimated blood loss was 314.1&#xa0;mL (95% CI: 153-475.3). The mean intraoperative IV fluids administered were 1985&#xa0;mL (95% CI: 1516.3-2453.7). The pooled rate of AKI post RALP was 7.2% (95% CI 19-23.9).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The rates of AKI after RALP are significant. Further studies are needed to detect the risk factors for AKI and to determine the rates of chronic kidney disease post-RALP.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors. The International Journal of Medical Robotics and Computer Assisted Surgery published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chandramohan</LastName><ForeName>Deepak</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine/Nephrology, University of Alabama at Birmingham, Birmingham, Alabama, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konda</LastName><ForeName>Raghunandan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine/Nephrology, University of Alabama at Birmingham, Birmingham, Alabama, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pujari</LastName><ForeName>Ashwini</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine/Nephrology, University of Alabama at Birmingham, Birmingham, Alabama, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avula</LastName><ForeName>Sreekant</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3909-2531</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine/Endocrinology, University of Minnesota Twin Cities, Minneapolis, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palleti</LastName><ForeName>Sujith Kumar</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine/Nephrology, Louisiana State University, Shreveport, Louisiana, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jena</LastName><ForeName>Nihar</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine/Cardiovascular Medicine, Trinity Health Oakland/Wayne State University, Pontiac, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naik</LastName><ForeName>Roopa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medicine, Geisinger Health, Wilkes-Barre, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bali</LastName><ForeName>Atul</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Geisinger Health, Wilkes-Barre, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Med Robot</MedlineTA><NlmUniqueID>101250764</NlmUniqueID><ISSNLinking>1478-5951</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011468" MajorTopicYN="Y">Prostatectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065287" MajorTopicYN="Y">Robotic Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="Y">Laparoscopy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011471" MajorTopicYN="N">Prostatic Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">pneumoperitoneum</Keyword><Keyword MajorTopicYN="N">prostate cancer</Keyword><Keyword MajorTopicYN="N">robot assisted laparoscopic radical prostatectomy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>3</Day><Hour>12</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38567745</ArticleId><ArticleId IdType="doi">10.1002/rcs.2630</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019;10(2):63&#x2010;89. https://doi.org/10.14740/wjon1191</Citation></Reference><Reference><Citation>Huang X, Wang L, Zheng X, Wang X. Comparison of perioperative, functional, and oncologic outcomes between standard laparoscopic and robotic&#x2010;assisted radical prostatectomy: a systemic review and meta&#x2010;analysis. Surg Endosc. 2017;31(3):1045&#x2010;1060. https://doi.org/10.1007/s00464&#x2010;016&#x2010;5125&#x2010;1</Citation></Reference><Reference><Citation>De Carlo F, Celestino F, Verri C, Masedu F, Liberati E, Di Stasi SM. Retropubic, laparoscopic, and robot&#x2010;assisted radical prostatectomy: surgical, oncological, and functional outcomes: a systematic review. Urol Int. 2014;93(4):373&#x2010;383. https://doi.org/10.1159/000366008</Citation></Reference><Reference><Citation>Costalonga EC, Costa ESVT, Caires R, Hung J, Yu L, Burdmann EA. Prostatic surgery associated acute kidney injury. World J Nephrol. 2014;3(4):198&#x2010;209.</Citation></Reference><Reference><Citation>Singh A, Dass B, Ejaz A, Bali A. Post&#x2010;obstructive diuresis: a cautionary tale. Cureus. 2019;11(12):e6328. https://doi.org/10.7759/cureus.6328</Citation></Reference><Reference><Citation>Chandramohan D, Garc&#xed;a JJC, Kata M, Naik R, Bali A, Shaik BF. Acute kidney injury. Annal of Clin Med &amp; Med Res. 2023;1(1):1&#x2010;17. https://doi.org/10.5281/zenodo</Citation></Reference><Reference><Citation>El&#x2010;Taji O, Howell&#x2010;Etienne J, Taktak S, Hanchanale V. Lower vs standard pressure pneumoperitoneum in robotic&#x2010;assisted radical prostatectomy: a systematic review and meta&#x2010;analysis. J Robot Surg. 2023;17(2):303&#x2010;312. https://doi.org/10.1007/s11701&#x2010;022&#x2010;01445&#x2010;2</Citation></Reference><Reference><Citation>Palleti SK, Avula S, Naik R. Chronic kidney disease. Int Clinc Med Case Rep Jour. 2023;2(11):1&#x2010;15.</Citation></Reference><Reference><Citation>Caddeo G, Williams ST, McIntyre CW, Selby NM. Acute kidney injury in urology patients: incidence, causes and outcomes. Nephro&#x2010;Urol Mon. 2013;5(5):955&#x2010;961. https://doi.org/10.5812/numonthly.12721</Citation></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et&#xa0;al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906. https://doi.org/10.1016/j.ijsu.2021.105906</Citation></Reference><Reference><Citation>Barker TH, Migliavaca CB, Stein C, et&#xa0;al. Conducting proportional meta&#x2010;analysis in different types of systematic reviews: a guide for synthesisers of evidence. BMC Med Res Methodol. 2021;21(1):1&#x2010;9. https://doi.org/10.1186/s12874&#x2010;021&#x2010;01381&#x2010;z</Citation></Reference><Reference><Citation>DerSimonian R, Laird N. Meta&#x2010;analysis in clinical trials. Contr Clin Trials. 1986;7(3):177&#x2010;188. https://doi.org/10.1016/0197&#x2010;2456(86)90046&#x2010;2</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta&#x2010;analyses. BMJ. 2003;327(7414):557&#x2010;560. https://doi.org/10.1136/bmj.327.7414.557</Citation></Reference><Reference><Citation>Wells GA, Shea B, O&#x2019;Connell D, et&#xa0;al. The Newcastle&#x2010;Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta&#x2010;Analyses; 2000.</Citation></Reference><Reference><Citation>Zhang Y, Huang L, Wang D, Ren P, Hong Q, Kang D. The ROBINS&#x2010;I and the NOS had similar reliability but differed in applicability: a random sampling observational studies of systematic reviews/meta&#x2010;analysis. J Evid Base Med. 2021;14(2):112&#x2010;122. https://doi.org/10.1111/jebm.12427</Citation></Reference><Reference><Citation>Ahn JH, Lim CH, Chung HI, Choi SU, Youn SZ, Lim HJ. Postoperative renal function in patients is unaltered after robotic&#x2010;assisted radical prostatectomy. Korean J Anesthesiol. 2011;60(3):192&#x2010;197. https://doi.org/10.4097/kjae.2011.60.3.192</Citation></Reference><Reference><Citation>Ergin G, Doluoglu OG, K&#x131;ra&#xe7; M, et&#xa0;al. Comparison of renal function after robot &#x2010; assisted laparoscopic radical prostatectomy versus retropubic radical prostatectomy. Int Braz J Urol. 2019;45(1):83&#x2010;88. https://doi.org/10.1590/s1677&#x2010;5538.ibju.2018.0103</Citation></Reference><Reference><Citation>Erkoc SK, Guclu CY, Ergin GY, Safak B, Meco BC, Yilmaz AA. Anesthesia management and patient outcomes in robotic assisted laparoscopic surgery: a single center experience. Medicine. 2022;11(4):1482&#x2010;1486. https://doi.org/10.5455/medscience.2022.08.192</Citation></Reference><Reference><Citation>Joo EY, Moon YJ, Yoon SH, Chin JH, Hwang JH, Kim YK. Comparison of acute kidney injury after robot&#x2010;assisted laparoscopic radical prostatectomy versus retropubic radical prostatectomy: a propensity score matching analysis. Medicine (Baltim). 2016;95(5):e2650. https://doi.org/10.1097/md.0000000000002650</Citation></Reference><Reference><Citation>Kim TL, Kim N, Shin HJ, Cho MR, Park HR, Kim SY. Intraoperative mean arterial pressure and acute kidney injury after robot&#x2010;assisted laparoscopic prostatectomy: a retrospective study. Sci Rep. 2023;13(1):3318. https://doi.org/10.1038/s41598&#x2010;023&#x2010;30506&#x2010;1</Citation></Reference><Reference><Citation>Kong YG, Park JH, Park JY, et&#xa0;al. Effect of intraoperative mannitol administration on acute kidney injury after robot&#x2010;assisted laparoscopic radical prostatectomy: a propensity score matching analysis. Medicine (Baltim). 2018;97(26):e11338. https://doi.org/10.1097/md.0000000000011338</Citation></Reference><Reference><Citation>Naito A, Taguchi S, Suzuki M, et&#xa0;al. Transient acute kidney injury observed immediately after robot&#x2010;assisted radical prostatectomy but not after open radical prostatectomy. Mol Clin Oncol. 2020;13(3):18. https://doi.org/10.3892/mco.2020.2087</Citation></Reference><Reference><Citation>Ning C, Hu X, Liu F, et&#xa0;al. Post&#x2010;surgical outcomes of patients with chronic kidney disease and end stage renal disease undergoing radical prostatectomy: 10&#x2010;year results from the US National Inpatient Sample. BMC Nephrol. 2019;20(1):278. https://doi.org/10.1186/s12882&#x2010;019&#x2010;1455&#x2010;2</Citation></Reference><Reference><Citation>Sato H, Narita S, Saito M, et&#xa0;al. Acute kidney injury and its impact on renal prognosis after robot&#x2010;assisted laparoscopic radical prostatectomy. Int J Med Robot. 2020;16(5):1&#x2010;7. https://doi.org/10.1016/s2666&#x2010;1683(20)34022&#x2010;2</Citation></Reference><Reference><Citation>Cho JE, Shim JK, Chang JH, et&#xa0;al. Effect of nicardipine on renal function after robot&#x2010;assisted laparoscopic radical prostatectomy. Urology. 2009;73(5):1056&#x2010;1060. https://doi.org/10.1016/j.urology.2008.08.490</Citation></Reference><Reference><Citation>Atkinson TM, Giraud GD, Togioka BM, Jones DB, Cigarroa JE. Cardiovascular and ventilatory consequences of laparoscopic surgery. Circulation. 2017;135(7):700&#x2010;710. https://doi.org/10.1161/circulationaha.116.023262</Citation></Reference><Reference><Citation>Maerz DA, Beck LN, Sim AJ, Gainsburg DM. Complications of robotic&#x2010;assisted laparoscopic surgery distant from the surgical site. Br J Anaesth. 2017;118(4):492&#x2010;503. https://doi.org/10.1093/bja/aex003</Citation></Reference><Reference><Citation>Vasdev N, Poon ASK, Gowrie&#x2010;Mohan S, et&#xa0;al. The physiologic and anesthetic considerations in elderly patients undergoing robotic renal surgery. Rev Urol. 2014;16(1):1.</Citation></Reference><Reference><Citation>Gumbert SD, Kork F, Jackson ML, et&#xa0;al. Perioperative acute kidney injury. Anesthesiology. 2020;132(1):180&#x2010;204. https://doi.org/10.1097/aln.0000000000002968</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">18802376</PMID><DateCompleted><Year>2008</Year><Month>11</Month><Day>12</Day></DateCompleted><DateRevised><Year>2017</Year><Month>01</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1660-2137</ISSN><JournalIssue CitedMedium="Internet"><Volume>109</Volume><Issue>4</Issue><PubDate><Year>2008</Year></PubDate></JournalIssue><Title>Nephron. Physiology</Title><ISOAbbreviation>Nephron Physiol</ISOAbbreviation></Journal><ArticleTitle>Cardiac surgery-associated acute kidney injury: putting together the pieces of the puzzle.</ArticleTitle><Pagination><StartPage>p55</StartPage><EndPage>p60</EndPage><MedlinePgn>p55-60</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1159/000142937</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute kidney injury (AKI) is a common problem in the context of cardiac surgery. There are both similarities and differences with AKI occurring in other clinical scenarios. In this paper, we discuss those aspects of AKI that are particular to cardiac surgery-associated AKI (CSA-AKI), with emphasis on recent advances in the field.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We summarize the recent literature relating to CSA-AKI, focusing on epidemiology, pathophysiology, risk prediction and prevention.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The Acute Kidney Injury Network (AKIN) criteria for the diagnosis and severity of AKI are a useful framework within which future epidemiological studies of AKI may be considered. Percent change in serum creatinine remains a sensitive and clinically relevant continuous measure of declining kidney function. New biomarkers of diagnosis are currently being validated, while biomarkers of prognosis are lacking. Notably, intraoperative antifibrinolytic therapy effects invalidate 'tubular proteinuria' biomarkers. Better characterization of genetic predisposition to CSA-AKI may enhance risk prediction, since currently available clinical models lack precision, particularly for the important clinical endpoint of new renal replacement therapy.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">CSA-AKI remains a clinically relevant problem for 5-10% of cardiac surgery patients and is associated with adverse clinical outcomes. Small changes in serum creatinine are important and should not be ignored. The overall incidence of new dialysis after cardiac surgery remains low.</AbstractText><CopyrightInformation>Copyright 2008 S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiothoracic Anesthesia and Critical Care Medicine, Duke University Medical Center, Durham, NC 27710, USA. andrew.shaw@duke.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swaminathan</LastName><ForeName>Madhav</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Stafford-Smith</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2008</Year><Month>09</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nephron Physiol</MedlineTA><NlmUniqueID>101159772</NlmUniqueID><ISSNLinking>1660-2137</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015984" MajorTopicYN="N">Causality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>21</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>9</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>11</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>9</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18802376</ArticleId><ArticleId IdType="doi">10.1159/000142937</ArticleId><ArticleId IdType="pii">000142937</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37814334</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>09</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Improvement of composite kidney outcomes by AKI care bundles: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>390</StartPage><MedlinePgn>390</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">390</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-023-04641-0</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Various approaches have been suggested to identify acute kidney injury (AKI) early and to initiate kidney-protective measures in patients at risk or with AKI. The objective of this study was to evaluate whether care bundles improve kidney outcomes in these patients.</AbstractText><AbstractText Label="METHODS">We conducted a systematic review of the literature to evaluate the clinical effectiveness of AKI care bundles with or without urinary biomarkers in the recognition and management of AKI. The main outcomes were major adverse kidney events (MAKEs) consisting of moderate-severe AKI, receipt of renal replacement therapy (RRT), and mortality.</AbstractText><AbstractText Label="RESULTS">Out of 7434 abstracts screened, 946 published studies were identified. Thirteen studies [five randomized controlled trials (RCTs) and eight non-RCTs] including 16,540 patients were eligible for inclusion in the meta-analysis. Meta-analysis showed a lower incidence of MAKE in the AKI care bundle group [odds ratio (OR) 0.73, 95% confidence interval (CI) 0.66-0.81] with differences in all 3 individual outcomes [moderate-severe AKI (OR 0.65, 95% CI 0.51-0.82), RRT (OR 0.63, 95% CI&#x2009;=&#x2009;0.46-0.88) and mortality]. Subgroup analysis of the RCTs, all adopted biomarker-based approach, decreased the risk of MAKE (OR 0.55, 95% CI 0.41-0.74). Network meta-analysis could reveal that the incorporation of biomarkers in care bundles carried a significantly lower risk of MAKE when compared to care bundles without biomarkers (OR&#x2009;=&#x2009;0.693, 95% CI&#x2009;=&#x2009;0.50-0.96), while the usual care subgroup had a significantly higher risk (OR&#x2009;=&#x2009;1.29, 95% CI&#x2009;=&#x2009;1.09-1.52).</AbstractText><AbstractText Label="CONCLUSION">Our meta-analysis demonstrated that care bundles decreased the risk of MAKE, moderate-severe AKI and need for RRT in AKI patients. Moreover, the inclusion of biomarkers in care bundles had a greater impact than care bundles without biomarkers.</AbstractText><CopyrightInformation>&#xa9; 2023. BioMed Central Ltd., part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>See</LastName><ForeName>Chun Yin</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, 100, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Heng-Chih</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, 100, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Nephrology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, Keelung, 204, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, Chang Gung University, Taoy&#xfc;an, 333, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Community Medicine Research Center, Keelung Chang Gung Memorial Hospital, Keelung, 204, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jui-Yi</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Internal Medicine, Chi-Mei Medical Center, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health and Nutrition, Chia Nan University of Pharmacy and Science, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Chun-Yi</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nursing, Asia University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Hung-Wei</ForeName><Initials>HW</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, 11696, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Nephrology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 11031, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yen-Ta</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Department of Surgery, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jung-Hua</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Communication, National Chung Cheng University, Chiayi, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Vin-Cent</ForeName><Initials>VC</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Clinical Research Building, National Taiwan University Hospital, 7 Chung-Shan South Road, Room 1555, Taipei, Taiwan. dr.vincentwu@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NSARF (National Taiwan University Hospital Study Group on Acute Renal Failure), Taipei, Taiwan. dr.vincentwu@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostermann</LastName><ForeName>Marlies</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Critical Care, King's College London, Guy's and St. Thomas' Foundation Trust, Westminster Bridge, London, SE1 7EH, UK. Marlies.Ostermann@gstt.nhs.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000099094">Network Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064872" MajorTopicYN="Y">Patient Care Bundles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Biomarkers</Keyword><Keyword MajorTopicYN="N">Care bundles</Keyword></KeywordList><CoiStatement>All authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>2</Day><Hour>12</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>10</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>9</Day><Hour>23</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37814334</ArticleId><ArticleId IdType="pmc">PMC10563300</ArticleId><ArticleId IdType="doi">10.1186/s13054-023-04641-0</ArticleId><ArticleId IdType="pii">10.1186/s13054-023-04641-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1411&#x2013;1423. doi: 10.1007/s00134-015-3934-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3934-7</ArticleId><ArticleId IdType="pubmed">26162677</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294(7):813&#x2013;818. doi: 10.1001/jama.294.7.813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.294.7.813</ArticleId><ArticleId IdType="pubmed">16106006</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, Nadim MK, Pickkers P, Gomez HA-O, Bell S, Joannidis MA-O, et al. Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup. (1759&#x2013;507X (Electronic)).</Citation><ArticleIdList><ArticleId IdType="pubmed">36823168</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss R, Saadat-Gilani K, Kerschke L, Wempe C, Meersch M, Zarbock A. EPIdemiology of surgery-associated acute kidney Injury (EPIS-AKI): study protocol for a multicentre, observational trial. BMJ Open. 2021;11(12):e055705. doi: 10.1136/bmjopen-2021-055705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-055705</ArticleId><ArticleId IdType="pmc">PMC8718477</ArticleId><ArticleId IdType="pubmed">35588372</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan S, Pannu N, Wilson T, Ball C, Tan Z, Tonelli M, et al. Prognostic implications of adding urine output to serum creatinine measurements for staging of acute kidney injury after major surgery: a cohort study. Nephrol Dial Transplant. 2016;31(12):2049&#x2013;2056. doi: 10.1093/ndt/gfw374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfw374</ArticleId><ArticleId IdType="pubmed">27941063</ArticleId></ArticleIdList></Reference><Reference><Citation>Gameiro J, Marques F, Lopes JA. Long-term consequences of acute kidney injury: a narrative review. Clin Kidney J. 2020;14(3):789&#x2013;804. doi: 10.1093/ckj/sfaa177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ckj/sfaa177</ArticleId><ArticleId IdType="pmc">PMC7986368</ArticleId><ArticleId IdType="pubmed">33777362</ArticleId></ArticleIdList></Reference><Reference><Citation>Heung M, Steffick DE, Zivin K, Gillespie BW, Banerjee T, Hsu CY, et al. Acute kidney injury recovery pattern and subsequent risk of CKD: an analysis of veterans health administration data. Am J Kidney Dis. 2016;67(5):742&#x2013;752. doi: 10.1053/j.ajkd.2015.10.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2015.10.019</ArticleId><ArticleId IdType="pmc">PMC6837804</ArticleId><ArticleId IdType="pubmed">26690912</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamme M, Legrand M, Geri G. Outcome of acute kidney injury: How to make a difference? Ann Intensive Care. 2021;11(1):60. doi: 10.1186/s13613-021-00849-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-021-00849-x</ArticleId><ArticleId IdType="pmc">PMC8050180</ArticleId><ArticleId IdType="pubmed">33856581</ArticleId></ArticleIdList></Reference><Reference><Citation>Alge JL, Arthur JM. Biomarkers of AKI: a review of mechanistic relevance and potential therapeutic implications. Clin J Am Soc Nephrol. 2015;10(1):147&#x2013;155. doi: 10.2215/CJN.12191213.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.12191213</ArticleId><ArticleId IdType="pmc">PMC4284423</ArticleId><ArticleId IdType="pubmed">25092601</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostermann M, Karsten E, Lumlertgul N. Biomarker-based management of AKI: Fact or fantasy? Nephron. 2021;146(3):295&#x2013;301. doi: 10.1159/000518365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000518365</ArticleId><ArticleId IdType="pmc">PMC9216309</ArticleId><ArticleId IdType="pubmed">34515152</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapoor PM, Karanjkar A, Magoon R, Taneja S, Das S, Malik V, et al. Effect of goal-directed therapy on post-operative neutrophil gelatinase-associated lipocalin profile in patients undergoing on-pump coronary artery surgery. Indian J Thorac Cardiovasc Surg. 2019;35(3):445&#x2013;452. doi: 10.1007/s12055-018-0758-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12055-018-0758-4</ArticleId><ArticleId IdType="pmc">PMC7525641</ArticleId><ArticleId IdType="pubmed">33061029</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT TJ, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022). Cochrane2022.</Citation></Reference><Reference><Citation>Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle&#x2013;Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis; 2000.</Citation></Reference><Reference><Citation>Owen RK, Bradbury N, Xin Y, Cooper N, Sutton A. MetaInsight: an interactive web-based tool for analyzing, interrogating, and visualizing network meta-analyses using R-shiny and netmeta. Res Synth Methods. 2019;10(4):569&#x2013;581. doi: 10.1002/jrsm.1373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1373</ArticleId><ArticleId IdType="pmc">PMC6973101</ArticleId><ArticleId IdType="pubmed">31349391</ArticleId></ArticleIdList></Reference><Reference><Citation>Claire R, Gluud C, Berlin I, Coleman T, Leonardi-Bee J. Using trial sequential analysis for estimating the sample sizes of further trials: example using smoking cessation intervention. BMC Med Res Methodol. 2020;20(1):284. doi: 10.1186/s12874-020-01169-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-020-01169-7</ArticleId><ArticleId IdType="pmc">PMC7702700</ArticleId><ArticleId IdType="pubmed">33256626</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang H. Trial sequential analysis: novel approach for meta-analysis (2383&#x2013;7977 (Electronic)).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8107247</ArticleId><ArticleId IdType="pubmed">33940767</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;cze I, Jauch D, G&#xf6;tz M, Kennedy P, Jung B, Zeman F, et al. Biomarker-guided Intervention to prevent acute kidney injury after major surgery: the prospective randomized BigpAK study. Ann Surg. 2018;267(6):1013&#x2013;1020. doi: 10.1097/SLA.0000000000002485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000002485</ArticleId><ArticleId IdType="pubmed">28857811</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M, Schmidt C, Hoffmeier A, Van Aken H, Wempe C, Gerss J, et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med. 2017;43(11):1551&#x2013;1561. doi: 10.1007/s00134-016-4670-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4670-3</ArticleId><ArticleId IdType="pmc">PMC5633630</ArticleId><ArticleId IdType="pubmed">28110412</ArticleId></ArticleIdList></Reference><Reference><Citation>Schanz M, Wasser C, Allgaeuer S, Schricker S, Dippon J, Alscher MD, et al. Urinary [TIMP-2]&#xb7;[IGFBP7]-guided randomized controlled intervention trial to prevent acute kidney injury in the emergency department. Nephrol Dial Transplant. 2019;34(11):1902&#x2013;1909. doi: 10.1093/ndt/gfy186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfy186</ArticleId><ArticleId IdType="pubmed">29961888</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, K&#xfc;llmar M, Ostermann M, Lucchese G, Baig K, Cennamo A, et al. Prevention of cardiac surgery-associated acute kidney injury by implementing the KDIGO guidelines in high-risk patients identified by biomarkers: the PrevAKI-Multicenter randomized controlled trial. Anesth Analg. 2021;133(2):292&#x2013;302. doi: 10.1213/ANE.0000000000005458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005458</ArticleId><ArticleId IdType="pubmed">33684086</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotwal S, Herath S, Erlich J, Boardman S, Qian J, Lawton P, et al. Electronic alerts and a care bundle for acute kidney injury&#x2014;an Australian cohort study. Nephrol Dial Transplant. 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">35438795</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourdeaux C, Ghosh E, Atallah L, Palanisamy K, Patel P, Thomas M, et al. Impact of a computerized decision support tool deployed in two intensive care units on acute kidney injury progression and guideline compliance: a prospective observational study.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7684927</ArticleId><ArticleId IdType="pubmed">33228770</ArticleId></ArticleIdList></Reference><Reference><Citation>Koeze J, van der Horst ICC, Wiersema R, Keus F, Dieperink W, Cox EGM, et al. Bundled care in acute kidney injury in critically ill patients, a before-after educational intervention study.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7469422</ArticleId><ArticleId IdType="pubmed">32883219</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolhe NV, Staples D, Reilly T, Merrison D, McIntyre CW, Fluck RJ, et al. Impact of compliance with a care bundle on acute kidney injury outcomes: a prospective observational study. PLoS ONE. 2015;10(7):e0132279. doi: 10.1371/journal.pone.0132279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0132279</ArticleId><ArticleId IdType="pmc">PMC4498890</ArticleId><ArticleId IdType="pubmed">26161979</ArticleId></ArticleIdList></Reference><Reference><Citation>Couturier C, Maillard N, Mariat C, Morel J, Palao JC, Bouchet JB, et al. Prevention of cardiac surgery-associated acute kidney injury by risk stratification using (TIMP-2)*(IGFBP7) Biomark Med. 2021;15(14):1201&#x2013;1210. doi: 10.2217/bmm-2020-0656.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/bmm-2020-0656</ArticleId><ArticleId IdType="pubmed">34474580</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelman DT, Crisafi C, Germain M, Greco B, Nathanson BH, Engelman RM, et al. Using urinary biomarkers to reduce acute kidney injury following cardiac surgery. J Thorac Cardiovasc Surg. 2020;160(5):1235&#x2013;46.e2. doi: 10.1016/j.jtcvs.2019.10.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2019.10.034</ArticleId><ArticleId IdType="pubmed">31757451</ArticleId></ArticleIdList></Reference><Reference><Citation>Halmy L, Riedel J, Zeman F, Tege B, Linder V, Gnewuch C, et al. Renal recovery after the implementation of an electronic alert and biomarker-guided kidney-protection strategy following major surgery. J Clin Med. 2021;10(21):5122. doi: 10.3390/jcm10215122.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10215122</ArticleId><ArticleId IdType="pmc">PMC8584790</ArticleId><ArticleId IdType="pubmed">34768642</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolhe NV, Reilly T, Leung J, Fluck RJ, Swinscoe KE, Selby NM, et al. A simple care bundle for use in acute kidney injury: a propensity score-matched cohort study. Nephrol Dial Transplant. 2016;31(11):1846&#x2013;1854. doi: 10.1093/ndt/gfw087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfw087</ArticleId><ArticleId IdType="pubmed">27190331</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzzi LM, Bergler T, Binnall B, Engelman DT, Forni L, Germain MJ, et al. Clinical use of [TIMP-2] [IGFBP7] biomarker testing to assess risk of acute kidney injury in critical care: guidance from an expert panel.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6585126</ArticleId><ArticleId IdType="pubmed">31221200</ArticleId></ArticleIdList></Reference><Reference><Citation>von Groote TC, Ostermann M, Forni LG, Meersch-Dini M, Zarbock A. The AKI care bundle: All bundle components are created equal-are they? Intensive Care Med. 2022;48(2):242&#x2013;245. doi: 10.1007/s00134-021-06601-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-021-06601-0</ArticleId><ArticleId IdType="pmc">PMC8799533</ArticleId><ArticleId IdType="pubmed">34921624</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Tie H, Shi R, Rossaint J, Zarbock A. Urinary [TIMP-2]&#xb7;[IGFBP7]-guided implementation of the KDIGO bundle to prevent acute kidney injury: a meta-analysis. Br J Anaesth. 2022;128(1):e24&#x2013;e26. doi: 10.1016/j.bja.2021.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2021.10.015</ArticleId><ArticleId IdType="pubmed">34794767</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostermann M, Zarbock A, Goldstein S, Kashani K, Macedo E, Murugan R, et al. Recommendations on acute kidney injury biomarkers from the acute disease quality initiative consensus conference: a consensus statement. JAMA Netw Open. 2020;3(10):e2019209. doi: 10.1001/jamanetworkopen.2020.19209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.19209</ArticleId><ArticleId IdType="pubmed">33021646</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaubroeck HAI, Vargas D, Vandenberghe W, Hoste EAJ. Impact of AKI care bundles on kidney and patient outcomes in hospitalized patients: a systematic review and meta-analysis.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8501614</ArticleId><ArticleId IdType="pubmed">34625046</ArticleId></ArticleIdList></Reference><Reference><Citation>Esmeijer K, Schoe A, Ruhaak LR, Hoogeveen EK, Soonawala D, Romijn FPHTM, et al. The predictive value of TIMP-2 and IGFBP7 for kidney failure and 30-day mortality after elective cardiac surgery. Sci Rep. 2021;11(1):1071. doi: 10.1038/s41598-020-80196-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-80196-2</ArticleId><ArticleId IdType="pmc">PMC7806984</ArticleId><ArticleId IdType="pubmed">33441876</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179&#x2013;c184. doi: 10.1159/000339789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000339789</ArticleId><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato R, Ariyoshi N, Hasegawa D, Crossey E, Hamahata N, Ishihara T, et al. Effects of inotropes on the mortality in patients with septic shock. J Intensive Care Med. 2021;36(2):211&#x2013;219. doi: 10.1177/0885066619892218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066619892218</ArticleId><ArticleId IdType="pubmed">31793373</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu YC, Shih MA-O, Tu YA-OX. Using normalized entropy to measure uncertainty of rankings for network meta-analyses. (1552-681X (Electronic)).</Citation><ArticleIdList><ArticleId IdType="pubmed">33754893</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A. Biomarker-guided intervention to prevent acute kidney injury (BigpAK-2). ClinicalTrials.gov identifier: NCT04647396. Updated August 16, 2023. https://www.clinicaltrials.gov/ct2/show/NCT04647396.</Citation></Reference><Reference><Citation>Zarbock A. Effect of an intervention to prevent acute kidney injury versus standard care in high-risk patients after major surgery (PrevProgAKI). ClinicalTrials.gov identifier: NCT05275218. Updated March 24, 2023. https://www.clinicaltrials.gov/ct2/show/NCT05275218</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38395357</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>06</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-5568</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Anaesthesia, critical care &amp; pain medicine</Title><ISOAbbreviation>Anaesth Crit Care Pain Med</ISOAbbreviation></Journal><ArticleTitle>Dexmedetomidine and acute kidney injury after non-cardiac surgery: A meta-analysis with trial sequential analysis.</ArticleTitle><Pagination><StartPage>101359</StartPage><MedlinePgn>101359</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.accpm.2024.101359</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2352-5568(24)00017-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute kidney injury (AKI) is a common complication after surgery and is associated with detrimental outcomes. This systematic review and meta-analysis evaluated perioperative dexmedetomidine on AKI and renal function after non-cardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed, Embase, and Cochrane Library databases were searched until August 2023 for randomised trials comparing dexmedetomidine with normal saline on AKI and renal function in adults undergoing non-cardiac surgery. The primary outcome was the incidence of AKI (according to Kidney Disease Improving Global Outcomes or Acute Kidney Injury Network criteria). Meta-analysis was performed using a random-effect model. We conducted sensitivity analysis, trial sequential analysis (TSA), and Grading of Recommendations Assessment, Development and Evaluation level of evidence.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-three trials involving 2440 patients were included. Dexmedetomidine administration, as compared to normal saline, significantly reduced the incidence of AKI (7.4% vs. 13.2%; risk ratio&#x2009;=&#x2009;0.57, 95% CI&#x2009;=&#x2009;0.40-0.83, P&#x2009;=&#x2009; 0.003, I<sup>2</sup>&#x2009;=&#x2009;0%; a high level of evidence); TSA and sensitivity analyses suggested the robustness of this outcome. For the renal function and inflammation parameters, dexmedetomidine decreased serum creatinine, blood urea nitrogen, cystatin C, tumour necrosis factor-&#x3b1;, and interleukin-6, and increased urine output and estimated glomerular filtration rate. Additionally, dexmedetomidine reduced postoperative nausea and vomiting and length of hospital stay. Dexmedetomidine was associated with an increased rate of bradycardia, but not hypotension.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Dexmedetomidine administration reduced the incidence of AKI and improved renal function after non-cardiac surgery. Based on a high level of evidence, dexmedetomidine is recommended as a component of perioperative renoprotection.</AbstractText><AbstractText Label="REGISTRATION" NlmCategory="BACKGROUND">International Prospective Register of Systematic Reviews; Registration number: CRD42022299252.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Soci&#xe9;t&#xe9; fran&#xe7;aise d'anesth&#xe9;sie et de r&#xe9;animation (Sfar). Published by Elsevier Masson SAS. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhuang</LastName><ForeName>Kai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China; Institute of Anaesthesiology, Soochow University, Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Hao-Tian</ForeName><Initials>HT</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China; Institute of Anaesthesiology, Soochow University, Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Yu-Qin</ForeName><Initials>YQ</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China; Institute of Anaesthesiology, Soochow University, Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Pain Medicine, University of California Davis Health, Sacramento, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Fu-Hai</ForeName><Initials>FH</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China; Institute of Anaesthesiology, Soochow University, Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Ke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China; Institute of Anaesthesiology, Soochow University, Suzhou, Jiangsu, China. Electronic address: pengke0422@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Anaesth Crit Care Pain Med</MedlineTA><NlmUniqueID>101652401</NlmUniqueID><ISSNLinking>2352-5568</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="Y">Dexmedetomidine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Dexmedetomidine</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Non-cardiac surgery</Keyword><Keyword MajorTopicYN="N">Renal function</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>7</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>24</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>23</Day><Hour>19</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38395357</ArticleId><ArticleId IdType="doi">10.1016/j.accpm.2024.101359</ArticleId><ArticleId IdType="pii">S2352-5568(24)00017-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36450405</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1756-1833</ISSN><JournalIssue CitedMedium="Internet"><Volume>379</Volume><PubDate><Year>2022</Year><Month>Nov</Month><Day>30</Day></PubDate></JournalIssue><Title>BMJ (Clinical research ed.)</Title><ISOAbbreviation>BMJ</ISOAbbreviation></Journal><ArticleTitle>Oxygen administration during surgery and postoperative organ injury: observational cohort study.</ArticleTitle><Pagination><StartPage>e070941</StartPage><MedlinePgn>e070941</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e070941</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmj-2022-070941</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To examine whether supraphysiological oxygen administration during surgery is associated with lower or higher postoperative kidney, heart, and lung injury.</AbstractText><AbstractText Label="DESIGN">Observational cohort study.</AbstractText><AbstractText Label="SETTING">42 medical centers across the United States participating in the Multicenter Perioperative Outcomes Group data registry.</AbstractText><AbstractText Label="PARTICIPANTS">Adult patients undergoing surgical procedures &#x2265;120 minutes' duration with general anesthesia and endotracheal intubation who were admitted to hospital after surgery between January 2016 and November 2018.</AbstractText><AbstractText Label="INTERVENTION">Supraphysiological oxygen administration, defined as the area under the curve of the fraction of inspired oxygen above air (21%) during minutes when the hemoglobin oxygen saturation was greater than 92%.</AbstractText><AbstractText Label="MAIN OUTCOMES">Primary endpoints were acute kidney injury defined using Kidney Disease Improving Global Outcomes criteria, myocardial injury defined as serum troponin &gt;0.04 ng/mL within 72 hours of surgery, and lung injury defined using international classification of diseases hospital discharge diagnosis codes.</AbstractText><AbstractText Label="RESULTS">The cohort comprised 350&#x2009;647 patients with median age 59 years (interquartile range 46-69 years), 180&#x2009;546 women (51.5%), and median duration of surgery 205 minutes (interquartile range 158-279 minutes). Acute kidney injury was diagnosed in 19&#x2009;207 of 297&#x2009;554 patients (6.5%), myocardial injury in 8972 of 320&#x2009;527 (2.8%), and lung injury in 13&#x2009;789 of 312&#x2009;161 (4.4%). The median fraction of inspired oxygen was 54.0% (interquartile range 47.5%-60.0%), and the area under the curve of supraphysiological inspired oxygen was 7951% min (5870-11&#x2009;107% min), equivalent to an 80% fraction of inspired oxygen throughout a 135 minute procedure, for example. After accounting for baseline covariates and other potential confounding variables, increased oxygen exposure was associated with a higher risk of acute kidney injury, myocardial injury, and lung injury. Patients at the 75th centile for the area under the curve of the fraction of inspired oxygen had 26% greater odds of acute kidney injury (95% confidence interval 22% to 30%), 12% greater odds of myocardial injury (7% to 17%), and 14% greater odds of lung injury (12% to 16%) compared with patients at the 25th centile. Sensitivity analyses evaluating alternative definitions of the exposure, restricting the cohort, and conducting an instrumental variable analysis confirmed these observations.</AbstractText><AbstractText Label="CONCLUSIONS">Increased supraphysiological oxygen administration during surgery was associated with a higher incidence of kidney, myocardial, and lung injury. Residual confounding of these associations cannot be excluded.</AbstractText><AbstractText Label="TRIAL REGISTRATION">Open Science Framework osf.io/cfd2m.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McIlroy</LastName><ForeName>David R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shotwell</LastName><ForeName>Matthew S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez</LastName><ForeName>Marcos G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaughn</LastName><ForeName>Michelle T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Michigan, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olsen</LastName><ForeName>Joanna S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Oregon Health and Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hennessy</LastName><ForeName>Cassandra</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wanderer</LastName><ForeName>Jonathan P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Semler</LastName><ForeName>Matthew S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rice</LastName><ForeName>Todd W</ForeName><Initials>TW</Initials><AffiliationInfo><Affiliation>Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kheterpal</LastName><ForeName>Sachin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Michigan, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Billings</LastName><ForeName>Frederic T</ForeName><Initials>FT</Initials><Suffix>4th</Suffix><Identifier Source="ORCID">0000-0001-7135-7785</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA frederic.t.billings@vumc.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Multicenter Perioperative Outcomes Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 GM129662</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM112871</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM145375</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ</MedlineTA><NlmUniqueID>8900488</NlmUniqueID><ISSNLinking>0959-8138</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055370" MajorTopicYN="Y">Lung Injury</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006335" MajorTopicYN="Y">Heart Injuries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/disclosure-of-interest/ and declare: support from United States NIH, Association of University Anesthesiologists, departmental and institutional resources at each contributing medical center, Blue Cross Blue Shield of Michigan/Blue Care Network for the submitted work; DRM is chair of the data safety and monitoring board for the HOT-ROX trial (ACTRN12619000115134), an investigator initiated, multicenter international, randomized controlled trial of restrictive FIO2, liberal FIO2, and usual FIO2 in surgical patients; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Cuff</LastName><ForeName>Germaine</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Freundlich</LastName><ForeName>Robert E</ForeName><Initials>RE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurz</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Naik</LastName><ForeName>Bhiken I</ForeName><Initials>BI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mathis</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schonberger</LastName><ForeName>Robert B</ForeName><Initials>RB</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>30</Day><Hour>20</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36450405</ArticleId><ArticleId IdType="pmc">PMC9710248</ArticleId><ArticleId IdType="doi">10.1136/bmj-2022-070941</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Greif R, Ak&#xe7;a O, Horn EP, Kurz A, Sessler DI, Outcomes Research Group . Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. N Engl J Med 2000;342:161-7. 10.1056/NEJM200001203420303&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200001203420303</ArticleId><ArticleId IdType="pubmed">10639541</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Botello SA, Garc&#xed;a-Granero E, Lillo R, L&#xf3;pez-Mozos F, Mill&#xe1;n M, Lled&#xf3; S. Randomized clinical trial to evaluate the effects of perioperative supplemental oxygen administration on the colorectal anastomosis. Br J Surg 2006;93:698-706. 10.1002/bjs.5370&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.5370</ArticleId><ArticleId IdType="pubmed">16703624</ArticleId></ArticleIdList></Reference><Reference><Citation>Allegranzi B, Zayed B, Bischoff P, et al. WHO Guidelines Development Group . New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infect Dis 2016;16:e288-303. 10.1016/S1473-3099(16)30402-9&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(16)30402-9</ArticleId><ArticleId IdType="pubmed">27816414</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenk M, Van Aken H, Zarbock A. The new World Health Organization recommendations on perioperative administration of oxygen to prevent surgical site infections: a dangerous reductionist approach? Anesth Analg 2017;125:682-7. 10.1213/ANE.0000000000002256&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000002256</ArticleId><ArticleId IdType="pubmed">28682957</ArticleId></ArticleIdList></Reference><Reference><Citation>Helmerhorst HJF, Schultz MJ, van der Voort PHJ, de Jonge E, van Westerloo DJ. Bench-to-bedside review: the effects of hyperoxia during critical illness. Crit Care 2015;19:284. 10.1186/s13054-015-0996-4&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-0996-4</ArticleId><ArticleId IdType="pmc">PMC4538738</ArticleId><ArticleId IdType="pubmed">26278383</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhilyaev SY, Moskvin AN, Platonova TF, Gutsaeva DR, Churilina IV, Demchenko IT. Hyperoxic vasoconstriction in the brain is mediated by inactivation of nitric oxide by superoxide anions. Neurosci Behav Physiol 2003;33:783-7. 10.1023/A:1025145331149&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1025145331149</ArticleId><ArticleId IdType="pubmed">14635993</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouren S, Souktani R, Beaussier M, et al. . Mechanisms of coronary vasoconstriction induced by high arterial oxygen tension. Am J Physiol 1997;272:H67-75.</Citation><ArticleIdList><ArticleId IdType="pubmed">9038923</ArticleId></ArticleIdList></Reference><Reference><Citation>Eltzschig HK, Bratton DL, Colgan SP. Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases. Nat Rev Drug Discov 2014;13:852-69. 10.1038/nrd4422&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd4422</ArticleId><ArticleId IdType="pmc">PMC4259899</ArticleId><ArticleId IdType="pubmed">25359381</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FT, 4th, Pretorius M, Schildcrout JS, et al. . Obesity and oxidative stress predict AKI after cardiac surgery. J Am Soc Nephrol 2012;23:1221-8. 10.1681/ASN.2011090940&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2011090940</ArticleId><ArticleId IdType="pmc">PMC3380645</ArticleId><ArticleId IdType="pubmed">22626819</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez MG, Pandharipande P, Morse J, et al. . Intraoperative cerebral oxygenation, oxidative injury, and delirium following cardiac surgery. Free Radic Biol Med 2017;103:192-8. 10.1016/j.freeradbiomed.2016.12.039&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2016.12.039</ArticleId><ArticleId IdType="pmc">PMC5258679</ArticleId><ArticleId IdType="pubmed">28039082</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez MG, Hughes CG, DeMatteo A, et al. . Intraoperative oxidative damage and delirium after cardiac surgery. Anesthesiology 2020;132:551-61. 10.1097/ALN.0000000000003016&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003016</ArticleId><ArticleId IdType="pmc">PMC7015795</ArticleId><ArticleId IdType="pubmed">31770146</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki S, Mihara Y, Hikasa Y, et al. Okayama Research Investigation Organizing Network (ORION) investigators . Current ventilator and oxygen management during general anesthesia: a multicenter, cross-sectional observational study. Anesthesiology 2018;129:67-76. 10.1097/ALN.0000000000002181&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000002181</ArticleId><ArticleId IdType="pubmed">29553985</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarte LA, Schober P, Loer SA. Benefits and harms of increased inspiratory oxygen concentrations. Curr Opin Anaesthesiol 2019;32:783-91. 10.1097/ACO.0000000000000791&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0000000000000791</ArticleId><ArticleId IdType="pubmed">31464698</ArticleId></ArticleIdList></Reference><Reference><Citation>Torbati D, Tan GH, Smith S, et al. . Multiple-organ effect of normobaric hyperoxia in neonatal rats. J Crit Care 2006;21:85-93, discussion 93-4. 10.1016/j.jcrc.2005.09.057&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2005.09.057</ArticleId><ArticleId IdType="pubmed">16616630</ArticleId></ArticleIdList></Reference><Reference><Citation>Colquhoun DA, Shanks AM, Kapeles SR, et al. . Considerations for integration of perioperative electronic health records across institutions for research and quality improvement: the approach taken by the Multicenter Perioperative Outcomes Group. Anesth Analg 2020;130:1133-46. 10.1213/ANE.0000000000004489&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000004489</ArticleId><ArticleId IdType="pmc">PMC7663856</ArticleId><ArticleId IdType="pubmed">32287121</ArticleId></ArticleIdList></Reference><Reference><Citation>Beasley R, Chien J, Douglas J, et al. . Thoracic Society of Australia and New Zealand oxygen guidelines for acute oxygen use in adults: &#x2018;Swimming between the flags&#x2019;. Respirology 2015;20:1182-91. 10.1111/resp.12620&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/resp.12620</ArticleId><ArticleId IdType="pmc">PMC4654337</ArticleId><ArticleId IdType="pubmed">26486092</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Driscoll BR, Howard LS, Earis J, Mak V, British Thoracic Society Emergency Oxygen Guideline Group. BTS Emergency Oxygen Guideline Development Group . BTS guideline for oxygen use in adults in healthcare and emergency settings. Thorax 2017;72(Suppl 1):ii1-90. 10.1136/thoraxjnl-2016-209729&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2016-209729</ArticleId><ArticleId IdType="pubmed">28507176</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012;120:c179-84. 10.1159/000339789&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000339789</ArticleId><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller T, Zeller T, Peetz D, et al. . Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-77. 10.1056/NEJMoa0903515&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0903515</ArticleId><ArticleId IdType="pubmed">19710485</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbott TEF, Fowler AJ, Pelosi P, et al. StEP-COMPAC Group . A systematic review and consensus definitions for standardised end-points in perioperative medicine: pulmonary complications. Br J Anaesth 2018;120:1066-79. 10.1016/j.bja.2018.02.007&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2018.02.007</ArticleId><ArticleId IdType="pubmed">29661384</ArticleId></ArticleIdList></Reference><Reference><Citation>Jammer I, Wickboldt N, Sander M, et al. European Society of Anaesthesiology (ESA) and the European Society of Intensive Care Medicine (ESICM) European Society of Anaesthesiology. European Society of Intensive Care Medicine . Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions: a statement from the ESA-ESICM joint taskforce on perioperative outcome measures. Eur J Anaesthesiol 2015;32:88-105. 10.1097/EJA.0000000000000118&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000118</ArticleId><ArticleId IdType="pubmed">25058504</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladha K, Vidal Melo MF, McLean DJ, et al. . Intraoperative protective mechanical ventilation and risk of postoperative respiratory complications: hospital based registry study. BMJ 2015;351:h3646. 10.1136/bmj.h3646&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h3646</ArticleId><ArticleId IdType="pmc">PMC4501577</ArticleId><ArticleId IdType="pubmed">26174419</ArticleId></ArticleIdList></Reference><Reference><Citation>Saager L, Hesler BD, You J, et al. . Intraoperative transitions of anesthesia care and postoperative adverse outcomes. Anesthesiology 2014;121:695-706. 10.1097/ALN.0000000000000401&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000401</ArticleId><ArticleId IdType="pubmed">25102312</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Vaughn MT, Dubovoy TZ, et al. . Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): a multicenter matched cohort analysis. Anesthesiology 2020;132:1371-81. 10.1097/ALN.0000000000003256&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003256</ArticleId><ArticleId IdType="pmc">PMC7864000</ArticleId><ArticleId IdType="pubmed">32282427</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan H, Sundararajan V, Halfon P, et al. . Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-9. 10.1097/01.mlr.0000182534.19832.83&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mlr.0000182534.19832.83</ArticleId><ArticleId IdType="pubmed">16224307</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore BJ, White S, Washington R, Coenen N, Elixhauser A. Identifying increased risk of readmission and in-hospital mortality using hospital administrative data: the AHRQ Elixhauser Comorbidity Index. Med Care 2017;55:698-705. 10.1097/MLR.0000000000000735&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0000000000000735</ArticleId><ArticleId IdType="pubmed">28498196</ArticleId></ArticleIdList></Reference><Reference><Citation>
van Buuren S, Groothuis-Oudshoorn K. mice: Multivariate Imputation by Chained Equations in R
. J Stat Softw
2011;45:1-67. https://www.jstatsoft.org/v45/i03/
10.18637/jss.v045.i03.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v045.i03</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin DB, Schenker N. Multiple imputation in health-care databases: an overview and some applications. Stat Med 1991;10:585-98. 10.1002/sim.4780100410&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.4780100410</ArticleId><ArticleId IdType="pubmed">2057657</ArticleId></ArticleIdList></Reference><Reference><Citation>Angrist JD, Imbens GW, Rubin DB. Identification of causal effects using instrumental variables. J Am Stat Assoc 1996;91:444-55 10.1080/01621459.1996.10476902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01621459.1996.10476902</ArticleId></ArticleIdList></Reference><Reference><Citation>Robins JM, Hern&#xe1;n MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology 2000;11:550-60. 10.1097/00001648-200009000-00011&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001648-200009000-00011</ArticleId><ArticleId IdType="pubmed">10955408</ArticleId></ArticleIdList></Reference><Reference><Citation>Greifer N. WeightIt: Weighting for Covariate Balance in Observational Studies. R package version 0.13.1. 2022. Available from: https://CRAN.R-project.org/package=WeightIt
</Citation></Reference><Reference><Citation>McGuinness SP, Parke RL, Drummond K, et al. SO-COOL investigators . A multicenter, randomized, controlled phase IIb trial of avoidance of hyperoxemia during cardiopulmonary bypass. Anesthesiology 2016;125:465-73. 10.1097/ALN.0000000000001226&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001226</ArticleId><ArticleId IdType="pubmed">27404222</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaefi S, Shankar P, Mueller AL, et al. . Intraoperative oxygen concentration and neurocognition after cardiac surgery. Anesthesiology 2021;134:189-201. 10.1097/ALN.0000000000003650&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003650</ArticleId><ArticleId IdType="pmc">PMC7855826</ArticleId><ArticleId IdType="pubmed">33331902</ArticleId></ArticleIdList></Reference><Reference><Citation>Holse C, Aasvang EK, Vester-Andersen M, et al. VIXIE Trial Group . Hyperoxia and antioxidants for myocardial injury in noncardiac surgery: a 2 &#xd7; 2 factorial, blinded, randomized clinical trial. Anesthesiology 2022;136:408-19. 10.1097/ALN.0000000000004117&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000004117</ArticleId><ArticleId IdType="pubmed">35120193</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruetzler K, Cohen B, Leung S, et al. . Supplemental intraoperative oxygen does not promote acute kidney injury or cardiovascular complications after noncardiac surgery: subanalysis of an alternating intervention trial. Anesth Analg 2020;130:933-40. 10.1213/ANE.0000000000004359&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000004359</ArticleId><ArticleId IdType="pubmed">31490254</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurz A, Kopyeva T, Suliman I, et al. . Supplemental oxygen and surgical-site infections: an alternating intervention controlled trial. Br J Anaesth 2018;120:117-26. 10.1016/j.bja.2017.11.003&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2017.11.003</ArticleId><ArticleId IdType="pubmed">29397118</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyhoff CS, Jorgensen LN, Wetterslev J, Christensen KB, Rasmussen LS, PROXI Trial Group . Increased long-term mortality after a high perioperative inspiratory oxygen fraction during abdominal surgery: follow-up of a randomized clinical trial. Anesth Analg 2012;115:849-54. 10.1213/ANE.0b013e3182652a51&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e3182652a51</ArticleId><ArticleId IdType="pubmed">22798533</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrando C, Aldecoa C, Unzueta C, et al. iPROVE-O2 Network . Effects of oxygen on post-surgical infections during an individualised perioperative open-lung ventilatory strategy: a randomised controlled trial. Br J Anaesth 2020;124:110-20. 10.1016/j.bja.2019.10.009&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2019.10.009</ArticleId><ArticleId IdType="pubmed">31767144</ArticleId></ArticleIdList></Reference><Reference><Citation>Staehr-Rye AK, Meyhoff CS, Scheffenbichler FT, et al. . High intraoperative inspiratory oxygen fraction and risk of major respiratory complications. Br J Anaesth 2017;119:140-9. 10.1093/bja/aex128&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aex128</ArticleId><ArticleId IdType="pubmed">28974067</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae J, Kim J, Lee S, et al. . Association between intraoperative hyperoxia and acute kidney injury after cardiac surgery: a retrospective observational study. J Cardiothorac Vasc Anesth 2021;35:2405-14. 10.1053/j.jvca.2020.11.054&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2020.11.054</ArticleId><ArticleId IdType="pubmed">33342731</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen SS, Holse C, Mathar CE, et al. . Intraoperative inspiratory oxygen fraction and myocardial injury after noncardiac surgery: results from an international observational study in relation to recent controlled trials. Anesth Analg 2022;135:1021-30. 10.1213/ANE.0000000000006042&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000006042</ArticleId><ArticleId IdType="pubmed">35417425</ArticleId></ArticleIdList></Reference><Reference><Citation>Leisman DE. The Goldilocks effect in the ICU-when the data speak, but not the truth. Crit Care Med 2020;48:1887-9. 10.1097/CCM.0000000000004669&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004669</ArticleId><ArticleId IdType="pubmed">33255103</ArticleId></ArticleIdList></Reference><Reference><Citation>Labrecque J, Swanson SA. Understanding the assumptions underlying instrumental variable analyses: a brief review of falsification strategies and related tools. Curr Epidemiol Rep 2018;5:214-20. 10.1007/s40471-018-0152-1&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40471-018-0152-1</ArticleId><ArticleId IdType="pmc">PMC6096851</ArticleId><ArticleId IdType="pubmed">30148040</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiser TG, Regenbogen SE, Thompson KD, et al. . An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 2008;372:139-44. 10.1016/S0140-6736(08)60878-8&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(08)60878-8</ArticleId><ArticleId IdType="pubmed">18582931</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31060732</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>123</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Jul</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review.</ArticleTitle><Pagination><StartPage>27</StartPage><EndPage>36</EndPage><MedlinePgn>27-36</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2019.03.028</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(19)30233-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Perioperative diabetic ketoacidosis (DKA) with near-normal blood glucose concentrations, termed euglycaemic ketoacidosis (EDKA), is an adverse effect associated with sodium-glucose co-transporter-2 inhibitors (SGLT2i). Guidelines are still evolving concerning the perioperative management of patients on SGLT2i. We performed a systematic review of published reports of DKA from SGLT2i in the surgical setting to understand better the clinical presentation and characteristics of SGLT2i-associated DKA.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched PubMed, Embase, and ProQuest for reports of perioperative DKA involving SGLT2i up to January 2019.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Forty-two reports of EDKA and five cases of hyperglycaemic diabetic ketoacidosis (HDKA) were identified from 33 publications. Canagliflozin was implicated in 26 cases. Presentation time varied from a few hours up to 6 weeks after operation. Precipitating factors may include diabetes medication changes, diet modifications, and intercurrent illnesses. There were 13 cases (12 EDKA and one HDKA) of bariatric surgery, 10 of them noted very-low-calorie diet regimes as a precipitating factor. No precise association between interruption of SGLT2i and the occurrence of DKA could be identified. Seven patients required mechanical ventilation, and acute kidney injury was noted in five. Five cases needed imaging to rule out anastomotic leak and pulmonary embolism, all of them revealed negative findings. Outcome data were available in 32 cases, all of them recovered completely.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">EDKA is likely to be under-recognised because of its atypical presentation and may delay the diagnosis. Understanding this clinical entity, vigilance towards monitoring plasma/capillary ketones helps in early identification and assists in the management.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 British Journal of Anaesthesia. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thiruvenkatarajan</LastName><ForeName>Venkatesan</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, The Queen Elizabeth Hospital, Adelaide, Australia; Discipline of Acute Care Medicine, University of Adelaide, Adelaide, Australia. Electronic address: Venkatesan.Thiruvenkatarajan@sa.gov.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer</LastName><ForeName>Emily Jane</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolic Unit, Royal Adelaide Hospital, Adelaide, Australia; Discipline of Medicine, University of Adelaide, Adelaide, Australia; Department of Endocrinology and Diabetes, The Metabolic Unit, The Queen Elizabeth Hospital, Adelaide, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nanjappa</LastName><ForeName>Nagesh</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, The Queen Elizabeth Hospital, Adelaide, Australia; Discipline of Acute Care Medicine, University of Adelaide, Adelaide, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Wijk</LastName><ForeName>Roelof M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, The Queen Elizabeth Hospital, Adelaide, Australia; Discipline of Acute Care Medicine, University of Adelaide, Adelaide, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jesudason</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolic Unit, Royal Adelaide Hospital, Adelaide, Australia; Discipline of Medicine, University of Adelaide, Adelaide, Australia; Department of Endocrinology and Diabetes, The Metabolic Unit, The Queen Elizabeth Hospital, Adelaide, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077203">Sodium-Glucose Transporter 2 Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016883" MajorTopicYN="N">Diabetic Ketoacidosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077203" MajorTopicYN="N">Sodium-Glucose Transporter 2 Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">diabetic ketoacidosis</Keyword><Keyword MajorTopicYN="N">euglycaemic ketoacidosis</Keyword><Keyword MajorTopicYN="N">hyperglycaemic diabetic ketoacidosis</Keyword><Keyword MajorTopicYN="N">perioperative</Keyword><Keyword MajorTopicYN="N">sodium-glucose co-transporter-2 inhibitors</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31060732</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2019.03.028</ArticleId><ArticleId IdType="pii">S0007-0912(19)30233-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39486762</PMID><DateCompleted><Year>2025</Year><Month>03</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-6259</ISSN><JournalIssue CitedMedium="Internet"><Volume>119</Volume><Issue>4</Issue><PubDate><Year>2025</Year><Month>Apr</Month></PubDate></JournalIssue><Title>The Annals of thoracic surgery</Title><ISOAbbreviation>Ann Thorac Surg</ISOAbbreviation></Journal><ArticleTitle>Goal-directed Perfusion to Reduce Acute Kidney Injury After Pediatric Cardiac Operation.</ArticleTitle><Pagination><StartPage>891</StartPage><EndPage>898</EndPage><MedlinePgn>891-898</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.athoracsur.2024.10.015</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0003-4975(24)00923-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Although goal-directed perfusion (GDP) during cardiopulmonary bypass (CPB) has been discussed extensively in adult studies, no pediatric indexed oxygen delivery (Do<sub>2</sub>i) thresholds are universally accepted, and no pediatric randomized controlled trial has been reported. This study aimed to determine whether the GDP initiative (maintaining Do<sub>2</sub>i &#x2265;360 mL/min/m<sup>2</sup> during CPB) could reduce the incidence of acute kidney injury (AKI) after pediatric cardiac operation and improve clinical outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This single-center randomized controlled trial enrolled 312 pediatric patients, who were randomized to receive either the GDP strategy or a conventional perfusion strategy during CPB. The primary outcome was the rate of postoperative AKI. Secondary outcomes included major postoperative complications, all-cause mortality within 30 days, and short-term clinical outcomes after operation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">AKI occurred in 43 patients (28.1%) in the GDP group and in 65 patients (42.2%) in the control group (relative risk, 0.67; 95% CI, 0.49-0.91; P&#xa0;= .010). In the subgroup analysis, the GDP group had a lower AKI rate compared with the control group among patients aged less than 1 year, with a nadir temperature greater than 32 &#xb0;C and a nadir hemoglobin value less than 8 g/L during CPB, with preoperative cyanosis, and with CPB duration from 60 to 120 minutes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The GDP strategy aimed at maintaining Do<sub>2</sub>i &#x2265;360 mL/min/m<sup>2</sup> during CPB is effective in reducing the risk of AKI after pediatric cardiac operation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yiheng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Henan Medical College of Zhengzhou University, Zhengzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Ronghua</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China. Electronic address: wr.zhou@hotmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ann Thorac Surg</MedlineTA><NlmUniqueID>15030100R</NlmUniqueID><ISSNLinking>0003-4975</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="Y">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010477" MajorTopicYN="Y">Perfusion</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006330" MajorTopicYN="Y">Heart Defects, Congenital</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Disclosures The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>24</Day><Hour>0</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>2</Day><Hour>23</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>1</Day><Hour>20</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39486762</ArticleId><ArticleId IdType="doi">10.1016/j.athoracsur.2024.10.015</ArticleId><ArticleId IdType="pii">S0003-4975(24)00923-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34837387</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-8737</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>12</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Clinical cardiology</Title><ISOAbbreviation>Clin Cardiol</ISOAbbreviation></Journal><ArticleTitle>Ultrafiltration and cardiopulmonary bypass associated acute kidney injury: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1700</StartPage><EndPage>1708</EndPage><MedlinePgn>1700-1708</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/clc.23750</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cardiopulmonary bypass is known to raise the risk of acute kidney injury (AKI). Previous studies have identified numerous risk factors of cardiopulmonary bypass including the possible impact of perioperative ultrafiltration. However, the association between ultrafiltration (UF) and AKI remains conflicting. Thus, we conducted a meta-analysis to further examine the relationship between UF and AKI.</AbstractText><AbstractText Label="HYPOTHESIS" NlmCategory="OBJECTIVE">Ultrafiltration during cardiac surgery increases the risk of developping Acute kidney Injury.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched PubMed, Web of Science, EBSCO, and SCOPUS through July 2021. The RevMan (version 5.4) software was used to calculate the pooled risk ratios (RRs) and mean differences along with their associated confidence intervals (95% CI).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 12 studies with a total of 8005 patients. There was no statistically significant difference in the incidence of AKI between the group who underwent UF and the control group who did not (RR&#x2009;=&#x2009;0.90, 95% CI&#x2009;=&#x2009;0.64-1). Subgroup analysis on patients with previous renal insufficiency also yielded nonsignificant difference&#xa0;(RR&#x2009;=&#x2009;0.84, 95% CI&#x2009;=&#x2009;0.53 -1.33,&#xa0;p&#x2009;=&#x2009;.47). Subgroup analysis based on volume of ultrafiltrate removed (&gt; or &lt;2900&#x2009;ml) was not significant and did not increase the AKI risk as predicted (RR&#x2009;=&#x2009;0.82, 95% CI&#x2009;=&#x2009;0.63 -1.07,&#xa0;p &#x2009;=&#x2009;.15). We also&#xa0;did subgroup analysis according to the type of UF and again no significant difference in AKI incidence between UF groups and controls was observed in either the conventional ultrafiltration (CUF), modified ultrafiltration (MUF), zero-balanced ultrafiltration (ZBUF), or combined MUF and CUF subgroups.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">UF in cardiac surgery is not associated with increased AKI incidence and may be safely used even in baseline chronic injury patients.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. Clinical Cardiology published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kandil</LastName><ForeName>Omneya A</ForeName><Initials>OA</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Alexandria University, Alexandria, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Motawea</LastName><ForeName>Karam R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Alexandria University, Alexandria, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darling</LastName><ForeName>Edward</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Perfusion, State University of New York Upstate Medical University, Syracuse, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riley</LastName><ForeName>Jeffrey B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Perfusion, State University of New York Upstate Medical University, Syracuse, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Jaffer</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-8961-218X</Identifier><AffiliationInfo><Affiliation>Medical Research Center, Kateb University, Kabul, Afghanistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elashhat</LastName><ForeName>Mohamed Abdalla Mohamed</ForeName><Initials>MAM</Initials><AffiliationInfo><Affiliation>Aswan Heart Center (Magdy Yacoub Foundation), Aswan Governorate, Aswan, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Searles</LastName><ForeName>Bruce</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Perfusion, State University of New York Upstate Medical University, Syracuse, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aiash</LastName><ForeName>Hani</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Perfusion, State University of New York Upstate Medical University, Syracuse, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Family Medicine, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, State University of New York Upstate Medical University, Syracuse, New York, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Cardiol</MedlineTA><NlmUniqueID>7903272</NlmUniqueID><ISSNLinking>0160-9289</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014462" MajorTopicYN="N">Ultrafiltration</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">fluid management</Keyword><Keyword MajorTopicYN="N">ultrafiltration</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>27</Day><Hour>8</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34837387</ArticleId><ArticleId IdType="pmc">PMC8715396</ArticleId><ArticleId IdType="doi">10.1002/clc.23750</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pickering JW, James MT, Palmer SC. Acute kidney injury and prognosis after cardiopulmonary bypass: a meta&#x2010;analysis of cohort studies. Am J Kidney Dis. 2015;65(2):283&#x2010;293.</Citation><ArticleIdList><ArticleId IdType="pubmed">25445101</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D, Liu B, Liang Z, et al. Acute kidney Injury following cardiopulmonary bypass: a challenging picture. Oxid Med Cell Longev. 2021;2021:13. 10.1155/2021/8873581</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/8873581</ArticleId><ArticleId IdType="pmc">PMC7963912</ArticleId><ArticleId IdType="pubmed">33763177</ArticleId></ArticleIdList></Reference><Reference><Citation>Searles B, Darling E. Ultrafiltration in cardiac surgery.&#xa0;In: Linda B, Mongero James, Beck R, eds. On Bypass: Advanced Perfusion Techniques. Chapter 9, 2009:193&#x2010;207.</Citation></Reference><Reference><Citation>Walpoth BH, Von Albertini B. Ultrafiltration in cardiac surgery. Journal of Extra&#x2010;Corporeal Technology. 1984;16(2):68&#x2010;72. 10.1007/978-1-59745-305-9_9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-59745-305-9_9</ArticleId></ArticleIdList></Reference><Reference><Citation>Long DM, Jenkins E, Griffith K. Perfusionist techniques of reducing acute kidney injury following cardiopulmonary bypass: an evidence&#x2010;based review. Perfusion (United Kingdom). 2015;30(1):25&#x2010;32. 10.1177/0267659114544395</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0267659114544395</ArticleId><ArticleId IdType="pubmed">25073949</ArticleId></ArticleIdList></Reference><Reference><Citation>Luciani GB, Menon T, Vecchi B, Auriemma S, Mazzucco A. Modified ultrafiltration reduces morbidity after adult cardiac operations: prospective, randomized clinical trial. Circulation. 2001;104:I&#x2010;253&#x2010;I&#x2010;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">11568065</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman JS, Hata M, Bellomo R, Kohchi K, Cheung HL, Buxton BF. Hemofiltration during cardiopulmonary bypass for high&#x2010;risk adult cardiac surgery. Int J Artif Organs. 2003;26(8):753&#x2010;757. 10.1177/039139880302600808</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/039139880302600808</ArticleId><ArticleId IdType="pubmed">14521173</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulos N, Bakhtiary F, Gr&#xfc;n V, Weber CF, Strasser C, Moritz A. The effect of normovolemic modified ultrafiltration on inflammatory mediators, endotoxins, terminal complement complexes and clinical outcome in high&#x2010;risk cardiac surgery patients. Perfusion (United Kingdom). 2013;28(4):306&#x2010;314. 10.1177/0267659113478450</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0267659113478450</ArticleId><ArticleId IdType="pubmed">23429100</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T, Gao CQ, Li JC, Wang JL, Li LB, Xiao CS. Effect of subzero&#x2010;balanced ultrafiltration on postoperative outcome of patients after cardiopulmonary bypass. Perfusion. 2009;24(6):401&#x2010;408. 10.1177/0267659109357977</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0267659109357977</ArticleId><ArticleId IdType="pubmed">20093335</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuntz RA, Holt DW, Turner S, Stichka L, Thacker B. Effects of conventional ultrafiltration on renal performance during adult cardiopulmonary bypass procedures. J Extra Corpor Technol. 2006;38(2):144&#x2010;153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4680751</ArticleId><ArticleId IdType="pubmed">16921688</ArticleId></ArticleIdList></Reference><Reference><Citation>Babka RM, Petress J, Briggs R, Helsel R, Mack J. Conventional haemofiltration during routine coronary bypass surgery. Perfusion. 1997;12(3):187&#x2010;192. 10.1177/026765919701200307</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/026765919701200307</ArticleId><ArticleId IdType="pubmed">9226707</ArticleId></ArticleIdList></Reference><Reference><Citation>Foroughi M, Argani H, Hassntash SA, Hekmat M, Majidi M, Beheshti M, Mehdizadeh B, Yekani B. Lack of renal protection of ultrafiltration during cardiac surgery: a randomized clinical trial. J Cardiovasc Surg. 2014;55(3):407&#x2010;413.</Citation><ArticleIdList><ArticleId IdType="pubmed">24189519</ArticleId></ArticleIdList></Reference><Reference><Citation>Musleh GS, Datta SS, Yonan NN, et al. Association of IL6 and IL10 with renal dysfunction and the use of haemofiltration during cardiopulmonary bypass. Eur J Cardiothorac Surg. 2009;35(3):511&#x2010;514. 10.1016/j.ejcts.2008.10.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2008.10.010</ArticleId><ArticleId IdType="pubmed">19084425</ArticleId></ArticleIdList></Reference><Reference><Citation>Matata BM, Scawn N, Morgan M, et al. A single&#x2010;center randomized trial of intraoperative zero&#x2010;balanced ultrafiltration during cardiopulmonary bypass for patients with impaired kidney function undergoing cardiac surgery. J Cardiothorac Vasc Anesth. 2015;29(5):1236&#x2010;1247. 10.1053/j.jvca.2015.02.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2015.02.020</ArticleId><ArticleId IdType="pubmed">26119403</ArticleId></ArticleIdList></Reference><Reference><Citation>Paugh TA, Dickinson TA, Martin JR, et al. Impact of ultrafiltration on kidney injury after cardiac surgery: the Michigan experience. Ann Thorac Surg. 2015;100(5):1683&#x2010;1688. 10.1016/j.athoracsur.2015.04.120</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2015.04.120</ArticleId><ArticleId IdType="pubmed">26209495</ArticleId></ArticleIdList></Reference><Reference><Citation>Roscitano A, Benedetto U, Goracci M, Capuano F, Lucani R, Sinatra R. Intraoperative continuous venovenous hemofiltration during coronary surgery. Asian Cardiovasc Thorac Ann. 2009;17(5):462&#x2010;466. 10.1177/0218492309348504</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0218492309348504</ArticleId><ArticleId IdType="pubmed">19917785</ArticleId></ArticleIdList></Reference><Reference><Citation>El&#x2010;Tahan MR, Hamad RA, Ghoneimy YF, El Shehawi MI, Shafi MA. A prospective, randomized study of the effects of continuous ultrafiltration in hepatic patients after cardiac valve surgery. J Cardiothorac Vasc Anesth. 2010;24(1):63&#x2010;68. 10.1053/j.jvca.2009.04.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2009.04.008</ArticleId><ArticleId IdType="pubmed">19800817</ArticleId></ArticleIdList></Reference><Reference><Citation>Coskun I, &#xc7;&#xf6;lkesen Y, Demirt&#xfc;rk OS, T&#xfc;nel HA, G&#xfc;lcan &#xd6;, T&#xfc;rk&#xf6;z R. The effects of perioperative ultrafiltration on postoperative outcomes in dialysis&#x2010;dependent patients undergoing open heart surgery. Turk&#xa0;J&#xa0;Thorac&#xa0;Cardiovasc&#xa0;Surg. 2013;21(3):603&#x2010;609. 10.5606/tgkdc.dergisi.2013.7133</Citation><ArticleIdList><ArticleId IdType="doi">10.5606/tgkdc.dergisi.2013.7133</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelman DT, Crisafi C, Germain M, et al. Using urinary biomarkers to reduce acute kidney injury following cardiac surgery. J Thorac Cardiovasc Surg. 2020;160(5):1235&#x2010;1246. 10.1016/j.jtcvs.2019.10.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2019.10.034</ArticleId><ArticleId IdType="pubmed">31757451</ArticleId></ArticleIdList></Reference><Reference><Citation>Soni SS, Cruz D, Bobek I, et al. NGAL: a biomarker of acute kidney injury and other systemic conditions. Int Urol Nephrol. 2010;42(1):141&#x2010;150. 10.1007/s11255-009-9608-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11255-009-9608-z</ArticleId><ArticleId IdType="pubmed">19582588</ArticleId></ArticleIdList></Reference><Reference><Citation>Heringlake M, Charitos EI, Erber K, Berggreen AE, Heinze H, Paarmann H. Preoperative plasma growth&#x2010;differentiation factor&#x2010;15 for prediction of acute kidney injury in patients undergoing cardiac surgery. Crit Care. 2016;20(1):1&#x2010;10. 10.1186/s13054-016-1482-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1482-3</ArticleId><ArticleId IdType="pmc">PMC5055664</ArticleId><ArticleId IdType="pubmed">27717384</ArticleId></ArticleIdList></Reference><Reference><Citation>Samy M, Fahmy TS, Effat H, Ashour A. Serum Cystatin C as a predictor of cardiac surgery associated&#x2010;acute kidney injury in patients with normal preoperative renal functions. A prospective cohort study. Egypt&#xa0;J&#xa0;Crit&#xa0;Care Med. 2017;5(1):41&#x2010;47. 10.1016/j.ejccm.2017.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejccm.2017.02.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobieski MA, Slaughter MS, Hart DE, Pappas PS, Tatooles AJ. Prospective study on cardiopulmonary bypass prime reduction and its effect on intraoperative blood product and hemoconcentrator use. Perfusion. 2005;20(1):31&#x2010;37. 10.1191/0267659105pf783oa</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/0267659105pf783oa</ArticleId><ArticleId IdType="pubmed">15751668</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw A, Raghunathan K. Fluid management in cardiac surgery: colloid or crystalloid? Anesthesiol Clin. 2013;31(2):269&#x2010;280. 10.1016/j.anclin.2012.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anclin.2012.12.007</ArticleId><ArticleId IdType="pubmed">23711644</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagshaw SM, Bellomo R. Cystatin C in acute kidney injury. Curr Opin Crit Care. 2010;16(6):533&#x2010;539. 10.1097/MCC.0b013e32833e8412</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCC.0b013e32833e8412</ArticleId><ArticleId IdType="pubmed">20736828</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31888922</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1555-905X</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month><Day>07</Day></PubDate></JournalIssue><Title>Clinical journal of the American Society of Nephrology : CJASN</Title><ISOAbbreviation>Clin J Am Soc Nephrol</ISOAbbreviation></Journal><ArticleTitle>Intraoperative Arterial Pressure Variability and Postoperative Acute Kidney Injury.</ArticleTitle><Pagination><StartPage>35</StartPage><EndPage>46</EndPage><MedlinePgn>35-46</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2215/CJN.06620619</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES">High BP variability may cause AKI because of inappropriate kidney perfusion. This study aimed to investigate the association between intraoperative BP variability and postoperative AKI in patients who underwent noncardiac surgery.</AbstractText><AbstractText Label="DESIGN, SETTING, PARTICIPANTS, &amp; MEASUREMENTS">We performed a cohort study of adults undergoing noncardiac surgery in hospitals in South Korea. We studied three cohorts using the following recording windows for intraoperative BP: discovery cohort, 1-minute intervals; first validation cohort, 5-minute intervals; and second validation cohort, 2-second intervals. We calculated four variability parameters (SD, coefficient of variation, variation independent of mean, and average real variability) based on the measured mean arterial pressure values. The primary outcomes were postoperative AKI (defined by the Kidney Disease Improving Global Outcomes serum creatinine cutoffs) and critical AKI (consisting of stage 2 or higher AKI and post-AKI death or dialysis within 90 days).</AbstractText><AbstractText Label="RESULTS">In the three cohorts, 45,520, 29,704, and 7435 patients were analyzed, each with 2230 (443 critical), 1552 (444 critical), and 300 (91 critical) postoperative AKI events, respectively. In the discovery cohort, all variability parameters were significantly associated with risk of AKI, even after adjusting for intraoperative hypotension. For example, average real variability was associated with higher risks of postoperative AKI (adjusted odds ratio, 1.13 per 1 SD increment; 95% CI, 1.07 to 1.19) and critical AKI (adjusted odds ratio, 1.13 per 1 SD increment; 95% CI, 1.02 to 1.26). Associations were evident predominantly among patients who also experienced intraoperative hypotension. In the validation analysis with 5-minute-interval BP records, all four variability parameters were associated with the risk of postoperative AKI or critical AKI. In the validation cohort with 2-second-interval BP records, average real variability was the only significant variability parameter.</AbstractText><AbstractText Label="CONCLUSIONS">Higher intraoperative BP variability is associated with higher risks of postoperative AKI after noncardiac surgery, independent of hypotension and other clinical characteristics.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 by the American Society of Nephrology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sehoon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4221-2453</Identifier><AffiliationInfo><Affiliation>Departments of Biomedical Sciences.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Armed Forces Capital Hospital, Gyeonggi-do, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Hyung-Chul</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Chul-Woo</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Yunhee</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Medical Research Collaborating Center.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Hyung Jin</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Biomedical Engineering, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sejoong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Internal Medicine, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University Bundang Hospital, Gyeonggi-do, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chin</LastName><ForeName>Ho Jun</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Internal Medicine, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University Bundang Hospital, Gyeonggi-do, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Myoungsuk</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Biomedical Research Institute, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yong Chul</ForeName><Initials>YC</Initials><Identifier Source="ORCID">0000-0003-3215-8681</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Dong Ki</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Internal Medicine, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kidney Research Institute, Seoul National University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joo</LastName><ForeName>Kwon Wook</ForeName><Initials>KW</Initials><AffiliationInfo><Affiliation>Internal Medicine, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kidney Research Institute, Seoul National University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yon Su</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Departments of Biomedical Sciences.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Internal Medicine, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kidney Research Institute, Seoul National University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Hajeong</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-1873-1587</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea; and.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin J Am Soc Nephrol</MedlineTA><NlmUniqueID>101271570</NlmUniqueID><ISSNLinking>1555-9041</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062186" MajorTopicYN="Y">Arterial Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001795" MajorTopicYN="N">Blood Pressure Determination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007432" MajorTopicYN="N">Intraoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">blood pressure</Keyword><Keyword MajorTopicYN="N">variability</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31888922</ArticleId><ArticleId IdType="pmc">PMC6946069</ArticleId><ArticleId IdType="doi">10.2215/CJN.06620619</ArticleId><ArticleId IdType="pii">01277230-202001000-00009</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abelha FJ, Botelho M, Fernandes V, Barros H: Determinants of postoperative acute kidney injury. Crit Care 13: R79, 2009</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2717442</ArticleId><ArticleId IdType="pubmed">19463152</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson C, Ozrazgat-Baslanti T, Kuxhausen A, Thottakkara P, Efron PA, Moore FA, Moldawer LL, Segal MS, Bihorac A: Cost and mortality associated with postoperative acute kidney injury. Ann Surg 261: 1207&#x2013;1214, 2015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4247993</ArticleId><ArticleId IdType="pubmed">24887982</ArticleId></ArticleIdList></Reference><Reference><Citation>Biteker M, Dayan A, Tekke&#x15f;in AI, Can MM, Tayc&#x131; &#x130;, &#x130;lhan E, &#x15e;ahin G: Incidence, risk factors, and outcomes of perioperative acute kidney injury in noncardiac and nonvascular surgery. Am J Surg 207: 53&#x2013;59, 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">24050540</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Kellum JA, Ronco C: Acute kidney injury. Lancet 380: 756&#x2013;766, 2012</Citation><ArticleIdList><ArticleId IdType="pubmed">22617274</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S, Cho H, Park S, Lee S, Kim K, Yoon HJ, Park J, Choi Y, Lee S, Kim JH, Kim S, Chin HJ, Kim DK, Joo KW, Kim YS, Lee H: Simple postoperative AKI risk (SPARK) classification before noncardiac surgery: A prediction index development study with external validation. J Am Soc Nephrol 30: 170&#x2013;181, 2019</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6317608</ArticleId><ArticleId IdType="pubmed">30563915</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Heung M, Rosenberg AL, Englesbe M, Shanks AM, Campbell DA Jr.: Development and validation of an acute kidney injury risk index for patients undergoing general surgery: Results from a national data set. Anesthesiology 110: 505&#x2013;515, 2009</Citation><ArticleIdList><ArticleId IdType="pubmed">19212261</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S, Lee H: Acute kidney injury prediction models: Current concepts and future strategies. Curr Opin Nephrol Hypertens 28: 552&#x2013;559, 2019</Citation><ArticleIdList><ArticleId IdType="pubmed">31356235</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares DM, Pessanha JF, Sharma A, Brocca A, Ronco C: Delayed Nephrology consultation and high mortality on acute kidney injury: A meta-analysis. Blood Purif 43: 57&#x2013;67, 2017</Citation><ArticleIdList><ArticleId IdType="pubmed">27915348</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S, Baek SH, Ahn S, Lee KH, Hwang H, Ryu J, Ahn SY, Chin HJ, Na KY, Chae DW, Kim S: Impact of electronic Acute Kidney Injury (AKI) alerts with automated nephrologist consultation on detection and Severity of AKI: A quality improvement study. Am J Kidney Dis 71: 9&#x2013;19, 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">28754457</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;cze I, Jauch D, G&#xf6;tz M, Kennedy P, Jung B, Zeman F, Gnewuch C, Graf BM, Gnann W, Banas B, Bein T, Schlitt HJ, Bergler T: Biomarker-guided intervention to prevent acute kidney injury after major surgery: The prospective randomized BigpAK study. Ann Surg 267: 1013&#x2013;1020, 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">28857811</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M, Schmidt C, Hoffmeier A, Van Aken H, Wempe C, Gerss J, Zarbock A: Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: The PrevAKI randomized controlled trial. Intensive Care Med 43: 1551&#x2013;1561, 2017</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5633630</ArticleId><ArticleId IdType="pubmed">28110412</ArticleId></ArticleIdList></Reference><Reference><Citation>Munshi R, Hsu C, Himmelfarb J: Advances in understanding ischemic acute kidney injury. BMC Med 9: 11, 2011</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3038966</ArticleId><ArticleId IdType="pubmed">21288330</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh M, Devereaux PJ, Garg AX, Kurz A, Turan A, Rodseth RN, Cywinski J, Thabane L, Sessler DI: Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: Toward an empirical definition of hypotension. Anesthesiology 119: 507&#x2013;515, 2013</Citation><ArticleIdList><ArticleId IdType="pubmed">23835589</ArticleId></ArticleIdList></Reference><Reference><Citation>KDIGO Work Group : KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2: 6, 2012</Citation></Reference><Reference><Citation>Salmasi V, Maheshwari K, Yang D, Mascha EJ, Singh A, Sessler DI, Kurz A: Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery: A retrospective cohort analysis. Anesthesiology 126: 47&#x2013;65, 2017</Citation><ArticleIdList><ArticleId IdType="pubmed">27792044</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesselink EM, Kappen TH, Torn HM, Slooter AJC, van Klei WA: Intraoperative hypotension and the risk of postoperative adverse outcomes: A systematic review. Br J Anaesth 121: 706&#x2013;721, 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">30236233</ArticleId></ArticleIdList></Reference><Reference><Citation>Collange O, Jazaerli L, Lejay A, Biermann C, Caillard S, Moulin B, Chakfe N, Severac F, Schaeffer M, Mertes PM, Steib A: Intraoperative pleth variability index is linked to delayed graft function after kidney transplantation. Transplant Proc 48: 2615&#x2013;2621, 2016</Citation><ArticleIdList><ArticleId IdType="pubmed">27788791</ArticleId></ArticleIdList></Reference><Reference><Citation>Mascha EJ, Yang D, Weiss S, Sessler DI: Intraoperative mean arterial pressure variability and 30-day mortality in patients having noncardiac surgery. Anesthesiology 123: 79&#x2013;91, 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">25929547</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Z, Liao X, Yin W, Kang Y, Guo J, Lu M: Relationship between short-term blood pressure variability and incidence of acute kidney injury in critically ill patients. Kidney Blood Press Res 42: 1238&#x2013;1246, 2017</Citation><ArticleIdList><ArticleId IdType="pubmed">29248933</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HC, Jung CW: Vital Recorder-a free research tool for automatic recording of high-resolution time-synchronised physiological data from multiple anaesthesia devices. Sci Rep 8: 1527, 2018</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5784161</ArticleId><ArticleId IdType="pubmed">29367620</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HC, Ryu HG, Chung EJ, Jung CW: Prediction of bispectral index during target-controlled infusion of propofol and remifentanil: A deep learning approach. Anesthesiology 128: 492&#x2013;501, 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">28953500</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikuya M, Ohkubo T, Metoki H, Asayama K, Hara A, Obara T, Inoue R, Hoshi H, Hashimoto J, Totsune K, Satoh H, Imai Y: Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: The Ohasama study. Hypertension 52: 1045&#x2013;1050, 2008</Citation><ArticleIdList><ArticleId IdType="pubmed">18981332</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO, Van Der Niepen P, O&#x2019;Brien E; Office versus Ambulatory Pressure Study Investigators : Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 348: 2407&#x2013;2415, 2003</Citation><ArticleIdList><ArticleId IdType="pubmed">12802026</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothwell PM, Howard SC, Dolan E, O&#x2019;Brien E, Dobson JE, Dahl&#xf6;f B, Sever PS, Poulter NR: Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 375: 895&#x2013;905, 2010</Citation><ArticleIdList><ArticleId IdType="pubmed">20226988</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierdomenico SD, Di Nicola M, Esposito AL, Di Mascio R, Ballone E, Lapenna D, Cuccurullo F: Prognostic value of different indices of blood pressure variability in hypertensive patients. Am J Hypertens 22: 842&#x2013;847, 2009</Citation><ArticleIdList><ArticleId IdType="pubmed">19498342</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin DC, Yun SR, Lee SW, Han SW, Kim W, Park J, Kim YK: Current characteristics of dialysis therapy in Korea: 2016 registry data focusing on diabetic patients. Kidney Res Clin Pract 37: 20&#x2013;29, 2018</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5875573</ArticleId><ArticleId IdType="pubmed">29629274</ArticleId></ArticleIdList></Reference><Reference><Citation>Bijker JB, van Klei WA, Kappen TH, van Wolfswinkel L, Moons KG, Kalkman CJ: Incidence of intraoperative hypotension as a function of the chosen definition: Literature definitions applied to a retrospective cohort using automated data collection. Anesthesiology 107: 213&#x2013;220, 2007</Citation><ArticleIdList><ArticleId IdType="pubmed">17667564</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg AX, Devereaux PJ, Yusuf S, Cuerden MS, Parikh CR, Coca SG, Walsh M, Novick R, Cook RJ, Jain AR, Pan X, Noiseux N, Vik K, Stolf NA, Ritchie A, Favaloro RR, Parvathaneni S, Whitlock RP, Ou Y, Lawrence M, Lamy A; CORONARY Investigators : Kidney function after off-pump or on-pump coronary artery bypass graft surgery: A randomized clinical trial [Published correction appears in JAMA 312: 97, 2014]. JAMA 311: 2191&#x2013;2198, 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">24886787</ArticleId></ArticleIdList></Reference><Reference><Citation>Shroyer AL, Grover FL, Hattler B, Collins JF, McDonald GO, Kozora E, Lucke JC, Baltz JH, Novitzky D; Veterans Affairs Randomized On/Off Bypass (ROOBY) Study Group : On-pump versus off-pump coronary-artery bypass surgery. N Engl J Med 361: 1827&#x2013;1837, 2009</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonventre JV, Weinberg JM: Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 14: 2199&#x2013;2210, 2003</Citation><ArticleIdList><ArticleId IdType="pubmed">12874476</ArticleId></ArticleIdList></Reference><Reference><Citation>Guazzi MD, Barbier P, Loaldi A, Montorsi P, Polese A, Tosi E, Fiorentini C: Intrarenal beta-receptor and renal baroreceptor interaction in the control of the renin response to transient reduction of the renal perfusion pressure in man. J Hypertens 3: 39&#x2013;45, 1985</Citation><ArticleIdList><ArticleId IdType="pubmed">2987340</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou TL, Kroon AA, Reesink KD, Schram MT, Koster A, Schaper NC, Dagnelie PC, van der Kallen CJH, Sep SJS, Stehouwer CDA, Henry RMA: Blood pressure variability in individuals with and without (pre)diabetes: The Maastricht Study. J Hypertens 36: 259&#x2013;267, 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">28885385</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarafidis PA, Ruilope LM, Loutradis C, Gorostidi M, de la Sierra A, de la Cruz JJ, Vinyoles E, Divis&#xf3;n-Garrote JA, Segura J, Banegas JR: Blood pressure variability increases with advancing chronic kidney disease stage: A cross-sectional analysis of 16&#x200a;546 hypertensive patients. J Hypertens 36: 1076&#x2013;1085, 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">29465710</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26119410</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>5</Issue><PubDate><Year>2015</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Meta-Analysis of Sodium Bicarbonate Therapy for Prevention of Cardiac Surgery-Associated Acute Kidney Injury.</ArticleTitle><Pagination><StartPage>1248</StartPage><EndPage>1256</EndPage><MedlinePgn>1248-56</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2015.03.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(15)00133-0</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study was to determine whether or not perioperative administration of sodium bicarbonate had a preventive effect on cardiac surgery-associated acute kidney injury (CSA-AKI) as shown in randomized controlled trials.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">The authors conducted a systematic review and meta-analysis using MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL), and KoreaMed.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">The authors searched MEDLINE, EMBASE, CENTRAL, and KoreaMed without language and date restrictions. They used both MeSH and free-text terms to identify relevant studies. Electronic searches were undertaken on July 31, 2014.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Five randomized controlled studies included in this review.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">There were no differences in the development of CSA-AKI among patients in the sodium bicarbonate group compared with those in the control group (5 trials, 1,092 patients; n = 233 of 547 in sodium bicarbonate (SB) group versus 225 of 545 in control group (SC); risk ratio (RR), 0.95; 95% confidence interval (CI), 0.74-1.22. Also, there were no statistical differences in in-hospital mortality (3 trials, 573 patients; n = 21 of 288 in SB versus 14 of 285 in SC; RR, 1.44; 95% CI, 0.76-2.72), need for renal replacement therapy (4 trials, 1,000 patients; n = 21 of 503 in SB versus 23 of 497 in SC; RR, 0.90; 95% CI, 0.50-1.60), length of stay in the intensive care unit (ICU) (hours) (4 trials, n = 969 patients, weighted men difference (WMD), 2.17; 95% CI, -1.15-5.49), and length of ventilation (hours) (4 trials, 969 patients; WMD, 0.34; 95% CI,-0.80-1.48).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Perioperative administration of sodium bicarbonate did not reduce the rate of CSA-AKI in randomized controlled trials. Therefore, use of perioperative administration of sodium bicarbonate for the prevention of CSA-AKI is questionable.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jun Hyun</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Departments of Anesthesiology and Pain Medicine, Ilsan Paik Hospital, Inje University, Goyang, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hyun Jung</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Preventive Medicine, College of Medicine, Korea University, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ji Yeon</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Departments of Anesthesiology and Pain Medicine, Ilsan Paik Hospital, Inje University, Goyang, Korea. Electronic address: jy925@paik.ac.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahn</LastName><ForeName>Hyeong sik</ForeName><Initials>Hs</Initials><AffiliationInfo><Affiliation>Preventive Medicine, College of Medicine, Korea University, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahn</LastName><ForeName>Il Min</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>Preventive Medicine, College of Medicine, Korea University, Seoul, Korea; Literary Arts, Brown University, Providence, RI.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choe</LastName><ForeName>Won Joo</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Departments of Anesthesiology and Pain Medicine, Ilsan Paik Hospital, Inje University, Goyang, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Choon-Hak</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Anesthesiology and Pain Medicine, Korea University Medical Center, Seoul, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>8MDF5V39QO</RegistryNumber><NameOfSubstance UI="D017693">Sodium Bicarbonate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="N">Heart Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017693" MajorTopicYN="N">Sodium Bicarbonate</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">sodium bicarbonate</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26119410</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2015.03.007</ArticleId><ArticleId IdType="pii">S1053-0770(15)00133-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29126653</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1874-1754</ISSN><JournalIssue CitedMedium="Internet"><Volume>251</Volume><PubDate><Year>2018</Year><Month>Jan</Month><Day>15</Day></PubDate></JournalIssue><Title>International journal of cardiology</Title><ISOAbbreviation>Int J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Perioperative levosimendan in cardiac surgery: A systematic review with meta-analysis and trial sequential analysis.</ArticleTitle><Pagination><StartPage>22</StartPage><EndPage>31</EndPage><MedlinePgn>22-31</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijcard.2017.10.077</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0167-5273(17)33562-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Several studies suggested beneficial effects of perioperative levosimendan on postoperative outcome after cardiac surgery. However, three large randomized controlled trials (RCTs) have been recently published and presented neutral results. We performed a systematic review with meta-analysis and trial sequential analysis (TSA) to assess benefits and harms of perioperative levosimendan therapy in cardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Electronic databases were searched up to September 2017 for RCTs on preoperative levosimendan versus any type of control. The Cochrane methodology was employed. We calculated odds ratio (OR) or Risk Ratio (OR) and 95% confidence interval (CI) using fixed-effects meta-analyses and we further performed TSA.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included data from 40 RCTs and 4246 patients. Pooled analysis of 5 low risk of bias trials (1910 patients) showed no association between levosimendan and mortality (OR 0.86 [95% CI, 0.62, 1.18], p=0.34, TSA inconclusive), acute kidney injury, need of renal replacement therapy, myocardial infarction, ventricular arrhythmias, and serious adverse events, but an association with higher incidence of supraventricular arrhythmias (RR 1.11 [95% CI, 1.00, 1.24], p=0.05, TSA inconclusive) and hypotension (RR 1.15 [95% CI, 1.01, 1.30], p=0.04, TSA inconclusive). Analysis including all 40 trials found that levosimendan was associated with lower postoperative mortality (OR 0.56 [95% CI, 0.44, 0.71], p&lt;0.00001, TSA conclusive), acute kidney injury, and renal replacement therapy, and higher incidence of hypotension.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There is not enough high-quality evidence to neither support nor discourage the systematic use of levosimendan in cardiac surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Putzu</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, Cardiocentro Ticino, Lugano, Switzerland. Electronic address: alessandroputzu@ymail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clivio</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, Cardiocentro Ticino, Lugano, Switzerland. Electronic address: sara.clivio@cardiocentro.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belletti</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cassina</LastName><ForeName>Tiziano</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, Cardiocentro Ticino, Lugano, Switzerland. Electronic address: tiziano.cassina@cardiocentro.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Cardiol</MedlineTA><NlmUniqueID>8200291</NlmUniqueID><ISSNLinking>0167-5273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006835">Hydrazones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011724">Pyridazines</NameOfSubstance></Chemical><Chemical><RegistryNumber>349552KRHK</RegistryNumber><NameOfSubstance UI="D000077464">Simendan</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Int J Cardiol. 2018 Jun 1;260:51. doi: 10.1016/j.ijcard.2018.01.040.</RefSource><PMID Version="1">29622452</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Int J Cardiol. 2018 Jun 1;260:53. doi: 10.1016/j.ijcard.2018.03.006.</RefSource><PMID Version="1">29622454</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Int J Cardiol. 2021 Jun 15;333:145. doi: 10.1016/j.ijcard.2021.02.050.</RefSource><PMID Version="1">33639185</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006835" MajorTopicYN="N">Hydrazones</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011724" MajorTopicYN="N">Pyridazines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077464" MajorTopicYN="N">Simendan</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Cardiology</Keyword><Keyword MajorTopicYN="N">Levosimendan</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29126653</ArticleId><ArticleId IdType="doi">10.1016/j.ijcard.2017.10.077</ArticleId><ArticleId IdType="pii">S0167-5273(17)33562-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30336845</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>14</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>121</Volume><Issue>5</Issue><PubDate><Year>2018</Year><Month>Nov</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Systematic review and consensus definitions for the Standardised Endpoints in Perioperative Medicine (StEP) initiative: renal endpoints.</ArticleTitle><Pagination><StartPage>1013</StartPage><EndPage>1024</EndPage><MedlinePgn>1013-1024</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2018.08.010</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(18)30652-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Renal injury is a common perioperative complication. The adoption of renal endpoints, standardised and valid for use in perioperative clinical trials, would enhance the quality of perioperative clinical research. The Standardised Endpoints in Perioperative Medicine (StEP) initiative was established to derive standardised endpoints for use in perioperative clinical trials.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review was conducted to identify renal endpoints currently reported in perioperative clinical trials. In parallel, an initial list of candidate endpoints was developed based on renal theme group expertise. A multi-round Delphi consensus process was used to refine this list and produce a suite of recommended perioperative renal outcome measures.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Based on our systematic review, 63 studies were included for analysis. Marked heterogeneity and imprecision of endpoint definitions were observed. Our initial list of candidate endpoints included 10 endpoints for consideration. The response rates for Delphi rounds 1, 2, and 3 were 89% (n=16), 90% (n=75), and 100% (n=6), respectively. A final list of four renal endpoints was identified: acute kidney injury defined by the Kidney Disease: Improving Global Outcomes (KDIGO) consensus criteria, acute kidney disease defined by &#x2265;30% decline in estimated glomerular filtration rate from baseline at 30 days after operation in patients meeting the acute-kidney-injury criteria within 7 days of surgery, the composite of death or renal replacement therapy, and the Major Adverse Kidney Events (MAKE) composite.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We identified four key renal outcome measures that should be considered for use in perioperative clinical trials. Using standardised definitions to capture and report these endpoints will facilitate improved benchmarking and meta-analysis of future trials.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McIlroy</LastName><ForeName>D R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia &amp; Perioperative Medicine, Alfred Hospital and Monash University, Melbourne, Vic, Australia. Electronic address: D.mcilroy@alfred.org.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, Vic, Australia; Australian and New Zealand Intensive Care Research Centre, Monash University School of Public Health and Preventive Medicine, Melbourne, Vic, Australia; School of Medicine, University of Melbourne, Melbourne, Vic, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Billings</LastName><ForeName>F T</ForeName><Initials>FT</Initials><Suffix>4th</Suffix><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karkouti</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Management, University of Toronto, Toronto, ON, Canada; Toronto General Hospital Research Institute, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prowle</LastName><ForeName>J R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Medicine Research Group, William Harvey Research Institute, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>A D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myles</LastName><ForeName>P S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia &amp; Perioperative Medicine, Alfred Hospital and Monash University, Melbourne, Vic, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D032921" MajorTopicYN="N">Consensus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023381" MajorTopicYN="N">Endpoint Determination</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="Y">Kidney</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007677" MajorTopicYN="N">Kidney Function Tests</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012015" MajorTopicYN="N">Reference Standards</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anaesthesia</Keyword><Keyword MajorTopicYN="N">clinical trials</Keyword><Keyword MajorTopicYN="N">complications</Keyword><Keyword MajorTopicYN="N">kidney</Keyword><Keyword MajorTopicYN="N">outcome measures</Keyword><Keyword MajorTopicYN="N">postoperative outcomes</Keyword><Keyword MajorTopicYN="N">surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30336845</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2018.08.010</ArticleId><ArticleId IdType="pii">S0007-0912(18)30652-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24103711</PMID><DateCompleted><Year>2014</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>6</Issue><PubDate><Year>2013</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Reducing mortality in acute kidney injury patients: systematic review and international web-based survey.</ArticleTitle><Pagination><StartPage>1384</StartPage><EndPage>1398</EndPage><MedlinePgn>1384-98</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2013.06.028</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(13)00390-X</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To identify all interventions that increase or reduce mortality in patients with acute kidney injury (AKI) and to establish the agreement between stated beliefs and actual practice in this setting.</AbstractText><AbstractText Label="DESIGN AND SETTING" NlmCategory="METHODS">Systematic literature review and international web-based survey.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">More than 300 physicians from 62 countries.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Several databases, including MEDLINE/PubMed, were searched with no time limits (updated February 14, 2012) to identify all the drugs/techniques/strategies that fulfilled all the following criteria: (a) published in a peer-reviewed journal, (b) dealing with critically ill adult patients with or at risk for acute kidney injury, and (c) reporting a statistically significant reduction or increase in mortality.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">Of the 18 identified interventions, 15 reduced mortality and 3 increased mortality. Perioperative hemodynamic optimization, albumin in cirrhotic patients, terlipressin for hepatorenal syndrome type 1, human immunoglobulin, peri-angiography hemofiltration, fenoldopam, plasma exchange in multiple-myeloma-associated AKI, increased intensity of renal replacement therapy (RRT), CVVH in severely burned patients, vasopressin in septic shock, furosemide by continuous infusion, citrate in continuous RRT, N-acetylcysteine, continuous and early RRT might reduce mortality in critically ill patients with or at risk for AKI; positive fluid balance, hydroxyethyl starch and loop diuretics might increase mortality in critically ill patients with or at risk for AKI. Web-based opinion differed from consensus opinion for 30% of interventions and self-reported practice for 3 interventions.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The authors identified all interventions with at least 1 study suggesting a significant effect on mortality in patients with or at risk of AKI and found that there is discordance between participant stated beliefs and actual practice regarding these topics.</AbstractText><CopyrightInformation>Copyright &#xa9; 2013 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, San Raffaele Scientific Institute, Milan, Italy. Electronic address: landoni.giovanni@hsr.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bove</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Sz&#xe9;kely</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Comis</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Rodseth</LastName><ForeName>Reitze N</ForeName><Initials>RN</Initials></Author><Author ValidYN="Y"><LastName>Pasero</LastName><ForeName>Daniela</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Ponschab</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Mucchetti</LastName><ForeName>Marta</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Bove</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Azzolini</LastName><ForeName>Maria L</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Caramelli</LastName><ForeName>Fabio</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Paternoster</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Pala</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Cabrini</LastName><ForeName>Luca</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Amitrano</LastName><ForeName>Daniele</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Borghi</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Capasso</LastName><ForeName>Antonella</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Cariello</LastName><ForeName>Claudia</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Carpanese</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Feltracco</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Gottin</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Lobreglio</LastName><ForeName>Rosetta</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Mattioli</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Monaco</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Morgese</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Musu</LastName><ForeName>Mario</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Pasin</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Pisano</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Roasio</LastName><ForeName>Agostino</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Russo</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Slaviero</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Villari</LastName><ForeName>Nicola</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Vittorio</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Zucchetti</LastName><ForeName>Mariachiara</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Guarracino</LastName><ForeName>Fabio</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Morelli</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>De Santis</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Del Sarto</LastName><ForeName>Paolo A</ForeName><Initials>PA</Initials></Author><Author ValidYN="Y"><LastName>Corcione</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Ranieri</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Finco</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Zangrillo</LastName><ForeName>Alberto</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019538" MajorTopicYN="N">Health Care Surveys</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="N">Monitoring, Intraoperative</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney failure</Keyword><Keyword MajorTopicYN="N">acute renal injury</Keyword><Keyword MajorTopicYN="N">anesthesia</Keyword><Keyword MajorTopicYN="N">consensus</Keyword><Keyword MajorTopicYN="N">consensus conference</Keyword><Keyword MajorTopicYN="N">critical care</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">renal failure</Keyword><Keyword MajorTopicYN="N">survival</Keyword><Keyword MajorTopicYN="N">web vote</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24103711</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2013.06.028</ArticleId><ArticleId IdType="pii">S1053-0770(13)00390-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26703329</PMID><DateCompleted><Year>2016</Year><Month>07</Month><Day>06</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><PubDate><Year>2015</Year><Month>Dec</Month><Day>25</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Fenoldopam to prevent acute kidney injury after major surgery-a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>449</StartPage><MedlinePgn>449</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">449</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-015-1166-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute kidney injury (AKI) after surgery is associated with increased mortality and healthcare costs. Fenoldopam is a selective dopamine-1 receptor agonist with renoprotective properties. We conducted a systematic review and meta-analysis of randomised controlled trials comparing fenoldopam with placebo to prevent AKI after major surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched EMBASE, PubMed, meta-Register of randomised controlled trials and Cochrane CENTRAL databases for trials comparing fenoldopam with placebo in patients undergoing major surgery. The primary outcome was incidence of new AKI. Secondary outcomes were requirement for renal replacement therapy and hospital mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eighty-three publications were screened; 23 studies underwent full data extraction and scoring. Six trials were suitable for inclusion in the data synthesis (total of 507 subjects undergoing cardiovascular surgery, partial nephrectomy, liver transplant surgery). Five studies were rated at high risk of bias. Data on post-operative incidence of AKI were available in five of the six trials (total of 471 patients) but definitions of AKI varied between studies. Of the 238 patients receiving fenoldopam, 45 (18.9%) developed AKI compared to 62 (26.6%) of the 233 patients who received placebo (p&#x2009;=&#x2009;0.004, I (2)&#x2009;=&#x2009;0 %; random-effects model odds ratio 0.46, 95% confidence interval 0.27-0.79). In patients treated with fenoldopam, there was no difference in renal replacement therapy (n&#x2009;=&#x2009;478; p&#x2009;=&#x2009;0.11, I (2)&#x2009;=&#x2009;47%; fixed-effect model odds ratio 0.27, 95% confidence interval 0.06-1.19) or hospital mortality (p&#x2009;=&#x2009;0.60, I (2)&#x2009;=&#x2009;0 %; fixed-effect model odds ratio 1.0, 95% confidence interval 0.14-7.37).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In this analysis, peri-operative treatment with fenoldopam was associated with a significant reduction in post-operative AKI but it had no impact on renal replacement therapy or hospital mortality. Equipoise remains for further large trials in this area since the studies were conducted in three types of surgery, the majority of studies were rated at high risk of bias and the criteria for AKI varied between trials.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gillies</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Critical Care &amp; Pain Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK. Michael.Gillies@ed.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kakar</LastName><ForeName>Vivek</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Critical Care, King's College Hospital NHS Foundation Hospital, London, UK. v.kakar@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parker</LastName><ForeName>Robert J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Aintree University Hospital NHS Foundation Hospital, Department of Critical Care Medicine, Liverpool, UK. robertparker@doctors.org.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Honor&#xe9;</LastName><ForeName>Patrick M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of ICU, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB University), Brussels, Belgium. Patrick.Honore@uzbrussel.be.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostermann</LastName><ForeName>Marlies</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nephrology &amp; Critical Care Medicine, King's College London, Guy's &amp; St Thomas' Foundation Hospital, London, UK. Marlies.Ostermann@gstt.nhs.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>12</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>INU8H2KAWG</RegistryNumber><NameOfSubstance UI="D018818">Fenoldopam</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018818" MajorTopicYN="N">Fenoldopam</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>12</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>12</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>12</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26703329</ArticleId><ArticleId IdType="pmc">PMC4699343</ArticleId><ArticleId IdType="doi">10.1186/s13054-015-1166-4</ArticleId><ArticleId IdType="pii">10.1186/s13054-015-1166-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carmichael P, Carmichael AR. Acute renal failure in the surgical setting. ANZ J Surg. 2003;73:144&#x2013;53. doi: 10.1046/j.1445-2197.2003.02640.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1445-2197.2003.02640.x</ArticleId><ArticleId IdType="pubmed">12608979</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Englesbe MJ, O&#x2019;Reilly M, Shanks AM, Fetterman DM, et al. Predictors of postoperative acute renal failure after non-cardiac surgery in patients with previously normal renal function. Anesthesiology. 2007;107:892&#x2013;902. doi: 10.1097/01.anes.0000290588.29668.38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.anes.0000290588.29668.38</ArticleId><ArticleId IdType="pubmed">18043057</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16:3365&#x2013;70. doi: 10.1681/ASN.2004090740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2004090740</ArticleId><ArticleId IdType="pubmed">16177006</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols AJ, Ruffolo RR, Jr, Brooks DP. The pharmacology of fenoldopam. Am J Hypertens. 1990;3:116S&#x2013;9S.</Citation><ArticleIdList><ArticleId IdType="pubmed">1974439</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpenny M, Rushe C, Breen P, Cunningham AJ, Boucher-Hayes D, Shorten GD. The effects of fenoldopam on renal function in patients undergoing elective aortic surgery. Eur J Anesthesiol. 2002;19:32&#x2013;9. doi: 10.1097/00003643-200201000-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003643-200201000-00005</ArticleId><ArticleId IdType="pubmed">11913801</ArticleId></ArticleIdList></Reference><Reference><Citation>Caimmi PP, Pagani L, Micalizzi E, Fiume C, Guani S, Bernardi M, et al. Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2003;17:491&#x2013;4. doi: 10.1016/S1053-0770(03)00155-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1053-0770(03)00155-1</ArticleId><ArticleId IdType="pubmed">12968238</ArticleId></ArticleIdList></Reference><Reference><Citation>Aravindan N, Natarajan M, Shaw AD. Fenoldopam inhibits nuclear translocation of nuclear factor kappa B in a rat model of surgical ischaemic acute renal failure. J Cardiothorac Vasc Anesth. 2006;20:179&#x2013;86. doi: 10.1053/j.jvca.2005.03.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2005.03.028</ArticleId><ArticleId IdType="pubmed">16616657</ArticleId></ArticleIdList></Reference><Reference><Citation>Landoni G, Biondi-Zoccai GG, Tumlin JA, Bove T, De Luca M, Calabr&#xf2; MG, et al. Beneficial impact of fenoldopam in critically ill patients with or at risk of acute renal failure: a meta-analysis of randomised clinical trials. Am J Kidney Dis. 2007;49(1):56&#x2013;68. doi: 10.1053/j.ajkd.2006.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2006.10.013</ArticleId><ArticleId IdType="pubmed">17185146</ArticleId></ArticleIdList></Reference><Reference><Citation>Landoni G, Biondi-Zoccai GG, Marino G, Bove T, Fochi O, Maj G, et al. Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis. J Cardiothorac Vasc Anesth. 2008;22(1):27&#x2013;33. doi: 10.1053/j.jvca.2007.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2007.07.015</ArticleId><ArticleId IdType="pubmed">18249327</ArticleId></ArticleIdList></Reference><Reference><Citation>Zangrillo A, Biondi-Zoccai GG, Frati E, Covello RD, Cabrini L, Guarracino F, et al. Fenoldopam and acute renal failure in cardiac surgery: a meta-analysis of randomized placebo-controlled trials. J Cardiothorac Vasc Anesth. 2012;26(3):407&#x2013;13. doi: 10.1053/j.jvca.2012.01.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2012.01.038</ArticleId><ArticleId IdType="pubmed">22459931</ArticleId></ArticleIdList></Reference><Reference><Citation>Joannidis M, Druml W, Forni LG, Groeneveld AB, Honore P, Oudemans-van Straaten HM, et al. Prevention of acute kidney injury and protection of renal function in the intensive care unit&#x2014;expert opinion of the working group of nephrology. ESICM. Intensive Care Med. 2010;26:392&#x2013;411. doi: 10.1007/s00134-009-1678-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-009-1678-y</ArticleId><ArticleId IdType="pubmed">19921152</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int (Suppl). 2012;1&#x2013;138.</Citation></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, The ADG, PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi: 10.1371/journal.pmed.1000097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000097</ArticleId><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, Gotzsche PC, J&#xfc;ni P, Moher D, Oxman AD, et al. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi: 10.1136/bmj.d5928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Barr LF, Kolodner K. N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery. Crit Care Med. 2008;36:1427&#x2013;35. doi: 10.1097/CCM.0b013e31816f48ba.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31816f48ba</ArticleId><ArticleId IdType="pubmed">18434903</ArticleId></ArticleIdList></Reference><Reference><Citation>Cogliati AA, Vellutini R, Nardini A, Urovi S, Hamdan M, Landoni G, et al. Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: a randomized clinical study. J Cardiothorac Vasc Anesth. 2007;21(6):847&#x2013;50. doi: 10.1053/j.jvca.2007.02.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2007.02.022</ArticleId><ArticleId IdType="pubmed">18068064</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranucci M, De Benedetti D, Bianchini C, Castelvecchio S, Ballotta A, Frigiola A, et al. Effects of fenoldopam infusion in complex cardiac surgical operations: a prospective, randomized, double-blind, placebo-controlled study. Minerva Anestesiol. 2010;76(4):249&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">20332738</ArticleId></ArticleIdList></Reference><Reference><Citation>Biancofiore G, Della Rocca G, Bindi L, Romanelli A, Esposito M, Meacci L, et al. Use of fenoldopam to control renal dysfunction early after liver transplantation. Liver Transpl. 2004;10:986&#x2013;92. doi: 10.1002/lt.20145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lt.20145</ArticleId><ArticleId IdType="pubmed">15390323</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Hara JF, Mahboobi R, Novak SM, Bonilla AM, Mascha EJ, Fergany AF, et al. Fenoldopam and renal function after partial nephrectomy in a solitary kidney: a randomized, blinded trial. Urology. 2013;81:340&#x2013;6. doi: 10.1016/j.urology.2012.09.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.urology.2012.09.041</ArticleId><ArticleId IdType="pubmed">23374797</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste E, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41:1411&#x2013;23. doi: 10.1007/s00134-015-3934-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3934-7</ArticleId><ArticleId IdType="pubmed">26162677</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson CE, Yavas S, Segal MS, Schold JD, Tribble CG, Layon AJ, et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation. 2009;119:2444&#x2013;53. doi: 10.1161/CIRCULATIONAHA.108.800011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.800011</ArticleId><ArticleId IdType="pubmed">19398670</ArticleId></ArticleIdList></Reference><Reference><Citation>Bihorac A, Yavas S, Subbiah S, Hobson CE, Schold JD, Gabrielli A, et al. Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg. 2009;249(5):851&#x2013;8. doi: 10.1097/SLA.0b013e3181a40a0b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e3181a40a0b</ArticleId><ArticleId IdType="pubmed">19387314</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang IY, Murray PT. Prevention of perioperative acute renal failure: what works? Best Pract Res Clin Anesthesiol. 2004;18:91&#x2013;111. doi: 10.1016/j.bpa.2003.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2003.09.006</ArticleId><ArticleId IdType="pubmed">14760876</ArticleId></ArticleIdList></Reference><Reference><Citation>Bove T, Zangrillo A, Guarracino F, Alvaro G, Persi B, Maglioni E, et al. Effect of Fenoldopam on use of renal replacement therapy among patients with acute kidney injury after cardiac surgery: A randomized clinical trial. JAMA. 2014;312(21):2244&#x2013;53. doi: 10.1001/jama.2014.13573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.13573</ArticleId><ArticleId IdType="pubmed">25265449</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32947294</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>132</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Retrograde Autologous Priming in Cardiac Surgery: Results From a Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>100</StartPage><EndPage>107</EndPage><MedlinePgn>100-107</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000005151</ELocationID><Abstract><AbstractText Label="BACKGROUND">Retrograde autologous priming (RAP) before cardiopulmonary bypass (CPB) may minimize allogeneic red cell transfusion. We conducted a systematic review of the literature to examine the impact of RAP on perioperative allogeneic red cell transfusions in cardiac surgical patients.</AbstractText><AbstractText Label="METHODS">This study involved a systematic review and meta-analysis of randomized controlled trials (RCTs) and observational studies evaluating the use of RAP in cardiac surgery involving CPB. The primary outcome was intraoperative allogeneic red cell transfusion. Secondary outcomes included whole hospital allogeneic transfusions and adverse events such as acute kidney injury (AKI) and stroke.</AbstractText><AbstractText Label="RESULTS">A total of 11 RCTs (n = 1337 patients) were included, comparing RAP patients (n = 674) to control (n = 663). In addition, 10 observational studies (n = 2327) were included, comparing RAP patients (n = 1257) to control (n = 1070). Overall, RAP was associated with a significantly reduced incidence of intraoperative red cell transfusion (n = 18 studies; odds ratio [OR] = 0.34; 95% confidence interval [CI], 0.22-0.55, P &lt; .001) compared to controls. This effect was seen among RCTs (n = 10 studies; OR = 0.19; 95% CI, 0.08-0.45, P &lt; .001) and observational studies (n = 8 studies; OR = 0.66; 95% CI, 0.50-0.87, P = .004) in isolation. RAP was also associated with a significantly reduced incidence of whole hospital red cell transfusion (n = 5 studies; OR = 0.28; 95% CI, 0.19-0.41, P &lt; .001). Among the studies that reported AKI and stroke outcomes, there was no statistically significant increased odds of AKI or stroke in either RAP or control patients.</AbstractText><AbstractText Label="CONCLUSIONS">Based on the pooled results of the available literature, RAP is associated with a significant reduction in intraoperative and whole hospital allogeneic red cell transfusion. Use of RAP may prevent hemodilution of cardiac surgical patients and thus, lessen transfusions. Additional high-quality prospective studies are necessary to determine the ideal priming volume necessary to confer the greatest benefit without incurring organ injury.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hensley</LastName><ForeName>Nadia B</ForeName><Initials>NB</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology/Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gyi</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology/Critical Care Medicine, The Johns Hopkins University, School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zorrilla-Vaca</LastName><ForeName>Andres</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Universidad del Valle School of Medicine, Cali, Columbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Chun W</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawton</LastName><ForeName>Jennifer S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Charles H</ForeName><Initials>CH</Initials><Suffix>4th</Suffix><AffiliationInfo><Affiliation>Department of Anesthesiology/Critical Care Medicine, The Johns Hopkins University, School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frank</LastName><ForeName>Steve M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology/Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grant</LastName><ForeName>Michael C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology/Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Brian C</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology/Critical Care Medicine, The Johns Hopkins University, School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Anesth Analg. 2021 Jan;132(1):98-99. doi: 10.1213/ANE.0000000000005286.</RefSource><PMID Version="1">33315607</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001804" MajorTopicYN="N">Blood Transfusion, Autologous</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>18</Day><Hour>20</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32947294</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000005151</ArticleId><ArticleId IdType="pii">00000539-202101000-00017</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ferraris VA, Brown JR, Despotis GJ, et al.; Society of Thoracic Surgeons Blood Conservation Guideline Task Force. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011;91:944&#x2013;982.</Citation></Reference><Reference><Citation>Pfuntner A, Wier LM, Stocks C. Most frequent procedures performed in US hospitals, 2010: statistical brief #149. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. 2006.Rockville, MD: Agency for Healthcare Research and Quality (US);</Citation></Reference><Reference><Citation>Panico FG, Neptune WB. A mechanism to eliminate the donor blood prime from the pump-oxygenator. Surg Forum. 1960;10:605&#x2013;609.</Citation></Reference><Reference><Citation>Rosengart TK, DeBois W, O&#x2019;Hara M, et al. Retrograde autologous priming for cardiopulmonary bypass: a safe and effective means of decreasing hemodilution and transfusion requirements. J Thorac Cardiovasc Surg. 1998;115:426&#x2013;438.</Citation></Reference><Reference><Citation>Wahba A, Milojevic M, Boer C, et al. 2019 EACTS/EACTA/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery. Eur J Cardiothorac Surg. 2020;57:210&#x2013;251.</Citation></Reference><Reference><Citation>Higgins JP, Altman DG, G&#xf8;tzsche PC, et al.; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.</Citation></Reference><Reference><Citation>Hultcrantz M, Rind D, Akl EA, et al. The GRADE Working Group clarifies the construct of certainty of evidence. J Clin Epidemiol. 2017;87:4&#x2013;13.</Citation></Reference><Reference><Citation>Cheng M, Li JQ, Wu TC, Tian WC. Short-term effects and safety analysis of retrograde autologous blood priming for cardiopulmonary bypass in patients with cardiac valve replacement surgery. Cell Biochem Biophys. 2015;73:441&#x2013;446.</Citation></Reference><Reference><Citation>Hofmann B, Kaufmann C, Stiller M, et al. Positive impact of retrograde autologous priming in adult patients undergoing cardiac surgery: a randomized clinical trial. J Cardiothorac Surg. 2018;13:50.</Citation></Reference><Reference><Citation>Hou X, Yang F, Liu R, et al. Retrograde autologous priming of the cardiopulmonary bypass circuit reduces blood transfusion in small adults: a prospective, randomized trial. Eur J Anaesthesiol. 2009;26:1061&#x2013;1066.</Citation></Reference><Reference><Citation>Reges RV, Vicente WV, Rodrigues AJ, et al. Retrograde autologous priming in cardiopulmonary bypass in adult patients: effects on blood transfusion and hemodilution. Rev Bras Cir Cardiovasc. 2011;26:609&#x2013;616.</Citation></Reference><Reference><Citation>Rousou JA, Engelman RM, Flack JE III, Deaton DW, Garb JL, Owen SG. The &#x2018;primeless pump&#x2019;: a novel technique for intraoperative blood conservation. Cardiovasc Surg. 1999;7:228&#x2013;235.</Citation></Reference><Reference><Citation>Saxena P, Saxena N, Jain A, Sharma VK. Intraoperative autologous blood donation and retrograde autologous priming for cardiopulmonary bypass: a safe and effective technique for blood conservation. Ann Card Anaesth. 2003;6:47&#x2013;51.</Citation></Reference><Reference><Citation>Shapira OM, Aldea GS, Treanor PR, et al. Reduction of allogeneic blood transfusions after open heart operations by lowering cardiopulmonary bypass prime volume. Ann Thorac Surg. 1998;65:724&#x2013;730.</Citation></Reference><Reference><Citation>Sobieski MA 2nd, Slaughter MS, Hart DE, Pappas PS, Tatooles AJ. Prospective study on cardiopulmonary bypass prime reduction and its effect on intraoperative blood product and hemoconcentrator use. Perfusion. 2005;20:31&#x2013;37.</Citation></Reference><Reference><Citation>Ancheri SA, Rao SV. Retrograde autologous priming reduces transfusion requirements during CPB. Indian J Appl Res. 2016;6:20&#x2013;24.</Citation></Reference><Reference><Citation>Kearsey C, Thekkudan J, Robbins S, Ng A, Lakshmanan S, Luckraz H. Assessing the effectiveness of retrograde autologous priming of the cardiopulmonary bypass machine in isolated coronary artery bypass grafts. Ann R Coll Surg Engl. 2013;95:207&#x2013;210.</Citation></Reference><Reference><Citation>Nanjappa A, Gill J, Sadat U, Colah S, Abu-Omar Y, Nair S. The effect of retrograde autologous priming on intraoperative blood product transfusion in coronary artery bypass grafting. Perfusion. 2013;28:530&#x2013;535.</Citation></Reference><Reference><Citation>Severdija EE, Heijmans JH, Theunissen M, Maessen JG, Roekaerts PH, Weerwind PW. Retrograde autologous priming reduces transfusion requirements in coronary artery bypass surgery. Perfusion. 2011;26:315&#x2013;321.</Citation></Reference><Reference><Citation>Teman N, Delavari N, Romano M, Prager R, Yang B, Haft J. Effects of autologous priming on blood conservation after cardiac surgery. Perfusion. 2014;29:333&#x2013;339.</Citation></Reference><Reference><Citation>Vandewiele K, Bov&#xe9; T, De Somer FM, et al. The effect of retrograde autologous priming volume on haemodilution and transfusion requirements during cardiac surgery. Interact Cardiovasc Thorac Surg. 2013;16:778&#x2013;783.</Citation></Reference><Reference><Citation>Williams HC, Schiller W, Mellert F, Fimmers R, Welz A, Probst C. Retrograde autologous priming in surgery of thoracic aortic aneurysm. Interact Cardiovasc Thorac Surg. 2019;28:876&#x2013;883.</Citation></Reference><Reference><Citation>Zelinka ES, Ryan P, McDonald J, Larson J. Retrograde autologous prime with shortened bypass circuits decreases blood transfusion in high-risk coronary artery surgery patients. J Extra Corpor Technol. 2004;36:343&#x2013;347.</Citation></Reference><Reference><Citation>Balachandran S, Cross MH, Karthikeyan S, Mulpur A, Hansbro SD, Hobson P. Retrograde autologous priming of the cardiopulmonary bypass circuit reduces blood transfusion after coronary artery surgery. Ann Thorac Surg. 2002;73:1912&#x2013;1918.</Citation></Reference><Reference><Citation>Hwang J, Huh J, Kim J, et al. The effect of retrograde autologous priming of the cardiopulmonary bypass circuit on cerebral oxygenation. J Cardiothorac Vasc Anesth. 2011;25:995&#x2013;999.</Citation></Reference><Reference><Citation>Trapp C, Schiller W, Mellert F, et al. Retrograde autologous priming as a safe and easy method to reduce hemodilution and transfusion requirements during cardiac surgery. Thorac Cardiovasc Surg. 2015;63:628&#x2013;634.</Citation></Reference><Reference><Citation>Murphy GS, Szokol JW, Nitsun M, et al. The failure of retrograde autologous priming of the cardiopulmonary bypass circuit to reduce blood use after cardiac surgical procedures. Anesth Analg. 2004;98:1201&#x2013;1207.</Citation></Reference><Reference><Citation>Sun P, Ji B, Sun Y, et al. Effects of retrograde autologous priming on blood transfusion and clinical outcomes in adults: a meta-analysis. Perfusion. 2013;28:238&#x2013;243.</Citation></Reference><Reference><Citation>Saczkowski R, Bernier PL, Tchervenkov CI, Arellano R. Retrograde autologous priming and allogeneic blood transfusions: a meta-analysis. Interact Cardiovasc Thorac Surg. 2009;8:373&#x2013;376.</Citation></Reference><Reference><Citation>Walsh M, Devereaux PJ, Garg AX, et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology. 2013;119:507&#x2013;515.</Citation></Reference><Reference><Citation>Sun LY, Chung AM, Farkouh ME, et al. Defining an intraoperative hypotension threshold in association with atroke in cardiac surgery. Anesthesiology. 2018;129:440&#x2013;447.</Citation></Reference><Reference><Citation>Joshi B, Ono M, Brown C, et al. Predicting the limits of cerebral autoregulation during cardiopulmonary bypass. Anesth Analg. 2012;114:503&#x2013;510.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36571785</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1816-5370</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Asian cardiovascular &amp; thoracic annals</Title><ISOAbbreviation>Asian Cardiovasc Thorac Ann</ISOAbbreviation></Journal><ArticleTitle>Systematic review and network meta-analysis of various nadir temperature strategies for hypothermic circulatory arrest for aortic arch surgery.</ArticleTitle><Pagination><StartPage>102</StartPage><EndPage>114</EndPage><MedlinePgn>102-114</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/02184923221144959</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The optimal nadir temperature for hypothermic circulatory arrest during aortic arch surgery remains unclear. We aimed to assess and compare clinical outcomes of all three temperature strategies (deep, moderate, and mild hypothermia) using a network meta-analysis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">After literature search with MEDLINE and EMBASE through December 2021, studies comparing clinical outcomes with deep (&lt;20&#xb0;C), moderate (20-28&#xb0;C), or mild (&gt;28&#xb0;C) hypothermic circulatory arrest were included. The outcomes of interest were perioperative mortality, stroke, transient ischemia attack (TIA), acute kidney injury (AKI), postoperative bleeding, operative time, and length of hospital stay.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-four comparative studies were identified, including 6018 patients undergoing aortic arch surgery using hypothermic circulatory arrest (deep: 2,978, moderate: 2,525, and mild: 515). Compared to deep hypothermia, mild and moderate hypothermia were associated with lower mortality (mild vs. deep: odds ratio [OR] 0.50; 95% confidence interval (CI) 0.29-0.87, moderate vs. deep: OR 0.68; 95% CI 0.54-0.86). In addition, mild hypothermia was associated with lower stroke (OR 0.50; 95% CI 0.28-0.89), AKI (OR 0.36; 95% CI 0.15-0.88) and postoperative bleeding (OR 0.55; 95% CI 0.31-0.97) compared to deep hypothermia. There was no significant difference between mild and moderate hypothermia in mortality, AKI or bleeding occurrence, while mild hypothermia was associated with shorter operative time and hospital stay. There was no significant difference in TIA rate among three groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Mild hypothermia was associated with overall more favorable clinical outcomes with comparable neurological complications compared to deep hypothermia. Furthermore, considering the shorter operative time and hospital stay compared with moderate hypothermia, mild hypothermia may be warranted when appropriate adjunctive cerebral perfusion is employed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shimamura</LastName><ForeName>Junichi</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-7980-5036</Identifier><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Department of Surgery, 10033London Health Sciences Centre, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yokoyama</LastName><ForeName>Yujiro</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-8552-9496</Identifier><AffiliationInfo><Affiliation>Department of Surgery, 14352Easton Hospital, Easton, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuno</LastName><ForeName>Toshiki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical center, Albert Einstein Medical College, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujisaki</LastName><ForeName>Tomohiro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai St Luke's and West, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fukuhara</LastName><ForeName>Shinichi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, University of Michigan Cardiovascular Center, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takayama</LastName><ForeName>Hiroo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Cardiothoracic Surgery, Department of Surgery, New York Presbyterian Hospital, Columbia University Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ota</LastName><ForeName>Takeyoshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Section of Cardiac and Thoracic Surgery, Department of Surgery, 2462The University of Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Michael Wa</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Department of Surgery, 10033London Health Sciences Centre, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000099094">Network Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Asian Cardiovasc Thorac Ann</MedlineTA><NlmUniqueID>9503417</NlmUniqueID><ISSNLinking>0218-4923</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001013" MajorTopicYN="N">Aorta, Thoracic</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013696" MajorTopicYN="N">Temperature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007035" MajorTopicYN="Y">Hypothermia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="Y">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050792" MajorTopicYN="N">Circulatory Arrest, Deep Hypothermia Induced</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010477" MajorTopicYN="N">Perfusion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002560" MajorTopicYN="N">Cerebrovascular Circulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007036" MajorTopicYN="Y">Hypothermia, Induced</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aortic arch</Keyword><Keyword MajorTopicYN="N">hypothermic circulatory arrest</Keyword><Keyword MajorTopicYN="N">network meta-analysis</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>26</Day><Hour>12</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36571785</ArticleId><ArticleId IdType="doi">10.1177/02184923221144959</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35917847</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-2291</ISSN><JournalIssue CitedMedium="Internet"><Volume>72</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Season>Nov-Dec</Season></PubDate></JournalIssue><Title>Brazilian journal of anesthesiology (Elsevier)</Title><ISOAbbreviation>Braz J Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Intraoperative fluid balance and cardiac surgery-associated acute kidney injury: a multicenter prospective study.</ArticleTitle><Pagination><StartPage>688</StartPage><EndPage>694</EndPage><MedlinePgn>688-694</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bjane.2022.07.006</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0104-0014(22)00089-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">Recent data suggest the regime of fluid therapy intraoperatively in patients undergoing major surgeries may interfere in patient outcomes. The development of postoperative Acute Kidney Injury (AKI) has been associated with both Restrictive Fluid Balance (RFB) and Liberal Fluid Balance (LFB) during non-cardiac surgery. In patients undergoing cardiac surgery, this influence remains unclear. The study objective was to evaluate the relationship between intraoperative RFB vs. LFB and the incidence of Cardiac-Surgery-Associated AKI (CSA-AKI) and major postoperative outcomes in patients undergoing on-pump Coronary Artery Bypass Grafting (CABG).</AbstractText><AbstractText Label="METHODS">This prospective, multicenter, observational cohort study was set at two high-complexity university hospitals in Brazil. Adult patients who required postoperative intensive care after undergoing elective on-pump CABG were allocated to two groups according to their intraoperative fluid strategy (RFB or LFB) with no intervention.</AbstractText><AbstractText Label="RESULTS">The primary endpoint was CSA-AKI. The secondary outcomes were in-hospital mortality, cardiovascular complications, ICU Length of Stay (ICU-LOS), and Hospital LOS (H-LOS). After propensity score matching, 180 patients remained in each group. There was no difference in risk of CSA-AKI between the two groups (RR&#xa0;=&#xa0;1.15; 95% CI, 0.85-1.56, p&#xa0;=&#xa0;0.36). The in-hospital mortality, H-LOS and cardiovascular complications were higher in the LFB group. ICU-LOS was not significantly different between the two groups. ROCcurve analysis determined a fluid balance above 2500 mL to accurately predict in-hospital mortality.</AbstractText><AbstractText Label="CONCLUSION">Patients undergoing on-pump CABG with LFB when compared with patients with RFB present similar CSA-AKI rates and ICU-LOS, but higher in-hospital mortality, cardiovascular complications, and H-LOS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Palomba</LastName><ForeName>Henrique</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Hospital Alem&#xe3;o Oswaldo Cruz, Departamento de Medicina Intensiva, S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Treml</LastName><ForeName>Ricardo E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Friedrich-Schiller-University, Department of Anaesthesiology and Intensive Care Medicine, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caldonazo</LastName><ForeName>Tulio</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Friedrich-Schiller-University, Department of Cardiothoracic Surgery, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katayama</LastName><ForeName>Henrique T</ForeName><Initials>HT</Initials><AffiliationInfo><Affiliation>Universidade de S&#xe3;o Paulo, Departamento de Anestesiologia, S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomes</LastName><ForeName>Brenno C</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Universidade Federal do Paran&#xe1;, Departamento de Medicina Integrada, Setor de Ci&#xea;ncias da Sa&#xfa;de, Curitiba, PR, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malbouisson</LastName><ForeName>Luiz M S</ForeName><Initials>LMS</Initials><AffiliationInfo><Affiliation>Universidade de S&#xe3;o Paulo, Departamento de Anestesiologia, S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva Junior</LastName><ForeName>Jo&#xe3;o Manoel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Universidade de S&#xe3;o Paulo, Departamento de Anestesiologia, S&#xe3;o Paulo, SP, Brazil. Electronic address: joao.s@usp.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Braz J Anesthesiol</MedlineTA><NlmUniqueID>101624623</NlmUniqueID><ISSNLinking>0104-0014</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="Y">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014882" MajorTopicYN="N">Water-Electrolyte Balance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">Cardiovascular disease</Keyword><Keyword MajorTopicYN="N">Coronary artery bypass</Keyword><Keyword MajorTopicYN="N">Fluid therapy</Keyword></KeywordList><CoiStatement>Conflicts of interest The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>2</Day><Hour>19</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35917847</ArticleId><ArticleId IdType="pmc">PMC9659999</ArticleId><ArticleId IdType="doi">10.1016/j.bjane.2022.07.006</ArticleId><ArticleId IdType="pii">S0104-0014(22)00089-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gumbert SD, Kork F, Jackson ML, et al. Perioperative Acute Kidney Injury. Anesthesiology. 2020;132:180&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10924686</ArticleId><ArticleId IdType="pubmed">31687986</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Lefrant J-Y, Guinot P-G, et al. Effect of individualized vs standard blood pressure management strategies on postoperative organ dysfunction among high-risk patients undergoing major surgery: a randomized clinical trial. JAMA. 2017;318:1346&#x2013;1357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5710560</ArticleId><ArticleId IdType="pubmed">28973220</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson M, Green J, Spiess B, et al. Measurement of blood loss in cardiac surgery: still too much. Ann Thorac Surg. 2018;105:1176&#x2013;1181.</Citation><ArticleIdList><ArticleId IdType="pubmed">29506777</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller TE, Myles PS. Perioperative fluid therapy for major surgery. Anesthesiology. 2019;130:825&#x2013;832.</Citation><ArticleIdList><ArticleId IdType="pubmed">30789364</ArticleId></ArticleIdList></Reference><Reference><Citation>Corredor C, Thomson R, Al-Subaie N. Long-Term Consequences of acute kidney injury after cardiac surgery: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth. 2016;30:69&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">26482483</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar AB, Suneja M, Riou B. Cardiopulmonary bypass&#x2013;associated acute kidney injury. Anesthesiology. 2011;114:964&#x2013;970.</Citation><ArticleIdList><ArticleId IdType="pubmed">21394005</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998;104:343&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pubmed">9576407</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakar CV, Yared JP, Worley S, Cotman K, Paganini EP. Renal dysfunction and serious infections after open-heart surgery. Kidney Int. 2003;64:239&#x2013;246.</Citation><ArticleIdList><ArticleId IdType="pubmed">12787415</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina A, Robba C, Calabr&#xf2; L, et al. Perioperative liberal versus restrictive fluid strategies and postoperative outcomes: a systematic review and metanalysis on randomised-controlled trials in major abdominal elective surgery. Crit Care. 2021;25:205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8194047</ArticleId><ArticleId IdType="pubmed">34116707</ArticleId></ArticleIdList></Reference><Reference><Citation>Varadhan KK, Lobo DN. A meta-analysis of randomised controlled trials of intravenous fluid therapy in major elective open abdominal surgery: getting the balance right. Proc Nutr Soc. 2010;69:488&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">20515521</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles PS, Bellomo R, Corcoran T, et al. Restrictive versus liberal fluid therapy for major abdominal surgery. New Engl J Med. 2018;378:2263&#x2013;2274.</Citation><ArticleIdList><ArticleId IdType="pubmed">29742967</ArticleId></ArticleIdList></Reference><Reference><Citation>Patil VP, Salunke BG. Fluid overload and acute kidney injury. Indian J Crit Care Med. 2020;24(Suppl 3):S94&#x2013;SS7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7347067</ArticleId><ArticleId IdType="pubmed">32704211</ArticleId></ArticleIdList></Reference><Reference><Citation>Osawa EA, Rhodes A, Landoni G, et al. Effect of perioperative goal-directed hemodynamic resuscitation therapy on outcomes following cardiac surgery: a randomized clinical trial and systematic review. Crit Care Med. 2016;44:724&#x2013;733.</Citation><ArticleIdList><ArticleId IdType="pubmed">26646462</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13(1):S31&#x2013;SS4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6398292</ArticleId><ArticleId IdType="pubmed">30930717</ArticleId></ArticleIdList></Reference><Reference><Citation>Berman M, Stamler A, Sahar G, et al. Validation of the 2000 Bernstein-Parsonnet score versus the EuroSCORE as a prognostic tool in cardiac surgery. Ann Thorac Surg. 2006;81:537&#x2013;540.</Citation><ArticleIdList><ArticleId IdType="pubmed">16427846</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannon JW. Hemorrhagic Shock. New Engl J Med. 2018;378:370&#x2013;379.</Citation><ArticleIdList><ArticleId IdType="pubmed">29365303</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva JM, Jr, de Oliveira AM, Nogueira FA, et al. The effect of excess fluid balance on the mortality rate of surgical patients: a multicenter prospective study. Crit Care. 2013;17:R288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057181</ArticleId><ArticleId IdType="pubmed">24326085</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease KDIGO. Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of acute kidney disease. Kidney Int. 2012;2:1&#x2013;141.</Citation></Reference><Reference><Citation>Miller TE, Roche AM, Mythen M. Fluid management and goal-directed therapy as an adjunct to Enhanced Recovery After Surgery (ERAS) Can J Anaesth. 2015;62:158&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">25391735</ArticleId></ArticleIdList></Reference><Reference><Citation>Vives M, Hernandez A, Parramon F, et al. Acute kidney injury after cardiac surgery: prevalence, impact and management challenges. Int J Nephrol Renovasc Dis. 2019;12:153&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6612286</ArticleId><ArticleId IdType="pubmed">31303781</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46:399&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3144483</ArticleId><ArticleId IdType="pubmed">21818162</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega-Loubon C, Fern&#xe1;ndez-Molina M, Carrascal-Hinojal Y, Fulquet-Carreras E. Cardiac surgery-associated acute kidney injury. Ann Card Anaesth. 2016;19:687&#x2013;698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070330</ArticleId><ArticleId IdType="pubmed">27716701</ArticleId></ArticleIdList></Reference><Reference><Citation>Protsyk V, Rasmussen BS, Guarracino F, Erb J, Turton E, Ender J. Fluid Management in cardiac surgery: results of a survey in european cardiac anesthesia departments. J Cardiothorac Vasc Anesth. 2017;31:1624&#x2013;1629.</Citation><ArticleIdList><ArticleId IdType="pubmed">28778778</ArticleId></ArticleIdList></Reference><Reference><Citation>Rettig TCD, Peelen LM, Geuzebroek GSC, et al. Impact of intraoperative hypotension during cardiopulmonary bypass on acute kidney injury after coronary artery bypass grafting. J Cardioth Vasc Anesth. 2017;31:522&#x2013;528.</Citation><ArticleIdList><ArticleId IdType="pubmed">27727080</ArticleId></ArticleIdList></Reference><Reference><Citation>Koc V, Delmas Benito L, de With E, Boerma EC. The effect of fluid overload on attributable morbidity after cardiac surgery: a retrospective study. Crit Care Res Pract. 2020;2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787830</ArticleId><ArticleId IdType="pubmed">33489370</ArticleId></ArticleIdList></Reference><Reference><Citation>Inkinen N, Pettil&#xe4; V, Lakkisto P, et al. Association of endothelial and glycocalyx injury biomarkers with fluid administration, development of acute kidney injury, and 90-day mortality: data from the FINNAKI observational study. Annals Intensive Care. 2019;9:103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6738365</ArticleId><ArticleId IdType="pubmed">31512003</ArticleId></ArticleIdList></Reference><Reference><Citation>Toraman F, Evrenkaya S, Yuce M, et al. Highly positive intraoperative fluid balance during cardiac surgery is associated with adverse outcome. Perfusion. 2004;19:85&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">15162922</ArticleId></ArticleIdList></Reference><Reference><Citation>Vretzakis G, Kleitsaki A, Stamoulis K, et al. Intra-operative intravenous fluid restriction reduces perioperative red blood cell transfusion in elective cardiac surgery, especially in transfusion-prone patients: a prospective, randomized controlled trial. J Cardioth Surg. 2010;5:7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2845571</ArticleId><ArticleId IdType="pubmed">20181257</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassinger AB, Wald EL, Goodman DM. Early postoperative fluid overload precedes acute kidney injury and is associated with higher morbidity in pediatric cardiac surgery patients. Pediatr Crit Care Med. 2014;15:131&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">24366508</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein A, de Souza LV, Belettini CR, et al. Fluid overload and changes in serum creatinine after cardiac surgery: predictors of mortality and longer intensive care stay. A prospective cohort study. Crit Care. 2012;16:R99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3580649</ArticleId><ArticleId IdType="pubmed">22651844</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Echeverri JE, Ligabo EV, Ronco C, Bellomo R. Fluid balance and acute kidney injury. Nat Rev Nephrol. 2010;6:107&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pubmed">20027192</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston WE. PRO: Fluid restriction in cardiac patients for noncardiac surgery is beneficial. Anesth Analg. 2006;102:340&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pubmed">16428518</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34850369</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1496-8975</ISSN><JournalIssue CitedMedium="Internet"><Volume>69</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Canadian journal of anaesthesia = Journal canadien d'anesthesie</Title><ISOAbbreviation>Can J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Intra-abdominal pressure during and after cardiac surgery: a single-centre prospective cohort study.</ArticleTitle><Pagination><StartPage>234</StartPage><EndPage>242</EndPage><MedlinePgn>234-242</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12630-021-02141-9</ELocationID><Abstract><AbstractText Label="PURPOSE">While intra-abdominal hypertension (IAH) has been associated with adverse outcomes in multiple settings, the epidemiology and clinical implications of IAH in the context of cardiac surgery are less known. In this study, we aimed to describe the prevalence of IAH in patients undergoing cardiac surgery and determine its association with patient characteristics and postoperative outcomes.</AbstractText><AbstractText Label="METHODS">We conducted a single-centre prospective cohort study in which intra-abdominal pressure was measured in the operating room after general anesthesia (T1), after the surgical procedure (T2), and two hours after intensive care unit (ICU) admission (T3) in a subset of patients. Intra-abdominal hypertension was defined as intra-abdominal pressure (IAP) &#x2265; 12 mm Hg. Postoperative outcomes included death, acute kidney injury (AKI), and length of stay in the ICU and hospital.</AbstractText><AbstractText Label="RESULTS">A total of 513 IAP measurements were obtained from 191 participants in the operating room and 131 participants in the ICU. Intra-abdominal hypertension was present in 105/191 (55%) at T1, 115/191 (60%) at T2, and 31/131 (24%) at T3. Intra-abdominal pressure was independently associated with body mass index, central venous pressure, and mean pulmonary artery pressure but was not associated with cumulative fluid balance. Intraoperative IAH was not associated with adverse outcomes including AKI.</AbstractText><AbstractText Label="CONCLUSIONS">Intra-abdominal hypertension is very common during cardiac surgery but its clinical implications are uncertain.</AbstractText><CopyrightInformation>&#xa9; 2021. Canadian Anesthesiologists' Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Richer-S&#xe9;guin</LastName><ForeName>&#xc9;milie</ForeName><Initials>&#xc9;</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Montreal Heart Institute, Universit&#xe9; de Montr&#xe9;al, 5000 Belanger Street, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayoub</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Montreal Heart Institute, Universit&#xe9; de Montr&#xe9;al, 5000 Belanger Street, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lebon</LastName><ForeName>Jean-S&#xe9;bastien</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Montreal Heart Institute, Universit&#xe9; de Montr&#xe9;al, 5000 Belanger Street, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cogan</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Montreal Heart Institute, Universit&#xe9; de Montr&#xe9;al, 5000 Belanger Street, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jarry</LastName><ForeName>St&#xe9;phanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Montreal Heart Institute, Universit&#xe9; de Montr&#xe9;al, 5000 Belanger Street, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamarche</LastName><ForeName>Yoan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Surgery, Montreal Heart Institute, Universit&#xe9; de Montr&#xe9;al, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denault</LastName><ForeName>Andr&#xe9; Y</ForeName><Initials>AY</Initials><Identifier Source="ORCID">0000-0003-0634-6291</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia, Montreal Heart Institute, Universit&#xe9; de Montr&#xe9;al, 5000 Belanger Street, Montreal, QC, Canada. andre.denault@umontreal.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beaubien-Souligny</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de Recherche, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><VernacularTitle>Pression intra-abdominale pendant et apr&#xe8;s la chirurgie cardiaque : une &#xe9;tude de cohorte prospective monocentrique.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Can J Anaesth</MedlineTA><NlmUniqueID>8701709</NlmUniqueID><ISSNLinking>0832-610X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059325" MajorTopicYN="Y">Intra-Abdominal Hypertension</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="fre"><AbstractText>R&#xe9;SUM&#xe9;: OBJECTIF: Bien que l&#x2019;hypertension intra-abdominale (HIA) ait &#xe9;t&#xe9; associ&#xe9;e &#xe0; des issues ind&#xe9;sirables dans de multiples contextes, l&#x2019;&#xe9;pid&#xe9;miologie et les implications cliniques de l&#x2019;HIA dans le contexte de la chirurgie cardiaque sont moins connues. Dans cette &#xe9;tude, nous avons cherch&#xe9; &#xe0; d&#xe9;crire la pr&#xe9;valence de l&#x2019;HIA chez les patients b&#xe9;n&#xe9;ficiant d&#x2019;une chirurgie cardiaque et &#xe0; d&#xe9;terminer son association avec les caract&#xe9;ristiques des patients et les issues postop&#xe9;ratoires. M&#xe9;THODE: Nous avons men&#xe9; une &#xe9;tude de cohorte prospective monocentrique dans laquelle la pression intra-abdominale a &#xe9;t&#xe9; mesur&#xe9;e en salle d&#x2019;op&#xe9;ration apr&#xe8;s une anesth&#xe9;sie g&#xe9;n&#xe9;rale (T1), apr&#xe8;s l&#x2019;intervention chirurgicale (T2) et deux heures apr&#xe8;s l&#x2019;admission &#xe0; l&#x2019;unit&#xe9; de soins intensifs (USI) (T3) dans un sous-ensemble de patients. L&#x2019;hypertension intra-abdominale a &#xe9;t&#xe9; d&#xe9;finie comme une pression intra-abdominale (PIA) &#x2265; 12 mmHg. Les issues postop&#xe9;ratoires comprenaient le d&#xe9;c&#xe8;s, l&#x2019;insuffisance r&#xe9;nale aigu&#xeb; (IRA), et la dur&#xe9;e du s&#xe9;jour &#xe0; l&#x2019;USI et &#xe0; l&#x2019;h&#xf4;pital. R&#xe9;SULTATS: Au total, 513 mesures de la PIA ont &#xe9;t&#xe9; obtenues aupr&#xe8;s de 191 participants en salle d&#x2019;op&#xe9;ration et de 131 participants &#xe0; l&#x2019;USI. L&#x2019;hypertension intra-abdominale &#xe9;tait pr&#xe9;sente chez 105/191 patients (55 %) &#xe0; T1, 115/191 (60 %) &#xe0; T2 et 31/131 (24 %) &#xe0; T3. La pression intra-abdominale &#xe9;tait ind&#xe9;pendamment associ&#xe9;e &#xe0; l&#x2019;indice de masse corporelle, &#xe0; la pression veineuse centrale et &#xe0; la pression art&#xe9;rielle pulmonaire moyenne, mais n&#x2019;&#xe9;tait pas associ&#xe9;e &#xe0; un bilan hydrique cumulatif. L&#x2019;HIA perop&#xe9;ratoire n&#x2019;&#xe9;tait pas associ&#xe9;e &#xe0; des issues ind&#xe9;sirables, y compris &#xe0; l&#x2019;IRA. CONCLUSION: L&#x2019;hypertension intra-abdominale est tr&#xe8;s fr&#xe9;quente lors d&#x2019;une chirurgie cardiaque, mais ses implications cliniques sont incertaines.</AbstractText><CopyrightInformation>&#xa9; 2021. Canadian Anesthesiologists' Society.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Abdominal hypertension</Keyword><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Intra-abdominal pressure</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>1</Day><Hour>7</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34850369</ArticleId><ArticleId IdType="doi">10.1007/s12630-021-02141-9</ArticleId><ArticleId IdType="pii">10.1007/s12630-021-02141-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Malbrain ML, Cheatham ML, Kirkpatrick A, et al. Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. I. Definitions. Intensive Care Med 2006; 32: 1722-32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-006-0349-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheatham ML, Malbrain ML, Kirkpatrick A, et al. Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. II. Recommendations. Intensive Care Med 2007; 33: 951-62.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-007-0592-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyoung KH, Hong SK. The duration of intra-abdominal hypertension strongly predicts outcomes for the critically ill surgical patients: a prospective observational study. World J Emerg Surg 2015; DOI: https://doi.org/10.1186/s13017-015-0016-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13017-015-0016-7</ArticleId><ArticleId IdType="pubmed">26056530</ArticleId><ArticleId IdType="pmc">4459464</ArticleId></ArticleIdList></Reference><Reference><Citation>Papavramidis TS, Marinis AD, Pliakos I, Kesisoglou I, Papavramidou N. Abdominal compartment syndrome - intra-abdominal hypertension: defining, diagnosing, and managing. J Emerg Trauma Shock 2011; 4: 279-91.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0974-2700.82224</ArticleId></ArticleIdList></Reference><Reference><Citation>De Laet IE, Malbrain ML, De Waele JJ. A clinician's guide to management of intra-abdominal hypertension and abdominal compartment syndrome in critically ill patients. Crit Care 2020; DOI: https://doi.org/10.1186/s13054-020-2782-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-2782-1</ArticleId><ArticleId IdType="pubmed">32204721</ArticleId><ArticleId IdType="pmc">7092484</ArticleId></ArticleIdList></Reference><Reference><Citation>Balogh Z, McKinley BA, Cocanour CS, et al. Supranormal trauma resuscitation causes more cases of abdominal compartment syndrome. Arch Surg 2003; 138: 637-42; discussion 642-3.</Citation></Reference><Reference><Citation>Warren OJ, Smith AJ, Alexiou C, et al. The inflammatory response to cardiopulmonary bypass: part 1--mechanisms of pathogenesis. J Cardiothorac Vasc Anesth 2009; 23: 223-31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2008.08.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Dabrowski W, Rzecki Z. Intra-abdominal and abdominal perfusion pressure in patients undergoing coronary artery bypass graft surgery. Acta Clin Belg 2009; 64: 216-24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/acb.2009.038</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazer R, Albarrati A, Ullah A, Alamro S, Kashour T. Intra-abdominal hypertension in obese patients undergoing coronary surgery: a prospective observational study. Surgery 2019; 166: 1128-34.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.surg.2019.05.038</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalfino L, Sicolo A, Paparella D, Mongelli M, Rubino G, Brienza N. Intra-abdominal hypertension in cardiac surgery. Interact Cardiovasc Thorac Surg 2013; 17: 644-51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivt272</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer D, D'Amours S, Aneman A. Intra-abdominal hypertension in postoperative cardiac surgery patients. Crit Care Resusc 2014; 16: 214-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25161025</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzeffi MA, Stafford P, Wallace K, et al. Intra-abdominal hypertension and postoperative kidney dysfunction in cardiac surgery patients. J Cardiothorac Vasc Anesth 2016; 30: 1571-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2016.05.028</ArticleId></ArticleIdList></Reference><Reference><Citation>Borioni R, Turani F, Fratticci L, Pederzoli A, Binaco I, Garofalo M. Acute mesenteric ischemia after cardiac surgery. Role of the abdominal compartment syndrome treatment. Ann Ital Chir 2015; 86: 386-9.</Citation></Reference><Reference><Citation>Nashef SA, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg 2012; 41: 734-44; discussion 744-5.</Citation></Reference><Reference><Citation>Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-54.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-145-4-200608150-00004</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkpatrick AW, Roberts DJ, De Waele J, et al. Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med 2013; 39: 1190-206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-013-2906-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Lameire N, Aspelin P, et al. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Inter Suppl 2012; 2: 1-138.</Citation></Reference><Reference><Citation>Jones PM, Bryson GL, Backman SB, Mehta S, Grocott HP. Statistical reporting and table construction guidelines for publication in the Canadian Journal of Anesthesia. Can J Anesth 2018; 65: 152-61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-017-1024-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Czajkowski M, Dabrowski W. Changes in intra-abdominal pressure during CABG with normovolemic hemodilution. Med Sci Monit 2006; 12: CR487-92.</Citation></Reference><Reference><Citation>Dabrowski W. Changes in intra-abdominal pressure and central venous and brain venous blood pressure in patients during extracorporeal circulation. Med Sci Monit 2007; 13: CR548-54.</Citation></Reference><Reference><Citation>Dabrowski W, Wacinski P, Visconti J. Abdominal perfusion pressure and coronary arterial perfusion pressure in patients undergoing coronary artery bypass graft surgery. Exp Clin Cardiol 2009; 14: e84-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20098574</ArticleId><ArticleId IdType="pmc">2807783</ArticleId></ArticleIdList></Reference><Reference><Citation>Smit M, Werner MJ, Lansink-Hartgring AO, Dieperink W, Zijlstra JG, van Meurs M. How central obesity influences intra-abdominal pressure: a prospective, observational study in cardiothoracic surgical patients. Ann Intensive Care 2016; DOI: https://doi.org/10.1186/s13613-016-0195-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-016-0195-8</ArticleId><ArticleId IdType="pubmed">27726116</ArticleId><ArticleId IdType="pmc">5056912</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilic B, Yapici N, Yapici F, et al. Factors associated with increased intra-abdominal pressure in patients undergoing cardiac surgery. Turk Gogus Kalp Damar Cerrahisi Derg 2020; 28: 134-42.</Citation><ArticleIdList><ArticleId IdType="doi">10.5606/tgkdc.dergisi.2020.18662</ArticleId></ArticleIdList></Reference><Reference><Citation>Chass&#xe9; M, Mathieu P, Voisine P, et al. The underestimated belly factor: waist circumference is linked to significant morbidity following isolated coronary artery bypass grafting. Can J Cardiol 2016; 32: 327-35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2015.06.031</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalfino L, Tullo L, Donadio I, Malcangi V, Brienza N. Intra-abdominal hypertension and acute renal failure in critically ill patients. Intensive Care Med 2008; 34: 707-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-007-0969-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullens W, Abrahams Z, Skouri HN, et al. Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol 2008; 51: 300-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2007.09.043</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakar CV, Arrigain S, Worley S, Yared JP, Paganini EP. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol 2005; 16: 162-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2004040331</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RH, Grab JD, O'Brien SM, et al. Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation 2006; 114: 2208-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.635573</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeysundera DN, Karkouti K, Dupuis JY, et al. Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. JAMA 2007; 297: 1801-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.297.16.1801</ArticleId></ArticleIdList></Reference><Reference><Citation>Malbrain ML, Deeren D, De Potter TJ. Intra-abdominal hypertension in the critically ill: it is time to pay attention. Curr Opin Crit Care 2005; 11: 156-71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ccx.0000155355.86241.1b</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohmand H, Goldfarb S. Renal dysfunction associated with intra-abdominal hypertension and the abdominal compartment syndrome. J Am Soc Nephrol 2011; 22: 615-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2010121222</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34665309</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-2323</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>World journal of surgery</Title><ISOAbbreviation>World J Surg</ISOAbbreviation></Journal><ArticleTitle>Acute Kidney Injury within an Enhanced Recovery after Surgery (ERAS) Program for Colorectal Surgery.</ArticleTitle><Pagination><StartPage>19</StartPage><EndPage>33</EndPage><MedlinePgn>19-33</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00268-021-06343-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">We aimed to determine the prevalence, risk factors, and outcomes of acute kidney injury (AKI) within an ERAS program for colorectal surgery (CRS).</AbstractText><AbstractText Label="METHODS">This is a retrospective case-control study conducted from March 2016 to September 2018 at a single tertiary hospital in Singapore. All adult patients requiring CRS within our ERAS program were considered eligible. Exclusions were stage 5 chronic kidney disease or patients requiring a synchronous liver resection. The primary outcome was AKI as defined by the Kidney Disease Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. Secondary outcomes included mortality, major complications, and hospital length of stay. Patient, surgical, and anaesthesia-related data were analysed to determine factors associated with AKI.</AbstractText><AbstractText Label="RESULTS">A total of 575 patients were eligible for the study. Twenty patients were excluded from the study leaving 555 patients for analysis. Mean age was 67.8 (SD 11.4) years. Seventy-four patients met the criteria for AKI (13.4%: stage 1-11.2%, stage 2-2.0%, stage 3-0.2%). One patient required renal replacement therapy (RRT). Patients with AKI had a longer length of stay (median [IQR], 11.0 [5.0-17.0] days vs 6.0 [4.0-8.0] days; P&#x2009;&lt;&#x2009;.001), more major complications (OR, 6.55; 95% CI, 3.00-14.35, P&#x2009;&lt;&#x2009;.001), and a trend towards higher mortality at one year (OR, 1.44; 95% CI 0.48-4.30; p&#x2009;=&#x2009;0.511. After multivariable regression analysis, factors associated with AKI were preoperative creatinine (OR, 1.01 per 10&#xa0;&#xb5;mol/l; 95% CI, 1.03-1.22; P&#x2009;=&#x2009;0.01), robotic surgery vs open surgery (OR, 0.15; 95% CI, 0.06-0.39; P&#x2009;&lt;&#x2009;0.001), anaesthesia duration (OR, 1.38 per hour; 95% CI, 1.22-1.55; P&#x2009;&lt;&#x2009;0.001), and major complications (OR, 5.55; 95% CI, 2.63-11.70; P&#x2009;&lt;&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSIONS">Within the present cohort, the implementation of an ERAS program for CRS was associated with a low prevalence of moderate to severe AKI despite a balanced intravenous fluid regimen. Patients having open surgery, longer procedures, and major complications are at increased risk of AKI.</AbstractText><CopyrightInformation>&#xa9; 2021. Soci&#xe9;t&#xe9; Internationale de Chirurgie.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Drakeford</LastName><ForeName>Paul Andrew</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Intensive Care and Pain Medicine, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Novena, 308433, Singapore. paul.drakeford@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tham</LastName><ForeName>Shu Qi</ForeName><Initials>SQ</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Intensive Care and Pain Medicine, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Novena, 308433, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwek</LastName><ForeName>Jia Li</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Intensive Care and Pain Medicine, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Novena, 308433, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Vera</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Intensive Care and Pain Medicine, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Novena, 308433, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Chien Joo</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Clinical Research &amp; Innovation Office, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Novena, 308433, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>How</LastName><ForeName>Kwang Yeong</ForeName><Initials>KY</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Novena, 308433, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ljungqvist</LastName><ForeName>Olle</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health, School of Health and Medical Sciences, Department of Surgery, &#xd6;rebro University, &#xd6;rebro, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World J Surg</MedlineTA><NlmUniqueID>7704052</NlmUniqueID><ISSNLinking>0364-2313</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003107" MajorTopicYN="Y">Colorectal Surgery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000080482" MajorTopicYN="Y">Enhanced Recovery After Surgery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>19</Day><Hour>12</Hour><Minute>27</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34665309</ArticleId><ArticleId IdType="doi">10.1007/s00268-021-06343-6</ArticleId><ArticleId IdType="pii">10.1007/s00268-021-06343-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gameiro J, Fonseca JA, Neves M et al (2018) Acute kidney injury in major abdominal surgery: incidence, risk factors, pathogenesis and outcomes. Ann Intensive Care 8:22&#x2013;24</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-018-0369-7</ArticleId></ArticleIdList></Reference><Reference><Citation>KDIGO Clinical Practice Guideline for Acute Kidney Injury, Kidney International Supplements (2012) Kidney Disease: Improving Global Outcomes (KDIGO) Working Group. Kidney Int Suppl 2:8&#x2013;12</Citation></Reference><Reference><Citation>Marcotte JH, Patel K, Desai R et al (2018) Acute kidney injury following implementation of an enhanced recovery after surgery (ERAS) protocol in colorectal surgery. Int J Colorectal Dis 33:1259&#x2013;1267</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00384-018-3084-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Koerner CP, Lopez-Aguiar AG, Zaidi M, Speegle S, Balch G (2019) Caution: increased acute kidney injury in enhanced recovery after surgery (ERAS) protocols. Am Surg 85:156&#x2013;161</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000313481908500221</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim JW, Kim KR, Jung Y et al (2020) Role of intraoperative oliguria in risk stratification for postoperative acute kidney injury in patients undergoing colorectal surgery with an enhanced recovery protocol: a propensity score matching analysis. PLoS ONE 15:e0231447</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0231447</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiener JGD, Goss L, Wahl TS et al (2020) The association of enhanced recovery pathway and acute kidney injury in patients undergoing colorectal surgery. Dis Colon Rectum 63:233&#x2013;241</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/DCR.0000000000001528</ArticleId></ArticleIdList></Reference><Reference><Citation>Grass F, Lovely JK, Crippa J et al (2019) Early acute kidney injury within an established enhanced recovery pathway: uncommon and transitory. World J Surg 43:1207&#x2013;1215</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-019-04923-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassinger TE, Turrentine FE, Thiele RH et al (2018) Acute kidney injury in the age of enhanced recovery protocols. Dis Colon Rectum 61:946&#x2013;954</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/DCR.0000000000001059</ArticleId></ArticleIdList></Reference><Reference><Citation>Long TE, Helgason D, Helgadottir S et al (2016) Acute kidney injury after abdominal surgery: incidence, risk factors, and outcome. Anesth Analg 122:1912&#x2013;1920</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000001323</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles PS, Bellomo R, Corcoran T et al (2018) Restrictive versus liberal fluid therapy for major abdominal surgery. N Engl J Med 378:2263&#x2013;2274</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1801601</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldheiser A, Aziz O, Baldini G et al (2016) Enhanced recovery after surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice. Acta Anaesthesiol Scand 60:289&#x2013;334</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.12651</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafsson UO, Scott MJ, Hubner M et al (2019) Guidelines for perioperative care in elective colorectal surgery: enhanced recovery after surgery (ERAS((R))) society recommendations: 2018. World J Surg 43:659&#x2013;695</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-018-4844-y</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M et al (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology 18:800&#x2013;804</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e3181577654</ArticleId></ArticleIdList></Reference><Reference><Citation>Encare ERAS Interactive Audit System, https://www.encare.net/healthcare-professionals/products-and-services/eras-interactive-audit-system-eias , 2019.</Citation></Reference><Reference><Citation>MDRD for Adults (Conventional Units), National Institute for Diabetes and Digestive and Kidney Diseases Online Calculator: https://www.niddk.nih.gov/health-information/professionals/clinical-tools-patient-management/kidney-disease/laboratory-evaluation/glomerular-filtration-rate-calculators/mdrd-adults-si-units . Accessed 15 Dec 2018</Citation></Reference><Reference><Citation>Shiba A, Uchino S, Fujii T et al (2018) Association between intraoperative oliguria and acute kidney injury after major noncardiac surgery. Anesth Analg 127:1229&#x2013;1235</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000003576</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor ME, Kirwan CJ, Pearse RM et al (2016) Incidence and associations of acute kidney injury after major abdominal surgery. Intensive Care Med 42:521&#x2013;530</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-4157-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Horres CR, Adam MA, Sun Z et al (2017) Enhanced recovery protocols for colorectal surgery and postoperative renal function: a retrospective review. Perioper Med (Lond) 6:13</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13741-017-0069-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Kork F, Balzer F, Spies CD et al (2015) Minor postoperative increases of creatinine are associated with higher mortality and longer hospital length of stay in surgical patients. Anesthesiology 123:1301&#x2013;1311</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000891</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortrie G, de Geus HRH, Betjes MGH (2019) The aftermath of acute kidney injury: a narrative review of long-term mortality and renal function. Crit Care 23:24</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2314-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Lilot M, Ehrenfeld JM, Lee C et al (2015) Variability in practice and factors predictive of total crystalloid administration during abdominal surgery: retrospective two-centre analysis. Br J Anaesth 114:767&#x2013;776</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeu452</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson C, Ruchi R, Bihorac A (2017) Perioperative acute kidney injury: risk factors and predictive strategies. Crit Care Clin 33:379&#x2013;396</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2016.12.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Elias KM, Stone AB, McGinigle K et al (2019) The reporting on eras compliance, outcomes, and elements research (RECOvER) checklist: a joint statement by the ERAS((R)) and ERAS((R)) USA societies. World J Surg 43:1&#x2013;8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-018-4753-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesselink EM, Kappen TH, Torn HM et al (2018) Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review. Br J Anaesth 121:706&#x2013;721</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2018.04.036</ArticleId></ArticleIdList></Reference><Reference><Citation>Goren O, Matot I (2015) Perioperative acute kidney injury. Br J Anaesth 115(Suppl 2):ii3-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aev380</ArticleId></ArticleIdList></Reference><Reference><Citation>Giglio M, Dalfino L, Puntillo F et al (2019) Hemodynamic goal-directed therapy and postoperative kidney injury: an updated meta-analysis with trial sequential analysis. Crit Care 23:232</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2516-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Lefrant JY, Guinot PG et al (2017) Effect of individualized vs standard blood pressure management strategies on postoperative organ dysfunction among high-risk patients undergoing major surgery: a randomized clinical trial. JAMA 318:1346&#x2013;1357</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.14172</ArticleId></ArticleIdList></Reference><Reference><Citation>Vittinghoff E, McCulloch CE (2007) Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 165:710&#x2013;718</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwk052</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35643076</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-1902</ISSN><JournalIssue CitedMedium="Internet"><Volume>70</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>The Thoracic and cardiovascular surgeon</Title><ISOAbbreviation>Thorac Cardiovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Effect of Ascorbic Acid on Cardiac Surgery-Associated Acute Kidney Injury Incidence.</ArticleTitle><Pagination><StartPage>566</StartPage><EndPage>574</EndPage><MedlinePgn>566-574</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0042-1744262</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Acute kidney injury (AKI) is associated with higher perioperative mortality and morbidity. Oxidative stress has been proposed as a cause of postoperative AKI. Ascorbic acid (AA) supplementation was suggested as a novel and promising antioxidant. The aim of this study was to evaluate the capability of AA to reduce the incidence of postoperative AKI in cardiac surgery patients.</AbstractText><AbstractText Label="METHODS">A prospective randomized trial was conducted in patients scheduled for on-pump cardiac surgery. Subjects in the AA group received 2&#x2009;g of AA intravenously during the induction of anesthesia, 2&#x2009;g before aortic cross-clamp removal and 1&#x2009;g every 8&#x2009;hours for five postoperative days (the JERICA protocol). Postoperatively, the patients were monitored for AKI and other complications. Malondialdehyde levels were monitored in a subpopulation of 100 patients to evaluate the effect of AA on oxidative stress level.</AbstractText><AbstractText Label="RESULTS">The AA and control group consisted of 163 and 169 patients, respectively. The groups were well matched for baseline demographics and had similar intraoperative characteristics. The incidence of AKI in the AA and control group was 20.9 and 28.4%, respectively (<i>p</i>&#x2009;=&#x2009;0.127). The estimated glomerular filtration rate did not differ between the study groups in the entire postoperative period. There was a trend toward higher malondialdehyde values with statistical significance on postoperative day 1 and lower in-hospital mortality in the AA group (0.6 vs. 4.1%, <i>p</i>&#x2009;=&#x2009;0.067).</AbstractText><AbstractText Label="CONCLUSION">Our results do not support the effectiveness of AA supplementation in reducing the incidence of postoperative AKI in on-pump cardiac surgery patients.</AbstractText><AbstractText Label="CLINICAL REGISTRATION NUMBER">This study was registered with the ISRCTN Registry under the trial registration number ISRCTN98572043.</AbstractText><CopyrightInformation>The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Djordjevic</LastName><ForeName>Anze</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7551-9534</Identifier><AffiliationInfo><Affiliation>Department of Cardiac Surgery, University Medical Centre Maribor, Maribor, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Susak</LastName><ForeName>Stamenko</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Institute of Cardiovascular Diseases of Vojvodina, Sremska Kamenica, Vojvodina, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotnik</LastName><ForeName>Petra</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Maribor, Maribor, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gorenjak</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Maribor, Maribor, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knez</LastName><ForeName>Zeljko</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Maribor, Maribor, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antonic</LastName><ForeName>Miha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, University Medical Centre Maribor, Maribor, Slovenia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Thorac Cardiovasc Surg</MedlineTA><NlmUniqueID>7903387</NlmUniqueID><ISSNLinking>0171-6425</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance></Chemical><Chemical><RegistryNumber>4Y8F71G49Q</RegistryNumber><NameOfSubstance UI="D008315">Malondialdehyde</NameOfSubstance></Chemical><Chemical><RegistryNumber>PQ6CK8PD0R</RegistryNumber><NameOfSubstance UI="D001205">Ascorbic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000975" MajorTopicYN="N">Antioxidants</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001205" MajorTopicYN="N">Ascorbic Acid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008315" MajorTopicYN="N">Malondialdehyde</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>1</Day><Hour>9</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35643076</ArticleId><ArticleId IdType="pmc">PMC9556162</ArticleId><ArticleId IdType="doi">10.1055/s-0042-1744262</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Thadhani R, Pascual M, Bonventre J V. Acute renal failure. N Engl J Med. 1996;334(22):1448&#x2013;1460.</Citation><ArticleIdList><ArticleId IdType="pubmed">8618585</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan S, Pannu N, Wilson T. Prognostic implications of adding urine output to serum creatinine measurements for staging of acute kidney injury after major surgery: a cohort study. Nephrol Dial Transplant. 2016;31(12):2049&#x2013;2056.</Citation><ArticleIdList><ArticleId IdType="pubmed">27941063</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadim M K, Forni L G, Bihorac A. Cardiac and vascular surgery-associated acute kidney injury: The 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) Group. J Am Heart Assoc. 2018;7(11):e008834.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6015369</ArticleId><ArticleId IdType="pubmed">29858368</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum J A, Lameire N. KDIGO Clinical Practice Guideline for acute kidney injury 2012. Kidney Int Suppl. 2012;2:1&#x2013;138.</Citation></Reference><Reference><Citation>Thiele R H, Isbell J M, Rosner M H. AKI associated with cardiac surgery. Clin J Am Soc Nephrol. 2015;10(03):500&#x2013;514.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4348689</ArticleId><ArticleId IdType="pubmed">25376763</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega-Loubon C, Fern&#xe1;ndez-Molina M, Carrascal-Hinojal Y, Fulquet-Carreras E. Cardiac surgery-associated acute kidney injury. Ann Card Anaesth. 2016;19(04):687&#x2013;698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070330</ArticleId><ArticleId IdType="pubmed">27716701</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozrazgat-Baslanti T, Thottakkara P, Huber M. Acute and chronic kidney disease and cardiovascular mortality after major surgery. Ann Surg. 2016;264(06):987&#x2013;996.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4936961</ArticleId><ArticleId IdType="pubmed">26756753</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonic M. Preoperative renal dysfunction is a predictor of postoperative atrial fibrillation in coronary artery bypass patients. http://actamedbio.mf.um.si/03_amb23_clanek_212-18.pdf Acta Medico-Biotechnica. 2019;12:29&#x2013;38.</Citation></Reference><Reference><Citation>Grieshaber P, M&#xf6;ller S, Arneth B. Predicting cardiac surgery-associated acute kidney injury using a combination of clinical risk scores and urinary biomarkers. Thorac Cardiovasc Surg. 2020;68(05):389&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pubmed">30743275</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonic M. Effect of ascorbic acid on postoperative acute kidney injury in coronary artery bypass graft patients: a pilot study. Heart Surg Forum. 2017;20(05):E214&#x2013;E218.</Citation><ArticleIdList><ArticleId IdType="pubmed">29087285</ArticleId></ArticleIdList></Reference><Reference><Citation>Luckraz H, Giri R, Wrigley B. Reduction in acute kidney injury post cardiac surgery using balanced forced diuresis: a randomized, controlled trial. Eur J Cardiothorac Surg. 2021;59(03):562&#x2013;569.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8043764</ArticleId><ArticleId IdType="pubmed">33236105</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol. 2017;13(11):697&#x2013;711.</Citation><ArticleIdList><ArticleId IdType="pubmed">28869251</ArticleId></ArticleIdList></Reference><Reference><Citation>Djordjevi&#x107; A, &#x160;u&#x161;ak S, Velicki L, Antoni&#x10d; M. Acute kidney injury after open-heart surgery procedures. Acta Clin Croat. 2021;60(01):120&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8305357</ArticleId><ArticleId IdType="pubmed">34588731</ArticleId></ArticleIdList></Reference><Reference><Citation>Djordjevi&#x107; A, Kotnik P, Horvat D, Knez &#x17d;, Antoni&#x10d; M. Pharmacodynamics of malondialdehyde as indirect oxidative stress marker after arrested-heart cardiopulmonary bypass surgery. Biomed Pharmacother. 2020;132:110877.</Citation><ArticleIdList><ArticleId IdType="pubmed">33096350</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonic M, Lipovec R, Gregorcic F, Juric P, Kosir G. Perioperative ascorbic acid supplementation does not reduce the incidence of postoperative atrial fibrillation in on-pump coronary artery bypass graft patients. J Cardiol. 2017;69(01):98&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">26917198</ArticleId></ArticleIdList></Reference><Reference><Citation>Modification of Diet in Renal Disease Study Group . Levey A S, Bosch J P, Lewis J B, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130(06):461&#x2013;470.</Citation><ArticleIdList><ArticleId IdType="pubmed">10075613</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer R S, Herron C R, Groom R C, Brown J R. Acute kidney injury subsequent to cardiac surgery. J Extra Corpor Technol. 2015;47(01):16&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4566816</ArticleId><ArticleId IdType="pubmed">26390675</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozcan A V, Sacar M, Aybek H. The effects of iloprost and vitamin C on kidney as a remote organ after ischemia/reperfusion of lower extremities. J Surg Res. 2007;140(01):20&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">17397869</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis J M, Witting P K. Protective role for antioxidants in acute kidney disease. Nutrients. 2017;9(07):718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5537833</ArticleId><ArticleId IdType="pubmed">28686196</ArticleId></ArticleIdList></Reference><Reference><Citation>Ka&#x17a;mierczak-Bara&#x144;ska J, Boguszewska K, Adamus-Grabicka A, Karwowski B T. Two faces of vitamin C-antioxidative and pro-oxidative agent. Nutrients. 2020;12(05):1501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7285147</ArticleId><ArticleId IdType="pubmed">32455696</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill A, Borgs C, Fitzner C, Stoppe C. Perioperative vitamin C and E levels in cardiac surgery patients and their clinical significance. Nutrients. 2019;11(09):2157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6769782</ArticleId><ArticleId IdType="pubmed">31505814</ArticleId></ArticleIdList></Reference><Reference><Citation>Jouybar R, Kabgani H, Kamalipour H. The perioperative effect of ascorbic acid on inflammatory response in coronary artery bypass graft surgery; a randomized controlled trial coronary artery bypass graft surgery. https://applications.emro.who.int/imemrf/Int_Cardiovasc_Res_J/Int_Cardiovasc_Res_J_2012_6_1_13_17.pdf Int Cardiovasc Res J. 2012;6:13&#x2013;17.</Citation></Reference><Reference><Citation>Amini S, Robabi H N, Tashnizi M A, Vakili V. Selenium, vitamin C and N-acetylcysteine do not reduce the risk of acute kidney injury after off-pump CABG: a randomized clinical trial. Rev Bras Cir Cardiovasc. 2018;33(02):129&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5985838</ArticleId><ArticleId IdType="pubmed">29898141</ArticleId></ArticleIdList></Reference><Reference><Citation>Safaei N, Babaei H, Azarfarin R, Jodati A R, Yaghoubi A, Sheikhalizadeh M A. Comparative effect of grape seed extract ( Vitis vinifera ) and ascorbic acid in oxidative stress induced by on-pump coronary artery bypass surgery . Ann Card Anaesth. 2017;20(01):45&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5290695</ArticleId><ArticleId IdType="pubmed">28074795</ArticleId></ArticleIdList></Reference><Reference><Citation>Dingchao H, Zhiduan Q, Liye H, Xiaodong F. The protective effects of high-dose ascorbic acid on myocardium against reperfusion injury during and after cardiopulmonary bypass. Thorac Cardiovasc Surg. 1994;42(05):276&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pubmed">7863489</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsson L, Tyd&#xe9;n H, Johansson O. Bubble and membrane oxygenators&#x2013;comparison of postoperative organ dysfunction with special reference to inflammatory activity. Scand J Thorac Cardiovasc Surg. 1990;24(01):59&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">2353184</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavarocchi N C, Pluth J R, Schaff H V. Complement activation during cardiopulmonary bypass. Comparison of bubble and membrane oxygenators. J Thorac Cardiovasc Surg. 1986;91(02):252&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pubmed">3511328</ArticleId></ArticleIdList></Reference><Reference><Citation>van Oeveren W, Kazatchkine M D, Descamps-Latscha B. Deleterious effects of cardiopulmonary bypass. A prospective study of bubble versus membrane oxygenation. J Thorac Cardiovasc Surg. 1985;89(06):888&#x2013;899.</Citation><ArticleIdList><ArticleId IdType="pubmed">3158783</ArticleId></ArticleIdList></Reference><Reference><Citation>Oktar G L, Sinci V, Kalaycioglu S. Biochemical and hemodynamic effects of ascorbic acid and alpha-tocopherol in coronary artery surgery. Scand J Clin Lab Invest. 2001;61(08):621&#x2013;629.</Citation><ArticleIdList><ArticleId IdType="pubmed">11768322</ArticleId></ArticleIdList></Reference><Reference><Citation>Kali&#x161;nik J M, Hrovat E, Hrastovec A. Creatinine, neutrophil gelatinase-associated lipocalin, and cystatin C in determining acute kidney injury after heart operations using cardiopulmonary bypass. Artif Organs. 2017;41(05):481&#x2013;489.</Citation><ArticleIdList><ArticleId IdType="pubmed">27862029</ArticleId></ArticleIdList></Reference><Reference><Citation>Jerin A, Mosa O F, Kali&#x161;nik J M, &#x17d;ibert J, Skitek M. Serum Klotho as a marker for early diagnosis of acute kidney injury after cardiac surgery. J Med Biochem. 2020;39(02):133&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7526019</ArticleId><ArticleId IdType="pubmed">33033444</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21924633</PMID><DateCompleted><Year>2012</Year><Month>09</Month><Day>10</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>1</Issue><PubDate><Year>2012</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Association between postoperative acute kidney injury and duration of cardiopulmonary bypass: a meta-analysis.</ArticleTitle><Pagination><StartPage>64</StartPage><EndPage>69</EndPage><MedlinePgn>64-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2011.07.007</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This meta-analysis examined the association between cardiopulmonary bypass (CPB) time and acute kidney injury (AKI).</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Meta-analysis of previously published studies.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Each single-center study was conducted in a surgical intensive care unit and/or academic or university hospital.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Adult patients undergoing heart surgery with CPB.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">A systematic literature review was conducted using PubMed, EMBASE, and Cochrane Library databases and Google Scholar from January 1980 through September 2009. Initial search results were refined to include human subjects, age &gt;18 years, randomized controlled trials, and prospective and retrospective cohort studies, meet the Acute Kidney Injury Network definition of renal failure, and report times on CPB.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">The length of time on CPB has been implicated as an independent risk factor for development of AKI after CPB (AKI-CPB). The 9 independent studies included in the final meta-analysis had 12,466 patients who underwent CPB. Out of these, 756 patients (6.06%) developed AKI-CPB. In 7 of the 9 studies, the mean CPB times were statistically longer in the AKI-CPB cohort compared with the control group (cohort without AKI). The absolute mean differences in CPB time between the 2 groups were 25.65 minutes with the fixed-effects model and 23.18 minutes with the random-effects model.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Longer CPB times are associated with a higher risk of developing AKI-CPB, which, in turn, has a significant effect on overall mortality as reported by the individual studies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2012 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Avinash B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA. avinash-kumar@uiowa.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suneja</LastName><ForeName>Manish</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Bayman</LastName><ForeName>Emine O</ForeName><Initials>EO</Initials></Author><Author ValidYN="Y"><LastName>Weide</LastName><ForeName>Garry D</ForeName><Initials>GD</Initials></Author><Author ValidYN="Y"><LastName>Tarasi</LastName><ForeName>Michele</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>09</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Cardiothorac Vasc Anesth. 2012 Apr;26(2):e19; author reply e19-20. doi: 10.1053/j.jvca.2011.12.012.</RefSource><PMID Version="1">22285125</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21924633</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2011.07.007</ArticleId><ArticleId IdType="pii">S1053-0770(11)00526-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26482483</PMID><DateCompleted><Year>2016</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Long-Term Consequences of Acute Kidney Injury After Cardiac Surgery: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>69</StartPage><EndPage>75</EndPage><MedlinePgn>69-75</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2015.07.013</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(15)00685-0</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To determine the effect of acute kidney injury (AKI) associated with cardiac surgery on long-term mortality.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Systematic review and meta-analysis of 9 observational studies extracted from the MEDLINE and EMBASE electronic databases.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Hospitals undertaking cardiac surgery.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">The study included 35,021 cardiac surgery patients from 9 observational studies.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">None.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">Nine studies including 35,021 patients reported incidence of AKI data. The median incidence of AKI was 27.75% (IQR, 16.3%-38.86%). There was significant variation in the reported incidence (range, 11.97%-54%), which can be explained by the different AKI definitions used in the included studies. Eight studies provided adjusted effect size data with 95% confidence intervals on the impact of the occurrence of postoperative AKI and long-term mortality outcomes. Occurrence of postoperative AKI is associated with a significantly increased risk of long-term mortality (HR, 1.68; 95% CI, 1.45-1.95; p&lt;0.00001). Recovery of renal function before hospital discharge is associated with a lower long-term mortality risk (HR, 1.31; 95% CI, 1.16-1.47; p&lt;0.00001) compared with patients who experienced persistent abnormal renal function on hospital discharge (HR, 2.71; 95% CI, 1.26-5.82; p = 0.01).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There is wide variation in the reported incidence of AKI after cardiac surgery, reflecting the different AKI classification systems used. AKI after cardiac surgery is associated with an increased risk of long-term mortality. Patients with persistent renal dysfunction after hospital discharge carry a higher risk of AKI.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Corredor</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Cardiothoracic Intensive Care Unit, St. George's Hospital NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomson</LastName><ForeName>Rebekah</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiothoracic Intensive Care Unit, St. George's Hospital NHS Foundation Trust, London, United Kingdom. Electronic address: carloscorredor@doctors.org.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Subaie</LastName><ForeName>Nawaf</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Cardiothoracic Intensive Care Unit, St. George's Hospital NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">incidence</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">mortality</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26482483</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2015.07.013</ArticleId><ArticleId IdType="pii">S1053-0770(15)00685-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36795704</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-111X</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>Perfusion</Title><ISOAbbreviation>Perfusion</ISOAbbreviation></Journal><ArticleTitle>Ultrafiltration in cardiac surgery: Results of a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>743</StartPage><EndPage>751</EndPage><MedlinePgn>743-751</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/02676591231157970</ELocationID><Abstract><AbstractText><i>Background</i>: Ultrafiltration is used with cardiopulmonary bypass to reduce the effects of hemodilution and restore electrolyte balance. We performed a systematic review and meta-analysis to analyze the effect of conventional and modified ultrafiltration on intraoperative blood transfusion.<i>Methods</i>: Utilizing the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement, we systematically searched MEDLINE, EMBASE, Web of Science, and Cochrane Library to perform a meta-analysis of studies of randomized controlled trials (RCTs) and observational studies evaluating conventional ultrafiltration (CUF) and modified ultrafiltration (MUF) on the primary outcome of intraoperative red cell transfusions.<i>Results</i>: A total of 7 RCTs (<i>n</i> = 928) were included, comparing modified ultrafiltration (<i>n</i> = 473 patients) to controls (<i>n</i> = 455 patients) and 2 observational studies (<i>n</i> = 47,007), comparing conventional ultrafiltration (<i>n</i> = 21,748) to controls (<i>n</i> = 25,427). Overall, MUF was associated with transfusion of fewer intraoperative red cell units per patient (<i>n</i> = 7); MD -0.73 units; 95% CI -1.12 to -0.35 <i>p</i> = 0.04; <i>p</i> for heterogeneity = 0.0001, <i>I</i><sup><i>2</i></sup> = 55%) compared to controls. CUF was no difference in intraoperative red cell transfusions compared to controls (<i>n</i> = 2); OR 3.09; 95% CI 0.26-36.59; <i>p</i> = 0.37; <i>p</i> for heterogeneity = 0.94, <i>I</i><sup><i>2</i></sup> = 0%. Review of the included observational studies revealed an association between larger volumes (&gt;2.2&#xa0;L in a 70&#xa0;kg patient) of CUF and risk of acute kidney injury (AKI).<i>Conclusion</i>: The results of this systematic review and meta-analysis suggest that MUF is associated with fewer intraoperative red cell transfusions. Based on limited studies, CUF does not appear to be associated with a difference in intraoperative red cell transfusion.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hensley</LastName><ForeName>Nadia B</ForeName><Initials>NB</Initials><Identifier Source="ORCID">0000-0002-2074-8441</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colao</LastName><ForeName>Joseph A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zorrilla-Vaca</LastName><ForeName>Andres</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nanavati</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Welch Medical Library, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawton</LastName><ForeName>Jennifer S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Cardiac Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raphael</LastName><ForeName>Jacob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Sidney Kimmel Medical College, Department of Anesthesiology, Thomas Jefferson University Hospitals, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzeffi</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0003-2955-4915</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, George Washington University Hospital, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wierschke</LastName><ForeName>Chad</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Surgery, Perfusion Division, Johns Hopkins Hospital, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kostibas</LastName><ForeName>Megan P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Brian C</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frank</LastName><ForeName>Steven M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grant</LastName><ForeName>Michael C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Perfusion</MedlineTA><NlmUniqueID>8700166</NlmUniqueID><ISSNLinking>0267-6591</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014462" MajorTopicYN="Y">Ultrafiltration</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">conventional ultrafiltration</Keyword><Keyword MajorTopicYN="N">modified ultrafiltration</Keyword><Keyword MajorTopicYN="N">red cell transfusion</Keyword><Keyword MajorTopicYN="N">ultrafiltration</Keyword></KeywordList><CoiStatement>Declaration of conflicting of interestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: NBH, MM, and JR has served on the scientific advisory board for Octapharma&#xae;, USA (Paramus, NJ). Only NBH has received royalties from Wolters Kluwer for uptodate.com contributions. MCG is a non-remunerated member of the Executive Board of the ERAS&#xae; Cardiac Society and receives salary support from the Agency for Healthcare Research and Quality. SMF serves on scientific advisory boards for Haemonetics.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>16</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36795704</ArticleId><ArticleId IdType="doi">10.1177/02676591231157970</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29205497</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8191</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>12</Issue><PubDate><Year>2017</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of cardiac surgery</Title><ISOAbbreviation>J Card Surg</ISOAbbreviation></Journal><ArticleTitle>The use of preoperative aspirin in cardiac surgery: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>758</StartPage><EndPage>774</EndPage><MedlinePgn>758-774</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jocs.13250</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Despite the fact that aspirin is of benefit to patients following coronary artery bypass grafting (CABG), continuation or administration of preoperative aspirin before CABG or any cardiac surgical procedure remains controversial. Therefore, we performed a systematic review and meta-analysis to assess the influence of preoperative aspirin administration on patients undergoing cardiac surgery.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Medline database was searched using OVID SP interface. Similar searches were performed separately in EMBASE, PubMed, and Cochrane Central Registry of Controlled Trials.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twelve randomized controlled trials and 28 observational studies met our inclusion criteria and were included in the meta-analysis. The use of preoperative aspirin in patients undergoing CABG at any dose is associated with reduced early mortality as well as a reduced incidence of postoperative acute kidney injury (AKI). Low-dose aspirin (&#x2264;160&#x2009;mg/d) is associated with a decreased incidence of perioperative myocardial infarction (MI). Administration of preoperative aspirin at any dose in patients undergoing cardiac surgery increases postoperative bleeding. Despite this effect of preoperative aspirin, it did not increase the rates of surgical re-exploration due to excessive postoperative bleeding nor did it increase the rates of packed red blood cell transfusions (PRBC) when preoperative low-dose aspirin (&#x2264;160&#x2009;mg/d) was administered.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Preoperative aspirin increases the risk for postoperative bleeding. However, this did not result in an increased need for chest re-exploration and did not increase the rates of PRBC transfusion when preoperative low-dose (&#x2264;160&#x2009;mg/d) aspirin was administered. Aspirin at any dose is associated with decreased mortality and AKI and low-dose aspirin (&#x2264;160&#x2009;mg/d) decreases the incidence of perioperative MI.</AbstractText><CopyrightInformation>&#xa9; 2017 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aboul-Hassan</LastName><ForeName>Sleiman Sebastian</ForeName><Initials>SS</Initials><Identifier Source="ORCID">0000-0003-4544-7466</Identifier><AffiliationInfo><Affiliation>Department of Cardiac Surgery, MEDINET Heart Center Ltd., Nowa Sol, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stankowski</LastName><ForeName>Tomasz</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Sana-Heart Center Cottbus, Cottbus, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marczak</LastName><ForeName>Jakub</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, MEDINET Heart Center Ltd., Nowa Sol, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Wroclaw Medical University, Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peksa</LastName><ForeName>Maciej</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, MEDINET Heart Center Ltd., Nowa Sol, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nawotka</LastName><ForeName>Marcin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, MEDINET Heart Center Ltd., Nowa Sol, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stanislawski</LastName><ForeName>Ryszard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, MEDINET Heart Center Ltd., Nowa Sol, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kryszkowski</LastName><ForeName>Bartosz</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of General and Oncological Surgery, Hospital in Jelenia Gora, Jelenia Gora, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cichon</LastName><ForeName>Romuald</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Warsaw Medical University, Warsaw, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Card Surg</MedlineTA><NlmUniqueID>8908809</NlmUniqueID><ISSNLinking>0886-0440</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010975">Platelet Aggregation Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>R16CO5Y76E</RegistryNumber><NameOfSubstance UI="D001241">Aspirin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001241" MajorTopicYN="N">Aspirin</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017707" MajorTopicYN="N">Erythrocyte Transfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010975" MajorTopicYN="N">Platelet Aggregation Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019106" MajorTopicYN="N">Postoperative Hemorrhage</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">coronary artery disease</Keyword><Keyword MajorTopicYN="N">outcomes</Keyword><Keyword MajorTopicYN="N">preoperative aspirin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29205497</ArticleId><ArticleId IdType="doi">10.1111/jocs.13250</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39144846</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Postoperative Acute Kidney Injury After Intraoperative Hypotension in Major Risk Procedures.</ArticleTitle><Pagination><StartPage>e64579</StartPage><MedlinePgn>e64579</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e64579</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.64579</ELocationID><Abstract><AbstractText>Background Reportedly prevalent, intraoperative hypotension (IOH) is linked to kidney injury and increased risk of mortality. In this study, we aimed to assess IOH incidence in high-risk non-cardiac surgery and its correlation with postoperative acute kidney injury (PO-AKI) and 30-day postoperative mortality. Methodology This retrospective cohort study included adult inpatients who underwent elective, non-cardiac, high-risk European Society of Anaesthesiology/European Society of Cardiology surgery from October to November of 2020, 2021, and 2022, excluding cardiac, intracranial, or emergency surgery. IOH was primarily defined by the 2022 Anesthesia Quality Institute. PO-AKI was defined as an increase in serum creatinine &#x2265;0.3 mg/dL within 48 hours, the need for dialysis in dialysis-na&#xef;ve patients, or the documentation of AKI in clinical records. For univariate analysis, the Mann-Whitney U test and chi-square or Fisher's exact tests were performed, as appropriate. Logistic regression was used to test risk factors for IOH in univariate analysis (p &lt; 0.1). The significance level considered in multivariate analysis was 5%. Results Of the 197 patients included, 111 (56.3%) experienced IOH. After adjustment, surgical time &gt;120 minutes remained associated with higher odds of IOH (odds ratio (OR) = 9.62, 95% confidence interval (CI) = 2.49-37.13), as well as combined general + locoregional (vs. general OR = 3.41, 95 CI% = 1.38-8.43, p = 0.008; vs. locoregional OR = 6.37, 95% CI = 1.48-27.47). No association was found between IOH and 30-day postoperative mortality (p = 0.565) or PO-AKI (p = 0.09). The incidence of PO-AKI was 14.9% (27 patients), being significantly associated with higher 30-day postoperative mortality (p = 0.018). Conclusions Our study highlights the high prevalence of IOH in high-risk non-cardiac surgical procedures. Its impact on PO-AKI and 30-day postoperative mortality appears less pronounced compared to the significant implications of PO-AKI, emphasizing the need for PO-AKI screening and renal protection strategies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024, Martins Lima et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martins Lima</LastName><ForeName>Patr&#xed;cia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Unidade Local de Sa&#xfa;de S&#xe3;o Jo&#xe3;o, Porto, PRT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferreira</LastName><ForeName>Luana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Unidade Local de Sa&#xfa;de S&#xe3;o Jo&#xe3;o, Porto, PRT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dias</LastName><ForeName>Ana L&#xed;dia</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Center for Research in Health Technologies and Health Systems (CINTESIS), Faculty of Medicine of Porto, Porto, PRT.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Unidade Local de Sa&#xfa;de S&#xe3;o Jo&#xe3;o, Porto, PRT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodrigues</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Unidade Local de Sa&#xfa;de S&#xe3;o Jo&#xe3;o, Porto, PRT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abelha</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Unidade Local de Sa&#xfa;de S&#xe3;o Jo&#xe3;o, Porto, PRT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mour&#xe3;o</LastName><ForeName>Joana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Physiology and Surgery, Faculdade de Medicina da Universidade do Porto, Porto, PRT.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Unidade Local de Sa&#xfa;de S&#xe3;o Jo&#xe3;o, Porto, PRT.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">hypotension</Keyword><Keyword MajorTopicYN="N">intraoperative complications</Keyword><Keyword MajorTopicYN="N">major surgery</Keyword><Keyword MajorTopicYN="N">non-cardiac surgery</Keyword><Keyword MajorTopicYN="N">postoperative complications</Keyword></KeywordList><CoiStatement>Human subjects: Consent was obtained or waived by all participants in this study. Comiss&#xe3;o de &#xc9;tica da Unidade Local de Sa&#xfa;de de S&#xe3;o Jo&#xe3;o issued approval 01-2020. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>15</Day><Hour>4</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39144846</ArticleId><ArticleId IdType="pmc">PMC11323959</ArticleId><ArticleId IdType="doi">10.7759/cureus.64579</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hypotension during surgery for high risk patients: cause or consequence of pathology? Tritapepe L. http://www.minervamedica.it/index2.t?show=R02Y2013N09A0978. Minerva Anestesiol. 2013;79:978&#x2013;990.</Citation><ArticleIdList><ArticleId IdType="pubmed">23719658</ArticleId></ArticleIdList></Reference><Reference><Citation>Association of intraoperative hypotension with postoperative morbidity and mortality: systematic review and meta-analysis. Wijnberge M, Schenk J, Bulle E, et al. BJS Open. 2021;5:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7893468</ArticleId><ArticleId IdType="pubmed">33609377</ArticleId></ArticleIdList></Reference><Reference><Citation>Incidence of intraoperative hypotension as a function of the chosen definition: literature definitions applied to a retrospective cohort using automated data collection. Bijker JB, van Klei WA, Kappen TH, van Wolfswinkel L, Moons KG, Kalkman CJ. Anesthesiology. 2007;107:213&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">17667564</ArticleId></ArticleIdList></Reference><Reference><Citation>Predictors of intraoperative hypotension and bradycardia. Cheung CC, Martyn A, Campbell N, et al. Am J Med. 2015;128:532&#x2013;538.</Citation><ArticleIdList><ArticleId IdType="pubmed">25541033</ArticleId></ArticleIdList></Reference><Reference><Citation>Intraoperative hypotension and its prediction. Vos JJ, Scheeren TW. Indian J Anaesth. 2019;63:877&#x2013;885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6868662</ArticleId><ArticleId IdType="pubmed">31772395</ArticleId></ArticleIdList></Reference><Reference><Citation>Postoperative acute kidney injury in adult non-cardiac surgery: joint consensus report of the Acute Disease Quality Initiative and PeriOperative Quality Initiative. Prowle JR, Forni LG, Bell M, et al. Nat Rev Nephrol. 2021;17:605&#x2013;618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8367817</ArticleId><ArticleId IdType="pubmed">33976395</ArticleId></ArticleIdList></Reference><Reference><Citation>Perioperative blood pressure management. Saugel B, Sessler DI. Anesthesiology. 2021;134:250&#x2013;261.</Citation><ArticleIdList><ArticleId IdType="pubmed">33206118</ArticleId></ArticleIdList></Reference><Reference><Citation>Minor postoperative increases of creatinine are associated with higher mortality and longer hospital length of stay in surgical patients. Kork F, Balzer F, Spies CD, Wernecke KD, Ginde AA, Jankowski J, Eltzschig HK. Anesthesiology. 2015;123:1301&#x2013;1311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4679549</ArticleId><ArticleId IdType="pubmed">26492475</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute kidney injury and mortality 1 year after major non-cardiac surgery. O'Connor ME, Hewson RW, Kirwan CJ, Ackland GL, Pearse RM, Prowle JR. Br J Surg. 2017;104:868&#x2013;876.</Citation><ArticleIdList><ArticleId IdType="pubmed">28218392</ArticleId></ArticleIdList></Reference><Reference><Citation>2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Halvorsen S, Mehilli J, Cassese S, et al. Eur Heart J. 2022;43:3826&#x2013;3924.</Citation><ArticleIdList><ArticleId IdType="pubmed">36017553</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyle DJ, Hendrix JM, Garmon EH. Treasure Island, FL: StatPearls Publishing; [ Aug; 2024 ]. 2024. American Society of Anesthesiologists Classification.</Citation><ArticleIdList><ArticleId IdType="pubmed">28722969</ArticleId></ArticleIdList></Reference><Reference><Citation>Is a mean arterial pressure less than 65 mm Hg an appropriate indicator of the quality of anesthesia care? Kamenetsky E, Hogue CW. Anesth Analg. 2021;132:942&#x2013;945.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7970395</ArticleId><ArticleId IdType="pubmed">33723192</ArticleId></ArticleIdList></Reference><Reference><Citation>Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions: a statement from the ESA-ESICM joint taskforce on perioperative outcome measures. Jammer I, Wickboldt N, Sander M, et al. Eur J Anaesthesiol. 2015;32:88&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">25058504</ArticleId></ArticleIdList></Reference><Reference><Citation>IBM SPSS Statistics for Windows [Computer Software]. Version 28. Armonk, N.Y., USA: IBM Corp.  [
Mar;
2024 
]. 2021. https://www.ibm.com/products/spss-statistics https://www.ibm.com/products/spss-statistics</Citation></Reference><Reference><Citation>R: A Language and Environment for Statistical Computing [Computer Software]. Version 4.3.2. Vienna, AUST: R Foundation for Statistical Computing. Computing.  [
Mar;
2024 
]. 2023. https://www.r-project.org/ https://www.r-project.org/</Citation></Reference><Reference><Citation>Sturgess DJ. Oh's Intensive Care Manual. Oxford: Butterworth-Heinemann; 2014. Haemodynamic monitoring; pp. 122&#x2013;137.</Citation></Reference><Reference><Citation>SBP is superior to MAP to reflect tissue perfusion and hemodynamic abnormality perioperatively. Sun J, Yuan J, Li B. Front Physiol. 2021;12:705558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8476970</ArticleId><ArticleId IdType="pubmed">34594235</ArticleId></ArticleIdList></Reference><Reference><Citation>Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery: a retrospective cohort analysis. Salmasi V, Maheshwari K, Yang D, Mascha EJ, Singh A, Sessler DI, Kurz A. Anesthesiology. 2017;126:47&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">27792044</ArticleId></ArticleIdList></Reference><Reference><Citation>Role of laparoscopy in the era of robotic surgery in urology in developing countries. Bansal D, Chaturvedi S, Maheshwari R, Kumar A. Indian J Urol. 2021;37:32&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8033240</ArticleId><ArticleId IdType="pubmed">33850353</ArticleId></ArticleIdList></Reference><Reference><Citation>The rise of minimally invasive surgery: 16 year analysis of the progressive replacement of open surgery with laparoscopy. St John A, Caturegli I, Kubicki NS, Kavic SM. JSLS. 2020;24:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7810432</ArticleId><ArticleId IdType="pubmed">33510568</ArticleId></ArticleIdList></Reference><Reference><Citation>Laparoscopic surgery: are vital signs important? Karnwal A, Arora CD, Lippmann M. Anesth Analg. 2017;124:704.</Citation><ArticleIdList><ArticleId IdType="pubmed">28098702</ArticleId></ArticleIdList></Reference><Reference><Citation>World Federation of Societies of Anesthesiologists. Intraoperative hypotension.  [
Mar;
2024 
];https://resources.wfsahq.org/atotw/intraoperative-hypotension/ 2009 21:2024.</Citation></Reference><Reference><Citation>Association between intraoperative hypotension and 30-day mortality, major adverse cardiac events, and acute kidney injury after non-cardiac surgery: a meta-analysis of cohort studies. Gu WJ, Hou BL, Kwong JS, et al. Int J Cardiol. 2018;258:68&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">29429638</ArticleId></ArticleIdList></Reference><Reference><Citation>The Intraoperative Complications Assessment and Reporting with Universal Standards (ICARUS) global surgical collaboration project: development of criteria for reporting adverse events during surgical procedures and evaluating their impact on the postoperative course. Cacciamani GE, Sholklapper T, Dell'Oglio P, et al. Eur Urol Focus. 2022;8:1847&#x2013;1858.</Citation><ArticleIdList><ArticleId IdType="pubmed">35177353</ArticleId></ArticleIdList></Reference><Reference><Citation>Perioperative acute kidney injury. Calvert S, Shaw A. Perioper Med (Lond) 2012;1:6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3886265</ArticleId><ArticleId IdType="pubmed">24764522</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney dysfunction in the postoperative period. Sear JW. Br J Anaesth. 2005;95:20&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">15531622</ArticleId></ArticleIdList></Reference><Reference><Citation>Microcirculation in acute and chronic kidney diseases. Zafrani L, Ince C. Am J Kidney Dis. 2015;66:1083&#x2013;1094.</Citation><ArticleIdList><ArticleId IdType="pubmed">26231789</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute kidney injury after major surgery: a retrospective analysis of Veterans Health Administration data. Grams ME, Sang Y, Coresh J, et al. Am J Kidney Dis. 2016;67:872&#x2013;880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4775458</ArticleId><ArticleId IdType="pubmed">26337133</ArticleId></ArticleIdList></Reference><Reference><Citation>Perioperative acute kidney injury. Gumbert SD, Kork F, Jackson ML, Vanga N, Ghebremichael SJ, Wang CY, Eltzschig HK. Anesthesiology. 2020;132:180&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10924686</ArticleId><ArticleId IdType="pubmed">31687986</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35125028</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-111X</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Perfusion</Title><ISOAbbreviation>Perfusion</ISOAbbreviation></Journal><ArticleTitle>Goal-directed perfusion for reducing acute kidney injury in cardiac surgery: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>591</StartPage><EndPage>599</EndPage><MedlinePgn>591-599</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/02676591211073783</ELocationID><Abstract><AbstractText Label="BACKGROUND">Acute kidney injury (AKI) is a common complication following cardiopulmonary bypass (CPB) which can affect morbidity and mortality. Goal-directed perfusion (GDP) intended to avoid the nadir oxygen delivery index below the critical value is associated with reduced postoperative AKI. However, current studies suggested that GDP can only decrease the incidence of AKI stage 1 but showed no effects on AKI stages 2-3 and mortality. The objective of the present meta-analysis is to deter the effects of GDP on postoperative AKI in any stage and mortality following cardiac surgery.</AbstractText><AbstractText Label="METHODS">MEDLINE, Embase, and the Cochrane Library were searched to identify all clinical trials comparing GDP with control (standard care) during cardiopulmonary bypass conducting in adults undergoing cardiac surgery. The primary outcome was postoperative acute kidney injury. Secondary outcomes included postoperative mortality and length of ICU stay. Data synthesis was obtained by using risk ratio with 95% confidence interval by a random-effects model.</AbstractText><AbstractText Label="RESULT">From 1094 potential studies, 3 trials enrolling 777 patients were included. Meta-analysis suggested the GDP strategy based on DO<sub>2</sub>i reduced postoperative AKI compared with standard CPB management (RR = 0.52; 95% CI: 0.38-0.70; <i>p</i> &lt; .0001), especially in AKI stage I (RR = 0.47; 95% CI: 0.33-0.66; <i>p</i> &lt; .0001). But the GDP strategy did not reduce the incidence of severe AKI (stages 2-3) and postoperative mortality.</AbstractText><AbstractText Label="CONCLUSION">The GDP strategy based on DO<sub>2</sub>i during CPB obviously reduces AKI stage 1 and thus reduces overall AKI incidence. But it shows no effects on severe AKI (stages 2-3) and mortality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Peng</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-3189-7263</Identifier><AffiliationInfo><Affiliation>Department of Cardiopulmonary Bypass, Fuwai Hospital, National Center for Cardiovascular Diseases, 34736Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jinping</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6025-449X</Identifier><AffiliationInfo><Affiliation>Department of Cardiopulmonary Bypass, Fuwai Hospital, National Center for Cardiovascular Diseases, 34736Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Peiyao</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-3422-0100</Identifier><AffiliationInfo><Affiliation>Department of Cardiopulmonary Bypass, Fuwai Hospital, National Center for Cardiovascular Diseases, 34736Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Liting</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiopulmonary Bypass, Fuwai Hospital, National Center for Cardiovascular Diseases, 34736Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiopulmonary Bypass, Fuwai Hospital, National Center for Cardiovascular Diseases, 34736Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yixuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiopulmonary Bypass, Fuwai Hospital, National Center for Cardiovascular Diseases, 34736Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Perfusion</MedlineTA><NlmUniqueID>8700166</NlmUniqueID><ISSNLinking>0267-6591</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006040" MajorTopicYN="N">Goals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010477" MajorTopicYN="N">Perfusion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">goal-directed perfusion</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>7</Day><Hour>5</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35125028</ArticleId><ArticleId IdType="doi">10.1177/02676591211073783</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30725141</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1238</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Intensive care medicine</Title><ISOAbbreviation>Intensive Care Med</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury in trauma patients admitted to the ICU: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>407</StartPage><EndPage>419</EndPage><MedlinePgn>407-419</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00134-019-05535-y</ELocationID><Abstract><AbstractText Label="PURPOSE">To perform a systematic review and meta-analysis of acute kidney injury (AKI) in trauma patients admitted to the intensive care unit (ICU).</AbstractText><AbstractText Label="METHODS">We conducted a systematic literature search of studies on AKI according to RIFLE, AKIN, or KDIGO criteria in trauma patients admitted to the ICU (PROSPERO CRD42017060420). We searched PubMed, Cochrane Database of Systematic Reviews, UpToDate, and NICE through 3 December 2018. Data were collected on incidence of AKI, risk factors, renal replacement therapy (RRT), renal recovery, length of stay (LOS), and mortality. Pooled analyses with random effects models yielded mean differences, OR, and RR, with 95% CI.</AbstractText><AbstractText Label="RESULTS">Twenty-four observational studies comprising 25,182 patients were included. Study quality (Newcastle-Ottawa scale) was moderate. Study heterogeneity was substantial. Incidence of post-traumatic AKI in the ICU was 24% (20-29), of which 13% (10-16) mild, 5% (3-7) moderate, and 4% (3-6) severe AKI. Risk factors for AKI were African American descent, high age, chronic hypertension, diabetes mellitus, high Injury Severity Score, abdominal injury, shock, low Glasgow Coma Scale (GCS)&#xa0;score, high APACHE II score, and sepsis. AKI patients had 6.0 (4.0-7.9) days longer ICU LOS and increased risk of death [RR 3.4 (2.1-5.7)] compared to non-AKI patients. In patients with AKI, RRT was used in 10% (6-15). Renal recovery occurred in 96% (78-100) of patients.</AbstractText><AbstractText Label="CONCLUSIONS">AKI occurred in 24% of trauma patients admitted to the ICU, with an RRT use among these of 10%. Presence of AKI was associated with increased LOS and mortality, but renal recovery in AKI survivors was good.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>S&#xf8;vik</LastName><ForeName>Signe</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4524-2268</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Akershus University Hospital, L&#xf8;renskog, Norway. signe.sovik@medisin.uio.no.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. signe.sovik@medisin.uio.no.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isachsen</LastName><ForeName>Marie Susanna</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Medical Library at Ullev&#xe5;l Hospital, University of Oslo Library, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nordhuus</LastName><ForeName>Kine Marie</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tveiten</LastName><ForeName>Christine Kooy</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eken</LastName><ForeName>Torsten</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-5943-4538</Identifier><AffiliationInfo><Affiliation>Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesiology, Division of Emergencies and Critical Care, Oslo University Hospital Ullev&#xe5;l, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sunde</LastName><ForeName>Kjetil</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-9518-5199</Identifier><AffiliationInfo><Affiliation>Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesiology, Division of Emergencies and Critical Care, Oslo University Hospital Ullev&#xe5;l, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brurberg</LastName><ForeName>Kjetil Gundro</ForeName><Initials>KG</Initials><Identifier Source="ORCID">0000-0002-5920-4652</Identifier><AffiliationInfo><Affiliation>Division for Health Services, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Evidence Based Practice, Western Norway University of Applied Sciences, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beitland</LastName><ForeName>Sigrid</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8803-0105</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology, Division of Emergencies and Critical Care, Oslo University Hospital Ullev&#xe5;l, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Renal Research Group Ullev&#xe5;l, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Intensive Care Med</MedlineTA><NlmUniqueID>7704851</NlmUniqueID><ISSNLinking>0342-4642</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Intensive Care Med. 2019 Jun;45(6):907-908. doi: 10.1007/s00134-019-05609-x.</RefSource><PMID Version="1">31016354</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012206" MajorTopicYN="N">Rhabdomyolysis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014947" MajorTopicYN="N">Wounds and Injuries</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Critical illness</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Risk factors</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword><Keyword MajorTopicYN="N">Wounds and injuries</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30725141</ArticleId><ArticleId IdType="doi">10.1007/s00134-019-05535-y</ArticleId><ArticleId IdType="pii">10.1007/s00134-019-05535-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ulus Travma Acil Cerrahi Derg. 2017 Jan;23(1):39-45</Citation><ArticleIdList><ArticleId IdType="pubmed">28261769</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2011 Oct;39(10):2246-52</Citation><ArticleIdList><ArticleId IdType="pubmed">21926487</ArticleId></ArticleIdList></Reference><Reference><Citation>J Trauma Acute Care Surg. 2012 Oct;73(4):832-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22902735</ArticleId></ArticleIdList></Reference><Reference><Citation>Injury. 2014 Jan;45(1):259-64</Citation><ArticleIdList><ArticleId IdType="pubmed">23921194</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 1991 Dec;100(6):1619-36</Citation><ArticleIdList><ArticleId IdType="pubmed">1959406</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2015 Aug;41(8):1411-23</Citation><ArticleIdList><ArticleId IdType="pubmed">26162677</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Kidney Dis. 2018 Dec;72(6):846-856</Citation><ArticleIdList><ArticleId IdType="pubmed">29866457</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Kidney Dis. 2016 Oct;68(4):564-570</Citation><ArticleIdList><ArticleId IdType="pubmed">27155727</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1993 Dec 22-29;270(24):2957-63</Citation><ArticleIdList><ArticleId IdType="pubmed">8254858</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin J Am Soc Nephrol. 2015 Nov 6;10(11):1911-20</Citation><ArticleIdList><ArticleId IdType="pubmed">26342043</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2003 Sep 6;327(7414):557-60</Citation><ArticleIdList><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2005 Aug 17;294(7):813-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16106006</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Fail. 2008;30(6):581-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18661407</ArticleId></ArticleIdList></Reference><Reference><Citation>Injury. 2008 May;39(5):612-22</Citation><ArticleIdList><ArticleId IdType="pubmed">18377909</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Trauma Emerg Surg. 2018 Aug;44(4):597-605</Citation><ArticleIdList><ArticleId IdType="pubmed">28717983</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2015 Mar 16;350:h1435</Citation><ArticleIdList><ArticleId IdType="pubmed">25778910</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Fail. 2010 Jul;32(6):673-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20540634</ArticleId></ArticleIdList></Reference><Reference><Citation>Injury. 2017 Oct;48(10):2145-2149</Citation><ArticleIdList><ArticleId IdType="pubmed">28842286</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Anaesthesiol Scand. 2019 Feb;63(2):200-207</Citation><ArticleIdList><ArticleId IdType="pubmed">30132785</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2018 Jun;44(6):857-867</Citation><ArticleIdList><ArticleId IdType="pubmed">29872882</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Anaesthesiol Scand. 2012 Feb;56(2):138-46</Citation><ArticleIdList><ArticleId IdType="pubmed">22092145</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Fail. 2010;32(9):1060-5</Citation><ArticleIdList><ArticleId IdType="pubmed">20863210</ArticleId></ArticleIdList></Reference><Reference><Citation>Injury. 2014 May;45(5):894-901</Citation><ArticleIdList><ArticleId IdType="pubmed">24456608</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Chem Lab Med. 2009;47(1):79-82</Citation><ArticleIdList><ArticleId IdType="pubmed">19055468</ArticleId></ArticleIdList></Reference><Reference><Citation>S Afr Med J. 2017 Apr 25;107(5):446-450</Citation><ArticleIdList><ArticleId IdType="pubmed">28492128</ArticleId></ArticleIdList></Reference><Reference><Citation>J Trauma. 1974 Mar;14(3):187-96</Citation><ArticleIdList><ArticleId IdType="pubmed">4814394</ArticleId></ArticleIdList></Reference><Reference><Citation>J Trauma Acute Care Surg. 2012 Jan;72(1):61-6; discussion 66-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22310117</ArticleId></ArticleIdList></Reference><Reference><Citation>J Nephrol. 2013 Nov-Dec;26(6):1083-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24249209</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2018 Sep;44(9):1447-1459</Citation><ArticleIdList><ArticleId IdType="pubmed">30043276</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2014 Jul 3;371(1):58-66</Citation><ArticleIdList><ArticleId IdType="pubmed">24988558</ArticleId></ArticleIdList></Reference><Reference><Citation>Indian J Crit Care Med. 2017 Dec;21(12):852-856</Citation><ArticleIdList><ArticleId IdType="pubmed">29307967</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 1985 Oct;13(10):818-29</Citation><ArticleIdList><ArticleId IdType="pubmed">3928249</ArticleId></ArticleIdList></Reference><Reference><Citation>J Trauma Acute Care Surg. 2013 Mar;74(3):912-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23425757</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Clin. 2012 Jan;28(1):99-111, vii</Citation><ArticleIdList><ArticleId IdType="pubmed">22123102</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Nephrol. 2009 Jun;71(6):669-79</Citation><ArticleIdList><ArticleId IdType="pubmed">19473636</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2010 Jul;252(1):158-65</Citation><ArticleIdList><ArticleId IdType="pubmed">20562612</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2007;11(2):R31</Citation><ArticleIdList><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference><Reference><Citation>J Crit Care. 2012 Oct;27(5):496-504</Citation><ArticleIdList><ArticleId IdType="pubmed">22591570</ArticleId></ArticleIdList></Reference><Reference><Citation>Indian J Crit Care Med. 2010 Jul;14(3):121-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21253345</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2018 Feb 26;8(1):3665</Citation><ArticleIdList><ArticleId IdType="pubmed">29483607</ArticleId></ArticleIdList></Reference><Reference><Citation>J Trauma Acute Care Surg. 2015 Sep;79(3):407-12</Citation><ArticleIdList><ArticleId IdType="pubmed">26307873</ArticleId></ArticleIdList></Reference><Reference><Citation>J Trauma Acute Care Surg. 2015 May;78(5):988-93</Citation><ArticleIdList><ArticleId IdType="pubmed">25909420</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bras Nefrol. 2013 Apr-Jun;35(2):127-31</Citation><ArticleIdList><ArticleId IdType="pubmed">23812570</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Trauma Resusc Emerg Med. 2010 Jan 05;18:1</Citation><ArticleIdList><ArticleId IdType="pubmed">20051113</ArticleId></ArticleIdList></Reference><Reference><Citation>J Trauma. 2009 Aug;67(2):283-7; discussion 287-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19667880</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurocrit Care. 2011 Jun;14(3):377-81</Citation><ArticleIdList><ArticleId IdType="pubmed">21298359</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Neurosurg. 2015;29(4):544-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25796992</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2017 Jun;43(6):730-749</Citation><ArticleIdList><ArticleId IdType="pubmed">28577069</ArticleId></ArticleIdList></Reference><Reference><Citation>Iran J Med Sci. 2015 Nov;40(6):485-92</Citation><ArticleIdList><ArticleId IdType="pubmed">26538776</ArticleId></ArticleIdList></Reference><Reference><Citation>Injury. 2015 Jan;46(1):105-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25240412</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Oct 17;8(10):e77376</Citation><ArticleIdList><ArticleId IdType="pubmed">24146987</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2017 Jun;43(6):855-866</Citation><ArticleIdList><ArticleId IdType="pubmed">28466146</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaesthesia. 2008 Sep;63(9):959-66</Citation><ArticleIdList><ArticleId IdType="pubmed">18549413</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Nephrol. 2015 Mar 19;16:30</Citation><ArticleIdList><ArticleId IdType="pubmed">25885883</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2004 Aug;8(4):R204-12</Citation><ArticleIdList><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2014 Feb 11;11(2):e1001601</Citation><ArticleIdList><ArticleId IdType="pubmed">24523666</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2016 Feb;42(2):137-46</Citation><ArticleIdList><ArticleId IdType="pubmed">26626062</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29136086</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>17</Day></DateCompleted><DateRevised><Year>2019</Year><Month>04</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>119</Volume><Issue>6</Issue><PubDate><Year>2017</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Intraoperative oliguria predicts acute kidney injury after major abdominal surgery.</ArticleTitle><Pagination><StartPage>1127</StartPage><EndPage>1134</EndPage><MedlinePgn>1127-1134</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/bja/aex255</ELocationID><Abstract><AbstractText Label="BACKGROUND">The threshold of intraoperative urine output below which the risk of acute kidney injury (AKI) increases is unclear. The aim of this retrospective cohort study was to investigate the relationship between intraoperative urine output during major abdominal surgery and the development of postoperative AKI and to identify an optimal threshold for predicting the differential risk of AKI.</AbstractText><AbstractText Label="METHODS">Perioperative data were collected retrospectively on 3560 patients undergoing major abdominal surgery (liver, colorectal, gastric, pancreatic, or oesophageal resection) at Kyoto University Hospital. We evaluated the relationship between intraoperative urine output and the development of postoperative AKI as defined by recent guidelines. Logistic regression analysis was performed to adjust for patient and operative variables, and the minimum P -value approach was used to determine the threshold of intraoperative urine output that independently altered the risk of AKI.</AbstractText><AbstractText Label="RESULTS">The overall incidence of AKI in the study population was 6.3%. Using the minimum P -value approach, a threshold of 0.3&#x2009;ml kg -1 h -1 was identified, below which there was an increased risk of AKI (adjusted odds ratio, 2.65; 95% confidence interval, 1.77-3.97; P &lt;0.001). The addition of oliguria &lt;0.3&#x2009;ml kg -1 h -1 to a model with conventional risk factors significantly improved risk stratification for AKI (net reclassification improvement, 0.159; 95% confidence interval, 0.049-0.270; P =0.005).</AbstractText><AbstractText Label="CONCLUSIONS">Among patients undergoing major abdominal surgery, intraoperative oliguria &lt;0.3&#x2009;ml kg -1 h -1 was significantly associated with increased risk of postoperative AKI.</AbstractText><CopyrightInformation>&#xa9; The Author 2017. Published by Oxford University Press on behalf of the British Journal of Anaesthesia. All rights reserved. For Permissions, please email: journals.permissions@oup.com</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mizota</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Kyoto University Hospital, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Healthcare Epidemiology, School of Public Health in the Graduate School of Medicine, Kyoto University, Yoshida Konoemachi, Sakyo-ku, Kyoto 606-8501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamada</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Kyoto University Hospital, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsukawa</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Kyoto University Hospital, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimizu</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Kyoto University Hospital, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kai</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Kyoto University Hospital, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="N">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="Y">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009846" MajorTopicYN="N">Oliguria</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="Y">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">general surgery</Keyword><Keyword MajorTopicYN="N">intraoperative</Keyword><Keyword MajorTopicYN="N">monitoring</Keyword><Keyword MajorTopicYN="N">oliguria</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29136086</ArticleId><ArticleId IdType="doi">10.1093/bja/aex255</ArticleId><ArticleId IdType="pii">S0007-0912(17)54140-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34148499</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>29</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1525-6049</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Renal failure</Title><ISOAbbreviation>Ren Fail</ISOAbbreviation></Journal><ArticleTitle>Preoperative proteinuria may be a risk factor for postoperative acute kidney injury&#xff1a;a meta-analysis.</ArticleTitle><Pagination><StartPage>958</StartPage><EndPage>967</EndPage><MedlinePgn>958-967</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/0886022X.2021.1940201</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate the relationship between preoperative proteinuria and postoperative acute kidney injury (AKI).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a search on databases included PubMed, Embase, the Cochrane Library, and Web of Science, from December 2009 to September 2020. Data extracted from eligible studies were synthesized to calculate the odds ratio (OR) and 95% confidence interval (CI). A fixed or random effects model was applied to calculate the pooled OR based on heterogeneity through the included studies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">This meta-analysis of 11 observational studies included 203,987 participants, of whom 21,621 patients suffered from postoperative AKI and 182,366 patients did not suffer from postoperative AKI. The combined results demonstrated that preoperative proteinuria is an independent risk factor for postoperative AKI (adjusted OR = 1.65, 95%CI:1.44-1.89, <i>p&#x2009;&lt;</i>&#x2009;0.001). Subgroup analysis showed that both preoperative mild proteinuria (adjusted OR = 1.30, 95%CI:1.24-1.36, <i>p</i>&#x2009;&lt;&#x2009;0.001) and preoperative heavy proteinuria (adjusted OR = 1.93, 95%CI:1.65-2.27, <i>p</i>&#x2009;&lt;&#x2009;0.001) were independent risk factors for postoperative AKI. The heterogeneity was combined because its values were lower. Further subgroup analysis found that preoperative proteinuria measured using dipstick was an independent risk factor for postoperative AKI (adjusted OR = 1.48, 95%CI:1.37-1.60, <i>p&#x2009;&lt;</i>&#x2009;0.001). Finally, preoperative proteinuria was an independent risk factor for postoperative AKI in the non-cardiac surgery group (adjusted OR = 2.06, 95%CI:1.31-3.24, <i>p</i>&#x2009;=&#x2009;0.002) and cardiac surgery group (adjusted OR = 1.69, 95%CI:1.39-2.06, <i>p&#x2009;&lt;</i>&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Preoperative proteinuria is an independent risk factor for postoperative AKI and in instances when proteinuria is detected using dipsticks.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Dan-Dan</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Department of Nephropathy, The First Affiliated Hospital, Anhui Medical University, Hefei, Anhui, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuan-Yuan</ForeName><Initials>YY</Initials><AffiliationInfo><Affiliation>Department of Nephropathy, The First Affiliated Hospital, Anhui Medical University, Hefei, Anhui, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Zhe</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Nephropathy, The First Affiliated Hospital, Anhui Medical University, Hefei, Anhui, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yong-Gui</ForeName><Initials>YG</Initials><AffiliationInfo><Affiliation>Department of Nephropathy, The First Affiliated Hospital, Anhui Medical University, Hefei, Anhui, P. R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ren Fail</MedlineTA><NlmUniqueID>8701128</NlmUniqueID><ISSNLinking>0886-022X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011507" MajorTopicYN="N">Proteinuria</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">proteinuria</Keyword><Keyword MajorTopicYN="N">surgery</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>21</Day><Hour>5</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34148499</ArticleId><ArticleId IdType="pmc">PMC8218691</ArticleId><ArticleId IdType="doi">10.1080/0886022X.2021.1940201</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Meersch M, Schmidt C, Zarbock A.. Perioperative acute kidney injury: an under-recognized problem. Anesth Analg. 2017;125(4):1223&#x2013;1232.</Citation><ArticleIdList><ArticleId IdType="pubmed">28787339</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;connor M, Kirwan C, Pearse R, et al. . Incidence and associations of acute kidney injury after major abdominal surgery. Intensive Care Med. 2016;42(4):521&#x2013;530.</Citation><ArticleIdList><ArticleId IdType="pubmed">26602784</ArticleId></ArticleIdList></Reference><Reference><Citation>Biteker M, Dayan A, Tekke&#x15f;in A&#x130;, et al. . Incidence, risk factors, and outcomes of perioperative acute kidney injury in noncardiac and nonvascular surgery. Am J Surg. 2014;207(1):53&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">24050540</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson C, Lysak N, Huber M, et al. . Epidemiology, outcomes, and management of acute kidney injury in the vascular surgery patient. J Vasc Surg. 2018;68(3):916&#x2013;928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6236681</ArticleId><ArticleId IdType="pubmed">30146038</ArticleId></ArticleIdList></Reference><Reference><Citation>Grams ME, Sang Y, Coresh J, et al. . Acute kidney injury after major surgery: a retrospective analysis of veterans health administration data. Am J Kidney Dis. 2016;67(6):872&#x2013;880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4775458</ArticleId><ArticleId IdType="pubmed">26337133</ArticleId></ArticleIdList></Reference><Reference><Citation>Sessler DI, Bloomstone JA, Aronson S, et al. . Perioperative quality initiative consensus statement on intraoperative blood pressure, risk and outcomes for elective surgery. Br J Anaesth. 2019;122(5):563&#x2013;574.</Citation><ArticleIdList><ArticleId IdType="pubmed">30916004</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostermann M, Cennamo A, Meersch M, et al. . A narrative review of the impact of surgery and anaesthesia on acute kidney injury. Anaesthesia. 2020;75(S1):e121&#x2013;e133.</Citation><ArticleIdList><ArticleId IdType="pubmed">31903567</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi EA, Kallmes DF, Fleming CJ, et al. . Predictors and outcomes of postcontrast acute kidney injury after endovascular renal artery intervention. J Vasc Interv Radiol. 2017;28(12):1687&#x2013;1692.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5698138</ArticleId><ArticleId IdType="pubmed">28947366</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao Y, Dong W, Li Z, et al. . Proteinuria as an independent risk factor for contrast-induced acute kidney injury and mortality in patients with stroke undergoing cerebral angiography. J NeuroIntervent Surg. 2017;9(5):445&#x2013;448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5520258</ArticleId><ArticleId IdType="pubmed">27106594</ArticleId></ArticleIdList></Reference><Reference><Citation>Li SY, Chuang CL, Yang WC, et al. . Proteinuria predicts postcardiotomy acute kidney injury in patients with preserved glomerular filtration rate. J Thorac Cardiovasc Surg. 2015;149(3):894&#x2013;899.</Citation><ArticleIdList><ArticleId IdType="pubmed">25433643</ArticleId></ArticleIdList></Reference><Reference><Citation>Grams ME, Sang Y, Ballew SH, CKD Prognosis Consortium, et al.. A meta-analysis of the association of estimated GFR, albuminuria, age, race, and sex with acute kidney injury. Am J Kidney Dis. 2015;66(4):591&#x2013;601.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4584180</ArticleId><ArticleId IdType="pubmed">25943717</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, PRISMA Group, et al.. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang W, Wu X.. Pre-, intra-, and post-operative factors for kidney injury of patients underwent cardiac surgery: a retrospective cohort study. Med Sci Monit. 2019;25:5841&#x2013;5849.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6693368</ArticleId><ArticleId IdType="pubmed">31383840</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG, Jammalamadaka D, Sint K, et al. . Preoperative proteinuria predicts acute kidney injury in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2012;143(2):495&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3341084</ArticleId><ArticleId IdType="pubmed">22050987</ArticleId></ArticleIdList></Reference><Reference><Citation>Safaei N, Ardalan M, Etemadi J.. Acute renal failure after cardiac surgery. Acta Med Iran. 2008;46:329&#x2013;332.</Citation></Reference><Reference><Citation>Kwon JT, Jung TE, Lee DH.. Predictive risk factors of acute kidney injury after on-pump coronary artery bypass grafting. Ann Transl Med. 2019;7(3):44&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6389572</ArticleId><ArticleId IdType="pubmed">30906748</ArticleId></ArticleIdList></Reference><Reference><Citation>He F, Zhang J, Lu Z, et al. . Risk factors and outcomes of acute kidney injury after intracoronary stent implantation. World J Emerg Med. 2012;3(3):197&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4129776</ArticleId><ArticleId IdType="pubmed">25215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang TM, Wu VC, Young GH, National Taiwan University Hospital Study Group of Acute Renal Failure, et al.. Preoperative proteinuria predicts adverse renal outcomes after coronary artery bypass grafting. J Am Soc Nephrol. 2011;22(1):156&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3014044</ArticleId><ArticleId IdType="pubmed">21115618</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahl TS, Graham LA, Morris MS, et al. . Association between preoperative proteinuria and postoperative acute kidney injury and readmission. JAMA Surg. 2018;153(9):e182009e182009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6233648</ArticleId><ArticleId IdType="pubmed">29971429</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimoto M, Murashima M, Kokubu M, et al. . Pre-operative proteinuria and post-operative acute kidney injury in noncardiac surgery: the NARA-acute kidney injury cohort study. Nephrol Dial Transplant. 2020;35(12):2111&#x2013;2116.</Citation><ArticleIdList><ArticleId IdType="pubmed">31891400</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksoy R, Adademir T, Yilmaz E, et al. . Is hypoalbuminemia a predictor for acute kidney injury after coronary bypass grafting in diabetes mellitus patients. Braz J Cardiovasc Surg. 2019;34(5):565&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6852450</ArticleId><ArticleId IdType="pubmed">31165612</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S, Lee S, Lee A, et al. . Preoperative dipstick albuminuria and other urine abnormalities predict acute kidney injury and patient outcomes. Surgery. 2018;163(5):1178&#x2013;1185.</Citation><ArticleIdList><ArticleId IdType="pubmed">29331401</ArticleId></ArticleIdList></Reference><Reference><Citation>Marouli D, Stylianou K, Papadakis E, et al. . Preoperative albuminuria and intraoperative chloride load: predictors of acute kidney injury following major abdominal surgery. JCM. 2018;7(11):431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6262448</ArticleId><ArticleId IdType="pubmed">30423970</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelman DT, Kellum JA.. The difficulty of predicting postoperative acute kidney injury from preoperative clinical data. J Thorac Cardiovasc Surg. 2018;156(3):1124.</Citation><ArticleIdList><ArticleId IdType="pubmed">29666013</ArticleId></ArticleIdList></Reference><Reference><Citation>Golden D, Corbett J, Forni LG.. Peri&#x2010;operative renal dysfunction: prevention and management. Anaesthesia. 2016;71:51&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">26620147</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson JL, Venner AA, Seiden-Long I.. Urine protein detection by dipstick: no interference from alkalinity or specific gravity. Clin Biochem. 2019;71:77&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">31299318</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SK, Moon SY, Oh CM, et al. . High normal urine albumin-to-creatinine ratio predicts development of hypertension in Korean men. Circ J. 2014;78(3):656&#x2013;661.</Citation><ArticleIdList><ArticleId IdType="pubmed">24334637</ArticleId></ArticleIdList></Reference><Reference><Citation>Vart P, Scheven L, Lambers Heerspink HJ, et al. . PREVEND study group and the RENAAL investigators. Urine albumin-creatinine ratio versus albumin excretion for albuminuria staging: a prospective longitudinal cohort study. Am J Kidney Dis. 2016;67(1):70&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">26188433</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter CE, Gansevoort RT, Scheven L, et al. . Influence of urine creatinine on the relationship between the albumin-to-creatinine ratio and cardiovascular events. CJASN. 2012;7(4):595&#x2013;603.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3315344</ArticleId><ArticleId IdType="pubmed">22383750</ArticleId></ArticleIdList></Reference><Reference><Citation>Romagnoli S, Ricci Z, Ronco C.. Therapy of acute kidney injury in the perioperative setting. Curr Opin Anaesthesiol. 2017;30(1):92&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">27841787</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Che M, Xie B, et al. . Preoperative serum cystatin C combined with dipstick proteinuria predicts acute kidney injury after cardiac surgery. Renal Failure. 2014;36(10):1497&#x2013;1503.</Citation><ArticleIdList><ArticleId IdType="pubmed">25155186</ArticleId></ArticleIdList></Reference><Reference><Citation>Vin-Cent W, Huang T-M, Pei-Chen W, et al. . Preoperative proteinuria is associated with long-term progression to chronic dialysis and mortality after coronary artery bypass grafting surgery. PLoS One. 2012;7:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3262783</ArticleId><ArticleId IdType="pubmed">22276092</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32658102</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1537-1921</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of neurosurgical anesthesiology</Title><ISOAbbreviation>J Neurosurg Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Perioperative Risk Factors Associated With Acute Kidney Injury in Patients After Brain Tumor Resection.</ArticleTitle><Pagination><StartPage>51</StartPage><EndPage>56</EndPage><MedlinePgn>51-56</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ANA.0000000000000716</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute kidney injury (AKI) is a serious complication after surgery. The aim of this study is to identify risk factors for postoperative AKI in patients undergoing brain tumor surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This single-center, retrospective, matched case-control study included patients undergoing elective brain tumor surgery between January 2016 and December 2018 at Beijing Tiantan Hospital, Capital Medical University, China. Patients developing postoperative AKI were compared with controls without AKI matched by age, sex, and date of surgery in a ratio of 1:3. AKI was defined using the Kidney Disease Improving Global Outcomes criteria.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 9933 patients were identified for review, of which 115 (1.16%) developed AKI; 345 matched patients were included in the control group. AKI occurred most commonly within the first 24 hours (41/97, 42.3%) and 48 hours (33/94, 35.1%) after surgery. Preoperative administration of mannitol (odds ratio [OR], 1.64; 95% confidence interval [CI], 1.04-2.60; P= 0.034), American Society of Anesthesiologists physical status III or higher (OR, 5.50; 95% CI, 2.23-13.59; P&lt;0.001), preoperative blood glucose (OR, 2.53; 95% CI, 1.23-5.22; P=0.012), craniopharyngioma (OR, 8.96; 95% CI, 3.55-22.63; P&lt;0.001), nonsteroidal anti-inflammatory drug administration (OR, 3.74; 95% CI, 1.66-8.42; P&lt;0.001), and intraoperative hypotension (OR, 2.13; 95% CI, 1.21-3.75; P=0.009) were independent risk factors for postoperative AKI.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Multiple factors, including preoperative administration of mannitol, are independently associated with the development of postoperative AKI in patients undergoing brain tumor surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jiaxin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yan</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Xiang</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ruowen</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xingyue</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Min</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Jia</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shu</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Yuming</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Ruquan</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosurg Anesthesiol</MedlineTA><NlmUniqueID>8910749</NlmUniqueID><ISSNLinking>0898-4921</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001932" MajorTopicYN="Y">Brain Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32658102</ArticleId><ArticleId IdType="doi">10.1097/ANA.0000000000000716</ArticleId><ArticleId IdType="pii">00008506-202201000-00011</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kovacheva VP, Aglio LS, Boland TA, et al. Acute kidney injury after craniotomy is associated with increased mortality: a cohort study. Neurosurgery. 2016;79:389&#x2013;396.</Citation></Reference><Reference><Citation>Kork F, Balzer F, Spies CD, et al. Minor postoperative increases of creatinine are associated with higher mortality and longer hospital length of stay in surgical patients. Anesthesiology. 2015;123:1301&#x2013;1311.</Citation></Reference><Reference><Citation>Doyle JF, Forni LG. Acute kidney injury: short-term and long-term effects. Crit Care. 2016;20:188&#x2013;195.</Citation></Reference><Reference><Citation>Dimick JB, Pronovost PJ, Cowan JA, et al. Complications and costs after high-risk surgery: where should we focus quality improvement initiatives? J Am Coll Surg. 2003;196:671&#x2013;678.</Citation></Reference><Reference><Citation>Vaara ST, Bellomo R. Postoperative renal dysfunction after noncardiac surgery. Curr Opin Crit Care. 2017;23:440&#x2013;446.</Citation></Reference><Reference><Citation>Meersch M, Schmidt C, Zarbock A. Perioperative acute kidney injury: an under-recognized problem. Anesth Analg. 2017;125:1223&#x2013;1232.</Citation></Reference><Reference><Citation>Kim MY, Park JH, Kang NR, et al. Increased risk of acute kidney injury associated with higher infusion rate of mannitol in patients with intracranial hemorrhage. J Neurosurg. 2014;120:1340&#x2013;1348.</Citation></Reference><Reference><Citation>Lin SY, Tang SC, Tsai LK, et al. Incidence and risk factors for acute kidney injury following mannitol infusion in patients with acute stroke. Medicine. 2015;94:e2032.</Citation></Reference><Reference><Citation>Hallqvist L, Granath F, Huldt E, et al. Intraoperative hypotension is associated with acute kidney injury in noncardiac surgery. Eur J Anaesthesiol. 2018;35:273&#x2013;279.</Citation></Reference><Reference><Citation>Tang Y, Zhu C, Liu J, et al. Association of intraoperative hypotension with acute kidney injury after noncardiac surgery in patients younger than 60 years old. Kidney Blood Press Res. 2019;44:211&#x2013;221.</Citation></Reference><Reference><Citation>Carney N, Totten AM, O&#x2019;Reilly C, et al. Guidelines for the management of severe traumatic brain injury, fourth edition. Neurosurgery. 2017;80:6&#x2013;15.</Citation></Reference><Reference><Citation>Quentin C, Charbonneau S, Moumdjian R, et al. A comparison of two doses of mannitol on brain relaxation during supratentorial brain tumor craniotomy: a randomized trial. Anesth Analg. 2013;116:862&#x2013;868.</Citation></Reference><Reference><Citation>Li S, Sun H, Liu X, et al. Mannitol improves intraoperative brain relaxation in patients with a midline shift undergoing supratentorial tumor surgery: a randomized controlled trial. J Neurosurg Anesthesiol. 2019. [Epub ahead of print].</Citation></Reference><Reference><Citation>Suzuki J, Tanaka S, Yoshimoto T, et al. Recirculation in the acute period of cerebral infarction: experimental research on brain swelling and its suppression by using mannitol or glycerol. Acta Neurochirurgica. 1980;54:219&#x2013;231.</Citation></Reference><Reference><Citation>Kellum JALN, Aspelin P, Barsoum RS, et al. KDIGO clinical practice guideline for acute kidney injury 2012. Kidney Int Suppl. 2012;2:1&#x2013;138.</Citation></Reference><Reference><Citation>Kazner E, Lanksch W, Steinhoff H, et al. Computerized axial tomography of the skull&#x2014;diagnostic possibilities and clinical results (author&#x2019;s transl). Fortschr Neurol Psychiatr Grenzgeb. 1975;43:487&#x2013;574.</Citation></Reference><Reference><Citation>Kertai MD, Zhou S, Karhausen JA, et al. Platelet counts, acute kidney injury, and mortality after coronary artery bypass grafting surgery. Anesthesiology. 2016;125:438&#x2013;439.</Citation></Reference><Reference><Citation>Thakar CV, Christianson A, Freyberg R, et al. Incidence and outcomes of acute kidney injury in intensive care units: a Veterans Administration study. Crit Care Med. 2009;37:2552&#x2013;2558.</Citation></Reference><Reference><Citation>O&#x2019;Connor ME, Hewson RW, Kirwan CJ, et al. Acute kidney injury and mortality 1 year after major non-cardiac surgery. Br J Surg. 2017;104:868&#x2013;876.</Citation></Reference><Reference><Citation>Biteker M, Dayan A, Tekkesin AI, et al. Incidence, risk factors, and outcomes of perioperative acute kidney injury in noncardiac and nonvascular surgery. Am J Surg. 2014;207:53&#x2013;59.</Citation></Reference><Reference><Citation>Nomani AZ, Nabi Z, Rashid H, et al. Osmotic nephrosis with mannitol: review article. Ren Fail. 2014;36:1169&#x2013;1176.</Citation></Reference><Reference><Citation>Fang L, You H, Chen B, et al. Mannitol is an independent risk factor of acute kidney injury after cerebral trauma: a case-control study. Ren Fail. 2010;32:673&#x2013;679.</Citation></Reference><Reference><Citation>Perez-Perez AJ, Pazos B, Sobrado J, et al. Acute renal failure following massive mannitol infusion. Am J Nephrol. 2002;22:573&#x2013;575.</Citation></Reference><Reference><Citation>Bragadottir G, Redfors B, Ricksten SE. Mannitol increases renal blood flow and maintains filtration fraction and oxygenation in postoperative acute kidney injury: a prospective interventional study. Crit Care. 2012;16:R159&#x2013;R167.</Citation></Reference><Reference><Citation>Redfors B, Sward K, Sellgren J, et al. Effects of mannitol alone and mannitol plus furosemide on renal oxygen consumption, blood flow and glomerular filtration after cardiac surgery. Intensive Care Med. 2009;35:115&#x2013;122.</Citation></Reference><Reference><Citation>Muller HL. Craniopharyngioma. Endocr Rev. 2014;35:513&#x2013;543.</Citation></Reference><Reference><Citation>Lu HA. Diabetes insipidus. Adv Exp Med Biol. 2017;969:213&#x2013;225.</Citation></Reference><Reference><Citation>Frisch A, Chandra P, Smiley D, et al. Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care. 2010;33:1783&#x2013;1788.</Citation></Reference><Reference><Citation>Palomba H, de Castro I, Neto AL, et al. Acute kidney injury prediction following elective cardiac surgery: AKICS Score. Kidney Int. 2007;72:624&#x2013;631.</Citation></Reference><Reference><Citation>Wang T, Fu X, Chen Q. Arachidonic acid metabolism and kidney inflammation. Int J Mol Sci. 2019;20:3683&#x2013;3711.</Citation></Reference><Reference><Citation>Zadrazil J. Nonsteroidal antiinflammatory drugs and the kidney. Vnitr Lek. 2006;52:686&#x2013;690.</Citation></Reference><Reference><Citation>Garg AX, Kurz A, Sessler DI, et al. Perioperative aspirin and clonidine and risk of acute kidney injury: a randomized clinical trial. JAMA. 2014;312:2254&#x2013;2264.</Citation></Reference><Reference><Citation>Walsh M, Devereaux PJ, Garg AX, et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology. 2013;119:507&#x2013;515.</Citation></Reference><Reference><Citation>Sun LY, Wijeysundera DN, Tait GA, et al. Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology. 2015;123:515&#x2013;523.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28060555</PMID><DateCompleted><Year>2018</Year><Month>08</Month><Day>08</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1521-0553</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of investigative surgery : the official journal of the Academy of Surgical Research</Title><ISOAbbreviation>J Invest Surg</ISOAbbreviation></Journal><ArticleTitle>Efficacy of N-Acetylcysteine in Preventing Acute Kidney Injury After Cardiac Surgery: A Meta-Analysis Study.</ArticleTitle><Pagination><StartPage>14</StartPage><EndPage>23</EndPage><MedlinePgn>14-23</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/08941939.2016.1269853</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate whether perioperative N-acetylcysteine (NAC) administration reduces the risk of cardiac surgery associated acute kidney injury (CSA-AKI).</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">A systematic literature review (Medline, PubMed, Cochrane, Biomedical central, Google Scholar) identified 10 studies (1391 patients; 695 NAC and 696 placebo) that compared the efficacy and adverse effects of perioperative NAC administration for CSA-AKI prevention in adults undergoing elective cardiac surgery. Meta-analysis was performed using Comprehensive Meta-Analysis statistical software.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Patients in the NAC-treated and placebo groups had similar rate of CSA-AKI occurrence, change in creatinine levels, as well as the in-hospital mortality rate (RR = 0.841, 95% CI = 0.691 to 1.023, p = 0.083; pooled difference in means = -0.328, 95% CI = -0.712 to 0.056, p = 0.094; RR = 0.741, 95% CI = 0.388 to 1.418, p = 0.366, respectively).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study does not support perioperative NAC administration as a mean to reduce the risk of CSA-AKI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mei</LastName><ForeName>Mei</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>a Department of Kidney , Southwest Hospital, Third Military Medical University , Chongqing 400038 , P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Hong-Wen</ForeName><Initials>HW</Initials><AffiliationInfo><Affiliation>a Department of Kidney , Southwest Hospital, Third Military Medical University , Chongqing 400038 , P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Qian-Guang</ForeName><Initials>QG</Initials><AffiliationInfo><Affiliation>a Department of Kidney , Southwest Hospital, Third Military Medical University , Chongqing 400038 , P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pu</LastName><ForeName>You-Min</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>a Department of Kidney , Southwest Hospital, Third Military Medical University , Chongqing 400038 , P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Mao-Zhi</ForeName><Initials>MZ</Initials><AffiliationInfo><Affiliation>a Department of Kidney , Southwest Hospital, Third Military Medical University , Chongqing 400038 , P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Bing-Bing</ForeName><Initials>BB</Initials><AffiliationInfo><Affiliation>a Department of Kidney , Southwest Hospital, Third Military Medical University , Chongqing 400038 , P.R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>01</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Invest Surg</MedlineTA><NlmUniqueID>8809255</NlmUniqueID><ISSNLinking>0894-1939</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016166">Free Radical Scavengers</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical><Chemical><RegistryNumber>WYQ7N0BPYC</RegistryNumber><NameOfSubstance UI="D000111">Acetylcysteine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000111" MajorTopicYN="N">Acetylcysteine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016166" MajorTopicYN="N">Free Radical Scavengers</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">N-acetylcysteine</Keyword><Keyword MajorTopicYN="N">acute kidney injury/kidney injury</Keyword><Keyword MajorTopicYN="N">cardiac surgery/heart surgery</Keyword><Keyword MajorTopicYN="N">coronary artery bypass</Keyword><Keyword MajorTopicYN="N">creatinine</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28060555</ArticleId><ArticleId IdType="doi">10.1080/08941939.2016.1269853</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28218392</PMID><DateCompleted><Year>2017</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2168</ISSN><JournalIssue CitedMedium="Internet"><Volume>104</Volume><Issue>7</Issue><PubDate><Year>2017</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The British journal of surgery</Title><ISOAbbreviation>Br J Surg</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury and mortality 1 year after major non-cardiac surgery.</ArticleTitle><Pagination><StartPage>868</StartPage><EndPage>876</EndPage><MedlinePgn>868-876</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/bjs.10498</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Even mild and transient acute kidney injury (AKI), defined by increases in serum creatinine level, has been associated with adverse outcomes after major surgery. However, characteristic decreases in creatinine concentration during major illness could confound accurate assessment of postoperative AKI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In a single-hospital, retrospective cohort study of non-cardiac surgery, the association between postoperative AKI, defined using the Kidney Disease: Improving Global Outcomes criteria, and 1-year survival was modelled using a multivariable Cox proportional hazards analysis. Factors associated with development of AKI were examined by means of multivariable logistic regression. Temporal changes in serum creatinine during and after the surgical admission in patients with and without AKI were compared.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Some 1869 patients were included in the study, of whom 128 (6&#xb7;8 per cent) sustained AKI (101 stage 1, 27 stage 2-3). Seventeen of the 128 patients with AKI (13&#xb7;3 per cent) died in hospital compared with 16 of 1741 (0&#xb7;9 per cent) without AKI (P &lt; 0&#xb7;001). By 1 year, 34 patients with AKI (26&#xb7;6 per cent) had died compared with 106 (6&#xb7;1 per cent) without AKI (P &lt; 0&#xb7;001). Over the 8-365 days after surgery, AKI was associated with an adjusted hazard ratio for death of 2&#xb7;96 (95 per cent c.i. 1&#xb7;86 to 4&#xb7;71; P &lt; 0&#xb7;001). Among hospital survivors without AKI, the creatinine level fell consistently (median difference at discharge versus baseline -7 (i.q.r. -15 to 0) &#xb5;mol/l), but not in those with AKI (0 (-16 to 26) &#xb5;mol/l) (P &lt; 0&#xb7;001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Although the majority of postoperative AKI was mild, there was a strong association with risk of death in the year after surgery. Underlying decreases in serum creatinine concentration after major surgery could lead to underestimation of AKI severity and overestimation of recovery.</AbstractText><CopyrightInformation>&#xa9; 2017 BJS Society Ltd Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>O'Connor</LastName><ForeName>M E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Medicine Research Group, William Harvey Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Adult Critical Care Unit, Royal London Hospital, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hewson</LastName><ForeName>R W</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Medicine Research Group, William Harvey Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Adult Critical Care Unit, Royal London Hospital, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia, Royal London Hospital, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirwan</LastName><ForeName>C J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Medicine Research Group, William Harvey Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Adult Critical Care Unit, Royal London Hospital, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Renal and Transplant Medicine, Royal London Hospital, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ackland</LastName><ForeName>G L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Medicine Research Group, William Harvey Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia, Royal London Hospital, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pearse</LastName><ForeName>R M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Medicine Research Group, William Harvey Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Adult Critical Care Unit, Royal London Hospital, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia, Royal London Hospital, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prowle</LastName><ForeName>J R</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0002-5002-2721</Identifier><AffiliationInfo><Affiliation>Critical Care and Perioperative Medicine Research Group, William Harvey Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Adult Critical Care Unit, Royal London Hospital, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Renal and Transplant Medicine, Royal London Hospital, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RP_2014-04-022</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>02</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Surg</MedlineTA><NlmUniqueID>0372553</NlmUniqueID><ISSNLinking>0007-1323</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009026" MajorTopicYN="Y">Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28218392</ArticleId><ArticleId IdType="doi">10.1002/bjs.10498</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36008696</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2584</ISSN><JournalIssue CitedMedium="Internet"><Volume>55</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>International urology and nephrology</Title><ISOAbbreviation>Int Urol Nephrol</ISOAbbreviation></Journal><ArticleTitle>Risk factors of perioperative acute kidney injury in elderly patients: a single-center retrospective study.</ArticleTitle><Pagination><StartPage>459</StartPage><EndPage>467</EndPage><MedlinePgn>459-467</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11255-022-03345-8</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The elderly are vulnerable to perioperative acute kidney injury. The aim of this study was to determine the risk factors that associated with acute kidney injury among elderly patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Clinical data of elderly patients (&gt;&#x2009;65&#xa0;years) who underwent noncardiac, nonrenal surgery between Dec 1 2009 and July 1 2016 were collected for this single-centered historical cohort study. Univariate and multivariate analyses were conducted to explore the risk factors that contribute to acute kidney injury, which was defined as a serum creatinine increase &gt;0.3&#xa0;mg/dL within 48&#xa0;h or 1.5 times increase in serum creatinine within 7 days after surgery.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">7775 patients were eligible for the final analysis, among which 511 (6.57%) patients developed acute kidney injury. We observed 21 risk factors being associated with perioperative acute kidney injury, with the most important disposing factors being history of kidney disease (adjusted OR&#x2009;=&#x2009;2.94, 95% CI 2.25-3.84), operation time&#x2009;&gt;&#x2009;180&#xa0;min (aOR&#x2009;=&#x2009;2.93, 95% CI 2.04-4.24), preoperative eGFR [15, 30) (aOR&#x2009;=&#x2009;2.43, 95% CI 1.29-4.45), and protective factor being intraoperative use of sufentanil (aOR&#x2009;=&#x2009;0.35, 95% CI 0.23-0.54).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study determined risk factors for perioperative acute kidney injury among the elderly in the Second Xiangya Hospital and visualized the risk factors using nomogram and Excel calculator, which may provide some clues to further investigations. Overall, the prevalence of AKI among this large cohort is 6.57%.</AbstractText><AbstractText Label="CLINICAL TRIALS REGISTRATION" NlmCategory="BACKGROUND">http://www.chictr.org.cn ; ChiCTR1900027007; October 28, 2019.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Nature B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Sun</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Province Center for Clinical Anesthesia and Anesthesiology, Research Institute of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhao</LastName><ForeName>Yujing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Province Center for Clinical Anesthesia and Anesthesiology, Research Institute of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Binyi</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Province Center for Clinical Anesthesia and Anesthesiology, Research Institute of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mo</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Le9 Healthcare Technology Co., Ltd., Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Junmei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China. xujunmei001@csu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Province Center for Clinical Anesthesia and Anesthesiology, Research Institute of Central South University, Changsha, China. xujunmei001@csu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Yulong</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-2677-654X</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China. cuiyulong@csu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Province Center for Clinical Anesthesia and Anesthesiology, Research Institute of Central South University, Changsha, China. cuiyulong@csu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Grant No. 2018YFC2001902</GrantID><Agency>National Key Research and Development Program of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int Urol Nephrol</MedlineTA><NlmUniqueID>0262521</NlmUniqueID><ISSNLinking>0301-1623</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Elderly patients</Keyword><Keyword MajorTopicYN="N">Risk factors</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>25</Day><Hour>23</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36008696</ArticleId><ArticleId IdType="doi">10.1007/s11255-022-03345-8</ArticleId><ArticleId IdType="pii">10.1007/s11255-022-03345-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Doyle JF, Forni LG (2016) Acute kidney injury: short-term and long-term effects. Crit Care 20(1):188</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1353-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Rewa O, Bagshaw SM (2014) Acute kidney injury-epidemiology, outcomes and economics. Nat Rev Nephrol 10(4):193&#x2013;207</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2013.282</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu JR, Zhu JM, Jiang J, Ding XQ, Fang Y, Shen B et al (2015) Risk factors for long-term mortality and progressive chronic kidney disease associated with acute kidney injury after cardiac surgery. Medicine (Baltimore) 94(45):e2025</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000002025</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Y, Ding X, Zhong Y, Zou J, Teng J, Tang Y et al (2010) Acute kidney injury in a chinese hospitalized population. Blood Purif 30(2):120&#x2013;126</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000319972</ArticleId></ArticleIdList></Reference><Reference><Citation>Koza Y (2016) Acute kidney injury: current concepts and new insights. J Inj Violence Res 8(1):58&#x2013;62</Citation></Reference><Reference><Citation>Hoste EA, Clermont G, Kersten A, Venkataraman R, Angus DC, De Bacquer D et al (2006) RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 10(3):R73</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc4915</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Murugan R (2016) Effects of non-severe acute kidney injury on clinical outcomes in critically ill patients. Crit Care 20(1):159</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1295-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutherland SM, Goldstein SL, Bagshaw SM (2018) Acute kidney injury and big data. Contrib Nephrol 193:55&#x2013;67</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000484963</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosner MH, La Manna G, Ronco C (2018) Acute kidney injury in the geriatric population. Contrib nephrol. Contributions to nephrology. S. Karger AG, Berlin, pp 149&#x2013;160</Citation></Reference><Reference><Citation>Chronopoulos A, Rosner MH, Cruz DN, Ronco C (2010) Acute kidney injury in elderly intensive care patients: a review. Intensive Care Med 36(9):1454&#x2013;1464</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-010-1957-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A (2012) KDIGO clinical practice guidelines for acute kidney injury. Nature Publ. Group, New York, p 138</Citation></Reference><Reference><Citation>Gumbert SD, Kork F, Jackson ML, Vanga N, Ghebremichael SJ, Wang CY et al (2020) Perioperative acute kidney injury. Anesthesiology 132(1):180&#x2013;204</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000002968</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Ye Y, Mi Q, Huang W, He T, Huang P et al (2016) A predictive model for assessing surgery-related acute kidney injury risk in hypertensive patients: a retrospective cohort study. PLoS ONE 11(11):e0165280</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0165280</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung S, Brovman EY, Aglio LS, Beutler SS, Urman RD (2020) Risk factors and associated complications of acute kidney injury in adult patients undergoing a craniotomy. Clin Neurol Neurosurg 190:105642</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2019.105642</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob KA, Leaf DE (2019) Prevention of cardiac surgery-associated acute kidney injury: a review of current strategies. Anesthesiol Clin 37(4):729&#x2013;749</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anclin.2019.08.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickering JW, James MT, Palmer SC (2015) Acute kidney injury and prognosis after cardiopulmonary bypass: a meta-analysis of cohort studies. Am J Kidney Dis 65(2):283&#x2013;293</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2014.09.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosla N, Soroko SB, Chertow GM, Himmelfarb J, Ikizler TA, Paganini E et al (2009) Preexisting chronic kidney disease: a potential for improved outcomes from acute kidney injury. Clin J Am Soc Nephrol 4(12):1914&#x2013;1919</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.01690309</ArticleId></ArticleIdList></Reference><Reference><Citation>Dean M (2004) Opioids in renal failure and dialysis patients. J Pain Symptom Manag 28(5):497&#x2013;504</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpainsymman.2004.02.021</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob KA, Leaf DE, Dieleman JM, van Dijk D, Nierich AP, Rosseel PM et al (2015) Intraoperative high-dose dexamethasone and severe AKI after cardiac surgery. J Am Soc Nephrol 26(12):2947&#x2013;2951</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2014080840</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitlock RP, Devereaux PJ, Teoh KH, Lamy A, Vincent J, Pogue J et al (2015) Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial. Lancet 386(10000):1243&#x2013;1253</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)00273-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun LY, Wijeysundera DN, Tait GA, Beattie WS (2015) Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology 123(3):515&#x2013;523</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000765</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh M, Devereaux PJ, Garg AX, Kurz A, Turan A, Rodseth RN et al (2013) Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology 119(3):507&#x2013;515</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3182a10e26</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngu JMC, Jabagi H, Chung AM, Boodhwani M, Ruel M, Bourke M et al (2020) Defining an intraoperative hypotension threshold in association with de novo renal replacement therapy after cardiac surgery. Anesthesiology 132(6):1447&#x2013;1457</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003254</ArticleId></ArticleIdList></Reference><Reference><Citation>Bijker JB, van Klei WA, Vergouwe Y, Eleveld DJ, van Wolfswinkel L, Moons KG et al (2009) Intraoperative hypotension and 1-year mortality after noncardiac surgery. Anesthesiology 111(6):1217&#x2013;1226</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181c14930</ArticleId></ArticleIdList></Reference><Reference><Citation>Bijker JB, van Klei WA, Kappen TH, van Wolfswinkel L, Moons KGM, Kalkman CJ (2007) Incidence of intraoperative hypotension as a function of the chosen definition-literature definitions applied to a retrospective cohort using automated data collection. Anesthesiology 107(2):213&#x2013;220</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.anes.0000270724.40897.8e</ArticleId></ArticleIdList></Reference><Reference><Citation>Singbartl K, Joannidis M (2015) Short-term effects of acute kidney injury. Crit Care Clin 31(4):751&#x2013;762</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2015.06.010</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40042458</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>11</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2060</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Annals of medicine</Title><ISOAbbreviation>Ann Med</ISOAbbreviation></Journal><ArticleTitle>Intraoperative hemodynamics in prediction of postoperative kidney injury after type a aortic dissection surgery: a retrospective cohort study.</ArticleTitle><Pagination><StartPage>2474859</StartPage><MedlinePgn>2474859</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2474859</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/07853890.2025.2474859</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Type A aortic dissection (TAAD) is a severe cardiovascular condition associated with high risks for postoperative complications, particularly renal dysfunction. This study investigated whether intraoperative hypotension and venous congestion are important predictors of postoperative kidney injury and major adverse events.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We retrospectively analyzed 543 adults undergoing TAAD surgery (2016-2023). Primary outcomes were acute kidney injury (AKI) and acute kidney disease (AKD). Secondary outcomes included death, stroke and composite outcome. Patients were divided into four groups: AKI only, AKD only, AKI and AKD, Non-AKI or AKD. We used restricted cubic spline and multivariate logistic regression models to adjust for confounding factors.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">AKI or AKD was significantly associated with each 10-minute epoch of central venous pressure (CVP) &#x2265;10, 12, 16, 20&#x2009;mmHg (all <i>p</i>&#x2009;&lt;&#x2009;0.001), with each 60-minute epoch of CVP &#x2265;10, 12, 16, 20&#x2009;mmHg area under the curve (AUC) (all p&#x2009;&lt;&#x2009;0.001). Regarding death, a 6% to 13% increase rate for each 10-minute epoch of CVP &#x2265;10, 12, 16, 20&#x2009;mmHg (all <i>p</i>&#x2009;&#x2264;&#x2009;0.003), a 5% to 21% increase for each 60-minute epoch of CVP &#x2265;10, 12, 16, 20&#x2009;mmHg AUC (all <i>p</i>&#x2009;&lt;&#x2009;0.001). In terms of stroke risk, a 5% increase rate for every 10-minute increase in the CVP AUC above 16&#x2009;mmHg, and an 11% increased risk for CVP AUC above 20&#x2009;mmHg (<i>p</i>&#x2009;=&#x2009;0.039 and <i>p</i>&#x2009;=&#x2009;0.031, respectively).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Elevated CVP and lower MAP levels were linked to postoperative AKI and AKD risk. CVP showed stronger associations with mortality and stroke. Optimizing perioperative hemodynamic management may improve individualized interventions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lihai</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of International Business, China Pharmaceutical University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bu</LastName><ForeName>Xinyi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Zhongda Hospital, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xuesheng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, First Affiliated Hospital of Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Siyu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of International Business, China Pharmaceutical University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Yali</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-8417-1672</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Hongwei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Jifang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of International Business, China Pharmaceutical University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Med</MedlineTA><NlmUniqueID>8906388</NlmUniqueID><ISSNLinking>0785-3890</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000784" MajorTopicYN="Y">Aortic Dissection</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="Y">Hemodynamics</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002496" MajorTopicYN="N">Central Venous Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="plain-language-summary" Language="eng"><AbstractText>Acute kidney injury and acute kidney disease are common and serious complications after Type A aortic dissection surgery.This observational cohort study showed that both intraoperative venous congestion and hypotension are associated with acute kidney injury and acute kidney disease. In addition intraoperative venous congestion displayed a direct correlation with postoperative outcomes such as death and stroke.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">acute kidney disease</Keyword><Keyword MajorTopicYN="N">intraoperative hypotension</Keyword><Keyword MajorTopicYN="N">type A aortic dissection</Keyword><Keyword MajorTopicYN="N">venous congestion</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>5</Day><Hour>12</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>5</Day><Hour>12</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>5</Day><Hour>10</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>3</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40042458</ArticleId><ArticleId IdType="pmc">PMC11884094</ArticleId><ArticleId IdType="doi">10.1080/07853890.2025.2474859</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mussa FF, Horton JD, Moridzadeh R, et al. . Acute aortic dissection and intramural hematoma: a systematic review. JAMA. 2016;316(7):754&#x2013;763. doi: 10.1001/jama.2016.10026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.10026</ArticleId><ArticleId IdType="pubmed">27533160</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Zhong G, Lv X, et al. . Risk factors for acute kidney injury after Stanford type A aortic dissection repair surgery: a systematic review and meta-analysis. Ren Fail. 2022;44(1):1462&#x2013;1476. doi: 10.1080/0886022X.2022.2113795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/0886022X.2022.2113795</ArticleId><ArticleId IdType="pmc">PMC9427034</ArticleId><ArticleId IdType="pubmed">36036431</ArticleId></ArticleIdList></Reference><Reference><Citation>Helgadottir S, Sigurdsson MI, Palsson R, et al. . Renal recovery and long-term survival following acute kidney injury after coronary artery surgery: a nationwide study. Acta Anaesthesiol Scand. 2016;60(9):1230&#x2013;1240. doi: 10.1111/aas.12758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.12758</ArticleId><ArticleId IdType="pubmed">27378715</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryd&#xe9;n LC, Sartipy U, Holzmann MJ.. Acute kidney injury after surgical AVR and long-term risk of death and end-stage renal disease. J Am Coll Cardiol. 2015;66(20):2263&#x2013;2264. doi: 10.1016/j.jacc.2015.08.883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2015.08.883</ArticleId><ArticleId IdType="pubmed">26553408</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Sileanu FE, Bihora A, et al. . Recovery after acute kidney injury. Am J Respir Crit Care Med. 2017;195(6):784&#x2013;791. doi: 10.1164/rccm.201604-0799OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201604-0799OC</ArticleId><ArticleId IdType="pmc">PMC5363967</ArticleId><ArticleId IdType="pubmed">27635668</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryo M, Masao I, Hidekazu M, et al. . The clinical course of acute kidney disease after cardiac surgery: a retrospective observational study. Sci Rep. 2020;10(1):6490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7162986</ArticleId><ArticleId IdType="pubmed">32300140</ArticleId></ArticleIdList></Reference><Reference><Citation>Chawla LS, Bellomo R, Bihorac A, et al. . Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol. 2017;13(4):241&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pubmed">28239173</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitra KN, Lui GF, Azra B, et al. . Cardiac and vascular surgery-associated acute kidney injury: the 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) Group. J Am Heart Assoc. 2018;7(11):e008834.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6015369</ArticleId><ArticleId IdType="pubmed">29858368</ArticleId></ArticleIdList></Reference><Reference><Citation>Anran D, Zhou Z, Fan J, et al. . Incorporating intraoperative blood pressure time-series variables to assist in prediction of acute kidney injury after type A acute aortic dissection repair: an interpretable machine learning model. Ann Med. 2023;55(2):2266458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10563625</ArticleId><ArticleId IdType="pubmed">37813109</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Hong L, Ma A, et al. . Intraoperative venous congestion rather than hypotension is associated with acute adverse kidney events after cardiac surgery: a retrospective cohort study. Br J Anaesth. 2022;128(5):785&#x2013;795. doi: 10.1016/j.bja.2022.01.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2022.01.032</ArticleId><ArticleId IdType="pubmed">35249707</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko T, Higashitani M, Sato A, et al. . Impact of acute kidney injury on early to long-term outcomes in patients who underwent surgery for type A acute aortic dissection. Am J Cardiol. 2015;116(3):463&#x2013;468. doi: 10.1016/j.amjcard.2015.04.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2015.04.043</ArticleId><ArticleId IdType="pubmed">26026862</ArticleId></ArticleIdList></Reference><Reference><Citation>Razminia M, Trivedi A, Molnar J, et al. . Validation of a new formula for mean arterial pressure calculation: the new formula is superior to the standard formula. Catheter Cardiovasc Interv. 2004;63(4):419&#x2013;425. doi: 10.1002/ccd.20217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.20217</ArticleId><ArticleId IdType="pubmed">15558774</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C-H, Chen S-W, Chen J-J, et al. . Incidence and transition of acute kidney injury, acute kidney disease to chronic kidney disease after acute type A aortic dissection surgery. J Clin Med. 2021;10(20):4769. doi: 10.3390/jcm10204769.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10204769</ArticleId><ArticleId IdType="pmc">PMC8540632</ArticleId><ArticleId IdType="pubmed">34682894</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng K, McIlroy DR, Bollen BA, et al. . Society of cardiovascular anesthesiologists clinical practice update for management of acute kidney injury associated with cardiac surgery. Anesth Analg. 2022;135(4):744&#x2013;756. doi: 10.1213/ANE.0000000000006068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000006068</ArticleId><ArticleId IdType="pubmed">35544772</ArticleId></ArticleIdList></Reference><Reference><Citation>Makhija N, Magoon R, Das D, et al. . Haemodynamic predisposition to acute kidney injury: shadow and light!. J Anaesthesiol Clin Pharmacol. 2022;38(3):353&#x2013;359. doi: 10.4103/joacp.JOACP_547_20.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/joacp.JOACP_547_20</ArticleId><ArticleId IdType="pmc">PMC9728413</ArticleId><ArticleId IdType="pubmed">36505192</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopitk&#xf3; C, Gondos T, F&#xfc;l&#xf6;p T, et al. . Reinterpreting renal hemodynamics: the importance of venous congestion and effective organ perfusion in acute kidney injury. Am J Med Sci. 2020;359(4):193&#x2013;205. doi: 10.1016/j.amjms.2020.01.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2020.01.012</ArticleId><ArticleId IdType="pubmed">32089228</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang PT, Lopez BE, Togashi K.. A decrease in effective renal perfusion pressure is associated with increased acute kidney injury in patients undergoing cardiac surgery. Cureus. 2023;15(9):e45036. doi: 10.7759/cureus.45036.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.45036</ArticleId><ArticleId IdType="pmc">PMC10566397</ArticleId><ArticleId IdType="pubmed">37829983</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniel DB, Rocio R, Jacques D.. Hemodynamic management of acute kidney injury. Curr Opin Crit Care. 2024;30(6):542&#x2013;547.</Citation><ArticleIdList><ArticleId IdType="pubmed">39503203</ArticleId></ArticleIdList></Reference><Reference><Citation>Isselbacher EM, Bonaca MP, Di Eusanio M, et al. . Recurrent aortic dissection: observations from the International Registry of Aortic Dissection. Circulation. 2016;134(14):1013&#x2013;1024. doi: 10.1161/CIRCULATIONAHA.115.019359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.115.019359</ArticleId><ArticleId IdType="pubmed">27587434</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyul-Toth A, Fulop GA, Tarantini S, et al. . Cerebral venous congestion exacerbates cerebral microhemorrhages in mice. Geroscience. 2022;44(2):805&#x2013;816. doi: 10.1007/s11357-021-00504-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-021-00504-0</ArticleId><ArticleId IdType="pmc">PMC9135950</ArticleId><ArticleId IdType="pubmed">34989944</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29721817</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1496-8975</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>8</Issue><PubDate><Year>2018</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Canadian journal of anaesthesia = Journal canadien d'anesthesie</Title><ISOAbbreviation>Can J Anaesth</ISOAbbreviation></Journal><ArticleTitle>The impact of hyperoxia on outcomes after cardiac surgery: a systematic review and narrative synthesis.</ArticleTitle><Pagination><StartPage>923</StartPage><EndPage>935</EndPage><MedlinePgn>923-935</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12630-018-1143-x</ELocationID><Abstract><AbstractText Label="PURPOSE">Historically, cardiac surgery patients have often been managed with supraphysiologic intraoperative oxygen levels to protect against the risks of cellular hypoxia inherent in the un-physiologic nature of surgery and cardiopulmonary bypass. This may result in excessive reactive oxygen species generation and exacerbation of ischemia-reperfusion injury. In this review, we synthesize all available data from randomized controlled trials (RCTs) to investigate the impact that hyperoxia has on postoperative organ dysfunction, length of stay, and mortality during adult cardiac surgery.</AbstractText><AbstractText Label="SOURCE">We searched Medline, Embase, Scopus, and Cochrane Central Register of Controlled Trials databases using a high-sensitivity strategy for RCTs that compared oxygenation strategies for adult cardiac surgery. Our primary outcome was postoperative organ dysfunction defined by postoperative increases in myocardial enzymes, acute kidney injury, and neurologic dysfunction. Secondary outcomes were mortality, ventilator days, and length of stay in the hospital and intensive care unit.</AbstractText><AbstractText Label="PRINCIPAL FINDINGS">We identified 12 RCTs that met our inclusion criteria. Risk of bias was unclear to high in all but one trial. Significant heterogeneity in timing of the treatment period and the oxygenation levels targeted was evident and precluded meta-analysis. The large majority of trials found no difference between hyperoxia and normoxia for any outcome. Two trials reported reduced postoperative myocardial enzymes and one trial reported reduced mechanical ventilation time in the normoxia group.</AbstractText><AbstractText Label="CONCLUSIONS">Hyperoxia had minimal impact on organ dysfunction, length of stay, and mortality in adult cardiac surgery. The current evidence base is small, heterogeneous, and at risk of bias.</AbstractText><AbstractText Label="TRIAL REGISTRATION">International Prospective Register of Systematic Reviews (PROSPERO) (CRD42017074712). Registered 17 August 2017.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Heinrichs</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Perioperative and Pain Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lodewyks</LastName><ForeName>Carly</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Surgery, Section of Cardiac Surgery, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neilson</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>George &amp; Fay Yee Center for Healthcare Innovation, University of Manitoba/Winnipeg Regional Health Authority, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neil John Maclean Health Sciences Library, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abou-Setta</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>George &amp; Fay Yee Center for Healthcare Innovation, University of Manitoba/Winnipeg Regional Health Authority, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grocott</LastName><ForeName>Hilary P</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Perioperative and Pain Medicine, University of Manitoba, Winnipeg, MB, Canada. hgrocott@sbgh.mb.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Section of Cardiac Surgery, University of Manitoba, Winnipeg, MB, Canada. hgrocott@sbgh.mb.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Manitoba, St. Boniface Hospital, CR3008 - 369 Tache Avenue, Winnipeg, MB, R2H 2A6, Canada. hgrocott@sbgh.mb.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><VernacularTitle>R&#xe9;percussions de l&#x2019;hyperoxie sur les r&#xe9;sultats apr&#xe8;s une chirurgie cardiaque&#xa0;: revue syst&#xe9;matique et synth&#xe8;se narrative.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Can J Anaesth</MedlineTA><NlmUniqueID>8701709</NlmUniqueID><ISSNLinking>0832-610X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015982" MajorTopicYN="N">Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015687" MajorTopicYN="N">Cell Hypoxia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018496" MajorTopicYN="N">Hyperoxia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29721817</ArticleId><ArticleId IdType="doi">10.1007/s12630-018-1143-x</ArticleId><ArticleId IdType="pii">10.1007/s12630-018-1143-x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36543389</PMID><DateRevised><Year>2023</Year><Month>01</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2211-4599</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>International journal of spine surgery</Title><ISOAbbreviation>Int J Spine Surg</ISOAbbreviation></Journal><ArticleTitle>Intraoperative Hypotension Is Not Correlated With Acute Kidney Injury During Spinal Fusion Surgery.</ArticleTitle><Pagination><StartPage>1061</StartPage><EndPage>1067</EndPage><MedlinePgn>1061-1067</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.14444/8367</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Intraoperative hypotension (IOH) has been found to be associated with organ damage, including cardiac injury and acute kidney injury (AKI). However, to our knowledge, this relationship has not been studied in a neurosurgery-specific patient population. In this report, we review our institutional experience to understand the magnitude of association between IOH in spinal fusion operations and incidence of postoperative AKI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective cohort study included 910 patients who underwent posterior spinal fusion procedures performed in the prone position. Intraoperative variables collected and analyzed include minute-by-minute mean arterial pressure (MAP) from an arterial catheter, intermittent blood pressure cuff readings, volume of administered intravenous fluids, urine output, and all relevant vitals and administered medications. The electronic medical record was queried for additional patient data. IOH was defined as MAP &lt;65 mm Hg for greater than 10 minutes. The primary endpoints of the study were presence and staging of AKI ( [Kidney Disease: Improving Global Outcomes] consensus classification), postoperative ileus, and postoperative troponin leak.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Using a partial correlation analysis, no association was found between IOH metrics (IOH occurrence, IOH duration &gt;10 minutes, and total IOH time) and any outcome metrics, including AKI, except for vasopressor usage and estimated blood loss. Patient age at surgery was not associated with any outcome variables. The lack of association between IOH and AKI contrasts with existing literature; this could be due to underlying differences in our patient population or could highlight a more complex relationship between IOH and AKI than previously understood.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Occurrence and duration of IOH were not associated with AKI, postoperative ileus, troponin leak, length of stay, or any other major outcome variables in spinal fusion patients.</AbstractText><AbstractText Label="CLINICAL RELEVANCE" NlmCategory="CONCLUSIONS">These findings depart from previous literature showing a correlation between IOH and AKI and provide level 3 evidence clinically relevant to spinal surgery. Further research is needed to better understand the exact nature of this relationship.</AbstractText><CopyrightInformation>This manuscript is generously published free of charge by ISASS, the International Society for the Advancement of Spine Surgery. Copyright &#xa9; 2022 ISASS. To see more or order reprints or permissions, see http://ijssurgery.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Blue</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA Rachel.blue@pennmedicine.upenn.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gutierrez</LastName><ForeName>Alexis</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmad</LastName><ForeName>Hasan S</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alexis</LastName><ForeName>Maya</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Rachit</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spadola</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wathen</LastName><ForeName>Connor</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weinstein</LastName><ForeName>Mitchell</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrov</LastName><ForeName>Dmitriy</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Spine Surg</MedlineTA><NlmUniqueID>101579005</NlmUniqueID><ISSNLinking>2211-4599</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">fusion</Keyword><Keyword MajorTopicYN="N">hypotension</Keyword><Keyword MajorTopicYN="N">intraoperative</Keyword><Keyword MajorTopicYN="N">spinal</Keyword></KeywordList><CoiStatement>Declaration of Conflicting Interests: The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>21</Day><Hour>20</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36543389</ArticleId><ArticleId IdType="pmc">PMC9807044</ArticleId><ArticleId IdType="doi">10.14444/8367</ArticleId><ArticleId IdType="pii">16/6/1061</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>S&#xfc;dfeld S, Brechnitz S, Wagner JY, et al. . Post-induction hypotension and early intraoperative hypotension associated with general anaesthesia. Br J Anaesth. 2017;119(1):57&#x2013;64. 10.1093/bja/aex127</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aex127</ArticleId><ArticleId IdType="pubmed">28974066</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann B, Junger A, Klasen J, et al. . The incidence and risk factors for hypotension after spinal anesthesia induction: an analysis with automated data collection. Anesth Analg. 2002;94(6):1521&#x2013;1529. 10.1097/00000539-200206000-00027</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-200206000-00027</ArticleId><ArticleId IdType="pubmed">12032019</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh M, Devereaux PJ, Garg AX, et al. . Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology. 2013;119(3):507&#x2013;515. 10.1097/ALN.0b013e3182a10e26</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3182a10e26</ArticleId><ArticleId IdType="pubmed">23835589</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun LY, Wijeysundera DN, Tait GA, Beattie WS. Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology. 2015;123(3):515&#x2013;523. 10.1097/ALN.0000000000000765</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000765</ArticleId><ArticleId IdType="pubmed">26181335</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory A, Stapelfeldt WH, Khanna AK, et al. . Intraoperative hypotension is associated with adverse clinical outcomes after noncardiac surgery. Anesth Analg. 2021;132(6):1654&#x2013;1665. 10.1213/ANE.0000000000005250</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005250</ArticleId><ArticleId IdType="pmc">PMC8115733</ArticleId><ArticleId IdType="pubmed">33177322</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyle JF, Forni LG. Acute kidney injury: short-term and long-term effects. Crit Care. 2016;20(1):188. 10.1186/s13054-016-1353-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1353-y</ArticleId><ArticleId IdType="pmc">PMC4931701</ArticleId><ArticleId IdType="pubmed">27373891</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmasi V, Maheshwari K, Yang D, et al. . Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery: a retrospective cohort analysis. Anesthesiology. 2017;126(1):47&#x2013;65. 10.1097/ALN.0000000000001432</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001432</ArticleId><ArticleId IdType="pubmed">27792044</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S, Lee H-C, Jung C-W, et al. . Intraoperative arterial pressure variability and postoperative acute kidney injury. Clin J Am Soc Nephrol. 2020;15(1):35&#x2013;46. 10.2215/CJN.06620619</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.06620619</ArticleId><ArticleId IdType="pmc">PMC6946069</ArticleId><ArticleId IdType="pubmed">31888922</ArticleId></ArticleIdList></Reference><Reference><Citation>Bijker JB, van Klei WA, Kappen TH, van Wolfswinkel L, Moons KGM, Kalkman CJ. Incidence of intraoperative hypotension as a function of the chosen definition: literature definitions applied to a retrospective cohort using automated data collection. Anesthesiology. 2007;107(2):213&#x2013;220. 10.1097/01.anes.0000270724.40897.8e</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.anes.0000270724.40897.8e</ArticleId><ArticleId IdType="pubmed">17667564</ArticleId></ArticleIdList></Reference><Reference><Citation>Vos JJ, Scheeren TWL. Intraoperative hypotension and its prediction. Indian J Anaesth. 2019;63(11):877&#x2013;885:11. 10.4103/ija.IJA_624_19</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ija.IJA_624_19</ArticleId><ArticleId IdType="pmc">PMC6868662</ArticleId><ArticleId IdType="pubmed">31772395</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Lameire N, Aspelin P, et al. . Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int. 2012;2(1):1&#x2013;138.</Citation></Reference><Reference><Citation>VanderWeele TJ, Mathur MB. Some desirable properties of the bonferroni correction: is the bonferroni correction really so bad? Am J Epidemiol. 2019;188(3):617&#x2013;618. 10.1093/aje/kwy250</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwy250</ArticleId><ArticleId IdType="pmc">PMC6395159</ArticleId><ArticleId IdType="pubmed">30452538</ArticleId></ArticleIdList></Reference><Reference><Citation>Barash PG. Clinical Anesthesia. Lippincott Williams &amp; Wilkins; 2009.</Citation></Reference><Reference><Citation>Bayliss WM. On the local reactions of the arterial wall to changes of internal pressure. J Physiol. 1902;28(3):220&#x2013;231. 10.1113/jphysiol.1902.sp000911</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.1902.sp000911</ArticleId><ArticleId IdType="pmc">PMC1540533</ArticleId><ArticleId IdType="pubmed">16992618</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee CJ, Kibler KK, Easley RB, et al. . Renovascular reactivity measured by near-infrared spectroscopy. J Appl Physiol (1985). 2012;113(2):307&#x2013;314. 10.1152/japplphysiol.00024.2012</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00024.2012</ArticleId><ArticleId IdType="pubmed">22628378</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesselink EM, Kappen TH, Torn HM, Slooter AJC, van Klei WA. Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review. Br J Anaesth. 2018;121(4):706&#x2013;721. 10.1016/j.bja.2018.04.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2018.04.036</ArticleId><ArticleId IdType="pubmed">30236233</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis MR, Naik BI, Freundlich RE, et al. . Preoperative risk and the association between hypotension and postoperative acute kidney injury. Anesthesiology. 2020;132(3):461&#x2013;475. 10.1097/ALN.0000000000003063</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003063</ArticleId><ArticleId IdType="pmc">PMC7015776</ArticleId><ArticleId IdType="pubmed">31794513</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K, Ando K, Kato F, et al. . Predictors of prolonged length of stay after lumbar interbody fusion: a multicenter study. Global Spine J. 2019;9(5):466&#x2013;472. 10.1177/2192568218800054</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2192568218800054</ArticleId><ArticleId IdType="pmc">PMC6686383</ArticleId><ArticleId IdType="pubmed">31431867</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuris EO, Veeramani A, McDonald CL, et al. . Predicting readmission after anterior, posterior, and posterior interbody lumbar spinal fusion: a neural network machine learning approach. World Neurosurg. 2021;151:e19&#x2013;e27. 10.1016/j.wneu.2021.02.114</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2021.02.114</ArticleId><ArticleId IdType="pubmed">33744425</ArticleId></ArticleIdList></Reference><Reference><Citation>Semler MW, Self WH, Wanderer JP, et al. . Balanced crystalloids versus saline in critically ill adults. N Engl J Med. 2018;378(9):829&#x2013;839. 10.1056/NEJMoa1711584</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1711584</ArticleId><ArticleId IdType="pmc">PMC5846085</ArticleId><ArticleId IdType="pubmed">29485925</ArticleId></ArticleIdList></Reference><Reference><Citation>Regolisti G, Maggiore U, Rossi GM, Cabassi A, Fiaccadori E. Hyperchloremia and acute kidney injury: a spurious association or a worrisome reality? Intern Emerg Med. 2020;15(2):187&#x2013;189. 10.1007/s11739-019-02213-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-019-02213-1</ArticleId><ArticleId IdType="pubmed">31650432</ArticleId></ArticleIdList></Reference><Reference><Citation>LaPar DJ, Rich JB, Isbell JM, et al. . Preoperative renal function predicts hospital costs and length of stay in coronary artery bypass grafting. Ann Thorac Surg. 2016;101(2):606&#x2013;612. 10.1016/j.athoracsur.2015.07.079</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2015.07.079</ArticleId><ArticleId IdType="pubmed">26680309</ArticleId></ArticleIdList></Reference><Reference><Citation>Najafi M, Goodarzynejad H, Karimi A, et al. . Is preoperative serum creatinine a reliable indicator of outcome in patients undergoing coronary artery bypass surgery? J Thorac Cardiovasc Surg. 2009;137(2):304&#x2013;308. 10.1016/j.jtcvs.2008.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2008.08.001</ArticleId><ArticleId IdType="pubmed">19185142</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz MG, Picone DS, Armstrong MK, et al. . The influence of SBP amplification on the accuracy of form-factor-derived mean arterial pressure. J Hypertens. 2020;38(6):1033&#x2013;1039. 10.1097/HJH.0000000000002385</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HJH.0000000000002385</ArticleId><ArticleId IdType="pubmed">32371792</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33248232</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-9488</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Season>Winter</Season></PubDate></JournalIssue><Title>Seminars in thoracic and cardiovascular surgery</Title><ISOAbbreviation>Semin Thorac Cardiovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Effect of Renin-Angiotensin System Inhibitors on Acute Kidney Injury Among Patients Undergoing Cardiac Surgery: A Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>1014</StartPage><EndPage>1022</EndPage><MedlinePgn>1014-1022</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.semtcvs.2020.11.024</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1043-0679(20)30419-6</ELocationID><Abstract><AbstractText>Acute kidney injury (AKI) is a frequent complication of cardiac surgery, which can lead to higher mortality and long-term renal function impairment. The effect of perioperative renin-angiotensin system inhibitors (RASi) therapy on AKI incidence in patients undergoing cardiac surgery remains controversial. We reviewed related studies in PubMed, Scopus, and Cochrane Library from inception to February 2020. Two randomized controlled trials and 21 cohort studies were included in the meta-analysis, involving 76,321 participants. The pooled odds ratio and 95% confidence interval were calculated using the DerSimonian and Laird random-effects model. The results showed no significant association between perioperative RASi therapy and postoperative AKI in patients undergoing cardiac surgery. We highlighted the limitations of existing studies and called for well-designed large-scale randomized controlled trials to verify the conclusion.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Han</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Management, University of Science and Technology of China, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Jingui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Management, Technical University of Munich, Heilbronn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Zhichao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Lee Kong Chian School of Business, Singapore Management University, Singapore. Electronic address: danielzheng@smu.edu.sg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ooi</LastName><ForeName>Oon Cheong</ForeName><Initials>OC</Initials><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic &amp; Vascular Surgery, National University Hospital, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Haidong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic &amp; Vascular Surgery, National University Hospital, Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Semin Thorac Cardiovasc Surg</MedlineTA><NlmUniqueID>8917640</NlmUniqueID><ISSNLinking>1043-0679</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000806">Angiotensin-Converting Enzyme Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Semin Thorac Cardiovasc Surg. 2021 Winter;33(4):1023-1024. doi: 10.1053/j.semtcvs.2021.01.037.</RefSource><PMID Version="1">33609675</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Semin Thorac Cardiovasc Surg. 2021 Winter;33(4):1025-1026. doi: 10.1053/j.semtcvs.2021.01.041.</RefSource><PMID Version="1">33609684</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000806" MajorTopicYN="N">Angiotensin-Converting Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012084" MajorTopicYN="N">Renin-Angiotensin System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Angiotensin II receptor blockers</Keyword><Keyword MajorTopicYN="N">Angiotensin-converting enzyme inhibitors</Keyword><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Renin-angiotensin system inhibitors</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>28</Day><Hour>20</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33248232</ArticleId><ArticleId IdType="doi">10.1053/j.semtcvs.2020.11.024</ArticleId><ArticleId IdType="pii">S1043-0679(20)30419-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34908546</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>134</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Postoperative Acute Kidney Injury Is Associated With Progression of Chronic Kidney Disease Independent of Severity.</ArticleTitle><Pagination><StartPage>49</StartPage><EndPage>58</EndPage><MedlinePgn>49-58</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000005702</ELocationID><Abstract><AbstractText Label="BACKGROUND">Both postoperative acute kidney injury (AKI) and preoperative chronic kidney disease (CKD) are associated with significantly worse outcomes following surgery. The relationship of both of these conditions with each other and with CKD progression after surgery remains poorly studied. Our objective was to assess if there was an interaction between preoperative kidney function estimated by preoperative estimated glomerular filtration rate (eGFR)/CKD stage, postoperative AKI, and eGFR/CKD progression within 1 year of surgery. Our hypothesis was that AKI severity would be associated with a faster time to eGFR/CKD stage progression within 1 year of surgery in a graded-fashion, which would be exacerbated by preoperative kidney dysfunction.</AbstractText><AbstractText Label="METHODS">This was a retrospective cohort study at Landspitali University Hospital in Iceland, which serves about 75% of the population. Participants included adults receiving their first major anesthetic between 2005 and 2018. Patients with CKD stage 5, undergoing major urologic procedures, or having missing creatinine values for follow-up of eGFR stage were excluded from analysis. The primary exposure was postoperative AKI stage within 7 days after surgery classified by the kidney disease improving global outcome (KDIGO) criteria. The primary outcome was time to progression of CKD by at least 1 eGFR/CKD stage within 1-year following surgery. Multivariable Cox proportional hazards models were used to estimate hazard of eGFR/CKD stage progression, including an interaction between AKI and preoperative CKD on eGFR/CKD stage progression.</AbstractText><AbstractText Label="RESULTS">A total of 5548 patients were studied. In the multivariable model adjusting for baseline eGFR/CKD stage, when compared to patients without AKI, postoperative AKI stage 1 (hazard ratio [HR], 5.91; 95% confidence interval [CI], 4.34-8.05), stage 2 (HR, 3.86; 95% CI, 1.82-8.16), and stage 3 (HR, 3.61; 95% CI, 1.49-8.74) were all independently associated with faster time to eGFR/CKD stage progression within 1 year following surgery, though increasing AKI severity did not confer additional risk. The only significant interaction between the degree of AKI and the preexisting renal function was for stage 1 AKI, where the odds of 1-year eGFR/CKD stage progression actually decreased in patients with preoperative CKD categories 3a, 3b, and 4.</AbstractText><AbstractText Label="CONCLUSIONS">KDIGO-AKI was independently associated with eGFR/CKD stage progression within the year following surgery after adjustment for baseline eGFR/CKD stage and without an interaction between worse preoperative kidney function and higher stage AKI. Our observations suggest that further studies are warranted to test whether CKD progression could be prevented by the adoption of perioperative kidney protective practices.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 International Anesthesia Research Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Privratsky</LastName><ForeName>Jamie R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>From the Critical Care and Perioperative Population Health Research (CAPER) Unit.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Perioperative Organ Protection (CPOP), Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krishnamoorthy</LastName><ForeName>Vijay</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>From the Critical Care and Perioperative Population Health Research (CAPER) Unit.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raghunathan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>From the Critical Care and Perioperative Population Health Research (CAPER) Unit.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology Service Division, Durham Veterans Affairs Medical Center, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohnuma</LastName><ForeName>Tetsu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>From the Critical Care and Perioperative Population Health Research (CAPER) Unit.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasouli</LastName><ForeName>Mohammad R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Stanford University, Palo Alto, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Thorir E</ForeName><Initials>TE</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sigurdsson</LastName><ForeName>Martin I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Division of Anesthesia and Intensive Care Medicine, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="Y">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="N">Glomerular Filtration Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007055" MajorTopicYN="N" Type="Geographic">Iceland</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>12</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34908546</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000005702</ArticleId><ArticleId IdType="pii">00000539-202201000-00011</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kork F, Balzer F, Spies CD, et al. Minor postoperative increases of creatinine are associated with higher mortality and longer hospital length of stay in surgical patients. Anesthesiology. 2015;123:1301&#x2013;1311.</Citation></Reference><Reference><Citation>O&#x2019;Connor ME, Hewson RW, Kirwan CJ, Ackland GL, Pearse RM, Prowle JR. Acute kidney injury and mortality 1 year after major non-cardiac surgery. Br J Surg. 2017;104:868&#x2013;876.</Citation></Reference><Reference><Citation>Mathis MR, Naik BI, Freundlich RE, et al.; Multicenter Perioperative Outcomes Group Investigators. Preoperative risk and the association between hypotension and postoperative acute kidney injury. Anesthesiology. 2020;132:461&#x2013;475.</Citation></Reference><Reference><Citation>Hu J, Chen R, Liu S, Yu X, Zou J, Ding X. Global incidence and outcomes of adult patients with acute kidney injury after cardiac surgery: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth. 2016;30:82&#x2013;89.</Citation></Reference><Reference><Citation>Hoste EA, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41:1411&#x2013;1423.</Citation></Reference><Reference><Citation>Lassnigg A, Schmidlin D, Mouhieddine M, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004;15:1597&#x2013;1605.</Citation></Reference><Reference><Citation>Hobson CE, Yavas S, Segal MS, et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation. 2009;119:2444&#x2013;2453.</Citation></Reference><Reference><Citation>Ishani A, Xue JL, Himmelfarb J, et al. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol. 2009;20:223&#x2013;228.</Citation></Reference><Reference><Citation>Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296&#x2013;1305.</Citation></Reference><Reference><Citation>Turan A, Cohen B, Adegboye J, et al. Mild acute kidney injury after noncardiac surgery is associated with long-term renal dysfunction: a retrospective cohort study. Anesthesiology. 2020;132:1053&#x2013;1061.</Citation></Reference><Reference><Citation>Ackland GL, Moran N, Cone S, Grocott MP, Mythen MG. Chronic kidney disease and postoperative morbidity after elective orthopedic surgery. Anesth Analg. 2011;112:1375&#x2013;1381.</Citation></Reference><Reference><Citation>Bahrainwala JZ, Gelfand SL, Shah A, Abramovitz B, Hoffman B, Leonberg-Yoo AK. Preoperative risk assessment and management in adults receiving maintenance dialysis and those with earlier stages of CKD. Am J Kidney Dis. 2020;75:245&#x2013;255.</Citation></Reference><Reference><Citation>Gaber AO, Moore LW, Aloia TA, et al. Cross-sectional and case-control analyses of the association of kidney function staging with adverse postoperative outcomes in general and vascular surgery. Ann Surg. 2013;258:169&#x2013;177.</Citation></Reference><Reference><Citation>Mathew A, Devereaux PJ, O&#x2019;Hare A, et al. Chronic kidney disease and postoperative mortality: a systematic review and meta-analysis. Kidney Int. 2008;73:1069&#x2013;1081.</Citation></Reference><Reference><Citation>Gumbert SD, Kork F, Jackson ML, et al. Perioperative acute kidney injury. Anesthesiology. 2020;132:180&#x2013;204.</Citation></Reference><Reference><Citation>Sigurdsson MI, Helgadottir S, Long TE, et al. Association between preoperative opioid and benzodiazepine prescription patterns and mortality after noncardiac surgery. JAMA Surg. 2019;154:e191652.</Citation></Reference><Reference><Citation>Palevsky PM, Liu KD, Brophy PD, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis. 2013;61:649&#x2013;672.</Citation></Reference><Reference><Citation>Foundation NK. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 suppl 1):S1&#x2013;S266.</Citation></Reference><Reference><Citation>Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515&#x2013;526.</Citation></Reference><Reference><Citation>Ishani A, Nelson D, Clothier B, et al. The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death. Arch Intern Med. 2011;171:226&#x2013;233.</Citation></Reference><Reference><Citation>Cho JS, Shim JK, Lee S, et al. Chronic progression of cardiac surgery associated acute kidney injury: intermediary role of acute kidney disease. J Thorac Cardiovasc Surg. 2021;161:681&#x2013;688.e3.</Citation></Reference><Reference><Citation>Sharma A, Mucino MJ, Ronco C. Renal functional reserve and renal recovery after acute kidney injury. Nephron Clin Pract. 2014;127:94&#x2013;100.</Citation></Reference><Reference><Citation>Long TE, Helgason D, Helgadottir S, et al. Acute kidney injury after abdominal surgery: incidence, risk factors, and outcome. Anesth Analg. 2016;122:1912&#x2013;1920.</Citation></Reference><Reference><Citation>Brown JR, Kramer RS, Coca SG, Parikh CR. Duration of acute kidney injury impacts long-term survival after cardiac surgery. Ann Thorac Surg. 2010;90:1142&#x2013;1148.</Citation></Reference><Reference><Citation>Coca SG, King JT Jr, Rosenthal RA, Perkal MF, Parikh CR. The duration of postoperative acute kidney injury is an additional parameter predicting long-term survival in diabetic veterans. Kidney Int. 2010;78:926&#x2013;933.</Citation></Reference><Reference><Citation>Nickolas TL, O&#x2019;Rourke MJ, Yang J, et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med. 2008;148:810&#x2013;819.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38472159</PMID><DateCompleted><Year>2025</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-111X</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Perfusion</Title><ISOAbbreviation>Perfusion</ISOAbbreviation></Journal><ArticleTitle>Meta-analysis of central and peripheral cannulation for type A aortic dissection.</ArticleTitle><Pagination><StartPage>417</StartPage><EndPage>430</EndPage><MedlinePgn>417-430</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/02676591241238865</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute type A aortic dissection necessitates rapid and effective arterial cannulation techniques for optimal outcomes. This meta-analysis compares the safety and effectiveness of direct aortic cannulation (AoC) with peripheral cannulation (PC) via the femoral or axillary arteries in aortic surgery for acute type A aortic dissection.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review following PRISMA guidelines identified 10 retrospective studies encompassing 2518 patients (961 AoC, 1557 PC). Pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated to analyze perioperative characteristics, short-term mortality rates, and postoperative complications including stroke and acute kidney injury.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Short-term mortality did not significantly differ between AoC and PC (OR [95% CI] = 0.78 [0.61-1.01], <i>p</i> = .06). Likewise, postoperative stroke (OR [95% CI] = 0.86 [0.63-1.17], <i>p</i> = .33) nor acute kidney injury (OR [95% CI] = 1.11 [0.89-1.37], <i>p</i> = .35) showed no significant differences. AoC exhibited shorter operation time whereas there were no significant differences in aortic cross clamp time and cardiopulmonary bypass time between both groups. Our meta-regression analysis, considering the distal extent of aortic replacement, indicated that variations in aortic replacement rates did not significantly impact the observed outcomes.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">AoC is a viable alternative to PC for acute type A aortic dissection. While both approaches offer comparable outcomes, AoC's advantage in shorter operation time warrants thoughtful consideration in clinical practice.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Naito</LastName><ForeName>Noritsugu</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-1789-5993</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Shizuoka Medical Center, Shizuoka, Japan.</Affiliation><Identifier Source="RINGGOLD">26357</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takagi</LastName><ForeName>Hisato</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Shizuoka Medical Center, Shizuoka, Japan.</Affiliation><Identifier Source="RINGGOLD">26357</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Perfusion</MedlineTA><NlmUniqueID>8700166</NlmUniqueID><ISSNLinking>0267-6591</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000784" MajorTopicYN="Y">Aortic Dissection</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002406" MajorTopicYN="Y">Catheterization, Peripheral</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002404" MajorTopicYN="Y">Catheterization</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001014" MajorTopicYN="Y">Aortic Aneurysm</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute aortic dissection</Keyword><Keyword MajorTopicYN="N">aortic cannulation</Keyword><Keyword MajorTopicYN="N">peripheral cannulation</Keyword><Keyword MajorTopicYN="N">surgical technique</Keyword></KeywordList><CoiStatement>Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>13</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38472159</ArticleId><ArticleId IdType="doi">10.1177/02676591241238865</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33888081</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2369</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>23</Day></PubDate></JournalIssue><Title>BMC nephrology</Title><ISOAbbreviation>BMC Nephrol</ISOAbbreviation></Journal><ArticleTitle>Modifiable risk factors of acute kidney injury after liver transplantation: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>149</StartPage><MedlinePgn>149</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">149</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12882-021-02360-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">Acute kidney injury (AKI) is a common and critical complication of liver transplantation (LT), which is associated with increased morbidity, mortality and health care cost. We aimed to identify modifiable risk factors of AKI after LT.</AbstractText><AbstractText Label="METHODS">A literature search of Pubmed, EMBASE and Cochrane Databases was performed to identify studies investigating risk factors of AKI after LT. The Newcastle-Ottawa Scale was used to rate study quality. Effect size and 95% confidence interval were pooled using a random-effect model with inverse-variance method.</AbstractText><AbstractText Label="RESULTS">Sixty-seven articles with 28,844 patients were included in the meta-analysis. Seventeen modifiable risk factors were found, including overweight, preoperative use of diuretic, preoperative anemia, donation after cardiac death organ, donor BMI&#x2009;&#x2265;&#x2009;30&#x2009;kg/m<sup>2</sup>, ABO-incompatible LT, low graft to recipient body weight ratio, intraoperative hypotension, major bleeding, intraoperative use of vasopressor, large RBC transfusion, postreperfusion syndrome, postoperative use of vasopressors, overexposure to calcineurin inhibitor, calcineurin inhibitor without mycophenolate mofetil, graft dysfunction and infection. A total of 38 articles were included in the systematic review, in which 8 modifiable risk factors and 1 protective factor were additionally associated in single studies with the incidence of AKI after LT.</AbstractText><AbstractText Label="CONCLUSIONS">Effective interventions based on identified modifiable risk factors in the perioperative management and graft allocation and preservation may be promising to reduce the incidence of AKI after LT.</AbstractText><AbstractText Label="TRIAL REGISTRATION">The protocol for this systematic review is registered with PROSPERO (No. CRD42020166918 ).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Affiliated Hospital of Qingdao University, School of Clinical Medicine, Qingdao University, No. 59, Haier Road, Qingdao, 266100, Shandong Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xueying</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, 610000, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lyu</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Affiliated Hospital of Qingdao University, School of Clinical Medicine, Qingdao University, No. 59, Haier Road, Qingdao, 266100, Shandong Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Xiaojun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Affiliated Hospital of Qingdao University, School of Clinical Medicine, Qingdao University, No. 59, Haier Road, Qingdao, 266100, Shandong Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miao</LastName><ForeName>Guishen</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Affiliated Hospital of Qingdao University, School of Clinical Medicine, Qingdao University, No. 59, Haier Road, Qingdao, 266100, Shandong Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Haichen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Affiliated Hospital of Qingdao University, School of Clinical Medicine, Qingdao University, No. 59, Haier Road, Qingdao, 266100, Shandong Province, China. chiefchu@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Nephrol</MedlineTA><NlmUniqueID>100967793</NlmUniqueID><ISSNLinking>1471-2369</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016031" MajorTopicYN="N">Liver Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014019" MajorTopicYN="N">Tissue Donors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Liver transplantation</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Modifiable risk factors</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>23</Day><Hour>5</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>4</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33888081</ArticleId><ArticleId IdType="pmc">PMC8063403</ArticleId><ArticleId IdType="doi">10.1186/s12882-021-02360-8</ArticleId><ArticleId IdType="pii">10.1186/s12882-021-02360-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ronco C, Bellomo R, Kellum JA. Acute kidney injury. Lancet. 2019;394(10212):1949&#x2013;1964. doi: 10.1016/S0140-6736(19)32563-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32563-2</ArticleId><ArticleId IdType="pubmed">31777389</ArticleId></ArticleIdList></Reference><Reference><Citation>Gumbert SD, Kork F, Jackson ML, Vanga N, Ghebremichael SJ, Wang CY, Eltzschig HK. Perioperative acute kidney injury. Anesthesiology. 2020;132(1):180&#x2013;204. doi: 10.1097/ALN.0000000000002968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000002968</ArticleId><ArticleId IdType="pmc">PMC10924686</ArticleId><ArticleId IdType="pubmed">31687986</ArticleId></ArticleIdList></Reference><Reference><Citation>Susantitaphong P, Cruz DN, Cerda J, Abulfaraj M, Alqahtani F, Koulouridis I, Jaber BL. World incidence of AKI: a meta-analysis. Clin J Am Soc Nephrol. 2013;8(9):1482&#x2013;1493. doi: 10.2215/CJN.00710113.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.00710113</ArticleId><ArticleId IdType="pmc">PMC3805065</ArticleId><ArticleId IdType="pubmed">23744003</ArticleId></ArticleIdList></Reference><Reference><Citation>Thongprayoon C, Kaewput W, Thamcharoen N, Bathini T, Watthanasuntorn K, Lertjitbanjong P, et al. Incidence and impact of acute kidney injury after liver transplantation: a meta-analysis. J Clin Med. 2019;8(3):372. 10.3390/jcm8030372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6463182</ArticleId><ArticleId IdType="pubmed">30884912</ArticleId></ArticleIdList></Reference><Reference><Citation>Durand F, Francoz C, Asrani SK, Khemichian S, Pham TA, Sung RS, Genyk YS, Nadim MK. Acute kidney injury after liver transplantation. Transplantation. 2018;102(10):1636&#x2013;1649. doi: 10.1097/TP.0000000000002305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0000000000002305</ArticleId><ArticleId IdType="pubmed">29847502</ArticleId></ArticleIdList></Reference><Reference><Citation>de Haan JE, Hoorn EJ, de Geus HRH. Acute kidney injury after liver transplantation: recent insights and future perspectives. Best Pract Res Clin Gastroenterol. 2017;31(2):161&#x2013;169. doi: 10.1016/j.bpg.2017.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpg.2017.03.004</ArticleId><ArticleId IdType="pubmed">28624104</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurzhagen JT, Dellepiane S, Cantaluppi V, Rabb H. AKI: an increasingly recognized risk factor for CKD development and progression. J Nephrol. 2020;33(6):1171&#x2013;1187. doi: 10.1007/s40620-020-00793-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40620-020-00793-2</ArticleId><ArticleId IdType="pubmed">32651850</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker H, Bell S. Strategies to reduce perioperative nephrotoxicity. Semin Nephrol. 2019;39(5):442&#x2013;453. doi: 10.1016/j.semnephrol.2019.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semnephrol.2019.06.004</ArticleId><ArticleId IdType="pubmed">31514908</ArticleId></ArticleIdList></Reference><Reference><Citation>Mcinnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM, Clifford T, et al. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies. Jama. 319(4):388.</Citation><ArticleIdList><ArticleId IdType="pubmed">29362800</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. J Am Med Assoc. 2000;283(15):2008&#x2013;12. 10.1001/jama.283.15.2008.</Citation><ArticleIdList><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603&#x2013;5. 10.1007/s10654-010-9491-z.</Citation><ArticleIdList><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Dersimonian R, Nan L. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177&#x2013;88. 10.1016/0197-2456(86)90046-2.</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Dersimonian R, Laird N. Meta-Analysis in Clinical Trials Revisited. Contemp Clin Trials. 2015;45(Pt A):139&#x2013;45. 10.1016/j.cct.2015.09.002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4639420</ArticleId><ArticleId IdType="pubmed">26343745</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thompson SG, Decks JJ, Altman DG. Measuring inconsistency in meta-analyses. Brit Med J. 2003;327(7414):557&#x2013;60. 10.1136/bmj.327.7414.557.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane handbook for systematic reviews of interventions, Version 5.1.0 (Online). [http://handbook-5-1.cochrane.org/]. Accessed 28 Apr 2020.</Citation></Reference><Reference><Citation>Easterbrook PJ, Gopalan R, Berlin JA, Matthews DR. Publication bias in clinical research. Lancet. 337(8746):867&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">1672966</ArticleId></ArticleIdList></Reference><Reference><Citation>Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication Bias in meta-analysis. Biometrics. 2000;56(2):455&#x2013;463. doi: 10.1111/j.0006-341X.2000.00455.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0006-341X.2000.00455.x</ArticleId><ArticleId IdType="pubmed">10877304</ArticleId></ArticleIdList></Reference><Reference><Citation>Zongyi Y, Baifeng L, Funian Z, Hao L, Xin W. Risk factors of acute kidney injury after orthotopic liver transplantation in China. Sci Rep. 2017;7(1):41555. doi: 10.1038/srep41555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep41555</ArticleId><ArticleId IdType="pmc">PMC5278509</ArticleId><ArticleId IdType="pubmed">28134286</ArticleId></ArticleIdList></Reference><Reference><Citation>Codes L, de Souza YG, D'Oliveira RAC, Bastos JLA, Bittencourt PL. Cumulative positive fluid balance is a risk factor for acute kidney injury and requirement for renal replacement therapy after liver transplantation. World J Transplant. 2018;8(2):44&#x2013;51. doi: 10.5500/wjt.v8.i2.44.</Citation><ArticleIdList><ArticleId IdType="doi">10.5500/wjt.v8.i2.44</ArticleId><ArticleId IdType="pmc">PMC5915376</ArticleId><ArticleId IdType="pubmed">29696105</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas ME, Blaine C, Dawnay A, Devonald MA, Ftouh S, Laing C, Latchem S, Lewington A, Milford DV, Ostermann M. The definition of acute kidney injury and its use in practice. Kidney Int. 2015;87(1):62&#x2013;73. doi: 10.1038/ki.2014.328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2014.328</ArticleId><ArticleId IdType="pubmed">25317932</ArticleId></ArticleIdList></Reference><Reference><Citation>Englberger L, Suri RM, Li Z, Casey ET, Daly RC, Dearani JA, Schaff HV. Clinical accuracy of RIFLE and acute kidney injury network (AKIN) criteria for acute kidney injury in patients undergoing cardiac surgery. Crit Care. 2011;15(1):R16. doi: 10.1186/cc9960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9960</ArticleId><ArticleId IdType="pmc">PMC3222049</ArticleId><ArticleId IdType="pubmed">21232094</ArticleId></ArticleIdList></Reference><Reference><Citation>Suneja M, Kumar AB. Obesity and perioperative acute kidney injury: A focused review. J Critical Care. 2014;29(4):694. doi: 10.1016/j.jcrc.2014.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2014.02.021</ArticleId><ArticleId IdType="pubmed">24666959</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M, Schmidt C, Zarbock A. Perioperative acute kidney injury. Anesth Analg. 2015;115(S2):1.</Citation><ArticleIdList><ArticleId IdType="pubmed">28787339</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwakernaak AJ, Toering TJ, Navis G. Body mass index and body fat distribution as renal risk factors: a focus on the role of renal haemodynamics. Nephrol Dial Transplant 2013, 28 (Suppl 4):iv42&#x2013;v49.</Citation><ArticleIdList><ArticleId IdType="pubmed">24179015</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho KM, Power BM. Benefits and risks of furosemide in acute kidney injury. Anaesthesia. 2010;65(3):283&#x2013;293. doi: 10.1111/j.1365-2044.2009.06228.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2009.06228.x</ArticleId><ArticleId IdType="pubmed">20085566</ArticleId></ArticleIdList></Reference><Reference><Citation>Lib&#xf3;rio AB, Barbosa ML, S&#xe1; VB, Leite TT. Impact of loop diuretics on critically ill patients with a positive fluid balance. Anaesthesia. 2020;75(S1). 10.1111/anae.14908.</Citation><ArticleIdList><ArticleId IdType="pubmed">31903562</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao GJ, Xu C, Ying JC, Lu WB, Hong GL, Li MF, Wu B, Yao YM, Lu ZQ. Association between furosemide administration and outcomes in critically ill patients with acute kidney injury. Crit Care. 2020;24(1):75. doi: 10.1186/s13054-020-2798-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-2798-6</ArticleId><ArticleId IdType="pmc">PMC7057586</ArticleId><ArticleId IdType="pubmed">32131879</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreischulte T, Morales DR, Bell S, Guthrie B. Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin&#x2013;angiotensin system inhibitors in the community increases the risk of acute kidney injury. Kidney Int. 2015;88(2):396&#x2013;403. doi: 10.1038/ki.2015.101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2015.101</ArticleId><ArticleId IdType="pubmed">25874600</ArticleId></ArticleIdList></Reference><Reference><Citation>Prieto-Garc&#xed;a L, Pericacho M, Sancho-Mart&#xed;nez SM, S&#xe1;nchez &#xc1;, Mart&#xed;nez-Salgado C, L&#xf3;pez-Novoa JM, L&#xf3;pez-Hern&#xe1;ndez FJ. Mechanisms of triple whammy acute kidney injury. Pharmacol Ther. 2016;167:132&#x2013;45. 10.1016/j.pharmthera.2016.07.011.</Citation><ArticleIdList><ArticleId IdType="pubmed">27490717</ArticleId></ArticleIdList></Reference><Reference><Citation>Karkouti K, Wijeysundera DN, Yau TM, Callum JL, Cheng DC, Crowther M, Dupuis J-Y, Fremes SE, Kent B, Laflamme C. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation. 2009;119(4):495&#x2013;502. doi: 10.1161/CIRCULATIONAHA.108.786913.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.786913</ArticleId><ArticleId IdType="pubmed">19153273</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller MM, Van Remoortel H, Meybohm P, Aranko K, Aubron C, Burger R, Carson JL, Cichutek K, De Buck E, Devine D, et al. Patient blood management: recommendations from the 2018 Frankfurt consensus conference. Jama. 2019;321(10):983&#x2013;997. doi: 10.1001/jama.2019.0554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.0554</ArticleId><ArticleId IdType="pubmed">30860564</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N, Qiao H, Guo J-F, Yang H-Y, Li X-Y, Li S-L, Wang D-X, Yang L. Preoperative hypoalbuminemia was associated with acute kidney injury in high-risk patients following non-cardiac surgery: a retrospective cohort study. BMC Anesthesiol. 2019;19(1):171. 10.1186/s12871-019-0842-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6719349</ArticleId><ArticleId IdType="pubmed">31477030</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu P-H, Thongprayoon C, Cheungpasitporn W, Mao MA, Sakhuja A, Kashani K. U-shape association of serum albumin level and acute kidney injury risk in hospitalized patients. PLoS One. 2018;13(6):e0199153. doi: 10.1371/journal.pone.0199153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0199153</ArticleId><ArticleId IdType="pmc">PMC6013099</ArticleId><ArticleId IdType="pubmed">29927987</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukhtar A, Masry AE, Moniem AA, Metini M, Fayez A, Khater YH. The impact of maintaining normal serum albumin level following living related liver transplantation: does serum albumin level affect the course? A pilot study. Transplant Proc. 2007;39(10):3214&#x2013;8. 10.1016/j.transproceed.2007.06.084.</Citation><ArticleIdList><ArticleId IdType="pubmed">18089356</ArticleId></ArticleIdList></Reference><Reference><Citation>Leithead JA, Rajoriya N, Gunson BK, Muiesan P, Ferguson JW. The evolving use of higher risk grafts is associated with an increased incidence of acute kidney injury after liver transplantation. J Hepatol. 2014;60(6):1180&#x2013;1186. doi: 10.1016/j.jhep.2014.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2014.02.019</ArticleId><ArticleId IdType="pubmed">24631601</ArticleId></ArticleIdList></Reference><Reference><Citation>Leithead JA, Tariciotti L, Gunson B, Holt A, Isaac J, Mirza DF, et al. Donation After Cardiac Death Liver Transplant Recipients Have an Increased Frequency of Acute Kidney Injury. Am J Transpl. 12(4):965&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">22226302</ArticleId></ArticleIdList></Reference><Reference><Citation>Jun I-G, Lee B, Kim S-O, Shin W-J, Bang J-Y, Song J-G, Song G-W, Lee S-G, Hwang G-S. Comparison of acute kidney injury between ABO-compatible and ABO-incompatible living donor liver transplantation: a propensity matching analysis. Liver Transpl. 2016;22(12):1656&#x2013;1665. doi: 10.1002/lt.24634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lt.24634</ArticleId><ArticleId IdType="pubmed">27595780</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu JH, Kwon Y, Kim J, Yang S-M, Kim WH, Jung C-W, Suh K-S, Lee KH. Influence of transfusion on the risk of acute kidney injury: ABO-compatible versus ABO-incompatible liver transplantation. J Clin Med. 2019;8(11):1785. doi: 10.3390/jcm8111785.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8111785</ArticleId><ArticleId IdType="pmc">PMC6912207</ArticleId><ArticleId IdType="pubmed">31731500</ArticleId></ArticleIdList></Reference><Reference><Citation>Utsumi M, Umeda Y, Sadamori H, Nagasaka T, Takaki A, Matsuda H, et al. Risk factors for acute renal injury in living donor liver transplantation: evaluation of the RIFLE criteria. Transplant Int. 2013;26(8):842&#x2013;52. 10.1111/tri.12138.</Citation><ArticleIdList><ArticleId IdType="pubmed">23855657</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan L, Yang Y, Ma G, Zhu T, Yang J, Liu H, Zhang W. Early acute kidney injury after liver transplantation in patients with normal preoperative renal function. Clin Res Hepatol Gastroenterol. 2019;43(4):475&#x2013;482. doi: 10.1016/j.clinre.2018.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinre.2018.07.009</ArticleId><ArticleId IdType="pubmed">31126850</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Wan L, May CN. Vasoactive drugs and acute kidney injury. Crit Care Med. 2008;36(10):2959. doi: 10.1097/CCM.0b013e318187b8ac.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318187b8ac</ArticleId><ArticleId IdType="pubmed">18382191</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Chen B, Zhang G, Wang K, Zhou L, Hu S. Cell apoptosis and fas gene expression in liver and renal tissues after ischemia-reperfusion injury in liver transplantation. Transplant Proc. 2010:42(5):1550&#x2013;6. 10.1016/j.transproceed.2010.01.055.</Citation><ArticleIdList><ArticleId IdType="pubmed">20620473</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman S, Davidson BR, Mallett SV. Early acute kidney injury after liver transplantation: predisposing factors and clinical implications. World J Hepatol. 2017;9(18):823&#x2013;832. doi: 10.4254/wjh.v9.i18.823.</Citation><ArticleIdList><ArticleId IdType="doi">10.4254/wjh.v9.i18.823</ArticleId><ArticleId IdType="pmc">PMC5491405</ArticleId><ArticleId IdType="pubmed">28706581</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonsalez SR, Cortes AL, da Silva RC, Lowe J, Prieto MC. Acute kidney injury overview: from basic findings to new prevention and therapy strategies. Pharmacol Ther 2019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10134404</ArticleId><ArticleId IdType="pubmed">30959059</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Bellomo R. Sepsis-associated acute kidney injury: macrohemodynamic and microhemodynamic alterations in the renal circulation. Semin Nephrol. 2015;35(1):64&#x2013;74. doi: 10.1016/j.semnephrol.2015.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semnephrol.2015.01.007</ArticleId><ArticleId IdType="pubmed">25795500</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomasev N, Glorot X, Rae JW, Zielinski M, Askham H, Saraiva A, Mottram A, Meyer C, Ravuri S, Protsyuk I, et al. A clinically applicable approach to continuous prediction of future acute kidney injury. Nature. 2019;572(7767):116&#x2013;119. doi: 10.1038/s41586-019-1390-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1390-1</ArticleId><ArticleId IdType="pmc">PMC6722431</ArticleId><ArticleId IdType="pubmed">31367026</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashani KB. Automated acute kidney injury alerts. Kidney Int. 2018;94(3):484&#x2013;90. 10.1016/j.kint.2018.02.014.</Citation><ArticleIdList><ArticleId IdType="pubmed">29728257</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29369117</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1365-2346</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>7</Issue><PubDate><Year>2018</Year><Month>Jul</Month></PubDate></JournalIssue><Title>European journal of anaesthesiology</Title><ISOAbbreviation>Eur J Anaesthesiol</ISOAbbreviation></Journal><ArticleTitle>Does goal-directed haemodynamic and fluid therapy improve peri-operative outcomes?: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>469</StartPage><EndPage>483</EndPage><MedlinePgn>469-483</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/EJA.0000000000000778</ELocationID><Abstract><AbstractText Label="BACKGROUND">Much uncertainty exists as to whether peri-operative goal-directed therapy is of benefit.</AbstractText><AbstractText Label="OBJECTIVES">To discover if peri-operative goal-directed therapy decreases mortality and morbidity in adult surgical patients.</AbstractText><AbstractText Label="DESIGN">An updated systematic review and random effects meta-analysis of randomised controlled trials.</AbstractText><AbstractText Label="DATA SOURCES">Medline, Embase and the Cochrane Library were searched up to 31 December 2016.</AbstractText><AbstractText Label="ELIGIBILITY CRITERIA">Randomised controlled trials enrolling adult surgical patients allocated to receive goal-directed therapy or standard care were eligible for inclusion. Trauma patients and parturients were excluded. Goal-directed therapy was defined as fluid and/or vasopressor therapy titrated to haemodynamic goals [e.g. cardiac output (CO)]. Outcomes included mortality, morbidity and hospital length of stay. Risk of bias was assessed using Cochrane methodology.</AbstractText><AbstractText Label="RESULTS">Ninety-five randomised trials (11&#x200a;659 patients) were included. Only four studies were at low risk of bias. Modern goal-directed therapy reduced mortality compared with standard care [odds ratio (OR) 0.66; 95% confidence interval (CI) 0.50 to 0.87; number needed to treat&#x200a;=&#x200a;59; N = 52; I&#x200a;=&#x200a;0.0%]. In subgroup analysis, there was no mortality benefit for fluid-only goal-directed therapy, cardiac surgery patients or nonelective surgery. Contemporary goal-directed therapy also reduced pneumonia (OR 0.69; 95% CI, 0.51 to 0. 92; number needed to treat&#x200a;=&#x200a;38), acute kidney injury (OR 0. 73; 95% CI, 0.58 to 0.92; number needed to treat&#x200a;=&#x200a;29), wound infection (OR 0.48; 95% CI, 0.37 to 0.63; number needed to treat&#x200a;=&#x200a;19) and hospital length of stay (days) (-0.90; 95% CI, -1.32 to -0.48; I&#x200a;=&#x200a;81. 2%). No important differences in outcomes were found for the pulmonary artery catheter studies, after accounting for advances in the standard of care.</AbstractText><AbstractText Label="CONCLUSION">Peri-operative modern goal-directed therapy reduces morbidity and mortality. Importantly, the quality of evidence was low to very low (e.g. Grading of Recommendations, Assessment, Development and Evaluation scoring), and there was much clinical heterogeneity among the goal-directed therapy devices and protocols. Additional well designed and adequately powered trials on peri-operative goal-directed therapy are necessary.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chong</LastName><ForeName>Matthew A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Perioperative Medicine (MAC, YW, IMC) and Department of Medicine, Western University, London, Ontario, Canada (NB).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yongjun</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Berbenetz</LastName><ForeName>Nicolas M</ForeName><Initials>NM</Initials></Author><Author ValidYN="Y"><LastName>McConachie</LastName><ForeName>Ian</ForeName><Initials>I</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Anaesthesiol</MedlineTA><NlmUniqueID>8411711</NlmUniqueID><ISSNLinking>0265-0215</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur J Anaesthesiol. 2018 Jul;35(7):467-468. doi: 10.1097/EJA.0000000000000812.</RefSource><PMID Version="1">29870473</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002302" MajorTopicYN="N">Cardiac Output</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006040" MajorTopicYN="N">Goals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29369117</ArticleId><ArticleId IdType="doi">10.1097/EJA.0000000000000778</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39048691</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>24</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Biomarker-guided acute kidney injury risk assessment under liberal versus restrictive fluid therapy - the prospective-randomized MAYDAY-trial.</ArticleTitle><Pagination><StartPage>17094</StartPage><MedlinePgn>17094</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">17094</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-68079-2</ELocationID><Abstract><AbstractText>Acute kidney injury (AKI) prevalence in surgical patients is high, emphasizing the need for preventative measures. This study addresses the insufficient evidence on nephroprotective intraoperative fluid resuscitation and highlights the drawbacks of relying solely on serum creatinine/urine output to monitor kidney function. This study assessed the impact of intraoperative fluid management on AKI in female breast cancer patients undergoing autologous breast reconstruction, utilizing novel urinary biomarkers (TIMP-2 and IGFBP-7). In a monocentric prospective randomized controlled trial involving 40 patients, liberal (LFA) and restrictive (FRV) fluid management strategies were compared. TIMP-2 and IGFBP-7 biomarker levels were assessed using the NephroCheck (bioMerieux, France) test kit at preoperative, immediate postoperative, and 24-h postoperative stages. FRV showed significantly higher immediate postoperative biomarker levels, indicating renal tubular stress. FRV patients had 21% (4/19) experiencing AKI compared to 13% (2/15) in the LFA group according to KDIGO criteria (p&#x2009;=&#x2009;0.385). Restrictive fluid resuscitation increases the risk of AKI in surgical patients significantly, emphasizing the necessity for individualized hemodynamic management. The findings underscore the importance of urinary biomarkers in early AKI detection.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Anker</LastName><ForeName>Alexandra M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Plastic, Reconstructive, Aesthetic, and Hand Surgery, University Hospital Regensburg, University of Regensburg, Franz-Josef-Strau&#xdf;-Allee 11, 93053, Regensburg, Germany. alexandra.anker@ukr.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruewe</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Plastic, Reconstructive, Aesthetic, and Hand Surgery, University Hospital Regensburg, University of Regensburg, Franz-Josef-Strau&#xdf;-Allee 11, 93053, Regensburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prantl</LastName><ForeName>Lukas</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Plastic, Reconstructive, Aesthetic, and Hand Surgery, University Hospital Regensburg, University of Regensburg, Franz-Josef-Strau&#xdf;-Allee 11, 93053, Regensburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baringer</LastName><ForeName>Magnus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Plastic, Reconstructive, Aesthetic, and Hand Surgery, University Hospital Regensburg, University of Regensburg, Franz-Josef-Strau&#xdf;-Allee 11, 93053, Regensburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pawlik</LastName><ForeName>Michael T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Caritas Hospital St. Josef, Landshuter Str. 65, 93053, Regensburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeman</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center for Clinical Studies, University Hospital Regensburg, University of Regensburg, Franz-Josef-Strau&#xdf;-Allee 11, 93053, Regensburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goecze</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Surgery and Operative Intensive Care, University Hospital Regensburg, University of Regensburg, Franz-Josef-Strau&#xdf;-Allee 11, 93053, Regensburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>Silvan M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Plastic, Reconstructive, Aesthetic, and Hand Surgery, University Hospital Regensburg, University of Regensburg, Franz-Josef-Strau&#xdf;-Allee 11, 93053, Regensburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C102529">insulin-like growth factor binding protein-related protein 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018969">Insulin-Like Growth Factor Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>127497-59-0</RegistryNumber><NameOfSubstance UI="D019716">Tissue Inhibitor of Metalloproteinase-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C560823">TIMP2 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="Y">Biomarkers</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="Y">Fluid Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018969" MajorTopicYN="Y">Insulin-Like Growth Factor Binding Proteins</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019716" MajorTopicYN="Y">Tissue Inhibitor of Metalloproteinase-2</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Breast neoplasms/surgery</Keyword><Keyword MajorTopicYN="N">Breast reconstruction</Keyword><Keyword MajorTopicYN="N">Fluid therapy</Keyword><Keyword MajorTopicYN="N">Intraoperative fluid management</Keyword><Keyword MajorTopicYN="N">Urinary biomarkers</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>26</Day><Hour>12</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>26</Day><Hour>12</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>24</Day><Hour>23</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39048691</ArticleId><ArticleId IdType="pmc">PMC11269689</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-68079-2</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-68079-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lewington, A. J., Cerda, J. &amp; Mehta, R. L. Raising awareness of acute kidney injury: A global perspective of a silent killer. Kidney Int.84, 457&#x2013;467 (2013). 10.1038/ki.2013.153</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2013.153</ArticleId><ArticleId IdType="pmc">PMC3758780</ArticleId><ArticleId IdType="pubmed">23636171</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo, R., Kellum, J. A. &amp; Ronco, C. Acute kidney injury. Lancet380, 756&#x2013;766 (2012). 10.1016/S0140-6736(11)61454-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)61454-2</ArticleId><ArticleId IdType="pubmed">22617274</ArticleId></ArticleIdList></Reference><Reference><Citation>Raphael Weiss, M. M., Pavenst&#xe4;dt, H.-J. &amp; Zarbock, A. Acute kidney injury&#x2014;A frequently underestimated problem in perioperative medicine. Dtsch. Arztebl. Int.1, 833&#x2013;842 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6962766</ArticleId><ArticleId IdType="pubmed">31888797</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor, M. E., Kirwan, C. J., Pearse, R. M. &amp; Prowle, J. R. Incidence and associations of acute kidney injury after major abdominal surgery. Intens. Care Med.42, 521&#x2013;530 (2016).10.1007/s00134-015-4157-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-4157-7</ArticleId><ArticleId IdType="pubmed">26602784</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock, A. et al. Epidemiology of surgery associated acute kidney injury (EPIS-AKI): A prospective international observational multi-center clinical study. Intens. Care Med.10.1007/s00134-023-07169-7 (2023).10.1007/s00134-023-07169-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-023-07169-7</ArticleId><ArticleId IdType="pmc">PMC10709241</ArticleId><ArticleId IdType="pubmed">37505258</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung, H. M. et al. Association between postoperative acute kidney injury and mortality after plastic and reconstructive surgery. Sci. Rep.12, 20050 (2022). 10.1038/s41598-022-24564-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-24564-0</ArticleId><ArticleId IdType="pmc">PMC9681753</ArticleId><ArticleId IdType="pubmed">36414767</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles, P. S. et al. Restrictive versus liberal fluid therapy for major abdominal surgery. N. Engl. J. Med.378, 2263&#x2013;2274 (2018). 10.1056/NEJMoa1801601</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1801601</ArticleId><ArticleId IdType="pubmed">29742967</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmid, S. et al. Algorithm-guided goal-directed haemodynamic therapy does not improve renal function after major abdominal surgery compared to good standard clinical care: A prospective randomised trial. Crit Care20, 50 (2016). 10.1186/s13054-016-1237-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1237-1</ArticleId><ArticleId IdType="pmc">PMC4782303</ArticleId><ArticleId IdType="pubmed">26951105</ArticleId></ArticleIdList></Reference><Reference><Citation>Gocze, I. et al. Biomarker-guided intervention to prevent acute kidney injury after major surgery: The prospective randomized BigpAK study. Ann. Surg.267, 1013&#x2013;1020 (2018). 10.1097/SLA.0000000000002485</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000002485</ArticleId><ArticleId IdType="pubmed">28857811</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, L. Y., Wijeysundera, D. N., Tait, G. A. &amp; Beattie, W. S. Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology123, 515&#x2013;523 (2015). 10.1097/ALN.0000000000000765</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000765</ArticleId><ArticleId IdType="pubmed">26181335</ArticleId></ArticleIdList></Reference><Reference><Citation>Karamanos, E., Walker, R., Wang, H. T. &amp; Shah, A. R. Perioperative fluid resuscitation in free flap breast reconstruction: When is enough enough? Plast. Reconstr. Surg. Glob. Open8, e2662 (2020). 10.1097/GOX.0000000000002662</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/GOX.0000000000002662</ArticleId><ArticleId IdType="pmc">PMC7253255</ArticleId><ArticleId IdType="pubmed">32537330</ArticleId></ArticleIdList></Reference><Reference><Citation>Motakef, S., Mountziaris, P. M., Ismail, I. K., Agag, R. L. &amp; Patel, A. Emerging paradigms in perioperative management for microsurgical free tissue transfer: Review of the literature and evidence-based guidelines. Plast. Reconstr. Surg.135, 290&#x2013;299 (2015). 10.1097/PRS.0000000000000839</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PRS.0000000000000839</ArticleId><ArticleId IdType="pubmed">25539313</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrone, R. D., Madias, N. E. &amp; Levey, A. S. Serum creatinine as an index of renal function: New insights into old concepts. Clin. Chem.38, 1933&#x2013;1953 (1992). 10.1093/clinchem/38.10.1933</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinchem/38.10.1933</ArticleId><ArticleId IdType="pubmed">1394976</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe5;rtensson, J., Martling, C.-R. &amp; Bell, M. Novel biomarkers of acute kidney injury and failure: Clinical applicability. Br. J. Anaesth.109, 843&#x2013;850 (2012). 10.1093/bja/aes357</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aes357</ArticleId><ArticleId IdType="pubmed">23048068</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostermann, M. et al. Recommendations on acute kidney injury biomarkers from the acute disease quality initiative consensus conference: A consensus statement. JAMA Netw. Open3, e2019209 (2020). 10.1001/jamanetworkopen.2020.19209</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.19209</ArticleId><ArticleId IdType="pubmed">33021646</ArticleId></ArticleIdList></Reference><Reference><Citation>Joannidis, M. et al. Use of cell cycle arrest biomarkers in conjunction with classical markers of acute kidney injury. Crit. Care Med.47, e820&#x2013;e826 (2019). 10.1097/CCM.0000000000003907</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000003907</ArticleId><ArticleId IdType="pmc">PMC6750148</ArticleId><ArticleId IdType="pubmed">31343478</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostermann, M. et al. Kinetics of urinary cell cycle arrest markers for acute kidney injury following exposure to potential renal insults. Crit. Care Med.46, 375&#x2013;383 (2018). 10.1097/CCM.0000000000002847</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002847</ArticleId><ArticleId IdType="pmc">PMC5821475</ArticleId><ArticleId IdType="pubmed">29189343</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Z., Tie, H., Shi, R., Rossaint, J. &amp; Zarbock, A. Urinary [TIMP-2]&#xb7;[IGFBP7]-guided implementation of the KDIGO bundle to prevent acute kidney injury: A meta-analysis. Br. J. Anaesth.128, e24&#x2013;e26 (2022). 10.1016/j.bja.2021.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2021.10.015</ArticleId><ArticleId IdType="pubmed">34794767</ArticleId></ArticleIdList></Reference><Reference><Citation>Obata, Y., Kamijo-Ikemori, A., Shimmi, S. &amp; Inoue, S. Clinical usefulness of urinary biomarkers for early prediction of acute kidney injury in patients undergoing transaortic valve implantation. Sci. Rep.13, 18569 (2023). 10.1038/s41598-023-46015-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-46015-0</ArticleId><ArticleId IdType="pmc">PMC10616062</ArticleId><ArticleId IdType="pubmed">37903844</ArticleId></ArticleIdList></Reference><Reference><Citation>Anker, A. M. et al. Assessment of DIEP flap perfusion with intraoperative indocyanine green fluorescence imaging in vasopressor-dominated hemodynamic support versus liberal fluid administration: A randomized controlled trial with breast cancer patients. Ann. Surg. Oncol.27, 399&#x2013;406 (2020). 10.1245/s10434-019-07758-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-019-07758-1</ArticleId><ArticleId IdType="pubmed">31468214</ArticleId></ArticleIdList></Reference><Reference><Citation>Anker, A. M. et al. Clinical impact of DIEP flap perforator characteristics&#x2014;A prospective indocyanine green fluorescence imaging study. J. Plast. Reconstr. Aesthetic Surg.73, 1526&#x2013;1533 (2020).10.1016/j.bjps.2020.01.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjps.2020.01.019</ArticleId><ArticleId IdType="pubmed">32507580</ArticleId></ArticleIdList></Reference><Reference><Citation>Anker, A. M. et al. Vasopressor support vs liberal fluid administration in deep inferior epigastric perforator (DIEP) free flap breast reconstruction&#x2014;A randomized controlled trial. Clin. Hemorheol. Microcirc.69, 37&#x2013;44 (2018). 10.3233/CH-189129</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CH-189129</ArticleId><ArticleId IdType="pubmed">29660924</ArticleId></ArticleIdList></Reference><Reference><Citation>Pajenda, S. et al. NephroCheck data compared to serum creatinine in various clinical settings. BMC Nephrol.16, 206 (2015). 10.1186/s12882-015-0203-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-015-0203-5</ArticleId><ArticleId IdType="pmc">PMC4674950</ArticleId><ArticleId IdType="pubmed">26651477</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja, A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin. Pract.120, c179&#x2013;c184 (2012). 10.1159/000339789</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000339789</ArticleId><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciolino, J. D., Kaizer, A. M. &amp; Bonner, L. B. Guidance on interim analysis methods in clinical trials. J. Clin. Transl. Sci.7, e124 (2023). 10.1017/cts.2023.552</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cts.2023.552</ArticleId><ArticleId IdType="pmc">PMC10260346</ArticleId><ArticleId IdType="pubmed">37313374</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu, F. et al. Efficacy and safety of platinum-based chemotherapy as first-line therapy for metastatic triple-negative breast cancer: A meta-analysis of randomized controlled trials. Technol. Cancer Res. Treat.20, 15330338211016368 (2021). 10.1177/15330338211016369</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/15330338211016369</ArticleId><ArticleId IdType="pmc">PMC8120541</ArticleId><ArticleId IdType="pubmed">33977814</ArticleId></ArticleIdList></Reference><Reference><Citation>McSweeney, K. R. et al. Mechanisms of cisplatin-induced acute kidney injury: Pathological mechanisms, pharmacological interventions, and genetic mitigations. Cancers13, 1572 (2021). 10.3390/cancers13071572</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13071572</ArticleId><ArticleId IdType="pmc">PMC8036620</ArticleId><ArticleId IdType="pubmed">33805488</ArticleId></ArticleIdList></Reference><Reference><Citation>Anker, A. M., Prantl, L. &amp; Klein, S. M. ASO author reflections: The silent force behind microsurgery. Ann. Surg. Oncol.27, 407&#x2013;408 (2020). 10.1245/s10434-019-08001-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-019-08001-7</ArticleId><ArticleId IdType="pubmed">31667724</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashani, K. et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit. Care Lond. Engl.17, R25 (2013).10.1186/cc12503</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc12503</ArticleId><ArticleId IdType="pmc">PMC4057242</ArticleId><ArticleId IdType="pubmed">23388612</ArticleId></ArticleIdList></Reference><Reference><Citation>Husain-Syed, F. et al. Persistent decrease of renal functional reserve in patients after cardiac surgery-associated acute kidney injury despite clinical recovery. Nephrol. Dial. Transplant.34, 308&#x2013;317 (2019). 10.1093/ndt/gfy227</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfy227</ArticleId><ArticleId IdType="pubmed">30053231</ArticleId></ArticleIdList></Reference><Reference><Citation>Siew, E. D., Ware, L. B. &amp; Ikizler, T. A. Biological markers of acute kidney injury. J. Am. Soc. Nephrol.22, 810&#x2013;820 (2011). 10.1681/ASN.2010080796</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2010080796</ArticleId><ArticleId IdType="pubmed">21493774</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco, C., Bellomo, R. &amp; Kellum, J. A. Acute kidney injury. The Lancet394, 1949&#x2013;1964 (2019).10.1016/S0140-6736(19)32563-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32563-2</ArticleId><ArticleId IdType="pubmed">31777389</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco, C., Kellum, J. A. &amp; Haase, M. Subclinical AKI is still AKI. Crit. Care Lond. Engl.16, 313 (2012).10.1186/cc11240</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11240</ArticleId><ArticleId IdType="pmc">PMC3580601</ArticleId><ArticleId IdType="pubmed">22721504</ArticleId></ArticleIdList></Reference><Reference><Citation>Gocze, I. et al. Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery. PLoS ONE10, e0120863 (2015). 10.1371/journal.pone.0120863</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0120863</ArticleId><ArticleId IdType="pmc">PMC4370650</ArticleId><ArticleId IdType="pubmed">25798585</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch, M. et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: The PrevAKI randomized controlled trial. Intens. Care Med43, 1551&#x2013;1561 (2017).10.1007/s00134-016-4670-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4670-3</ArticleId><ArticleId IdType="pmc">PMC5633630</ArticleId><ArticleId IdType="pubmed">28110412</ArticleId></ArticleIdList></Reference><Reference><Citation>Jufar, A. H. et al. Renal functional reserve: From physiological phenomenon to clinical biomarker and beyond. Am. J. Physiol. Regul. Integr. Comp. Physiol.319, R690&#x2013;R702 (2020). 10.1152/ajpregu.00237.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.00237.2020</ArticleId><ArticleId IdType="pubmed">33074016</ArticleId></ArticleIdList></Reference><Reference><Citation>Fawcett, W. J. &amp; Thomas, M. Pre-operative fasting in adults and children: Clinical practice and guidelines. Anaesthesia74, 83&#x2013;88 (2019). 10.1111/anae.14500</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.14500</ArticleId><ArticleId IdType="pubmed">30500064</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37884769</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1496-8975</ISSN><JournalIssue CitedMedium="Internet"><Volume>70</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Canadian journal of anaesthesia = Journal canadien d'anesthesie</Title><ISOAbbreviation>Can J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Predictors of acute kidney injury after lung resection surgery: a retrospective case-control study.</ArticleTitle><Pagination><StartPage>1901</StartPage><EndPage>1908</EndPage><MedlinePgn>1901-1908</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12630-023-02602-3</ELocationID><Abstract><AbstractText Label="PURPOSE">Patients undergoing lung resection are at increased risk for acute kidney injury (AKI) in the immediate postoperative period, with important consequences for longer term morbidity and mortality. Lung resection surgery has unique considerations that could increase the risk of AKI, including lung resection volume, duration of one-lung ventilation (OLV), and intraoperative fluid restriction. Yet, specific risk factor data are lacking. The objective of this study was to identify independent risk factors for early AKI after lung resection surgery.</AbstractText><AbstractText Label="METHODS">We conducted a retrospective case-control study of all patients presenting for elective lung resection surgery at an academic medical centre over a four-year period. Cases were patients who experienced an AKI and control patients were those who did not experience an AKI, based on KDIGO criteria. Baseline demographics and comorbidities along with duration of OLV and amount of lung resected were collected by retrospective chart review. The data were analyzed using multivariable logistic regression to identify independent predictors of AKI.</AbstractText><AbstractText Label="RESULTS">Acute kidney injury occurred within 48&#xa0;hr in 57/1,045 (5.5%; 95% confidence interval, 4.2 to 7.0) of patients. On multivariable analysis, our model of best fit included preoperative serum creatinine, male sex, use of angiotensin II receptor blockers, and duration of OLV. The rate of complications, intensive care unit admission, and risk of death were all higher in the group of patients who experienced AKI.</AbstractText><AbstractText Label="CONCLUSIONS">Acute kidney injury occurs frequently after lung resection surgery and is associated with increased risk of postoperative complications. Increased duration of OLV may be a risk factor for AKI in this population.</AbstractText><CopyrightInformation>&#xa9; 2023. Canadian Anesthesiologists' Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bohn</LastName><ForeName>Ethan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Max Rady College of Medicine, University of Manitoba, 2nd Floor Harry Medovy House, 671 William Avenue, Winnipeg, MB, R3E 0Z2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Srinathan</LastName><ForeName>Sadeesh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Section of Thoracic Surgery, Department of Surgery, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adu-Quaye</LastName><ForeName>Joel</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Max Rady College of Medicine, University of Manitoba, 2nd Floor Harry Medovy House, 671 William Avenue, Winnipeg, MB, R3E 0Z2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Funk</LastName><ForeName>Duane</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3155-9793</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Max Rady College of Medicine, University of Manitoba, 2nd Floor Harry Medovy House, 671 William Avenue, Winnipeg, MB, R3E 0Z2, Canada. duane.funk@umanitoba.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Critical Care Medicine, Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada. duane.funk@umanitoba.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Pr&#xe9;dicteurs d&#x2019;insuffisance r&#xe9;nale aigu&#xeb; apr&#xe8;s une chirurgie de r&#xe9;section pulmonaire : une &#xe9;tude cas t&#xe9;moins r&#xe9;trospective.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Can J Anaesth</MedlineTA><NlmUniqueID>8701709</NlmUniqueID><ISSNLinking>0832-610X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="fre"><AbstractText>R&#xe9;SUM&#xe9;: OBJECTIF: Les patient&#xb7;es b&#xe9;n&#xe9;ficiant d&#x2019;une r&#xe9;section pulmonaire courent un risque accru d&#x2019;insuffisance r&#xe9;nale aigu&#xeb; (IRA) en p&#xe9;riode postop&#xe9;ratoire imm&#xe9;diate, avec des cons&#xe9;quences importantes pour la morbidit&#xe9; et la mortalit&#xe9; &#xe0; long terme. La chirurgie de r&#xe9;section pulmonaire entra&#xee;ne des consid&#xe9;rations uniques qui pourraient augmenter le risque d&#x2019;IRA, notamment le volume de la r&#xe9;section pulmonaire, la dur&#xe9;e de la ventilation unipulmonaire (VUP) et la restriction liquidienne perop&#xe9;ratoire. Pourtant, les donn&#xe9;es sp&#xe9;cifiques sur les facteurs de risque font d&#xe9;faut. L&#x2019;objectif de cette &#xe9;tude &#xe9;tait d&#x2019;identifier les facteurs de risque ind&#xe9;pendants d&#x2019;IRA pr&#xe9;coce apr&#xe8;s une chirurgie de r&#xe9;section pulmonaire. M&#xe9;THODE: Nous avons men&#xe9; une &#xe9;tude cas t&#xe9;moins r&#xe9;trospective de toute la patient&#xe8;le se pr&#xe9;sentant pour une chirurgie de r&#xe9;section pulmonaire non urgente dans un centre m&#xe9;dical universitaire sur une p&#xe9;riode de quatre ans. Les cas &#xe9;taient des patient&#xb7;es qui ont pr&#xe9;sent&#xe9; une IRA et des patient&#xb7;es t&#xe9;moins qui n&#x2019;ont pas eu d&#x2019;IRA, selon les crit&#xe8;res KDIGO. Les donn&#xe9;es d&#xe9;mographiques et les comorbidit&#xe9;s de base ainsi que la dur&#xe9;e de la VUP et le volume de poumon r&#xe9;s&#xe9;qu&#xe9; ont &#xe9;t&#xe9; recueillis par examen r&#xe9;trospectif des dossiers. Les donn&#xe9;es ont &#xe9;t&#xe9; analys&#xe9;es &#xe0; l&#x2019;aide d&#x2019;une r&#xe9;gression logistique multivari&#xe9;e afin d&#x2019;identifier des pr&#xe9;dicteurs ind&#xe9;pendants d&#x2019;IRA. R&#xe9;SULTATS: Une insuffisance r&#xe9;nale aigu&#xeb; est survenue dans les premi&#xe8;res 48 heures postop&#xe9;ratoires chez 57/1045 (5,5&#xa0;%; intervalle de confiance &#xe0; 95&#xa0;%, 4,2 &#xe0; 7,0) des patient&#xb7;es. Sur l&#x2019;analyse multivari&#xe9;e, notre mod&#xe8;le de meilleur ajustement incluait la cr&#xe9;atinin&#xe9;mie pr&#xe9;op&#xe9;ratoire, le sexe masculin, l&#x2019;utilisation d&#x2019;antagonistes des r&#xe9;cepteurs de l&#x2019;angiotensine II et la dur&#xe9;e de la VUP. Le taux de complications, l&#x2019;admission en unit&#xe9; de soins intensifs et le risque de d&#xe9;c&#xe8;s &#xe9;taient tous plus &#xe9;lev&#xe9;s dans le groupe de patient&#xb7;es ayant pr&#xe9;sent&#xe9; une IRA. CONCLUSION: L&#x2019;insuffisance r&#xe9;nale aigu&#xeb; survient fr&#xe9;quemment apr&#xe8;s une chirurgie de r&#xe9;section pulmonaire et est associ&#xe9;e &#xe0; un risque accru de complications postop&#xe9;ratoires. Une dur&#xe9;e prolong&#xe9;e de VUP pourrait constituer un facteur de risque d&#x2019;IRA dans cette population.</AbstractText><CopyrightInformation>&#xa9; 2023. Canadian Anesthesiologists' Society.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">perioperative medicine</Keyword><Keyword MajorTopicYN="N">thoracic surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>9</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>27</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>26</Day><Hour>23</Hour><Minute>41</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37884769</ArticleId><ArticleId IdType="doi">10.1007/s12630-023-02602-3</ArticleId><ArticleId IdType="pii">10.1007/s12630-023-02602-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bihorac A, Yavas S, Subbiah S, et al. Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg 2009; 249: 851&#x2013;8. https://doi.org/10.1097/sla.0b013e3181a40a0b</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/sla.0b013e3181a40a0b</ArticleId><ArticleId IdType="pubmed">19387314</ArticleId></ArticleIdList></Reference><Reference><Citation>Biteker M, Dayan A, Tekke&#x15f;in A, et al. Incidence, risk factors, and outcomes of perioperative acute kidney injury in noncardiac and nonvascular surgery. Am J Surg 2014; 207: 53&#x2013;9. https://doi.org/10.1016/j.amjsurg.2013.04.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2013.04.006</ArticleId><ArticleId IdType="pubmed">24050540</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson C, Ozrazgat-Baslanti T, Kuxhausen A, et al. Cost and mortality associated with postoperative acute kidney injury. Ann Surg 2015; 261: 1207&#x2013;14. https://doi.org/10.1097/sla.0000000000000732</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/sla.0000000000000732</ArticleId><ArticleId IdType="pubmed">24887982</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmichael P, Carmichael AR. Acute renal failure in the surgical setting. ANZ J Surg 2003; 73: 144&#x2013;53. https://doi.org/10.1046/j.1445-2197.2003.02640.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1445-2197.2003.02640.x</ArticleId><ArticleId IdType="pubmed">12608979</ArticleId></ArticleIdList></Reference><Reference><Citation>Abelha FJ, Botelho M, Fernandes V, Barros H. Determinants of postoperative acute kidney injury. Crit Care 2009; 13: R79. https://doi.org/10.1186/cc7894</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc7894</ArticleId><ArticleId IdType="pubmed">19463152</ArticleId><ArticleId IdType="pmc">2717442</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Englesbe MJ, et al. Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology 2007; 107: 892&#x2013;902. https://doi.org/10.1097/01.anes.0000290588.29668.38</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.anes.0000290588.29668.38</ArticleId><ArticleId IdType="pubmed">18043057</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Heung M, et al. Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set. Anesthesiology 2009; 110: 505&#x2013;15. https://doi.org/10.1097/aln.0b013e3181979440</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aln.0b013e3181979440</ArticleId><ArticleId IdType="pubmed">19212261</ArticleId></ArticleIdList></Reference><Reference><Citation>Borthwick E, Ferguson A. Perioperative acute kidney injury: risk factors, recognition, management, and outcomes. BMJ 2010; 341: c3365. https://doi.org/10.1136/bmj.c3365</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.c3365</ArticleId><ArticleId IdType="pubmed">20603317</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Xu S, Yan B, et al. Incidence and associations of acute kidney injury after general thoracic surgery: a system review and meta-analysis. J Clin Med 2022; 12: 37. https://doi.org/10.3390/jcm12010037</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12010037</ArticleId><ArticleId IdType="pubmed">36614838</ArticleId><ArticleId IdType="pmc">9821434</ArticleId></ArticleIdList></Reference><Reference><Citation>Amar D, Burt ME, Roistacher N, Reinsel RA, Ginsberg RJ, Wilson RS. Value of perioperative Doppler echocardiography in patients undergoing major lung resection. Ann Thorac Surg 1996; 61: 516&#x2013;20. https://doi.org/10.1016/0003-4975(95)00939-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-4975(95)00939-6</ArticleId><ArticleId IdType="pubmed">8572758</ArticleId></ArticleIdList></Reference><Reference><Citation>Foroulis CN, Kotoulas CS, Kakouros S, et al. Study on the late effect of pneumonectomy on right heart pressures using Doppler echocardiography. Eur J Cardiothorac Surg 2004; 26: 508&#x2013;14. https://doi.org/10.1016/j.ejcts.2004.05.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2004.05.036</ArticleId><ArticleId IdType="pubmed">15302044</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz WE, Gasior TA, Quinlan JJ, et al. Immediate effects of lung transplantation on right ventricular morphology and function in patients with variable degrees of pulmonary hypertension. J Am Coll Cardiol 1996; 27: 384&#x2013;91. https://doi.org/10.1016/0735-1097(95)00502-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0735-1097(95)00502-1</ArticleId><ArticleId IdType="pubmed">8557910</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalewski J, Brocki M, Dryja&#x144;ski T, Kapro&#x144; K, Barcikowski S. Right ventricular morphology and function after pulmonary resection. Eur J Cardiothorac Surg 1999; 15: 444&#x2013;8. https://doi.org/10.1016/s1010-7940(99)00032-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1010-7940(99)00032-9</ArticleId><ArticleId IdType="pubmed">10371119</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedoto A, Amar D. Right heart function in thoracic surgery: role of echocardiography. Curr Opin Anaesthesiol 2009; 22: 44&#x2013;9. https://doi.org/10.1097/aco.0b013e32831d7b72</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aco.0b013e32831d7b72</ArticleId><ArticleId IdType="pubmed">19295291</ArticleId></ArticleIdList></Reference><Reference><Citation>Smulders SA, Holverda S, Vonk-Noordegraaf A, et al. Cardiac function and position more than 5 years after pneumonectomy. Ann Thorac Surg 2007; 83: 1986-92.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2007.01.036</ArticleId><ArticleId IdType="pubmed">17532383</ArticleId></ArticleIdList></Reference><Reference><Citation>Venuta F, Sciomer S, Andreetti C, et al. Long-term Doppler echocardiographic evaluation of the right heart after major lung resections. Eur J Cardiothorac Surg 2007; 32: 787&#x2013;90. https://doi.org/10.1016/j.ejcts.2007.07.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2007.07.033</ArticleId><ArticleId IdType="pubmed">17768065</ArticleId></ArticleIdList></Reference><Reference><Citation>Lohser J, Slinger P. Lung injury after one-lung ventilation: a review of the pathophysiologic mechanisms affecting the ventilated and the collapsed lung. Anesth Analg 2015; 121: 302&#x2013;18. https://doi.org/10.1213/ane.0000000000000808</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0000000000000808</ArticleId><ArticleId IdType="pubmed">26197368</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai Y, Parodo J, Kajikawa O, et al. Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. JAMA 2003; 289: 2104&#x2013;12. https://doi.org/10.1001/jama.289.16.2104</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.289.16.2104</ArticleId><ArticleId IdType="pubmed">12709468</ArticleId></ArticleIdList></Reference><Reference><Citation>Licker M, Cartier V, Robert J, et al. Risk factors of acute kidney injury according to RIFLE criteria after lung cancer surgery. Ann Thorac Surg 2011; 91: 844&#x2013;50. https://doi.org/10.1016/j.athoracsur.2010.10.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2010.10.037</ArticleId><ArticleId IdType="pubmed">21353011</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa S, Griesdale DE, Lohser J. Acute kidney injury after lung resection surgery: incidence and perioperative risk factors. Anesth Analg 2012; 114: 1256&#x2013;62. https://doi.org/10.1213/ane.0b013e31824e2d20</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e31824e2d20</ArticleId><ArticleId IdType="pubmed">22451594</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012; 120: c179&#x2013;84. https://doi.org/10.1159/000339789</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000339789</ArticleId><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Naruka V, McKie MA, Ahmadi N, Pama EAC, Coonar AS, Merits Collaborators. Multicentre evaluation of renal impairment in thoracic surgery (MERITS): a retrospective cohort study. BMJ Open 2022; 12: e058542. https://doi.org/10.1136/bmjopen-2021-058542</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-058542</ArticleId><ArticleId IdType="pubmed">36167391</ArticleId><ArticleId IdType="pmc">9516206</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora P, Rajagopalam S, Ranjan R, et al. Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clin J Am Soc Nephrol 2008; 3: 1266&#x2013;73. https://doi.org/10.2215/cjn.05271107</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/cjn.05271107</ArticleId><ArticleId IdType="pubmed">18667735</ArticleId><ArticleId IdType="pmc">2518804</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25952257</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>28</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1533-3450</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>12</Issue><PubDate><Year>2015</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of the American Society of Nephrology : JASN</Title><ISOAbbreviation>J Am Soc Nephrol</ISOAbbreviation></Journal><ArticleTitle>Intraoperative High-Dose Dexamethasone and Severe AKI after Cardiac Surgery.</ArticleTitle><Pagination><StartPage>2947</StartPage><EndPage>2951</EndPage><MedlinePgn>2947-51</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1681/ASN.2014080840</ELocationID><Abstract><AbstractText>Administration of prophylactic glucocorticoids has been suggested as a strategy to reduce postoperative AKI and other adverse events after cardiac surgery requiring cardiopulmonary bypass. In this post hoc analysis of a large placebo-controlled randomized trial of dexamethasone in 4465 adult patients undergoing cardiac surgery, we examined severe AKI, defined as use of RRT, as a primary outcome. Secondary outcomes were doubling of serum creatinine level or AKI-RRT, as well as AKI-RRT or in-hospital mortality (RRT/death). The primary outcome occurred in ten patients (0.4%) in the dexamethasone group and in 23 patients (1.0%) in the placebo group (relative risk, 0.44; 95% confidence interval, 0.19 to 0.96). In stratified analyses, the strongest signal for potential benefit of dexamethasone was in patients with an eGFR&lt;15 ml/min per 1.73 m(2). In conclusion, compared with placebo, intraoperative dexamethasone appeared to reduce the incidence of severe AKI after cardiac surgery in those with advanced CKD.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 by the American Society of Nephrology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jacob</LastName><ForeName>Kirolos A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Departments of Anesthesiology and Intensive Care Medicine and Cardiothoracic Surgery, University Medical Center Utrecht, Utrecht, The Netherlands; k.a.jacob@umcutrecht.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leaf</LastName><ForeName>David E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Division of Renal Medicine, the Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dieleman</LastName><ForeName>Jan M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Departments of Anesthesiology and Intensive Care Medicine and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Dijk</LastName><ForeName>Diederik</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Departments of Anesthesiology and Intensive Care Medicine and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nierich</LastName><ForeName>Arno P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Isala Klinieken, Zwolle, The Netherlands;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosseel</LastName><ForeName>Peter M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology Amphia Ziekenhuis, Breda, The Netherlands;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Maaten</LastName><ForeName>Joost M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology University Medical Center, Groningen, The Netherlands;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hofland</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology Erasmus Medical Center, Rotterdam, The Netherlands;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diephuis</LastName><ForeName>Jan C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology Medisch Spectrum Twente, Enschede, The Netherlands;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Lange</LastName><ForeName>Fellery</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiac Anesthesiology Medical Center Leeuwarden, Leeuwarden, The Netherlands; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boer</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology Vrije Universiteit University Medical Center, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kluin</LastName><ForeName>Jolanda</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery, University Medical Center Utrecht, Utrecht, The Netherlands;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waikar</LastName><ForeName>Sushrut S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Division of Renal Medicine, the Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Dexamethasone for Cardiac Surgery (DECS) Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00293592</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>R01 DK093574</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>05</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Soc Nephrol</MedlineTA><NlmUniqueID>9013836</NlmUniqueID><ISSNLinking>1046-6673</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>7S5I7G3JQL</RegistryNumber><NameOfSubstance UI="D003907">Dexamethasone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Nephrol. 2015 Sep;11(9):509-10. doi: 10.1038/nrneph.2015.106.</RefSource><PMID Version="1">26122731</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003907" MajorTopicYN="N">Dexamethasone</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="N">Glomerular Filtration Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="N">Intraoperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute renal failure</Keyword><Keyword MajorTopicYN="N">cardiovascular</Keyword><Keyword MajorTopicYN="N">clinical trial</Keyword><Keyword MajorTopicYN="N">creatinine</Keyword><Keyword MajorTopicYN="N">dialysis</Keyword><Keyword MajorTopicYN="N">ischemia&#x2013;reperfusion</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25952257</ArticleId><ArticleId IdType="pmc">PMC4657835</ArticleId><ArticleId IdType="doi">10.1681/ASN.2014080840</ArticleId><ArticleId IdType="pii">ASN.2014080840</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mariscalco G, Lorusso R, Dominici C, Renzulli A, Sala A: Acute kidney injury: a relevant complication after cardiac surgery. Ann Thorac Surg 92: 1539&#x2013;1547, 2011</Citation><ArticleIdList><ArticleId IdType="pubmed">21872837</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh CR, Devarajan P, Zappitelli M, Sint K, Thiessen-Philbrook H, Li S, Kim RW, Koyner JL, Coca SG, Edelstein CL, Shlipak MG, Garg AX, Krawczeski CD, TRIBE-AKI Consortium : Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery. J Am Soc Nephrol 22: 1737&#x2013;1747, 2011</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3171944</ArticleId><ArticleId IdType="pubmed">21836147</ArticleId></ArticleIdList></Reference><Reference><Citation>Scrascia G, Guida P, Rotunno C, de Luca Tupputi Schinosa L, Paparella D: Anti-inflammatory strategies to reduce acute kidney injury in cardiac surgery patients: a meta-analysis of randomized controlled trials. Artif Organs 38: 101&#x2013;112, 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">23876045</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW: Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16: 3365&#x2013;3370, 2005</Citation><ArticleIdList><ArticleId IdType="pubmed">16177006</ArticleId></ArticleIdList></Reference><Reference><Citation>Waikar SS, Bonventre JV: Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol 20: 672&#x2013;679, 2009</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2653692</ArticleId><ArticleId IdType="pubmed">19244578</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosner MH, Okusa MD: Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 1: 19&#x2013;32, 2006</Citation><ArticleIdList><ArticleId IdType="pubmed">17699187</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakar CV, Arrigain S, Worley S, Yared JP, Paganini EP: A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol 16: 162&#x2013;168, 2005</Citation><ArticleIdList><ArticleId IdType="pubmed">15563569</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeysundera DN, Karkouti K, Dupuis JY, Rao V, Chan CT, Granton JT, Beattie WS: Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. JAMA 297: 1801&#x2013;1809, 2007</Citation><ArticleIdList><ArticleId IdType="pubmed">17456822</ArticleId></ArticleIdList></Reference><Reference><Citation>Boodhwani M, Rubens FD, Wozny D, Nathan HJ: Effects of mild hypothermia and rewarming on renal function after coronary artery bypass grafting. Ann Thorac Surg 87: 489&#x2013;495, 2009</Citation><ArticleIdList><ArticleId IdType="pubmed">19161766</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranucci M, Pavesi M, Mazza E, Bertucci C, Frigiola A, Menicanti L, Ditta A, Boncilli A, Conti D: Risk factors for renal dysfunction after coronary surgery: the role of cardiopulmonary bypass technique. Perfusion 9: 319&#x2013;326, 1994</Citation><ArticleIdList><ArticleId IdType="pubmed">7833539</ArticleId></ArticleIdList></Reference><Reference><Citation>Valeri CR, MacGregor H, Ragno G, Healey N, Fonger J, Khuri SF: Effects of centrifugal and roller pumps on survival of autologous red cells in cardiopulmonary bypass surgery. Perfusion 21: 291&#x2013;296, 2006</Citation><ArticleIdList><ArticleId IdType="pubmed">17201084</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeulen Windsant IC, Snoeijs MG, Hanssen SJ, Altintas S, Heijmans JH, Koeppel TA, Schurink GW, Buurman WA, Jacobs MJ: Hemolysis is associated with acute kidney injury during major aortic surgery. Kidney Int 77: 913&#x2013;920, 2010</Citation><ArticleIdList><ArticleId IdType="pubmed">20182411</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieleman JM, Nierich AP, Rosseel PM, van der Maaten JM, Hofland J, Diephuis JC, Schepp RM, Boer C, Moons KG, van Herwerden LA, Tijssen JG, Numan SC, Kalkman CJ, van Dijk D, Dexamethasone for Cardiac Surgery (DECS) Study Group : Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. JAMA 308: 1761&#x2013;1767, 2012</Citation><ArticleIdList><ArticleId IdType="pubmed">23117776</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative workgroup : Acute renal failure&#x2014;definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8: R204&#x2013;R212, 2004</Citation><ArticleIdList><ArticleId IdType="pmc">PMC522841</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase M, Bellomo R, Haase-Fielitz A: Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-associated acute kidney injury. J Am Coll Cardiol 55: 2024&#x2013;2033, 2010</Citation><ArticleIdList><ArticleId IdType="pubmed">20447525</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheridan AM, Bonventre JV: Cell biology and molecular mechanisms of injury in ischemic acute renal failure. Curr Opin Nephrol Hypertens 9: 427&#x2013;434, 2000</Citation><ArticleIdList><ArticleId IdType="pubmed">10926180</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, YF, Tsai, WC, Lin, CC, Tsai, LY, Lee, CS, Huang, CH, Pan, PC, Chen, ML: Effect of leukocyte depletion on endothelial cell activation and transendothelial migration of leukocytes during cardiopulmonary bypass. Ann Thorac Surg 78: 634&#x2013;642; discussion 642&#x2013;633, 2004</Citation><ArticleIdList><ArticleId IdType="pubmed">15276536</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutton TA, Fisher CJ, Molitoris BA: Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int 62: 1539&#x2013;1549, 2002</Citation><ArticleIdList><ArticleId IdType="pubmed">12371954</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Garvin LM, Nickola TJ, Watson AM, Colberg-Poley AM, Rose MC: IL-1&#x3b2; induction of MUC5AC gene expression is mediated by CREB and NF-&#x3ba;B and repressed by dexamethasone. Am J Physiol Lung Cell Mol Physiol 306: L797&#x2013;L807, 2014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3989721</ArticleId><ArticleId IdType="pubmed">24487386</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannon R, Croxtall JD, Getting SJ, Roviezzo F, Yona S, Paul-Clark MJ, Gavins FN, Perretti M, Morris JF, Buckingham JC, Flower RJ: Aberrant inflammation and resistance to glucocorticoids in annexin 1&#x2013;/&#x2013; mouse. FASEB J 17: 253&#x2013;255, 2003</Citation><ArticleIdList><ArticleId IdType="pubmed">12475898</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafezi-Moghadam A, Simoncini T, Yang Z, Limbourg FP, Plumier JC, Rebsamen MC, Hsieh CM, Chui DS, Thomas KL, Prorock AJ, Laubach VE, Moskowitz MA, French BA, Ley K, Liao JK: Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med 8: 473&#x2013;479, 2002</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2668717</ArticleId><ArticleId IdType="pubmed">11984591</ArticleId></ArticleIdList></Reference><Reference><Citation>Harling L, Punjabi PP, Athanasiou T: Miniaturized extracorporeal circulation vs. off-pump coronary artery bypass grafting: what the evidence shows? Perfusion 26[Suppl 1]: 40&#x2013;47, 2011</Citation><ArticleIdList><ArticleId IdType="pubmed">21933821</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaer DJ, Schaer CA, Buehler PW, Boykins RA, Schoedon G, Alayash AI, Schaffner A: CD163 is the macrophage scavenger receptor for native and chemically modified hemoglobins in the absence of haptoglobin. Blood 107: 373&#x2013;380, 2006</Citation><ArticleIdList><ArticleId IdType="pubmed">16189277</ArticleId></ArticleIdList></Reference><Reference><Citation>Buechler C, Ritter M, Ors&#xf3; E, Langmann T, Klucken J, Schmitz G: Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J Leukoc Biol 67: 97&#x2013;103, 2000</Citation><ArticleIdList><ArticleId IdType="pubmed">10648003</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf6;gger P, Dreier J, Droste A, Buck F, Sorg C: Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163). J Immunol 161: 1883&#x2013;1890, 1998</Citation><ArticleIdList><ArticleId IdType="pubmed">9712057</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Z, Niven-Fairchild T, Tadesse S, Norwitz ER, Buhimschi CS, Buhimschi IA, Guller S: Glucocorticoids enhance CD163 expression in placental Hofbauer cells. Endocrinology 154: 471&#x2013;482, 2013</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3529384</ArticleId><ArticleId IdType="pubmed">23142809</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel UD, Garg AX, Krumholz HM, Shlipak MG, Coca SG, Sint K, Thiessen-Philbrook H, Koyner JL, Swaminathan M, Passik CS, Parikh CR, Translational Research Investigating Biomarker Endpoints in Acute Kidney Injury (TRIBE-AKI) Consortium : Preoperative serum brain natriuretic peptide and risk of acute kidney injury after cardiac surgery. Circulation 125: 1347&#x2013;1355, 2012</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3312808</ArticleId><ArticleId IdType="pubmed">22322531</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) : A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604&#x2013;612, 2009</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2763564</ArticleId><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R: European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16: 9&#x2013;13, 1999</Citation><ArticleIdList><ArticleId IdType="pubmed">10456395</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38537086</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-9159</ISSN><JournalIssue CitedMedium="Internet"><Volume>110</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of surgery (London, England)</Title><ISOAbbreviation>Int J Surg</ISOAbbreviation></Journal><ArticleTitle>Effect of dexmedetomidine on the incidence of postoperative acute kidney injury in living donor liver transplantation recipients: a randomized controlled trial.</ArticleTitle><Pagination><StartPage>4161</StartPage><EndPage>4169</EndPage><MedlinePgn>4161-4169</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/JS9.0000000000001331</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute kidney injury (AKI) is one of the most common complications after living-donor liver transplantation (LDLT) that has great impact on recipient and graft outcomes. Dexmedetomidine is reported to decrease the incidence of AKI. In the current study, the authors investigated whether intraoperative dexmedetomidine infusion would reduce the AKI following LDLT.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">In total, 205 adult patients undergoing elective LDLT were randomly assigned to the dexmedetomidine group ( n =103) or the control group ( n =102). Dexmedetomidine group received continuous dexmedetomidine infusion at a rate of 0.4&#xa0;mcg/kg/h after the anesthesia induction until 2&#xa0;h after graft reperfusion. The primary outcome was to compare the incidence of AKI. Secondary outcomes included serial lactate levels during surgery, chronic kidney disease, major adverse cardiovascular events, early allograft dysfunction, graft failure, overall mortality, duration of mechanical ventilation, intensive care unit, and hospital length of stay. Intraoperative hemodynamic parameters were also collected.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 205 recipients, 42.4% ( n =87) developed AKI. The incidence of AKI was lower in the dexmedetomidine group (35.0%, n =36/103) compared with the control (50.0%, n =51/102) ( P =0.042). There were significantly lower lactate levels in the dexmedetomidine group after reperfusion [4.39 (3.99-4.8) vs 5.02 (4.62-5.42), P =0.031] until the end of surgery [4.23 (3.73-4.74) vs 5.35 (4.84-5.85), P =0.002]. There were no significant differences in the other secondary outcomes besides lactate. Also, intraoperative mean blood pressure, cardiac output, and systemic vascular resistance did not show any difference.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our study suggests that intraoperative dexmedetomidine administration was associated with significantly decreased AKI incidence and lower intraoperative serum lactate levels in LDLT recipients, without untoward hemodynamic effects.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kwon</LastName><ForeName>Hye-Mee</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Seoul 05505, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Sa-Jin</ForeName><Initials>SJ</Initials></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Sang-Bin</ForeName><Initials>SB</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jae Hwan</ForeName><Initials>JH</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sung-Hoon</ForeName><Initials>SH</Initials></Author><Author ValidYN="Y"><LastName>Jun</LastName><ForeName>In-Gu</ForeName><Initials>IG</Initials></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Jun-Gol</ForeName><Initials>JG</Initials></Author><Author ValidYN="Y"><LastName>Hwang</LastName><ForeName>Gyu-Sam</ForeName><Initials>GS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Surg</MedlineTA><NlmUniqueID>101228232</NlmUniqueID><ISSNLinking>1743-9159</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="Y">Dexmedetomidine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016031" MajorTopicYN="Y">Liver Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019520" MajorTopicYN="Y">Living Donors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Nothing to declare. Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>23</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>27</Day><Hour>18</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>27</Day><Hour>15</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38537086</ArticleId><ArticleId IdType="pmc">PMC11254204</ArticleId><ArticleId IdType="doi">10.1097/JS9.0000000000001331</ArticleId><ArticleId IdType="pii">01279778-990000000-01274</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>MacDonald AJ, Nadim MK, Durand F, et al. . Acute kidney injury in cirrhosis: implications for liver transplantation. Curr Opin Crit Care 2019;25:171&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pubmed">30676329</ArticleId></ArticleIdList></Reference><Reference><Citation>Sang BH, Bang JY, Song JG, et al. . Hypoalbuminemia within two postoperative days is an independent risk factor for acute kidney injury following living donor liver transplantation: a propensity score analysis of 998 consecutive patients. Crit Care Med 2015;43:2552&#x2013;2561.</Citation><ArticleIdList><ArticleId IdType="pubmed">26308436</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilmi IA, Damian D, Al-Khafaji A, et al. . Acute kidney injury following orthotopic liver transplantation: incidence, risk factors, and effects on patient and graft outcomes. Br J Anaesth 2015;114:919&#x2013;926.</Citation><ArticleIdList><ArticleId IdType="pubmed">25673576</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson A, Pham PT. Kidney dysfunction in the recipients of liver transplants. 2005:11;S47&#x2013;S51.</Citation><ArticleIdList><ArticleId IdType="pubmed">16237714</ArticleId></ArticleIdList></Reference><Reference><Citation>Saner FH, Cicinnati VR, Sotiropoulos G, et al. . Strategies to prevent or reduce acute and chronic kidney injury in liver transplantation. Liver Int 2012;32:179&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">21745304</ArticleId></ArticleIdList></Reference><Reference><Citation>Pham PT, Pham PC, Wilkinson AH. Management of renal dysfunction in the liver transplant recipient. Curr Opin Organ Transpl 2009;14:231&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pubmed">19395967</ArticleId></ArticleIdList></Reference><Reference><Citation>de Haan JE, Hoorn EJ, de Geus HRH. Acute kidney injury after liver transplantation: recent insights and future perspectives. Best Pract Res Clin Gastroenterol 2017;31:161&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pubmed">28624104</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramsay M. The reperfusion syndrome: have we made any progress? Liver Transpl 2008;14:412&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="pubmed">18383086</ArticleId></ArticleIdList></Reference><Reference><Citation>Jochmans I, Meurisse N, Neyrinck A, et al. . Hepatic ischemia/reperfusion injury associates with acute kidney injury in liver transplantation: prospective cohort study. Liver Transpl 2017;23:634&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pubmed">28124458</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman S, Davidson BR, Mallett SV. Early acute kidney injury after liver transplantation: predisposing factors and clinical implications. World J Hepatol 2017;9:823&#x2013;832.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5491405</ArticleId><ArticleId IdType="pubmed">28706581</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokodai K, Lannsj&#xf6; C, Kjaernet F, et al. . Association of post-reperfusion syndrome and ischemia-reperfusion injury with acute kidney injury after liver transplantation. Acta Anaesthesiol Scand 2020;64:742&#x2013;750.</Citation><ArticleIdList><ArticleId IdType="pubmed">32020588</ArticleId></ArticleIdList></Reference><Reference><Citation>Zager RA, Johnson AC, Frostad KB. Acute hepatic ischemic-reperfusion injury induces a renal cortical &#x201c;stress response,&#x201d; renal &#x201c;cytoresistance,&#x201d; and an endotoxin hyperresponsive state. Am J Physiol Renal Physiol 2014;307:F856&#x2013;F868.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4187044</ArticleId><ArticleId IdType="pubmed">25080526</ArticleId></ArticleIdList></Reference><Reference><Citation>Leithead JA, Armstrong MJ, Corbett C, et al. . Hepatic ischemia reperfusion injury is associated with acute kidney injury following donation after brain death liver transplantation. Transpl Int 2013;26:1116&#x2013;1125.</Citation><ArticleIdList><ArticleId IdType="pubmed">24033747</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang H, Hu B, Li Z, et al. . Dexmedetomidine controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Inflammation 2014;37:1763&#x2013;1770.</Citation><ArticleIdList><ArticleId IdType="pubmed">24803295</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Feng X, Hu X, et al. . Dexmedetomidine ameliorates acute stress-induced kidney injury by attenuating oxidative stress and apoptosis through inhibition of the ROS/JNK signaling pathway. Oxid Med Cell Longev 2018;2018:4035310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6140004</ArticleId><ArticleId IdType="pubmed">30250633</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammar AS, Mahmoud KM, Kasemy ZA, et al. . Cardiac and renal protective effects of dexmedetomidine in cardiac surgeries: A randomized controlled trial. Saudi J Anaesth 2016;10:395&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5044722</ArticleId><ArticleId IdType="pubmed">27833481</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J, Sun P, Zhao H, et al. . Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Crit Care 2011;15:R153 R153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3219027</ArticleId><ArticleId IdType="pubmed">21702944</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Mao X, Chen H, et al. . Dexmedetomidine alleviates LPS-induced apoptosis and inflammation in macrophages by eliminating damaged mitochondria via PINK1 mediated mitophagy. Int Immunopharmacol 2019;73:471&#x2013;481.</Citation><ArticleIdList><ArticleId IdType="pubmed">31170676</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao H, Chi X, Jin Y, et al. . Dexmedetomidine inhibits TLR4/NF-&#x3ba;B activation and reduces acute kidney injury after orthotopic autologous liver transplantation in rats. Sci Rep 2015;5:16849.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4653646</ArticleId><ArticleId IdType="pubmed">26585410</ArticleId></ArticleIdList></Reference><Reference><Citation>Soh S, Shim J-K, Song J-W, et al. . Effect of dexmedetomidine on acute kidney injury after aortic surgery: a single-centre, placebo-controlled, randomised controlled trial. Br J Anaesth 2020;124:386&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pubmed">32007239</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho JS, Shim JK, Soh S, et al. . Perioperative dexmedetomidine reduces the incidence and severity of acute kidney injury following valvular heart surgery. Kidney Int 2016;89:693&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pubmed">26444030</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue F, Zhang W, Chu HC. Assessing perioperative dexmedetomidine reduces the incidence and severity of acute kidney injury following valvular heart surgery. Kidney Int 2016;89:1164.</Citation><ArticleIdList><ArticleId IdType="pubmed">27083295</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni C, Masters J, Zhu L, et al. . Study design of the DAS-OLT trial: a randomized controlled trial to evaluate the impact of dexmedetomidine on early allograft dysfunction following liver transplantation. Trials 2020;21:582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7317895</ArticleId><ArticleId IdType="pubmed">32591004</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2844940</ArticleId><ArticleId IdType="pubmed">20332509</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung KW, Kang J, Kwon HM, et al. . Effect of remote ischemic preconditioning conducted in living liver donors on postoperative liver function in donors and recipients following liver transplantation: a randomized clinical trial. Ann Surg 2020;271:646&#x2013;653.</Citation><ArticleIdList><ArticleId IdType="pubmed">31356262</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang S, Ahn CS, Kim KH, et al. . A cross-sectional analysis of long-term immunosuppressive regimens after liver transplantation at Asan Medical Center: Increased preference for mycophenolate mofetil. Ann Hepatobiliary Pancreat Surg 2018;22:19&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5845607</ArticleId><ArticleId IdType="pubmed">29536052</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon YI, Song GW, Lee SG, et al. . Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma. J Hepatol 2018;68:1153&#x2013;1162.</Citation><ArticleIdList><ArticleId IdType="pubmed">29452208</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SG. A complete treatment of adult living donor liver transplantation: a review of surgical technique and current challenges to expand indication of patients. Am J Transpl 2015;15:17&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">25358749</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 2013;17:204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057151</ArticleId><ArticleId IdType="pubmed">23394211</ArticleId></ArticleIdList></Reference><Reference><Citation>Durand F, Francoz C, Asrani SK, et al. . Acute kidney injury after liver transplantation. Transplantation 2018;102:1636&#x2013;1649.</Citation><ArticleIdList><ArticleId IdType="pubmed">29847502</ArticleId></ArticleIdList></Reference><Reference><Citation>Leithead JA, Tariciotti L, Gunson B, et al. . Donation after cardiac death liver transplant recipients have an increased frequency of acute kidney injury. Am J Transpl 2012;12:965&#x2013;975.</Citation><ArticleIdList><ArticleId IdType="pubmed">22226302</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan L, Bagshaw SM, Langenberg C, et al. . Pathophysiology of septic acute kidney injury: what do we really know? Crit Care Med 2008;36:S198&#x2013;S203.</Citation><ArticleIdList><ArticleId IdType="pubmed">18382194</ArticleId></ArticleIdList></Reference><Reference><Citation>Paugam-Burtz C, Kavafyan J, Merckx P, et al. . Postreperfusion syndrome during liver transplantation for cirrhosis: outcome and predictors. Liver Transpl 2009;15:522&#x2013;529.</Citation><ArticleIdList><ArticleId IdType="pubmed">19399736</ArticleId></ArticleIdList></Reference><Reference><Citation>Cakir M, Polat A, Tekin S, et al. . The effect of dexmedetomidine against oxidative and tubular damage induced by renal ischemia reperfusion in rats. Ren Fail 2015;37:704&#x2013;708.</Citation><ArticleIdList><ArticleId IdType="pubmed">25687385</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan F, Chen Y, Yuan D, et al. . Dexmedetomidine protects against acute kidney injury through downregulating inflammatory reactions in endotoxemia rats. Biomed Rep 2015;3:365&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4467244</ArticleId><ArticleId IdType="pubmed">26137237</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Y, Hu X, Feng X, et al. . Dexmedetomidine alleviates lipopolysaccharide-induced acute kidney injury by inhibiting the NLRP3 inflammasome activation via regulating the TLR4/NOX4/NF-kappaB pathway. J Cell Biochem 2019;120:18509&#x2013;18523.</Citation><ArticleIdList><ArticleId IdType="pubmed">31243816</ArticleId></ArticleIdList></Reference><Reference><Citation>An X, Shang F. RA-XII exerts anti-oxidant and anti-inflammatory activities on lipopolysaccharide-induced acute renal injury by suppressing NF-&#x3ba;B and MAPKs regulated by HO-1/Nrf2 pathway. Biochem Biophys Res Commun 2018;495:2317&#x2013;2323.</Citation><ArticleIdList><ArticleId IdType="pubmed">29277609</ArticleId></ArticleIdList></Reference><Reference><Citation>Fayed NA, Sayed EI, Saleh SM, et al. . Effect of dexmedetomidine on hepatic ischemia-reperfusion injury in the setting of adult living donor liver transplantation. Clin Transplant 2016;30:470&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pubmed">26856320</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell SC, Vinnakota A, Deo SV, et al. . Relationship between intraoperative serum lactate and hemoglobin levels on postoperative renal function in patients undergoing elective cardiac surgery. J Card Surg 2018;33:316&#x2013;321.</Citation><ArticleIdList><ArticleId IdType="pubmed">29726039</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Zerillo J, Tabrizian P, et al. . Postoperative meld-lactate and isolated lactate values as outcome predictors following orthotopic liver transplantation. Shock (Augusta, Ga) 2017;48:36&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">28125529</ArticleId></ArticleIdList></Reference><Reference><Citation>Barreto AG, Daher EF, Silva Junior GB, et al. . Risk factors for acute kidney injury and 30-day mortality after liver transplantation. Ann Hepatol 2015;14:688&#x2013;694.</Citation><ArticleIdList><ArticleId IdType="pubmed">26256897</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D, Liu Z, Bi JF, et al. . Risk factors for the incidence and severity of acute kidney injury after liver transplantation. Turkish J Gastroenterol 2021;32:82&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8975344</ArticleId><ArticleId IdType="pubmed">33893770</ArticleId></ArticleIdList></Reference><Reference><Citation>Miranda ML, Balarini MM, Bouskela E. Dexmedetomidine attenuates the microcirculatory derangements evoked by experimental sepsis. Anesthesiology 2015;122:619&#x2013;630.</Citation><ArticleIdList><ArticleId IdType="pubmed">25313879</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh YC, Sun WZ, Ko WJ, et al. . Dexmedetomidine prevents alterations of intestinal microcirculation that are induced by surgical stress and pain in a novel rat model. Anesth Analg 2012;115:46&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">22504209</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez G, Tapia P, Alegr&#xed;a L, et al. . Effects of dexmedetomidine and esmolol on systemic hemodynamics and exogenous lactate clearance in early experimental septic shock. Crit Care 2016;20:234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4969982</ArticleId><ArticleId IdType="pubmed">27480413</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyamoto K, Nakashima T, Shima N, et al. . Effect of dexmedetomidine on lactate clearance in patients with septic shock: a subanalysis of a multicenter randomized controlled trial. Shock (Augusta, Ga) 2018;50:162&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pubmed">29117063</ArticleId></ArticleIdList></Reference><Reference><Citation>Jun IG, Lee B, Kim SO, et al. . Comparison of acute kidney injury between ABO-compatible and ABO-incompatible living donor liver transplantation: A propensity matching analysis. Liver Transpl 2016;22:1656&#x2013;1665.</Citation><ArticleIdList><ArticleId IdType="pubmed">27595780</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 2012;81:442&#x2013;448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3788581</ArticleId><ArticleId IdType="pubmed">22113526</ArticleId></ArticleIdList></Reference><Reference><Citation>Weerink MAS, Struys M, Hannivoort LN, et al. . Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin Pharmacokinet 2017;56:893&#x2013;913.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5511603</ArticleId><ArticleId IdType="pubmed">28105598</ArticleId></ArticleIdList></Reference><Reference><Citation>Deiner S, Luo X, Lin HM, et al. . Intraoperative infusion of dexmedetomidine for prevention of postoperative delirium and cognitive dysfunction in elderly patients undergoing major elective noncardiac surgery: a randomized clinical trial. JAMA Surg 2017;152:e171505.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5831461</ArticleId><ArticleId IdType="pubmed">28593326</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Yang J, Nie XL, et al. . Impact of dexmedetomidine on the incidence of delirium in elderly patients after cardiac surgery: a randomized controlled trial. PLoS One 2017;12:e0170757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5300174</ArticleId><ArticleId IdType="pubmed">28182690</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36614838</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>21</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Incidence and Associations of Acute Kidney Injury after General Thoracic Surgery: A System Review and Meta-Analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">37</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm12010037</ELocationID><Abstract><AbstractText>(1) Background: Acute kidney injury (AKI) is related to adverse outcomes in critical illness and cardiovascular surgery. In this study, a systematic literature review and meta-analysis was carried out to evaluate the incidence and associations of AKI as a postoperative complication of thoracic (including lung resection and esophageal) surgical procedures. (2) Methods: Adopting a systematic strategy, the electronic reference databases (PubMed, EMBASE, and Cochrane Library) were searched for articles researching postoperative renal outcomes that were diagnosed using RIFLE, AKIN or KDIGO consensus criteria in the context of a thoracic operation. A random-effects model was applied to estimate the incidence of AKI and, where reported, the pooled relative risk of mortality and non-renal complications after AKI. The meta-analysis is registered in PROSPERO under the number CRD42021274166. (3) Results: In total, 20 studies with information gathered from 34,826 patients after thoracic surgery were covered. Comprehensively, the incidence of AKI was estimated to be 8.8% (95% CI: 6.7&#x2212;10.8%). A significant difference was found in the mortality of patients with and without AKI (RR = 2.93, 95% CI: 1.79&#x2212;4.79, p &lt; 0.001). Additionally, in patients experiencing AKI, cardiovascular and respiratory complications were more common (p = 0.01 and p &lt; 0.001, respectively). (4) Conclusions: AKI is a common complication associated with adverse outcomes following general thoracic surgery. An important issue in perioperative care, AKI should be considered as a highly significant prognostic indicator and an attractive target for potential therapeutic interventions, especially in high-risk populations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Shanshan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Bing</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Haining People's Hospital, Haining 314499, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Xiaodong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Honggang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Caifei</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Shengmei</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-1877-9812</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310000, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">incidence</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">postoperative</Keyword><Keyword MajorTopicYN="N">systematic reviews</Keyword><Keyword MajorTopicYN="N">thoracic surgery</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>8</Day><Hour>1</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36614838</ArticleId><ArticleId IdType="pmc">PMC9821434</ArticleId><ArticleId IdType="doi">10.3390/jcm12010037</ArticleId><ArticleId IdType="pii">jcm12010037</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nooreldeen R., Bach H. Current and Future Development in Lung Cancer Diagnosis. Int. J. Mol. Sci. 2021;22:8661. doi: 10.3390/ijms22168661.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22168661</ArticleId><ArticleId IdType="pmc">PMC8395394</ArticleId><ArticleId IdType="pubmed">34445366</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209&#x2013;249. doi: 10.3322/caac.21660.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21660</ArticleId><ArticleId IdType="pubmed">33538338</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufmann K.B., Stein L., Bogatyreva L., Ulbrich F., Kaifi J.T., Hauschke D., Loop T., Goebel U. Oesophageal Doppler guided goal-directed haemodynamic therapy in thoracic surgery&#x2014;A single centre randomized parallel-arm trial. Br. J. Anaesth. 2017;118:852&#x2013;861. doi: 10.1093/bja/aew447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aew447</ArticleId><ArticleId IdType="pubmed">28575331</ArticleId></ArticleIdList></Reference><Reference><Citation>Saftic I., Bille A., Asemota N., Berjon de la Vega L., Routledge T., King J., Phipps K.H., Pilling J. Risks and rewards of the surgical treatment of lung cancer in octogenarians. Interact. Cardiovasc. Thorac. Surg. 2021;33:905&#x2013;912. doi: 10.1093/icvts/ivab194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivab194</ArticleId><ArticleId IdType="pmc">PMC8632787</ArticleId><ArticleId IdType="pubmed">34436584</ArticleId></ArticleIdList></Reference><Reference><Citation>Naruka V., McKie M.A., Khushiwal R., Clayton J., Aresu G., Peryt A., Villar S.S., MacKay J., Coonar A.S. Acute kidney injury after thoracic surgery: A proposal for a multicentre evaluation (MERITS) Interact. Cardiovasc. Thorac. Surg. 2019;29:861&#x2013;866. doi: 10.1093/icvts/ivz184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivz184</ArticleId><ArticleId IdType="pubmed">31393555</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E.H., Kim H.R., Baek S.H., Kim K.M., Chin J.H., Choi D.K., Kim W.J., Choi I.C. Risk factors of postoperative acute kidney injury in patients undergoing esophageal cancer surgery. J. Cardiothorac. Vasc. Anesth. 2014;28:936&#x2013;942. doi: 10.1053/j.jvca.2013.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2013.12.006</ArticleId><ArticleId IdType="pubmed">24680132</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Zhou Y., Gao S., Du C., Yao L., Yang R. Effects of preoperative pulmonary function on short-term outcomes and overall survival after video-assisted thoracic surgery lobectomy. Ann. Transl. Med. 2021;9:1651. doi: 10.21037/atm-21-5244.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm-21-5244</ArticleId><ArticleId IdType="pmc">PMC8667134</ArticleId><ArticleId IdType="pubmed">34988160</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy C.F., Dunne T., Elliott J.A., Kamarajah S.K., Leighton J., Evans R.P.T., Bundred J., King S., Ravi N., Donohoe C.L., et al. Acute Kidney Injury After Esophageal Cancer Surgery: Incidence, Risk Factors, and Impact on Oncologic Outcomes. Ann. Surg. 2022;275:e683&#x2013;e689. doi: 10.1097/SLA.0000000000004146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000004146</ArticleId><ArticleId IdType="pubmed">32740248</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa S., Griesdale D.E., Lohser J. Acute kidney injury after lung resection surgery: Incidence and perioperative risk factors. Anesth. Analg. 2012;114:1256&#x2013;1262. doi: 10.1213/ANE.0b013e31824e2d20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e31824e2d20</ArticleId><ArticleId IdType="pubmed">22451594</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Wang T., Feng X., Sun L. Incidence and risk factors of acute kidney injury after esophageal cancer surgery: A nested case-control study. Int. J. Surg. 2017;39:11&#x2013;15. doi: 10.1016/j.ijsu.2017.01.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2017.01.043</ArticleId><ArticleId IdType="pubmed">28104467</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardinale D., Cosentino N., Moltrasio M., Sandri M.T., Petrella F., Colombo A., Bacchiani G., Tessitore A., Bonomi A., Veglia F., et al. Acute kidney injury after lung cancer surgery: Incidence and clinical relevance, predictors, and role of N-terminal pro B-type natriuretic peptide. Lung Cancer. 2018;123:155&#x2013;159. doi: 10.1016/j.lungcan.2018.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lungcan.2018.07.009</ArticleId><ArticleId IdType="pubmed">30089588</ArticleId></ArticleIdList></Reference><Reference><Citation>Assaad S., Kyriakides T., Tellides G., Kim A.W., Perkal M., Perrino A. Extravascular Lung Water and Tissue Perfusion Biomarkers After Lung Resection Surgery Under a Normovolemic Fluid Protocol. J. Cardiothorac. Vasc. Anesth. 2015;29:977&#x2013;983. doi: 10.1053/j.jvca.2014.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2014.12.020</ArticleId><ArticleId IdType="pubmed">25922205</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Yu W., Gao M., Gu C., Yu Y. Preoperative Prophylactic Intraaortic Balloon Pump Reduces the Incidence of Postoperative Acute Kidney Injury and Short-Term Death of High-Risk Patients Undergoing Coronary Artery Bypass Grafting: A Meta-Analysis of 17 Studies. Ann. Thorac. Surg. 2016;101:2007&#x2013;2019. doi: 10.1016/j.athoracsur.2015.10.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2015.10.078</ArticleId><ArticleId IdType="pubmed">27045229</ArticleId></ArticleIdList></Reference><Reference><Citation>Thongprayoon C., Lertjitbanjong P., Cheungpasitporn W., Hansrivijit P., Fulop T., Kovvuru K., Kanduri S.R., Davis P.W., Vallabhajosyula S., Bathini T., et al. Incidence and impact of acute kidney injury on patients with implantable left ventricular assist devices: A Meta-analysis. Ren. Fail. 2020;42:495&#x2013;512. doi: 10.1080/0886022X.2020.1768116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/0886022X.2020.1768116</ArticleId><ArticleId IdType="pmc">PMC7301695</ArticleId><ArticleId IdType="pubmed">32434422</ArticleId></ArticleIdList></Reference><Reference><Citation>Tinica G., Brinza C., Covic A., Popa I.V., Tarus A., Bacusca A.E., Burlacu A. Determinants of acute kidney injury after cardiac surgery: A systematic review. Rev. Cardiovasc. Med. 2020;21:601&#x2013;610.</Citation><ArticleIdList><ArticleId IdType="pubmed">33388005</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes M., Majoni M., Garg A.X., Dubois L. Systematic Review and Meta-Analysis of Preventative Strategies for Acute Kidney Injury in Patients Undergoing Abdominal Aortic Aneurysm Repair. Ann. Vasc. Surg. 2021;74:419&#x2013;430. doi: 10.1016/j.avsg.2020.12.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2020.12.061</ArticleId><ArticleId IdType="pubmed">33548402</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor M.E., Kirwan C.J., Pearse R.M., Prowle J.R. Incidence and associations of acute kidney injury after major abdominal surgery. Intensive Care Med. 2016;42:521&#x2013;530. doi: 10.1007/s00134-015-4157-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-4157-7</ArticleId><ArticleId IdType="pubmed">26602784</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J., Chen R., Liu S., Yu X., Zou J., Ding X. Global Incidence and Outcomes of Adult Patients With Acute Kidney Injury After Cardiac Surgery: A Systematic Review and Meta-Analysis. J. Cardiothorac. Vasc. Anesth. 2016;30:82&#x2013;89. doi: 10.1053/j.jvca.2015.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2015.06.017</ArticleId><ArticleId IdType="pubmed">26482484</ArticleId></ArticleIdList></Reference><Reference><Citation>Grams M.E., Sang Y., Coresh J., Ballew S., Matsushita K., Molnar M.Z., Szabo Z., Kalantar-Zadeh K., Kovesdy C.P. Acute Kidney Injury After Major Surgery: A Retrospective Analysis of Veterans Health Administration Data. Am. J. Kidney Dis. 2016;67:872&#x2013;880. doi: 10.1053/j.ajkd.2015.07.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2015.07.022</ArticleId><ArticleId IdType="pmc">PMC4775458</ArticleId><ArticleId IdType="pubmed">26337133</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., Moher D., Becker B.J., Sipe T.A., Thacker S.B. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008&#x2013;2012. doi: 10.1001/jama.283.15.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.283.15.2008</ArticleId><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D., Shamseer L., Clarke M., Ghersi D., Liberati A., Petticrew M., Shekelle P., Stewart L.A. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst. Rev. 2015;4:1. doi: 10.1186/2046-4053-4-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Elm E., Altman D.G., Egger M., Pocock S.J., G&#xf8;tzsche P.C., Vandenbroucke J.P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet. 2007;370:1453&#x2013;1457. doi: 10.1016/S0140-6736(07)61602-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)61602-X</ArticleId><ArticleId IdType="pubmed">18064739</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R., Ronco C., Kellum J.A., Mehta R.L., Palevsky P. Acute renal failure&#x2014;definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit. Care. 2004;8:R204&#x2013;R212. doi: 10.1186/cc2872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc2872</ArticleId><ArticleId IdType="pmc">PMC522841</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta R.L., Kellum J.A., Shah S.V., Molitoris B.A., Ronco C., Warnock D.G., Levin A., Acute Kidney Injury N. Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit. Care. 2007;11:R31. doi: 10.1186/cc5713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc5713</ArticleId><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin. Pract. 2012;120:c179&#x2013;c184. doi: 10.1159/000339789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000339789</ArticleId><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 2010;25:603&#x2013;605. doi: 10.1007/s10654-010-9491-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-010-9491-z</ArticleId><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Licker M., Cartier V., Robert J., Diaper J., Villiger Y., Tschopp J.M., Inan C. Risk factors of acute kidney injury according to RIFLE criteria after lung cancer surgery. Ann. Thorac. Surg. 2011;91:844&#x2013;850. doi: 10.1016/j.athoracsur.2010.10.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2010.10.037</ArticleId><ArticleId IdType="pubmed">21353011</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren H., Meng L. Acute kidney injury treatment for elderly patients after esophageal cancer operation. Zhonghua Yi Xue Za Zhi. 2015;95:2000&#x2013;2002.</Citation><ArticleIdList><ArticleId IdType="pubmed">26710809</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn H.J., Kim J.A., Lee A.R., Yang M., Jung H.J., Heo B. The Risk of Acute Kidney Injury from Fluid Restriction and Hydroxyethyl Starch in Thoracic Surgery. Anesth. Analg. 2016;122:186&#x2013;193. doi: 10.1213/ANE.0000000000000974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000000974</ArticleId><ArticleId IdType="pubmed">26418125</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon T., Tsai J.Y., Vachhani S., Peng S.P., Feng L., Vaporciyan A.A., Cata J.P. The Use of Intraoperative Dexmedetomidine Is Not Associated With a Reduction in Acute Kidney Injury After Lung Cancer Surgery. J. Cardiothorac. Vasc. Anesth. 2016;30:51&#x2013;55. doi: 10.1053/j.jvca.2015.03.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2015.03.025</ArticleId><ArticleId IdType="pubmed">26260907</ArticleId></ArticleIdList></Reference><Reference><Citation>Konda P., Ai D., Guerra C.E., Rodriguez-Restrepo A., Mehran R.J., Rice D., Hofstetter W., Heir J., Kwater P., Gottumukkala V., et al. Identification of Risk Factors Associated With Postoperative Acute Kidney Injury After Esophagectomy for Esophageal Cancer. J. Cardiothorac. Vasc. Anesth. 2017;31:474&#x2013;481. doi: 10.1053/j.jvca.2016.07.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2016.07.030</ArticleId><ArticleId IdType="pubmed">27720491</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteser&#xed;n Matesanz C., de la Gala F., Rancan L., Pi&#xf1;eiro P., Sim&#xf3;n C., Tejedor A., Vara E., Gonzalez-Cantero J.L., Garutti I. Predictive value of plasma cytokines for acute kidney injury following lung resection surgery: Prospective observational study. Braz. J. Anesthesiol. 2019;69:242&#x2013;252. doi: 10.1016/j.bjan.2018.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjan.2018.12.009</ArticleId><ArticleId IdType="pmc">PMC9391883</ArticleId><ArticleId IdType="pubmed">31133282</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh T.K., Kim J., Han S., Kim K., Jheon S., Ji E. Effect of sevoflurane-based or propofol-based anaesthesia on the incidence of postoperative acute kidney injury: A retrospective propensity score-matched analysis. Eur. J. Anaesthesiol. 2019;36:649&#x2013;655. doi: 10.1097/EJA.0000000000001020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000001020</ArticleId><ArticleId IdType="pubmed">31107350</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.A., Ahn H.J., Oh A.R., Choi J. Restrictive intraoperative fluid management was associated with higher incidence of composite complications compared to less restrictive strategies in open thoracotomy: A retrospective cohort study. Sci. Rep. 2020;10:8449. doi: 10.1038/s41598-020-65532-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-65532-w</ArticleId><ArticleId IdType="pmc">PMC7242459</ArticleId><ArticleId IdType="pubmed">32439944</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng Z.T., Mu D.L. Impact of oliguria during lung surgery on postoperative acute kidney injury. Beijing Da Xue Xue Bao Yi Xue Ban. 2020;53:188&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7867982</ArticleId><ArticleId IdType="pubmed">33550355</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao B.C., Lei S.H., Yang X., Zhang Y., Qiu S.D., Liu W.F., Li C., Liu K.X. Assessment of prognostic value of intraoperative oliguria for postoperative acute kidney injury: A retrospective cohort study. Br. J. Anaesth. 2021;126:799&#x2013;807. doi: 10.1016/j.bja.2020.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.11.018</ArticleId><ArticleId IdType="pubmed">33342539</ArticleId></ArticleIdList></Reference><Reference><Citation>Garutti I., De la Gala F., Pineiro P., Rancan L., Vara E., Reyes A., Puente-Maestu L., Bellon J.M., Simon C. Usefulness of combining clinical and biochemical parameters for prediction of postoperative pulmonary complications after lung resection surgery. J. Clin. Monit. Comput. 2019;33:1043&#x2013;1054. doi: 10.1007/s10877-019-00257-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-019-00257-4</ArticleId><ArticleId IdType="pubmed">30656507</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer T.M., Sterne J. Meta-Analysis in Stata. BMJ Publishing Group; London, UK: 2008.</Citation></Reference><Reference><Citation>Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629&#x2013;634. doi: 10.1136/bmj.315.7109.629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson C., Lysak N., Huber M., Scali S., Bihorac A. Epidemiology, outcomes, and management of acute kidney injury in the vascular surgery patient. J. Vasc. Surg. 2018;68:916&#x2013;928. doi: 10.1016/j.jvs.2018.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2018.05.017</ArticleId><ArticleId IdType="pmc">PMC6236681</ArticleId><ArticleId IdType="pubmed">30146038</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassnigg A., Schmidlin D., Mouhieddine M., Bachmann L.M., Druml W., Bauer P., Hiesmayr M. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: A prospective cohort study. J. Am. Soc. Nephrol. 2004;15:1597&#x2013;1605. doi: 10.1097/01.ASN.0000130340.93930.DD.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ASN.0000130340.93930.DD</ArticleId><ArticleId IdType="pubmed">15153571</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes J.A., Jorge S. The RIFLE and AKIN classifications for acute kidney injury: A critical and comprehensive review. Clin. Kidney J. 2013;6:8&#x2013;14. doi: 10.1093/ckj/sfs160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ckj/sfs160</ArticleId><ArticleId IdType="pmc">PMC5094385</ArticleId><ArticleId IdType="pubmed">27818745</ArticleId></ArticleIdList></Reference><Reference><Citation>Silver S.A., Harel Z., McArthur E., Nash D.M., Acedillo R., Kitchlu A., Garg A.X., Chertow G.M., Bell C.M., Wald R. Causes of Death after a Hospitalization with AKI. J. Am. Soc. Nephrol. 2018;29:1001&#x2013;1010. doi: 10.1681/ASN.2017080882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2017080882</ArticleId><ArticleId IdType="pmc">PMC5827605</ArticleId><ArticleId IdType="pubmed">29242248</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelman S. Acute Kidney Injury after Surgery: Where Does the Journey Lead? Anesthesiology. 2020;132:5&#x2013;7. doi: 10.1097/ALN.0000000000003027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003027</ArticleId><ArticleId IdType="pubmed">31687985</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchino S. Creatinine. Curr. Opin. Crit. Care. 2010;16:562&#x2013;567. doi: 10.1097/MCC.0b013e32833ea7f3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCC.0b013e32833ea7f3</ArticleId><ArticleId IdType="pubmed">20736825</ArticleId></ArticleIdList></Reference><Reference><Citation>Matot I., Paskaleva R., Eid L., Cohen K., Khalaileh A., Elazary R., Keidar A. Effect of the volume of fluids administered on intraoperative oliguria in laparoscopic bariatric surgery: A randomized controlled trial. Arch. Surg. 2012;147:228&#x2013;234. doi: 10.1001/archsurg.2011.308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.2011.308</ArticleId><ArticleId IdType="pubmed">22106246</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles P.S., McIlroy D.R., Bellomo R., Wallace S. Importance of intraoperative oliguria during major abdominal surgery: Findings of the Restrictive versus Liberal Fluid Therapy in Major Abdominal Surgery trial. Br. J. Anaesth. 2019;122:726&#x2013;733. doi: 10.1016/j.bja.2019.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2019.01.010</ArticleId><ArticleId IdType="pubmed">30916001</ArticleId></ArticleIdList></Reference><Reference><Citation>In&#xe1;cio R., Gameiro J., Amaro S., Duarte M. Intraoperative oliguria does not predict postoperative acute kidney injury in major abdominal surgery: A cohort analysis. J. Bras. Nefrol. 2021;43:9&#x2013;19. doi: 10.1590/2175-8239-jbn-2019-0244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/2175-8239-jbn-2019-0244</ArticleId><ArticleId IdType="pmc">PMC8061965</ArticleId><ArticleId IdType="pubmed">32779689</ArticleId></ArticleIdList></Reference><Reference><Citation>Huo W., Zhang K., Nie Z., Li Q., Jin F. Kidney injury molecule-1 (KIM-1): A novel kidney-specific injury molecule playing potential double-edged functions in kidney injury. Transplant. Rev. 2010;24:143&#x2013;146. doi: 10.1016/j.trre.2010.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trre.2010.02.002</ArticleId><ArticleId IdType="pubmed">20447817</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinna M.M., Altaf F.M.N., Mosa O.F. Serum and Urinary NGAL and Cystatin C Levels as Diagnostic Tools for Acute Kidney Injury and Chronic Kidney Disease: A Histobiochemical Comparative Study. Curr. Pharm. Des. 2019;25:1122&#x2013;1133. doi: 10.2174/1381612825666190516080920.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612825666190516080920</ArticleId><ArticleId IdType="pubmed">31096894</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi A., Lee C.H., Yun Y.M., Kim H., Moon H.W., Hur M. Effectiveness of Plasma and Urine Neutrophil Gelatinase-Associated Lipocalin for Predicting Acute Kidney Injury in High-Risk Patients. Ann. Lab. Med. 2021;41:60&#x2013;67. doi: 10.3343/alm.2021.41.1.60.</Citation><ArticleIdList><ArticleId IdType="doi">10.3343/alm.2021.41.1.60</ArticleId><ArticleId IdType="pmc">PMC7443531</ArticleId><ArticleId IdType="pubmed">32829580</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M., Schmidt C., Hoffmeier A., Van Aken H., Wempe C., Gerss J., Zarbock A. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: The PrevAKI randomized controlled trial. Intensive Care Med. 2017;43:1551&#x2013;1561. doi: 10.1007/s00134-016-4670-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4670-3</ArticleId><ArticleId IdType="pmc">PMC5633630</ArticleId><ArticleId IdType="pubmed">28110412</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;cze I., Jauch D., G&#xf6;tz M., Kennedy P., Jung B., Zeman F., Gnewuch C., Graf B.M., Gnann W., Banas B., et al. Biomarker-guided Intervention to Prevent Acute Kidney Injury After Major Surgery: The Prospective Randomized BigpAK Study. Ann. Surg. 2018;267:1013&#x2013;1020. doi: 10.1097/SLA.0000000000002485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000002485</ArticleId><ArticleId IdType="pubmed">28857811</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A., K&#xfc;llmar M., Ostermann M., Lucchese G., Baig K., Cennamo A., Rajani R., McCorkell S., Arndt C., Wulf H., et al. Prevention of Cardiac Surgery-Associated Acute Kidney Injury by Implementing the KDIGO Guidelines in High-Risk Patients Identified by Biomarkers: The PrevAKI-Multicenter Randomized Controlled Trial. Anesth. Analg. 2021;133:292&#x2013;302. doi: 10.1213/ANE.0000000000005458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005458</ArticleId><ArticleId IdType="pubmed">33684086</ArticleId></ArticleIdList></Reference><Reference><Citation>Esmeijer K., Schoe A., Ruhaak L.R., Hoogeveen E.K., Soonawala D., Romijn F., Shirzada M.R., van Dissel J.T., Cobbaert C.M., de Fijter J.W. The predictive value of TIMP-2 and IGFBP7 for kidney failure and 30-day mortality after elective cardiac surgery. Sci. Rep. 2021;11:1071. doi: 10.1038/s41598-020-80196-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-80196-2</ArticleId><ArticleId IdType="pmc">PMC7806984</ArticleId><ArticleId IdType="pubmed">33441876</ArticleId></ArticleIdList></Reference><Reference><Citation>Gameiro J., Fonseca J.A., Neves M., Jorge S., Lopes J.A. Acute kidney injury in major abdominal surgery: Incidence, risk factors, pathogenesis and outcomes. Ann. Intensive Care. 2018;8:22. doi: 10.1186/s13613-018-0369-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-018-0369-7</ArticleId><ArticleId IdType="pmc">PMC5807256</ArticleId><ArticleId IdType="pubmed">29427134</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M., Schmidt C., Zarbock A. Perioperative Acute Kidney Injury: An Under-Recognized Problem. Anesth. Analg. 2017;125:1223&#x2013;1232. doi: 10.1213/ANE.0000000000002369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000002369</ArticleId><ArticleId IdType="pubmed">28787339</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan X., Lee J.W., Bowser J.L., Neudecker V., Sridhar S., Eltzschig H.K. Targeting Hypoxia Signaling for Perioperative Organ Injury. Anesth. Analg. 2018;126:308&#x2013;321. doi: 10.1213/ANE.0000000000002288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000002288</ArticleId><ArticleId IdType="pmc">PMC5735013</ArticleId><ArticleId IdType="pubmed">28759485</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh P., Ricksten S.E., Bragadottir G., Redfors B., Nordquist L. Renal oxygenation and haemodynamics in acute kidney injury and chronic kidney disease. Clin. Exp. Pharmacol. Physiol. 2013;40:138&#x2013;147. doi: 10.1111/1440-1681.12036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1440-1681.12036</ArticleId><ArticleId IdType="pmc">PMC3710120</ArticleId><ArticleId IdType="pubmed">23360244</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollmann C., Fernandes N.L., Biccard B.M. A Systematic Review of Outcomes Associated With Withholding or Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Before Noncardiac Surgery. Anesth. Analg. 2018;127:678&#x2013;687. doi: 10.1213/ANE.0000000000002837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000002837</ArticleId><ArticleId IdType="pubmed">29381513</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi K., Hayashida M., Kudoh O., Niimi N., Kataoka K., Kakemizu-Watanabe M., Yamamoto M., Hara A., Kawagoe I., Yamaguchi K. Continuing versus withholding angiotensin receptor blocker (ARB)/calcium channel blocker (CCB) combination tablets during perioperative periods in patients undergoing minor surgery: A single-blinded randomized controlled trial. J. Anesth. 2022;36:374&#x2013;382. doi: 10.1007/s00540-022-03053-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-022-03053-8</ArticleId><ArticleId IdType="pmc">PMC9156462</ArticleId><ArticleId IdType="pubmed">35247102</ArticleId></ArticleIdList></Reference><Reference><Citation>Norman J.T., Stidwill R., Singer M., Fine L.G. Angiotensin II Blockade Augments Renal Cortical Microvascular pO2 Indicating a Novel, Potentially Renoprotective Action. Nephron Physiol. 2003;94:p39&#x2013;p46. doi: 10.1159/000071289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000071289</ArticleId><ArticleId IdType="pubmed">12845221</ArticleId></ArticleIdList></Reference><Reference><Citation>Gayat E., Hollinger A., Cariou A., Deye N., Vieillard-Baron A., Jaber S., Chousterman B.G., Lu Q., Laterre P.F., Monnet X., et al. Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury. Intensive Care Med. 2018;44:598&#x2013;605. doi: 10.1007/s00134-018-5160-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-018-5160-6</ArticleId><ArticleId IdType="pubmed">29766216</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N., Qiao H., Guo J.F., Yang H.Y., Li X.Y., Li S.L., Wang D.X., Yang L. Preoperative hypoalbuminemia was associated with acute kidney injury in high-risk patients following non-cardiac surgery: A retrospective cohort study. BMC Anesthesiol. 2019;19:171. doi: 10.1186/s12871-019-0842-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-019-0842-3</ArticleId><ArticleId IdType="pmc">PMC6719349</ArticleId><ArticleId IdType="pubmed">31477030</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedermann C.J., Wiedermann W., Joannidis M. Causal relationship between hypoalbuminemia and acute kidney injury. World J. Nephrol. 2017;6:176&#x2013;187. doi: 10.5527/wjn.v6.i4.176.</Citation><ArticleIdList><ArticleId IdType="doi">10.5527/wjn.v6.i4.176</ArticleId><ArticleId IdType="pmc">PMC5500455</ArticleId><ArticleId IdType="pubmed">28729966</ArticleId></ArticleIdList></Reference><Reference><Citation>Degoul S., Chazard E., Lamer A., Lebuffe G., Duhamel A., Tavernier B. lntraoperative administration of 6% hydroxyethyl starch 130/0.4 is not associated with acute kidney injury in elective non-cardiac surgery: A sequential and propensity-matched analysis. Anaesth. Crit. Care Pain. Med. 2020;39:199&#x2013;206. doi: 10.1016/j.accpm.2019.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.accpm.2019.08.002</ArticleId><ArticleId IdType="pubmed">32068135</ArticleId></ArticleIdList></Reference><Reference><Citation>He S.J., Liu Q., Li H.Q., Tian F., Chen S.Y., Weng J.X. Role of statins in preventing cardiac surgery-associated acute kidney injury: An updated meta-analysis of randomized controlled trials. Ther. Clin. Risk Manag. 2018;14:475&#x2013;482. doi: 10.2147/TCRM.S160298.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/TCRM.S160298</ArticleId><ArticleId IdType="pmc">PMC5842775</ArticleId><ArticleId IdType="pubmed">29551897</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi R., Tie H.T. Dexmedetomidine as a promising prevention strategy for cardiac surgery-associated acute kidney injury: A meta-analysis. Crit. Care. 2017;21:198. doi: 10.1186/s13054-017-1776-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-017-1776-0</ArticleId><ArticleId IdType="pmc">PMC5541647</ArticleId><ArticleId IdType="pubmed">28768524</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsabbagh M.M., Asmar A., Ejaz N.I., Aiyer R.K., Kambhampati G., Ejaz A.A. Update on clinical trials for the prevention of acute kidney injury in patients undergoing cardiac surgery. Am. J. Surg. 2013;206:86&#x2013;95. doi: 10.1016/j.amjsurg.2012.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2012.08.007</ArticleId><ArticleId IdType="pubmed">23411349</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao B.C., Shen P., Liu K.X. Perioperative Statins Do Not Prevent Acute Kidney Injury After Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials. J. Cardiothorac. Vasc. Anesth. 2017;31:2086&#x2013;2092. doi: 10.1053/j.jvca.2017.04.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2017.04.038</ArticleId><ArticleId IdType="pubmed">28803772</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J.W., Shim J.K., Soh S., Jang J., Kwak Y.L. Double-blinded, randomized controlled trial of N-acetylcysteine for prevention of acute kidney injury in high risk patients undergoing off-pump coronary artery bypass. Nephrology. 2015;20:96&#x2013;102. doi: 10.1111/nep.12361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nep.12361</ArticleId><ArticleId IdType="pubmed">25384603</ArticleId></ArticleIdList></Reference><Reference><Citation>Piggott K.D., Liu A., Monczka J., Fakioglu H., Narasimhulu S.S., Pourmoghadam K., DeCampli W. Inadequate preoperative nutrition might be associated with acute kidney injury and greater illness severity postoperatively. J. Thorac. Cardiovasc. Surg. 2018;155:2104&#x2013;2109. doi: 10.1016/j.jtcvs.2017.12.080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2017.12.080</ArticleId><ArticleId IdType="pubmed">29366566</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Adas Z., Lodewyk K., Robinson D., Qureshi S., Kabbani L.S., Sullivan B., Shepard A.D., Weaver M.R., Nypaver T.J. Contrast-induced nephropathy after peripheral vascular intervention: Long-term renal outcome and risk factors for progressive renal dysfunction. J. Vasc. Surg. 2019;69:913&#x2013;920. doi: 10.1016/j.jvs.2018.06.196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2018.06.196</ArticleId><ArticleId IdType="pubmed">30292616</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles P.S., Bellomo R., Corcoran T., Forbes A., Peyton P., Story D., Christophi C., Leslie K., McGuinness S., Parke R., et al. Restrictive versus Liberal Fluid Therapy for Major Abdominal Surgery. N. Engl. J. Med. 2018;378:2263&#x2013;2274. doi: 10.1056/NEJMoa1801601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1801601</ArticleId><ArticleId IdType="pubmed">29742967</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle J.R., Kirwan C.J., Bellomo R. Fluid management for the prevention and attenuation of acute kidney injury. Nat. Rev. Nephrol. 2014;10:37&#x2013;47. doi: 10.1038/nrneph.2013.232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2013.232</ArticleId><ArticleId IdType="pubmed">24217464</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33548402</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1615-5947</ISSN><JournalIssue CitedMedium="Internet"><Volume>74</Volume><PubDate><Year>2021</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Annals of vascular surgery</Title><ISOAbbreviation>Ann Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>Systematic Review and Meta-Analysis of Preventative Strategies for Acute Kidney Injury in Patients Undergoing Abdominal Aortic Aneurysm Repair.</ArticleTitle><Pagination><StartPage>419</StartPage><EndPage>430</EndPage><MedlinePgn>419-430</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.avsg.2020.12.061</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0890-5096(21)00125-4</ELocationID><Abstract><AbstractText Label="BACKGOUND" NlmCategory="BACKGROUND">To assess the effect of various preventative interventions for reducing the incidence of postoperative acute kidney injury (AKI) in patients undergoing elective abdominal aortic aneurysm (AAA) repair.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We included randomized controlled trials of 10 patients or more which tested a preventative intervention versus standard therapy or placebo in patients undergoing elective AAA repair using the open or endovascular approach. Studies including mixed patient populations such as those with aortic occlusive disease, thoracoabdominal aneurysms or ruptured aneurysms were ineligible for review. We searched Medline (1966-2019), EMBASE (1947-2019), CINAHL (1961-2019), Web of Science (1945-2019), Scopus (1966-2019), and The Cochrane Library (1996-2019) for trials available as published manuscripts in English. Study quality was assessed using the Cochrane Collaboration risk of bias tool. Where possible we pooled the results of similar interventions using random effects meta-analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included 17 trials involving 1443 participants. Most trials were small, single-center studies, with varying definitions of AKI and a high or moderate risk of bias. The preventative strategies with possible protective effects were mannitol, a composite of antioxidant supplements, an open extraperitoneal approach, and human atrial natriuretic peptide (hANP). Curcumin, methylprednisolone, carbon dioxide contrast medium, hemodynamic monitoring and N-acetylcysteine were found to be ineffective. Six trials with a total of 355 participants reported on remote ischemic preconditioning (RIPC) and our meta-analysis showed no statistically significant difference between RIPC and standard treatment (OR 1.20, 95% CI 0.37, 3.89); although the results should be interpreted with caution due to considerable statistical heterogeneity (I<sup>2</sup>&#x202f;=&#x202f;70%). None of the interventions studied significantly reduced receipt of renal replacement therapy (RRT).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Interventions that have shown some potential to reduce AKI after AAA repair include mannitol, a composite of antioxidant supplements, an open extraperitoneal approach and hANP. These conclusions are limited by the small size, high risk of bias and inconsistency of the included trials. Large, high quality, multi-center randomized trials will help determine which interventions are effective in reducing the incidence of postoperative AKI among patients undergoing elective AAA repair.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fernandes</LastName><ForeName>Michaela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Majoni</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garg</LastName><ForeName>Amit X</ForeName><Initials>AX</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada; Division of Nephrology, London Health Sciences Centre, London, Ontario, Canada; Institute for Clinical Evaluative Sciences, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dubois</LastName><ForeName>Luc</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada; Institute for Clinical Evaluative Sciences, London, Ontario, Canada; Division of Vascular Surgery, London Health Sciences Centre, London, Ontario, Canada. Electronic address: luc.dubois@uwo.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ann Vasc Surg</MedlineTA><NlmUniqueID>8703941</NlmUniqueID><ISSNLinking>0890-5096</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance></Chemical><Chemical><RegistryNumber>IT942ZTH98</RegistryNumber><NameOfSubstance UI="D003474">Curcumin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000975" MajorTopicYN="N">Antioxidants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017544" MajorTopicYN="N">Aortic Aneurysm, Abdominal</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003474" MajorTopicYN="N">Curcumin</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="N">Endovascular Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019194" MajorTopicYN="Y">Ischemic Preconditioning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014656" MajorTopicYN="N">Vascular Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Abdominal</Keyword><Keyword MajorTopicYN="N">Acute Kidney Injury</Keyword><Keyword MajorTopicYN="N">Aortic Aneurysm</Keyword><Keyword MajorTopicYN="N">Preventive Medicine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>6</Day><Hour>20</Hour><Minute>10</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33548402</ArticleId><ArticleId IdType="doi">10.1016/j.avsg.2020.12.061</ArticleId><ArticleId IdType="pii">S0890-5096(21)00125-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36912515</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-9159</ISSN><JournalIssue CitedMedium="Internet"><Volume>109</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of surgery (London, England)</Title><ISOAbbreviation>Int J Surg</ISOAbbreviation></Journal><ArticleTitle>The correlation of intraoperative oliguria with acute kidney injury after noncardiac surgery: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>449</StartPage><EndPage>457</EndPage><MedlinePgn>449-457</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/JS9.0000000000000284</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute kidney injury (AKI) occurs commonly after major surgery and is correlated with increased in-hospital morbidity and mortality. There is no consensus on whether intraoperative oliguria affects postoperative AKI. We conducted a meta-analysis to systematically assess the correlation of intraoperative oliguria with postoperative AKI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed, Embase, Web of Science, and Cochrane Library databases were searched to identify reports on the relationship between intraoperative oliguria and postoperative AKI. Quality was assessed using the Newcastle-Ottawa Scale. The primary outcomes were the unadjusted and multivariate-adjusted odds ratios (ORs) for intraoperative oliguria to correlate with postoperative AKI. The secondary outcomes included intraoperative urine output in the AKI and non-AKI groups, the demand for postoperative renal replacement therapy (RRT), in-hospital mortality, and length of hospital stay in the oliguria and non-oliguria groups.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Nine eligible studies with 18&#xa0;473 patients were included. The meta-analysis revealed that patients with intraoperative oliguria had a considerably greater risk of postoperative AKI (unadjusted OR: 2.03, 95% CI: 1.60-2.58, I2 =63%, P &lt;0.00001; multivariate-adjusted OR: 2.00, 95% CI: 1.64-2.44, I2 =40%, P &lt;0.00001). Further subgroup analysis did not find differences between different oliguria criteria or surgical types. Furthermore, the AKI group's pooled intraoperative urine output was less (mean differences: -0.16, 95% CI: -0.26 to -0.07, P &lt;0.001). Intraoperative oliguria was associated with increased demand for postoperative RRT (risk ratios: 4.71, 95% CI: 2.83-7.84, P &lt;0.001) and in-hospital mortality (risk ratios: 1.83, 95% CI: 1.24-2.69, P =0.002), but not with prolonged length of hospital stay (mean differences: 0.55, 95% CI: -0.27 to 1.38, P =0.19).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Intraoperative oliguria was significantly associated with a higher incidence of postoperative AKI, as well as increased in-hospital mortality and demand for postoperative RRT, but not with prolonged hospitalization.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pang</LastName><ForeName>Zhaohua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Shuang</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3899-0145</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xing</LastName><ForeName>Manyu</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3897-1622</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Nannan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Qulian</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0002-5636-8491</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Wangyuan</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-4813-2806</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Centre for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Surg</MedlineTA><NlmUniqueID>101228232</NlmUniqueID><ISSNLinking>1743-9159</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="Y">Renal Replacement Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest. Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>13</Day><Hour>9</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36912515</ArticleId><ArticleId IdType="pmc">PMC10389605</ArticleId><ArticleId IdType="doi">10.1097/JS9.0000000000000284</ArticleId><ArticleId IdType="pii">01279778-202303000-00030</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Garg AX, Kurz A, Sessler DI, et al. . Perioperative aspirin and clonidine and risk of acute kidney injury: a randomized clinical trial. JAMA 2014;312:2254&#x2013;2264.</Citation><ArticleIdList><ArticleId IdType="pubmed">25399007</ArticleId></ArticleIdList></Reference><Reference><Citation>Biteker M, Dayan A, Tekkesin AI, et al. . Incidence, risk factors, and outcomes of perioperative acute kidney injury in noncardiac and nonvascular surgery. Am J Surg 2014;207:53&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">24050540</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor ME, Kirwan CJ, Pearse RM, et al. . Incidence and associations of acute kidney injury after major abdominal surgery. Intensive Care Med 2016;42:521&#x2013;530.</Citation><ArticleIdList><ArticleId IdType="pubmed">26602784</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Burdick E, Honour M, et al. . Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16:3365&#x2013;3370.</Citation><ArticleIdList><ArticleId IdType="pubmed">16177006</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaara ST, Bellomo R. Postoperative renal dysfunction after noncardiac surgery. Curr Opin Crit Care 2017;23:440&#x2013;446.</Citation><ArticleIdList><ArticleId IdType="pubmed">28820797</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012;120:c179&#x2013;c184.</Citation><ArticleIdList><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Zacharias M, Mugawar M, Herbison GP, et al. . Interventions for protecting renal function in the perioperative period. Cochrane Database Syst Rev 2013;9:CD003590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7154582</ArticleId><ArticleId IdType="pubmed">24027097</ArticleId></ArticleIdList></Reference><Reference><Citation>Goren O, Matot I. Perioperative acute kidney injury. Br J Anaesth 2015;115(Suppl 2):ii3&#x2013;ii14.</Citation><ArticleIdList><ArticleId IdType="pubmed">26658199</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Englesbe MJ, et al. . Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology 2007;107:892&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pubmed">18043057</ArticleId></ArticleIdList></Reference><Reference><Citation>Romagnoli S, Zagli G, Tuccinardi G, et al. . Postoperative acute kidney injury in high-risk patients undergoing major abdominal surgery. J Crit Care 2016;35:120&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pubmed">27481746</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Heung M, et al. . Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set. Anesthesiology 2009;110:505&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pubmed">19212261</ArticleId></ArticleIdList></Reference><Reference><Citation>Long TE, Helgason D, Helgadottir S, et al. . Acute kidney injury after abdominal surgery: incidence, risk factors, and outcome. Anesth Analg 2016;122:1912&#x2013;1920.</Citation><ArticleIdList><ArticleId IdType="pubmed">27195635</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafsson UO, Scott MJ, Hubner M, et al. . Guidelines for perioperative care in elective colorectal surgery: Enhanced Recovery After Surgery (ERAS(R)) Society Recommendations: 2018. World J Surg 2019;43:659&#x2013;695.</Citation><ArticleIdList><ArticleId IdType="pubmed">30426190</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmichael JC, Keller DS, Baldini G, et al. . Clinical practice guidelines for enhanced recovery after colon and rectal surgery from the American Society of Colon and Rectal Surgeons and Society of American Gastrointestinal and Endoscopic Surgeons. Dis Colon Rectum 2017;60:761&#x2013;784.</Citation><ArticleIdList><ArticleId IdType="pubmed">28682962</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Kirwan CJ, Bellomo R. Fluid management for the prevention and attenuation of acute kidney injury. Nat Rev Nephrol 2014;10:37&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">24217464</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiba A, Uchino S, Fujii T, et al. . Association between intraoperative oliguria and acute kidney injury after major noncardiac surgery. Anesth Analg 2018;127:1229&#x2013;1235.</Citation><ArticleIdList><ArticleId IdType="pubmed">29933276</ArticleId></ArticleIdList></Reference><Reference><Citation>Slankamenac K, Beck-Schimmer B, Breitenstein S, et al. . Novel prediction score including pre- and intraoperative parameters best predicts acute kidney injury after liver surgery. World J Surg 2013;37:2618&#x2013;2628.</Citation><ArticleIdList><ArticleId IdType="pubmed">23959337</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizota T, Yamamoto Y, Hamada M, et al. . Intraoperative oliguria predicts acute kidney injury after major abdominal surgery. Br J Anaesth 2017;119:1127&#x2013;1134.</Citation><ArticleIdList><ArticleId IdType="pubmed">29136086</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles PS, Mcilroy DR, Bellomo R, et al. . Importance of intraoperative oliguria during major abdominal surgery: findings of the Restrictive versus Liberal Fluid Therapy in Major Abdominal Surgery trial. Br J Anaesth 2019;122:726&#x2013;733.</Citation><ArticleIdList><ArticleId IdType="pubmed">30916001</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng ZT, Mu DL. Impact of oliguria during lung surgery on postoperative acute kidney injury. Beijing Da Xue Xue Bao Yi Xue Ban 2020;53:188&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7867982</ArticleId><ArticleId IdType="pubmed">33550355</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim JW, Kim KR, Jung Y, et al. . Role of intraoperative oliguria in risk stratification for postoperative acute kidney injury in patients undergoing colorectal surgery with an enhanced recovery protocol: a propensity score matching analysis. PLoS One 2020;15:e0231447.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164643</ArticleId><ArticleId IdType="pubmed">32302336</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao BC, Lei SH, Yang X, et al. . Assessment of prognostic value of intraoperative oliguria for postoperative acute kidney injury: a retrospective cohort study. Br J Anaesth 2021;126:799&#x2013;807.</Citation><ArticleIdList><ArticleId IdType="pubmed">33342539</ArticleId></ArticleIdList></Reference><Reference><Citation>Alpert RA, Roizen MF, Hamilton WK, et al. . Intraoperative urinary output does not predict postoperative renal function in patients undergoing abdominal aortic revascularization. Surgery 1984;95:707&#x2013;711.</Citation><ArticleIdList><ArticleId IdType="pubmed">6427960</ArticleId></ArticleIdList></Reference><Reference><Citation>Knos GB, Berry AJ, Isaacson IJ, et al. . Intraoperative urinary output and postoperative blood urea nitrogen and creatinine levels in patients undergoing aortic reconstructive surgery. J Clin Anesth 1989;1:181&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">2627385</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, Koyner JL, Hoste E, et al. . Update on perioperative acute kidney injury. Anesth Analg 2018;127:1236&#x2013;1245.</Citation><ArticleIdList><ArticleId IdType="pubmed">30138176</ArticleId></ArticleIdList></Reference><Reference><Citation>Goren O, Levy A, Cattan A, et al. . Acute kidney injury in pancreatic surgery; association with urine output and intraoperative fluid administration. Am J Surg 2017;214:246&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pubmed">28223046</ArticleId></ArticleIdList></Reference><Reference><Citation>Inacio R, Gameiro J, Amaro S, et al. . Intraoperative oliguria does not predict postoperative acute kidney injury in major abdominal surgery: a cohort analysis. J Bras Nefrol 2021;43:9&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8061965</ArticleId><ArticleId IdType="pubmed">32779689</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, Mckenzie JE, Bossuyt PM, et al. . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg 2021;88:105906.</Citation><ArticleIdList><ArticleId IdType="pubmed">33789826</ArticleId></ArticleIdList></Reference><Reference><Citation>Susantitaphong P, Cruz DN, Cerda J, et al. . World incidence of AKI: a meta-analysis. Clin J Am Soc Nephrol 2013;8:1482&#x2013;1493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3805065</ArticleId><ArticleId IdType="pubmed">23744003</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo D, Wan X, Liu J, et al. . Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res 2018;27:1785&#x2013;1805.</Citation><ArticleIdList><ArticleId IdType="pubmed">27683581</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X, Wang W, Liu J, et al. . Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 2014;14:135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Zou W. Research progress in influence of perioperative hypotension on postoperative outcome of patients. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2021;46:84&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10878287</ArticleId><ArticleId IdType="pubmed">33678641</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang S, Zou W. Effect of the intraoperative use of the Hypotension Prediction Index on postoperative hypotension in the postanaesthesia care unit. Comment on Br J Anaesth 2021; 127: 681&#x2013;8. Br J Anaesth 2022;128:E340&#x2013;E341.</Citation><ArticleIdList><ArticleId IdType="pubmed">35331545</ArticleId></ArticleIdList></Reference><Reference><Citation>Sear JW. Kidney dysfunction in the postoperative period. Br J Anaesth 2005;95:20&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">15531622</ArticleId></ArticleIdList></Reference><Reference><Citation>Abelha FJ, Botelho M, Fernandes V, et al. . Determinants of postoperative acute kidney injury. Crit Care 2009;13:R79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2717442</ArticleId><ArticleId IdType="pubmed">19463152</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Liu YL, Licari E, et al. . Oliguria as predictive biomarker of acute kidney injury in critically ill patients. Crit Care 2011;15:R172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3387614</ArticleId><ArticleId IdType="pubmed">21771324</ArticleId></ArticleIdList></Reference><Reference><Citation>Small RG, Witt RE. Major and minor surgery. JAMA 1965;191:180&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pubmed">14233251</ArticleId></ArticleIdList></Reference><Reference><Citation>Macedo E, Malhotra R, Bouchard J, et al. . Oliguria is an early predictor of higher mortality in critically ill patients. Kidney Int 2011;80:760&#x2013;767.</Citation><ArticleIdList><ArticleId IdType="pubmed">21716258</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccinni P, Cruz DN, Gramaticopolo S, et al. . Prospective multicenter study on epidemiology of acute kidney injury in the ICU: a critical care nephrology Italian collaborative effort (NEFROINT). Minerva Anestesiol 2011;77:1072&#x2013;1083.</Citation><ArticleIdList><ArticleId IdType="pubmed">21597441</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostermann M, Liu K. Pathophysiology of AKI. Best Pract Res Clin Anaesthesiol 2017;31:305&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pubmed">29248138</ArticleId></ArticleIdList></Reference><Reference><Citation>Grams ME, Sang Y, Coresh J, et al. . Acute kidney injury after major surgery: a retrospective analysis of veterans health administration data. Am J Kidney Dis 2016;67:872&#x2013;880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4775458</ArticleId><ArticleId IdType="pubmed">26337133</ArticleId></ArticleIdList></Reference><Reference><Citation>du Toit L, Biccard BM. The relationship between intraoperative oliguria and acute kidney injury. Br J Anaesth 2019;122:707&#x2013;710.</Citation><ArticleIdList><ArticleId IdType="pubmed">30961912</ArticleId></ArticleIdList></Reference><Reference><Citation>Egal M, de Geus HR, van Bommel J, et al. . Targeting oliguria reversal in perioperative restrictive fluid management does not influence the occurrence of renal dysfunction: a systematic review and meta-analysis. Eur J Anaesthesiol 2016;33:425&#x2013;435.</Citation><ArticleIdList><ArticleId IdType="pubmed">26840829</ArticleId></ArticleIdList></Reference><Reference><Citation>Egal M, Erler NS, de Geus HR, et al. . Targeting oliguria reversal in goal-directed hemodynamic management does not reduce renal dysfunction in perioperative and critically ill patients: a systematic review and meta-analysis. Anesth Analg 2016;122:173&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">26505575</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho KM, Sheridan DJ. Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ 2006;333:420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1553510</ArticleId><ArticleId IdType="pubmed">16861256</ArticleId></ArticleIdList></Reference><Reference><Citation>Matot I, Paskaleva R, Eid L, et al. . Effect of the volume of fluids administered on intraoperative oliguria in laparoscopic bariatric surgery: a randomized controlled trial. Arch Surg 2012;147:228&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pubmed">22106246</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SJ, Lehner GF, Forni LG, et al. . Oliguria in critically ill patients: a narrative review. J Nephrol 2018;31:855&#x2013;862.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6244549</ArticleId><ArticleId IdType="pubmed">30298272</ArticleId></ArticleIdList></Reference><Reference><Citation>Kambhampati G, Ross EA, Alsabbagh MM, et al. . Perioperative fluid balance and acute kidney injury. Clin Exp Nephrol 2012;16:730&#x2013;738.</Citation><ArticleIdList><ArticleId IdType="pubmed">22457087</ArticleId></ArticleIdList></Reference><Reference><Citation>Nisanevich V, Felsenstein I, Almogy G, et al. . Effect of intraoperative fluid management on outcome after intraabdominal surgery. Anesthesiology 2005;103:25&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">15983453</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira C, Garzotto F, Piccinni P, et al. . Fluid balance and urine volume are independent predictors of mortality in acute kidney injury. Crit Care 2013;17:R14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057508</ArticleId><ArticleId IdType="pubmed">23347825</ArticleId></ArticleIdList></Reference><Reference><Citation>Schortgen F, Schetz M. Does this critically ill patient with oliguria need more fluids, a vasopressor, or neither? Intensive Care Med 2017;43:907&#x2013;910.</Citation><ArticleIdList><ArticleId IdType="pubmed">28293703</ArticleId></ArticleIdList></Reference><Reference><Citation>Perner A, Prowle J, Joannidis M, et al. . Fluid management in acute kidney injury. Intensive Care Med 2017;43:807&#x2013;815.</Citation><ArticleIdList><ArticleId IdType="pubmed">28470347</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Yang R, Xu J, et al. . Effects of intraoperative fluid management on postoperative outcomes after lobectomy. Ann Thorac Surg 2019;107:1663&#x2013;1669.</Citation><ArticleIdList><ArticleId IdType="pubmed">30641068</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25167086</PMID><DateCompleted><Year>2015</Year><Month>01</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-0293</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>12</Issue><PubDate><Year>2014</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Critical care medicine</Title><ISOAbbreviation>Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Transfusion triggers for guiding RBC transfusion for cardiovascular surgery: a systematic review and meta-analysis*.</ArticleTitle><Pagination><StartPage>2611</StartPage><EndPage>2624</EndPage><MedlinePgn>2611-24</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CCM.0000000000000548</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Restrictive red cell transfusion is recommended to minimize risk associated with exposure to allogeneic blood. However, perioperative anemia is an independent risk factor for adverse outcomes after cardiovascular surgery. The purpose of this systematic review and meta-analysis is to determine whether perioperative restrictive transfusion thresholds are associated with inferior clinical outcomes in randomized trials of cardiovascular surgery patients.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">The Cochrane Central Register of Controlled Trials, MEDLINE, and EMBASE from inception to October 2013; reference lists of published guidelines, reviews, and associated articles, as well as conference proceedings. No language restrictions were applied.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="METHODS">We included controlled trials in which adult patients undergoing cardiac or vascular surgery were randomized to different transfusion thresholds, described as a hemoglobin or hematocrit level below which RBCs were transfused.</AbstractText><AbstractText Label="DATA EXTRACTION" NlmCategory="METHODS">Two authors independently extracted data from included trials. We pooled risk ratios of dichotomous outcomes and mean differences of continuous outcomes across trials using random-effects models.</AbstractText><AbstractText Label="DATA SYNTHESIS" NlmCategory="RESULTS">Seven studies (enrolling 1,262 participants) met inclusion criteria with restrictive and liberal transfusion thresholds most commonly differing by a hemoglobin of 1 g/dL or hematocrit of 6-7%, resulting in decreased transfusions by 0.71 units of RBCs (95% CI, 0.31-1.09, p = 0.0002) without an associated change in adverse events: mortality (risk ratio, 1.12; 95% CI, 0.65-1.95; p = 0.60), myocardial infarction (risk ratio, 0.94; 95% CI, 0.30-2.99; p = 0.92), stroke (risk ratio, 1.15; 95% CI, 0.57-2.32; p = 0.70), acute renal failure (risk ratio, 0.98; 95% CI, 0.64-1.49; p = 0.91), infections (risk ratio, 1.23; 95% CI, 0.85-1.78; p = 0.27), or length of stay. There was no between-trial heterogeneity for any pooled analysis. Including four pediatric trials (456 participants) and 10 trials utilizing only intraoperative acute normovolemic hemodilution (872 participants) did not substantially change the results except that unlike the transfusion threshold trials, the hemodilution trials did not reduce the proportion of patients transfused (interaction p = 0.01).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Further randomized controlled trials are necessary to determine the optimal transfusion strategy for patients undergoing cardiovascular surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Curley</LastName><ForeName>Gerard F</ForeName><Initials>GF</Initials><AffiliationInfo><Affiliation>1Departments of Anesthesia and Critical Care, Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. 2Departments of Medicine and Laboratory Medicine and Pathobiology (Mount Sinai Hospital), Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. 3Department of Anesthesia, Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. 4Departments of Critical Care and Medicine, Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shehata</LastName><ForeName>Nadine</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Mazer</LastName><ForeName>C David</ForeName><Initials>CD</Initials></Author><Author ValidYN="Y"><LastName>Hare</LastName><ForeName>Gregory M T</ForeName><Initials>GM</Initials></Author><Author ValidYN="Y"><LastName>Friedrich</LastName><ForeName>Jan O</ForeName><Initials>JO</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Canadian Institutes of Health Research</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Med</MedlineTA><NlmUniqueID>0355501</NlmUniqueID><ISSNLinking>0090-3493</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care Med. 2014 Dec;42(12):2647-8. doi: 10.1097/CCM.0000000000000588.</RefSource><PMID Version="1">25402293</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D013504" MajorTopicYN="N">Cardiovascular Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017707" MajorTopicYN="N">Erythrocyte Transfusion</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006400" MajorTopicYN="N">Hematocrit</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006438" MajorTopicYN="N">Hemodilution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006454" MajorTopicYN="N">Hemoglobins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25167086</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000000548</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24954246</PMID><DateCompleted><Year>2015</Year><Month>03</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1523-6838</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><Issue>4</Issue><PubDate><Year>2014</Year><Month>Oct</Month></PubDate></JournalIssue><Title>American journal of kidney diseases : the official journal of the National Kidney Foundation</Title><ISOAbbreviation>Am J Kidney Dis</ISOAbbreviation></Journal><ArticleTitle>Remote ischemic preconditioning for prevention of acute kidney injury: a meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>574</StartPage><EndPage>583</EndPage><MedlinePgn>574-83</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.ajkd.2014.04.029</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0272-6386(14)00877-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Remote ischemic preconditioning (RIPC) to prevent acute kidney injury (AKI) following cardiac and vascular interventions is a controversial practice.</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">We conducted a systematic review and meta-analysis using the MEDLINE database (1966 through November 2013), EMBASE (1988 through November 2013), and Cochrane Library database.</AbstractText><AbstractText Label="SETTING &amp; POPULATION" NlmCategory="METHODS">Patients undergoing cardiac and vascular interventions.</AbstractText><AbstractText Label="SELECTION CRITERIA FOR STUDIES" NlmCategory="METHODS">Randomized controlled trials comparing patient outcome with or without RIPC for prevention of AKI following cardiac and vascular interventions.</AbstractText><AbstractText Label="INTERVENTION" NlmCategory="METHODS">RIPC using an inflatable tourniquet around the limb or cross-clamping the iliac arteries versus non-RIPC.</AbstractText><AbstractText Label="OUTCOMES" NlmCategory="RESULTS">AKI, need for renal replacement therapy, postoperative kidney biomarkers, in-hospital mortality, and length of intensive care unit and hospital stay.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">13 trials (1,334 participants) were included. RIPC decreased the risk of AKI for patients undergoing cardiac and vascular interventions compared with the control group (11 trials; 1,216 participants; risk ratio [RR], 0.70; 95% CI, 0.48-1.02; P = 0.06; I(2) = 45%) with marginal statistical significance. There were no differences in levels of postoperative kidney biomarkers (serum creatinine and glomerular filtration rate), incidence of renal replacement therapy, in-hospital mortality, hospital stay, or intensive care unit stay between the 2 groups. Metaregression analysis indicated that contrast intervention was not a covariate contributing significantly to heterogeneity on the risk estimate for AKI incidence; also, there was no dose effect of RIPC using tourniquet cuff around the limb on AKI prevention based on different ischemia duration.</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Different AKI definitions adopted in the trials included.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">RIPC might be beneficial for the prevention of AKI following cardiac and vascular interventions, but the current evidence is not robust enough to make a recommendation. Adequately powered trials are needed to provide more evidence in the future.</AbstractText><CopyrightInformation>Copyright &#xa9; 2014 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Kidney Disease Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lang</LastName><ForeName>Xia-Bing</ForeName><Initials>XB</Initials><AffiliationInfo><Affiliation>Kidney Disease Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ping</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Kidney Disease Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Rong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Kidney Disease Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yong-Fei</ForeName><Initials>YF</Initials><AffiliationInfo><Affiliation>Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, Li Ka Shing Faculty of Medicine, and Centre for Genomic Sciences, the University of Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jiang-Hua</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Kidney Disease Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China. Electronic address: chenjianghua@zju.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>06</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Kidney Dis</MedlineTA><NlmUniqueID>8110075</NlmUniqueID><ISSNLinking>0272-6386</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013504" MajorTopicYN="N">Cardiovascular Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019194" MajorTopicYN="N">Ischemic Preconditioning</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="N">blood supply</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007677" MajorTopicYN="N">Kidney Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Remote ischemic preconditioning (RIPC)</Keyword><Keyword MajorTopicYN="N">acute kidney injury (AKI)</Keyword><Keyword MajorTopicYN="N">acute renal failure</Keyword><Keyword MajorTopicYN="N">cardiac and vascular interventions</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">renal impairment</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24954246</ArticleId><ArticleId IdType="doi">10.1053/j.ajkd.2014.04.029</ArticleId><ArticleId IdType="pii">S0272-6386(14)00877-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33993820</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2154-8331</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Hospital practice (1995)</Title><ISOAbbreviation>Hosp Pract (1995)</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury and cardiac arrest in the modern era: an updated systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>280</StartPage><EndPage>291</EndPage><MedlinePgn>280-291</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21548331.2021.1931234</ELocationID><Abstract><AbstractText><b>Objective</b>: Acute kidney injury (AKI) is associated with higher morbidity and mortality in cardiac arrest (CA). There are limited contemporary data on the incidence and outcomes of AKI in CA.<b>Methods</b>: We comprehensively searched the databases of MEDLINE, EMBASE, PUBMED, and the Cochrane from inception to November 2020. Observational studies that reported the incidence of AKI in CA survivors were included. Data from each study were combined using the random effects to calculate pooled incidence and risk ratios with 95% confidence intervals (CIs). The primary outcome was short-term mortality and secondary outcomes included long-term mortality, incidence of AKI, and use of renal replacement therapy (RRT). Subgroup and meta-regression analyses were performed to explore heterogeneity.<b>Main results</b>: A total of 25 observational studies comprising 8,165 patients were included. The incidence of AKI in CA survivors was 40.3% (range 32.9-47.8%). In stage 3 AKI, one-fourth of patients required RRT. AKI was associated with an increased risk of both short-term (OR 2.27 [95% CI 1.74-2.96]; <i>p</i> &lt;&#xa0;0.001) and long-term mortality (OR 1.51 [95% CI 1.93-3.25]; <i>p</i> &lt;&#xa0;0.001). Meta-regression and subgroup analyses did not suggest any effect of hypothermia on incidence of AKI.<b>Conclusion</b>: AKI complicates the care of 40% of CA survivors and is associated with significantly increased short- and long-term mortality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prasitlumkum</LastName><ForeName>Narut</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-7956-0574</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, University of California Riverside, Riverside, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheungpasitporn</LastName><ForeName>Wisit</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0001-9954-9711</Identifier><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sato</LastName><ForeName>Ryota</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Critical Care Unit, Cleveland Clinic, Cleveland, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chokesuwattanaskul</LastName><ForeName>Ronpichai</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thongprayoon</LastName><ForeName>Charat</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-8313-3604</Identifier><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patlolla</LastName><ForeName>Sri Harsha</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Mayo Clinic, Rochester, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bathini</LastName><ForeName>Tarun</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3775-8689</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Arizona, Tucson, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0003-1814-7003</Identifier><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Jacksonville, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rab</LastName><ForeName>S Tanveer</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Section of Interventional Cardiology, Division of Cardiovascular Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kashani</LastName><ForeName>Kianoush</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care, Department of Medicine, Mayo Clinic, Rochester, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vallabhajosyula</LastName><ForeName>Saraschandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Section of Interventional Cardiology, Division of Cardiovascular Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hosp Pract (1995)</MedlineTA><NlmUniqueID>101268948</NlmUniqueID><ISSNLinking>2154-8331</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006323" MajorTopicYN="N">Heart Arrest</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Acute renal failure</Keyword><Keyword MajorTopicYN="N">Cardiac arrest</Keyword><Keyword MajorTopicYN="N">Cardiopulmonary arrest</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>17</Day><Hour>5</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33993820</ArticleId><ArticleId IdType="doi">10.1080/21548331.2021.1931234</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36635145</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>The Prognostic Significance of Red Cell Distribution Width in Cardiac Surgery: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>471</StartPage><EndPage>479</EndPage><MedlinePgn>471-479</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2022.11.015</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(22)00818-7</ELocationID><Abstract><AbstractText>RED CELL DISTRIBUTION WIDTH (RDW) is a routinely available biomarker of likely erythropoietic dysfunction, which may be associated with adverse outcomes after cardiac surgery. This systematic review and meta-analysis aimed to clarify the prognostic value of RDW in patients undergoing cardiac surgery.&#xa0;The authors searched MEDLINE, Embase, and the Cochrane Library from inception to May 10, 2022 for studies investigating the association between elevated RDW (as defined by the authors of included studies) and adverse outcomes after cardiac surgery. Herein, the authors extracted maximally adjusted hazard ratios (HRs) and odds ratios (ORs) with associated CIs, and pooled them using random-effects inverse- variance modeling. The authors explored interstudy heterogeneity using metaregression. The authors included 26 studies involving 48,092 patients who had undergone cardiac surgery. Elevated preoperative RDW was associated with long-term mortality (pooled HR 1.63, 95% CI 1.05-2.52), short-term mortality (pooled OR 2.16, 95% CI 1.21-3.87), acute kidney injury (AKI; pooled OR 1.30, 95% CI 1.19-1.41) and postoperative atrial fibrillation (POAF; pooled OR 1.44, 95% CI 1.05-1.96). Some studies suggested a significant association between preoperative RDW elevation and neurologic complications; however, their number was insufficient for meta-analysis. The postoperative RDW levels were less consistently reported and could not be meta-analyzed. In conclusion, the authors found that elevated preoperative RDW was associated with increased short- and long-term mortality, POAF, and AKI after cardiac surgery. Further research is needed to investigate its role in the risk stratification of patients undergoing cardiac surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Frentiu</LastName><ForeName>Angela A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Surgery (School of Clinical Sciences at Monash Health), Monash University, Clayton, Australia. Electronic address: angela.frentiu@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Melbourne Medical School, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caruana</LastName><ForeName>Carla Borg</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, 145 Studley Road, Heidelberg, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raveendran</LastName><ForeName>Dev</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Melbourne Medical School, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perry</LastName><ForeName>Luke A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Melbourne Medical School, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Australia; Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Parkville, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penny-Dimri</LastName><ForeName>Jahan C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Surgery (School of Clinical Sciences at Monash Health), Monash University, Clayton, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramson</LastName><ForeName>Dhruvesh M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Surgery (School of Clinical Sciences at Monash Health), Monash University, Clayton, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Segal</LastName><ForeName>Reny</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Melbourne Medical School, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Australia; Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Parkville, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Melbourne Medical School, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Australia; Department of Intensive Care, Austin Hospital, 145 Studley Road, Heidelberg, Victoria, Australia; Department of Intensive Care, Austin Hospital, Heidelberg, Australia; Australian and New Zealand Intensive Care Research Centre, Melbourne, Australia; Monash University School and Public Health and Preventive Medicine, Monash University, Clayton, Australia; Data Analytics Research and Evaluation (DARE) Centre, Austin Hospital, Heidelberg, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Julian A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Surgery (School of Clinical Sciences at Monash Health), Monash University, Clayton, Australia; Department of Cardiothoracic Surgery, Monash Health, Clayton, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhengyang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Melbourne Medical School, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Australia; Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Parkville, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004909" MajorTopicYN="N">Erythrocyte Indices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Red cell distribution width (RDW)</Keyword><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">post-operative atrial fibrillation</Keyword><Keyword MajorTopicYN="N">prognosis</Keyword></KeywordList><CoiStatement>Conflict of Interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>12</Day><Hour>22</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36635145</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2022.11.015</ArticleId><ArticleId IdType="pii">S1053-0770(22)00818-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38580478</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Outcomes of Vasopressin-Receptor Agonists Versus Norepinephrine in Adults With Perioperative Hypotension: A Systematic Review.</ArticleTitle><Pagination><StartPage>1577</StartPage><EndPage>1586</EndPage><MedlinePgn>1577-1586</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2024.03.014</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(24)00178-2</ELocationID><Abstract><AbstractText>Consensus statements recommend the use of norepinephrine and/or vasopressin for hypotension in cardiac surgery. However, there is a paucity of data among other surgical subgroups and vasopressin analogs. Therefore, the authors conducted a systematic review of randomized controlled trials (RCTs) to compare vasopressin-receptor agonists with norepinephrine for hypotension among those undergoing surgery with general anesthesia. This review was registered prospectively (CRD42022316328). Literature searches were conducted by a medical librarian to November 28, 2023, across MEDLINE, EMBASE, CENTRAL, and Web of Science. The authors included RCTs enrolling adults (&#x2265;18 years of age) undergoing any surgery under general anesthesia who developed perioperative hypotension and comparing vasopressin receptor agonists with norepinephrine. The risk of bias was assessed by the Cochrane risk of bias tool for randomized trials (RoB-2). Thirteen (N = 719) RCTs were included, of which 8 (n = 585) enrolled patients undergoing cardiac surgery. Five trials compared norepinephrine with vasopressin, 4 trials with terlipressin, 1 trial with ornipressin, and the other 3 trials used vasopressin as adjuvant therapy. There was no significant difference in all-cause mortality. Among patients with vasoplegic shock after cardiac surgery, vasopressin was associated with significantly lower intensive care unit (N = 385; 2 trials; mean 100.8 v 175.2 hours, p &lt; 0.005; median 120 [IQR 96-168] v 144 [96-216] hours, p = 0.007) and hospital lengths of stay, as well as fewer cases of acute kidney injury and atrial fibrillation compared with norepinephrine. One trial also found that terlipressin was associated with a significantly lower incidence of acute kidney injury versus norepinephrine overall. Vasopressin and norepinephrine restored mean arterial blood pressure with no significant differences; however, the use of vasopressin with norepinephrine was associated with significantly higher mean arterial blood pressure versus norepinephrine alone. Further high-quality trials are needed to determine pooled treatment effects, especially among noncardiac surgical patients and those treated with vasopressin analogs.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Heybati</LastName><ForeName>Kiyan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Guozhen</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellythy</LastName><ForeName>Luqman</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poudel</LastName><ForeName>Keshav</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Jiawen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Fangwen</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chelf</LastName><ForeName>Cynthia J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Mayo Clinic Libraries, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ripoll</LastName><ForeName>Juan G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramakrishna</LastName><ForeName>Harish</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN. Electronic address: ramakrishna.harish@mayo.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber><NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>11000-17-2</RegistryNumber><NameOfSubstance UI="D014667">Vasopressins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017483">Receptors, Vasopressin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009638" MajorTopicYN="Y">Norepinephrine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="Y">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014667" MajorTopicYN="N">Vasopressins</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017483" MajorTopicYN="N">Receptors, Vasopressin</DescriptorName><QualifierName UI="Q000819" MajorTopicYN="N">agonists</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">hypotension</Keyword><Keyword MajorTopicYN="N">norepinephrine</Keyword><Keyword MajorTopicYN="N">outcomes</Keyword><Keyword MajorTopicYN="N">perioperative</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword><Keyword MajorTopicYN="N">vasopressin</Keyword></KeywordList><CoiStatement>Declaration of competing interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>14</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>6</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>5</Day><Hour>22</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38580478</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2024.03.014</ArticleId><ArticleId IdType="pii">S1053-0770(24)00178-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36167391</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Multicentre evaluation of renal impairment in thoracic surgery (MERITS): a retrospective cohort study.</ArticleTitle><Pagination><StartPage>e058542</StartPage><MedlinePgn>e058542</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e058542</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2021-058542</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To measure the unit-level variation in Acute Kidney Injury (AKI) incidence post-thoracic surgery over a contemporary 1-year period. Secondary aims include examining the associations with sex, age group, operation type, length of stay and mortality.</AbstractText><AbstractText Label="DESIGN">A multicentre, observational, retrospective study in thoracic surgery.</AbstractText><AbstractText Label="SETTING">17 of 35 Society for Cardiothoracic Surgery of Great Britain and Ireland (SCTS) units participated. The student wing, known as SCTS STUDENTS, supported data collection.</AbstractText><AbstractText Label="PARTICIPANTS">Overall, 15&#x2009;229 patients were collected of which 15&#x2009;154 were included for analysis after exclusions. All patients (age&#x2265;18 years) undergoing any thoracic surgery from 1 April 2016 to 31 March 2017 were included. For analysis, we excluded patients with preoperative end-stage renal failure and those with incomplete data.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">The primary outcome is the incidence of AKI within 7&#x2009;days of the procedure or discharge date if earlier. Secondary outcomes include assessing associations with patient demographics (age, sex), type of procedure (open and minimally invasive), length of stay and mortality.</AbstractText><AbstractText Label="RESULTS">Out of 15&#x2009;154 patients AKI was diagnosed in 1090 patients (7.2%) within 7&#x2009;days of surgery with AKI stage 1 (4.8%), stage 2 (1.7%) and stage 3 (0.7%). There was a statistically significant variation in AKI incidence between units from 3.1 to 16.1% (p&lt;0.05). Significant differences between AKI and non-AKI were found in post-operative length of stay (7 vs 3&#x2009;days, p&lt;0.001), 30-day mortality (9 vs 1.6%, p&lt;0.001), 90-day mortality (14.7&#x2009;vs 4.4%, p&lt;0.001) and 1-year mortality (23.1 vs 12.2 %, p&lt;0.001).</AbstractText><AbstractText Label="CONCLUSIONS">Following thoracic surgery, AKI incidence ranged from 3.1% to 16.1% between units (p&lt;0.05) with associations between AKI and both length of stay and mortality. We propose AKI as a suitable comparative and absolute quality measure in thoracic surgery. Reducing rates of AKI may improve patient outcomes, length of stay and reduce costs.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Naruka</LastName><ForeName>Vinci</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-9222-2684</Identifier><AffiliationInfo><Affiliation>Thoracic Surgery, Royal Papworth Hospital, Cambridge University Health Partners, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKie</LastName><ForeName>Mikel Alexander</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0002-1711-4034</Identifier><AffiliationInfo><Affiliation>Papworth Trials Unit Collaboration (PTUC), Papworth Hospital NHS Foundation Trust, Cambridge, UK and Medical Research Council Biostatistics Unit, Cambridge, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Research Council Biostatistics Unit, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmadi</LastName><ForeName>Navid</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-0425-2606</Identifier><AffiliationInfo><Affiliation>Thoracic Surgery, Royal Papworth Hospital, Cambridge University Health Partners, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pama</LastName><ForeName>E A Claudia</ForeName><Initials>EAC</Initials><Identifier Source="ORCID">0000-0002-0260-5615</Identifier><AffiliationInfo><Affiliation>Thoracic Surgery, Royal Papworth Hospital, Cambridge University Health Partners, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coonar</LastName><ForeName>Aman S</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0001-7858-3283</Identifier><AffiliationInfo><Affiliation>Thoracic Surgery, Royal Papworth Hospital, Cambridge University Health Partners, Cambridge, UK aman.coonar@nhs.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collaborators</LastName><ForeName>Merits</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>MERITS Collaborators, Cambridge, GB &amp; Ireland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013903" MajorTopicYN="Y">Thoracic Surgery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019616" MajorTopicYN="Y">Thoracic Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AUDIT</Keyword><Keyword MajorTopicYN="N">Acute renal failure</Keyword><Keyword MajorTopicYN="N">Thoracic surgery</Keyword></KeywordList><CoiStatement>Competing interests: None</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>27</Day><Hour>20</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36167391</ArticleId><ArticleId IdType="pmc">PMC9516206</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2021-058542</ArticleId><ArticleId IdType="pii">bmjopen-2021-058542</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>LCCOP . Report | Society for cardiothoracic surgery, 2019. Available: https://scts.org/lccop-2019-report/ [Accessed 11 Mar 2021].</Citation></Reference><Reference><Citation>West D. Personal communication. SCTS Thoracic Surgery Audit Lead. 2021.</Citation></Reference><Reference><Citation>Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl
2012;2:1&#x2013;138
http://www.kisupplements.org/article/S2157-1716(15)31044-3/fulltext</Citation></Reference><Reference><Citation>Ishikawa S, Griesdale DEG, Lohser J. Acute kidney injury after lung resection surgery: incidence and perioperative risk factors. Anesth Analg 2012;114:1256&#x2013;62. 10.1213/ANE.0b013e31824e2d20</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e31824e2d20</ArticleId><ArticleId IdType="pubmed">22451594</ArticleId></ArticleIdList></Reference><Reference><Citation>Licker M, Cartier V, Robert J, et al. . Risk factors of acute kidney injury according to RIFLE criteria after lung cancer surgery. Ann Thorac Surg 2011;91:844&#x2013;50. 10.1016/j.athoracsur.2010.10.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2010.10.037</ArticleId><ArticleId IdType="pubmed">21353011</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardinale D, Cosentino N, Moltrasio M, et al. . Acute kidney injury after lung cancer surgery: incidence and clinical relevance, predictors, and role of N-terminal pro B-type natriuretic peptide. Lung Cancer 2018;123:155&#x2013;9. 10.1016/j.lungcan.2018.07.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lungcan.2018.07.009</ArticleId><ArticleId IdType="pubmed">30089588</ArticleId></ArticleIdList></Reference><Reference><Citation>Loef BG, Epema AH, Smilde TD, et al. . Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol 2005;16:195&#x2013;200. 10.1681/ASN.2003100875</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2003100875</ArticleId><ArticleId IdType="pubmed">15563558</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Delgado JC, Esteve F, Torrado H, et al. . Influence of acute kidney injury on short- and long-term outcomes in patients undergoing cardiac surgery: risk factors and prognostic value of a modified RIFLE classification. Crit Care 2013;17:R293. 10.1186/cc13159</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13159</ArticleId><ArticleId IdType="pmc">PMC4056889</ArticleId><ArticleId IdType="pubmed">24330769</ArticleId></ArticleIdList></Reference><Reference><Citation>Vives M, Wijeysundera D, Marczin N, et al. . Cardiac surgery-associated acute kidney injury. Interact Cardiovasc Thorac Surg 2014;18:637&#x2013;45. 10.1093/icvts/ivu014</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivu014</ArticleId><ArticleId IdType="pubmed">24535092</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute Kidney Injury and Prognosis After Cardiopulmonary Bypass: A Meta-analysis of Cohort Studies - American Journal of Kidney Diseases. Available: https://www.ajkd.org/article/S0272-6386(14)01252-9/fulltext [Accessed 25 Jun 2019].</Citation><ArticleIdList><ArticleId IdType="pubmed">25445101</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell S, Davey P, Nathwani D, et al. . Risk of AKI with gentamicin as surgical prophylaxis. J Am Soc Nephrol 2014;25:2625&#x2013;32. 10.1681/ASN.2014010035</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2014010035</ArticleId><ArticleId IdType="pmc">PMC4214537</ArticleId><ArticleId IdType="pubmed">24876113</ArticleId></ArticleIdList></Reference><Reference><Citation>Naruka V, Mckie MA, Khushiwal R, et al. . Acute kidney injury after thoracic surgery: a proposal for a multicentre evaluation (MERITS). Interact Cardiovasc Thorac Surg 2019;29:861&#x2013;6. 10.1093/icvts/ivz184</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivz184</ArticleId><ArticleId IdType="pubmed">31393555</ArticleId></ArticleIdList></Reference><Reference><Citation>Algorithm for detecting acute repeat kidney injury (AKI) based on serum creatinine changes with time this algorithm relates to the NHS England patient safety alert: NHS/PSA/D/2014/010. Available: zotero://attachment/611/ [Accessed 25 Jun 2019].</Citation></Reference><Reference><Citation>MERITS Step by step video for data collection - YouTube.. Available: https://www.youtube.com/watch?v=a_PVuXU3bP8&amp;feature=youtu.be [Accessed 25 Jun 2019].</Citation></Reference><Reference><Citation>World Health Organization . Integrated care for older people: guidelines on community-level interventions to manage declines in intrinsic capacity. Geneva: World Health organization, 2017. https://www.who.int/publications/i/item/9789241550109</Citation><ArticleIdList><ArticleId IdType="pubmed">29608259</ArticleId></ArticleIdList></Reference><Reference><Citation>Oldest old | Encyclopedia.com. Available: https://www.encyclopedia.com/social-sciences/encyclopedias-almanacs-transcripts-and-maps/oldest-old [Accessed 11 May 2022].</Citation></Reference><Reference><Citation>Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996;275:1489&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">8622223</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Connor ME, Hewson RW, Kirwan CJ, et al. . Acute kidney injury and mortality 1 year after major non-cardiac surgery. Br J Surg 2017;104:868&#x2013;76. 10.1002/bjs.10498</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.10498</ArticleId><ArticleId IdType="pubmed">28218392</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 2012;81:442&#x2013;8. 10.1038/ki.2011.379</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2011.379</ArticleId><ArticleId IdType="pmc">PMC3788581</ArticleId><ArticleId IdType="pubmed">22113526</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyle JF, Forni LG. Acute kidney injury: short-term and long-term effects. Critical Care 2016;20:188. 10.1186/s13054-016-1353-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1353-y</ArticleId><ArticleId IdType="pmc">PMC4931701</ArticleId><ArticleId IdType="pubmed">27373891</ArticleId></ArticleIdList></Reference><Reference><Citation>Batchelor TJP, Rasburn NJ, Abdelnour-Berchtold E, et al. . Guidelines for enhanced recovery after lung surgery: recommendations of the enhanced recovery after surgery (ERAS&#xae;) Society and the European Society of thoracic surgeons (ESTs). European Journal of Cardio-Thoracic Surgery 2019;55:91&#x2013;115. 10.1093/ejcts/ezy301</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezy301</ArticleId><ArticleId IdType="pubmed">30304509</ArticleId></ArticleIdList></Reference><Reference><Citation>Getting It Right First Time - GIRFT. Get. It Right First Time - GIRFT. Available: http://www.gettingitrightfirsttime.co.uk/ [Accessed 11 Mar 2021].</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32299694</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-685X</ISSN><JournalIssue CitedMedium="Internet"><Volume>162</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The Journal of thoracic and cardiovascular surgery</Title><ISOAbbreviation>J Thorac Cardiovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Costs and consequences of acute kidney injury after cardiac surgery: A cohort study.</ArticleTitle><Pagination><StartPage>880</StartPage><EndPage>887</EndPage><MedlinePgn>880-887</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jtcvs.2020.01.101</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-5223(20)30516-X</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Acute kidney injury (AKI) is common after cardiac surgery. We quantified the mortality and costs of varying degrees of AKI using a population-based cohort in Alberta, Canada.</AbstractText><AbstractText Label="METHODS">A cohort of patients undergoing cardiac surgery from 2004 to 2009 was assembled from linked Alberta administrative databases. AKI was classified by Kidney Disease Improving Global Outcomes stages of severity. Our outcomes were in-hospital mortality, length of stay, and costs; among survivors, we also examined mortality and costs at 365&#xa0;days. Estimates were adjusted for demographic characteristics, comorbidities, and other covariates.</AbstractText><AbstractText Label="RESULTS">Ten thousand one hundred seventy participants were included, of whom 9771 patients were discharged to community. Overall in-hospital mortality, costs, and length of stay were 4%, 7&#xa0;days, and Can $34,000, respectively. Postcardiac surgery, AKI occurred in 25%. Compared with those without AKI, AKI was independently associated with increased in-hospital mortality across severity categories, with the highest risk (adjusted odds ratio, 37.1; 95% confidence interval, 26.3-52.1; P&#xa0;&lt;&#xa0;.001) in patients who required acute dialysis. AKI severity was associated with increased hospital days and costs, with costs ranging from 1.21 for stage 1 AKI (95% confidence interval, 1.17-1.23) to 2.74 for acute dialysis (95% confidence interval, 2.49-3.00) (P&#xa0;&lt;&#xa0;.001) times higher than in patients without AKI, after covariate adjustment. Postdischarge to 365&#xa0;days, patients with AKI continued to experience increased costs up to 1.35-fold, and patients who required dialysis acutely continued to experience a 2.86-fold increased mortality.</AbstractText><AbstractText Label="CONCLUSIONS">AKI remains an important indicator of mortality and health care costs postcardiac surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lau</LastName><ForeName>Darren</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pannu</LastName><ForeName>Neesh</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>James</LastName><ForeName>Matthew T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hemmelgarn</LastName><ForeName>Brenda R</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kieser</LastName><ForeName>Teresa M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Department of Cardiac Sciences, Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer</LastName><ForeName>Steven R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klarenbach</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. Electronic address: swk@ualberta.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Thorac Cardiovasc Surg</MedlineTA><NlmUniqueID>0376343</NlmUniqueID><ISSNLinking>0022-5223</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Thorac Cardiovasc Surg. 2021 Sep;162(3):888-889. doi: 10.1016/j.jtcvs.2020.02.043.</RefSource><PMID Version="1">32164947</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Thorac Cardiovasc Surg. 2021 Sep;162(3):889-891. doi: 10.1016/j.jtcvs.2020.02.081.</RefSource><PMID Version="1">32336513</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Thorac Cardiovasc Surg. 2021 Sep;162(3):891-892. doi: 10.1016/j.jtcvs.2020.05.070.</RefSource><PMID Version="1">32682588</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000416" MajorTopicYN="N" Type="Geographic">Alberta</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017721" MajorTopicYN="Y">Hospital Costs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">perioperative care</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32299694</ArticleId><ArticleId IdType="doi">10.1016/j.jtcvs.2020.01.101</ArticleId><ArticleId IdType="pii">S0022-5223(20)30516-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26351826</PMID><DateCompleted><Year>2016</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1365-2346</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Jan</Month></PubDate></JournalIssue><Title>European journal of anaesthesiology</Title><ISOAbbreviation>Eur J Anaesthesiol</ISOAbbreviation></Journal><ArticleTitle>Comparison of hydroxyethyl starch colloids with crystalloids for surgical patients: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>42</StartPage><EndPage>48</EndPage><MedlinePgn>42-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/EJA.0000000000000328</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Fluid therapy is one of the most ubiquitous medical therapeutic interventions. There is a debate over whether colloids or crystalloids are better for fluid resuscitation. Recent large trials and meta-analyses suggest no mortality benefit and possible harm with hydroxyethyl starch (HES) use. However, these trials were conducted in critically ill and septic patients and their applicability to perioperative patients has been challenged.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We aimed to evaluate the impact of HES use in scheduled and elective surgical patients.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Systematic review and meta-analysis of randomised controlled trials (RCTs).</AbstractText><AbstractText Label="ELIGIBILITY CRITERIA" NlmCategory="METHODS">Only RCTs comparing the use of the synthetic colloid HES with any crystalloid in adults undergoing noncardiac surgery (up to 24&#x200a;h postop) were considered eligible. For each eligible trial, we extracted the outcomes of all-cause mortality within 90 days, length of hospital stay, major infectious complications, acute kidney injury (AKI) and renal replacement therapy (RRT).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 1555 citations, selected 90 for full-text evaluation, and identified 13 eligible RCTs. Trials were small (n&#x200a;=&#x200a;20 to 202) with low event rates. There was a trend to increased mortality with HES within 90 days [13/373 vs. 3/368; risk ratio 2.97; 95% confidence interval (95% CI) 0.96 to 9.19; I&#x200a;=&#x200a;0%], no difference in AKI and RRT (risk ratio 1.11; 95% CI 0.26 to 4.69; I&#x200a;=&#x200a;34%), and no difference in major infectious complications (risk ratio 1.19; 95% CI 0.59 to 2.39; I&#x200a;=&#x200a;0%). Patients resuscitated with HES had a shorter length of hospital stay (mean difference -1.52 days; 95% CI -2.87 to -0.18), although heterogeneity was high (I&#x200a;=&#x200a;90%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This meta-analysis, based on small studies with low event rates, suggests that there are currently insufficient data to identify a difference in outcomes associated with crystalloids and HES in scheduled or elective noncardiac surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Raiman</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Department of Anaesthesia, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban (MR), Department of Anaesthesia, Grey's Hospital, Pietermaritzburg (CGM), Perioperative Research Group, Department of Anaesthesia, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban (BMB), Perioperative Research Group, Department of Anaesthesia, Grey's Hospital, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Pietermaritzburg, South Africa, and Department of Outcomes Research, Cleveland Clinic, Cleveland, Ohio, USA (RNR).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitchell</LastName><ForeName>Colin G</ForeName><Initials>CG</Initials></Author><Author ValidYN="Y"><LastName>Biccard</LastName><ForeName>Bruce M</ForeName><Initials>BM</Initials></Author><Author ValidYN="Y"><LastName>Rodseth</LastName><ForeName>Reitze N</ForeName><Initials>RN</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Anaesthesiol</MedlineTA><NlmUniqueID>8411711</NlmUniqueID><ISSNLinking>0265-0215</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077324">Crystalloid Solutions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006895">Hydroxyethyl Starch Derivatives</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007552">Isotonic Solutions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010952">Plasma Substitutes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur J Anaesthesiol. 2017 Jan;34(1):28-29. doi: 10.1097/EJA.0000000000000464.</RefSource><PMID Version="1">27136489</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000077324" MajorTopicYN="N">Crystalloid Solutions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006895" MajorTopicYN="N">Hydroxyethyl Starch Derivatives</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007552" MajorTopicYN="N">Isotonic Solutions</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010952" MajorTopicYN="N">Plasma Substitutes</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26351826</ArticleId><ArticleId IdType="doi">10.1097/EJA.0000000000000328</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32320757</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-5568</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Anaesthesia, critical care &amp; pain medicine</Title><ISOAbbreviation>Anaesth Crit Care Pain Med</ISOAbbreviation></Journal><ArticleTitle>Haemodynamic management during hyperthermic intraperitoneal chemotherapy: A systematic review.</ArticleTitle><Pagination><StartPage>531</StartPage><EndPage>542</EndPage><MedlinePgn>531-542</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.accpm.2020.03.019</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2352-5568(20)30067-9</ELocationID><Abstract><AbstractText Label="CONTEXT">Hyperthermic intraperitoneal chemotherapy (HIPEC) is a surgical technique for peritoneal carcinomatosis combining cytoreduction surgery and peritoneal irrigation of cytotoxic agents responsible for haemodynamics and fluid homeostasis alterations. To this day, no guidelines exist concerning intraoperative management.</AbstractText><AbstractText Label="OBJECTIVES">To review data on haemodynamic monitoring and management of patients undergoing HIPEC and to help design a standardised anaesthetic protocol.</AbstractText><AbstractText Label="DATA SOURCES">MEDLINE, EMBASE and Cochrane library were searched using the following.</AbstractText><AbstractText Label="STUDY SELECTION">Original articles and case-reports. Letters to editors and reviews were excluded.</AbstractText><AbstractText Label="DATA EXTRACTION">Data on haemodynamic management, morbidity and mortality.</AbstractText><AbstractText Label="DATA SYNTHESIS">Haemodynamic management during HIPEC is highly variable and depends on local protocols. Only one randomised controlled trial evaluated the benefit of goal-directed fluid administration (GDFA). GDFA guided by advanced haemodynamic monitoring resulted in significantly less complication, shorter length of stay and less mortality compared to standard fluid administration. Renal protection protocol did not decrease the risk of acute kidney injury (AKI).</AbstractText><AbstractText Label="CONCLUSION">Our review reveals that fluid administration guided by advanced monitoring seems to be associated with less postoperative morbidity and mortality after HIPEC. Nevertheless, the literature review shows that intraoperative haemodynamic management is highly variable for this surgery. The use of renal protection strategy does not decrease the prevalence of AKI. Further prospective trials comparing different fluid management and haemodynamic monitoring strategies are urgently needed (PROSPERO registration CRD42018115720).</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Soci&#xe9;t&#xe9; fran&#xe7;aise d'anesth&#xe9;sie et de r&#xe9;animation (Sfar). All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bezu</LastName><ForeName>Lucillia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Service d'anesth&#xe9;sie, h&#xf4;pitaux universitaires Paris Ouest, h&#xf4;pital europ&#xe9;en Georges Pompidou, Assistance publique-H&#xf4;pitaux de Paris, 20, rue Leblanc, 75015 Paris, France; Universit&#xe9; Paris Descartes, Sorbonne Paris Cit&#xe9;, Paris, France. Electronic address: lucilliabe@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raineau</LastName><ForeName>M&#xe9;gane</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Service d'anesth&#xe9;sie, h&#xf4;pitaux universitaires Paris Ouest, h&#xf4;pital europ&#xe9;en Georges Pompidou, Assistance publique-H&#xf4;pitaux de Paris, 20, rue Leblanc, 75015 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delom&#xe9;nie</LastName><ForeName>Myriam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Service de chirurgie canc&#xe9;rologique gyn&#xe9;cologique et du sein, h&#xf4;pitaux universitaires Paris Ouest, h&#xf4;pital europ&#xe9;en Georges Pompidou, Assistance publique-H&#xf4;pitaux de Paris, 20, rue Leblanc, 75015 Paris, France; Universit&#xe9; Paris Descartes, Sorbonne Paris Cit&#xe9;, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cholley</LastName><ForeName>Bernard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Service d'anesth&#xe9;sie, h&#xf4;pitaux universitaires Paris Ouest, h&#xf4;pital europ&#xe9;en Georges Pompidou, Assistance publique-H&#xf4;pitaux de Paris, 20, rue Leblanc, 75015 Paris, France; Universit&#xe9; Paris Descartes, Sorbonne Paris Cit&#xe9;, Paris, France; Inserm UMR S1140, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pirracchio</LastName><ForeName>Romain</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Service d'anesth&#xe9;sie, h&#xf4;pitaux universitaires Paris Ouest, h&#xf4;pital europ&#xe9;en Georges Pompidou, Assistance publique-H&#xf4;pitaux de Paris, 20, rue Leblanc, 75015 Paris, France; Universit&#xe9; Paris Descartes, Sorbonne Paris Cit&#xe9;, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Anaesth Crit Care Pain Med</MedlineTA><NlmUniqueID>101652401</NlmUniqueID><ISSNLinking>2352-5568</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065426" MajorTopicYN="N">Cytoreduction Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006979" MajorTopicYN="Y">Hyperthermia, Induced</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010534" MajorTopicYN="Y">Peritoneal Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anaesthesia</Keyword><Keyword MajorTopicYN="N">Fluid administration</Keyword><Keyword MajorTopicYN="N">Haemodynamic monitoring</Keyword><Keyword MajorTopicYN="N">Hyperthermic intraperitoneal chemotherapy</Keyword><Keyword MajorTopicYN="N">Management</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32320757</ArticleId><ArticleId IdType="doi">10.1016/j.accpm.2020.03.019</ArticleId><ArticleId IdType="pii">S2352-5568(20)30067-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37702193</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1878-3503</ISSN><JournalIssue CitedMedium="Internet"><Volume>118</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>02</Day></PubDate></JournalIssue><Title>Transactions of the Royal Society of Tropical Medicine and Hygiene</Title><ISOAbbreviation>Trans R Soc Trop Med Hyg</ISOAbbreviation></Journal><ArticleTitle>Prevalence of acute kidney injury among dengue cases: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>11</EndPage><MedlinePgn>1-11</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/trstmh/trad067</ELocationID><Abstract><AbstractText>Numerous studies have shown a correlation between dengue virus (DENV) infection and kidney disease. However, there is no existing meta-analysis on the prevalence of kidney diseases in the dengue population. A thorough systematic review and meta-analysis were undertaken to determine the prevalence of renal problems in people with DENV infection in order to fill this knowledge gap. A rigorous electronic literature search was carried out up to 25 January 2023 in a number of databases, including ProQuest, EBSCOhost, Scopus, PubMed and Web of Science. The search aimed to find articles that reported on the prevalence of kidney diseases in patients with DENV infection. Using the modified Newcastle-Ottawa Scale, the quality of the included studies was assessed. The meta-analysis included a total of 37 studies with 21&#xa0;764 participants reporting on the prevalence of acute kidney injury (AKI) in individuals with DENV infection. The pooled prevalence of AKI in dengue patients was found to be 8% (95% confidence interval 6 to 11), with high heterogeneity across studies. The studies included are of moderate quality. The study revealed a high AKI prevalence in dengue patients, underlining the need for regular renal examination to detect AKI early and reduce hospitalization risk. Further research is needed to understand the dengue-kidney relationship and develop effective management strategies.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bushi</LastName><ForeName>Ganesh</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Global Center for Evidence Synthesis, Chandigarh 160036, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shabil</LastName><ForeName>Muhammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Global Center for Evidence Synthesis, Chandigarh 160036, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Padhi</LastName><ForeName>Bijaya Kumar</ForeName><Initials>BK</Initials><Identifier Source="ORCID">0000-0002-2828-2375</Identifier><AffiliationInfo><Affiliation>Department of Community Medicine and School of Public Health, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Public Health, School of Medical Sciences, University of Hyderabad, Hyderabad 500046, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pandey</LastName><ForeName>Pratima</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Global Center for Evidence Synthesis, Chandigarh 160036, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Satapathy</LastName><ForeName>Prakasini</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Global Center for Evidence Synthesis, Chandigarh 160036, India.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rustagi</LastName><ForeName>Sarvesh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Applied and Life Sciences, Uttaranchal University, Dehradun, Uttarakhand, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pradhan</LastName><ForeName>Keerti Bhusan</ForeName><Initials>KB</Initials><AffiliationInfo><Affiliation>Department of Healthcare Management, Chitkara University Punjab, Patiala 140401, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qaim</LastName><ForeName>Zahraa Haleem</ForeName><Initials>ZH</Initials><AffiliationInfo><Affiliation>Department of Anesthesia Techniques, Al-Mustaqbal University College, 51001 Hillah, Babylon, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sah</LastName><ForeName>Ranjit</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Tribhuvan University Teaching Hospital, Kathmandu 46000, Nepal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Microbiology, DY Patil Medical College, Hospital and Research Centre, DY Patil Vidyapeeth, Pune 411000, Maharashtra, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trans R Soc Trop Med Hyg</MedlineTA><NlmUniqueID>7506129</NlmUniqueID><ISSNLinking>0035-9203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="Y">Dengue</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AKI</Keyword><Keyword MajorTopicYN="N">dengue</Keyword><Keyword MajorTopicYN="N">kidney diseases</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">prevalence</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>3</Day><Hour>9</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>13</Day><Hour>5</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37702193</ArticleId><ArticleId IdType="doi">10.1093/trstmh/trad067</ArticleId><ArticleId IdType="pii">7272638</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36040611</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>11</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8191</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of cardiac surgery</Title><ISOAbbreviation>J Card Surg</ISOAbbreviation></Journal><ArticleTitle>Renal outcomes in valve-in-valve transcatheter versus redo surgical aortic valve replacement: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>3743</StartPage><EndPage>3753</EndPage><MedlinePgn>3743-3753</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jocs.16890</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Postoperative acute kidney injury (AKI) and the requirement for renal replacement therapy (RRT) remain common and significant complications of both transcatheter valve-in-valve aortic valve replacement (ViV-TAVR) and redo surgical aortic valve replacement (SAVR). Nevertheless, the understanding of renal outcomes in the population undergoing either redo SAVR or ViV-TAVR remains controversial.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic database search with meta-analysis was conducted of comparative original articles of ViV-TAVR versus redo SAVR in EMBASE, MEDLINE, Cochrane database, and Google Scholar, from inception to September 2021. Primary outcomes were AKI and RRT. Secondary outcomes were stroke, major bleeding, pacemaker implantation rate, operative mortality, and 30-day mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our search yielded 5435 relevant studies. Eighteen studies met the inclusion criteria with a total of 11,198 patients. We found ViV-TAVR to be associated with lower rates of AKI, postoperative RRT, major bleeding, pacemaker implantation, operative mortality, and 30-day mortality. No significant difference was observed in terms of stroke rate. The mean incidence of AKI in ViV-TAVR was 6.95% (&#xb1;6%) and in redo SAVR was 15.2% (&#xb1;9.6%). For RRT, our data showed that VIV-TAVR to be 1.48% (&#xb1;1.46%) and redo SAVR to be 8.54% (&#xb1;8.06%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Renoprotective strategies should be put into place to prevent and reduce AKI incidence regardless of the treatment modality. Patients undergoing re-intervention for the aortic valve constitute a high-risk and frail population in which ViV-TAVR demonstrated it might be a feasible option for carefully selected patients. Long-term follow-up data and randomized control trials will be needed to evaluate mortality and morbidity outcomes between these 2 treatments.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Journal of Cardiac Surgery published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arjomandi Rad</LastName><ForeName>Arian</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4931-4049</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Imperial College London, Faculty of Medicine, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naruka</LastName><ForeName>Vinci</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Imperial College NHS Trust, Hammersmith Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vardanyan</LastName><ForeName>Robert</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-8111-2084</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Imperial College London, Faculty of Medicine, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salmasi</LastName><ForeName>Mohammad Yousuf</ForeName><Initials>MY</Initials><Identifier Source="ORCID">0000-0002-4085-1294</Identifier><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tasoudis</LastName><ForeName>Panagiotis T</ForeName><Initials>PT</Initials><Identifier Source="ORCID">0000-0001-7735-9474</Identifier><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, University of Thessaly, Biopolis, Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kendall</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, James Cook University Hospital, Middlesborough, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casula</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Imperial College NHS Trust, Hammersmith Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Athanasiou</LastName><ForeName>Thanos</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Imperial College NHS Trust, Hammersmith Hospital, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Card Surg</MedlineTA><NlmUniqueID>8908809</NlmUniqueID><ISSNLinking>0886-0440</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001021" MajorTopicYN="N">Aortic Valve</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="Y">Aortic Valve Stenosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019918" MajorTopicYN="Y">Heart Valve Prosthesis Implantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065467" MajorTopicYN="Y">Transcatheter Aortic Valve Replacement</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ViV-TAVR</Keyword><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">redo SAVR</Keyword><Keyword MajorTopicYN="N">renal failure</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>30</Day><Hour>11</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36040611</ArticleId><ArticleId IdType="pmc">PMC9804591</ArticleId><ArticleId IdType="doi">10.1111/jocs.16890</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Isaacs AJ, Shuhaiber J, Salemi A, Isom OW, Sedrakyan A. National trends in utilization and in&#x2010;hospital outcomes of mechanical versus bioprosthetic aortic valve replacements. J Thorac Cardiovasc Surg. 2015;149(5):1262&#x2010;1269.</Citation><ArticleIdList><ArticleId IdType="pubmed">25791947</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar N, Garg N. Acute kidney injury after aortic valve replacement in a nationally representative cohort in the USA. Nephrol Dial Transplant. 2019;34(2):295&#x2010;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">29684164</ArticleId></ArticleIdList></Reference><Reference><Citation>Devireddy C, Hiremath S. Acute kidney injury after transcatheter aortic valve replacement. Circ Cardiovasc Interv. 2018;11(8):7135.</Citation><ArticleIdList><ArticleId IdType="pubmed">30354790</ArticleId></ArticleIdList></Reference><Reference><Citation>Elhmidi Y, Bleiziffer S, Deutsch MA, et al. Acute kidney injury after transcatheter aortic valve implantation: incidence, predictors and impact on mortality. Arch Cardiovasc Dis. 2014;107(2):133&#x2010;139.</Citation><ArticleIdList><ArticleId IdType="pubmed">24556191</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed A, Levy KH. Valve&#x2010;in&#x2010;valve transcatheter aortic valve replacement versus redo surgical aortic valve replacement: a systematic review and meta&#x2010;analysis. J Card Surg. 2021;36(7):2486&#x2010;2495.</Citation><ArticleIdList><ArticleId IdType="pubmed">33797799</ArticleId></ArticleIdList></Reference><Reference><Citation>Majmundar M, Doshi R, Kumar A, et al. Valve&#x2010;in&#x2010;valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis. EuroIntervention. 2021;17:1227&#x2010;1237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9724873</ArticleId><ArticleId IdType="pubmed">34521614</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirji SA, Percy ED, Zogg CK, et al. Comparison of in&#x2010;hospital outcomes and readmissions for valve&#x2010;in&#x2010;valve transcatheter aortic valve replacement vs. reoperative surgical aortic valve replacement: a contemporary assessment of real&#x2010;world outcomes. Eur Heart J. 2020;41(29):2747&#x2010;2755.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7395321</ArticleId><ArticleId IdType="pubmed">32445575</ArticleId></ArticleIdList></Reference><Reference><Citation>Erlebach M, Wottke M, Deutsch M&#x2010;A, et al. Redo aortic valve surgery versus transcatheter valve&#x2010;in&#x2010;valve implantation for failing surgical bioprosthetic valves: consecutive patients in a single&#x2010;center setting. J Thorac Dis. 2015;7(9):1494&#x2010;1500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4598513</ArticleId><ArticleId IdType="pubmed">26543594</ArticleId></ArticleIdList></Reference><Reference><Citation>Stankowski T, Aboul&#x2010;Hassan SS, Seifi Zinab F, et al. Femoral transcatheter valve&#x2010;in&#x2010;valve implantation as alternative strategy for failed aortic bioprostheses: a single&#x2010;centre experience with long&#x2010;term follow&#x2010;up. Int J Cardiol. 2020;306:25&#x2010;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">32087937</ArticleId></ArticleIdList></Reference><Reference><Citation>Woitek FJ, Stachel G, Kiefer P, et al. Treatment of failed aortic bioprostheses: an evaluation of conventional redo surgery and transfemoral transcatheter aortic valve&#x2010;in&#x2010;valve implantation. Int J Cardiol. 2020;300:80&#x2010;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">31740140</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel PM, Chiou E, Cao Y, et al. Isolated redo aortic valve replacement versus valve&#x2010;in&#x2010;valve transcatheter valve replacement. Ann Thorac Surg. 2021;112(2):539&#x2010;545.</Citation><ArticleIdList><ArticleId IdType="pubmed">33129775</ArticleId></ArticleIdList></Reference><Reference><Citation>van Steenbergen GJ, van Straten B, Lam KY, van Veghel D, Dekker L, Tonino PA. Report on outcomes of valve&#x2010;in&#x2010;valve transcatheter aortic valve implantation and redo surgical aortic valve replacement in the Netherlands. Netherlands Hear J. 2021;2021:1&#x2010;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8799804</ArticleId><ArticleId IdType="pubmed">34373997</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam DY, Dharma C, Rocha RV, et al. Transcatheter ViV versus redo surgical AVR for the management of failed biological prosthesis: early and late outcomes in a propensity&#x2010;matched cohort. JACC Cardiovasc Interv. 2020;13(6):765&#x2010;774.</Citation><ArticleIdList><ArticleId IdType="pubmed">31954671</ArticleId></ArticleIdList></Reference><Reference><Citation>Vukadinovikj A, Baumg&#xe1;rtner E, Bohmann K, H&#xe4;rter D, Wimmer&#x2010;Greinecker G, Burgdorf C. Transcatheter valve&#x2010;in&#x2010;valve implantation versus surgical redo aortic root replacement in patients with degenerated freestyle aortic bioprosthesis. Catheter Cardiovasc Interv. 2021;97(7):1472&#x2010;1478.</Citation><ArticleIdList><ArticleId IdType="pubmed">33522093</ArticleId></ArticleIdList></Reference><Reference><Citation>Dokollari A, Cameli M, Mandoli GE, et al. Early and midterm clinical outcomes of transcatheter valve&#x2010;in&#x2010;valve implantation versus redo surgical aortic valve replacement for aortic bioprosthetic valve degeneration: two faces of the same medal. J Cardiothorac Vasc Anesth. 2021;35(11):3223&#x2010;3231.</Citation><ArticleIdList><ArticleId IdType="pubmed">34175205</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi CH, Cao K, Malaver D, et al. Redo&#x2010;aortic valve replacement in prior stentless prosthetic aortic valves: transcatheter versus surgical approach. Catheter Cardiovasc Interv. 2021;99:181&#x2010;192.</Citation><ArticleIdList><ArticleId IdType="pubmed">34402588</ArticleId></ArticleIdList></Reference><Reference><Citation>Ejiofor JI, Yammine M, Harloff MT, et al. Reoperative surgical aortic valve replacement versus transcatheter valve&#x2010;in&#x2010;valve replacement for degenerated bioprosthetic aortic valves. Ann Thorac Surg. 2016;102(5):1452&#x2010;1458.</Citation><ArticleIdList><ArticleId IdType="pubmed">27526654</ArticleId></ArticleIdList></Reference><Reference><Citation>Silaschi M, Wendler O, Seiffert M, et al. Transcatheter valve&#x2010;in&#x2010;valve implantation versus redo surgical aortic valve replacement in patients with failed aortic bioprostheses. Interact Cardiovasc Thorac Surg. 2017;24(1):63&#x2010;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">27624351</ArticleId></ArticleIdList></Reference><Reference><Citation>Grubitzsch H, Zobel S, Christ T, et al. Redo procedures for degenerated stentless aortic xenografts and the role of valve&#x2010;in&#x2010;valve transcatheter techniques. Eur J Cardiothorac Surg. 2017;51(4):653&#x2010;659.</Citation><ArticleIdList><ArticleId IdType="pubmed">28062549</ArticleId></ArticleIdList></Reference><Reference><Citation>Spaziano M, Mylotte D, Th&#xe9;riault&#x2010;Lauzier P, et al. Transcatheter aortic valve implantation versus redo surgery for failing surgical aortic bioprostheses: a multicentre propensity score analysis. EuroIntervention. 2017;13(10):1149&#x2010;1156.</Citation><ArticleIdList><ArticleId IdType="pubmed">28760721</ArticleId></ArticleIdList></Reference><Reference><Citation>Santarpino G, Pietsch LE, Jessl J, et al. Transcatheter aortic valve&#x2010;in&#x2010;valve implantation and sutureless aortic valve replacement: two strategies for one goal in redo patients. Minerva Cardioangiol. 2016;64(6):581&#x2010;585.</Citation><ArticleIdList><ArticleId IdType="pubmed">26859231</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedeek AF, Greason KL, Sandhu GS, Dearani JA, Holmes DR, Schaff HV. Transcatheter valve&#x2010;in&#x2010;valve vs surgical replacement of failing stented aortic biological valves. Ann Thorac Surg. 2019;108(2):424&#x2010;430.</Citation><ArticleIdList><ArticleId IdType="pubmed">31055036</ArticleId></ArticleIdList></Reference><Reference><Citation>Deharo P, Bisson A, Herbert J, et al. Transcatheter valve&#x2010;in&#x2010;valve aortic valve replacement as an alternative to surgical re&#x2010;replacement. J Am Coll Cardiol. 2020;76(5):489&#x2010;499.</Citation><ArticleIdList><ArticleId IdType="pubmed">32731926</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik AH, Yandrapalli S, Zaid S, et al. Valve&#x2010;in&#x2010;valve transcatheter implantation versus redo surgical aortic valve replacement. Am J Cardiol. 2020;125(9):1378&#x2010;1384.</Citation><ArticleIdList><ArticleId IdType="pubmed">32139158</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronel R, De Groot JR, Van Lieshout JJ. Defining heart failure. Cardiovasc Res. 2001;50(3):419&#x2010;422.</Citation><ArticleIdList><ArticleId IdType="pubmed">11376615</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohbot Y, Candellier A, Diouf M, et al. Severe aortic stenosis and chronic kidney disease: outcomes and impact of aortic valve replacement. J Am Heart Assoc. 2020;9(19):e017190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7792421</ArticleId><ArticleId IdType="pubmed">32964785</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic&#x2010;valve replacement in intermediate&#x2010;risk patients. N Engl J Med. 2016;374(17):1609&#x2010;1620. 10.1056/NEJMoa1514616</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1514616</ArticleId><ArticleId IdType="pubmed">27040324</ArticleId></ArticleIdList></Reference><Reference><Citation>Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic&#x2010;valve replacement in intermediate&#x2010;risk patients. N Engl J Med. 2017;376(14):1321&#x2010;1331. 10.1056/NEJMoa1700456</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1700456</ArticleId><ArticleId IdType="pubmed">28304219</ArticleId></ArticleIdList></Reference><Reference><Citation>Thyregod HG, Steinbr&#xfc;chel DA, Ihlemann N, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1&#x2010;year results from the all&#x2010;comers NOTION randomized clinical trial. J Am Coll Cardiol. 2015;65(20):2184&#x2010;2194.</Citation><ArticleIdList><ArticleId IdType="pubmed">25787196</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagur R, Webb JG, Nietlispach F, et al. Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J. 2010;31(7):865&#x2010;874.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2848323</ArticleId><ArticleId IdType="pubmed">20037180</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah K, Chaker Z, Busu T, et al. Meta&#x2010;analysis comparing renal outcomes after transcatheter versus surgical aortic valve replacement. J Interv Cardiol. 2019;2019:3537256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6739771</ArticleId><ArticleId IdType="pubmed">31772526</ArticleId></ArticleIdList></Reference><Reference><Citation>Okusa MD. The inflammatory cascade in acute ischemic renal failure. Nephron. 2002;90(2):133&#x2010;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">11818695</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherner M, Wahlers T. Acute kidney injury after transcatheter aortic valve implantation. J Thorac Dis. 2015;7(9):1527&#x2010;1535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4598516</ArticleId><ArticleId IdType="pubmed">26543598</ArticleId></ArticleIdList></Reference><Reference><Citation>Grodecki K, Stebbins A, Vemulapalli S, et al. Incidence, predictors, and outcomes of acute kidney injury in patients undergoing transcatheter aortic valve replacement: insights from the Society of Thoracic Surgeons/American College of Cardiology National Cardiovascular Data Registry&#x2010;Transcatheter Valve Therapy Registry. Circ Cardiovasc Interv. 2021;14:e010032.</Citation><ArticleIdList><ArticleId IdType="pubmed">33877860</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshaikh HN, Katz NM, Gani F, et al. Financial impact of acute kidney injury after cardiac operations in the United States. Ann Thorac Surg. 2018;105(2):469&#x2010;475.</Citation><ArticleIdList><ArticleId IdType="pubmed">29275828</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahid S, Ullah W, Khan MU, Salama A, Krupica T, Khan MZ. Predictors of acute kidney injury after transcatheter aortic valve implantation (from national inpatient sample [2011&#x2013;2018]). Am J Cardiol. 2021;151:120&#x2010;122.</Citation><ArticleIdList><ArticleId IdType="pubmed">34006370</ArticleId></ArticleIdList></Reference><Reference><Citation>Noce A, Marrone G, Rovella V, et al. Fenoldopam mesylate: a narrative review of its use in acute kidney injury. Curr Pharm Biotechnol. 2019;20(5):366&#x2010;375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6751352</ArticleId><ArticleId IdType="pubmed">31038062</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbanti M, Gulino S, Capranzano P, et al. Acute kidney injury with the RenalGuard system in patients undergoing transcatheter aortic valve replacement: the PROTECT&#x2010;TAVI trial (PROphylactic effect of furosEmide&#x2010;induCed diuresis with matched isotonic intravenous hydration in transcatheter aortic valve implantation). JACC Cardiovasc Interv. 2015;8(12):1595&#x2010;1604.</Citation><ArticleIdList><ArticleId IdType="pubmed">26386766</ArticleId></ArticleIdList></Reference><Reference><Citation>Francone M, Budde RPJ, Bremerich J, et al. CT and MR imaging prior to transcatheter aortic valve implantation: standardisation of scanning protocols, measurements and reporting&#x2014;a consensus document by the European Society of Cardiovascular Radiology (ESCR). Eur Radiol. 2020;30(5):2627&#x2010;2650.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7160220</ArticleId><ArticleId IdType="pubmed">31489471</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi JY, Hong GR, Hong SJ, et al. Transcatheter aortic valve replacement with minimal contrast dye in patients with renal insufficiency. Yonsei Med J. 2021;62(11):990&#x2010;996.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8542473</ArticleId><ArticleId IdType="pubmed">34672132</ArticleId></ArticleIdList></Reference><Reference><Citation>Gozdek M, Raffa GM, Suwalski P, et al. Comparative performance of transcatheter aortic valve&#x2010;in&#x2010;valve implantation versus conventional surgical redo aortic valve replacement in patients with degenerated aortic valve bioprostheses: systematic review and meta&#x2010;analysis. Eur J Cardiothorac Surg. 2018;53(3):495&#x2010;504.</Citation><ArticleIdList><ArticleId IdType="pubmed">29029105</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37312156</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1749-799X</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>13</Day></PubDate></JournalIssue><Title>Journal of orthopaedic surgery and research</Title><ISOAbbreviation>J Orthop Surg Res</ISOAbbreviation></Journal><ArticleTitle>Regional versus general anesthesia in older patients for hip fracture surgery: a systematic review and meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>428</StartPage><MedlinePgn>428</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">428</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13018-023-03903-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The optimal anesthesia technique for older patients undergoing hip fracture surgery remains controversial. We performed a systematic review and meta-analysis of updated randomized controlled trials (RCTs) to assess whether regional anesthesia was superior to general anesthesia in hip fracture surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched PubMed, EMBASE, Web of Science, and the Cochrane Central Register of Controlled Trials from January 2000 until April 2022. RCTs directly comparing regional and general anesthesia in hip fracture surgery were included in the analysis. The incidence of delirium and mortality were the primary outcomes and other perioperative outcomes including complications were secondary outcomes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirteen studies involving 3736 patients were included in this study. There was no significant difference in the incidence of delirium (odds ratio [OR] 1.09; 95% confidence interval [CI] 0.86, 1.37) and mortality (OR 1.08; 95% CI 0.71, 1.64) between the two groups. Patients receiving regional anesthesia in hip fracture surgery were associated with a reduction in operative time (weighted mean difference [WMD]: -&#x2009;4.74; 95% CI -&#x2009;8.85, -&#x2009;0.63), intraoperative blood loss (WMD: -&#x2009;0.25; 95% CI -&#x2009;0.37, -&#x2009;0.12), postoperative pain score (WMD: -&#x2009;1.77; 95% CI -&#x2009;2.79, -&#x2009;0.74), length of stay (WMD: -&#x2009;0.10; 95% CI -&#x2009;0.18, -&#x2009;0.02), and risk of acute kidney injury (AKI) (OR 0.56; 95% CI 0.36, 0.87). No significant difference was observed in the other perioperative outcomes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">For older patients undergoing hip fracture surgery, RA did not significantly reduce the incidence of postoperative delirium and mortality compared to GA. Due to the limitations of this study, the evidence on delirium and mortality was still inconclusive and further high-quality studies are needed.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhou</LastName><ForeName>Sheng-Liang</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, No. 37 Guoxue Road, Sichuan Province, 610041, Chengdu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Shao-Yun</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, No. 37 Guoxue Road, Sichuan Province, 610041, Chengdu, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthopedics, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, Sichuan Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Si</LastName><ForeName>Hai-Bo</ForeName><Initials>HB</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, No. 37 Guoxue Road, Sichuan Province, 610041, Chengdu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, No. 37 Guoxue Road, Sichuan Province, 610041, Chengdu, People's Republic of China. shenbin_1971@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>81974347</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Orthop Surg Res</MedlineTA><NlmUniqueID>101265112</NlmUniqueID><ISSNLinking>1749-799X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003693" MajorTopicYN="Y">Delirium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="Y">Hip Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000765" MajorTopicYN="N">Anesthesia, Conduction</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005592" MajorTopicYN="Y">Fracture Fixation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anesthesia</Keyword><Keyword MajorTopicYN="N">General</Keyword><Keyword MajorTopicYN="N">Hip fracture</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Regional</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>14</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>13</Day><Hour>23</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37312156</ArticleId><ArticleId IdType="pmc">PMC10262548</ArticleId><ArticleId IdType="doi">10.1186/s13018-023-03903-5</ArticleId><ArticleId IdType="pii">10.1186/s13018-023-03903-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17(12):1726&#x2013;1733. doi: 10.1007/s00198-006-0172-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-006-0172-4</ArticleId><ArticleId IdType="pubmed">16983459</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Feng J, Wang S, Gao P, Xu L, Zhu J, Jia J, Liu L, Liu G, Wang J, et al. Incidence of and trends in hip fracture among adults in urban China: a nationwide retrospective cohort study. PLoS Med. 2020;17(8):e1003180. doi: 10.1371/journal.pmed.1003180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003180</ArticleId><ArticleId IdType="pmc">PMC7410202</ArticleId><ArticleId IdType="pubmed">32760065</ArticleId></ArticleIdList></Reference><Reference><Citation>Briot K, Maravic M, Roux C. Changes in number and incidence of hip fractures over 12 years in France. Bone. 2015;81:131&#x2013;137. doi: 10.1016/j.bone.2015.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2015.07.009</ArticleId><ArticleId IdType="pubmed">26164476</ArticleId></ArticleIdList></Reference><Reference><Citation>Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB. Incidence and mortality of hip fractures in the United States. JAMA. 2009;302(14):1573&#x2013;1579. doi: 10.1001/jama.2009.1462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.1462</ArticleId><ArticleId IdType="pmc">PMC4410861</ArticleId><ArticleId IdType="pubmed">19826027</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YP, Kuo YJ, Hung SW, Wen TW, Chien PC, Chiang MH, Maffulli N, Lin CY. Loss of skeletal muscle mass can be predicted by sarcopenia and reflects poor functional recovery at 1 year after surgery for geriatric hip fractures. Injury. 2021;52(11):3446&#x2013;3452. doi: 10.1016/j.injury.2021.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2021.08.007</ArticleId><ArticleId IdType="pubmed">34404509</ArticleId></ArticleIdList></Reference><Reference><Citation>Cauley JA, Chalhoub D, Kassem AM. Fuleihan GE-H: geographic and ethnic disparities in osteoporotic fractures. Nat Rev Endocrinol. 2014;10(6):338&#x2013;351. doi: 10.1038/nrendo.2014.51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrendo.2014.51</ArticleId><ArticleId IdType="pubmed">24751883</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsillo E, Pintore A, Asparago G, Oliva F, Maffulli N. Cephalomedullary nailing for reverse oblique intertrochanteric fractures 31A3 (AO/OTA) Orthop Rev. 2022;14(6):38560. doi: 10.52965/001c.38560.</Citation><ArticleIdList><ArticleId IdType="doi">10.52965/001c.38560</ArticleId><ArticleId IdType="pmc">PMC9568432</ArticleId><ArticleId IdType="pubmed">36267220</ArticleId></ArticleIdList></Reference><Reference><Citation>Gargano G, Poeta N, Oliva F, Migliorini F, Maffulli N. Zimmer Natural Nail and ELOS nails in pertrochanteric fractures. J Orthop Surg Res. 2021;16(1):509. doi: 10.1186/s13018-021-02634-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13018-021-02634-9</ArticleId><ArticleId IdType="pmc">PMC8371819</ArticleId><ArticleId IdType="pubmed">34407829</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Fleisher LA, Even-Shoshan O, Mi L, Silber JH. Nonoperative care for hip fracture in the elderly: the influence of race, income, and comorbidities. Med Care. 2010;48(4):314&#x2013;320. doi: 10.1097/MLR.0b013e3181ca4126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e3181ca4126</ArticleId><ArticleId IdType="pmc">PMC4882126</ArticleId><ArticleId IdType="pubmed">20355262</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravi B, Pincus D, Choi S, Jenkinson R, Wasserstein DN, Redelmeier DA. Association of duration of surgery with postoperative delirium among patients receiving hip fracture repair. JAMA Netw Open. 2019;2(2):e190111. doi: 10.1001/jamanetworkopen.2019.0111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2019.0111</ArticleId><ArticleId IdType="pmc">PMC6484601</ArticleId><ArticleId IdType="pubmed">30794305</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai V, Chan PH, Prentice HA, Zohman GL, Diekmann GR, Maletis GB, Fasig BH, Diaz D, Chung E, Qiu CY. Is anesthesia technique associated with a higher risk of mortality or complications within 90 days of surgery for geriatric patients with hip fractures? Clin Orthop Relat Res. 2018;476(6):1178&#x2013;1188. doi: 10.1007/s11999.0000000000000147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11999.0000000000000147</ArticleId><ArticleId IdType="pmc">PMC6263607</ArticleId><ArticleId IdType="pubmed">29601378</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishi T, Maeda T, Imatoh T, Babazono A. Comparison of regional with general anesthesia on mortality and perioperative length of stay in older patients after hip fracture surgery. Int J Qual Health Care: J Int Soc Qual Health Care. 2019;31(9):669&#x2013;675.</Citation><ArticleIdList><ArticleId IdType="pubmed">30452640</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan L, McKeever TM, Nightingale J, Deakin DE, Moppett IK. Spinal or general anaesthesia for surgical repair of hip fracture and subsequent risk of mortality and morbidity: a database analysis using propensity score-matching. Anaesthesia. 2020;75(9):1173&#x2013;1179. doi: 10.1111/anae.15042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.15042</ArticleId><ArticleId IdType="pubmed">32337715</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X, Tan Y, Gao Y, Liu Z. Comparative efficacy of Neuraxial and general anesthesia for hip fracture surgery: a meta-analysis of randomized clinical trials. BMC Anesthesiol. 2020;20(1):162. doi: 10.1186/s12871-020-01074-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-020-01074-y</ArticleId><ArticleId IdType="pmc">PMC7325684</ArticleId><ArticleId IdType="pubmed">32605591</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Li J, Yuan L, Wu J, Jiang C, Daniels J, Mehta RL, Wang M, Yeung J, Jackson T, et al. Effect of regional versus general anesthesia on incidence of postoperative delirium in older patients undergoing hip fracture surgery: the RAGA randomized trial. JAMA. 2022;327(1):50&#x2013;58. doi: 10.1001/jama.2021.22647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.22647</ArticleId><ArticleId IdType="pmc">PMC8689436</ArticleId><ArticleId IdType="pubmed">34928310</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang LL, Fang PP, Fang YX, Lu Y, Xu GH, Liu XS. Comparison of effects between combined lumbar-sacral plexus block plus general anesthesia and unilateral spinal anesthesia in elderly patients undergoing hip fracture surgery: a pilot randomized controlled trial. Evid-Based Complement Altern Med. 2021 doi: 10.1155/2021/6685497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6685497</ArticleId><ArticleId IdType="pmc">PMC8105098</ArticleId><ArticleId IdType="pubmed">34012474</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Feng R, Carson JL, Gaskins LJ, Dillane D, Sessler DI, Sieber F, Magaziner J, Marcantonio ER, Mehta S, et al. Spinal anesthesia or general anesthesia for hip surgery in older adults. N Engl J Med. 2021;385(22):2025&#x2013;2035. doi: 10.1056/NEJMoa2113514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2113514</ArticleId><ArticleId IdType="pubmed">34623788</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ (Clin Res Ed) 2015;350:g7647.</Citation><ArticleIdList><ArticleId IdType="pubmed">25555855</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Altman DG, G&#xf8;tzsche PC, J&#xfc;ni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JAC. The cochrane collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ (Clin Res Ed) 2011;343:d5928. doi: 10.1136/bmj.d5928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135. doi: 10.1186/1471-2288-14-135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-135</ArticleId><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, White IR, Anzures-Cabrera J. Meta-analysis of skewed data: combining results reported on log-transformed or raw scales. Stat Med. 2008;27(29):6072&#x2013;6092. doi: 10.1002/sim.3427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.3427</ArticleId><ArticleId IdType="pmc">PMC2978323</ArticleId><ArticleId IdType="pubmed">18800342</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res Ed) 1997;315(7109):629&#x2013;634. doi: 10.1136/bmj.315.7109.629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzimas P, Samara E, Petrou A, Korompilias A, Chalkias A, Papadopoulos G. The influence of anesthetic techniques on postoperative cognitive function in elderly patients undergoing hip fracture surgery: general versus spinal anesthesia. Injury. 2018;49(12):2221&#x2013;2226. doi: 10.1016/j.injury.2018.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2018.09.023</ArticleId><ArticleId IdType="pubmed">30526923</ArticleId></ArticleIdList></Reference><Reference><Citation>Meuret P, Bouvet L, Villet B, Hafez M, Allaouchiche B, Boselli E. Hypobaric unilateral spinal anaesthesia versus general anaesthesia in elderly patients undergoing hip fracture surgical repair: a prospective randomised open trial. Turk J Anaesthesiol Reanim. 2018;46(2):121&#x2013;130. doi: 10.5152/TJAR.2018.90699.</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/TJAR.2018.90699</ArticleId><ArticleId IdType="pmc">PMC5937458</ArticleId><ArticleId IdType="pubmed">29744247</ArticleId></ArticleIdList></Reference><Reference><Citation>Haghighi M, Sedighinejad A, Nabi BN, Mardani-Kivi M, Tehran SG, Mirfazli SA, Mirbolook A, Saheli NA. Is spinal anesthesia with low dose lidocaine better than sevoflorane anesthesia in patients undergoing hip fracture surgery. Arch Bone Jt Surg. 2017;5(4):226&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5592363</ArticleId><ArticleId IdType="pubmed">28913379</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Mehta S, Bannister ER, Hesketh PJ, Horan AD, Elkassabany NM. Pilot randomized controlled trial of spinal versus general anesthesia for hip fracture surgery. J Am Geriatr Soc. 2016;64(12):2604&#x2013;2606. doi: 10.1111/jgs.14373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.14373</ArticleId><ArticleId IdType="pmc">PMC5180205</ArticleId><ArticleId IdType="pubmed">27996117</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MJ, Griffiths R. General versus regional anaesthesia for hip fractures. A pilot randomised controlled trial of 322 patients. Injury. 2015;46(8):1562&#x2013;1566. doi: 10.1016/j.injury.2015.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2015.05.004</ArticleId><ArticleId IdType="pubmed">26049662</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina A, Frassanito L, Colombo D, Vergari A, Draisci G, Della Corte F, Antonelli M. Hemodynamic changes associated with spinal and general anesthesia for hip fracture surgery in severe ASA III elderly population: a pilot trial. Minerva Anestesiol. 2013;79(9):1021&#x2013;1029.</Citation><ArticleIdList><ArticleId IdType="pubmed">23635998</ArticleId></ArticleIdList></Reference><Reference><Citation>Biboulet P, Jourdan A, Van Haevre V, Morau D, Bernard N, Bringuier S, Capdevila X. Hemodynamic profile of target-controlled spinal anesthesia compared with 2 target-controlled general anesthesia techniques in elderly patients with cardiac comorbidities. Reg Anesth Pain Med. 2012;37(4):433&#x2013;440. doi: 10.1097/AAP.0b013e318252e901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AAP.0b013e318252e901</ArticleId><ArticleId IdType="pubmed">22609644</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoppenstein D, Zohar E, Ramaty E, Shabat S, Fredman B. The effects of general versus spinal anesthesia on frontal cerebral oxygen saturation in geriatric patients undergoing emergency surgical fixation of the neck of femur. J Clin Anesth. 2005;17(6):431&#x2013;438. doi: 10.1016/j.jclinane.2004.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2004.09.013</ArticleId><ArticleId IdType="pubmed">16171663</ArticleId></ArticleIdList></Reference><Reference><Citation>Casati A, Aldegheri G, Vinciguerra E, Marsan A, Fraschini G, Torri G. Randomized comparison between sevoflurane anaesthesia and unilateral spinal anaesthesia in elderly patients undergoing orthopaedic surgery. Eur J Anaesthesiol. 2003;20(8):640&#x2013;646. doi: 10.1097/00003643-200308000-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003643-200308000-00009</ArticleId><ArticleId IdType="pubmed">12932066</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidari SM, Soltani H, Hashemi SJ, Talakoub R, Soleimani B. Comparative study of two anesthesia methods according to postoperative complications and 1 month mortality rate in the candidates of hip surgery. J Res Med Sci. 2011;16(3):323&#x2013;330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3214341</ArticleId><ArticleId IdType="pubmed">22091252</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Donnell CM, McLoughlin L, Patterson CC, Clarke M, McCourt KC, McBrien ME, McAuley DF, Shields MO. Perioperative outcomes in the context of mode of anaesthesia for patients undergoing hip fracture surgery: systematic review and meta-analysis. Br J Anaesth. 2018;120(1):37&#x2013;50. doi: 10.1016/j.bja.2017.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2017.09.002</ArticleId><ArticleId IdType="pubmed">29397135</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim EM, Li G, Kim M. Development of a risk score to predict postoperative delirium in patients with hip fracture. Anesth Analg. 2020;130(1):79&#x2013;86. doi: 10.1213/ANE.0000000000004386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000004386</ArticleId><ArticleId IdType="pmc">PMC6917900</ArticleId><ArticleId IdType="pubmed">31478933</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudolph JL, Marcantonio ER. Review articles: postoperative delirium: acute change with long-term implications. Anesth Analg. 2011;112(5):1202&#x2013;1211. doi: 10.1213/ANE.0b013e3182147f6d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e3182147f6d</ArticleId><ArticleId IdType="pmc">PMC3090222</ArticleId><ArticleId IdType="pubmed">21474660</ArticleId></ArticleIdList></Reference><Reference><Citation>Maffulli N, Aicale R. Proximal femoral fractures in the elderly: a few things to know, and some to forget. Medicina (Kaunas) 2022;58(10):1314. doi: 10.3390/medicina58101314.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58101314</ArticleId><ArticleId IdType="pmc">PMC9612001</ArticleId><ArticleId IdType="pubmed">36295475</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel V, Champaneria R, Dretzke J, Yeung J. Effect of regional versus general anaesthesia on postoperative delirium in elderly patients undergoing surgery for hip fracture: a systematic review. BMJ Open. 2018;8(12):e020757. doi: 10.1136/bmjopen-2017-020757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-020757</ArticleId><ArticleId IdType="pmc">PMC6286489</ArticleId><ArticleId IdType="pubmed">30518580</ArticleId></ArticleIdList></Reference><Reference><Citation>Fong TG, Tulebaev SR, Inouye SK. Delirium in elderly adults: diagnosis, prevention and treatment. Nat Rev Neurol. 2009;5(4):210&#x2013;220. doi: 10.1038/nrneurol.2009.24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2009.24</ArticleId><ArticleId IdType="pmc">PMC3065676</ArticleId><ArticleId IdType="pubmed">19347026</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcantonio ER. Delirium in hospitalized older adults. N Engl J Med. 2017;377(15):1456&#x2013;1466. doi: 10.1056/NEJMcp1605501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcp1605501</ArticleId><ArticleId IdType="pmc">PMC5706782</ArticleId><ArticleId IdType="pubmed">29020579</ArticleId></ArticleIdList></Reference><Reference><Citation>Malhas L, Perlas A, Tierney S, Chan VWS, Beattie S. The effect of anesthetic technique on mortality and major morbidity after hip fracture surgery: a retrospective, propensity-score matched-pairs cohort study. Reg Anesth Pain Med. 2019;44(9):847&#x2013;853. doi: 10.1136/rapm-2019-100417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rapm-2019-100417</ArticleId><ArticleId IdType="pubmed">31300593</ArticleId></ArticleIdList></Reference><Reference><Citation>Guay J, Choi P, Suresh S, Albert N, Kopp S, Pace NL. Neuraxial blockade for the prevention of postoperative mortality and major morbidity: an overview of cochrane systematic reviews. Cochrane Database Syst Rev. 2014;1:CD010108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7087466</ArticleId><ArticleId IdType="pubmed">24464831</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Waesberghe J, Stevanovic A, Rossaint R, Coburn M. General versus neuraxial anaesthesia in hip fracture patients: a systematic review and meta-analysis. BMC Anesthesiol. 2017;17:1&#x2013;025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5490182</ArticleId><ArticleId IdType="pubmed">28659127</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu C-C, Weng S-F, Chen K-T, Chien C-C, Shieh J-P, Chen J-Y, Wang J-J. Propensity score-matched comparison of postoperative adverse outcomes between geriatric patients given a general or a neuraxial anesthetic for hip surgery: a population-based study. Anesthesiology. 2015;123(1):136&#x2013;147. doi: 10.1097/ALN.0000000000000695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000695</ArticleId><ArticleId IdType="pubmed">25955981</ArticleId></ArticleIdList></Reference><Reference><Citation>Richman JM, Rowlingson AJ, Maine DN, Courpas GE, Weller JF, Wu CL. Does neuraxial anesthesia reduce intraoperative blood loss? A meta-analysis. J Clin Anesth. 2006;18(6):427&#x2013;435. doi: 10.1016/j.jclinane.2006.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2006.02.006</ArticleId><ArticleId IdType="pubmed">16980159</ArticleId></ArticleIdList></Reference><Reference><Citation>Ing C, Sun LS, Friend AF, Kim M, Berman MF, Paganelli W, Li G, Williams RK. Differences in intraoperative hemodynamics between spinal and general anesthesia in infants undergoing pyloromyotomy. Paediatr Anaesth. 2017;27(7):733&#x2013;741. doi: 10.1111/pan.13156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.13156</ArticleId><ArticleId IdType="pmc">PMC5461197</ArticleId><ArticleId IdType="pubmed">28419639</ArticleId></ArticleIdList></Reference><Reference><Citation>Modig J. Regional anaesthesia and blood loss. Acta Anaesthesiol Scand Suppl. 1988;89:44&#x2013;48. doi: 10.1111/j.1399-6576.1988.tb02842.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.1988.tb02842.x</ArticleId><ArticleId IdType="pubmed">3067490</ArticleId></ArticleIdList></Reference><Reference><Citation>Quaranta M, Miranda L, Oliva F, Migliorini F, Pezzuti G, Maffulli N. Haemoglobin and transfusions in elderly patients with hip fractures: the effect of a dedicated orthogeriatrician. J Orthop Surg Res. 2021;16(1):387. doi: 10.1186/s13018-021-02524-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13018-021-02524-0</ArticleId><ArticleId IdType="pmc">PMC8207795</ArticleId><ArticleId IdType="pubmed">34134743</ArticleId></ArticleIdList></Reference><Reference><Citation>Mounet B, Choquet O, Swisser F, Biboulet P, Bernard N, Bringuier S, Capdevila X. Impact of multiple nerves blocks anaesthesia on intraoperative hypotension and mortality in hip fracture surgery intermediate-risk elderly patients: a propensity score-matched comparison with spinal and general anaesthesia. Anaesth Crit Care Pain Med. 2021;40(4):100924. doi: 10.1016/j.accpm.2021.100924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.accpm.2021.100924</ArticleId><ArticleId IdType="pubmed">34217841</ArticleId></ArticleIdList></Reference><Reference><Citation>Korhonen A-M, Valanne JV, Jokela RM, Ravaska P, Korttila KT. A comparison of selective spinal anesthesia with hyperbaric bupivacaine and general anesthesia with desflurane for outpatient knee arthroscopy. Anesth Analg. 2004;99(6):1668&#x2013;1673. doi: 10.1213/01.ANE.0000139351.40608.05.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ANE.0000139351.40608.05</ArticleId><ArticleId IdType="pubmed">15562051</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonano C, Leitgeb U, Sitzwohl C, Ihra G, Weinstabl C, Kettner SC. Spinal versus general anesthesia for orthopedic surgery: anesthesia drug and supply costs. Anesth Analg. 2006;102(2):524&#x2013;529. doi: 10.1213/01.ane.0000194292.81614.c6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000194292.81614.c6</ArticleId><ArticleId IdType="pubmed">16428554</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu SS, Strodtbeck WM, Richman JM, Wu CL. A comparison of regional versus general anesthesia for ambulatory anesthesia: a meta-analysis of randomized controlled trials. Anesth Analg. 2005;101(6):1634&#x2013;1642. doi: 10.1213/01.ANE.0000180829.70036.4F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ANE.0000180829.70036.4F</ArticleId><ArticleId IdType="pubmed">16301234</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant MC, Pio Roda CM, Canner JK, Sommer P, Galante D, Hobson D, Gearhart S, Wu CL, Wick E. The impact of anesthesia-influenced process measure compliance on length of stay: results from an enhanced recovery after surgery for colorectal surgery cohort. Anesth Analg. 2019;128(1):68&#x2013;74. doi: 10.1213/ANE.0000000000003458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000003458</ArticleId><ArticleId IdType="pubmed">29782405</ArticleId></ArticleIdList></Reference><Reference><Citation>Nawi SNM, Wong B, Edwards S, Loh X, Maddison J. A retrospective observational study on the types of anaesthesia in hip fracture surgery. J Perioper Pract. 2021;33(1&#x2013;2):15&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">34197241</ArticleId></ArticleIdList></Reference><Reference><Citation>Kir G, Buget M, Koltka K, Kir MC, Pembeci K. The impact of timing of surgery and the anesthesia technique in hip fracture surgery on in-hospital mortality and length of hospital stay. J Acad Res Med-Jarem. 2020;10(1):82&#x2013;87. doi: 10.4274/jarem.galenos.2019.2076.</Citation><ArticleIdList><ArticleId IdType="doi">10.4274/jarem.galenos.2019.2076</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith LM, Cozowicz C, Uda Y, Memtsoudis SG, Barrington MJ. Neuraxial and combined neuraxial/general anesthesia compared to general anesthesia for major truncal and lower limb surgery: a systematic review and meta-analysis. Anesth Analg. 2017;125(6):1931&#x2013;1945. doi: 10.1213/ANE.0000000000002069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000002069</ArticleId><ArticleId IdType="pubmed">28537970</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Rosenbaum PR, Ludwig JM, Zubizarreta JR, Silber JH. Anesthesia technique, mortality, and length of stay after hip fracture surgery. JAMA. 2014;311(24):2508&#x2013;2517. doi: 10.1001/jama.2014.6499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.6499</ArticleId><ArticleId IdType="pmc">PMC4344128</ArticleId><ArticleId IdType="pubmed">25058085</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H-J, Park H-S, Go Y-J, Koh WU, Kim H, Song J-G, Ro Y-J. Effect of anesthetic technique on the occurrence of acute kidney injury after total knee arthroplasty. J Clin Med. 2019;8(6):778. doi: 10.3390/jcm8060778.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8060778</ArticleId><ArticleId IdType="pmc">PMC6616515</ArticleId><ArticleId IdType="pubmed">31159309</ArticleId></ArticleIdList></Reference><Reference><Citation>Block BM, Liu SS, Rowlingson AJ, Cowan AR, Cowan JA, Wu CL. Efficacy of postoperative epidural analgesia: a meta-analysis. JAMA. 2003;290(18):2455&#x2013;2463. doi: 10.1001/jama.290.18.2455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.290.18.2455</ArticleId><ArticleId IdType="pubmed">14612482</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Xu X, Ni H. Small studies may overestimate the effect sizes in critical care meta-analyses: a meta-epidemiological study. Crit Care. 2013;17(1):R2. doi: 10.1186/cc11919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11919</ArticleId><ArticleId IdType="pmc">PMC4056100</ArticleId><ArticleId IdType="pubmed">23302257</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39490985</PMID><DateCompleted><Year>2025</Year><Month>01</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1523-1755</ISSN><JournalIssue CitedMedium="Internet"><Volume>107</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Kidney international</Title><ISOAbbreviation>Kidney Int</ISOAbbreviation></Journal><ArticleTitle>A sub-study of the POISE-3 randomized trial examined effects of a perioperative hypotension-avoidance strategy versus a hypertension-avoidance strategy on the risk of acute kidney injury.</ArticleTitle><Pagination><StartPage>155</StartPage><EndPage>168</EndPage><MedlinePgn>155-168</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.kint.2024.10.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0085-2538(24)00717-8</ELocationID><Abstract><AbstractText>In this pre-specified sub-study of the POISE-3 trial, we examined the effect of a perioperative hypotension-avoidance strategy versus a hypertension-avoidance strategy on the risk of postoperative acute kidney injury (AKI). Altogether, 7307 patients were included from 110 hospitals in 22 countries. Patients were 45 years and older, had or were at risk of atherosclerotic disease, took at least one antihypertensive medication, and were scheduled for noncardiac surgery. Hypotension-avoidance strategy: (i) target intraoperative mean arterial pressure (MAP) 80 mm&#xa0;Hg or over, (ii) on day of surgery and for two days after, hold renin-angiotensin-aldosterone system inhibitors and use other antihypertensives in stepwise fashion if systolic blood pressure (SBP) 130 mm&#xa0;Hg or more. Hypertension-avoidance strategy: (i) target intraoperative MAP 60 mm&#xa0;Hg or more, (ii) continue all antihypertensives before and after surgery. Primary outcome: postoperative AKI, an increase in serum creatinine concentration of either 26.5 &#x3bc;mol/L or more (0.3 mg/dL or more) within 48 hours of randomization or 50% or more within seven days of randomization. The hypotension-avoidance group (3654 patients) used fewer antihypertensive medications than the hypertension-avoidance group (3653 patients); specifically, 6% vs. 38% used an ACEI or ARB on the day of surgery, and 6% vs. 47% and 7% vs. 50% one and two days after surgery, respectively. Patients also spent about half as much intraoperative time with a MAP under 80 mm&#xa0;Hg (27 vs. 60 minutes, respectively), but had little difference in average BP before or after surgery. There was no significant difference in AKI risk (15.1% vs. 14.4%). Results were consistent with other definitions of AKI and in patients with preexisting chronic kidney disease. Thus, a hypotension-avoidance strategy targeting a MAP greater than 80 mm&#xa0;Hg in the operating room and discontinued blood pressure medication during the perioperative period did not confer a lower risk of AKI compared to a hypertension avoidance strategy. Clinical trial registration number: NCT03505723.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><CollectiveName>POISE-3 Trial Investigators and Study Groups</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03505723</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Kidney Int</MedlineTA><NlmUniqueID>0323470</NlmUniqueID><ISSNLinking>0085-2538</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000959">Antihypertensive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="Y">Hypertension</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000959" MajorTopicYN="Y">Antihypertensive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062186" MajorTopicYN="N">Arterial Pressure</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">antihypertensive medication</Keyword><Keyword MajorTopicYN="N">hypotension</Keyword><Keyword MajorTopicYN="N">mean arterial pressure</Keyword><Keyword MajorTopicYN="N">noncardiac surgery</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Garg</LastName><ForeName>Amit X</ForeName><Initials>AX</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marcucci</LastName><ForeName>Maura</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cuerden</LastName><ForeName>Meaghan S</ForeName><Initials>MS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sontrop</LastName><ForeName>Jessica M</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Painter</LastName><ForeName>Thomas W</ForeName><Initials>TW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lomivorotov</LastName><ForeName>Vladimir</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chan</LastName><ForeName>Matthew T V</ForeName><Initials>MTV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Borges</LastName><ForeName>Flavia K</ForeName><Initials>FK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leslie</LastName><ForeName>Kate</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Duceppe</LastName><ForeName>Emmanuelle</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parikh</LastName><ForeName>Chirag R</ForeName><Initials>CR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roshanov</LastName><ForeName>Pavel</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mart&#xed;nez-Zapata</LastName><ForeName>Mar&#xed;a Jos&#xe9;</ForeName><Initials>MJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>Chew Yin</ForeName><Initials>CY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Xavier</LastName><ForeName>Denis</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Efremov</LastName><ForeName>Sergey</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kleinlugtenbelt</LastName><ForeName>Ydo V</ForeName><Initials>YV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Szczeklik</LastName><ForeName>Wojciech</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schmartz</LastName><ForeName>Denis</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meyhoff</LastName><ForeName>Christian S</ForeName><Initials>CS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Short</LastName><ForeName>Timothy G</ForeName><Initials>TG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amir</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Torres</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wittmann</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patel</LastName><ForeName>Ameen</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ruetzler</LastName><ForeName>Kurt</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parlow</LastName><ForeName>Joel L</ForeName><Initials>JL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jayaram</LastName><ForeName>Raja</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Polanczyk</LastName><ForeName>Carisi A</ForeName><Initials>CA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleischmann</LastName><ForeName>Edith</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tandon</LastName><ForeName>Vikas</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Astrakov</LastName><ForeName>Sergey V</ForeName><Initials>SV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Conen</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kei Wu</LastName><ForeName>William Ka</ForeName><Initials>WK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cheong</LastName><ForeName>Chao Chia</ForeName><Initials>CC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ayad</LastName><ForeName>Sabry</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kirov</LastName><ForeName>Mikhail</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Nadal</LastName><ForeName>Miriam</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Likhvantsev</LastName><ForeName>Valery V</ForeName><Initials>VV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paniagua</LastName><ForeName>Pilar</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aguado</LastName><ForeName>Hector J</ForeName><Initials>HJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ofori</LastName><ForeName>Sandra N</ForeName><Initials>SN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vincent</LastName><ForeName>Jessica</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Copland</LastName><ForeName>Ingrid</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Balasubramanian</LastName><ForeName>Kumar</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Biccard</LastName><ForeName>Bruce M</ForeName><Initials>BM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Srinathan</LastName><ForeName>Sadeesh</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ismoilov</LastName><ForeName>Samandar</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>Michael Ke</ForeName><Initials>MK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurz</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Belley-Cote</LastName><ForeName>Emilie P</ForeName><Initials>EP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bhatt</LastName><ForeName>Keyur</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eikelboom</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gross</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lamy</LastName><ForeName>Andre</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>McGillion</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>McIntyre</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Richards</LastName><ForeName>Toby</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Spence</LastName><ForeName>Jessica</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Van Helder</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Whitlock</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Devereaux</LastName><ForeName>P J</ForeName><Initials>PJ</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>3</Day><Hour>0</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39490985</ArticleId><ArticleId IdType="doi">10.1016/j.kint.2024.10.007</ArticleId><ArticleId IdType="pii">S0085-2538(24)00717-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39095375</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>02</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Risk factors for acute kidney injury in preterm neonates after noncardiac surgery: a single-center retrospective cohort study.</ArticleTitle><Pagination><StartPage>17965</StartPage><MedlinePgn>17965</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">17965</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-67782-4</ELocationID><Abstract><AbstractText>Postoperative acute kidney injury (AKI) is a common complication that is associated with chronic kidney disease, early postsurgical mortality, and prolonged hospital stays. Preterm neonates who undergo surgery are at risk factors for AKI due to underdeveloped kidneys. To date, little is known about the incidence and perioperative risk factors for AKI in preterm neonates undergoing noncardiac surgery. Preterm neonates who underwent noncardiac surgery between January May 1, 2020, and February 28, 2023, were enrolled in the trial according to the inclusion criteria. Both multivariable and logistic regression analyses were used to analyze the associations between characteristic data and AKI. In total, 106 preterm neonates met the inclusion criteria, and 25 preterm neonates (23.6%) developed postoperative AKI. Multivariate analysis revealed that the factors associated with AKI were gestational age&#x2009;&lt;&#x2009;32&#xa0;weeks [OR: 4.88; 95% CI (1.23-19.42)], preoperative sepsis [OR: 3.98; 95% CI (1.29-12.28)], and intraoperative hypotension [OR: 3.75; 95% CI (1.26-11.15)]. Preterm neonates who developed AKI were more likely to have longer hospital length of stays (38 [18,69] days vs. 21[12,46]) and higher medical costs (93,181.6 [620450.0,173,219.0] &#xffe5; vs. 58,134.6 [31015.1,97,224,1) &#xffe5; than neonates who did not develop AKI. Preterm neonates who underwent noncardiac surgery had a high incidence of AKI. Independent risk factors for AKI in preterm neonates who underwent noncardiac surgery were low gestational age, preoperative sepsis, and intraoperative hypotension. Preterm neonates who developed AKI were more likely to have longer hospital stays and higher medical costs.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Su-Jing</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fujian Children's Hospital, (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Fang</LastName><ForeName>Tuan-Fang</ForeName><Initials>TF</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fujian Children's Hospital, (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Min-Yi</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fujian Children's Hospital, (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shu</LastName><ForeName>Nan-Nan</ForeName><Initials>NN</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fujian Children's Hospital, (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fujian Children's Hospital, (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Gu</LastName><ForeName>Hong-Bin</ForeName><Initials>HB</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Dan</LastName><ForeName>Ying-Zhi</ForeName><Initials>YZ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fujian Children's Hospital, (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lu</LastName><ForeName>Guo-Lin</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fujian Children's Hospital, (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China. guolinlu2020@fjmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2021Y9172</GrantID><Agency>Joint Funds for the Innovation of science and Technology, Fujian province</Agency><Country/></Grant><Grant><GrantID>2022J011067</GrantID><Agency>the Natural Science Foundation of Fujian Province</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007234" MajorTopicYN="Y">Infant, Premature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="Y">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005865" MajorTopicYN="N">Gestational Age</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Hypotension</Keyword><Keyword MajorTopicYN="N">Noncardiac surgery</Keyword><Keyword MajorTopicYN="N">Preterm neonate</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>3</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>3</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>2</Day><Hour>23</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39095375</ArticleId><ArticleId IdType="pmc">PMC11297254</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-67782-4</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-67782-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Srinivasan, N., Schwartz, A., John, E., Price, R. &amp; Amin, S. Acute kidney injury impairs postnatal renal adaptation and increases morbidity and mortality in very low-birth-weight infants. Am. J. Perinatol.35(1), 39&#x2013;47 (2018). 10.1055/s-0037-1604470</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1604470</ArticleId><ArticleId IdType="pubmed">28768337</ArticleId></ArticleIdList></Reference><Reference><Citation>Akcan-Arikan, A. et al. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int.71(10), 1028&#x2013;1035 (2007). 10.1038/sj.ki.5002231</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ki.5002231</ArticleId><ArticleId IdType="pubmed">17396113</ArticleId></ArticleIdList></Reference><Reference><Citation>Shalaby, M. A. et al. Incidence, risk factors, and outcome of neonatal acute kidney injury: a prospective cohort study. Pediatr. Nephrol.33(9), 1617&#x2013;1624 (2018). 10.1007/s00467-018-3966-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00467-018-3966-7</ArticleId><ArticleId IdType="pubmed">29869723</ArticleId></ArticleIdList></Reference><Reference><Citation>Jetton, J. G. et al. Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study. Lancet Child Adolesc. Health1(3), 184&#x2013;194 (2017). 10.1016/S2352-4642(17)30069-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(17)30069-X</ArticleId><ArticleId IdType="pmc">PMC5933049</ArticleId><ArticleId IdType="pubmed">29732396</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, Y., Hua, X., Yang, G., Xiang, B. &amp; Jiang, X. Incidence, risk factors, and outcomes of acute kidney injury in neonates after surgical procedures. Pediatr. Nephrol.35(7), 1341&#x2013;1346 (2020). 10.1007/s00467-020-04532-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00467-020-04532-4</ArticleId><ArticleId IdType="pubmed">32232634</ArticleId></ArticleIdList></Reference><Reference><Citation>Englberger, L. et al. Clinical accuracy of RIFLE and acute kidney injury network (AKIN) criteria for acute kidney injury in patients undergoing cardiac surgery. Crit. Care15(1), R16 (2011). 10.1186/cc9960</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9960</ArticleId><ArticleId IdType="pmc">PMC3222049</ArticleId><ArticleId IdType="pubmed">21232094</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman, C., Tambay Perez, A., Selewski, D. T. &amp; Steflik, H. J. Neonatal acute kidney injury. Front. Pediatr.10, 842544 (2022). 10.3389/fped.2022.842544</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.842544</ArticleId><ArticleId IdType="pmc">PMC9021424</ArticleId><ArticleId IdType="pubmed">35463895</ArticleId></ArticleIdList></Reference><Reference><Citation>Grocott, M. P. et al. Perioperative increase in global blood flow to explicit defined goals and outcomes after surgery: A cochrane systematic review. Br. J. Anaesth.111(4), 535&#x2013;548 (2013). 10.1093/bja/aet155</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aet155</ArticleId><ArticleId IdType="pubmed">23661403</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg, P. M. et al. Severe acute kidney injury in neonates with necrotizing enterocolitis: Risk factors and outcomes. Pediatr. Res.90(3), 642&#x2013;649 (2021). 10.1038/s41390-020-01320-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-020-01320-6</ArticleId><ArticleId IdType="pmc">PMC8277891</ArticleId><ArticleId IdType="pubmed">33446918</ArticleId></ArticleIdList></Reference><Reference><Citation>Blinder, J. J. et al. Congenital heart surgery in infants: effects of acute kidney injury on outcomes. J. Thorac. Cardiovasc. Surg.143(2), 368&#x2013;374 (2012). 10.1016/j.jtcvs.2011.06.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2011.06.021</ArticleId><ArticleId IdType="pubmed">21798562</ArticleId></ArticleIdList></Reference><Reference><Citation>Jetton, J. G. &amp; Askenazi, D. J. Update on acute kidney injury in the neonate. Curr. Opin. Pediatr.24(2), 191&#x2013;196 (2012). 10.1097/MOP.0b013e32834f62d5</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOP.0b013e32834f62d5</ArticleId><ArticleId IdType="pmc">PMC5545784</ArticleId><ArticleId IdType="pubmed">22227783</ArticleId></ArticleIdList></Reference><Reference><Citation>Weintraub, A. S., Connors, J., Carey, A., Blanco, V. &amp; Green, R. S. The spectrum of onset of acute kidney injury in premature infants less than 30 weeks gestation. J. Perinatol.36(6), 474&#x2013;480 (2016). 10.1038/jp.2015.217</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jp.2015.217</ArticleId><ArticleId IdType="pubmed">26796125</ArticleId></ArticleIdList></Reference><Reference><Citation>Wingert, T. et al. Acute kidney injury and outcomes in children undergoing noncardiac surgery: A propensity-matched analysis. Anesth. Analg.132(2), 332&#x2013;340 (2021). 10.1213/ANE.0000000000005069</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005069</ArticleId><ArticleId IdType="pmc">PMC7855789</ArticleId><ArticleId IdType="pubmed">32739953</ArticleId></ArticleIdList></Reference><Reference><Citation>Stojanovi&#x107;, V., Bari&#x161;i&#x107;, N., Milanovi&#x107;, B. &amp; Doronjski, A. Acute kidney injury in preterm infants admitted to a neonatal intensive care unit. Pediatr. Nephrol.29(11), 2213&#x2013;2220 (2014). 10.1007/s00467-014-2837-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00467-014-2837-0</ArticleId><ArticleId IdType="pubmed">24839217</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavanaugh, K. J., Jetton, J. G. &amp; Kent, A. L. Neonatal acute kidney injury: Understanding of the impact on the smallest patients. Crit. Care Clin.37(2), 349&#x2013;363 (2021). 10.1016/j.ccc.2020.11.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2020.11.007</ArticleId><ArticleId IdType="pubmed">33752860</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, C. C. et al. Incidence and outcomes of acute kidney injury in extremely-low-birth-weight infants. PLoS One12(11), e0187764 (2017). 10.1371/journal.pone.0187764</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0187764</ArticleId><ArticleId IdType="pmc">PMC5673227</ArticleId><ArticleId IdType="pubmed">29108006</ArticleId></ArticleIdList></Reference><Reference><Citation>Blatt, N. B., Srinivasan, S., Mottes, T., Shanley, M. M. &amp; Shanley, T. P. Biology of sepsis: its relevance to pediatric nephrology. Pediatr. Nephrol.29(12), 2273&#x2013;2287 (2014). 10.1007/s00467-013-2677-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00467-013-2677-3</ArticleId><ArticleId IdType="pmc">PMC4092055</ArticleId><ArticleId IdType="pubmed">24408224</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent, K., Murphy, H. J., Ross, J. R. &amp; Twombley, K. E. Acute kidney injury guidelines are associated with improved recognition and follow-up for neonatal patients. Adv. Neonatal. Care20(4), 269&#x2013;275 (2020). 10.1097/ANC.0000000000000664</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ANC.0000000000000664</ArticleId><ArticleId IdType="pubmed">31567184</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojo, B. &amp; Campbell, C. H. Perioperative acute kidney injury: Impact and recent update. Curr. Opin. Anaesthesiol.35(2), 215&#x2013;223 (2022). 10.1097/ACO.0000000000001104</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0000000000001104</ArticleId><ArticleId IdType="pubmed">35102042</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi, Y. &amp; Yamaoka, K. Analysis of intraoperative modifiable factors to prevent acute kidney injury after elective noncardiac surgery: Intraoperative hypotension and crystalloid administration related to acute kidney injury. JA Clin. Rep.7(1), 27 (2021). 10.1186/s40981-021-00429-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40981-021-00429-9</ArticleId><ArticleId IdType="pmc">PMC7991025</ArticleId><ArticleId IdType="pubmed">33761037</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmasi, V. et al. Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery: A retrospective cohort analysis. Anesthesiology126(1), 47&#x2013;65 (2017). 10.1097/ALN.0000000000001432</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001432</ArticleId><ArticleId IdType="pubmed">27792044</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmody, J. B., Swanson, J. R., Rhone, E. T. &amp; Charlton, J. R. Recognition and reporting of AKI in very low birth weight infants. Clin. J. Am. Soc. Nephrol.9(12), 2036&#x2013;2043 (2014). 10.2215/CJN.05190514</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.05190514</ArticleId><ArticleId IdType="pmc">PMC4255405</ArticleId><ArticleId IdType="pubmed">25280497</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36520229</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1438-8359</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of anesthesia</Title><ISOAbbreviation>J Anesth</ISOAbbreviation></Journal><ArticleTitle>Association between intraoperative oliguria and postoperative acute kidney injury in non-cardiac surgical patients: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>219</StartPage><EndPage>233</EndPage><MedlinePgn>219-233</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00540-022-03150-8</ELocationID><Abstract><AbstractText Label="PURPOSE">This systematic review and meta-analysis aimed to evaluate the association between intraoperative oliguria and the risk of postoperative acute kidney injury (AKI) in patients undergoing non-cardiac surgery.</AbstractText><AbstractText Label="METHODS">The MEDLINE and EMBASE databases were searched up to August 2022 for studies in adult patients undergoing non-cardiac surgery, where the association between intraoperative urine output and the risk of postoperative AKI was assessed. Both randomised and non-randomised studies were eligible for inclusion. Study selection and risk of bias assessment were independently performed by two investigators. The risk of bias was evaluated using the Newcastle-Ottawa scale. We performed meta-analysis of the reported multivariate adjusted odds ratios for the association between intraoperative oliguria (defined as urine output&#x2009;&lt;&#x2009;0.5&#xa0;mL/kg/hr) and the risk of postoperative AKI using the inverse-variance method with random effects models. We conducted sensitivity analyses using varying definitions of oliguria as well as by pooling unadjusted odds ratios to establish the robustness of the primary meta-analysis. We also conducted subgroup analyses according to surgery type and definition of AKI to explore potential sources of clinical or methodological heterogeneity.</AbstractText><AbstractText Label="RESULTS">Eleven studies (total 49,252 patients from 11 observational studies including a post hoc analysis of a randomised controlled trial) met the selection criteria. Seven of these studies contributed data from a total 17,148 patients to the primary meta-analysis. Intraoperative oliguria was associated with a significantly elevated risk of postoperative AKI (pooled adjusted odds ratio [OR] 1.74; 95% confidence interval [CI] 1.36-2.23, p&#x2009;&lt;&#x2009;0.0001, 8 studies). Sensitivity analyses supported the robustness of the primary meta-analysis. There was no evidence of any significant subgroup differences according to surgery type or definition of AKI.</AbstractText><AbstractText Label="CONCLUSIONS">This study demonstrated a significant association between intraoperative oliguria and the risk of postoperative AKI, regardless of the definitions of oliguria or AKI used. Further prospective and multi-centre studies using standardised definitions of intraoperative oliguria are required to define the thresholds of oliguria and establish strategies to minimise the risk of AKI.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s) under exclusive licence to Japanese Society of Anesthesiologists.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Milder</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Westmead Hospital, Westmead, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Sophie S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Westmead Hospital, Westmead, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ong</LastName><ForeName>Sharon G K</ForeName><Initials>SGK</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Sengkang General Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgical Intensive Care, Singapore General Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kam</LastName><ForeName>Peter C A</ForeName><Initials>PCA</Initials><Identifier Source="ORCID">0000-0002-8771-5599</Identifier><AffiliationInfo><Affiliation>Discipline of Anaesthesia, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, 2006, Australia. peter.kam@sydney.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>J Anesth</MedlineTA><NlmUniqueID>8905667</NlmUniqueID><ISSNLinking>0913-8668</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009846" MajorTopicYN="Y">Oliguria</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Intraoperative oliguria</Keyword><Keyword MajorTopicYN="N">Mechanisms</Keyword><Keyword MajorTopicYN="N">Thresholds</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>11</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36520229</ArticleId><ArticleId IdType="doi">10.1007/s00540-022-03150-8</ArticleId><ArticleId IdType="pii">10.1007/s00540-022-03150-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kellum JA, Sileanu FE, Murugan R, Lucko N, Shaw AD, Clermont G. Classifying AKI by urine output versus serum creatinine level. J Am Soc Nephrol. 2015;26:2231&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">25568178</ArticleId><ArticleId IdType="pmc">4552117</ArticleId><ArticleId IdType="doi">10.1681/ASN.2014070724</ArticleId></ArticleIdList></Reference><Reference><Citation>Eknoyan G. The origins of nephrology&#x2013;galen, the founding father of experimental renal physiology. Am J Nephrol. 1989;9:66&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">2655450</ArticleId><ArticleId IdType="doi">10.1159/000167939</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M, Schmidt C, Hoffmeier A, Van Aken H, Wempe C, Gerss J, Zarbock A. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med. 2017;43:1551&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">28110412</ArticleId><ArticleId IdType="pmc">5633630</ArticleId><ArticleId IdType="doi">10.1007/s00134-016-4670-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Roneo C, Kellum J, Mehta RL, Palevsky P. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (ADQI) group. Crit Care. 2004;8:R204&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">15312219</ArticleId><ArticleId IdType="pmc">522841</ArticleId><ArticleId IdType="doi">10.1186/cc2872</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV, Molitoris BA, Warnock DG, Levin A. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.</Citation><ArticleIdList><ArticleId IdType="pubmed">17331245</ArticleId><ArticleId IdType="pmc">2206446</ArticleId><ArticleId IdType="doi">10.1186/cc5713</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease: Improving Global Outcomes (KIDGO). Acute Kidney Injury Work Group. KDIGO clinical practice guidelines for acute kidney injury. Kidney Int. 2012; Suppl 2;1&#x2013;138.</Citation></Reference><Reference><Citation>Macedo E, Malhotra R, Claure-Del Granado R, Fedullo P, Mehta RL. Defining urine output criterion for acute kidney injury in critically ill patients. Nephrol Dial Transplant. 2011;26:509&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">20562094</ArticleId><ArticleId IdType="doi">10.1093/ndt/gfq332</ArticleId></ArticleIdList></Reference><Reference><Citation>Gameiro J, Neves JB, Rodrigues N, Bekerman C, Melo MJ, Pereira M, Teixeira C, Mendes I, Jorge S, Rosa R, Lopes JA. Acute kidney injury, long-term renal function and mortality in patients undergoing major abdominal surgery: a cohort analysis. Clin Kidney J. 2016;9:192&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">26985368</ArticleId><ArticleId IdType="pmc">4792619</ArticleId><ArticleId IdType="doi">10.1093/ckj/sfv144</ArticleId></ArticleIdList></Reference><Reference><Citation>Kullmar M, Meersch M. intraoperative oliguria: physiological or beginning acute kidney injury? Anesth Analg. 2018;127:1109&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">30335658</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000003786</ArticleId></ArticleIdList></Reference><Reference><Citation>du Toit L, Biccard BM. The relationship between intraoperative oliguria and acute kidney injury. Br J Anaesth. 2019;122:707&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">30961912</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2019.03.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukazawa K, Lee HT. Volatile anesthetics and AKI: risks, mechanisms, and a potential therapeutic window. J Am Soc Nephrol. 2014;25:884&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">24511126</ArticleId><ArticleId IdType="pmc">4005317</ArticleId><ArticleId IdType="doi">10.1681/ASN.2013111215</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen NT, Perez RV, Fleming N, Rivers R, Wolfe BM. Effect of prolonged pneumoperitoneum on intraoperative urine output during laparoscopic gastric bypass. J Am Coll Surg. 2002;195:476&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">12375752</ArticleId><ArticleId IdType="doi">10.1016/S1072-7515(02)01321-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Kork F, Balzer F, Spies CD, Wernecke KD, Ginde AA, Janowski J, Eltzchig HK. Minor postoperative increases of creatinine are associated with higher mortality and longer hospital stay in surgical patients. Anesthesiology. 2015;123:1301&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">26492475</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000000891</ArticleId></ArticleIdList></Reference><Reference><Citation>McIlroy DR, Belloma R, Billings FT, Karkouti K, Prowle JR, Shaw AD, Myles PS. Systematic review and consensus definitions for the standardised endpoints in perioperative medicine (StEP) initiative: renal endpoints. Br J Anaesth. 2018;121:1013&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">30336845</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2018.08.010</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neal JB, Shaw AD, Billings FT. Acute kidney injury following cardiac surgery: current understanding and future directions. Crit Care. 2016;20:187.</Citation><ArticleIdList><ArticleId IdType="pubmed">27373799</ArticleId><ArticleId IdType="pmc">4931708</ArticleId><ArticleId IdType="doi">10.1186/s13054-016-1352-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Grams ME, Sang Y, Coresh J, Ballew S, Matsushita K, Molnar MZ, Szabo Z, Kalantar-Zadeh K, Kovesdy CP. Acute kidney injury after major surgery: a retrospective analysis of veterans health administration data. Am J Kidney Dis. 2016;67:872&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">26337133</ArticleId><ArticleId IdType="doi">10.1053/j.ajkd.2015.07.022</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakar CV, Kharat V, Blank S, Leonard AC. Acute kidney injury after gastric bypass surgery. Clin J Am Soc Nephrol. 2007;2:426&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">17699447</ArticleId><ArticleId IdType="doi">10.2215/CJN.03961106</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabezuelo JB, Ramirez P, Rios A, Acosta F, Torres D, Sansano T, Pons JA, Bru M, Montoya M, Bueno FS, Robles R. Risk factors of acute renal failure after liver transplantation. Kidney Int. 2006;69:1073&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">16528257</ArticleId><ArticleId IdType="doi">10.1038/sj.ki.5000216</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012;81:442&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22113526</ArticleId><ArticleId IdType="doi">10.1038/ki.2011.379</ArticleId></ArticleIdList></Reference><Reference><Citation>Hultstrom M. Neurohormonal interactions on the renal oxygen delivery and consumption in haemorrhagic shock-induced acute kidney injury. Acta Physiol (Oxf). 2013;209:11&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">23837642</ArticleId><ArticleId IdType="doi">10.1111/apha.12147</ArticleId></ArticleIdList></Reference><Reference><Citation>Fani F, Regolisti G, Delsante M, Cantalappi V, Castellano G, Gesualdo L, Villa G, Fiaccadori E. Recent advances in the pathogenetic mechanisms of sepsis-associated acute kidney injury. J Nephrol. 2018;31:351&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29273917</ArticleId><ArticleId IdType="doi">10.1007/s40620-017-0452-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Prowle JR. Paradigms of acute kidney injury in the intensive care setting. Nat Rev Nephrol. 2018;14:217&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">29355173</ArticleId><ArticleId IdType="doi">10.1038/nrneph.2017.184</ArticleId></ArticleIdList></Reference><Reference><Citation>Goren O, Matot I. (2015) Perioperative acute kidney injury. Br J Anaesth. 115 Suppl 2: ii3&#x2013;14.</Citation></Reference><Reference><Citation>Burton D, Nicholson G, Hall G. Endocrine and metabolic response to surgery. Continuing Education Anaesthesia Critical Care Pain. 2004;4:169&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bjaceaccp/mkh040</ArticleId></ArticleIdList></Reference><Reference><Citation>Philbin DM, Coggins CH. Plasma antidiuretic hormone levels in cardiac surgical patients during morphine and halothane anesthesia. Anesthesiology. 1978;49:95&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">686433</ArticleId><ArticleId IdType="doi">10.1097/00000542-197808000-00007</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozkurt P, Kaya G, Yuksel Y, Fatius A, Bakan M, Hacibekiroglu M, Kavunoblu G. Effects of systemic and epidural morphine on antidiuretic hormone levels in children. Paediatr Anaesth. 2003;13:508&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">12846707</ArticleId><ArticleId IdType="doi">10.1046/j.1460-9592.2003.01096.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Abuelo JG. Normotensive ischemic acute renal failure. N Engl J Med. 2007;357:797&#x2013;805.</Citation><ArticleIdList><ArticleId IdType="pubmed">17715412</ArticleId><ArticleId IdType="doi">10.1056/NEJMra064398</ArticleId></ArticleIdList></Reference><Reference><Citation>Nash DM, Mustafa RA, McArthur E, Wijeysundera DN, Paterson JM, Sharan S, Vinden C, Wald R, Welk B, Sessler DI, Devereaux PJ. Combined general and neuraxial anesthesia versus general anesthesia: a population-based cohort study. Can J Anaesth. 2015;62:356&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">25622933</ArticleId><ArticleId IdType="doi">10.1007/s12630-015-0315-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SJ, Lehner GF, Forni LG, Joannidis M. Oliguria in critically ill patients: a narrative review. J Nephrol. 2018;31:855&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">30298272</ArticleId><ArticleId IdType="pmc">6244549</ArticleId><ArticleId IdType="doi">10.1007/s40620-018-0539-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu AW, Chang LS, Birkett DH, Babayan RK. Changes in urinary output and electrolytes during gaseous and gasless laparoscopy. Urol Res. 1996;24:361&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9008330</ArticleId><ArticleId IdType="doi">10.1007/BF00389794</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas GNC, Leitao AC, Alencar RL, Xavier RM, Daher ED, Junior GB. Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs. J Bras Nefrol. 2019;41:124&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">30281062</ArticleId><ArticleId IdType="doi">10.1590/2175-8239-jbn-2018-0107</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Novoa JM, Quiros Y, Vicente L, Morales AI, Lopez-Hernandez FJ. New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney Int. 2011;79:33&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">20861826</ArticleId><ArticleId IdType="doi">10.1038/ki.2010.337</ArticleId></ArticleIdList></Reference><Reference><Citation>Mingeot-Leclercq MP, Tulkens PM. Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother. 1999;43:1003&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">10223907</ArticleId><ArticleId IdType="pmc">89104</ArticleId><ArticleId IdType="doi">10.1128/AAC.43.5.1003</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff J, Mulrow C, Moher D. The PRISMA statement for reporting systematic reviews: development of the PRISMA 2020 statement. J Clin Epidemiol. 2021;134:103&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">33577987</ArticleId><ArticleId IdType="doi">10.1016/j.jclinepi.2021.02.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (eds). (2022) Cochrane Handbook for systematic reviews of interventions version 6.3 (updated February 2022). Cochrane</Citation></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">20652370</ArticleId><ArticleId IdType="doi">10.1007/s10654-010-9491-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles PS, McIIroy DR, Bellomo R, Wallace S. Importance of intraoperative oliguria during major abdominal surgery: findings of the restrictive versus liberal fluid therapy in major abdominal surgery trial. Br J Anaesth. 2019;122:726&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">30916001</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2019.01.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Englesbe MJ, O&#x2019;Reilly M, Shanks AM, Fetterman DM, Rosenberg AL, Swartz RD. Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology. 2007;107:892&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pubmed">18043057</ArticleId><ArticleId IdType="doi">10.1097/01.anes.0000290588.29668.38</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizota T, Yamamoto Y, Hamada M, Matsukawa S, Shimizu S, Kai S. Intraoperative oliguria predicts acute kidney injury after major abdominal surgery. Br J Anaesth. 2017;119:1127&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">29136086</ArticleId><ArticleId IdType="doi">10.1093/bja/aex255</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao BC, Lei SH, Yang X, Zhang Y, Qiu SD, Liu WF, Li C, Liu KX. Assessment of prognostic value of intraoperative oliguria for postoperative acute kidney injury: a retrospective cohort study. Br J Anaesth. 2020;126:799&#x2013;807.</Citation><ArticleIdList><ArticleId IdType="pubmed">33342539</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2020.11.018</ArticleId></ArticleIdList></Reference><Reference><Citation>Inacio R, Gameiro J, Amaro S, Duarte M. Intraoperative oliguria does not predict postoperative acute kidney injury in major abdominal surgery: a cohort analysis. J Bras Nefrol. 2021;43:9&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">32779689</ArticleId><ArticleId IdType="doi">10.1590/2175-8239-jbn-2019-0244</ArticleId></ArticleIdList></Reference><Reference><Citation>Goren O, Levy A, Cattan A, Lahat G, Matot I. Acute kidney injury in pancreatic surgery; association with urine output and intraoperative fluid administration. Am J Surg. 2017;214:246&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">28223046</ArticleId><ArticleId IdType="doi">10.1016/j.amjsurg.2017.01.040</ArticleId></ArticleIdList></Reference><Reference><Citation>Valencia Morales DJ, Plack DL, Kendrick ML, Schroeder DR, Sprung, J, Weingarten TN. (2022) Urine output and acute kidney injury following laparoscopic pancreas operations. HPB, Article in press</Citation></Reference><Reference><Citation>Kim WH, Lee HC, Lim L, Ryu HG, Jung CW. Intraoperative oliguria with decreased SvO<sub>2</sub> predicts acute kidney injury after living donor liver transplantation. J Clin Med. 2018;8(29):1&#x2013;14.</Citation></Reference><Reference><Citation>Slankamenac K, Beck-Schimmer B, Breitenstein S, Puhan MA, Clavien PA. Novel prediction score including pre- and intraoperative parameters best predicts acute kidney injury after liver surgery. World J Surg. 2013;37(11):2618&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">23959337</ArticleId><ArticleId IdType="doi">10.1007/s00268-013-2159-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Hur M, Park SK, Yoo S, Choi SN, Jeong CW, Kim WH, Kim JT, Kwak C, Bahk JH. The association between intraoperative urine output and postoperative acute kidney injury differs between partial and radical nephrectomy. Sci Rep. 2019;9(760):1&#x2013;9.</Citation></Reference><Reference><Citation>Shiba A, Uchino S, FujiiT Takinami M, Uezono S. Association between intraoperative oliguria and acute kidney injury after major noncardiac surgery. Anesth Analg. 2018;127:1229&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">29933276</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000003576</ArticleId></ArticleIdList></Reference><Reference><Citation>Altman DG, Lausen B, Sauerbrei W, Schumacher M. Dangers of using &#x201c;optimal&#x201d; cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst. 1994;86:829&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">8182763</ArticleId><ArticleId IdType="doi">10.1093/jnci/86.11.829</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Sutton AJ, Ioannidis JPA, Terrin N, Jones DR, Lau J. Carpenter j, Rucker G, Harbord RM, Schmid CH, Tetzlaff J, Deeks JJ, Peter J, Macaskill P, Schwarzer G, Duval s, Altman DG, Moher d, H'iggins JPT. (2011) Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ.;343 4002</Citation></Reference><Reference><Citation>Puckett JR, Pickering JW, Palmer SC, McCall JL, Kluger MT, De Zoysa J, Endre ZH, Soop M. Low versus standard urine output targets in patients undergoing major abdominal surgery: a randomized noninferiority trial. Ann Surg. 2017;265(5):874&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">27763895</ArticleId><ArticleId IdType="doi">10.1097/SLA.0000000000002044</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Liu YL, Licari E, Bagshaw SM,Egi M, Haase M, Haase-Fielitz A, Kellum JA, Cruz D, Ronco C, Tsutsui K, Oliguria as predictive biomarker of acute kidney injury in critically ill patients. Crit Care. 2011;15:R172. https://doi.org/10.1186/cc10318 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10318</ArticleId><ArticleId IdType="pubmed">21771324</ArticleId><ArticleId IdType="pmc">3387614</ArticleId></ArticleIdList></Reference><Reference><Citation>Md Ralib A, Pickering JW, Shaw GM, Endre ZH. The urine output definition of acute kidney injury is too liberal. Crit Care. 2013;17:R112.</Citation><ArticleIdList><ArticleId IdType="pubmed">23787055</ArticleId><ArticleId IdType="pmc">4056349</ArticleId><ArticleId IdType="doi">10.1186/cc12784</ArticleId></ArticleIdList></Reference><Reference><Citation>Fliser D, Laville M, Covic A, Fouque D, Vanholder R, Juillard L, Van Biesen W. A European Renal Best Practice (ERBP) position statement on Kidney Disease Improving Global Outcome (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast induced nephropathty. Nephrol Dial Transpl. 2012;27:4263&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfs375</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39531998</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>99</Volume><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Continuation versus discontinuation of renin-angiotensin aldosterone system inhibitors before non-cardiac surgery: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>111679</StartPage><MedlinePgn>111679</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2024.111679</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(24)00308-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A large number of patients undergoing noncardiac surgeries are on long-term use of angiotensin-converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARBs). The current guidelines regarding the continuation or discontinuation of renin-angiotensin-aldosterone system inhibitors (RAAS) inhibitors before noncardiac surgery are conflicting. This meta-analysis aims to evaluate whether continuing or withholding RAAS inhibitors before noncardiac surgery influences perioperative mortality and complications.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A thorough literature search was performed across PubMed/MEDLINE, Embase, and the Cochrane Library from their inception up to August 30, 2024 to identify eligible randomized controlled trials (RCTs) and cohort studies. Clinical outcomes were evaluated using a random-effects model to pool odds ratios (ORs) with 95&#xa0;% confidence intervals (CIs).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The analysis included 16 studies with a total of 59,105 patients on RAAS inhibitors before noncardiac surgery. Withholding RAAS inhibitors was associated with a significantly lower incidence of intraoperative hypotension (OR&#xa0;=&#xa0;0.49; 95&#xa0;% CI&#xa0;=&#xa0;0.29 to 0.83) and acute kidney injury (AKI) (OR&#xa0;=&#xa0;0.88; 95&#xa0;% CI&#xa0;=&#xa0;0.82 to 0.95) than continuing the therapy. However, there was no statistically significant difference in reducing mortality (OR&#xa0;=&#xa0;1.10; 95&#xa0;% CI&#xa0;=&#xa0;0.86 to 1.40), major adverse cardiovascular events (MACE) (OR&#xa0;=&#xa0;1.27; 95&#xa0;% CI&#xa0;=&#xa0;0.75 to 2.16), myocardial infarction (OR&#xa0;=&#xa0;0.83; 95&#xa0;% CI&#xa0;=&#xa0;0.27 to 2.59) or stroke events (OR&#xa0;=&#xa0;0.70; 95&#xa0;% CI&#xa0;=&#xa0;0.36 to 1.36) between the two groups.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Withholding RAAS inhibitors before noncardiac surgery reduces intraoperative hypotension and AKI with nonsignificant effects on mortality and MACE.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Mushood</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fatima</LastName><ForeName>Eeshal</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine, Services Institute of Medical Sciences, Lahore, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shafiq</LastName><ForeName>Aimen</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahsan</LastName><ForeName>Areeba</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Foundation University Medical College, Islamabad, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zulfiqar</LastName><ForeName>Eeshal</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masood</LastName><ForeName>Fouad</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, King Abdulaziz Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Raheel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Royal Brompton Hospital, London, UK; Department of Cardiology, National Heart and Lung Institute, Imperial College London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yasmin</LastName><ForeName>Farah</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asghar</LastName><ForeName>Muhammad Sohaib</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA; Department of Internal Medicine, AdventHealth, Sebring, FL, USA. Electronic address: msohaibasghar123@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000806">Angiotensin-Converting Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057911">Angiotensin Receptor Antagonists</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>J Clin Anesth. 2025 Jan;100:111705. doi: 10.1016/j.jclinane.2024.111705.</RefSource><PMID Version="1">39603926</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012084" MajorTopicYN="Y">Renin-Angiotensin System</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000806" MajorTopicYN="Y">Angiotensin-Converting Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057911" MajorTopicYN="Y">Angiotensin Receptor Antagonists</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D028761" MajorTopicYN="N">Withholding Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Angiotensin receptor blockers</Keyword><Keyword MajorTopicYN="N">Angiotensin-converting enzyme inhibitors</Keyword><Keyword MajorTopicYN="N">Hypertension</Keyword><Keyword MajorTopicYN="N">Non-cardiac surgery</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>25</Day><Hour>1</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>13</Day><Hour>14</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>12</Day><Hour>18</Hour><Minute>9</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39531998</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2024.111679</ArticleId><ArticleId IdType="pii">S0952-8180(24)00308-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40423764</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1868-4297</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>4</Issue><PubDate><Year>2025</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Cardiovascular intervention and therapeutics</Title><ISOAbbreviation>Cardiovasc Interv Ther</ISOAbbreviation></Journal><ArticleTitle>Comprehensive analysis of acute kidney injury incidence following transcatheter versus surgical aortic valve replacement in aortic stenosis: a systematic review and meta-analysis of 13,777 patients.</ArticleTitle><Pagination><StartPage>932</StartPage><EndPage>942</EndPage><MedlinePgn>932-942</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12928-025-01144-3</ELocationID><Abstract><AbstractText>This systematic review and meta-analysis evaluate Acute Kidney Injury (AKI) differences between surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) and how surgical risk stratification and diagnostic criteria influence outcomes. Following the PRISMA guidelines, we included both non-randomized studies&#xa0;and randomized clinical trials that reported AKI criteria and patients' surgical risk in patients with aortic stenosis by searching PubMed, Scopus, and Web of Science until late September. We executed a random-effects model in Review Manager to pool effect estimates of AKI incidence or the need for dialysis as an odds ratio (OR) and I<sup>2</sup> heterogeneity, and we utilized R for meta-regression to address any heterogeneity with subgroup analysis for surgical risk, AKI criteria, and study design. We used the Newcastle Ottawa Scale (NOS) and the Cochrane Risk of Bias Tool (RoB-1) for risk of bias assessment and GRADE for certainty assessment. Involving 17 studies&#xa0;and a total of 13,777 patients, we found that the AKI incidence was significantly lower in TAVR compared to SAVR (OR&#x2009;=&#x2009;0.36; 95% CI: [0.30, 0.44], I<sup>2</sup>&#x2009;=&#x2009;55%, P&#x2009;=&#x2009;0.003), along with the need for dialysis (OR&#x2009;=&#x2009;0.35; 95% CI: [0.19, 0.63], I<sup>2</sup>&#x2009;=&#x2009;0%, P&#x2009;=&#x2009;0.92). The study also found that intermediate and low-risk patients had more favorable outcomes. However, the retrospective study design and VARC-2 criteria were associated with unfavorable outcomes. TAVR effectively reduced the risk of AKI in all surgical risk categories and the need for dialysis compared to SAVR in patients with AS.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s) under exclusive licence to Japanese Association of Cardiovascular Intervention and Therapeutics.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alazzam</LastName><ForeName>Ahmad</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9291-8748</Identifier><AffiliationInfo><Affiliation>The Hashemite University, Zarqa, 13133, Jordan. ahmadyousefalazzam@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aldroubi</LastName><ForeName>Yacoub</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Jordan, Amman, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alhusban</LastName><ForeName>Tariq</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Jordanian Royal Medical Services, Prince Hashim Military Hospital, Zarqa, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Said</LastName><ForeName>Mosab</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Yarmouk University Faculty of Medicine - Irbid, Aydoun, Jordan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Cardiovasc Interv Ther</MedlineTA><NlmUniqueID>101522043</NlmUniqueID><ISSNLinking>1868-4297</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001021" MajorTopicYN="Y">Aortic Valve</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="Y">Aortic Valve Stenosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019918" MajorTopicYN="Y">Heart Valve Prosthesis Implantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065467" MajorTopicYN="Y">Transcatheter Aortic Valve Replacement</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AKI</Keyword><Keyword MajorTopicYN="N">Dialysis</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">SAVR</Keyword><Keyword MajorTopicYN="N">TAVI</Keyword><Keyword MajorTopicYN="N">TAVR</Keyword></KeywordList><CoiStatement>Declarations. Conflict of interest: The authors declared no potential conflicts of interest. Ethical considerations: Not applicable. Consent to participate: Not applicable. Consent for publication: Not applicable.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>16</Day><Hour>0</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>27</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>27</Day><Hour>11</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40423764</ArticleId><ArticleId IdType="doi">10.1007/s12928-025-01144-3</ArticleId><ArticleId IdType="pii">10.1007/s12928-025-01144-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561&#x2013;632. https://doi.org/10.1093/EURHEARTJ/EHAB395 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/EURHEARTJ/EHAB395</ArticleId><ArticleId IdType="pubmed">34453165</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Committee Members, Otto CM, Nishimura RA, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021;77(4):450&#x2013;500. https://doi.org/10.1016/j.jacc.2020.11.035 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.11.035</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien SM, Shahian DM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2&#x2013;isolated valve surgery. Ann Thorac Surg. 2009;88(1 Suppl):S23-42. https://doi.org/10.1016/j.athoracsur.2009.05.056 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2009.05.056</ArticleId><ArticleId IdType="pubmed">19559823</ArticleId></ArticleIdList></Reference><Reference><Citation>Mack MJ, Leon MB, Smith CR, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet (London, England). 2015;385(9986):2477&#x2013;84. https://doi.org/10.1016/S0140-6736(15)60308-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)60308-7</ArticleId><ArticleId IdType="pubmed">25788234</ArticleId></ArticleIdList></Reference><Reference><Citation>MacCarthy P, Smith D, Muir D, et al. Extended statement by the british cardiovascular intervention society president regarding transcatheter aortic valve implantation. Interv Cardiol (London, England). 2021;16: e03.</Citation><ArticleIdList><ArticleId IdType="doi">10.15420/icr.2021.02</ArticleId><ArticleId IdType="pmc">8054375</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouabdallaoui N, Stevens SR, Doenst T, et al. STS and EuroSCORE-2 Appropriately Assess 30-day Post-operative Mortality in the STICH Trial and a Contemporary Cohort of Patients with Left Ventricular Dysfunction Undergoing Surgical Revascularization. Circ Heart Fail. 2018;11(11): e005531. https://doi.org/10.1161/CIRCHEARTFAILURE.118.005531 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.118.005531</ArticleId><ArticleId IdType="pubmed">30571194</ArticleId><ArticleId IdType="pmc">6309904</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonow RO, Brown AS, Gillam LD, et al. ACC/AATS/AHA/ASE/EACTS/HVS/SCA/SCAI/SCCT/SCMR/STS 2017 appropriate use criteria for the treatment of patients with severe aortic stenosis: a report of the American College of Cardiology Appropriate use criteria task force, american association for thoraci. J Am Coll Cardiol. 2017;70(20):2566&#x2013;98. https://doi.org/10.1016/j.jacc.2017.09.018 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.09.018</ArticleId><ArticleId IdType="pubmed">29054308</ArticleId></ArticleIdList></Reference><Reference><Citation>Kliuk-Ben Bassat O, Finkelstein A, Bazan S, et al. Acute kidney injury after transcatheter aortic valve implantation and mortality risk-long-term follow-up. Nephrol Dial Transplant. 2020;35(3):433&#x2013;8. https://doi.org/10.1093/NDT/GFY264 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/NDT/GFY264</ArticleId><ArticleId IdType="pubmed">30169857</ArticleId></ArticleIdList></Reference><Reference><Citation>Holzhey DM, Shi W, Rastan A, Borger MA, H&#xe4;nsig M, Mohr FW. Transapical versus conventional aortic valve replacement - A propensity-matched comparison. Heart Surg Forum. 2012;15(1):4&#x2013;8. https://doi.org/10.1532/HSF98.20111084 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1532/HSF98.20111084</ArticleId></ArticleIdList></Reference><Reference><Citation>aaaaaaaaaaa.pdf.</Citation></Reference><Reference><Citation>Porter J, Davis B. Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia. Best Pract Res Clin Haematol. 2002;15(2):329&#x2013;68. https://doi.org/10.1053/beha.2002.0214 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/beha.2002.0214</ArticleId><ArticleId IdType="pubmed">12401311</ArticleId></ArticleIdList></Reference><Reference><Citation>ACSD Operative Risk Calculator | STS. Accessed October 27, 2024. https://www.sts.org/resources/acsd-operative-risk-calculator</Citation></Reference><Reference><Citation>Nashef SAM, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE) q.</Citation></Reference><Reference><Citation>Nezic D, Spasic T, Micovic S, et al. Clinical performances of the EuroSCORE II in a single-centre, contemporary cardiac surgical cohort. J Cardiothorac Surg. 2015;10(1):1. https://doi.org/10.1186/1749-8090-10-S1-A59 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-8090-10-S1-A59</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71. https://doi.org/10.1136/bmj.n71 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId><ArticleId IdType="pmc">8005924</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagur R, Webb JG, Nietlispach F, et al. Acute kidney injury following transcatheter aortic valve implantation: Predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J. 2010;31(7):865&#x2013;74. https://doi.org/10.1093/eurheartj/ehp552 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehp552</ArticleId><ArticleId IdType="pubmed">20037180</ArticleId></ArticleIdList></Reference><Reference><Citation>Shavit L, Silberman S, Tauber R, Merin O, Bitran D, Fink D. Outcomes of transcatheter aortic valve implantation compared with surgical aortic valve replacement in geriatric patients with chronic kidney disease. Clin Nephrol. 2018;90(2):87&#x2013;93. https://doi.org/10.5414/CN109363 .</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/CN109363</ArticleId><ArticleId IdType="pubmed">29792393</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamburino C, Barbanti M, D&#x2019;Errigo P, et al. 1-year outcomes after transfemoral transcatheter or surgical aortic valve replacement: Results from the Italian OBSERVANT study. J Am Coll Cardiol. 2015;66(7):804&#x2013;12. https://doi.org/10.1016/j.jacc.2015.06.013 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2015.06.013</ArticleId><ArticleId IdType="pubmed">26271063</ArticleId></ArticleIdList></Reference><Reference><Citation>Thongprayoon C, Cheungpasitporn W, Srivali N, et al. AKI after transcatheter or surgical aortic valve replacement. J Am Soc Nephrol. 2016;27(6):1854&#x2013;60. https://doi.org/10.1681/ASN.2015050577 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2015050577</ArticleId><ArticleId IdType="pubmed">26487562</ArticleId></ArticleIdList></Reference><Reference><Citation>Za&#x142;eska-Kociecka M, Skrobisz A, Wo&#x17a;niak S, et al. Patterns of changes in functional and neurocognitive status in elderly patients after transcatheter vs. Surgical aortic valve replacements Minerva Anestesiol. 2018;84(3):328&#x2013;36. https://doi.org/10.23736/S0375-9393.17.11905-X .</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0375-9393.17.11905-X</ArticleId><ArticleId IdType="pubmed">28984092</ArticleId></ArticleIdList></Reference><Reference><Citation>Catalano M, Lin D, Cassiere H, et al. Incidence of Acute Kidney Injury in Patients with Chronic Renal Insufficiency: Transcatheter versus Surgical Aortic Valve Replacement. J Interv Cardiol. 2019;2019:1&#x2013;6. https://doi.org/10.1155/2019/9780415 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/9780415</ArticleId></ArticleIdList></Reference><Reference><Citation>Jalava MP, Laakso T, Virtanen M, et al. Transcatheter and surgical aortic valve replacement in patients with recent acute heart failure. Ann Thorac Surg. 2020;109(1):110&#x2013;7. https://doi.org/10.1016/j.athoracsur.2019.05.044 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2019.05.044</ArticleId><ArticleId IdType="pubmed">31288017</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim EC, Kim SH, Lee Y, et al. The impact of surgical versus transcatheter aortic valve replacement on postprocedural acute kidney injury in patients with chronic kidney disease. J Chest Surg. 2022;55(6):435&#x2013;41. https://doi.org/10.5090/JCS.22.029 .</Citation><ArticleIdList><ArticleId IdType="doi">10.5090/JCS.22.029</ArticleId><ArticleId IdType="pubmed">36196595</ArticleId><ArticleId IdType="pmc">9733416</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolar T, Laki&#x10d; N, Kotnik A, &#x160;tubljar D, Fras Z, Bunc M. Similar clinical outcomes with transcatheter aortic valve implantation and surgical aortic valve replacement in octogenarians with aortic stenosis. Front Cardiovasc Med. 2022;9:947197. https://doi.org/10.3389/fcvm.2022.947197 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.947197</ArticleId><ArticleId IdType="pubmed">36386346</ArticleId><ArticleId IdType="pmc">9640378</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolar T, Bunc M, Jelenc M, Terseglav S, Kotnik A, Laki&#x10d; N. Minimally invasive surgical aortic valve replacement versus transfemoral transcatheter aortic valve implantation in low-risk octogenarians: Observational, retrospective and single-center study. Wien Klin Wochenschr. 2023;135(23&#x2013;24):703&#x2013;11. https://doi.org/10.1007/s00508-022-02094-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00508-022-02094-z</ArticleId><ArticleId IdType="pubmed">36239806</ArticleId></ArticleIdList></Reference><Reference><Citation>Korczak A, Morawiec R, Stegienta M, et al. Acute kidney injury as the most important predictor of poor prognosis after interventional treatment for aortic stenosis. Kardiol Pol. 2022;80(10):1032&#x2013;8. https://doi.org/10.33963/KP.a2022.0182 .</Citation><ArticleIdList><ArticleId IdType="doi">10.33963/KP.a2022.0182</ArticleId><ArticleId IdType="pubmed">35924995</ArticleId></ArticleIdList></Reference><Reference><Citation>Latib A, Maisano F, Bertoldi L, et al. Transcatheter vs surgical aortic valve replacement in intermediate- surgical-risk patients with aortic stenosis: A propensity score-matched case-control study. Am Heart J. 2012;164(6):910&#x2013;7. https://doi.org/10.1016/j.ahj.2012.09.005 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2012.09.005</ArticleId><ArticleId IdType="pubmed">23194492</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin PH, Wei HJ, Hsieh SR, et al. One-year and five-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement in a taiwanese elderly population. J Clin Med. 2023;12(10):3429. https://doi.org/10.3390/jcm12103429 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12103429</ArticleId><ArticleId IdType="pubmed">37240534</ArticleId><ArticleId IdType="pmc">10219031</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuillard A, Garrouste C, Pereira B, et al. Evolution of chronic kidney disease after surgical aortic valve replacement or transcatheter aortic valve implantation. Arch Cardiovasc Dis. 2019;112(3):162&#x2013;70. https://doi.org/10.1016/j.acvd.2018.10.003 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acvd.2018.10.003</ArticleId><ArticleId IdType="pubmed">30655226</ArticleId></ArticleIdList></Reference><Reference><Citation>McInerney A, Rod&#xe9;s-Cabau J, Veiga G, et al. Transcatheter versus surgical aortic valve replacement in patients with morbid obesity: a multicentre propensity scorematched analysis. EuroIntervention. 2022;18(5):E417-27. https://doi.org/10.4244/EIJ-D-21-00891 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4244/EIJ-D-21-00891</ArticleId><ArticleId IdType="pubmed">35321860</ArticleId><ArticleId IdType="pmc">10241265</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609&#x2013;20. https://doi.org/10.1056/NEJMoa1514616 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1514616</ArticleId><ArticleId IdType="pubmed">27040324</ArticleId></ArticleIdList></Reference><Reference><Citation>Conte JV, Gleason TG, Resar JR, et al. Transcatheter or surgical aortic valve replacement in patients with prior coronary artery bypass grafting. Ann Thorac Surg. 2016;101:72&#x2013;9. https://doi.org/10.1016/j.athoracsur.2015.06.067 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2015.06.067</ArticleId><ArticleId IdType="pubmed">26433523</ArticleId></ArticleIdList></Reference><Reference><Citation>Conte JV, Hermiller JJ, Resar JR, et al. Complications after self-expanding transcatheter or surgical aortic valve replacement. Semin Thorac Cardiovasc Surg. 2017;29(3):321&#x2013;30. https://doi.org/10.1053/j.semtcvs.2017.06.001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semtcvs.2017.06.001</ArticleId><ArticleId IdType="pubmed">29195573</ArticleId></ArticleIdList></Reference><Reference><Citation>Biondi-Zoccai G, Peruzzi M, Abbate A, et al. Network meta-analysis on the comparative effectiveness and safety of transcatheter aortic valve implantation with CoreValve or Sapien devices versus surgical replacement. Hear lung Vessel. 2014;6(4):232&#x2013;43.</Citation></Reference><Reference><Citation>Swift SL, Puehler T, Misso K, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis: A systematic review and meta-Analysis. BMJ Open. 2021;11(12): e054222. https://doi.org/10.1136/bmjopen-2021-054222 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-054222</ArticleId><ArticleId IdType="pubmed">34873012</ArticleId><ArticleId IdType="pmc">8650468</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardar P, Kundu A, Chatterjee S, et al. Transcatheter versus surgical aortic valve replacement in intermediate-risk patients: Evidence from a meta-analysis. Catheter Cardiovasc Interv. 2017;90(3):504&#x2013;15. https://doi.org/10.1002/ccd.27041 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.27041</ArticleId><ArticleId IdType="pubmed">28398671</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad Y, Howard JP, Arnold AD, et al. Transcatheter versus surgical aortic valve replacement in lower-risk and higher-risk patients: a meta-analysis of randomized trials. Eur Heart J. 2023;44(10):836&#x2013;52. https://doi.org/10.1093/eurheartj/ehac642 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac642</ArticleId><ArticleId IdType="pubmed">36660821</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagaraja V, Raval J, Eslick GD, Ong ATL. Transcatheter versus surgical aortic valve replacement: A systematic review and meta-analysis of randomised and non-randomised trials. Open Hear. 2014;1(1):1&#x2013;8. https://doi.org/10.1136/openhrt-2013-000013 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/openhrt-2013-000013</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31. https://doi.org/10.1186/cc5713 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc5713</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId><ArticleId IdType="pmc">2206446</ArticleId></ArticleIdList></Reference><Reference><Citation>Kappetein AP, Head SJ, G&#xe9;n&#xe9;reux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J. 2012;33(19):2403&#x2013;18. https://doi.org/10.1093/eurheartj/ehs255 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehs255</ArticleId><ArticleId IdType="pubmed">23026477</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacquaniti A, Ceresa F, Campo S, et al. Surgical aortic valve replacement and renal dysfunction: from acute kidney injury to chronic disease. J Clin Med. 2024;13(10):2933. https://doi.org/10.3390/jcm13102933 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm13102933</ArticleId><ArticleId IdType="pubmed">38792474</ArticleId><ArticleId IdType="pmc">11122348</ArticleId></ArticleIdList></Reference><Reference><Citation>Giraldo-Grueso M, Bedi RS, Tafur-Soto J, Su J, Spindel SM. Zero to hero? reducing the rate of acute kidney injury in transcatheter aortic valve replacement: the low contrast approach. Ochsner J. 2023;23(4):284&#x2013;8. https://doi.org/10.31486/TOJ.23.0103 .</Citation><ArticleIdList><ArticleId IdType="doi">10.31486/TOJ.23.0103</ArticleId><ArticleId IdType="pubmed">38143547</ArticleId><ArticleId IdType="pmc">10741818</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala S, Ma Z, Peng K, Ji F, Li D. Postoperative acute kidney injury after transcatheter aortic valve replacement. Curr Anesthesiol Rep. 2024;14:1&#x2013;6. https://doi.org/10.1007/s40140-024-00626-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40140-024-00626-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasmin F, Mashkoor Y, Najeeb H, et al. Efficacy of the Renal-guard system in the prevention of contrast-induced nephropathy following cardiac interventions among patients with chronic kidney disease. Front Cardiovasc Med. 2025;12:1438076. https://doi.org/10.3389/FCVM.2025.1438076/BIBTEX .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FCVM.2025.1438076/BIBTEX</ArticleId><ArticleId IdType="pubmed">40099270</ArticleId><ArticleId IdType="pmc">11911345</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26181335</PMID><DateCompleted><Year>2015</Year><Month>11</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>123</Volume><Issue>3</Issue><PubDate><Year>2015</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery.</ArticleTitle><Pagination><StartPage>515</StartPage><EndPage>523</EndPage><MedlinePgn>515-23</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0000000000000765</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Intraoperative hypotension (IOH) may be associated with postoperative acute kidney injury (AKI), but the duration of hypotension for triggering harm is unclear. The authors investigated the association between varying periods of IOH with mean arterial pressure (MAP) less than 55, less than 60, and less than 65 mmHg with AKI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The authors conducted a retrospective cohort study of 5,127 patients undergoing noncardiac surgery (2009 to 2012) with invasive MAP monitoring and length of stay of 1 or more days. Exclusion criteria were preoperative MAP less than 65 mmHg, dialysis dependence, urologic surgery, and surgical duration less than 30 min. The primary exposure was IOH. The primary outcome was AKI (50% or 0.3 mg/dl increase in creatinine) during the first 2 postoperative days. Multivariable logistic regression was used to model the exposure-outcome relationship.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">AKI occurred in 324 (6.3%) patients and was associated with MAP less than 60 mmHg for 11 to 20 min and MAP less than 55 mmHg for more than 10 min in a graded fashion. The adjusted odds ratio of AKI for MAP less than 55 mmHg was 2.34 (1.35 to 4.05) for 11- to 20-min exposure and 3.53 (1.51 to 8.25) for more than 20 min. For MAP less than 60 mmHg, the adjusted odds ratio for AKI was 1.84 (1.11 to 3.06) for 11- to 20-min exposure.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In this analysis, postoperative AKI is associated with sustained intraoperative periods of MAP less than 55 and less than 60 mmHg. This study provides an impetus for clinical trials to determine whether interventions that promptly treat IOH and are tailored to individual patient physiology could help reduce the risk of AKI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Louise Y</ForeName><Initials>LY</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia, Toronto General Hospital and University of Toronto, Toronto, Ontario, Canada (L.Y.S., D.N.W., G.A.T., W.S.B.); Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Ontario, Canada (D.N.W.); Institute of Health Policy Management and Evaluation, Toronto, Ontario, Canada (D.N.W.); and Cardiovascular Research Program, Institute for Clinical Evaluative Sciences, Totonto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wijeysundera</LastName><ForeName>Duminda N</ForeName><Initials>DN</Initials></Author><Author ValidYN="Y"><LastName>Tait</LastName><ForeName>Gordon A</ForeName><Initials>GA</Initials></Author><Author ValidYN="Y"><LastName>Beattie</LastName><ForeName>W Scott</ForeName><Initials>WS</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Canadian Institutes of Health Research</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Ren Fail. 2016;38(1):168-9. doi: 10.3109/0886022X.2015.1128448.</RefSource><PMID Version="1">26727185</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="N">Monitoring, Intraoperative</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>11</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26181335</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000000765</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30601331</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>29</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1540-0514</ISSN><JournalIssue CitedMedium="Internet"><Volume>52</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Shock (Augusta, Ga.)</Title><ISOAbbreviation>Shock</ISOAbbreviation></Journal><ArticleTitle>Does Fenoldopam Protect Kidney in Cardiac Surgery? A Systemic Review and Meta-Analysis With Trial Sequential Analysis.</ArticleTitle><Pagination><StartPage>326</StartPage><EndPage>333</EndPage><MedlinePgn>326-333</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SHK.0000000000001313</ELocationID><Abstract><AbstractText Label="PURPOSE">To assess the benefits and harms of fenoldopam for nephroprotective effects in adult patients undergoing cardiac surgery.</AbstractText><AbstractText Label="METHODS">We conducted a systematic review with meta-analysis of randomized controlled trials (RCTs) comparing fenoldopam with placebo in cardiac surgery. Trials were systematically searched from PubMed, EMBASE, CENTRAL, and CNKI databases, up to July 30, 2018. A trial sequential analysis (TSA) was used to determine whether the present evidence was valid and conclusive for the primary outcomes.</AbstractText><AbstractText Label="RESULTS">A total of seven randomized controlled trials involving 1,107 adult patients undergoing cardiac surgery fulfilled the inclusion criteria. The pooled analysis suggested that the use of fenoldopam was associated with a reduction in the incidence of AKI (18 of 216 [8.3%] in the fenoldopam group versus 45 of 222 [20.3%] in the placebo group, RR&#x200a;=&#x200a;0.42 [0.26, 0.69], P&#x200a;=&#x200a;0.0006) and with a higher rate of hypotension (92/357 [25.8%] versus 51/348 [14.7%], RR&#x200a;=&#x200a;1.76 [1.29, 2.39], P&#x200a;=&#x200a;0.0003). There was no significant effect on renal replacement therapy requirement (77 of 540 [14.3%] versus 75 of 536 [14.0%], P&#x200a;=&#x200a;0.96) or hospital mortality (87/392 [22.2%] versus 83/383 [21.7%], P&#x200a;=&#x200a;0.86). TSA supported the results of the conventional analysis on AKI.</AbstractText><AbstractText Label="CONCLUSIONS">Low-dose dopamine offers transient improvements in renal physiology, but no good evidence shows that it offers important clinical benefits to patients with or at risk for acute renal failure.Among patients treated with fenoldopam, there was a decrease in AKI and an increased incidence of hypotension, had no significant effect on RRT or mortality. Given that most studies were small and the definition of AKI was variable between studies, there is not enough evidence to support the systematic use of fenoldopam in cardiac surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Haibing</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Zhongnan Hospital, Wuhan University, Wuhan, Hubei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Qin</ForeName><Initials>Q</Initials></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Zhiyong</ForeName><Initials>Z</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Shock</MedlineTA><NlmUniqueID>9421564</NlmUniqueID><ISSNLinking>1073-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>INU8H2KAWG</RegistryNumber><NameOfSubstance UI="D018818">Fenoldopam</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018818" MajorTopicYN="N">Fenoldopam</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="Y">Kidney</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30601331</ArticleId><ArticleId IdType="doi">10.1097/SHK.0000000000001313</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25631390</PMID><DateCompleted><Year>2016</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2015</Year><Month>Jan</Month><Day>29</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Intraoperative renal near-infrared spectroscopy indicates developing acute kidney injury in infants undergoing cardiac surgery with cardiopulmonary bypass: a case-control study.</ArticleTitle><Pagination><StartPage>27</StartPage><MedlinePgn>27</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">27</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-015-0760-9</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Acute kidney injury (AKI) is a frequent complication after cardiac surgery with cardiopulmonary bypass in infants. Renal near-infrared spectroscopy (NIRS) is used to evaluate regional oximetry in a non-invasive continuous real-time fashion, and reflects tissue perfusion. The aim of this study was to evaluate the relationship between renal oximetry and development of AKI in the operative and post-operative setting in infants undergoing cardiopulmonary bypass surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this prospective study, we enrolled 59 infants undergoing cardiopulmonary bypass surgery for congenital heart disease for univentricular (n&#x2009;=&#x2009;26) or biventricular (n&#x2009;=&#x2009;33) repair. Renal NIRS was continuously measured intraoperatively and for at least 24 hours postoperatively and analysed for the intraoperative and first 12 hours, first 24 hours and first 48 hours postoperatively. The renal oximetry values were correlated with the paediatric risk, injury, failure, loss, end (pRIFLE) classification for AKI, renal biomarkers and the postoperative course.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-eight (48%) infants developed AKI based on pRIFLE classification. Already during intraoperative renal oximetry and further in the first 12 hours, 24 hours and 48 hours postoperatively, significantly lower renal oximetry values in AKI patients compared with patients with normal renal function were recorded (P&#x2009;&lt;&#x2009;0.05). Of the 28 patients who developed AKI, 3 (11%) needed renal replacement therapy and 2 (7%) died. In the non-AKI group, no deaths occurred. Infants with decreased renal oximetry values developed significantly higher lactate levels 24 hours after surgery. Cystatin C was a late parameter of AKI, and neutrophil gelatinase-associated lipocalin values were not correlated with AKI occurrence.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our results suggest that prolonged low renal oximetry values during cardiac surgery correlate with the development of AKI and may be superior to conventional biochemical markers. Renal NIRS might be a promising non-invasive tool of multimodal monitoring of kidney function and developing AKI in infants undergoing cardiac surgery with cardiopulmonary bypass.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ruf</LastName><ForeName>Bettina</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Centre Munich, Technical University, Lazarettstr. 36, 80636, Munich, Germany. ruf@dhm.mhn.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonelli</LastName><ForeName>Vittorio</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, German Heart Centre Munich, Technical University, Lazarettstr. 36, 80636, Munich, Germany. bonelli@dhm.mhn.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balling</LastName><ForeName>Gunter</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Centre Munich, Technical University, Lazarettstr. 36, 80636, Munich, Germany. balling@dhm.mhn.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xf6;rer</LastName><ForeName>J&#xfc;rgen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Thoracic and Cardiovascular Surgery, German Heart Centre Munich, Technical University, Lazarettstr. 36, 80636, Munich, Germany. hoerer@dhm.mhn.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagdyman</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Centre Munich, Technical University, Lazarettstr. 36, 80636, Munich, Germany. nagdyman@dhm.mhn.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braun</LastName><ForeName>Siegmund Lorenz</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Institute of Laboratory Medicine, German Heart Centre Munich, Technical University, Lazarettstr. 36, 80636, Munich, Germany. braun@dhm.mhn.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ewert</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Centre Munich, Technical University, Lazarettstr. 36, 80636, Munich, Germany. prof.ewert@dhm.mhn.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reiter</LastName><ForeName>Karl</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatric Intensive Care, University Children`s Hospital, von Haunersche Children hospital, Ludwigs-Maximilian University, Lindwurmstr. 4, 80337, Munich, Germany. karl.reiter@med.uni-muenchen.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006330" MajorTopicYN="N">Heart Defects, Congenital</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="N">blood supply</QualifierName><QualifierName UI="Q000293" MajorTopicYN="Y">injuries</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019265" MajorTopicYN="N">Spectroscopy, Near-Infrared</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>1</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25631390</ArticleId><ArticleId IdType="pmc">PMC4336470</ArticleId><ArticleId IdType="doi">10.1186/s13054-015-0760-9</ArticleId><ArticleId IdType="pii">s13054-015-0760-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Li S, Krawczeski CD, Zappitelli M, Devarajan P, Thiessen-Philbrook H, Coca SG, et al. Incidence, risk factors, and outcomes of acute kidney injury after pediatric cardiac surgery: a prospective multicenter study. Crit Care Med. 2011;39:1493&#x2013;9. doi: 10.1097/CCM.0b013e31821201d3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31821201d3</ArticleId><ArticleId IdType="pmc">PMC3286600</ArticleId><ArticleId IdType="pubmed">21336114</ArticleId></ArticleIdList></Reference><Reference><Citation>Zappitelli M, Bernier PL, Saczkowski RS, Tchervenkov CI, Gottesman R, Dancea A, et al. A small post-operative rise in serum creatinine predicts acute kidney injury in children undergoing cardiac surgery. Kidney Int. 2009;76:885&#x2013;92. doi: 10.1038/ki.2009.270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2009.270</ArticleId><ArticleId IdType="pubmed">19641482</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen K. Acute kidney injury in children undergoing surgery for congenital heart disease. Eur J Pediatr Surg. 2012;22:426&#x2013;33. doi: 10.1055/s-0032-1322540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0032-1322540</ArticleId><ArticleId IdType="pubmed">22903254</ArticleId></ArticleIdList></Reference><Reference><Citation>Blinder JJ, Goldstein SL, Lee VV, Baycroft A, Fraser CD, Nelson D, et al. Congenital heart surgery in infants: effects of acute kidney injury on outcomes. J Thorac Cardiovasc Surg. 2012;143:368&#x2013;74. doi: 10.1016/j.jtcvs.2011.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2011.06.021</ArticleId><ArticleId IdType="pubmed">21798562</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydin SI, Seiden HS, Blaufox AD, Parnell VA, Choudhury T, Punnoose A, et al. Acute kidney injury after surgery for congenital heart disease. Ann Thorac Surg. 2012;94:1589&#x2013;95. doi: 10.1016/j.athoracsur.2012.06.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2012.06.050</ArticleId><ArticleId IdType="pubmed">22884599</ArticleId></ArticleIdList></Reference><Reference><Citation>Akcan-Arikan A, Zappitelli M, Loftis LL, Washburn KK, Jefferson LS, Goldstein SL. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int. 2007;71:1028&#x2013;35. doi: 10.1038/sj.ki.5002231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ki.5002231</ArticleId><ArticleId IdType="pubmed">17396113</ArticleId></ArticleIdList></Reference><Reference><Citation>Devarajan P. Biomarkers for the early detection of acute kidney injury. Curr Opin Pediatr. 2011;23:194&#x2013;200. doi: 10.1097/MOP.0b013e328343f4dd.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOP.0b013e328343f4dd</ArticleId><ArticleId IdType="pmc">PMC3257513</ArticleId><ArticleId IdType="pubmed">21252674</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanmassenhove J, Vanholder R, Nagler E, Van Biesen W. Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transplant. 2013;28:254&#x2013;73. doi: 10.1093/ndt/gfs380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfs380</ArticleId><ArticleId IdType="pubmed">23115326</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcaraz AJ, Gil-Ruiz MA, Castillo A, L&#xf3;pez J, Romero C, Fern&#xe1;ndez SN, et al. Postoperative neutrophil gelatinase-associated lipocalin predicts acute kidney injury after pediatric cardiac surgery. Pediatr Crit Care Med. 2014;15:121&#x2013;30. doi: 10.1097/PCC.0000000000000034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000000034</ArticleId><ArticleId IdType="pubmed">24366512</ArticleId></ArticleIdList></Reference><Reference><Citation>Murkin JM, Arango M. Near-infrared spectroscopy as an index of brain and tissue oxygenation. Br J Anaesth. 2009;103(Suppl 1):i3&#x2013;13. doi: 10.1093/bja/aep299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aep299</ArticleId><ArticleId IdType="pubmed">20007987</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann GM, Stuth EA, Jaquiss RD, Vanderwal PL, Staudt SR, Troshynski TJ, et al. Changes in cerebral and somatic oxygenation during stage 1 palliation of hypoplastic left heart syndrome using continuous regional cerebral perfusion. J Thorac Cardiovasc Surg. 2004;127:223&#x2013;33. doi: 10.1016/j.jtcvs.2003.08.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2003.08.021</ArticleId><ArticleId IdType="pubmed">14752434</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranucci M, Isgr&#xf2; G, De la Torre T, Romitti F, Conti D, Carlucci C. Near-infrared spectroscopy correlates with continuous superior vena cava oxygen saturation in pediatric cardiac surgery patients. Pediatr Anesth. 2008;18:1163&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19076569</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson SJ, Berens RJ, Havens PL, Kim MK, Hoffmann GM. Effect of volume resuscitation on regional perfusion in dehydrated pediatric patients as measured by two- site near-infrared spectroscopy. Pediatr Emerg Care. 2009;25:150&#x2013;3. doi: 10.1097/PEC.0b013e31819a7f60.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PEC.0b013e31819a7f60</ArticleId><ArticleId IdType="pubmed">19262423</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman J, Almodovar MC, Zuk J, Friesen RH. Correlation of abdominal site near-infrared spectroscopy with gastric tonometry in infants following surgery for congenital heart disease. Pediatr Crit Care Med. 2008;9:62&#x2013;8. doi: 10.1097/01.PCC.0000298640.47574.DA.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.PCC.0000298640.47574.DA</ArticleId><ArticleId IdType="pubmed">18477915</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhalala U, Nishisaki A, McQueen D, Bird GL, Morrison WE, Nadkarni VM, et al. Change in regional (somatic) near-infrared spectroscopy is not a useful indictor of clinically detectable low cardiac output in children after surgery for congenital heart defects. Pediatr Crit Care Med. 2012;13:529&#x2013;34. doi: 10.1097/PCC.0b013e3182389531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0b013e3182389531</ArticleId><ArticleId IdType="pubmed">22596064</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazle MA, Gajarski RJ, Aiyagari R, Yu S, Abraham A, Donohue J, et al. Urinary biomarkers and renal near-infrared spectroscopy predict intensive care unit outcomes after cardiac surgery in infants younger than 6&#xa0;months of age. J Thorac Cardiovasc Surg. 2013;146:861&#x2013;7. doi: 10.1016/j.jtcvs.2012.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2012.12.012</ArticleId><ArticleId IdType="pmc">PMC3653979</ArticleId><ArticleId IdType="pubmed">23317940</ArticleId></ArticleIdList></Reference><Reference><Citation>Slater JP, Guarino T, Stack J, Vinod K, Bustami RT, Brown JM, 3rd, et al. Cerebral oxygen desaturation predicts cognitive decline and longer hospital stay after cardiac surgery. Ann Thorac Surg. 2009;87:36&#x2013;45. doi: 10.1016/j.athoracsur.2008.08.070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2008.08.070</ArticleId><ArticleId IdType="pubmed">19101265</ArticleId></ArticleIdList></Reference><Reference><Citation>Dent CL, Spaeth JP, Jones BV, Schwartz SM, Glauser TA, Hallinan B, et al. Brain magnetic resonance imaging abnormalities after the Norwood procedure using regional cerebral perfusion. J Thorac Cardiovasc Surg. 2005;130:1523&#x2013;30. doi: 10.1016/j.jtcvs.2005.07.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2005.07.051</ArticleId><ArticleId IdType="pubmed">16307993</ArticleId></ArticleIdList></Reference><Reference><Citation>Kussman BD, Wypij D, Laussen PC, Soul JS, Bellinger DC, DiNardo JA, et al. Relationship of intraoperative cerebral oxygen saturation to neurodevelopmental outcome and brain magnetic resonance imaging at 1&#xa0;year of age in infants undergoing biventricular repair. Circulation. 2010;122:245&#x2013;54. doi: 10.1161/CIRCULATIONAHA.109.902338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.109.902338</ArticleId><ArticleId IdType="pmc">PMC2945235</ArticleId><ArticleId IdType="pubmed">20606124</ArticleId></ArticleIdList></Reference><Reference><Citation>Colasacco C, Worthen M, Peterson B, Lamberti J, Spear R. Near-infrared spectroscopy monitoring to predict postoperative renal insufficiency following repair of congenital heart disease. World J Pediatr Cong Heart Surg. 2011;2:536&#x2013;40. doi: 10.1177/2150135111411932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2150135111411932</ArticleId><ArticleId IdType="pubmed">23804464</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernal NP, Hoffmann GM, Ghanayem NS, Arca MJ. Cerebral and somatic near-infrared spectroscopy in normal newborns. J Pediatr Surg. 2010;45:1306&#x2013;10. doi: 10.1016/j.jpedsurg.2010.02.110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2010.02.110</ArticleId><ArticleId IdType="pubmed">20620336</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI. Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg. 2002;123:110&#x2013;8. doi: 10.1067/mtc.2002.119064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mtc.2002.119064</ArticleId><ArticleId IdType="pubmed">11782764</ArticleId></ArticleIdList></Reference><Reference><Citation>Krawczeski CD, Woo JG, Wang Y, Bennet MR, Ma Q, Devarajan P. Neutrophil gelatinase-associated lipocalin concentrations predict development of acute kidney injury in neonates and children after cardiopulmonary bypass. J Pediatr. 2011;158:1009&#x2013;15.e1. doi: 10.1016/j.jpeds.2010.12.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2010.12.057</ArticleId><ArticleId IdType="pubmed">21300375</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan CJ, Zappitelli M, Robertson CMT, Alton GY, Sauve RS, Joffe AR, et al. Risk factors for and outcomes of acute kidney injury in neonates undergoing complex cardiac surgery. J Pediatr. 2013;162:120&#x2013;127.e1. doi: 10.1016/j.jpeds.2012.06.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2012.06.054</ArticleId><ArticleId IdType="pubmed">22878115</ArticleId></ArticleIdList></Reference><Reference><Citation>Owens GE, King K, Gurney JG, Charpie JR. Low renal oximetry correlates with acute kidney injury after infant cardiac surgery. Pediatr Cardiol. 2011;32:183&#x2013;8. doi: 10.1007/s00246-010-9839-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00246-010-9839-x</ArticleId><ArticleId IdType="pubmed">21085945</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagdyman N, Ewert P, Peters B, Miera O, Fleck T, Berger F. Comparison of different near-infrared spectroscopic cerebral oxygenation indices with central venous and jugular venous oxygenation saturation in children. Paediatr Anaesth. 2008;18:160&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">18184248</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakravati SB, Mittnacht AJ, Katz JC, Nguyen K, Joashi U, Svrivastava S. Multisite near-infrared spectroscopy predicts elevated blood lactate level in children after cardiac surgery. J Cardiothorac Vasc Anesth. 2009;23:663&#x2013;7. doi: 10.1053/j.jvca.2009.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2009.03.014</ArticleId><ArticleId IdType="pubmed">19447648</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno GE, Pil&#xe1;n ML, Manara C, Magliola R, Vassallo JC, Balestrini M, et al. Regional venous oxygen saturation versus mixed venous saturation after paediatric cardiac surgery. Acta Anaesthesiol Scand. 2013;57:373&#x2013;9. doi: 10.1111/aas.12016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.12016</ArticleId><ArticleId IdType="pubmed">23210461</ArticleId></ArticleIdList></Reference><Reference><Citation>McQuillen PS, Nishimoto MS, Bottrell CL, Fineman LD, Hamrick SE, Glidden DV, et al. Regional and central venous oxygen saturation monitoring following pediatric cardiac surgery: concordance and association with clinical variables. Pediatr Crit Care Med. 2007;8:154&#x2013;60. doi: 10.1097/01.PCC.0000257101.37171.BE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.PCC.0000257101.37171.BE</ArticleId><ArticleId IdType="pubmed">17273125</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortmann LA, Fontenot EE, Seib PM, Eble BK, Brown R, Bhutta AT. Use of near-infrared spectroscopy for estimation of renal oxygenation in children with heart disease. Pediatr Cardiol. 2011;32:748&#x2013;53. doi: 10.1007/s00246-011-9960-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00246-011-9960-5</ArticleId><ArticleId IdType="pubmed">21445607</ArticleId></ArticleIdList></Reference><Reference><Citation>Zappitelli M. Preoperative predictors of acute kidney injury&#x2014;from clinical scores to biomarkers. Pediatr Nephrol. 2013;28:1173&#x2013;82. doi: 10.1007/s00467-012-2355-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00467-012-2355-x</ArticleId><ArticleId IdType="pubmed">23142867</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1:19&#x2013;32. doi: 10.2215/CJN.00240605.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.00240605</ArticleId><ArticleId IdType="pubmed">17699187</ArticleId></ArticleIdList></Reference><Reference><Citation>Malec E, Januszewska K, Kolcz J, Mroczek T. Right ventricle-to-pulmonary artery shunt versus modified Blalock-Taussig shunt in the Norwood procedure for hypoplastic left heart syndrome &#x2013; influence on early and late haemodynamic status. Eur J Cardiothorac Surg. 2003;23:728&#x2013;34. doi: 10.1016/S1010-7940(03)00072-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1010-7940(03)00072-1</ArticleId><ArticleId IdType="pubmed">12754025</ArticleId></ArticleIdList></Reference><Reference><Citation>Zappitelli M, Krawczeski CD, Devarajan P, Wang Z, Sint K, Thiessen-Philbrook H, et al. Early postoperative serum cystatin C predicts severe acute kidney injury following pediatric cardiac surgery. Kidney Int. 2011;80:655&#x2013;62. doi: 10.1038/ki.2011.123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2011.123</ArticleId><ArticleId IdType="pmc">PMC3312809</ArticleId><ArticleId IdType="pubmed">21525851</ArticleId></ArticleIdList></Reference><Reference><Citation>Krawczeski CD, Vandervoorde RG, Kathman T, Bennett MR, Woo JG, Wang Y, et al. Serum cystatin C is an early predictive biomarker of acute kidney injury after pediatric cardiopulmonary bypass. Clin J Am Soc Nephrol. 2010;5:1552&#x2013;7. doi: 10.2215/CJN.02040310.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.02040310</ArticleId><ArticleId IdType="pmc">PMC2974393</ArticleId><ArticleId IdType="pubmed">20538834</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365:1231&#x2013;8. doi: 10.1016/S0140-6736(05)74811-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(05)74811-X</ArticleId><ArticleId IdType="pubmed">15811456</ArticleId></ArticleIdList></Reference><Reference><Citation>Dent CL, Ma Q, Dastrala S, Bennet M, Mitsnefes MM, Barasch J, et al. Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care. 2007;11:R127. doi: 10.1186/cc6192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc6192</ArticleId><ArticleId IdType="pmc">PMC2246223</ArticleId><ArticleId IdType="pubmed">18070344</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennet M, Dent CL, Ma Q, Dastrala S, Grenier F, Workman R, et al. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol. 2008;3:665&#x2013;73. doi: 10.2215/CJN.04010907.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.04010907</ArticleId><ArticleId IdType="pmc">PMC2386703</ArticleId><ArticleId IdType="pubmed">18337554</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh CR, Devarajan P, Zappitelli M, Sint K, Thiessen-Philbrook H, Li S, et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery. J Am Soc Nephrol. 2011;22:1737&#x2013;47. doi: 10.1681/ASN.2010111163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2010111163</ArticleId><ArticleId IdType="pmc">PMC3171944</ArticleId><ArticleId IdType="pubmed">21836147</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">23439962</PMID><DateCompleted><Year>2013</Year><Month>02</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2037-0504</ISSN><JournalIssue CitedMedium="Print"><Volume>1</Volume><Issue>3</Issue><PubDate><Year>2009</Year></PubDate></JournalIssue><Title>HSR proceedings in intensive care &amp; cardiovascular anesthesia</Title><ISOAbbreviation>HSR Proc Intensive Care Cardiovasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Acute renal failure and cardiac surgery.</ArticleTitle><Pagination><StartPage>13</StartPage><EndPage>21</EndPage><MedlinePgn>13-21</MedlinePgn></Pagination><Abstract><AbstractText>Acute renal failure (ARF) is s a major complication after cardiac surgery and its prevalence still remains high. Even minor changes in serum creatinine are related to an increase morbidity and mortality. Recently two consensus conferences have suggested new diagnostic criteria to define acute kidney injury and risk scores to better identify patients who will probably develop ARF after cardiac surgery. In fact a prompt recognition of high risk patients could allow a more aggressive therapy at a reversible stage of an incoming ARF. To date prophylactic strategies of renal function preservation during surgery include the avoidance of nephrotoxic insult and the prevention or correction of renal hypoperfusion. Although there are still no pharmacological agents able to prevent the perioperative ARF, several trials are investigating new pharmacological approaches. When prophylactic strategies fail and severe ARF occurs, renal replacement therapy becomes mandatory. The timing and the kind of renal replacement therapy remain an open issue. Further randomized case-control studies with adequate statistical power are needed to have more conclusive data. Aim of this paper is to start from the acute renal injury physiopathology to analyze the most common prophylactic and pharmacological strategies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bove</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Universit&#xe0; Vita-Salute San Raffaele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monaco</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Covello</LastName><ForeName>R D</ForeName><Initials>RD</Initials></Author><Author ValidYN="Y"><LastName>Zangrillo</LastName><ForeName>A</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>HSR Proc Intensive Care Cardiovasc Anesth</MedlineTA><NlmUniqueID>101522989</NlmUniqueID><ISSNLinking>2037-0504</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">acute renal failure</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">renal replacement therapy</Keyword></KeywordList><CoiStatement><b>Conflict of interest</b> No conflict of interest acknowledged by the authors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2009</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23439962</ArticleId><ArticleId IdType="pmc">PMC3484552</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chertow G M, Levy E M, Hammermeister K E. et al. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998;104:343&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pubmed">9576407</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum J A. et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:204&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC522841</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta R L, Kellum J A, Shah S V. et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuitunen A, Vento A, Suojaranta-Ylinen R. et al. Acute renal failure after cardiac surgery: evaluation of the RIFLE classification. Ann Thorac Surg. 2006;81:542&#x2013;546.</Citation><ArticleIdList><ArticleId IdType="pubmed">16427848</ArticleId></ArticleIdList></Reference><Reference><Citation>Heringlake M, Knappe M, Vargas Hein O. et al. Renal dysfunction according to the ADQI-RIFLE system and clinical practice patterns after cardiac surgery in Germany. Minerva Anestesiol. 2006;72:645&#x2013;654.</Citation><ArticleIdList><ArticleId IdType="pubmed">16865083</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow G M, Lazarus J M, Christiansen C L. et al. Preoperative renal risk stratification. Circulation. 1997;95:878&#x2013;884.</Citation><ArticleIdList><ArticleId IdType="pubmed">9054745</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakar C V, Arrigain S, Worley S. et al. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol. 2005;16:162&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">15563569</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang I Y, Murray P T. Prevention of perioperative acute renal failure: what works? Best Practice &amp; Research Clinical Anaesthesiology. 2004;18:91&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pubmed">14760876</ArticleId></ArticleIdList></Reference><Reference><Citation>Marathias K P, Vassili M, Robola A. et al. Preoperative intravenous hydration confers renoprotection in patients with chronic kidney disease undergoing cardiac surgery. Artificial Organs. 2006;30:615&#x2013;621.</Citation><ArticleIdList><ArticleId IdType="pubmed">16911315</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee R W C, Di Giantomasso D, Bellomo R. et al. Vasoactive drugs and the kidney. Best Practice &amp; Research Clinical Anaesthesiology. 2004;18:53&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">14760874</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giantomasso D, May C N, Bellomo R. Norepinephrine and vital organ blood flow. Intensive Care Medicine. 2008;28:1804&#x2013;1809.</Citation><ArticleIdList><ArticleId IdType="pubmed">12447527</ArticleId></ArticleIdList></Reference><Reference><Citation>Morimatsu M, Uchino S, Chung J. et al. Norepinephrine for severe vasodilatation after cardiac surgery: impact on renal function. Intensive Care Medicine. 2003;29:1106&#x2013;1112.</Citation><ArticleIdList><ArticleId IdType="pubmed">12761617</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta R L, Chertow G M. Diuretics in critically ill patients with acute renal failure. JAMA. 2003;289:1379&#x2013;1381.</Citation><ArticleIdList><ArticleId IdType="pubmed">12636449</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassnigg A, Donner E, Grubhofer G. et al. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol. 2000;1:97&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">10616845</ArticleId></ArticleIdList></Reference><Reference><Citation>Ip -Yam P C, Murphy S, Baines M. et al. Renal function and proteinuria after cardiopulmonary bypass: the effects of temperature and mannitol. Anesth Analg. 1994;78:842&#x2013;847.</Citation><ArticleIdList><ArticleId IdType="pubmed">8160980</ArticleId></ArticleIdList></Reference><Reference><Citation>Loef B G, Henning R H, Baines M. et al. Effect of dexamethasone on perioperative renal function impairment during cardiac surgery with cardiopulmonary bypass. Br J Anaest. 2004;93:793&#x2013;798.</Citation><ArticleIdList><ArticleId IdType="pubmed">15377582</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Chapman M, Finfer S. et al. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet. 2000;356:2139&#x2013;2143.</Citation><ArticleIdList><ArticleId IdType="pubmed">11191541</ArticleId></ArticleIdList></Reference><Reference><Citation>Aravindan N, Natarajan M, Shaw A D. Fenoldopam inhibits nuclear translocation of nuclear factor kappa B in a rat model of surgical ischemic acute renal failure. JCTVA. 2006;20:179&#x2013;186.</Citation><ArticleIdList><ArticleId IdType="pubmed">16616657</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranucci M, Soro G, Barzaghi N. et al. Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients. Ann Thorac Surg. 2004;78:1332&#x2013;1338.</Citation><ArticleIdList><ArticleId IdType="pubmed">15464494</ArticleId></ArticleIdList></Reference><Reference><Citation>Bove T, Landoni G, Calabr&#xf2; M G. et al. Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery. A prospective double blind, randomized clinical trial. Circulation. 2005;111:3230&#x2013;3235.</Citation><ArticleIdList><ArticleId IdType="pubmed">15967861</ArticleId></ArticleIdList></Reference><Reference><Citation>Landoni G, Biondi-Zoccai G G, Tumlin J A. Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. Am J Kidney Dis. 2007;49:56&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">17185146</ArticleId></ArticleIdList></Reference><Reference><Citation>Landoni G, Biondi-Zoccai G G, Marino G. et al. Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis. J Cardiothorac Vasc Anesth. 2008;22:27&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">18249327</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase M, Haase-Fielitz A, Bagshaw S M. et al. Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients. Crit Care Med. 2007;35:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">17414730</ArticleId></ArticleIdList></Reference><Reference><Citation>Mentzer R M, Oz M C, Sladen R N. et al. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery. JACC. 2007;49:716&#x2013;726.</Citation><ArticleIdList><ArticleId IdType="pubmed">17291938</ArticleId></ArticleIdList></Reference><Reference><Citation>Sackner-Bernstein J D, Skopicki H A, Aaronson K D. et al. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation. 2005;111:1487&#x2013;1491.</Citation><ArticleIdList><ArticleId IdType="pubmed">15781736</ArticleId></ArticleIdList></Reference><Reference><Citation>Amano J, Suzuki A, Sunamori M. et al. Effect of calcium antagonist diltiazem on renal function in open heart surgery. Chest. 1995;107:1260&#x2013;1265.</Citation><ArticleIdList><ArticleId IdType="pubmed">7750316</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergman A S F, Odar-Cederlof I, Westman L. et al. Diltiazem infusion for renal protection in cardiac surgical patients with preexisting renal dysfunction. JCTVA. 2002;16:294&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">12073199</ArticleId></ArticleIdList></Reference><Reference><Citation>Diltiazem may preserve renal tubular integrity after cardiac surgery. Can J Anesth. 2003;30:107&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">12620953</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgera S, Woydt R, Kern H. et al. Low-dose prostacyclin preserves renal function in high-risk patients after coronary bypass surgery. Crit Care Med. 2002;30:107&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">11902251</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer B K, Preuner J, Ebenburger A. et al. Lack of renoprotective effect of theophylline during aorto-coronary bypass surgery. Nephrol Dial Transplant. 2007;17:107&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">11981083</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles P S, Hunt J O, Holdgaard H O. et al. Clonidine and cardiac surgery:haemodinamic and metabolic effects, myocardial ischaemia and recovery. Anaesth Intensive Care. 1999;27:137&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">10212709</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulka P J, Tryba M, Zenz M. Preoperative alpha sub 2 adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery:results of a randomized, controlled trial. Crit Care Med. 1996;24:947&#x2013;952.</Citation><ArticleIdList><ArticleId IdType="pubmed">8681596</ArticleId></ArticleIdList></Reference><Reference><Citation>Durmaz I, Yagdi T, Calkaur T. et al. Prophylactic dialysis in patients with renal dysfunction undergoing onpump coronmary artery bypass surgery. Annals of Thoracic Surgery. 2003;75:859&#x2013;864.</Citation><ArticleIdList><ArticleId IdType="pubmed">12645707</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Ronco C. Indications and criteria for initiating renal replacement therapy in the intensive care unit. Kidney International. 1998;66:106&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pubmed">9573585</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25622933</PMID><DateCompleted><Year>2015</Year><Month>12</Month><Day>29</Day></DateCompleted><DateRevised><Year>2015</Year><Month>03</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1496-8975</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>4</Issue><PubDate><Year>2015</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Canadian journal of anaesthesia = Journal canadien d'anesthesie</Title><ISOAbbreviation>Can J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Combined general and neuraxial anesthesia versus general anesthesia: a population-based cohort study.</ArticleTitle><Pagination><StartPage>356</StartPage><EndPage>368</EndPage><MedlinePgn>356-68</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12630-015-0315-1</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To determine whether combining spinal or epidural anesthesia with general anesthesia (combined anesthesia) reduces major medical complications of elective surgery compared with general anesthesia alone.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a propensity-matched population-based historical cohort study using large healthcare databases from Ontario, Canada. We identified patients undergoing 21 different elective procedures that were amenable to either combined anesthesia or general anesthesia alone in 108 hospitals from 2004 to 2011. We assessed the following four outcomes together as a composite and individually in the 30&#xa0;days following surgery: acute kidney injury, stroke, myocardial infarction, and all-cause mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Prior to matching, we identified 21,701 patients receiving general anesthesia and 8,042 patients receiving combined anesthesia. After matching, our cohort included 12,379 patients. Twenty-eight baseline characteristics were well-matched between the combined (n&#xa0;=&#xa0;4,773) and general anesthesia groups (n&#xa0;=&#xa0;7,606). Mean patient age was 66&#xa0;yr. Relative to general anesthesia alone, combined anesthesia was not associated with a reduced risk for the composite outcome [104/4,773 (2.2%) vs 162/7,606 (2.1%); odds ratio (OR) 0.97; 95% confidence interval (CI) 0.75 to 1.24] or for any of the four component outcomes when examined separately: acute kidney injury (OR 0.93; 95% CI 0.58 to 1.51), stroke (OR 0.79; 95% CI 0.36 to 1.73), myocardial infarction (OR 1.04; 95% CI 0.69 to 1.57), and all-cause mortality (OR 0.91; 95% CI 0.59 to 1.42).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The addition of spinal or epidural anesthesia to general anesthesia was not associated with a reduced risk of major medical complications among 21 different elective procedures when compared with general anesthesia alone.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nash</LastName><ForeName>Danielle M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Institute for Clinical Evaluative Sciences Western, London Health Sciences Centre, 800 Commissioners Rd. E, Room ELL-113A, London, ON, N6A 4G5, Canada, danielle.nash@ices.on.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mustafa</LastName><ForeName>Reem A</ForeName><Initials>RA</Initials></Author><Author ValidYN="Y"><LastName>McArthur</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Wijeysundera</LastName><ForeName>Duminda N</ForeName><Initials>DN</Initials></Author><Author ValidYN="Y"><LastName>Paterson</LastName><ForeName>J Michael</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Sharan</LastName><ForeName>Sumit</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Vinden</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Wald</LastName><ForeName>Ron</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Welk</LastName><ForeName>Blayne</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials></Author><Author ValidYN="Y"><LastName>Devereaux</LastName><ForeName>P J</ForeName><Initials>PJ</Initials></Author><Author ValidYN="Y"><LastName>Walsh</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Garg</LastName><ForeName>Amit X</ForeName><Initials>AX</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>01</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Can J Anaesth</MedlineTA><NlmUniqueID>8701709</NlmUniqueID><ISSNLinking>0832-610X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000767" MajorTopicYN="N">Anesthesia, Epidural</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000775" MajorTopicYN="N">Anesthesia, Spinal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009864" MajorTopicYN="N" Type="Geographic">Ontario</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>12</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25622933</ArticleId><ArticleId IdType="doi">10.1007/s12630-015-0315-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32782813</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2054-3581</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Canadian journal of kidney health and disease</Title><ISOAbbreviation>Can J Kidney Health Dis</ISOAbbreviation></Journal><ArticleTitle>Starch or Saline After Cardiac Surgery: A Double-Blinded Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>2054358120940434</StartPage><MedlinePgn>2054358120940434</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2054358120940434</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/2054358120940434</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Despite decades of investigation, the balance of clinical risks and benefits of fluid supplementation with starch remain unresolved. Patient-centered outcomes have not been well explored in a "real-world" trial in cardiac surgery.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We sought to compare a starch-based fluid strategy with a saline-based fluid strategy in the cardiac surgery patient.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A pragmatic blinded randomized controlled trial comparing starch-based with saline-based fluid strategy.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">A large tertiary academic center in London Ontario between September 2009 and February 2011.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Patients undergoing planned, isolated coronary revascularization.</AbstractText><AbstractText Label="MEASUREMENTS" NlmCategory="METHODS">Serum creatinine and patient weight were measured daily postoperatively.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients were randomized to receive 6% hydroxyethyl starch (Voluven) or saline for perioperative fluid requirements. Fluid administration was not protocolized. Co-primary outcomes were incidence of acute kidney injury (AKI) and maximum postoperative weight gain. Secondary outcomes included bleeding, transfusion, inotropic and ventilator support, and fluid utilization.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The study was prematurely terminated due to resource limitations. A total of 69 patients (19% female, mean age = 65) were randomized. Using RIFLE criteria for AKI, "risk" occurred in 12 patients in each group (risk ratio [RR] = 1.0; 95% confidence interval [CI] = 0.5-1.9; <i>P</i> = 1.00), whereas "injury" occurred in 7 of 35 (20%) and 3 of 34 (9%) of patients in the starch and saline groups, respectively (RR = 2.3; 95% CI = 0.6-8.1; <i>P</i> = .31). Maximum weight gain, bleeding and blood product usage, and overall fluid requirement were similar between groups.</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">The study had to be prematurely terminated due to resource limitations which led to a small sample size which was not sufficiently powered to detect a difference in the primary outcomes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This pragmatic double-blinded randomized controlled trial revealed a number of interesting hypothesis-generating trends and confirmed the feasibility of undertaking a logistically complex trial in a pragmatic fashion.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2020.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nagpal</LastName><ForeName>A Dave</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Cardiac Surgery, Western University, London Health Sciences Centre, London, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Critical Care Western, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cowan</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9480-969X</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Division of Nephrology, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Linna</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Cardiac Surgery, Western University, London Health Sciences Centre, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nusca</LastName><ForeName>Graeme</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Cardiac Surgery, Western University, London Health Sciences Centre, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Linrui</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Cardiac Surgery, Western University, London Health Sciences Centre, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Novick</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Cardiac Surgery, Western University, London Health Sciences Centre, London, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Critical Care Western, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harle</LastName><ForeName>Chris C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Anesthesia &amp; Perioperative Medicine, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>House</LastName><ForeName>Andrew A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Nephrology, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fox</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Cardiac Surgery, Western University, London Health Sciences Centre, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Philip M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Anesthesia &amp; Perioperative Medicine, Western University, London, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology &amp; Biostatistics, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Can J Kidney Health Dis</MedlineTA><NlmUniqueID>101640242</NlmUniqueID><ISSNLinking>2054-3581</ISSNLinking></MedlineJournalInfo><OtherAbstract Type="Publisher" Language="fre"><AbstractText Label="CONTEXTE" NlmCategory="BACKGROUND">L&#x2019;&#xe9;quilibre entre les avantages et les risques cliniques d&#x2019;une suppl&#xe9;mentation en fluides &#xe0; base d&#x2019;amidon n&#x2019;est toujours pas &#xe9;tabli malgr&#xe9; des d&#xe9;cennies d&#x2019;&#xe9;tudes. Les r&#xe9;sultats des patients subissant une chirurgie cardiaque n&#x2019;ont pas &#xe9;t&#xe9; explor&#xe9;s suffisamment dans le cadre d&#x2019;un essai concret.</AbstractText><AbstractText Label="OBJECTIF" NlmCategory="OBJECTIVE">Comparer deux strat&#xe9;gies de suppl&#xe9;mentation liquidienne, une solution &#xe0; base d&#x2019;amidon et une solution saline, chez des patients subissant une chirurgie cardiaque.</AbstractText><AbstractText Label="TYPE D&#x2019;&#xc9;TUDE" NlmCategory="UNASSIGNED">Un essai pragmatique, contr&#xf4;l&#xe9;, &#xe0; r&#xe9;partition al&#xe9;atoire et men&#xe9; en double insu comparant deux strat&#xe9;gies de suppl&#xe9;mentation liquidienne une solution &#xe0; base d&#x2019;amidon et une solution saline.</AbstractText><AbstractText Label="CADRE" NlmCategory="UNASSIGNED">Un grand centre universitaire de soins tertiaires de London (Ontario) entre septembre 2009 et f&#xe9;vrier 2011.</AbstractText><AbstractText Label="SUJETS" NlmCategory="UNASSIGNED">Des patients subissant une revascularisation coronarienne planifi&#xe9;e et isol&#xe9;e.</AbstractText><AbstractText Label="MESURES" NlmCategory="UNASSIGNED">La cr&#xe9;atinine s&#xe9;rique et le poids du patient ont &#xe9;t&#xe9; mesur&#xe9;s quotidiennement &#xe0; la suite de l&#x2019;intervention.</AbstractText><AbstractText Label="M&#xc9;THODOLOGIE" NlmCategory="UNASSIGNED">Les patients ont &#xe9;t&#xe9; r&#xe9;partis al&#xe9;atoirement pour recevoir du Voluven (solution d&#x2019;amidon hydroxy&#xe9;thyl&#xe9; &#xe0; 6 %) ou une solution saline pour les fluidiques p&#xe9;riop&#xe9;ratoires. L&#x2019;administration ne s&#x2019;est pas faite selon un protocole &#xe9;tabli. L&#x2019;incidence d&#x2019;insuffisance r&#xe9;nale aigu&#xeb; (IRA) et un gain pond&#xe9;ral maximal apr&#xe8;s l&#x2019;intervention constituaient les deux principaux r&#xe9;sultats mesur&#xe9;s. Les r&#xe9;sultats secondaires incluaient une h&#xe9;morragie, l&#x2019;utilisation de transfusion sanguine, d&#x2019;inotrope, d&#x2019;assistance respiratoire et l&#x2019;administration de fluides.</AbstractText><AbstractText Label="R&#xc9;SULTATS" NlmCategory="UNASSIGNED">L&#x2019;&#xe9;tude a &#xe9;t&#xe9; interrompue pr&#xe9;matur&#xe9;ment par manque de ressources. Les 69 patients (19 % de femmes) r&#xe9;partis al&#xe9;atoirement avaient en moyenne 65 ans. La classification RIFLE avait permis de d&#xe9;tecter un &#xab;&#x2009;risque&#x2009;&#xbb; d&#x2019;IRA chez 12 patients dans chacun des groupes (RC: 1,0; IC 95 %: 0,5-1,9; <i>p</i>=1,00) et une &#xab;&#x2009;insuffisance&#x2009;&#xbb; chez 7 patients sur 35 (20 %) du groupe &#xab;&#x2009;amidon&#x2009;&#xbb; et 3 patients sur 34 (9 %) du groupe &#xab;&#x2009;saline&#x2009;&#xbb; (RC: 2,3; IC 95 %: 0,6-8,1; <i>p</i>=0,31). Le gain pond&#xe9;ral maximal, le nombre d&#x2019;h&#xe9;morragies, l&#x2019;utilisation de produits sanguins et les besoins liquidiens &#xe9;taient similaires dans les deux groupes.</AbstractText><AbstractText Label="LIMITES" NlmCategory="UNASSIGNED">L&#x2019;&#xe9;tude a &#xe9;t&#xe9; interrompue pr&#xe9;matur&#xe9;ment en raison d&#x2019;un manque de ressources. Par cons&#xe9;quent, le faible &#xe9;chantillon de patients s&#x2019;av&#xe8;re insuffisamment puissant pour d&#xe9;tecter des diff&#xe9;rences significatives entre les deux groupes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Cette &#xe9;tude a mis en lumi&#xe8;re quelques tendances permettant d&#x2019;&#xe9;mettre des hypoth&#xe8;ses int&#xe9;ressantes. L&#x2019;&#xe9;tude a &#xe9;galement confirm&#xe9; la possibilit&#xe9; d&#x2019;entreprendre un essai logistique complexe de mani&#xe8;re pragmatique.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2020.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac surgical procedures</Keyword><Keyword MajorTopicYN="N">critical care</Keyword><Keyword MajorTopicYN="N">fluid therapy</Keyword><Keyword MajorTopicYN="N">postoperative care</Keyword></KeywordList><CoiStatement>Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>7</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32782813</ArticleId><ArticleId IdType="pmc">PMC7388134</ArticleId><ArticleId IdType="doi">10.1177/2054358120940434</ArticleId><ArticleId IdType="pii">10.1177_2054358120940434</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hoffmann JN, Vollmar B, Laschke MW, et al. Hydroxyethyl starch (130 kD), but not crystalloid volume support, improves microcirculation during normotensive endotoxemia. Anesthesiology. 2002;97:460-470.</Citation><ArticleIdList><ArticleId IdType="pubmed">12151938</ArticleId></ArticleIdList></Reference><Reference><Citation>Funk W, Baldinger V. Microcirculatory perfusion during volume therapy. Anesthesiology. 1995;82(4):975-982.</Citation><ArticleIdList><ArticleId IdType="pubmed">7717571</ArticleId></ArticleIdList></Reference><Reference><Citation>Morisaki H, Bloos F, Keys J, Martin C, Neal A, Sibbald WJ. Compared with crystalloid, colloid therapy slows progression of extrapulmonary tissue injury in septic sheep. J Appl Physiol (1985). 1994;77(3):1507-1518.</Citation><ArticleIdList><ArticleId IdType="pubmed">7530707</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125-139.</Citation><ArticleIdList><ArticleId IdType="pubmed">18184958</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson IJ. Renal impact of fluid management with colloids: a comparative review. Eur J Anaesthesiol. 2006;23(9):721-738.</Citation><ArticleIdList><ArticleId IdType="pubmed">16723059</ArticleId></ArticleIdList></Reference><Reference><Citation>Krausz MM, Bashenko Y, Hirsh M. Crystalloid or colloid resuscitation of uncontrolled hemorrhagic shock after moderate splenic injury. Shock. 2000;13:230-235.</Citation><ArticleIdList><ArticleId IdType="pubmed">10718381</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ. 1998;317:235-240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC28613</ArticleId><ArticleId IdType="pubmed">9677209</ArticleId></ArticleIdList></Reference><Reference><Citation>Metildi LA, Shackford SR, Virgilio RW, Peters RM. Crystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency. Surg Gynecol Obstet. 1984;158(3):207-212.</Citation><ArticleIdList><ArticleId IdType="pubmed">6701732</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin DT, Steinberg SM, Kopolovic R, Carey LC, Cloutier CT. Crystalloid versus colloid resuscitation in experimental hemorrhagic pancreatitis. Surg Gynecol Obstet. 1984;159(5):445-449.</Citation><ArticleIdList><ArticleId IdType="pubmed">6208625</ArticleId></ArticleIdList></Reference><Reference><Citation>Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl Starch 130/0.42 versus Ringer&#x2019;s acetate in severe sepsis. N Engl J Med. 2012;367:124-134.</Citation><ArticleIdList><ArticleId IdType="pubmed">22738085</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutter TC, Ruth CA, Dart AB. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev. 2013;7:CD007594.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11561698</ArticleId><ArticleId IdType="pubmed">23881659</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarychanski R, Abou-Setta AM, Turgeon AF, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation. JAMA. 2013;309:678-688.</Citation><ArticleIdList><ArticleId IdType="pubmed">23423413</ArticleId></ArticleIdList></Reference><Reference><Citation>Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901-1911.</Citation><ArticleIdList><ArticleId IdType="pubmed">23075127</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A, Pieper K, Myburgh JA, et al. Reanalysis of the Crystalloid versus Hydroxyethyl Starch Trial (CHEST). N Engl J Med. 2017;377:298-300.</Citation><ArticleIdList><ArticleId IdType="pubmed">28723325</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob M, Fellahi JL, Chappell D, et al. The impact of hydroxyethyl starches in cardiac surgery: a meta-analysis. Crit Care. 2014;18:1-13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4301454</ArticleId><ArticleId IdType="pubmed">25475406</ArticleId></ArticleIdList></Reference><Reference><Citation>Min JJ, Cho HS, Jeon S, Lee JH, Lee JJ, Lee YT. Effects of 6% hydroxyethyl starch 130/0.4 on postoperative blood loss and kidney injury in off-pump coronary arterial bypass grafting. Medicine (Baltimore). 2017;96(18):e6801.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5419925</ArticleId><ArticleId IdType="pubmed">28471979</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin C, Jacob M, Vicaut E, et al. 130/0.4 on renal function in surgical patients. Anesthesiology. 2013;118:387-394.</Citation><ArticleIdList><ArticleId IdType="pubmed">23340352</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi X-Y, Zou Z, He X-Y, Xu HT, Yuan HB, Liu H. Hydroxyethyl starch for cardiovascular surgery: a systematic review of randomized controlled trials. Eur J Clin Pharmacol. 2011;67(8):767-782.</Citation><ArticleIdList><ArticleId IdType="pubmed">21365330</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RH, Grab JD, O&#x2019;Brien SM, et al. Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation. 2006;114:2208-2216. doi:10.1161/CIRCULATIONAHA.106.635573</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.635573</ArticleId><ArticleId IdType="pubmed">17088458</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeysundera DN, Karkouti K, Dupuis J-Y, et al. Derivation and validation of a Simplified Predictive Index for renal replacement therapy after cardiac surgery. JAMA. 2007;297:1801-1809.</Citation><ArticleIdList><ArticleId IdType="pubmed">17456822</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Lazarus JM, Christiansen CL, et al. Preoperative renal risk stratification. Circulation. 1997;95:878-884.</Citation><ArticleIdList><ArticleId IdType="pubmed">9054745</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakar CV, Arrigain S, Worley S, Yared JP, Paganini EP. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol. 2005;16(1):162-168.</Citation><ArticleIdList><ArticleId IdType="pubmed">15563569</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, The ADQI Workgroup. Acute renal failure&#x2014;definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204-R212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC522841</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. In: Perel P, ed. Cochrane database of systematic reviews. Chichester, England: John Wiley; 2011:CD000567.</Citation><ArticleIdList><ArticleId IdType="pubmed">21412866</ArticleId></ArticleIdList></Reference><Reference><Citation>Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247-2256.</Citation><ArticleIdList><ArticleId IdType="pubmed">15163774</ArticleId></ArticleIdList></Reference><Reference><Citation>Caironi P, Tognoni G, Masson S, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370:1412-1421.</Citation><ArticleIdList><ArticleId IdType="pubmed">24635772</ArticleId></ArticleIdList></Reference><Reference><Citation>Magder S, Potter BJ, Varennes B, Doucette S, Fergusson D, Canadian Critical Care Trials Group. Fluids after cardiac surgery: a pilot study of the use of colloids versus crystalloids*. Crit Care Med. 2010;38(11):2117-2124.</Citation><ArticleIdList><ArticleId IdType="pubmed">20802322</ArticleId></ArticleIdList></Reference><Reference><Citation>
Goldacre B.
AllTrials.net. http://www.alltrials.net/. Accessed February 2,
2018.</Citation></Reference><Reference><Citation>Hobson CE, Yavas S, Segal MS, et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation. 2009;119:2444-2453.</Citation><ArticleIdList><ArticleId IdType="pubmed">19398670</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuitunen A, Vento A, Suojaranta-Ylinen R, Pettil&#xe4; V. Acute renal failure after cardiac surgery: evaluation of the RIFLE classification. Ann Thorac Surg. 2006;81(2):542-546.</Citation><ArticleIdList><ArticleId IdType="pubmed">16427848</ArticleId></ArticleIdList></Reference><Reference><Citation>Verheij J, van Lingen A, Beishuizen A, et al. Cardiac response is greater for colloid than saline fluid loading after cardiac or vascular surgery. Intensive Care Med. 2006;32:1030-1038.</Citation><ArticleIdList><ArticleId IdType="pubmed">16791665</ArticleId></ArticleIdList></Reference><Reference><Citation>Nisanevich V, Felsenstein I, Almogy G, et al. Effect of intraoperative fluid management on outcome after intraabdominal surgery. Anesthesiology. 2005;103:25-32.</Citation><ArticleIdList><ArticleId IdType="pubmed">15983453</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandstrup B, T&#xf8;nnesen H, Beier-Holgersen R, et al. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens. Ann Surg. 2003;238:641-648.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1356139</ArticleId><ArticleId IdType="pubmed">14578723</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xc3;&#xb8;ller AM, Pedersen T, Svendsen PE, Engquist A. Perioperative risk factors in elective pneumonectomy: the impact of excess fluid balance. Eur J Anaesthesiol. 2002;19(1):57-62.</Citation><ArticleIdList><ArticleId IdType="pubmed">11913805</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38895108</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2052-0034</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Gastroenterology report</Title><ISOAbbreviation>Gastroenterol Rep (Oxf)</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury after radical gastrectomy: incidence, risk factors, and impact on prognosis.</ArticleTitle><Pagination><StartPage>goae061</StartPage><MedlinePgn>goae061</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">goae061</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/gastro/goae061</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Acute kidney injury (AKI) is a serious adverse event often overlooked following major abdominal surgery. While radical gastrectomy stands as the primary curative method for treating gastric cancer patients, little information exists regarding AKI post-surgery. Hence, this study aimed to ascertain the incidence rate, risk factors, and consequences of AKI among patients undergoing radical gastrectomy.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This was a population-based, retrospective cohort study. The incidence of AKI was calculated. Multivariate logistic regression was used to identify independent predictors of AKI. Survival curves were plotted by using the Kaplan-Meier method and differences in survival rates between groups were analyzed by using the log-rank test.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Of the 2,875 patients enrolled in this study, 61 (2.1%) developed postoperative AKI, with AKI Network 1, 2, and 3 in 50 (82.0%), 6 (9.8%), and 5 (8.2%), respectively. Of these, 49 patients had fully recovered by discharge. Risk factors for AKI after radical gastrectomy were preoperative hypertension (odds ratio [OR], 1.877; 95% CI, 1.064-3.311; <i>P&#x2009;</i>=<i>&#x2009;</i>0.030), intraoperative blood loss (OR, 1.001; 95% CI, 1.000-1.002; <i>P&#x2009;</i>=<i>&#x2009;</i>0.023), operation time (OR, 1.303; 95% CI, 1.030-1.649; <i>P&#x2009;</i>=<i>&#x2009;</i>0.027), and postoperative intensive care unit (ICU) admission (OR, 4.303; 95% CI, 2.301-8.045; <i>P&#x2009;</i>&lt;<i>&#x2009;</i>0.001). The probability of postoperative complications, mortality during hospitalization, and length of stay in patients with AKI after surgery were significantly higher than those in patients without AKI. There was no statistical difference in overall survival (OS) rates between patients with AKI and without AKI (1-year, 3-year, 5-year overall survival rates of patients with AKI and without AKI were 93.3% vs 92.0%, 70.9% vs 73.6%, and 57.1% vs 67.1%, respectively, <i>P&#x2009;</i>=<i>&#x2009;</i>0.137).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">AKI following radical gastrectomy is relatively rare and typically self-limited. AKI is linked with preoperative hypertension, intraoperative blood loss, operation time, and postoperative ICU admission. While AKI raises the likelihood of postoperative complications, it does not affect OS.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press and Sixth Affiliated Hospital of Sun Yat-sen University.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Benlong</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of General Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of General Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Yunhe</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of General Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zijian</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of General Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Yixun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of General Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lin</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-7905-2505</Identifier><AffiliationInfo><Affiliation>Department of General Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Kecheng</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of General Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing, P. R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Gastroenterol Rep (Oxf)</MedlineTA><NlmUniqueID>101620508</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AKIN criteria</Keyword><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">complication</Keyword><Keyword MajorTopicYN="N">gastric cancer</Keyword><Keyword MajorTopicYN="N">surgery</Keyword></KeywordList><CoiStatement>No potential conflict of interest relevant to this article was reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>19</Day><Hour>4</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38895108</ArticleId><ArticleId IdType="pmc">PMC11183343</ArticleId><ArticleId IdType="doi">10.1093/gastro/goae061</ArticleId><ArticleId IdType="pii">goae061</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sung H, Ferlay J, Siegel RL. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">33538338</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie Y, Wu K, Yu J. et al. A global burden of gastric cancer: the major impact of China. Expert Rev Gastroenterol Hepatol 2017;11:651&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">28351219</ArticleId></ArticleIdList></Reference><Reference><Citation>Allemani C, Weir HK, Carreira H. et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 2015;385:977&#x2013;1010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4588097</ArticleId><ArticleId IdType="pubmed">25467588</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng X, Lu Y.. A review of capecitabine-based adjuvant therapy for gastric cancer in the Chinese population. Future Oncol 2018;14:771&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29252007</ArticleId></ArticleIdList></Reference><Reference><Citation>Kodera Y. The current state of stomach cancer surgery in the world. Jpn J Clin Oncol 2016;46:1062&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">27576437</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokunaga M, Kurokawa Y, Machida R. et al. Impact of postoperative complications on survival outcomes in patients with gastric cancer: exploratory analysis of a randomized controlled JCOG1001 trial. Gastric Cancer 2021;24:214&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">32601909</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Xu L, Wang Q. et al. Postoperative complications and prognosis after radical gastrectomy for gastric cancer: a systematic review and meta-analysis of observational studies. World J Surg Oncol 2019;17:52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6423865</ArticleId><ArticleId IdType="pubmed">30885211</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Huang C, Sun Y. et al. Morbidity and mortality of laparoscopic versus open D2 distal gastrectomy for advanced gastric cancer: a randomized controlled trial. J Clin Oncol 2016;34:1350&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">26903580</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Veen A, Brenkman HJF, Seesing MFJ. et al. Laparoscopic versus open gastrectomy for gastric cancer (LOGICA): a multicenter randomized clinical trial. J Clin Oncol 2021;39:978&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">34581617</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyung WJ, Yang HK, Park YK. et al. Long-term outcomes of laparoscopic distal gastrectomy for locally advanced gastric cancer: the KLASS-02-RCT randomized clinical trial. J Clin Oncol 2020;38:3304&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">32816629</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Xing G, Wang L. et al. Acute kidney injury in China: a cross-sectional survey. Lancet 2015;386:1465&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">26466051</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco C, Bellomo R, Kellum JA.. Acute kidney injury. Lancet 2019;394:1949&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">31777389</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV. et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11:R31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo-Vecino JM, Ripoll&#xe9;s-Melchor J, Mythen MG. et al. Effect of goal-directed haemodynamic therapy on postoperative complications in low-moderate risk surgical patients: a multicentre randomised controlled trial (FEDORA trial). Br J Anaesth 2018;120:734&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">29576114</ArticleId></ArticleIdList></Reference><Reference><Citation>Dindo D, Demartines N, Clavien PA.. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1360123</ArticleId><ArticleId IdType="pubmed">15273542</ArticleId></ArticleIdList></Reference><Reference><Citation>Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 2017;20:1&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5215069</ArticleId><ArticleId IdType="pubmed">27342689</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JY, Xi HQ, Chen L.. Emphasis on standardization of follow-up after gastrectomy. Zhonghua Wai Ke Za Zhi 2018;56:586&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">30107700</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim CS, Oak CY, Kim HY. et al. Incidence, predictive factors, and clinical outcomes of acute kidney injury after gastric surgery for gastric cancer. PLoS One 2013;8:e82289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3857284</ArticleId><ArticleId IdType="pubmed">24349249</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Feng G, Yang Y. et al. Acute kidney injury after radical gastrectomy: a single center study. Int Urol Nephrol 2014;46:973&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">24318368</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Chen X, Shen Z. et al. Prediction models for acute kidney injury in patients with gastrointestinal cancers: a real-world study based on Bayesian networks. Ren Fail 2020;42:869&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7472473</ArticleId><ArticleId IdType="pubmed">32838613</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y, Nie S, Li L. et al. Epidemiology and outcomes of acute kidney injury in hospitalized cancer patients in China. Int J Cancer 2019;144:2644&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">30426496</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy DJ, Pande SD, Liew ZH. et al. Role of parathyroid hormone assay and bedside ultrasound in the emergency department in differentiating acute kidney injury from chronic kidney disease: a systematic review. Emerg Med Int 2019;2019:2102390.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6434274</ArticleId><ArticleId IdType="pubmed">30993021</ArticleId></ArticleIdList></Reference><Reference><Citation>Schol PB, Terink IM, Lanc&#xe9; MD. et al. Liberal or restrictive fluid management during elective surgery: a systematic review and meta-analysis. J Clin Anesth 2016;35:26&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">27871539</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva JM Jr., de Oliveira AM, Nogueira FA. et al. The effect of excess fluid balance on the mortality rate of surgical patients: a multicenter prospective study. Crit Care 2013;17:R288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057181</ArticleId><ArticleId IdType="pubmed">24326085</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmasi V, Maheshwari K, Yang D. et al. Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery: a retrospective cohort analysis. Anesthesiology 2017;126:47&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">27792044</ArticleId></ArticleIdList></Reference><Reference><Citation>Ejaz AA, Johnson RJ, Shimada M. et al. The role of uric acid in acute kidney injury. Nephron 2019;142:275&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">30991383</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallqvist L, Granath F, Huldt E. et al. Intraoperative hypotension is associated with acute kidney injury in noncardiac surgery: an observational study. Eur J Anaesthesiol 2018;35:273&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29210843</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles PS, Bellomo R, Corcoran T. et al.; Australian and New Zealand College of Anaesthetists Clinical Trials Network and the Australian and New Zealand Intensive Care Society Clinical Trials Group. Restrictive versus liberal fluid therapy for major abdominal surgery. N Engl J Med 2018;378:2263&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">29742967</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughson MD, Puelles VG, Hoy WE. et al. Hypertension, glomerular hypertrophy and nephrosclerosis: the effect of race. Nephrol Dial Transplant 2014;29:1399&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4071048</ArticleId><ArticleId IdType="pubmed">24327566</ArticleId></ArticleIdList></Reference><Reference><Citation>Slagelse C, Gammelager H, Iversen LH. et al. Renin-angiotensin system blocker use and the risk of acute kidney injury after colorectal cancer surgery: a population-based cohort study. BMJ Open 2019;9:e032964.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6887015</ArticleId><ArticleId IdType="pubmed">31753901</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis MR, Naik BI, Freundlich RE, Multicenter Perioperative Outcomes Group Investigators et al.Preoperative risk and the association between hypotension and postoperative acute kidney injury. Anesthesiology 2020;132:461&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7015776</ArticleId><ArticleId IdType="pubmed">31794513</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahuja S, Mascha EJ, Yang D. et al. Associations of intraoperative radial arterial systolic, diastolic, mean, and pulse pressures with myocardial and acute kidney injury after noncardiac surgery: a retrospective cohort analysis. Anesthesiology 2020;132:291&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pubmed">31939844</ArticleId></ArticleIdList></Reference><Reference><Citation>Davison E, Affleck A, Daratha KB.. Intraoperative hypotension and acute kidney injury in non-cardiac surgery at a large tertiary care medical center. AANA J 2022;90:58&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">35076385</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun LY, Wijeysundera DN, Tait GA. et al. Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology 2015;123:515&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">26181335</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh M, Devereaux PJ, Garg AX. et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology 2013;119:507&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">23835589</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw AD, Khanna AK, Smischney NJ. et al. Intraoperative hypotension is associated with persistent acute kidney disease after noncardiac surgery: a multicentre cohort study. Br J Anaesth 2022;129:13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">35595549</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Garot M, Godet T. et al.; FLASH Trial Group. Effect of hydroxyethyl starch vs saline for volume replacement therapy on death or postoperative complications among high-risk patients undergoing major abdominal surgery: the FLASH randomized clinical trial. JAMA 2020;323:225&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6990683</ArticleId><ArticleId IdType="pubmed">31961418</ArticleId></ArticleIdList></Reference><Reference><Citation>Opperer M, Poeran J, Rasul R. et al. Use of perioperative hydroxyethyl starch 6% and albumin 5% in elective joint arthroplasty and association with adverse outcomes: a retrospective population based analysis. BMJ 2015;350:h1567.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4376265</ArticleId><ArticleId IdType="pubmed">25817299</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy CF, Dunne T, Elliott JA. et al. Acute kidney injury after esophageal cancer surgery: incidence, risk factors, and impact on oncologic outcomes. Ann Surg 2022;275:e683&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">32740248</ArticleId></ArticleIdList></Reference><Reference><Citation>Slagelse C, Gammelager H, Iversen LH. et al. Acute kidney injury and 1-year mortality after colorectal cancer surgery: a population-based cohort study. BMJ Open 2019;9:e024817.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6429863</ArticleId><ArticleId IdType="pubmed">30872545</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell S, Dekker FW, Vadiveloo T. et al. Risk of postoperative acute kidney injury in patients undergoing orthopaedic surgery&#x2014;development and validation of a risk score and effect of acute kidney injury on survival: observational cohort study. BMJ 2015;351:h5639.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4641433</ArticleId><ArticleId IdType="pubmed">26561522</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakkar M, Bruno VD, Guida G. et al. Postoperative acute kidney injury defined by RIFLE criteria predicts early health outcome and long-term survival in patients undergoing redo coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 2016;152:235&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4915911</ArticleId><ArticleId IdType="pubmed">27016793</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillies MA, Habicher M, Jhanji S. et al. Incidence of postoperative death and acute kidney injury associated with i.v. 6% hydroxyethyl starch use: systematic review and meta-analysis. Br J Anaesth 2014;112:25&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">24046292</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Linden P, James M, Mythen M. et al. Safety of modern starches used during surgery. Anesth Analg 2013;116:35&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">23115254</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson C, Ruchi R, Bihorac A.. Perioperative acute kidney injury: risk factors and predictive strategies. Crit Care Clin 2017;33:379&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5617733</ArticleId><ArticleId IdType="pubmed">28284301</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39657393</PMID><DateCompleted><Year>2025</Year><Month>01</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>101</Volume><PubDate><Year>2025</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Mitochondrial oxygenation monitoring and acute kidney injury risk in cardiac surgery: A prospective cohort study.</ArticleTitle><Pagination><StartPage>111715</StartPage><MedlinePgn>111715</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2024.111715</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(24)00345-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cardiac surgery-associated acute kidney injury (CSA-AKI) is a common complication of cardiac surgery and is associated with increased morbidity and mortality. Recent guidelines emphasize the need for new monitoring methods to facilitate targeted CSA-AKI prevention and treatment strategies. In vivo real-time measurement of mitochondrial oxygen tension (mitoPO<sub>2</sub>), could potentially fulfil this role during cardiac surgery, as suggested in our previous pilot study.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this prospective observational study, we investigated 75 cardiac surgery patients with an increased preoperative CSA-AKI risk. The primary aim of this study was to assess whether patients who developed CSA-AKI experienced prolonged periods of mitoPO<sub>2</sub>&#xa0;&lt;&#xa0;20&#xa0;mmHg during surgery. mitoPO<sub>2</sub> was measured intraoperatively, and CSA-AKI was defined according to the Kidney Disease: Improving Global Outcomes criteria. Four additional mitoPO<sub>2</sub> thresholds (&lt;25, &lt;30, &lt;35, and&#xa0;&lt;&#xa0;40&#xa0;mmHg) were analyzed, including the predictive capacity of all thresholds for CSA-AKI.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">This study found that patients who developed CSA-AKI had a significantly longer intraoperative time with mitoPO<sub>2</sub>&#xa0;&lt;20&#xa0;mmHg and&#xa0;&lt;25, &lt;30, &lt;35, and&#xa0;&lt;40&#xa0;mmHg. Subsequently, we tested all thresholds for their association with the risk of CSA-AKI, with the &lt;25&#xa0;mmHg threshold demonstrating the highest significant odds ratio. Every minute spent below &lt;25&#xa0;mmHg increased the risk of CSA-AKI by 0.7&#xa0;% (P&#xa0;=&#xa0;0.021).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study highlighted the association between mitoPO<sub>2</sub> and the onset of CSA-AKI. Extended durations below the mitoPO<sub>2</sub> threshold of 25&#xa0;mmHg significantly correlate with an elevated CSA-AKI risk. Using mitoPO<sub>2</sub> as a monitoring tool shows promise in potentially predicting and possibly preventing CSA-AKI when used as a treatment trigger in cardiac surgery patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Wijs</LastName><ForeName>Calvin J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Anesthesiology, Department of Anesthesiology, Erasmus MC, Rotterdam, the Netherlands. Electronic address: c.dewijs@erasmusmc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Streng</LastName><ForeName>Lucia W J M</ForeName><Initials>LWJM</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Anesthesiology, Department of Anesthesiology, Erasmus MC, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stolker</LastName><ForeName>Robert Jan</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Anesthesiology, Department of Anesthesiology, Erasmus MC, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ter Horst</LastName><ForeName>Maarten</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Anesthesiology, Department of Anesthesiology, Erasmus MC, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoorn</LastName><ForeName>Ewout J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahtab</LastName><ForeName>Edris A F</ForeName><Initials>EAF</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Erasmus MC, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mik</LastName><ForeName>Egbert G</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Anesthesiology, Department of Anesthesiology, Erasmus MC, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harms</LastName><ForeName>Floor A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Anesthesiology, Department of Anesthesiology, Erasmus MC, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="Y">Monitoring, Intraoperative</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="Y">Oxygen</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="Y">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010101" MajorTopicYN="N">Oxygen Consumption</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Coronary artery bypass grafting</Keyword><Keyword MajorTopicYN="N">Mitochondrial oxygenation</Keyword></KeywordList><CoiStatement>Declaration of competing interest Egbert G. Mik is listed as an inventor of patents related to mitochondrial oxygen measurements held by the Academic Medical Centre Amsterdam and the Erasmus Medical Centre Rotterdam, the Netherlands. He is the founder and shareholder of Photonics Healthcare, a company that holds exclusive licenses to these patents and that markets the COMET&#xae; system. He was not involved in the data analysis. All other authors declare no relevant conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>21</Day><Hour>9</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>11</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>10</Day><Hour>18</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39657393</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2024.111715</ArticleId><ArticleId IdType="pii">S0952-8180(24)00345-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40305034</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>11</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-6262</ISSN><JournalIssue CitedMedium="Internet"><Volume>160</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA surgery</Title><ISOAbbreviation>JAMA Surg</ISOAbbreviation></Journal><ArticleTitle>Postoperative Outcomes Among Sodium-Glucose Cotransporter 2 Inhibitor Users.</ArticleTitle><Pagination><StartPage>681</StartPage><EndPage>689</EndPage><MedlinePgn>681-689</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamasurg.2025.0940</ELocationID><Abstract><AbstractText Label="IMPORTANCE" NlmCategory="UNASSIGNED">Case reports and small retrospective studies have suggested that there is an increased risk of postoperative euglycemic ketoacidosis (eKA) and acute kidney injury (AKI) among patients using sodium-glucose cotransporter 2 inhibitors (SGLT2i) preoperatively. However, there has not been a representative assessment of the risks of these agents among patients undergoing surgery.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To evaluate the risk of postoperative eKA, AKI, and mortality within 30 days after surgery among preoperative long-term SGLT2i users compared with nonusers.</AbstractText><AbstractText Label="DESIGN, SETTINGS, AND PARTICIPANTS" NlmCategory="UNASSIGNED">This is a multicenter, propensity-matched, retrospective case-control study from the Veterans Affairs Health Care System (VAHCS) National Registry performed from January 1, 2014, to December 31, 2022. Adult patients using SGLT2i preoperatively who underwent inpatient surgical procedures were compared with a 1:5 matched control group using propensity score matching, including the patient's demographic characteristics, comorbidities, and surgical characteristics. Data analysis was performed from June 2023 to August 2024.</AbstractText><AbstractText Label="EXPOSURE" NlmCategory="UNASSIGNED">Long-term use of SGLT2i, defined as having more than 3 fills of outpatient prescription or less than a 180-day gap of the last fill according to the VAHCS pharmacy registries.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES" NlmCategory="UNASSIGNED">The primary outcome was the rate of postoperative eKA among SGLT2i users vs control patients. Secondary outcomes included postoperative AKI and 30-day mortality after surgery.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Among 462&#x202f;968 patients undergoing surgery, 7448 SGLT2i users (mean [SD] age, 67.7 [8.1] years; 7204 [96.7%] male) and 455&#x202f;520 nonusers (mean [SD] age, 65.8 [11.0] years; 424&#x202f;785 [93.3%] male) were identified. After propensity score matching, 7439 patients were identified as SGLT2i users and compared with 33&#x202f;489 control patients. SGLT2i use was associated with an increased risk of eKA (odds ratio [OR], 1.11; 95% CI, 1.05-1.17) but reduced risks of perioperative AKI (OR, 0.69; 95% CI, 0.62-0.78) and 30-day mortality (OR, 0.70; 95% CI, 0.55-0.88). The mortality rate 30 days after surgery was 1.1% among SGLT2i users vs 1.6% among control patients. The median hospital length of stay among the patients presenting with eKA increased by 3 days (median [IQR], 6 [3-10] days for those with eKA vs 3 [2-6] days for those without eKA).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE" NlmCategory="UNASSIGNED">Patients treated with SGLT2i had a small but significantly higher risk of postoperative eKA but lower risks of postoperative AKI and 30-day mortality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tallarico</LastName><ForeName>Roberta Teixeira</ForeName><Initials>RT</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine in St Louis, St Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jing</LastName><ForeName>Bocheng</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Geriatrics, University of California, San Francisco.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Northern California Institute for Research and Education, San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Kaiwei</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Northern California Institute for Research and Education, San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chawla</LastName><ForeName>Shweta Amy</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>School of Medicine, University of California, San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Yanting</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badathala</LastName><ForeName>Anusha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Veterans Affairs Medical Center, San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Catherine L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallace</LastName><ForeName>Arthur W</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veterans Affairs Medical Center, San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Legrand</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Surg</MedlineTA><NlmUniqueID>101589553</NlmUniqueID><ISSNLinking>2168-6254</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077203">Sodium-Glucose Transporter 2 Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077203" MajorTopicYN="Y">Sodium-Glucose Transporter 2 Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="Y">Surgical Procedures, Operative</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Tallarico reported receiving grants from the National Institute of General Medical Sciences and the Department of Anesthesia and Perioperative Care and Department of Epidemiology and Biostatistics at the University of California, San Francisco (UCSF) during the conduct of the study. Dr Chen reported receiving grants from the National Institute on Aging, Patricia Sander Awards for Anesthesia Researchers, and UCSF Anesthesia Research outside the submitted work. Dr Legrand reported receiving grants from the National Institute of General Medical Sciences and National Institute of Diabetes and Digestive and Kidney Diseases during the conduct of the study; and receiving personal fees from La Jolla, Viatris, Radiometer, and Alexion outside the submitted work. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>11</Day><Hour>12</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>30</Day><Hour>12</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>30</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40305034</ArticleId><ArticleId IdType="pmc">PMC12044541</ArticleId><ArticleId IdType="doi">10.1001/jamasurg.2025.0940</ArticleId><ArticleId IdType="pii">2833369</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Burke KR, Schumacher CA, Harpe SE. SGLT2 inhibitors: a systematic review of diabetic ketoacidosis and related risk factors in the primary literature. Pharmacotherapy. 2017;37(2):187-194. doi: 10.1002/phar.1881</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/phar.1881</ArticleId><ArticleId IdType="pubmed">27931088</ArticleId></ArticleIdList></Reference><Reference><Citation>Morace C, Lorello G, Bellone F, et al. Ketoacidosis and SGLT2 inhibitors: a narrative review. Metabolites. 2024;14(5):264. doi: 10.3390/metabo14050264</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo14050264</ArticleId><ArticleId IdType="pmc">PMC11122992</ArticleId><ArticleId IdType="pubmed">38786741</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardia A, Wai M, Fontes ML. Sodium-glucose cotransporter-2 inhibitors: an overview and perioperative implications. Curr Opin Anaesthesiol. 2019;32(1):80-85. doi: 10.1097/ACO.0000000000000674</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0000000000000674</ArticleId><ArticleId IdType="pubmed">30531609</ArticleId></ArticleIdList></Reference><Reference><Citation>Braunwald E. Gliflozins in the management of cardiovascular disease. N Engl J Med. 2022;386(21):2024-2034. doi: 10.1056/NEJMra2115011</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2115011</ArticleId><ArticleId IdType="pubmed">35613023</ArticleId></ArticleIdList></Reference><Reference><Citation>Madhok J, Vanneman MW. SGLT-2 inhibitors: proliferating indications and perioperative pitfalls. J Cardiothorac Vasc Anesth. 2022;36(7):1815-1819. doi: 10.1053/j.jvca.2022.02.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2022.02.019</ArticleId><ArticleId IdType="pubmed">35331629</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallik R, Chowdhury TA. Pharmacotherapy to delay the progression of diabetic kidney disease in people with type 2 diabetes: past, present and future. Ther Adv Endocrinol Metab. 2022;13:20420188221081601. doi: 10.1177/20420188221081601</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20420188221081601</ArticleId><ArticleId IdType="pmc">PMC8905210</ArticleId><ArticleId IdType="pubmed">35281302</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavrakanas TA, Tsoukas MA, Brophy JM, Sharma A, Gariani K. SGLT-2 inhibitors improve cardiovascular and renal outcomes in patients with CKD: a systematic review and meta-analysis. Sci Rep. 2023;13(1):15922. doi: 10.1038/s41598-023-42989-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-42989-z</ArticleId><ArticleId IdType="pmc">PMC10517929</ArticleId><ArticleId IdType="pubmed">37741858</ArticleId></ArticleIdList></Reference><Reference><Citation>Neal B, Perkovic V, Mahaffey KW, et al. ; CANVAS Program Collaborative Group . Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017;377(7):644-657. doi: 10.1056/NEJMoa1611925</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1611925</ArticleId><ArticleId IdType="pubmed">28605608</ArticleId></ArticleIdList></Reference><Reference><Citation>Nespoux J, Vallon V. Renal effects of SGLT2 inhibitors: an update. Curr Opin Nephrol Hypertens. 2020;29(2):190-198. doi: 10.1097/MNH.0000000000000584</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MNH.0000000000000584</ArticleId><ArticleId IdType="pmc">PMC7224333</ArticleId><ArticleId IdType="pubmed">31815757</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuen BL, Young T, Heerspink HJL, et al. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2019;7(11):845-854. doi: 10.1016/S2213-8587(19)30256-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(19)30256-6</ArticleId><ArticleId IdType="pubmed">31495651</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni L, Yuan C, Chen G, Zhang C, Wu X. SGLT2i: beyond the glucose-lowering effect. Cardiovasc Diabetol. 2020;19(1):98. doi: 10.1186/s12933-020-01071-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-020-01071-y</ArticleId><ArticleId IdType="pmc">PMC7320582</ArticleId><ArticleId IdType="pubmed">32590982</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahtta D, Ramsey DJ, Lee MT, et al. Utilization rates of SGLT2 inhibitors and GLP-1 receptor agonists and their facility-level variation among patients with atherosclerotic cardiovascular disease and type 2 diabetes: insights from the Department of Veterans Affairs. Diabetes Care. 2022;45(2):372-380. doi: 10.2337/dc21-1815</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc21-1815</ArticleId><ArticleId IdType="pmc">PMC8914426</ArticleId><ArticleId IdType="pubmed">35015080</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta S, Kumar T, Singh S, Ambwani S, Charan J, Varthya SB. Euglycemic diabetic ketoacidosis associated with SGLT2 inhibitors: a systematic review and quantitative analysis. J Family Med Prim Care. 2022;11(3):927-940. doi: 10.4103/jfmpc.jfmpc_644_21</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jfmpc.jfmpc_644_21</ArticleId><ArticleId IdType="pmc">PMC9051698</ArticleId><ArticleId IdType="pubmed">35495849</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampani E, Sarafidis P, Dimitriadis C, et al. Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review. BMC Nephrol. 2020;21(1):276. doi: 10.1186/s12882-020-01930-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-020-01930-6</ArticleId><ArticleId IdType="pmc">PMC7364613</ArticleId><ArticleId IdType="pubmed">32669085</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki Y, Sasabuchi Y, Horikita S, et al. The effect of preoperative sodium-glucose cotransporter 2 inhibitors on the incidence of perioperative metabolic acidosis: a retrospective cohort study. BMC Endocr Disord. 2022;22(1):209. doi: 10.1186/s12902-022-01126-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12902-022-01126-z</ArticleId><ArticleId IdType="pmc">PMC9392326</ArticleId><ArticleId IdType="pubmed">35987618</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta PB, Robinson A, Burkhardt D, Rushakoff RJ. Inpatient perioperative euglycemic diabetic ketoacidosis due to sodium-glucose cotransporter-2 inhibitors&#x2014;lessons from a case series and strategies to decrease incidence. Endocr Pract. 2022;28(9):884-888. doi: 10.1016/j.eprac.2022.06.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eprac.2022.06.006</ArticleId><ArticleId IdType="pubmed">35753675</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia B, Ostermann M, Legrand M. How to manage sodium-glucose cotransporter-2 inhibitors in the critically ill patient? Intensive Care Med. 2025;51(1):143-145. doi: 10.1007/s00134-024-07704-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-024-07704-0</ArticleId><ArticleId IdType="pubmed">39621048</ArticleId></ArticleIdList></Reference><Reference><Citation>Chacko B, Whitley M, Beckmann U, Murray K, Rowley M. Postoperative euglycaemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitors (gliflozins): a report of two cases and review of the literature. Anaesth Intensive Care. 2018;46(2):215-219. doi: 10.1177/0310057X1804600212</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0310057X1804600212</ArticleId><ArticleId IdType="pubmed">29519226</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau A, Bruce S, Wang E, Ree R, Rondi K, Chau A. Perioperative implications of sodium-glucose cotransporter-2 inhibitors: a case series of euglycemic diabetic ketoacidosis in three patients after cardiac surgery. Can J Anaesth. 2018;65(2):188-193. doi: 10.1007/s12630-017-1018-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-017-1018-6</ArticleId><ArticleId IdType="pubmed">29168157</ArticleId></ArticleIdList></Reference><Reference><Citation>Darwish AM. Metabolic acidosis in postsurgical patient on canagliflozin and metformin: a case report. A A Pract. 2019;12(7):221-222. doi: 10.1213/XAA.0000000000000888</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/XAA.0000000000000888</ArticleId><ArticleId IdType="pubmed">30234515</ArticleId></ArticleIdList></Reference><Reference><Citation>Goto S, Ishikawa JY, Idei M, Iwabuchi M, Namekawa M, Nomura T. Life-threatening complications related to delayed diagnosis of euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitors: a report of 2 cases. Am J Case Rep. 2021;22:e929773. doi: 10.12659/AJCR.929773</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/AJCR.929773</ArticleId><ArticleId IdType="pmc">PMC7980085</ArticleId><ArticleId IdType="pubmed">33723205</ArticleId></ArticleIdList></Reference><Reference><Citation>Kietaibl AT, Fasching P, Glaser K, Petter-Puchner AH. New diabetic medication sodium-glucose cotransporter-2 inhibitors can induce euglycemic ketoacidosis and mimic surgical diseases: a case report and review of literature. Front Surg. 2022;9:828649. doi: 10.3389/fsurg.2022.828649</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fsurg.2022.828649</ArticleId><ArticleId IdType="pmc">PMC8987984</ArticleId><ArticleId IdType="pubmed">35402477</ArticleId></ArticleIdList></Reference><Reference><Citation>Yared KE, Mancini GJ. euglycemic diabetic ketoacidosis associated with use of SGLT2 inhibitor after laparoscopic Roux-en-Y gastric bypass. Am Surg. 2021;87(12):1997-1999. doi: 10.1177/0003134820940286</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0003134820940286</ArticleId><ArticleId IdType="pubmed">32812784</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang KM, Isom RT. SGLT2 inhibitor-induced euglycemic diabetic ketoacidosis: a case report. Kidney Med. 2020;2(2):218-221. doi: 10.1016/j.xkme.2019.12.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xkme.2019.12.006</ArticleId><ArticleId IdType="pmc">PMC7380362</ArticleId><ArticleId IdType="pubmed">32734242</ArticleId></ArticleIdList></Reference><Reference><Citation>van Niekerk C, Wallace J, Takata M, Yu R. Euglycaemic diabetic ketoacidosis in bariatric surgery patients with type 2 diabetes taking canagliflozin. <i>BMJ Case Rep</i>. Published online August 20, 2018. doi: 10.1136/bcr-2017-221527</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2017-221527</ArticleId><ArticleId IdType="pmc">PMC6109719</ArticleId><ArticleId IdType="pubmed">30131409</ArticleId></ArticleIdList></Reference><Reference><Citation>Seki H, Watanabe H, Yorozu T. Postoperative ketoacidosis with hypoglycemia in a nondiabetic patient taking dapagliflozin for heart failure: a case report. A A Pract. 2022;16(3):e01570. doi: 10.1213/XAA.0000000000001570</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/XAA.0000000000001570</ArticleId><ArticleId IdType="pmc">PMC9323548</ArticleId><ArticleId IdType="pubmed">35285818</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown F, McColl T. Euglycemic diabetic ketoacidosis secondary to dapagliflozin use: a case report. J Emerg Med. 2018;54(1):109-111. doi: 10.1016/j.jemermed.2017.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jemermed.2017.10.001</ArticleId><ArticleId IdType="pubmed">29157798</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane S, Paskar D, Hamed S, Goffi A. When guidelines fail: euglycemic diabetic ketoacidosis after bariatric surgery in a patient taking a sodium-glucose cotransporter-2 inhibitor: a case report. A A Pract. 2018;11(2):46-48. doi: 10.1213/XAA.0000000000000734</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/XAA.0000000000000734</ArticleId><ArticleId IdType="pubmed">29634546</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonanni FB, Fei P, Fitzpatrick LL. Normoglycemic ketoacidosis in a postoperative gastric bypass patient taking canagliflozin. Surg Obes Relat Dis. 2016;12(1):e11-e12. doi: 10.1016/j.soard.2015.08.502</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.soard.2015.08.502</ArticleId><ArticleId IdType="pubmed">26686305</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuchay MS, Mishra SK, Mehta Y. Empagliflozin induced euglycemic diabetic ketoacidosis in a patient undergoing coronary artery bypass graft despite discontinuation of the drug 48 hours prior to the surgery. Diabetes Metab Syndr. 2021;15(3):909-911. doi: 10.1016/j.dsx.2021.04.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.016</ArticleId><ArticleId IdType="pubmed">33915345</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackintosh C, Tewari A, Siegel J, Wang RD, Freeman W. Postoperative euglycemic diabetic ketoacidosis and encephalopathy related to SGLT-2 inhibitors: a case report and discussion of diabetes treatment and &#x201c;sweet pee encephalopathy&#x201d; in perioperative hospital management. Neurohospitalist. 2020;10(1):51-54. doi: 10.1177/1941874419835035</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1941874419835035</ArticleId><ArticleId IdType="pmc">PMC6900651</ArticleId><ArticleId IdType="pubmed">31839866</ArticleId></ArticleIdList></Reference><Reference><Citation>Osafehinti DA, Okoli OJ, Karam JG. A case of SGLT2 inhibitor-associated euglycemic diabetic ketoacidosis following coronary artery bypass surgery. AACE Clin Case Rep. 2020;7(1):20-22. doi: 10.1016/j.aace.2020.11.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aace.2020.11.014</ArticleId><ArticleId IdType="pmc">PMC7924150</ArticleId><ArticleId IdType="pubmed">33851014</ArticleId></ArticleIdList></Reference><Reference><Citation>Szalat A, Perlman A, Muszkat M, Khamaisi M, Abassi Z, Heyman SN. Can SGLT2 inhibitors cause acute renal failure? plausible role for altered glomerular hemodynamics and medullary hypoxia. Drug Saf. 2018;41(3):239-252. doi: 10.1007/s40264-017-0602-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-017-0602-6</ArticleId><ArticleId IdType="pubmed">28952138</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayhew D, Mendonca V, Murthy BVS. A review of ASA physical status&#x2014;historical perspectives and modern developments. Anaesthesia. 2019;74(3):373-379. doi: 10.1111/anae.14569</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.14569</ArticleId><ArticleId IdType="pubmed">30648259</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . International Statistical Classification of Diseases, Tenth Revision (ICD-10). World Health Organization; 1992.</Citation></Reference><Reference><Citation>Barski L, Eshkoli T, Brandstaetter E, Jotkowitz A. Euglycemic diabetic ketoacidosis. Eur J Intern Med. 2019;63:9-14. doi: 10.1016/j.ejim.2019.03.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2019.03.014</ArticleId><ArticleId IdType="pubmed">30910328</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens PE, Ahmed SB, Carrero JJ, et al. ; Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group . KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4S):S117-S314. doi: 10.1016/j.kint.2023.10.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2023.10.018</ArticleId><ArticleId IdType="pubmed">38490803</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui DTW, Wu T, Au ICH, et al. A population-based study of SGLT2 inhibitor-associated postoperative diabetic ketoacidosis in patients with type 2 diabetes. Drug Saf. 2023;46(1):53-64. doi: 10.1007/s40264-022-01247-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-022-01247-3</ArticleId><ArticleId IdType="pubmed">36289137</ArticleId></ArticleIdList></Reference><Reference><Citation>Auerbach JS, Gershengorn HB, Aljure OD, et al. Postcardiac surgery euglycemic diabetic ketoacidosis in patients on sodium-glucose cotransporter 2 inhibitors. J Cardiothorac Vasc Anesth. 2023;37(6):956-963. doi: 10.1053/j.jvca.2023.01.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2023.01.041</ArticleId><ArticleId IdType="pubmed">36872114</ArticleId></ArticleIdList></Reference><Reference><Citation>Handelsman Y, Henry RR, Bloomgarden ZT, et al. American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of SGLT-2 inhibitors and diabetic ketoacidosis. Endocr Pract. 2016;22(6):753-762. doi: 10.4158/EP161292.PS</Citation><ArticleIdList><ArticleId IdType="doi">10.4158/EP161292.PS</ArticleId><ArticleId IdType="pubmed">27082665</ArticleId></ArticleIdList></Reference><Reference><Citation>Tallarico RT, McCoy IE, D&#xe9;pret F, Legrand M. Meaning and management of perioperative oliguria. Anesthesiology. 2024;140(2):304-312. doi: 10.1097/ALN.0000000000004746</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000004746</ArticleId><ArticleId IdType="pmc">PMC10843636</ArticleId><ArticleId IdType="pubmed">37812766</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzareschi DV, Fong N, Mavrothalassitis O, et al. ; MPOG Collaborators . Intraoperative use of albumin in major noncardiac surgery: incidence, variability, and association with outcomes. Ann Surg. 2023;278(4):e745-e753.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10481928</ArticleId><ArticleId IdType="pubmed">36521076</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu C, Fong N, Lazzareschi D, et al. Fluids, vasopressors, and acute kidney injury after major abdominal surgery between 2015 and 2019: a multicentre retrospective analysis. Br J Anaesth. 2022;129(3):317-326. doi: 10.1016/j.bja.2022.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2022.05.002</ArticleId><ArticleId IdType="pubmed">35688657</ArticleId></ArticleIdList></Reference><Reference><Citation>Legrand M, Rossignol P. Cardiovascular consequences of acute kidney injury. N Engl J Med. 2020;382(23):2238-2247. doi: 10.1056/NEJMra1916393</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1916393</ArticleId><ArticleId IdType="pubmed">32492305</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xe9;pret F, Prud&#x2019;homme M, Legrand M. A role of remote organs effect in acute kidney injury outcome. Nephron. 2017;137(4):273-276. doi: 10.1159/000476077</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000476077</ArticleId><ArticleId IdType="pubmed">28586768</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34748518</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>134</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Remote Ischemic Preconditioning Reduces Acute Kidney Injury After Cardiac Surgery: A Systematic Review and Meta-analysis of Randomized Controlled Trials.</ArticleTitle><Pagination><StartPage>592</StartPage><EndPage>605</EndPage><MedlinePgn>592-605</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000005804</ELocationID><Abstract><AbstractText Label="BACKGROUND">Results from previous studies evaluating the effects of remote ischemic preconditioning (RIPC) on morbidity and mortality after cardiac surgery are inconsistent. This meta-analysis of randomized controlled trials (RCTs) aims to determine whether RIPC improves cardiac and renal outcomes in adults undergoing cardiac surgery.</AbstractText><AbstractText Label="METHODS">PubMed, EMBASE, and Cochrane Library were comprehensively searched to identify RCTs comparing RIPC with control in cardiac surgery. The coprimary outcomes were the incidence of postoperative myocardial infarction (MI) and the incidence of postoperative acute kidney injury (AKI). Meta-analyses were performed using a random-effect model. Subgroup analyses were conducted according to volatile only anesthesia versus propofol anesthesia with or without volatiles, high-risk patients versus non-high-risk patients, and Acute Kidney Injury Network (AKIN) or Kidney Disease Improving Global Outcomes (KDIGO) criteria versus other criteria for AKI diagnosis.</AbstractText><AbstractText Label="RESULTS">A total of 79 RCTs with 10,814 patients were included. While the incidence of postoperative MI did not differ between the RIPC and control groups (8.2% vs 9.7%; risk ratio [RR] = 0.87, 95% confidence interval [CI], 0.76-1.01, P = .07, I2 = 0%), RIPC significantly reduced the incidence of postoperative AKI (22% vs 24.4%; RR = 0.86, 95% CI, 0.77-0.97, P = .01, I2 = 34%). The subgroup analyses showed that RIPC was associated with a reduced incidence of MI in non-high-risk patients, and that RIPC was associated with a reduced incidence of AKI in volatile only anesthesia, in non-high-risk patients, and in the studies using AKIN or KDIGO criteria for AKI diagnosis.</AbstractText><AbstractText Label="CONCLUSIONS">This meta-analysis demonstrates that RIPC reduces the incidence of AKI after cardiac surgery. This renoprotective effect of RIPC is mainly evident during volatile only anesthesia, in non-high-risk patients, and when AKIN or KDIGO criteria used for AKI diagnosis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 International Anesthesia Research Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Yu-Qin</ForeName><Initials>YQ</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology, First Affiliated Hospital of Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Xiao-Mei</ForeName><Initials>XM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Utah Health, Salt Lake City, Utah.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Transitional Residency Program, Intermountain Medical Center, Murray, Utah.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shan</LastName><ForeName>Xi-Sheng</ForeName><Initials>XS</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology, First Affiliated Hospital of Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Qing-Cai</ForeName><Initials>QC</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology, First Affiliated Hospital of Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Zhengyuan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of California Davis Health, Sacramento, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Fu-Hai</ForeName><Initials>FH</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology, First Affiliated Hospital of Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of California Davis Health, Sacramento, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Ke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology, First Affiliated Hospital of Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019194" MajorTopicYN="N">Ischemic Preconditioning</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>8</Day><Hour>17</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34748518</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000005804</ArticleId><ArticleId IdType="pii">00000539-202203000-00022</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Muehlschlegel JD, Perry TE, Liu KY, et al.; CABG Genomics Investigators. Troponin is superior to electrocardiogram and creatinine kinase MB for predicting clinically significant myocardial injury after coronary artery bypass grafting. Eur Heart J. 2009;30:1574&#x2013;1583.</Citation></Reference><Reference><Citation>Thiele RH, Isbell JM, Rosner MH. AKI associated with cardiac surgery. Clin J Am Soc Nephrol. 2015;10:500&#x2013;514.</Citation></Reference><Reference><Citation>Gho BC, Schoemaker RG, van den Doel MA, Duncker DJ, Verdouw PD. Myocardial protection by brief ischemia in noncardiac tissue. Circulation. 1996;94:2193&#x2013;2200.</Citation></Reference><Reference><Citation>Hausenloy DJ, Candilio L, Evans R, et al. Remote ischemic preconditioning and outcomes of cardiac surgery. N Engl J Med. 2015;373:1408&#x2013;1417.</Citation></Reference><Reference><Citation>Hong DM, Lee EH, Kim HJ, et al. Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote Ischaemic Preconditioning with Postconditioning Outcome Trial. Eur Heart J. 2014;35:176&#x2013;183.</Citation></Reference><Reference><Citation>Meybohm P, Bein B, Brosteanu O, et al.; RIPHeart Study Collaborators. A multicenter trial of remote ischemic preconditioning for heart surgery. N Engl J Med. 2015;373:1397&#x2013;1407.</Citation></Reference><Reference><Citation>Thielmann M, Kottenberg E, Kleinbongard P, et al. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial. Lancet. 2013;382:597&#x2013;604.</Citation></Reference><Reference><Citation>Zarbock A, Schmidt C, Van Aken H, et al. Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA. 2015;313:2133&#x2013;2141.</Citation></Reference><Reference><Citation>Pierce B, Bole I, Patel V, Brown DL. Clinical outcomes of remote ischemic preconditioning prior to cardiac surgery: a meta-analysis of randomized controlled trials. J Am Heart Assoc. 2017;6:e004666.</Citation></Reference><Reference><Citation>Xie J, Zhang X, Xu J, et al. Effect of remote ischemic preconditioning on outcomes in adult cardiac surgery: a systematic review and meta-analysis of randomized controlled studies. Anesth Analg. 2018;127:30&#x2013;38.</Citation></Reference><Reference><Citation>Zhou H, Yang L, Wang G, et al. Remote ischemic preconditioning prevents postoperative acute kidney injury after open total aortic arch replacement: a double-blind, randomized, sham-controlled trial. Anesth Analg. 2019;129:287&#x2013;293.</Citation></Reference><Reference><Citation>Jin X, Wang L, Li L, Zhao X. Protective effect of remote ischemic pre-conditioning on patients undergoing cardiac bypass valve replacement surgery: a randomized controlled trial. Exp Ther Med. 2019;17:2099&#x2013;2106.</Citation></Reference><Reference><Citation>Jiang Q, Xiang B, Wang H, Huang K, Kong H, Hu S. Remote ischaemic preconditioning ameliorates sinus rhythm restoration rate through Cox maze radiofrequency procedure associated with inflammation reaction reduction. Basic Res Cardiol. 2019;114:14.</Citation></Reference><Reference><Citation>Song JW, Lee WK, Lee S, Shim JK, Kim HJ, Kwak YL. Remote ischaemic conditioning for prevention of acute kidney injury after valvular heart surgery: a randomised controlled trial. Br J Anaesth. 2018;121:1034&#x2013;1040.</Citation></Reference><Reference><Citation>Zarbock A, Kellum JA, Van Aken H, et al. Long-term effects of remote ischemic preconditioning on kidney function in high-risk cardiac surgery patients: follow-up results from the RenalRIP trial. Anesthesiology. 2017;126:787&#x2013;798.</Citation></Reference><Reference><Citation>Kim TK, Min JJ, Cho YJ, et al. Effects of delayed remote ischemic preconditioning on peri-operative myocardial injury in patients undergoing cardiac surgery - a randomized controlled trial. Int J Cardiol. 2017;227:511&#x2013;515.</Citation></Reference><Reference><Citation>Cho YJ, Lee EH, Lee K, et al. Long-term clinical outcomes of Remote Ischemic Preconditioning and Postconditioning Outcome (RISPO) trial in patients undergoing cardiac surgery. Int J Cardiol. 2017;231:84&#x2013;89.</Citation></Reference><Reference><Citation>Walsh M, Whitlock R, Garg AX, et al.; Remote IMPACT Investigators. Effects of remote ischemic preconditioning in high-risk patients undergoing cardiac surgery (Remote IMPACT): a randomized controlled trial. CMAJ. 2016;188:329&#x2013;336.</Citation></Reference><Reference><Citation>Hu Q, Luo W, Huang L, Huang R, Chen R, Gao Y. Multiorgan protection of remote ischemic perconditioning in valve replacement surgery. J Surg Res. 2016;200:13&#x2013;20.</Citation></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.</Citation></Reference><Reference><Citation>Gumbert SD, Kork F, Jackson ML, et al. Perioperative acute kidney injury. Anesthesiology. 2020;132:180&#x2013;204.</Citation></Reference><Reference><Citation>Higgins JP, Altman DG, G&#xf8;tzsche PC, et al.; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.</Citation></Reference><Reference><Citation>Higgins JPT, Thomas J, Chandler J, et al. Cochrane Handbook for Systematic Reviews of Interventions. 2019Cochrane; . version 6.0 (updated July 2019). Accessed October 20, 2020 www.training.cochrane.org/handbook .</Citation></Reference><Reference><Citation>Subramani Y, Nagappa M, Kumar K, et al. Medications for the prevention of pruritus in women undergoing cesarean delivery with Intrathecal morphine: a systematic review and bayesian network meta-analysis of randomized controlled trials. J Clin Anesth. 2021;68:110102.</Citation></Reference><Reference><Citation>Peng K, Shen YP, Ying YY, et al. Perioperative dexmedetomidine and 5-year survival in patients undergoing cardiac surgery. Br J Anaesth. 2021;127:215&#x2013;223.</Citation></Reference><Reference><Citation>Ahmad AM, Ali GS, Tariq W. Remote ischemic preconditioning is a safe adjuvant technique to myocardial protection but adds no clinical benefit after on-pump coronary artery bypass grafting. Heart Surg Forum. 2014;17:E220&#x2013;E223.</Citation></Reference><Reference><Citation>Ali N, Rizwi F, Iqbal A, Rashid A. Induced remote ischemic pre-conditioning on ischemia-reperfusion injury in patients undergoing coronary artery bypass. J Coll Physicians Surg Pak. 2010;20:427&#x2013;431.</Citation></Reference><Reference><Citation>Bagheri S, Shahbazi S, Shafa M, Borhani-Haghighi A, Kiani M, Sagheb MM. The effect of remote ischemic preconditioning on the incidence of acute kidney injury in patients undergoing coronary artery bypass graft surgery: a randomized controlled trial. Iran J Med Sci. 2018;43:587&#x2013;595.</Citation></Reference><Reference><Citation>Bautin AE, Galagudza MM, Datsenko SV, et al. Effects of remote ischemic preconditioning on perioperative period in elective aortic valve replacement. Anesteziol Reanimatol. 201411&#x2013;17.</Citation></Reference><Reference><Citation>Candilio L, Malik A, Ariti C, et al. Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial. Heart. 2015;101:185&#x2013;192.</Citation></Reference><Reference><Citation>Cao Z, Shen R, Zhang X, Cheng G, Yan Z. Effects of remote ischemic preconditioning on acute myocardial injury in patients undergoing valve replacement. Ir J Med Sci. 2017;186:889&#x2013;893.</Citation></Reference><Reference><Citation>Choi YS, Shim JK, Kim JC, et al. Effect of remote ischemic preconditioning on renal dysfunction after complex valvular heart surgery: a randomized controlled trial. J Thorac Cardiovasc Surg. 2011;142:148&#x2013;154.</Citation></Reference><Reference><Citation>Coverdale NS, Hamilton A, Petsikas D, et al. Remote ischemic preconditioning in high-risk cardiovascular surgery patients: a randomized-controlled trial. Semin Thorac Cardiovasc Surg. 2018;30:26&#x2013;33.</Citation></Reference><Reference><Citation>Deja MA, Piekarska M, Malinowski M, et al. Can human myocardium be remotely preconditioned? The results of a randomized controlled trial. Eur J Cardiothorac Surg. 2019;55:1086&#x2013;1094.</Citation></Reference><Reference><Citation>Frey UH, Klaassen M, Ochsenfarth C, et al. Remote ischaemic preconditioning increases serum extracellular vesicle concentrations with altered micro-RNA signature in CABG patients. Acta Anaesthesiol Scand. 2019;63:483&#x2013;492.</Citation></Reference><Reference><Citation>Gallagher SM, Jones DA, Kapur A, et al. Remote ischemic preconditioning has a neutral effect on the incidence of kidney injury after coronary artery bypass graft surgery. Kidney Int. 2015;87:473&#x2013;481.</Citation></Reference><Reference><Citation>Gasparovic H, Kopjar T, Rados M, et al. Impact of remote ischemic preconditioning preceding coronary artery bypass grafting on inducing neuroprotection. J Thorac Cardiovasc Surg. 2019;157:1466&#x2013;XXX.1476.e3</Citation></Reference><Reference><Citation>Gedik N, Thielmann M, Kottenberg E, et al. No evidence for activated autophagy in left ventricular myocardium at early reperfusion with protection by remote ischemic preconditioning in patients undergoing coronary artery bypass grafting. PLoS One. 2014;9:e96567.</Citation></Reference><Reference><Citation>Gedik N, Kottenberg E, Thielmann M, et al. Potential humoral mediators of remote ischemic preconditioning in patients undergoing surgical coronary revascularization. Sci Rep. 2017;7:12660.</Citation></Reference><Reference><Citation>Hausenloy DJ, Mwamure PK, Venugopal V, et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet. 2007;370:575&#x2013;579.</Citation></Reference><Reference><Citation>Heusch G, Musiolik J, Kottenberg E, Peters J, Jakob H, Thielmann M. STAT5 activation and cardioprotection by remote ischemic preconditioning in humans: short communication. Circ Res. 2012;110:111&#x2013;115.</Citation></Reference><Reference><Citation>Holmberg FE, Ottas KA, Andreasen C, et al. Conditioning techniques and ischemic reperfusion injury in relation to on-pump cardiac surgery. Scand Cardiovasc J. 2014;48:241&#x2013;248.</Citation></Reference><Reference><Citation>Hong DM, Mint JJ, Kim JH, et al. The effect of remote ischaemic preconditioning on myocardial injury in patients undergoing off-pump coronary artery bypass graft surgery. Anaesth Intensive Care. 2010;38:924&#x2013;929.</Citation></Reference><Reference><Citation>Hong DM, Jeon Y, Lee CS, et al. Effects of remote ischemic preconditioning with postconditioning in patients undergoing off-pump coronary artery bypass surgery&#x2013;randomized controlled trial. Circ J. 2012;76:884&#x2013;890.</Citation></Reference><Reference><Citation>Hu Q, Luo W, Huang L, Huang R, Chen R. Apoptosis-related microRNA changes in the right atrium induced by remote ischemic perconditioning during valve replacement surgery. Sci Rep. 2016;6:18959.</Citation></Reference><Reference><Citation>Hudetz JA, Patterson KM, Iqbal Z, Gandhi SD, Pagel PS. Remote ischemic preconditioning prevents deterioration of short-term postoperative cognitive function after cardiac surgery using cardiopulmonary bypass: results of a pilot investigation. J Cardiothorac Vasc Anesth. 2015;29:382&#x2013;388.</Citation></Reference><Reference><Citation>Javaherforoosh Zadeh F, Moadeli M, Soltanzadeh M, Janatmakan F. Effect of remote ischemic preconditioning on troponin I in CABG. Anesth Pain Med. 2017;7:e12549.</Citation></Reference><Reference><Citation>Jin L, He Z, Peng Z. Protection of noninvasive limb ischemic preconditioning on myocardium in patients undergoing heart valve surgery under cardiopulmonary bypass. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011;36:768&#x2013;775.</Citation></Reference><Reference><Citation>Jing GX, Zheng LL. Protective effects of remote ischemic preconditioning on cerebral injury in patients undergoing cardiac valve replacement with CPB. J Xi&#x2019;an Jiaotong University (Med Sci). 2011;32:473&#x2013;475.</Citation></Reference><Reference><Citation>Joung KW, Rhim JH, Chin JH, et al. Effect of remote ischemic preconditioning on cognitive function after off-pump coronary artery bypass graft: a pilot study. Korean J Anesthesiol. 2013;65:418&#x2013;424.</Citation></Reference><Reference><Citation>Karami A, Khosravi MB, Shafa M, et al. Cardioprotective effect of extended remote ischemic preconditioning in patients coronary artery bypass grafting undergoing: a randomized clinical trial. Iran J Med Sci. 2016;41:265&#x2013;274.</Citation></Reference><Reference><Citation>Karuppasamy P, Chaubey S, Dew T, et al. Remote intermittent ischemia before coronary artery bypass graft surgery: a strategy to reduce injury and inflammation? Basic Res Cardiol. 2011;106:511&#x2013;519.</Citation></Reference><Reference><Citation>Kim JC, Shim JK, Lee S, Yoo YC, Yang SY, Kwak YL. Effect of combined remote ischemic preconditioning and postconditioning on pulmonary function in valvular heart surgery. Chest. 2012;142:467&#x2013;475.</Citation></Reference><Reference><Citation>Kim TK, Nam K, Cho YJ, Choi S, Row HS, Jeon Y. Effect of remote ischaemic conditioning on coagulation function as measured by whole blood impedance aggregometry and rotational thromboelastometry in off-pump coronary artery bypass surgery: a randomised controlled trial. Thromb Res. 2020;187:72&#x2013;78.</Citation></Reference><Reference><Citation>Kleinbongard P, Gedik N, Kirca M, et al. Mitochondrial and contractile function of human right atrial tissue in response to remote ischemic conditioning. J Am Heart Assoc. 2018;7:e009540.</Citation></Reference><Reference><Citation>Kleinbongard P, Peters J, Jakob H, Heusch G, Thielmann M. Persistent survival benefit from remote ischemic pre-conditioning in patients undergoing coronary artery bypass surgery. J Am Coll Cardiol. 2018;71:252&#x2013;254.</Citation></Reference><Reference><Citation>Kottenberg E, Thielmann M, Bergmann L, et al. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial. Acta Anaesthesiol Scand. 2012;56:30&#x2013;38.</Citation></Reference><Reference><Citation>Kottenberg E, Musiolik J, Thielmann M, Jakob H, Peters J, Heusch G. Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischemic preconditioning during coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2014;147:376&#x2013;382.</Citation></Reference><Reference><Citation>Krogstad LE, Slagsvold KH, Wahba A. Remote ischemic preconditioning and incidence of postoperative atrial fibrillation. Scand Cardiovasc J. 2015;49:117&#x2013;122.</Citation></Reference><Reference><Citation>Li L, Luo W, Huang L, et al. Remote perconditioning reduces myocardial injury in adult valve replacement: a randomized controlled trial. J Surg Res. 2010;164:e21&#x2013;e26.</Citation></Reference><Reference><Citation>Lomivorotov VV, Shmyrev VA, Nepomnyaschih VA, et al. Remote ischaemic preconditioning does not protect the heart in patients undergoing coronary artery bypass grafting. Interact Cardiovasc Thorac Surg. 2012;15:18&#x2013;22.</Citation></Reference><Reference><Citation>Lotfi AS, Eftekhari H, Atreya AR, et al. Randomized controlled trial of remote ischemic preconditioning and atrial fibrillation in patients undergoing cardiac surgery. World J Cardiol. 2016;8:615&#x2013;622.</Citation></Reference><Reference><Citation>Lucchinetti E, Bestmann L, Feng J, et al. Remote ischemic preconditioning applied during isoflurane inhalation provides no benefit to the myocardium of patients undergoing on-pump coronary artery bypass graft surgery: lack of synergy or evidence of antagonism in cardioprotection? Anesthesiology. 2012;116:296&#x2013;310.</Citation></Reference><Reference><Citation>Meybohm P, Renner J, Broch O, et al. Postoperative neurocognitive dysfunction in patients undergoing cardiac surgery after remote ischemic preconditioning: a double-blind randomized controlled pilot study. PLoS One. 2013;8:e64743.</Citation></Reference><Reference><Citation>Meybohm P, Kohlhaas M, Stoppe C, et al.; RIPHeart (Remote Ischemic Preconditioning for Heart Surgery) Study Collaborators. RIPHeart (Remote Ischemic Preconditioning for Heart Surgery) study: myocardial dysfunction, postoperative neurocognitive dysfunction, and 1 year follow-up. J Am Heart Assoc. 2018;7:e008077.</Citation></Reference><Reference><Citation>Min JJ, Bae JY, Kim TK, et al. Pulmonary protective effects of remote ischaemic preconditioning with postconditioning in patients undergoing cardiac surgery involving cardiopulmonary bypass: a substudy of the remote ischaemic preconditioning with postconditioning outcome trial. Heart Lung Circ. 2016;25:484&#x2013;492.</Citation></Reference><Reference><Citation>Moscarelli M, Fiorentino F, Suleiman MS, et al. Remote ischaemic preconditioning in isolated aortic valve and coronary artery bypass surgery: a randomized trial&#x2020;. Eur J Cardiothorac Surg. 2019;55:905&#x2013;912.</Citation></Reference><Reference><Citation>Nederlof R, Weber NC, Juffermans NP, et al. A randomized trial of remote ischemic preconditioning and control treatment for cardioprotection in sevoflurane-anesthetized CABG patients. BMC Anesthesiol. 2017;17:51.</Citation></Reference><Reference><Citation>Nouraei SM, Baradari AG, Jazayeri A. Does remote ischaemic preconditioning protect kidney and cardiomyocytes after coronary revascularization? A double blind controlled clinical trial. Med Arch. 2016;70:373&#x2013;378.</Citation></Reference><Reference><Citation>Pinaud F, Corbeau JJ, Baufreton C, et al. Remote ischemic preconditioning in aortic valve surgery: Results of a randomized controlled study. J Cardiol. 2016;67:36&#x2013;41.</Citation></Reference><Reference><Citation>Rahman IA, Mascaro JG, Steeds RP, et al. Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment? Circulation. 2010;122:S53&#x2013;S59.</Citation></Reference><Reference><Citation>Saxena P, Aggarwal S, Misso NL, et al. Remote ischaemic preconditioning down-regulates kinin receptor expression in neutrophils of patients undergoing heart surgery. Interact Cardiovasc Thorac Surg. 2013;17:653&#x2013;658.</Citation></Reference><Reference><Citation>Slagsvold KH, Rognmo O, H&#xf8;ydal M, Wisl&#xf8;ff U, Wahba A. Remote ischemic preconditioning preserves mitochondrial function and influences myocardial microRNA expression in atrial myocardium during coronary bypass surgery. Circ Res. 2014;114:851&#x2013;859.</Citation></Reference><Reference><Citation>Slagsvold KH, Moreira JB, Rognmo O, et al. Remote ischemic preconditioning preserves mitochondrial function and activates pro-survival protein kinase Akt in the left ventricle during cardiac surgery: a randomized trial. Int J Cardiol. 2014;177:409&#x2013;417.</Citation></Reference><Reference><Citation>Song Y, Song JW, Lee S, Jun JH, Kwak YL, Shim JK. Effects of remote ischemic preconditioning in patients with concentric myocardial hypertrophy: a randomized, controlled trial with molecular insights. Int J Cardiol. 2017;249:36&#x2013;41.</Citation></Reference><Reference><Citation>Stokfisz K, Ledakowicz-Polak A, Zag&#xf3;rski M, Jander S, Przybylak K, Zieli&#x144;ska M. The clinical utility of remote ischemic preconditioning in protecting against cardiac surgery-associated acute kidney injury: a pilot randomized clinical trial. Adv Clin Exp Med. 2020;29:189&#x2013;196.</Citation></Reference><Reference><Citation>Thielmann M, Kottenberg E, Boengler K, et al. Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest. Basic Res Cardiol. 2010;105:657&#x2013;664.</Citation></Reference><Reference><Citation>Tuter DS, Komarov RN, Glasachev OS, et al. Remote ischemic preconditioning with the use of lower limb before coronary artery bypass surgery with cardiopulmonary bypass and anesthesia with propofol. Kardiologiia. 2019;59:38&#x2013;44.</Citation></Reference><Reference><Citation>Venugopal V, Hausenloy DJ, Ludman A, et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia: a randomised controlled trial. Heart. 2009;95:1567&#x2013;1571.</Citation></Reference><Reference><Citation>Venugopal V, Laing CM, Ludman A, Yellon DM, Hausenloy D. Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: a secondary analysis of 2 small randomized trials. Am J Kidney Dis. 2010;56:1043&#x2013;1049.</Citation></Reference><Reference><Citation>Wagner R, Piler P, Bedanova H, Adamek P, Grodecka L, Freiberger T. Myocardial injury is decreased by late remote ischaemic preconditioning and aggravated by tramadol in patients undergoing cardiac surgery: a randomised controlled trial. Interact Cardiovasc Thorac Surg. 2010;11:758&#x2013;762.</Citation></Reference><Reference><Citation>Wang Q, Luo W, Zhou Q. Intervention of NGAL and HO-1 in valve replacement surgery-induced acute kidney injury. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2014;39:1001&#x2013;1007.</Citation></Reference><Reference><Citation>Wang H, Lyu Y, Liao Q, et al. Effects of remote ischemic preconditioning in patients undergoing off-pump coronary artery bypass graft surgery. Front Physiol. 2019;10:495.</Citation></Reference><Reference><Citation>Williams JM, Young P, Pilcher J, et al. Remote ischaemic preconditioning does not alter perioperative cytokine production in high-risk cardiac surgery. Heart Asia. 2012;4:97&#x2013;101.</Citation></Reference><Reference><Citation>Wu Q, Gui P, Wu J, et al. Effect of limb ischemic preconditioning on myocardial injury in patients undergoing mitral valve replacement surgery. A randomized controlled trial. Circ J. 2011;75:1885&#x2013;1889.</Citation></Reference><Reference><Citation>Xie JJ, Liao XL, Chen WG, et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing heart valve surgery: randomised controlled trial. Heart. 2012;98:384&#x2013;388.</Citation></Reference><Reference><Citation>Yildirim F, Iskesen I, Kurdal AT, et al. Is &#x201c;attenuation of oxidative stress&#x201d; helpful to understand the mechanism of remote ischemic preconditioning in cardiac surgery? J Cardiothorac Vasc Anesth. 2016;30:134&#x2013;140.</Citation></Reference><Reference><Citation>Yildirim F, Senarslan DA, Iskesen I, et al. Remote preconditioning might protect the kidney in heart surgery. GKDA Derg. 2018;24:103&#x2013;110.</Citation></Reference><Reference><Citation>Young PJ, Dalley P, Garden A, et al. A pilot study investigating the effects of remote ischemic preconditioning in high-risk cardiac surgery using a randomised controlled double-blind protocol. Basic Res Cardiol. 2012;107:256.</Citation></Reference><Reference><Citation>Zimmerman RF, Ezeanuna PU, Kane JC, et al. Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery. Kidney Int. 2011;80:861&#x2013;867.</Citation></Reference><Reference><Citation>Jones WK, Fan GC, Liao S, et al. Peripheral nociception associated with surgical incision elicits remote nonischemic cardioprotection via neurogenic activation of protein kinase C signaling. Circulation. 2009;120:S1&#x2013;S9.</Citation></Reference><Reference><Citation>Heusch G. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. Circ Res. 2015;116:674&#x2013;699.</Citation></Reference><Reference><Citation>Heusch G, B&#xf8;tker HE, Przyklenk K, Redington A, Yellon D. Remote ischemic conditioning. J Am Coll Cardiol. 2015;65:177&#x2013;195.</Citation></Reference><Reference><Citation>Wu Q, Wang T, Chen S, et al. Cardiac protective effects of remote ischaemic preconditioning in children undergoing tetralogy of Fallot repair surgery: a randomized controlled trial. Eur Heart J. 2018;39:1028&#x2013;1037.</Citation></Reference><Reference><Citation>Nadim MK, Forni LG, Bihorac A, et al. Cardiac and vascular surgery-associated acute kidney injury: the 20th international consensus conference of the ADQI (Acute Disease Quality Initiative) Group. J Am Heart Assoc. 2018;7:e008834.</Citation></Reference><Reference><Citation>Swyers T, Redford D, Larson DF. Volatile anesthetic-induced preconditioning. Perfusion. 2014;29:10&#x2013;15.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38137465</PMID><DateRevised><Year>2023</Year><Month>12</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>07</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>Urinary Collectrin as Promising Biomarker for Acute Kidney Injury in Patients Undergoing Cardiac Surgery.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3244</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines11123244</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Early detection of acute kidney injury (AKI) is crucial for timely intervention and improved patient outcomes after cardiac surgery. This study aimed to evaluate the potential of urinary collectrin as a novel biomarker for AKI in this patient population.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this prospective, observational cohort study, 63 patients undergoing elective cardiac surgery with cardiopulmonary bypass (CPB) were studied at the Medical University of Vienna between 2016 and 2018. We collected urine samples prospectively at four perioperative time points, and urinary collectrin was measured using an enzyme-linked immunosorbent assay. Patients were divided into two groups, AKI and non-AKI, defined by Kidney Disease: Improving Global Outcomes Guidelines, and differences between groups were analyzed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Postoperative AKI was found in 19 (30%) patients. Urine sample analysis revealed an inverse correlation between urinary collectrin and creatinine and AKI stages, as well as significant changes in collectrin levels during the perioperative course. Baseline collectrin levels were 5050 &#xb1; 3294 pg/mL, decreased after the start of CPB, reached their nadir at the end of surgery, and began to recover slightly on postoperative day (POD) 1. The most effective timepoint for distinguishing between AKI and non-AKI patients based on collectrin levels was POD 1, with collectrin levels of 2190 &#xb1; 3728 pg/mL in AKI patients and 3768 &#xb1; 3435 pg/mL in non-AKI patients (<i>p</i> = 0.01).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Urinary collectrin shows promise as a novel biomarker for the early detection of AKI in patients undergoing cardiac surgery on CPB. Its dynamic changes throughout the perioperative period, especially on POD 1, provide valuable insights for timely diagnosis and intervention. Further research and validation studies are needed to confirm its clinical usefulness and potential impact on patient outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tichy</LastName><ForeName>Johanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine and Pain Medicine, Division of Cardiac Thoracic Vascular Anesthesia and Intensive Care Medicine, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pajenda</LastName><ForeName>Sahra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernardi</LastName><ForeName>Martin H</ForeName><Initials>MH</Initials><Identifier Source="ORCID">0000-0002-8297-898X</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine and Pain Medicine, Division of Cardiac Thoracic Vascular Anesthesia and Intensive Care Medicine, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wagner</LastName><ForeName>Ludwig</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryz</LastName><ForeName>Sylvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine and Pain Medicine, Division of Cardiac Thoracic Vascular Anesthesia and Intensive Care Medicine, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aiad</LastName><ForeName>Monika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerges</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lassnigg</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine and Pain Medicine, Division of Cardiac Thoracic Vascular Anesthesia and Intensive Care Medicine, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herkner</LastName><ForeName>Harald</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-1329-6149</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winnicki</LastName><ForeName>Wolfgang</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-0511-6120</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">collectrin</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38137465</ArticleId><ArticleId IdType="pmc">PMC10741128</ArticleId><ArticleId IdType="doi">10.3390/biomedicines11123244</ArticleId><ArticleId IdType="pii">biomedicines11123244</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Uchino S., Bellomo R., Goldsmith D., Bates S., Ronco C. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit. Care Med. 2006;34:1913&#x2013;1917. doi: 10.1097/01.CCM.0000224227.70642.4F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000224227.70642.4F</ArticleId><ArticleId IdType="pubmed">16715038</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrier R.W., Wang W., Poole B., Mitra A. Acute renal failure: Definitions, diagnosis, pathogenesis, and therapy. J. Clin. Investig. 2004;114:5&#x2013;14. doi: 10.1172/JCI200422353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI200422353</ArticleId><ArticleId IdType="pmc">PMC437979</ArticleId><ArticleId IdType="pubmed">15232604</ArticleId></ArticleIdList></Reference><Reference><Citation>Lameire N., Van Biesen W., Vanholder R. Acute renal failure. Lancet. 2005;365:417&#x2013;430. doi: 10.1016/S0140-6736(05)70238-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(05)70238-5</ArticleId><ArticleId IdType="pubmed">15680458</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouchard J., Acharya A., Cerda J., Maccariello E.R., Madarasu R.C., Tolwani A.J., Liang X., Fu P., Liu Z.H., Mehta R.L. A Prospective International Multicenter Study of AKI in the Intensive Care Unit. Clin. J. Am. Soc. Nephrol. 2015;10:1324&#x2013;1331. doi: 10.2215/CJN.04360514.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.04360514</ArticleId><ArticleId IdType="pmc">PMC4527019</ArticleId><ArticleId IdType="pubmed">26195505</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostermann M., Zarbock A., Goldstein S., Kashani K., Macedo E., Murugan R., Bell M., Forni L., Guzzi L., Joannidis M., et al. Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference: A Consensus Statement. JAMA Netw. Open. 2020;3:e2019209. doi: 10.1001/jamanetworkopen.2020.19209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.19209</ArticleId><ArticleId IdType="pubmed">33021646</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanmassenhove J., Van Biesen W., Vanholder R., Lameire N. Subclinical AKI: Ready for primetime in clinical practice? J. Nephrol. 2019;32:9&#x2013;16. doi: 10.1007/s40620-018-00566-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40620-018-00566-y</ArticleId><ArticleId IdType="pubmed">30523562</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutin L., Latosinska A., Mischak H., Deniau B., Asakage A., Legrand M., Gayat E., Mebazaa A., Chadjichristos C.E., Depret F. Subclinical and clinical acute kidney injury share similar urinary peptide signatures and prognosis. Intensive Care Med. 2023;49:1191&#x2013;1202. doi: 10.1007/s00134-023-07198-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-023-07198-2</ArticleId><ArticleId IdType="pubmed">37670154</ArticleId></ArticleIdList></Reference><Reference><Citation>Moledina D.G., Parikh C.R. Phenotyping of Acute Kidney Injury: Beyond Serum Creatinine. Semin. Nephrol. 2018;38:3&#x2013;11. doi: 10.1016/j.semnephrol.2017.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semnephrol.2017.09.002</ArticleId><ArticleId IdType="pmc">PMC5753429</ArticleId><ArticleId IdType="pubmed">29291759</ArticleId></ArticleIdList></Reference><Reference><Citation>Menez S., Parikh C.R. Assessing the health of the nephron in acute kidney injury: Biomarkers of kidney function and injury. Curr. Opin. Nephrol. Hypertens. 2019;28:560&#x2013;566. doi: 10.1097/MNH.0000000000000538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MNH.0000000000000538</ArticleId><ArticleId IdType="pmc">PMC7391114</ArticleId><ArticleId IdType="pubmed">31369422</ArticleId></ArticleIdList></Reference><Reference><Citation>Srisawat N., Kellum J.A. The Role of Biomarkers in Acute Kidney Injury. Crit. Care Clin. 2020;36:125&#x2013;140. doi: 10.1016/j.ccc.2019.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2019.08.010</ArticleId><ArticleId IdType="pubmed">31733675</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulvichit W., Kellum J.A., Srisawat N. Biomarkers in Acute Kidney Injury. Crit. Care Clin. 2021;37:385&#x2013;398. doi: 10.1016/j.ccc.2020.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2020.11.012</ArticleId><ArticleId IdType="pubmed">33752862</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashani K., Al-Khafaji A., Ardiles T., Artigas A., Bagshaw S.M., Bell M., Bihorac A., Birkhahn R., Cely C.M., Chawla L.S., et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit. Care. 2013;17:R25. doi: 10.1186/cc12503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc12503</ArticleId><ArticleId IdType="pmc">PMC4057242</ArticleId><ArticleId IdType="pubmed">23388612</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Zou Z., Jin J., Teng J., Xu J., Shen B., Jiang W., Zhuang Y., Liu L., Luo Z., et al. Urinary TIMP-2 and IGFBP7 for the prediction of acute kidney injury following cardiac surgery. BMC Nephrol. 2017;18:177. doi: 10.1186/s12882-017-0592-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-017-0592-8</ArticleId><ArticleId IdType="pmc">PMC5450378</ArticleId><ArticleId IdType="pubmed">28558754</ArticleId></ArticleIdList></Reference><Reference><Citation>Han W.K., Bailly V., Abichandani R., Thadhani R., Bonventre J.V. Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney Int. 2002;62:237&#x2013;244. doi: 10.1046/j.1523-1755.2002.00433.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1523-1755.2002.00433.x</ArticleId><ArticleId IdType="pubmed">12081583</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Huang Y., Shang W., Zhang Y., Liu Y., Xu G. The Predictive Value of Urinary Kidney Injury Molecular 1 for the Diagnosis of Contrast-Induced Acute Kidney Injury after Cardiac Catheterization: A Meta-Analysis. J. Interv. Cardiol. 2020;2020:4982987. doi: 10.1155/2020/4982987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/4982987</ArticleId><ArticleId IdType="pmc">PMC7443242</ArticleId><ArticleId IdType="pubmed">32863790</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett M., Dent C.L., Ma Q., Dastrala S., Grenier F., Workman R., Syed H., Ali S., Barasch J., Devarajan P. Urine NGAL Predicts Severity of Acute Kidney Injury After Cardiac Surgery: A Prospective Study. Clin. J. Am. Soc. Nephrol. 2008;3:665&#x2013;673. doi: 10.2215/CJN.04010907.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.04010907</ArticleId><ArticleId IdType="pmc">PMC2386703</ArticleId><ArticleId IdType="pubmed">18337554</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh C.R., Abraham E., Ancukiewicz M., Edelstein C.L. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J. Am. Soc. Nephrol. 2005;16:3046&#x2013;3052. doi: 10.1681/ASN.2005030236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2005030236</ArticleId><ArticleId IdType="pubmed">16148039</ArticleId></ArticleIdList></Reference><Reference><Citation>Pajenda S., Mechtler K., Wagner L. Urinary neprilysin in the critically ill patient. BMC Nephrol. 2017;18:172. doi: 10.1186/s12882-017-0587-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-017-0587-5</ArticleId><ArticleId IdType="pmc">PMC5445475</ArticleId><ArticleId IdType="pubmed">28545475</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernardi M.H., Wagner L., Ryz S., Puchinger J., Nixdorf L., Edlinger-Stanger M., Geilen J., Kainz M., Hiesmayr M.J., Lassnigg A. Urinary neprilysin for early detection of acute kidney injury after cardiac surgery: A prospective observational study. Eur. J. Anaesthesiol. EJA. 2021;38:13&#x2013;21. doi: 10.1097/EJA.0000000000001321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000001321</ArticleId><ArticleId IdType="pubmed">32941200</ArticleId></ArticleIdList></Reference><Reference><Citation>Khorashadi M., Beunders R., Pickkers P., Legrand M. Proenkephalin: A New Biomarker for Glomerular Filtration Rate and Acute Kidney Injury. Nephron. 2020;144:655&#x2013;661. doi: 10.1159/000509352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000509352</ArticleId><ArticleId IdType="pmc">PMC7845419</ArticleId><ArticleId IdType="pubmed">32739920</ArticleId></ArticleIdList></Reference><Reference><Citation>Bullen A.L., Fregoso A., Ascher S.B., Shlipak M.G., Ix J.H., Rifkin D.E. Markers of Kidney Tubule Dysfunction and MAKE. Nephron. 2023 doi: 10.1159/000531946. in press .</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000531946</ArticleId><ArticleId IdType="pubmed">37524063</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho K.M., Morgan D.J.R. The Proximal Tubule as the Pathogenic and Therapeutic Target in Acute Kidney Injury. Nephron. 2022;146:494&#x2013;502. doi: 10.1159/000522341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000522341</ArticleId><ArticleId IdType="pubmed">35272287</ArticleId></ArticleIdList></Reference><Reference><Citation>Villa G., Katz N., Ronco C. Extracorporeal Membrane Oxygenation and the Kidney. Cardiorenal Med. 2015;6:50&#x2013;60. doi: 10.1159/000439444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000439444</ArticleId><ArticleId IdType="pmc">PMC4698639</ArticleId><ArticleId IdType="pubmed">27194996</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiele R.H., Isbell J.M., Rosner M.H. AKI Associated with Cardiac Surgery. Clin. J. Am. Soc. Nephrol. 2015;10:500&#x2013;514. doi: 10.2215/CJN.07830814.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.07830814</ArticleId><ArticleId IdType="pmc">PMC4348689</ArticleId><ArticleId IdType="pubmed">25376763</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen S.B., Boyko Y., Ranucci M., de Somer F., Ravn H.B. Cardiac surgery-Associated acute kidney injury&#x2014;A narrative review. Perfusion. 2023 doi: 10.1177/02676591231211503. in press .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/02676591231211503</ArticleId><ArticleId IdType="pubmed">37905794</ArticleId></ArticleIdList></Reference><Reference><Citation>Massoth C., Zarbock A., Meersch M. Acute Kidney Injury in Cardiac Surgery. Crit. Care Clin. 2021;37:267&#x2013;278. doi: 10.1016/j.ccc.2020.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2020.11.009</ArticleId><ArticleId IdType="pubmed">33752855</ArticleId></ArticleIdList></Reference><Reference><Citation>Danilczyk U., Sarao R., Remy C., Benabbas C., Stange G., Richter A., Arya S., Pospisilik J.A., Singer D., Camargo S.M., et al. Essential role for collectrin in renal amino acid transport. Nature. 2006;444:1088&#x2013;1091. doi: 10.1038/nature05475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05475</ArticleId><ArticleId IdType="pubmed">17167413</ArticleId></ArticleIdList></Reference><Reference><Citation>Pajenda S., Wagner L., Gerges D., Herkner H., Tevdoradze T., Mechtler K., Schmidt A., Winnicki W. Urinary Collectrin (TMEM27) as Novel Marker for Acute Kidney Injury. Life. 2022;12:1391. doi: 10.3390/life12091391.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12091391</ArticleId><ArticleId IdType="pmc">PMC9503639</ArticleId><ArticleId IdType="pubmed">36143426</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum J.A., Lameire N., KDIGO AKI Guideline Work Group Diagnosis, evaluation, and management of acute kidney injury: A KDIGO summary (Part 1) Crit. Care. 2013;17:204. doi: 10.1186/cc11454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11454</ArticleId><ArticleId IdType="pmc">PMC4057151</ArticleId><ArticleId IdType="pubmed">23394211</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostermann M., Kunst G., Baker E., Weerapolchai K., Lumlertgul N. Cardiac Surgery Associated AKI Prevention Strategies and Medical Treatment for CSA-AKI. J. Clin. Med. 2021;10:5285. doi: 10.3390/jcm10225285.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10225285</ArticleId><ArticleId IdType="pmc">PMC8618011</ArticleId><ArticleId IdType="pubmed">34830567</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C.-Y., Chen Y.-C., Tsai F.-C., Tian Y.-C., Jenq C.-C., Fang J.-T., Yang C.-W. RIFLE classification is predictive of short-term prognosis in critically ill patients with acute renal failure supported by extracorporeal membrane oxygenation. Nephrol. Dial. Transplant. 2006;21:2867&#x2013;2873. doi: 10.1093/ndt/gfl326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfl326</ArticleId><ArticleId IdType="pubmed">16799171</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan X., Jia S., Meng X., Dong P., Jia M., Wan J., Hou X. Acute kidney injury in adult postcardiotomy patients with extracorporeal membrane oxygenation: Evaluation of the RIFLE classification and the Acute Kidney Injury Network criteria. Eur. J. Cardio-Thorac. Surg. 2010;37:334&#x2013;338. doi: 10.1016/j.ejcts.2009.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2009.07.004</ArticleId><ArticleId IdType="pubmed">19692267</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Bellomo R. Cardiac surgery-associated acute kidney injury: Risk factors, pathophysiology and treatment. Nat. Rev. Nephrol. 2017;13:697&#x2013;711. doi: 10.1038/nrneph.2017.119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2017.119</ArticleId><ArticleId IdType="pubmed">28869251</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J., Chen R., Liu S., Yu X., Zou J., Ding X. Global Incidence and Outcomes of Adult Patients With Acute Kidney Injury After Cardiac Surgery: A Systematic Review and Meta-Analysis. J. Cardiothorac. Vasc. Anesth. 2016;30:82&#x2013;89. doi: 10.1053/j.jvca.2015.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2015.06.017</ArticleId><ArticleId IdType="pubmed">26482484</ArticleId></ArticleIdList></Reference><Reference><Citation>Lannemyr L., Bragadottir G., Krumbholz V., Redfors B., Sellgren J., Ricksten S.E. Effects of Cardiopulmonary Bypass on Renal Perfusion, Filtration, and Oxygenation in Patients Undergoing Cardiac Surgery. Anesthesiology. 2017;126:205&#x2013;213. doi: 10.1097/ALN.0000000000001461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001461</ArticleId><ArticleId IdType="pubmed">27906706</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco C., Haapio M., House A.A., Anavekar N., Bellomo R. Cardiorenal Syndrome. J. Am. Coll. Cardiol. 2008;52:1527&#x2013;1539. doi: 10.1016/j.jacc.2008.07.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2008.07.051</ArticleId><ArticleId IdType="pubmed">19007588</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinze C., Schmidt-Ott K.M. Acute kidney injury biomarkers in the single-cell transcriptomic era. Am. J. Physiol. Cell Physiol. 2022;323:C1430&#x2013;C1443. doi: 10.1152/ajpcell.00079.2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00079.2022</ArticleId><ArticleId IdType="pubmed">36154695</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen Y., Parikh C.R. Current concepts and advances in biomarkers of acute kidney injury. Crit. Rev. Clin. Lab. Sci. 2021;58:354&#x2013;368. doi: 10.1080/10408363.2021.1879000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408363.2021.1879000</ArticleId><ArticleId IdType="pubmed">33556265</ArticleId></ArticleIdList></Reference><Reference><Citation>Poudel N., Zheng S., Schinderle C.M., Sun N., Hu S., Okusa M.D. Peritubular Capillary Oxygen Consumption in Sepsis-Induced AKI: Multi-Parametric Photoacoustic Microscopy. Nephron. 2020;144:621&#x2013;625. doi: 10.1159/000511167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000511167</ArticleId><ArticleId IdType="pmc">PMC7935434</ArticleId><ArticleId IdType="pubmed">33147592</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu P.L., Gigliotti J.C., Cechova S., Bodonyi-Kovacs G., Wang Y.T., Chen L.J., Smoller S.W., Cai J.W., Isakson B.E., Franceschini N., et al. Collectrin (Tmem27) deficiency in proximal tubules causes hypertension in mice and a TMEM27 variant associates with blood pressure in males in a Latino cohort. Am. J. Physiol.-Ren. Physiol. 2023;324:F30&#x2013;F42. doi: 10.1152/ajprenal.00176.2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00176.2022</ArticleId><ArticleId IdType="pmc">PMC9762972</ArticleId><ArticleId IdType="pubmed">36264884</ArticleId></ArticleIdList></Reference><Reference><Citation>Malakauskas S.M., Quan H., Fields T.A., McCall S.J., Yu M.J., Kourany W.M., Frey C.W., Le T.H. Aminoaciduria and altered renal expression of luminal amino acid transporters in mice lacking novel gene collectrin. Am. J. Physiol.-Ren. Physiol. 2007;292:F533&#x2013;F544. doi: 10.1152/ajprenal.00325.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00325.2006</ArticleId><ArticleId IdType="pubmed">16985211</ArticleId></ArticleIdList></Reference><Reference><Citation>Esterh&#xe1;zy D., Akpinar P., Stoffel M. Tmem27 dimerization, deglycosylation, plasma membrane depletion, and the extracellular Phe-Phe motif are negative regulators of cleavage by Bace2. Biol. Chem. 2012;393:473&#x2013;484. doi: 10.1515/hsz-2012-0104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/hsz-2012-0104</ArticleId><ArticleId IdType="pubmed">22628310</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Wada J., Yasuhara A., Iseda I., Eguchi J., Fukui K., Yang Q., Yamagata K., Hiesberger T., Igarashi P., et al. The role for HNF-1beta-targeted collectrin in maintenance of primary cilia and cell polarity in collecting duct cells. PLoS ONE. 2007;2:e414. doi: 10.1371/journal.pone.0000414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0000414</ArticleId><ArticleId IdType="pmc">PMC1853234</ArticleId><ArticleId IdType="pubmed">17476336</ArticleId></ArticleIdList></Reference><Reference><Citation>Udzik J., Pacholewicz J., Biskupski A., Walerowicz P., Januszkiewicz K., Kwiatkowska E. Alterations to Kidney Physiology during Cardiopulmonary Bypass-A Narrative Review of the Literature and Practical Remarks. J. Clin. Med. 2023;12:6894. doi: 10.3390/jcm12216894.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12216894</ArticleId><ArticleId IdType="pmc">PMC10647422</ArticleId><ArticleId IdType="pubmed">37959359</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaiao S.M., Paiva J. Biomarkers of renal recovery after acute kidney injury. Rev. Bras. Ter. Intensiv. 2017;29:373&#x2013;381. doi: 10.5935/0103-507X.20170051.</Citation><ArticleIdList><ArticleId IdType="doi">10.5935/0103-507X.20170051</ArticleId><ArticleId IdType="pmc">PMC5632981</ArticleId><ArticleId IdType="pubmed">29044306</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M., Schmidt C., Hoffmeier A., Van Aken H., Wempe C., Gerss J., Zarbock A. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: The PrevAKI randomized controlled trial. Intensive Care Med. 2017;43:1551&#x2013;1561. doi: 10.1007/s00134-016-4670-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4670-3</ArticleId><ArticleId IdType="pmc">PMC5633630</ArticleId><ArticleId IdType="pubmed">28110412</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon S.J., Park H.B., Yoon S.Y., Lee S.C. Urinary Biomarkers for Early Detection of Recovery in Patients with Acute Kidney Injury. J. Korean Med. Sci. 2013;28:1181&#x2013;1186. doi: 10.3346/jkms.2013.28.8.1181.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2013.28.8.1181</ArticleId><ArticleId IdType="pmc">PMC3744706</ArticleId><ArticleId IdType="pubmed">23960445</ArticleId></ArticleIdList></Reference><Reference><Citation>Aregger F., Uehlinger D.E., Witowski J., Brunisholz R.A., Hunziker P., Frey F.J., Jorres A. Identification of IGFBP-7 by urinary proteomics as a novel prognostic marker in early acute kidney injury. Kidney Int. 2014;85:909&#x2013;919. doi: 10.1038/ki.2013.363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2013.363</ArticleId><ArticleId IdType="pubmed">24067438</ArticleId></ArticleIdList></Reference><Reference><Citation>Srisawat N., Murugan R., Lee M., Kong L., Carter M., Angus D.C., Kellum J.A., Genetic and Inflammatory Markers of Sepsis (GenIMS) Study Investigators Plasma neutrophil gelatinase-associated lipocalin predicts recovery from acute kidney injury following community-acquired pneumonia. Kidney Int. 2011;80:545&#x2013;552. doi: 10.1038/ki.2011.160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2011.160</ArticleId><ArticleId IdType="pmc">PMC3257035</ArticleId><ArticleId IdType="pubmed">21677634</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollinger A., Wittebole X., Francois B., Pickkers P., Antonelli M., Gayat E., Chousterman B.G., Lascarrou J.B., Dugernier T., Di Somma S., et al. Proenkephalin A 119-159 (Penkid) Is an Early Biomarker of Septic Acute Kidney Injury: The Kidney in Sepsis and Septic Shock (Kid-SSS) Study. Kidney Int. Rep. 2018;3:1424&#x2013;1433. doi: 10.1016/j.ekir.2018.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ekir.2018.08.006</ArticleId><ArticleId IdType="pmc">PMC6224621</ArticleId><ArticleId IdType="pubmed">30450469</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39049867</PMID><DateRevised><Year>2024</Year><Month>07</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2321-3868</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Burns &amp; trauma</Title><ISOAbbreviation>Burns Trauma</ISOAbbreviation></Journal><ArticleTitle>Intraoperative hypotension associated with postoperative acute kidney injury in hypertension patients undergoing non-cardiac surgery: a retrospective cohort study.</ArticleTitle><Pagination><StartPage>tkae029</StartPage><MedlinePgn>tkae029</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">tkae029</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/burnst/tkae029</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Acute kidney injury (AKI) is a common surgical complication and is associated with intraoperative hypotension. However, the total duration and magnitude of intraoperative hypotension associated with AKI remains unknown. In this study, the causal relationship between the intraoperative arterial pressure and postoperative AKI was investigated among chronic hypertension patients undergoing non-cardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A retrospective cohort study of 6552 hypertension patients undergoing non-cardiac surgery (2011 to 2019) was conducted. The primary outcome was AKI as diagnosed with the Kidney Disease-Improving Global Outcomes criteria and the primary exposure was intraoperative hypotension. Patients' baseline demographics, pre- and post-operative data were harvested and then analyzed with multivariable logistic regression to assess the exposure-outcome relationship.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Among 6552 hypertension patients, 579 (8.84%) had postoperative AKI after non-cardiac surgery. The proportions of patients admitted to ICU (3.97 vs. 1.24%, <i>p</i>&#x2009;&lt;&#x2009;0.001) and experiencing all-cause death (2.76 vs. 0.80%, <i>p</i>&#x2009;&lt;&#x2009;0.001) were higher in the patients with postoperative AKI. Moreover, the patients with postoperative AKI had longer hospital stays (13.50 vs. 12.00&#xa0;days, <i>p</i>&#x2009;&lt;&#x2009;0.001). Intraoperative mean arterial pressure (MAP) &lt; 60&#xa0;mmHg for &gt;20&#xa0;min was an independent risk factor of postoperative AKI. Furthermore, MAP &lt;60&#xa0;mmHg for &gt;10&#xa0;min was also an independent risk factor of postoperative AKI in patients whose MAP was measured invasively in the subgroup analysis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Our work suggested that MAP &lt; 60&#xa0;mmHg for &gt;10&#xa0;min measured invasively or 20&#xa0;min measured non-invasively during non-cardiac surgery may be the threshold of postoperative AKI development in hypertension patients. This work may serve as a perioperative management guide for chronic hypertension patients.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="UNASSIGNED">clinical trial number: ChiCTR2100050209 (8/22/2021). http://www.chictr.org.cn/showproj.aspx?proj=132277.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha, 410013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Yeshuo</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Geriatrics, Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha, 410013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha, 410013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ouyang</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha, 410013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zongdao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Geriatrics, Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha, 410013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha, 410013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Operation Center, Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha, 410013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Emergency, Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha, 410013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Daqing</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-1235-0537</Identifier><AffiliationInfo><Affiliation>Division of Anesthetics, Pain Medicine &amp; Intensive Care, Department of Surgery and Cancer, Chelsea and Westminster Hospital, Imperial College London, South Kensington Campus, London SW7 2AZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Yongzhong</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0009-0006-0777-6196</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha, 410013, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Center, Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha, 410013, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Burns Trauma</MedlineTA><NlmUniqueID>101651457</NlmUniqueID><ISSNLinking>2321-3868</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Chronic hypertension</Keyword><Keyword MajorTopicYN="N">Intraoperative hypotension</Keyword><Keyword MajorTopicYN="N">Non-cardiac surgery</Keyword></KeywordList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>26</Day><Hour>12</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>26</Day><Hour>12</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>25</Day><Hour>4</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39049867</ArticleId><ArticleId IdType="pmc">PMC11267586</ArticleId><ArticleId IdType="doi">10.1093/burnst/tkae029</ArticleId><ArticleId IdType="pii">tkae029</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zeng X, McMahon GM, Brunelli SM, Bates DW, Waikar SS. Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals. Clin J Am Soc Nephrol. 2014;9:12&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3878695</ArticleId><ArticleId IdType="pubmed">24178971</ArticleId></ArticleIdList></Reference><Reference><Citation>Signe S, Marie SI, Isachsen MS, Nordhuus KM, Tveiten CK, Eken T, et al. &#xa0;Acute kidney injury in trauma patients admitted to the ICU: a systematic review and meta-analysis. Intensive Care Med. 2019;45:407&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">30725141</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulger F, Pehlivanlar Kucuk M, Kucuk AO, Ilkaya NK, Murat N, Bilgic B, et al. &#xa0;Evaluation of acute kidney injury (AKI) with RIFLE, AKIN, CK, and KDIGO in critically ill trauma patients. Eur J Trauma Emerg Surg. 2018;44:597&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pubmed">28717983</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomozawa A, Ishikawa S, Shiota N, Cholvisudhi P, Makita K. Perioperative risk factors for acute kidney injury after liver resection surgery: an historical cohort study. Can J Anaesth. 2015;62:753&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">25925634</ArticleId></ArticleIdList></Reference><Reference><Citation>Slankamenac K, Breitenstein S, Held U, Beck-Schimmer B, Puhan MA, Clavien PA. Development and validation of a prediction score for postoperative acute renal failure following liver resection. Ann Surg. 2009;250:720&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19809295</ArticleId></ArticleIdList></Reference><Reference><Citation>Graziani MP, Moser M, Bozzola CM, Galvez HM, Irman GJ, Alvarez PG, et al. &#xa0;Acute kidney injury in children after cardiac surgery: risk factors and outcomes. A retrospective, cohort study. Arch Argent Pediatr. 2019;117:e557&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">31758882</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X, Wan X, Ji X, Chen X, Liu J, Chen W, et al. &#xa0;Reassessment of acute kidney injury after cardiac surgery: a retrospective study. Intern Med. 2017;56:275&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5348450</ArticleId><ArticleId IdType="pubmed">28154270</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore PK, Hsu RK, Liu KD. Management of Acute Kidney Injury: Core curriculum 2018. Am J Kidney Dis. 2018;72:136&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">29478864</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;53:961&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2726041</ArticleId><ArticleId IdType="pubmed">19346042</ArticleId></ArticleIdList></Reference><Reference><Citation>Thanaboriboon C, Vanichvithya P, Jinaworn P. What is the risk of intraoperative cerebral oxygen desaturation in patients undergoing shoulder surgery in the beach chair position? &#xa0;Clin Orthop Relat Res. 2021;479:2677&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8726564</ArticleId><ArticleId IdType="pubmed">34128914</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi JW, Kim DK, Jeong HJ, Kim YR, Chung YJ, Son YH. Risk factors associated with hypotensive bradycardic events during open shoulder surgery in the beach chair position. Korean J Anesthesiol. 2021;74:38&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7862927</ArticleId><ArticleId IdType="pubmed">32013327</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai S, Li X, Yang Y, Cao Y, Wang E, Dong Z. A retrospective cohort analysis for the risk factors of intraoperative hypotension. Int J Clin Pract. 2020;74:e13521.</Citation><ArticleIdList><ArticleId IdType="pubmed">32353902</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y, Bass GA, Ahl R, Pourlotfi A, Geijer H, Montgomery S, et al. &#xa0;The statistical importance of P-POSSUM scores for predicting mortality after emergency laparotomy in geriatric patients. BMC Med Inform Decis Mak. 2020;20:86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7206787</ArticleId><ArticleId IdType="pubmed">32380980</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun LY, Wijeysundera DN, Tait GA, Beattie WS. Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology. 2015;123:515&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">26181335</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang YZ, Zhu CN, Liu JB, Wang A, Duan K, Li B, et al. &#xa0;Association of Intraoperative Hypotension with acute kidney injury after noncardiac surgery in patients younger than 60 years old. Kidney Blood Press Res. 2019;44:211&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">30928979</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangasamy V, de &#xa0;GuerreL, Xu X, Schermerhorn ML, Novack V, Subramaniam B. Association between intraoperative hypotension and postoperative adverse outcomes in patients undergoing vascular surgery - a retrospective observational study. J Cardiothorac Vasc Anesth. 2020;S1053&#x2013;0770:31191&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">33293215</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal A, Wei G, Boucher R, Ahmed F, Beddhu S. Modification of the effects of intensive systolic blood pressure control on kidney outcomes by baseline body mass index. Nephrology (Carlton). 2021;26:303&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10324634</ArticleId><ArticleId IdType="pubmed">33538091</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei J, Zhu J, Zhang J, Jiang S, Qu L, Wang L, et al. &#xa0;Aging impairs renal autoregulation in mice. Hypertension. 2020;75:405&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7027982</ArticleId><ArticleId IdType="pubmed">31838907</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan F, Geurts AM, Pabbidi MR, Ge Y, Zhang C, Wang S, et al. &#xa0;A mutation in gamma-Adducin impairs autoregulation of renal blood flow and promotes the development of kidney disease. J Am Soc Nephrol. 2020;31:687&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7191921</ArticleId><ArticleId IdType="pubmed">32029431</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng L, Wang Y, Zhang L, McDonagh DL. Heterogeneity and variability in pressure autoregulation of organ blood flow: lessons learned over 100+ years. Crit Care Med. 2019;47:436&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">30516567</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng L, Yu W, Wang T, Zhang L, Heerdt PM, Gelb AW. Blood pressure targets in perioperative care. Hypertension. 2018;72:806&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">30354725</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y-Z, Zeng P, Liao Y, Qin Z, Zhang H, Li B, et al. &#xa0;Correlation between perioperative parecoxib use and postoperative acute kidney injury in patients undergoing non-cardiac surgery: a retrospective cohort analysis. BMJ Open. 2021;11:e047840.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8388276</ArticleId><ArticleId IdType="pubmed">34433595</ArticleId></ArticleIdList></Reference><Reference><Citation>Long TE, Helgason D, Helgadottir S, Palsson R, Gudbjartsson T, Sigurdsson GH, et al. &#xa0;Acute kidney injury after abdominal surgery: incidence, risk factors, and outcome. Anesth Analg. 2016;122:1912&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">27195635</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JY, Yao YM, Tian Y. Early predictive value of high density lipoprotein cholesterol for secondary acute kidney injury in sepsis patients. Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2022;38:130&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11704516</ArticleId><ArticleId IdType="pubmed">35220701</ArticleId></ArticleIdList></Reference><Reference><Citation>Rewa O, Bagshaw SM. Acute kidney injury-epidemiology, outcomes and economics. Nat Rev Nephrol. 2014;10:193&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">24445744</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Heung M, Rosenberg AL, Englesbe M, Shanks AM, et al. &#xa0;Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set. Anesthesiology. 2009;110:505&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">19212261</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang WW, Zhu WZ, Mu DL, Ji XQ, Li XY, Ma D, et al. &#xa0;Intraoperative hypotension is associated with shortened overall survival after lung cancer surgery. BMC Anesthesiol. 2020;20:160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7322881</ArticleId><ArticleId IdType="pubmed">32600326</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Perez JS, Lu K, George AJ, Ma D. Role of toll-like receptor-4 in renal graft ischemia-reperfusion injury. American journal of physiology Renal physiology. 2014;306:F801&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3989634</ArticleId><ArticleId IdType="pubmed">24523386</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J, Sun P, Zhao H, Watts HR, Sanders RD, Terrando N, et al. &#xa0;Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Crit Care. 2011;15:R153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3219027</ArticleId><ArticleId IdType="pubmed">21702944</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Y, Fu Y, Wu W, Tang C, Dong Z. Autophagy in acute kidney injury and maladaptive kidney repair. Burns. Trauma. 2023;11:tkac059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9867874</ArticleId><ArticleId IdType="pubmed">36694860</ArticleId></ArticleIdList></Reference><Reference><Citation>Ologunde R, Zhao H, Lu K, Ma D. Organ cross talk and remote organ damage following acute kidney injury. Int Urol Nephrol. 2014;46:2337&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">24966098</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka S, Okusa MD. Crosstalk between the nervous system and the kidney. Kidney Int. 2020;97:466&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7039752</ArticleId><ArticleId IdType="pubmed">32001065</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Xu J, Fu P, Ma L. MicroRNAs in septic acute kidney injury. Burns Trauma. 2023;11:tkad008.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10027606</ArticleId><ArticleId IdType="pubmed">36959845</ArticleId></ArticleIdList></Reference><Reference><Citation>Meidert AS, Nold JS, Hornung R, Paulus AC, Zwissler B, Czerner S. The impact of continuous non-invasive arterial blood pressure monitoring on blood pressure stability during general anaesthesia in orthopaedic patients: a randomised trial. Eur J Anaesthesiol. 2017;34:716&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">28922340</ArticleId></ArticleIdList></Reference><Reference><Citation>Turan A, Chang C, Cohen B, Saasouh W, Essber H, Yang D, et al. &#xa0;Incidence, severity, and detection of blood pressure perturbations after abdominal surgery: a prospective blinded observational study. Anesthesiology. 2019;130:550&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30875354</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B, Lin LY, Liu XA, Ling YS, Zhang YY, Luo AQ, et al. &#xa0;Invasive blood pressure measurement and In-hospital mortality in critically ill patients with hypertension. Front Cardiovasc Med. 2021;8:720605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440864</ArticleId><ArticleId IdType="pubmed">34540920</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufmann T, Cox EGM, Wiersema R, Hiemstra B, Eck RJ, Koster G, et al. &#xa0;Non-invasive oscillometric versus invasive arterial blood pressure measurements in critically ill patients: a post hoc analysis of a prospective observational study. J Crit Care. 2020;57:118&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">32109843</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27617407</PMID><DateCompleted><Year>2018</Year><Month>06</Month><Day>06</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1559-0488</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>5</Issue><PubDate><Year>2017</Year><Season>Sep/Oct</Season></PubDate></JournalIssue><Title>Journal of burn care &amp; research : official publication of the American Burn Association</Title><ISOAbbreviation>J Burn Care Res</ISOAbbreviation></Journal><ArticleTitle>Risk Factors for Acute Kidney Injury in Patients With Burn Injury: A Meta-Analysis and Systematic Review.</ArticleTitle><Pagination><StartPage>271</StartPage><EndPage>282</EndPage><MedlinePgn>271-282</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/BCR.0000000000000438</ELocationID><Abstract><AbstractText>Acute kidney injury (AKI) is a fatal complication of burn injury. Few systematic reviews to date have focused on the risk factors predisposing to AKI in patients with burn injury. The aim of this article is to identify the risk factors for the occurrence of AKI in burn patients, thus providing theoretical evidence for prevention and treatment. We performed a systematic review and meta-analysis of studies determining the prevalence, risk factors, and outcomes of AKI in patients with burn injury. An electronic search (up to April 2016) was performed using Pubmed, Embase, Web of Knowledge, and the Cochrane Library databases. Finally, a total of 18 articles (nine prospective cohort, seven retrospective cohort, two case-control) meeting the eligibility criteria were included. The pooled incidence of AKI was 39.6% (95% confidence interval = 34.7-44.4%). Significant risk factors for the occurrence of AKI included age (odds ratio [OR] = 3.78 [1.28-6.27]), TBSA (OR = 15.66 [11.01-20.31]), full-thickness TBSA (OR = 15.66 [11.01-20.31]), flame burn (OR = 1.56 [1.09-2.25]), inhalation injury (OR = 2.97 [1.80-4.89]), abbreviated burn severity index on admission (OR = 2.42 [1.87-2.98]), sequential organ failure assessment score on admission (OR = 2.69 [1.39-3.98]), baseline blood urea nitrogen (OR = 2.11 [0.72-3.51]), serum creatinine (OR = 2.69 [1.39-3.98]), and sepsis (OR = 4.42 [1.75-11.18]). In addition, burn patients with AKI are more likely to have long stay in intensive care unit and high mortality. AKI is a common complication and occurs at a remarkable rate in burn patients. We identified 10 variables as independent risk factors for the development of AKI in burn patients. Our findings may help clinicians to develop effective preventive and therapeutic strategies and provide appropriate, timely initial treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Guosheng</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>From the Department of Burn Surgery, Changhai Hospital, Second Military Medical University, Shanghai, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Yongqiang</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chen</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Xudong</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yu</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Bing</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Guangyi</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Zhaofan</ForeName><Initials>Z</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Burn Care Res</MedlineTA><NlmUniqueID>101262774</NlmUniqueID><ISSNLinking>1559-047X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002056" MajorTopicYN="N">Burns</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007676" MajorTopicYN="N">Kidney Failure, Chronic</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007677" MajorTopicYN="N">Kidney Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051437" MajorTopicYN="N">Renal Insufficiency</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27617407</ArticleId><ArticleId IdType="doi">10.1097/BCR.0000000000000438</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39269909</PMID><DateCompleted><Year>2025</Year><Month>02</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>140</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Association Between Glycemic Variability and Persistent Acute Kidney Injury After Noncardiac Major Surgery: A Multicenter Retrospective Cohort Study.</ArticleTitle><Pagination><StartPage>636</StartPage><EndPage>645</EndPage><MedlinePgn>636-645</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000007131</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">While the relationship between glycemic variability (GV) and acute kidney injury (AKI) has been a subject of interest, the specific association of GV with persistent AKI beyond 48 hours postoperative after noncardiac surgery is not well-established.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective cohort study aimed to describe the patterns of different GV metrics in the immediate 48 hours after noncardiac surgery, evaluate the association between GV indices and persistent AKI within the 7-day postoperative window, and compare the risk identification capabilities of various GV for persistent AKI. A total of 10,937 patients who underwent major noncardiac surgery across 3 medical centers in eastern China between January 2015 and September 2023 were enrolled. GV was characterized using the coefficient of variations (CV), mean amplitude of glycemic excursions (MAGE), and the blood glucose risk index (BGRI). Multivariable logistic regression was used to examine the relationship between GV and AKI. Optimal cutoff values for GV metrics were calculated through the risk identification models, and an independent cohort from the INformative Surgical Patient dataset for Innovative Research Environment (INSPIRE) database with 7714 eligible cases served to externally validate the risk identification capability.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall, 274 (2.5%) of the 10,937 patients undergoing major noncardiac surgery met the criteria of persistent AKI. Higher GV was associated with an increased risk of persistent AKI (CV: odds ratio [OR] = 1.26, 95% confidence interval [CI], 1.08-1.46; MAGE: OR = 1.31, 95% CI, 1.15-1.49; BGRI: OR = 1.18, 95% CI, 1.08-1.29). Compared to models that did not consider glycemic factors, MAGE and BGRI independently contributed to predicting persistent AKI (MAGE: areas under the curve [AUC] = 0.768, P = .011; BGRI: AUC = 0.764, P = .014), with cutoff points of 3.78 for MAGE, and 3.02 for BGRI. The classification of both the internal and external validation cohorts using cutoffs demonstrated good performance, achieving the best AUC values of 0.768 for MAGE in the internal cohort and 0.777 for MAGE in the external cohort.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">GV measured within 48 hours postoperative period is an independent risk factor for persistent AKI in patients undergoing noncardiac surgery. Specific cutoff points can be used to stratify at-risk patients. These findings indicate that stabilizing GV may potentially mitigate adverse kidney outcomes after noncardiac surgery, highlighting the importance of glycemic control in the perioperative period.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 International Anesthesia Research Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Siyu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the School of International Business, China Pharmaceutical University, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Ke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Nanjing First Hospital, Nanjing Medical University, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Huili</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Fan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>From the School of International Business, China Pharmaceutical University, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Nanjing First Hospital, Nanjing Medical University, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Liu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Nanjing First Hospital, Nanjing Medical University, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Yali</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Nanjing First Hospital, Nanjing Medical University, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lihai</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Nanjing First Hospital, Nanjing Medical University, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Hongwei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Nanjing First Hospital, Nanjing Medical University, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Jifang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the School of International Business, China Pharmaceutical University, Jiangsu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="Y">Blood Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="Y">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>20</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>13</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39269909</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000007131</ArticleId><ArticleId IdType="pii">00000539-990000000-00945</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Thiele RH, Theodore DJ, Gan TJ. Outcome of organ dysfunction in the perioperative period. Anesth Analg. 2021;133:393&#x2013;405.</Citation></Reference><Reference><Citation>James MT, Bhatt M, Pannu N, Tonelli M. Long-term outcomes of acute kidney injury and strategies for improved care. Nat Rev Nephrol. 2020;16:193&#x2013;205.</Citation></Reference><Reference><Citation>Prowle JR, Forni LG, Bell M, et al. Postoperative acute kidney injury in adult non-cardiac surgery: joint consensus report of the Acute Disease Quality Initiative and PeriOperative Quality Initiative. Nat Rev Nephrol. 2021;17:605&#x2013;618.</Citation></Reference><Reference><Citation>Duff S, Murray PT. Defining early recovery of acute kidney injury. Clin J Am Soc Nephrol. 2020;15:1358&#x2013;1360.</Citation></Reference><Reference><Citation>Chawla LS, Bellomo R, Bihorac A, et al.; Acute Disease Quality Initiative Workgroup 16. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol. 2017;13:241&#x2013;257.</Citation></Reference><Reference><Citation>Kellum JA, Sileanu FE, Bihorac A, Hoste EAJ, Chawla LS. Recovery after acute kidney injury. Am J Respir Crit Care Med. 2017;195:784&#x2013;791.</Citation></Reference><Reference><Citation>Coca SG, King JT, Rosenthal RA, Perkal MF, Parikh CR. The duration of postoperative acute kidney injury is an additional parameter predicting long-term survival in diabetic veterans. Kidney Int. 2010;78:926&#x2013;933.</Citation></Reference><Reference><Citation>Korenkevych D, Ozrazgat-Baslanti T, Thottakkara P, et al. The pattern of longitudinal change in serum creatinine and 90-day mortality after major surgery. Ann Surg. 2016;263:1219&#x2013;1227.</Citation></Reference><Reference><Citation>Ferenbach DA, Bonventre JV. Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD. Nat Rev Nephrol. 2015;11:264&#x2013;276.</Citation></Reference><Reference><Citation>Hapca S, Siddiqui MK, Kwan RSY, et al.; BEAt-DKD Consortium. The relationship between AKI and CKD in patients with type 2 diabetes: an observational cohort study. J Am Soc Nephrol. 2021;32:138&#x2013;150.</Citation></Reference><Reference><Citation>Forni LG, Darmon M, Ostermann M, et al. Renal recovery after acute kidney injury. Intensive Care Med. 2017;43:855&#x2013;866.</Citation></Reference><Reference><Citation>Samoni S, De Rosa S, Ronco C, Castellano G. Update on persistent acute kidney injury in critical illnesses. Clin Kidney J. 2023;16:1813&#x2013;1823.</Citation></Reference><Reference><Citation>Ceriello A, Monnier L, Owens D. Glycaemic variability in diabetes: clinical and therapeutic implications. Lancet Diabetes Endocrinol. 2019;7:221&#x2013;230.</Citation></Reference><Reference><Citation>Ravi R, Balasubramaniam V, Kuppusamy G, Ponnusankar S. Current concepts and clinical importance of glycemic variability. Diabetes Metab Syndr. 2021;15:627&#x2013;636.</Citation></Reference><Reference><Citation>Alfieri V, Myasoedova VA, Vinci MC, et al. The role of glycemic variability in cardiovascular disorders. Int J Mol Sci . 2021;22:8393.</Citation></Reference><Reference><Citation>Nam K, Jeon Y, Kim WH, et al. Intraoperative glucose variability, but not average glucose concentration, may be a risk factor for acute kidney injury after cardiac surgery: a retrospective study. Can J Anaesth. 2019;66:921&#x2013;933.</Citation></Reference><Reference><Citation>Sim MA, Liu W, Ng RRG, Ti LK, Chew STH. Wider perioperative glycemic fluctuations increase risk of postoperative acute kidney injury: a prospective cohort study. Medicine (Baltimore). 2015;94:e1953.</Citation></Reference><Reference><Citation>Park J, Oh AR, Lee SH, et al. Associations between preoperative glucose and hemoglobin A1c level and myocardial injury after noncardiac surgery. J Am Heart Assoc. 2021;10:e019216.</Citation></Reference><Reference><Citation>Yoo S, Lee H-J, Lee H, Ryu H-G. Association between perioperative hyperglycemia or glucose variability and postoperative acute kidney injury after liver transplantation: A retrospective observational study. Anesth Analg. 2017;124:35&#x2013;41.</Citation></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453&#x2013;1457.</Citation></Reference><Reference><Citation>Lim L, Lee H. INSPIRE, a publicly available research dataset for perioperative medicine (version 1.0). PhysioNet. 2023.</Citation></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:c179&#x2013;c184.</Citation></Reference><Reference><Citation>Harrell F. Introduction to Survival Analysis. Regression Modeling Strategies: With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis. 2nd ed. Springer International Publishing AG; 2015:399&#x2013;422.</Citation></Reference><Reference><Citation>Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295:1681&#x2013;1687.</Citation></Reference><Reference><Citation>Ellger B, Debaveye Y, Vanhorebeek I, et al. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes. 2006;55:1096&#x2013;1105.</Citation></Reference><Reference><Citation>Dou L, Jourde-Chiche N. Endothelial toxicity of high glucose and its by-products in diabetic kidney disease. Toxins (Basel). 2019;11:578.</Citation></Reference><Reference><Citation>Simha V, Shah P. Perioperative glucose control in patients with diabetes undergoing elective surgery. JAMA. 2019;321:399&#x2013;400.</Citation></Reference><Reference><Citation>Zhang Z-Y, Miao L-F, Qian L-L, et al. Molecular mechanisms of glucose fluctuations on diabetic complications. Front Endocrinol (Lausanne). 2019;10:640.</Citation></Reference><Reference><Citation>Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:2610&#x2013;2642.</Citation></Reference><Reference><Citation>Boucai L, Southern WN, Zonszein J. Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities. Am J Med. 2011;124:1028&#x2013;1035.</Citation></Reference><Reference><Citation>Godat E, Preiser J-C, Aude J-C, Kalfon P. Dynamic properties of glucose complexity during the course of critical illness: a pilot study. J Clin Monit Comput. 2020;34:361&#x2013;370.</Citation></Reference><Reference><Citation>Rangasamy V, Xu X, Susheela AT, Subramaniam B. Comparison of glycemic variability indices: blood glucose, risk index, and coefficient of variation in predicting adverse outcomes for patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth. 2020;34:1794&#x2013;1802.</Citation></Reference><Reference><Citation>Chao W-C, Tseng C-H, Wu C-L, Shih S-J, Yi C-Y, Chan M-C. Higher glycemic variability within the first day of ICU admission is associated with increased 30-day mortality in ICU patients with sepsis. Ann Intensive Care. 2020;10:17.</Citation></Reference><Reference><Citation>Kovatchev BP, Otto E, Cox D, Gonder-Frederick L, Clarke W. Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care. 2006;29:2433&#x2013;2438.</Citation></Reference><Reference><Citation>Baghurst PA. Calculating the mean amplitude of glycemic excursion from continuous glucose monitoring data: an automated algorithm. Diabetes Technol Ther. 2011;13:296&#x2013;302.</Citation></Reference><Reference><Citation>Carlsson CJ, N&#xf8;rgaard K, Oxb&#xf8;ll A-B, et al. Continuous glucose monitoring reveals perioperative hypoglycemia in most patients with diabetes undergoing major surgery: a prospective cohort study. Ann Surg. 2023;277:603&#x2013;611.</Citation></Reference><Reference><Citation>Perez-Guzman MC, Duggan E, Gibanica S, et al. Continuous glucose monitoring in the operating room and cardiac intensive care unit. Diabetes Care. 2021;44:e50&#x2013;e52.</Citation></Reference><Reference><Citation>Zarbock A, Weiss R, Albert F, et al.; EPIS-AKI Investigators. Epidemiology of surgery associated acute kidney injury (EPIS-AKI): a prospective international observational multi-center clinical study. Intensive Care Med. 2023;49:1441&#x2013;1455.</Citation></Reference><Reference><Citation>Zhuo X-Y, Lei S-H, Sun L, et al. Preoperative risk prediction models for acute kidney injury after noncardiac surgery: an independent external validation cohort study. Br J Anaesth. Published online March 24, 2024.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29124867</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>09</Day></DateCompleted><DateRevised><Year>2019</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1440-1797</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Nephrology (Carlton, Vic.)</Title><ISOAbbreviation>Nephrology (Carlton)</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury in critically ill surgical patients: Epidemiology, risk factors and outcomes.</ArticleTitle><Pagination><StartPage>39</StartPage><EndPage>46</EndPage><MedlinePgn>39-46</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/nep.13192</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">Acute kidney injury (AKI) is one of the most serious complications seen in intensive care units (ICUs). However, its epidemiology, risk factors and clinical outcomes in surgical critically ill patients remains unclear.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A prospective cohort study was conducted in surgical intensive care unit (ICU) of the university hospital in Bangkok, Thailand. AKI was diagnosed according to the KDIGO 2012 criteria.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 189 of the 400 patients enrolled in our study developed AKI (47.3%). The severity was: stage 1 = 29.6% of all AKI (56 cases), stage 2 = 30.7% (58 cases), and stage 3 = 39.7% (75 cases). Risk factors of AKI development included a higher BMI, a greater APACHE-II score, septic shock, use of mechanical ventilation, acute medical complications during surgical admission, and pre-existing chronic kidney disease. After adjustment for covariates, only the most severe stage of AKI (stage 3) was associated with increasing 28-day ICU mortality compared with no AKI stage, HR = 7.75 (95% CI, 1.46-41.20, P = 0.02).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Acute kidney injury is common and is associated with an increase in mortality in surgical ICU patients. There should be more focus on patients with AKI risk factors to prevent this deleterious event.</AbstractText><CopyrightInformation>&#xa9; 2017 Asian Pacific Society of Nephrology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Trongtrakul</LastName><ForeName>Konlawij</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-2544-7322</Identifier><AffiliationInfo><Affiliation>Critical Care Division, Department of Emergency Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sawawiboon</LastName><ForeName>Chaiwut</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Critical Care Division, Department of Emergency Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Amanda Y</ForeName><Initials>AY</Initials><AffiliationInfo><Affiliation>Renal and Metabolic Division, The George Institute for Global Health, Camperdown, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chitsomkasem</LastName><ForeName>Anusang</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Critical Care Division, Department of Emergency Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Limphunudom</LastName><ForeName>Ploynapas</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurathong</LastName><ForeName>Sathit</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Nephrology Division, Department of Internal Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prommool</LastName><ForeName>Surazee</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Nephrology Division, Department of Internal Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trakarnvanich</LastName><ForeName>Thananda</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Nephrology Division, Department of Internal Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Srisawat</LastName><ForeName>Nattachai</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Excellence Centre for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, Thai Red Cross and Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Research Fund of Navamindradhiraj University, Bangkok, Thailand</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Nephrology (Carlton)</MedlineTA><NlmUniqueID>9615568</NlmUniqueID><ISSNLinking>1320-5358</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013785" MajorTopicYN="N" Type="Geographic">Thailand</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute renal failure</Keyword><Keyword MajorTopicYN="N">clinical epidemiology</Keyword><Keyword MajorTopicYN="N">critically ill patients</Keyword><Keyword MajorTopicYN="N">surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29124867</ArticleId><ArticleId IdType="doi">10.1111/nep.13192</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36950854</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1525-6049</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Renal failure</Title><ISOAbbreviation>Ren Fail</ISOAbbreviation></Journal><ArticleTitle>Intraoperative dexmedetomidine use is associated with lower incidence of acute kidney injury after non-cardiac surgery.</ArticleTitle><Pagination><StartPage>2192285</StartPage><MedlinePgn>2192285</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2192285</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/0886022X.2023.2192285</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Previous studies have shown that perioperative dexmedetomidine could reduce the incidence of postoperative AKI in cardiovascular surgery, however, its effectiveness in the non-cardiovascular surgery patient population has not been reported. The aim of this study was to investigate the effect of intraoperative dexmedetomidine on the incidence of postoperative AKI and postoperative ICU admissions in patients undergoing non-cardiovascular surgery.</AbstractText><AbstractText Label="DESIGN AND SETTING" NlmCategory="UNASSIGNED">A single-center retrospective cohort study obtained from the database of the Center for Anesthesia and Surgery, the Third Xiangya Hospital.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="UNASSIGNED">Inpatients between 18 and 75&#x2009;years of age who were admitted to our hospital for non-cardiovascular surgery from 2012 to 2019.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Overall 2391 patients who used dexmedetomidine intraoperatively were analyzed in comparison to 4552 patients who did not use dexmedetomidine after one-to-two matching. The two cohorts had similar baseline values and demographic characteristics. The incidence of AKI was lower in patients with intraoperative dexmedetomidine use than in the nonuse group (OR 0.60, <i>p</i>&#x2009;&lt;&#x2009;.001). The rate of severe renal failure needing dialysis was also lower than in the nonuse group (<i>&#x3b2;</i> = -0.02, <i>p</i>&#x2009;&lt;&#x2009;.05). After adjusting for confounding factors, the rate of AKI was still lower in the dexmedetomidine group. The rate of postoperative ICU admissions and in-hospital deaths were similar in the two groups (<i>p</i>&#x2009;&gt;&#x2009;.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">For non-cardiovascular surgery patient population, intraoperative use of dexmedetomidine was associated with a lower incidence and less severity of postoperative AKI. However, there was no significant correlation with postoperative ICU occupancy or in-hospital mortality. Further prospective RCTs are needed in the future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Yong-Zhong</ForeName><Initials>YZ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology of the Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qiong</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Cardiology of the Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhi</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Nephrology of the Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology of the Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology of the Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Qin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology of the Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Operation center of the Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Nephrology of the Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ren Fail</MedlineTA><NlmUniqueID>8701128</NlmUniqueID><ISSNLinking>0886-022X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="Y">Dexmedetomidine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dexmedetomidine</Keyword><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">non-cardiovascular surgery</Keyword><Keyword MajorTopicYN="N">retrospective study</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>23</Day><Hour>3</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36950854</ArticleId><ArticleId IdType="pmc">PMC10038018</ArticleId><ArticleId IdType="doi">10.1080/0886022X.2023.2192285</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bellomo C, Kellum R, Ronco JA.. Acute kidney injury. Lancet. 2019;394(10212):1949&#x2013;1964.</Citation><ArticleIdList><ArticleId IdType="pubmed">31777389</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholz H, Boivin FJ, Schmidt-Ott KM, et al. . Kidney physiology and susceptibility to acute kidney injury: implications for renoprotection. Nat Rev Nephrol. 2021;17(5):335&#x2013;349.</Citation><ArticleIdList><ArticleId IdType="pubmed">33547418</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EAJ, Kellum JA, Selby NM, et al. . Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol. 2018;14(10):607&#x2013;625.</Citation><ArticleIdList><ArticleId IdType="pubmed">30135570</ArticleId></ArticleIdList></Reference><Reference><Citation>Medve C, Gondos L, Kopitko T.. The value of combined hemodynamic, respiratory and intra-abdominal pressure monitoring in predicting acute kidney injury after major intraabdominal surgeries. Ren Fail. 2019;41(1):150&#x2013;158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6442204</ArticleId><ArticleId IdType="pubmed">30909772</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopitk&#xf3; C, Gondos T, F&#xfc;l&#xf6;p T, et al. . Reinterpreting renal hemodynamics: the importance of venous congestion and effective organ perfusion in acute kidney injury. Am J Med Sci. 2020;359(4):193&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">32089228</ArticleId></ArticleIdList></Reference><Reference><Citation>Coursin DB, Maccioli DB, Coursin GA.. Dexmedetomidine. Curr Opin Crit Care. 2001;7(4):221&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">11571417</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles PS, Hunt JO, Holdgaard HO, et al. . Clonidine and cardiac surgery: haemodynamic and metabolic effects, myocardial ischaemia and recovery. Anaesth Intensive Care. 1999;27(2):137&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">10212709</ArticleId></ArticleIdList></Reference><Reference><Citation>Ming S, Xie Y, Du X, et al. . Effect of dexmedetomidine on perioperative hemodynamics and organ protection in children with congenital heart disease: a randomized controlled trial. Medicine. 2021;100(1):e23998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7793469</ArticleId><ArticleId IdType="pubmed">33429762</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan X-S, Dai H-R, Zhao D, et al. . Dexmedetomidine reduces acute kidney injury after endovascular aortic repair of stanford type B aortic dissection: a randomized, double-blind, placebo-controlled pilot study. J Clin Anesth. 2021;75:110498.</Citation><ArticleIdList><ArticleId IdType="pubmed">34488061</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski DM, Axelrod DM, Axelrod SM, et al. . Dexmedetomidine is associated with lower incidence of acute kidney injury after congenital heart surgery. Pediatr Crit Care Med. 2016;17(2):128&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pubmed">26673841</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y-Z, Zeng P, Liao Y, et al. . Correlation between perioperative parecoxib use and postoperative acute kidney injury in patients undergoing non-cardiac surgery: a retrospective cohort analysis. BMJ Open. 2021;11(8):e047840.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8388276</ArticleId><ArticleId IdType="pubmed">34433595</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersmann A, M&#xfc;ller-Wieland D, M&#xfc;ller UA, et al. . Definition, classification and diagnosis of diabetes mellitus. Exp Clin Endocrinol Diabetes. 2019;127(S01):S1&#x2013;S7.</Citation><ArticleIdList><ArticleId IdType="pubmed">31860923</ArticleId></ArticleIdList></Reference><Reference><Citation>Muntner P, Carey RM, Gidding S, et al. . Potential US population impact of the 2017 ACC/AHA high blood pressure guideline. Circulation. 2018;137(2):109&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5873602</ArticleId><ArticleId IdType="pubmed">29133599</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, Koyner JL, Hoste EAJ, et al. . Update on perioperative acute kidney injury. Anesth Analg. 2018;127(5):1236&#x2013;1245.</Citation><ArticleIdList><ArticleId IdType="pubmed">30138176</ArticleId></ArticleIdList></Reference><Reference><Citation>Biteker M, Dayan A, Tekke&#x15f;in A&#x130;, et al. . Incidence, risk factors, and outcomes of perioperative acute kidney injury in noncardiac and nonvascular surgery. Am J Surg. 2014;207(1):53&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">24050540</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Bellomo R.. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol. 2017;13(11):697&#x2013;711.</Citation><ArticleIdList><ArticleId IdType="pubmed">28869251</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang C, Hu Y, Gao J, et al. . Dexmedetomidine pretreatment attenuates myocardial ischemia reperfusion induced acute kidney injury and endoplasmic reticulum stress in human and rat. Life Sci. 2020;257:118004.</Citation><ArticleIdList><ArticleId IdType="pubmed">32621918</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho JS, Shim J-K, Soh S, et al. . Perioperative dexmedetomidine reduces the incidence and severity of acute kidney injury following valvular heart surgery. Kidney Int. 2016;89(3):693&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pubmed">26444030</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Jin Y, Feng C, et al. . Renoprotective effect of intraoperative dexmedetomidine in renal transplantation. Comput Math Methods Med. 2022;2022:9275406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8863455</ArticleId><ArticleId IdType="pubmed">35211189</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriyama N, Kanmura T, Kiyonaga Y.. Effects of dexmedetomidine on lipopolysaccharide-induced acute kidney injury in rats and mitochondrial function in cell culture. Biomed Pharmacother. 2020;125:109912.</Citation><ArticleIdList><ArticleId IdType="pubmed">32014689</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y, Kim D-H, Kwon TD, et al. . Effect of intraoperative dexmedetomidine on renal function after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a randomized, placebo-controlled trial. Int J Hyperthermia. 2019;36(1):1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">30354794</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai Y, Zhu K, Li C, et al. . Dexmedetomidine alleviates cisplatininduced acute kidney injury by attenuating endoplasmic reticulum stressinduced apoptosis via the alpha2AR/PI3K/AKT pathway. Mol Med Rep. 2020;21(3):1597&#x2013;1605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7003053</ArticleId><ArticleId IdType="pubmed">32016445</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39628731</PMID><DateRevised><Year>2024</Year><Month>12</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Minimizing Acute Kidney Injury in Pediatric Cardiac Surgery: Incidence, Early Detection, and Preemptive Measures.</ArticleTitle><Pagination><StartPage>e72916</StartPage><MedlinePgn>e72916</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e72916</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.72916</ELocationID><Abstract><AbstractText>Background Acute kidney injury (AKI) poses a significant challenge in pediatric cardiac surgery, having a profound impact on patient morbidity and mortality. This study aims to determine the incidence of AKI, explore novel biomarkers for early detection,&#xa0;assess potential risk factors along with preemptive strategies to minimize its incidence and compare the results with similar studies that did not use these interventions. Methods This prospective observational cohort study, conducted from October 2022 to June 2024 at a tertiary care center, involved 44 pediatric patients, aged three months to 15 years, undergoing cardiac surgery. Kidney function was assessed through preoperative and postoperative measurements of serum creatinine, urine output, blood urea, and newer biomarkers such as cystatin C and urine neutrophil gelatinase-associated lipocalin (NGAL). AKI was defined and classified using the Acute Kidney Injury Network (AKIN) criteria, based on increases in serum creatinine or reductions in urine output within the first three days post surgery. To reduce the risk of AKI, a low-dose vasopressin infusion and blood transfusion were administered to maintain renal perfusion and optimal hematocrit levels. The incidence of AKI was calculated and compared with other studies that did not utilize these strategies Results AKI occurred in 31.8% (n=14) of the pediatric patients undergoing cardiac surgery. To reduce the risk of AKI, preemptive low-dose vasopressin was used as a preventive strategy. Patients who developed AKI exhibited significant elevations in serum creatinine, blood urea, and cystatin C, with postoperative NGAL levels exceeding 50 ng/ml. The study found a strong correlation between lower intraoperative hematocrit levels (&lt;30%) and a higher incidence of AKI (100% vs. 6.2%, p&lt;0.001). Conclusions Effective management of intraoperative hematocrit levels and the preemptive use of vasopressin are promising strategies for reducing AKI risk by optimizing renal perfusion and function during cardiac surgery.&#xa0;Early detection through biomarkers like cystatin C and NGAL offers the potential for timely intervention and better patient outcomes. These findings contribute to improving risk assessment and perioperative management in pediatric patients vulnerable to AKI.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024, Sharma et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Vipul</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Anaesthesiology, Dr. D Y Patil Medical College, Hospital and Research Centre, Dr. D Y Patil Vidyapeeth (Deemed to be University), Pune, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atluri</LastName><ForeName>Harika</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Anaesthesiology, Dr. D Y Patil Medical College, Hospital and Research Centre, Dr. D Y Patil Vidyapeeth (Deemed to be University), Pune, IND.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">: acute kidney injury</Keyword><Keyword MajorTopicYN="N">cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">cystatin c</Keyword><Keyword MajorTopicYN="N">hematocrit</Keyword><Keyword MajorTopicYN="N">neutrophil gelatinase-associated lipocalin (ngal)</Keyword><Keyword MajorTopicYN="N">pediatric cardiac surgery</Keyword><Keyword MajorTopicYN="N">serum creatinine</Keyword><Keyword MajorTopicYN="N">vasopressin</Keyword></KeywordList><CoiStatement>Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Dr.D.Y.Patil Medical College, Hospital and Research Centre Institutional Ethics Sub-Committee issued approval IESC/PGS/2022/156. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>4</Day><Hour>11</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>4</Day><Hour>11</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>4</Day><Hour>4</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39628731</ArticleId><ArticleId IdType="pmc">PMC11613292</ArticleId><ArticleId IdType="doi">10.7759/cureus.72916</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Acute renal failure: an important complication of cardiac surgery in infants. Chesney RW, Kaplan BS. J Pediatr. 1975;87:381&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pubmed">1165517</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute renal failure complicating cardiopulmonary bypass surgery. Rigden SP, Barratt TM, Dillon MJ, De Leval M, Stark J. Arch Dis Child. 1982;57:425&#x2013;430.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1627665</ArticleId><ArticleId IdType="pubmed">7092306</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute kidney injury in children after cardiopulmonary bypass: risk factors and outcome. Sethi SK, Kumar M, Sharma R, Bazaz S, Kher V. https://doi.org/10.1007/s13312-015-0611-4. Indian Pediatr. 2015;52:223&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">25848999</ArticleId></ArticleIdList></Reference><Reference><Citation>Validation of cell-cycle arrest biomarkers for acute kidney injury after pediatric cardiac surgery. Meersch M, Schmidt C, Van Aken H, et al.  https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0110865 PLoS One. 2014;9:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4208780</ArticleId><ArticleId IdType="pubmed">25343505</ArticleId></ArticleIdList></Reference><Reference><Citation>Incidence, risk factors, and outcomes of acute kidney injury after pediatric cardiac surgery: a prospective multicenter study. Li S, Krawczeski CD, Zappitelli M, et al. Crit Care Med. 2011;39:1493&#x2013;1499.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3286600</ArticleId><ArticleId IdType="pubmed">21336114</ArticleId></ArticleIdList></Reference><Reference><Citation>Congenital heart surgery in infants: effects of acute kidney injury on outcomes. Blinder JJ, Goldstein SL, Lee VV, Baycroft A, Fraser CD, Nelson D, Jefferies JL. J Thorac Cardiovasc Surg. 2012;143:368&#x2013;374.</Citation><ArticleIdList><ArticleId IdType="pubmed">21798562</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk factors for and outcomes of acute kidney injury in neonates undergoing complex cardiac surgery. Morgan CJ, Zappitelli M, Robertson CM, et al. J Pediatr. 2013;162:120&#x2013;127.</Citation><ArticleIdList><ArticleId IdType="pubmed">22878115</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of perfusion modes on microcirculation during acute and chronic cardiac support: is there a difference? Ji B, Undar A. Perfusion. 2007;22:115&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">17708160</ArticleId></ArticleIdList></Reference><Reference><Citation>Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-associated acute kidney injury. Haase M, Bellomo R, Haase-Fielitz A. J Am Coll Cardiol. 2010;55:2024&#x2013;2033.</Citation><ArticleIdList><ArticleId IdType="pubmed">20447525</ArticleId></ArticleIdList></Reference><Reference><Citation>Plasma IL-6 and IL-10 concentrations predict AKI and long-term mortality in adults after cardiac surgery. Zhang WR, Garg AX, Coca SG, et al. J Am Soc Nephrol. 2015;26:3123&#x2013;3132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4657830</ArticleId><ArticleId IdType="pubmed">25855775</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute kidney injury is associated with higher morbidity and resource utilization in pediatric patients undergoing heart surgery. T&#xf3;th R, Breuer T, Cser&#xe9;p Z, et al.  https://www.annalsthoracicsurgery.org/article/S0003-4975(11)02536-7/fulltext. Ann Thorac Surg. 2012;93:1984&#x2013;1990.</Citation><ArticleIdList><ArticleId IdType="pubmed">22226235</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute kidney injury after surgery for congenital heart disease. Aydin SI, Seiden HS, Blaufox AD, Parnell VA, Choudhury T, Punnoose A, Schneider J. Ann Thorac Surg. 2012;94:1589&#x2013;1595.</Citation><ArticleIdList><ArticleId IdType="pubmed">22884599</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk factors for acute kidney injury after congenital cardiac surgery in infants and children: a retrospective observational study. Park SK, Hur M, Kim E, et al. PLoS One. 2016;11:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5104485</ArticleId><ArticleId IdType="pubmed">27832187</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute kidney injury classification: AKIN and RIFLE criteria in critical patients. Lin CY, Chen YC. World J Crit Care Med. 2012;1:40&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3953858</ArticleId><ArticleId IdType="pubmed">24701400</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardiorenal syndrome. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. J Am Coll Cardiol. 2008;52:1527&#x2013;1539.</Citation><ArticleIdList><ArticleId IdType="pubmed">19007588</ArticleId></ArticleIdList></Reference><Reference><Citation>A small post-operative rise in serum creatinine predicts acute kidney injury in children undergoing cardiac surgery. Zappitelli M, Bernier PL, Saczkowski RS, et al. Kidney Int. 2009;76:885&#x2013;892.</Citation><ArticleIdList><ArticleId IdType="pubmed">19641482</ArticleId></ArticleIdList></Reference><Reference><Citation>Impact of minimal increases in serum creatinine on outcome in patients after cardiothoracic surgery: do we have to revise current definitions of acute renal failure? Lassnigg A, Schmid ER, Hiesmayr M, Falk C, Druml W, Bauer P, Schmidlin D. Crit Care Med. 2008;36:1129&#x2013;1137.</Citation><ArticleIdList><ArticleId IdType="pubmed">18379238</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasopressin and shock. Forrest P. Anaesth Intensive Care. 2001;29:463&#x2013;472.</Citation><ArticleIdList><ArticleId IdType="pubmed">11669425</ArticleId></ArticleIdList></Reference><Reference><Citation>Regulation of ACTH secretion from corticotrophs: the interaction of vasopressin and CRF. Bilezikjian LM, Vale WW. Ann N Y Acad Sci. 1987;512:85&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">2831787</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasopressin in the pediatric cardiac intensive care unit: myth or reality. Singh VK, Sharma R, Agrawal A, Varma A. Ann Pediatr Cardiol. 2009;2:65&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2840775</ArticleId><ArticleId IdType="pubmed">20300273</ArticleId></ArticleIdList></Reference><Reference><Citation>Early postoperative serum cystatin C predicts severe acute kidney injury following pediatric cardiac surgery. Zappitelli M, Krawczeski CD, Devarajan P, et al. Kidney Int. 2011;80:655&#x2013;662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3312809</ArticleId><ArticleId IdType="pubmed">21525851</ArticleId></ArticleIdList></Reference><Reference><Citation>Effects of vasopressin on renal function in children with severe forms of shock. Meyer S, Gottschling S. Crit Care Med. 2008;36:2959.</Citation><ArticleIdList><ArticleId IdType="pubmed">18812815</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiology of cardiac surgery-associated acute kidney injury in neonates: a retrospective study. Alabbas A, Campbell A, Skippen P, Human D, Matsell D, Mammen C. Pediatr Nephrol. 2013;28:1127&#x2013;1134.</Citation><ArticleIdList><ArticleId IdType="pubmed">23519522</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute kidney injury and fluid overload in neonates following surgery for congenital heart disease. Piggott KD, Soni M, Decampli WM, et al. World J Pediatr Congenit Heart Surg. 2015;6:401&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">26180155</ArticleId></ArticleIdList></Reference><Reference><Citation>Low-Dose vasopressin and renal perfusion in pediatric cardiac surgery. Kumar A, Ghotra GS, Raj S, Tiwari N, Ramamurthy HR. Ann Card Anaesth. 2023;26:309&#x2013;317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10451146</ArticleId><ArticleId IdType="pubmed">37470530</ArticleId></ArticleIdList></Reference><Reference><Citation>Whole blood assessment of neutrophil gelatinase-associated lipocalin versus pediatricRIFLE for acute kidney injury diagnosis and prognosis after pediatric cardiac surgery: cross-sectional study*. Ricci Z, Netto R, Garisto C, Iacoella C, Favia I, Cogo P. Pediatr Crit Care Med. 2012;13:667&#x2013;670.</Citation><ArticleIdList><ArticleId IdType="pubmed">22895007</ArticleId></ArticleIdList></Reference><Reference><Citation>The combined use of neutrophil gelatinase-associated lipocalin and brain natriuretic peptide improves risk stratification in pediatric cardiac surgery. Cantinotti M, Storti S, Lorenzoni V, et al. Clin Chem Lab Med. 2012;50:2009&#x2013;2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">23089537</ArticleId></ArticleIdList></Reference><Reference><Citation>Peritoneal dialysis does not adversely affect kidney function recovery after congenital heart surgery. Riley AA, Jefferies JL, Nelson DP, et al. Int J Artif Organs. 2014;37:39&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4304647</ArticleId><ArticleId IdType="pubmed">24634333</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27530232</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2018</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-7716</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>5</Issue><PubDate><Year>2017</Year><Month>Feb</Month><Day>10</Day></PubDate></JournalIssue><Title>Antioxidants &amp; redox signaling</Title><ISOAbbreviation>Antioxid Redox Signal</ISOAbbreviation></Journal><ArticleTitle>Does Furosemide Increase Oxidative Stress in Acute Kidney Injury?</ArticleTitle><Pagination><StartPage>221</StartPage><EndPage>226</EndPage><MedlinePgn>221-226</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/ars.2016.6845</ELocationID><Abstract><AbstractText>Furosemide, a loop diuretic, is used to increase urine output in patients with acute kidney injury (AKI). It remains uncertain whether the benefits of furosemide in AKI outweigh its potential harms. We investigated if furosemide influenced oxidative stress in 30 critically ill patients with AKI by measuring changes in F<sub>2</sub>-isoprostanes (F<sub>2</sub>-IsoPs), markers of in vivo oxidative stress, in plasma and urine following intravenous furosemide. Urine F<sub>2</sub>-IsoPs were higher in sepsis (p&#x2009;=&#x2009;0.001) and increased in proportion to urine furosemide (p&#x2009;=&#x2009;0.001). The furosemide-induced increase in urine F<sub>2</sub>-IsoPs differed depending on AKI severity (p&#x2009;&lt;&#x2009;0.001) and was greatest in those with the most severe AKI. Furosemide had no effect on plasma F<sub>2</sub>-IsoPs. We demonstrate for the first time that furosemide increases renal oxidative stress in AKI and find that patients with the most severe AKI-to whom the largest doses are likely to be administered-showed the greatest increase in oxidative stress. These findings lead to the hypothesis that the common practice of administering high-dose furosemide to convert oliguric to nonoliguric AKI may induce harmful oxidative stress in the kidneys, and an adequately powered, randomized controlled trial is required to determine if clinical benefits of this dosing strategy justify its potential harms. Antioxid. Redox Signal. 26, 221-226.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Silbert</LastName><ForeName>Benjamin I</ForeName><Initials>BI</Initials><AffiliationInfo><Affiliation>1 Department of Intensive Care Medicine, Fiona Stanley Hospital , Murdoch, Australia .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2 School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia , Perth, Australia .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Kwok M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>3 Department of Intensive Care Medicine, Royal Perth Hospital , Perth, Australia .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>4 School of Population Health, University of Western Australia , Crawley, Australia .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>5 School of Veterinary and Life Sciences, Murdoch University , Murdoch, Australia .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipman</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>6 Burns, Trauma and Critical Care Research Centre, School of Medicine, University of Queensland , Brisbane, Australia .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>7 Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital , Herston, Australia .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>8 Faculty of Health, Queensland University of Technology , Brisbane, Australia .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Jason A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>6 Burns, Trauma and Critical Care Research Centre, School of Medicine, University of Queensland , Brisbane, Australia .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>7 Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital , Herston, Australia .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corcoran</LastName><ForeName>Tomas B</ForeName><Initials>TB</Initials><AffiliationInfo><Affiliation>2 School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia , Perth, Australia .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>9 Department of Anaesthesia and Pain Medicine, Royal Perth Hospital , Perth, Australia .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morgan</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>1 Department of Intensive Care Medicine, Fiona Stanley Hospital , Murdoch, Australia .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pavey</LastName><ForeName>Warren</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>5 School of Veterinary and Life Sciences, Murdoch University , Murdoch, Australia .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>10 Department of Anaesthesia and Pain Medicine, Fiona Stanley Hospital , Murdoch, Australia .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mas</LastName><ForeName>Emilie</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>2 School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia , Perth, Australia .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barden</LastName><ForeName>Anne E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>2 School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia , Perth, Australia .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mori</LastName><ForeName>Trevor A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>2 School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia , Perth, Australia .</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>09</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Antioxid Redox Signal</MedlineTA><NlmUniqueID>100888899</NlmUniqueID><ISSNLinking>1523-0864</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004232">Diuretics</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D028441">F2-Isoprostanes</NameOfSubstance></Chemical><Chemical><RegistryNumber>7LXU5N7ZO5</RegistryNumber><NameOfSubstance UI="D005665">Furosemide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004232" MajorTopicYN="N">Diuretics</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D028441" MajorTopicYN="N">F2-Isoprostanes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005665" MajorTopicYN="N">Furosemide</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007677" MajorTopicYN="N">Kidney Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute renal failure</Keyword><Keyword MajorTopicYN="N">diuretic</Keyword><Keyword MajorTopicYN="N">harms</Keyword><Keyword MajorTopicYN="N">oliguria</Keyword><Keyword MajorTopicYN="N">prevention</Keyword><Keyword MajorTopicYN="N">urine output</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27530232</ArticleId><ArticleId IdType="doi">10.1089/ars.2016.6845</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32681793</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1643-3750</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><PubDate><Year>2020</Year><Month>Jul</Month><Day>18</Day></PubDate></JournalIssue><Title>Medical science monitor : international medical journal of experimental and clinical research</Title><ISOAbbreviation>Med Sci Monit</ISOAbbreviation></Journal><ArticleTitle>Early Acute Kidney Injury Associated with Liver Transplantation: A Retrospective Case-Control Study.</ArticleTitle><Pagination><StartPage>e923864</StartPage><MedlinePgn>e923864</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.12659/MSM.923864</ELocationID><Abstract><AbstractText>BACKGROUND A retrospective case-control study was carried out to assess the occurrence of acute kidney injury (AKI) in liver transplantation (LT) recipients and its related risk factors. MATERIAL AND METHODS The study enrolled 131 patients undergoing LT from December 2017 to June 2019 at Beijing Tsinghua Chang Gung Hospital, China. AKI and its classification were defined according to KDIGO guidelines. We collected patients' demographic characteristics and perioperative parameters, and identified independent risk factors of AKI by multivariate logistic regression analysis. RESULTS We included 122 patients in analysis. AKI occurred in 52 (42.6%) patients (22.1% stage I, 8.2% stage II, and 12.3% stage III). AKI was notably associated with 12 factors: sex, body mass index (BMI), hepatic etiology, MELD score, ascites, prothrombin time (PT), international normalized ratio of prothrombin time (INR), preoperative total bilirubin (TBIL), operative time, total fluid intake, fresh frozen plasma (FFP), and estimated blood loss (EBL) (P&lt;0.05). The factors independently associated with AKI were BMI (adjusted odds ratio: 0.605, 95% confidence interval: 0.425-0.859; P=0.005) and intraoperative FFP infusion (adjusted odds ratio: 0.998, 95% confidence interval: 0.995-1.000; P=0.047). Compared with the non-AKI group, the AKI group showed higher likelihood of renal replacement therapy (RRT), and longer ICU and hospital stays, higher in-hospital mortality, and higher hospitalization costs (P&lt;0.05). CONCLUSIONS There is a high risk of AKI in patients undergoing LT. BMI and intraoperative FFP infusion are factors independently correlated with AKI. AKI can result in extended hospital stays and higher hospitalization expenses.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Mengzhuo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Yuanchao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Linlin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Haijing</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xian</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Huan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Beijing, China (mainland).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Med Sci Monit</MedlineTA><NlmUniqueID>9609063</NlmUniqueID><ISSNLinking>1234-1010</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016031" MajorTopicYN="N">Liver Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflicts of interest</b>. None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>7</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32681793</ArticleId><ArticleId IdType="pmc">PMC7387046</ArticleId><ArticleId IdType="doi">10.12659/MSM.923864</ArticleId><ArticleId IdType="pii">923864</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McCauley J, Van Thiel DH, Starzl TE, Puschett JB. Acute and chronic renal failure in liver transplantation. Nephron. 1990;55(2):121&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2957102</ArticleId><ArticleId IdType="pubmed">2362625</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima EQ, Zanetta DM, Castro I, et al. Risk factors for development of acute renal failure after liver transplantation. Ren Fail. 2003;25(4):553&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">12911159</ArticleId></ArticleIdList></Reference><Reference><Citation>Thongprayoon C, Kaewput W, Thamcharoen N, et al. Incidence and impact of acute kidney injury after liver transplantation: A meta-analysis. J Clin Medm. 2019;8(3):372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6463182</ArticleId><ArticleId IdType="pubmed">30884912</ArticleId></ArticleIdList></Reference><Reference><Citation>Tinti F, Melandro F, Umbro I, et al. Female gender and overestimation of glomerular filtration rate: Independent predictors of acute kidney injury after liver transplantation. Clin Nephrol. 2020;93(2):92&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">31793872</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav K, Serrano OK, Peterson KJ, et al. The liver recipient with acute renal dysfunction: A single institution evaluation of the simultaneous liver-kidney transplant candidate. Clin Transplant. 2018;32(1)</Citation><ArticleIdList><ArticleId IdType="pubmed">29105843</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman S, Davidson BR, Mallett SV. Early acute kidney injury after liver transplantation: Predisposing factors and clinical implications. World J Hepatol. 2017;9(18):823&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5491405</ArticleId><ArticleId IdType="pubmed">28706581</ArticleId></ArticleIdList></Reference><Reference><Citation>Barri YM, Sanchez EQ, Jennings LW, et al. Acute kidney injury following liver transplantation: Definition and outcome. Liver Transpl. 2009;15(5):475&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">19399734</ArticleId></ArticleIdList></Reference><Reference><Citation>Angeli P, Gines P, Wong F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites. J Hepatol. 2015;62(4):968&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">25638527</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadim MK, Durand F, Kellum JA, et al. Management of the critically ill patient with cirrhosis: A multidisciplinary perspective. J Hepatol. 2016;64(3):717&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">26519602</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirivatanauksorn Y, Parakonthun T, Premasathian N, et al. Renal dysfunction after orthotopic liver transplantation. Transplant Proc. 2014;46(3):818&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">24767356</ArticleId></ArticleIdList></Reference><Reference><Citation>Durand F, Francoz C, Asrani SK, et al. Acute kidney injury after liver transplantation. Transplantation. 2018;102(10):1636&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">29847502</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilbao I, Charco R, Balsells J, et al. Risk factors for acute renal failure requiring dialysis after liver transplantation. Clin Transplant. 1998;12(2):123&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">9575400</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiwall R, Sarin SK, Kumar S, et al. Development of predisposition, injury, response, organ failure model for predicting acute kidney injury in acute on chronic liver failure. Liver Int. 2017;37(10):1497&#x2013;507.</Citation><ArticleIdList><ArticleId IdType="pubmed">28393476</ArticleId></ArticleIdList></Reference><Reference><Citation>Utsumi M, Umeda Y, Sadamori H, et al. Risk factors for acute renal injury in living donor liver transplantation: Evaluation of the RIFLE criteria. Transpl Int. 2013;26(8):842&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">23855657</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlegel A, Linecker M, Kron P, et al. Risk assessment in high- and low-MELD liver transplantation. Am J Transplant. 2017;17(4):1050&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">27676319</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano TG, Schmidtbauer I, Silva FM, et al. Role of MELD score and serum creatinine as prognostic tools for the development of acute kidney injury after liver transplantation. PLoS One. 2013;8(5):e64089.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3662723</ArticleId><ArticleId IdType="pubmed">23717537</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebron Gallardo M, Herrera Gutierrez ME, Seller Perez G, et al. Risk factors for renal dysfunction in the postoperative course of liver transplant. Liver Transpl. 2004;10(11):1379&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">15497160</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SK, Park JB, Kim SJ, et al. Early postoperative renal dysfunction in the adult living donor liver transplantation. Transplant Proc. 2007;39(5):1517&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">17580177</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Singhapricha T, Hu KQ, et al. Postliver transplant acute renal injury and failure by the RIFLE criteria in patients with normal pretransplant serum creatinine concentrations: A matched study. Transplantation. 2011;91(3):348&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">21127462</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilmi IA, Damian D, Al-Khafaji A, et al. Acute kidney injury following orthotopic liver transplantation: Incidence, risk factors, and effects on patient and graft outcomes. Br J Anaesth. 2015;114(6):919&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">25673576</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JY, Park JH, Lee SS, et al. The association of preoperative body mass index with acute kidney injury in liver transplantation recipients: A retrospective study. Korean J Crit Care Med. 2017;32(3):265&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6786735</ArticleId><ArticleId IdType="pubmed">31723645</ArticleId></ArticleIdList></Reference><Reference><Citation>Iglesias JI, DePalma JA, Levine JS. Risk factors for acute kidney injury following orthotopic liver transplantation: The impact of changes in renal function while patients await transplantation. BMC Nephrol. 2010;11:30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2991287</ArticleId><ArticleId IdType="pubmed">21059264</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonard J, Heimbach JK, Malinchoc M, et al. The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database. Am J Transplant. 2008;8(3):667&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">18294163</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong RJ, Cheung R, Perumpail RB, et al. Diabetes mellitus, and not obesity, is associated with lower survival following liver transplantation. Dig Dis Sci. 2015;60(4):1036&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">25596720</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalisvaart M, Schlegel A, Umbro I, et al. The AKI Prediction Score: A new prediction model for acute kidney injury after liver transplantation. HPB (Oxford) 2019;21(12):1707&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">31153834</ArticleId></ArticleIdList></Reference><Reference><Citation>Olthoff KM, Kulik L, Samstein B, et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl. 2010;16(8):943&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">20677285</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon KS, Chen CC, Thorat A, et al. Fibrinolysis after reperfusion of liver graft. Acta Anaesthesiol Taiwan. 2015;53(1):41&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">25649273</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39977357</PMID><DateCompleted><Year>2025</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1873-734X</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Feb</Month><Day>04</Day></PubDate></JournalIssue><Title>European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery</Title><ISOAbbreviation>Eur J Cardiothorac Surg</ISOAbbreviation></Journal><ArticleTitle>Intravenous amino acids for renal protection in patients receiving temporary mechanical circulatory support: a secondary subgroup analysis of the PROTECTION study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">ezaf035</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/ejcts/ezaf035</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">In cardiac surgery patients, acute kidney injury (AKI) frequently occurs in the setting of haemodynamic instability and treatment with temporary mechanical circulatory support (tMCS). Recent evidence suggests amino acids (AA) infusion may reduce AKI rate. However, the effect of AA infusion in patients requiring tMCS may be less effective.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a secondary analysis of the PROTECTION multicentre randomized controlled trial including all patients treated with tMCS. Patients undergoing elective cardiac surgery with cardiopulmonary bypass were randomized to receive 2&#x2009;g/kg ideal body weight/day of intravenous AA to a maximum of 100&#x2009;g/day or matching placebo from operating room admission until up to 3&#x2009;days, receipt of renal-replacement therapy, discharge from ICU or death. The primary outcome of the PROTECTION study was the rate of AKI, as in this secondary analysis. A total of 3511 patients were randomized in the study.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We studied 232 patients who received tMCS, 112 randomized to AA infusion and 120 to placebo. The median preoperative serum creatinine value was significantly higher among AA group patients (AA: 1.08, interquartile range 0.90-1.26; placebo: 0.98, interquartile range 0.85-1.15; P&#x2009;=&#x2009;0.02). The rate of AKI, however, was lower in patients randomized to AA (44.6% vs 60.8%; relative risk 0.73; 95% confidence interval (0.57-0.94); P&#x2009;=&#x2009;0.01; number needed to treat&#x2009;=&#x2009;6). We found no significant differences in secondary outcomes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Short-term AA infusion appears to reduce rate of AKI among patients requiring tMCS. Use of AA in this population at high-risk for renal failure appears justified.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION NUMBER" NlmCategory="BACKGROUND">ClinicalTrials.gov NCT03709264.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site&#x2014;for further information please contact journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Belletti</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3131-0565</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pisano</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scandroglio</LastName><ForeName>Anna Mara</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0003-0639-8227</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garofalo</LastName><ForeName>Eugenio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, Department of Medical and Surgical Sciences, Magna Gr&#xe6;cia University of Catanzaro, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calabr&#xf2;</LastName><ForeName>Maria Grazia</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrod</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Torino, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monaco</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-5186-1976</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brambillasca</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baiardo Redaelli</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meroi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Azienda Sanitaria Universitaria Friuli Centrale, Department of Emergency "Santa Maria Della Misericordia", University Hospital of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fominskiy</LastName><ForeName>Evgeny</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vignale</LastName><ForeName>Rosaria</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiovascular Anesthesia and ICU, San Carlo Hospital, Potenza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ajello</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venditto</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scquizzato</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-1394-8402</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porta</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Torino, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Losiggio</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><Identifier Source="ORCID">0009-0001-6181-7976</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suriano</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pontillo</LastName><ForeName>Domenico</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orso</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Azienda Sanitaria Universitaria Friuli Centrale, Department of Emergency "Santa Maria Della Misericordia", University Hospital of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomasi</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Pharmacy, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paternoster</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Health Science Anesthesia and ICU, School of Medicine, University of Basilicata, San Carlo Hospital, Potenza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lomivorotov</LastName><ForeName>Vladimir</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Penn State Milton S. Hershey Medical Center, Penn State College of Medicine, Hershey, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Longhini</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, Department of Medical and Surgical Sciences, Magna Gr&#xe6;cia University of Catanzaro, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-8594-5980</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zangrillo</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7687-7648</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maisano</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiac Surgery Department, San Raffaele University Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-1650-8939</Identifier><AffiliationInfo><Affiliation>Department of Critical Care, The University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Data Analytics Research and Evaluation Centre, Austin Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Royal Melbourne Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pieri</LastName><ForeName>Marina</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4101-800X</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>PROTECTION Study Group Collaborators
</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03709264</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>RF-2016-02363260</GrantID><Agency>Italian Ministry of Health</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Cardiothorac Surg</MedlineTA><NlmUniqueID>8804069</NlmUniqueID><ISSNLinking>1010-7940</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000596">Amino Acids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000596" MajorTopicYN="Y">Amino Acids</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="Y">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007262" MajorTopicYN="N">Infusions, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute heart failure</Keyword><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Cardiogenic shock</Keyword><Keyword MajorTopicYN="N">Extracorporeal membrane oxygenation</Keyword><Keyword MajorTopicYN="N">Micro-axial flow pump</Keyword><Keyword MajorTopicYN="N">Renal-replacement therapy</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>D'Amico</LastName><ForeName>Filippo</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Manazza</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marmiere</LastName><ForeName>Marilena</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marzaroli</LastName><ForeName>Matteo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Monti</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oliva</LastName><ForeName>Federico Mattia</ForeName><Initials>FM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pruna</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Turi</LastName><ForeName>Stefano</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Veneziano</LastName><ForeName>Marta</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vietri</LastName><ForeName>Simone</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zaraca</LastName><ForeName>Luisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fraja</LastName><ForeName>Diana Di</ForeName><Initials>DD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Verniero</LastName><ForeName>Luigi</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bruni</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perrelli</LastName><ForeName>Giulia</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Prezzi</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Massaro</LastName><ForeName>Cristiano</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferrante</LastName><ForeName>Palma</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arangino</LastName><ForeName>Cristina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Angelini</LastName><ForeName>Filippo</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bacchetti</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vitielli</LastName><ForeName>Michelangelo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gallicchio</LastName><ForeName>Francesca</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bradic</LastName><ForeName>Nikola</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ti</LastName><ForeName>Lian Kah</ForeName><Initials>LK</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>24</Day><Hour>23</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>20</Day><Hour>18</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>20</Day><Hour>13</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39977357</ArticleId><ArticleId IdType="doi">10.1093/ejcts/ezaf035</ArticleId><ArticleId IdType="pii">8026694</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37588172</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2772-6096</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>BJA open</Title><ISOAbbreviation>BJA Open</ISOAbbreviation></Journal><ArticleTitle>Incidence of acute kidney injury after noncardiac surgery in patients receiving intraoperative dexmedetomidine: a retrospective study.</ArticleTitle><Pagination><StartPage>100136</StartPage><MedlinePgn>100136</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100136</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bjao.2023.100136</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Postoperative acute kidney injury (AKI) is a common complication and is associated with increased hospital length of stay and 30 day all-cause mortality. Unfortunately, we have neither a defined strategy to prevent AKI nor an effective treatment. <i>In&#xa0;vitro</i>, animal, and human studies have suggested that dexmedetomidine may have a renoprotective effect. We conducted a retrospective cohort study to evaluate if intraoperative dexmedetomidine was associated with a reduced incidence of AKI.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We collected data from 6625 patients who underwent major non-cardiothoracic cancer surgery. Before and after propensity score matching, we compared the incidence of postoperative AKI in patients who received intraoperative dexmedetomidine and those who did not. AKI was defined according to the Kidney Disease Improving Global Outcomes (creatinine alone values) criteria and calculated for postoperative Days 1, 2, and 3.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Twenty per cent (<i>n</i>=1301) of the patients received dexmedetomidine. The mean [standard deviation] administered dose was 78 [49.4] mcg. Patients treated with dexmedetomidine were matched to those who did not receive the drug. Patients receiving dexmedetomidine had a longer anaesthesia duration than the non-dexmedetomidine group. The incidence of AKI was not significantly different between the groups (dexmedetomidine 8% <i>vs</i> no dexmedetomidine 7%; <i>P</i>=0.333). The 30 day rates of infection, cardiovascular complications, or reoperation attributable to bleeding were higher in patients treated with dexmedetomidine. The 30 day mortality rate was not statistically different between the groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The administration of dexmedetomidine during major non-cardiothoracic cancer surgery is not associated with a reduction in AKI within 72 h after surgery.</AbstractText><CopyrightInformation>&#xa9; 2023 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Paredes-Flores</LastName><ForeName>Manuel A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Advocate Christ Medical Center Internal Medicine Residency, Oak Lawn, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lasala</LastName><ForeName>Javier D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Surgical Oncology Research Group, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moon</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhavsar</LastName><ForeName>Shreyas</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hagan</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huepenbecker</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Gynecology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carram</LastName><ForeName>Nicolas P</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>Anesthesiology and Surgical Oncology Research Group, Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia, Hospital General de Agudos 'Teodoro Alvarez', Ciudad Aut&#xf3;noma de Buenos Aires, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramirez</LastName><ForeName>Maria F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Surgical Oncology Research Group, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maheswari</LastName><ForeName>Kamal</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of General Anesthesia and Outcomes Research, Anesthesia Institute, Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cata</LastName><ForeName>Juan P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Surgical Oncology Research Group, Houston, TX, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BJA Open</MedlineTA><NlmUniqueID>9918419157906676</NlmUniqueID><ISSNLinking>2772-6096</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">dexmedetomidine</Keyword><Keyword MajorTopicYN="N">intraoperative dexmedetomidine</Keyword><Keyword MajorTopicYN="N">oncologic surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>17</Day><Hour>4</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37588172</ArticleId><ArticleId IdType="pmc">PMC10430864</ArticleId><ArticleId IdType="doi">10.1016/j.bjao.2023.100136</ArticleId><ArticleId IdType="pii">S2772-6096(23)00015-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Steiner C.A., Karaca Z., Moore B.J., Imshaug M.C., Pickens G. Agency for Healthcare Research and Quality; Rockville, MD: 2006. Surgeries in hospital-based ambulatory surgery and hospital inpatient settings, 2014: statistical brief #223. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs.</Citation><ArticleIdList><ArticleId IdType="pubmed">28722845</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiser T.G., Regenbogen S.E., Thompson K.D., et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet. 2008;372:139&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pubmed">18582931</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu C., Fong N., Lazzareschi D., et al. Fluids, vasopressors, and acute kidney injury after major abdominal surgery between 2015 and 2019: a multicentre retrospective analysis. Br J Anaesth. 2022;129:317&#x2013;326.</Citation><ArticleIdList><ArticleId IdType="pubmed">35688657</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanner P.M., Wulff D.U., Djurdjevic M., Korte W., Schnider T.W., Filipovic M. Targeting higher intraoperative blood pressures does not reduce adverse cardiovascular events following noncardiac surgery. J&#xa0;Am Coll Cardiol. 2021;78:1753&#x2013;1764.</Citation><ArticleIdList><ArticleId IdType="pubmed">34711333</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis M.R., Naik B.I., Freundlich R.E., et al. Preoperative risk and the association between hypotension and postoperative acute kidney injury. Anesthesiol. 2020;132:461&#x2013;475.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7015776</ArticleId><ArticleId IdType="pubmed">31794513</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S., Tremper K.K., Heung M., et al. Development and validation of an acute kidney injury risk index for patients undergoing general surgery. Anesthesiol. 2009;110:505&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pubmed">19212261</ArticleId></ArticleIdList></Reference><Reference><Citation>Romagnoli S., Ricci Z. Postoperative acute kidney injury. Minerva Anestesiol. 2015;81:684&#x2013;696.</Citation><ArticleIdList><ArticleId IdType="pubmed">25057935</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M., Schmidt C., Zarbock A. Perioperative acute kidney injury: an under-recognized problem. Anesth Analg. 2017;125:1223&#x2013;1232.</Citation><ArticleIdList><ArticleId IdType="pubmed">28787339</ArticleId></ArticleIdList></Reference><Reference><Citation>Romagnoli S., Ricci Z., Ronco C. Perioperative acute kidney injury: prevention, early recognition, and supportive measures. Nephron. 2018;140:105&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pubmed">29945154</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson C., Ozrazgat-Baslanti T., Kuxhausen A., et al. Cost and mortality associated with postoperative acute kidney injury. Ann Surg. 2015;261:1207&#x2013;1214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4247993</ArticleId><ArticleId IdType="pubmed">24887982</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J., Sun P., Zhao H., et al. Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Crit Care. 2011;15:R153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3219027</ArticleId><ArticleId IdType="pubmed">21702944</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh M., Devereaux P.J., Garg A.X., et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiol. 2013;119:507&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pubmed">23835589</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmasi V., Maheshwari K., Yang D., et al. Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery. Anesthesiol. 2017;126:47&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">27792044</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S. Dexmedetomidine: present and future directions. Kor J Anesthesiol. 2019;72:323&#x2013;330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6676029</ArticleId><ArticleId IdType="pubmed">31220910</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan F., Chen Y., Yuan D., Gong C., Li X., Zhou S. Dexmedetomidine protects against acute kidney injury through downregulating inflammatory reactions in endotoxemia rats. Biomed Rep. 2015;3:365&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4467244</ArticleId><ArticleId IdType="pubmed">26137237</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniguchi T., Kurita A., Kobayashi K., Yamamoto K., Inaba H. Dose- and time-related effects of dexmedetomidine on mortality and inflammatory responses to endotoxin-induced shock in rats. J&#xa0;Anesth. 2008;22:221&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pubmed">18685927</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong X., Xing Q., Li Y., Han X., Sun L. Dexmedetomidine protects against ischemia&#x2013;reperfusion injury in rat skeletal muscle. J&#xa0;Surg Res. 2014;186:240&#x2013;245.</Citation><ArticleIdList><ArticleId IdType="pubmed">24007817</ArticleId></ArticleIdList></Reference><Reference><Citation>Basile D.P., Anderson M.D., Sutton T.A. Pathophysiology of acute kidney injury. Compr Physiol. 2012;2:1303&#x2013;1353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3919808</ArticleId><ArticleId IdType="pubmed">23798302</ArticleId></ArticleIdList></Reference><Reference><Citation>Klune J.R., Dhupar R., Cardinal J., Billiar T.R., Tsung A. HMGB1: endogenous danger signaling. Mol Med. 2008;14:476&#x2013;484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2323334</ArticleId><ArticleId IdType="pubmed">18431461</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings F.T., Chen S.W., Kim M., et al. &#x3b1;2-Adrenergic agonists protect against radiocontrast-induced nephropathy in mice. Am J Physiol Ren Physiol. 2008;295:F741&#x2013;F748.</Citation><ArticleIdList><ArticleId IdType="pubmed">18579700</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsing C.H., Lin C.F., So E., et al. &#x3b1;2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5. Am J Physiol Ren Physiol. 2012;303:F1443&#x2013;F1453.</Citation><ArticleIdList><ArticleId IdType="pubmed">22933299</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavon H., Matzner P., Benbenishty A., et al. Dexmedetomidine promotes metastasis in rodent models of breast, lung, and colon cancers. Br J Anaesth. 2018;120:188&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6246773</ArticleId><ArticleId IdType="pubmed">29397129</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Datoo T., Zhao H., et al. Midazolam and dexmedetomidine affect neuroglioma and lung carcinoma cell biology in&#xa0;vitro and in&#xa0;vivo. Anesthesiol. 2018;129:1000&#x2013;1014.</Citation><ArticleIdList><ArticleId IdType="pubmed">30157038</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho J.S., Shim J.K., Soh S., Kim M.K., Kwak Y.L. Perioperative dexmedetomidine reduces the incidence and severity of acute kidney injury following valvular heart surgery. Kidney Int. 2016;89:693&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pubmed">26444030</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski D.M., Axelrod D.M., Sutherland S.M., Tesoro T.M., Krawczeski C.D. Dexmedetomidine is associated with lower incidence of acute kidney injury after congenital heart surgery. Pediatr Crit Care Med. 2016;17:128&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pubmed">26673841</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji F., Li Z., Nguyen H., et al. Perioperative dexmedetomidine improves outcomes of cardiac surgery. Circulation. 2013;127:1576&#x2013;1584.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3979354</ArticleId><ArticleId IdType="pubmed">23513068</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji F., Li Z., Young J.N., Yeranossian A., Liu H. Post-bypass dexmedetomidine use and postoperative acute kidney injury in patients undergoing cardiac surgery with cardiopulmonary bypass. PLoS One. 2013;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3795046</ArticleId><ArticleId IdType="pubmed">24130886</ArticleId></ArticleIdList></Reference><Reference><Citation>Loomba R.S., Villarreal E.G., Dhargalkar J., et al. The effect of dexmedetomidine on renal function after surgery: a systematic review and meta-analysis. J&#xa0;Clin Pharm Ther. 2022;47:287&#x2013;297.</Citation><ArticleIdList><ArticleId IdType="pubmed">34510502</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng K., Li D., Applegate R.L., 2nd, Lubarsky D.A., Ji F.H., Liu H. Effect of dexmedetomidine on cardiac surgery-associated acute kidney injury: a meta-analysis with trial sequential analysis of randomized controlled trials. J&#xa0;Cardiothorac Vasc Anesth. 2020;34:603&#x2013;613.</Citation><ArticleIdList><ArticleId IdType="pubmed">31587928</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega-Loubon C., Fern&#xe1;ndez-Molina M., Carrascal-Hinojal Y., Fulquet-Carreras E. Cardiac surgery-associated acute kidney injury. Ann Card Anaesth. 2016;19:687&#x2013;698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070330</ArticleId><ArticleId IdType="pubmed">27716701</ArticleId></ArticleIdList></Reference><Reference><Citation>Huepenbecker S.P., Iniesta M.D., Zorrilla-Vaca A., et al. Incidence of acute kidney injury after open gynecologic surgery in an enhanced recovery after surgery pathway. Gynecol Oncol. 2021;163:191&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8824770</ArticleId><ArticleId IdType="pubmed">34400005</ArticleId></ArticleIdList></Reference><Reference><Citation>Karol M.D., Maze M. Pharmacokinetics and interaction pharmacodynamics of dexmedetomidine in humans. Best Pract Res Clin Anaesth. 2000;14:261&#x2013;269.</Citation></Reference><Reference><Citation>Lankadeva Y.R., May C.N., Bellomo R., Evans R.G. Role of perioperative hypotension in postoperative acute kidney injury: a narrative review. Br J Anaesth. 2022;128:931&#x2013;948.</Citation><ArticleIdList><ArticleId IdType="pubmed">35465952</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon T., Tsai J.Y., Vachhani S., et al. The use of intraoperative dexmedetomidine is not associated with a reduction in acute kidney injury after lung cancer surgery. J&#xa0;Cardiothorac Vasc Anesth. 2016;30:51&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">26260907</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S., Yao H., Cheng N., et al. Determining whether dexmedetomidine provides a reno-protective effect in patients receiving laparoscopic radical prostatectomy: a pilot study. Int Urol Nephrol. 2019;51:1553&#x2013;1561.</Citation><ArticleIdList><ArticleId IdType="pubmed">31187424</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Liu M., Yang Y., Cao J., Mi W. Dexmedetomidine exerts a protective effect on ischemia-reperfusion injury after hepatectomy: a prospective, randomized, controlled study. J&#xa0;Clin Anesth. 2020;61</Citation><ArticleIdList><ArticleId IdType="pubmed">31669050</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F., Duan H., Xie Y. Preventive effects of dexmedetomidine on renal dysfunction and hemodynamic stability in malignant obstructive jaundice patients during peri-operative period. Med Sci Monit. 2019;25:6782&#x2013;6787.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6752108</ArticleId><ArticleId IdType="pubmed">31498783</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y., Kim D.-H., Kwon T.D., et al. Effect of intraoperative dexmedetomidine on renal function after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a randomized, placebo-controlled trial. Int J Hyperther. 2018;36:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">30354794</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarani B., Dunkman W.J., Dean, et al. Transfusion of fresh frozen plasma in critically ill surgical patients is associated with an increased risk of infection. Crit Care Med. 2008;36:1114&#x2013;1118.</Citation><ArticleIdList><ArticleId IdType="pubmed">18379235</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellenberger C., Schorer R., Diaper J., et al. Myocardial injury after major noncardiac surgery: a secondary analysis of a randomized controlled trial. Surgery. 2022;171:1626&#x2013;1634.</Citation><ArticleIdList><ArticleId IdType="pubmed">34809970</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum J.A. Persistent acute kidney injury. Crit Care Med. 2015;43:1785&#x2013;1786.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4507291</ArticleId><ArticleId IdType="pubmed">26181122</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31166234</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>07</Day></DateCompleted><DateRevised><Year>2020</Year><Month>05</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>130</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Association of Intraoperative Tidal Volumes and Acute Kidney Injury After Noncardiac Surgery.</ArticleTitle><Pagination><StartPage>925</StartPage><EndPage>932</EndPage><MedlinePgn>925-932</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000004254</ELocationID><Abstract><AbstractText Label="BACKGROUND">Patients with acute lung injury who received lower tidal volume (VT) ventilation had significantly fewer days with acute kidney injury (AKI) when compared to those receiving higher VTs. There is a paucity of studies on the relationship between intraoperative VTs and postoperative AKI in patients undergoing noncardiac surgery. We therefore sought to assess the association of mean delivered intraoperative VT per kilogram based on predicted body weight (PBW) and postoperative AKI.</AbstractText><AbstractText Label="METHODS">This retrospective cohort study was conducted in a large tertiary multispecialty academic medical center. Adult patients who underwent noncardiac surgery between January 2005 and July 2016 under general anesthesia with endotracheal intubation and mechanical ventilation were included. A total of 41,224 patients were included in the study.The relationship between mean intraoperative VT per PBW and AKI was assessed using logistic regression, adjusting for prespecified potential confounding variables. The secondary outcomes were postoperative major pulmonary complications, myocardial injury after noncardiac surgery (MINS), and in-hospital mortality.</AbstractText><AbstractText Label="RESULTS">The incidence of AKI was 10.9% in the study population. Postoperative renal replacement therapy was required in 0.1% of patients. Higher delivered mean intraoperative VT per PBW was significantly associated with increased odds of AKI. The estimated odds ratio for each 1 mL increase in VT per kilogram of PBW (1 unit) was 1.05 (95% confidence interval [CI], 1.02-1.08; P = .001), after adjusting for potential confounding variables. A higher delivered mean intraoperative VT per PBW was significantly associated with increased odds of postoperative myocardial injury and was not significantly associated with major postoperative pulmonary complications or in-hospital mortality after noncardiac surgery.</AbstractText><AbstractText Label="CONCLUSIONS">In adult patients undergoing noncardiac surgery, higher delivered mean intraoperative VTs per PBW are associated with an increased odds of developing AKI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Argalious</LastName><ForeName>Maged Y</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>From the Department of General Anesthesiology and the Center for Anesthesiology Education, Anesthesiology Institute, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Guangmei</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Davison</LastName><ForeName>Rajeev Krishnaney</ForeName><Initials>RK</Initials></Author><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Courtney</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Bhavani</LastName><ForeName>Sekar</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006335" MajorTopicYN="N">Heart Injuries</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007432" MajorTopicYN="Y">Intraoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="Y">Tidal Volume</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31166234</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000004254</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26386737</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1523-6838</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><Issue>6</Issue><PubDate><Year>2015</Year><Month>Dec</Month></PubDate></JournalIssue><Title>American journal of kidney diseases : the official journal of the National Kidney Foundation</Title><ISOAbbreviation>Am J Kidney Dis</ISOAbbreviation></Journal><ArticleTitle>Urine Biomarkers and Perioperative Acute Kidney Injury: The&#xa0;Impact of Preoperative Estimated GFR.</ArticleTitle><Pagination><StartPage>1006</StartPage><EndPage>1014</EndPage><MedlinePgn>1006-14</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.ajkd.2015.07.027</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0272-6386(15)01063-X</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The interaction between baseline kidney function and the performance of biomarkers of acute kidney injury (AKI) on the development of AKI is unclear.</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Post hoc analysis of prospective cohort study.</AbstractText><AbstractText Label="SETTING &amp; PARTICIPANTS" NlmCategory="METHODS">The 1,219 TRIBE-AKI Consortium adult cardiac surgery cohort participants.</AbstractText><AbstractText Label="PREDICTOR" NlmCategory="METHODS">Unadjusted postoperative urinary biomarkers of AKI measured within 6 hours of surgery.</AbstractText><AbstractText Label="OUTCOME" NlmCategory="RESULTS">AKI was defined as AKI Network stage 1 (any AKI) or higher, as well as a doubling of serum creatinine level from the preoperative value or the need for post-operative dialysis (severe AKI).</AbstractText><AbstractText Label="MEASUREMENTS" NlmCategory="METHODS">Stratified analyses by preoperative estimated glomerular filtration rate (eGFR)&#xa0;&#x2264; 60 versus &gt; 60mL/min/1.73m(2).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">180 (42%) patients with preoperative eGFRs&#x2264;60mL/min/1.73m(2) developed clinical AKI compared with 246 (31%) of those with eGFRs&gt;60mL/min/1.73m(2) (P&lt;0.001). For log2-transformed biomarker concentrations, there was a significant interaction between any AKI and baseline eGFR for interleukin 18 (P=0.007) and borderline significance for liver-type fatty acid binding protein (P=0.06). For all biomarkers, the adjusted relative risk (RR) point estimates for the risk for any AKI were higher in those with elevated baseline eGFRs compared with those with eGFRs&#x2264;60mL/min/1.73m(2). However, the difference in magnitude of these risks was low (adjusted RRs were 1.04 [95% CI, 0.99-1.09] and 1.11 [95% CI, 1.07-1.15] for those with preoperative eGFRs&#x2264;60mL/min/1.73m(2) and those with higher eGFRs, respectively). Although no biomarker displayed an interaction for baseline eGFR and severe AKI, log2-transformed interleukin 18 and kidney injury molecule 1 had significant adjusted RRs for severe AKI in those with and without baseline eGFRs&#x2264;60mL/min/1.73m(2).</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Limited numbers of patients with severe AKI and post-operative dialysis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The association between early postoperative AKI urinary biomarkers and AKI is modified by preoperative eGFR. The degree of this modification and its impact on the biomarker-AKI association is small across biomarkers. Our findings suggest that distinct biomarker cutoffs for those with and without a preoperative eGFR&#x2264;60mL/min/1.73m(2) is not necessary.</AbstractText><CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Koyner</LastName><ForeName>Jay L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Section of Nephrology, Department of Medicine, University of Chicago, Pritzker School of Medicine, Chicago, IL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coca</LastName><ForeName>Steven G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Clinical Epidemiology Research Center, Yale University School of Medicine, New Haven, CT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thiessen-Philbrook</LastName><ForeName>Heather</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, University of Western Ontario, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Uptal D</ForeName><Initials>UD</Initials><AffiliationInfo><Affiliation>Duke University, School of Medicine, Durham, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shlipak</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, San Francisco VA Medical Center, University of California, San Francisco, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garg</LastName><ForeName>Amit X</ForeName><Initials>AX</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, University of Western Ontario, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parikh</LastName><ForeName>Chirag R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Clinical Epidemiology Research Center, Yale University School of Medicine, New Haven, CT. Electronic address: chirag.parikh@yale.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Translational Research Investigating Biomarker Endpoints for Acute Kidney Injury (TRIBE-AKI) Consortium</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Translational Research Investigating Biomarker Endpoints for Acute Kidney Injury TRIBE-AKI Consortium</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL085757</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23DK081616</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24DK090203</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK079310</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 DK080132</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01HL085757</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 DK081616</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23DK080132</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DK082185</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24 DK090203</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000430</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01DK082185</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>09</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Kidney Dis</MedlineTA><NlmUniqueID>8110075</NlmUniqueID><ISSNLinking>0272-6386</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D055316">Cystatin C</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000652" MajorTopicYN="Y">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055316" MajorTopicYN="N">Cystatin C</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="Y">Glomerular Filtration Rate</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000652" MajorTopicYN="Y">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Urine biomarkers</Keyword><Keyword MajorTopicYN="N">acute kidney injury (AKI)</Keyword><Keyword MajorTopicYN="N">acute renal failure (ARF)</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">effect modification</Keyword><Keyword MajorTopicYN="N">estimated glomerular filtration rate (eGFR)</Keyword><Keyword MajorTopicYN="N">interleukin 18 (IL-18)</Keyword><Keyword MajorTopicYN="N">liver-type fatty acid binding protein (L-FABP)</Keyword><Keyword MajorTopicYN="N">perioperative AKI</Keyword><Keyword MajorTopicYN="N">prognosis</Keyword><Keyword MajorTopicYN="N">surgical complication</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Raman</LastName><ForeName>Jai</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jeevanandam</LastName><ForeName>Valluvan</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Akhter</LastName><ForeName>Shahab</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Devarajan</LastName><ForeName>Prasad</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bennett</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ma</LastName><ForeName>Qing</ForeName><Initials>Q</Initials></Investigator><Investigator ValidYN="Y"><LastName>Griffiths</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Edelstein</LastName><ForeName>Charles</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Passik</LastName><ForeName>Cary</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nagy</LastName><ForeName>Judy</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Swaminathan</LastName><ForeName>Madhav</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chu</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goldbach</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guo</LastName><ForeName>Lin Ruo</ForeName><Initials>LR</Initials></Investigator><Investigator ValidYN="Y"><LastName>McKenzie</LastName><ForeName>Neil</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Myers</LastName><ForeName>Mary Lee</ForeName><Initials>ML</Initials></Investigator><Investigator ValidYN="Y"><LastName>Novick</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quantz</LastName><ForeName>Mac</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schumann</LastName><ForeName>Virginia</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Webster</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zappitelli</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Palijan</LastName><ForeName>Ana</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dewar</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Darr</LastName><ForeName>Umer</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hashim</LastName><ForeName>Sabet</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Elefteriades</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Geirsson</LastName><ForeName>Arnar</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garwood</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kemp</LastName><ForeName>Rowena</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Butrymowicz</LastName><ForeName>Isabel</ForeName><Initials>I</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26386737</ArticleId><ArticleId IdType="mid">NIHMS717511</ArticleId><ArticleId IdType="pmc">PMC4658239</ArticleId><ArticleId IdType="doi">10.1053/j.ajkd.2015.07.027</ArticleId><ArticleId IdType="pii">S0272-6386(15)01063-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Koyner JL, Cerda J, Goldstein SL, et al. The Daily Burden of Acute Kidney Injury: A World Kidney Day Survey of U.S. Nephrologists. Journal of the American Society of Nephrology. 2013;24:3A. Oral Abstract Presented at ASN Renal Week - Thursdayvember 7, 2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">24815216</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyner JL, Parikh CR. Clinical Utility of Biomarkers of AKI in Cardiac Surgery and Critical Illness. Clin J Am Soc Nephrol. 2013;8(6):1034&#x2013;1042.</Citation><ArticleIdList><ArticleId IdType="pubmed">23471130</ArticleId></ArticleIdList></Reference><Reference><Citation>Bihorac A, Chawla LS, Shaw AD, et al. Validation of Cell-Cycle Arrest Biomarkers for Acute Kidney Injury Using Clinical Adjudication. Am J Respir Crit Care Med. 2014;189(8):932&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24559465</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashani K, Al-Khafaji A, Ardiles T, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013;17(1):R25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057242</ArticleId><ArticleId IdType="pubmed">23388612</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyner JL, Garg AX, Coca SG, et al. Biomarkers Predict Progression of Acute Kidney Injury after Cardiac Surgery. J Am Soc Nephrol. 2012;23(5):905&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3338298</ArticleId><ArticleId IdType="pubmed">22383693</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh CR, Coca SG, Thiessen-Philbrook H, et al. Postoperative Biomarkers Predict Acute Kidney Injury and Poor Outcomes after Adult Cardiac Surgery. J Am Soc Nephrol. 2011;22(9):1748&#x2013;1757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3171945</ArticleId><ArticleId IdType="pubmed">21836143</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. Jama. 2005;294(7):813&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pubmed">16106006</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakar CV, Christianson A, Freyberg R, Almenoff P, Render ML. Incidence and outcomes of acute kidney injury in intensive care units: a Veterans Administration study. Crit Care Med. 2009;37(9):2552&#x2013;2558.</Citation><ArticleIdList><ArticleId IdType="pubmed">19602973</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RH, Grab JD, O&#x2019;Brien SM, et al. Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation. 2006;114(21):2208&#x2013;2216. quiz 2208.</Citation><ArticleIdList><ArticleId IdType="pubmed">17088458</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakar C, Liangos O, Yared J-P, Nelson D, Hariachar S, Paganini E. Predicting acute renal failure after cardiac surgery: Validation and redefinition of a risk stratification alogorithm. Hemodial Int. 2003;7:143&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">19379354</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeysundera DN, Karkouti K, Dupuis JY, et al. Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. Jama. 2007;297(16):1801&#x2013;1809.</Citation><ArticleIdList><ArticleId IdType="pubmed">17456822</ArticleId></ArticleIdList></Reference><Reference><Citation>Malyszko J, Malyszko JS, Bachorzewska-Gajewska H, Poniatowski B, Dobrzycki S, Mysliwiec M. Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients. Transplant Proc. 2009;41(1):158&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pubmed">19249502</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolignano D, Lacquaniti A, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(2):337&#x2013;344.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2637601</ArticleId><ArticleId IdType="pubmed">19176795</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieplinger B, Mueller T, Kollerits B, et al. Pro-A-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD Study. Kidney Int. 2009;75(4):408&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="pubmed">19052536</ArticleId></ArticleIdList></Reference><Reference><Citation>Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 2002;62(1):237&#x2013;244.</Citation><ArticleIdList><ArticleId IdType="pubmed">12081583</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyner JL, Vaidya VS, Bennett MR, et al. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol. 2010;5(12):2154&#x2013;2165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2994075</ArticleId><ArticleId IdType="pubmed">20798258</ArticleId></ArticleIdList></Reference><Reference><Citation>McIlroy DR, Wagener G, Lee HT. Neutrophil Gelatinase-Associated Lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance. Clin J Am Soc Nephrol. 2010;5(2):211&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2827603</ArticleId><ArticleId IdType="pubmed">20056755</ArticleId></ArticleIdList></Reference><Reference><Citation>Endre ZH, Pickering JW, Walker RJ, et al. Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int. 2011;79(10):1119&#x2013;1130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3884688</ArticleId><ArticleId IdType="pubmed">21307838</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh CR, Devarajan P, Zappitelli M, et al. Postoperative Biomarkers Predict Acute Kidney Injury and Poor Outcomes after Pediatric Cardiac Surgery. J Am Soc Nephrol. 2011;22(9):1737&#x2013;1747.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3171944</ArticleId><ArticleId IdType="pubmed">21836147</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC522841</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2763564</ArticleId><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh CR, Thiessen-Philbrook H, Garg AX, et al. Performance of Kidney Injury Molecule-1 and Liver Fatty Acid-Binding Protein and Combined Biomarkers of AKI after Cardiac Surgery. Clin J Am Soc Nephrol. 2013;8(7):1079&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3700701</ArticleId><ArticleId IdType="pubmed">23599408</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyner JL, Garg AX, Shlipak MG, et al. Urinary cystatin C and acute kidney injury after cardiac surgery. Am J Kidney Dis. 2013;61(5):730&#x2013;738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3627833</ArticleId><ArticleId IdType="pubmed">23332602</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar AO, Parikh CR, Sint K, et al. Association of postoperative proteinuria with AKI after cardiac surgery among patients at high risk. Clin J Am Soc Nephrol. 2012;7(11):1749&#x2013;1760.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3488955</ArticleId><ArticleId IdType="pubmed">22977220</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou G. A modified poisson regression approach to prospective studies with binary data. American journal of epidemiology. 2004;159(7):702&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pubmed">15033648</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosch JP, Saccaggi A, Lauer A, Ronco C, Belledonne M, Glabman S. Renal functional reserve in humans. Effect of protein intake on glomerular filtration rate. Am J Med. 1983;75(6):943&#x2013;950.</Citation><ArticleIdList><ArticleId IdType="pubmed">6650549</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco C, Rosner MH. Acute kidney injury and residual renal function. Crit Care. 2012;16(4):144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3580707</ArticleId><ArticleId IdType="pubmed">22866976</ArticleId></ArticleIdList></Reference><Reference><Citation>Waikar SS, Betensky RA, Emerson SC, Bonventre JV. Imperfect gold standards for kidney injury biomarker evaluation. J Am Soc Nephrol. 2012;23(1):13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3695762</ArticleId><ArticleId IdType="pubmed">22021710</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37711553</PMID><DateRevised><Year>2023</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2297-055X</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in cardiovascular medicine</Title><ISOAbbreviation>Front Cardiovasc Med</ISOAbbreviation></Journal><ArticleTitle>Perioperative selenium administration in cardiac surgery patients, a way out to reduce post surgical adversities? A meta analysis.</ArticleTitle><Pagination><StartPage>1235247</StartPage><MedlinePgn>1235247</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1235247</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcvm.2023.1235247</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">The oxidative damage suffered in cardiac surgery is associated with declining trace elements which lead to the development of multi organ dysfunction (MOD), acute kidney injury (AKI), or increased length of hospital stay (LOS). Recent evidence shows the cardioprotective role of the trace element selenium as it mitigates worsening outcomes post cardiac surgery. Hence, this meta analysis aims to investigate the role of selenium in lowering cardiac surgery related adverse outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Literature search of five electronic databases was performed from the inception of the paper till 29th July, 2023. Eligibility criteria included; (a) randomized clinical trials with Adult patients (&#x2265;18 years) undergoing cardiac surgery (b) intervention with selenium pre or/and postoperatively; (c) a control group of a placebo, normal saline, or no selenium. Outcomes of interest include postoperative mortality, LOS in the hospital and Intensive Care Unit (ICU), AKI, troponin I, and Creatinine Kinase-MB (CK-MB). The Cochrane bias assessment tool was used to evaluate the risk of bias. Outcomes were pooled with the Mantel-Haenszel Random-effects model using Review Manager.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Seven RCTs with 2,521 patients and 65% of males were included in this paper. No noticable differences were observed between selenium and control groups in terms of postoperative AKI, mortality, LOS in hospital and ICU, troponin I, and CK-MB levels. All studies had a low risk of bias on quality assessment.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">Our meta analysis demonstrated no discernible effects of selenium infusion on post operative complications among patients undergoing cardiac surgery. Further large scale multi centered studies comparing the protective role of selenium with combined therapy of other bioactive agents are needed to provide convincing explanations.</AbstractText><AbstractText Label="SYSTEMATIC REVIEW REGISTRATION" NlmCategory="UNASSIGNED">PROSPERO Identifier: 424920.</AbstractText><CopyrightInformation>&#xa9; 2023 Rehan, Hussain, Imran, Eqbal and Asghar.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rehan</LastName><ForeName>Syeda Tayyaba</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussain</LastName><ForeName>Hassan Ul</ForeName><Initials>HU</Initials><AffiliationInfo><Affiliation>Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Imran</LastName><ForeName>Laiba</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eqbal</LastName><ForeName>Farea</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asghar</LastName><ForeName>Muhammad Sohaib</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Mayo Clinic-Rochester, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cardiovasc Med</MedlineTA><NlmUniqueID>101653388</NlmUniqueID><ISSNLinking>2297-055X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AKI</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">meta analysis</Keyword><Keyword MajorTopicYN="N">oxidative damage</Keyword><Keyword MajorTopicYN="N">selenium</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>15</Day><Hour>3</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37711553</ArticleId><ArticleId IdType="pmc">PMC10497979</ArticleId><ArticleId IdType="doi">10.3389/fcvm.2023.1235247</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chaney MA, Il C. Outcome after cardiac surgery: the devil is in the details. J Cardiothorac Vasc Anesth. (2022) 36(1):91&#x2013;2. 10.1053/j.jvca.2021.10.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2021.10.025</ArticleId><ArticleId IdType="pubmed">34794878</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutcheson R, Rocic P. The metabolic syndrome, oxidative stress, environment, and cardiovascular disease: the great exploration. Exp Diabetes Res. (2012) 2012:271028. 10.1155/2012/271028</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/271028</ArticleId><ArticleId IdType="pmc">PMC3399393</ArticleId><ArticleId IdType="pubmed">22829804</ArticleId></ArticleIdList></Reference><Reference><Citation>Vukicevic P, Klisic A, Neskovic V, Babic L, Mikic A, Bogavac-Stanojevic N, et al. Oxidative stress in patients before and after on-pump and off-pump coronary artery bypass grafting: relationship with syntax score. Oxid Med Cell Longev. (2021) 2021:3315951. 10.1155/2021/3315951</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/3315951</ArticleId><ArticleId IdType="pmc">PMC8352695</ArticleId><ArticleId IdType="pubmed">34381560</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakkar M, Guida G, Suleiman MS, Angelini GD. Cardiopulmonary bypass and oxidative stress. Oxid Med Cell Longev. (2015) 2015:189863. 10.1155/2015/189863</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/189863</ArticleId><ArticleId IdType="pmc">PMC4334937</ArticleId><ArticleId IdType="pubmed">25722792</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadifard N, Humphries KH, Gotay C, Mena-S&#xe1;nchez G, Salas-Salvad&#xf3; J, Esmaillzadeh A, et al. Trace minerals intake: risks and benefits for cardiovascular health. Crit Rev Food Sci Nutr. (2019) 59(8):1334&#x2013;46. 10.1080/10408398.2017.1406332</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2017.1406332</ArticleId><ArticleId IdType="pubmed">29236516</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoppe C, Sch&#xe4;lte G, Rossaint R, Coburn M, Graf B, Spillner J, et al. The intraoperative decrease of selenium is associated with the postoperative development of multiorgan dysfunction in cardiac surgical patients. Crit Care Med. (2011) 39(8):1879&#x2013;85. 10.1097/CCM.0b013e3182190d48</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3182190d48</ArticleId><ArticleId IdType="pubmed">21460705</ArticleId></ArticleIdList></Reference><Reference><Citation>Eslami G, Salehi R, Samaee H, Habibi V, Shokrzadeh M, Moradimajd P. Relationship between selenium trace and patient outcome after open-heart surgery. Anesth Pain Med. (2020) 10(4):e105895. 10.5812/aapm.105895</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/aapm.105895</ArticleId><ArticleId IdType="pmc">PMC7539050</ArticleId><ArticleId IdType="pubmed">33134151</ArticleId></ArticleIdList></Reference><Reference><Citation>Benstoem C, Goetzenich A, Kraemer S, Borosch S, Manzanares W, Hardy G, et al. Selenium and its supplementation in cardiovascular disease&#x2013;what do we know? Nutrients. (2015) 7(5):3094&#x2013;118. 10.3390/nu7053094</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu7053094</ArticleId><ArticleId IdType="pmc">PMC4446741</ArticleId><ArticleId IdType="pubmed">25923656</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins DJA, Kitts D, Giovannucci EL, Sahye-Pudaruth S, Paquette M, Blanco Mejia S, et al. Selenium, antioxidants, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. (2020) 112(6):1642&#x2013;52. 10.1093/ajcn/nqaa245</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/nqaa245</ArticleId><ArticleId IdType="pmc">PMC7727482</ArticleId><ArticleId IdType="pubmed">33053149</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoppe C, Spillner J, Rossaint R, Coburn M, Sch&#xe4;lte G, Wildenhues A, et al. Selenium blood concentrations in patients undergoing elective cardiac surgery and receiving perioperative sodium selenite. Nutrition. (2013) 29(1):158&#x2013;65. 10.1016/j.nut.2012.05.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2012.05.013</ArticleId><ArticleId IdType="pubmed">23010420</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang JF, Hsu CP, Ouyang CH, Cheng CT, Wang CC, Liao CH, et al. The impact of selenium supplementation on trauma patients-systematic review and meta-analysis. Nutrients. (2022) 14(2):342. 10.3390/nu14020342</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14020342</ArticleId><ArticleId IdType="pmc">PMC8780440</ArticleId><ArticleId IdType="pubmed">35057521</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill A, Clasen KC, Wendt S, Majoros &#xc1;G, Stoppe C, Adhikari NKJ, et al. Effects of vitamin C on organ function in cardiac surgery patients: a systematic review and meta-analysis. Nutrients. (2019) 11(9):2103. 10.3390/nu11092103</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11092103</ArticleId><ArticleId IdType="pmc">PMC6769534</ArticleId><ArticleId IdType="pubmed">31487905</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, Mulrow C, G&#xf8;tzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. (2009) 339:b2700. 10.1136/bmj.b2700</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2700</ArticleId><ArticleId IdType="pmc">PMC2714672</ArticleId><ArticleId IdType="pubmed">19622552</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, G&#xf8;tzsche PC, J&#xfc;ni P, Moher D, Oxman AD, et al. The cochrane collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ. (2011) 343:d5928. 10.1136/bmj.d5928</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. 
Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022). Chichester (UK): Cochrane;  (2022). Available at:
www.training.cochrane.org/handbook</Citation></Reference><Reference><Citation>Stoppe C, McDonald B, Meybohm P, Christopher KB, Fremes S, Whitlock R, et al. Effect of high-dose selenium on postoperative organ dysfunction and mortality in cardiac surgery patients: the SUSTAIN CSX randomized clinical trial. JAMA Surg. (2023) 37:1172&#x2013;80. 10.1001/jamasurg.2022.6855</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2022.6855</ArticleId><ArticleId IdType="pmc">PMC9857635</ArticleId><ArticleId IdType="pubmed">36630120</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt T, Pargger H, Seeberger E, Eckhart F, von Felten S, Haberth&#xfc;r C. Effect of high-dose sodium selenite in cardiac surgery patients: a randomized controlled bi-center trial. Clin Nutr. (2018) 37(4):1172&#x2013;80. 10.1016/j.clnu.2017.04.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2017.04.019</ArticleId><ArticleId IdType="pubmed">28502744</ArticleId></ArticleIdList></Reference><Reference><Citation>Amini S, Robabi HN, Tashnizi MA, Selenium VV. Vitamin C and N-acetylcysteine do not reduce the risk of acute kidney injury after off-pump CABG: a randomized clinical trial. Braz J Cardiovasc Surg. (2018) 33:129&#x2013;34. 10.21470/1678-9741-2017-0071</Citation><ArticleIdList><ArticleId IdType="doi">10.21470/1678-9741-2017-0071</ArticleId><ArticleId IdType="pmc">PMC5985838</ArticleId><ArticleId IdType="pubmed">29898141</ArticleId></ArticleIdList></Reference><Reference><Citation>Laaf E, Benstoem C, Rossaint R, Wendt S, Fitzner C, Moza A, et al. High-dose supplementation of selenium in left ventricular assist device implant surgery: a double-blinded, randomized controlled pilot trial. J Parenter Enteral Nutr. (2022) 46(6):1412&#x2013;9. 10.1002/jpen.2309</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jpen.2309</ArticleId><ArticleId IdType="pubmed">34859459</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeraati AA, Amini S, Samadi M, Mortazi H, Zeraati T, Samadi K. Evaluation of the preventive effect of selenium on acute kidney injury following on-pump cardiac surgery. Hypertension. (2021) 25(52):0&#x2013;99. 10.32592/ircmj.2021.23.9.377</Citation></Reference><Reference><Citation>Sedighinejad A, Imantalab V, Mirmansouri A, Mohammadzadeh JA, Nassiri SN, Naderi NB, et al. Effect of selenium on ischemia-reperfusion injury in the coronary artery bypass graft surgery: a clinical trial study. Iran. Red. Crescent. Med. J. (2019) 21 10.5812/ircmj.42562</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/ircmj.42562</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafa M, Azemati S, Abasi M, Hemati R. Effect of selenium added to the cardioplegic solution on cardiac protection in coronary artery bypass grafting surgeries: a randomized, double-blinded, clinical trial study. Iran Red Crescent Med J. (2019) 21(10). 10.5812/ircmj.92737</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/ircmj.92737</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirmansouri A, Imantalab V, Mohammadzadeh Jouryabi A, Kanani G, Naderi Nabi B, Farzi F, et al. Effect of selenium on stress response in coronary artery bypass graft surgery: a clinical trial. Anesth Pain Med. (2017) 7(1):e43864. 10.5812/aapm.43864</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/aapm.43864</ArticleId><ArticleId IdType="pmc">PMC5554419</ArticleId><ArticleId IdType="pubmed">28920049</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy G, Hardy I, Manzanares W. Selenium supplementation in the critically ill. Nutr Clin Pract. (2012) 27(1):21&#x2013;33. 10.1177/0884533611434116</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0884533611434116</ArticleId><ArticleId IdType="pubmed">22307489</ArticleId></ArticleIdList></Reference><Reference><Citation>Bleys J, Navas-Acien A, Guallar E. Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults. Arch Intern Med. (2008) 168(4):404&#x2013;10. 10.1001/archinternmed.2007.74</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2007.74</ArticleId><ArticleId IdType="pubmed">18299496</ArticleId></ArticleIdList></Reference><Reference><Citation>Angstwurm MW, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, et al. Selenium in intensive care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med. (2007) 35(1):118&#x2013;26. 10.1097/01.CCM.0000251124.83436.0E</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000251124.83436.0E</ArticleId><ArticleId IdType="pubmed">17095947</ArticleId></ArticleIdList></Reference><Reference><Citation>Leong JY, van der Merwe J, Pepe S, Bailey M, Perkins A, Lymbury R, et al. Perioperative metabolic therapy improves redox status and outcomes in cardiac surgery patients: a randomised trial. Heart Lung Circ. (2010) 19(10):584&#x2013;91. 10.1016/j.hlc.2010.06.659</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2010.06.659</ArticleId><ArticleId IdType="pubmed">20674497</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayman MP. The importance of selenium to human health. Lancet. (2000) 356(9225):233&#x2013;41. 10.1016/S0140-6736(00)02490-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(00)02490-9</ArticleId><ArticleId IdType="pubmed">10963212</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevanovic A, Coburn M, Menon A, Rossaint R, Heyland D, Sch&#xe4;lte G, et al. The importance of intraoperative selenium blood levels on organ dysfunction in patients undergoing off-pump cardiac surgery: a randomised controlled trial. PLoS One. (2014) 9(8):e104222. 10.1371/journal.pone.0104222</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0104222</ArticleId><ArticleId IdType="pmc">PMC4132095</ArticleId><ArticleId IdType="pubmed">25118980</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedighinejad A, Imantalab V, Mirmansouri A, Mohammadzadeh Jouryabi A, Kanani G, Nassiri Sheikhani N, et al. Effects of low-dose selenium on the inflammatory response in coronary artery bypass graft surgery: a clinical trial. Iran Red Crescent Med J. (2016) 18(8):e37918. 10.5812/ircmj.37918</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/ircmj.37918</ArticleId><ArticleId IdType="pmc">PMC5070486</ArticleId><ArticleId IdType="pubmed">27795837</ArticleId></ArticleIdList></Reference><Reference><Citation>Koszta G, Kacska Z, Szatm&#xe1;ri K, Szerafin T, F&#xfc;lesdi B. Lower whole blood selenium level is associated with higher operative risk and mortality following cardiac surgery. J Anesth. (2012) 26(6):812&#x2013;21. 10.1007/s00540-012-1454-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-012-1454-y</ArticleId><ArticleId IdType="pubmed">22847607</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang SS, Al Kharusi L, Gosselin A, Chirico A, Baradari PG, Cameron MJ. Iron supplementation for patients undergoing cardiac surgery: a systematic review and meta-analysis of randomized controlled trials. Can J Anaesth. (2022) 69(1):129&#x2013;39. 10.1007/s12630-021-02113-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-021-02113-z</ArticleId><ArticleId IdType="pubmed">34559371</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S, Panchal P, Gilotra K, Wilfred AM, Hou W, Siegal D, et al. Intravenous iron therapy for patients with preoperative iron deficiency or anaemia undergoing cardiac surgery reduces blood transfusions: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg. (2020) 31(2):141&#x2013;51. 10.1093/icvts/ivaa094</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivaa094</ArticleId><ArticleId IdType="pubmed">32642775</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L, Yang X, Zhang S, Zhou X. Iron metabolism-related indicators as predictors of the incidence of acute kidney injury after cardiac surgery: a meta-analysis. Ren Fail. (2023) 45(1):2201362. 10.1080/0886022X.2023.2201362</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/0886022X.2023.2201362</ArticleId><ArticleId IdType="pmc">PMC10120464</ArticleId><ArticleId IdType="pubmed">37073631</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger MM, Soguel L, Shenkin A, Revelly JP, Pinget C, Baines M, et al. Influence of early antioxidant supplements on clinical evolution and organ function in critically ill cardiac surgery, major trauma, and subarachnoid hemorrhage patients. Crit Care. (2008) 12(4):R101. 10.1186/cc6981</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc6981</ArticleId><ArticleId IdType="pmc">PMC2575590</ArticleId><ArticleId IdType="pubmed">18687132</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SH, Kwon SW, Lee Y, Nam SH. Fast and simple selenium speciation by solid phase extraction and laser-induced breakdown spectroscopy. J Anal Sci Technol. (2020) 11(1):1&#x2013;8. 10.1186/s40543-019-0200-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40543-019-0200-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehdi Y, Hornick JL, Istasse L, Dufrasne I. Selenium in the environment, metabolism and involvement in body functions. Molecules. (2013) 18(3):3292&#x2013;311. 10.3390/molecules18033292</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules18033292</ArticleId><ArticleId IdType="pmc">PMC6270138</ArticleId><ArticleId IdType="pubmed">23486107</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37842473</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Factors Associated With Acute Kidney Injury in Patients Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>e45131</StartPage><MedlinePgn>e45131</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e45131</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.45131</ELocationID><Abstract><AbstractText>The aim of this meta-analysis is to assess the effect of different independent predictors on acute kidney injury (AKI) after transcatheter aortic valve implantation (TAVI). This meta-analysis adhered to the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).&#xa0;A comprehensive database search was conducted using PubMed, Web of Science, and Scopus for the period from January 1, 2015, to August 15, 2023. The following key terms were employed: "transcatheter aortic valve implantation" OR "transcatheter aortic valve replacement" AND "acute kidney injury" OR "acute renal failure." Our search was limited to studies published exclusively in the English language. The statistical analysis was conducted using RevMan version 5.4.1 (The Cochrane Collaboration). Estimates were presented as odds ratio&#xa0;(OR) with 95% confidence interval&#xa0;(CI) for categorical variables, while continuous variables were reported as mean difference (MD) with 95% CI. A total of 19 studies met the selection criteria and were included in the meta-analysis. The pooled incidence of AKI was reported as 20% (95% CI: 18-20%).&#xa0;Factors significantly associated with post-TAVI AKI encompass hypertension, chronic kidney disease (CKD), low estimated glomerular filtration rate (eGFR), high baseline creatinine levels, peripheral vascular disease (PVD), Society of Thoracic Surgeons (STS) score, European System for Cardiac Operative Risk Evaluation (EUROscore) II, and the transfemoral surgical approach.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023, Benaicha et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Benaicha</LastName><ForeName>Karima</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Internal Medicine, University Hospital Isaad Hassani Beni Messous, Algiers, DZA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aldroubi</LastName><ForeName>Basel</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Medical College, Tishreen University, Latakia, SYR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yousuf</LastName><ForeName>Paras</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Emergency Medicine, Jinnah Postgraduate Medical Centre, Karachi, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nath</LastName><ForeName>Rabinder</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Medical College, Ghulam Muhammad Mahar, Sukkur, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saveeta</LastName><ForeName>Fnu</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Internal Medicine, People's University of Medical and Health Sciences, Nawabshah, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanwal</LastName><ForeName>Fnu</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Medical College, Chandka Medical College, Larkana, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fatima</LastName><ForeName>Tehreem</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Internal Medicine, United Medical and Dental College, Creek General Hospital, Karachi, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirani</LastName><ForeName>Shamsha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiology, Baqai Hospital, Karachi, PAK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">factors</Keyword><Keyword MajorTopicYN="N">post-operative</Keyword><Keyword MajorTopicYN="N">systematic review and meta-analysis</Keyword><Keyword MajorTopicYN="N">transcatheter aortic valve implantation (tavi)</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>16</Day><Hour>4</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37842473</ArticleId><ArticleId IdType="pmc">PMC10569799</ArticleId><ArticleId IdType="doi">10.7759/cureus.45131</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Acute kidney injury after transcatheter aortic valve replacement. Devireddy C, Hiremath S. Circ Cardiovasc Interv. 2018;11:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">30354790</ArticleId></ArticleIdList></Reference><Reference><Citation>Impact of transcatheter aortic valve replacement on severity of chronic kidney disease. Cubeddu RJ, Asher CR, Lowry AM, et al. J Am Coll Cardiol. 2020;76:1410&#x2013;1421.</Citation><ArticleIdList><ArticleId IdType="pubmed">32943158</ArticleId></ArticleIdList></Reference><Reference><Citation>Structural deterioration of transcatheter versus surgical aortic valve bioprostheses in the PARTNER-2 trial. Pibarot P, Ternacle J, Jaber WA, et al. J Am Coll Cardiol. 2020;76:1830&#x2013;1843.</Citation><ArticleIdList><ArticleId IdType="pubmed">33059828</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute kidney injury after transcatheter aortic valve implantation. Scherner M, Wahlers T. J Thorac Dis. 2015;7:1527&#x2013;1535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4598516</ArticleId><ArticleId IdType="pubmed">26543598</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute kidney injury after aortic valve replacement: incidence, risk factors and outcomes. Najjar M, Salna M, George I. Expert Rev Cardiovasc Ther. 2015;13:301&#x2013;316.</Citation><ArticleIdList><ArticleId IdType="pubmed">25592763</ArticleId></ArticleIdList></Reference><Reference><Citation>Incidence and predictors of acute kidney injury in patients undergoing transcatheter aortic valve implantation. Elhmidi Y, Bleiziffer S, Piazza N, et al. Am Heart J. 2011;161:735&#x2013;739.</Citation><ArticleIdList><ArticleId IdType="pubmed">21473973</ArticleId></ArticleIdList></Reference><Reference><Citation>Frequency, determinants, and prognostic effects of acute kidney injury and red blood cell transfusion in patients undergoing transcatheter aortic valve implantation. Nuis RJ, Van Mieghem NM, Tzikas A, et al. Catheter Cardiovasc Interv. 2011;77:881&#x2013;889.</Citation><ArticleIdList><ArticleId IdType="pubmed">21061244</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and clinical outcome. Saia F, Ciuca C, Taglieri N, et al. Int J Cardiol. 2013;168:1034&#x2013;1040.</Citation><ArticleIdList><ArticleId IdType="pubmed">23164594</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute kidney injury in transcatheter aortic valve replacement. Abbas S, Qayum I, Wahid R, et al. Cureus. 2021;13:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8214866</ArticleId><ArticleId IdType="pubmed">34168922</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence and risk factors associated with acute kidney injury after transcatheter aortic valve replacement at a Tertiary Hospital in Riyadh, Saudi Arabia. Alhamad FS, Almohaimeed YS, Alhayzan MH, et al. Cureus. 2023;15:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10495037</ArticleId><ArticleId IdType="pubmed">37700997</ArticleId></ArticleIdList></Reference><Reference><Citation>Prognostic usefulness of acute kidney injury after transcatheter aortic valve replacement. Arsalan M, Squiers JJ, Farkas R, et al. Am J Cardiol. 2016;117:1327&#x2013;1331.</Citation><ArticleIdList><ArticleId IdType="pubmed">26976788</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute kidney injury after transcatheter aortic valve replacement mediates the effect of chronic kidney disease. Crimi G, De Marzo V, De Marco F, et al. J Am Heart Assoc. 2022;11:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9673702</ArticleId><ArticleId IdType="pubmed">36172945</ArticleId></ArticleIdList></Reference><Reference><Citation>Factors contributing to acute kidney injury and the impact on mortality in patients undergoing transcatheter aortic valve replacement. Crowhurst JA, Savage M, Subban V, et al. Heart Lung Circ. 2016;25:282&#x2013;289.</Citation><ArticleIdList><ArticleId IdType="pubmed">26672437</ArticleId></ArticleIdList></Reference><Reference><Citation>Metabolite profiles predict acute kidney injury and mortality in patients undergoing transcatheter aortic valve replacement. Elmariah S, Farrell LA, Daher M, et al. J Am Heart Assoc. 2016;5:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4943248</ArticleId><ArticleId IdType="pubmed">27068627</ArticleId></ArticleIdList></Reference><Reference><Citation>Atherosclerosis on CT angiogram predicts acute kidney injury after transcatheter aortic valve replacement. Kandathil A, Abbara S, Hanna M, et al. AJR Am J Roentgenol. 2018;211:677&#x2013;683.</Citation><ArticleIdList><ArticleId IdType="pubmed">30016147</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of acute kidney injury classifications in patients undergoing transcatheter aortic valve implantation: predictors and long-term outcomes. Koifman E, Segev A, Fefer P, et al. Catheter Cardiovasc Interv. 2016;87:523&#x2013;531.</Citation><ArticleIdList><ArticleId IdType="pubmed">26268940</ArticleId></ArticleIdList></Reference><Reference><Citation>Periprocedural bleeding, acute kidney injury, and long-term mortality after transcatheter aortic valve implantation. Konigstein M, Ben-Assa E, Banai S, et al.  https://pubmed.ncbi.nlm.nih.gov/25547551/ Can J Cardiol. 2015;31:56&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">25547551</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute kidney injury after aortic valve replacement in a nationally representative cohort in the USA. Kumar N, Garg N. Nephrol Dial Transplant. 2019;34:295&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">29684164</ArticleId></ArticleIdList></Reference><Reference><Citation>Prognostic value of renal function in patients with aortic stenosis treated with transcatheter aortic valve replacement. Meneguz-Moreno RA, Ramos AI, Siqueira D, et al. Catheter Cardiovasc Interv. 2017;89:452&#x2013;459.</Citation><ArticleIdList><ArticleId IdType="pubmed">27514499</ArticleId></ArticleIdList></Reference><Reference><Citation>Packed red blood cell transfusion associates with acute kidney injury after transcatheter aortic valve replacement. Merchant AM, Neyra JA, Minhajuddin A, et al. BMC Anesthesiol. 2019;19:99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6560735</ArticleId><ArticleId IdType="pubmed">31185915</ArticleId></ArticleIdList></Reference><Reference><Citation>Influence of preoperative serum creatinine level and intraoperative volume of contrast medium on the risk of acute kidney injury after transfemoral transcatheter aortic valve implantation: a retrospective observational study. Miura D, Yamada Y, Kusaba S, et al. BMC Res Notes. 2019;12:484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6683543</ArticleId><ArticleId IdType="pubmed">31383003</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute kidney injury and acute kidney recovery following transcatheter aortic valve replacement. Peillex M, Marchandot B, Matsushita K, et al.  https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0255806 PLos One. 2021;16:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8354447</ArticleId><ArticleId IdType="pubmed">34375346</ArticleId></ArticleIdList></Reference><Reference><Citation>Atherosclerosis burden of the aortic valve and aorta and risk of acute kidney injury after transcatheter aortic valve implantation. van Rosendael PJ, Kamperidis V, van der Kley F, et al. J Cardiovasc Comput Tomogr. 2015;9:129&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">25819195</ArticleId></ArticleIdList></Reference><Reference><Citation>The extent of aortic atherosclerosis predicts the occurrence, severity, and recovery of acute kidney injury after transcatheter aortic valve replacement: a volumetric multislice computed tomography analysis. Shishikura D, Kataoka Y, Pisaniello AD, Delacroix S, Montarello JK, Nicholls SJ, Worthley SG. Circ Cardiovasc Interv. 2018;11:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">30354779</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute kidney injury following transcatheter aortic valve implantation: association with contrast media dosage and contrast media based risk predication models. Sudarsky D, Drutin Y, Kusniec F, et al. J Clin Med. 2022;11:1181.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8911230</ArticleId><ArticleId IdType="pubmed">35268271</ArticleId></ArticleIdList></Reference><Reference><Citation>Incidence and risk factors of acute kidney injury following transcatheter aortic valve replacement. Thongprayoon C, Cheungpasitporn W, Srivali N, Kittanamongkolchai W, Greason KL, Kashani KB. Nephrology (Carlton) 2016;21:1041&#x2013;1046.</Citation><ArticleIdList><ArticleId IdType="pubmed">26714182</ArticleId></ArticleIdList></Reference><Reference><Citation>Predictors of acute kidney injury after transcatheter aortic valve implantation (From National Inpatient Sample [2011-2018]) Zahid S, Ullah W, Khan MU, Salama A, Krupica T, Khan MZ. Am J Cardiol. 2021;151:120&#x2013;122.</Citation><ArticleIdList><ArticleId IdType="pubmed">34006370</ArticleId></ArticleIdList></Reference><Reference><Citation>Independent risk factors contributing to acute kidney injury according to updated Valve Academic Research Consortium-2 criteria after transcatheter aortic valve implantation: a meta-analysis and meta-regression of 13 studies. Wang J, Yu W, Zhou Y, et al. J Cardiothorac Vasc Anesth. 2017;31:816&#x2013;826.</Citation><ArticleIdList><ArticleId IdType="pubmed">28385646</ArticleId></ArticleIdList></Reference><Reference><Citation>Chronic kidney disease is not associated with a higher risk for mortality or acute kidney injury in transcatheter aortic valve implantation. Wessely M, Rau S, Lange P, et al. Nephrol Dial Transplant. 2012;27:3502&#x2013;3508.</Citation><ArticleIdList><ArticleId IdType="pubmed">22535634</ArticleId></ArticleIdList></Reference><Reference><Citation>Renal functional reserve and renal recovery after acute kidney injury. Sharma A, Mucino MJ, Ronco C. Nephron Clin Pract. 2014;127:94&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">25343829</ArticleId></ArticleIdList></Reference><Reference><Citation>The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia. DeFronzo RA, Davidson JA, Del Prato S. Diabetes Obes Metab. 2012;14:5&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">21955459</ArticleId></ArticleIdList></Reference><Reference><Citation>Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group. Dimopoulos MA, Terpos E, Chanan-Khan A, et al. J Clin Oncol. 2010;28:4976&#x2013;4984.</Citation><ArticleIdList><ArticleId IdType="pubmed">20956629</ArticleId></ArticleIdList></Reference><Reference><Citation>The effects of VARC-defined acute kidney injury after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis. Khawaja MZ, Thomas M, Joshi A, et al. EuroIntervention. 2012;8:563&#x2013;570.</Citation><ArticleIdList><ArticleId IdType="pubmed">22995082</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical impact of acute kidney injury on short- and long-term outcomes after transcatheter aortic valve implantation with the CoreValve prosthesis. Mu&#xf1;oz-Garc&#xed;a AJ, Mu&#xf1;oz-Garc&#xed;a E, Jim&#xe9;nez-Navarro MF, Dom&#xed;nguez-Franco AJ, Alonso-Briales JH, Hern&#xe1;ndez-Garc&#xed;a JM, de Teresa-Galv&#xe1;n E. J Cardiol. 2015;66:46&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">25454207</ArticleId></ArticleIdList></Reference><Reference><Citation>A meta-analysis of transcatheter aortic valve implantation versus surgical aortic valve replacement. Takagi H, Niwa M, Mizuno Y, Goto SN, Umemoto T. Ann Thorac Surg. 2013;96:513&#x2013;519.</Citation><ArticleIdList><ArticleId IdType="pubmed">23816417</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical outcomes after transapical and transfemoral transcatheter aortic valve insertion: an evolving experience. Murashita T, Greason KL, Pochettino A, et al. Ann Thorac Surg. 2016;102:56&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">27112646</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39366655</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-5568</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Anaesthesia, critical care &amp; pain medicine</Title><ISOAbbreviation>Anaesth Crit Care Pain Med</ISOAbbreviation></Journal><ArticleTitle>Effect of perioperative erythropoietin on postoperative morbidity and mortality after cardiac surgery: a meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>101428</StartPage><MedlinePgn>101428</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.accpm.2024.101428</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2352-5568(24)00086-9</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Cardiac surgery is known to have high rates of perioperative red blood cell (RBC) transfusions which are associated with increased postoperative mortality and morbidity. Perioperative erythropoietin (EPO) has been suggested to lower perioperative RBC transfusions, and the effect on postoperative morbidity or mortality is unknown.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The registered study protocol is available on PROSPERO (CRD42022314538). We searched the Pubmed, EMbase, and Cochrane CENTRAL databases for randomized controlled trials (RCT) of EPO in cardiac surgery. Outcomes were short-term mortality, acute kidney injury (AKI), re-operation, cerebrovascular accident (CVA), perioperative myocardial infarction (MI), infectious complications, and RBC transfusions. RCT studies of perioperative EPO that reported at least one prespecified outcome of interest were included.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 21 RCT's (n&#x2009;=&#x2009;2,763 patients) were included. Mortality analysis included 17 studies (EPO 1,272 patients, control 1,235) and showed no significant difference (risk difference (RD) 0.0004, 95%CI: -0.016, 0.009). EPO did not reduce the incidence of AKI (RD -0.006, 95% CI: -0.038, 0.026) and reoperation (RD 0.001, 95% CI: -0.013, 0.015). The incidence of CVA (RD -0.004, 95% CI: -0.015, 0.007) and perioperative MI (RD -0.008, 95% CI: -0.021, 0.005) was similar between the groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Although EPO had been proven to reduce perioperative RBC transfusions, we did not find that it reduces the incidence of postoperative short-term mortality, AKI, and reoperation. The study results support that perioperative EPO is also safe, with no rise in thrombotic events, including CVA and perioperative MI.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Soci&#xe9;t&#xe9; fran&#xe7;aise d'anesth&#xe9;sie et de r&#xe9;animation (Sfar). Published by Elsevier Masson SAS. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abraham</LastName><ForeName>Dana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Carmel Medical Center, Haifa, Israel; The Ruth &amp; Baruch Rappaport Faculty of Medicine, Technion, Haifa, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leviner</LastName><ForeName>Dror B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Carmel Medical Center, Haifa, Israel; The Ruth &amp; Baruch Rappaport Faculty of Medicine, Technion, Haifa, Israel. Electronic address: drorleviner@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ronai</LastName><ForeName>Tom</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>The Ruth &amp; Baruch Rappaport Faculty of Medicine, Technion, Haifa, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwartz</LastName><ForeName>Naama</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Research Authority, Carmel Medical Center, Haifa, Israel; School of Public Health-University of Haifa, Haifa, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levi</LastName><ForeName>Amos</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Rabin Medical Center, Petach Tikva, Israel; School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharoni</LastName><ForeName>Erez</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Carmel Medical Center, Haifa, Israel; The Ruth &amp; Baruch Rappaport Faculty of Medicine, Technion, Haifa, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Anaesth Crit Care Pain Med</MedlineTA><NlmUniqueID>101652401</NlmUniqueID><ISSNLinking>2352-5568</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>11096-26-7</RegistryNumber><NameOfSubstance UI="D004921">Erythropoietin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017707" MajorTopicYN="Y">Erythrocyte Transfusion</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004921" MajorTopicYN="Y">Erythropoietin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Erythropoietin</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Perioperative care</Keyword><Keyword MajorTopicYN="N">Postoperative outcomes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>24</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>6</Day><Hour>7</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>19</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39366655</ArticleId><ArticleId IdType="doi">10.1016/j.accpm.2024.101428</ArticleId><ArticleId IdType="pii">S2352-5568(24)00086-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">37652847</PMID><DateRevised><Year>2023</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Pulmonary Vasodilator and Inodilator Drugs in Cardiac Surgery: A Systematic Review With Bayesian Network Meta-Analysis.</ArticleTitle><Pagination><StartPage>2261</StartPage><EndPage>2271</EndPage><MedlinePgn>2261-2271</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2023.07.041</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(23)00533-5</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The authors performed a systematic review to evaluate the effect of pharmacologic therapy on pulmonary hypertension in the perioperative setting of elective cardiac surgery (PROSPERO CRD42023321041).</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Systematic review of randomized controlled trials with a Bayesian network meta-analysis.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">The authors searched biomedical databases for randomized controlled trials on the perioperative use of inodilators and pulmonary vasodilators in adult cardiac surgery, with in-hospital mortality as the primary outcome and duration of ventilation, length of stay in the intensive care unit, stage 3 acute kidney injury, cardiogenic shock requiring mechanical support, and change in mean pulmonary artery pressure as secondary outcomes.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Twenty-eight studies randomizing 1,879 patients were included.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Catecholamines and noncatecholamine inodilators, arterial pulmonary vasodilators, vasodilators, or their combination were considered eligible interventions compared with placebo or standard care.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">Ten studies reported in-hospital mortality and assigned 855 patients to 12 interventions. Only inhaled prostacyclin use was supported by a statistically discernible improvement in mortality, with a number-needed-to-treat estimate of at least 3.3, but a wide credible interval (relative risk 1.26&#xa0;&#xd7;&#xa0;10<sup>-17</sup> - 0.7). Inhaled prostacyclin and nitric oxide were associated with a reduction in intensive care unit stay, and none of the included interventions reached a statistically evident difference compared to usual care or placebo in the other secondary clinical outcomes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Inhaled prostacyclin was the only pharmacologic intervention whose use is supported by a statistically discernible improvement in mortality in the perioperative cardiac surgery setting as treatment of pulmonary hypertension. However, available evidence has significant limitations, mainly the low number of events and imprecision.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sardo</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Monserrato, Italy. Electronic address: salvatore.sardo@unica.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tripodi</LastName><ForeName>Vincenzo Francesco</ForeName><Initials>VF</Initials><AffiliationInfo><Affiliation>Department of Human Pathology, Unit of Anesthesia and Intensive Care, University Hospital of Messina, Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guerzoni</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musu</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cortegiani</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgical Oncological and Oral Science, University of Palermo, Palermo, Italy; Department of Anesthesia, Intensive Care, and Emergency, University Hospital "Policlinico Paolo Giaccone", Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finco</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Monserrato, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac</Keyword><Keyword MajorTopicYN="N">cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">network meta-analysis</Keyword><Keyword MajorTopicYN="N">pulmonary hypertension</Keyword><Keyword MajorTopicYN="N">vasodilator</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>31</Day><Hour>22</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37652847</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2023.07.041</ArticleId><ArticleId IdType="pii">S1053-0770(23)00533-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35279277</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>128</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Renal function during sevoflurane or total intravenous propofol anaesthesia: a single-centre parallel randomised controlled study.</ArticleTitle><Pagination><StartPage>838</StartPage><EndPage>848</EndPage><MedlinePgn>838-848</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2022.02.030</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(22)00097-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">The choice of anaesthetic may influence regulation of renal perfusion and function. We investigated renal function in patients anaesthetised with propofol or sevoflurane before surgery and postoperatively.</AbstractText><AbstractText Label="METHODS">Patients with ASA physical status 1-2 planned for spinal surgery were randomised to propofol or sevoflurane anaesthesia. Blood and urine were collected before anaesthesia, during anaesthesia (before surgery), during postoperative care, and the day after surgery.</AbstractText><AbstractText Label="RESULTS">Twenty-seven patients completed the study protocol (average age, 51 yr; average BMI, 28 kg m<sup>-2</sup>) and 11 were women. Urine output and sodium excretion were lower during sevoflurane anaesthesia (n=14) than during propofol anaesthesia (n=13) (0.3 vs 1.1 ml kg<sup>-1</sup> h<sup>-1</sup> [P=0.01] and 2.6 vs 6.0 mmol h<sup>-1</sup> [P=0.04], respectively). Urinary potassium excretion was lower during anaesthesia than after, without intergroup difference (2.3 vs 5.7 mmol h<sup>-1</sup>, P&lt;0.001). Sevoflurane anaesthesia increased plasma renin compared with baseline (138 vs 23 mIU L<sup>-1</sup>, P&lt;0.001) and propofol anaesthesia (138 vs 27 mIU L<sup>-1</sup>, P=0.008). Plasma arginine-vasopressin did not change significantly during anaesthesia, but was elevated postoperatively compared with baseline irrespective of anaesthetic (21 vs 12 ng L<sup>-1</sup>, P=0.02). Sevoflurane caused higher postoperative plasma creatinine than propofol (83 vs 66 mmol L<sup>-1</sup>, P=0.01). Kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin did not change significantly in either group.</AbstractText><AbstractText Label="CONCLUSIONS">Sevoflurane anaesthesia reduced urine output and sodium excretion and increased plasma renin compared with propofol anaesthesia. The impact of this on acute kidney injury and fluid resuscitation during surgery warrants further investigation.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION">EudraCT: 2017-001646-10; Clinicaltrials.gov: NCT0333680.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Franz&#xe9;n</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, Anaesthesiology and Intensive Care, Uppsala University, Uppsala, Sweden. Electronic address: stephanie.franzen@surgsci.uu.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Semenas</LastName><ForeName>Egidijus</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, Anaesthesiology and Intensive Care, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taavo</LastName><ForeName>Micael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, Anaesthesiology and Intensive Care, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xe5;rtensson</LastName><ForeName>Johan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, Anaesthesiology and Intensive Care, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larsson</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frithiof</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, Anaesthesiology and Intensive Care, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018685">Anesthetics, Inhalation</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018686">Anesthetics, Intravenous</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008738">Methyl Ethers</NameOfSubstance></Chemical><Chemical><RegistryNumber>38LVP0K73A</RegistryNumber><NameOfSubstance UI="D000077149">Sevoflurane</NameOfSubstance></Chemical><Chemical><RegistryNumber>9NEZ333N27</RegistryNumber><NameOfSubstance UI="D012964">Sodium</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.15</RegistryNumber><NameOfSubstance UI="D012083">Renin</NameOfSubstance></Chemical><Chemical><RegistryNumber>YI7VU623SF</RegistryNumber><NameOfSubstance UI="D015742">Propofol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018685" MajorTopicYN="Y">Anesthetics, Inhalation</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018686" MajorTopicYN="N">Anesthetics, Intravenous</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008738" MajorTopicYN="Y">Methyl Ethers</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015742" MajorTopicYN="Y">Propofol</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012083" MajorTopicYN="N">Renin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077149" MajorTopicYN="N">Sevoflurane</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012964" MajorTopicYN="N">Sodium</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">fluid therapy</Keyword><Keyword MajorTopicYN="N">propofol</Keyword><Keyword MajorTopicYN="N">renin</Keyword><Keyword MajorTopicYN="N">sevoflurane</Keyword><Keyword MajorTopicYN="N">sodium excretion</Keyword><Keyword MajorTopicYN="N">vasopressin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>13</Day><Hour>20</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35279277</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2022.02.030</ArticleId><ArticleId IdType="pii">S0007-0912(22)00097-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36367845</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-6576</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Acta anaesthesiologica Scandinavica</Title><ISOAbbreviation>Acta Anaesthesiol Scand</ISOAbbreviation></Journal><ArticleTitle>The prognostic value of elevated neutrophil-lymphocyte ratio for cardiac surgery-associated acute kidney injury: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>131</StartPage><EndPage>141</EndPage><MedlinePgn>131-141</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/aas.14170</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients undergoing cardiac surgery are at significant risk of developing postoperative acute kidney injury (AKI). Neutrophil-lymphocyte ratio (NLR) is a widely available inflammatory biomarker which may be of prognostic value in this setting.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a systematic review and meta-analysis of studies reporting associations between perioperative NLR with postoperative AKI. We searched Medline, Embase and the Cochrane Library, without language restriction, from inception to May 2022 for relevant studies. We meta-analysed the reported odds ratios (ORs) with 95% confidence intervals (CIs) for both elevated preoperative and postoperative NLR with risk of postoperative AKI and need for renal replacement therapy (RRT). We conducted a meta-regression to explore inter-study statistical heterogeneity.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twelve studies involving 10,724 participants undergoing cardiac surgery were included, with eight studies being deemed at high risk of bias using PROBAST modelling. We found statistically significant associations between elevated preoperative NLR and postoperative AKI (OR 1.45, 95% CI 1.18-1.77), as well as postoperative need for RRT (OR 2.37, 95% CI 1.50-3.72). Postoperative NLR measurements were not of prognostic significance.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Elevated preoperative NLR is a reliable inflammatory biomarker for predicting AKI following cardiac surgery.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Acta Anaesthesiologica Scandinavica published by John Wiley &amp; Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wheatley</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-1312-7735</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia, Perioperative Medicine and Pain Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Royal Melbourne Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhengyang</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-6114-8629</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia, Royal Melbourne Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, Melbourne Medical School, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loth</LastName><ForeName>Joel</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3949-9764</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia, Royal Melbourne Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plummer</LastName><ForeName>Mark P</ForeName><Initials>MP</Initials><Identifier Source="ORCID">0000-0002-9640-1911</Identifier><AffiliationInfo><Affiliation>Department of Critical Care, Melbourne Medical School, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Royal Adelaide Hospital, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penny-Dimri</LastName><ForeName>Jahan C</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0001-8148-1237</Identifier><AffiliationInfo><Affiliation>Department of Surgery (School of Clinical Sciences at Monash Health), Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Monash Health, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Segal</LastName><ForeName>Reny</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-5805-5491</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia, Royal Melbourne Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, Melbourne Medical School, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Julian</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1244-4277</Identifier><AffiliationInfo><Affiliation>Department of Surgery (School of Clinical Sciences at Monash Health), Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Monash Health, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perry</LastName><ForeName>Luke A</ForeName><Initials>LA</Initials><Identifier Source="ORCID">0000-0002-7494-8406</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia, Royal Melbourne Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, Melbourne Medical School, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Anaesthesiol Scand</MedlineTA><NlmUniqueID>0370270</NlmUniqueID><ISSNLinking>0001-5172</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008214" MajorTopicYN="N">Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute Kidney Injury</Keyword><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">Cardiac Surgery</Keyword><Keyword MajorTopicYN="N">Neutrophil-lymphocyte ratio</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>11</Day><Hour>13</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36367845</ArticleId><ArticleId IdType="pmc">PMC10099461</ArticleId><ArticleId IdType="doi">10.1111/aas.14170</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Birnie K, Verheyden V, Pagano D, et al. Predictive models for kidney disease: improving global outcomes (KDIGO) defined acute kidney injury in UK cardiac surgery. Crit Care. 2014;18(6):606.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4258283</ArticleId><ArticleId IdType="pubmed">25673427</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon PJ, Stafford&#x2010;Smith M, White WD, et al. Acute renal failure following cardiac surgery. Nephrol Dial Transplant. 1999;14(5):1158&#x2010;1162.</Citation><ArticleIdList><ArticleId IdType="pubmed">10344355</ArticleId></ArticleIdList></Reference><Reference><Citation>Bove T, Monaco F, Covello RD, Zangrillo A. Acute renal failure and cardiac surgery. HSR Proc Intensive Care Cardiovasc Anesth. 2009;1(3):13&#x2010;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3484552</ArticleId><ArticleId IdType="pubmed">23439962</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson CE, Yavas S, Segal MS, et al. Acute kidney injury is associated with increased long&#x2010;term mortality after cardiothoracic surgery. Circulation. 2009;119(18):2444&#x2010;2453.</Citation><ArticleIdList><ArticleId IdType="pubmed">19398670</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao H, Katz N, Ariyanon W, et al. Cardiac surgery&#x2010;associated acute kidney injury. Cardiorenal Med. 2013;3(3):178&#x2010;199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3884176</ArticleId><ArticleId IdType="pubmed">24454314</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Auriemma S, Fabbri A, et al. The pathophysiology of cardiac surgery&#x2010;associated acute kidney injury (CSA&#x2010;AKI). Int J Artif Organs. 2008;31(2):166&#x2010;178.</Citation><ArticleIdList><ArticleId IdType="pubmed">18311733</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Bellomo R. Cardiac surgery&#x2010;associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol. 2017;13(11):697&#x2010;711.</Citation><ArticleIdList><ArticleId IdType="pubmed">28869251</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Perry LA, Penny&#x2010;Dimri JC, et al. The association of neutrophil&#x2010;lymphocyte ratio and platelet&#x2010;lymphocyte ratio with retinal vein occlusion: a systematic review and meta&#x2010;analysis. Acta Ophthalmol. 2022;100(3):635&#x2010;647.</Citation><ArticleIdList><ArticleId IdType="pubmed">34219390</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson SM, Perry LA, Borg C, et al. Prognostic significance of preoperative neutrophil&#x2010;lymphocyte ratio in vascular surgery: systematic review and meta&#x2010;analysis. Vasc Endovascular Surg. 2020;54(8):697&#x2010;706.</Citation><ArticleIdList><ArticleId IdType="pubmed">32840176</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansanayudh N, Numthavaj P, Muntham D, et al. Prognostic effect of mean platelet volume in patients with coronary artery disease. A systematic review and meta&#x2010;analysis. Thromb Haemost. 2015;114(6):1299&#x2010;1309.</Citation><ArticleIdList><ArticleId IdType="pubmed">26245769</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Perry LA, Edwards TL. Association between platelet indices and retinal vein occlusion: a systematic review and meta&#x2010;analysis. Retina. 2021;41(2):238&#x2010;248.</Citation><ArticleIdList><ArticleId IdType="pubmed">33475270</ArticleId></ArticleIdList></Reference><Reference><Citation>Borg Caruana C, Jackson SM, Ngyuen Khuong J, et al. Systematic review and meta&#x2010;analysis of postoperative troponin as a predictor of mortality and major adverse cardiac events after vascular surgery. J Vasc Surg. 2020;72(3):1132&#x2010;1143.e1.</Citation><ArticleIdList><ArticleId IdType="pubmed">32305383</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Perry LA, Penny&#x2010;Dimri JC, et al. Donor cardiac troponin for prognosis of adverse outcomes in cardiac transplantation recipients: a systematic review and meta&#x2010;analysis. Transplant Direct. 2021;8(1):1261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8670586</ArticleId><ArticleId IdType="pubmed">34912948</ArticleId></ArticleIdList></Reference><Reference><Citation>Attaran S, Sherwood R, Desai J, et al. Brain natriuretic peptide a predictive marker in cardiac surgery. Interact Cardiovasc Thorac Surg. 2009;9(4):662&#x2010;666.</Citation><ArticleIdList><ArticleId IdType="pubmed">19584071</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Perry LA, Penny&#x2010;Dimri JC, et al. Prognostic significance of elevated troponin in adult heart transplant recipients: a systematic review and meta&#x2010;analysis. Exp Clin Transplant. 2022;20:633&#x2010;641. doi:10.6002/ect.2021.0386</Citation><ArticleIdList><ArticleId IdType="doi">10.6002/ect.2021.0386</ArticleId><ArticleId IdType="pubmed">35037610</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell R, Khuong JN, Liu Z, et al. Perioperative gabapentinoid use lowers short&#x2010;term opioid consumption following lower limb arthroplasty: systematic review and meta&#x2010;analysis. J Opioid Manag. 2021;17(3):251&#x2010;272.</Citation><ArticleIdList><ArticleId IdType="pubmed">34259336</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Perry LA, Morgan V. The association between platelet indices and presence and severity of psoriasis: a systematic review and meta&#x2010;analysis. Clin Exp Med. 2022. doi:10.1007/s10238-022-00820-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-022-00820-5</ArticleId><ArticleId IdType="pmc">PMC10224874</ArticleId><ArticleId IdType="pubmed">35377095</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramson DM, Gao H, Penny&#x2010;Dimri JC, et al. Duration of post&#x2010;operative antibiotic treatment in acute complicated appendicitis: systematic review and meta&#x2010;analysis. ANZ J Surg. 2021;91(7&#x2013;8):1397&#x2010;1404.</Citation><ArticleIdList><ArticleId IdType="pubmed">33576567</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Perry LA, Penny&#x2010;Dimri JC, et al. Elevated cardiac troponin to detect acute cellular rejection after cardiac transplantation: a systematic review and meta&#x2010;analysis. Transpl Int. 2022;8(1):e1261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9215116</ArticleId><ArticleId IdType="pubmed">35755856</ArticleId></ArticleIdList></Reference><Reference><Citation>Korantzopoulos P, Sontis N, Liu T, et al. Association between red blood cell distribution width and postoperative atrial fibrillation after cardiac surgery: a pilot observational study. Int J Cardiol. 2015;185:19&#x2010;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">25777283</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran D, Penny&#x2010;Dimri JC, Segal R, et al. The prognostic significance of postoperative hyperbilirubinemia in cardiac surgery: systematic review and meta&#x2010;analysis. J Cardiothorac Surg. 2022;17(1):129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9137213</ArticleId><ArticleId IdType="pubmed">35619178</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry LA, Liu Z, Loth J, et al. Perioperative neutrophil&#x2010;lymphocyte ratio predicts mortality after cardiac surgery: systematic review and meta&#x2010;analysis. J Cardiothorac Vasc Anesth. 2022;36(5):1296&#x2010;1303.</Citation><ArticleIdList><ArticleId IdType="pubmed">34404595</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Nguyen Khuong J, Borg Caruana C, et al. The prognostic value of elevated perioperative neutrophil&#x2010;lymphocyte ratio in predicting postoperative atrial fibrillation after cardiac surgery: a systematic review and meta&#x2010;analysis. Heart Lung Circ. 2020;29(7):1015&#x2010;1024.</Citation><ArticleIdList><ArticleId IdType="pubmed">32089488</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley RD, Hayden JA, Steyerberg EW, et al. Prognosis research strategy (PROGRESS) 2: prognostic factor research. PLoS Med. 2013;10(2):e1001380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3564757</ArticleId><ArticleId IdType="pubmed">23393429</ArticleId></ArticleIdList></Reference><Reference><Citation>Altman DG. Systematic reviews of evaluations of prognostic variables. BMJ. 2001;323(7306):224&#x2010;228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1120839</ArticleId><ArticleId IdType="pubmed">11473921</ArticleId></ArticleIdList></Reference><Reference><Citation>Moons KG, de Groot JA, Bouwmeester W, et al. Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist. PLoS Med. 2014;11(10):e1001744.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4196729</ArticleId><ArticleId IdType="pubmed">25314315</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, et al. Meta&#x2010;analysis of observational studies in epidemiology: a proposal for reporting. Meta&#x2010;analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283(15):2008&#x2010;2012.</Citation><ArticleIdList><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Geersing GJ, Bouwmeester W, Zuithoff P, Spijker R, Leeflang M, Moons KG. Search filters for finding prognostic and diagnostic prediction studies in Medline to enhance systematic reviews. PLoS One. 2012;7(2):e32844.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3290602</ArticleId><ArticleId IdType="pubmed">22393453</ArticleId></ArticleIdList></Reference><Reference><Citation>
Covidence Systematic Review Software
. Veritas Health Innovation, Melbourne, Australia. Available at www.covidence.org
</Citation></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez&#x2010;Meca J, Marin&#x2010;Martinez F, Chacon&#x2010;Moscoso S. Effect&#x2010;size indices for dichotomized outcomes in meta&#x2010;analysis. Psychol Methods. 2003;8(4):448&#x2010;467.</Citation><ArticleIdList><ArticleId IdType="pubmed">14664682</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff RF, Moons KGM, Riley RD, et al. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann Intern Med. 2019;170(1):51&#x2010;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">30596875</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeks JJ, Higgins JPT, Altman DG, eds. Chapter 10: Analysing data and undertaking meta&#x2010;analyses. Cochrane Handbook for Systematic Reviews of Interventions. 6.1th ed. Cochrane; 2020.</Citation></Reference><Reference><Citation>Page MJ, Higgins JPT, Sterne JAC, eds. Chapter 13: assessing risk of bias due to missing results in a synthesis. Cochrane Handbook for Systematic Reviews of Interventions. 6.1th ed. Cochrane; 2020.</Citation></Reference><Reference><Citation>Huguet A, Hayden JA, Stinson J, et al. Judging the quality of evidence in reviews of prognostic factor research: adapting the GRADE framework. Syst Rev. 2013;2:71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3930077</ArticleId><ArticleId IdType="pubmed">24007720</ArticleId></ArticleIdList></Reference><Reference><Citation>Viechtbauer W. Conducting meta&#x2010;analyses in R with the metafor package. J Stat Softw. 2010;36(3):48.</Citation></Reference><Reference><Citation>Ginestet C. ggplot2: elegant graphics for data analysis. J R Stat Soc A Stat Soc. 2011;174(1):245&#x2010;246.</Citation></Reference><Reference><Citation>Azab B, Shariff MA, Bachir R, Nabagiez JP, McGinn JT Jr. Elevated preoperative neutrophil/lymphocyte ratio as a predictor of increased long&#x2010;term survival in minimal invasive coronary artery bypass surgery compared to sternotomy. J Cardiothorac Surg. 2013;8:193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3850883</ArticleId><ArticleId IdType="pubmed">24070055</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson PH, Croal BL, Cuthbertson BH, et al. Preoperative neutrophil&#x2010;lymphocyte ratio and outcome from coronary artery bypass grafting. Am Heart J. 2007;154(5):995&#x2010;1002.</Citation><ArticleIdList><ArticleId IdType="pubmed">17967611</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurbuz O, Kumtepe G, Ozkan H, et al. Predictive value of neutrophil&#x2010;lymphocyte ratio for long&#x2010;term cardiovascular event following coronary artery bypass grafting. Braz J Cardiovasc Surg. 2020;35(3):274&#x2010;284.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7299596</ArticleId><ArticleId IdType="pubmed">32549098</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim WH, Park JY, Ok SH, Shin IW, Sohn JT. Association between the neutrophil/lymphocyte ratio and acute kidney injury after cardiovascular surgery: a retrospective observational study. Medicine. 2015;94(43):e1867.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4985412</ArticleId><ArticleId IdType="pubmed">26512598</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo CH, Eun Jung D, Park YS, et al. Neutrophil, lymphocyte, and platelet counts and acute kidney injury after cardiovascular surgery. J Cardiothorac Vasc Anesth. 2018;32(1):212&#x2010;222.</Citation><ArticleIdList><ArticleId IdType="pubmed">29128485</ArticleId></ArticleIdList></Reference><Reference><Citation>Parlar H, Arikan AA, Onmez A. Dynamic changes in perioperative cellular inflammation and acute kidney injury after coronary artery bypass grafting. Braz J Cardiovasc Surg. 2021;36(3):354&#x2010;364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8357379</ArticleId><ArticleId IdType="pubmed">34387973</ArticleId></ArticleIdList></Reference><Reference><Citation>Parlar H, Saskin H. Are pre and postoperative platelet to lymphocyte ratio and neutrophil to lymphocyte ratio associated with early postoperative AKI following CABG? Braz J Cardiovasc Surg. 2018;33(3):233&#x2010;241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6089132</ArticleId><ArticleId IdType="pubmed">30043915</ArticleId></ArticleIdList></Reference><Reference><Citation>Silberman S, Abu&#x2010;Yunis U, Tauber R, et al. Neutrophil&#x2010;lymphocyte ratio: prognostic impact in heart surgery. Early outcomes and late survival. Ann Thorac Surg. 2018;105(2):581&#x2010;586.</Citation><ArticleIdList><ArticleId IdType="pubmed">29132702</ArticleId></ArticleIdList></Reference><Reference><Citation>Usta S, Abanoz M. Can peroperative neutrophil to lymphocyte ratio change (Deltanlr) be used as a parameter in predicting acute renal failure following coronary bypass operations with cardiopulmonary bypass? Heart Surg Forum. 2021;24(1):E194&#x2010;E200.</Citation><ArticleIdList><ArticleId IdType="pubmed">33635250</ArticleId></ArticleIdList></Reference><Reference><Citation>Weedle RC, Da Costa M, Veerasingam D, Soo AWS. The use of neutrophil lymphocyte ratio to predict complications post cardiac surgery. Ann Transl Med. 2019;7(23):778.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6989975</ArticleId><ArticleId IdType="pubmed">32042794</ArticleId></ArticleIdList></Reference><Reference><Citation>Guangqing Z, Liwei C, Fei L, et al. Predictive value of neutrophil to lymphocyte ratio on acute kidney injury after on&#x2010;pump coronary artery bypass: a retrospective, single&#x2010;center study. Gen Thorac Cardiovasc Surg. 2022;70:624&#x2010;633.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9206599</ArticleId><ArticleId IdType="pubmed">35103920</ArticleId></ArticleIdList></Reference><Reference><Citation>He W, Zhou Y. The platelet&#x2010;lymphocyte ratio is a promising predictor of early postoperative acute kidney injury following cardiac surgery: a case&#x2010;control study. Ann Transl Med. 2021;9(24):1751.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8756252</ArticleId><ArticleId IdType="pubmed">35071445</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchioni M, Primiceri G, Ingrosso M, et al. The clinical use of the neutrophil to lymphocyte ratio (NLR) in urothelial cancer: a systematic review. Clin Genitourin Cancer. 2016;14(6):473&#x2010;484.</Citation><ArticleIdList><ArticleId IdType="pubmed">27209348</ArticleId></ArticleIdList></Reference><Reference><Citation>Xin&#x2010;Ji Z, Yong&#x2010;Gang L, Xiao&#x2010;Jun S, Xiao&#x2010;Wu C, Dong Z, Da&#x2010;Jian Z. The prognostic role of neutrophils to lymphocytes ratio and platelet count in gastric cancer: a meta&#x2010;analysis. Int J Surg. 2015;21:84&#x2010;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">26225826</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Zhang HY, Li J, Shao XY, Zhang CX. The elevated NLR, PLR and PLT may predict the prognosis of patients with colorectal cancer: a systematic review and meta&#x2010;analysis. Oncotarget. 2017;8(40):68837&#x2010;68846.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5620300</ArticleId><ArticleId IdType="pubmed">28978160</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Ran Y. Prognostic role of elevated platelet count in patients with lung cancer: a systematic review and meta&#x2010;analysis. Int J Clin Exp Med. 2015;8(4):5379&#x2010;5387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4483921</ArticleId><ArticleId IdType="pubmed">26131114</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology. 2007;73(3&#x2013;4):215&#x2010;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">18424885</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Yang JX, Cao DY, et al. Preoperative neutrophil&#x2010;lymphocyte and platelet&#x2010;lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma. Onco Targets Ther. 2013;6:211&#x2010;216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3604973</ArticleId><ArticleId IdType="pubmed">23525143</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik HZ, Prasad KR, Halazun KJ, et al. Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg. 2007;246(5):806&#x2010;814.</Citation><ArticleIdList><ArticleId IdType="pubmed">17968173</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P, Lim E. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non&#x2010;small cell lung cancer. J Thorac Cardiovasc Surg. 2009;137(2):425&#x2010;428.</Citation><ArticleIdList><ArticleId IdType="pubmed">19185164</ArticleId></ArticleIdList></Reference><Reference><Citation>Proctor MJ, McMillan DC, Morrison DS, Fletcher CD, Horgan PG, Clarke SJ. A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer. Br J Cancer. 2012;107(4):695&#x2010;699.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3419948</ArticleId><ArticleId IdType="pubmed">22828611</ArticleId></ArticleIdList></Reference><Reference><Citation>Yilmaz H, Cakmak M, Inan O, Darcin T, Akcay A. Can neutrophil&#x2010;lymphocyte ratio be independent risk factor for predicting acute kidney injury in patients with severe sepsis? Ren Fail. 2015;37(2):225&#x2010;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">25394529</ArticleId></ArticleIdList></Reference><Reference><Citation>Gameiro J, Fonseca JA, Dias JM, et al. Neutrophil, lymphocyte and platelet ratio as a predictor of postoperative acute kidney injury in major abdominal surgery. BMC Nephrol. 2018;19(1):320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6231266</ArticleId><ArticleId IdType="pubmed">30419844</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Huang L, He H, Zhao Y, Niu D, Lyu J. Red cell distribution width to platelet ratio is associated with increasing In&#x2010;hospital mortality in critically ill patients with acute kidney injury. Dis Markers. 2022;2022:4802702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786548</ArticleId><ArticleId IdType="pubmed">35082929</ArticleId></ArticleIdList></Reference><Reference><Citation>Demirjian S, Bashour CA, Shaw A, et al. Predictive accuracy of a perioperative laboratory test&#x2010;based prediction model for moderate to severe acute kidney injury after cardiac surgery. JAMA. 2022;327(10):956&#x2010;964.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8905398</ArticleId><ArticleId IdType="pubmed">35258532</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadim MK, Forni LG, Bihorac A, et al. Cardiac and vascular surgery&#x2010;associated acute kidney injury: the 20th international consensus conference of the ADQI (acute disease quality initiative) group. J Am Heart Assoc. 2018;7(11):1&#x2010;23: (In eng).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6015369</ArticleId><ArticleId IdType="pubmed">29858368</ArticleId></ArticleIdList></Reference><Reference><Citation>Hote M. Cardiac surgery risk scoring systems: in quest for the best. Heart Asia. 2018;10(1):e011017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5890060</ArticleId><ArticleId IdType="pubmed">29637928</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong CF, Li YC, Wang TL, Chang H. Stratification of adverse outcomes by preoperative risk factors in coronary artery bypass graft patients: an artificial neural network prediction model. AMIA Annu Symp Proc. 2003;2003:160&#x2010;164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1480326</ArticleId><ArticleId IdType="pubmed">14728154</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostermann M, Lumlertgul N, Wilson FP. Predictive models for acute kidney injury following cardiac surgery: the importance of accurate and actionable prediction. JAMA. 2022;327(10):927&#x2010;929.</Citation><ArticleIdList><ArticleId IdType="pubmed">35258544</ArticleId></ArticleIdList></Reference><Reference><Citation>Echarri G, Duque&#x2010;Sosa P, Callejas R, et al. External validation of predictive models for acute kidney injury following cardiac surgery: a prospective multicentre cohort study. Eur J Anaesthesiol. 2017;34(2):81&#x2010;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">27984332</ArticleId></ArticleIdList></Reference><Reference><Citation>Prins C, de Villiers JI, Botes L, Smit FE. Cardiac surgery risk&#x2010;stratification models. Cardiovasc J Afr. 2012;23(3):160&#x2010;164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3721858</ArticleId><ArticleId IdType="pubmed">22555640</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung D. The role of perioperative shared decision making: when risk is non&#x2010;modifiable. Curr Anesthesiol Rep. 2022;12:148&#x2010;155.</Citation></Reference><Reference><Citation>Brown JR, Cochran RP, Leavitt BJ, et al. Multivariable prediction of renal insufficiency developing after cardiac surgery. Circulation. 2007;116(11):139&#x2010;143.</Citation><ArticleIdList><ArticleId IdType="pubmed">17846294</ArticleId></ArticleIdList></Reference><Reference><Citation>Palomba H, de Castro I, Neto AL, Lage S, Yu L. Acute kidney injury prediction following elective cardiac surgery: AKICS score. Kidney Int. 2007;72(5):624&#x2010;631.</Citation><ArticleIdList><ArticleId IdType="pubmed">17622275</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, K&#xfc;llmar M, Ostermann M, et al. Prevention of cardiac surgery&#x2010;associated acute kidney injury by implementing the KDIGO guidelines in high&#x2010;risk patients identified by biomarkers: the PrevAKI&#x2010;multicenter randomized controlled trial. Anesth Analg. 2021;133(2):292&#x2010;302.</Citation><ArticleIdList><ArticleId IdType="pubmed">33684086</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;llmar M, Wei&#xdf; R, Ostermann M, et al. A multinational observational study exploring adherence with the kidney disease: improving global outcomes recommendations for prevention of acute kidney injury after cardiac surgery. Anesth Analg. 2020;130(4):910&#x2010;916.</Citation><ArticleIdList><ArticleId IdType="pubmed">31922998</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Lazarus JM, Christiansen CL, et al. Preoperative renal risk stratification. Circulation. 1997;95(4):878&#x2010;884.</Citation><ArticleIdList><ArticleId IdType="pubmed">9054745</ArticleId></ArticleIdList></Reference><Reference><Citation>Huen SC, Parikh CR. Predicting acute kidney injury after cardiac surgery: a systematic review. Ann Thorac Surg. 2012;93(1):337&#x2010;347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3286599</ArticleId><ArticleId IdType="pubmed">22186469</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristovic D, Horvatic I, Husedzinovic I, et al. Cardiac surgery&#x2010;associated acute kidney injury: risk factors analysis and comparison of prediction models. Interact Cardiovasc Thorac Surg. 2015;21(3):366&#x2010;373.</Citation><ArticleIdList><ArticleId IdType="pubmed">26091696</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakar CV, Arrigain S, Worley S, Yared JP, Paganini EP. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol. 2005;16(1):162&#x2010;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">15563569</ArticleId></ArticleIdList></Reference><Reference><Citation>Afari ME, Bhat T. Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update. Expert Rev Cardiovasc Ther. 2016;14(5):573&#x2010;577.</Citation><ArticleIdList><ArticleId IdType="pubmed">26878164</ArticleId></ArticleIdList></Reference><Reference><Citation>Paunel&#x2010;G&#xf6;rg&#xfc;l&#xfc; A, Wacker M, El Aita M, et al. cfDNA correlates with endothelial damage after cardiac surgery with prolonged cardiopulmonary bypass and amplifies NETosis in an intracellular TLR9&#x2010;independent manner. Sci Rep. 2017;7(1):17421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5727170</ArticleId><ArticleId IdType="pubmed">29234042</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieleman JM, Peelen LM, Coulson TG, et al. Age and other perioperative risk factors for postoperative systemic inflammatory response syndrome after cardiac surgery. Br J Anaesth. 2017;119(4):637&#x2010;644.</Citation><ArticleIdList><ArticleId IdType="pubmed">29121297</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27312130</PMID><DateCompleted><Year>2018</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1440-1797</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>9</Issue><PubDate><Year>2017</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Nephrology (Carlton, Vic.)</Title><ISOAbbreviation>Nephrology (Carlton)</ISOAbbreviation></Journal><ArticleTitle>Hyperchloremic acidosis is associated with acute kidney injury after abdominal surgery.</ArticleTitle><Pagination><StartPage>720</StartPage><EndPage>727</EndPage><MedlinePgn>720-727</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/nep.12840</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">Hyperchloremic acidosis may have an important role as a precursor of acute kidney injury (AKI) in the hyperchloremic environment induced by chloride-rich fluids, but this remains unclear. We tested the hypothesis that hyperchloremic acidosis assessed by the Stewart approach is associated with postoperative AKI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A historical cohort study was conducted in adult patients who had normal renal function preoperatively and required admission to the intensive care unit after elective abdominal surgery. The Risk, Injury, Failure, Loss of kidney function, End stage kidney disease (RIFLE) classification was used for definition of AKI.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 206 patients (144 male, 69.9%) included in the study, 42 (20.4%) had postoperative AKI (AKI group) and 164 (79.6%) did not (non-AKI group). Base excess-chloride (BE-Cl) and strong ion difference (SID, approximated as Na-Cl) decreased, and the chloride level on postoperative day 1 increased compared with preoperative values in both groups (P &lt; 0.05). In the AKI group, BE-Cl and SID were lower, and chloride was higher than in the non-AKI group (P &lt; 0.05). The intraoperative load of chloride ions in fluids increased the risk of postoperative AKI (P &lt; 0.01). In multivariate logistic regression analysis, postoperative BE-Cl &lt; -7 mEq/L (i.e. SID &lt;31 mEq/L) was an independent risk factor for AKI (odds ratio; 2.8, 95% CI; 1.2-6.4, P = 0.01). In the AKI group, stays in the intensive care unit and in hospital were longer than those in the non-AKI group (P &lt; 0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Hyperchloremic acidosis is associated with postoperative AKI, and this may be attenuated by reducing the intraoperative chloride load.</AbstractText><CopyrightInformation>&#xa9; 2016 Asian Pacific Society of Nephrology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Toyonaga</LastName><ForeName>Yosuke</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, National Center for Global Health and Medicine, Toyama, Shinjuku, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kikura</LastName><ForeName>Mutsuhito</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hamamatsu Rosai Hospital, Japan Organizaition of Occupational Health and Safety, Higashi-ku, Hamamatsu, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Nephrology (Carlton)</MedlineTA><NlmUniqueID>9615568</NlmUniqueID><ISSNLinking>1320-5358</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002712">Chlorides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="N">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000136" MajorTopicYN="Y">Acid-Base Equilibrium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000138" MajorTopicYN="N">Acidosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002712" MajorTopicYN="N">Chlorides</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Stewart approach</Keyword><Keyword MajorTopicYN="N">abdominal surgery</Keyword><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">hyperchloremic acidosis</Keyword><Keyword MajorTopicYN="N">intraoperative chloride load</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27312130</ArticleId><ArticleId IdType="doi">10.1111/nep.12840</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27523464</PMID><DateCompleted><Year>2017</Year><Month>03</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1444-2892</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>11</Issue><PubDate><Year>2016</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Heart, lung &amp; circulation</Title><ISOAbbreviation>Heart Lung Circ</ISOAbbreviation></Journal><ArticleTitle>Characterising the Role of Perioperative Erythropoietin for Preventing Acute Kidney Injury after Cardiac Surgery: Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>1067</StartPage><EndPage>1076</EndPage><MedlinePgn>1067-1076</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hlc.2016.04.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1443-9506(16)30217-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The role of perioperative erythropoietin (EPO) for preventing cardiac surgery associated acute kidney injury (CSA-AKI) remains uncertain with published trials producing conflicting results. Perspective into the factors at work is needed, due to ongoing uncertainty.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We undertook the systematic review and meta-analysis of randomised-controlled trials (RCTs) using random-effects modelling. The primary outcome was safety and efficacy of perioperative EPO to prevent CSA-AKI and the secondary outcomes were change in serum creatinine, urinary neutrophil gelatinase-associated lipocalin, time in ICU, rates of postoperative transfusions, haemodialysis, and mortality. Subgroup analysis explored the effect of the timing of the EPO dose in relation to surgery, the dose response, and the impact of the preoperative risk for CSA-AKI for the patient group.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Six RCTs were included, which totalled 473 participants. Erythropoietin administration did not reduce the incidence of CSA-AKI compared with controls (OR: 0.69, 95% CI: 0.35 to 1.36, P=0.28; I<sup>2</sup>=64%, P=0.001), however, subgroup analysis suggested administrating EPO before anaesthesia was correlated with a reduction in CSA-AKI (OR: 0.27, 95% CI: 0.13 to 0.54, P=0.0002; I<sup>2</sup>=0%, P=0.98). Additionally, in low risk populations, perioperative EPO administration correlated with significant reduction in CSA-AKI when compared to controls (OR: 0.25, 95% CI: 0.11 to 0.56, P=0.0008; I<sup>2</sup>=0%, P=0.86).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our findings suggest that administering EPO before anaesthesia is emerging as an important factor for efficacy. Erythropoietin may have a role in preventing CSA-AKI, however, additional high-quality prospective studies are warranted, particularly aimed at describing the methodological components, such as the timing and size of the dose, which potentiate the cytoprotective effect of EPO in the clinical setting.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Penny-Dimri</LastName><ForeName>Jahan Che</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Surgery (School of Clinical Sciences at Monash Health), Monash University and Department of Cardiothoracic Surgery, Monash Health, Melbourne, Vic., Australia. Electronic address: jcpen1@student.monash.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cochrane</LastName><ForeName>Andrew D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Surgery (School of Clinical Sciences at Monash Health), Monash University and Department of Cardiothoracic Surgery, Monash Health, Melbourne, Vic., Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perry</LastName><ForeName>Luke A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Department of Surgery (School of Clinical Sciences at Monash Health), Monash University and Department of Cardiothoracic Surgery, Monash Health, Melbourne, Vic., Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Julian A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Surgery (School of Clinical Sciences at Monash Health), Monash University and Department of Cardiothoracic Surgery, Monash Health, Melbourne, Vic., Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>05</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Heart Lung Circ</MedlineTA><NlmUniqueID>100963739</NlmUniqueID><ISSNLinking>1443-9506</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C554270">EPO protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>11096-26-7</RegistryNumber><NameOfSubstance UI="D004921">Erythropoietin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004921" MajorTopicYN="N">Erythropoietin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Erythropoietin</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Perioperative care</Keyword><Keyword MajorTopicYN="N">Pharmacology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27523464</ArticleId><ArticleId IdType="doi">10.1016/j.hlc.2016.04.016</ArticleId><ArticleId IdType="pii">S1443-9506(16)30217-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35834360</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1525-6049</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Renal failure</Title><ISOAbbreviation>Ren Fail</ISOAbbreviation></Journal><ArticleTitle>Effect of dexmedetomidine for prevention of acute kidney injury after cardiac surgery: an updated systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1150</StartPage><EndPage>1159</EndPage><MedlinePgn>1150-1159</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/0886022X.2022.2097923</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Acute kidney injury (AKI) is a serious complication related to cardiac surgery. Several studies have been conducted to investigate the effect of dexmedetomidine administration on AKI prevention.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To assess if dexmedetomidine is associated with a protective effect of renal function after cardiac surgery. And the aim of conducting this meta-analysis is to summarize the literature and determine the clinical utility of dexmedetomidine administration in patients undergoing cardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">PubMed, Cochrane Library, and EMBASE databases were comprehensively searched for all randomized controlled trials (RCTs) published before 1 December, 2021 that investigated the effect of dexmedetomidine on AKI prevention.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Our analysis included 16 studies involving 2148 patients. Compared with the control group, dexmedetomidine administration significantly reduced AKI incidence (OR, 0.47; 95% CI, 0.36-0.61; <i>p</i>&#x2009;&lt;&#x2009;&#x2009;0.00001; <i>I</i><sup>2</sup>&#x2009;=&#x2009;26%) and the length of stay in the intensive care unit (ICU) but did not alter mortality rate, length of stay in the hospital, and mechanical ventilation time. Furthermore, the incidence of delirium among patients treated with dexmedetomidine was significantly decreased.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Dexmedetomidine administration has a positive effect on preventing AKI and postoperative delirium after cardiac surgery and significantly reduces the length of stay in the ICU.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Qinxue</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Qianxiu</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratory of Anesthesiology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Yong-Hong</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Jianguo</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-5830-3317</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Anesthesiology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ren Fail</MedlineTA><NlmUniqueID>8701128</NlmUniqueID><ISSNLinking>0886-022X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003693" MajorTopicYN="Y">Delirium</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="Y">Dexmedetomidine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dexmedetomidine</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">renal function</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>14</Day><Hour>12</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35834360</ArticleId><ArticleId IdType="pmc">PMC9291681</ArticleId><ArticleId IdType="doi">10.1080/0886022X.2022.2097923</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Engelman DT, Crisafi C, Germain M, et al. . Using urinary biomarkers to reduce acute kidney injury following cardiac surgery. J Thorac Cardiovasc Surg. 2020;160(5):1235&#x2013;1246.e1232.</Citation><ArticleIdList><ArticleId IdType="pubmed">31757451</ArticleId></ArticleIdList></Reference><Reference><Citation>Katayama HT, Gomes B, Lobo C, for the BraSIS Study Group Investigators, et al.. The effects of acute kidney injury in a multicenter cohort of high-risk surgical patients. Ren Fail. 2021;43(1):1338&#x2013;1348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8477947</ArticleId><ArticleId IdType="pubmed">34579622</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Bellomo R.. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol. 2017;13(11):697&#x2013;711.</Citation><ArticleIdList><ArticleId IdType="pubmed">28869251</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thomas J, Chandler J, et al. . Cochrane handbook for systematic reviews of interventions. Chichester (UK): John Wiley &amp; Sons; 2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammar A, Mahmoud K, Kasemy Z, et al. . Cardiac and renal protective effects of dexmedetomidine in cardiac surgeries: a randomized controlled trial. Saudi J Anaesth. 2016. Oct-Dec;10(4):395&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5044722</ArticleId><ArticleId IdType="pubmed">27833481</ArticleId></ArticleIdList></Reference><Reference><Citation>Soliman R, Hussien M.. Comparison of the renoprotective effect of dexmedetomidine and dopamine in high-risk renal patients undergoing cardiac surgery: a double-blind randomized study. Ann Card Anaesth. 2017;20(4):408&#x2013;415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5661309</ArticleId><ArticleId IdType="pubmed">28994675</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang C, Hu Y, Gao J, et al. . Dexmedetomidine pretreatment attenuates myocardial ischemia reperfusion induced acute kidney injury and endoplasmic reticulum stress in human and rat. Life Sci. 2020;257:118004.</Citation><ArticleIdList><ArticleId IdType="pubmed">32621918</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Zhang K, Wang W, et al. . Dexmedetomidine sedation reduces atrial fibrillation after cardiac surgery compared to propofol: a randomized controlled trial. Crit Care. 2016;20(1):298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5031329</ArticleId><ArticleId IdType="pubmed">27654700</ArticleId></ArticleIdList></Reference><Reference><Citation>Djaiani G, Silverton N, Fedorko L, et al. . Dexmedetomidine versus propofol sedation reduces delirium after cardiac surgery: a randomized controlled trial. Anesthesiology. 2016;124(2):362&#x2013;368.</Citation><ArticleIdList><ArticleId IdType="pubmed">26575144</ArticleId></ArticleIdList></Reference><Reference><Citation>Balkanay OO, Goksedef D, Omeroglu SN, et al. . The dose-related effects of dexmedetomidine on renal functions and serum neutrophil gelatinase-associated lipocalin values after coronary artery bypass grafting: a randomized, triple-blind, placebo-controlled study. Interact CardioVasc Thorac Surg. 2015;20(2):209&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pubmed">25392341</ArticleId></ArticleIdList></Reference><Reference><Citation>Soh S, Shim JK, Song JW, et al. . Effect of dexmedetomidine on acute kidney injury after aortic surgery: a single-centre, placebo-controlled, randomised controlled trial. Br J Anaesth. 2020;124(4):386&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pubmed">32007239</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai M, Kang F, Han M, et al. . The effect of dexmedetomidine on renal function in patients undergoing cardiac valve replacement under cardiopulmonary bypass: a double-blind randomized controlled trial. J Clin Anesth. 2017;40:33&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">28625442</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo YY, Kim JY, Lee JY, et al. . The effect of intraoperative dexmedetomidine on acute kidney injury after pediatric congenital heart surgery: a prospective randomized trial. Medicine. 2017;96(28):e7480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5515761</ArticleId><ArticleId IdType="pubmed">28700489</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim EH, Lee JH, Kim HS, et al. . Effects of intraoperative dexmedetomidine on the incidence of acute kidney injury in pediatric cardiac surgery patients: a randomized controlled trial. Paediatr Anaesth. 2020;30(10):1132&#x2013;1138.</Citation><ArticleIdList><ArticleId IdType="pubmed">32780926</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JB, Bang SH, Chee HK, et al. . Efficacy and safety of dexmedetomidine for postoperative delirium in adult cardiac surgery on cardiopulmonary bypass. Korean J Thorac Cardiovasc Surg. 2014;47(3):249&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4157475</ArticleId><ArticleId IdType="pubmed">25207222</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Yang J, Nie XL, et al. . Impact of dexmedetomidine on the incidence of delirium in elderly patients after cardiac surgery: a randomized controlled trial. PLoS One. 2017;12(2):e0170757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5300174</ArticleId><ArticleId IdType="pubmed">28182690</ArticleId></ArticleIdList></Reference><Reference><Citation>Soliman R, Zohry G.. The myocardial protective effect of dexmedetomidine in high-risk patients undergoing aortic vascular surgery. Ann Card Anaesth. 2016;19(4):606&#x2013;613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070319</ArticleId><ArticleId IdType="pubmed">27716690</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho JS, Shim JK, Soh S, et al. . Perioperative dexmedetomidine reduces the incidence and severity of acute kidney injury following valvular heart surgery. Kidney Int. 2016;89(3):693&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pubmed">26444030</ArticleId></ArticleIdList></Reference><Reference><Citation>Shehabi Y, Grant P, Wolfenden H, et al. . Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial (DEXmedetomidine COmpared to Morphine-DEXCOM study). Anesthesiology. 2009;111(5):1075&#x2013;1084.</Citation><ArticleIdList><ArticleId IdType="pubmed">19786862</ArticleId></ArticleIdList></Reference><Reference><Citation>Leino K, Hynynen M, Jalonen J, the Dexmedetomidine in Cardiac Surgery Study Group, et al.. Renal effects of dexmedetomidine during coronary artery bypass surgery: a randomized placebo-controlled study. BMC Anesthesiol. 2011;11(1):9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3123640</ArticleId><ArticleId IdType="pubmed">21605394</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng K, Li D, Applegate RL, 2nd, et al. . Effect of dexmedetomidine on cardiac Surgery-Associated acute kidney injury: a Meta-Analysis with trial sequential analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2020;34(3):603&#x2013;613.</Citation><ArticleIdList><ArticleId IdType="pubmed">31587928</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao J, Wan W, Zhang Y, et al. . Administration of dexmedetomidine does not produce long-term protective effect on testicular damage post testicular Ischemia-Reperfusion injury. Drug Des Devel Ther. 2021;15:315&#x2013;321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850429</ArticleId><ArticleId IdType="pubmed">33536744</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Sheng B, Wang S, et al. . Dexmedetomidine prevents acute kidney injury after adult cardiac surgery: a meta-analysis of randomized controlled trials. BMC Anesthesiol. 2018;18(1):7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5769334</ArticleId><ArticleId IdType="pubmed">29334927</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman RM, Sharpe MD, Jagger JE, et al. . 36th international symposium on intensive care and emergency medicine: Brussels, Belgium. 15&#x2013;18 march 2016. Crit Care. 20:94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5493079</ArticleId><ArticleId IdType="pubmed">27885969</ArticleId></ArticleIdList></Reference><Reference><Citation>Turan A, Duncan A, Leung S, et al. . Dexmedetomidine for reduction of atrial fibrillation and delirium after cardiac surgery (DECADE): a randomised placebo-controlled trial. Lancet. 2020;396(10245):177&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">32682483</ArticleId></ArticleIdList></Reference><Reference><Citation>Skrobik Y, Duprey MS, Hill NS, et al. . Low-Dose nocturnal dexmedetomidine prevents ICU delirium. A randomized, placebo-controlled trial. Am J Respir Crit Care Med. 2018;197(9):1147&#x2013;1156.</Citation><ArticleIdList><ArticleId IdType="pubmed">29498534</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasin L, Landoni G, Nardelli P, et al. . Dexmedetomidine reduces the risk of delirium, agitation and confusion in critically ill patients: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2014;28(6):1459&#x2013;1466.</Citation><ArticleIdList><ArticleId IdType="pubmed">25034724</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Wu J, Hu Z, et al. . Dexmedetomidine alleviates lipopolysaccharide-induced acute kidney injury by inhibiting p75NTR-mediated oxidative stress and apoptosis. Oxid Med Cell Longev. 2020;2020:5454210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7648709</ArticleId><ArticleId IdType="pubmed">33194004</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Feng X, Li B, et al. . Dexmedetomidine protects against Lipopolysaccharide-Induced acute kidney injury by enhancing autophagy through inhibition of the PI3K/AKT/mTOR pathway. Front Pharmacol. 2020;11:128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7052304</ArticleId><ArticleId IdType="pubmed">32158395</ArticleId></ArticleIdList></Reference><Reference><Citation>Ninni S, Seunes C, Ortmans S, et al. . Peri-operative acute kidney injury upon cardiac surgery time-of-day. Int J Cardiol. 2018;272:54&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">30077533</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28803772</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>6</Issue><PubDate><Year>2017</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Perioperative Statins Do Not Prevent Acute Kidney Injury After Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials.</ArticleTitle><Pagination><StartPage>2086</StartPage><EndPage>2092</EndPage><MedlinePgn>2086-2092</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2017.04.038</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(17)30430-5</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To evaluate whether perioperative statins reduce the risk of acute kidney injury (AKI) after cardiac surgery.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Systematic review and meta-analysis of randomized trials.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Perioperative management in hospitals that perform cardiac surgery.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Adult patients undergoing cardiac surgery.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">PubMed, EMBASE, and the Cochrane Library databases were searched for randomized trials. Random-effects meta-analyses were performed to compare the effects of statins versus placebo/control. Trial sequential analysis was conducted to confirm the results.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">The primary outcome was incidence of postoperative AKI. Eight trials enrolling 3,204 patients were included. The statin arms and the control arms were comparable in incidence of postoperative AKI (risk ratio [RR] = 1.02, 95% confidence interval [CI] = 0.82-1.28), need for renal replacement therapy (RR = 1.09, 95% CI = 0.45-2.66), mechanical ventilation duration (mean difference [MD] = 24.84 min, 95% CI = -55.53-105.20), intensive care unit length of stay (MD = 0.04 days, 95% CI = -3.13-3.20), hospital length of stay (MD = -0.08 days, 95% CI = -0.31-0.15), and in-hospital mortality (RR = 3.76, 95% CI = 0.93-15.14). Trial sequential analysis confirmed that it is unlikely that perioperative statin therapy could achieve a 20% or more relative risk reduction in AKI incidence.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Among patients undergoing cardiac surgery, perioperative statin treatment did not reduce the risk of AKI. Statin therapy should not be initiated to prevent AKI following cardiac surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Bing-Cheng</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Pu</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ke-Xuan</ForeName><Initials>KX</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, China. Electronic address: liukexuan507@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>04</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019161">Hydroxymethylglutaryl-CoA Reductase Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Cardiothorac Vasc Anesth. 2017 Dec;31(6):2093-2095. doi: 10.1053/j.jvca.2017.06.003.</RefSource><PMID Version="1">28939318</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019161" MajorTopicYN="N">Hydroxymethylglutaryl-CoA Reductase Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="Y">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">statin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28803772</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2017.04.038</ArticleId><ArticleId IdType="pii">S1053-0770(17)30430-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39878550</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-9159</ISSN><JournalIssue CitedMedium="Internet"><Volume>111</Volume><Issue>4</Issue><PubDate><Year>2025</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of surgery (London, England)</Title><ISOAbbreviation>Int J Surg</ISOAbbreviation></Journal><ArticleTitle>Individualized blood pressure regulation and acute kidney injury in older patients having major abdominal surgery: a pilot randomized trial.</ArticleTitle><Pagination><StartPage>2894</StartPage><EndPage>2902</EndPage><MedlinePgn>2894-2902</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/JS9.0000000000002289</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute kidney injury (AKI) is a common postoperative complication, and hypotension may contribute. We therefore tested the primary hypothesis that individualized intraoperative blood pressure regulation reduces postoperative AKI in older surgical patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We enrolled patients &#x2265;60&#xa0;years old scheduled for elective major abdominal surgery with invasive arterial pressure monitoring. All had goal-directed fluid management based on stroke volume variation cardiac output, and administration of a starch. Participants were randomly assigned to: (1) individualized blood pressure management targeting a systolic blood pressure (SBP) within -20% and&#xa0;+10% if baseline SBP was &#x2265;130&#xa0;mmHg or diastolic blood pressure was &#x2265;80&#xa0;mmHg, or otherwise, to target SBP within&#xa0;&#xb1;10% of the baseline value; (2) maintenance of SBP &#x2265;90&#xa0;mmHg and MAP &#x2265;65&#xa0;mmHg. Metaraminol was used to achieve the blood pressure target. AKI incidence was assessed by Kidney Disease Improving Global Outcomes criteria during the initial 7 postoperative days.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">192 patients were assigned to individualized ( n =&#xa0;96) or routine ( n =&#xa0;96) pressure management. 179 patients were included in the intention-to-treat analysis. Age averaged 68&#xa0;&#xb1;&#xa0;5 (SD) years and 64% were male. Randomization to the individualized management reduced the area under MAP &lt;65&#xa0;mmHg (median difference:&#xa0;-37 [-47 to -25] mmHg-minute, P &lt; 0.001]. The incidence of the AKI was 11% in patients assigned to individualized management vs. 16 % in those assigned to routine management: relative risk 0.72 (95% confidence interval, 0.34-1.54), P =&#xa0;0.396. Patients assigned to individualized pressure management had more urine output, a shorter postoperative mechanical ventilation duration, and faster recovery of bowel function.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Individualized blood pressure management markedly reduced hypotension. As expected in a pilot trial, the 28% reduction in AKI was not statistically significant. However, the reduction was clinically meaningful and suggests that a full trial is warranted.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pang</LastName><ForeName>Zhaohua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Zhujiang Hospital of Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Shuang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Nannan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Xiaoyan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Qulian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>Center for Outcomes Research and Department of Anesthesiology, UTHealth, Houston, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Wangyuan</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Centre for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Surg</MedlineTA><NlmUniqueID>101228232</NlmUniqueID><ISSNLinking>1743-9159</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="Y">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="Y">Blood Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="N">Monitoring, Intraoperative</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">anesthesia</Keyword><Keyword MajorTopicYN="N">individualized</Keyword><Keyword MajorTopicYN="N">intraoperative hypotension</Keyword><Keyword MajorTopicYN="N">major abdominal surgery</Keyword><Keyword MajorTopicYN="N">older patients</Keyword></KeywordList><CoiStatement>DIS is an advisor for perceptive medical.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>16</Day><Hour>18</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>1</Month><Day>29</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>1</Month><Day>29</Day><Hour>9</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39878550</ArticleId><ArticleId IdType="pmc">PMC12175809</ArticleId><ArticleId IdType="doi">10.1097/JS9.0000000000002289</ArticleId><ArticleId IdType="pii">01279778-990000000-02134</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yokota LG, Sampaio BM, Rocha EP, et al. Acute kidney injury in elderly patients: narrative review on incidence, risk factors, and mortality. Int J Nephrol Renovasc Dis 2018;11:217&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6097506</ArticleId><ArticleId IdType="pubmed">30147352</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg AX, Kurz A, Sessler DI, et al. Perioperative aspirin and clonidine and risk of acute kidney injury: a randomized clinical trial. Jama 2014;312:2254&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">25399007</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco C, Bellomo R, Kellum JA. Acute kidney injury. Lancet (London, England) 2019;394:1949&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">31777389</ArticleId></ArticleIdList></Reference><Reference><Citation>French WB, Shah PR, Fatani YI, et al. Mortality and costs associated with acute kidney injury following major elective, non-cardiac surgery. J Clin Anesth 2022;82:110933.</Citation><ArticleIdList><ArticleId IdType="pubmed">35933842</ArticleId></ArticleIdList></Reference><Reference><Citation>Turan A, Cohen B, Adegboye J, et al. Mild acute kidney injury after noncardiac surgery is associated with long-term renal dysfunction: a retrospective cohort study. Anesthesiology 2020;132:1053&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">31929326</ArticleId></ArticleIdList></Reference><Reference><Citation>Gumbert SD, Kork F, Jackson ML, et al. Perioperative acute kidney injury. Anesthesiology 2020;132:180&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10924686</ArticleId><ArticleId IdType="pubmed">31687986</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok V, Nixon J, Hu J, et al. The impact of perioperative acute kidney injury/failure on short and long surgical outcomes. Anesthesiol Perioper Sci 2023;1:9.</Citation></Reference><Reference><Citation>Kouz K, Hoppe P, Briesenick L, et al. Intraoperative hypotension: pathophysiology, clinical relevance, and therapeutic approaches. Indian J Anaesth 2020;64:90&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7017666</ArticleId><ArticleId IdType="pubmed">32139925</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory A, Stapelfeldt WH, Khanna AK, et al. Intraoperative hypotension is associated with adverse clinical outcomes after noncardiac surgery. Anesthesia Analg 2021;132:1654&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8115733</ArticleId><ArticleId IdType="pubmed">33177322</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijnberge M, Geerts BF, Hol L, et al. Effect of a machine learning-derived early warning system for intraoperative hypotension vs standard care on depth and duration of intraoperative hypotension during elective noncardiac surgery: the HYPE randomized clinical trial. Jama 2020;323:1052&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7078808</ArticleId><ArticleId IdType="pubmed">32065827</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Lefrant JY, Guinot PG, et al. Effect of individualized vs standard blood pressure management strategies on postoperative organ dysfunction among high-risk patients undergoing major surgery: a randomized clinical trial. Jama 2017;318:1346&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5710560</ArticleId><ArticleId IdType="pubmed">28973220</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanner PM, Wulff DU, Djurdjevic M, et al. Targeting higher intraoperative blood pressures does not reduce adverse cardiovascular events following noncardiac surgery. J Am Coll Cardiol 2021;78:1753&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">34711333</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis MR, Naik BI, Freundlich RE, et al. Preoperative risk and the association between hypotension and postoperative acute kidney injury. Anesthesiology 2020;132:461&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7015776</ArticleId><ArticleId IdType="pubmed">31794513</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackland GL, Brudney CS, Cecconi M, et al. Perioperative quality initiative consensus statement on the physiology of arterial blood pressure control in perioperative medicine. Br J Anaesth 2019;122:542&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">30916002</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng L, Yu W, Wang T, et al. Blood pressure targets in perioperative care. Hypertension (Dallas, Tex: 1979) 2018;72:806&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">30354725</ArticleId></ArticleIdList></Reference><Reference><Citation>Langer T, Santini A, Zadek F, et al. Intraoperative hypotension is not associated with postoperative cognitive dysfunction in elderly patients undergoing general anesthesia for surgery: results of a randomized controlled pilot trial. J Clin Anesth 2019;52:111&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">30243062</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson S, Eldadah B, Halter JB, et al. Acute kidney injury in older adults. J Am Soc Nephrol 2011;22:28&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">21209252</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG. Acute kidney injury in elderly persons. Am J Kidney Dis 2010;56:122&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2902696</ArticleId><ArticleId IdType="pubmed">20346560</ArticleId></ArticleIdList></Reference><Reference><Citation>Butcher NJ, Monsour A, Mew EJ, et al. Guidelines for reporting outcomes in trial reports: the CONSORT-outcomes 2022 extension. Jama 2022;328:2252&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">36511921</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou LC, Li SZ, Xiong LZ, et al. Effect of dopamine and metaraminol on the renal function of patients with septic shock. Chinese Med J 2007;120:680&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">17517184</ArticleId></ArticleIdList></Reference><Reference><Citation>Lankadeva YR, Cochrane AD, Marino B, et al. Strategies that improve renal medullary oxygenation during experimental cardiopulmonary bypass may mitigate postoperative acute kidney injury. Kidney Int 2019;95:1338&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">31005272</ArticleId></ArticleIdList></Reference><Reference><Citation>Sessler DI, Bloomstone JA, Aronson S, et al. Perioperative quality initiative consensus statement on intraoperative blood pressure, risk and outcomes for elective surgery. Br J Anaesth 2019;122:563&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">30916004</ArticleId></ArticleIdList></Reference><Reference><Citation>Bijker JB, van Klei WA, Kappen TH, et al. Incidence of intraoperative hypotension as a function of the chosen definition: literature definitions applied to a retrospective cohort using automated data collection. Anesthesiology 2007;107:213&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">17667564</ArticleId></ArticleIdList></Reference><Reference><Citation>Inker LA, Eneanya ND, Coresh J, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. New Engl J Med 2021;385:1737&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8822996</ArticleId><ArticleId IdType="pubmed">34554658</ArticleId></ArticleIdList></Reference><Reference><Citation>Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 2001;286:2703&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">11730446</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Wu Y, Yue P, et al. Delirium assessment using confusion assessment method for the intensive care unit in Chinese critically ill patients. J Crit Care 2013;28:223&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">23159138</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012;120:c179&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Biteker M, Dayan A, Tekke&#x15f;in A, et al. Incidence, risk factors, and outcomes of perioperative acute kidney injury in noncardiac and nonvascular surgery. Am J Surg 2014;207:53&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">24050540</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge S, Nie S, Liu Z, et al. Epidemiology and outcomes of acute kidney injury in elderly Chinese patients: a subgroup analysis from the EACH study. BMC Nephrol 2016;17:136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5041437</ArticleId><ArticleId IdType="pubmed">27682843</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor ME, Kirwan CJ, Pearse RM, et al. Incidence and associations of acute kidney injury after major abdominal surgery. Intensive Care Med 2016;42:521&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">26602784</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocks K, Torgerson DJ. Sample size calculations for pilot randomized trials: a confidence interval approach. J Clin Epidemiol 2013;66:197&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">23195919</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesselink EM, Wagemakers SH, van Waes JAR, et al. Associations between intraoperative hypotension, duration of surgery and postoperative myocardial injury after noncardiac surgery: a retrospective single-centre cohort study. Br J Anaesth 2022;129:487&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">36064492</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun LY, Wijeysundera DN, Tait GA, et al. Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology 2015;123:515&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">26181335</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimada T, Mascha EJ, Yang D, et al. Intra-operative hypertension and myocardial injury and/or mortality and acute kidney injury after noncardiac surgery: a retrospective cohort analysis. Eur J Anaesthesiol 2022;39:315&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">35066561</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidebotham D, Barlow CJ. The winner&#x2019;s curse: why large effect sizes in discovery trials always get smaller and often disappear completely. Anaesthesia 2024;79:86&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">37889911</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P, Ware JH, Mehta C. Sample size re-estimation for adaptive sequential design in clinical trials. J Biopharm Stat 2008;18:1184&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">18991116</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesselink EM, Kappen TH, Torn HM, et al. Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review. Br J Anaesth 2018;121:706&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">30236233</ArticleId></ArticleIdList></Reference><Reference><Citation>Lankadeva YR, May CN, Bellomo R, et al. Role of perioperative hypotension in postoperative acute kidney injury: a narrative review. Br J Anaesth 2022;128:931&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">35465952</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y, Zhu C, Liu J, et al. Association of intraoperative hypotension with acute kidney injury after noncardiac surgery in patients younger than 60 years old. Kidney Blood Pressure Res 2019;44:211&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">30928979</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang Z, Liang S, Xing M, et al. The correlation of intraoperative oliguria with acute kidney injury after noncardiac surgery: a systematic review and meta-analysis. International J Surg (London, England) 2023;109:449&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10389605</ArticleId><ArticleId IdType="pubmed">36912515</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Kirwan CJ, Bellomo R. Fluid management for the prevention and attenuation of acute kidney injury. Nat Rev Nephrol 2014;10:37&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">24217464</ArticleId></ArticleIdList></Reference><Reference><Citation>Legrand M, Kothari R, Fong N, et al. Norepinephrine versus phenylephrine for treating hypotension during general anaesthesia in adult patients undergoing major noncardiac surgery: a multicentre, open-label, cluster-randomised, crossover, feasibility, and pilot trial. Br J Anaesth 2023;130:519&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">36925330</ArticleId></ArticleIdList></Reference><Reference><Citation>Devereaux PJ, Biccard BM, Sigamani A, et al. Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery. Jama 2017;317:1642&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">28444280</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmasi V, Maheshwari K, Yang D, et al. Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery: a retrospective cohort analysis. Anesthesiology 2017;126:47&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">27792044</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarychanski R, Abou-Setta AM, Turgeon AF, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. Jama 2013;309:678&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">23423413</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagore D, Candela A, B&#xfc;rge M, et al. Hydroxyethyl starch and acute kidney injury in high-risk patients undergoing cardiac surgery: a prospective multicenter study. J Clin Anesth 2021;73:110367.</Citation><ArticleIdList><ArticleId IdType="pubmed">34090184</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang MJ, Chen N, Ye CY, et al. Association between hydroxyethyl starch 130/0.4 administration during noncardiac surgery and postoperative acute kidney injury: a propensity score-matched analysis of a large cohort in China. J Clin Anesth 2024;96:111493.</Citation><ArticleIdList><ArticleId IdType="pubmed">38723416</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40372573</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1438-8359</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>4</Issue><PubDate><Year>2025</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of anesthesia</Title><ISOAbbreviation>J Anesth</ISOAbbreviation></Journal><ArticleTitle>Prophylactic corticosteroids in neonatal cardiac surgeries using cardiopulmonary bypass: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>577</StartPage><EndPage>589</EndPage><MedlinePgn>577-589</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00540-025-03506-w</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Neonates undergoing cardiopulmonary bypass (CPB) are at a high risk of a systemic inflammatory response leading to cardiac, respiratory, and renal dysfunction due to their small body size and insufficient adrenal stress response. We hypothesized that corticosteroids reduce systemic inflammatory response and improve clinical outcomes in neonates undergoing cardiac surgery with CPB.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic search was conducted on six databases including MEDLINE from their inceptions to August 20, 2024. Inclusion criteria were randomized controlled trials (RCTs) comparing corticosteroids and placebo in neonates undergoing cardiac surgery with CPB. The primary outcomes were IL-6 and IL-10 serum levels. The secondary outcomes were postoperative clinical outcomes such as length of intensive care unit (ICU) stay, mortality, and incidence of acute kidney injury. Pooled risk ratios or mean differences (MDs) and 95% confidence intervals (CIs) were calculated using random-effects meta-analysis. Certainty of evidence were assessed following GRADE. This study was registered in PROSPERO (CRD42024548217).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seven RCTs met all inclusion criteria, consisting of 316 patients. Administration of corticosteroids significantly decreased plasma IL-6 on POD1 (MD -64.21&#xa0;pg/mL, 95% CI -118.26 to -10.16) and plasma IL-10 on POD1 (MD -&#xa0;4.60&#xa0;pg/mL, 95% CI -&#xa0;8.07 to -&#xa0;1.12). We confirmed corticosteroids administration did not improve clinical outcomes.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Corticosteroids significantly reduced inflammatory cytokines on POD1. Routine prophylactic use of corticosteroids is not recommended even in neonatal cardiac surgery, however, because of high incidence of adrenal insufficiency in neonates after cardiac surgery with CPB, neonates with clinically suspected adrenal insufficiency could benefit from perioperative corticosteroids administration.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s) under exclusive licence to Japanese Society of Anesthesiologists.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kataoka</LastName><ForeName>Kumi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, 555 University Ave, #2211, Toronto, ON, M5G 1X8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Sierra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sumie</LastName><ForeName>Makoto</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, 555 University Ave, #2211, Toronto, ON, M5G 1X8, Canada. makoto.sumie@sickkids.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada. makoto.sumie@sickkids.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program in Child Health Evaluative Sciences, SickKids Research Institute, Toronto, ON, Canada. makoto.sumie@sickkids.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, St. Mary's Hospital, Fukuoka, Japan. makoto.sumie@sickkids.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. makoto.sumie@sickkids.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adam</LastName><ForeName>Ruxandra-Ioana</ForeName><Initials>RI</Initials><AffiliationInfo><Affiliation>Department of Psychology, Queen's University, Kingston, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niimi</LastName><ForeName>Naoko</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, 555 University Ave, #2211, Toronto, ON, M5G 1X8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cunningham</LastName><ForeName>Jessie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Hospital for Sick Children, Health Sciences Library, 555 University Avenue, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Alan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Program in Child Health Evaluative Sciences, SickKids Research Institute, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>William C K</ForeName><Initials>WCK</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, 555 University Ave, #2211, Toronto, ON, M5G 1X8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayes</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, 555 University Ave, #2211, Toronto, ON, M5G 1X8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maynes</LastName><ForeName>Jason T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, 555 University Ave, #2211, Toronto, ON, M5G 1X8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program in Molecular Medicine, SickKids Research Institute, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aoyama</LastName><ForeName>Kazuyoshi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, 555 University Ave, #2211, Toronto, ON, M5G 1X8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program in Child Health Evaluative Sciences, SickKids Research Institute, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PJX179857</GrantID><Acronym>CAPMC</Acronym><Agency> CIHR</Agency><Country>Canada</Country></Grant><Grant><GrantID>PJT183603</GrantID><Acronym>CAPMC</Acronym><Agency> CIHR</Agency><Country>Canada</Country></Grant><Grant><GrantID>PJX179857</GrantID><Acronym>CAPMC</Acronym><Agency> CIHR</Agency><Country>Canada</Country></Grant><Grant><GrantID>PJT183603</GrantID><Acronym>CAPMC</Acronym><Agency> CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>J Anesth</MedlineTA><NlmUniqueID>8905667</NlmUniqueID><ISSNLinking>0913-8668</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical><Chemical><RegistryNumber>130068-27-8</RegistryNumber><NameOfSubstance UI="D016753">Interleukin-10</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="Y">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="Y">Adrenal Cortex Hormones</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016753" MajorTopicYN="N">Interleukin-10</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac surgical procedures</Keyword><Keyword MajorTopicYN="N">Cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Newborn</Keyword><Keyword MajorTopicYN="N">Steroids</Keyword></KeywordList><CoiStatement>Declarations. Conflict of interest: All authors declare no conflict of interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>29</Day><Hour>18</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>15</Day><Hour>12</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>15</Day><Hour>11</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40372573</ArticleId><ArticleId IdType="doi">10.1007/s00540-025-03506-w</ArticleId><ArticleId IdType="pii">10.1007/s00540-025-03506-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Costello JM, Pasquali SK, Jacobs JP, He X, Hill KD, Cooper DS, Backer CL, Jacobs ML. Gestational age at birth and outcomes after neonatal cardiac surgery: an analysis of the society of thoracic surgeons congenital heart surgery database. Circulation. 2014;129:2511&#x2013;7. https://doi.org/10.1161/CIRCULATIONAHA.113.005864/-/DC1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.113.005864/-/DC1</ArticleId></ArticleIdList></Reference><Reference><Citation>Steurer MA, Peyvandi S, Costello JM, Moon-Grady AJ, Habib RH, Hill KD, Jacobs ML, Jelliffe-Pawlowski LL, Keller RL, Pasquali SK, Reddy VM. Association between Z-score for birth weight and postoperative outcomes in neonates and infants with congenital heart disease. J Thorac Cardiovasc Surg. 2021;162:1838-1847.e4. https://doi.org/10.1016/j.jtcvs.2021.01.065 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2021.01.065</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1993;55:552&#x2013;9. https://doi.org/10.1016/0003-4975(93)91048-R .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-4975(93)91048-R</ArticleId></ArticleIdList></Reference><Reference><Citation>Seghaye MC, Duchateau J, Bruniaux J, Demontoux S, Bosson C, Serraf A, Lecronier G, Mokhfi E, Planch&#xe9; C. Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations. J Thorac Cardiovasc Surg. 1996;111:545&#x2013;53. https://doi.org/10.1016/S0022-5223(96)70306-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-5223(96)70306-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler J, Pathi VL, Paton RD, Logan RW, MacArthur KJ, Jamieson MP, Pollock JC. Acute-phase responses to cardiopulmonary bypass in children weighing less than 10 kilograms. Ann Thorac Surg. 1996;62:538&#x2013;42.</Citation></Reference><Reference><Citation>Finn A, Naik S, Klein N, Levinsky RJ, Strobel S, Elliott M. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1993;105:234&#x2013;41.</Citation></Reference><Reference><Citation>Steinberg JB, Kapelanski DP, Olson JD, Weiler JM. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1993;106:1008&#x2013;16.</Citation></Reference><Reference><Citation>Kawamura T, Wakusawa R, Okada K, Inadat S. Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury. Can J Anaesth. 1993;40:1016&#x2013;21. https://doi.org/10.1007/BF03009470/METRICS .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03009470/METRICS</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcaraz AJ, Manzano L, Sancho L, Vigil MD, Esquivel F, Maroto E, Reyes E, Alvarez-Mon M. Different proinflammatory cytokine serum pattern in neonate patients undergoing open heart surgery. Relevance of IL-8. J Clin Immunol. 2005;25:238&#x2013;45. https://doi.org/10.1007/S10875-005-4081-7/METRICS .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S10875-005-4081-7/METRICS</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashraf SS, Tian Y, Zacharrias S, Cowan D, Martin P, Watterson K. Effects of cardiopulmonary bypass on neonatal and paediatric inflammatory profiles. Eur J Cardio Thorac Surg. 1997;12:862&#x2013;8. https://doi.org/10.1016/S1010-7940(97)00261-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1010-7940(97)00261-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozik DJ, Tweddell JS. Characterizing the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg. 2006;81:S2347&#x2013;54. https://doi.org/10.1016/j.athoracsur.2006.02.073 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2006.02.073</ArticleId></ArticleIdList></Reference><Reference><Citation>Gist KM, Blinder JJ, Bailly D, Borasino S, Askenazi DJ, Cooper DS, Krawczeski CD, Gaies M, Morales DL, Hock KM, Alten J. Neonatal and paediatric heart and renal outcomes network: design of a multi-centre retrospective cohort study. Cardiol Young. 2019;29:511&#x2013;8. https://doi.org/10.1017/S1047951119000210 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1047951119000210</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan CJ, Zappitelli M, Robertson CMT, Alton GY, Sauve RS, Joffe AR, Ross DB, Rebeyka IM. Risk factors for and outcomes of acute kidney injury in neonates undergoing complex cardiac surgery. J Pediatr. 2013;162:120-127.e1. https://doi.org/10.1016/j.jpeds.2012.06.054 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2012.06.054</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang A, Rosenfeld CR, Mikhael M, McPhaul MJ, Koch JD. Adrenal insufficiency in neonates undergoing cardiopulmonary bypass and postoperative hypothalamic-pituitary-adrenal function after prophylactic glucocorticoids. J Perinatol. 2019;39(5):640&#x2013;7. https://doi.org/10.1038/s41372-019-0344-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41372-019-0344-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Checchia PA, Bronicki RA, Costello JM, Nelson DP. Steroid use before pediatric cardiac operations using cardiopulmonary bypass: an international survey of 36 centers. Pediatr Crit Care Med. 2005;6:441&#x2013;4. https://doi.org/10.1097/01.PCC.0000163678.20704.C5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.PCC.0000163678.20704.C5</ArticleId></ArticleIdList></Reference><Reference><Citation>Fudulu DP, Schadenberg A, Gibbison B, Jenkins I, Lightman S, Angelini GD, Stoica S. Corticosteroids and other anti-inflammatory strategies in pediatric heart surgery: a national survey of practice. World J Pediatr Congenit Heart Surg. 2018;9:289&#x2013;93. https://doi.org/10.1177/2150135118762392 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2150135118762392</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeshita J, Nakajima Y, Tachibana K, Takeuchi M, Shime N. Efficacy of perioperative prophylactic administration of corticosteroids in pediatric cardiac surgeries using cardiopulmonary bypass: a systematic review with meta-analysis. Anaesth Crit Care Pain Med. 2023. https://doi.org/10.1016/J.ACCPM.2023.101281 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.ACCPM.2023.101281</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med. 2021;18:372.</Citation></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:1&#x2013;8. https://doi.org/10.1186/CC5713/COMMENTS .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/CC5713/COMMENTS</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson J, Tong S, Hancock H, Hauck A, Da Cruz E, Kaufman J. Prospective validation of the vasoactive-inotropic score and correlation to short-term outcomes in neonates and infants after cardiothoracic surgery. Intensiv Care Med. 2012;38:1184&#x2013;90. https://doi.org/10.1007/S00134-012-2544-X/METRICS .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00134-012-2544-X/METRICS</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:698&#x2013;702. https://doi.org/10.1136/BMJ.C332 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ.C332</ArticleId></ArticleIdList></Reference><Reference><Citation>Meikle AW, Tyler FH. Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function. Am J Med. 1977;63:200&#x2013;7. https://doi.org/10.1016/0002-9343(77)90233-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(77)90233-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S, Zhao Z, Liu X, Shu Q, Tan L, Lin R, Shi Z, Fang X. Perioperative risk factors for prolonged mechanical ventilation following cardiac surgery in neonates and young infants. Chest. 2008;134:768&#x2013;74.</Citation></Reference><Reference><Citation>Mitchell M, Muftakhidinov B, Winchen T, Trande A (2024) Engauge Digitizer Software. http://markummitchell.github.io/engauge-digitizer . Accessed 15 Aug 2024</Citation></Reference><Reference><Citation>Basaran M, Sever K, Kafali E, Ugurlucan M, Sayin OA, Tansel T, Alpagut U, Dayioglu E, Onursal E. Serum lactate level has prognostic significance after pediatric cardiac surgery. J Cardiothorac Vasc Anesth. 2006;20:43&#x2013;7. https://doi.org/10.1053/j.jvca.2004.10.010 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2004.10.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Duke T, Butt W, South M, Karl TR. Early markers of major adverse events in children after cardiac operations. J Thorac Cardiovasc Surg. 1997;114:1042&#x2013;52. https://doi.org/10.1016/S0022-5223(97)70018-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-5223(97)70018-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI. Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg. 2002;123:110&#x2013;8. https://doi.org/10.1067/mtc.2002.119064 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mtc.2002.119064</ArticleId></ArticleIdList></Reference><Reference><Citation>Padley JR, Cole AD, Pye VE, Chard RB, Nicholson IA, Jacobe S, Baines D, Badawi N, Walker K, Scarfe G, Leclair K, Sholler GF, Winlaw DS. Five-year analysis of operative mortality and neonatal outcomes in congenital heart disease. Heart Lung Circ. 2011;20:460&#x2013;7. https://doi.org/10.1016/j.hlc.2011.03.009 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2011.03.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Savovi&#x107; J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019. https://doi.org/10.1136/BMJ.L4898 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ.L4898</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Coello PA, Guyatt GH, Yepes-Nu&#xf1;ez JJ, Akl EA, Hazlewood G, Pardo-Hernandez H, Etxeandia-Ikobaltzeta I, Qaseem A, Williams JW, Tugwell P, Flottorp S, Chang Y, Zhang Y, Mustafa RA, Rojas MX, Xie F, Sch&#xfc;nemann HJ. GRADE guidelines: 20. Assessing the certainty of evidence in the importance of outcomes or values and preferences&#x2014;inconsistency, imprecision, and other domains. J Clin Epidemiol. 2019;111:83&#x2013;93. https://doi.org/10.1016/j.jclinepi.2018.05.011 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2018.05.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Alonso-Coello P, Guyatt GH, Yepes-Nu&#xf1;ez JJ, Akl EA, Hazlewood G, Pardo-Hernandez H, Etxeandia-Ikobaltzeta I, Qaseem A, Williams JW, Tugwell P, Flottorp S, Chang Y, Zhang Y, Mustafa RA, Rojas MX, Sch&#xfc;nemann HJ. GRADE guidelines: 19. Assessing the certainty of evidence in the importance of outcomes or values and preferences&#x2014;risk of bias and indirectness. J Clin Epidemiol. 2019;111:94&#x2013;104. https://doi.org/10.1016/j.jclinepi.2018.01.013 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2018.01.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Santesso N, Glenton C, Dahm P, Garner P, Akl EA, Alper B, Brignardello-Petersen R, Carrasco-Labra A, De Beer H, Hultcrantz M, Kuijpers T, Meerpohl J, Morgan R, Mustafa R, Skoetz N, Sultan S, Wiysonge C, Guyatt G, Sch&#xfc;nemann HJ. GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions. J Clin Epidemiol. 2020;119:126&#x2013;35. https://doi.org/10.1016/j.jclinepi.2019.10.014 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2019.10.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629&#x2013;34. https://doi.org/10.1136/BMJ.315.7109.629 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ.315.7109.629</ArticleId></ArticleIdList></Reference><Reference><Citation>Ando M, Park IS, Wada N, Takahashi Y. Steroid supplementation: a legitimate pharmacotherapy after neonatal open heart surgery. Ann Thorac Surg. 2005;80:1672&#x2013;8. https://doi.org/10.1016/J.ATHORACSUR.2005.04.035 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.ATHORACSUR.2005.04.035</ArticleId></ArticleIdList></Reference><Reference><Citation>Keski-Nisula J, Pesonen E, Olkkola KT, Peltola K, Neuvonen PJ, Tuominen N, Sairanen H, Andersson S, Suominen PK. Methylprednisolone in neonatal cardiac surgery: reduced inflammation without improved clinical outcome. Ann Thorac Surg. 2013;95:2126&#x2013;32. https://doi.org/10.1016/J.ATHORACSUR.2013.02.013 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.ATHORACSUR.2013.02.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesonen E, Keski-Nisula J, Andersson S, Palo R, Salminen J, Suominen PK. High-dose methylprednisolone and endothelial glycocalyx in paediatric heart surgery. Acta Anaesthesiol Scand. 2016;60:1386&#x2013;94. https://doi.org/10.1111/AAS.12785 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/AAS.12785</ArticleId></ArticleIdList></Reference><Reference><Citation>Suominen PK, Keski-Nisula J, Ojala T, Rautiainen P, Jahnukainen T, H&#xe4;stbacka J, Neuvonen PJ, Pitk&#xe4;nen O, Niemel&#xe4; J, Kaskinen A, Salminen J, Lapatto R. Stress-dose corticosteroid versus placebo in neonatal cardiac operations: a randomized controlled trial. Ann Thorac Surg. 2017;104:1378&#x2013;85. https://doi.org/10.1016/J.ATHORACSUR.2017.01.111 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.ATHORACSUR.2017.01.111</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahnukainen T, Keski-Nisula J, Tainio J, Valkonen H, P&#xe4;til&#xe4; T, Jalanko H, Suominen P. Efficacy of corticosteroids in prevention of acute kidney injury in neonates undergoing cardiac surgery&#x2014;a randomized controlled trial. Acta Anaesthesiol Scand. 2018;62:1072&#x2013;9. https://doi.org/10.1111/AAS.13134 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/AAS.13134</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EM, Martin RH, Buckley JR, Zyblewski SC, Kavarana MN, Bradley SM, Alsoufi B, Mahle WT, Hassid M, Atz AM. Corticosteroid therapy in neonates undergoing cardiopulmonary bypass: randomized controlled trial. J Am Coll Cardiol. 2019;74:659&#x2013;68. https://doi.org/10.1016/J.JACC.2019.05.060 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JACC.2019.05.060</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaskinen AK, Keski-Nisula J, Martelius L, Moilanen E, H&#xe4;m&#xe4;l&#xe4;inen M, Rautiainen P, Andersson S, Pitk&#xe4;nen-Argillander OM. Lung injury after neonatal congenital cardiac surgery is mild and modifiable by corticosteroids. J Cardiothorac Vasc Anesth. 2021;35:2100&#x2013;7. https://doi.org/10.1053/J.JVCA.2021.01.017 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/J.JVCA.2021.01.017</ArticleId></ArticleIdList></Reference><Reference><Citation>Heying R, Wehage E, Schumacher K, Tassani P, Haas F, Lange R, Hess J, Seghaye M-C. Dexamethasone pretreatment provides antiinflammatory and myocardial protection in neonatal arterial switch operation. Ann Thorac Surg. 2012;93:869&#x2013;76. https://doi.org/10.1016/J.ATHORACSUR.2011.11.059 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.ATHORACSUR.2011.11.059</ArticleId></ArticleIdList></Reference><Reference><Citation>Fillinger MP, Rassias AJ, Guyre PM, Sanders JH, Beach M, Janice Pahl R, Brad Watson P, Whalen K, Yeo K-TJ, Yeager MP. Glucocorticoid effects on the inflammatory and clinical responses to cardiac surgery. J Cardiothorac Vasc Anesth. 2002;16:163&#x2013;9. https://doi.org/10.1053/jcan.2002.31057 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jcan.2002.31057</ArticleId></ArticleIdList></Reference><Reference><Citation>El Azab SR, Rosseel PMJ, de Lange JJ, Groeneveld ABJ, van Strik R, van Wijk EM, Scheffer GJ. Dexamethasone decreases the pro- to anti-inflammatory cytokine ratio during cardiac surgery. Br J Anaesth. 2002;88:496&#x2013;501. https://doi.org/10.1093/bja/88.4.496 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/88.4.496</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbison B, Lizardi JC, Mart&#xed;nez KI, Fudulu DP, Andrade MA, P&#xe9;rez-Gaxiola G, Schadenberg AW, Stoica SC, Lightman SL, Angelini GD, Reeves BC. Prophylactic corticosteroids for paediatric heart surgery with cardiopulmonary bypass. Cochrane Database Syst Rev. 2020. https://doi.org/10.1002/14651858.CD013101.PUB2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013101.PUB2</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheema HA, Khan AA, Ahmad AH, Khan AA, Khalid A, Shahid A, Hermis AH, Syed A, Bansal N, Yuki K, Ghelani SJ, Dani SS. Perioperative prophylactic corticosteroids for cardiac surgery in children: a systematic review and meta-analysis. Am Heart J. 2023;266:159&#x2013;67. https://doi.org/10.1016/J.AHJ.2023.09.006 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.AHJ.2023.09.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Losiggio R, Lomivorotov V, Ursoleo JD, Kotani Y, Monaco F, Milojevic M, Yavorovskiy A, Lee TC, Oriani A, Di Prima AL, Mucchetti M. The effects of corticosteroids on survival in pediatric and nonelderly adult patients undergoing cardiac surgery: a meta-analysis of randomized studies. J Cardiothorac Vasc Anesth. 2024. https://doi.org/10.1053/J.JVCA.2024.07.001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/J.JVCA.2024.07.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Jouan J, Golmard L, Benhamouda N, Durrleman N, Golmard J-L, Ceccaldi R, Trinquart L, Fabiani J-N, Tartour E, Jeunemaitre X, Menasch&#xe9; P. Gene polymorphisms and cytokine plasma levels as predictive factors of complications after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2012;144:467-473.e2. https://doi.org/10.1016/J.JTCVS.2011.12.022 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JTCVS.2011.12.022</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmartz D, Tabardel Y, Preiser JC, Barvais L, d&#x2019;Hollander A, Duchateau J, Vincent JL. Does aprotinin influence the inflammatory response to cardiopulmonary bypass in patients? J Thorac Cardiovasc Surg. 2003;125:184&#x2013;90. https://doi.org/10.1067/mtc.2003.64 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mtc.2003.64</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamura T, Wakusawa R, Inada K. Interleukin-10 and interleukin-1 receptor antagonists increase during cardiac surgery. Can J Anaesth. 1997;44:38&#x2013;42. https://doi.org/10.1007/BF03014322 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03014322</ArticleId></ArticleIdList></Reference><Reference><Citation>Minshawi F, Lanvermann S, McKenzie E, Jeffery R, Couper K, Papoutsopoulou S, Roers A, Muller W. The generation of an engineered interleukin-10 protein with improved stability and biological function. Front Immunol. 2020. https://doi.org/10.3389/fimmu.2020.01794 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01794</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen ML, Andreas Hoschtitzky J, Peters MJ, Elliott M, Goldman A, James I, Klein NJ. Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery. Crit Care Med. 2006;34:2658&#x2013;65. https://doi.org/10.1097/01.CCM.0000240243.28129.36 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000240243.28129.36</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Webb A. Oxford handbook of critical care. Oxford: Oxford University Press; 2009.</Citation></Reference><Reference><Citation>Congress F (1992) Notes and news Forthcoming events</Citation></Reference><Reference><Citation>Withington DE, Fontela PS, Harrington KP, Tchervenkov C, Lands LC. A comparison of three dose timings of methylprednisolone in infant cardiopulmonary bypass. Springerplus. 2014. https://doi.org/10.1186/2193-1801-3-484 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2193-1801-3-484</ArticleId></ArticleIdList></Reference><Reference><Citation>Varan B, Tokel K, Mercan S, D&#xf6;nmez A, Aslamaci S. Systemic inflammatory response related to cardiopulmonary bypass and its modification by methyl prednisolone: high dose versus low dose. Pediatr Cardiol. 2002;23:437&#x2013;41. https://doi.org/10.1007/s00246-002-0118-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00246-002-0118-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Keski-Nisula J, Pesonen E, Olkkola KT, Ahlroth T, Puntila J, Andersson S, Neuvonen PJ, Suominen PK. High-dose methylprednisolone has no benefit over moderate dose for the correction of tetralogy of fallot. Annal Thorac Surg. 2016;102:870&#x2013;6. https://doi.org/10.1016/j.athoracsur.2016.02.089 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2016.02.089</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawford JH, Hull MS, Borasino S, Steenwyk BL, Hock KM, Wall K, Alten JA. Adrenal insufficiency in neonates after cardiac surgery with cardiopulmonary bypass. Paediatr Anaesth. 2017;27:77&#x2013;84. https://doi.org/10.1111/PAN.13013 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/PAN.13013</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunst G, Milojevic M, Boer C, De Filip MJJ, Somer TG, van den Goor J, Jones TJ, Lomivorotov V, Merkle F, Ranucci M, Puis L, Wahba A, Alston P, Fitzgerald D, Nikolic A, Onorati F, Rasmussen BS, Svenmarker S. 2019 EACTS/EACTA/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery. Br J Anaesth. 2019;123:713&#x2013;57.</Citation></Reference><Reference><Citation>Palanzo DA, Wise RK, Woitas KR, &#xdc;ndar A, Clark JB, Myers JL. Safety and utility of modified ultrafiltration in pediatric cardiac surgery. Perfusion. 2023;38:150&#x2013;5. https://doi.org/10.1177/02676591211043697 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/02676591211043697</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasquali SK, Li JS, He X, Jacobs ML, O&#x2019;Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Gaynor JW. Perioperative methylprednisolone and outcome in neonates undergoing heart surgery. Pediatrics. 2012. https://doi.org/10.1542/peds.2011-2034 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2011-2034</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Xu Y, Yu H. Prophylactic corticosteroids for infants undergoing cardiac surgery with cardiopulmonary bypass: a systematic review and meta-analysis of randomized controlled trials. BMC Anesthesiol. 2024. https://doi.org/10.1186/s12871-024-02772-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-024-02772-7</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25758322</PMID><DateCompleted><Year>2015</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2015</Volume><Issue>3</Issue><PubDate><Year>2015</Year><Month>Mar</Month><Day>11</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass.</ArticleTitle><Pagination><StartPage>CD010480</StartPage><MedlinePgn>CD010480</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">CD010480</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD010480.pub2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute kidney injury (AKI) is common in patients undergoing cardiac surgery among whom it is associated with poor outcomes, prolonged hospital stays and increased mortality. Statin drugs can produce more than one effect independent of their lipid lowering effect, and may improve kidney injury through inhibition of postoperative inflammatory responses.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This review aimed to look at the evidence supporting the benefits of perioperative statins for AKI prevention in hospitalised adults after surgery who require cardiac bypass. The main objectives were to 1) determine whether use of statins was associated with preventing AKI development; 2) determine whether use of statins was associated with reductions in in-hospital mortality; 3) determine whether use of statins was associated with reduced need for RRT; and 4) determine any adverse effects associated with the use of statins.</AbstractText><AbstractText Label="SEARCH METHODS" NlmCategory="METHODS">We searched the Cochrane Renal Group's Specialised Register to 13 January 2015 through contact with the Trials' Search Co-ordinator using search terms relevant to this review.</AbstractText><AbstractText Label="SELECTION CRITERIA" NlmCategory="METHODS">Randomised controlled trials (RCTs) that compared administration of statin therapy with placebo or standard clinical care in adult patients undergoing surgery requiring cardiopulmonary bypass and reporting AKI, serum creatinine (SCr) or need for renal replacement therapy (RRT) as an outcome were eligible for inclusion. All forms and dosages of statins in conjunction with any duration of pre-operative therapy were considered for inclusion in this review.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS" NlmCategory="METHODS">All authors extracted data independently and assessments were cross-checked by a second author. Likewise, assessment of study risk of bias was initially conducted by one author and then by a second author to ensure accuracy. Disagreements were arbitrated among authors until consensus was reached. Authors from two of the included studies provided additional data surrounding post-operative SCr as well as need for RRT. Meta-analyses were used to assess the outcomes of AKI, SCr and mortality rate. Data for the outcomes of RRT and adverse effects were not pooled. Adverse effects taken into account were those reported by the authors of included studies.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">We included seven studies (662 participants) in this review. All except one study was assessed as being at high risk of bias. Three studies assessed atorvastatin, three assessed simvastatin and one investigated rosuvastatin. All studies collected data during the immediate perioperative period only; data collection to hospital discharge and postoperative biochemical data collection ranged from 24 hours to 7 days. Overall, pre-operative statin treatment was not associated with a reduction in postoperative AKI, need for RRT, or mortality. Only two studies (195 participants) reported postoperative SCr level. In those studies, patients allocated to receive statins had lower postoperative SCr concentrations compared with those allocated to no drug treatment/placebo (MD 21.2 &#xb5;mol/L, 95% CI -31.1 to -11.1). Adverse effects were adequately reported in only one study; no difference was found between the statin group compared to placebo.</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS" NlmCategory="CONCLUSIONS">Analysis of currently available data did not suggest that preoperative statin use is associated with decreased incidence of AKI in adults after surgery who required cardiac bypass. Although a significant reduction in SCr was seen postoperatively in people treated with statins, this result was driven by results from a single study, where SCr was considered as a secondary outcome. The results of the meta-analysis should be interpreted with caution; few studies were included in subgroup analyses, and significant differences in methodology exist among the included studies. Large high quality RCTs are required to establish the safety and efficacy of statins to prevent AKI after cardiac surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lewicki</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Monash Medical Centre, 246 Clayton Road, Clayton, VIC, Australia, 3168.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Irene</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Antoine G</ForeName><Initials>AG</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005464">Fluorobenzenes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006538">Heptanoic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019161">Hydroxymethylglutaryl-CoA Reductase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011758">Pyrroles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013449">Sulfonamides</NameOfSubstance></Chemical><Chemical><RegistryNumber>83MVU38M7Q</RegistryNumber><NameOfSubstance UI="D000068718">Rosuvastatin Calcium</NameOfSubstance></Chemical><Chemical><RegistryNumber>A0JWA85V8F</RegistryNumber><NameOfSubstance UI="D000069059">Atorvastatin</NameOfSubstance></Chemical><Chemical><RegistryNumber>AGG2FN16EV</RegistryNumber><NameOfSubstance UI="D019821">Simvastatin</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>doi: 10.1002/14651858.CD010480</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069059" MajorTopicYN="N">Atorvastatin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="N">Coronary Artery Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005464" MajorTopicYN="N">Fluorobenzenes</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006538" MajorTopicYN="N">Heptanoic Acids</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019161" MajorTopicYN="N">Hydroxymethylglutaryl-CoA Reductase Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011758" MajorTopicYN="N">Pyrroles</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068718" MajorTopicYN="N">Rosuvastatin Calcium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019821" MajorTopicYN="N">Simvastatin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013449" MajorTopicYN="N">Sulfonamides</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>  Michelle Lewicki: None known.   Irene Ng: None known.   Antoine G Schneider: None known; </CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>3</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25758322</ArticleId><ArticleId IdType="pmc">PMC10788137</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD010480.pub2</ArticleId></ArticleIdList><ReferenceList><Title>References to studies included in this review</Title><ReferenceList><Title>Almansob 2012 {published data only}</Title><Reference><Citation>Almansob MA, Xu B, Zhou L, Hu XX, Chen W, Chang FJ, et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology 2012;32(9):2304&#x2010;13. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">22796581</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chello 2006 {published data only}</Title><Reference><Citation>Chello M, Patti G, Candura D, Mastrobuoni S, Sciascio G, Agro F, et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Critical Care Medicine 2006;34(3):660&#x2010;7. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16505650</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Christenson 1999 {published data only}</Title><Reference><Citation>Christenson JT. Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. American Journal of Cardiology 2001;88(8):896&#x2010;9. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">11676957</ArticleId></ArticleIdList></Reference><Reference><Citation>Christenson JT. Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovascular Surgery 2001;9(1):33&#x2010;43. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">11137806</ArticleId></ArticleIdList></Reference><Reference><Citation>Christenson JT. Preoperative lipid&#x2010;control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio&#x2010;Thoracic Surgery 1999;15(4):394&#x2010;9. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">10371111</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mannacio 2008 {published data only}</Title><Reference><Citation>Mannacio VA, Iorio D, Amicis V, Lello F, Musumeci F. Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. Journal of Thoracic &amp; Cardiovascular Surgery 2008;136(6):1541&#x2010;8. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19114204</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Prowle 2012 {published data only}</Title><Reference><Citation>Prowle JR, Calzavacca P, Licari E, Ligabo EV, Echeverri JE, Haase M, et al. Pilot double&#x2010;blind, randomized controlled trial of short&#x2010;term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology 2012;17(3):215&#x2010;24. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">22117606</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Licari E, Calzavacca P, Ligabo EV, Echeverri JE, Hasse M, et al. Peri&#x2010;operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine 2010;36:S88. [EMBASE: 70290230]</Citation></Reference></ReferenceList><ReferenceList><Title>Spadaccio 2010 {published data only}</Title><Reference><Citation>Spadaccio C, Pollari F, Casacalenda A, Alfano G, Genovese J, Covino E, et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. Journal of Cardiovascular Pharmacology 2010;55(1):30&#x2010;8. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19834333</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tamayo 2009 {published data only}</Title><Reference><Citation>Tamayo E, Alonso O, Alvarez FJ, Castrodeza J, Florez S, Stefano S. Effects of simvastatin on acute&#x2010;phase protein levels after cardiac surgery [Efecto de la simvastatina en la concentracion de las proteinas de fase aguda despues de la cirugia cardiaca]. Medicina Clinica 2008;130(20):773&#x2010;5. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">18579030</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamayo E, Alvarez FJ, Alonso O, Bustamente R, Castrodeza J, Soria S, et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. Journal of Cardiovascular Surgery 2009;50(5):687&#x2010;94. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19741581</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to studies excluded from this review</Title><ReferenceList><Title>Acikel 2010 {published data only}</Title><Reference><Citation>Acikel S, Muderrisoglu H, Yildirir A, Aydinalp A, Sade E, Bayraktar N, et al. Prevention of contrast&#x2010;induced impairment of renal function by short&#x2010;term or long&#x2010;term statin therapy in patients undergoing elective coronary angiography. Blood Coagulation &amp; Fibrinolysis 2010;21(8):750&#x2010;7. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">20962623</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Almeida 2010 {published data only}</Title><Reference><Citation>Almeida R, Coelho OR, Meneses FH, Oliveira G, Molinari G, Franca R, et al. The APVS (atorvastatin in the perioperative of vascular surgery) study [abstract]. Circulation 2010;122(2):e345. [EMBASE: 70233157]</Citation></Reference></ReferenceList><ReferenceList><Title>Antoniades 2010 {published data only}</Title><Reference><Citation>Antoniades C, Bakogiannis C, Tousoulis D, Reilly S, Zhang MH, Paschalis A, et al. Preoperative atorvastatin treatment in CABG patients rapidly improves vein graft redox state by inhibition of Rac1 and NADPH&#x2010;oxidase activity. Circulation 2010;122(11 Suppl):S66&#x2010;73. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">20837928</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniades C, Bakogiannis C, Tousoulis D, Zhang MH, Demosthenous M, Antonopoulos A, et al. Preoperative atorvastatin treatment rapidly improves vein graft redox state by inhibiting rac1 and NADPH oxidase activity in patients undergoing elective CABG [abstract]. European Heart Journal 2010;31(Suppl 1):310. [EMBASE: 70280690]</Citation><ArticleIdList><ArticleId IdType="pubmed">20837928</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniades C, Demosthenous M, Margaritis M, Tousoulis D, Antonopoulos A, Paschalis A, et al. Short&#x2010;term preoperative treatment with atorvastatin improves myocardial redox state in patients undergoing elective CABG by affecting NADPH oxidase activity and NOS coupling [abstract]. European Heart Journal 2010;31(Suppl 1):60. [EMBASE: 70279719]</Citation></Reference></ReferenceList><ReferenceList><Title>Antoniades 2010a {published data only}</Title><Reference><Citation>Antoniades CA, Paschalis A, Tousoulis D, Bakogiannis C, Dimosthenous M, Antonopoulos AS, et al. Atorvastatin rapidly modifies vascular redox and increases nitric oxide bioavailability in human arteries [abstract]. Journal of the American College of Cardiology 2010;55(10 Suppl 1):A123. [EMBASE: 70096347]</Citation></Reference><Reference><Citation>Demosthenous M, Antoniades C, Paschalis A, Tousoulis D, Bakogiannis C, Antonopoulos AS, et al. Atorvastatin rapidly modifies vascular redox state and improves nitric oxide bioavailability in human vessels obtained from patients with advanced atherosclerosis [abstract]. European Heart Journal 2010;31(Suppl 1):1023. [EMBASE: 70283432]</Citation></Reference></ReferenceList><ReferenceList><Title>ARMYDA&#x2010;CIN 2011 {published data only}</Title><Reference><Citation>Patti G, Ricottini E, Nusca A, Colonna G, Pasceri V, D'Ambrosio A, et al. Short&#x2010;term, high&#x2010;dose Atorvastatin pretreatment to prevent contrast&#x2010;induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA&#x2010;CIN [atorvastatin for reduction of myocardial damage during angioplasty&#x2010;&#x2010;contrast&#x2010;induced nephropathy] trial. American Journal of Cardiology 2011;108(1):1&#x2010;7. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">21529740</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Barbir 1994 {published data only}</Title><Reference><Citation>Barbir M, Hunt BJ, Galloway D, Taylor A, Ilsley C, Mitchell A, et al. A randomized pilot trial of low&#x2010;dose combination lipid&#x2010;lowering therapy following coronary artery bypass grafting. Clinical Cardiology 1994;17(2):59&#x2010;64. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">8162627</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Berkan 2009 {published data only}</Title><Reference><Citation>Berkan O, Katrancioglu N, Ozker E, Ozerdem G, Bakici Z, Yilmaz MB. Reduced P&#x2010;selectin in hearts pretreated with fluvastatin: a novel benefit for patients undergoing open heart surgery. Thoracic &amp; Cardiovascular Surgeon 2009;57(2):91&#x2010;5. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19241310</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Caorsi 2008 {published data only}</Title><Reference><Citation>Caorsi C, Pineda F, Munoz C. Pravastatin immunomodulates IL&#x2010;6 and C&#x2010;reactive protein, but not IL&#x2010;1 and TNF&#x2010;alpha, in cardio&#x2010;pulmonary bypass. European Cytokine Network 2008;19(2):99&#x2010;103. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">18632424</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chello 2003 {published data only}</Title><Reference><Citation>Chello M, Mastroroberto P, Patti G, D'Ambrosio A, Morichetti MC, Sciascio G, et al. Simvastatin attenuates leucocyte&#x2010;endothelial interactions after coronary revascularisation with cardiopulmonary bypass. Heart 2003;89(5):538&#x2010;43. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1767656</ArticleId><ArticleId IdType="pubmed">12695460</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chello 2005 {published data only}</Title><Reference><Citation>Chello M, Goffredo C, Patti G, Candura D, Melfi R, Mastrobuoni S, et al. Effects of atorvastatin on arterial endothelial function in coronary bypass surgery. European Journal of Cardio&#x2010;Thoracic Surgery 2005;28(6):805&#x2010;10. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16274999</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chello 2007 {published data only}</Title><Reference><Citation>Chello M, Anselmi A, Spadaccio C, Patti G, Goffredo C, Sciascio G, et al. Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery. Annals of Thoracic Surgery 2007;83(4):1374&#x2010;80. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">17383342</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chen 2009a {published data only}</Title><Reference><Citation>Chen GL, Su JZ. Atorvastatin attenuated contrast induced renal function damage. Chung&#x2010;Hua Hsin Hsueh Kuan Ping Tsa Chih [Chinese Journal of Cardiology] 2009;37(5):389&#x2010;93. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19781210</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cobbaert 1992 {published data only}</Title><Reference><Citation>Cobbaert C, Sergeant P, Meyns B, Szecsi J, Kesteloot H. Time course of serum Lp(a) in men after coronary artery bypass grafting. Acta Cardiologica 1992;47(6):529&#x2010;42. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">1290314</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Coccia 2007 {published data only}</Title><Reference><Citation>Coccia R, Spadaccio C, Foppoli C, Perluigi M, Covino E, Lusini M, et al. The effect of simvastatin on erythrocyte membrane fluidity during oxidative stress induced by cardiopulmonary bypass: a randomized controlled study. Clinical Therapeutics 2007;29(8):1706&#x2010;17. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">17919551</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dotani 2003 {published data only}</Title><Reference><Citation>Dotani MI, Morise AP, Haque R, Jain AC, Gupta N, Gibson CM. Association between short&#x2010;term simvastatin therapy before coronary artery bypass grafting and postoperative myocardial blood flow as assessed by positron emission tomography. American Journal of Cardiology 2003;91(9):1107&#x2010;9. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">12714156</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dunkelgrun 2009 {published data only}</Title><Reference><Citation>Dunkelgrun M, Boersma E, Schouten O, Koopman&#x2010;van Gemert AW, Poorten F, Bax JJ, et al. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate&#x2010;risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE&#x2010;IV). Annals of Surgery 2009;249(6):921&#x2010;6. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19474688</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Durazzo 2004 {published data only}</Title><Reference><Citation>Caramelli B, Durazzo A, Ikeoka D, Bernoche C, Monachini M, Puech Leao P, et al. Short&#x2010;term treatment with atorvastatin for prevention of cardiac complications after vascular surgery [abstract no: 086]. Atherosclerosis Supplements 2002;3(2):83. [CENTRAL: CN&#x2010;00831428]</Citation></Reference><Reference><Citation>Durazzo AE, Machado FS, Ikeoka DT, Bernoche C, Monachini MC, Puech&#x2010;Leao P, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. Journal of Vascular Surgery 2004;39(5):967&#x2010;75. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">15111846</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Faulkner 2000 {published data only}</Title><Reference><Citation>Faulkner MA, Wadibia EC, Lucas BD, Hilleman DE. Impact of pharmacy counseling on compliance and effectiveness of combination lipid&#x2010;lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial. Pharmacotherapy: The Journal of Human Pharmacology &amp; Drug Therapy 2000;20(4):410&#x2010;6. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">10772372</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Flaker 1999 {published data only}</Title><Reference><Citation>Flaker GC, Warnica JW, Sacks FM, Moye LA, Davis BR, Rouleau JL, et al. Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE Investigators. Journal of the American College of Cardiology 1999;34(1):106&#x2010;12. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">10399998</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>FLARE Study 1999 {published data only}</Title><Reference><Citation>Lloyd GW, Jackson G, Foley DP, Boersma E, Shepherd J, Serruys PW. The influence of plasma lipoprotein (a) on angiographic restenosis and coronary events in patients undergoing planned coronary balloon angioplasty. Ancillary analysis of the Fluvastatin Angioplasty Restenosis (FLARE) trial. Atherosclerosis 2001;158(2):445&#x2010;54. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">11583725</ArticleId></ArticleIdList></Reference><Reference><Citation>Serruys PW, Foley DP, Jackson G, Bonnier H, Macaya C, Vrolix M, et al. A randomized placebo&#x2010;controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial. European Heart Journal 1999;20(1):58&#x2010;69. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">10075142</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Florens 2001 {published data only}</Title><Reference><Citation>Florens E, Salvi S, Peynet J, Elbim C, Mallat Z, Bel A, et al. Can statins reduce the inflammatory response to cardiopulmonary bypass? A clinical study. Journal of Cardiac Surgery 2001;16(3):232&#x2010;9. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">11824669</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Foley 1994 {published data only}</Title><Reference><Citation>Foley DP, Bonnier H, Jackson G, Macaya C, Shepherd J, Vrolix M, et al. Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group. American Journal of Cardiology 1994;73(14):50D&#x2010;61D. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">8198025</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Han 2014 {published data only}</Title><Reference><Citation>Han Y, Zhu G, Han L, Hou F, Huang W, Liu H, et al. Short&#x2010;term rosuvastatin therapy for prevention of contrast&#x2010;induced acute kidney injury in patients with diabetes and chronic kidney disease. Journal of the American College of Cardiology 2014;63(1):62&#x2010;70. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">24076297</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ji 2009 {published data only}</Title><Reference><Citation>Ji Q, Mei Y, Wang X, Sun Y, Feng J, Cai J, et al. Effect of preoperative atorvastatin therapy on atrial fibrillation following off&#x2010;pump coronary artery bypass grafting. Circulation Journal 2009;73(12):2244&#x2010;9. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19822977</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kesteloot 1992 {published data only}</Title><Reference><Citation>Kesteloot H, Cobbaert C, Meyns B, Szecsi J, Lesaffre E, Sergeant P. Time course of serum lipid and lipoprotein levels after coronary bypass surgery: modification by pravastatin. Acta Cardiologica 1992;47(6):519&#x2010;28. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">1290313</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kourliouros 2011 {published data only}</Title><Reference><Citation>Kourliouros A, Valencia O, Hosseini MT, Mayr M, Sarsam M, Camm J, et al. Preoperative high&#x2010;dose atorvastatin for prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery 2011;141(1):244&#x2010;8. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">20624624</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Krivoy 2008 {published data only}</Title><Reference><Citation>Krivoy N, Adler Z, Saloma R, Hawadie A, Azzam ZS. Targeting C&#x2010;reactive protein levels using high&#x2010;dose atorvastatin before coronary artery bypass graft surgery. Experimental &amp; Clinical Cardiology 2008;13(4):171&#x2010;4. [EMBASE: 2009154149]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2663479</ArticleId><ArticleId IdType="pubmed">19343161</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Li 2012a {published data only}</Title><Reference><Citation>Li W, Fu X, Wang Y, Li X, Yang Z, Wang X, et al. Beneficial effects of high&#x2010;dose atorvastatin pretreatment on renal function in patients with acute ST&#x2010;segment elevation myocardial infarction undergoing emergency percutaneous coronary intervention. Cardiology 2012;122(3):195&#x2010;202. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">22854323</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>LIPS Study 2002 {published data only}</Title><Reference><Citation>Arampatzis CA, Goedhart D, Serruys PW, Saia F, Lemos PA, Feyter P, et al. Fluvastatin reduces the impact of diabetes on long&#x2010;term outcome after coronary intervention&#x2010;&#x2010;a Lescol Intervention Prevention Study (LIPS) substudy. American Heart Journal 2005;149(2):329&#x2010;35. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">15846273</ArticleId></ArticleIdList></Reference><Reference><Citation>Serruys PW, Feyter P, Macaya C, Kokott N, Puel J, Vrolix M, et al. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;287(24):3215&#x2010;22. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">12076217</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lotfi 2008 {published data only}</Title><Reference><Citation>Lotfi A, Schweiger MJ, Giugliano GR, Murphy SA, Cannon CP, TIMI 22 Investigators. High&#x2010;dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients&#x2010;&#x2010;a Pravastatin or Atorvastatin Evaluation and Infection Therapy&#x2010;Thrombolysis in Myocardial Infarction 22 (PROVE IT&#x2010;TIMI 22) analysis. American Heart Journal 2008;155(5):954&#x2010;8. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">18440347</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ludman 2010 {published data only}</Title><Reference><Citation>Ludman AJ, Hausenloy DJ, Venugopal V, Babu G, Boston&#x2010;Griffiths E, Lawrence D, et al. The effect of high&#x2010;dose atorvastatin on a background of standard&#x2010;dose chronic statin therapy in patients undergoing cardiac surgery [abstract]. European Heart Journal 2010;31(Suppl 1):70. [EMBASE: 70279760]</Citation></Reference></ReferenceList><ReferenceList><Title>Morawietz 2006 {published data only}</Title><Reference><Citation>Morawietz H, Erbs S, Holtz J, Schubert A, Krekler M, Goettsch W, et al. Endothelial Protection, AT1 blockade and Cholesterol&#x2010;Dependent Oxidative Stress: the EPAS trial. Circulation 2006;114(1 Suppl):1296&#x2010;301. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16820589</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Nakamura 2006b {published data only}</Title><Reference><Citation>Nakamura K, Masuda H, Kariyazono H, Arima J, Iguro Y, Yamada K, et al. Effects of atorvastatin and aspirin combined therapy on inflammatory responses in patients undergoing coronary artery bypass grafting. Cytokine 2006;36(5&#x2010;6):201&#x2010;10. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">17300951</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ozhan 2010 {published data only}</Title><Reference><Citation>Ozhan H, Erden I, Ordu S, Aydin M, Caglar O, Basar C, et al. Efficacy of short&#x2010;term high&#x2010;dose atorvastatin for prevention of contrast&#x2010;induced nephropathy in patients undergoing coronary angiography. Angiology 2010;61(7):711&#x2010;4. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">20395226</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Post&#x2010;CABG Trial 1997 {published data only}</Title><Reference><Citation>Alaupovic P, Fesmire JD, Hunnighake D, Domanski M, Forman S, Knatterud GL, et al. The effect of aggressive and moderate lowering of LDL&#x2010;cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial. Atherosclerosis 1999;146(2):369&#x2010;79. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">10532693</ArticleId></ArticleIdList></Reference><Reference><Citation>Campeau L, Lesperance J, Bilodeau L, Fortier A, Guertin MC, Knatterud GL. Effect of cholesterol lowering and cardiovascular risk factors on the progression of aortoiliac arteriosclerosis: a quantitative cineangiography study. Angiology 2005;56(2):191&#x2010;9. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">15793608</ArticleId></ArticleIdList></Reference><Reference><Citation>Canner PL, Thompson B, Knatterud GL, Geller N, Campeau L, Zucker D. An application of the Zucker&#x2010;Wittes modified ratio estimate statistic in the Post Coronary Artery Bypass Graft (CABG) clinical trial. Controlled Clinical trials 1997;18(4):318&#x2010;27. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">9257071</ArticleId></ArticleIdList></Reference><Reference><Citation>Domanski M, Tian X, Fleg J, Coady S, Gosen C, Kirby R, et al. Pleiotropic effect of lovastatin, with and without cholestyramine, in the post coronary artery bypass graft (Post CABG) trial. American Journal of Cardiology 2008;102(8):1023&#x2010;7. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">18929703</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunninghake DB. Therapeutic efficacy of the lipid&#x2010;lowering armamentarium: the clinical benefits of aggressive lipid&#x2010;lowering therapy. American Journal of Medicine 1998;104(2A):9S&#x2010;13S. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">9550501</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukamal KJ, Girotra S, Mittleman MA. Alcohol consumption, atherosclerotic progression, and prognosis among patients with coronary artery bypass grafts. American Heart Journal 2006;151(2):368&#x2010;72. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16442902</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukamal KJ, Smith CC, Karlamangla AS, Moore AA. Moderate alcohol consumption and safety of lovastatin and warfarin among men: the post&#x2010;coronary artery bypass graft trial. American Journal of Medicine 2006;119(5):434&#x2010;40. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16651056</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukamal KJ, Wellenius GA, Mittleman MA. Hematologic parameters, atherosclerotic progression, and prognosis in patients with previous coronary artery bypass grafting (from the Post CABG Trial). American Journal of Cardiology 2009;103(3):328&#x2010;32. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19166684</ArticleId></ArticleIdList></Reference><Reference><Citation>Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low&#x2010;density lipoprotein cholesterol levels and low&#x2010;dose anticoagulation on obstructive changes in saphenous&#x2010;vein coronary&#x2010;artery bypass grafts [erratum appears in N Engl J Med 1997 Dec 18;337(25):1859]. New England Journal of Medicine 1997;336(3):153&#x2010;62. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">8992351</ArticleId></ArticleIdList></Reference><Reference><Citation>Wee CC, Girotra S, Weinstein AR, Mittleman MA, Mukamal KJ. The relationship between obesity and atherosclerotic progression and prognosis among patients with coronary artery bypass grafts the effect of aggressive statin therapy. Journal of the American College of Cardiology 2008;52(8):620&#x2010;5. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">18702964</ArticleId></ArticleIdList></Reference><Reference><Citation>Wellenius GA, Mukamal KJ, Winkelmayer WC, Mittleman MA. Renal dysfunction increases the risk of saphenous vein graft occlusion: results from the Post&#x2010;CABG trial. Atherosclerosis 2007;193(2):414&#x2010;20. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16905139</ArticleId></ArticleIdList></Reference><Reference><Citation>White CW, Gobel FL, Campeau L, Knatterud GL, Forman SA, Forrester JS, et al. Effect of an aggressive lipid&#x2010;lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trial. Circulation 2001;104(22):2660&#x2010;5. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">11723015</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>PRATO&#x2010;ACS Study 2014 {published data only}</Title><Reference><Citation>Leoncini M, Toso A, Maioli M, Tropeano F, Villani S, Bellandi F. Early high&#x2010;dose rosuvastatin for contrast&#x2010;induced nephropathy prevention in acute coronary syndrome: Results from the PRATO&#x2010;ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast&#x2010;induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome). Journal of the American College of Cardiology 2014;63(1):71&#x2010;9. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">24076283</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>PROMISS Study 2008 {published data only}</Title><Reference><Citation>Jo SH, Koo BK, Park JS, Kang HJ, Cho YS, Kim YJ, et al. Prevention of radiocontrast medium&#x2010;induced nephropathy using short&#x2010;term high&#x2010;dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial&#x2010;&#x2010;a randomized controlled study. American Heart Journal 2008;155(3):499. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">18294484</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Qian 2008 {published data only}</Title><Reference><Citation>Qian YJ, Xiao XJ, Yuan HS, Tang H, Shao HZ, Wei DM. Combination pharmacological cardioversion of permanent atrial fibrillation in post&#x2010;prosthetic mitral valve replacement outpatients: a novel approach for the treatment of atrial fibrillation. Journal of International Medical Research 2008;36(3):537&#x2010;43. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">18534136</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Radaelli 2007 {published data only}</Title><Reference><Citation>Radaelli A, Loardi C, Cazzaniga M, Balestri G, DeCarlini C, Cerrito MG, et al. Inflammatory activation during coronary artery surgery and its dose&#x2010;dependent modulation by statin/ACE&#x2010;inhibitor combination. Arteriosclerosis, Thrombosis &amp; Vascular Biology 2007;27(12):2750&#x2010;5. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">17823365</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>RAP Study 2010 {published data only}</Title><Reference><Citation>Billings FT 4th, Pretorius M, Siew ED, Yu C, Brown NJ. Early postoperative statin therapy is associated with a lower incidence of acute kidney injury after cardiac surgery. Journal of Cardiothoracic &amp; Vascular Anesthesia 2010;24(6):913&#x2010;20. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2992577</ArticleId><ArticleId IdType="pubmed">20599398</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Riahi 2006 {published data only}</Title><Reference><Citation>Riahi S, Schmidt EB, Amanavicius N, Karmisholt J, Jensen HS, Christoffersen RP, et al. The effect of atorvastatin on heart rate variability and lipoproteins in patients treated with coronary bypass surgery. International Journal of Cardiology 2006;111(3):436&#x2010;41. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16290290</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sasmazel 2010 {published data only}</Title><Reference><Citation>Sasmazel A, Baysal A, Fedekar A, Buyukbayrak F, Bugra O, Erdem H, et al. The effect of statin therapy on stimulation of endothelium&#x2010;derived nitric oxide before and after coronary artery bypass surgery. Heart Surgery Forum 2010;13(4):E243&#x2010;6. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">20719727</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Schanzer 2008 {published data only}</Title><Reference><Citation>Schanzer A, Hevelone N, Owens CD, Beckman JA, Belkin M, Conte MS. Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia. Journal of Vascular Surgery 2008;47(4):774&#x2010;81. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">18381138</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Schouten 2009 {published data only}</Title><Reference><Citation>Schouten O, Boersma E, Hoeks SE, Benner R, Urk H, Sambeek MR, et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. New England Journal of Medicine 2009;361(10):980&#x2010;9. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19726772</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Song 2008 {published data only}</Title><Reference><Citation>Song YB, On YK, Kim JH, Shin DH, Kim JS, Sung J, et al. The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off&#x2010;pump coronary artery bypass grafting surgery. American Heart Journal 2008;156(2):373&#x2010;16. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">18657672</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>STATIN&#x2010;STEMI Study 2010 {published data only}</Title><Reference><Citation>Kim JS, Kim J, Choi D, Lee CJ, Lee SH, Ko YG, et al. Efficacy of high&#x2010;dose atorvastatin loading before primary percutaneous coronary intervention in ST&#x2010;segment elevation myocardial infarction: the STATIN STEMI trial. [Erratum appears in JACC Cardiovasc Interv. 2012 Feb;5(2):248]. JACC: Cardiovascular Interventions 2010;3(3):332&#x2010;9. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">20298994</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Su 2011 {published data only}</Title><Reference><Citation>Su JZ, Xue Y, Cai WQ, Huang QY, Chai DJ, Chen GL, et al. Association between high sensitivity C&#x2010;reactive protein and contrast induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention: impact of atorvastatin. Chung&#x2010;Hua Hsin Hsueh Kuan Ping Tsa Chih [Chinese Journal of Cardiology] 2011;39(9):807&#x2010;11. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">22321227</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sun 2009a {published data only}</Title><Reference><Citation>Sun YF, Mei YQ, Ji Q, Wang XS, Feng J, Cai JZ, et al. Effect of atorvastatin on postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. Chung&#x2010;Hua i Hsueh Tsa Chih [Chinese Medical Journal] 2009;89(42):2988&#x2010;91. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">20137710</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tetik 2010 {published data only}</Title><Reference><Citation>Tetik S, Ak K, Isbir S, Eksioglu&#x2010;Demiralp E, Arsan S, Iqbal O, et al. Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study. Clinical &amp; Applied Thrombosis/Hemostasis 2010;16(2):189&#x2010;98. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19703819</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Toso 2010 {published data only}</Title><Reference><Citation>Toso A, Leoncini M, Maioli M, Gallopin M, Tedeschi D, Amato M, et al. Short&#x2010;term high&#x2010;dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction. Journal of Cardiovascular Medicine 2011;12(5):318&#x2010;21. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">21045713</ArticleId></ArticleIdList></Reference><Reference><Citation>Toso A, Maioli M, Leoncini M, Gallopin M, Tedeschi D, Micheletti C, et al. Usefulness of atorvastatin (80 mg) in prevention of contrast&#x2010;induced nephropathy in patients with chronic renal disease. American Journal of Cardiology 2010;105(3):288&#x2010;92. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">20102936</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Xinwei 2009 {published data only}</Title><Reference><Citation>Xinwei J, Xianghua F, Jing Z, Xinshun G, Ling X, Weize F, et al. Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast&#x2010;induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention. American Journal of Cardiology 2009;104(4):519&#x2010;24. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19660605</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zhou 2009 {published data only}</Title><Reference><Citation>Zhou X, Jin YZ, Wang Q, Min R, Zhang XY. Efficacy of high dose atorvastatin on preventing contrast induced nephropathy in patients underwent coronary angiography. Chung&#x2010;Hua Hsin Hsueh Kuan Ping Tsa Chih [Chinese Journal of Cardiology] 2009;37(5):394&#x2010;6. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19781211</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zhou 2010 {published data only}</Title><Reference><Citation>Zhou Q, Wang G, Gao C, Chen T. Effect of ulinastatin on perioperative inflammatory response to coronary artery bypass grafting with cardiopulmonary bypass. Zhong Nan da Xue Xue Bao. Yi Xue Ban [Journal of Central South University Medical Sciences] 2010;35(2):107&#x2010;10. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">20197607</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to studies awaiting assessment</Title><ReferenceList><Title>de Oliveira 2012 {published data only}</Title><Reference><Citation>Oliveira MS, Martins KB, Costa JR Jr, Abizaid A, Stadler J, Mattos LA, et al. Impact on renal function of rosuvastatin preload prior to elective percutaneous coronary intervention in chronic statin users [Impacto na funcao renal de uma dose de reforco de rosuvastatina previa a intervencao coronaria percutanea eletiva nos pacientes em uso cronico de estatina]. Revista Brasileira de Cardiologia Invasiva 2012;20(3):303&#x2010;8. [EMBASE: 2013021434]</Citation></Reference></ReferenceList><ReferenceList><Title>Han 2013 {published data only}</Title><Reference><Citation>Han S, Li XM, Mohammed Ali LA, Fu NK, Jin DX, Cong HL. Effect of short&#x2010;term different statins loading dose on renal function and CI&#x2010;AKI incidence in patients undergoing invasive coronary procedures. International Journal of Cardiology 2013;168(5):5101&#x2010;3. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">23972962</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Liu 2013 {published data only}</Title><Reference><Citation>Liu WJ, Zhang BC, Guo R, Wei YD, Li WM, Xu YW. Renoprotective effect of alprostadil in combination with statins in patients with mild to moderate renal failure undergoing coronary angiography. Chinese Medical Journal 2013;126(18):3475&#x2010;80. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">24034093</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>NAPLES II Study 2009 {published data only}</Title><Reference><Citation>Briguori C, Visconti G, Focaccio A, Golia B, Chieffo A, Castelli A, et al. Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction. Journal of the American College of Cardiology 2009;54(23):2157&#x2010;63. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19664895</ArticleId></ArticleIdList></Reference><Reference><Citation>Quintavalle C, Fiore D, Micco F, Visconti G, Focaccio A, Golia B, et al. Impact of a high loading dose of atorvastatin on contrast&#x2010;induced acute kidney injury. Circulation 2012;126(25):3008&#x2010;16. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">23147173</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>ROSA&#x2010;cIN Trial 2013 {published data only}</Title><Reference><Citation>Kaya A, Kurt M, Tanboga IH, Isik T, Ekinci M, Aksakal E, et al. Rosuvastatin versus atorvastatin to prevent contrast induced nephropathy in patients undergoing primary percutaneous coronary intervention (ROSA&#x2010;cIN trial). Acta Cardiologica 2013;68(5):489&#x2010;94. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">24283110</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to ongoing studies</Title><ReferenceList><Title>NCT01547455 {published data only}</Title><Reference><Citation>Zhou S. Anti&#x2010;inflammatory and renoprotective effect of pretreatment loading dose atorvastatin in CABG. www.clinicaltrials.gov/ct2/show/NCT01547455 (accessed 13 January 2015).</Citation></Reference></ReferenceList><ReferenceList><Title>STATIN AKI 2011 {published data only}</Title><Reference><Citation>Billings FT 4th, Ball SK, Roberts LJ 2nd, Pretorius M. Postoperative acute kidney injury is associated with hemoglobinemia and an enhanced oxidative stress response. Free Radical Biology &amp; Medicine 2011;50(11):1480&#x2010;7. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3090463</ArticleId><ArticleId IdType="pubmed">21334433</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>Additional references</Title><ReferenceList><Title>Ali 2005</Title><Reference><Citation>Ali IS, Buth KJ. Preoperative statin use and in&#x2010;hospital outcomes following heart surgery in patients with unstable angina. European Journal of Cardio&#x2010;Thoracic Surgery 2005;27(6):1051&#x2010;6. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">15896616</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Arora 2008</Title><Reference><Citation>Arora P, Rajagopalam S, Ranjan R, Kolli H, Singh M, Venuto R, et al. Preoperative use of angiotensin&#x2010;converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clinical Journal of the American Society of Nephrology: CJASN 2008;3(5):1266&#x2010;73. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2518804</ArticleId><ArticleId IdType="pubmed">18667735</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Asimakopoulos 2005</Title><Reference><Citation>Asimakopoulos G, Karagounis AP, Valencia O, Alexander N, Howlader M, Sarsam MA, et al. Renal function after cardiac surgery off&#x2010; versus on&#x2010;pump coronary artery bypass: analysis using the Cockroft&#x2010;Gault formula for estimating creatinine clearance. Annals of Thoracic Surgery 2005;79(6):2024&#x2010;31. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">15919303</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Baigent 2005</Title><Reference><Citation>Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol&#x2010;lowering treatment: prospective meta&#x2010;analysis of data from 90,056 participants in 14 randomised trials of statins. [Erratum appears in Lancet. 2008 Jun 21;371(9630):2084], [Erratum appears in Lancet. 2005 Oct 15&#x2010;21;366(9494):1358]. Lancet 2005;366(9493):1267&#x2010;78. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16214597</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bellomo 2004</Title><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative workgroup. Acute renal failure &#x2013; definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical Care 2004;8(4):R204&#x2010;12. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC522841</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Billings 2010</Title><Reference><Citation>Billings FT 4th, Pretorius M, Siew ED, Yu C, Brown NJ. Early postoperative statin therapy is associated with a lower incidence of acute kidney injury after cardiac surgery. Journal of Cardiothoracic &amp; Vascular Anesthesia 2010;24(6):913&#x2010;20. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2992577</ArticleId><ArticleId IdType="pubmed">20599398</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bove 2004</Title><Reference><Citation>Bove T, Calabr&#xf2; MG, Landoni G, Aletti G, Marino G, Crescenzi G, et al. The incidence and risk of acute renal failure after cardiac surgery. Journal of Cardiothoracic &amp; Vascular Anesthesia 2004;18(4):442&#x2010;5. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">15365924</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Boyle 1997</Title><Reference><Citation>Boyle EM Jr, Pohlman TH, Johnson MC, Verrier ED. Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response. Annals of Thoracic Surgery 1997;63(1):277&#x2010;84. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">8993292</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chawla 2012</Title><Reference><Citation>Chawla LS, Zhao Y, Lough FC, Schroeder E, Seneff MG, Brennan JM. Off&#x2010;pump versus on&#x2010;pump coronary artery bypass grafting outcomes stratified by preoperative renal function. Journal of the American Society of Nephrology 2012;23(8):1389&#x2010;97. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3402290</ArticleId><ArticleId IdType="pubmed">22595302</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chertow 1997</Title><Reference><Citation>Chertow GM, Lazarus JM, Christiansen CL, Cook EF, Hammermeister KE, Grover F, et al. Preoperative renal risk stratification. Circulation 1997;95(4):878&#x2010;84. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">9054745</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chukwuemeka 2005</Title><Reference><Citation>Chukwuemeka A, Weisel A, Maganti M, Nette AF, Wijeysundera DN, Beattie WS, et al. Renal dysfunction in high&#x2010;risk patients after on&#x2010;pump and off&#x2010;pump coronary artery bypass surgery: a propensity score analysis. Annals of Thoracic Surgery 2005;80(6):2148&#x2010;53. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16305860</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Clark 2006</Title><Reference><Citation>Clark LL, Ikonomidis JS, Crawford FA Jr, Crumbley A 3rd, Kratz JM, Stroud MR, et al. Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: an 8&#x2010;year retrospective cohort study. Journal of Thoracic &amp; Cardiovascular Surgery 2006;131(3):679&#x2010;85. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16515923</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Coca 2009</Title><Reference><Citation>Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR. Long&#x2010;term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta&#x2010;analysis. American Journal of Kidney Diseases 2009;53(6):961&#x2010;73. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2726041</ArticleId><ArticleId IdType="pubmed">19346042</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Conlon 1999</Title><Reference><Citation>Conlon PJ, Stafford&#x2010;Smith M, White WD, Newman MF, King S, Winn MP, et al. Acute renal failure following cardiac surgery. Nephrology Dialysis Transplantation 1999;14(5):1158&#x2010;62. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">10344355</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>DerSimonian 1986</Title><Reference><Citation>DerSimonian R, Laird N. Meta&#x2010;analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177&#x2010;88. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Devarajan 2006</Title><Reference><Citation>Devarajan P. Update on mechanisms of ischemic acute kidney injury. Journal of the American Society of Nephrology 2006;17(6):1503&#x2010;20. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16707563</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Egger 1997</Title><Reference><Citation>Egger M, Davey Smith G, Phillips AN. Meta&#x2010;analysis: Principles and procedures. BMJ 1997;315(7121):1533&#x2010;7. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2127925</ArticleId><ArticleId IdType="pubmed">9432252</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Endo 1976</Title><Reference><Citation>Endo A, Kuroda M, Tanzawa K. Competitive inhibition of 3&#x2010;hydroxy&#x2010;3&#x2010;methylglutaryl coenzyme A reductase by ML&#x2010;236A and ML&#x2010;236B fungal metabolites, having hypocholesterolemic activity. FEBS Letters 1976;72(2):323&#x2010;6. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16386050</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gueler 2002</Title><Reference><Citation>Gueler F, Rong S, Park JK, Fiebeler A, Menne J, Elger M, et al. Postischemic acute renal failure is reduced by short&#x2010;term statin treatment in a rat model. Journal of the American Society of Nephrology 2002;13(9):2288&#x2010;98. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">12191973</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Haslinger&#x2010;L&#xf6;ffler 2008</Title><Reference><Citation>Haslinger&#x2010;L&#xf6;ffler B. Multiple effects of HMG&#x2010;CoA reductase inhibitors (statins) besides their lipid&#x2010;lowering function. Kidney International 2008;74(5):553&#x2010;5. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">18709024</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Higgins 2003</Title><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta&#x2010;analyses. BMJ 2003;327(7414):557&#x2010;60. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Higgins 2011</Title><Reference><Citation>Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane&#x2010;handbook.org.</Citation></Reference></ReferenceList><ReferenceList><Title>Inman 2005</Title><Reference><Citation>Inman SR, Davis NA, Mazzone ME, Olson KM, Lukaszek VA, Yoder KN. Simvastatin and L&#x2010;arginine preserve renal function after ischemia/reperfusion injury. American Journal of the Medical Sciences 2005;329(1):13&#x2010;7. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">15654174</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Jo 2008</Title><Reference><Citation>Jo SH, Koo BK, Park JS, Kang HJ, Cho YS, Kim YJ, et al. Prevention of radiocontrast medium&#x2010;induced nephropathy using short&#x2010;term high&#x2010;dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial&#x2010;&#x2010;a randomized controlled study. American Heart Journal 2008;155(3):499, e1&#x2010;8. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">18294484</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Karkouti 2009</Title><Reference><Citation>Karkouti K, Wijeysundera DN, Yau TM, Callum JL, Cheng DC, Crowther M, et al. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation 2009;119(4):495&#x2010;502. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19153273</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lafrance 2010</Title><Reference><Citation>Lafrance JP, Miller DR. Acute kidney injury associates with increased long&#x2010;term mortality. Journal of the American Society of Nephrology 2010;21(2):345&#x2010;52. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2834549</ArticleId><ArticleId IdType="pubmed">20019168</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lamy 2012</Title><Reference><Citation>Lamy A, Devereaux PJ, Prabhakaran D, Taggart DP, Hu S, Paolasso E, et al. Off&#x2010;pump or on&#x2010;pump coronary&#x2010;artery bypass grafting at 30 days. New England Journal of Medicine 2012;366(16):1489&#x2010;97. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">22449296</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Li 2012</Title><Reference><Citation>Li Y, Liu Y, Fu L, Mei C, Dai B. Efficacy of short&#x2010;term high&#x2010;dose statin in preventing contrast&#x2010;induced nephropathy: a meta&#x2010;analysis of seven randomized controlled trials. PLoS One 2012;7(4):e34450. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3325242</ArticleId><ArticleId IdType="pubmed">22511942</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Liakopoulos 2008</Title><Reference><Citation>Liakopoulos OJ, Choi YH, Haldenwang PL, Strauch J, Wittwer T, D&#xf6;rge H, et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta&#x2010;analysis of over 30,000 patients. European Heart Journal 2008;29(12):1548&#x2010;59. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">18506053</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Liakopoulos 2012</Title><Reference><Citation>Liakopoulos OJ, Kuhn EW, Slottosch I, Wassmer G, Wahlers T. Preoperative statin therapy for patients undergoing cardiac surgery. Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD008493.pub2]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD008493.pub2</ArticleId><ArticleId IdType="pubmed">22513959</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mangano 1998</Title><Reference><Citation>Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Annals of Internal Medicine 1998;128(3):194&#x2010;203. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">9454527</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mariscalco 2011</Title><Reference><Citation>Mariscalco G, Lorusso R, Dominici C, Renzulli A, Sala A. Acute kidney injury: a relevant complication after cardiac surgery. Annals of Thoracic Surgery 2011;92(4):1539&#x2010;47. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">21872837</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mehta 2007</Title><Reference><Citation>Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Critical Care 2007;11(2):R31. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mistiaen 2009</Title><Reference><Citation>Mistiaen W, Cauwelaert P, Muylaert P, Worm E. A thousand pericardial valves in aortic position: risk factors for postoperative acute renal function impairment in elderly. Journal of Cardiovascular Surgery 2009;50(2):233&#x2010;7. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">18948862</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Morgan 2009</Title><Reference><Citation>Morgan C, Zappitelli M, Gill P. Statin prophylaxis and inflammatory mediators following cardiopulmonary bypass: a systematic review. Critical Care 2009;13(5):R165. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2784396</ArticleId><ArticleId IdType="pubmed">19840397</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ostermann 2000</Title><Reference><Citation>Ostermann ME, Taube D, Morgan CJ, Evans TW. Acute renal failure following cardiopulmonary bypass: a changing picture. Intensive Care Medicine 2000;26(5):565&#x2010;71. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">10923731</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ozan 2010</Title><Reference><Citation>Ozhan H, Erden I, Ordu S, Aydin M, Caglar O, Basar C, et al. Efficacy of short&#x2010;term high&#x2010;dose atorvastatin for prevention of contrast&#x2010;induced nephropathy in patients undergoing coronary angiography. Angiology 2010;61(7):711&#x2010;4. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">20395226</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Pan 2004</Title><Reference><Citation>Pan W, Pintar T, Anton J, Lee VV, Vaughn WK, Collard CD. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation 2004;110(11 Suppl 1):II45&#x2010;9. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">15364837</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Patti 2008</Title><Reference><Citation>Patti G. Short&#x2010;term high&#x2010;dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction. Journal of Cardiovascular Medicine 2011;12(5):305&#x2010;8. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">21451331</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Srisawat 2010</Title><Reference><Citation>Srisawat N, Lawsin L, Uchino S, Bellomo R, Kellum JA, BEST Kidney Investigators. Cost of acute renal replacement therapy in the intensive care unit: results from The Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) study. Critical Care 2010;14(2):R46. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2887158</ArticleId><ArticleId IdType="pubmed">20346163</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sterne 2001</Title><Reference><Citation>Sterne JA, Egger M, Smith GD. Systematic reviews in health care: investigating and dealing with publication and other biases in meta&#x2010;analysis. BMJ 2001;327(7304):101&#x2010;5. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1120714</ArticleId><ArticleId IdType="pubmed">11451790</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Swaminathan 2007</Title><Reference><Citation>Swaminathan M, Shaw AD, Phillips&#x2010;Bute BG, McGugan&#x2010;Clark PL, Archer LE, Talbert S, et al. Trends in acute renal failure associated with coronary artery bypass graft surgery in the United States. Critical Care Medicine 2007;35(10):2286&#x2010;91. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">17944016</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tabata 2007</Title><Reference><Citation>Tabata M, Khalpey Z, Pirundini PA, Byrne ML, Cohn LH, Rawn JD. Renoprotective effect of preoperative statins in coronary artery bypass grafting. American Journal of Cardiology 2007;100(3):442&#x2010;4. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">17659925</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Thakar 2003</Title><Reference><Citation>Thakar CV, Liangos O, Yared JP, Nelson D, Piedmonte MR, Hariachar S, et al. ARF after open&#x2010;heart surgery: Influence of gender and race. American Journal of Kidney Diseases 2003;41(4):742&#x2010;51. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">12666060</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Yokota 2003</Title><Reference><Citation>Yokota N, O'Donnell M, Daniels F, Burne&#x2010;Taney M, Keane W, Kasiske B, et al. Protective effect of HMG&#x2010;CoA reductase inhibitor on experimental renal ischemia&#x2010;reperfusion injury. American Journal of Nephrology 2003;23(1):13&#x2010;7. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">12373076</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to other published versions of this review</Title><ReferenceList><Title>Lewicki 2013</Title><Reference><Citation>Lewicki M, Ng I, Schneider AG. HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass. Cochrane Database of Systematic Reviews 2013, Issue 4. [DOI: 10.1002/14651858.CD010480]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD010480</ArticleId><ArticleId IdType="pmc">PMC10788137</ArticleId><ArticleId IdType="pubmed">25758322</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38381960</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>140</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Candidate Kidney Protective Strategies for Patients Undergoing Major Abdominal Surgery: A Secondary Analysis of the RELIEF Trial Cohort.</ArticleTitle><Pagination><StartPage>1111</StartPage><EndPage>1125</EndPage><MedlinePgn>1111-1125</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0000000000004957</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute kidney injury (AKI) is common after major abdominal surgery. Selection of candidate kidney protective strategies for testing in large trials should be based on robust preliminary evidence.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A secondary analysis of the Restrictive versus Liberal Fluid Therapy in Major Abdominal Surgery (RELIEF) trial was conducted in adult patients undergoing major abdominal surgery and randomly assigned to a restrictive or liberal perioperative fluid regimen. The primary outcome was maximum AKI stage before hospital discharge. Two multivariable ordinal regression models were developed to test the primary hypothesis that modifiable risk factors associated with increased maximum stage of postoperative AKI could be identified. Each model used a separate approach to variable selection to assess the sensitivity of the findings to modeling approach. For model 1, variable selection was informed by investigator opinion; for model 2, the Least Absolute Shrinkage and Selection Operator (LASSO) technique was used to develop a data-driven model from available variables.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 2,444 patients analyzed, stage 1, 2, and 3 AKI occurred in 223 (9.1%), 59 (2.4%), and 36 (1.5%) patients, respectively. In multivariable modeling by model 1, administration of a nonsteroidal anti-inflammatory drug or cyclooxygenase-2 inhibitor, intraoperatively only (odds ratio, 1.77 [99% CI, 1.11 to 2.82]), and preoperative day-of-surgery administration of an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker compared to no regular use (odds ratio, 1.84 [99% CI, 1.15 to 2.94]) were associated with increased odds for greater maximum stage AKI. These results were unchanged in model 2, with the additional finding of an inverse association between nadir hemoglobin concentration on postoperative day 1 and greater maximum stage AKI.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Avoiding intraoperative nonsteroidal anti-inflammatory drugs or cyclooxygenase-2 inhibitors is a potential strategy to mitigate the risk for postoperative AKI. The findings strengthen the rationale for a clinical trial comprehensively testing the risk-benefit ratio of these drugs in the perioperative period.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 American Society of Anesthesiologists. All Rights Reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McIlroy</LastName><ForeName>David R</ForeName><Initials>DR</Initials><Identifier Source="ORCID">0000-0002-8919-992X</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee; Monash University, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Xiaoke</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Vanderbilt University, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shotwell</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Vanderbilt University, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallace</LastName><ForeName>Sophia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Monash University, Melbourne, Australia; Department of Anaesthesia and Perioperative Medicine, Alfred Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, Australia; Australian and New Zealand Intensive Care Research Centre, Monash University School of Public Health and Preventive Medicine, Melbourne, Australia; Department of Critical Care Critical Care, Department of Medicine and Radiology, University of Melbourne, Melbourne, Australia; Department of Intensive Care, Royal Melbourne Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garg</LastName><ForeName>Amit X</ForeName><Initials>AX</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Departments of Medicine, Epidemiology and Biostatistics, Schulich School of Medicine Dentistry, and the London Health Sciences Centre, London, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leslie</LastName><ForeName>Kate</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Critical Care, University of Melbourne, Melbourne, Australia; Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peyton</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Critical Care, University of Melbourne, Melbourne, Australia; Department of Anaesthesia, Austin Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Story</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Critical Care, University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myles</LastName><ForeName>Paul S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Monash University, Melbourne, Australia; Department of Anaesthesia and Perioperative Medicine, Alfred Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="Y">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>15</Day><Hour>5</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>21</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>21</Day><Hour>15</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38381960</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000004957</ArticleId><ArticleId IdType="pii">139849</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39384347</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2211-9132</ISSN><JournalIssue CitedMedium="Print"><PubDate><Year>2024</Year><Month>Sep</Month><Day>26</Day></PubDate></JournalIssue><Title>Kidney research and clinical practice</Title><ISOAbbreviation>Kidney Res Clin Pract</ISOAbbreviation></Journal><ArticleTitle>Predicting long-term mortality of patients with postoperative acute kidney injury following noncardiac general anesthesia surgery using machine learning.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.23876/j.krcp.24.106</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">This study addresses the gap in knowledge regarding the long-term mortality implications of postoperative acute kidney injury (PO-AKI) utilizing advanced machine learning techniques to predict outcomes more accurately than traditional statistical models.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A retrospective cohort study was conducted using data from seven institutions between March 2009 and December 2019. Machine learning models were developed to predict all-cause mortality of PO-AKI patients using 23 preoperative variables and one postoperative variable. Model performance was compared to a traditional statistical approach with Cox regression analysis. The concordance index was used as a predictive performance metric to compare prediction capabilities among different models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Among 199,403 patients, 2,105 developed PO-AKI. During a median follow-up of 144 months (interquartile range, 99.61-170.71 months), 472 in-hospital deaths occurred. Subjects with PO-AKI had a significantly lower survival rate than those without PO-AKI (p &lt; 0.001). For predicting mortality, the XGBoost with an accelerated failure time model had the highest concordance index (0.7521), followed by random survival forest (0.7371), multivariable Cox regression model (0.7318), survival support vector machine (0.7304), and gradient boosting (0.7277).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">XGBoost with an accelerated failure time model was developed in this study to predict long-term mortality associated with PO-AKI. Its performance was superior to conventional models. The application of machine learning techniques may offer a promising approach to predict mortality following PO-AKI more accurately, providing a basis for developing targeted interventions and clinical guidelines to improve patient outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Bo Yeon</ForeName><Initials>BY</Initials><AffiliationInfo><Affiliation>Department of Biomedicine and Health Sciences, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Wona</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Biomedicine and Health Sciences, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Min</LastName><ForeName>Jiwon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Byung Ha</ForeName><Initials>BH</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koh</LastName><ForeName>Eun Sil</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Su Yeon</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ban</LastName><ForeName>Tae Hyun</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yong Kyun</ForeName><Initials>YK</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Hye Eun</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>In Young</ForeName><Initials>IY</Initials><AffiliationInfo><Affiliation>Department of Biomedicine and Health Sciences, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Kidney Res Clin Pract</MedlineTA><NlmUniqueID>101586778</NlmUniqueID><ISSNLinking>2211-9132</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">General anesthesia</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>21</Hour><Minute>31</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39384347</ArticleId><ArticleId IdType="doi">10.23876/j.krcp.24.106</ArticleId><ArticleId IdType="pii">j.krcp.24.106</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36270701</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>129</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Clinical effectiveness and safety of spinal anaesthesia compared with general anaesthesia in patients undergoing hip fracture surgery using a consensus-based core outcome set and patient-and public-informed outcomes: a systematic review and meta-analysis of randomised controlled trials.</ArticleTitle><Pagination><StartPage>788</StartPage><EndPage>800</EndPage><MedlinePgn>788-800</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2022.07.031</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(22)00427-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">We conducted a systematic review and meta-analysis of contemporary RCTs to determine the clinical effectiveness of spinal vs general anaesthesia (SA vs GA) in patients undergoing hip fracture surgery using a consensus-based core outcome set, and outcomes defined as important by patient and public involvement (PPI) initiatives.</AbstractText><AbstractText Label="METHODS">RCTs comparing any of the core outcomes (mortality, time from injury to surgery, acute coronary syndrome, hypotension, acute kidney injury, delirium, pneumonia, orthogeriatric input, being out of bed at day 1 postoperatively, and pain) or PPI-defined outcomes (return to preoperative residence, quality of life, and mobility status) between SA and GA were identified from MEDLINE, Embase, Cochrane Library, and Web of Science (2000 to February 2022). Pooled relative risks (RRs) and mean differences (95% confidence intervals [CIs]) were estimated.</AbstractText><AbstractText Label="RESULTS">There was no significant difference in the risk of delirium comparing SA vs GA (RR=1.07; 95% CI, 0.90-1.29). Comparing SA vs GA, the RR for mortality was 0.56 (95% CI, 0.22-1.44) in-hospital, 1.07 (95% CI, 0.52-2.23) at 30 days, and 1.08 (95% CI, 0.55-2.12) at 90 days. Spinal anaesthesia reduced the risk of acute kidney injury compared with GA: RR=0.59 (95% CI, 0.39-0.89). There were no significant differences in the risk of other outcomes. Few studies reported PPI-defined outcomes, with most studies reporting on one to three core outcomes.</AbstractText><AbstractText Label="CONCLUSIONS">Except for acute kidney injury, there were no differences between SA and GA in hip fracture surgery when using a consensus-based core outcome set and patient and public involvement-defined outcomes. Most studies reported limited outcomes from the core outcome set, and few reported outcomes important to patients, which should be considered when designing future RCTs.</AbstractText><AbstractText Label="PROSPERO REGISTRATION">CRD42021275206.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kunutsor</LastName><ForeName>Setor K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>National Institute for Health Research Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol, Bristol, UK; Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Learning &amp; Research Building (Level 1), Southmead Hospital, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamal</LastName><ForeName>Pravakar B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Learning &amp; Research Building (Level 1), Southmead Hospital, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomassini</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Warwick Clinical Trials Unit, University of Warwick, Warwick, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeung</LastName><ForeName>Joyce</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Warwick Clinical Trials Unit, University of Warwick, Warwick, UK; University Hospitals of Birmingham NHS Foundation Trust, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitehouse</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>National Institute for Health Research Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol, Bristol, UK; Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Learning &amp; Research Building (Level 1), Southmead Hospital, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matharu</LastName><ForeName>Gulraj S</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Learning &amp; Research Building (Level 1), Southmead Hospital, Bristol, UK. Electronic address: gulraj.matharu@bristol.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Br J Anaesth. 2023 Apr;130(4):385-389. doi: 10.1016/j.bja.2023.01.013.</RefSource><PMID Version="1">36801101</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000775" MajorTopicYN="Y">Anesthesia, Spinal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D032921" MajorTopicYN="N">Consensus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="Y">Hip Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003693" MajorTopicYN="Y">Delirium</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">complication</Keyword><Keyword MajorTopicYN="N">core outcome set</Keyword><Keyword MajorTopicYN="N">general anaesthesia</Keyword><Keyword MajorTopicYN="N">hip fracture</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">spinal anaesthesia</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>21</Day><Hour>21</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36270701</ArticleId><ArticleId IdType="pmc">PMC9642835</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2022.07.031</ArticleId><ArticleId IdType="pii">S0007-0912(22)00427-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mamarelis G., Oduoza U., Chekuri R., Estfan R., Greer T. Mortality in patients with proximal femoral fracture during the COVID-19 pandemic: a U.K. hospital's experience. JB JS Open Access. 2020;5:e20.00086.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7682983</ArticleId><ArticleId IdType="pubmed">33244510</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper C., Campion G., Melton L.J., 3rd Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992;2:285&#x2013;289.</Citation><ArticleIdList><ArticleId IdType="pubmed">1421796</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnell O., Kanis J. An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporos Int. 2004;15:897&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pubmed">15490120</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnell O., Kanis J. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17:1726&#x2013;1733.</Citation><ArticleIdList><ArticleId IdType="pubmed">16983459</ArticleId></ArticleIdList></Reference><Reference><Citation>National hip fracture database (NHFD) Royal College of Physicians; London: 2017. Annual report 2017.</Citation></Reference><Reference><Citation>White S.M., Griffiths R. Projected incidence of proximal femoral fracture in England: a report from the NHS hip fracture anaesthesia network (HIPFAN) Injury. 2011;42:1230&#x2013;1233.</Citation><ArticleIdList><ArticleId IdType="pubmed">21183180</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawley S., Javaid M.K., Prieto-Alhambra D., et al. Clinical effectiveness of orthogeriatric and fracture liaison service models of care for hip fracture patients: population-based longitudinal study. Age Ageing. 2016;45:236&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4776625</ArticleId><ArticleId IdType="pubmed">26802076</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen A., Tsang C., Boulton C., Wakeman R., Moppett I. Understanding mortality rates after hip fracture repair using ASA physical status in the National Hip Fracture Database. Anaesthesia. 2017;72:961&#x2013;966.</Citation><ArticleIdList><ArticleId IdType="pubmed">28585391</ArticleId></ArticleIdList></Reference><Reference><Citation>Flikweert E.R., Wendt K.W., Diercks R.L., et al. Complications after hip fracture surgery: are they preventable? Eur J Trauma Emerg Surg. 2018;44:573&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6096618</ArticleId><ArticleId IdType="pubmed">28795198</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin S., Kim S.H., Park K.K., Kim S.J., Bae J.C., Choi Y.S. Effects of anesthesia techniques on outcomes after hip fracture surgery in elderly patients: a prospective, randomized, controlled trial. J&#xa0;Clin Med. 2020;9:1605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7355551</ArticleId><ArticleId IdType="pubmed">32466360</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowark A., Rossaint R., Coburn M. General versus spinal anesthesia for the elderly hip fractured patient. Curr Opin Anaesthesiol. 2019;32:116&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">30543554</ArticleId></ArticleIdList></Reference><Reference><Citation>Guay J., Parker M.J., Gajendragadkar P.R., Kopp S. Anaesthesia for hip fracture surgery in adults. Cochrane Database Syst Rev. 2016;2:CD000521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6464323</ArticleId><ArticleId IdType="pubmed">26899415</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel V., Champaneria R., Dretzke J., Yeung J. Effect of regional versus general anaesthesia on postoperative delirium in elderly patients undergoing surgery for hip fracture: a systematic review. BMJ Open. 2018;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6286489</ArticleId><ArticleId IdType="pubmed">30518580</ArticleId></ArticleIdList></Reference><Reference><Citation>Luger T.J., Kammerlander C., Gosch M., et al. Neuroaxial versus general anaesthesia in geriatric patients for hip fracture surgery: does it matter? Osteoporos Int. 2010;21:S555&#x2013;S572.</Citation><ArticleIdList><ArticleId IdType="pubmed">21057995</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X., Tan Y., Gao Y., Liu Z. Comparative efficacy of Neuraxial and general anesthesia for hip fracture surgery: a meta-analysis of randomized clinical trials. BMC Anesthesiol. 2020;20:162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7325684</ArticleId><ArticleId IdType="pubmed">32605591</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Waesberghe J., Stevanovic A., Rossaint R., Coburn M. General vs. neuraxial anaesthesia in hip fracture patients: a systematic review and meta-analysis. BMC Anesthesiol. 2017;17:87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5490182</ArticleId><ArticleId IdType="pubmed">28659127</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D.X., Yang L., Ding L., Li S.Y., Qi Y.N., Li Q. Perioperative outcomes in geriatric patients undergoing hip fracture surgery with different anesthesia techniques: a systematic review and meta-analysis. Medicine (Baltimore) 2019;98</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6919429</ArticleId><ArticleId IdType="pubmed">31804347</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence. Hip fracture: the management of hip fracture in adults. NICE clinical guideline 124. June 2011. Available from: https://www.nice.org.uk/guidance/cg124 (accessed 10 August 2022).</Citation></Reference><Reference><Citation>O'Donnell C.M., Black N., McCourt K.C., et al. Development of a Core Outcome Set for studies evaluating the effects of anaesthesia on perioperative morbidity and mortality following hip fracture surgery. Br J Anaesth. 2019;122:120&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pubmed">30579390</ArticleId></ArticleIdList></Reference><Reference><Citation>Haywood K.L., Griffin X.L., Achten J., Costa M.L. Developing a core outcome set for hip fracture trials. Bone Jt J. 2014;96-B:1016. &#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">25086115</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles P.S., Grocott M.P., Boney O., Moonesinghe S.R., Group Co-S Standardizing end points in perioperative trials: towards a core and extended outcome set. Br J Anaesth. 2016;116:586&#x2013;589.</Citation><ArticleIdList><ArticleId IdType="pubmed">27106961</ArticleId></ArticleIdList></Reference><Reference><Citation>Beer N., Riffat A., Volkmer B., Wyatt D., Lambe K., Sheehan K.J. Patient perspectives of recovery after hip fracture: a systematic review and qualitative synthesis. Disabil Rehabil. 2021:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">34428389</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang L., Fang P., Fang Y., Lu Y., Xu G., Liu X. Comparison of effects between combined lumbar-sacral plexus block plus general anesthesia and unilateral spinal anesthesia in elderly patients undergoing hip fracture surgery: a pilot randomized controlled trial. Evid Based Complement Alternat Med. 2021;2021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8105098</ArticleId><ArticleId IdType="pubmed">34012474</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T., Li J., Yuan L., et al. Effect of regional vs general anesthesia on incidence of postoperative delirium in older patients undergoing hip fracture surgery: the Raga randomized trial. JAMA. 2022;327:50&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8689436</ArticleId><ArticleId IdType="pubmed">34928310</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman M.D., Feng R., Carson J.L., et al. Spinal anesthesia or general anesthesia for hip surgery in older adults. N&#xa0;Engl J Med. 2021;385:2025&#x2013;2035.</Citation><ArticleIdList><ArticleId IdType="pubmed">34623788</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3090117</ArticleId><ArticleId IdType="pubmed">21603045</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouzzani M., Hammady H., Fedorowicz Z., Elmagarmid A. Rayyan&#x2014;a web and mobile app for systematic reviews. Syst Rev. 2016;5:210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5139140</ArticleId><ArticleId IdType="pubmed">27919275</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa M.L., Griffin X.L., Achten J., et al. World Hip Trauma Evaluation (WHiTE): framework for embedded comprehensive cohort studies. BMJ Open. 2016;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5093367</ArticleId><ArticleId IdType="pubmed">27797994</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin X.L., McArthur J., Achten J., Parsons N., Costa M.L. The Warwick Hip Trauma Evaluation Two&#x2014;an abridged protocol for the WHiTE Two Study: an embedded randomised trial comparing the Dual-Mobility with polyethylene cups in hip arthroplasty for fracture. Bone Jt Res. 2013;2:210&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3791483</ArticleId><ArticleId IdType="pubmed">24089291</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin X.L., McArthur J., Achten J., Parsons N., Costa M.L. The Warwick Hip Trauma Evaluation One&#x2014;an abridged protocol for the WHiTE One Study: an embedded randomised trial comparing the X-bolt with slidinghip screw fixation in extracapsular hip fractures. Bone Jt Res. 2013;2:206&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3791484</ArticleId><ArticleId IdType="pubmed">24089290</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsons N., Griffin X.L., Achten J., Costa M.L. Outcome assessment after hip fracture: is EQ-5D the answer? Bone Jt Res. 2014;3:69&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3963508</ArticleId><ArticleId IdType="pubmed">24648420</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamitani K., Higuchi A., Asahi T., Yoshida H. [Postoperative delirium after general anesthesia vs. spinal anesthesia in geriatric patients] Masui. 2003;52:972&#x2013;975.</Citation><ArticleIdList><ArticleId IdType="pubmed">14531256</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P., Altman D.G., Gotzsche P.C., et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt G., Oxman A.D., Akl E.A., et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J&#xa0;Clin Epidemiol. 2011;64:383&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pubmed">21195583</ArticleId></ArticleIdList></Reference><Reference><Citation>Hozo S.P., Djulbegovic B., Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1097734</ArticleId><ArticleId IdType="pubmed">15840177</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trial. 1986;7:177&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539&#x2013;1558.</Citation><ArticleIdList><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson S.G., Sharp S.J. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med. 1999;18:2693&#x2013;2708.</Citation><ArticleIdList><ArticleId IdType="pubmed">10521860</ArticleId></ArticleIdList></Reference><Reference><Citation>Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088&#x2013;1101.</Citation><ArticleIdList><ArticleId IdType="pubmed">7786990</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629&#x2013;634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne J.A., Sutton A.J., Ioannidis J.P., et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002.</Citation><ArticleIdList><ArticleId IdType="pubmed">21784880</ArticleId></ArticleIdList></Reference><Reference><Citation>Biboulet P., Jourdan A., Van Haevre V., et al. Hemodynamic profile of target-controlled spinal anesthesia compared with 2 target-controlled general anesthesia techniques in elderly patients with cardiac comorbidities. Reg Anesth Pain Med. 2012;37:433&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pubmed">22609644</ArticleId></ArticleIdList></Reference><Reference><Citation>Casati A., Aldegheri G., Vinciguerra F., Marsan A., Fraschini G., Torri G. Randomized comparison between sevoflurane anaesthesia and unilateral spinal anaesthesia in elderly patients undergoing orthopaedic surgery. Eur J Anaesthesiol. 2003;20:640&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pubmed">12932066</ArticleId></ArticleIdList></Reference><Reference><Citation>Haghighi M., Sedighinejad A., Nabi B.N., et al. Is spinal anesthesia with low dose lidocaine better than sevoflorane anesthesia in patients undergoing hip fracture surgery. Arch Bone Jt Surg. 2017;5:226&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5592363</ArticleId><ArticleId IdType="pubmed">28913379</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoppenstein D., Zohar E., Ramaty E., Shabat S., Fredman B. The effects of general vs spinal anesthesia on frontal cerebral oxygen saturation in geriatric patients undergoing emergency surgical fixation of the neck of femur. J&#xa0;Clin Anesth. 2005;17:431&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pubmed">16171663</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina A., Frassanito L., Colombo D., et al. Hemodynamic changes associated with spinal and general anesthesia for hip fracture surgery in severe ASA III elderly population: a pilot trial. Minerva Anestesiol. 2013;79:1021&#x2013;1029.</Citation><ArticleIdList><ArticleId IdType="pubmed">23635998</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman M.D., Ellenberg S.S., Sieber F.E., et al. Regional versus general anesthesia for promoting independence after hip fracture (REGAIN): protocol for a pragmatic, international multicentre trial. BMJ Open. 2016;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5129073</ArticleId><ArticleId IdType="pubmed">27852723</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker M.J., Griffiths R. General versus regional anaesthesia for hip fractures. A pilot randomised controlled trial of 322 patients. Injury. 2015;46:1562&#x2013;1566.</Citation><ArticleIdList><ArticleId IdType="pubmed">26049662</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzimas P., Samara E., Petrou A., Korompilias A., Chalkias A., Papadopoulos G. The influence of anesthetic techniques on postoperative cognitive function in elderly patients undergoing hip fracture surgery: general vs spinal anesthesia. Injury. 2018;49:2221&#x2013;2226.</Citation><ArticleIdList><ArticleId IdType="pubmed">30526923</ArticleId></ArticleIdList></Reference><Reference><Citation>Meuret P., Bouvet L., Villet B., Hafez M., Allaouchiche B., Boselli E. Hypobaric unilateral spinal anaesthesia versus general anaesthesia in elderly patients undergoing hip fracture surgical repair: a prospective randomised open trial. Turk J Anaesthesiol Reanim. 2018;46:121&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5937458</ArticleId><ArticleId IdType="pubmed">29744247</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren W.-X., Wu R.-R. Effect of general and sub-arachnoid anesthesia on the incidence of postoperative delirium and cognitive impairments in elderly Chinese patients. Trop J Pharm Res. 2021;20:433&#x2013;439.</Citation></Reference><Reference><Citation>Urwin S.C., Parker M.J., Griffiths R. General versus regional anaesthesia for hip fracture surgery: a meta-analysis of randomized trials. Br J Anaesth. 2000;84:450&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pubmed">10823094</ArticleId></ArticleIdList></Reference><Reference><Citation>Hip fracture in adults NICE quality standard. Available from: https://www.nice.org.uk/guidance/qs16/documents/draft-quality-standard-2 (accessed 13 May 2022).</Citation></Reference><Reference><Citation>Evered L.A., Vitug S., Scott D.A., Silbert B. Preoperative frailty predicts postoperative neurocognitive disorders after total hip joint replacement surgery. Anesth Analg. 2020;131:1582&#x2013;1588.</Citation><ArticleIdList><ArticleId IdType="pubmed">33079882</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowark A., Adam C., Ahrens J., et al. Improve hip fracture outcome in the elderly patient (iHOPE): a study protocol for a pragmatic, multicentre randomised controlled trial to test the efficacy of spinal versus general anaesthesia. BMJ Open. 2018;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6196806</ArticleId><ArticleId IdType="pubmed">30341135</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths R., Babu S., Dixon P., et al. Guideline for the management of hip fractures 2020: guideline by the Association of Anaesthetists. Anaesthesia. 2021;76:225&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pubmed">33289066</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35244046</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>101</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>04</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Effects of perioperative erythropoietin administration on acute kidney injury and red blood cell transfusion in patients undergoing cardiac surgery: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>e28920</StartPage><MedlinePgn>e28920</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e28920</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000028920</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The renoprotective effects of erythropoietin (EPO) are well-known; however, the optimal timing of EPO administration remains controversial. Red blood cell (RBC) transfusion is an independent risk factor for cardiac surgery-associated acute kidney injury (CSA-AKI). We aimed to evaluate the efficacy of EPO on CSA-AKI and RBC transfusion according to the timing of administration.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched the Cochrane Library, EMBASE, and MEDLINE databases for randomized controlled trials. The primary outcome was the incidence of CSA-AKI following perioperative EPO administration, and the secondary outcomes were changes in serum creatinine, S-cystatin C, S-neutrophil gelatinase-associated lipocalin, urinary neutrophil gelatinase-associated lipocalin, length of hospital and intensive care unit (ICU) stay, volume of RBC transfusion, and mortality. The subgroup analysis was stratified according to the timing of EPO administration in relation to surgery.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eight randomized controlled trials with 610 patients were included in the study. EPO administration significantly decreased the incidence of CSA-AKI (odds ratio: 0.60, 95% confidence interval [CI]: 0.43-0.85, P&#x200a;=&#x200a;.004; I2&#x200a;=&#x200a;52%; P for heterogeneity&#x200a;=&#x200a;.04), intra-operative RBC transfusion (standardized mean difference: -0.30, 95% CI: -0.55 to -0.05, P&#x200a;=&#x200a;.02; I2&#x200a;=&#x200a;15%, P for heterogeneity&#x200a;=&#x200a;.31), and hospital length of stay (mean difference: -1.54&#x200a;days, 95% CI: -2.70 to -0.39, P&#x200a;=&#x200a;.009; I2&#x200a;=&#x200a;75%, P for heterogeneity&#x200a;=&#x200a;.001) compared with control groups. Subgroup analyses revealed that pre-operative EPO treatment significantly reduced the incidence of CSA-AKI, intra-operative RBC transfusion, serum creatinine, and length of hospital and ICU stay.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Pre-operative administration of EPO may reduce the incidence of CSA-AKI and RBC transfusion, but not in patients administered EPO during the intra-operative or postoperative period. Therefore, pre-operative EPO treatment can be considered to improve postoperative outcomes by decreasing the length of hospital and ICU stay in patients undergoing cardiac surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Hyeon Ju</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Eunji</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jun</LastName><ForeName>Injae</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hyun Jung</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine, Institute for Evidence-based Medicine Cochrane Korea, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Choon Hak</ForeName><Initials>CH</Initials><Identifier Source="ORCID">0000-0003-0089-7682</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071068">Lipocalin-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>11096-26-7</RegistryNumber><NameOfSubstance UI="D004921">Erythropoietin</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017707" MajorTopicYN="Y">Erythrocyte Transfusion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004921" MajorTopicYN="N">Erythropoietin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071068" MajorTopicYN="N">Lipocalin-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no funding and conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>4</Day><Hour>8</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35244046</ArticleId><ArticleId IdType="pmc">PMC8896477</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000028920</ArticleId><ArticleId IdType="pii">00005792-202203040-00013</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gaffney AM, Sladen RN. Acute kidney injury in cardiac surgery. Curr Opin Anaesthesiol 2015;28:50&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25486486</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao H, Katz N, Ariyanon W, et al. . Cardiac surgery-associated acute kidney injury. Blood Purif 2014;37: (Suppl 2): 34&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">25196567</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol 2017;13:697&#x2013;711.</Citation><ArticleIdList><ArticleId IdType="pubmed">28869251</ArticleId></ArticleIdList></Reference><Reference><Citation>Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 1999;341:233&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1220352</ArticleId><ArticleId IdType="pubmed">10393078</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman MD, Shaefi S, Sladen RN. Preventing acute kidney injury after cardiac surgery. Curr Opin Anaesthesiol 2011;24:70&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">21157303</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeulen Windsant IC, Snoeijs MG, Hanssen SJ, et al. . Hemolysis is associated with acute kidney injury during major aortic surgery. Kidney Int 2010;77:913&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">20182411</ArticleId></ArticleIdList></Reference><Reference><Citation>Kindzelski BA, Corcoran P, Siegenthaler MP, Horvath KA. Postoperative acute kidney injury following intraoperative blood product transfusions during cardiac surgery. Perfusion 2018;33:62&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">28581343</ArticleId></ArticleIdList></Reference><Reference><Citation>Almac E, Ince C. The impact of storage on red cell function in blood transfusion. Best Pract Res Clin Anaesthesiol 2007;21:195&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">17650772</ArticleId></ArticleIdList></Reference><Reference><Citation>Comporti M, Signorini C, Buonocore G, Ciccoli L. Iron release, oxidative stress and erythrocyte ageing. Free Radic Biol Med 2002;32:568&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">11909691</ArticleId></ArticleIdList></Reference><Reference><Citation>Hod EA, Brittenham GM, Billote GB, et al. . Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron. Blood 2011;118:6675&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3242722</ArticleId><ArticleId IdType="pubmed">22021369</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeulen Windsant IC, Hanssen SJ, Buurman WA, Jacobs MJ. Cardiovascular surgery and organ damage: time to reconsider the role of hemolysis. J Thorac Cardiovasc Surg 2011;142:01&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">21570697</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan UA, Coca SG, Hong K, et al. . Blood transfusions are associated with urinary biomarkers of kidney injury in cardiac surgery. J Thorac Cardiovasc Surg 2014;148:726&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4104243</ArticleId><ArticleId IdType="pubmed">24820190</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase-Fielitz A, Bellomo R, Devarajan P, et al. . Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery&#x2014;a prospective cohort study. Crit Care Med 2009;37:553&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">19114878</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh CR, Thiessen-Philbrook H, Garg AX, et al. . Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery. Clin J Am Soc Nephrol 2013;8:1079&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3700701</ArticleId><ArticleId IdType="pubmed">23599408</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra J, Ma Q, Prada A, et al. . Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003;14:2534&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">14514731</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra J, Dent C, Tarabishi R, et al. . Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005;365:1231&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">15811456</ArticleId></ArticleIdList></Reference><Reference><Citation>Newman DJ, Thakkar H, Edwards RG, et al. . Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995;47:312&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">7731163</ArticleId></ArticleIdList></Reference><Reference><Citation>Spahillari A, Parikh CR, Sint K, et al. . Serum cystatin C- versus creatinine-based definitions of acute kidney injury following cardiac surgery: a prospective cohort study. Am J Kidney Dis 2012;60:922&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3496012</ArticleId><ArticleId IdType="pubmed">22809763</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson CE, Yavas S, Segal MS, et al. . Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation 2009;119:2444&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">19398670</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao H, Katz N, Ariyanon W, et al. . Cardiac surgery-associated acute kidney injury. Cardiorenal Med 2013;3:178&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3884176</ArticleId><ArticleId IdType="pubmed">24454314</ArticleId></ArticleIdList></Reference><Reference><Citation>Howell NJ, Keogh BE, Bonser RS, et al. . Mild renal dysfunction predicts in-hospital mortality and post-discharge survival following cardiac surgery. Eur J Cardiothorac Surg 2008;34:390&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">18502144</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs SA, Thakar CV. Perioperative risk assessment, prevention, and treatment of acute kidney injury. Int Anesthesiol Clin 2009;47:89&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">19820480</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega-Loubon C, Fern&#xe1;ndez-Molina M, Carrascal-Hinojal Y, Fulquet-Carreras E. Cardiac surgery-associated acute kidney injury. Ann Card Anaesth 2016;19:687&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070330</ArticleId><ArticleId IdType="pubmed">27716701</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar AB, Suneja M, Bayman EO, Weide GD, Tarasi M. Association between postoperative acute kidney injury and duration of cardiopulmonary bypass: a meta-analysis. J Cardiothorac Vasc Anesth 2012;26:64&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21924633</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyake T, Kung CK, Goldwasser E. Purification of human erythropoietin. J Biol Chem 1977;252:5558&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">18467</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachmann S, Le Hir M, Eckardt KU. Co-localization of erythropoietin mRNA and ecto-5&#x2032;-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin. J Histochem Cytochem 1993;41:335&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">8429197</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahlmann FH, Fliser D. Erythropoietin and renoprotection. Curr Opin Nephrol Hypertens 2009;18:15&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">19077684</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharples EJ, Patel N, Brown P, et al. . Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 2004;15:2115&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">15284297</ArticleId></ArticleIdList></Reference><Reference><Citation>Spandou E, Tsouchnikas I, Karkavelas G, et al. . Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model. Nephrol Dial Transplant 2006;21:330&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">16221709</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel NS, Sharples EJ, Cuzzocrea S, et al. . Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo. Kidney Int 2004;66:983&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15327391</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo YC, Shim JK, Kim JC, Jo YY, Lee JH, Kwak YL. Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. Anesthesiology 2011;115:929&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">22027622</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasanarong A, Duangchana S, Sumransurp S, Homvises B, Satdhabudha O. Prophylaxis with erythropoietin versus placebo reduces acute kidney injury and neutrophil gelatinase-associated lipocalin in patients undergoing cardiac surgery: a randomized, double-blind controlled trial. BMC Nephrol 2013;14:136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3704968</ArticleId><ArticleId IdType="pubmed">23829828</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh SW, Chin HJ, Chae DW, Na KY. Erythropoietin improves long-term outcomes in patients with acute kidney injury after coronary artery bypass grafting. J Korean Med Sci 2012;27:506&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3342541</ArticleId><ArticleId IdType="pubmed">22563215</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JH, Shim JK, Song JW, Song Y, Kim HB, Kwak YL. Effect of erythropoietin on the incidence of acute kidney injury following complex valvular heart surgery: a double blind, randomized clinical trial of efficacy and safety. Crit Care 2013;17:R254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4056185</ArticleId><ArticleId IdType="pubmed">24156702</ArticleId></ArticleIdList></Reference><Reference><Citation>Dardashti A, Ederoth P, Algotsson L, et al. . Erythropoietin and protection of renal function in cardiac surgery (the EPRICS Trial). Anesthesiology 2014;121:582&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">25225746</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JE, Song SW, Kim JY, Lee HJ, Chung KH, Shim YH. Effect of a single bolus of erythropoietin on renoprotection in patients undergoing thoracic aortic surgery with moderate hypothermic circulatory arrest. Ann Thorac Surg 2016;101:690&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">26576750</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Zou YR, Zhong X, et al. . Erythropoietin pretreatment ameliorates renal ischaemia-reperfusion injury by activating PI3K/Akt signalling. Nephrology (Carlton) 2015;20:266&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">25581532</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen S, Jin Y, Li W, et al. . Recombinant human erythropoietin pretreatment attenuates acute renal tubular injury against ischemia-reperfusion by restoring transient receptor potential channel-6 expression and function in collecting ducts. Crit Care Med 2014;42:e663&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">25072760</ArticleId></ArticleIdList></Reference><Reference><Citation>Elshiekh M, Kadkhodaee M, Seifi B, Ranjbaran M, Ahghari P. Ameliorative effect of recombinant human erythropoietin and ischemic preconditioning on renal ischemia reperfusion injury in rats. Nephrourol Mon 2015;7:e31152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4744640</ArticleId><ArticleId IdType="pubmed">26866008</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson DW, Pat B, Vesey DA, Guan Z, Endre Z, Gobe GC. Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure. Kidney Int 2006;69:1806&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">16598197</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009;62:1006&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">19631508</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Savovi&#x107; J, Page MJ, et al. . RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366:l4898.</Citation><ArticleIdList><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 2014;14:135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Song YR, Lee T, You SJ, et al. . Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: a pilot study. Am J Nephrol 2009;30:253&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">19494484</ArticleId></ArticleIdList></Reference><Reference><Citation>de Seigneux S, Ponte B, Weiss L, et al. . Epoetin administrated after cardiac surgery: effects on renal function and inflammation in a randomized controlled study. BMC Nephrol 2012;13:132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3506492</ArticleId><ArticleId IdType="pubmed">23033926</ArticleId></ArticleIdList></Reference><Reference><Citation>Karkouti K, Wijeysundera DN, Yau TM, et al. . Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation 2009;119:495&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pubmed">19153273</ArticleId></ArticleIdList></Reference><Reference><Citation>Katavetin P, Tungsanga K, Eiam-Ong S, Nangaku M. Antioxidative effects of erythropoietin. Kidney Int Suppl 2007;S10&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">17943138</ArticleId></ArticleIdList></Reference><Reference><Citation>Joyeux-Faure M. Cellular protection by erythropoietin: new therapeutic implications? J Pharmacol Exp Ther 2007;323:759&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">17717190</ArticleId></ArticleIdList></Reference><Reference><Citation>Salahudeen AK, Haider N, Jenkins J, et al. . Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury. Am J Physiol Renal Physiol 2008;294:F1354&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">18385271</ArticleId></ArticleIdList></Reference><Reference><Citation>Vesey DA, Cheung C, Pat B, Endre Z, Gob&#xe9; G, Johnson DW. Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant 2004;19:348&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">14736958</ArticleId></ArticleIdList></Reference><Reference><Citation>Tramontano AF, Muniyappa R, Black AD, et al. . Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway. Biochem Biophys Res Commun 2003;308:990&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">12927817</ArticleId></ArticleIdList></Reference><Reference><Citation>Fust&#xe9; B, Serradell M, Escolar G, et al. . Erythropoietin triggers a signaling pathway in endothelial cells and increases the thrombogenicity of their extracellular matrices in vitro. Thromb Haemost 2002;88:678&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">12362243</ArticleId></ArticleIdList></Reference><Reference><Citation>Katavetin P, Inagi R, Miyata T, et al. . Erythropoietin induces heme oxygenase-1 expression and attenuates oxidative stress. Biochem Biophys Res Commun 2007;359:928&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">17560935</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Oliva JF, Casanova-Gonz&#xe1;lez M, Garc&#xed;a-Garc&#xed;a I, et al. . Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: a parallel, randomized, double blind study. BMC Nephrol 2005;6:05.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1164417</ArticleId><ArticleId IdType="pubmed">15910687</ArticleId></ArticleIdList></Reference><Reference><Citation>McIlroy DR, Wagener G, Lee HT. Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance. Clin J Am Soc Nephrol 2010;5:211&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2827603</ArticleId><ArticleId IdType="pubmed">20056755</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyner JL, Vaidya VS, Bennett MR, et al. . Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol 2010;5:2154&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2994075</ArticleId><ArticleId IdType="pubmed">20798258</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Y, Lin L, Lian Q, Zou H, Chu H. Real-world performance of meta-analysis methods for double-zero-event studies with dichotomous outcomes using the cochrane database of systematic reviews. J Gen Intern Med 2019;34:960&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6544742</ArticleId><ArticleId IdType="pubmed">30887438</ArticleId></ArticleIdList></Reference><Reference><Citation>Mat&#x11b;jkov&#xe1; &#x160;, Scheuerle A, Wagner F, et al. . Carbamylated erythropoietin-FC fusion protein and recombinant human erythropoietin during porcine kidney ischemia/reperfusion injury. Intensive Care Med 2013;39:497&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pubmed">23291730</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghaboura N, Tamareille S, Ducluzeau PH, et al. . Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3&#x3b2; signaling. Basic Res Cardiol 2011;106:147&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">20981553</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C, Lin Z, Luo Q, Xia X, Yu X, Huang F. Efficacy and safety of erythropoietin to prevent acute kidney injury in patients with critical illness or perioperative care: a systematic review and meta-analysis of randomized controlled trials. J Cardiovasc Pharmacol 2015;65:593&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4461384</ArticleId><ArticleId IdType="pubmed">26065644</ArticleId></ArticleIdList></Reference><Reference><Citation>Luten M, Roerdinkholder-Stoelwinder B, Schaap NP, de Grip WJ, Bos HJ, Bosman GJ. Survival of red blood cells after transfusion: a comparison between red cells concentrates of different storage periods. Transfusion 2008;48:1478&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">18482180</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasocki S, Longrois D, Montravers P, Beaumont C. Hepcidin and anemia of the critically ill patient: bench to bedside. Anesthesiology 2011;114:688&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">21258235</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FTt, Ball SK, Roberts LJ, 2nd, Pretorius M. Postoperative acute kidney injury is associated with hemoglobinemia and an enhanced oxidative stress response. Free Radic Biol Med 2011;50:1480&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3090463</ArticleId><ArticleId IdType="pubmed">21334433</ArticleId></ArticleIdList></Reference><Reference><Citation>Donadee C, Raat NJ, Kanias T, et al. . Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation 2011;124:465&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3891836</ArticleId><ArticleId IdType="pubmed">21747051</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase M, Bellomo R, Haase-Fielitz A. Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-associated acute kidney injury. J Am Coll Cardiol 2010;55:2024&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">20447525</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabrilove J. Overview: erythropoiesis, anemia, and the impact of erythropoietin. Semin Hematol 2000;37: (Suppl 6): 01&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">11068948</ArticleId></ArticleIdList></Reference><Reference><Citation>Weltert L, Rondinelli B, Bello R, et al. . A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial. Transfusion 2015;55:1644&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">25702777</ArticleId></ArticleIdList></Reference><Reference><Citation>Alghamdi AA, Albanna MJ, Guru V, Brister SJ. Does the use of erythropoietin reduce the risk of exposure to allogeneic blood transfusion in cardiac surgery? A systematic review and meta-analysis. J Card Surg 2006;21:320&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">16684074</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39494507</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1525-6049</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Renal failure</Title><ISOAbbreviation>Ren Fail</ISOAbbreviation></Journal><ArticleTitle>Intraoperative hyperthermia is associated with increased acute kidney injury following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a retrospective cohort study.</ArticleTitle><Pagination><StartPage>2420835</StartPage><MedlinePgn>2420835</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2420835</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/0886022X.2024.2420835</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Acute kidney injury (AKI) is common after cytoreduction surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) for peritoneal surface malignancies. Herein we analyzed the association between intraoperative hyperthermia and AKI following CRS-HIPEC.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">In this retrospective cohort study, we collected baseline and perioperative data from patients who underwent CRS-HIPEC mainly for pseudomyxoma peritonei between 2014 and 2020. Nasopharyngeal temperature was recorded at 5-min intervals. The area above the threshold was calculated for intraoperative hyperthermia (&gt;37.0&#x2009;&#xb0;C). AKI was diagnosed and classified according to the KDIGO creatinine criteria. A multivariable logistic regression model was established to assess the association between hyperthermia and AKI.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 480 patients were included in the analysis. Of these, 10.6% (51/480) developed AKI within 7 postoperative days. After correction for confounding factors, a larger area above the threshold of hyperthermia was significantly associated with an increased risk of AKI (odds ratio [OR] 1.36, 95% CI 1.14-1.63, <i>p</i>&#x2009;=&#x2009;0.001). Among other factors, older age (OR 1.05, 95% CI 1.02-1.09, <i>p</i>&#x2009;=&#x2009;0.002), postoperative hypotension requiring vasopressors (OR 2.09, 95% CI 1.02-4.27, <i>p</i>&#x2009;=&#x2009;0.042), and intraperitoneal chemotherapy containing cisplatin (OR 2.75, 95% CI 1.20-6.33, <i>p</i>&#x2009;=&#x2009;0.017) were also associated with an increased risk of AKI. Patients with AKI required longer mechanical ventilation, stayed longer in the intensive care unit and hospital, developed more complications, and required more intensive care unit readmission.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Among patients undergoing CRS-HIPEC, intraoperative hyperthermia was independently associated with a higher risk of AKI; this effect was additive to other risk factors including cisplatin-containing chemotherapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Shun-Cai</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Peking University First Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Aerospace Center Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Jia-Hui</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Peking University First Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Peking University First Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Rui-Qing</ForeName><Initials>RQ</Initials><AffiliationInfo><Affiliation>Department of Myxoma, Aerospace Center Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Su-Li</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Aerospace Center Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dong-Xin</ForeName><Initials>DX</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Peking University First Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Outcomes Research Consortium, Houston, TX, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ren Fail</MedlineTA><NlmUniqueID>8701128</NlmUniqueID><ISSNLinking>0886-022X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065426" MajorTopicYN="Y">Cytoreduction Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000084262" MajorTopicYN="Y">Hyperthermic Intraperitoneal Chemotherapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010534" MajorTopicYN="Y">Peritoneal Neoplasms</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006979" MajorTopicYN="Y">Hyperthermia, Induced</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011553" MajorTopicYN="N">Pseudomyxoma Peritonei</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Peritoneal surface malignancies</Keyword><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cytoreductive surgery</Keyword><Keyword MajorTopicYN="N">hyperthermic intraperitoneal chemotherapy</Keyword><Keyword MajorTopicYN="N">postoperative complications</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>12</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>5</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39494507</ArticleId><ArticleId IdType="pmc">PMC11536636</ArticleId><ArticleId IdType="doi">10.1080/0886022X.2024.2420835</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Macr&#xec; A. New approach to peritoneal surface malignancies. World J Gastrointest Oncol. 2010;2(1):9&#x2013;11. doi: 10.4251/wjgo.v2.i1.9.</Citation><ArticleIdList><ArticleId IdType="doi">10.4251/wjgo.v2.i1.9</ArticleId><ArticleId IdType="pmc">PMC2999159</ArticleId><ArticleId IdType="pubmed">21160811</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua TC, Liauw W, Saxena A, et al. . Evolution of locoregional treatment for peritoneal carcinomatosis: single-center experience of 308 procedures of &#xad;cytoreductive &#xad;surgery and perioperative intraperitoneal chemotherapy. Am J Surg. 2011;201(2):149&#x2013;156. doi: 10.1016/j.amjsurg.2010.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2010.02.012</ArticleId><ArticleId IdType="pubmed">20832051</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugarbaker PH. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol. 2001;27(3):239&#x2013;243. doi: 10.1053/ejso.2000.1038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/ejso.2000.1038</ArticleId><ArticleId IdType="pubmed">11373099</ArticleId></ArticleIdList></Reference><Reference><Citation>Deraco M, Baratti D, Cabras AD, et al. . Experience with peritoneal mesothelioma at the Milan National Cancer Institute. World J Gastrointest Oncol. 2010;2(2):76&#x2013;84. doi: 10.4251/wjgo.v2.i2.76.</Citation><ArticleIdList><ArticleId IdType="doi">10.4251/wjgo.v2.i2.76</ArticleId><ArticleId IdType="pmc">PMC2999160</ArticleId><ArticleId IdType="pubmed">21160925</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Yu Y, Liu Y.. Report on the 9(th) International Congress on Peritoneal Surface Malignancies. Cancer Biol Med. 2014;11(4):281&#x2013;284. doi: 10.7497/j.issn.2095-3941.2014.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.7497/j.issn.2095-3941.2014.04.008</ArticleId><ArticleId IdType="pmc">PMC4296089</ArticleId><ArticleId IdType="pubmed">25610715</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb CA, Weyker PD, Moitra VK, et al. . An overview of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for the anesthesiologist. Anesth Analg. 2013;116(4):924&#x2013;931. doi: 10.1213/ANE.0b013e3182860fff.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e3182860fff</ArticleId><ArticleId IdType="pubmed">23460568</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheshadri DB, Chakravarthy MR.. Anaesthetic considerations in the perioperative management of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Indian J Surg Oncol. 2016;7(2):236&#x2013;243. doi: 10.1007/s13193-016-0508-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13193-016-0508-2</ArticleId><ArticleId IdType="pmc">PMC4818608</ArticleId><ArticleId IdType="pubmed">27065715</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezu L, Raineau M, Delom&#xe9;nie M, et al. . Haemodynamic management during hyperthermic intraperitoneal chemotherapy: a systematic review. Anaesth Crit Care Pain Med. 2020;39(4):531&#x2013;542. doi: 10.1016/j.accpm.2020.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.accpm.2020.03.019</ArticleId><ArticleId IdType="pubmed">32320757</ArticleId></ArticleIdList></Reference><Reference><Citation>Turan A, Cohen B, Adegboye J, et al. . Mild acute kidney injury after noncardiac surgery is associated with long-term renal dysfunction: a retrospective cohort study. Anesthesiology. 2020;132(5):1053&#x2013;1061. doi: 10.1097/ALN.0000000000003109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003109</ArticleId><ArticleId IdType="pubmed">31929326</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EA, De Corte W.. AKI patients have worse long-term outcomes, especially in the immediate post-ICU period. Crit Care. 2012;16(4):148. doi: 10.1186/cc11470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11470</ArticleId><ArticleId IdType="pmc">PMC3580744</ArticleId><ArticleId IdType="pubmed">22958588</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson C, Ozrazgat-Baslanti T, Kuxhausen A, et al. . Cost and mortality associated with postoperative acute kidney injury. Ann Surg. 2015;261(6):1207&#x2013;1214. doi: 10.1097/SLA.0000000000000732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000000732</ArticleId><ArticleId IdType="pmc">PMC4247993</ArticleId><ArticleId IdType="pubmed">24887982</ArticleId></ArticleIdList></Reference><Reference><Citation>Biteker M, Dayan A, Tekke&#x15f;in A&#x130;, et al. . Incidence, risk factors, and outcomes of perioperative acute kidney injury in noncardiac and nonvascular surgery. Am J Surg. 2014;207(1):53&#x2013;59. doi: 10.1016/j.amjsurg.2013.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2013.04.006</ArticleId><ArticleId IdType="pubmed">24050540</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Kellum JA, Ronco C.. Acute kidney injury. Lancet. 2012;380(9843):756&#x2013;766. doi: 10.1016/S0140-6736(11)61454-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)61454-2</ArticleId><ArticleId IdType="pubmed">22617274</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Xiao Z, Zhao X, et al. . Incidence, risk factors, and outcomes of the transition of HIPEC-induced acute kidney injury to acute kidney disease: a retrospective study. Ren Fail. 2024;46(1):2338482. doi: 10.1080/0886022X.2024.2338482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/0886022X.2024.2338482</ArticleId><ArticleId IdType="pmc">PMC11011229</ArticleId><ArticleId IdType="pubmed">38604946</ArticleId></ArticleIdList></Reference><Reference><Citation>Sin EI, Chia CS, Tan GHC, et al. . Acute kidney injury in ovarian cancer patients undergoing cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. Int J Hyperthermia. 2017;33(6):690&#x2013;695. doi: 10.1080/02656736.2017.1293304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02656736.2017.1293304</ArticleId><ArticleId IdType="pubmed">28540777</ArticleId></ArticleIdList></Reference><Reference><Citation>Angeles MA, Quenet F, Vieille P, et al. . Predictive risk &#xad;factors of acute kidney injury after cytoreductive surgery and cisplatin-based hyperthermic intra-peritoneal &#xad;chemotherapy for ovarian peritoneal carcinomatosis. Int J Gynecol Cancer. 2019;29(2):382&#x2013;391. doi: 10.1136/ijgc-2018-000099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ijgc-2018-000099</ArticleId><ArticleId IdType="pubmed">30674567</ArticleId></ArticleIdList></Reference><Reference><Citation>Hakeam HA, Breakiet M, Azzam A, et al. . The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive &#xad;surgery. Ren Fail. 2014;36(10):1486&#x2013;1491. doi: 10.3109/0886022X.2014.949758.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/0886022X.2014.949758</ArticleId><ArticleId IdType="pubmed">25155314</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjona-S&#xe1;nchez A, Cadenas-Febres A, Cabrera-Bermon J, et al. . Assessment of RIFLE and AKIN criteria to define acute renal dysfunction for HIPEC procedures for ovarian and non-ovarian peritoneal malignances. Eur J Surg Oncol. 2016;42(6):869&#x2013;876. doi: 10.1016/j.ejso.2015.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejso.2015.12.016</ArticleId><ArticleId IdType="pubmed">26898841</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye J, Ren Y, Wei Z, et al. . Nephrotoxicity and long-term survival investigations for patients with peritoneal carcinomatosis using hyperthermic intraperitoneal chemotherapy with cisplatin: a retrospective cohort study. Surg Oncol. 2018;27(3):456&#x2013;461. doi: 10.1016/j.suronc.2018.05.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.suronc.2018.05.025</ArticleId><ArticleId IdType="pubmed">30217302</ArticleId></ArticleIdList></Reference><Reference><Citation>Naffouje SA, Tulla KA, Chorley R, et al. . Acute kidney injury increases the rate of major morbidities in cytoreductive surgery and HIPEC. Ann Med Surg. 2018;35:163&#x2013;168. doi: 10.1016/j.amsu.2018.09.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2018.09.036</ArticleId><ArticleId IdType="pmc">PMC6178214</ArticleId><ArticleId IdType="pubmed">30310679</ArticleId></ArticleIdList></Reference><Reference><Citation>Hod T, Freedberg KJ, Motwani SS, et al. . Acute kidney injury after cytoreductive surgery and hyperthermic intraoperative cisplatin chemotherapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2021;161(4):1510&#x2013;1518. doi: 10.1016/j.jtcvs.2020.05.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2020.05.033</ArticleId><ArticleId IdType="pubmed">32631662</ArticleId></ArticleIdList></Reference><Reference><Citation>Liesenfeld LF, Wagner B, Hillebrecht HC, et al. . HIPEC-induced acute kidney injury: a retrospective clinical study and preclinical model. Ann Surg Oncol. 2022;29(1):139&#x2013;151. doi: 10.1245/s10434-021-10376-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-021-10376-5</ArticleId><ArticleId IdType="pmc">PMC8677640</ArticleId><ArticleId IdType="pubmed">34260006</ArticleId></ArticleIdList></Reference><Reference><Citation>Cata JP, Zavala AM, Van Meter A, et al. . Identification of risk factors associated with postoperative acute kidney injury after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a retrospective study. Int J Hyperthermia. 2018;34(5):538&#x2013;544. doi: 10.1080/02656736.2017.1368096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02656736.2017.1368096</ArticleId><ArticleId IdType="pubmed">28812384</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceresoli M, Coccolini F, Ansaloni L.. HIPEC and nephrotoxicity: a cisplatin induced effect? Eur J Surg Oncol. 2016;42(6):909&#x2013;910. doi: 10.1016/j.ejso.2015.08.174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejso.2015.08.174</ArticleId><ArticleId IdType="pubmed">26965304</ArticleId></ArticleIdList></Reference><Reference><Citation>Coccolini F, Corbella D, Finazzi P, et al. . Time course of cytokines, hemodynamic and metabolic parameters during hyperthermic intraperitoneal chemotherapy. Minerva Anestesiol. 2016;82(3):310&#x2013;319.</Citation><ArticleIdList><ArticleId IdType="pubmed">26184701</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman CL, Johnson BD, Vargas NT, et al. . Both hyperthermia and dehydration during physical work in the heat contribute to the risk of acute kidney injury. J Appl Physiol. 2020;128(4):715&#x2013;728. doi: 10.1152/japplphysiol.00787.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00787.2019</ArticleId><ArticleId IdType="pmc">PMC7191500</ArticleId><ArticleId IdType="pubmed">32078468</ArticleId></ArticleIdList></Reference><Reference><Citation>Boodhwani M, Rubens FD, Wozny D, et al. . Effects of mild hypothermia and rewarming on renal function after coronary artery bypass grafting. Ann Thorac Surg. 2009;87(2):489&#x2013;495. doi: 10.1016/j.athoracsur.2008.10.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2008.10.078</ArticleId><ArticleId IdType="pubmed">19161766</ArticleId></ArticleIdList></Reference><Reference><Citation>Newland RF, Baker RA, Mazzone AL, et al. . Rewarming temperature during cardiopulmonary bypass and acute kidney injury: a multicenter analysis. Ann Thorac Surg. 2016;101(5):1655&#x2013;1662. doi: 10.1016/j.athoracsur.2016.01.086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2016.01.086</ArticleId><ArticleId IdType="pubmed">27041450</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendrix RJ, Kassira JP, Lambert LA.. Elevated maximum core body temperature during hyperthermic intraperitoneal chemoperfusion (HIPEC) is associated with &#xad;increased postoperative complications. Ann Surg Oncol. 2020;27(1):232&#x2013;239. doi: 10.1245/s10434-019-07495-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-019-07495-5</ArticleId><ArticleId IdType="pubmed">31286314</ArticleId></ArticleIdList></Reference><Reference><Citation>Solanki SL, Mukherjee S, Agarwal V, et al. . Society of Onco-Anaesthesia and Perioperative Care consensus guidelines for perioperative management of patients for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC). Indian J Anaesth. 2019;63(12):972&#x2013;987. doi: 10.4103/ija.IJA_765_19.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ija.IJA_765_19</ArticleId><ArticleId IdType="pmc">PMC6921319</ArticleId><ArticleId IdType="pubmed">31879421</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221(1):29&#x2013;42. doi: 10.1097/00000658-199501000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-199501000-00004</ArticleId><ArticleId IdType="pmc">PMC1234492</ArticleId><ArticleId IdType="pubmed">7826158</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Zhou Y-F, Liang H, et al. . Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies. World J Gastroenterol. 2016;22(30):6906&#x2013;6916. doi: 10.3748/wjg.v22.i30.6906.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v22.i30.6906</ArticleId><ArticleId IdType="pmc">PMC4974588</ArticleId><ArticleId IdType="pubmed">27570426</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan H, Li B, Couris CM, et al. . Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676&#x2013;682. doi: 10.1093/aje/kwq433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwq433</ArticleId><ArticleId IdType="pubmed">21330339</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr NJ, Cecil TD, Mohamed F, et al. . A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the Peritoneal Surface Oncology Group International (PSOGI) modified Delphi process. Am J Surg Pathol. 2016;40(1):14&#x2013;26. doi: 10.1097/PAS.0000000000000535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PAS.0000000000000535</ArticleId><ArticleId IdType="pubmed">26492181</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacquet P, Sugarbaker PH.. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359&#x2013;374. doi: 10.1007/978-1-4613-1247-5_23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4613-1247-5_23</ArticleId><ArticleId IdType="pubmed">8849962</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179&#x2013;c184. doi: 10.1159/000339789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000339789</ArticleId><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Katayama H, Kurokawa Y, Nakamura K, et al. . Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria. Surg Today. 2016;46(6):668&#x2013;685. doi: 10.1007/s00595-015-1236-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00595-015-1236-x</ArticleId><ArticleId IdType="pmc">PMC4848327</ArticleId><ArticleId IdType="pubmed">26289837</ArticleId></ArticleIdList></Reference><Reference><Citation>Valenzuela CD, Levine EA, Mangieri CW, et al. . Repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for cancers with peritoneal metastasis: a 30-year institutional experience. Ann Surg Oncol. 2022;29(6):3436&#x2013;3445. doi: 10.1245/s10434-022-11441-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-022-11441-3</ArticleId><ArticleId IdType="pmc">PMC10088912</ArticleId><ArticleId IdType="pubmed">35286531</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang JF, Lv L, Zhao S, et al. . Hyperthermic intraperitoneal chemotherapy (HIPEC) combined with surgery: a 12-year meta-analysis of this promising treatment strategy for advanced gastric cancer at different stages. Ann Surg Oncol. 2022;29(5):3170&#x2013;3186. doi: 10.1245/s10434-021-11316-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-021-11316-z</ArticleId><ArticleId IdType="pubmed">35175455</ArticleId></ArticleIdList></Reference><Reference><Citation>Balachandran R, Mogensen LZ, Christensen P, et al. . Organ-specific adverse effects after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2022;29(9):6049&#x2013;6083. doi: 10.1245/s10434-022-11356-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-022-11356-z</ArticleId><ArticleId IdType="pubmed">35217973</ArticleId></ArticleIdList></Reference><Reference><Citation>Fakheri RJ, Goldfarb DS.. Ambient temperature as a contributor to kidney stone formation: implications of global warming. Kidney Int. 2011;79(11):1178&#x2013;1185. doi: 10.1038/ki.2011.76.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2011.76</ArticleId><ArticleId IdType="pubmed">21451456</ArticleId></ArticleIdList></Reference><Reference><Citation>Lameire NH, Bagga A, Cruz D, et al. . Acute kidney injury: an increasing global concern. Lancet. 2013;382(9887):170&#x2013;179. doi: 10.1016/S0140-6736(13)60647-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)60647-9</ArticleId><ArticleId IdType="pubmed">23727171</ArticleId></ArticleIdList></Reference><Reference><Citation>Upamalika SWAM, Wannige CT, Vidanagamachchi SM, et al. . A review of molecular mechanisms linked to potential renal injury agents in tropical rural farming communities. Environ Toxicol Pharmacol. 2022;92:103850. doi: 10.1016/j.etap.2022.103850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.etap.2022.103850</ArticleId><ArticleId IdType="pubmed">35301132</ArticleId></ArticleIdList></Reference><Reference><Citation>Hess HW, Stooks JJ, Baker TB, et al. . Kidney injury risk during prolonged exposure to current and projected wet bulb temperatures occurring during extreme heat events in healthy young men. J Appl Physiol. 2022;133(1):27&#x2013;40. doi: 10.1152/japplphysiol.00601.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00601.2021</ArticleId><ArticleId IdType="pmc">PMC9236880</ArticleId><ArticleId IdType="pubmed">35616302</ArticleId></ArticleIdList></Reference><Reference><Citation>Houser MC, Mac V, Smith DJ, et al. . Inflammation-related factors identified as biomarkers of dehydration and &#xad;subsequent acute kidney injury in agricultural workers. Biol Res Nurs. 2021;23(4):676&#x2013;688. doi: 10.1177/10998004211016070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10998004211016070</ArticleId><ArticleId IdType="pmc">PMC8726423</ArticleId><ArticleId IdType="pubmed">34018403</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen KL, Shamavonian R, Karpes JB, et al. . Acute kidney injury following hyperthermic intraperitoneal chemotherapy with cisplatin. Anticancer Res. 2021;41(3):1641&#x2013;1646. doi: 10.21873/anticanres.14926.</Citation><ArticleIdList><ArticleId IdType="doi">10.21873/anticanres.14926</ArticleId><ArticleId IdType="pubmed">33788760</ArticleId></ArticleIdList></Reference><Reference><Citation>Sastry J, Kellie SJ.. Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine. Pediatr Hematol Oncol. 2005;22(5):441&#x2013;445. doi: 10.1080/08880010590964381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08880010590964381</ArticleId><ArticleId IdType="pubmed">16020136</ArticleId></ArticleIdList></Reference><Reference><Citation>Arany I, Safirstein RL.. Cisplatin nephrotoxicity. Semin Nephrol. 2003;23(5):460&#x2013;464. doi: 10.1016/s0270-9295(03)00089-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0270-9295(03)00089-5</ArticleId><ArticleId IdType="pubmed">13680535</ArticleId></ArticleIdList></Reference><Reference><Citation>Madias NE, Harrington JT.. Platinum nephrotoxicity. Am J Med. 1978;65(2):307&#x2013;314. doi: 10.1016/0002-9343(78)90825-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(78)90825-2</ArticleId><ArticleId IdType="pubmed">99034</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein RS, Mayor GH.. Minireview. The nephrotoxicity of cisplatin. Life Sci. 1983;32(7):685&#x2013;690. doi: 10.1016/0024-3205(83)90299-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0024-3205(83)90299-0</ArticleId><ArticleId IdType="pubmed">6338333</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansaloni L, Coccolini F, Morosi L, et al. . Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer. Br J Cancer. 2015;112(2):306&#x2013;312. doi: 10.1038/bjc.2014.602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bjc.2014.602</ArticleId><ArticleId IdType="pmc">PMC4453456</ArticleId><ArticleId IdType="pubmed">25461804</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhadjari N, Gabato W, Calabrese D, et al. . Reply letter to: HIPEC and nephrotoxicity: a cisplatin induced effect? Eur J Surg Oncol. 2016;42(6):907&#x2013;908. doi: 10.1016/j.ejso.2016.02.243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejso.2016.02.243</ArticleId><ArticleId IdType="pubmed">26996250</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohno S, Siddik ZH, Kido Y, et al. . Thermal enhancement of drug uptake and DNA adducts as a possible mechanism for the effect of sequencing hyperthermia on cisplatin-induced cytotoxicity in L1210 cells. Cancer Chemother Pharmacol. 1994;34(4):302&#x2013;306. doi: 10.1007/BF00686037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00686037</ArticleId><ArticleId IdType="pubmed">8033297</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Vaart PJ, van der Vange N, Zoetmulder FA, et al. . Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines. Eur J Cancer. 1998;34(1):148&#x2013;154. doi: 10.1016/s0959-8049(97)00370-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0959-8049(97)00370-5</ArticleId><ArticleId IdType="pubmed">9624250</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobamowo H, Prabhakar SS.. The kidney in aging: physiological changes and pathological implications. Prog Mol Biol Transl Sci. 2017;146:303&#x2013;340. doi: 10.1016/bs.pmbts.2016.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.pmbts.2016.12.018</ArticleId><ArticleId IdType="pubmed">28253989</ArticleId></ArticleIdList></Reference><Reference><Citation>Smischney NJ, Shaw AD, Stapelfeldt WH, et al. . Postoperative hypotension in patients discharged to the intensive care unit after non-cardiac surgery is associated with adverse clinical outcomes. Crit Care. 2020;24(1):682. doi: 10.1186/s13054-020-03412-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03412-5</ArticleId><ArticleId IdType="pmc">PMC7720547</ArticleId><ArticleId IdType="pubmed">33287872</ArticleId></ArticleIdList></Reference><Reference><Citation>Liem VGB, Hoeks SE, Mol KHJM, et al. . Postoperative &#xad;hypotension after noncardiac surgery and the &#xad;association with myocardial injury. Anesthesiology. 2020;133(3):510&#x2013;522. doi: 10.1097/ALN.0000000000003368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003368</ArticleId><ArticleId IdType="pubmed">32487822</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Burdick E, Honour M, et al. . Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16(11):3365&#x2013;3370. doi: 10.1681/ASN.2004090740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2004090740</ArticleId><ArticleId IdType="pubmed">16177006</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhadjari N, Gabato W, Calabrese D, et al. . Hyperthermic intraperitoneal chemotherapy with cisplatin: amifostine prevents acute severe renal impairment. Eur J Surg Oncol. 2016;42(2):219&#x2013;223. doi: 10.1016/j.ejso.2015.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejso.2015.07.016</ArticleId><ArticleId IdType="pubmed">26278017</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurreck A, Gronau F, Alberto Vilchez ME, et al. . Sodium thiosulfate reduces acute kidney injury in patients undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with cisplatin: a single-center observational study. Ann Surg Oncol. 2022;29(1):152&#x2013;162. doi: 10.1245/s10434-021-10508-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-021-10508-x</ArticleId><ArticleId IdType="pmc">PMC8677645</ArticleId><ArticleId IdType="pubmed">34350529</ArticleId></ArticleIdList></Reference><Reference><Citation>Markowiak T, Kerner N, Neu R, et al. . Adequate nephroprotection reduces renal complications after hyperthermic intrathoracic chemotherapy. J Surg Oncol. 2019;120(7):1220&#x2013;1226. doi: 10.1002/jso.25726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jso.25726</ArticleId><ArticleId IdType="pubmed">31602673</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33549321</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>126</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Mar</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Intraoperative venous congestion and acute kidney injury in cardiac surgery: an observational cohort study.</ArticleTitle><Pagination><StartPage>599</StartPage><EndPage>607</EndPage><MedlinePgn>599-607</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2020.12.028</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(20)31050-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Increased intravascular volume has been associated with protection from acute kidney injury (AKI), but in patients with congestive heart failure, venous congestion is associated with increased AKI. We tested the hypothesis that intraoperative venous congestion is associated with AKI after cardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In patients enrolled in the Statin AKI Cardiac Surgery trial, venous congestion was quantified as the area under the curve (AUC) of central venous pressure (CVP) &gt;12, 16, or 20 mm Hg during surgery (mm Hg min). AKI was defined using Kidney Disease Improving Global Outcomes (KDIGO) criteria and urine concentrations of tissue inhibitor of metalloproteinase-2 and insulin-like growth factor binding protein 7 ([TIMP-2]&#x22c5;[IGFBP7]), a marker of renal stress. We measured associations between venous congestion, AKI and [TIMP-2]&#x22c5;[IGFBP7], adjusted for potential confounders. Values are reported as median (25th-75th percentile).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Based on KDIGO criteria, 104 of 425 (24.5%) patients developed AKI. The venous congestion AUCs were 273 mm Hg min (81-567) for CVP &gt;12 mm Hg, 66 mm Hg min (12-221) for CVP &gt;16 mm Hg, and 11 mm Hg min (1-54) for CVP &gt;20 mm Hg. A 60 mm Hg min increase above the median venous congestion AUC above each threshold was independently associated with increased AKI (odds ratio=1.06; 95% confidence interval [CI], 1.02-1.10; P=0.008; odds ratio=1.12; 95% CI, 1.02-1.23; P=0.013; and odds ratio=1.30; 95% CI, 1.06-1.59; P=0.012 for CVP&gt;12, &gt;16, and &gt;20 mm Hg, respectively). Venous congestion before cardiopulmonary bypass was also associated with increased [TIMP-2]&#x22c5;[IGFBP7] measured during cardiopulmonary bypass and after surgery, but neither venous congestion after cardiopulmonary bypass nor venous congestion throughout surgery was associated with postoperative [TIMP-2]&#x22c5;[IGFBP7].</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Intraoperative venous congestion was independently associated with increased AKI after cardiac surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 British Journal of Anaesthesia. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lopez</LastName><ForeName>Marcos G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Division of Anesthesiology Critical Care Medicine, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: marcos.g.lopez@vumc.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shotwell</LastName><ForeName>Matthew S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morse</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Yafen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Anesthesia, Department of Anesthesiology, University of Texas Health Science Center at Houston, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wanderer</LastName><ForeName>Jonathan P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Absi</LastName><ForeName>Tarek S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balsara</LastName><ForeName>Keki R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levack</LastName><ForeName>Melissa M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Ashish S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hernandez</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Anesthesiology Critical Care Medicine, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA; Division of Cardiothoracic Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Billings</LastName><ForeName>Frederic T</ForeName><Initials>FT</Initials><Suffix>4th</Suffix><AffiliationInfo><Affiliation>Division of Anesthesiology Critical Care Medicine, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA; Division of Cardiothoracic Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 GM102676</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 GM129662</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 HL133985</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM112871</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Br J Anaesth. 2021 Sep;127(3):e81-e82. doi: 10.1016/j.bja.2021.05.028.</RefSource><PMID Version="1">34176595</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002496" MajorTopicYN="Y">Central Venous Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006940" MajorTopicYN="N">Hyperemia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007432" MajorTopicYN="N">Intraoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">central venous pressure</Keyword><Keyword MajorTopicYN="N">urine biomarkers</Keyword><Keyword MajorTopicYN="N">venous congestion</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>7</Day><Hour>20</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33549321</ArticleId><ArticleId IdType="pmc">PMC8014941</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2020.12.028</ArticleId><ArticleId IdType="pii">S0007-0912(20)31050-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rosner M.H., Okusa M.D. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1:19&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">17699187</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M., Schmidt C., Zarbock A. Perioperative acute kidney injury: an under-recognized problem. Anesth Analg. 2017;125:1223&#x2013;1232.</Citation><ArticleIdList><ArticleId IdType="pubmed">28787339</ArticleId></ArticleIdList></Reference><Reference><Citation>McIlroy D.R., Lopez M.G., Billings F.T.T. Perioperative clinical trials in AKI. Semin Nephrol. 2020;40:173&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172010</ArticleId><ArticleId IdType="pubmed">32303280</ArticleId></ArticleIdList></Reference><Reference><Citation>Gumbert S.D., Kork F., Jackson M.L. Perioperative acute kidney injury. Anesthesiology. 2020;132:180&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10924686</ArticleId><ArticleId IdType="pubmed">31687986</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullens W., Abrahams Z., Francis G.S. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J&#xa0;Am Coll Cardiol. 2009;53:589&#x2013;596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2856960</ArticleId><ArticleId IdType="pubmed">19215833</ArticleId></ArticleIdList></Reference><Reference><Citation>Damman K., van Deursen V.M., Navis G., Voors A.A., van Veldhuisen D.J., Hillege H.L. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J&#xa0;Am Coll Cardiol. 2009;53:582&#x2013;588.</Citation><ArticleIdList><ArticleId IdType="pubmed">19215832</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelman S. Venous function and central venous pressure: a physiologic story. Anesthesiology. 2008;108:735&#x2013;748.</Citation><ArticleIdList><ArticleId IdType="pubmed">18362606</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo P.C., Rastogi S., Onat D. Activation of endothelial cells in conduit veins of dogs with heart failure and veins of normal dogs after vascular stretch by acute volume loading. J&#xa0;Card Fail. 2009;15:457&#x2013;463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5657491</ArticleId><ArticleId IdType="pubmed">19477407</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka M., Yoshida H., Furuhashi M. Deterioration of renal function by chronic heart failure is associated with congestion and oxidative stress in the tubulointerstitium. Intern Med. 2011;50:2877&#x2013;2887.</Citation><ArticleIdList><ArticleId IdType="pubmed">22129502</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitaka C., Nagura T., Saknishi N., Tsunoda Y., Amaha K. Two-dimensional echocardiographic evaluation of inferior vena cava, right ventricle, and left ventricle during positive-pressure ventilation with varying levels of positive end-expiratory pressure. Crit Care Med. 1989;17:205&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">2646069</ArticleId></ArticleIdList></Reference><Reference><Citation>Matot I., Paskaleva R., Eid L. Effect of the volume of fluids administered on intraoperative oliguria in laparoscopic bariatric surgery: a randomized controlled trial. Arch Surg. 2012;147:228&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pubmed">22106246</ArticleId></ArticleIdList></Reference><Reference><Citation>Elijaiek R., Cavayas Y., Rodrigue E. High postoperative portal venous flow pulsatility indicates right ventricular dysfunction and predicts complications in cardiac surgery patients. Br J Anaesth. 2018;122:206&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pubmed">30686306</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Wang X., Honore P.M., Spapen H.D., Liu D. Renal failure in critically ill patients, beware of applying (central venous) pressure on the kidney. Ann Intensive Care. 2018;8:91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6146958</ArticleId><ArticleId IdType="pubmed">30238174</ArticleId></ArticleIdList></Reference><Reference><Citation>Burnett J.C., Jr., Knox F.G. Renal interstitial pressure and sodium excretion during renal vein constriction. Am J Physiol. 1980;238:F279&#x2013;F282.</Citation><ArticleIdList><ArticleId IdType="pubmed">7377299</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadimioglu N., Ertug Z., Yegin A., Sanli S., Gurkan A., Demirbas A. Correlation of peripheral venous pressure and central venous pressure in kidney recipients. Transplant Proc. 2006;38:440&#x2013;442.</Citation><ArticleIdList><ArticleId IdType="pubmed">16549142</ArticleId></ArticleIdList></Reference><Reference><Citation>Palomba H., de Castro I., Neto A.L., Lage S., Yu L. Acute kidney injury prediction following elective cardiac surgery: AKICS score. Kidney Int. 2007;72:624&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pubmed">17622275</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams J.B., Peterson E.D., Wojdyla D. Central venous pressure after coronary artery bypass surgery: does it predict postoperative mortality or renal failure? J&#xa0;Crit Care. 2014;29:1006&#x2013;1010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4315310</ArticleId><ArticleId IdType="pubmed">25035048</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Ma J., Zhao L. High central venous pressure is associated with acute kidney injury and mortality in patients underwent cardiopulmonary bypass surgery. J&#xa0;Crit Care. 2018;48:211&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pubmed">30243200</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings I.V.F.T., Hendricks P.A., Schildcrout J.S. High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial. JAMA. 2016;315:877&#x2013;888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4843765</ArticleId><ArticleId IdType="pubmed">26906014</ArticleId></ArticleIdList></Reference><Reference><Citation>Roger C., Muller L., Riou B. Comparison of different techniques of central venous pressure measurement in mechanically ventilated critically ill patients. Br J Anaesth. 2017;118:223&#x2013;231.</Citation><ArticleIdList><ArticleId IdType="pubmed">28100526</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman E., Grable E., Fine J. Central venous pressure and direct serial measurements as guides in blood-volume replacement. Lancet. 1966;2:609&#x2013;614.</Citation><ArticleIdList><ArticleId IdType="pubmed">4161963</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmood S.S., Pinsky M.R. Heart-lung interactions during mechanical ventilation: the basics. Ann Transl Med. 2018;6:349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6186561</ArticleId><ArticleId IdType="pubmed">30370276</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey A.S., Stevens L.A., Schmid C.H. A&#xa0;new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2763564</ArticleId><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1&#x2013;138.</Citation></Reference><Reference><Citation>Macedo E., Malhotra R., Claure-Del Granado R., Fedullo P., Mehta R.L. Defining urine output criterion for acute kidney injury in critically ill patients. Nephrol Dial Transplant. 2011;26:509&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3108356</ArticleId><ArticleId IdType="pubmed">20562094</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashani K., Al-Khafaji A., Ardiles T. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013;17:R25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057242</ArticleId><ArticleId IdType="pubmed">23388612</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M., Schmidt C., Van Aken H. Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery. PloS One. 2014;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3968141</ArticleId><ArticleId IdType="pubmed">24675717</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings J.J., Shaw A.D., Shi J., Lopez M.G., O'Neal J.B., Billings F.T.T. Intraoperative prediction of cardiac surgery-associated acute kidney injury using urinary biomarkers of cell cycle arrest. J&#xa0;Thorac Cardiovasc Surg. 2019;157:1545&#x2013;1553. e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6431272</ArticleId><ArticleId IdType="pubmed">30389130</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilarczyk K., Edayadiyil-Dudasova M., Wendt D. Urinary [TIMP-2]&#x2217;[IGFBP7] for early prediction of acute kidney injury after coronary artery bypass surgery. Ann Intensive Care. 2015;5:50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4679715</ArticleId><ArticleId IdType="pubmed">26669781</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakar C.V., Arrigain S., Worley S., Yared J.P., Paganini E.P. A&#xa0;clinical score to predict acute renal failure after cardiac surgery. J&#xa0;Am Soc Nephrol. 2005;16:162&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">15563569</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottschalk C.W., Mylle M. Micropuncture study of pressures in proximal tubules and peritubular capillaries of the rat kidney and their relation to ureteral and renal venous pressures. Am J Physiol. 1956;185:430&#x2013;439.</Citation><ArticleIdList><ArticleId IdType="pubmed">13327061</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishimoto T., Maekawa M., Abe Y., Yamamoto K. Intrarenal&#xa0;distribution of blood flow and renin release during renal venous pressure elevation. Kidney Int. 1973;4:259&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pubmed">4752169</ArticleId></ArticleIdList></Reference><Reference><Citation>Kranzhofer R., Schmidt J., Pfeiffer C.A., Hagl S., Libby P., Kubler W. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1999;19:1623&#x2013;1629.</Citation><ArticleIdList><ArticleId IdType="pubmed">10397679</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo P.C., Doran A.C., Onat D. Venous congestion, endothelial and neurohormonal activation in acute decompensated heart failure: cause or effect? Curr Heart Fail Rep. 2015;12:215&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4426008</ArticleId><ArticleId IdType="pubmed">25740404</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostreva D.R., Seagard J.L., Castaner A., Kampine J.P. Reflex effects of renal afferents on the heart and kidney. Am J Physiol. 1981;241:R286&#x2013;R292.</Citation><ArticleIdList><ArticleId IdType="pubmed">7304772</ArticleId></ArticleIdList></Reference><Reference><Citation>Afsar B., Ortiz A., Covic A., Solak Y., Goldsmith D., Kanbay M. Focus on renal congestion in heart failure. Clin Kidney J. 2016;9:39&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4720202</ArticleId><ArticleId IdType="pubmed">26798459</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35403562</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1525-6049</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Renal failure</Title><ISOAbbreviation>Ren Fail</ISOAbbreviation></Journal><ArticleTitle>Intraoperative vasopressor use and early postoperative acute kidney injury in elderly patients undergoing elective noncardiac surgery.</ArticleTitle><Pagination><StartPage>648</StartPage><EndPage>659</EndPage><MedlinePgn>648-659</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/0886022X.2022.2061997</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Intraoperative hypotension is a risk factor for postoperative acute kidney injury (AKI). Elderly patients are susceptible due to reduced responses to acute hemodynamic changes.</AbstractText><AbstractText Label="AIMS" NlmCategory="UNASSIGNED">Determine the association between hypotension identified from anesthetic charts and postoperative AKI in elderly patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Retrospective cohort study of elective noncardiac surgery patients &#x2265;65&#x2009;years, at an Australian tertiary hospital (December 2019-March 2021), with the primary outcome of AKI &#x2264;48&#x2009;h of surgery. Factors of interest were intraoperative hypotension determined from anesthetic charts (mean arterial pressure &lt;60&#x2009;mmHg, systolic blood pressure &lt;90&#x2009;mmHg, recorded 5-min) and intraoperative vasopressor use.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">In 830 patients (mean age 75&#x2009;years), systolic hypotension was more frequent than mean arterial hypotension (25.7% vs. 11.9%). Most hypotensive episodes were brief (7.2% of systolic and 4.2% of mean arterial hypotension lasted &gt;10&#x2009;min) but vasopressors were used in 84.7% of cases. The incidence of postoperative AKI was 13.9%. Systolic hypotension &gt;20&#x2009;min was associated with AKI (OR, 3.88; 95% CI: 1.38-10.9), which was not significant after adjusting for vasopressors, creatinine, American Society of Anesthesiologists class, and hemoglobin drop. The cumulative dose of any specific vasopressor &gt;20&#x2009;mg (or &gt;10&#x2009;mg epinephrine) was independently associated with AKI (adjusted OR, 2.47; 95% CI: 1.34-4.58). Every 5&#x2009;mg increase in the total dose of all intraoperative vasopressors used during surgery was associated with 11% increased odds of AKI (95% CI: 3-19%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">High vasopressor use was associated with postoperative AKI in elderly patients undergoing noncardiac surgery, independent of hypotension identified from anesthetic charts.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ariyarathna</LastName><ForeName>Dilshan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Monash Health, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhonsle</LastName><ForeName>Ajinkya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Monash Health, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nim</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Monash Health, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Colin K L</ForeName><Initials>CKL</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Monash Health, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Gabriella H</ForeName><Initials>GH</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Monash Health, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sim</LastName><ForeName>Nicholle</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Monash Health, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Joy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Monash Health, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nan</LastName><ForeName>Kirrolos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Monash Health, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Andy K H</ForeName><Initials>AKH</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Monash Health, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nephrology, Monash Health, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ren Fail</MedlineTA><NlmUniqueID>8701128</NlmUniqueID><ISSNLinking>0886-022X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062606" MajorTopicYN="N">Tertiary Care Centers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="N">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Geriatrics</Keyword><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">hypotension</Keyword><Keyword MajorTopicYN="N">operative</Keyword><Keyword MajorTopicYN="N">surgical procedures</Keyword><Keyword MajorTopicYN="N">vasoconstrictor agents</Keyword></KeywordList><CoiStatement>The authors have no competing interests to declare. We have not received any funding for this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>11</Day><Hour>8</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35403562</ArticleId><ArticleId IdType="pmc">PMC9009951</ArticleId><ArticleId IdType="doi">10.1080/0886022X.2022.2061997</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gu WJ, Hou BL, Kwong JSW, et al. . Association between intraoperative hypotension and 30-day mortality, major adverse cardiac events, and acute kidney injury after non-cardiac surgery: a meta-analysis of cohort studies. Int J Cardiol. 2018;258:68&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">29429638</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijnberge M, Schenk J, Bulle E, et al. . Association of intraoperative hypotension with postoperative morbidity and mortality: systematic review and Meta-analysis. BJS Open. 2021;5(1):zraa018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7893468</ArticleId><ArticleId IdType="pubmed">33609377</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson C, Ozrazgat-Baslanti T, Kuxhausen A, et al. . Cost and mortality associated with postoperative acute kidney injury. Ann Surg. 2015;261(6):1207&#x2013;1214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4247993</ArticleId><ArticleId IdType="pubmed">24887982</ArticleId></ArticleIdList></Reference><Reference><Citation>Grams ME, Sang Y, Coresh J, et al. . Acute kidney injury after major surgery: a retrospective analysis of veterans health administration data. Am J Kidney Dis. 2016;67(6):872&#x2013;880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4775458</ArticleId><ArticleId IdType="pubmed">26337133</ArticleId></ArticleIdList></Reference><Reference><Citation>Bihorac A, Yavas S, Subbiah S, et al. . Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg. 2009;249(5):851&#x2013;858.</Citation><ArticleIdList><ArticleId IdType="pubmed">19387314</ArticleId></ArticleIdList></Reference><Reference><Citation>Turan A, Cohen B, Adegboye J, et al. . Mild acute kidney injury after noncardiac surgery is associated with long-term renal dysfunction: a retrospective cohort study. Anesthesiology. 2020;132(5):1053&#x2013;1061.</Citation><ArticleIdList><ArticleId IdType="pubmed">31929326</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai X, Hummel SL, Salazar JB, et al. . Cardiovascular physiology in the older adults. J Geriatr Cardiol. 2015;12(3):196&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4460159</ArticleId><ArticleId IdType="pubmed">26089840</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Lameire N, Aspelin P, et al. . Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1&#x2013;138.</Citation></Reference><Reference><Citation>American Society of Anesthesiologists . ASA Physical Status Classification System [updated 2020 Dec 13; cited 2021 Nov 22; Published 2014]. Available from: https://www.asahq.org/standards-and-guidelines/asa-physical-status-classification-system</Citation></Reference><Reference><Citation>Levey AS, Stevens LA, Schmid CH, et al. . A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2763564</ArticleId><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>Abhayaratna WP, Smith WT, Becker NG, et al. . Prevalence of heart failure and systolic ventricular dysfunction in older Australians: the Canberra heart study. Med J Aust. 2006;184(4):151&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pubmed">16489896</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh M, Devereaux PJ, Garg AX, et al. . Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology. 2013;119(3):507&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pubmed">23835589</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun LY, Wijeysundera DN, Tait GA, et al. . Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology. 2015;123(3):515&#x2013;523.</Citation><ArticleIdList><ArticleId IdType="pubmed">26181335</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmasi V, Maheshwari K, Yang D, et al. . Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery: a retrospective cohort analysis. Anesthesiology. 2017;126(1):47&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">27792044</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Jiang Z, Ying J, et al. . Optimal blood pressure decreases acute kidney injury after gastrointestinal surgery in elderly hypertensive patients: a randomized study: optimal blood pressure reduces acute kidney injury. J Clin Anesth. 2017;43:77&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">29055803</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesselink EM, Kappen TH, Torn HM, et al. . Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review. Br J Anaesth. 2018;121(4):706&#x2013;721.</Citation><ArticleIdList><ArticleId IdType="pubmed">30236233</ArticleId></ArticleIdList></Reference><Reference><Citation>Giglio M, Dalfino L, Puntillo F, et al. . Hemodynamic goal-directed therapy and postoperative kidney injury: an updated meta-analysis with trial sequential analysis. Crit Care. 2019;23(1):232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6593609</ArticleId><ArticleId IdType="pubmed">31242941</ArticleId></ArticleIdList></Reference><Reference><Citation>Grocott MP, Optimisation Systematic Review Steering Group, Dushianthan A, et al. . Perioperative increase in global blood flow to explicit defined goals and outcomes after surgery: a cochrane systematic review. Br J Anaesth. 2013;111(4):535&#x2013;548.</Citation><ArticleIdList><ArticleId IdType="pubmed">23661403</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Chua HR, Bagshaw SM, et al. . Clinical review: volume of fluid resuscitation and the incidence of acute kidney injury &#x2013; a systematic review. Crit Care. 2012;16(4):230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3580679</ArticleId><ArticleId IdType="pubmed">22866958</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Englesbe MJ, et al. . Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology. 2007;107(6):892&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pubmed">18043057</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu CY, Ordonez JD, Chertow GM, et al. . The risk of acute renal failure in patients with chronic kidney disease. Kidney Int. 2008;74(1):101&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2673528</ArticleId><ArticleId IdType="pubmed">18385668</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh M, Garg AX, Devereaux PJ, et al. . The association between perioperative hemoglobin and acute kidney injury in patients having noncardiac surgery. Anesth Analg. 2013;117(4):924&#x2013;931.</Citation><ArticleIdList><ArticleId IdType="pubmed">24023017</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler AJ, Ahmad T, Phull MK, et al. . Meta-analysis of the association between preoperative anaemia and mortality after surgery. Br J Surg. 2015;102(11):1314&#x2013;1324.</Citation><ArticleIdList><ArticleId IdType="pubmed">26349842</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira C, Rosa R, Rodrigues N, et al. . Acute kidney injury after major abdominal surgery: a retrospective cohort analysis. Crit Care Res Pract. 2014;2014:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3955689</ArticleId><ArticleId IdType="pubmed">24719758</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyigun M, Aykut G, Tosun M, et al. . Perioperative risk factors of acute kidney injury after non-cardiac surgery: a multicenter, prospective, observational study in patients with low grade American society of anesthesiologists physical status. Am J Surg. 2019;218(3):457&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pubmed">30739741</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S, Cho H, Park S, et al. . Simple postoperative AKI risk (SPARK) classification before noncardiac surgery: a prediction index development study with external validation. J Am Soc Nephrol. 2019;30(1):170&#x2013;181.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6317608</ArticleId><ArticleId IdType="pubmed">30563915</ArticleId></ArticleIdList></Reference><Reference><Citation>Abelha FJ, Botelho M, Fernandes V, et al. . Determinants of postoperative acute kidney injury. Crit Care. 2009;13(3):R79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2717442</ArticleId><ArticleId IdType="pubmed">19463152</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Jiang L, Wang B, et al. . Epidemiological characteristics of and risk factors for patients with postoperative acute kidney injury: a multicenter prospective study in 30 Chinese intensive care units. Int Urol Nephrol. 2018;50(7):1319&#x2013;1328.</Citation><ArticleIdList><ArticleId IdType="pubmed">29480442</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourafkari L, Arora P, Porhomayon J, et al. . Acute kidney injury after non-cardiovascular surgery: risk factors and impact on development of chronic kidney disease and long-term mortality. Curr Med Res Opin. 2018;34(10):1829&#x2013;1837.</Citation><ArticleIdList><ArticleId IdType="pubmed">29613817</ArticleId></ArticleIdList></Reference><Reference><Citation>Bijker JB, van Klei WA, Kappen TH, et al. . Incidence of intraoperative hypotension as a function of the chosen definition: literature definitions applied to a retrospective cohort using automated data collection. Anesthesiology. 2007;107(2):213&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">17667564</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40100411</PMID><DateCompleted><Year>2025</Year><Month>03</Month><Day>18</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1432-1262</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Mar</Month><Day>18</Day></PubDate></JournalIssue><Title>International journal of colorectal disease</Title><ISOAbbreviation>Int J Colorectal Dis</ISOAbbreviation></Journal><ArticleTitle>Risk factors for postoperative acute kidney injury in colorectal cancer: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>70</StartPage><MedlinePgn>70</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">70</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00384-025-04860-7</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To thoroughly examine the risk factors that may predispose patients with colorectal cancer to postoperative acute kidney injury (AKI).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">To find relevant studies (from the beginning up to May 2024), two researchers searched PubMed, Web of Science, the Cochrane Library, and Embase databases. Two researchers evaluated the quality of the literature using the Newcastle-Ottawa Scale (NOS) and extracted data individually. Data analysis was performed using the Review Manager 5.4.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our meta-analysis included 23 studies, encompassing a total of 167,904 patients. The identified risk factors for postoperative AKI in colorectal cancer patients were male sex, older age, body mass index (BMI)&#x2009;&#x2265;&#x2009;25&#xa0;kg/m<sup>2</sup>, hypertension, diabetes mellitus (DM), chronic kidney disease (CKD), hypoalbuminemia, emergency surgery, open surgery, prolonged operation time, American Society of Anesthesiologists (ASA) score&#x2009;&#x2265;&#x2009;3, and intraoperative transfusion. In contrast, anemia and elevated creatinine levels did not emerge as significant risk factors for AKI in this population.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">To mitigate the incidence of postoperative AKI among these patients, healthcare professionals must proactively identify these risk factors and implement appropriate preventive measures.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Huang</LastName><ForeName>Lumei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Emergency, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Nanjing Medical University, Taizhou, Jiangsu Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Xiao</LastName><ForeName>Aifang</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Emergency, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Nanjing Medical University, Taizhou, Jiangsu Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yufeng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Emergency, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Nanjing Medical University, Taizhou, Jiangsu Province, China. 13814452410@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Int J Colorectal Dis</MedlineTA><NlmUniqueID>8607899</NlmUniqueID><ISSNLinking>0179-1958</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="Y">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017594" MajorTopicYN="N">Publication Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Colorectal cancer</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Postoperative</Keyword><Keyword MajorTopicYN="N">Risk factors</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>18</Day><Hour>18</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>18</Day><Hour>18</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>18</Day><Hour>12</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>3</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40100411</ArticleId><ArticleId IdType="pmc">PMC11920323</ArticleId><ArticleId IdType="doi">10.1007/s00384-025-04860-7</ArticleId><ArticleId IdType="pii">10.1007/s00384-025-04860-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Patel SG, Dominitz JA (2024) Screening for colorectal cancer. Ann Intern Med 177(4):ITC49&#x2013;ITC64. 10.7326/AITC202404160</Citation><ArticleIdList><ArticleId IdType="pubmed">38588547</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia C, Dong X, Li H et al (2022) Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl) 135(5):584&#x2013;590. 10.1097/CM9.0000000000002108</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8920425</ArticleId><ArticleId IdType="pubmed">35143424</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P, Gao Y, Kong Z et al (2024) Immune checkpoint inhibitors and acute kidney injury. Front Immunol 23(15):1353339. 10.3389/fimmu.2024.1353339</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10920224</ArticleId><ArticleId IdType="pubmed">38464524</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, Weiss R, Albert F et al (2023) Epidemiology of surgery associated acute kidney injury (EPIS-AKI): a prospective international observational multi-center clinical study. Intensive Care Med 49(12):1441&#x2013;1455. 10.1007/s00134-023-07169-7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10709241</ArticleId><ArticleId IdType="pubmed">37505258</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyer N, Eldridge J, Prowle JR et al (2022) Postoperative acute kidney injury. Clin J Am Soc Nephrol 17(10):1535&#x2013;1545. 10.2215/CJN.16541221</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9528271</ArticleId><ArticleId IdType="pubmed">35710717</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S, Gudsoorkar P, Jhaveri KD et al (2022) Acute kidney injury in critically Ill patients with cancer. Clin J Am Soc Nephrol 17(9):1385&#x2013;1398. 10.2215/CJN.15681221</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9625110</ArticleId><ArticleId IdType="pubmed">35338071</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatraju PK, Zelnick LR, Stanaway IB et al (2024) Acute kidney injury, systemic inflammation, and long-term cognitive function: ASSESS-AKI. Clin J Am Soc Nephrol 19(7):829&#x2013;836. 10.2215/CJN.0000000000000473</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11254015</ArticleId><ArticleId IdType="pubmed">38728094</ArticleId></ArticleIdList></Reference><Reference><Citation>Andresen K, Carreira H, Strongman H et al (2023) The risk of acute kidney injury in colorectal cancer survivors: an english population-based matched cohort study. BMC Cancer 23(1):839. 10.1186/s12885-023-11329-9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10483792</ArticleId><ArticleId IdType="pubmed">37679679</ArticleId></ArticleIdList></Reference><Reference><Citation>Loria A, Melucci A, Speranza J et al (2022) Acute kidney injury is a common and significant complication following ileostomy formation. Colorectal Dis 24(1):102&#x2013;110. 10.1111/codi.15917</Citation><ArticleIdList><ArticleId IdType="pubmed">34536959</ArticleId></ArticleIdList></Reference><Reference><Citation>Loria A, Fleming FJ et al (2022) Postoperative acute kidney injury in colorectal surgery. Dis Colon Rectum 65(3):308&#x2013;312. 10.1097/DCR.0000000000002390</Citation><ArticleIdList><ArticleId IdType="pubmed">35138283</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A et al (2012) KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 120(4):c179&#x2013;c184. 10.1159/000339789</Citation><ArticleIdList><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilton R et al (2011) Defining acute renal failure. CMAJ 183(10):1167&#x2013;1169. 10.1503/cmaj.081170</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3134724</ArticleId><ArticleId IdType="pubmed">21624906</ArticleId></ArticleIdList></Reference><Reference><Citation>Causey MW, Maykel JA, Hatch Q et al (2011) Identifying risk factors for renal failure and myocardial infarction following colorectal surgery. J Surg Res 170(1):32&#x2013;37. 10.1016/j.jss.2011.03.027</Citation><ArticleIdList><ArticleId IdType="pubmed">21601222</ArticleId></ArticleIdList></Reference><Reference><Citation>Paquette IM, Solan P, Rafferty JF et al (2013) Readmission for dehydration or renal failure after ileostomy creation. Dis Colon Rectum 56(8):974&#x2013;979. 10.1097/DCR.0b013e31828d02ba</Citation><ArticleIdList><ArticleId IdType="pubmed">23838866</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghadamyeghaneh Z, Phelan MJ, Carmichael JC et al (2014) Preoperative dehydration increases risk of postoperative acute renal failure in colon and rectal surgery. J Gastrointest Surg 18(12):2178&#x2013;2185. 10.1007/s11605-014-2661-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25238816</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim SY, Lee JY, Yang JH et al (2016) Predictive factors of acute kidney injury in patients undergoing rectal surgery. Kidney Res Clin Pract 35(3):160&#x2013;164. 10.1016/j.krcp.2016.05.006</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5025479</ArticleId><ArticleId IdType="pubmed">27668159</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang JY, Lee J, Oh J et al (2016) The Influence of propofol and sevoflurane on acute kidney injury after colorectal surgery: a retrospective cohort study. Anesth Analg 123(2):363&#x2013;370. 10.1213/ANE.0000000000001274</Citation><ArticleIdList><ArticleId IdType="pubmed">27088995</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassinger TE, Turrentine FE, Thiele RH et al (2018) Acute kidney injury in the age of enhanced recovery protocols. Dis Colon Rectum 61(8):946&#x2013;954. 10.1097/DCR.0000000000001059</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6042978</ArticleId><ArticleId IdType="pubmed">29994959</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassinger TE, Mehaffey JH, Mullen MG et al (2018) Ureteral stents increase risk of postoperative acute kidney injury following colorectal surgery. Surg Endosc 32(7):3342&#x2013;3348. 10.1007/s00464-018-6054-y</Citation><ArticleIdList><ArticleId IdType="pubmed">29340810</ArticleId></ArticleIdList></Reference><Reference><Citation>Grass F, Lovely JK, Crippa J et al (2019) Early acute kidney injury within an established enhanced recovery pathway: uncommon and transitory. World J Surg 43(5):1207&#x2013;1215. 10.1007/s00268-019-04923-1</Citation><ArticleIdList><ArticleId IdType="pubmed">30684001</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadam VR, Loo V, Edwards S et al (2020) Incidence of acute kidney &#x131;njury during the perioperative period in the colorectal division of surgery - Retrospective study. Indian J Anaesth 64(10):894&#x2013;897. 10.4103/ija.IJA_276_20</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7791423</ArticleId><ArticleId IdType="pubmed">33437079</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiener JGD, Goss L, Wahl TS et al (2020) The association of enhanced recovery pathway and acute kidney injury in patients undergoing colorectal surgery. Dis Colon Rectum 63(2):233&#x2013;241. 10.1097/DCR.0000000000001528</Citation><ArticleIdList><ArticleId IdType="pubmed">31842161</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim JW, Kwak J, Roh K et al (2020) Impact of intraoperative zero-balance fluid therapy on the occurrence of acute kidney injury in patients who had undergone colorectal cancer resection within an enhanced recovery after surgery protocol: a propensity score matching analysis. Int J Colorectal Dis 35(8):1537&#x2013;1548. 10.1007/s00384-020-03616-9</Citation><ArticleIdList><ArticleId IdType="pubmed">32385595</ArticleId></ArticleIdList></Reference><Reference><Citation>Essber H, Cohen B, Artis AS et al (2021) Renal injury after open versus laparoscopic non-cardiac surgery: a retrospective cohort analysis. Braz J Anesthesiol 71(1):50&#x2013;57. 10.1016/j.bjane.2020.12.008</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9373244</ArticleId><ArticleId IdType="pubmed">33712254</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim JH, Bang JY, Kim SH et al (2021) Association of preoperative prognostic nutritional index and postoperative acute kidney injury in patients with colorectal cancer surgery. Nutrients 13(5):1604. 10.3390/nu13051604</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8170895</ArticleId><ArticleId IdType="pubmed">34064893</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim JH, Kang SJ, Bang JY et al (2021) Comparison of the effects of laparoscopic and open surgery on postoperative acute kidney injury in patients with colorectal cancer: propensity score analysis. J Clin Med 10(7):1438. 10.3390/jcm10071438</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8036786</ArticleId><ArticleId IdType="pubmed">33916162</ArticleId></ArticleIdList></Reference><Reference><Citation>Lumlertgul N, Ostermann M, McCorkell S et al (2021) Association of plasma and urine NGAL with acute kidney injury after elective colorectal surgery: a cohort study. Ann Med Surg (Lond) 62:315&#x2013;322. 10.1016/j.amsu.2021.01.060</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7847815</ArticleId><ArticleId IdType="pubmed">33552490</ArticleId></ArticleIdList></Reference><Reference><Citation>Zorrilla-Vaca A, Mena GE, Ripolles-Melchor J et al (2021) Risk factors for acute kidney injury in an enhanced recovery pathway for colorectal surgery. Surg Today 51(4):537&#x2013;544. 10.1007/s00595-020-02107-2</Citation><ArticleIdList><ArticleId IdType="pubmed">32785846</ArticleId></ArticleIdList></Reference><Reference><Citation>Paek JH, Kang SI, Ryu J et al (2021) Renal outcomes of laparoscopic versus open surgery in patients with rectal cancer: a propensity score analysis. Kidney Res Clin Pract 40(4):634&#x2013;644. 10.23876/j.krcp.21.002</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8685360</ArticleId><ArticleId IdType="pubmed">34781644</ArticleId></ArticleIdList></Reference><Reference><Citation>Drakeford PA, Tham SQ, Kwek JL et al (2021) Acute kidney injury within an enhanced recovery after surgery (ERAS) program for colorectal surgery. World J Surg 6(1):19&#x2013;33. 10.1007/s00268-021-06343-6</Citation><ArticleIdList><ArticleId IdType="pubmed">34665309</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Wan X, Zhang Y et al (2023) Analysis of factors associated with postoperative acute kidney injury in patients with colorectal cancer and the development of a risk prediction model: a retrospective study. Updates Surg 75(5):1171&#x2013;1178. 10.1007/s13304-023-01481-z</Citation><ArticleIdList><ArticleId IdType="pubmed">36892811</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh Thanh L, Dao Bui Quy Q, Nguyen Manh K et al (2023) Preoperative urine neutrophil gelatinase-associated lipocalin predicts mortality in colorectal cancer patients after laparoscopic surgery: a single-center study. Health Sci Rep 6(10):e1612. 10.1002/hsr2.1612</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10556407</ArticleId><ArticleId IdType="pubmed">37808929</ArticleId></ArticleIdList></Reference><Reference><Citation>Omar M, Tarek A, Abdeslam B et al (2023) Risk factors of acute renal failure in patients with protective ileostomy after rectal cancer surgery. BMC Surg 23(1):107. 10.1186/s12893-023-02016-4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10148495</ArticleId><ArticleId IdType="pubmed">37118719</ArticleId></ArticleIdList></Reference><Reference><Citation>Neugarten J, Golestaneh L et al (2022) Sex differences in acute kidney injury. Semin Nephrol 42(2):208&#x2013;218. 10.1016/j.semnephrol.2022.04.010</Citation><ArticleIdList><ArticleId IdType="pubmed">35718367</ArticleId></ArticleIdList></Reference><Reference><Citation>Perschinka F, Boyer N, Forni LG et al (2023) Renal function in very old critically ill patients. Curr Opin Crit Care 29(6):534&#x2013;541. 10.1097/MCC.0000000000001088</Citation><ArticleIdList><ArticleId IdType="pubmed">37861208</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Wu H, Liu C et al (2023) Intraoperative renal desaturation and postoperative acute kidney injury in older patients undergoing liver resection: a prospective cohort study. J Clin Anesth 87:111084. 10.1016/j.jclinane.2023.111084</Citation><ArticleIdList><ArticleId IdType="pubmed">36905791</ArticleId></ArticleIdList></Reference><Reference><Citation>Doganci M, Zeynelo&#x11f;lu P, Kayhan Z et al (2023) Determination of risk factors for postoperative acute kidney injury in patients with gynecologic malignancies. Cureus 15(7):e41836. 10.7759/cureus.41836</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10423056</ArticleId><ArticleId IdType="pubmed">37575800</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Zhang C et al (2022) From AKI to CKD: maladaptive repair and the underlying mechanisms. Int J Mol Sci 23(18):10880. 10.3390/ijms231810880</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9504835</ArticleId><ArticleId IdType="pubmed">36142787</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K, He JC et al (2022) AKI-to-CKD transition is a potential mechanism for non-albuminuric diabetic kidney disease. Fac Rev 11:21. 10.12703/r/11-21</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9340655</ArticleId><ArticleId IdType="pubmed">35949261</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewitte A, Labat A, Duvignaud PA et al (2021) High mean arterial pressure target to improve sepsis-associated acute kidney injury in patients with prior hypertension: a feasibility study. Ann Intensive Care 11(1):139. 10.1186/s13613-021-00925-2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8458519</ArticleId><ArticleId IdType="pubmed">34553274</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu VC, Lin YF, Teng NC et al (2022) Angiotensin II receptor blocker associated with less outcome risk in patients with acute kidney disease. Front Pharmacol 13:714658. 10.3389/fphar.2022.714658</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9065477</ArticleId><ArticleId IdType="pubmed">35517809</ArticleId></ArticleIdList></Reference><Reference><Citation>Lizano-D&#xed;ez I, Poteet S, Burniol-Garcia A et al (2022) The burden of perioperative hypertension/hypotension: a systematic review. PLoS One 17(2):e0263737. 10.1371/journal.pone.0263737</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8827488</ArticleId><ArticleId IdType="pubmed">35139104</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y, Li B, Ouyang W et al (2023) Intraoperative hypertension is associated with postoperative acute kidney injury after laparoscopic surgery. J Pers Med 13(3):541. 10.3390/jpm13030541</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10058414</ArticleId><ArticleId IdType="pubmed">36983722</ArticleId></ArticleIdList></Reference><Reference><Citation>Hapca S, Siddiqui MK, Kwan RSY et al (2021) The relationship between AKI and CKD in patients with type 2 diabetes: an observational cohort study. J Am Soc Nephrol 32(1):138&#x2013;150. 10.1681/ASN.2020030323</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7894655</ArticleId><ArticleId IdType="pubmed">32948670</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Zhao YT et al (2021) Development and Validation of a prediction model for acute kidney injury among patients with acute decompensated heart failure. Front Cardiovasc Med 8:719307. 10.3389/fcvm.2021.719307</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8634389</ArticleId><ArticleId IdType="pubmed">34869626</ArticleId></ArticleIdList></Reference><Reference><Citation>Hryciw N, Joannidis M, Hiremath S et al (2021) Intravenous albumin for mitigating hypotension and augmenting ultrafiltration during kidney replacement therapy. Clin J Am Soc Nephrol 16(5):820&#x2013;828. 10.2215/CJN.09670620</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8259476</ArticleId><ArticleId IdType="pubmed">33115729</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannion JD, Rather A, Fisher A et al (2024) Systemic inflammation and acute kidney injury after colorectal surgery. BMC Nephrol 25(1):92. 10.1186/s12882-024-03526-w</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10929149</ArticleId><ArticleId IdType="pubmed">38468201</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao L, Ru W, Hu C et al (2022) Interaction of hemoglobin, transfusion, and acute kidney injury in patients undergoing cardiopulmonary bypass: a group-based trajectory analysis. Ren Fail 44(1):1368&#x2013;1375. 10.1080/0886022X.2022.2108840</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9373743</ArticleId><ArticleId IdType="pubmed">35946481</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35304919</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1399-0012</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Clinical transplantation</Title><ISOAbbreviation>Clin Transplant</ISOAbbreviation></Journal><ArticleTitle>Perioperative fluid management and outcomes in adult deceased donor liver transplantation - A systematic review of the literature and expert panel recommendations.</ArticleTitle><Pagination><StartPage>e14651</StartPage><MedlinePgn>e14651</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ctr.14651</ELocationID><Abstract><AbstractText Label="BACKGROUND">Fluid management practices during and after liver transplantation vary widely among centers despite better understanding of the pathophysiology of end-stage liver disease and of the effects of commonly used fluids. This reflects a lack of high quality trials in this setting, but also provides a rationale for both systematic review of all relevant studies in liver recipients and evaluation of new evidence from closely related domains, including hepatology, non-transplant abdominal surgery, and critical care.</AbstractText><AbstractText Label="OBJECTIVES">To develop evidence-based recommendations for perioperative fluid management to optimize immediate and short-term outcomes following liver transplantation.</AbstractText><AbstractText Label="DATA SOURCES">Ovid MEDLINE, Embase, Scopus, Google Scholar, and Cochrane Central.</AbstractText><AbstractText Label="METHODS">Systematic review following PRISMA guidelines and recommendations using the GRADE approach derived from an international expert panel. Studies included those evaluating the following postoperative outcomes: acute kidney injury, respiratory complications, operative blood loss/red cell units required, and intensive care length of stay. PROSPERO protocol ID: CRD42021241392 RESULTS: Following expert panel review, 18 of 1624 screened studies met eligibility criteria for inclusion in the final quantitative synthesis. These included six single center RCTs, 11 single center observational studies, and one observational study comparing centers with different fluid management techniques. Definitions of interventions and outcomes varied between studies. Recommendations are therefore based substantially on expert opinion and evidence from other clinical settings.</AbstractText><AbstractText Label="CONCLUSIONS">A moderately restrictive or "replacement only" fluid regime is recommended, especially during the dissection phase of the transplant procedure. Sustained hypervolemia, based on absence of fluid responsiveness, elevated filling pressures and/or echocardiographic findings, should be avoided (Quality of Evidence: Moderate | Grade of Recommendation: Weak for restrictive fluid regime. Strong for avoidance of hypervolemia). Mean Arterial Pressure (MAP) should be maintained at &gt;60-65 mmHg in all cases (Quality of Evidence: Low | Grade of Recommendation: Strong). There is insufficient evidence in this population to support preferential use of any specific colloid or crystalloid for routine volume replacement. However, we recommend against the use of 130/.4 HES given the high incidence of AKI in this population.</AbstractText><CopyrightInformation>&#xa9; 2022 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Morkane</LastName><ForeName>Clare M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Kings College Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sapisochin</LastName><ForeName>Gonzalo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Multio-Organ Transplant &amp; HPB Surgical Oncology, Division of General Surgery, University Health Network, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mukhtar</LastName><ForeName>Ahmed M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Cairo University, Giza, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reyntjens</LastName><ForeName>Koen M E M</ForeName><Initials>KMEM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Rijksuniversiteit, University Medical Center Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wagener</LastName><ForeName>Gebhard</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Columbia University Medical Center, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spiro</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care Medicine, Royal Free Hospital, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Surgery &amp; Interventional Science, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raptis</LastName><ForeName>Dimitri A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Clinical Service of HPB Surgery and Liver Transplantation, Royal Free Hospital, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Surgery &amp; Interventional Science, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klinck</LastName><ForeName>John R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Division of Perioperative Care, Addenbrooke's Hospital, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>ERAS4OLT.org Working Group</CollectiveName><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Kings College Hospital, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Clin Transplant</MedlineTA><NlmUniqueID>8710240</NlmUniqueID><ISSNLinking>0902-0063</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016031" MajorTopicYN="Y">Liver Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019520" MajorTopicYN="N">Living Donors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">albumin</Keyword><Keyword MajorTopicYN="N">cardiac output</Keyword><Keyword MajorTopicYN="N">central venous pressure</Keyword><Keyword MajorTopicYN="N">colloid</Keyword><Keyword MajorTopicYN="N">crystalloid</Keyword><Keyword MajorTopicYN="N">fluid</Keyword><Keyword MajorTopicYN="N">goal-directed fluid</Keyword><Keyword MajorTopicYN="N">inotropes</Keyword><Keyword MajorTopicYN="N">intraoperative</Keyword><Keyword MajorTopicYN="N">liver transplant</Keyword><Keyword MajorTopicYN="N">perioperative</Keyword><Keyword MajorTopicYN="N">vasopressors</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Niemann</LastName><ForeName>Claus</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pollok</LastName><ForeName>Joerg-Matthias</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berenguer</LastName><ForeName>Marina</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tinguely</LastName><ForeName>Pascale</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vailas</LastName><ForeName>Michail</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Milan</LastName><ForeName>Michele Mazza</ForeName><Initials>MM</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>19</Day><Hour>8</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35304919</ArticleId><ArticleId IdType="doi">10.1111/ctr.14651</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Guyatt G, Oxman AD, Akl EA, et&#xa0;al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383-394. https://doi.org/10.1016/j.jclinepi.2010.04.026</Citation></Reference><Reference><Citation>Murad MH, Mustafa RA, Sch&#xfc;nemann HJ, Sultan S, Santesso N. Rating the certainty in evidence in the absence of a single estimate of effect. Evid Based Med. 2017;22(3):85-87. https://doi.org/10.1136/ebmed-2017-110668</Citation></Reference><Reference><Citation>Andrews J, Guyatt G, Oxman AD, et&#xa0;al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol. 2013;66(7):719-725. https://doi.org/10.1016/j.jclinepi.2012.03.013</Citation></Reference><Reference><Citation>Andrews JC, Sch&#xfc;nemann HJ, Oxman AD, et&#xa0;al. GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. J Clin Epidemiol. 2013;66(7):726-735. https://doi.org/10.1016/j.jclinepi.2013.02.003</Citation></Reference><Reference><Citation>Joosten A, Lucidi V, Ickx B, et&#xa0;al. Intraoperative hypotension during liver transplant surgery is associated with postoperative acute kidney injury: a historical cohort study. BMC Anesthesiol. 2021;21(1):12. https://doi.org/10.1186/s12871-020-01228-y</Citation></Reference><Reference><Citation>Jun I-G, Kwon H-M, Jung K-W, et&#xa0;al. The impact of postreperfusion syndrome on acute kidney injury in living donor liver transplantation: a propensity score analysis. Anesth Analg.. 2018;127(2):369-378. https://doi.org/10.1213/ANE.0000000000003370</Citation></Reference><Reference><Citation>Reydellet L, Blasco V, Mercier MF, et&#xa0;al. Impact of a goal-directed therapy protocol on postoperative fluid balance in patients undergoing liver transplantation: a retrospective study. Ann Fr Anesth Reanim. 2014;33(4):e47-e54. https://doi.org/10.1016/j.annfar.2013.12.016</Citation></Reference><Reference><Citation>Martin D, Koti R, Gurusamy K, et&#xa0;al. The cardiac output optimisation following liver transplant (COLT) trial: a feasibility randomised controlled trial. Hpb. 2020;22(8):1112-1120. https://doi.org/10.1016/j.hpb.2019.11.011</Citation></Reference><Reference><Citation>Reviewers CIGA, Reviewers CIGA. Human albumin administration in critically ill patients: systematic review of randomised controlled trials Why albumin may not work. BMJ. 1998;317(7153):235-240. https://doi.org/10.1136/bmj.317.7153.235</Citation></Reference><Reference><Citation>Roberts I, Blackhall K, Alderson P, Bunn F, Schierhout G. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev. 2011. https://doi.org/10.1002/14651858.CD001208.pub4</Citation></Reference><Reference><Citation>Haase N, Perner A. Colloid solutions in the perioperative setting. BMJ. 2015;350(mar27 6):h1656-h1656. https://doi.org/10.1136/bmj.h1656</Citation></Reference><Reference><Citation>Hadengue A, Moreau R, Gaudin C, Bacq Y, Champigneulle B, Lebrec D. Total effective vascular compliance in patients with cirrhosis: a study of the response to acute blood volume expansion. Hepatology. 1992;15(5):809-815. https://doi.org/10.1002/hep.1840150511</Citation></Reference><Reference><Citation>M&#xf8;ller S, Bendtsen F, Henriksen JH. Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis. Gastroenterology. 1995;109(6):1917-1925. https://doi.org/10.1016/0016-5085(95)90759-9</Citation></Reference><Reference><Citation>Massicotte L, Perrault M-A, Denault AY, et&#xa0;al. Effects of phlebotomy and phenylephrine infusion on portal venous pressure and systemic hemodynamics during liver transplantation. Transplantation. 2010;89(8):920-927. https://doi.org/10.1097/TP.0b013e3181d7c40c</Citation></Reference><Reference><Citation>Wagener G, Gubitosa G, Renz J, et&#xa0;al. Vasopressin decreases portal vein pressure and flow in the native liver during liver transplantation. Liver Transpl. 2008;14(11):1664-1670. https://doi.org/10.1002/lt.21602</Citation></Reference><Reference><Citation>Narahara Y, Kanazawa H, Taki Y, et&#xa0;al. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis. J Gastroenterol Hepatol. 2009;24(11):1791-1797. https://doi.org/10.1111/j.1440-1746.2009.05873.x</Citation></Reference><Reference><Citation>Mukhtar A, Salah M, Aboulfetouh F, et&#xa0;al. The use of terlipressin during living donor liver transplantation: effects on systemic and splanchnic hemodynamics and renal function*: Crit Care Med. 2011;39(6):1329-1334. https://doi.org/10.1097/CCM.0b013e3182120842</Citation></Reference><Reference><Citation>Martin GS, Kaufman DA, Marik PE, et&#xa0;al. Perioperative Quality Initiative (POQI) consensus statement on fundamental concepts in perioperative fluid management: fluid responsiveness and venous capacitance. Perioper Med. 2020;9(1):12. https://doi.org/10.1186/s13741-020-00142-8</Citation></Reference><Reference><Citation>Villanueva C, Colomo A, Bosch A, et&#xa0;al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368(1):11-21. https://doi.org/10.1056/NEJMoa1211801</Citation></Reference><Reference><Citation>Odutayo A, Desborough MJR, Trivella M, et&#xa0;al. Restrictive versus liberal blood transfusion for gastrointestinal bleeding: a systematic review and meta-analysis of randomised controlled trials. Lancet Gastroenterol Hepatol. 2017;2(5):354-360. https://doi.org/10.1016/S2468-1253(17)30054-7</Citation></Reference><Reference><Citation>Hong SH, Park CS, Jung HS, et&#xa0;al. A comparison of intra-operative blood loss and acid-base balance between vasopressor and inotrope strategy during living donor liver transplantation: a randomised, controlled study: vasopressor vs inotrope strategy for liver transplantation. Anaesthesia. 2012;67(10):1091-1100. https://doi.org/10.1111/j.1365-2044.2012.07198.x</Citation></Reference><Reference><Citation>Wang B, He HK, Cheng B, Wei K, Min S. Effect of low central venous pressure on postoperative pulmonary complications in patients undergoing liver transplantation. Surg. 2013;43(7):777-781. https://doi.org/10.1007/s00595-012-0419-y</Citation></Reference><Reference><Citation>Massicotte L, Denault AY, Beaulieu D, et&#xa0;al. Transfusion rate for 500 consecutive liver transplantations: experience of one liver transplantation center. Transplantation. 2012;93(12):1276-1281. https://doi.org/10.1097/TP.0b013e318250fc25</Citation></Reference><Reference><Citation>Paulsen AW, Whitten CW, Ramsay MA, Klintmalm GB. Considerations for anesthetic management during veno-venous bypass in adult hepatic transplantation. Anesth Analg. 1989;68(4):489-496.</Citation></Reference><Reference><Citation>Sahmeddini MA, Janatmakan F, Khosravi MB, et&#xa0;al. Restricted crystalloid fluid therapy during orthotopic liver transplant surgery and its effect on respiratory and renal insufficiency in the early post-operative period: a randomized clinical trial. Int. 2014;5(3):113-119.</Citation></Reference><Reference><Citation>Jiang GQ, Peng MH, Yang DH. Effect of perioperative fluid therapy on early phase prognosis after liver transplantation. Hepatobiliary Pancreat Dis Int. 2008;7(4):367-372.</Citation></Reference><Reference><Citation>Jipa LN, Droc G, Diculescu M. The influence of intraoperative fluid management on postoperative pulmonary complications in liver-transplant patients. Archives of the Balkan Medical Union. 2017;52(3):278-284.</Citation></Reference><Reference><Citation>Schroeder RA, Collins BH, Tuttle-Newhall E, et&#xa0;al. Intraoperative fluid management during orthotopic liver transplantation. J Cardiothorac Vasc Anesth. 2004;18(4):438-441.</Citation></Reference><Reference><Citation>Carrier FM, Sylvestre MP, Massicotte L, Bilodeau M, Chasse M. Effects of intraoperative hemodynamic management on postoperative acute kidney injury in liver transplantation: an observational cohort study. PLoS One. 2020;15(8):e0237503. https://doi.org/10.1371/journal.pone.0237503</Citation></Reference><Reference><Citation>Myles PS, Bellomo R, Corcoran T, et&#xa0;al. Restrictive versus liberal fluid therapy for major abdominal surgery. N Engl J Med. 2018;378(24):2263-2274. https://doi.org/10.1056/NEJMoa1801601</Citation></Reference><Reference><Citation>Pearse RM, Harrison DA, MacDonald N, et&#xa0;al. Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery: a randomized clinical trial and systematic review. JAMA. 2014;311(21):2181. https://doi.org/10.1001/jama.2014.5305</Citation></Reference><Reference><Citation>Wrzosek A, Jakowicka-Wordliczek J, Zajaczkowska R, et&#xa0;al. Perioperative restrictive versus goal-directed fluid therapy for adults undergoing major non-cardiac surgery. Cochrane Database Syst Rev. 2019. https://doi.org/10.1002/14651858.CD012767.pub2</Citation></Reference><Reference><Citation>Diaper J, Schiffer E, Barcelos GK, et&#xa0;al. Goal-directed hemodynamic therapy versus restrictive normovolemic therapy in major open abdominal surgery: A randomized controlled trial. Surgery. 2021;169(5):1164-1174. https://doi.org/10.1016/j.surg.2020.09.035</Citation></Reference><Reference><Citation>Joosten A, Delaporte A, Ickx B, et&#xa0;al. Crystalloid versus colloid for intraoperative goal-directed fluid therapy using a closed-loop system. Anesthesiology. 2018;128(1):55-66. https://doi.org/10.1097/ALN.0000000000001936</Citation></Reference><Reference><Citation>Reiterer C, Kabon B, Zotti O, Obradovic M, Kurz A, Fleischmann E. Effect of goal-directed crystalloid- versus colloid-based fluid strategy on tissue oxygen tension: a randomised controlled trial. Br J Anaesth. 2019;123(6):768-776. https://doi.org/10.1016/j.bja.2019.08.027</Citation></Reference><Reference><Citation>Joosten A, Coeckelenbergh S, Alexander B, et&#xa0;al. Hydroxyethyl starch for perioperative goal-directed fluid therapy in 2020: a narrative review. BMC Anesthesiol. 2020;20(1):209. https://doi.org/10.1186/s12871-020-01128-1</Citation></Reference><Reference><Citation>Umbro I, Tinti F, Scalera I, et&#xa0;al. Acute kidney injury and post-reperfusion syndrome in liver transplantation. WJG. 2016;22(42):9314. https://doi.org/10.3748/wjg.v22.i42.9314</Citation></Reference><Reference><Citation>Mizota T, Hamada M, Matsukawa S, Seo H, Tanaka T, Segawa H. Relationship between intraoperative hypotension and acute kidney injury after living donor liver transplantation: a retrospective analysis. J Cardiothorac Vasc Anesth. 2017;31(2):582-589. https://doi.org/10.1053/j.jvca.2016.12.002</Citation></Reference><Reference><Citation>Walsh M, Devereaux PJ, Garg AX, et&#xa0;al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery. Anesthesiology. 2013;119(3):507-515. https://doi.org/10.1097/ALN.0b013e3182a10e26</Citation></Reference><Reference><Citation>Futier E, Lefrant J-Y, Guinot P-G, et&#xa0;al. Effect of individualized vs standard blood pressure management strategies on postoperative organ dysfunction among high-risk patients undergoing major surgery: a randomized clinical trial. JAMA. 2017;318(14):1346. https://doi.org/10.1001/jama.2017.14172</Citation></Reference><Reference><Citation>Nygren A, Thor&#xe9;n A, Ricksten S-E. Norepinephrine and intestinal mucosal perfusion in vasodilatory shock after cardiac surgery. Shock. 2007;28(5):536-543. https://doi.org/10.1097/shk.0b013e318063e71f</Citation></Reference><Reference><Citation>Nygren A, Thor&#xe9;n A, Ricksten S-E. Vasopressors and intestinal mucosal perfusion after cardiac surgery: Norepinephrine vs. phenylephrine: Crit Care Med. 2006;34(3):722-729. https://doi.org/10.1097/01.CCM.0000201879.20281.C6</Citation></Reference><Reference><Citation>Fuda G, Denault A, Deschamps A, et&#xa0;al. Risk factors involved in central-to-radial arterial pressure gradient during cardiac surgery. Anesth Analg. 2016;122(3):624-632. https://doi.org/10.1213/ANE.0000000000001096</Citation></Reference><Reference><Citation>Lakhal K, Macq C, Ehrmann S, Boulain T, Capdevila X. Noninvasive monitoring of blood pressure in the critically ill: Reliability according to the cuff site (arm, thigh, or ankle). Crit Care Med. 2012;40(4):1207-1213. https://doi.org/10.1097/CCM.0b013e31823dae42</Citation></Reference><Reference><Citation>Weinberg L, Broad J, Pillai P, et&#xa0;al. Sodium bicarbonate infusion in patients undergoing orthotopic liver transplantation: a single center randomized controlled pilot trial. Clin Transplant. 2016;30(5):556-565. https://doi.org/10.1111/ctr.12721</Citation></Reference><Reference><Citation>Hand WR, Whiteley JR, Epperson TI, et&#xa0;al. Hydroxyethyl starch and acute kidney injury in orthotopic liver transplantation: a single-center retrospective review. Anesth Analg. 2015;120(3):619-626. https://doi.org/10.1213/ANE.0000000000000374</Citation></Reference><Reference><Citation>Zarychanski R, Abou-Setta AM, Turgeon AF, et&#xa0;al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically Ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA. 2013;309(7):678. https://doi.org/10.1001/jama.2013.430</Citation></Reference><Reference><Citation>Mutter TC, Ruth CA, Dart AB. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev. 2013. https://doi.org/10.1002/14651858.CD007594.pub3</Citation></Reference><Reference><Citation>Wagener G, Bezinover D, Wang C, et&#xa0;al. Fluid management during kidney transplantation: a consensus statement of the committee on transplant anesthesia of the American Society of anesthesiologists. Transplantation. 2021;105(8):1677-1684. https://doi.org/10.1097/TP.0000000000003581</Citation></Reference><Reference><Citation>Mukhtar A, Aboulfetouh F, Obayah G, et&#xa0;al. The safety of modern hydroxyethyl starch in living donor liver transplantation: a comparison with human albumin. Anesthesia &amp; Analgesia. 2009;109(3):924-930. https://doi.org/10.1213/ane.0b013e3181aed54f</Citation></Reference><Reference><Citation>Kabon B, Sessler DI, Kurz A, the Crystalloid-Colloid Study Team. Effect of Intraoperative goal-directed balanced crystalloid versus colloid administration on major postoperative morbidity. Anesthesiology. 2019;130(5):728-744. https://doi.org/10.1097/ALN.0000000000002601</Citation></Reference><Reference><Citation>Lobo DN, Stanga Z, Aloysius MM, et&#xa0;al. Effect of volume loading with 1 liter intravenous infusions of 0.9% saline, 4% succinylated gelatine (Gelofusine) and 6% hydroxyethyl starch (Voluven) on blood volume and endocrine responses: a randomized, three-way crossover study in healthy volunteers. Crit Care Med. 2010;38(2):464-470. https://doi.org/10.1097/CCM.0b013e3181bc80f1</Citation></Reference><Reference><Citation>Awad S, Dharmavaram S, Wearn CS, Dube MG, Lobo DN. Effects of an intraoperative infusion of 4% succinylated gelatine (Gelofusine &#xae;) and 6% hydroxyethyl starch (Voluven &#xae;) on blood volume &#x2020;. Br J Anaesth. 2012;109(2):168-176. https://doi.org/10.1093/bja/aes098</Citation></Reference><Reference><Citation>China L, Freemantle N, Forrest E, et&#xa0;al. A randomized trial of albumin infusions in hospitalized patients with cirrhosis. N Engl J Med. 2021;384(9):808-817. https://doi.org/10.1056/NEJMoa2022166</Citation></Reference><Reference><Citation>A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350(22):2247-2256. https://doi.org/10.1056/NEJMoa040232</Citation></Reference><Reference><Citation>Patel A, Laffan MA, Waheed U, Brett SJ. Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality. BMJ. 2014;349(jul22 10):g4561-g4561. https://doi.org/10.1136/bmj.g4561</Citation></Reference><Reference><Citation>Amouzandeh M, Nowak G, Januszkiewicz A, Wernerman J, Rooyackers O, Norberg &#xc5;. Albumin mass balance and kinetics in liver transplantation. Crit Care. 2018;22(1):152. https://doi.org/10.1186/s13054-018-2053-6</Citation></Reference><Reference><Citation>Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and Plasma-Lyte&#xae; 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2012;256(1):18-24. https://doi.org/10.1097/SLA.0b013e318256be72</Citation></Reference><Reference><Citation>Yunos NM, Bellomo R, Glassford N, Sutcliffe H, Lam Q, Bailey M. Chloride-liberal vs. chloride-restrictive intravenous fluid administration and acute kidney injury: an extended analysis. Intensive Care Med. 2015;41(2):257-264. https://doi.org/10.1007/s00134-014-3593-0</Citation></Reference><Reference><Citation>Nadeem A, Salahuddin N, El Hazmi A, et&#xa0;al. Chloride-liberal fluids are associated with acute kidney injury after liver transplantation. Crit Care. 2014;18(6):625. https://doi.org/10.1186/s13054-014-0625-7</Citation></Reference><Reference><Citation>Sen A, Keener CM, Sileanu FE, et&#xa0;al. Chloride content of fluids used for large-volume resuscitation is associated with reduced survival. Crit Care Med. 2017;45(2):e146-e153. https://doi.org/10.1097/CCM.0000000000002063</Citation></Reference><Reference><Citation>Masevicius FD, Rubatto Birri PN, Risso Vazquez A, et&#xa0;al. Relationship of at admission lactate, unmeasured anions, and chloride to the outcome of critically Ill patients. Crit Care Med. 2017;45(12):e1233-e1239. https://doi.org/10.1097/CCM.0000000000002730</Citation></Reference><Reference><Citation>Morard I, Gasche Y, Kneteman M, et&#xa0;al. Identifying risk factors for central pontine and extrapontine myelinolysis after liver transplantation: a case-control study. Neurocrit Care. 2014;20(2):287-295. https://doi.org/10.1007/s12028-013-9928-9</Citation></Reference><Reference><Citation>Finfer S, Micallef BN, Hammond S, et&#xa0;al. Balanced Multielectrolyte Solution versus Saline in Critically Ill Adults. N Engl J Med 2022;386:815-826. https://doi.org/10.1056/NEJMoa2114464. Epub 2022 Jan 18.</Citation></Reference><Reference><Citation>Nishimura A, Tabuchi Y, Kikuchi M, Masuda R, Goto K, Iijima T. The amount of fluid given during surgery that leaks into the interstitium correlates with infused fluid volume and varies widely between patients: Anesth Analg. 2016;123(4):925-932. https://doi.org/10.1213/ANE.0000000000001505</Citation></Reference><Reference><Citation>Chappell D, Jacob M, Hofmann-Kiefer K, Conzen P, Rehm M. A rational approach to perioperative fluid management. Anesthesiology. 2008;109(4):723-740. https://doi.org/10.1097/ALN.0b013e3181863117</Citation></Reference><Reference><Citation>Chappell D, Bruegger D, Potzel J, et&#xa0;al. Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx. Crit Care. 2014;18(5):538. https://doi.org/10.1186/s13054-014-0538-5</Citation></Reference><Reference><Citation>Zitek T, Skaggs ZD, Rahbar A, Patel J, Khan M. Does intravenous lactated Ringer's solution raise serum lactate? J Emerg Med. 2018;55(3):313-318. https://doi.org/10.1016/j.jemermed.2018.05.031</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37525360</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1534-6080</ISSN><JournalIssue CitedMedium="Internet"><Volume>108</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>Transplantation</Title><ISOAbbreviation>Transplantation</ISOAbbreviation></Journal><ArticleTitle>Intraoperative Vasoactive Medications and Perioperative Outcomes in Liver Transplantation: A Systematic Review and Network Meta-analyses.</ArticleTitle><Pagination><StartPage>854</StartPage><EndPage>873</EndPage><MedlinePgn>854-873</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/TP.0000000000004744</ELocationID><Abstract><AbstractText>We conducted a systematic review and network meta-analyses evaluating the effects of different intraoperative vasoactive drugs on acute kidney injury (AKI) and other perioperative outcomes in adult liver transplant recipients. We searched multiple electronic databases using words from the "liver transplantation" and "vasoactive drug" domains. We included all randomized controlled trials conducted in adult liver transplant recipients comparing 2 different intravenous vasoactive drugs or 1 against a standard of care that reported AKI, intraoperative blood loss, or any other postoperative outcome. We conducted 4 frequentist network meta-analyses using random effect models, based on the interventions' mechanism of action, and evaluated the quality of evidence (QoE) using Grading of Recommendations, Assessment, Development, and Evaluations recommendations. We included 9 randomized controlled trials comparing different vasopressor drugs (vasoconstrictor or inotrope), 3 comparing a somatostatin infusion (or its analogues) to a standard of care, 11 comparing different vasodilator infusions together or against a standard of care, and 2 comparing vasoconstrictor boluses at graft reperfusion. Intravenous clonidine was associated with shorter duration of mechanical ventilation, intensive care unit, and hospital length of stay (very low QoE), and some vasodilators were associated with lower creatinine level 24&#x2009;h after surgery (low to very low QoE). Phenylephrine and terlipressin were associated with less intraoperative blood loss when compared with norepinephrine (low and moderate QoE). None of the vasoactive drugs improve any other postoperative outcomes, including AKI. There is still important equipoise regarding the best vasoactive drug to use in liver transplantation for most outcomes. Further studies are required to better inform clinical practice.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Carrier</LastName><ForeName>Fran&#xe7;ois Martin</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Centre hospitalier de l'Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Critical Care Division, Centre hospitalier de l'Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Innovation and Evaluation Hub, Centre de recherche du CHUM, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girard</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Centre hospitalier de l'Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Critical Care Division, Centre hospitalier de l'Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Innovation and Evaluation Hub, Centre de recherche du CHUM, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuo</LastName><ForeName>Rui Min</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziegler</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Library, Centre hospitalier de l'Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trottier</LastName><ForeName>Helen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Social and Preventive Medicine, &#xc9;cole de Sant&#xe9; Publique de l'Universit&#xe9; de Montr&#xe9;al, Centre hospitalier universitaire Sainte-Justine, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chass&#xe9;</LastName><ForeName>Micha&#xeb;l</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Critical Care Division, Centre hospitalier de l'Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Innovation and Evaluation Hub, Centre de recherche du CHUM, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000099094">Network Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transplantation</MedlineTA><NlmUniqueID>0132144</NlmUniqueID><ISSNLinking>0041-1337</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014665">Vasodilator Agents</NameOfSubstance></Chemical></ChemicalList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="N">Intraoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016031" MajorTopicYN="Y">Liver Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="Y">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014665" MajorTopicYN="N">Vasodilator Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37525360</ArticleId><ArticleId IdType="doi">10.1097/TP.0000000000004744</ArticleId><ArticleId IdType="pii">00007890-202404000-00011</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adam R, Karam V, Delvart V, et al.; All contributing centers ( www.eltr.org ). Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry(ELTR). J Hepatol. 2012;57:675&#x2013;688.</Citation></Reference><Reference><Citation>Kwong AJ, Kim WR, Lake JR, et al. OPTN/SRTR 2019 annual data report: liver. Am J Transplant. 2021;21:208&#x2013;315.</Citation></Reference><Reference><Citation>Dutkowski P, Oberkofler CE, B&#xe9;chir M, et al. The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis. Liver Transpl. 2011;17:674&#x2013;684.</Citation></Reference><Reference><Citation>Johnson RJ, Bradbury LL, Martin K, et al.; UK Transplant Registry. Organ donation and transplantation in the UK-the last decade: a report from the UK national transplant registry. Transplantation. 2014;97(Suppl 1):S1&#x2013;S27.</Citation></Reference><Reference><Citation>Parikh A, Washburn KW, Matsuoka L, et al. A multicenter study of 30 days complications after deceased donor liver transplantation in the model for end-stage liver disease score era. Liver Transpl. 2015;21:1160&#x2013;1168.</Citation></Reference><Reference><Citation>Pereira AA, Bhattacharya R, Carithers R, et al. Clinical factors predicting readmission after orthotopic liver transplantation. Liver Transpl. 2012;18:1037&#x2013;1045.</Citation></Reference><Reference><Citation>Sirivatanauksorn Y, Parakonthun T, Premasathian N, et al. Renal dysfunction after orthotopic liver transplantation. Transplant Proc. 2014;46:818&#x2013;821.</Citation></Reference><Reference><Citation>Wiesen P, Massion PB, Joris J, et al. Incidence and risk factors for early renal dysfunction after liver transplantation. World J Transplant. 2016;6:220&#x2013;232.</Citation></Reference><Reference><Citation>Thongprayoon C, Kaewput W, Thamcharoen N, et al. Incidence and impact of acute kidney injury after liver transplantation: a meta-analysis. J Clin Med. 2019;8:372.</Citation></Reference><Reference><Citation>Hilmi IA, Damian D, Al-Khafaji A, et al. Acute kidney injury following orthotopic liver transplantation: incidence, risk factors, and effects on patient and graft outcomes. Br J Anaesth. 2015;114:919&#x2013;926.</Citation></Reference><Reference><Citation>Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med. 2003;349:931&#x2013;940.</Citation></Reference><Reference><Citation>Gastaca MB. Complications after orthotopic liver transplantation: a review of incidence and risk factors. Transplant Proc. 2012;44:1545&#x2013;1549.</Citation></Reference><Reference><Citation>Smoter P, Nyckowski P, Grat M, et al. Risk factors of acute renal failure after orthotopic liver transplantation: single-center experience. Transplant Proc. 2014;46:2786&#x2013;2789.</Citation></Reference><Reference><Citation>Cywinski JB, Alster JM, Miller C, et al. Prediction of intraoperative transfusion requirements during orthotopic liver transplantation and the influence on postoperative patient survival. Anesth Analg. 2014;118:428&#x2013;437.</Citation></Reference><Reference><Citation>Massicotte L, Beaulieu D, Thibeault L, et al. Coagulation defects do not predict blood product requirements during liver transplantation. Transplantation. 2008;85:956&#x2013;962.</Citation></Reference><Reference><Citation>Taura P, Martinez-Palli G, Blasi A, et al. Intraoperative management of high-risk liver transplant recipients: concerns and challenges. Transplant Proc. 2016;48:2491&#x2013;2494.</Citation></Reference><Reference><Citation>Molenaar IQ, Warnaar N, Groen H, et al. Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis. Am J Transplant. 2007;7:185&#x2013;194.</Citation></Reference><Reference><Citation>Mizota T, Hamada M, Matsukawa S, et al. Relationship between intraoperative hypotension and acute kidney injury after living donor liver transplantation&#x2014;a retrospective analysis. J Cardiothorac Vasc Anesth. 2017;31:582&#x2013;589.</Citation></Reference><Reference><Citation>Joosten A, Lucidi V, Ickx B, et al. Intraoperative hypotension during liver transplant surgery is associated with postoperative acute kidney injury: a historical cohort study. BMC Anesthesiol. 2021;21:12&#x2013;10.</Citation></Reference><Reference><Citation>Wang L, Bui CM, Hofer I, et al. Intraoperative hypotension and 30-d mortality after liver transplantation. Transplant Direct. 2022;8:e1380.</Citation></Reference><Reference><Citation>Carrier FM, Chass&#xe9; M, Wang HT, et al. Restrictive fluid management strategies and outcomes in liver transplantation: a systematic review. Can J Anesth Can Anesth. 2020;67:109&#x2013;127.</Citation></Reference><Reference><Citation>Myles PS, Bellomo R, Corcoran T, et al.; Australian and New Zealand College of Anaesthetists Clinical Trials Network and the Australian and New Zealand Intensive Care Society Clinical Trials Group. Restrictive versus liberal fluid therapy for major abdominal surgery. N Engl J Med. 2018;378:2263&#x2013;2274.</Citation></Reference><Reference><Citation>Corcoran T, Emma Joy Rhodes J, Clarke S, et al. Perioperative fluid management strategies in major surgery: a stratified meta-analysis. Anesth Analg. 2012;114:640&#x2013;651.</Citation></Reference><Reference><Citation>Pearse RM, Harrison DA, MacDonald N, et al.; OPTIMISE Study Group. Effect of a perioperative, cardiac output&#x2013;guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery: a randomized clinical trial and systematic review. JAMA. 2014;311:2181&#x2013;2190.</Citation></Reference><Reference><Citation>Prowle JR, Chua HR, Bagshaw SM, et al. Clinical review: volume of fluid resuscitation and the incidence of acute kidney injury&#x2014;a systematic review. Crit Care. 2012;16:230.</Citation></Reference><Reference><Citation>Esler MI. Sympathetic nervous activity and the effects of its inhibition with clonidine in alcoholic cirrhosis. Ann Intern Med. 1992;116:446.</Citation></Reference><Reference><Citation>Meco M, Allaz MC, Cirri SE. of Fenoldopam mesylate infusion on splanchnic perfusion after myocardial revascularization on cardiopulmonary bypass: an ultrasound Doppler study. J Cardiothorac Vasc Anesth. 2011;25:642&#x2013;646.</Citation></Reference><Reference><Citation>Halpenny M, Lakshmi S, O&#x2019;Donnell A, et al. Fenoldopam: renal and splanchnic effects in patients undergoing coronary artery bypass grafting: renal and splanchnic effects of fenoldopam. Anaesthesia. 2001;56:953&#x2013;960.</Citation></Reference><Reference><Citation>Schnuelle P, Gottmann U, Hoeger S, et al. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. JAMA. 2009;302:1067&#x2013;1075.</Citation></Reference><Reference><Citation>Higgins JPT, Thomas J, Chadler J, eds. Cochrane Handbook for Systematic Reviews of Interventions. 2nd edition. Wiley-Blackwell; 2020.</Citation></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906.</Citation></Reference><Reference><Citation>Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162:777&#x2013;784.</Citation></Reference><Reference><Citation>Bramer WM, Giustini D, De Jonge GB, et al. De-duplication of database search results for systematic reviews in EndNote. J Med Libr Assoc. 2016;104:240&#x2013;243.</Citation></Reference><Reference><Citation>PRISMA-S G, Rethlefsen ML, Kirtley S, et al. PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews. Syst Rev. 2021;10:39.</Citation></Reference><Reference><Citation>Sterne JAC, Savovi&#x107; J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.</Citation></Reference><Reference><Citation>R&#xfc;cker G. Network meta-analysis, electrical networks and graph theory. Res Synth Methods. 2012;3:312&#x2013;324.</Citation></Reference><Reference><Citation>Schwarzer G, Carpenter JR, R&#xfc;cker G. Meta-Analysis With R. Springer International Publishing; 2015.</Citation></Reference><Reference><Citation>Doi SA, Furuya-Kanamori L, Xu C, et al. The Odds Ratio is &#x201c;portable&#x201d; across baseline risk but not the relative risk: time to do away with the log link in binomial regression. J Clin Epidemiol. 2022;142:288&#x2013;293.</Citation></Reference><Reference><Citation>Luo D, Wan X, Liu J, et al. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27:1785&#x2013;1805.</Citation></Reference><Reference><Citation>Carrier FM, Vincelette C, Amzallag E, et al. Perioperative clinical practice in liver transplantation: an international survey. Can Anesth. [Epub ahead of print June 2, 2023]. doi:10.1007/s12630-023-02499-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-023-02499-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Balshem H, Helfand M, Sch&#xfc;nemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64:401&#x2013;406.</Citation></Reference><Reference><Citation>Salanti G, Del Giovane C, Chaimani A, et al. Evaluating the quality of evidence from a network meta-analysis. Tu YK, ed. PLoS One. 2014;9:e99682.</Citation></Reference><Reference><Citation>Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383&#x2013;394.</Citation></Reference><Reference><Citation>Guyatt GH, Oxman AD, Santesso N, et al. GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes. J Clin Epidemiol. 2013;66:158&#x2013;172.</Citation></Reference><Reference><Citation>Soleimanpour H, Shahsavari Nia K, Sanaie S, et al. Use of dexmedetomidine in liver disease: a systematic review and meta-analysis. Hepat Mon. 2019;19:e98530.</Citation></Reference><Reference><Citation>Won YJ, Kim HJ, Lim BG, et al. Effect of perioperative terlipressin on postoperative renal function in patients who have undergone living donor liver transplantation: a meta-analysis of randomized controlled trials. Transplant Proc. 2015;47:1917&#x2013;1925.</Citation></Reference><Reference><Citation>Kulkarni AV, Kumar K, Candia R, et al. Prophylactic perioperative terlipressin therapy for preventing acute kidney injury in living donor liver transplant recipients: a systematic review and meta-analysis. J Clin Exp Hepatol. 2022;12:417&#x2013;427.</Citation></Reference><Reference><Citation>Gavriilidis P, Hidalgo E, Sutcliffe RP, et al. Terlipressin versus placebo in living donor liver transplantation. Hepatobiliary Pancreat Dis Int. 2022;21:76&#x2013;79.</Citation></Reference><Reference><Citation>Zhang L, Li M, Yang LE. of different vasopressors on hemodynamics in patients undergoing orthotopic liver transplantation. Chin Med J (Engl). 2005;118:1952&#x2013;1958.</Citation></Reference><Reference><Citation>Ponnudurai RN, Koneru B, Akhtar SA, et al. Vasopressor administration during liver transplant surgery and its effect on endotracheal reintubation rate in the postoperative period: a prospective, randomized, double-blind, placebo-controlled trial. Clin Ther. 2005;27:192&#x2013;198.</Citation></Reference><Reference><Citation>Mukhtar A, Salah M, Aboulfetouh F, et al. The use of terlipressin during living donor liver transplantation: effects on systemic and splanchnic hemodynamics and renal function. Crit Care Med. 2011;39:1329&#x2013;1334.</Citation></Reference><Reference><Citation>Hong S, Lee J, Choi J, et al. Perioperative assessment of terlipressin infusion during living donor liver transplantation. J Int Med Res. 2012;40:225&#x2013;236.</Citation></Reference><Reference><Citation>Hong SH, Park CS, Jung HS, et al. A comparison of intra-operative blood loss and acid-base balance between vasopressor and inotrope strategy during living donor liver transplantation: a randomised, controlled study: vasopressor vs inotrope strategy for liver transplantation. Anaesthesia. 2012;67:1091&#x2013;1100.</Citation></Reference><Reference><Citation>Fayed N, Refaat EK, Yassein TE, et al. Effect of perioperative terlipressin infusion on systemic, hepatic, and renal hemodynamics during living donor liver transplantation. J Crit Care. 2013;28:775&#x2013;782.</Citation></Reference><Reference><Citation>Ibrahim N, Hasanin A, Allah S, et al. The haemodynamic effects of the perioperative terlipressin infusion in living donor liver transplantation: a randomised controlled study. Indian J Anaesth. 2015;59:156.</Citation></Reference><Reference><Citation>Kandil MA, Abouelenain KM, Alsebaey A, et al. Impact of terlipressin infusion during and after live donor liver transplantation on incidence of acute kidney injury and neutrophil gelatinase-associated lipocalin serum levels: a randomized controlled trial. Clin Transplant. 2017;31:e13019&#x2013;e13019.</Citation></Reference><Reference><Citation>Reddy MS, Kaliamoorthy I, Rajakumar A, et al. Double-blind randomized controlled trial of the routine perioperative use of terlipressin in adult living donor liver transplantation: Reddy et al. Liver Transpl. 2017;23:1007&#x2013;1014.</Citation></Reference><Reference><Citation>Feng ZY, Xu X, Wu L-J, et al. Downregulation of endothelin-1 by somatostatin improves liver function of recipients undergoing adult-to-adult living donor liver transplantation. Chin Med J (Engl). 2010;123:1961&#x2013;1966.</Citation></Reference><Reference><Citation>Sahmeddini MA, Amini A, Naderi NT. The effect of octreotide on urine output during orthotopic liver transplantation and early postoperative renal function; a randomized, double-blind, placebo-controlled trial. Hepat Mon. 2013;13:e12787.</Citation></Reference><Reference><Citation>Troisi RI, Vanlander A, Giglio MC, et al. Somatostatin as inflow modulator in liver-transplant recipients with severe portal hypertension: a randomized trial. Ann Surg. 2019;269:1025&#x2013;1033.</Citation></Reference><Reference><Citation>Swygert TH, Roberts LC, Valek TR, et al. Effect of intraoperative low-dose dopamine on renal function in liver transplant recipients. Anesthesiology. 1991;75:571&#x2013;576.</Citation></Reference><Reference><Citation>De Kock M, Laterre PF, Van Obbergh L, et al. The Effects of intraoperative intravenous clonidine on fluid requirements, hemodynamic variables, and support during liver transplantation: a prospective, randomized study. Anesth Analg. 1998;86:468&#x2013;476.</Citation></Reference><Reference><Citation>Ramsay MA, Jones CC, Emmett ME, et al. The effect of a fenoldopam infusion on postoperative renal function in patients undergoing liver transplantation: [2002][A-242]. Anesthesiology. 2002;96:A242.</Citation></Reference><Reference><Citation>Biancofiore G, Rocca GD, Bindi L, et al. Use of fenoldopam to control renal dysfunction early after liver transplantation. Liver Transpl. 2004;10:986&#x2013;992.</Citation></Reference><Reference><Citation>Rocca GD, Pompei L, Costa MG, et al. Fenoldopam mesylate and renal function in patients undergoing liver transplantation: a randomized, controlled pilot trial. Anesth Analg. 2004;99:1604&#x2013;1609.</Citation></Reference><Reference><Citation>Pugliese F, Ruberto F, Bruno K, et al. Fenoldopam and gastric tonometry during orthotopic liver transplantation. Transplant Proc. 2007;39:1886&#x2013;1888.</Citation></Reference><Reference><Citation>Fayed NA, Sayed EI, Saleh SM, et al. Effect of dexmedetomidine on hepatic ischemia-reperfusion injury in the setting of adult living donor liver transplantation. Clin Transplant. 2016;30:470&#x2013;482.</Citation></Reference><Reference><Citation>Xu G, Li L, Sun Z, et al. Effects of dexmedetomidine on postoperative cognitive dysfunction and serum levels of b-amyloid and neuronal microtubule-associated protein in orthotopic liver transplantation patients. Ann Transplant. 2016;21:508&#x2013;515.</Citation></Reference><Reference><Citation>Khalil MK, Afifi MH, Ismael EA, et al. Perioperative effect of continuous infusion of dexmedetomedine on indirect gas calorimetry monitoring in liver transplantation. Biomed J Sci Tech Res. 2017;1:240&#x2013;247.</Citation></Reference><Reference><Citation>Jung K, Kwon H, Moon Y, et al. Impact of dexmedetomidine on acute kidney injury following living donor liver transplantation: a randomized controlled pilot study. Intensive Care Med Exp. 2018;6(Suppl 2):87.</Citation></Reference><Reference><Citation>Lee H, Yang SM, Chung J, et al. Effect of perioperative low-dose dexmedetomidine on postoperative delirium after living-donor liver transplantation: a randomized controlled trial. Transplant Proc. 2020;52:239&#x2013;245.</Citation></Reference><Reference><Citation>Ryu HG, Jung CW, Lee HC, et al. Epinephrine and phenylephrine pretreatments for preventing postreperfusion syndrome during adult liver transplantation. Liver Transpl. 2012;18:1430&#x2013;1439.</Citation></Reference><Reference><Citation>Fayed NA, Murad WS. Goal directed preemptive ephedrine attenuates the reperfusion syndrome during adult living donor liver transplantation. Egypt J Anaesth. 2014;30:187&#x2013;195.</Citation></Reference><Reference><Citation>Brustia R, Monsel A, Skurzak S, et al. Guidelines for perioperative care for liver transplantation: enhanced recovery after surgery (ERAS) recommendations. Transplantation. 2022;106:552&#x2013;561.</Citation></Reference><Reference><Citation>Chadha R, Patel D, Bhangui P, et al. Optimal anesthetic conduct regarding immediate and short&#x2010;term outcomes after liver transplantation&#x2014;systematic review of the literature and expert panel recommendations. Clin Transplant. 2022;36:e14613.</Citation></Reference><Reference><Citation>De Backer D, Biston P, Devriendt J, et al.; SOAP II Investigators. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362:779&#x2013;789.</Citation></Reference><Reference><Citation>Russell JA, Walley KR, Singer J, et al.; VASST Investigators. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877&#x2013;887.</Citation></Reference><Reference><Citation>Gordon AC, Mason AJ, Thirunavukkarasu N, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA J Am Med Assoc. 2016;316:509&#x2013;518.</Citation></Reference><Reference><Citation>Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181&#x2013;1247.</Citation></Reference><Reference><Citation>Hajjar LA, Vincent JL, Barbosa Gomes Galas FR, et al. Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: the VANCS randomized controlled trial. Anesthesiology. 2017;126:85&#x2013;93.</Citation></Reference><Reference><Citation>Ivanics T, Wallace D, Abreu P, et al. Survival after liver transplantation: an international comparison between the United States and the United Kingdom in the years 2008&#x2013;2016. Transplantation. 2022;106:1390&#x2013;1400.</Citation></Reference><Reference><Citation>Alconchel F, Tinguely P, Frola C, et al. Are short&#x2010;term complications associated with poor allograft and patient survival after liver transplantation? A systematic review of the literature and expert panel recommendations. Clin Transplant. 2022;36:e14704.</Citation></Reference><Reference><Citation>Cristin DJ, Forman LM, Jackson WEB. Survival: targeting health&#x2010;related quality of life outcomes after liver transplantation. Clin Liver Dis. 2021;17:359&#x2013;364.</Citation></Reference><Reference><Citation>Fodor M, Zoller H, Oberhuber R, et al. The need to update endpoints and outcome analysis in the rapidly changing field of liver transplantation. Transplantation. 2022;106:938&#x2013;949.</Citation></Reference><Reference><Citation>Massicotte L, Perrault MA, Denault AY, et al. Effects of phlebotomy and phenylephrine infusion on portal venous pressure and systemic hemodynamics during liver transplantation. Transplantation. 2010;89:920&#x2013;927.</Citation></Reference><Reference><Citation>Mukhtar A, Lotfy A, Hussein A, et al. Splanchnic and systemic circulation cross talks: implication for hemodynamic management of liver transplant recipient. Best Pract Res Clin Anaesthesiol. 2020;34:109&#x2013;118.</Citation></Reference><Reference><Citation>Arora V, Maiwall R, Rajan V, et al. Terlipressin is superior to noradrenaline in the management of acute kidney injury in acute on chronic liver failure. Hepatology. 2020;71:600&#x2013;610.</Citation></Reference><Reference><Citation>Wells M, Chande N, Adams P, et al. Meta-analysis: vasoactive medications for the management of acute variceal bleeds. Aliment Pharmacol Ther. 2012;35:1267&#x2013;1278.</Citation></Reference><Reference><Citation>Mansournia MA, Higgins JPT, Sterne JAC, et al. Biases in randomized trials: a conversation between trialists and epidemiologists. Epidemiol Camb Mass. 2017;28:54&#x2013;59.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35247976</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2369</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>05</Day></PubDate></JournalIssue><Title>BMC nephrology</Title><ISOAbbreviation>BMC Nephrol</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury following major emergency abdominal surgery - a retrospective cohort study based on medical records data.</ArticleTitle><Pagination><StartPage>94</StartPage><MedlinePgn>94</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">94</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12882-022-02708-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">Acute Kidney Injury (AKI) is a frequent and serious postoperative complication in trauma or critically ill patients in the intensive care unit. We aimed to estimate the risk of AKI following major emergency abdominal surgery and the association between AKI and 90-day postoperative mortality.</AbstractText><AbstractText Label="METHODS">In this retrospective cohort study, we included patients undergoing major emergency abdominal surgery at the Department of Surgery, Zealand University Hospital, Denmark, from 2010 to 2016. The primary outcome was the occurrence of AKI within postoperative day seven (POD7). AKI was defined according to the Kidney Disease: Improving Global Outcomes (KDIGO)-criteria. The risk of AKI was analysed with a multivariable logistic regression. The association between AKI and 90-day mortality was analysed with a multivariable survival analysis.</AbstractText><AbstractText Label="RESULTS">In the cohort, 122 out of 703 (17.4%) surgical patients had AKI within POD7. Of these, 82 (67.2%) had AKI stage 1, 26 (21.3%) had AKI stage 2, and 14 (11.5%) had AKI stage 3. Fifty-eight percent of the patients who developed postoperative AKI did so within the first 24&#xa0;h of surgery. Ninety-day mortality was significantly higher in patients with AKI compared with patients without AKI (41/122 (33.6%) versus 40/581 (6.9%), adjusted hazard ratio 4.45 (95% confidence interval 2.69-7.39, P&#x2009;&lt;&#x2009;0.0001)), and rose with increasing KDIGO stage. Pre-existing hypertension and intraoperative peritoneal contamination were independently associated with the risk of AKI.</AbstractText><AbstractText Label="CONCLUSIONS">The risk of AKI is high after major emergency abdominal surgery and is independently associated with the risk of death within 90&#xa0;days of surgery.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mikkelsen</LastName><ForeName>Theis B</ForeName><Initials>TB</Initials><Identifier Source="ORCID">0000-0003-2748-4001</Identifier><AffiliationInfo><Affiliation>Center for Surgical Science, Department of Surgery, Zealand University Hospital, Lykkebaekvej 1, 4600, Koege, Denmark. theismikkelsen92@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schack</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Department of Surgery, Zealand University Hospital, Lykkebaekvej 1, 4600, Koege, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oreskov</LastName><ForeName>Jakob O</ForeName><Initials>JO</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Department of Surgery, Zealand University Hospital, Lykkebaekvej 1, 4600, Koege, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf6;genur</LastName><ForeName>Ismail</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Department of Surgery, Zealand University Hospital, Lykkebaekvej 1, 4600, Koege, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burcharth</LastName><ForeName>Jakob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Department of Surgery, Zealand University Hospital, Lykkebaekvej 1, 4600, Koege, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ekeloef</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Department of Surgery, Zealand University Hospital, Lykkebaekvej 1, 4600, Koege, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Nephrol</MedlineTA><NlmUniqueID>100967793</NlmUniqueID><ISSNLinking>1471-2369</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="N">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008499" MajorTopicYN="N">Medical Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Abdominal surgery</Keyword><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Emergency surgery</Keyword><Keyword MajorTopicYN="N">Intensive care</Keyword><Keyword MajorTopicYN="N">Postoperative complications</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>6</Day><Hour>20</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35247976</ArticleId><ArticleId IdType="pmc">PMC8897898</ArticleId><ArticleId IdType="doi">10.1186/s12882-022-02708-8</ArticleId><ArticleId IdType="pii">10.1186/s12882-022-02708-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Long TE, Helgason D, Helgadottir S, Palsson R, Gudbjartsson T, Sigurdsson GH, et al. Acute kidney injury after abdominal surgery: incidence, risk factors, and outcome. Anesth Analg. 2016;122(6):1912&#x2013;1920.</Citation><ArticleIdList><ArticleId IdType="pubmed">27195635</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Connor ME, Hewson RW, Kirwan CJ, Ackland GL, Pearse RM, Prowle JR. Acute kidney injury and mortality 1 year after major non-cardiac surgery. Br J Surg. 2017;104(7):868&#x2013;876.</Citation><ArticleIdList><ArticleId IdType="pubmed">28218392</ArticleId></ArticleIdList></Reference><Reference><Citation>Briggs A, Havens JM, Salim A, Christopher KB. Acute kidney injury predicts mortality in emergency general surgery patients. Am J Surg. 2018;216(3):420&#x2013;426.</Citation><ArticleIdList><ArticleId IdType="pubmed">29615192</ArticleId></ArticleIdList></Reference><Reference><Citation>Demarchi AC, de Almeida CT, Ponce D, e Castro MC, Danaga AR, Yamaguti FA, et al. Intra-abdominal pressure as a predictor of acute kidney injury in postoperative abdominal surgery. Renal Failure. 2014;36(4):557&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">24456177</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira C, Rosa R, Rodrigues N, Mendes I, Peixoto L, Dias S, et al. Acute kidney injury after major abdominal surgery: a retrospective cohort analysis. Crit Care Res Pract. 2014;2014:132175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3955689</ArticleId><ArticleId IdType="pubmed">24719758</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu HC, Wang WJ, Chen YW, Chen HH. The association between the duration of postoperative acute kidney injury and in-hospital mortality in critically ill patients after non-cardiac surgery: an observational cohort study. Ren Fail. 2015;37(6):985&#x2013;993.</Citation><ArticleIdList><ArticleId IdType="pubmed">25982008</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuhrman DY, Kellum JA. Epidemiology and pathophysiology of cardiac surgery-associated acute kidney injury. Curr Opin Anaesthesiol. 2017;30(1):60&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">27820742</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Neal JB, Shaw AD, Billings FTt. Acute kidney injury following cardiac surgery: current understanding and future directions. Crit Care (London, England) 2016;20(1):187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4931708</ArticleId><ArticleId IdType="pubmed">27373799</ArticleId></ArticleIdList></Reference><Reference><Citation>Biteker M, Dayan A, Tekkesin AI, Can MM, Tayci I, Ilhan E, et al. Incidence, risk factors, and outcomes of perioperative acute kidney injury in noncardiac and nonvascular surgery. Am J Surg. 2014;207(1):53&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">24050540</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Lameire N, Aspelin P, Barsoum RS, Burdmann EA, Goldstein SL, et al. Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1&#x2013;138.</Citation></Reference><Reference><Citation>Kellum JA, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1) Crit Care (London, England) 2013;17(1):204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057151</ArticleId><ArticleId IdType="pubmed">23394211</ArticleId></ArticleIdList></Reference><Reference><Citation>Peacock O, Bassett MG, Kuryba A, Walker K, Davies E, Anderson I, et al. Thirty-day mortality in patients undergoing laparotomy for small bowel obstruction. Br J Surg. 2018;105(8):1006&#x2013;1013.</Citation><ArticleIdList><ArticleId IdType="pubmed">29603126</ArticleId></ArticleIdList></Reference><Reference><Citation>Straatman J, Cuesta MA, de Lange-de Klerk ES, van der Peet DL. Long-term survival after complications following major abdominal surgery. J Gastrointestinal Surg. 2016;20(5):1034&#x2013;1041.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4850172</ArticleId><ArticleId IdType="pubmed">26857591</ArticleId></ArticleIdList></Reference><Reference><Citation>Desborough JP. The stress response to trauma and surgery. Br J Anaesth. 2000;85(1):109&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">10927999</ArticleId></ArticleIdList></Reference><Reference><Citation>Oreskov JO, Burcharth J, Nielsen AF, Ekeloef S, Kleif J, G&#xf6;genur I. Quality of recovery after major emergency abdominal surgery: a prospective observational cohort study. Minerva Chir. 2020;75(2):104&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pubmed">32009335</ArticleId></ArticleIdList></Reference><Reference><Citation>Saunders DI, Murray D, Pichel AC, Varley S, Peden CJ. Variations in mortality after emergency laparotomy: the first report of the UK Emergency Laparotomy Network. Br J Anaesth. 2012;109(3):368&#x2013;375.</Citation><ArticleIdList><ArticleId IdType="pubmed">22728205</ArticleId></ArticleIdList></Reference><Reference><Citation>Tengberg LT, Bay-Nielsen M, Bisgaard T, Cihoric M, Lauritsen ML, Foss NB. Multidisciplinary perioperative protocol in patients undergoing acute high-risk abdominal surgery. Br J Surg. 2017;104(4):463&#x2013;471.</Citation><ArticleIdList><ArticleId IdType="pubmed">28112798</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg (London, England) 2014;12(12):1495&#x2013;1499.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245&#x2013;1251.</Citation><ArticleIdList><ArticleId IdType="pubmed">7722560</ArticleId></ArticleIdList></Reference><Reference><Citation>Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1360123</ArticleId><ArticleId IdType="pubmed">15273542</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Heung M, Rosenberg AL, Englesbe M, Shanks AM, et al. Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set. Anesthesiology. 2009;110(3):505&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pubmed">19212261</ArticleId></ArticleIdList></Reference><Reference><Citation>Abelha FJ, Botelho M, Fernandes V, Barros H. Determinants of postoperative acute kidney injury. Critical care (London, England) 2009;13(3):R79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2717442</ArticleId><ArticleId IdType="pubmed">19463152</ArticleId></ArticleIdList></Reference><Reference><Citation>Romagnoli S, Ricci Z. Postoperative acute kidney injury. Minerva Anestesiol. 2015;81(6):684&#x2013;696.</Citation><ArticleIdList><ArticleId IdType="pubmed">25057935</ArticleId></ArticleIdList></Reference><Reference><Citation>Park YS, Jun IG, Go Y, Song JG, Hwang GS. Comparison of acute kidney injury between open and laparoscopic pylorus-preserving pancreaticoduodenectomy: Propensity score analysis. PloS one. 2018;13(8):e0202980.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6108515</ArticleId><ArticleId IdType="pubmed">30142190</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun LY, Wijeysundera DN, Tait GA, Beattie WS. Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology. 2015;123(3):515&#x2013;523.</Citation><ArticleIdList><ArticleId IdType="pubmed">26181335</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostermann M, Liu K. Pathophysiology of AKI. Best Pract Res Clin Anaesthesiol. 2017;31(3):305&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pubmed">29248138</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol. 2017;13(11):697&#x2013;711.</Citation><ArticleIdList><ArticleId IdType="pubmed">28869251</ArticleId></ArticleIdList></Reference><Reference><Citation>Alazawi W, Pirmadjid N, Lahiri R, Bhattacharya S. Inflammatory and immune responses to surgery and their clinical impact. Ann Surg. 2016;264(1):73&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">27275778</ArticleId></ArticleIdList></Reference><Reference><Citation>Finnerty CC, Mabvuure NT, Ali A, Kozar RA, Herndon DN. The surgically induced stress response. JPEN J Parenter Enteral Nutr. 2013;37(5 Suppl):21s&#x2013;s29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3920901</ArticleId><ArticleId IdType="pubmed">24009246</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuki K, Murakami N. Sepsis pathophysiology and anesthetic consideration. Cardiovasc Hematol Disord: Drug Targets. 2015;15(1):57&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4704087</ArticleId><ArticleId IdType="pubmed">25567335</ArticleId></ArticleIdList></Reference><Reference><Citation>Pironi L. Definitions of intestinal failure and the short bowel syndrome. Best Pract Res Clin Gastroenterol. 2016;30(2):173&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">27086884</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller TE, Pearse RM. Perioperative fluid management: moving toward more answers than questions-a commentary on the RELIEF study. Perioperative Med (London, England) 2019;8:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6628482</ArticleId><ArticleId IdType="pubmed">31338159</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles PS, Bellomo R, Corcoran T, Forbes A, Peyton P, Story D, et al. Restrictive versus Liberal Fluid Therapy for Major Abdominal Surgery. N Engl J Med. 2018;378(24):2263&#x2013;2274.</Citation><ArticleIdList><ArticleId IdType="pubmed">29742967</ArticleId></ArticleIdList></Reference><Reference><Citation>Egal M, Erler NS, de Geus HR, van Bommel J, Groeneveld AB. Targeting oliguria reversal in goal-directed hemodynamic management does not reduce renal dysfunction in perioperative and critically ill patients: a systematic review and meta-analysis. Anesth Analg. 2016;122(1):173&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">26505575</ArticleId></ArticleIdList></Reference><Reference><Citation>Giglio M, Dalfino L, Puntillo F, Brienza N. Hemodynamic goal-directed therapy and postoperative kidney injury: an updated meta-analysis with trial sequential analysis. Crit Care (London, England) 2019;23(1):232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6593609</ArticleId><ArticleId IdType="pubmed">31242941</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Lefrant JY, Guinot PG, Godet T, Lorne E, Cuvillon P, et al. Effect of individualized vs standard blood pressure management strategies on postoperative organ dysfunction among high-risk patients undergoing major surgery: a randomized clinical trial. JAMA. 2017;318(14):1346&#x2013;1357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5710560</ArticleId><ArticleId IdType="pubmed">28973220</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson C, Ruchi R, Bihorac A. Perioperative acute kidney injury: risk factors and predictive strategies. Crit Care Clin. 2017;33(2):379&#x2013;396.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5617733</ArticleId><ArticleId IdType="pubmed">28284301</ArticleId></ArticleIdList></Reference><Reference><Citation>Gameiro J, Neves JB, Rodrigues N, Bekerman C, Melo MJ, Pereira M, et al. Acute kidney injury, long-term renal function and mortality in patients undergoing major abdominal surgery: a cohort analysis. Clin Kidney J. 2016;9(2):192&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4792619</ArticleId><ArticleId IdType="pubmed">26985368</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasparini A, Evans M, Coresh J, Grams ME, Norin O, Qureshi AR, et al. Prevalence and recognition of chronic kidney disease in Stockholm healthcare. Nephrol Dial Transplant. 2016;31(12):2086&#x2013;2094.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5146708</ArticleId><ArticleId IdType="pubmed">27738231</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirst JA, Hill N, O'Callaghan CA, Lasserson D, McManus RJ, Ogburn E, et al. Prevalence of chronic kidney disease in the community using data from OxRen: a UK population-based cohort study. Br J Gen Pract. 2020;70(693):e285&#x2013;e293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7015167</ArticleId><ArticleId IdType="pubmed">32041766</ArticleId></ArticleIdList></Reference><Reference><Citation>Zdrojewski L, Zdrojewski T, Rutkowski M, Bandosz P, Krol E, Wyrzykowski B, et al. Prevalence of chronic kidney disease in a representative sample of the Polish population: results of the NATPOL 2011 survey. Nephrol Dial Transplant. 2016;31(3):433&#x2013;439.</Citation><ArticleIdList><ArticleId IdType="pubmed">26560810</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32828488</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>28</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>126</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Pharmacological interventions for the prevention of renal injury in surgical patients: a systematic literature review and meta-analysis.</ArticleTitle><Pagination><StartPage>131</StartPage><EndPage>138</EndPage><MedlinePgn>131-138</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2020.06.064</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(20)30567-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">The aim of this systematic review was to summarise the results of randomised controlled trials (RCTs) that have evaluated pharmacological interventions for renoprotection in people undergoing surgery.</AbstractText><AbstractText Label="METHODS">Searches were conducted to update a previous review using the Cochrane Central Register of Controlled Trials, MEDLINE, and EMBASE to August 23, 2019. RCTs evaluating the use of pharmacological interventions for renal protection in the perioperative period were included. The co-primary outcome measures were 30-day mortality and acute kidney injury (AKI). Pooled effect estimates were expressed as risk ratios (RRs) (95% confidence intervals).</AbstractText><AbstractText Label="RESULTS">We included 228 trials enrolling 56 047 patients. Twenty-three trials were considered to be at low risk of bias across all domains. Atrial natriuretic peptides (14 trials; n=2207) reduced 30-day mortality (RR: 0.63 [0.41, 0.97]) and AKI events (RR: 0.43 [0.33, 0.56]) without heterogeneity. These effects were consistent across cardiac surgery and vascular surgery subgroups, and in sensitivity analyses restricted to studies at low risk of bias. Inodilators (13 trials; n=2941) reduced mortality (RR: 0.71 [0.53, 0.94]) and AKI events (RR: 0.65 [0.50, 0.85]) in the primary analysis and in cardiac surgery cohorts. Vasopressors (4 trials; n=1047) reduced AKI (RR: 0.56 [0.36, 0.86]). Nitric oxide donors, alpha-2-agonists, and calcium channel blockers reduced AKI in primary analyses, but not after exclusion of studies at risk of bias. Overall, assessment of the certainty of the effect estimates was low.</AbstractText><AbstractText Label="CONCLUSIONS">There are multiple effective pharmacological renoprotective interventions for people undergoing surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pathak</LastName><ForeName>Suraj</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, National Institute for Health Research Leicester Biomedical Research Unit in Cardiovascular Medicine, University of Leicester, Leicester, UK. Electronic address: sp633@le.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olivieri</LastName><ForeName>Guido</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, National Institute for Health Research Leicester Biomedical Research Unit in Cardiovascular Medicine, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohamed</LastName><ForeName>Walid</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, National Institute for Health Research Leicester Biomedical Research Unit in Cardiovascular Medicine, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbasciano</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, National Institute for Health Research Leicester Biomedical Research Unit in Cardiovascular Medicine, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roman</LastName><ForeName>Marius</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, National Institute for Health Research Leicester Biomedical Research Unit in Cardiovascular Medicine, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomassini</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, National Institute for Health Research Leicester Biomedical Research Unit in Cardiovascular Medicine, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Florence</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, National Institute for Health Research Leicester Biomedical Research Unit in Cardiovascular Medicine, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wozniak</LastName><ForeName>Marcin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, National Institute for Health Research Leicester Biomedical Research Unit in Cardiovascular Medicine, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Gavin J</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, National Institute for Health Research Leicester Biomedical Research Unit in Cardiovascular Medicine, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RG/13/6/29947</GrantID><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058647">Adrenergic alpha-2 Receptor Agonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002121">Calcium Channel Blockers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020030">Nitric Oxide Donors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>85637-73-6</RegistryNumber><NameOfSubstance UI="D009320">Atrial Natriuretic Factor</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058647" MajorTopicYN="N">Adrenergic alpha-2 Receptor Agonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009320" MajorTopicYN="N">Atrial Natriuretic Factor</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002121" MajorTopicYN="N">Calcium Channel Blockers</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020030" MajorTopicYN="N">Nitric Oxide Donors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="N">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">clinical outcome</Keyword><Keyword MajorTopicYN="N">kidney injury</Keyword><Keyword MajorTopicYN="N">pharmacological interventions</Keyword><Keyword MajorTopicYN="N">renal protection</Keyword><Keyword MajorTopicYN="N">surgery</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>8</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32828488</ArticleId><ArticleId IdType="pmc">PMC7844346</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2020.06.064</ArticleId><ArticleId IdType="pii">S0007-0912(20)30567-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zacharias M., Mugawar M., Herbison G.P. Interventions for protecting renal function in the perioperative period. Cochrane Database Syst Rev. 2013;2013:CD003590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7154582</ArticleId><ArticleId IdType="pubmed">24027097</ArticleId></ArticleIdList></Reference><Reference><Citation>Adabag A.S., Ishani A., Bloomfield H.E., Ngo A.K., Wilt T.J. Efficacy of N-acetylcysteine in preventing renal injury after heart surgery: a systematic review of randomized trials. Eur Heart J. 2009;30:1910&#x2013;1917.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2719697</ArticleId><ArticleId IdType="pubmed">19282300</ArticleId></ArticleIdList></Reference><Reference><Citation>Ring A., Morris T., Wozniak M. A&#xa0;phase I study to determine the pharmacokinetic profile, safety and tolerability of sildenafil (Revatio&#xae;) in cardiac surgery: the REVAKI-1 study. Br J Clin Pharmacol. 2017;83:709&#x2013;720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5346869</ArticleId><ArticleId IdType="pubmed">27779776</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease: Improving Global Outcomes KDIGO clinical practice guideline for acute kidney injury. Kidney Int Supple. 2012;2:23&#x2013;24.</Citation></Reference><Reference><Citation>Patel N.N., Rogers C.A., Angelini G.D., Murphy G.J. Pharmacological therapies for the prevention of acute kidney injury following cardiac surgery: a systematic review. Heart Fail Rev. 2011;16:553&#x2013;567.</Citation><ArticleIdList><ArticleId IdType="pubmed">21400231</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J., Green Se.  The Cochrane Collaboration; 2011. Cochrane Handbook for systematic reviews of interventions.https://handbook-5-1.cochrane.org/ Version 5.1.0 (updated March 2011)</Citation></Reference><Reference><Citation>Suraj P., Roman M., Abbasciano R., Murphy G.  2019. Interventions for the prevention of renal injury in surgical patients. A systematic literature review and meta-analysis. PROSPERO 2018 CRD42018115851. PROSPERO: international prospective register of systematic reviews.https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=115851</Citation></Reference><Reference><Citation>Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting Items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P.T., Thomas J., Chandler J. Cochrane Handbook for systematic reviews of interventions. www.training.cochrane.org/handbook Version 6.0 (updated July 2019). Available from:</Citation></Reference><Reference><Citation>Guyatt G.H., Oxman A.D., Kunz R. Going from evidence to recommendations. BMJ. 2008;336:1049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2376019</ArticleId><ArticleId IdType="pubmed">18467413</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt G.H., Oxman A.D., Vist G.E. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei C., Berra L., Rezoagli E. Nitric oxide decreases acute kidney injury and stage 3 chronic kidney disease after cardiac surgery. Am J Respir Crit Care Med. 2018;198:1279&#x2013;1287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6290943</ArticleId><ArticleId IdType="pubmed">29932345</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39243815</PMID><DateCompleted><Year>2024</Year><Month>12</Month><Day>04</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2341-1929</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Revista espanola de anestesiologia y reanimacion</Title><ISOAbbreviation>Rev Esp Anestesiol Reanim (Engl Ed)</ISOAbbreviation></Journal><ArticleTitle>Intraoperative goal-directed hemodynamic therapy through fluid administration to optimize the stroke volume: A meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>719</StartPage><EndPage>731</EndPage><MedlinePgn>719-731</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.redare.2024.09.004</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2341-1929(24)00128-8</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To evaluate the clinical impact of optimizing stroke volume (SV) through fluid administration as part of goal-directed hemodynamic therapy (GDHT) in adult patients undergoing elective major abdominal surgery.</AbstractText><AbstractText Label="METHODS">This systematic review and meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement and was registered in the PROSPERO database in January 2024. The intervention was defined as intraoperative GDHT based on the optimization or maximization of SV through fluid challenges, or by using dynamic indices of fluid responsiveness, including stroke volume variation, pulse pressure variation, and plethysmography variation index compared to usual fluid management. The primary outcome was postoperative complications. Secondary outcome variables included postoperative acute kidney injury (AKI), length of stay (LOS), intraoperative fluid administration, and 30-day mortality.</AbstractText><AbstractText Label="RESULTS">A total of 29 randomized controlled trials (RCTs) met the inclusion criteria. There were no significant differences in the incidence of postoperative complications (RR 0.89; 95% CI, 0.78-1.00), postoperative AKI (OR 0.97; (95% IC, 0.55-1.70), and mortality (OR 0.80; 95% CI, 0.50-1.29). GDHT was associated with a reduced LOS compared to usual care (SMD: -0.17 [-0.32; -0.03]). The subgroup in which hydroxyethyl starch was used for hemodynamic optimization was associated with fewer complications (RR 0.79; 95% CI, 0.65-0.94), whereas the subgroup of patients in whom crystalloids were used was associated with an increased risk of postoperative complications (RR 1.08; 95% CI, 1.04-1.12).</AbstractText><AbstractText Label="CONCLUSIONS">In adults undergoing major surgery, goal-directed hemodynamic therapy focused on fluid-based stroke volume optimization did not reduce postoperative morbidity and mortality.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Sociedad Espa&#xf1;ola de Anestesiolog&#xed;a, Reanimaci&#xf3;n y Terap&#xe9;utica del Dolor. Publicado por Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ripoll&#xe9;s-Melchor</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Infanta Leonor University Hospital, Madrid, Spain; Universidad Complutense de Madrid, Madrid, Spain; Fluid Therapy and Hemodynamic Monitoring Group of the Spanish Society of Anesthesiology and Critical Care, Madrid, Spain. Electronic address: ripo542@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Espinosa</LastName><ForeName>&#xc1; V</ForeName><Initials>&#xc1;V</Initials><AffiliationInfo><Affiliation>Fluid Therapy and Hemodynamic Monitoring Group of the Spanish Society of Anesthesiology and Critical Care, Madrid, Spain; Department of Anesthesia, Mohammed Bin Khalifa Cardiac Centre, Awali, Bahrain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Valdes-Bango</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Infanta Leonor University Hospital, Madrid, Spain; Universidad Complutense de Madrid, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navarro-P&#xe9;rez</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Universidad Complutense de Madrid, Madrid, Spain; Fluid Therapy and Hemodynamic Monitoring Group of the Spanish Society of Anesthesiology and Critical Care, Madrid, Spain; Department of Anesthesia, Cl&#xed;nico San Carlos University Hospital, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abad-Motos</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Donostia University Hospital, San Sebasti&#xe1;n, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorente</LastName><ForeName>J V</ForeName><Initials>JV</Initials><AffiliationInfo><Affiliation>Fluid Therapy and Hemodynamic Monitoring Group of the Spanish Society of Anesthesiology and Critical Care, Madrid, Spain; Department of Anesthesia, Juan Ram&#xf3;n Jim&#xe9;nez University Hospital, Huelva, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colomina</LastName><ForeName>M J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Fluid Therapy and Hemodynamic Monitoring Group of the Spanish Society of Anesthesiology and Critical Care, Madrid, Spain; Department of Anesthesia, Bellvitge University Hospital, Barcelona, Spain; Barcelona University, Barcelona, Spain; Bellvitge Biomedical Reseach-IDIBELL-Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;ez-Ruiz</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Infanta Leonor University Hospital, Madrid, Spain; Universidad Complutense de Madrid, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abad-Gurumeta</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Infanta Leonor University Hospital, Madrid, Spain; Universidad Complutense de Madrid, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monge-Garc&#xed;a</LastName><ForeName>M I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Fluid Therapy and Hemodynamic Monitoring Group of the Spanish Society of Anesthesiology and Critical Care, Madrid, Spain; Department of Critical Care, Jerez de la Frontera University Hospital, Jerez de la Frontera, C&#xe1;diz, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Esp Anestesiol Reanim (Engl Ed)</MedlineTA><NlmUniqueID>101778594</NlmUniqueID><ISSNLinking>2341-1929</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006895">Hydroxyethyl Starch Derivatives</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="Y">Fluid Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="Y">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="Y">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="Y">Intraoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="Y">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="N">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006895" MajorTopicYN="N">Hydroxyethyl Starch Derivatives</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Complicaciones postoperatorias/epidemiolog&#xed;a</Keyword><Keyword MajorTopicYN="N">Fluid therapy/methods*</Keyword><Keyword MajorTopicYN="N">Fluid therapy/statistics &amp; numerical data</Keyword><Keyword MajorTopicYN="N">Fluidoterapia/estad&#xed;stica y datos num&#xe9;ricos</Keyword><Keyword MajorTopicYN="N">Fluidoterapia/m&#xe9;todos*</Keyword><Keyword MajorTopicYN="N">Hemodin&#xe1;mica/fisiolog&#xed;a</Keyword><Keyword MajorTopicYN="N">Hemodynamics/physiology</Keyword><Keyword MajorTopicYN="N">Postoperative complications/epidemiology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>5</Day><Hour>5</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>8</Day><Hour>13</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>7</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39243815</ArticleId><ArticleId IdType="doi">10.1016/j.redare.2024.09.004</ArticleId><ArticleId IdType="pii">S2341-1929(24)00128-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27034948</PMID><DateCompleted><Year>2016</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2314-6141</ISSN><JournalIssue CitedMedium="Internet"><Volume>2016</Volume><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>BioMed research international</Title><ISOAbbreviation>Biomed Res Int</ISOAbbreviation></Journal><ArticleTitle>Rhabdomyolysis following Cardiac Surgery: A Prospective, Descriptive, Single-Center Study.</ArticleTitle><Pagination><StartPage>7497936</StartPage><MedlinePgn>7497936</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">7497936</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2016/7497936</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Rhabdomyolysis (RML) following cardiac surgery and its relationship with acute kidney injury (AKI) require investigation.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">All patients undergoing cardiac surgery in our hospital were enrolled in this prospective study during a 1-year period. To investigate the occurrence of RML and its association with AKI, all patients in the study underwent serial assessment of serum creatine kinase (CK) and myoglobin levels. Serial renal function, prior statin treatment, and outcome variables were recorded.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 201 patients were included in the study: 185 men and 16 women with a mean age of 52.0 &#xb1; 12.4 years. According to the presence of RML (CK of &#x2265;2,500&#x2009;U/L), the patients were divided into Group I (RML present in 17 patients) and Group II (RML absent in 184 patients). Seven patients in Group I had AKI (41%) where 34 patients in group II had AKI (18.4%), P = 0.025. We observed a significantly longer duration of ventilation, length of stay in the ICU, and hospitalization in Group I (P &lt; 0.001 for all observations).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">An early elevation of serum CK above 2500&#x2009;U/L postoperatively in high-risk cardiac surgery could be used to diagnose RML that may predict the concomitance of early AKI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Omar</LastName><ForeName>Amr S</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0001-8560-2745</Identifier><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery/Cardiac Anaesthesia &amp; ICU Section, Heart Hospital, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar; Department of Critical Care Medicine, Beni-Suef University, P.O. Box 62511, Beni-Suef, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ewila</LastName><ForeName>Hesham</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery/Cardiac Anaesthesia &amp; ICU Section, Heart Hospital, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar; Department of Anesthesia, Suez Canal University, P.O. Box 351-41511, Ismailia, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aboulnaga</LastName><ForeName>Sameh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery/Cardiac Anaesthesia &amp; ICU Section, Heart Hospital, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar; Department of Anesthesia, Ain Shams University, Kasr-El-Zaafaran, P.O. Box 11566, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tuli</LastName><ForeName>Alejandro Kohn</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery/Cardiac Anaesthesia &amp; ICU Section, Heart Hospital, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Rajvir</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology Research Centre, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>02</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biomed Res Int</MedlineTA><NlmUniqueID>101600173</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009211">Myoglobin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.3.2</RegistryNumber><NameOfSubstance UI="D003402">Creatine Kinase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003402" MajorTopicYN="N">Creatine Kinase</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009211" MajorTopicYN="N">Myoglobin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012206" MajorTopicYN="N">Rhabdomyolysis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>2</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27034948</ArticleId><ArticleId IdType="pmc">PMC4789372</ArticleId><ArticleId IdType="doi">10.1155/2016/7497936</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lane R., Phillips M. Rhabdomyolysis. The British Medical Journal. 2003;327(7407):115&#x2013;116. doi: 10.1136/bmj.327.7407.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7407.115</ArticleId><ArticleId IdType="pmc">PMC1126495</ArticleId><ArticleId IdType="pubmed">12869426</ArticleId></ArticleIdList></Reference><Reference><Citation>Bywaters E. G., Beall D. Crush injuries with impairment of renal function. British Medical Journal. 1941;1, article 427 doi: 10.1136/bmj.1.4185.427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.1.4185.427</ArticleId><ArticleId IdType="pmc">PMC2161734</ArticleId><ArticleId IdType="pubmed">20783577</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren J. D., Blumbergs P. C., Thompson P. D. Rhabdomyolysis: a review. Muscle and Nerve. 2002;25(3):332&#x2013;347. doi: 10.1002/mus.10053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10053</ArticleId><ArticleId IdType="pubmed">11870710</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccario M., Fumagalli C., Dottori V., et al. Rhabdomyolytic acute renal failure in cardiac surgery. A clinical case. Minerva Anestesiologica. 1995;61(9):397&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pubmed">8919837</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudarsanan S., Omar A. S., Pattath R. A., Al Mulla A. Acute kidney injury associated with rhabdomyolysis after coronary artery bypass graft: a case report and review of the literatures. BMC Research Notes. 2014;7(1, article 152) doi: 10.1186/1756-0500-7-152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-0500-7-152</ArticleId><ArticleId IdType="pmc">PMC3984756</ArticleId><ArticleId IdType="pubmed">24636137</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetto U., Angeloni E., Luciani R., et al. Acute kidney injury after coronary artery bypass grafting: does rhabdomyolysis play a role? Journal of Thoracic and Cardiovascular Surgery. 2010;140(2):464&#x2013;470. doi: 10.1016/j.jtcvs.2010.03.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2010.03.028</ArticleId><ArticleId IdType="pubmed">20416892</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofmann D., Buettner M., Rissner F., Wahl M., Sakka S. G. Prognostic value of serum myoglobin in patients after cardiac surgery. Journal of Anesthesia. 2007;21(3):304&#x2013;310. doi: 10.1007/s00540-007-0507-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-007-0507-0</ArticleId><ArticleId IdType="pubmed">17680179</ArticleId></ArticleIdList></Reference><Reference><Citation>Huerta-Alard&#xed;n A. L., Varon J., Marik P. E. Bench-to-bedside review: rhabdomyolysis&#x2014;an overview for clinicians. Critical Care. 2005;9(2):158&#x2013;169. doi: 10.1186/cc2978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc2978</ArticleId><ArticleId IdType="pmc">PMC1175909</ArticleId><ArticleId IdType="pubmed">15774072</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagandr&#xe9; S., Arnalsteen L., Vallet B., et al. Predictive factors for rhabdomyolysis after bariatric surgery. Obesity Surgery. 2006;16(10):1365&#x2013;1370. doi: 10.1381/096089206778663643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1381/096089206778663643</ArticleId><ArticleId IdType="pubmed">17059748</ArticleId></ArticleIdList></Reference><Reference><Citation>Minnema B. J., Neligan P. C., Quraishi N. A., Fehlings M. G., Prakash S. A case of occult compartment syndrome and nonresolving rhabdomyolysis. Journal of General Internal Medicine. 2008;23(6):871&#x2013;874. doi: 10.1007/s11606-008-0569-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-008-0569-1</ArticleId><ArticleId IdType="pmc">PMC2517868</ArticleId><ArticleId IdType="pubmed">18350340</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajjar L., Grande S., Galas F., Roquim A., Sampaio L., Auler J. Risk factors and outcome of rhabdomyolysis after cardiac surgery. Critical Care. 2008;12(supplement 2):p. P470. doi: 10.1186/cc6691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc6691</ArticleId></ArticleIdList></Reference><Reference><Citation>Mognol P., Vignes S., Chosidow D., Marmuse J.-P. Rhabdomyolysis after laparoscopic bariatric surgery. Obesity Surgery. 2004;14(1):91&#x2013;94. doi: 10.1381/096089204772787356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1381/096089204772787356</ArticleId><ArticleId IdType="pubmed">14980040</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta R. L., Kellum J. A., Shah S. V., et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Critical Care. 2007;11(2, article R31) doi: 10.1186/cc5713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc5713</ArticleId><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Capote K., Balion C. M., Hill S. A., Cleve R., Yang L., Sharif A. E. Utility of urine myoglobin for the prediction of acute renal failure in patients with suspected rhabdomyolysis: a systematic review. Clinical Chemistry. 2009;55(12):2190&#x2013;2197. doi: 10.1373/clinchem.2009.128546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2009.128546</ArticleId><ArticleId IdType="pubmed">19797717</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagele P., Brown F., Gage B. F., et al. High-sensitivity cardiac troponin T in prediction and diagnosis of myocardial infarction and long-term mortality after noncardiac surgery. American Heart Journal. 2013;166(2):325.e1&#x2013;332.e1. doi: 10.1016/j.ahj.2013.04.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2013.04.018</ArticleId><ArticleId IdType="pmc">PMC3728677</ArticleId><ArticleId IdType="pubmed">23895816</ArticleId></ArticleIdList></Reference><Reference><Citation>Nashef S. A. M., Roques F., Michel P., Gauducheau E., Lemeshow S., Salamon R. European system for cardiac operative risk evaluation (EuroSCORE) European Journal of Cardio-thoracic Surgery. 1999;16(1):9&#x2013;13. doi: 10.1016/S1010-7940(99)00134-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1010-7940(99)00134-7</ArticleId><ArticleId IdType="pubmed">10456395</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiret L., Hatton F., Desmonts J. M., Vourc'h G. Prediction of outcome of anaesthesia in patients over 40 years: a multifactorial risk index. Statistics in Medicine. 1988;7(9):947&#x2013;954. doi: 10.1002/sim.4780070906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.4780070906</ArticleId><ArticleId IdType="pubmed">3175394</ArticleId></ArticleIdList></Reference><Reference><Citation>Black H. R., Quallich H., Gareleck C. B. Racial differences in serum creatine kinase levels. The American Journal of Medicine. 1986;81(3):479&#x2013;487. doi: 10.1016/0002-9343(86)90303-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(86)90303-7</ArticleId><ArticleId IdType="pubmed">3752149</ArticleId></ArticleIdList></Reference><Reference><Citation>Alterman I., Sidi A., Azamfirei L., Copotoiu S., Ezri T. Rhabdomyolysis: another complication after prolonged surgery. Journal of Clinical Anesthesia. 2007;19(1):64&#x2013;66. doi: 10.1016/j.jclinane.2006.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2006.06.002</ArticleId><ArticleId IdType="pubmed">17321931</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccario M., Fumagalli C., Dottori V., et al. The association between rhabdomyolysis and acute renal failure in patients undergoing cardiopulmonary bypass. Journal of Cardiovascular Surgery. 1996;37(2):153&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pubmed">8675522</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanardo G., Michielon P., Paccagnella A., et al. Acute renal failure in the patient undergoing cardiac operation: prevalence, mortality rate, and main risk factors. Journal of Thoracic and Cardiovascular Surgery. 1994;107(6):1489&#x2013;1495.</Citation><ArticleIdList><ArticleId IdType="pubmed">8196394</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangos G. J., Horton D., Brown M. A., Trew P., Chan W. Y. L., Whitworth J. A. Acute renal failure following cardiac surgery: incidence, outcomes and risk factors. Australian and New Zealand Journal of Medicine. 1995;25(4):284&#x2013;289. doi: 10.1111/j.1445-5994.1995.tb01891.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1445-5994.1995.tb01891.x</ArticleId><ArticleId IdType="pubmed">8540867</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberg M., Stecker J. F., Jr., Scarff J. E., Jr., Wombolt D. G. Rhabdomyolysis associated with urethral stricture repair: report of a case. Journal of Urology. 1980;124(5):730&#x2013;731.</Citation><ArticleIdList><ArticleId IdType="pubmed">7452806</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimmo G. R., Stewart S. M., English P. J. Myoglobinuric acute renal failure associated with major urological surgery&#x2014;an avoidable problem? Intensive Care Medicine. 1988;14(3):244&#x2013;245. doi: 10.1007/bf00718000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/bf00718000</ArticleId><ArticleId IdType="pubmed">3379187</ArticleId></ArticleIdList></Reference><Reference><Citation>de Menezes Ettinger J. E. M. T., Dos Santos Filho P. V., Azaro E., Bastos Melo C. A., Fahel E., Pena Batista P. B. Prevention of rhabdomyolysis in bariatric surgery. Obesity Surgery. 2005;15(6):874&#x2013;879. doi: 10.1381/0960892054222669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1381/0960892054222669</ArticleId><ArticleId IdType="pubmed">15978162</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilhelmi M., Winterhalter M., Fischer S., et al. Massive postoperative rhabdomyolysis following combined CABG/abdominal aortic replacement: a possible association with HMG-CoA reductase inhibitors. Cardiovascular Drugs and Therapy. 2002;16(5):471&#x2013;475. doi: 10.1023/a:1022198705168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/a:1022198705168</ArticleId><ArticleId IdType="pubmed">12652117</ArticleId></ArticleIdList></Reference><Reference><Citation>Antons K. A., Williams C. D., Baker S. K., Phillips P. S. Clinical perspectives of statin-induced rhabdomyolysis. The American Journal of Medicine. 2006;119(5):400&#x2013;409. doi: 10.1016/j.amjmed.2006.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2006.02.007</ArticleId><ArticleId IdType="pubmed">16651050</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulik A., Ruel M. Statins and coronary artery bypass graft surgery: preoperative and postoperative efficacy and safety. Expert Opinion on Drug Safety. 2009;8(5):559&#x2013;571. doi: 10.1517/14740330903188413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14740330903188413</ArticleId><ArticleId IdType="pubmed">19673591</ArticleId></ArticleIdList></Reference><Reference><Citation>Bray R. J. Propofol infusion syndrome in children. Paediatric Anaesthesia. 1998;8(6):491&#x2013;499. doi: 10.1046/j.1460-9592.1998.00282.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1460-9592.1998.00282.x</ArticleId><ArticleId IdType="pubmed">9836214</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh U., Scheld W. M. Infectious etiologies of rhabdomyolysis: three case reports and review. Clinical Infectious Diseases. 1996;22(4):642&#x2013;649. doi: 10.1093/clinids/22.4.642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/22.4.642</ArticleId><ArticleId IdType="pubmed">8729203</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu R.-B., Ho Y.-L., Chen R. J., Wang S.-S., Lin F.-Y., Chu S.-H. Outcome of medical and surgical treatment in patients with acute type B aortic dissection. Annals of Thoracic Surgery. 2005;79(3):790&#x2013;794. doi: 10.1016/j.athoracsur.2004.07.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2004.07.061</ArticleId><ArticleId IdType="pubmed">15734378</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon P. J., Stafford-Smith M., White W. D., et al. Acute renal failure following cardiac surgery. Nephrology Dialysis Transplantation. 1999;14(5):1158&#x2013;1162. doi: 10.1093/ndt/14.5.1158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/14.5.1158</ArticleId><ArticleId IdType="pubmed">10344355</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharp L. S., Rozycki G. S., Feliciano D. V. Rhabdomyolysis and secondary renal failure in critically ill surgical patients. American Journal of Surgery. 2004;188(6):801&#x2013;806. doi: 10.1016/j.amjsurg.2004.08.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2004.08.050</ArticleId><ArticleId IdType="pubmed">15619503</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Abdellati E., Eyselbergs M., Sirimsi H., et al. An observational study on rhabdomyolysis in the intensive care unit. Exploring its risk factors and main complication: acute kidney injury. Annals of Intensive Care. 2013;3(1):1&#x2013;8. doi: 10.1186/2110-5820-3-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2110-5820-3-8</ArticleId><ArticleId IdType="pmc">PMC3614462</ArticleId><ArticleId IdType="pubmed">23497406</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurence A. S. Serum myoglobin and creatine kinase following surgery. British Journal of Anaesthesia. 2000;84(6):763&#x2013;766. doi: 10.1093/oxfordjournals.bja.a013590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.bja.a013590</ArticleId><ArticleId IdType="pubmed">10895753</ArticleId></ArticleIdList></Reference><Reference><Citation>Lappalainen H., Tiula E., Uotila L., M&#xe4;ntt&#xe4;ri M. Elimination kinetics of myoglobin and creatine kinase in rhabdomyolysis: implications for follow-up. Critical Care Medicine. 2002;30(10):2212&#x2013;2215. doi: 10.1097/00003246-200210000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200210000-00006</ArticleId><ArticleId IdType="pubmed">12394946</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberry C., Stone F., Kalbfleisch K. Rhabdomyolysis-induced severe hyperkalemia. The Western Journal of Emergency Medicine. 2009;10(4, article 302)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2791742</ArticleId><ArticleId IdType="pubmed">20046258</ArticleId></ArticleIdList></Reference><Reference><Citation>Omar A. S., Abouelnagah G. Successful prevention of rhabdomyolysis (RML) after bariatric surgery (BS) in intensive care settings. Critical Care &amp; Shock. 2013;16(1):12&#x2013;18.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">28593413</PMID><DateCompleted><Year>2018</Year><Month>10</Month><Day>01</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-2218</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>9</Issue><PubDate><Year>2017</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Surgical endoscopy</Title><ISOAbbreviation>Surg Endosc</ISOAbbreviation></Journal><ArticleTitle>Effect of ulinastatin on postoperative renal function in patients undergoing robot-assisted laparoscopic partial nephrectomy: a randomized trial.</ArticleTitle><Pagination><StartPage>3728</StartPage><EndPage>3736</EndPage><MedlinePgn>3728-3736</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00464-017-5608-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">Robot-assisted laparoscopic partial nephrectomy (RLPN) is an emerging technique for treating small renal masses. Although RLPN has many advantages, ischemic kidney injury is inevitable during renal artery clamping. The overall incidence of acute kidney injury (AKI) after partial nephrectomy has been reported to be up to 39%. Moreover, effective pharmacological protection against AKI after partial nephrectomy has not yet been demonstrated. Ulinastatin has been shown to protect the kidney from ischemia/reperfusion injury via its anti-inflammatory and anti-oxidant activities. Therefore, this study aimed to evaluate the effect of ulinastatin on postoperative kidney function in patients undergoing RLPN.</AbstractText><AbstractText Label="METHODS">In this randomized, double-blinded, placebo-controlled study, patients undergoing RLPN received either intravenous ulinastatin (100,000&#xa0;units/10&#xa0;kg; ulinastatin group, n&#xa0;=&#xa0;35) or the same volume of normal saline (control group, n&#xa0;=&#xa0;35) for 1&#xa0;h starting 10&#xa0;min before renal artery clamping. The primary outcome was incidence of postoperative AKI. Secondary outcomes were levels of serum creatinine, estimated glomerular filtration rate (eGFR), cystatin C, and inflammatory markers and were measured before operation and at 1, 24, 48, and 72&#xa0;h postoperatively.</AbstractText><AbstractText Label="RESULTS">The incidence of postoperative AKI was 18% in the ulinastatin group, whereas it was 30% in the control group (p&#xa0;=&#xa0;0.251). No significant differences in postoperative changes of serum creatinine, eGFR, or cystatin C were observed between the two groups. Postoperative inflammatory markers including C-reactive protein, white blood cell count, and neutrophil percentage were significantly increased until 72&#xa0;h after operation compared to the preoperative values in both groups, with no significant differences between the groups.</AbstractText><AbstractText Label="CONCLUSIONS">Administration of ulinastatin (100,000&#xa0;units/10&#xa0;kg) during the warm ischemia and reperfusion periods did not show any beneficial effects on postoperative kidney function or inflammatory responses in patients undergoing RLPN.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Bora</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sook Young</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, School of Medicine, Ajou University, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Na Young</ForeName><Initials>NY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rha</LastName><ForeName>Koon Ho</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Young Deuk</ForeName><Initials>YD</Initials><AffiliationInfo><Affiliation>Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sujung</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>So Yeon</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea. KIMSY326@yuhs.ac.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea. KIMSY326@yuhs.ac.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Surg Endosc</MedlineTA><NlmUniqueID>8806653</NlmUniqueID><ISSNLinking>0930-2794</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006023">Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>OR3S9IF86U</RegistryNumber><NameOfSubstance UI="C028665">urinastatin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003250" MajorTopicYN="N">Constriction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="N">Glomerular Filtration Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006023" MajorTopicYN="N">Glycoproteins</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007680" MajorTopicYN="N">Kidney Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="Y">Laparoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009392" MajorTopicYN="Y">Nephrectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065287" MajorTopicYN="Y">Robotic Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D052096" MajorTopicYN="N">Warm Ischemia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Nephrectomy</Keyword><Keyword MajorTopicYN="N">Reperfusion injury</Keyword><Keyword MajorTopicYN="N">Robotic surgical procedures</Keyword><Keyword MajorTopicYN="N">Ulinastatin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28593413</ArticleId><ArticleId IdType="doi">10.1007/s00464-017-5608-8</ArticleId><ArticleId IdType="pii">10.1007/s00464-017-5608-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eur Urol. 2016 Apr;69(4):745-52</Citation><ArticleIdList><ArticleId IdType="pubmed">26525838</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 2003 Feb;98 (2):465-73</Citation><ArticleIdList><ArticleId IdType="pubmed">12552207</ArticleId></ArticleIdList></Reference><Reference><Citation>BJU Int. 2011 Sep;108(6 Pt 2):935-41</Citation><ArticleIdList><ArticleId IdType="pubmed">21917094</ArticleId></ArticleIdList></Reference><Reference><Citation>Korean J Anesthesiol. 2012 Feb;62(2):148-53</Citation><ArticleIdList><ArticleId IdType="pubmed">22379570</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood Transfus. 2014 Jan;12 Suppl 1:s109-18</Citation><ArticleIdList><ArticleId IdType="pubmed">23736923</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2000 Apr;69(4):1121-6</Citation><ArticleIdList><ArticleId IdType="pubmed">10800804</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2003 Jul;31(7):1987-92</Citation><ArticleIdList><ArticleId IdType="pubmed">12847393</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Pharmacol Sin. 2004 Oct;25(10 ):1334-40</Citation><ArticleIdList><ArticleId IdType="pubmed">15456536</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 2009 Mar;110(3):505-15</Citation><ArticleIdList><ArticleId IdType="pubmed">19212261</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Urol. 2014 Feb;21(2):200-3</Citation><ArticleIdList><ArticleId IdType="pubmed">23819791</ArticleId></ArticleIdList></Reference><Reference><Citation>J Endourol. 2009 Sep;23(9):1457-60</Citation><ArticleIdList><ArticleId IdType="pubmed">19698038</ArticleId></ArticleIdList></Reference><Reference><Citation>Nephrol Dial Transplant. 2011 Nov;26(11):3496-501</Citation><ArticleIdList><ArticleId IdType="pubmed">21406544</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2009 May 5;150(9):604-12</Citation><ArticleIdList><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>Hepatobiliary Pancreat Dis Int. 2009 Feb;8(1):53-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19208516</ArticleId></ArticleIdList></Reference><Reference><Citation>Transplant Proc. 2008 Mar;40(2):387-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18374077</ArticleId></ArticleIdList></Reference><Reference><Citation>Urology. 2013 Feb;81(2):340-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23374797</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 2007 Dec;107(6):892-902</Citation><ArticleIdList><ArticleId IdType="pubmed">18043057</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Urol. 2013 Dec;64(6):988-93</Citation><ArticleIdList><ArticleId IdType="pubmed">23122834</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Urol. 2016 Feb;23(2):122-31</Citation><ArticleIdList><ArticleId IdType="pubmed">26585191</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurol Res. 2010 Nov;32(9):925-32</Citation><ArticleIdList><ArticleId IdType="pubmed">20223106</ArticleId></ArticleIdList></Reference><Reference><Citation>Urology. 2009 May;73(5):1056-60</Citation><ArticleIdList><ArticleId IdType="pubmed">19394503</ArticleId></ArticleIdList></Reference><Reference><Citation>BJU Int. 2013 Jul;112(1):74-80</Citation><ArticleIdList><ArticleId IdType="pubmed">23452148</ArticleId></ArticleIdList></Reference><Reference><Citation>J Urol. 2009 Sep;182(3):844-53</Citation><ArticleIdList><ArticleId IdType="pubmed">19616235</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Urol. 2012 Sep;19(9):823-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22568789</ArticleId></ArticleIdList></Reference><Reference><Citation>Urology. 2012 Apr;79(4):821-5</Citation><ArticleIdList><ArticleId IdType="pubmed">22469577</ArticleId></ArticleIdList></Reference><Reference><Citation>J Endourol. 2015 Apr;29(4):444-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25203268</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiothorac Vasc Anesth. 2013 Jun;27(3):479-84</Citation><ArticleIdList><ArticleId IdType="pubmed">23545347</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Clin Pract Nephrol. 2007 Aug;3(8):439-42</Citation><ArticleIdList><ArticleId IdType="pubmed">17653122</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxid Med Cell Longev. 2015 ;2015 :624819</Citation><ArticleIdList><ArticleId IdType="pubmed">26161241</ArticleId></ArticleIdList></Reference><Reference><Citation>J Urol. 2010 Apr;183(4):1317-23</Citation><ArticleIdList><ArticleId IdType="pubmed">20171688</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Ther Med. 2015 Feb;9(2):411-416</Citation><ArticleIdList><ArticleId IdType="pubmed">25574207</ArticleId></ArticleIdList></Reference><Reference><Citation>BJU Int. 2016 Mar;117(3):531-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26435486</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Anaesth. 2016 Jan;116(1):70-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26675951</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Surg (Torino). 2007 Aug;48(4):497-503</Citation><ArticleIdList><ArticleId IdType="pubmed">17653011</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2016 Feb 17;20:42</Citation><ArticleIdList><ArticleId IdType="pubmed">26884251</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25212718</PMID><DateCompleted><Year>2015</Year><Month>11</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>5</Issue><PubDate><Year>2014</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Sodium bicarbonate in the prevention of cardiac surgery-associated acute kidney injury: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>517</StartPage><MedlinePgn>517</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">517</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-014-0517-x</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Sodium bicarbonate (SBIC) was reported to be a promising approach to prevent cardiac surgery-associated acute kidney injury (CSA-AKI). However, the results remain controversial. We conducted a systematic review and meta-analysis to evaluate the efficacy and safety of SBIC on the prevention of CSA-AKI in adult patients undergoing cardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed, EMbase, Web of science, EBSCO, and Cochrane library databases were systematically searched. Randomized controlled trials (RCTs) assessing the effect of SBIC versus placebo on the prevention of CSA-AKI in adult patients undergoing cardiac surgery were included. Two investigators independently searched articles, extracted data, and assessed the quality of included studies. The primary outcome was the incidence of CSA-AKI. Meta-analysis was performed using random-effects models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Five RCTs involving 1079 patients were included in the meta-analysis. Overall, compared with placebo, SBIC was not associated with a reduced risk of CSA-AKI (relative risk [RR] 0.99; 95% confidence interval [CI] 0.78 to 1.24; P&#x2009;=&#x2009;0.911). SBIC failed to alter the clinical outcomes of hospital length of stay (weighted mean difference [WMD] 0.23 days; 95%CI -0.88 to 1.33 days; P&#x2009;=&#x2009;0.688), renal replacement therapy (RR 0.94; 95%CI 0.49 to 1.82; P&#x2009;=&#x2009;0.861), hospital mortality (RR 1.37; 95%CI 0.46 to 4.13; P&#x2009;=&#x2009;0.572), postoperative atrial fibrillation (RR 1.02; 95%CI 0.65 to 1.61; P&#x2009;=&#x2009;0.915). However, SBIC was associated with significant increased risks in longer duration of ventilation (WMD 0.64 hours; 95%CI 0.16 to 1.11 hours; P&#x2009;=&#x2009;0.008), longer ICU length of stay (WMD 2.06 days; 95%CI 0.54 to 3.58 days; P&#x2009;=&#x2009;0.008), and increased incidence of alkalemia (RR 2.21; 95%CI 1.42 to 3.42; P &lt;0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">SBIC could not reduce the incidence of CSA-AKI. Contrarily, SBIC prolongs the duration of ventilation and ICU length of stay, and increases the risk of alkalemia. Thus, SBIC should not be recommended for the prevention of CSA-AKI and perioperative SBIC infusion should be administrated with caution.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tie</LastName><ForeName>Hong-Tao</ForeName><Initials>HT</Initials></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Ming-Zhu</ForeName><Initials>MZ</Initials></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Ming-Jing</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Min</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Qing-Chen</ForeName><Initials>QC</Initials></Author><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>Jing-Yuan</ForeName><Initials>JY</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>8MDF5V39QO</RegistryNumber><NameOfSubstance UI="D017693">Sodium Bicarbonate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care. 2014 Nov 27;18(6):672. doi: 10.1186/s13054-014-0672-0.</RefSource><PMID Version="1">25672967</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017693" MajorTopicYN="N">Sodium Bicarbonate</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>9</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25212718</ArticleId><ArticleId IdType="pmc">PMC4177432</ArticleId><ArticleId IdType="doi">10.1186/s13054-014-0517-x</ArticleId><ArticleId IdType="pii">s13054-014-0517-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mao H, Katz N, Ariyanon W, Blanca-Martos L, Adybelli Z, Giuliani A, Danesi TH, Kim JC, Nayak A, Neri M, Virzi GM, Brocca A, Scalzotto E, Salvador L, Ronco C. Cardiac surgery-associated acute kidney injury. Cardiorenal Med. 2013;3:178&#x2013;199. doi: 10.1159/000353134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000353134</ArticleId><ArticleId IdType="pmc">PMC3884176</ArticleId><ArticleId IdType="pubmed">24454314</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Duca D, Alam A, Tangri N, Albert C, Goldberg P, Iqbal S, de Varennes B. Preventing Acute Renal Failure after Cardiac Surgery in High Risk Patients using Sodium Bicarbonate Therapy (PARACHUTE): interim analysis of a double-blind randomized controlled study [abstract] Circulation. 2010;122</Citation></Reference><Reference><Citation>Haase M, Haase-Fielitz A, Bellomo R, Devarajan P, Story D, Matalanis G, Reade MC, Bagshaw SM, Seevanayagam N, Seevanayagam S, Doolan L, Buxton B, Dragun D. Sodium bicarbonate to prevent increases in serum creatinine after cardiac surgery: a pilot double-blind, randomized controlled trial. Crit Care Med. 2009;37:39&#x2013;47. doi: 10.1097/CCM.0b013e318193216f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318193216f</ArticleId><ArticleId IdType="pubmed">19112278</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase M, Haase-Fielitz A, Plass M, Kuppe H, Hetzer R, Hannon C, Murray PT, Bailey MJ, Bellomo R, Bagshaw SM. Prophylactic perioperative sodium bicarbonate to prevent acute kidney injury following open heart surgery: a multicenter double-blinded randomized controlled trial. PLoS Med. 2013;10:e1001426. doi: 10.1371/journal.pmed.1001426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001426</ArticleId><ArticleId IdType="pmc">PMC3627643</ArticleId><ArticleId IdType="pubmed">23610561</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristeller JL, Zavorsky GS, Prior JE, Keating DA, Brady MA, Romaldini TA, Hickman TL, Stahl RF. Lack of effectiveness of sodium bicarbonate in preventing kidney injury in patients undergoing cardiac surgery: a randomized controlled trial. Pharmacotherapy. 2013;33:710&#x2013;717. doi: 10.1002/phar.1262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/phar.1262</ArticleId><ArticleId IdType="pubmed">23553549</ArticleId></ArticleIdList></Reference><Reference><Citation>McGuinness SP, Parke RL, Bellomo R, Van Haren FMP, Bailey M. Sodium bicarbonate infusion to reduce cardiac surgery-associated acute kidney injury: a phase II multicenter double-blind randomized controlled trial. Crit Care Med. 2013;41:1599&#x2013;1607. doi: 10.1097/CCM.0b013e31828a3f99.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31828a3f99</ArticleId><ArticleId IdType="pubmed">23685640</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Auriemma S, Fabbri A, D&#x2019;Onofrio A, Katz N, McCullough PA, Ricci Z, Shaw A, Ronco C. The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI) Int J Artif Organs. 2008;31:166&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pubmed">18311733</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon PJ, Stafford-Smith M, White WD, Newman MF, King S, Winn MP, Landolfo K. Acute renal failure following cardiac surgery. Nephrol Dial Transplant. 1999;14:1158&#x2013;1162. doi: 10.1093/ndt/14.5.1158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/14.5.1158</ArticleId><ArticleId IdType="pubmed">10344355</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasta JF, Kane-Gill SL, Durtschi AJ, Pathak DS, Kellum JA. Costs and outcomes of acute kidney injury (AKI) following cardiac surgery. Nephrol Dial Transplant. 2008;23:1970&#x2013;1974. doi: 10.1093/ndt/gfm908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfm908</ArticleId><ArticleId IdType="pubmed">18178605</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen MK, Gammelager H, Mikkelsen MM, Hjortdal VE, Layton JB, Johnsen SP, Christiansen CF. Post-operative acute kidney injury and five-year risk of death, myocardial infarction, and stroke among elective cardiac surgical patients: a cohort study. Crit Care. 2013;17:R292. doi: 10.1186/cc13158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13158</ArticleId><ArticleId IdType="pmc">PMC4057271</ArticleId><ArticleId IdType="pubmed">24330762</ArticleId></ArticleIdList></Reference><Reference><Citation>Karkouti K, Wijeysundera DN, Yau TM, Callum JL, Cheng DC, Crowther M, Dupuis JY, Fremes SE, Kent B, Laflamme C, Lamy A, Legare JF, Mazer CD, McCluskey SA, Rubens FD, Sawchuk C, Beattie WS. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation. 2009;119:495&#x2013;502. doi: 10.1161/CIRCULATIONAHA.108.786913.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.786913</ArticleId><ArticleId IdType="pubmed">19153273</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar AB, Suneja M, Bayman EO, Weide GD, Tarasi M. Association between postoperative acute kidney injury and duration of cardiopulmonary bypass: a meta-analysis. J Cardiothorac Vasc Anesth. 2012;26:64&#x2013;69. doi: 10.1053/j.jvca.2011.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2011.07.007</ArticleId><ArticleId IdType="pubmed">21924633</ArticleId></ArticleIdList></Reference><Reference><Citation>Swaminathan M, Hudson CC, Phillips-Bute BG, Patel UD, Mathew JP, Newman MF, Milano CA, Shaw AD, Stafford-Smith M. Impact of early renal recovery on survival after cardiac surgery-associated acute kidney injury. Ann Thorac Surg. 2010;89:1098&#x2013;1104. doi: 10.1016/j.athoracsur.2009.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2009.12.018</ArticleId><ArticleId IdType="pubmed">20338313</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman MD, Shaefi S, Sladen RN. Preventing acute kidney injury after cardiac surgery. Curr Opin Anaesthesiol. 2011;24:70&#x2013;76. doi: 10.1097/ACO.0b013e3283422ebc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0b013e3283422ebc</ArticleId><ArticleId IdType="pubmed">21157303</ArticleId></ArticleIdList></Reference><Reference><Citation>Stafford-Smith M, Shaw A, Swaminathan M. Cardiac surgery and acute kidney injury: emerging concepts. Curr Opin Crit Care. 2009;15:498&#x2013;502. doi: 10.1097/MCC.0b013e328332f753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCC.0b013e328332f753</ArticleId><ArticleId IdType="pubmed">19812485</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakris GL, Lass N, Gaber AO, Jones JD, Burnett JC., Jr Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol. 1990;258:F115&#x2013;F120.</Citation><ArticleIdList><ArticleId IdType="pubmed">2301588</ArticleId></ArticleIdList></Reference><Reference><Citation>Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 1990;186:1&#x2013;85. doi: 10.1016/0076-6879(90)86093-B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0076-6879(90)86093-B</ArticleId><ArticleId IdType="pubmed">2172697</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. doi: 10.1136/bmj.b2535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2535</ArticleId><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Green S: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. Available from www.cochrane-handbook.org</Citation></Reference><Reference><Citation>Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi: 10.1136/bmj.d5928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13. doi: 10.1186/1471-2288-5-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-5-13</ArticleId><ArticleId IdType="pmc">PMC1097734</ArticleId><ArticleId IdType="pubmed">15840177</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557&#x2013;560. doi: 10.1136/bmj.327.7414.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Heringlake M, Heinze H, Schubert M, Nowak Y, Guder J, Kleinebrahm M, Paarmann H, Hanke T, Schon J. A perioperative infusion of sodium bicarbonate does not improve renal function in cardiac surgery patients: a prospective observational cohort study. Crit Care. 2012;16:R156. doi: 10.1186/cc11476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11476</ArticleId><ArticleId IdType="pmc">PMC3580746</ArticleId><ArticleId IdType="pubmed">22898367</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha A, Panagopoulos P, Gupta D, Khoury P, Apostolou D, Al-Baghdadi Y, Safadi L, Patel P, Orlewicz M. Peri-operative sodium bicarbonate infusion (POSBI) in the post-cardiac surgery patient: results of single-institution retrospective study. Crit Care Med. 2011;39:193. doi: 10.1097/CCM.0b013e318202e7d4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318202e7d4</ArticleId><ArticleId IdType="pubmed">21178531</ArticleId></ArticleIdList></Reference><Reference><Citation>Markovic D, Grkovic S, Bradic Z, Mikic A, Tutus V, Putnik S. Sodium bicarbonate in the prevention of AKI in adult cardiac surgical patients with preoperative chronic renal failure. Appl Cardiopulm Pathophysiol. 2012;16:263&#x2013;264.</Citation></Reference><Reference><Citation>Billings FT, 4th, Ball SK, Roberts LJ, 2nd, Pretorius M. Postoperative acute kidney injury is associated with hemoglobinemia and an enhanced oxidative stress response. Free Radic Biol Med. 2011;50:1480&#x2013;1487. doi: 10.1016/j.freeradbiomed.2011.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2011.02.011</ArticleId><ArticleId IdType="pmc">PMC3090463</ArticleId><ArticleId IdType="pubmed">21334433</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1:19&#x2013;32. doi: 10.2215/CJN.00240605.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.00240605</ArticleId><ArticleId IdType="pubmed">17699187</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase M, Haase-Fielitz A, Bagshaw SM, Ronco C, Bellomo R. Cardiopulmonary bypass-associated acute kidney injury: a pigment nephropathy? Contrib Nephrol. 2007;156:340&#x2013;353. doi: 10.1159/000102125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000102125</ArticleId><ArticleId IdType="pubmed">17464145</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34039667</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1533-3450</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of the American Society of Nephrology : JASN</Title><ISOAbbreviation>J Am Soc Nephrol</ISOAbbreviation></Journal><ArticleTitle>Long-Term Kidney Outcomes Following Dialysis-Treated Childhood Acute Kidney Injury: A Population-Based Cohort Study.</ArticleTitle><Pagination><StartPage>2005</StartPage><EndPage>2019</EndPage><MedlinePgn>2005-2019</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1681/ASN.2020111665</ELocationID><Abstract><AbstractText Label="BACKGROUND">AKI is common during pediatric hospitalizations and associated with adverse short-term outcomes. However, long-term outcomes among survivors of pediatric AKI who received dialysis remain uncertain.</AbstractText><AbstractText Label="METHODS">To determine the long-term risk of kidney failure (defined as receipt of chronic dialysis or kidney transplant) or death over a 22-year period for pediatric survivors of dialysis-treated AKI, we used province-wide health administrative databases to perform a retrospective cohort study of all neonates and children (aged 0-18 years) hospitalized in Ontario, Canada, from April 1, 1996, to March 31, 2017, who survived a dialysis-treated AKI episode. Each AKI survivor was matched to four hospitalized pediatric comparators without dialysis-treated AKI, on the basis of age, sex, and admission year. We reported the incidence of each outcome and performed Cox proportional hazards regression analyses, adjusting for relevant covariates.</AbstractText><AbstractText Label="RESULTS">We identified 1688 pediatric dialysis-treated AKI survivors (median age 5 years) and 6752 matched comparators. Among AKI survivors, 53.7% underwent mechanical ventilation and 33.6% had cardiac surgery. During a median 9.6-year follow-up, AKI survivors were at significantly increased risk of a composite outcome of kidney failure or death versus comparators. Death occurred in 113 (6.7%) AKI survivors, 44 (2.6%) developed kidney failure, 174 (12.1%) developed hypertension, 213 (13.1%) developed CKD, and 237 (14.0%) had subsequent AKI. AKI survivors had significantly higher risks of developing CKD and hypertension versus comparators. Risks were greatest in the first year after discharge and gradually decreased over time.</AbstractText><AbstractText Label="CONCLUSIONS">Survivors of pediatric dialysis-treated AKI are at higher long-term risks of kidney failure, death, CKD, and hypertension, compared with a matched hospitalized cohort.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 by the American Society of Nephrology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>Cal H</ForeName><Initials>CH</Initials><Identifier Source="ORCID">0000-0002-2223-0646</Identifier><AffiliationInfo><Affiliation>Division of Paediatric Nephrology, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeyakumar</LastName><ForeName>Nivethika</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>ICES, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>ICES, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wald</LastName><ForeName>Ron</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Nephrology, St. Michael's Hospital and University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garg</LastName><ForeName>Amit X</ForeName><Initials>AX</Initials><AffiliationInfo><Affiliation>ICES, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nash</LastName><ForeName>Danielle M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>ICES, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McArthur</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>ICES, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greenberg</LastName><ForeName>Jason H</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0001-5874-1109</Identifier><AffiliationInfo><Affiliation>Division of Nephrology, Department of Pediatrics, Yale University, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Askenazi</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Pediatric Nephrology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mammen</LastName><ForeName>Cherry</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thabane</LastName><ForeName>Lehana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biostatistics Unit, St Joseph's Healthcare, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldstein</LastName><ForeName>Stuart</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Acute Care Nephrology, Cincinnati Children's Hospital, Cincinnati, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parekh</LastName><ForeName>Rulan S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Division of Paediatric Nephrology, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zappitelli</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Paediatric Nephrology, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chanchlani</LastName><ForeName>Rahul</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-9366-3118</Identifier><AffiliationInfo><Affiliation>ICES, London, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pediatric Nephrology, Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001863</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Soc Nephrol</MedlineTA><NlmUniqueID>9013836</NlmUniqueID><ISSNLinking>1046-6673</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Am Soc Nephrol. 2021 Oct;32(10):2681-2682. doi: 10.1681/ASN.2021060879.</RefSource><PMID Version="1">34531178</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Am Soc Nephrol. 2021 Oct;32(10):2679. doi: 10.1681/ASN.2021060862.</RefSource><PMID Version="1">34531179</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Am Soc Nephrol. 2021 Oct;32(10):2680. doi: 10.1681/ASN.2021060753.</RefSource><PMID Version="1">34531180</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007676" MajorTopicYN="N">Kidney Failure, Chronic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009026" MajorTopicYN="N">Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009864" MajorTopicYN="N" Type="Geographic">Ontario</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006435" MajorTopicYN="Y">Renal Dialysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute renal failure</Keyword><Keyword MajorTopicYN="N">blood pressure</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">chronic kidney disease</Keyword><Keyword MajorTopicYN="N">clinical epidemiology</Keyword><Keyword MajorTopicYN="N">dialysis</Keyword><Keyword MajorTopicYN="N">end stage kidney disease</Keyword><Keyword MajorTopicYN="N">hypertension</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">pediatric nephrology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>27</Day><Hour>5</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34039667</ArticleId><ArticleId IdType="pmc">PMC8455253</ArticleId><ArticleId IdType="doi">10.1681/ASN.2020111665</ArticleId><ArticleId IdType="pii">00001751-202108000-00021</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Koralkar R, Ambalavanan N, Levitan EB, McGwin G, Goldstein S, Askenazi D: Acute kidney injury reduces survival in very low birth weight infants. Pediatr Res 69: 354&#x2013;358, 2011</Citation><ArticleIdList><ArticleId IdType="pubmed">21178824</ArticleId></ArticleIdList></Reference><Reference><Citation>Gadepalli SK, Selewski DT, Drongowski RA, Mychaliska GB: Acute kidney injury in congenital diaphragmatic hernia requiring extracorporeal life support: an insidious problem. J Pediatr Surg 46: 630&#x2013;635, 2011</Citation><ArticleIdList><ArticleId IdType="pubmed">21496529</ArticleId></ArticleIdList></Reference><Reference><Citation>Jetton JG, Boohaker LJ, Sethi SK, Wazir S, Rohatgi S, Soranno DE, et al. .; Neonatal Kidney Collaborative (NKC): Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study. Lancet Child Adolesc Health 1: 184&#x2013;194, 2017</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5933049</ArticleId><ArticleId IdType="pubmed">29732396</ArticleId></ArticleIdList></Reference><Reference><Citation>Stojanovi&#x107; V, Bari&#x161;i&#x107; N, Radovanovi&#x107; T, Bjelica M, Milanovi&#x107; B, Doronjski A: Acute kidney injury in premature newborns&#x2014;definition, etiology, and outcome. Pediatr Nephrol 32: 1963&#x2013;1970, 2017</Citation><ArticleIdList><ArticleId IdType="pubmed">28555296</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutherland SM, Ji J, Sheikhi FH, Widen E, Tian L, Alexander SR, et al. .: AKI in hospitalized children: epidemiology and clinical associations in a national cohort. Clin J Am Soc Nephrol 8: 1661&#x2013;1669, 2013</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3789331</ArticleId><ArticleId IdType="pubmed">23833312</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaddourah A, Basu RK, Bagshaw SM, Goldstein SL; AWARE Investigators: Epidemiology of acute kidney injury in critically ill children and young adults. N Engl J Med 376: 11&#x2013;20, 2017</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5322803</ArticleId><ArticleId IdType="pubmed">27959707</ArticleId></ArticleIdList></Reference><Reference><Citation>Susantitaphong P, Cruz DN, Cerda J, Abulfaraj M, Alqahtani F, Koulouridis I, et al. .; Acute Kidney Injury Advisory Group of the American Society of Nephrology: World incidence of AKI: a meta-analysis. Clin J Am Soc Nephrol 8: 1482&#x2013;1493, 2013</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3805065</ArticleId><ArticleId IdType="pubmed">23744003</ArticleId></ArticleIdList></Reference><Reference><Citation>Chanchlani R, Nash DM, McArthur E, Zappitelli M, Archer V, Kuwornu JP, et al. .: Secular trends in incidence, modality and mortality with dialysis receiving AKI in children in Ontario: a population-based cohort study. Clin J Am Soc Nephrol 14: 1288&#x2013;1296, 2019</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6730522</ArticleId><ArticleId IdType="pubmed">31444174</ArticleId></ArticleIdList></Reference><Reference><Citation>Kari JA, Alhasan KA, Shalaby MA, Khathlan N, Safdar OY, Al Rezgan SA, et al. .: Outcome of pediatric acute kidney injury: a multicenter prospective cohort study. Pediatr Nephrol 33: 335&#x2013;340, 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">28917005</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutherland SM, Byrnes JJ, Kothari M, Longhurst CA, Dutta S, Garcia P, et al. .: AKI in hospitalized children: comparing the pRIFLE, AKIN, and KDIGO definitions. Clin J Am Soc Nephrol 10: 554&#x2013;561, 2015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4386245</ArticleId><ArticleId IdType="pubmed">25649155</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkandari O, Eddington KA, Hyder A, Gauvin F, Ducruet T, Gottesman R, et al. .: Acute kidney injury is an independent risk factor for pediatric intensive care unit mortality, longer length of stay and prolonged mechanical ventilation in critically ill children: a two-center retrospective cohort study. Crit Care 15: R146, 1-12, 2011</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3219018</ArticleId><ArticleId IdType="pubmed">21663616</ArticleId></ArticleIdList></Reference><Reference><Citation>Hessey E, Morissette G, Lacroix J, Perreault S, Samuel S, Dorais M, et al. .: Long-term mortality after acute kidney injury in the pediatric ICU. Hosp Pediatr 8: 260&#x2013;268, 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">29712717</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenberg JH, Coca S, Parikh CR: Long-term risk of chronic kidney disease and mortality in children after acute kidney injury: a systematic review. BMC Nephrol 15: 184, 1-11, 2014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4251927</ArticleId><ArticleId IdType="pubmed">25416588</ArticleId></ArticleIdList></Reference><Reference><Citation>Wald R, Quinn RR, Luo J, Li P, Scales DC, Mamdani MM, et al. .; University of Toronto Acute Kidney Injury Research Group: Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA 302: 1179&#x2013;1185, 2009</Citation><ArticleIdList><ArticleId IdType="pubmed">19755696</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EAJ, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al. .: Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 41: 1411&#x2013;1423, 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">26162677</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA, et al. .: Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 20: 223&#x2013;228, 2009</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2615732</ArticleId><ArticleId IdType="pubmed">19020007</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG, Singanamala S, Parikh CR: Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 81: 442&#x2013;448, 2012</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3788581</ArticleId><ArticleId IdType="pubmed">22113526</ArticleId></ArticleIdList></Reference><Reference><Citation>Wald R, Quinn RR, Adhikari NK, Burns KE, Friedrich JO, Garg AX, et al. .; University of Toronto Acute Kidney Injury Research Group: Risk of chronic dialysis and death following acute kidney injury. Am J Med 125: 585&#x2013;593, 2012</Citation><ArticleIdList><ArticleId IdType="pubmed">22516564</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu V-C, Wu C-H, Huang T-M, Wang C-Y, Lai C-F, Shiao C-C, et al. .; NSARF Group: Long-term risk of coronary events after AKI. J Am Soc Nephrol 25: 595&#x2013;605, 2014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3935592</ArticleId><ArticleId IdType="pubmed">24503241</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu CY, Hsu RK, Yang J, Ordonez JD, Zheng S, Go AS: Elevated BP after AKI. J Am Soc Nephrol 27: 914&#x2013;923, 2016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4769190</ArticleId><ArticleId IdType="pubmed">26134154</ArticleId></ArticleIdList></Reference><Reference><Citation>Odutayo A, Wong CX, Farkouh M, Altman DG, Hopewell S, Emdin CA, et al. .: AKI and long-term risk for cardiovascular events and mortality. J Am Soc Nephrol 28: 377&#x2013;387, 2017</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5198285</ArticleId><ArticleId IdType="pubmed">27297949</ArticleId></ArticleIdList></Reference><Reference><Citation>Silver SA, Goldstein SL, Harel Z, Harvey A, Rompies EJ, Adhikari NK, et al. .: Ambulatory care after acute kidney injury: an opportunity to improve patient outcomes. Can J Kidney Health Dis 2: 36, 1-13 2015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4595050</ArticleId><ArticleId IdType="pubmed">26445676</ArticleId></ArticleIdList></Reference><Reference><Citation>Harel Z, Wald R, Bargman JM, Mamdani M, Etchells E, Garg AX, et al. .: Nephrologist follow-up improves all-cause mortality of severe acute kidney injury survivors. Kidney Int 83: 901&#x2013;908, 2013</Citation><ArticleIdList><ArticleId IdType="pubmed">23325077</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenberg JH, Zappitelli M, Devarajan P, Thiessen-Philbrook HR, Krawczeski C, Li S, et al. .; TRIBE-AKI Consortium: Kidney outcomes 5 years after pediatric cardiac surgery: the TRIBE-AKI Study. JAMA Pediatr 170: 1071&#x2013;1078, 2016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5476457</ArticleId><ArticleId IdType="pubmed">27618162</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper DS, Claes D, Goldstein SL, Bennett MR, Ma Q, Devarajan P, et al. .: Follow-Up Renal Assessment of Injury Long-Term After Acute Kidney Injury (FRAIL-AKI). Clin J Am Soc Nephrol 11: 21&#x2013;29, 2016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4702230</ArticleId><ArticleId IdType="pubmed">26576618</ArticleId></ArticleIdList></Reference><Reference><Citation>Zappitelli M, Parikh CR, Kaufman JS, Go AS, Kimmel PL, Hsu C, et al. .; Assessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury (ASSESS-AKI) Investigators: Acute kidney injury and risk of CKD and hypertension after pediatric cardiac surgery. Clin J Am Soc Nephrol 15: 1403-1412, 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7536759</ArticleId><ArticleId IdType="pubmed">32948644</ArticleId></ArticleIdList></Reference><Reference><Citation>Benisty K, Morgan C, Hessey E, Huynh L, Joffe AR, Garros D, et al. .: Kidney and blood pressure abnormalities 6 years after acute kidney injury in critically ill children: a prospective cohort study. Pediatr Res 88: 271&#x2013;278, 2020</Citation><ArticleIdList><ArticleId IdType="pubmed">31896128</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmeister PA, Hingorani SR, Storer BE, Baker KS, Sanders JE: Hypertension in long-term survivors of pediatric hematopoietic cell transplantation. Biol Blood Marrow Transplant 16: 515&#x2013;524, 2010</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2839006</ArticleId><ArticleId IdType="pubmed">19961945</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon S, Kirkendall ES, Nguyen H, Goldstein SL: Acute kidney injury associated with high nephrotoxic medication exposure leads to chronic kidney disease after 6 months. J Pediatr 165: 522&#x2013;7.e2, 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">24928698</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollander SA, Montez-Rath ME, Axelrod DM, Krawczeski CD, May LJ, Maeda K, et al. .: Recovery from acute kidney injury and CKD following heart transplantation in children, adolescents, and young adults: a retrospective cohort study. Am J Kidney Dis 68: 212&#x2013;218, 2016</Citation><ArticleIdList><ArticleId IdType="pubmed">26970941</ArticleId></ArticleIdList></Reference><Reference><Citation>Mammen C, Al Abbas A, Skippen P, Nadel H, Levine D, Collet JP, et al. .: Long-term risk of CKD in children surviving episodes of acute kidney injury in the intensive care unit: a prospective cohort study. Am J Kidney Dis 59: 523&#x2013;530, 2012</Citation><ArticleIdList><ArticleId IdType="pubmed">22206744</ArticleId></ArticleIdList></Reference><Reference><Citation>Askenazi DJ, Feig DI, Graham NM, Hui-Stickle S, Goldstein SL: 3-5 year longitudinal follow-up of pediatric patients after acute renal failure. Kidney Int 69: 184&#x2013;189, 2006</Citation><ArticleIdList><ArticleId IdType="pubmed">16374442</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui-Stickle S, Brewer ED, Goldstein SL: Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis 45: 96&#x2013;101, 2005</Citation><ArticleIdList><ArticleId IdType="pubmed">15696448</ArticleId></ArticleIdList></Reference><Reference><Citation>Madsen NL, Goldstein SL, Fr&#xf8;slev T, Christiansen CF, Olsen M: Cardiac surgery in patients with congenital heart disease is associated with acute kidney injury and the risk of chronic kidney disease. Kidney Int 92: 751&#x2013;756, 2017</Citation><ArticleIdList><ArticleId IdType="pubmed">28412020</ArticleId></ArticleIdList></Reference><Reference><Citation>Statistics Canada: Ontario [Province] and Canada [Country] (table). Census Profile. 2016 Census. Ottawa: Statistics Canada. Available at: https://www12.statcan.gc.ca/census-recensement/2016/dp-pd/prof/index.cfm?Lang=E. Accessed June 13, 2021</Citation></Reference><Reference><Citation>Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, et al. .; RECORD Working Committee: The Reporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med 12: e1001885, 2015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4595218</ArticleId><ArticleId IdType="pubmed">26440803</ArticleId></ArticleIdList></Reference><Reference><Citation>Dart A, Chartier M, Komenda P, Walld R, Koseva I, Burchill C, et al. .: Evaluation of administrative case definitions for chronic kidney disease in children. Pediatr Res 87: 569&#x2013;575, 2020</Citation><ArticleIdList><ArticleId IdType="pubmed">31578037</ArticleId></ArticleIdList></Reference><Reference><Citation>Pace R, Peters T, Rahme E, Dasgupta K: Validity of health administrative database definitions for hypertension: a systematic review. Can J Cardiol 33: 1052&#x2013;1059, 2017</Citation><ArticleIdList><ArticleId IdType="pubmed">28754391</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Arienzo D, Hessey E, Ali R, Perreault S, Samuel S, Roy L, et al. .: A validation study of administrative health care data to detect acute kidney injury in the pediatric intensive care unit. Can J Kidney Health Dis 6: 2054358119827525, 2019</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6376545</ArticleId><ArticleId IdType="pubmed">30792872</ArticleId></ArticleIdList></Reference><Reference><Citation>Canadian Institute for Health Information (CIHI): Health Indicators 2013. Canadian Institute for Health Information. Available at: https://www.cihi.ca/sites/default/files/document/health-indicators-2013-en.pdf. Accessed June 13, 2021</Citation></Reference><Reference><Citation>Bollman R: Rural Demography Update. Rural Ontario Institute. Available at: http://www.ruralontarioinstitute.ca/file.aspx?id=26acac18-6d6e-4fc5-8be6-c16d326305fe. Accessed June 13, 2021</Citation></Reference><Reference><Citation>Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI: Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg 123: 110&#x2013;118, 2002</Citation><ArticleIdList><ArticleId IdType="pubmed">11782764</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon TD, Haaland W, Hawley K, Lambka K, Mangione-Smith R: Development and validation of the Pediatric Medical Complexity Algorithm (PMCA) version 3.0. Acad Pediatr 18: 577&#x2013;580, 2018</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6035108</ArticleId><ArticleId IdType="pubmed">29496546</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein JP, Moeschberger ML: Survival Analysis Techniques for Censored and Truncated Data. Springer-Verlag New York, 2003. DOI: 10.1007/b97377</Citation></Reference><Reference><Citation>Chawla LS, Eggers PW, Star RA, Kimmel PL: Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 371: 58&#x2013;66, 2014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9720902</ArticleId><ArticleId IdType="pubmed">24988558</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatachalam MA, Weinberg JM, Kriz W, Bidani AK: Failed tubule recovery, AKI-CKD transition, and kidney disease progression. J Am Soc Nephrol 26: 1765&#x2013;1776, 2015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4520181</ArticleId><ArticleId IdType="pubmed">25810494</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath KA: Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 20: 1&#x2013;17, 1992</Citation><ArticleIdList><ArticleId IdType="pubmed">1621674</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatachalam MA, Griffin KA, Lan R, Geng H, Saikumar P, Bidani AK: Acute kidney injury: a springboard for progression in chronic kidney disease. Am J Physiol Renal Physiol 298: F1078&#x2013;F1094, 2010</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2867413</ArticleId><ArticleId IdType="pubmed">20200097</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath KA, Croatt AJ, Haggard JJ, Grande JP: Renal response to repetitive exposure to heme proteins: chronic injury induced by an acute insult. Kidney Int 57: 2423&#x2013;2433, 2000</Citation><ArticleIdList><ArticleId IdType="pubmed">10844611</ArticleId></ArticleIdList></Reference><Reference><Citation>Basile DP, Donohoe D, Roethe K, Osborn JL: Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 281: F887&#x2013;F899, 2001</Citation><ArticleIdList><ArticleId IdType="pubmed">11592947</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu CY: Yes, AKI truly leads to CKD. J Am Soc Nephrol 23: 967&#x2013;969, 2012</Citation><ArticleIdList><ArticleId IdType="pubmed">22499588</ArticleId></ArticleIdList></Reference><Reference><Citation>Polichnowski AJ, Lan R, Geng H, Griffin KA, Venkatachalam MA, Bidani AK: Severe renal mass reduction impairs recovery and promotes fibrosis after AKI. J Am Soc Nephrol 25: 1496&#x2013;1507, 2014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4073422</ArticleId><ArticleId IdType="pubmed">24511135</ArticleId></ArticleIdList></Reference><Reference><Citation>Basile DP, Donohoe DL, Roethe K, Mattson DL: Chronic renal hypoxia after acute ischemic injury: effects of L-arginine on hypoxia and secondary damage. Am J Physiol Renal Physiol 284: F338&#x2013;F348, 2003</Citation><ArticleIdList><ArticleId IdType="pubmed">12388385</ArticleId></ArticleIdList></Reference><Reference><Citation>Chawla LS, Amdur RL, Amodeo S, Kimmel PL, Palant CE: The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney Int 79: 1361&#x2013;1369, 2011</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3257034</ArticleId><ArticleId IdType="pubmed">21430640</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo LJ, Go AS, Chertow GM, McCulloch CE, Fan D, Ordo&#xf1;ez JD, et al. .: Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int 76: 893&#x2013;899, 2009</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2771754</ArticleId><ArticleId IdType="pubmed">19641480</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishani A, Nelson D, Clothier B, Schult T, Nugent S, Greer N, et al. .: The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death. Arch Intern Med 171: 226&#x2013;233, 2011</Citation><ArticleIdList><ArticleId IdType="pubmed">21325112</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakar CV, Christianson A, Himmelfarb J, Leonard AC: Acute kidney injury episodes and chronic kidney disease risk in diabetes mellitus. Clin J Am Soc Nephrol 6: 2567&#x2013;2572, 2011</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3359576</ArticleId><ArticleId IdType="pubmed">21903988</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg AX, Suri RS, Barrowman N, Rehman F, Matsell D, Rosas-Arellano MP, et al. .: Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. JAMA 290: 1360&#x2013;1370, 2003</Citation><ArticleIdList><ArticleId IdType="pubmed">12966129</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano D, Ito A, Yamada A, Kakegawa D, Miwa S, Umeda C, et al. .: Independent risk factors and 2-year outcomes of acute kidney injury after surgery for congenital heart disease. Am J Nephrol 46: 204&#x2013;209, 2017</Citation><ArticleIdList><ArticleId IdType="pubmed">28858859</ArticleId></ArticleIdList></Reference><Reference><Citation>Hessey E, Perreault S, Dorais M, Roy L, Zappitelli M: Acute kidney injury in critically ill children and subsequent chronic kidney disease. Can J Kidney Health Dis 6: 2054358119880188, 2019</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6794652</ArticleId><ArticleId IdType="pubmed">31662875</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J-W, Jeng M-J, Yang L-Y, Chen T-J, Chiang S-C, Soong W-J, et al. .: The epidemiology and prognostic factors of mortality in critically ill children with acute kidney injury in Taiwan. Kidney Int 87: 632&#x2013;639, 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">25252027</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of Finance: Ontario Population Projections Update, 2017&#x2013;2041. Ministry of Finance. Available at: https://www.fin.gov.on.ca/en/economy/demographics/projections/#s4f. Accessed June 13, 2021</Citation></Reference><Reference><Citation>Palevsky PM, Molitoris BA, Okusa MD, Levin A, Waikar SS, Wald R, et al. .: Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol 7: 844&#x2013;850, 2012</Citation><ArticleIdList><ArticleId IdType="pubmed">22442182</ArticleId></ArticleIdList></Reference><Reference><Citation>Palevsky PM: Endpoints for clinical trials of acute kidney injury. Nephron 140: 111&#x2013;115, 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">30205392</ArticleId></ArticleIdList></Reference><Reference><Citation>Waikar SS, Wald R, Chertow GM, Curhan GC, Winkelmayer WC, Liangos O, et al. .: Validity of International Classification of Diseases, Ninth Revision, Clinical Modification codes for acute renal failure. J Am Soc Nephrol 17: 1688&#x2013;1694, 2006</Citation><ArticleIdList><ArticleId IdType="pubmed">16641149</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam NN, McArthur E, Kim SJ, Knoll GA: Validation of kidney transplantation using administrative data. Can J Kidney Health Dis 2: 20: 1-5, 2015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4445504</ArticleId><ArticleId IdType="pubmed">26019887</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38658274</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">0219-3108</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Asian journal of surgery</Title><ISOAbbreviation>Asian J Surg</ISOAbbreviation></Journal><ArticleTitle>Effects of dexmedetomidine on renal function after cardiac surgery for infective endocarditis: An interim analysis of a randomized controlled trial.</ArticleTitle><Pagination><StartPage>4322</StartPage><EndPage>4329</EndPage><MedlinePgn>4322-4329</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.asjsur.2024.04.028</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1015-9584(24)00688-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients undergoing cardiac surgery for infective endocarditis (IE) are at a high risk of postoperative acute kidney injury (AKI) owing to heightened systemic inflammation. Therefore, we aimed to investigate the effect of dexmedetomidine on postoperative AKI in patients who underwent cardiac surgery for IE.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 63 patients who underwent cardiac surgery for IE were randomly assigned to receive either intravenous dexmedetomidine infusion of 0.4&#xa0;&#x3bc;g&#xa0;kg<sup>-1</sup>&#xa0;h<sup>-1</sup> (DEX group) or normal saline infusion (control group) for 24&#xa0;h after induction of anesthesia. The occurrence of AKI within seven days postoperation, epinephrine, norepinephrine, and interleukin-6 levels, as well as postoperative morbidities, were assessed. An intertrim analysis was conducted using Pocock's alpha spending function at &#x3b1;&#xa0;=&#xa0;0.05 and &#x3b2;&#xa0;=&#xa0;0.2.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">This trial was early terminated according to the results of interim analysis performed when 60&#xa0;% of the pre-set number of patients have been collected. The incidence of AKI was significantly lower in the DEX group than in the control group (32.3&#xa0;% vs. 9.4&#xa0;%, p&#xa0;=&#xa0;0.025). Patients in the DEX group had significantly lower epinephrine levels than those in the control group, whereas norepinephrine and interleukin-6 levels were similar. Perioperative mean arterial pressure or heart rate did not differ between the groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Dexmedetomidine administration for 24&#xa0;h starting from induction of anesthesia significantly reduced the incidence of postoperative AKI after cardiac surgery for IE (by 29&#xa0;% vs. control) without hemodynamic side effects. This was accompanied by a significant attenuation of postoperative increase in serum epinephrine levels.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Asian Surgical Association and Taiwan Society of Coloproctology. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ham</LastName><ForeName>Sung Yeon</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shim</LastName><ForeName>Jae-Kwang</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sak</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Seo Hee</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soh</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwak</LastName><ForeName>Young-Lan</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: ylkwak@yuhs.ac.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Asian J Surg</MedlineTA><NlmUniqueID>8900600</NlmUniqueID><ISSNLinking>1015-9584</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber><NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>YKH834O4BH</RegistryNumber><NameOfSubstance UI="D004837">Epinephrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058647">Adrenergic alpha-2 Receptor Agonists</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="Y">Dexmedetomidine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004696" MajorTopicYN="Y">Endocarditis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007262" MajorTopicYN="N">Infusions, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009638" MajorTopicYN="N">Norepinephrine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004837" MajorTopicYN="N">Epinephrine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058647" MajorTopicYN="N">Adrenergic alpha-2 Receptor Agonists</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">Dexmedetomidine</Keyword><Keyword MajorTopicYN="N">Infective endocarditis</Keyword></KeywordList><CoiStatement>Declaration of competing interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>25</Day><Hour>0</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>24</Day><Hour>22</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38658274</ArticleId><ArticleId IdType="doi">10.1016/j.asjsur.2024.04.028</ArticleId><ArticleId IdType="pii">S1015-9584(24)00688-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33039183</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0267</ISSN><JournalIssue CitedMedium="Internet"><Volume>52</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Injury</Title><ISOAbbreviation>Injury</ISOAbbreviation></Journal><ArticleTitle>Predictors of postoperative acute kidney injury in patients undergoing hip fracture surgery: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>330</StartPage><EndPage>338</EndPage><MedlinePgn>330-338</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.injury.2020.09.060</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0020-1383(20)30795-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The present study aimed to summarize the predictors of acute kidney injury (AKI) in patients after hip surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A literature search was performed using PubMed, EMBASE, Cochrane Library, and Web of Science for studies assessing the predictors of AKI after hip fracture surgery. Pooled odds ratio (OR) and mean difference (MD) of those who experienced AKI compared to those who did not were calculated for each variable. Evidence was assessed using the Newcastle-Ottawa Scale.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Ten studies with 34 potential factors were included in the meta-analysis. In the primary analysis, 12 factors were associated with AKI, comprising males (OR 1.25; 95% confidence interval (CI) 1.14-1.36), advanced age (MD 2.28; 95% CI 0.80-3.75), myocardial infarction (OR 1.39; 95% CI 1.18-1.63), hypertension (OR 1.46; 95% CI 1.13-1.89), diabetes (OR 1.84; 95% CI 1.40-2.42), chronic kidney disease (OR 3.66; 95% CI 2.21-6.07), hip arthroplasty (OR 1.35; 95% CI 1.22-1.50), angiotensin-converting enzyme inhibitors/angiotensin receptor blockers use (OR 2.28; 95% CI 1.68-3.08), more intraoperative blood loss (MD 44.06; 95% CI 2.88-85.24), higher preoperative blood urea nitrogen levels (MD 5.29; 95% CI 3.38-7.20), higher preoperative serum creatinine levels (MD 0.4; 95% CI 0.26-0.53), and lower preoperative estimated glomerular filtration rate (MD -19.59; 95% CI -26.92--12.26). Another 13 factors related to AKI in individual studies were identified in the systematic review.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Related prophylaxis strategies should be implemented in patients involved with the above-mentioned characteristics to prevent AKI after hip surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Xinfeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou 215006, China; Orthopaedic Institute, Medical College, Soochow University, Suzhou 215007, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yijian</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou 215006, China; Orthopaedic Institute, Medical College, Soochow University, Suzhou 215007, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teng</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou 215006, China; Orthopaedic Institute, Medical College, Soochow University, Suzhou 215007, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Angela Carley</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>School of Public Health and Health Systems, University of Waterloo, Waterloo, Ontario NZL 3G1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou 215006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Huilin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou 215006, China; Orthopaedic Institute, Medical College, Soochow University, Suzhou 215007, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Fan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou 215006, China; Orthopaedic Institute, Medical College, Soochow University, Suzhou 215007, China. Electronic address: fanhe@suda.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Injury</MedlineTA><NlmUniqueID>0226040</NlmUniqueID><ISSNLinking>0020-1383</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000806">Angiotensin-Converting Enzyme Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000806" MajorTopicYN="N">Angiotensin-Converting Enzyme Inhibitors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="Y">Hip Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="Y">Myocardial Infarction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Hip fracture</Keyword><Keyword MajorTopicYN="N">Hip surgery</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Postoperative acute kidney injury</Keyword><Keyword MajorTopicYN="N">Predictors</Keyword><Keyword MajorTopicYN="N">Systematic reviews</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no conflict of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>11</Day><Hour>20</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33039183</ArticleId><ArticleId IdType="doi">10.1016/j.injury.2020.09.060</ArticleId><ArticleId IdType="pii">S0020-1383(20)30795-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39419173</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-2291</ISSN><JournalIssue CitedMedium="Internet"><Volume>74</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Season>Nov-Dec</Season></PubDate></JournalIssue><Title>Brazilian journal of anesthesiology (Elsevier)</Title><ISOAbbreviation>Braz J Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Intraoperative hypotension during critical phases of liver transplantation and its impact on acute kidney injury: a retrospective cohort study.</ArticleTitle><Pagination><StartPage>844566</StartPage><MedlinePgn>844566</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">844566</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bjane.2024.844566</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0104-0014(24)00088-5</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Acute Kidney Injury (AKI) following Liver Transplantation (LT) is associated with prolonged ICU and hospital stay, increased risk of chronic renal disease, and decreased graft survival. Intraoperative hypotension is a modifiable risk factor associated with postoperative AKI. We aimed to determine in which phase of LT hypotension has the strongest association with AKI: the anhepatic or neohepatic phase.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective cohort study included adult patients undergoing LT between January 2010 and June 2022. Exclusion criteria were re-do or combined transplantations, preoperative dialysis, and early graft failure or death. Primary outcome was AKI as defined by KDIGO. Hypotension was Mean Arterial Pressure (MAP) below predefined thresholds in minutes. Risk adjusted logistic regression analysis considered hypotension in 3 periods: the total procedure, anhepatic phase, and neohepatic phase.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our cohort included 1153 patients. The median MELD-NA score was 19 (IQR 11-28), and 412 (35.9%) were living-related donations. AKI occurred in 544 patients (47.2%). The unadjusted model showed an association with AKI for MAP &lt; 60 mmHg (OR = 1.011 [1.0, 1.022], p = 0.047) and MAP &lt; 55 mmHg (OR = 1.023 [1.002, 1.047], p = 0.040) in the anhepatic phase, and for MAP &lt; 60 mmHg (OR = 1.032 [1.01, 1.056], p = 0.006) in the neohepatic phase. The adjusted model did not reach significance in the subgroups but did in the total procedure: MAP &lt; 60 mmHg (OR = 1.005 [1.002, 1.008], p &lt; 0.001) and MAP &lt; 55 mmHg (OR = 1.008 [1.003-1.013], p = 0.004).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Intraoperative hypotension is independently associated with AKI following LT. This association is seen during the anhepatic phase. Maintaining MAP above 60 mmHg may improve kidney function after LT.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024. Published by Elsevier Espa&#xf1;a S.L.U.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bieze</LastName><ForeName>Matthanja</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Toronto General Hospital, Department of Anesthesia and Pain Management, Toronto, Ontario, Canada; University of Toronto, Temerty Faculty of Medicine, Department of Anesthesiology and Pain Medicine, Toronto, Ontario, Canada. Electronic address: matth.bieze@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zabida</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Toronto General Hospital, Department of Anesthesia and Pain Management, Toronto, Ontario, Canada; University of Toronto, Temerty Faculty of Medicine, Department of Anesthesiology and Pain Medicine, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinelli</LastName><ForeName>Eduarda Schutz</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Toronto General Hospital, Department of Anesthesia and Pain Management, Toronto, Ontario, Canada; University of Toronto, Temerty Faculty of Medicine, Department of Anesthesiology and Pain Medicine, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caragata</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Austin Health, Department of Anesthesia, Melbourne, Australia; University of Melbourne, School of Medicine, Department of Critical Care, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Stella</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Health Network, Department of Biostatistics, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carroll</LastName><ForeName>Jo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Toronto General Hospital, Department of Anesthesia and Pain Management, Toronto, Ontario, Canada; University of Toronto, Temerty Faculty of Medicine, Department of Anesthesiology and Pain Medicine, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Selzner</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Temerty Faculty of Medicine, Toronto General Hospital, Department of Surgery, and the Multi-Organ Transplant Program, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCluskey</LastName><ForeName>Stuart A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Toronto General Hospital, Department of Anesthesia and Pain Management, Toronto, Ontario, Canada; University of Toronto, Temerty Faculty of Medicine, Department of Anesthesiology and Pain Medicine, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Braz J Anesthesiol</MedlineTA><NlmUniqueID>101624623</NlmUniqueID><ISSNLinking>0104-0014</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016031" MajorTopicYN="Y">Liver Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="Y">Intraoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Blood pressure</Keyword><Keyword MajorTopicYN="N">Hypotension</Keyword><Keyword MajorTopicYN="N">Liver transplantation</Keyword><Keyword MajorTopicYN="N">Postoperative complications</Keyword><Keyword MajorTopicYN="N">Reperfusion</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>7</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>19</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39419173</ArticleId><ArticleId IdType="pmc">PMC11541844</ArticleId><ArticleId IdType="doi">10.1016/j.bjane.2024.844566</ArticleId><ArticleId IdType="pii">S0104-0014(24)00088-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Durand F, Francoz C, Asrani SK, et al. Acute Kidney Injury After Liver Transplantation. Transplantation. 2018;102:1636&#x2013;1649.</Citation><ArticleIdList><ArticleId IdType="pubmed">29847502</ArticleId></ArticleIdList></Reference><Reference><Citation>Thongprayoon C, Kaewput W, Thamcharoen N, et al. Incidence and Impact of Acute Kidney Injury after Liver Transplantation: A Meta-Analysis. J Clin Med. 2019;8:372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6463182</ArticleId><ArticleId IdType="pubmed">30884912</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilmi IA, Damian D, Al-Khafaji A, et al. Acute kidney injury following orthotopic liver transplantation: incidence, risk factors, and effects on patient and graft outcomes. Br J Anaesth. 2015;114:919&#x2013;926.</Citation><ArticleIdList><ArticleId IdType="pubmed">25673576</ArticleId></ArticleIdList></Reference><Reference><Citation>Contreras G, Garces G, Quartin AA, et al. An epidemiologic study of early renal replacement therapy after orthotopic liver transplantation. J Am Soc Nephrol. 2002;13:228&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pubmed">11752042</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:c179&#x2013;c184.</Citation><ArticleIdList><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Locke JE, Shelton B, Orandi B, et al. Obesity is a risk factor for progression to kidney transplant waitlisting after liver transplantation. Clin Transplant. 2021;35:e14317.</Citation><ArticleIdList><ArticleId IdType="pubmed">33866616</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobeika MJ, Saharia A, Mobley CM, et al. Donation after circulatory death liver transplantation: An in-depth analysis and propensity score-matched comparison. Clin Transplant. 2021;35:e14304.</Citation><ArticleIdList><ArticleId IdType="pubmed">33792971</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YJ, Li JH, Guan Y, Xie QH, Hao CM, Wang ZX. Diabetes mellitus is a risk factor of acute kidney injury in liver transplantation patients. Hepatobiliary Pancreat Dis Int. 2021;20:215&#x2013;221.</Citation><ArticleIdList><ArticleId IdType="pubmed">33752999</ArticleId></ArticleIdList></Reference><Reference><Citation>Caragata R, Emerson S, Santema ML, et al. Intraoperative hypotension and the risk of acute kidney injury following liver transplantation. Clin Transplant. 2023;37:e15053.</Citation><ArticleIdList><ArticleId IdType="pubmed">37350742</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaker TM, Eason JD, Davidson BR, et al. Which cava anastomotic techniques are optimal regarding immediate and short-term outcomes after liver transplantation: A systematic review of the literature and expert panel recommendations. Clin Transplant. 2022;36:e14681.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10078200</ArticleId><ArticleId IdType="pubmed">35567584</ArticleId></ArticleIdList></Reference><Reference><Citation>SJr DeMaria, Nolasco L, Igwe D, Jules RS, Bekki Y, Smith NK. Prediction, prevention, and treatment of post reperfusion syndrome in adult orthotopic liver transplant patients. Clin Transplant. 2023;37:e15014.</Citation><ArticleIdList><ArticleId IdType="pubmed">37178452</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh M, Devereaux PJ, Garg AX, et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology. 2013;119:507&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pubmed">23835589</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao P, Zhao S, Lyu L, et al. Association of intraoperative hypotension with acute kidney injury after liver resection surgery: an observational cohort study. BMC Nephrol. 2020;21:456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7607844</ArticleId><ArticleId IdType="pubmed">33138788</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmasi V, Maheshwari K, Yang D, et al. Relationship between Intraoperative Hypotension, Defined by Either Reduction from Baseline or Absolute Thresholds, and Acute Kidney and Myocardial Injury after Noncardiac Surgery: A Retrospective Cohort Analysis. Anesthesiology. 2017;126:47&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">27792044</ArticleId></ArticleIdList></Reference><Reference><Citation>Wehrle CJ, Zhang M, Khalil M, et al. Impact of Back-to-Base Normothermic Machine Perfusion on Complications and Costs: A Multi-Center, Real-World Risk-Matched Analysis. Ann Surg. 2024;280:300&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pubmed">38557793</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheruku SR, Raphael J, Neyra JA, Fox AA. Acute Kidney Injury after Cardiac Surgery: Prediction, Prevention, and Management. Anesthesiology. 2023;139:880&#x2013;898.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10841304</ArticleId><ArticleId IdType="pubmed">37812758</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, Weiss R, Albert F, et al. Epidemiology of surgery associated acute kidney injury (EPIS-AKI): a prospective international observational multi-center clinical study. Intensive Care Med. 2023;49:1441&#x2013;1455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10709241</ArticleId><ArticleId IdType="pubmed">37505258</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherqui D, Lauzet JY, Rotman N, et al. Orthotopic liver transplantation with preservation of the caval and portal flows. Technique and results in 62 cases. Transplantation. 1994;58:793&#x2013;796.</Citation><ArticleIdList><ArticleId IdType="pubmed">7940712</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim WH, Oh HW, Yang SM, et al. Intraoperative Hemodynamic Parameters and Acute Kidney Injury After Living Donor Liver Transplantation. Transplantation. 2019;103:1877&#x2013;1886.</Citation><ArticleIdList><ArticleId IdType="pubmed">30720690</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng J, Li Q, Wu Q, et al. A Novel Online Calculator Predicting Acute Kidney Injury After Liver Transplantation: A Retrospective Study. Transpl Int. 2023;36:10887.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9892055</ArticleId><ArticleId IdType="pubmed">36744052</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong HY, Chen F, He Y, et al. Intrarenal resistance index for the assessment of acute renal injury in a rat liver transplantation model. BMC Nephrol. 2013;14:55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3599562</ArticleId><ArticleId IdType="pubmed">23453043</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacoviello M, Monitillo F, Leone M, et al. The Renal Arterial Resistance Index Predicts Worsening Renal Function in Chronic Heart Failure Patients. Cardiorenal Med. 2016;7:42&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5159733</ArticleId><ArticleId IdType="pubmed">27994601</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorelli S, Biancofiore G, Feltracco P, et al. Acute kidney injury after liver transplantation, perioperative risk factors, and outcome: prospective observational study of 1681 patients (OLTx Study) Minerva Anestesiol. 2022;88:248&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pubmed">34709014</ArticleId></ArticleIdList></Reference><Reference><Citation>de Haan JE, Hoorn EJ, de Geus HRH. Acute kidney injury after liver transplantation: Recent insights and future perspectives. Best Pract Res Clin Gastroenterol. 2017;31:161&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pubmed">28624104</ArticleId></ArticleIdList></Reference><Reference><Citation>Widmer JD, Schlegel A, Ghazaly M, et al. Piggyback or Cava Replacement: Which Implantation Technique Protects Liver Recipients From Acute Kidney Injury and Complications? Liver Transpl. 2018;24:1746&#x2013;1756.</Citation><ArticleIdList><ArticleId IdType="pubmed">30230686</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih TH, Chen CC, Chen CL, et al. Acute Kidney Injury in Adult Living Donor Liver Transplantation Performed with Different Methods of Inferior Vena Cava Clamping Maneuvers. Transplant Proc. 2020;52:1849&#x2013;1851.</Citation><ArticleIdList><ArticleId IdType="pubmed">32448664</ArticleId></ArticleIdList></Reference><Reference><Citation>Gumbert SD, Kork F, Jackson ML, et al. Perioperative Acute Kidney Injury. Anesthesiology. 2020;132:180&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10924686</ArticleId><ArticleId IdType="pubmed">31687986</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31394251</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1615-5947</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><PubDate><Year>2020</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Annals of vascular surgery</Title><ISOAbbreviation>Ann Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>Effect of Remote Ischemic Preconditioning on Patients Undergoing Elective Major Vascular Surgery: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>452</StartPage><EndPage>462</EndPage><MedlinePgn>452-462</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.avsg.2019.05.035</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0890-5096(19)30530-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Whether remote ischemic preconditioning (RIPC), through several cycles of ischemia-reperfusion, can generate endogenous protective substances to protect patients undergoing elective major vascular surgery remains unclear. The results derived from many randomized controlled trials (RCTs) have been discrepant.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed (1966 to May 2018) and EMBASE (1966 to May 2018) databases were searched to identify all published RCTs that assessed the effect of RIPC in patients undergoing elective major vascular surgery. Then, we performed a systematic review and meta-analysis to merge the outcomes of RIPC procedures from each RCT, which included all-cause mortality, myocardial infarction (MI), acute kidney injury (AKI), and/or new-onset arrhythmia.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 909 patients were enrolled from 10 eligible studies that were conducted from 2007 through 2016. A fixed effect model was utilized in this study to pool each effect size. Pooled analyses of all RCTs showed that RIPC did not reduce the incidence of all-cause mortality (pooled risk ratio [RR] 1.36, 95% confidence interval [CI] 0.63-2.92, P&#xa0;=&#xa0;0.56), MI (pooled RR 0.77, 95% CI 0.48-1.22, P&#xa0;=&#xa0;0.38), AKI (pooled RR 0.93, 95% CI 0.68-1.27, P&#xa0;=&#xa0;0.10), or new-onset arrhythmia (pooled RR 1.47, 95% CI 0.83-2.60, P&#xa0;=&#xa0;0.52) compared with the control treatment. The publication bias detected by Begg's test was low.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There is no prominent evidence to support the hypothesis that RIPC can provide perioperative protection to patients undergoing elective major vascular surgery. Therefore, the routine use of RIPC to reduce the incidence of perioperative complications of these operations may not be recommended.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ouyang</LastName><ForeName>Huan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Graduate School, University of Newcastle, Callaghan, Newcastle, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jiahui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, The First People's Hospital, Jiujiang, Jiangxi Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Cuifu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Zhiwei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jiasheng</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Weimin</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China. Electronic address: drzwm@sina.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ann Vasc Surg</MedlineTA><NlmUniqueID>8703941</NlmUniqueID><ISSNLinking>0890-5096</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019194" MajorTopicYN="N">Ischemic Preconditioning</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012039" MajorTopicYN="N">Regional Blood Flow</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060205" MajorTopicYN="Y">Therapeutic Occlusion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014656" MajorTopicYN="Y">Vascular Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31394251</ArticleId><ArticleId IdType="doi">10.1016/j.avsg.2019.05.035</ArticleId><ArticleId IdType="pii">S0890-5096(19)30530-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32030221</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2072-1439</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>12</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of thoracic disease</Title><ISOAbbreviation>J Thorac Dis</ISOAbbreviation></Journal><ArticleTitle>Serum alpha 1-antitrypsin predicts severe acute kidney injury after cardiac surgery.</ArticleTitle><Pagination><StartPage>5053</StartPage><EndPage>5062</EndPage><MedlinePgn>5053-5062</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.21037/jtd.2019.12.17</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Human alpha 1-antitrypsin (A1AT) is involved in the pathophysiological process underlying ischemic acute kidney injury (AKI). To test the hypothesis that serum A1AT (sA1AT) is a predictor for severe AKI after cardiopulmonary bypass (CPB), we conducted a prospective cohort study in 201 patients undergoing cardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We collected blood and urine samples, and analyzed the sA1AT and other injury biomarkers during the perioperative period. Severe AKI is defined as Kidney Disease Improving Global Outcomes (KDIGO) stage 2 or 3, and overall AKI is defined as KDIGO stage 1, 2, or 3.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Ninety-one (45.3%) patients developed overall AKI, and 22 (10.9%) among them developed severe AKI after operation. sA1AT level spiked 2 hours after surgery in patients who subsequently developed severe AKI, while serum creatinine peaked 12 hours after operation. Higher postoperative sA1AT independently correlated to the development of severe AKI [OR, 1.54 (1.17-2.03); P=0.002]. The highest quartile of postoperative sA1AT level was associated with 6-fold higher hazards of severe AKI compared to the lowest quartile. Higher sA1AT levels were correlated with longer stays in the intensive care unit and the hospital. For predicting severe AKI, the AUC of sA1AT 2 hours after CPB reached 0.814. After combining with urine T cell immunoglobulin mucin-1 and clinical model, the AUC improved to 0.923.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In summary, sA1AT is a valuable predictor of severe AKI development and prolonged ICU and hospital stays in patients after cardiac surgery.</AbstractText><CopyrightInformation>2019 Journal of Thoracic Disease. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Songlin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Jianwei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Zhiwen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Zhiwen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Tong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Shaoyi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ai</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>J Thorac Dis</MedlineTA><NlmUniqueID>101533916</NlmUniqueID><ISSNLinking>2072-1439</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Serum alpha 1-antitrypsin (sA1AT)</Keyword><Keyword MajorTopicYN="N">acute kidney injury (AKI)</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">cardiopulmonary bypass (CPB)</Keyword><Keyword MajorTopicYN="N">predictor</Keyword></KeywordList><CoiStatement>Conflicts of Interest: The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32030221</ArticleId><ArticleId IdType="pmc">PMC6988039</ArticleId><ArticleId IdType="doi">10.21037/jtd.2019.12.17</ArticleId><ArticleId IdType="pii">jtd-11-12-5053</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huen SC, Parikh CR. Predicting acute kidney injury after cardiac surgery: a systematic review. Ann Thorac Surg 2012;93:337-47. 10.1016/j.athoracsur.2011.09.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3286599</ArticleId><ArticleId IdType="pubmed">22186469</ArticleId></ArticleIdList></Reference><Reference><Citation>Engoren M, Habib RH, Arslanian-Engoren C, et al. The effect of acute kidney injury and discharge creatinine level on mortality following cardiac surgery. Crit Care Med 2014;42:2069-74. 10.1097/CCM.0000000000000409</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000000409</ArticleId><ArticleId IdType="pubmed">24810529</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neal JB, Shaw AD, Billings FT. Acute kidney injury following cardiac surgery: current understanding and future directions. Crit Care 2016;20:187. 10.1186/s13054-016-1352-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1352-z</ArticleId><ArticleId IdType="pmc">PMC4931708</ArticleId><ArticleId IdType="pubmed">27373799</ArticleId></ArticleIdList></Reference><Reference><Citation>Han SS, Shin N, Baek SH, et al. Effects of acute kidney injury and chronic kidney disease on long-term mortality after coronary artery bypass grafting. Am Heart J 2015;169:419-25. 10.1016/j.ahj.2014.12.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2014.12.019</ArticleId><ArticleId IdType="pubmed">25728733</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickering JW, James MT, Palmer SC. Acute kidney injury and prognosis after cardiopulmonary bypass: a meta-analysis of cohort studies. Am J Kidney Dis 2015;65:283-93. 10.1053/j.ajkd.2014.09.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2014.09.008</ArticleId><ArticleId IdType="pubmed">25445101</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 2006;1:19-32. 10.2215/CJN.00240605</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.00240605</ArticleId><ArticleId IdType="pubmed">17699187</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar AB, Suneja M. Cardiopulmonary bypass-associated acute kidney injury. Anesthesiology 2011;114:964-70. 10.1097/ALN.0b013e318210f86a</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318210f86a</ArticleId><ArticleId IdType="pubmed">21394005</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouma HR, Mungroop HE, de Geus AF, et al. Acute kidney injury classification underestimates long-term mortality after cardiac valve operations. Ann Thorac Surg 2018;106:92-8. 10.1016/j.athoracsur.2018.01.066</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2018.01.066</ArticleId><ArticleId IdType="pubmed">29501641</ArticleId></ArticleIdList></Reference><Reference><Citation>Du SL, Zeng XZ, Tian JW, et al. Advanced oxidation protein products in predicting acute kidney injury following cardiac surgery. Biomarkers 2015;20:206-11. 10.3109/1354750X.2015.1062917</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/1354750X.2015.1062917</ArticleId><ArticleId IdType="pubmed">26154394</ArticleId></ArticleIdList></Reference><Reference><Citation>Karnaukhova E, Krupnikova SS, Rajabi M, et al. Heme binding to human alpha-1 proteinase inhibitor. Biochim Biophys Acta 2012;1820:2020-9. 10.1016/j.bbagen.2012.09.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2012.09.012</ArticleId><ArticleId IdType="pubmed">23000493</ArticleId></ArticleIdList></Reference><Reference><Citation>Zager RA, Johnson AC, Frostad KB. Combined iron sucrose and protoporphyrin treatment protects against ischemic and toxin-mediated acute renal failure. Kidney Int 2016;90:67-76. 10.1016/j.kint.2016.01.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2016.01.022</ArticleId><ArticleId IdType="pmc">PMC4934680</ArticleId><ArticleId IdType="pubmed">27165818</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonigk D, Al-Omari M, Maegel L, et al. Anti-inflammatory and immunomodulatory properties of a1-antitrypsin without inhibition of elastase. Proc Natl Acad Sci 2013;110:15007-12. 10.1073/pnas.1309648110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1309648110</ArticleId><ArticleId IdType="pmc">PMC3773761</ArticleId><ArticleId IdType="pubmed">23975926</ArticleId></ArticleIdList></Reference><Reference><Citation>Janciauskiene S, Tumpara S, Wiese M, et al. Alpha1-antitrypsin binds hemin and prevents oxidative activation of human neutrophils: putative pathophysiological significance. J Leukoc Biol 2017;102:1127-41. 10.1189/jlb.3A0317-124R</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.3A0317-124R</ArticleId><ArticleId IdType="pubmed">28716864</ArticleId></ArticleIdList></Reference><Reference><Citation>Janciauskiene S, Wrenger S, Immenschuh S, et al. The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions. Front Pharmacol 2018;9:341. 10.3389/fphar.2018.00341</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2018.00341</ArticleId><ArticleId IdType="pmc">PMC5914301</ArticleId><ArticleId IdType="pubmed">29719508</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Lameire N, Aspelin P, et al. KDIGO Clinical Practice Guideline for Acute Kidney Injury 2012. Kidney Int Suppl 2012;2:1-138.</Citation></Reference><Reference><Citation>Hazle MA, Gajarski RJ, Aiyagari R, et al. Urinary biomarkers and renal near-infrared spectroscopy predict intensive care unit outcomes after cardiac surgery in infants younger than 6 months of age. J Thorac Cardiovasc Surg 2013;146:861-867.e1. 10.1016/j.jtcvs.2012.12.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2012.12.012</ArticleId><ArticleId IdType="pmc">PMC3653979</ArticleId><ArticleId IdType="pubmed">23317940</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmedany SM, Naga SS, Elsharkawy R, et al. Novel urinary biomarkers and the early detection of acute kidney injury after open cardiac surgeries. J Crit Care 2017;40:171-7. 10.1016/j.jcrc.2017.03.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2017.03.029</ArticleId><ArticleId IdType="pubmed">28411423</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufeld T, Foerster KA, Schilling T, et al. Preoperative serum uric acid predicts incident acute kidney injury following cardiac surgery. BMC Nephrol 2018;19:161. 10.1186/s12882-018-0970-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-018-0970-x</ArticleId><ArticleId IdType="pmc">PMC6031174</ArticleId><ArticleId IdType="pubmed">29973162</ArticleId></ArticleIdList></Reference><Reference><Citation>Zelt JGE, Mielniczuk LM, Liu PP, et al. Utility of Novel Cardiorenal Biomarkers in the Prediction and Early Detection of Congestive Kidney Injury Following Cardiac Surgery. J Clin Med 2018;7:540. 10.3390/jcm7120540</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm7120540</ArticleId><ArticleId IdType="pmc">PMC6306702</ArticleId><ArticleId IdType="pubmed">30545066</ArticleId></ArticleIdList></Reference><Reference><Citation>Krawczeski CD, Goldstein SL, Woo JG, et al. Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass. J Am Coll Cardiol 2011;58:2301-9. 10.1016/j.jacc.2011.08.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2011.08.017</ArticleId><ArticleId IdType="pmc">PMC3220882</ArticleId><ArticleId IdType="pubmed">22093507</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Chen C, Teng S, et al. Urinary Matrix Metalloproteinase-7 Predicts Severe AKI and Poor Outcomes after Cardiac Surgery. J Am Soc Nephrol 2017;28:3373-82. 10.1681/ASN.2017020142</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2017020142</ArticleId><ArticleId IdType="pmc">PMC5661292</ArticleId><ArticleId IdType="pubmed">28698269</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35595549</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>06</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>129</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Intraoperative hypotension is associated with persistent acute kidney disease after noncardiac surgery: a multicentre cohort study.</ArticleTitle><Pagination><StartPage>13</StartPage><EndPage>21</EndPage><MedlinePgn>13-21</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2022.03.027</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(22)00157-X</ELocationID><Abstract><AbstractText Label="BACKGROUND">Whilst intraoperative hypotension is associated with postoperative acute kidney injury (AKI), the link between&#xa0;intraoperative hypotension and acute kidney disease (AKD), defined as continuing renal dysfunction for up to 3 months after exposure, has not yet been studied.</AbstractText><AbstractText Label="METHODS">We conducted a retrospective multicentre cohort study using data from noncardiac, non-obstetric surgery extracted from a US electronic health records database. Primary outcome was the association between intraoperative hypotension, at three MAP thresholds (&#x2264;75, &#x2264;65, and &#x2264;55 mm Hg), and the following two AKD subtypes: (i) persistent (initial AKI incidence within 7 days of surgery, with continuation between 8 and 90 days post-surgery) and (ii) delayed (renal impairment without AKI within 7 days, with AKI occurring between 8 and 90 days post-surgery). Secondary outcomes included healthcare resource utilisation for patients with either AKD subtype or no AKD.</AbstractText><AbstractText Label="RESULTS">A total of 112 912 surgeries qualified for the study. We observed a rate of 2.2% for delayed AKD and 0.6% for persistent AKD. Intraoperative hypotension was significantly associated with persistent AKD at MAP &#x2264;55 mm Hg (hazard ratio 1.1; 95% confidence interval: 1.38-1.22; P&lt;0.004). However, IOH was not significantly associated with delayed AKD across any of the MAP thresholds. Patients with delayed or persistent AKD had higher healthcare resource utilisation across both hospital and intensive care admissions, compared with patients with no AKD.</AbstractText><AbstractText Label="CONCLUSIONS">Intraoperative hypotension is associated with persistent but not delayed acute kidney disease. Both types of acute kidney disease appear to be associated with increased healthcare utilisation. Correction of intraoperative hypotension is a potential opportunity to decrease postoperative kidney injury and associated costs.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Andrew D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Intensive Care and Resuscitation, Cleveland Clinic, Cleveland, OH, USA. Electronic address: shawa8@ccf.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khanna</LastName><ForeName>Ashish K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Section on Critical Care Medicine, Wake Forest University School of Medicine, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, NC, USA; Perioperative Outcomes and Informatics Collaborative, Winston-Salem, NC, USA; Outcomes Research Consortium, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smischney</LastName><ForeName>Nathan J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shenoy</LastName><ForeName>Apeksha V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Boston Strategic Partners, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boero</LastName><ForeName>Isabel J</ForeName><Initials>IJ</Initials><AffiliationInfo><Affiliation>Boston Consulting Group, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bershad</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Edwards Lifesciences, Irvine, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hwang</LastName><ForeName>Seungyoung</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Boston Strategic Partners, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Qinyu</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Boston Consulting Group, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stapelfeldt</LastName><ForeName>Wolf H</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Indiana University School of Medicine, Indianapolis, IN, USA; Anesthesiology Services, Richard L. Roudebush VA Medical Center, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney disease</Keyword><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">electronica heath record database</Keyword><Keyword MajorTopicYN="N">healthcare resource utilisation</Keyword><Keyword MajorTopicYN="N">intraoperative hypotension</Keyword><Keyword MajorTopicYN="N">mean arterial pressure</Keyword><Keyword MajorTopicYN="N">noncardiac surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>20</Day><Hour>22</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35595549</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2022.03.027</ArticleId><ArticleId IdType="pii">S0007-0912(22)00157-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34661665</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>10</Issue><PubDate><Year>2021</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>External Validation of a Prediction Model for Acute Kidney Injury Following Noncardiac Surgery.</ArticleTitle><Pagination><StartPage>e2127362</StartPage><MedlinePgn>e2127362</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2127362</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2021.27362</ELocationID><Abstract><AbstractText Label="IMPORTANCE">The Simple Postoperative AKI Risk (SPARK) index is a prediction model for postoperative acute kidney injury (PO-AKI) in patients undergoing noncardiac surgery. External validation has not been performed.</AbstractText><AbstractText Label="OBJECTIVE">To externally validate the SPARK index.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This single-center retrospective cohort study included adults who underwent noncardiac surgery under general anesthesia from 2007 to 2011. Those with obstetric or urological surgery, estimated glomerular filtration rate (eGFR) of less than 15 mL/min/1.73 m2, preoperative dialysis, or an expected surgical duration of less than 1 hour were excluded. The study was conducted at Nara Medical University Hospital. Data analysis was conducted from January to July 2021.</AbstractText><AbstractText Label="EXPOSURES">Risk factors for AKI included in SPARK index.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">PO-AKI, defined as an increase in serum creatinine of at least 0.3 mg/dL within 48 hours or 150% compared with preoperative baseline value or urine output of less than 0.5 mL/kg/h for at least 6 hours within 1 week after surgery, and critical AKI, defined as either AKI stage 2 or greater and/or any AKI connected to postoperative death or requiring kidney replacement therapy before discharge. The discrimination and calibration of the SPARK index were examined with area under the receiver operating characteristic curves (AUC) and calibration plots, respectively.</AbstractText><AbstractText Label="RESULTS">Among 5135 participants (2410 [46.9%] men), 303 (5.9%) developed PO-AKI, and 137 (2.7%) developed critical AKI. Compared with the SPARK cohort, participants in our cohort were older (median [IQR] age, 56 [44-66] years vs 63 [50-73] years), had lower baseline eGFR (median [IQR], 82.1 [71.4-95.1] mL/min/1.73 m2 vs 78.2 [65.6-92.2] mL/min/1.73 m2), and had a higher prevalence of comorbidities (eg, diabetes: 3956 of 51&#x202f;041 [7.8%] vs 802 [15.6%]). The incidence of PO-AKI and critical AKI increased as the scores on the SPARK index increased. For example, 10 of 593 participants (1.7%) in SPARK class A, indicating lowest risk, experienced PO-AKI, while 53 of 332 (16.0%) in SPARK class D, indicating highest risk, experienced PO-AKI. However, AUCs for PO-AKI and critical AKI were 0.67 (95% CI, 0.63-0.70) and 0.62 (95% CI, 0.57-0.67), respectively, and the calibration was poor (PO-AKI: y&#x2009;=&#x2009;0.24x&#x2009;+&#x2009;3.28; R2&#x2009;=&#x2009;0.86; critical AKI: y&#x2009;=&#x2009;0.20x&#x2009;+&#x2009;2.08; R2&#x2009;=&#x2009;0.51). Older age, diabetes, expected surgical duration, emergency surgery, renin-angiotensin-aldosterone system blockade use, and hyponatremia were not associated with PO-AKI in our cohort, resulting in overestimation of the predicted probability of AKI in our cohort.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">In this study, the incidence of PO-AKI increased as the scores on the SPARK index increased. However, the predicted probability might not be accurate in cohorts with older patients with more comorbidities.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nishimoto</LastName><ForeName>Masatoshi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Nara Medical University, Kashihara, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murashima</LastName><ForeName>Miho</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Nara Medical University, Kashihara, Nara, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nephrology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kokubu</LastName><ForeName>Maiko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Nara Prefecture General Medical Center, Nara, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsui</LastName><ForeName>Masaru</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Nara Medical University, Kashihara, Nara, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nephrology, Nara Prefecture General Medical Center, Nara, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eriguchi</LastName><ForeName>Masahiro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Nara Medical University, Kashihara, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samejima</LastName><ForeName>Ken-Ichi</ForeName><Initials>KI</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Nara Medical University, Kashihara, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akai</LastName><ForeName>Yasuhiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Nara Medical University, Kashihara, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsuruya</LastName><ForeName>Kazuhiko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Nara Medical University, Kashihara, Nara, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="Y">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Akai reported receiving personal fees from commercial sponsors outside the submitted work. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>18</Day><Hour>12</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34661665</ArticleId><ArticleId IdType="pmc">PMC8524308</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.27362</ArticleId><ArticleId IdType="pii">2785082</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lassnigg A, Schmidlin D, Mouhieddine M, et al. . Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004;15(6):1597-1605. doi:10.1097/01.ASN.0000130340.93930.DD</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ASN.0000130340.93930.DD</ArticleId><ArticleId IdType="pubmed">15153571</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JR, Cochran RP, Dacey LJ, et al. ; Northern New England Cardiovascular Disease Study Group . Perioperative increases in serum creatinine are predictive of increased 90-day mortality after coronary artery bypass graft surgery. Circulation. 2006;114(1)(suppl):I409-I413. doi:10.1161/CIRCULATIONAHA.105.000596</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.000596</ArticleId><ArticleId IdType="pubmed">16820609</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998;104(4):343-348. doi:10.1016/S0002-9343(98)00058-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(98)00058-8</ArticleId><ArticleId IdType="pubmed">9576407</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu CY, Chertow GM, McCulloch CE, Fan D, Ordo&#xf1;ez JD, Go AS. Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol. 2009;4(5):891-898. doi:10.2215/CJN.05571008</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.05571008</ArticleId><ArticleId IdType="pmc">PMC2676192</ArticleId><ArticleId IdType="pubmed">19406959</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishani A, Nelson D, Clothier B, et al. . The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death. Arch Intern Med. 2011;171(3):226-233. doi:10.1001/archinternmed.2010.514</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2010.514</ArticleId><ArticleId IdType="pubmed">21325112</ArticleId></ArticleIdList></Reference><Reference><Citation>Newsome BB, Warnock DG, McClellan WM, et al. . Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med. 2008;168(6):609-616. doi:10.1001/archinte.168.6.609</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.168.6.609</ArticleId><ArticleId IdType="pubmed">18362253</ArticleId></ArticleIdList></Reference><Reference><Citation>Huen SC, Parikh CR. Predicting acute kidney injury after cardiac surgery: a systematic review. Ann Thorac Surg. 2012;93(1):337-347. doi:10.1016/j.athoracsur.2011.09.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3286599</ArticleId><ArticleId IdType="pubmed">22186469</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S, Cho H, Park S, et al. . Simple Postoperative AKI Risk (SPARK) classification before noncardiac surgery: a prediction index development study with external validation. J Am Soc Nephrol. 2019;30(1):170-181. doi:10.1681/ASN.2018070757</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2018070757</ArticleId><ArticleId IdType="pmc">PMC6317608</ArticleId><ArticleId IdType="pubmed">30563915</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimoto M, Murashima M, Kokubu M, et al. . Positive association between intra-operative fluid balance and post-operative acute kidney injury in non-cardiac surgery: the NARA-AKI cohort study. J Nephrol. 2020;33(3):561-568. doi:10.1007/s40620-019-00688-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40620-019-00688-x</ArticleId><ArticleId IdType="pubmed">31865609</ArticleId></ArticleIdList></Reference><Reference><Citation>Murashima M, Nishimoto M, Kokubu M, et al. . Inflammation as a predictor of acute kidney injury and mediator of higher mortality after acute kidney injury in non-cardiac surgery. Sci Rep. 2019;9(1):20260. doi:10.1038/s41598-019-56615-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-56615-4</ArticleId><ArticleId IdType="pmc">PMC6937243</ArticleId><ArticleId IdType="pubmed">31889082</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagawa M, Nishimoto M, Kokubu M, et al. . Acute kidney injury as an independent predictor of infection and malignancy: the NARA-AKI cohort study. J Nephrol. 2019;32(6):967-975. doi:10.1007/s40620-019-00662-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40620-019-00662-7</ArticleId><ArticleId IdType="pubmed">31617159</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimoto M, Murashima M, Kokubu M, et al. . Pre-operative proteinuria and post-operative acute kidney injury in noncardiac surgery: the NARA-Acute Kidney Injury cohort study. Nephrol Dial Transplant. 2020;35(12):2111-2116. doi:10.1093/ndt/gfz269</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfz269</ArticleId><ArticleId IdType="pubmed">31891400</ArticleId></ArticleIdList></Reference><Reference><Citation>Nara Medical University . Clinical research: a retrospective cohort study of the onset and prognostic predictors of postoperative acute renal failure in non-cardiac surgery. Accessed September 15, 2021. http://nephrology.naramed-u.ac.jp/research/clinical.html</Citation></Reference><Reference><Citation>World Medical Association . World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-2194. doi:10.1001/jama.2013.281053</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.281053</ArticleId><ArticleId IdType="pubmed">24141714</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group . KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl.
2012;2: 1-138. Accessed September 15, 2021. https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2012-AKI-Guideline-English.pdf</Citation></Reference><Reference><Citation>Matsuo S, Imai E, Horio M, et al. ; Collaborators developing the Japanese equation for estimated GFR . Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982-992. doi:10.1053/j.ajkd.2008.12.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2008.12.034</ArticleId><ArticleId IdType="pubmed">19339088</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Englesbe MJ, et al. . Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology. 2007;107(6):892-902. doi:10.1097/01.anes.0000290588.29668.38</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.anes.0000290588.29668.38</ArticleId><ArticleId IdType="pubmed">18043057</ArticleId></ArticleIdList></Reference><Reference><Citation>Moons KG, Kengne AP, Grobbee DE, et al. . Risk prediction models: II, external validation, model updating, and impact assessment. Heart. 2012;98(9):691-698. doi:10.1136/heartjnl-2011-301247</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2011-301247</ArticleId><ArticleId IdType="pubmed">22397946</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell S, Dekker FW, Vadiveloo T, et al. . Risk of postoperative acute kidney injury in patients undergoing orthopaedic surgery&#x2014;development and validation of a risk score and effect of acute kidney injury on survival: observational cohort study. BMJ. 2015;351:h5639. doi:10.1136/bmj.h5639</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h5639</ArticleId><ArticleId IdType="pmc">PMC4641433</ArticleId><ArticleId IdType="pubmed">26561522</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EH, Kim HR, Baek SH, et al. . Risk factors of postoperative acute kidney injury in patients undergoing esophageal cancer surgery. J Cardiothorac Vasc Anesth. 2014;28(4):936-942. doi:10.1053/j.jvca.2013.12.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2013.12.006</ArticleId><ArticleId IdType="pubmed">24680132</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagawa M, Ogata A, Hamano T. Pre- and/or intra-operative prescription of diuretics, but not renin-angiotensin-system inhibitors, is significantly associated with acute kidney injury after non-cardiac surgery: a retrospective cohort study. PLoS One. 2015;10(7):e0132507. doi:10.1371/journal.pone.0132507</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0132507</ArticleId><ArticleId IdType="pmc">PMC4492997</ArticleId><ArticleId IdType="pubmed">26146836</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis MR, Naik BI, Freundlich RE, et al. ; Multicenter Perioperative Outcomes Group Investigators . Preoperative risk and the association between hypotension and postoperative acute kidney injury. Anesthesiology. 2020;132(3):461-475. doi:10.1097/ALN.0000000000003063</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003063</ArticleId><ArticleId IdType="pmc">PMC7015776</ArticleId><ArticleId IdType="pubmed">31794513</ArticleId></ArticleIdList></Reference><Reference><Citation>STARSurg Collaborative . Association between peri-operative angiotensin-converting enzyme inhibitors and angiotensin-2 receptor blockers and acute kidney injury in major elective non-cardiac surgery: a multicentre, prospective cohort study. Anaesthesia. 2018;73(10):1214-1222. doi:10.1111/anae.14349</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.14349</ArticleId><ArticleId IdType="pubmed">29984818</ArticleId></ArticleIdList></Reference><Reference><Citation>Rueggeberg A, Boehm S, Napieralski F, et al. . Development of a risk stratification model for predicting acute renal failure in orthotopic liver transplantation recipients. Anaesthesia. 2008;63(11):1174-1180. doi:10.1111/j.1365-2044.2008.05604.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2008.05604.x</ArticleId><ArticleId IdType="pubmed">18803627</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Heung M, et al. . Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set. Anesthesiology. 2009;110(3):505-515. doi:10.1097/ALN.0b013e3181979440</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181979440</ArticleId><ArticleId IdType="pubmed">19212261</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyle JM, Moualla S, Arrigain S, et al. . Risks and outcomes of acute kidney injury requiring dialysis after cardiac transplantation. Am J Kidney Dis. 2006;48(5):787-796. doi:10.1053/j.ajkd.2006.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2006.08.002</ArticleId><ArticleId IdType="pubmed">17059998</ArticleId></ArticleIdList></Reference><Reference><Citation>Slankamenac K, Breitenstein S, Held U, Beck-Schimmer B, Puhan MA, Clavien PA. Development and validation of a prediction score for postoperative acute renal failure following liver resection. Ann Surg. 2009;250(5):720-728. doi:10.1097/SLA.0b013e3181bdd840</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e3181bdd840</ArticleId><ArticleId IdType="pubmed">19809295</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa S, Griesdale DE, Lohser J. Acute kidney injury after lung resection surgery: incidence and perioperative risk factors. Anesth Analg. 2012;114(6):1256-1262. doi:10.1213/ANE.0b013e31824e2d20</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e31824e2d20</ArticleId><ArticleId IdType="pubmed">22451594</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmasi V, Maheshwari K, Yang D, et al. . Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery: a retrospective cohort analysis. Anesthesiology. 2017;126(1):47-65. doi:10.1097/ALN.0000000000001432</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001432</ArticleId><ArticleId IdType="pubmed">27792044</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M, Li G, Mohan S, Turnbull ZA, Kiran RP, Li G. Intraoperative data enhance the detection of high-risk acute kidney injury patients when added to a baseline prediction model. Anesth Analg. 2021;132(2):430-441. doi:10.1213/ANE.0000000000005057</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005057</ArticleId><ArticleId IdType="pmc">PMC7855510</ArticleId><ArticleId IdType="pubmed">32769380</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36912758</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-9159</ISSN><JournalIssue CitedMedium="Internet"><Volume>109</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of surgery (London, England)</Title><ISOAbbreviation>Int J Surg</ISOAbbreviation></Journal><ArticleTitle>Comparison of risk of complication between neuraxial anaesthesia and general anaesthesia for hip fracture surgery: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>458</StartPage><EndPage>468</EndPage><MedlinePgn>458-468</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/JS9.0000000000000291</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Controversy remains over the choice of anaesthetic technique for patients undergoing surgery for hip fracture.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">The aim was to compare the risk of complication of neuraxial anaesthesia with that of general anaesthesia in patients undergoing hip fracture surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This systematic review was performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines and was registered at PROSPERO (CRD42022337384). The study included eligible randomised controlled trials published before February 2022. Data synthesis was performed to compare the differences between general and neuraxial anaesthesia. Meta-regression analysis was performed to investigate the influence of the publication year. A subgroup analysis was performed based on patient age and the anaesthetic technique used. A grading of recommendations, assessment, development and evaluations assessment was performed to assess the quality of each outcome.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty randomised controlled trials and 4802 patients were included. Data synthesis revealed significant higher risk of acute kidney injury in the general anaesthesia group ( P =0.01). There were no significant differences between the two techniques in postoperative short-term mortality ( P =0.34), delirium ( P =0.40), postoperative nausea and vomiting ( P =0.40), cardiac infarction ( P =0.31), acute heart failure ( P =0.34), pulmonary embolism ( P =0.24) and pneumonia ( P =0.15). Subgroup analysis based on patient age and use of sedative medication did not reveal any significant differences. Meta-regression analysis of the publication year versus each adverse event revealed no statistically significant differences.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">A significantly higher risk of postoperative acute kidney injury was found in patients receiving general anaesthesia. This study revealed no significant differences in terms of postoperative mortality and other complications between general and neuraxial anaesthesia. The results were consistent across the age groups.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Departments of Orthopedics.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hairui</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-5188-3435</Identifier><AffiliationInfo><Affiliation>Plastic Surgery, West China Hospital, West China School of Medicine, Sichuan University, Chengdu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Songlin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Science.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yiou</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Science.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Ruichen</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>School of Medicine, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Wenwei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Science.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Gang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Departments of Orthopedics.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Departments of Orthopedics.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Surg</MedlineTA><NlmUniqueID>101228232</NlmUniqueID><ISSNLinking>1743-9159</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="Y">Hip Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020250" MajorTopicYN="N">Postoperative Nausea and Vomiting</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000776" MajorTopicYN="Y">Anesthesiology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>None. Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>13</Day><Hour>10</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36912758</ArticleId><ArticleId IdType="pmc">PMC10389547</ArticleId><ArticleId IdType="doi">10.1097/JS9.0000000000000291</ArticleId><ArticleId IdType="pii">01279778-202303000-00031</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Curtis EM, Moon RJ, Harvey NC, et al. . The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide. Bone 2017;104:29&#x2013;38. 10.1016/j.bone.2017.01.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2017.01.024</ArticleId><ArticleId IdType="pmc">PMC5420448</ArticleId><ArticleId IdType="pubmed">28119181</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donnell CM, McLoughlin L, Patterson CC, et al. . Perioperative outcomes in the context of mode of anaesthesia for patients undergoing hip fracture surgery: systematic review and meta-analysis. Br J Anaesth 2018;1:37&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">29397135</ArticleId></ArticleIdList></Reference><Reference><Citation>Werner M, Macke C, Gogol M, et al. . Differences in hip fracture care in Europe: a systematic review of recent annual reports of hip fracture registries. Eur J Trauma Emerg Surg 2022;3:1625&#x2013;1638.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9192454</ArticleId><ArticleId IdType="pubmed">34623474</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsoulis M, Benetou V, Karapetyan T, et al. . Excess mortality after hip fracture in elderly persons from Europe and the USA: the CHANCES project. J Intern Med 2017;3:300&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pubmed">28093824</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik AT, Panni UY, Masri BA, et al. . The impact of surgeon volume and hospital volume on postoperative mortality and morbidity after hip fractures: a systematic review. Int J Surg 2018;54:316&#x2013;327.</Citation><ArticleIdList><ArticleId IdType="pubmed">29102691</ArticleId></ArticleIdList></Reference><Reference><Citation>He R, Wang G, Li T, et al. . Factors associated with 90-day acute ischemic stroke in patients &#x2265;70&#x2009;years old with total hip arthroplasty for hip fracture. BMC Geriatr 2022;1:28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8733812</ArticleId><ArticleId IdType="pubmed">34991502</ArticleId></ArticleIdList></Reference><Reference><Citation>Guay J, Parker MJ, Gajendragadkar PR, et al. . Anaesthesia for hip fracture surgery in adults. Cochrane Database Syst Rev 2016;2:Cd000521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6464323</ArticleId><ArticleId IdType="pubmed">26899415</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X, Tan Y, Gao Y, et al. . Comparative efficacy of neuraxial and general anesthesia for hip fracture surgery: a meta-analysis of randomized clinical trials. BMC Anesthesiol 2020;1:162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7325684</ArticleId><ArticleId IdType="pubmed">32605591</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Feng R, Carson JL, et al. . Spinal anesthesia or general anesthesia for hip surgery in older adults. N Engl J Med 2021;22:2025&#x2013;2035.</Citation><ArticleIdList><ArticleId IdType="pubmed">34623788</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Silber JH, Elkassabany NM, et al. . Comparative effectiveness of regional versus general anesthesia for hip fracture surgery in adults. Anesthesiology 2012;1:72&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">22713634</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn EJ, Kim HJ, Kim KW, et al. . Comparison of general anaesthesia and regional anaesthesia in terms of mortality and complications in elderly patients with hip fracture: a nationwide population-based study. BMJ Open 2019;9:e029245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6738684</ArticleId><ArticleId IdType="pubmed">31501111</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravi B, Pincus D, Choi S, et al. . Association of duration of surgery with postoperative delirium among patients receiving hip fracture repair. JAMA Netw Open 2019;2:e190111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6484601</ArticleId><ArticleId IdType="pubmed">30794305</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu CC, Weng SF, Chen KT, et al. . Propensity score-matched comparison of postoperative adverse outcomes between geriatric patients given a general or a neuraxial anesthetic for hip surgery: a population-based study. Anesthesiol 2015;1:136&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">25955981</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Li J, Yuan L, et al. . Effect of regional vs general anesthesia on incidence of postoperative delirium in older patients undergoing hip fracture surgery: the raga randomized trial. Jama 2022;1:50&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8689436</ArticleId><ArticleId IdType="pubmed">34928310</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donnell CM, Black N, McCourt KC, et al. . Development of a Core Outcome Set for studies evaluating the effects of anaesthesia on perioperative morbidity and mortality following hip fracture surgery. Br J Anaesth 2019;1:120&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pubmed">30579390</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzimas P, Samara E, Petrou A, et al. . The influence of anesthetic techniques on postoperative cognitive function in elderly patients undergoing hip fracture surgery: general vs spinal anesthesia. Injury 2018;12:2221&#x2013;2226.</Citation><ArticleIdList><ArticleId IdType="pubmed">30526923</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang L, Fang P, Fang Y, et al. . Comparison of effects between combined lumbar-sacral plexus block plus general anesthesia and unilateral spinal anesthesia in elderly patients undergoing hip fracture surgery: a pilot randomized controlled trial. Evid Based Complement Alternat Med 2021;&#x25a0;:6685497. 10.1155/2021/6685497</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6685497</ArticleId><ArticleId IdType="pmc">PMC8105098</ArticleId><ArticleId IdType="pubmed">34012474</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin S, Kim SH, Park KK, et al. . Effects of anesthesia techniques on outcomes after hip fracture surgery in elderly patients: a prospective, randomized, controlled trial. J Clin Med 2020;6:1605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7355551</ArticleId><ArticleId IdType="pubmed">32466360</ArticleId></ArticleIdList></Reference><Reference><Citation>Meuret P, Bouvet L, Villet B, et al. . Hypobaric unilateral spinal anaesthesia versus general anaesthesia in elderly patients undergoing hip fracture surgical repair: a prospective randomised open trial. Turk J Anaesthesiol Reanim 2018;2:121&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5937458</ArticleId><ArticleId IdType="pubmed">29744247</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonin M, Delsuc C, Meuret P, et al. . Hypobaric unilateral spinal anesthesia versus general anesthesia for hip fracture surgery in the elderly: a randomized controlled trial. Anesth Analg 2022;6:1262&#x2013;1270.</Citation><ArticleIdList><ArticleId IdType="pubmed">36135347</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel V, Champaneria R, Dretzke J, et al. . Effect of regional versus general anaesthesia on postoperative delirium in elderly patients undergoing surgery for hip fracture: a systematic review. BMJ Open 2018;12:e020757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6286489</ArticleId><ArticleId IdType="pubmed">30518580</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Waesberghe J, Stevanovic A, Rossaint R, et al. . General vs. neuraxial anaesthesia in hip fracture patients: a systematic review and meta-analysis. BMC Anesthesiol 2017;1:87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5490182</ArticleId><ArticleId IdType="pubmed">28659127</ArticleId></ArticleIdList></Reference><Reference><Citation>Urwin SC, Parker MJ, Griffiths R. General versus regional anaesthesia for hip fracture surgery: a meta-analysis of randomized trials. Br J Anaesth 2000;4:450&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pubmed">10823094</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorenson RM, Pace NL. Anesthetic techniques during surgical repair of femoral neck fractures. A meta-analysis, Anesthesiol 1992;6:1095&#x2013;1104.</Citation><ArticleIdList><ArticleId IdType="pubmed">1466461</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg 2021;88:105906. 10.1016/j.ijsu.2021.105906</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2021.105906</ArticleId><ArticleId IdType="pubmed">33789826</ArticleId></ArticleIdList></Reference><Reference><Citation>Shea BJ, Reeves BC, Wells G, et al. . AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. Bmj 2017;358:j4008. 10.1136/bmj.j4008</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.j4008</ArticleId><ArticleId IdType="pmc">PMC5833365</ArticleId><ArticleId IdType="pubmed">28935701</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, et al. . What is &#x2018;quality of evidence&#x2019; and why is it important to clinicians? Bmj 2008;7651:995&#x2013;998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2364804</ArticleId><ArticleId IdType="pubmed">18456631</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt G, Oxman AD, Akl EA, et al. . GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011;4:383&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pubmed">21195583</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, G&#xf8;tzsche PC, et al. . The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928. 10.1136/bmj.d5928</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Soft 2010;3:1&#x2013;48.</Citation></Reference><Reference><Citation>Higgins JP, Thomas J, Chandler J, et al. . Cochrane Handbook for Systematic Reviews of Interventions. John Wiley &amp; Sons; 2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo D, Wan X, Liu J, et al. . Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res 2018;6:1785&#x2013;1805.</Citation><ArticleIdList><ArticleId IdType="pubmed">27683581</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X, Wang W, Liu J, et al. . Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 2014;14:135. 10.1186/1471-2288-14-135</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-135</ArticleId><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Biboulet P, Jourdan A, Van Haevre V, et al. . Hemodynamic profile of target-controlled spinal anesthesia compared with 2 target-controlled general anesthesia techniques in elderly patients with cardiac comorbidities. Reg Anesth Pain Med 2012;4:433&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pubmed">22609644</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigler D, Adelh&#xf8;j B, Petring OU, et al. . Mental function and morbidity after acute hip surgery during spinal and general anaesthesia. Anaesthesia 1985;40:672&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pubmed">4025772</ArticleId></ArticleIdList></Reference><Reference><Citation>Casati A, Aldegheri G, Vinciguerra E, et al. . Randomized comparison between sevoflurane anaesthesia and unilateral spinal anaesthesia in elderly patients undergoing orthopaedic surgery. Eur J Anaesthesiol 2003;20:640&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pubmed">12932066</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis FM, Laurenson VG. Spinal anaesthesia or general anaesthesia for emergency hip surgery in elderly patients. Anaesth Intensive Care 1981;9:352&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">6797318</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis FM, Woolner DF, Frampton C, et al. . Prospective, multi-centre trial of mortality following general or spinal anaesthesia for hip fracture surgery in the elderly. Br J Anaesth 1987;59:1080&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">3311100</ArticleId></ArticleIdList></Reference><Reference><Citation>Haghighi M, Sedighinejad A, Nabi BN, et al. . Is Spinal Anesthesia with Low Dose Lidocaine Better than Sevoflorane Anesthesia in Patients Undergoing Hip Fracture Surgery. Arch Bone Jt Surg 2017;5:226&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5592363</ArticleId><ArticleId IdType="pubmed">28913379</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Li J, Yuan L, et al. . Effect of Regional vs General Anesthesia on Incidence of Postoperative Delirium in Older Patients Undergoing Hip Fracture Surgery: The RAGA Randomized Trial. Jama 2022;327:50&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8689436</ArticleId><ArticleId IdType="pubmed">34928310</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenzie PJ, Wishart HY, Dewar KM, et al. . Comparison of the effects of spinal anaesthesia and general anaesthesia on postoperative oxygenation and perioperative mortality. Br J Anaesth 1980;52:49&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">6769450</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenzie PJ, Wishart HY, Smith G. Long-term outcome after repair of fractured neck of femur. Comparison of subarachnoid and general anaesthesia. Br J Anaesth 1984;56:581&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">6721969</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenzie PJ, Wishart HY, Gray I, et al. . Effects of anaesthetic technique on deep vein thrombosis. A comparison of subarachnoid and general anaesthesia. Br J Anaesth 1985;57:853&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">4027101</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina A, Frassanito L, Colombo D, et al. . Hemodynamic changes associated with spinal and general anesthesia for hip fracture surgery in severe ASA III elderly population: a pilot trial. Minerva Anestesiol 2013;79:1021&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23635998</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Mehta S, Bannister ER, et al. . Pilot Randomized Controlled Trial of Spinal Versus General Anesthesia for Hip Fracture Surgery. J Am Geriatr Soc 2016;64:2604&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5180205</ArticleId><ArticleId IdType="pubmed">27996117</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MJ, Griffiths R. General versus regional anaesthesia for hip fractures. A pilot randomised controlled trial of 322 patients. Injury 2015;46:1562&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">26049662</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang L, Fang P, Fang Y, et al. . Comparison of Effects between Combined Lumbar-Sacral Plexus Block plus General Anesthesia and Unilateral Spinal Anesthesia in Elderly Patients Undergoing Hip Fracture Surgery: A Pilot Randomized Controlled Trial. Evid Based Complement Alternat Med 2021;2021:6685497.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8105098</ArticleId><ArticleId IdType="pubmed">34012474</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickstr&#xf6;m I, Holmberg I, Stef&#xe1;nsson T. Survival of female geriatric patients after hip fracture surgery. A comparison of 5 anesthetic methods. Acta Anaesthesiol Scand 1982;26:607&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">7158270</ArticleId></ArticleIdList></Reference><Reference><Citation>Mufarrih SH, Qureshi NQ, Schaefer MS, et al. . Regional anaesthesia for lower extremity amputation is associated with reduced postoperative complications compared with general anaesthesia. Eur J Vasc Endovasc Surg 2021;3:476&#x2013;484.</Citation><ArticleIdList><ArticleId IdType="pubmed">34303598</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa AS, Ferrito C, Paiva JA. Intubation-associated pneumonia: an integrative review. Intensive Crit Care Nurs 2018;44:45&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">28869146</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Z, Hu J, Ma D. Postoperative delirium: perioperative assessment, risk reduction, and management. Br J Anaesth 2020;4:492&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pubmed">32798069</ArticleId></ArticleIdList></Reference><Reference><Citation>Palanne R, Rantasalo M, Vakkuri A, et al. . Effects of anaesthesia method and tourniquet use on recovery following total knee arthroplasty: a randomised controlled study. Br J Anaesth 2020;5:762&#x2013;772.</Citation><ArticleIdList><ArticleId IdType="pubmed">32620260</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu SY, Li C, Zhang PX. Enhanced recovery after surgery for hip fractures: a systematic review and meta-analysis. Perioper Med (Lond) 2021;1:31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8436561</ArticleId><ArticleId IdType="pubmed">34511117</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu W, Yan Y, Sun Y, et al. . Implementation of Enhanced Recovery After Surgery (ERAS) protocol for elderly patients receiving surgery for intertrochanteric fracture: a propensity score-matched analysis. J Orthop Surg Res 2021;1:469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8317361</ArticleId><ArticleId IdType="pubmed">34315507</ArticleId></ArticleIdList></Reference><Reference><Citation>Morcos MW, Nowak L, Schemitsch E. Prolonged surgical time increases the odds of complications following total knee arthroplasty. Can J Surg 2021;3:E273&#x2013;E279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8327989</ArticleId><ArticleId IdType="pubmed">33908732</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornell&#xe0; N, Sancho J, Sitges-Serra A. Short and long-term outcomes after surgical procedures lasting for more than six hours. Sci Rep 2017;1:9221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5569056</ArticleId><ArticleId IdType="pubmed">28835620</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Zhang J, Yang L, et al. . Isoflurane and sevoflurane increase interleukin-6 levels through the nuclear factor-kappa B pathway in neuroglioma cells. Br J Anaesth 2013;Suppl 1:i82&#x2013;i91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3667345</ArticleId><ArticleId IdType="pubmed">23604542</ArticleId></ArticleIdList></Reference><Reference><Citation>Pu X, Sun JM. General anesthesia vs spinal anesthesia for patients undergoing total-hip arthroplasty: a meta-analysis. Med (Baltimore) 2019;16:e14925.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6494405</ArticleId><ArticleId IdType="pubmed">31008923</ArticleId></ArticleIdList></Reference><Reference><Citation>Maradit Kremers H, Larson DR, Crowson CS, et al. . Prevalence of total hip and knee replacement in the United States. J Bone Joint Surg Am 2015;17:1386&#x2013;1397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4551172</ArticleId><ArticleId IdType="pubmed">26333733</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Zhi X, Zhang H. Investigation on the etiology of patients undergoing nontraumatic total hip arthroplasty in China. J Orthop Surg (Hong Kong) 2022;1:10225536221092114.</Citation><ArticleIdList><ArticleId IdType="pubmed">35400228</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhandari M, Swiontkowski M. Management of acute hip fracture. N Engl J Med 2017;21:2053&#x2013;2062.</Citation><ArticleIdList><ArticleId IdType="pubmed">29166235</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones MD, Parry M, Whitehouse MR, et al. . Early death following revision total hip arthroplasty. Hip Int 2018;4:400&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">29218686</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosk CA, Mus M, Vroemen JP, et al. . Dementia and delirium, the outcomes in elderly hip fracture patients. Clin Interv Aging 2017;12:421&#x2013;430.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5354532</ArticleId><ArticleId IdType="pubmed">28331300</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang W, Lv H, Feng C, et al. . Preventable risk factors of mortality after hip fracture surgery: systematic review and meta-analysis. Int J Surg 2018;52:320&#x2013;328.</Citation><ArticleIdList><ArticleId IdType="pubmed">29530826</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandharipande P, Ely EW. Sedative and analgesic medications: risk factors for delirium and sleep disturbances in the critically ill. Crit Care Clin 2006;2:313&#x2013;327.</Citation><ArticleIdList><ArticleId IdType="pubmed">16678002</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EHZ, Sunderland S, Edwards NY, et al. . A single prophylactic dose of ondansetron given at cessation of postoperative propofol sedation decreases postoperative nausea and vomiting in cardiac surgery patients: a randomized controlled trial. Anesth Analg 2020;4:1164&#x2013;1172.</Citation><ArticleIdList><ArticleId IdType="pubmed">32925337</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng H, Chen BP, Soleas IM, et al. . Prolonged operative duration increases risk of surgical site infections: a systematic review. Surg Infect (Larchmt) 2017;6:722&#x2013;735.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5685201</ArticleId><ArticleId IdType="pubmed">28832271</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowak LL, Schemitsch EH. Duration of surgery affects the risk of complications following total hip arthroplasty. Bone Joint J 2019;6_Supple_B:51&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">31146572</ArticleId></ArticleIdList></Reference><Reference><Citation>Said CM, Delahunt M, Ciavarella V, et al. . Factors impacting early mobilization following hip fracture: an observational study. J Geriatr Phys Ther 2021;2:88&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">33534334</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenyon-Smith T, Nguyen E, Oberai T, et al. . Early mobilization post-hip fracture surgery. Geriatr Orthop Surg Rehabil 2019;10:2151459319826431. 10.1177/2151459319826431</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2151459319826431</ArticleId><ArticleId IdType="pmc">PMC6454638</ArticleId><ArticleId IdType="pubmed">31001454</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37063282</PMID><DateRevised><Year>2023</Year><Month>04</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1663-9812</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in pharmacology</Title><ISOAbbreviation>Front Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Correlation between perioperative dexmedetomidine administration and postoperative acute kidney injury in hypertensive patients undergoing non-cardiac surgery.</ArticleTitle><Pagination><StartPage>1143176</StartPage><MedlinePgn>1143176</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1143176</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fphar.2023.1143176</ELocationID><Abstract><AbstractText><b>Background:</b> Previous studies have suggested that dexmedetomidine may have a protective effect on renal function. However, it is currently unclear whether perioperative dexmedetomidine administration is associated with postoperative acute kidney injury (AKI) incidence risk in hypertensive patients undergoing non-cardiac surgery. <b>Methods:</b> This investigation was a retrospective cohort study. Hypertensive patients undergoing non-cardiac surgery in Third Xiangya Hospital of Central South University from June 2018 to December 2019 were included. The relevant data were extracted through electronic cases. The univariable analysis identified demographic, preoperative laboratory, and intraoperative factors associated with acute kidney injury. Multivariable stepwise logistic regression was used to assess the association between perioperative dexmedetomidine administration and postoperative acute kidney injury after adjusting for interference factors. In addition, we further performed sensitivity analyses in four subgroups to further validate the robustness of the results. <b>Results:</b> A total of 5769 patients were included in this study, with a 7.66% incidence of postoperative acute kidney injury. The incidence of postoperative acute kidney injury was lower in the dexmedetomidine-administered group than in the control group (4.12% vs. 8.06%, <i>p</i> &lt; 0.001). In the multivariable stepwise logistic regression analysis, perioperative dexmedetomidine administration significantly reduced the risk of postoperative acute kidney injury after adjusting for interference factors [odds ratio (OR) = 0.56, 95% confidence interval (CI): 0.36-0.87, <i>p</i> = 0.010]. In addition, sensitivity analysis in four subgroups indicated parallel findings: i) eGRF &lt;90&#xa0;mL/min&#xb7;1.73/m<sup>2</sup> subgroup (OR = 0.40, 95% CI: 0.19-0.84, <i>p</i> = 0.016), ii) intraoperative blood loss &lt;1000&#xa0;mL subgroup (OR = 0.58, 95% CI: 0.36-0.94, <i>p</i> = 0.025), iii) non-diabetes subgroup (OR = 0.51, 95% CI: 0.29-0.89, <i>p</i> = 0.018), and iv) older subgroup (OR = 0.55, 95% CI: 0.32-0.93, <i>p</i> = 0.027). <b>Conclusion:</b> In conclusion, our study suggests that perioperative dexmedetomidine administration is associated with lower risk and less severity of postoperative acute kidney injury in hypertensive individuals undergoing non-cardiac surgery. Therefore, future large-scale RCT studies are necessary to validate this benefit.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Li, Chen, Zeng and Luo.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Operation Center, Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Minghua</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Youjie</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Siwan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pharmacol</MedlineTA><NlmUniqueID>101548923</NlmUniqueID><ISSNLinking>1663-9812</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AKI stage</Keyword><Keyword MajorTopicYN="N">dexmedetomidine</Keyword><Keyword MajorTopicYN="N">hypertensive</Keyword><Keyword MajorTopicYN="N">incidence risk</Keyword><Keyword MajorTopicYN="N">non-cardiac surgery</Keyword><Keyword MajorTopicYN="N">postoperative acute kidney injury</Keyword><Keyword MajorTopicYN="N">renal function</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>17</Day><Hour>3</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37063282</ArticleId><ArticleId IdType="pmc">PMC10090366</ArticleId><ArticleId IdType="doi">10.3389/fphar.2023.1143176</ArticleId><ArticleId IdType="pii">1143176</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abdel-Kader K., Palevsky P. M. (2009). Acute kidney injury in the elderly. Clin. Geriatr. Med. 25 (3), 331&#x2013;358. 10.1016/j.cger.2009.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cger.2009.04.001</ArticleId><ArticleId IdType="pmc">PMC2748997</ArticleId><ArticleId IdType="pubmed">19765485</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauerle J. D., Grenz A., Kim J. H., Lee H. T., Eltzschig H. K. (2011). Adenosine generation and signaling during acute kidney injury. J. Am. Soc. Nephrol. 22 (1), 14&#x2013;20. 10.1681/ASN.2009121217</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2009121217</ArticleId><ArticleId IdType="pubmed">21209250</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckman K. D. (2014). How to document and code for hypertensive diseases in ICD-10. Fam. Pract. Manag. 21 (2), 5&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24693838</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R., Kellum J. A., Ronco C. (2012). Acute kidney injury. Lancet 380 (9843), 756&#x2013;766. 10.1016/S0140-6736(11)61454-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)61454-2</ArticleId><ArticleId IdType="pubmed">22617274</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwers S., Sudano I., Kokubo Y., Sulaica E. M. (2021). Arterial hypertension. Lancet 398 (10296), 249&#x2013;261. 10.1016/S0140-6736(21)00221-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00221-X</ArticleId><ArticleId IdType="pubmed">34019821</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyle D. J., Goyal A., Bansal P., Garmon E. H. (2021). American society of anesthesiologists classification. Treasure Island: StatPearls Publishing.</Citation><ArticleIdList><ArticleId IdType="pubmed">28722969</ArticleId></ArticleIdList></Reference><Reference><Citation>Gameiro J., Fonseca J. A., Marques F., Lopes J. A. (2020). Management of acute kidney injury following major abdominal surgery: A contemporary Review. J. Clin. Med. 9 (8), 2679. 10.3390/jcm9082679</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9082679</ArticleId><ArticleId IdType="pmc">PMC7463962</ArticleId><ArticleId IdType="pubmed">32824854</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J., Sun P., Zhao H., Watts H. R., Sanders R. D., Terrando N., et al. (2011). Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Crit. Care 15 (3), R153. 10.1186/cc10283</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10283</ArticleId><ArticleId IdType="pmc">PMC3219027</ArticleId><ArticleId IdType="pubmed">21702944</ArticleId></ArticleIdList></Reference><Reference><Citation>Gumbert S. D., Kork F., Jackson M. L., Vanga N., Ghebremichael S. J., Wang C. Y., et al. (2020). Perioperative acute kidney injury. Anesthesiology 132 (1), 180&#x2013;204. 10.1097/ALN.0000000000002968</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000002968</ArticleId><ArticleId IdType="pmc">PMC10924686</ArticleId><ArticleId IdType="pubmed">31687986</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B., Tian T., Li X., Liu W., Chen Y., Jiang T., et al. (2022). Perioperative dexmedetomidine administration does not reduce the risk of acute kidney injury after non-cardiac surgery: A meta-analysis. Chin. Med. J. Engl. 135 (23), 2798&#x2013;2804. 10.1097/cm9.0000000000002408</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/cm9.0000000000002408</ArticleId><ArticleId IdType="pmc">PMC9944691</ArticleId><ArticleId IdType="pubmed">36728946</ArticleId></ArticleIdList></Reference><Reference><Citation>Ida M., Sumida M., Naito Y., Tachiiri Y., Kawaguchi M. (2020). Impact of intraoperative hypotension and blood loss on acute kidney injury after pancreas surgery. Braz. J. Anesthesiol. Engl. Ed. 70 (4), 343&#x2013;348. 10.1016/j.bjan.2020.04.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjan.2020.04.011</ArticleId><ArticleId IdType="pmc">PMC9373639</ArticleId><ArticleId IdType="pubmed">32739201</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang K., Gao Y., Wang S. C., Liu H. T., Kong W. L., Zhang X., et al. (2018). Dexmedetomidine protects against lipopolysaccharide-induced sepsis-associated acute kidney injury via an &#x3b1;7 nAChR-dependent pathway. Biomed. Pharmacother. 106, 210&#x2013;216. 10.1016/j.biopha.2018.06.059</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2018.06.059</ArticleId><ArticleId IdType="pubmed">29960167</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum J. A., Lameire N., Aspelin P., Barsoum R. S., Burdmann E. A., Goldstein S. L., et al. (2012). Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int. Suppl. 2 (1), 1&#x2013;138.</Citation></Reference><Reference><Citation>Kim M., Brady J. E., Li G. (2014). Variations in the risk of acute kidney injury across intraabdominal surgery procedures. Anesth. Analg. 119 (5), 1121&#x2013;1132. 10.1213/ANE.0000000000000425</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000000425</ArticleId><ArticleId IdType="pubmed">25191972</ArticleId></ArticleIdList></Reference><Reference><Citation>Kork F., Balzer F., Spies C. D., Wernecke K. D., Ginde A. A., Jankowski J., et al. (2015). Minor postoperative increases of creatinine are associated with higher mortality and longer hospital length of stay in surgical patients. Anesthesiology 123 (6), 1301&#x2013;1311. 10.1097/ALN.0000000000000891</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000891</ArticleId><ArticleId IdType="pmc">PMC4679549</ArticleId><ArticleId IdType="pubmed">26492475</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulka P. J., Tryba M., Zenz M. (1996). Preoperative alpha2-adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: Results of a randomized, controlled trial. Crit. Care Med. 24 (6), 947&#x2013;952. 10.1097/00003246-199606000-00012</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199606000-00012</ArticleId><ArticleId IdType="pubmed">8681596</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S. (2019). Dexmedetomidine: Present and future directions. Korean J. Anesthesiol. 72 (4), 323&#x2013;330. 10.4097/kja.19259</Citation><ArticleIdList><ArticleId IdType="doi">10.4097/kja.19259</ArticleId><ArticleId IdType="pmc">PMC6676029</ArticleId><ArticleId IdType="pubmed">31220910</ArticleId></ArticleIdList></Reference><Reference><Citation>Leino K., Hynynen M., Jalonen J., Salmenpera M., Scheinin H., Aantaa R., et al. (2011). Renal effects of dexmedetomidine during coronary artery bypass surgery: A randomized placebo-controlled study. BMC Anesthesiol. 11, 9. 10.1186/1471-2253-11-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2253-11-9</ArticleId><ArticleId IdType="pmc">PMC3123640</ArticleId><ArticleId IdType="pubmed">21605394</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang H., Liu H. Z., Wang H. B., Zhong J. Y., Yang C. X., Zhang B. (2017). Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation. Inflamm. Res. 66 (5), 399&#x2013;411. 10.1007/s00011-017-1023-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-017-1023-9</ArticleId><ArticleId IdType="pubmed">28224201</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Li Y., Kang L., Wang Q. (2021). Recent advances in the clinical value and potential of dexmedetomidine. J. Inflamm. Res. 14, 7507&#x2013;7527. 10.2147/JIR.S346089</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S346089</ArticleId><ArticleId IdType="pmc">PMC8724687</ArticleId><ArticleId IdType="pubmed">35002284</ArticleId></ArticleIdList></Reference><Reference><Citation>Ljungqvist O., Scott M., Fearon K. C. (2017). Enhanced recovery after surgery: A Review. JAMA Surg. 152 (3), 292&#x2013;298. 10.1001/jamasurg.2016.4952</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2016.4952</ArticleId><ArticleId IdType="pubmed">28097305</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis M. R., Naik B. I., Freundlich R. E., Shanks A. M., Heung M., Kim M., et al. (2020). Preoperative risk and the association between hypotension and postoperative acute kidney injury. Anesthesiology 132 (3), 461&#x2013;475. 10.1097/aln.0000000000003063</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aln.0000000000003063</ArticleId><ArticleId IdType="pmc">PMC7015776</ArticleId><ArticleId IdType="pubmed">31794513</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M., Schmidt C., Zarbock A. (2017). Perioperative acute kidney injury: An under-recognized problem. Anesth. Analg. 125 (4), 1223&#x2013;1232. 10.1213/ANE.0000000000002369</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000002369</ArticleId><ArticleId IdType="pubmed">28787339</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadim M. K., Forni L. G., Bihorac A., Hobson C., Koyner J. L., Shaw A., et al. (2018). Cardiac and vascular surgery-associated acute kidney injury: The 20th international consensus conference of the ADQI (acute disease quality initiative) group. J. Am. Heart Assoc. 7 (11), e008834. 10.1161/jaha.118.008834</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/jaha.118.008834</ArticleId><ArticleId IdType="pmc">PMC6015369</ArticleId><ArticleId IdType="pubmed">29858368</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J. T. (2017). Postoperative acute kidney injury. Korean J. Anesthesiol. 70 (3), 258&#x2013;266. 10.4097/kjae.2017.70.3.258</Citation><ArticleIdList><ArticleId IdType="doi">10.4097/kjae.2017.70.3.258</ArticleId><ArticleId IdType="pmc">PMC5453887</ArticleId><ArticleId IdType="pubmed">28580076</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S. W., Kim M., Kim J. Y., Ham A., Brown K. M., Mori-Akiyama Y., et al. (2012). Paneth cell-mediated multiorgan dysfunction after acute kidney injury. J. Immunol. 189 (11), 5421&#x2013;5433. 10.4049/jimmunol.1200581</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1200581</ArticleId><ArticleId IdType="pmc">PMC3504173</ArticleId><ArticleId IdType="pubmed">23109723</ArticleId></ArticleIdList></Reference><Reference><Citation>Patschan D., M&#xfc;ller G. A. (2016). Acute kidney injury in diabetes mellitus. Int. J. Nephrol. 2016, 6232909. 10.1155/2016/6232909</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/6232909</ArticleId><ArticleId IdType="pmc">PMC5126418</ArticleId><ArticleId IdType="pubmed">27974972</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle J. R., Forni L. G., Bell M., Chew M. S., Edwards M., Grams M. E., et al. (2021). Postoperative acute kidney injury in adult non-cardiac surgery: Joint consensus report of the acute disease quality initiative and PeriOperative quality initiative. Nat. Rev. Nephrol. 17 (9), 605&#x2013;618. 10.1038/s41581-021-00418-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-021-00418-2</ArticleId><ArticleId IdType="pmc">PMC8367817</ArticleId><ArticleId IdType="pubmed">33976395</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrier R. W., Wang W. (2004). Acute renal failure and sepsis. N. Engl. J. Med. 351 (2), 159&#x2013;169. 10.1056/NEJMra032401</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra032401</ArticleId><ArticleId IdType="pubmed">15247356</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan X. S., Dai H. R., Zhao D., Yang B. W., Feng X. M., Liu H., et al. (2021). Dexmedetomidine reduces acute kidney injury after endovascular aortic repair of stanford type B aortic dissection: A randomized, double-blind, placebo-controlled pilot study. J. Clin. Anesth. 75, 110498. 10.1016/j.jclinane.2021.110498</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2021.110498</ArticleId><ArticleId IdType="pubmed">34488061</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen J., Chu Y., Wang C., Yan S. (2022). Risk factors for acute kidney injury after major abdominal surgery in the elderly aged 75 years and above. BMC Nephrol. 23 (1), 224. 10.1186/s12882-022-02822-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-022-02822-7</ArticleId><ArticleId IdType="pmc">PMC9229523</ArticleId><ArticleId IdType="pubmed">35739472</ArticleId></ArticleIdList></Reference><Reference><Citation>Si Y., Bao H., Han L., Shi H., Zhang Y., Xu L., et al. (2013). Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the JAK/STAT signaling activation. J. Transl. Med. 11, 141. 10.1186/1479-5876-11-141</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-11-141</ArticleId><ArticleId IdType="pmc">PMC3700850</ArticleId><ArticleId IdType="pubmed">23759023</ArticleId></ArticleIdList></Reference><Reference><Citation>Taoda M., Adachi Y. U., Uchihashi Y., Watanabe K., Satoh T., Vizi E. S. (2001). Effect of dexmedetomidine on the release of [3H]-noradrenaline from rat kidney cortex slices: Characterization of alpha2-adrenoceptor. Neurochem. Int. 38 (4), 317&#x2013;322. 10.1016/s0197-0186(00)00096-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0197-0186(00)00096-6</ArticleId><ArticleId IdType="pubmed">11137626</ArticleId></ArticleIdList></Reference><Reference><Citation>Vestergaard S. V., Christiansen C. F., Thomsen R. W., Birn H., Heide-J&#xf8;rgensen U. (2021). Identification of patients with CKD in medical databases: A comparison of different algorithms. Clin. J. Am. Soc. Nephrol. 16 (4), 543&#x2013;551. 10.2215/cjn.15691020</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/cjn.15691020</ArticleId><ArticleId IdType="pmc">PMC8092062</ArticleId><ArticleId IdType="pubmed">33707181</ArticleId></ArticleIdList></Reference><Reference><Citation>Zappitelli M., Parikh C. R., Kaufman J. S., Go A. S., Kimmel P. L., Hsu C. Y., et al. (2020). Acute kidney injury and risk of CKD and hypertension after pediatric cardiac surgery. Clin. J. Am. Soc. Nephrol. 15 (10), 1403&#x2013;1412. 10.2215/cjn.00150120</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/cjn.00150120</ArticleId><ArticleId IdType="pmc">PMC7536759</ArticleId><ArticleId IdType="pubmed">32948644</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36883092</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Beneficial Impacts of Fenoldopam on Patients With or at Risk for Acute Renal Failure and Undergoing Surgery: A Meta-Analysis of Randomized Clinical Trials.</ArticleTitle><Pagination><StartPage>e34584</StartPage><MedlinePgn>e34584</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e34584</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.34584</ELocationID><Abstract><AbstractText>This meta-analysis aims to determine the beneficial impacts of fenoldopam on patients with or at high risk of acute kidney injury (AKI) and undergoing surgery. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed while performing the present meta-analysis.&#xa0;Two investigators searched electronic databases&#xa0;including PubMed, EMBASE, and the Cochrane library, from inception until January 10, 2023, for relevant studies. The key terms used to search for relevant articles included "fenoldopam", "acute kidney injury" and "surgery".&#xa0;The primary outcome was the incidence of new AKI. Secondary outcomes included change in serum creatine from baseline (mg/dl), length of stay in ICU (days), renal replacement therapy (RRT), and all-cause mortality that included mortality before or at 30 days. A total of 10 studies&#xa0;involving 1484 patients were included in the present meta-analysis. The risk of AKI was lower in the fenoldopam group compared to the control group [risk ratio (RR): 0.73, 95% CI: 0.57-0.95]. The length of ICU stay was also shorter in the fenoldopam group [mean difference (MD): -0.35 days, 95% confidence interval (CI): -0.68, -0.03]. No significant differences were reported in terms of all-cause mortality, change in serum creatinine, and RRT.&#xa0;In conclusion, our meta-analysis of studies on the use of fenoldopam in adult patients undergoing major surgery showed that fenoldopam significantly reduces the risk of AKI and shortens ICU stays. However, there was no significant impact on all-cause mortality or RRT.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023, Kondabolu et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kondabolu</LastName><ForeName>Sai Kiran</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Internal Medicine, Andhra Medical College, Visakhapatnam, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kakarlapudi</LastName><ForeName>Yasitha</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Internal Medicine, Andhra Medical College, Visakhapatnam, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malik</LastName><ForeName>Haider</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Internal Medicine, Shifa Tameer-E-Millat University Shifa College of Medicine, Islamabad, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malik</LastName><ForeName>Hamza</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Medicine, Foundation University Medical College, Rawalpindi, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Saima</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Internal Medicine, Sir Syed College of Medical Sciences for Girls, Karachi, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar Komminni</LastName><ForeName>Praveen</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Internal Medicine, Suraksha Hospital, Hyderabad, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palleti</LastName><ForeName>Sujith K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Nephrology, Loyola University Medical Center, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirani</LastName><ForeName>Shamsha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiology, Baqai Hospital, Karachi, PAK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">fenoldopam</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">nephroprotective effects</Keyword><Keyword MajorTopicYN="N">surgical patients</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>8</Day><Hour>1</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36883092</ArticleId><ArticleId IdType="pmc">PMC9985827</ArticleId><ArticleId IdType="doi">10.7759/cureus.34584</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Acute kidney injury. Bellomo R, Kellum JA, Ronco C. Lancet. 2012;380:756&#x2013;766.</Citation><ArticleIdList><ArticleId IdType="pubmed">22617274</ArticleId></ArticleIdList></Reference><Reference><Citation>Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study. Mehta RL, Burdmann EA, Cerd&#xe1; J, et al. Lancet. 2016;387:2017&#x2013;2025.</Citation><ArticleIdList><ArticleId IdType="pubmed">27086173</ArticleId></ArticleIdList></Reference><Reference><Citation>World incidence of AKI: a meta-analysis. Susantitaphong P, Cruz DN, Cerda J, Abulfaraj M, Alqahtani F, Koulouridis I, Jaber BL. Clin J Am Soc Nephrol. 2013;8:1482&#x2013;1493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3805065</ArticleId><ArticleId IdType="pubmed">23744003</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenoldopam to prevent acute kidney injury after major surgery-a systematic review and meta-analysis. Gillies MA, Kakar V, Parker RJ, Honor&#xe9; PM, Ostermann M. Crit Care. 2015;19:449.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4699343</ArticleId><ArticleId IdType="pubmed">26703329</ArticleId></ArticleIdList></Reference><Reference><Citation>Characterization of the peripheral and central effects of SK&amp;amp;F 82526, a novel dopamine receptor agonist. Hahn RA, Wardell JR Jr, Sarau HM, Ridley PT. https://pubmed.ncbi.nlm.nih.gov/6127401/ J Pharmacol Exp Ther. 1982;223:305&#x2013;313.</Citation><ArticleIdList><ArticleId IdType="pubmed">6127401</ArticleId></ArticleIdList></Reference><Reference><Citation>Potential of dopamine A-1 agonists in the management of acute renal failure. Singer I, Epstein M. Am J Kidney Dis. 1998;31:743&#x2013;755.</Citation><ArticleIdList><ArticleId IdType="pubmed">9590183</ArticleId></ArticleIdList></Reference><Reference><Citation>Tubuloglomerular feedback and blood flow autoregulation during DA1-induced renal vasodilation. Pollock DM, Arendshorst WJ. Am J Physiol. 1990;258:0&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">1969238</ArticleId></ArticleIdList></Reference><Reference><Citation>Renal and endocrine effects of fenoldopam and metoclopramide in normal man. Girbes AR, Smit AJ, Meijer S, Reitsma WD. Nephron. 1990;56:179&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">1978736</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenoldopam improves corticomedullary oxygen delivery and attenuates angiogenesis gene expression in acute ischemic renal injury. Aravindan N, Samuels J, Riedel B, Shaw A. Kidney Blood Press Res. 2006;29:165&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pubmed">16931895</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenoldopam for preventing and treating acute kidney injury. Esezobor CI, Bhatt GC, Effa EE, Hodson EM. Cochrane Database Syst Rev. 2017;2017:0.</Citation></Reference><Reference><Citation>N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery. Barr LF, Kolodner K. Crit Care Med. 2008;36:1427&#x2013;1435.</Citation><ArticleIdList><ArticleId IdType="pubmed">18434903</ArticleId></ArticleIdList></Reference><Reference><Citation>Use of fenoldopam to control renal dysfunction early after liver transplantation. Biancofiore G, Della Rocca G, Bindi L, et al. Liver Transpl. 2004;10:986&#x2013;992.</Citation><ArticleIdList><ArticleId IdType="pubmed">15390323</ArticleId></ArticleIdList></Reference><Reference><Citation>Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial. Bove T, Landoni G, Calabr&#xf2; MG, et al. Circulation. 2005;111:3230&#x2013;3235.</Citation><ArticleIdList><ArticleId IdType="pubmed">15967861</ArticleId></ArticleIdList></Reference><Reference><Citation>Effect of fenoldopam on use of renal replacement therapy among patients with acute kidney injury after cardiac surgery: a randomized clinical trial. Bove T, Zangrillo A, Guarracino F, et al. JAMA. 2014;312:2244&#x2013;2253.</Citation><ArticleIdList><ArticleId IdType="pubmed">25265449</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass. Caimmi PP, Pagani L, Micalizzi E, et al. J Cardiothorac Vasc Anesth. 2003;17:491&#x2013;494.</Citation><ArticleIdList><ArticleId IdType="pubmed">12968238</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: a randomized clinical study. Cogliati AA, Vellutini R, Nardini A, Urovi S, Hamdan M, Landoni G, Guelfi P. J Cardiothorac Vasc Anesth. 2007;21:847&#x2013;850.</Citation><ArticleIdList><ArticleId IdType="pubmed">18068064</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenoldopam and renal function after partial nephrectomy in a solitary kidney: a randomized, blinded trial. O'Hara JF Jr, Mahboobi R, Novak SM, et al. Urology. 2013;81:340&#x2013;345.</Citation><ArticleIdList><ArticleId IdType="pubmed">23374797</ArticleId></ArticleIdList></Reference><Reference><Citation>A comparison of fenoldopam with dopamine and sodium nitroprusside in patients undergoing cross-clamping of the abdominal aorta. Oliver WC Jr, Nuttall GA, Cherry KJ, Decker PA, Bower T, Ereth MH. Anesth Analg. 2006;103:833&#x2013;840.</Citation><ArticleIdList><ArticleId IdType="pubmed">17000789</ArticleId></ArticleIdList></Reference><Reference><Citation>Effects of fenoldopam infusion in complex cardiac surgical operations: a prospective, randomized, double-blind, placebo-controlled study. Ranucci M, De Benedetti D, Bianchini C, Castelvecchio S, Ballotta A, Frigiola A, Menicanti L. https://www.minervamedica.it/en/journals/minerva-anestesiologica/article.php?cod=R02Y2010N04A0249. Minerva Anestesiol. 2010;76:249&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">20332738</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenoldopam mesylate and renal function in patients undergoing liver transplantation: a randomized, controlled pilot trial. Rocca GD, Pompei L, Costa MG, et al. Anesth Analg. 2004;99:1604&#x2013;1609.</Citation><ArticleIdList><ArticleId IdType="pubmed">15562040</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Hobson CE, Yavas S, Segal MS, Schold JD, Tribble CG, Layon AJ, Bihorac A. Circulation. 2009;119:2444&#x2013;2453.</Citation><ArticleIdList><ArticleId IdType="pubmed">19398670</ArticleId></ArticleIdList></Reference><Reference><Citation>Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Bihorac A, Yavas S, Subbiah S, et al. Ann Surg. 2009;249:851&#x2013;858.</Citation><ArticleIdList><ArticleId IdType="pubmed">19387314</ArticleId></ArticleIdList></Reference><Reference><Citation>Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. Landoni G, Biondi-Zoccai GG, Tumlin JA, et al. Am J Kidney Dis. 2007;49:56&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">17185146</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenoldopam and acute renal failure in cardiac surgery: a meta-analysis of randomized placebo-controlled trials. Zangrillo A, Biondi-Zoccai GG, Frati E, et al. J Cardiothorac Vasc Anesth. 2012;26:407&#x2013;413.</Citation><ArticleIdList><ArticleId IdType="pubmed">22459931</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33281072</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1444-2892</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>May</Month></PubDate></JournalIssue><Title>Heart, lung &amp; circulation</Title><ISOAbbreviation>Heart Lung Circ</ISOAbbreviation></Journal><ArticleTitle>Myocardial Protection in Adult Cardiac Surgery With del Nido Versus Blood Cardioplegia: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>642</StartPage><EndPage>655</EndPage><MedlinePgn>642-655</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hlc.2020.10.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1443-9506(20)31491-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Myocardial protection in adult cardiac surgery is commonly achieved with either multidose blood cardioplegia or single-dose del Nido crystalloid cardioplegia.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">The aim of this systematic review and meta-analysis was to compare the outcomes of del Nido cardioplegia versus blood cardioplegia in adult cardiac surgery.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">All English-language articles were searched in MEDLINE (PubMed), the Cochrane Central Register of Controlled Trials (CENTRAL), and Google Scholar up to March 2020, to identify randomised control trials, prospective observational studies, and retrospective analyses (with or without propensity matching) reporting any or all of the primary and secondary endpoints. The primary endpoint was all-cause mortality. Secondary endpoints included cardiopulmonary bypass (CPB) and aortic cross-clamp (AoX) time; cardioplegia volume; need for defibrillation after AoX release; intraoperative glucose; postoperative myocardial enzyme release; postoperative left ventricular ejection fraction (LVEF); incidence of postoperative acute kidney injury (AKI), atrial fibrillation (AF), stroke, and low cardiac output syndrome (LCOS); postoperative blood transfusion; duration of mechanical ventilation; and length of intensive care unit (ICU) and hospital stay.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-nine (29) studies were included. There was no difference in the primary outcome of mortality between the two groups (odds ratio [OR], 1.18; 95% confidence interval [CI], 0.82-1.72 [p=0.37]). del Nido cardioplegia was associated with significantly shorter CPB (mean difference [MD],&#xa0;-7.42 minutes; 95% CI,&#xa0;-12.53 to&#xa0;-2.31 [p=0.004]) and AoX times (MD,&#xa0;-6.39 minutes; 95% CI,&#xa0;-10.30 to&#xa0;-2.48 [p=0.001]), and lower cardioplegia volumes. Significantly fewer patients required defibrillation after AoX release in the del Nido group. Intraoperative glucose homeostasis was better preserved in the del Nido group. Postoperative cardiac troponin T release and the number of patients needing transfusions were less in the del Nido group. No differences were seen in postoperative LVEF, or in the incidence of AKI, stroke, AF, and LCOS. Duration of mechanical ventilation, and length of ICU and hospital stay were similar.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Although this meta-analysis failed to find any mortality benefits with del Nido cardioplegia, significant benefits were seen in a number of intraoperative and postoperative variables. del Nido cardioplegia is a safe and favourable alternative to blood cardioplegia in adult cardiac surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Misra</LastName><ForeName>Satyajeet</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, Odisha, India. Electronic address: misrasatyajeet@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Srinivasan</LastName><ForeName>Anand</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, Odisha, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jena</LastName><ForeName>Sritam Swarup</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, Odisha, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellapukonda</LastName><ForeName>Snigdha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, Odisha, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Heart Lung Circ</MedlineTA><NlmUniqueID>100963739</NlmUniqueID><ISSNLinking>1443-9506</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002314">Cardioplegic Solutions</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002314" MajorTopicYN="Y">Cardioplegic Solutions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006324" MajorTopicYN="N">Heart Arrest, Induced</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="N">Ventricular Function, Left</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adult cardiac surgery</Keyword><Keyword MajorTopicYN="N">Blood cardioplegia</Keyword><Keyword MajorTopicYN="N">del Nido cardioplegia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>7</Day><Hour>5</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33281072</ArticleId><ArticleId IdType="doi">10.1016/j.hlc.2020.10.016</ArticleId><ArticleId IdType="pii">S1443-9506(20)31491-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39489662</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>12</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>The Effects of Angiotensin II versus Norepinephrine on Pulmonary Vascular Resistance in Cardiac Surgery: Post Hoc Analysis of a Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>2950</StartPage><EndPage>2958</EndPage><MedlinePgn>2950-2958</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2024.09.148</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(24)00782-1</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To assess whether angiotensin II infusion increases pulmonary vascular resistance (PVR) relative to norepinephrine.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Secondary analysis of a double-blinded randomized feasibility study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Two tertiary metropolitan hospitals in Melbourne, Australia.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Fifty-eight adult patients undergoing cardiac surgery using cardiopulmonary bypass with an elevated risk of acute kidney injury (AKI).</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Angiotensin II infusion compared with norepinephrine infusion.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">There was no significant difference in the primary outcome of PVR both intraoperatively and postoperatively between the angiotensin II group and the norepinephrine group. The study drug (angiotensin II or norepinephrine) infusion rate was associated with a small increase in PVR (&#x3b2; = 0.08; p = 0.01). The strongest association with PVR was the random effect (ie, patient effect) (p &lt; 0.001). This effect was consistent across secondary outcomes. Randomization to norepinephrine instead of to angiotensin II was associated with reduced mean systemic arterial to mean pulmonary arterial pressure ratio postoperatively (&#x3b2; = -0.65; p = 0.01).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The results of this study suggest that in cardiac surgery patients and at doses used in the prior feasibility study, angiotensin II did not have significant effects on the pulmonary vasculature compared with norepinephrine. Moreover, at doses used in this study, neither drug appeared to have a substantial effect on the pulmonary circulation relative to surgical and patient factors.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Jolene</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Perioperative Medicine, Alfred Health and Monash University, Melbourne, Victoria, Australia; Department of Anaesthesia and Pain Medicine, Fiona Stanley Hospital, Western Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Kathy</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Heidelberg, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miles</LastName><ForeName>Lachlan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Heidelberg, Victoria, Australia; Department of Critical Care, Melbourne Medical School, University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Melbourne Medical School, University of Melbourne, Parkville, Victoria, Australia; Department of Intensive Care, Austin Hospital, Heidelberg, Victoria, Australia; Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia; Data Analytics Research and Evaluation, Austin Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coulson</LastName><ForeName>Tim G</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Perioperative Medicine, Alfred Health and Monash University, Melbourne, Victoria, Australia; Department of Critical Care, Melbourne Medical School, University of Melbourne, Parkville, Victoria, Australia. Electronic address: tim.coulson@unimelb.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber><NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>11128-99-7</RegistryNumber><NameOfSubstance UI="D000804">Angiotensin II</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009638" MajorTopicYN="Y">Norepinephrine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000804" MajorTopicYN="Y">Angiotensin II</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014655" MajorTopicYN="Y">Vascular Resistance</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="N">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">angiotensin II</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">norepinephrine</Keyword><Keyword MajorTopicYN="N">pulmonary arterial pressure</Keyword><Keyword MajorTopicYN="N">pulmonary vascular resistance</Keyword><Keyword MajorTopicYN="N">vasopressors</Keyword></KeywordList><CoiStatement>Declaration of competing interest R.B. reports serving as a paid member of medical advisory boards for La Jolla Pharmaceutical, Viatris, and Paion Pharma. All other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>24</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>0</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>3</Day><Hour>21</Hour><Minute>56</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39489662</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2024.09.148</ArticleId><ArticleId IdType="pii">S1053-0770(24)00782-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">30264290</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2110-5820</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>Annals of intensive care</Title><ISOAbbreviation>Ann Intensive Care</ISOAbbreviation></Journal><ArticleTitle>Perioperative statin therapy in cardiac and non-cardiac surgery: a systematic review and meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>95</StartPage><MedlinePgn>95</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">95</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13613-018-0441-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The effects of perioperative statin therapy on clinical outcome after cardiac or non-cardiac surgery are controversial. We aimed to assess the association between perioperative statin therapy and postoperative outcome.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Electronic databases were searched up to May 1, 2018, for randomized controlled trials of perioperative statin therapy versus placebo or no treatment in adult cardiac or non-cardiac surgery. Postoperative outcomes were: myocardial infarction, stroke, acute kidney injury (AKI), and mortality. We calculated risk ratio (RR) or odds ratio (OR) and 95% confidence interval (CI) using fixed-effects meta-analyses. We performed meta-regression and subgroup analyses to assess the possible influence of statin therapy regimen on clinical outcomes and trial sequential analysis to evaluate the risk of&#xa0;random errors and futility.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included data from 35 RCTs involving 8200 patients. Perioperative statin therapy was associated with lower incidence of postoperative myocardial infarction in non-cardiac surgery (OR&#x2009;=&#x2009;0.44 [95% CI 0.30-0.64], p&#x2009;&lt;&#x2009;0.0001), but not in cardiac surgery (OR&#x2009;=&#x2009;0.93 [95% CI 0.70-1.24], p&#x2009;=&#x2009;0.61)&#xa0;(p<sub>subgroup</sub>&#x2009;=&#x2009;0.002). Higher incidence of AKI was present in cardiac surgery patients receiving perioperative statins (RR&#x2009;=&#x2009;1.15 [95% CI 1.00-1.31], p&#x2009;=&#x2009;0.05), nonetheless not in non-cardiac surgery (RR&#x2009;=&#x2009;1.52 [95% CI 0.71-3.26], p&#x2009;=&#x2009;0.28)&#xa0;(p<sub>subgroup</sub>&#x2009;=&#x2009;0.47). No difference in postoperative stroke and mortality was present in either cardiac or non-cardiac surgery. However, low risk of bias trials performed in cardiac surgery showed a higher mortality with statins versus placebo (OR&#x2009;=&#x2009;3.71 [95% CI 1.03-13.34], p&#x2009;=&#x2009;0.04). Subgroup and meta-regression analyses failed to find possible relationships between length of statin regimens and clinical outcomes. Trial sequential analysis suggested no firm conclusions on the topic.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Perioperative statins appear to be protective against postoperative myocardial infarction in non-cardiac surgery and associated with higher AKI in cardiac surgery. Possible positive or even negative effects on mortality could not be excluded and merits further investigations. Currently, no randomized evidence supports the systematic administration of statins in surgical patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Putzu</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Anesthesiology, Department of Anesthesiology, Pharmacology and Intensive Care Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Carvalho E Silva</LastName><ForeName>Carolina Maria Pinto Domingues</ForeName><Initials>CMPD</Initials><AffiliationInfo><Affiliation>Division of Anesthesia and Intensive Care, InCor, Instituto do Cancer, Universidade de Sao Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Almeida</LastName><ForeName>Juliano Pinheiro</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Division of Anesthesia and Intensive Care, InCor, Instituto do Cancer, Universidade de Sao Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belletti</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cassina</LastName><ForeName>Tiziano</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, Cardiocentro Ticino, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy. landoni.giovanni@hsr.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vita-Salute San Raffaele University, Milan, Italy. landoni.giovanni@hsr.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hajjar</LastName><ForeName>Ludhmila Abrahao</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Department of Cardiopneumology, InCor, Universidade de Sao Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Ann Intensive Care</MedlineTA><NlmUniqueID>101562873</NlmUniqueID><ISSNLinking>2110-5820</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Intensive care medicine</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Non-cardiac surgery</Keyword><Keyword MajorTopicYN="N">Statins</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30264290</ArticleId><ArticleId IdType="pmc">PMC6160380</ArticleId><ArticleId IdType="doi">10.1186/s13613-018-0441-3</ArticleId><ArticleId IdType="pii">10.1186/s13613-018-0441-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Le Manach Y, Coriat P, Collard CD, Riedel B. Statin therapy within the perioperative period. Anesthesiology. 2008;108(6):1141&#x2013;1146. doi: 10.1097/ALN.0b013e318173ef8e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318173ef8e</ArticleId><ArticleId IdType="pubmed">18497615</ArticleId></ArticleIdList></Reference><Reference><Citation>Amar D, Park B, Zhang H, et al. Beneficial effects of perioperative statins for major pulmonary resection. J Thorac Cardiovasc Surg. 2015;149(6):1532&#x2013;1538. doi: 10.1016/j.jtcvs.2014.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2014.12.016</ArticleId><ArticleId IdType="pmc">PMC4758508</ArticleId><ArticleId IdType="pubmed">25623903</ArticleId></ArticleIdList></Reference><Reference><Citation>Durazzo AE, Machado FS, Ikeoka DT, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg. 2004;39(5):967&#x2013;975. doi: 10.1016/j.jvs.2004.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2004.01.004</ArticleId><ArticleId IdType="pubmed">15111846</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, Wesorick DH, Sussman JB, et al. Effect of perioperative statins on death, myocardial infarction, atrial fibrillation, and length of stay: a systematic review and meta-analysis. Arch Surg. 2012;147(2):181&#x2013;189. doi: 10.1001/archsurg.2011.897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.2011.897</ArticleId><ArticleId IdType="pubmed">22351917</ArticleId></ArticleIdList></Reference><Reference><Citation>de Waal BA, Buise MP, van Zundert AA. Perioperative statin therapy in patients at high risk for cardiovascular morbidity undergoing surgery: a review. Br J Anaesth. 2015;114(1):44&#x2013;52. doi: 10.1093/bja/aeu295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeu295</ArticleId><ArticleId IdType="pubmed">25186819</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FT, Hendricks PA, Schildcrout JS, et al. High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial. JAMA. 2016;315(9):877&#x2013;888. doi: 10.1001/jama.2016.0548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0548</ArticleId><ArticleId IdType="pmc">PMC4843765</ArticleId><ArticleId IdType="pubmed">26906014</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z, Jayaram R, Jiang L, et al. Perioperative rosuvastatin in cardiac surgery. N Engl J Med. 2016;374(18):1744&#x2013;1753. doi: 10.1056/NEJMoa1507750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1507750</ArticleId><ArticleId IdType="pubmed">27144849</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. doi: 10.1136/bmj.b2700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2700</ArticleId><ArticleId IdType="pmc">PMC2714672</ArticleId><ArticleId IdType="pubmed">19622552</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Green S (editors). Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. www.handbook.cochrane.org. Accessed 25 Sept 2018.</Citation></Reference><Reference><Citation>Putzu A, Landoni G, Hajjar LA. Perioperative statin therapy: a systematic review, meta-analysis and trial sequential analysis of randomized controlled trials. PROSPERO 2018 CRD42018093997. http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42018093997. Accessed 25 Sept 2018.</Citation></Reference><Reference><Citation>Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol. 2008;61:763&#x2013;769. doi: 10.1016/j.jclinepi.2007.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2007.10.007</ArticleId><ArticleId IdType="pubmed">18411040</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorlund K, Devereaux PJ, Wetterslev J, et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? Int J Epidemiol. 2009;38:276&#x2013;286. doi: 10.1093/ije/dyn179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyn179</ArticleId><ArticleId IdType="pubmed">18824467</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorlund K, Engstr&#xf8;m&#xa0;J, Wetterslev J, Brok J, Imberger G, Gluud C. User manual for trial sequential analysis (TSA). Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen, Denmark. 2011. p. 1&#x2013;115. www.ctu.dk/tsa. Accessed 25 Sept 2018.</Citation></Reference><Reference><Citation>Almansob MA, Xu B, Zhou L, et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: a randomized controlled trial. Arterioscler Thromb Vasc Biol. 2012;32(9):2304&#x2013;2313. doi: 10.1161/ATVBAHA.112.252098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.112.252098</ArticleId><ArticleId IdType="pubmed">22796581</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydin U, Yilmaz M, Duzyol C, et al. Efficiency of postoperative statin treatment for preventing new-onset postoperative atrial fibrillation in patients undergoing isolated coronary artery bypass grafting: a prospective randomized study. Anatol J Cardiol. 2015;15(6):491&#x2013;495. doi: 10.5152/akd.2014.5531.</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/akd.2014.5531</ArticleId><ArticleId IdType="pmc">PMC5779143</ArticleId><ArticleId IdType="pubmed">26006137</ArticleId></ArticleIdList></Reference><Reference><Citation>Baran C, Durdu S, Dalva K, et al. Effects of preoperative short term use of atorvastatin on endothelial progenitor cells after coronary surgery: a randomized, controlled trial. Stem Cell Rev. 2012;8(3):963&#x2013;971. doi: 10.1007/s12015-011-9321-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-011-9321-z</ArticleId><ArticleId IdType="pubmed">22076751</ArticleId></ArticleIdList></Reference><Reference><Citation>Bass AR, Szymonifka JD, Rondina MT, et al. Postoperative myocardial injury and inflammation is not blunted by a trial of atorvastatin in orthopedic surgery patients. HSS J. 2018;14(1):67&#x2013;76. doi: 10.1007/s11420-017-9577-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11420-017-9577-1</ArticleId><ArticleId IdType="pmc">PMC5786589</ArticleId><ArticleId IdType="pubmed">29398998</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkan O, Katrancioglu N, Ozker E, Ozerdem G, Bakici Z, Yilmaz MB. Reduced P-selectin in hearts pretreated with fluvastatin: a novel benefit for patients undergoing open heart surgery. Thorac Cardiovasc Surg. 2009;57(2):91&#x2013;95. doi: 10.1055/s-2008-1039107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2008-1039107</ArticleId><ArticleId IdType="pubmed">19241310</ArticleId></ArticleIdList></Reference><Reference><Citation>Berwanger O, de Barros ESPG, Barbosa RR, et al. Atorvastatin for high-risk statin-naive patients undergoing noncardiac surgery: the lowering the risk of operative complications using atorvastatin loading dose (LOAD) randomized trial. Am Heart J. 2017;184:88&#x2013;96. doi: 10.1016/j.ahj.2016.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2016.11.001</ArticleId><ArticleId IdType="pubmed">27892891</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrascal Y, Arnold RJ, De la Fuente L, et al. Efficacy of atorvastatin in prevention of atrial fibrillation after heart valve surgery in the PROFACE trial (PROphylaxis of postoperative atrial Fibrillation After Cardiac surgEry) J Arrhythm. 2016;32(3):191&#x2013;197. doi: 10.1016/j.joa.2016.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joa.2016.01.010</ArticleId><ArticleId IdType="pmc">PMC4913150</ArticleId><ArticleId IdType="pubmed">27354864</ArticleId></ArticleIdList></Reference><Reference><Citation>Castano M, Gonzalez-Santos JM, Lopez J, et al. Effect of preoperative oral pravastatin reload in systemic inflammatory response and myocardial damage after coronary artery bypass grafting. A pilot double-blind placebo-controlled study. J Cardiovasc Surg (Torino) 2015;56(4):617&#x2013;629.</Citation><ArticleIdList><ArticleId IdType="pubmed">25968407</ArticleId></ArticleIdList></Reference><Reference><Citation>Chello M, Patti G, Candura D, et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit Care Med. 2006;34(3):660&#x2013;667. doi: 10.1097/01.CCM.0000201407.89977.EA.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000201407.89977.EA</ArticleId><ArticleId IdType="pubmed">16505650</ArticleId></ArticleIdList></Reference><Reference><Citation>Christenson JT. Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. Eur J Cardiothorac Surg. 1999;15(4):394&#x2013;399. doi: 10.1016/S1010-7940(99)00034-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1010-7940(99)00034-2</ArticleId><ArticleId IdType="pubmed">10371111</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehghani MR, Kasianzadeh M, Rezaei Y, Sepehrvand N. Atorvastatin reduces the incidence of postoperative atrial fibrillation in statin-naive patients undergoing isolated heart valve surgery: a double-blind, placebo-controlled randomized trial. J Cardiovasc Pharmacol Ther. 2015;20(5):465&#x2013;472. doi: 10.1177/1074248414564869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1074248414564869</ArticleId><ArticleId IdType="pubmed">25540059</ArticleId></ArticleIdList></Reference><Reference><Citation>Hua P, Liu J, Tao J, et al. Efficacy and mechanism of preoperative simvastatin therapy on myocardial protection after extracorporeal circulation. Biomed Res Int. 2017;2017:6082430. doi: 10.1155/2017/6082430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/6082430</ArticleId><ArticleId IdType="pmc">PMC5698794</ArticleId><ArticleId IdType="pubmed">29250545</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji Q, Mei Y, Wang X, et al. Effect of preoperative atorvastatin therapy on atrial fibrillation following off-pump coronary artery bypass grafting. Circ J. 2009;73(12):2244&#x2013;2249. doi: 10.1253/circj.CJ-09-0352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-09-0352</ArticleId><ArticleId IdType="pubmed">19822977</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannacio VA, Iorio D, De Amicis V, Di Lello F, Musumeci F. Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. J Thorac Cardiovasc Surg. 2008;136(6):1541&#x2013;1548. doi: 10.1016/j.jtcvs.2008.06.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2008.06.038</ArticleId><ArticleId IdType="pubmed">19114204</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansour H, Ghaleb R. Atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery. Atheroscler Suppl. 2017;25:e2. doi: 10.1016/j.atherosclerosissup.2017.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosissup.2017.03.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Neilipovitz DT, Bryson GL, Taljaard M. STAR VaS&#x2013;short term atorvastatin regime for vasculopathic subjects: a randomized placebo-controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Can J Anaesth. 2012;59(6):527&#x2013;537. doi: 10.1007/s12630-012-9702-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-012-9702-z</ArticleId><ArticleId IdType="pubmed">22528165</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JH, Shim JK, Song JW, Soh S, Kwak YL. Effect of atorvastatin on the incidence of acute kidney injury following valvular heart surgery: a randomized, placebo-controlled trial. Intensive Care Med. 2016;42(9):1398&#x2013;1407. doi: 10.1007/s00134-016-4358-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4358-8</ArticleId><ArticleId IdType="pubmed">27120082</ArticleId></ArticleIdList></Reference><Reference><Citation>Patti G, Chello M, Candura D, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation. 2006;114(14):1455&#x2013;1461. doi: 10.1161/CIRCULATIONAHA.106.621763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.621763</ArticleId><ArticleId IdType="pubmed">17000910</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Calzavacca P, Licari E, et al. Pilot double-blind, randomized controlled trial of short-term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology (Carlton) 2012;17(3):215&#x2013;224. doi: 10.1111/j.1440-1797.2011.01546.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1797.2011.01546.x</ArticleId><ArticleId IdType="pubmed">22117606</ArticleId></ArticleIdList></Reference><Reference><Citation>Shyamsundar M, McAuley DF, Shields MO, et al. Effect of simvastatin on physiological and biological outcomes in patients undergoing esophagectomy: a randomized placebo-controlled trial. Ann Surg. 2014;259(1):26&#x2013;31. doi: 10.1097/SLA.0b013e31829d686b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e31829d686b</ArticleId><ArticleId IdType="pubmed">23817506</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh PP, Lemanu DP, Soop M, Bissett IP, Harrison J, Hill AG. Perioperative simvastatin therapy in major colorectal surgery: a prospective, double-blind randomized controlled trial. J Am Coll Surg. 2016;223(2):308&#x2013;320 e1. doi: 10.1016/j.jamcollsurg.2016.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2016.04.004</ArticleId><ArticleId IdType="pubmed">27086089</ArticleId></ArticleIdList></Reference><Reference><Citation>Spadaccio C, Pollari F, Casacalenda A, et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. J Cardiovasc Pharmacol. 2010;55(1):30&#x2013;38. doi: 10.1097/FJC.0b013e3181c37d4d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FJC.0b013e3181c37d4d</ArticleId><ArticleId IdType="pubmed">19834333</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Ji Q, Mei Y, et al. Role of preoperative atorvastatin administration in protection against postoperative atrial fibrillation following conventional coronary artery bypass grafting. Int Heart J. 2011;52(1):7&#x2013;11. doi: 10.1536/ihj.52.7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1536/ihj.52.7</ArticleId><ArticleId IdType="pubmed">21321461</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamayo E, Alvarez FJ, Alonso O, et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. J Cardiovasc Surg (Torino) 2009;50(5):687&#x2013;694.</Citation><ArticleIdList><ArticleId IdType="pubmed">19741581</ArticleId></ArticleIdList></Reference><Reference><Citation>Vukovic PM, Maravic-Stojkovic VR, Peric MS, et al. Steroids and statins: an old and a new anti-inflammatory strategy compared. Perfusion. 2011;26(1):31&#x2013;37. doi: 10.1177/0267659110385607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0267659110385607</ArticleId><ArticleId IdType="pubmed">20921085</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia J, Qu Y, Shen H, Liu X. Patients with stable coronary artery disease receiving chronic statin treatment who are undergoing noncardiac emergency surgery benefit from acute atorvastatin reload. Cardiology. 2014;128(3):285&#x2013;292. doi: 10.1159/000362593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000362593</ArticleId><ArticleId IdType="pubmed">24903511</ArticleId></ArticleIdList></Reference><Reference><Citation>Youn YN, Park SY, Hwang Y, Joo HC, Yoo KJ. Impact of high-dose statin pretreatment in patients with stable angina during off-pump coronary artery bypass. Korean J Thorac Cardiovasc Surg. 2011;44(3):208&#x2013;214. doi: 10.5090/kjtcs.2011.44.3.208.</Citation><ArticleIdList><ArticleId IdType="doi">10.5090/kjtcs.2011.44.3.208</ArticleId><ArticleId IdType="pmc">PMC3249304</ArticleId><ArticleId IdType="pubmed">22263153</ArticleId></ArticleIdList></Reference><Reference><Citation>Parepa IR, Suceveanu AI, Mazilu L, Mohamed A, Nita D, Tuta LA. Preventing cardiac complications after non-cardiac non-vascular surgery by using perioperative statin therapy. Farmacia. 2017;65(1):120&#x2013;124.</Citation></Reference><Reference><Citation>Song YB, On YK, Kim JH, et al. The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery. Am Heart J. 2008;156(2):373 e9&#x2013;16. doi: 10.1016/j.ahj.2008.04.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2008.04.020</ArticleId><ArticleId IdType="pubmed">18657672</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia J, Qu Y, Yin C, Xu D. Preoperative rosuvastatin protects patients with coronary artery disease undergoing noncardiac surgery. Cardiology. 2015;131(1):30&#x2013;37. doi: 10.1159/000371872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000371872</ArticleId><ArticleId IdType="pubmed">25832289</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura K, Masuda H, Kariyazono H, et al. Effects of atorvastatin and aspirin combined therapy on inflammatory responses in patients undergoing coronary artery bypass grafting. Cytokine. 2006;36:201&#x2013;210. doi: 10.1016/j.cyto.2006.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2006.11.001</ArticleId><ArticleId IdType="pubmed">17300951</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders RD, Nicholson A, Lewis SR, Smith AF, Alderson P. Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery. Cochrane Database Syst Rev. 2013;7:CD009971.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8928737</ArticleId><ArticleId IdType="pubmed">23824754</ArticleId></ArticleIdList></Reference><Reference><Citation>Putzu A, Capelli B, Belletti A, et al. Perioperative statin therapy in cardiac surgery: a meta-analysis of randomized controlled trials. Crit Care. 2016;20(1):395. doi: 10.1186/s13054-016-1560-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1560-6</ArticleId><ArticleId IdType="pmc">PMC5139027</ArticleId><ArticleId IdType="pubmed">27919293</ArticleId></ArticleIdList></Reference><Reference><Citation>Juo YY, Mantha A, Ebrahimi R, Ziaeian B, Benharash P. Incidence of myocardial infarction after high-risk vascular operations in adults. JAMA Surg. 2017;152(11):e173360. doi: 10.1001/jamasurg.2017.3360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2017.3360</ArticleId><ArticleId IdType="pmc">PMC5831417</ArticleId><ArticleId IdType="pubmed">28877308</ArticleId></ArticleIdList></Reference><Reference><Citation>Devereaux PJ, Xavier D, Pohue J, et al. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study. Ann Intern Med. 2011;154(8):523&#x2013;528. doi: 10.7326/0003-4819-154-8-201104190-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-154-8-201104190-00003</ArticleId><ArticleId IdType="pubmed">21502650</ArticleId></ArticleIdList></Reference><Reference><Citation>Almuti K, Rimawi R, Spevack D, Ostfeld RJ. Effects of statins beyond lipid lowering: potential for clinical benefits. Int J Cardiol. 2006;109(1):7&#x2013;15. doi: 10.1016/j.ijcard.2005.05.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2005.05.056</ArticleId><ArticleId IdType="pubmed">16054715</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R. Perioperative statins in cardiac surgery and acute kidney injury. JAMA. 2016;315(9):873&#x2013;874. doi: 10.1001/jama.2016.0245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0245</ArticleId><ArticleId IdType="pubmed">26905755</ArticleId></ArticleIdList></Reference><Reference><Citation>Golomb BA, Evans MA. Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism. Am J Cardiovasc Drugs. 2008;8(6):373&#x2013;418. doi: 10.2165/0129784-200808060-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/0129784-200808060-00004</ArticleId><ArticleId IdType="pmc">PMC2849981</ArticleId><ArticleId IdType="pubmed">19159124</ArticleId></ArticleIdList></Reference><Reference><Citation>Kain V, Kapadia B, Misra P, Saxena U. Simvastatin may induce insulin resistance through a novel fatty acid mediated cholesterol independent mechanism. Sci Rep. 2015;5:13823. doi: 10.1038/srep13823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep13823</ArticleId><ArticleId IdType="pmc">PMC4561915</ArticleId><ArticleId IdType="pubmed">26345110</ArticleId></ArticleIdList></Reference><Reference><Citation>Frieden TR. Evidence for health decision making&#x2014;beyond randomized, controlled trials. N Engl J Med. 2017;377:465&#x2013;475. doi: 10.1056/NEJMra1614394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1614394</ArticleId><ArticleId IdType="pubmed">28767357</ArticleId></ArticleIdList></Reference><Reference><Citation>Baiardo Redaelli M, Landoni G, Di Sanzo S, et al. Interventions affecting mortality in critically ill and perioperative patients: a systematic review of contemporary trials. J Crit Care. 2017;41:107&#x2013;111. doi: 10.1016/j.jcrc.2017.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2017.05.005</ArticleId><ArticleId IdType="pubmed">28505485</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33494652</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1525-6049</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Renal failure</Title><ISOAbbreviation>Ren Fail</ISOAbbreviation></Journal><ArticleTitle>Inhaled nitric oxide and acute kidney injury risk: a meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>281</StartPage><EndPage>290</EndPage><MedlinePgn>281-290</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/0886022X.2021.1873805</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">There are conflicting results as to the effect of inhaled nitric oxide (iNO) therapy on the risk of acute kidney injury (AKI). The aim of this study was to perform a meta-analysis to assess the updated data.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We systematically searched Web of Science, the Cochrane Library, Wanfang, and PubMed for relevant randomized control trials between database inception and 9/07/2020. Relative risks (RRs) with 95% confidence intervals (CIs) predicting the risk of AKI were extracted to obtain summary estimates using fixed-effects models. The Trim and Fill method was used to evaluate the sensitivity of the results and adjust for publication bias in meta-analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">15 randomized controlled studies from 14 articles involving 1853 patients were included in the study. Analyzing the eligible studies we found: (1) iNO therapy significantly increased the risk of AKI in acute respiratory distress syndrome patients (RR 1.55, 95% CI 1.15-2.10, <i>p</i>&#x2009;=&#x2009;0.004; <i>I</i> <sup>2</sup> for heterogeneity 0%; <i>P</i> <sub>het</sub> = 0.649). (2) The use of iNO was associated with reduced AKI risk in patients undergoing cardiac surgery (RR 0.80, 95% CI 0.64-0.99, <i>p</i>&#x2009;=&#x2009;0.037; <i>I</i> <sup>2</sup> for heterogeneity 0%; <i>P</i> <sub>het</sub> = 0.528). (3) For organ transplantation recipients, there was no effect of iNO administration on the risk of AKI (RR 0.50, 95% CI 0.16-1.56, <i>p</i>&#x2009;=&#x2009;0.233; <i>I</i> <sup>2</sup> for heterogeneity 0%; <i>P</i> <sub>het</sub> = 0.842). The Trim and Fill analysis showed that the overall effect of this meta-analysis was stable.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The effect of iNO on AKI risk might be disease-specific. Future RCTs with larger patient populations should aim to validate our findings.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Junqiu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Journal Editorial Department, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cong</LastName><ForeName>Xuhui</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miao</LastName><ForeName>Mengrong</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yitian</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jiaqiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ren Fail</MedlineTA><NlmUniqueID>8701128</NlmUniqueID><ISSNLinking>0886-022X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014665">Vasodilator Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>31C4KY9ESH</RegistryNumber><NameOfSubstance UI="D009569">Nitric Oxide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000280" MajorTopicYN="N">Administration, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009569" MajorTopicYN="N">Nitric Oxide</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="N">Respiratory Distress Syndrome</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014665" MajorTopicYN="N">Vasodilator Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Inhaled nitric oxide</Keyword><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">acute respiratory distress syndrome</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">organ transplantation</Keyword><Keyword MajorTopicYN="N">randomized controlled trial</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>26</Day><Hour>5</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33494652</ArticleId><ArticleId IdType="pmc">PMC7850389</ArticleId><ArticleId IdType="doi">10.1080/0886022X.2021.1873805</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bhatraju P, Crawford J, Hall M, et al. . Inhaled nitric oxide: current clinical concepts. Nitric Oxide. 2015;50:114&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pubmed">26335378</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes M, Brisbois EJ.. Clinical use of inhaled nitric oxide: local and systemic applications. Free Radic Biol Med. 2020;152:422&#x2013;431.</Citation><ArticleIdList><ArticleId IdType="pubmed">31785330</ArticleId></ArticleIdList></Reference><Reference><Citation>Adhikari NK, Burns KE, Friedrich JO, et al. . Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. BMJ. 2007;334(7597):779.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1852043</ArticleId><ArticleId IdType="pubmed">17383982</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan SY, Huang TM, Wu HY, et al. . Inhaled nitric oxide therapy and risk of renal dysfunction: a systematic review and meta-analysis of randomized trials. Crit Care. 2015;19(1):137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4384233</ArticleId><ArticleId IdType="pubmed">25887847</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, et al. . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, G&#xf8;tzsche PC, et al. . The Cochrane collaboration&#x2019;s tool for assessing risk of bias in randomised trials. Version 2. BMJ. 2011;343:d5928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thompson SG, Deeks JJ, et al. . Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M, et al. . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629&#x2013;634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Zimmerman JL, Taylor RW, et al. . Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med. 1998;26(1):15&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">9428538</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinsella JP, Walsh WF, Bose CL, et al. . Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial. Lancet. 1999;354(9184):1061&#x2013;1065.</Citation><ArticleIdList><ArticleId IdType="pubmed">10509496</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundin S, Mang H, Smithies M, et al. . Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. Intensive Care Med. 1999;25(9):911&#x2013;919.</Citation><ArticleIdList><ArticleId IdType="pubmed">10501745</ArticleId></ArticleIdList></Reference><Reference><Citation>Payen D, Vallet B.. Results of the French prospective multicentric randomized double-blind placebo-controlled trial on inhaled nitric oxide in ARDS. Intensive Care Medicine. 1999;25S:166.</Citation></Reference><Reference><Citation>Taylor RW, Zimmerman JL, Dellinger RP, et al. . Inhaled Nitric Oxide in ARDS Study Group. Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA. 2004;291(13):1603&#x2013;1609.</Citation><ArticleIdList><ArticleId IdType="pubmed">15069048</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrin G, Roch A, Michelet P, et al. . Inhaled nitric oxide does not prevent pulmonary edema after lung transplantation measured by lung water content: a randomized clinical study. Chest. 2006;129(4):1024&#x2013;1030.</Citation><ArticleIdList><ArticleId IdType="pubmed">16608953</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes JL, Sampaio RO, Brand&#xe3;o CM, et al. . Comparison of inhaled nitric oxide versus oxygen on hemodynamics in patients with mitral stenosis and severe pulmonary hypertension after mitral valve surgery. Am J Cardiol. 2011;107(7):1040&#x2013;1045.</Citation><ArticleIdList><ArticleId IdType="pubmed">21296315</ArticleId></ArticleIdList></Reference><Reference><Citation>Potapov E, Meyer D, Swaminathan M, et al. . Inhaled nitric oxide after left ventricular assist device implantation: a prospective, randomized, double-blind, multicenter, placebo-controlled trial. J Heart Lung Transplant. 2011;30(8):870&#x2013;878.</Citation><ArticleIdList><ArticleId IdType="pubmed">21530317</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang JD Jr., Smith AB, Brandon A, et al. . A randomized clinical trial testing the anti-inflammatory effects of preemptive inhaled nitric oxide in human liver transplantation. PLoS One. 2014;9(2):e86053.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3922702</ArticleId><ArticleId IdType="pubmed">24533048</ArticleId></ArticleIdList></Reference><Reference><Citation>Trzeciak S, Glaspey LJ, Dellinger RP, et al. . Randomized controlled trial of inhaled nitric oxide for the treatment of microcirculatory dysfunction in patients with sepsis*. Crit Care Med. 2014;42(12):2482&#x2013;2492.</Citation><ArticleIdList><ArticleId IdType="pubmed">25080051</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkes MT, Conroy AL, Opoka RO, et al. . Inhaled nitric oxide as adjunctive therapy for severe malaria: a randomized controlled trial. Malar J. 2015;14(1):421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4625637</ArticleId><ArticleId IdType="pubmed">26510464</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu DH, Gao HX, Yi B, et al. . Inhaled nitric oxide in neonates with hypoxic respiratory failure: a clinical randomized controlled study. Chinese J Neonatol. 2016;31(3):182&#x2013;188.</Citation></Reference><Reference><Citation>Lei C, Berra L, Rezoagli E, et al. . Nitric oxide decreases acute kidney injury and stage 3 chronic kidney disease after cardiac surgery. Am J Respir Crit Care Med. 2018;198(10):1279&#x2013;1287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6290943</ArticleId><ArticleId IdType="pubmed">29932345</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamenshchikov NO, Mandel IA, Podoksenov YK, et al. . Nitric oxide provides myocardial protection when added to the cardiopulmonary bypass circuit during cardiac surgery: randomized trial. J Thorac Cardiovasc Surg. 2019;157(6):2328&#x2013;2336.</Citation><ArticleIdList><ArticleId IdType="pubmed">30447958</ArticleId></ArticleIdList></Reference><Reference><Citation>Duval S, Tweedie R.. A nonparametric &#x201c;trim and fill&#x201d; method of accounting for publication bias in meta-analysis. J Am Stat Assoc. 2000;95(449):89&#x2013;98.</Citation></Reference><Reference><Citation>Rehberg S, Maybauer MO, Maybauer DM, et al. . The role of nitric oxide and reactive nitrogen species in experimental ARDS. Front Biosci. 2010;2:18&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">20036926</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang CH, Wei W, Liu L.. Regulation of DNA repair by S-nitrosylation. Biochim Biophys Acta. 2012;1820(6):730&#x2013;735.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170507</ArticleId><ArticleId IdType="pubmed">21571039</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaise GA, Gauvin D, Gangal M, et al. . Nitric oxide, cell signaling and cell death. Toxicology. 2005;208(2):177&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pubmed">15691583</ArticleId></ArticleIdList></Reference><Reference><Citation>Creagh-Brown BC, Griffiths MJ, Evans TW.. Bench-to-bedside review: inhaled nitric oxide therapy in adults. Crit Care. 2009;13(3):221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2717403</ArticleId><ArticleId IdType="pubmed">19519946</ArticleId></ArticleIdList></Reference><Reference><Citation>Hruby Z, Rosinski M, Tyran B.. Parenchymal injury in remnant-kidney model may be linked to apoptosis of renal cells mediated by nitric oxide. J Nephrol. 2008;21(5):686&#x2013;693.</Citation><ArticleIdList><ArticleId IdType="pubmed">18949723</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#x17a;dzik W, Albert J, Harbut P, et al. . Prolonged exposure to inhaled nitric oxide transiently modifies tubular function in healthy piglets and promotes tubular apoptosis. Acta Physiol. 2009;195(4):495&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pubmed">18826500</ArticleId></ArticleIdList></Reference><Reference><Citation>Dincel G, Yildirim S.. Increased expressions of eNOS and iNOS correlate with apoptosis of diabetic nephropathy in streptozotocin-induced type 1 diabetic rats. Kafkas Univ Vet Fak Derg. 2016;22:381&#x2013;390.</Citation></Reference><Reference><Citation>Mosa OF, Skitek M, Kalisnik JM, et al. . Evaluation of serum cysteine-rich protein 61 and cystatin C levels for assessment of acute kidney injury after cardiac surgery. Ren Fail. 2016;38(5):699&#x2013;705.</Citation><ArticleIdList><ArticleId IdType="pubmed">26982887</ArticleId></ArticleIdList></Reference><Reference><Citation>Arellano DL. Acute kidney injury following cardiothoracic surgery. Crit Care Nurs Clin North Am. 2019;31(3):407&#x2013;417.</Citation><ArticleIdList><ArticleId IdType="pubmed">31351558</ArticleId></ArticleIdList></Reference><Reference><Citation>Minneci PC, Deans KJ, Zhi H, et al. . Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. J Clin Invest. 2005;115(12):3409&#x2013;3417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1283939</ArticleId><ArticleId IdType="pubmed">16294219</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J, Spina S, Zadek F, et al. . Effect of nitric oxide on postoperative acute kidney injury in patients who underwent cardiopulmonary bypass: a systematic review and meta-analysis with trial sequential analysis. Ann Intensive Care. 2019;9(1):129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6872705</ArticleId><ArticleId IdType="pubmed">31754841</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami S, Bacha EA, Mazmanian GM, et al. . Effects of various timings and concentrations of inhaled nitric oxide in lung ischemia-reperfusion. The Paris-Sud University Lung Transplantation Group. Am J Respir Crit Care Med. 1997;156(2):454&#x2013;458.</Citation><ArticleIdList><ArticleId IdType="pubmed">9279223</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsumi H, Nishikawa M, Yamashita F, et al. . Prevention of hepatic ischemia/reperfusion injury by prolonged delivery of nitric oxide to the circulating blood in mice. Transplantation. 2008;85(2):264&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pubmed">18212632</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40203179</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>143</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Perioperative Nitric Oxide Conditioning Reduces Acute Kidney Injury in Cardiac Surgery Patients with Chronic Kidney Disease (the DEFENDER Trial): A Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>287</StartPage><EndPage>299</EndPage><MedlinePgn>287-299</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0000000000005494</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Postoperative acute kidney injury (AKI) is a significant concern for cardiac surgery patients with chronic kidney disease (CKD). Effective pharmacologic interventions to mitigate these risks are urgently needed. This study aimed to evaluate the efficacy and safety of perioperative nitric oxide (NO) administration in preventing AKI and limiting CKD progression in patients undergoing cardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 136 patients with CKD undergoing elective cardiac surgery with cardiopulmonary bypass were randomized into two equal groups: the NO group (n = 68), receiving 80 parts per million NO during the intraoperative period and for 6&#x2009;h postsurgery, and the control group (n = 68), receiving a sham treatment. The primary outcome was AKI incidence within 7 days postsurgery.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">AKI incidence was significantly lower in the NO group (16 of 68 patients, 23.5%) compared to the control group (27 of 68 patients, 39.7%) with a relative risk of 0.59 (95% CI, 0.35 to 0.99; P = 0.043). Six months postsurgery, the glomerular filtration rate was higher in the NO group (50&#x2009;ml &#xb7; min -1 &#xb7; 1.73 m -2 [45; 54]) compared to the control group (45&#x2009;ml &#xb7; min -1 &#xb7; 1.73 m -2 [41; 51]; P = 0.038). Postoperative pneumonia was significantly less frequent in the NO group: 10 of 68 (14.7%) versus 20 of 68 (29.4%) with a relative risk of 0.5 (95% CI, 0.25 to 0.99; P = 0.039). NO administration was safe: methemoglobin and nitrogen dioxide levels remained within acceptable ranges, oxidative-nitrosyl stress did not increase, and there were no significant differences between the groups in blood transfusion requirements, platelet counts, or postoperative blood loss volumes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Perioperative NO administration in CKD patients undergoing cardiac surgery with cardiopulmonary bypass is safe, reduces the incidence of AKI, and slows the progression of renal dysfunction.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 American Society of Anesthesiologists. All Rights Reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kamenshchikov</LastName><ForeName>Nikolay O</ForeName><Initials>NO</Initials><Identifier Source="ORCID">0000-0003-4289-4439</Identifier><AffiliationInfo><Affiliation>Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tyo</LastName><ForeName>Mark A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berra</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts; Department of Anaesthesia, Harvard Medical School, Boston, Massachusetts; and Respiratory Care Service, Patient Care Services, Massachusetts General Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kravchenko</LastName><ForeName>Igor V</ForeName><Initials>IV</Initials><AffiliationInfo><Affiliation>Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kozlov</LastName><ForeName>Boris N</ForeName><Initials>BN</Initials><AffiliationInfo><Affiliation>Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gusakova</LastName><ForeName>Anna M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Podoksenov</LastName><ForeName>Yuri K</ForeName><Initials>YK</Initials><AffiliationInfo><Affiliation>Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>31C4KY9ESH</RegistryNumber><NameOfSubstance UI="D009569">Nitric Oxide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009569" MajorTopicYN="Y">Nitric Oxide</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="Y">Renal Insufficiency, Chronic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="Y">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>8</Day><Hour>12</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>9</Day><Hour>18</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>9</Day><Hour>14</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40203179</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000005494</ArticleId><ArticleId IdType="pii">00000542-202508000-00016</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhang D, Teng J, Luo Z, Ding X, Jiang W: Risk factors and prognosis of acute kidney injury after cardiac surgery in patients with chronic kidney disease. Blood Purif 2023; 52:166&#x2013;73. doi:10.1159/000526120</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000526120</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho JS, Shim JK, Lee S, et al.: Chronic progression of cardiac surgery associated acute kidney injury: Intermediary role of acute kidney disease. J Thorac Cardiovasc Surg 2021; 161:681&#x2013;8.e3. doi:10.1016/j.jtcvs.2019.10.101</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2019.10.101</ArticleId></ArticleIdList></Reference><Reference><Citation>Molinari L, Sakhuja A, Kellum JA: Perioperative renoprotection: General mechanisms and treatment approaches. Anesth Analg 2020; 131:1679&#x2013;92. doi:10.1213/ANE.0000000000005107</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005107</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei C, Berra L, Rezoagli E, et al.: Nitric oxide decreases acute kidney injury and stage 3 chronic kidney disease after cardiac surgery. Am J Respir Crit Care Med 2018; 198:1279&#x2013;87. doi:10.1164/rccm.201710-2150OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201710-2150OC</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamenshchikov NO, Anfinogenova YJ, Kozlov BN, et al.: Nitric oxide delivery during cardiopulmonary bypass reduces acute kidney injury: A randomized trial. J Thorac Cardiovasc Surg 2022; 163:1393&#x2013;403.e9. doi:10.1016/j.jtcvs.2020.03.182</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2020.03.182</ArticleId></ArticleIdList></Reference><Reference><Citation>Baylis C: Nitric oxide deficiency in chronic kidney disease. Am J Physiol Renal Physiol 2008; 294:F1&#x2013;9. doi:10.1152/ajprenal.00424.2007</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00424.2007</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeulen Windsant IC, de Wit NC, Sertorio JT, et al.: Hemolysis during cardiac surgery is associated with increased intravascular nitric oxide consumption and perioperative kidney and intestinal tissue damage. Front Physiol 2014; 5:340. doi:10.3389/fphys.2014.00340</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2014.00340</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamenshchikov NO, Duong N, Berra L: Nitric oxide in cardiac surgery: A review article. Biomedicines 2023; 11:1085. doi:10.3390/biomedicines11041085</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11041085</ArticleId></ArticleIdList></Reference><Reference><Citation>De Backer D: Detailing the cardiovascular profile in shock patients. Crit Care 2017; 21:311. doi:10.1186/s13054-017-1908-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-017-1908-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M, Schmidt C, Hoffmeier A, et al.: Prevention of cardiac surgery&#x2013;associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: The PrevAKI randomized controlled trial. Intensive Care Med 2017; 43:1551&#x2013;61. doi:10.1007/s00134-016-4670-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4670-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghadimi K, Cappiello JL, Wright MC, et al.; INSPIRE-FLO Investigators: Inhaled epoprostenol compared with nitric oxide for right ventricular support after major cardiac surgery. Circulation 2023; 148:1316&#x2013;29. doi:10.1161/CIRCULATIONAHA.122.062464</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.062464</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, K&#xfc;llmar M, Ostermann M, et al.: Prevention of Cardiac surgery&#x2013;associated acute kidney injury by implementing the KDIGO guidelines in high-risk patients identified by biomarkers: The PrevAKI-multicenter randomized controlled trial. Anesth Analg 2021; 133:292&#x2013;302. doi:10.1213/ANE.0000000000005458</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005458</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukaida H, Matsushita S, Yamamoto T, et al.: Oxygen delivery-guided perfusion for the prevention of acute kidney injury: A randomized controlled trial. J Thorac Cardiovasc Surg 2023; 165:750&#x2013;60.e5. doi:10.1016/j.jtcvs.2021.03.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2021.03.032</ArticleId></ArticleIdList></Reference><Reference><Citation>Signori D, Magliocca A, Hayashida K, et al.: Inhaled nitric oxide: Role in the pathophysiology of cardio-cerebrovascular and respiratory diseases. Intensive Care Med Exp 2022; 10:28. doi:10.1186/s40635-022-00455-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40635-022-00455-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Spina S, Lei C, Pinciroli R, Berra L: Hemolysis and kidney injury in cardiac surgery: The protective role of nitric oxide therapy. Semin Nephrol 2019; 39:484&#x2013;95. doi:10.1016/j.semnephrol.2019.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semnephrol.2019.06.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenberg JW, Hogue S, Raees MA, et al.: Exogenous nitric oxide delivery protects against cardiopulmonary bypass-associated acute kidney injury: Histologic and serologic evidence from an ovine model. J Thorac Cardiovasc Surg 2023; 166:e164&#x2013;73. doi:10.1016/j.jtcvs.2023.03.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2023.03.030</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamenshchikov NO, Podoksenov YK, Kozlov BN, et al.: The nephroprotective effect of nitric oxide during extracorporeal circulation: An experimental study. Biomedicines 2024; 12:1298. doi:10.3390/biomedicines12061298</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines12061298</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeulen Windsant IC, Snoeijs MG, Hanssen SJ, et al.: Hemolysis is associated with acute kidney injury during major aortic surgery. Kidney Int 2010; 77:913&#x2013;20. doi:10.1038/ki.2010.24</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2010.24</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FT 4th, Ball SK, Roberts LJ 2nd, Pretorius M: Postoperative acute kidney injury is associated with hemoglobinemia and an enhanced oxidative stress response. Free Radic Biol Med 2011; 50:1480&#x2013;7. doi:10.1016/j.freeradbiomed.2011.02.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2011.02.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishi S, Nagasu H, Kidokoro K, Kashihara N: Oxidative stress and the role of redox signalling in chronic kidney disease. Nat Rev Nephrol 2024; 20:101&#x2013;19. doi:10.1038/s41581-023-00775-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-023-00775-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Landoni G, Monaco F, Ti LK, et al.; PROTECTION Study Group: A randomized trial of intravenous amino acids for kidney protection. N Engl J Med 2024; 391:687&#x2013;98. doi:10.1056/NEJMoa2403769</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2403769</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao B, Xu J, Qi Z, Harris RC, Zhang MZ: Role of renal cortical cyclooxygenase-2 expression in hyperfiltration in rats with high-protein intake. Am J Physiol Renal Physiol 2006; 291:F368&#x2013;74. doi:10.1152/ajprenal.00500.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00500.2005</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheruku SR, Raphael J, Neyra JA, Fox AA: Acute kidney injury after cardiac surgery: Prediction, prevention, and management. A nesthesiology 2023; 139:880&#x2013;98. doi:10.1097/ALN.0000000000004734</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000004734</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Luo Q, Wang L, Han L: Diagnostic value of neutrophil gelatinase-associated lipocalin for early diagnosis of cardiac surgery&#x2013;associated acute kidney injury: A meta-analysis. Eur J Cardiothorac Surg 2016; 49:746&#x2013;55. doi:10.1093/ejcts/ezv199</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezv199</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG, Garg AX, Swaminathan M, et al.; TRIBE-AKI Consortium: Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery. Nephrol Dial Transplant 2013; 28:2787&#x2013;99. doi:10.1093/ndt/gft405</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gft405</ArticleId></ArticleIdList></Reference><Reference><Citation>Casanova AG, Sancho-Mart&#xed;nez SM, Vicente-Vicente L, et al.: Diagnosis of cardiac surgery&#x2013;associated acute kidney injury: State of the art and perspectives. J Clin Med 2022; 11:4576. doi:10.3390/jcm11154576</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11154576</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Lu Y, Sun M, et al.: Pneumonia after cardiovascular surgery: Incidence, risk factors and interventions. Front Cardiovasc Med 2022; 9:911878. doi:10.3389/fcvm.2022.911878</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.911878</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalashnikova TP, Arsenyeva IA, Kamenshchikov NO, et al.: Antibacterial effect of nitric oxide on the causative agents of hospital-acquired pneumonia (experimental study). General Reanimatol 2024; 20:32&#x2013;41. doi:10.15360/1813-9779-2024-3-2424</Citation><ArticleIdList><ArticleId IdType="doi">10.15360/1813-9779-2024-3-2424</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Fenza R, Shetty NS, Gianni S, et al.; Nitric Oxide Investigators: High-dose inhaled nitric oxide in acute hypoxemic respiratory failure due to COVID-19: A multicenter phase II trial. Am J Respir Crit Care Med 2023; 208:1293&#x2013;304. doi:10.1164/rccm.202304-0637OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202304-0637OC</ArticleId></ArticleIdList></Reference><Reference><Citation>Gianetti J, Del Sarto P, Bevilacqua S, et al.: Supplemental nitric oxide and its effect on myocardial injury and function in patients undergoing cardiac surgery with extracorporeal circulation. J Thorac Cardiovasc Surg 2004; 127:44&#x2013;50. doi:10.1016/j.jtcvs.2002.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2002.08.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolcz J, Karnas E, Madeja Z, Zuba-Surma EK: The cardioprotective and anti-inflammatory effect of inhaled nitric oxide during Fontan surgery in patients with single ventricle congenital heart defects: A prospective randomized study. J Intensive Care 2022; 10:48. doi:10.1186/s40560-022-00639-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40560-022-00639-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y, Kamenshchikov N, Zheng Z, Lei C: Inhaled nitric oxide and postoperative outcomes in cardiac surgery with cardiopulmonary bypass: A systematic review and meta-analysis. Nitric Oxide 2024; 146:64&#x2013;74. doi:10.1016/j.niox.2024.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.niox.2024.03.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Coutrot M, D&#xe9;pret F, Legrand M: Is nitric oxide nephro- or cardioprotective? Am J Respir Crit Care Med 2019; 199:1441&#x2013;2. doi:10.1164/rccm.201812-2344LE</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201812-2344LE</ArticleId></ArticleIdList></Reference><Reference><Citation>Baaten CCFMJ, Sternkopf M, Henning T, Marx N, Jankowski J, Noels H: Platelet function in CKD: A systematic review and meta-analysis. J Am Soc Nephrol 2021; 32:1583&#x2013;98. doi:10.1681/ASN.2020101440</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2020101440</ArticleId></ArticleIdList></Reference><Reference><Citation>Gwozdzinski K, Pieniazek A, Gwozdzinski L: Reactive oxygen species and their involvement in red blood cell damage in chronic kidney disease. Oxid Med Cell Longev 2021; 2021:6639199. doi:10.1155/2021/6639199</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6639199</ArticleId></ArticleIdList></Reference><Reference><Citation>Schurle A, Koyner JL: CSA-AKI: Incidence, epidemiology, clinical outcomes, and economic impact. J Clin Med 2021; 10:5746. doi:10.3390/jcm10245746</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10245746</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Qi PK, Yang ZL, Huang N: Nitric oxide based strategies for applications of biomedical devices. Biosurf Biotribol 2015; 1:177&#x2013;201. doi:10.1016/j.bsbt.2015.08.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bsbt.2015.08.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlapbach LJ, Gibbons KS, Horton SB, et al.; NITRIC Study Group, the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS CTG), and the ANZICS Paediatric Study Group (PSG): Effect of nitric oxide via cardiopulmonary bypass on ventilator-free days in young children undergoing congenital heart disease surgery: The NITRIC randomized clinical trial. JAMA 2022; 328:38&#x2013;47. doi:10.1001/jama.2022.9376</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.9376</ArticleId></ArticleIdList></Reference><Reference><Citation>Muenster S, Zarragoikoetxea I, Moscatelli A, et al.: Inhaled NO at a crossroads in cardiac surgery: Current need to improve mechanistic understanding, clinical trial design and scientific evidence. Front Cardiovasc Med 2024; 11:1374635. doi:10.3389/fcvm.2024.1374635</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2024.1374635</ArticleId></ArticleIdList></Reference><Reference><Citation>Armenta A, Madero M, Rodriguez-Iturbe B: Functional reserve of the kidney. Clin J Am Soc Nephrol 2022; 17:458&#x2013;66. doi:10.2215/CJN.11070821</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.11070821</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;cze I, Jauch D, G&#xf6;tz M, et al.: Biomarker-guided intervention to prevent acute kidney injury after major surgery: The prospective randomized BigpAK study. Ann Surg 2018; 267:1013&#x2013;20. doi:10.1097/SLA.0000000000002485</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000002485</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26065644</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1533-4023</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>6</Issue><PubDate><Year>2015</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of cardiovascular pharmacology</Title><ISOAbbreviation>J Cardiovasc Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Efficacy and Safety of Erythropoietin to Prevent Acute Kidney Injury in Patients With Critical Illness or Perioperative Care: A Systematic Review and Meta-analysis of Randomized Controlled Trials.</ArticleTitle><Pagination><StartPage>593</StartPage><EndPage>600</EndPage><MedlinePgn>593-600</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/FJC.0000000000000229</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim was to investigate the efficacy and safety of erythropoietin (EPO) to prevent acute kidney injury (AKI) in patients with critical illness or perioperative care.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Randomized controlled trials comparing EPO with placebo for AKI prevention in adult patients with critical illness or perioperative care were searched in MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, the Web of Science, and Clinical Trials.gov until October 2014. The outcomes of interest included the incidence of AKI, dialysis requirement, mortality, and adverse event. Fixed effect model was used to calculate the pooled risk ratio (RR) and 95% confidence interval (CI) for eligible studies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Ten randomized controlled trials involving 2759 participants were identified and included in the analysis. Compared with placebo, EPO administration did not reduce the incidence of AKI (RR, 0.97; 95% CI, 0.79-1.19; P = 0.782), dialysis requirement (RR, 0.72; 95% CI, 0.31-1.70; P = 0.457), or mortality (RR, 0.96; 95% CI, 0.78-1.18; P = 0.705). Moreover, EPO had no effect on the risk of adverse events, but estimations of RR were difficult due to their relatively infrequent occurrence.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This meta-analysis suggests that prophylactic administration of EPO in patients with critical illness or perioperative care does not prevent AKI, dialysis requirement, or mortality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Key Laboratory of Nephrology, Ministry of Health, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Zhenchuan</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Qimei</ForeName><Initials>Q</Initials></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Xi</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Xueqing</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Fengxian</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Pharmacol</MedlineTA><NlmUniqueID>7902492</NlmUniqueID><ISSNLinking>0160-2446</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>11096-26-7</RegistryNumber><NameOfSubstance UI="D004921">Erythropoietin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004921" MajorTopicYN="N">Erythropoietin</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006435" MajorTopicYN="N">Renal Dialysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>6</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26065644</ArticleId><ArticleId IdType="pmc">PMC4461384</ArticleId><ArticleId IdType="doi">10.1097/FJC.0000000000000229</ArticleId><ArticleId IdType="pii">00005344-201506000-00012</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hoste EA, Schurgers M. Epidemiology of acute kidney injury: how big is the problem? Crit Care Med. 2008;36:S146&#x2013;S151.</Citation><ArticleIdList><ArticleId IdType="pubmed">18382186</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera-Guti&#xe9;rrez ME, Seller-P&#xe9;rez G, S&#xe1;nchez-Izquierdo-Riera JA, et al. Prevalence of acute kidney injury in intensive care units: the &#x201c;COrte de prevalencia de disFunci&#xf3;n RenAl y DEpuraci&#xf3;n en cr&#xed;ticos&#x201d; point-prevalence multicenter study. J Crit Care. 2013;28:687&#x2013;694.</Citation><ArticleIdList><ArticleId IdType="pubmed">23845794</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG, Yusuf B, Shlipak MG, et al. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;53:961&#x2013;973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2726041</ArticleId><ArticleId IdType="pubmed">19346042</ArticleId></ArticleIdList></Reference><Reference><Citation>Liotta M, Olsson D, Sartipy U, et al. Minimal changes in postoperative creatinine values and early and late mortality and cardiovascular events after coronary artery bypass grafting. Am J Cardiol. 2014;113:70&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">24176074</ArticleId></ArticleIdList></Reference><Reference><Citation>Rewa O, Bagshaw SM. Acute kidney injury-epidemiology, outcomes and economics. Nat Rev Nephrol. 2014;10:193&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">24445744</ArticleId></ArticleIdList></Reference><Reference><Citation>Jelkmann W. Erythropoietin after a century of research: younger than ever. Eur J Haematol. 2007;78:183&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">17253966</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernhardt WM, Eckardt KU. Physiological basis for the use of erythropoietin in critically ill patients at risk for acute kidney injury. Curr Opin Crit Care. 2008;14:621&#x2013;626.</Citation><ArticleIdList><ArticleId IdType="pubmed">19005302</ArticleId></ArticleIdList></Reference><Reference><Citation>Coldewey SM, Khan AI, Kapoor A, et al. Erythropoietin attenuates acute kidney dysfunction in murine experimental sepsis by activation of the &#x3b2;-common receptor. Kidney Int. 2013;84:482&#x2013;490.</Citation><ArticleIdList><ArticleId IdType="pubmed">23594675</ArticleId></ArticleIdList></Reference><Reference><Citation>Corwin HL, Gettinger A, Pearl RG, et al. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA. 2002;288:2827&#x2013;2835.</Citation><ArticleIdList><ArticleId IdType="pubmed">12472324</ArticleId></ArticleIdList></Reference><Reference><Citation>Napolitano LM, Fabian TC, Kelly KM, et al. Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. J Trauma. 2008;65:285&#x2013;297.</Citation><ArticleIdList><ArticleId IdType="pubmed">18695463</ArticleId></ArticleIdList></Reference><Reference><Citation>Endre ZH, Walker RJ, Pickering JW, et al. Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney Int. 2010;77:1020&#x2013;1030.</Citation><ArticleIdList><ArticleId IdType="pubmed">20164823</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo YC, Shim JK, Kim JC, et al. Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. Anesthesiology. 2011;115:929&#x2013;937.</Citation><ArticleIdList><ArticleId IdType="pubmed">22027622</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh SW, Chin HJ, Chae DW, et al. Erythropoietin improves long-term outcomes in patients with acute kidney injury after coronary artery bypass grafting. J Korean Med Sci. 2012;27:506&#x2013;511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3342541</ArticleId><ArticleId IdType="pubmed">22563215</ArticleId></ArticleIdList></Reference><Reference><Citation>de Seigneux S, Ponte B, Weiss L, et al. Epoetin administrated after cardiac surgery: effects on renal function and inflammation in a randomized controlled study. BMC Nephrol. 2012;13:132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3506492</ArticleId><ArticleId IdType="pubmed">23033926</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasanarong A, Duangchana S, Sumransurp S, et al. Prophylaxis with erythropoietin versus placebo reduces acute kidney injury and Neutrophil Gelatinase-associated Lipocalin in patients undergoing cardiac surgery: a randomized, double-blind controlled trial. BMC Nephrol. 2013;14:136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3704968</ArticleId><ArticleId IdType="pubmed">23829828</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JH, Shim JK, Song JW, et al. Effect of erythropoietin on the incidence of acute kidney injury following complex valvular heart surgery: a double blind, randomized clinical trial of efficacy and safety. Crit Care. 2013;17:R254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4056185</ArticleId><ArticleId IdType="pubmed">24156702</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JE, Ham SY, Shim YH. Prevention of acute kidney injury by erythropoietin in patients undergoing thoracic aorta surgery with hypothermic circulatory arrest. Eur J Anaesthesiol. 2013;30(suppl 51):63&#x2013;64.</Citation></Reference><Reference><Citation>Dardashti A, Ederoth P, Algotsson L, et al. Erythropoietin and protection of renal function in cardiac surgery (the EPRICS Trial). Anesthesiology. 2014;121:582&#x2013;590.</Citation><ArticleIdList><ArticleId IdType="pubmed">25225746</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Green S.
Cochrane handbook for systematic reviews of interventions Version 5.1.0 (updated March 2011). Available at: http://handbook.cochrane.org. Accessed October 1, 2014.</Citation></Reference><Reference><Citation>Song YR, Lee T, You SJ, et al. Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: a pilot study. Am J Nephrol. 2009;30:253&#x2013;260.</Citation><ArticleIdList><ArticleId IdType="pubmed">19494484</ArticleId></ArticleIdList></Reference><Reference><Citation>Clec'h C, Gonzalez F, Lautrette A, et al. Multiple-center evaluation of mortality associated with acute kidney injury in critically ill patients: a competing risks analysis. Crit Care. 2011;15:R128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3218994</ArticleId><ArticleId IdType="pubmed">21586153</ArticleId></ArticleIdList></Reference><Reference><Citation>Singbartl K, Kellum JA. AKI in the ICU: definition, epidemiology, risk stratification, and outcomes. Kidney Int. 2012;81:819&#x2013;825.</Citation><ArticleIdList><ArticleId IdType="pubmed">21975865</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G, Huang H, Wu H, et al. Erythropoietin attenuates cardiopulmonary bypass-induced renal inflammatory injury by inhibiting nuclear factor-&#x3ba;B p65 expression. Eur J Pharmacol. 2012;689:154&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pubmed">22659586</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoyanoff TR, Todaro JS, Aguirre MV, et al. Amelioration of lipopolysaccharide-induced acute kidney injury by erythropoietin: involvement of mitochondria-regulated apoptosis. Toxicology. 2014;318:13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">24561306</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghaboura N, Tamareille S, Ducluzeau PH, et al. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3&#x3b2; signaling. Basic Res Cardiol. 2011;106:147&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pubmed">20981553</ArticleId></ArticleIdList></Reference><Reference><Citation>Mat&#x11b;jkov&#xe1; &#x160;, Scheuerle A, Wagner F, et al. Carbamylated erythropoietin-FC fusion protein and recombinant human erythropoietin during porcine kidney ischemia/reperfusion injury. Intensive Care Med. 2013;39:497&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pubmed">23291730</ArticleId></ArticleIdList></Reference><Reference><Citation>Zacharias M, Mugawar M, Herbison GP, et al. Interventions for protecting renal function in the perioperative period. Cochrane Database Syst Rev. 2013;9:CD003590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7154582</ArticleId><ArticleId IdType="pubmed">24027097</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40943838</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>17</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>28</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Perioperative Myocardial Injury and Acute Kidney Injury in Patients Undergoing Hepatic Resection: Incidence, Risk Factors, and Effects on Outcomes.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">6080</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm14176080</ELocationID><Abstract><AbstractText><b>Background/Objectives:</b> Perioperative organ injury (POI) is frequently observed following hepatectomy as acute kidney injury (AKI), perioperative myocardial injury (PMI), or both. We aimed to determine the incidences of POI, PMI, and AKI, reveal the risk factors and predictive tools for POI occurrence, and evaluate the relationship between POI and patient outcomes. <b>Methods:</b> This was a single-center historical cohort study of consecutive patients. The primary endpoint was the occurrence of POI within 3 days following hepatectomy. <b>Results:</b> Out of 128 patients, POI, PMI, and AKI occurred in 48 (37.5%), 36 (28.1%), and 23 (18%) patients, respectively. Ten (7.8%) patients suffered from both PMI and AKI. The presence of chronic kidney disease or systolic/valvular heart disease, fluid balance more than 365 mL/h, and intraoperative bleeding more than 950 mL were the risk factors for POI. A tool created by using the intraoperative decline of central venous oxygen saturation and lactate value during skin closure performed well in predicting POI (area under the ROC curve: 0.79, <i>p</i> &lt; 0.001). In patients with POI, the number of those who needed intensive care unit (ICU) follow-up for more than 1 day was significantly higher (21% vs. 6%, <i>p</i>: 0.01). The length of hospital stay for these patients was significantly longer as well (11 (8-18) vs. 9 (7-13) days, <i>p</i>: 0.02). Two patients (20% of 10 patients who suffered from both AKI and PMI) died in the 90-day follow-up. <b>Conclusions:</b> POI is a common complication following hepatectomy and is associated with longer hospital and ICU stays. Patients who suffer from both AKI and PMI have a higher risk of mortality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abdullah</LastName><ForeName>Taner</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Reanimation, Ba&#x15f;ak&#x15f;ehir &#xc7;am &amp; Sakura City Hospital, 34480 Istanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x15e;ent&#xfc;rk</LastName><ForeName>Mert</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2373-6451</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Reanimation, School of Medicine, Ac&#x131;badem University, 34750 Istanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf6;kduman</LastName><ForeName>H&#xfc;r&#xfc; Ceren</ForeName><Initials>HC</Initials><Identifier Source="ORCID">0000-0003-1904-4954</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Reanimation, Ba&#x15f;ak&#x15f;ehir &#xc7;am &amp; Sakura City Hospital, 34480 Istanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eni&#x15f;te</LastName><ForeName>&#x130;&#x15f;bara Alp</ForeName><Initials>&#x130;A</Initials><Identifier Source="ORCID">0000-0003-2882-6376</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Reanimation, Ba&#x15f;ak&#x15f;ehir &#xc7;am &amp; Sakura City Hospital, 34480 Istanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuda&#x15f;</LastName><ForeName>&#x130;lyas</ForeName><Initials>&#x130;</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Ba&#x15f;ak&#x15f;ehir &#xc7;am &amp; Sakura City Hospital, 34480 Istanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bostanc&#x131;</LastName><ForeName>&#xd6;zg&#xfc;r</ForeName><Initials>&#xd6;</Initials><AffiliationInfo><Affiliation>Liver Transplantation &amp; Hepatopancreatobiliary Surgery Unit, Department of General Surgery, Istanbul Ba&#x15f;ak&#x15f;ehir &#xc7;am &amp; Sakura City Hospital, 34480 Istanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#x131;nac&#x131;</LastName><ForeName>Erdem</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-0380-7585</Identifier><AffiliationInfo><Affiliation>Liver Transplantation &amp; Hepatopancreatobiliary Surgery Unit, Department of General Surgery, Istanbul Ba&#x15f;ak&#x15f;ehir &#xc7;am &amp; Sakura City Hospital, 34480 Istanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;zden</LastName><ForeName>&#x130;lgin</ForeName><Initials>&#x130;</Initials><Identifier Source="ORCID">0000-0001-7360-628X</Identifier><AffiliationInfo><Affiliation>Liver Transplantation &amp; Hepatopancreatobiliary Surgery Unit, Department of General Surgery, Istanbul Ba&#x15f;ak&#x15f;ehir &#xc7;am &amp; Sakura City Hospital, 34480 Istanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;m&#xfc;&#x15f; &#xd6;zcan</LastName><ForeName>Funda</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Reanimation, Ba&#x15f;ak&#x15f;ehir &#xc7;am &amp; Sakura City Hospital, 34480 Istanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>0</GrantID><Agency>Ac&#x131;badem University</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">hepatic resection</Keyword><Keyword MajorTopicYN="N">perioperative acute kidney injury</Keyword><Keyword MajorTopicYN="N">perioperative myocardial injury</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>13</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40943838</ArticleId><ArticleId IdType="pmc">PMC12429616</ArticleId><ArticleId IdType="doi">10.3390/jcm14176080</ArticleId><ArticleId IdType="pii">jcm14176080</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fujii T., Takakura M., Taniguchi T., Tamura T., Nishiwaki K. Intraoperative hypotension affects postoperative acute kidney injury depending on the invasiveness of abdominal surgery: A retrospective cohort study. Medicine. 2023;102:e36465. doi: 10.1097/MD.0000000000036465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000036465</ArticleId><ArticleId IdType="pmc">PMC10695494</ArticleId><ArticleId IdType="pubmed">38050260</ArticleId></ArticleIdList></Reference><Reference><Citation>Wis&#xe9;n E., Almazrooa A., Bown L.S., Rizell M., Ricksten S., Kvarnstr&#xf6;m A., Svennerholm K. Myocardial, renal and intestinal injury in liver resection surgery-A prospective observational pilot study. Acta Anaesthesiol. Scand. 2021;65:886&#x2013;894. doi: 10.1111/aas.13823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.13823</ArticleId><ArticleId IdType="pubmed">33811772</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim C., Audureau E., Salloum C., Levesque E., Lahat E., Merle J.C., Compagnon P., Dhonneur G., Feray C., Azoulay D. Acute kidney injury following hepatectomy for hepatocellular carcinoma: Incidence, risk factors and prognostic value. HPB. 2016;18:540&#x2013;548. doi: 10.1016/j.hpb.2016.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hpb.2016.04.004</ArticleId><ArticleId IdType="pmc">PMC4913133</ArticleId><ArticleId IdType="pubmed">27317959</ArticleId></ArticleIdList></Reference><Reference><Citation>Joliat G.-R., Labgaa I., Demartines N., Halkic N. Acute kidney injury after liver surgery: Does postoperative urine output correlate with postoperative serum creatinine? HPB. 2020;22:144&#x2013;150. doi: 10.1016/j.hpb.2019.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hpb.2019.06.016</ArticleId><ArticleId IdType="pubmed">31431415</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K.F., Lo E.Y.J., Wong K.K.C., Fung A.K.Y., Chong C.C.N., Wong J., Ng K.K.C., Lai P.B.S. Acute kidney injury following hepatectomy and its impact on long-term survival for patients with hepatocellular carcinoma. BJS Open. 2021;5:zrab077. doi: 10.1093/bjsopen/zrab077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bjsopen/zrab077</ArticleId><ArticleId IdType="pmc">PMC8487667</ArticleId><ArticleId IdType="pubmed">34601569</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A., Weiss R., Albert F., Rutledge K., Kellum J.A., Bellomo R., Grigoryev E., Candela-Toha A.M., Demir Z.A., Legros V., et al. EPIS-AKI Investigators. Epidemiology of surgery associated acute kidney injury (EPIS-AKI): A prospective international observational multi-center clinical study. Intensive Care Med. 2023;49:1441&#x2013;1455. doi: 10.1007/s00134-023-07169-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-023-07169-7</ArticleId><ArticleId IdType="pmc">PMC10709241</ArticleId><ArticleId IdType="pubmed">37505258</ArticleId></ArticleIdList></Reference><Reference><Citation>Halvorsen S., Mehilli J., Cassese S., Hall T.S., Abdelhamid M., Barbato E., De Hert S., de Laval I., Geisler T., Hinterbuchner L., et al. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur. Heart J. 2022;43:3826&#x2013;3924. doi: 10.1093/eurheartj/ehac270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac270</ArticleId><ArticleId IdType="pubmed">36017553</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruetzler K., Khanna A.K., Sessler D.I. Myocardial Injury After Noncardiac Surgery: Preoperative, Intraoperative, and Postoperative Aspects, Implications and Directions. Anesth. Analg. 2020;131:173&#x2013;186. doi: 10.1213/ANE.0000000000004567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000004567</ArticleId><ArticleId IdType="pubmed">31880630</ArticleId></ArticleIdList></Reference><Reference><Citation>Smilowitz N.R., Redel-Traub G.B., Hausvater A., Armanious A., Nicholson J., Puelacher C., Berger J.S. Myocardial Injury After Noncardiac Surgery: A Systematic Review and Meta-Analysis. Cardiol. Rev. 2019;27:267&#x2013;273. doi: 10.1097/CRD.0000000000000254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CRD.0000000000000254</ArticleId><ArticleId IdType="pmc">PMC6776733</ArticleId><ArticleId IdType="pubmed">30985328</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdullah T., G&#xf6;kduman H.C., Eni&#x15f;te &#x130;.A., Kuda&#x15f; &#x130;., Ali A., Kinaci E., &#xd6;zden I., &#xd6;zcan F.G. Mean arterial pressure versus cardiac index for haemodynamic management and myocardial injury after hepatopancreatic surgery: A randomised controlled trial. Eur. J. Anaesthesiol. 2024;41:831&#x2013;840. doi: 10.1097/EJA.0000000000002059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000002059</ArticleId><ArticleId IdType="pubmed">39262319</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa S., Tanaka M., Maruyama F., Fukagawa A., Shiota N., Matsumura S., Makita K. Effects of acute kidney injury after liver resection on long-term outcomes. Korean J. Anesth. 2017;70:527&#x2013;534. doi: 10.4097/kjae.2017.70.5.527.</Citation><ArticleIdList><ArticleId IdType="doi">10.4097/kjae.2017.70.5.527</ArticleId><ArticleId IdType="pmc">PMC5645585</ArticleId><ArticleId IdType="pubmed">29046772</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin. Pract. 2012;120:c179&#x2013;c184. doi: 10.1159/000339789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000339789</ArticleId><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Strasberg S.M., Belghiti J., Clavien P.-A., Gadzijev E., Garden J., Lau W.-Y., Makuuchi M., Strong R. The Brisbane 2000 terminology of liver anatomy and resections. HPB. 2000;2:333&#x2013;339. doi: 10.1016/S1365-182X(17)30755-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1365-182X(17)30755-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Picado A., Albinarrate A., Barrachina B. Determination of Perioperative Blood Loss: Accuracy or Approximation? Anesth. Analg. 2017;125:280&#x2013;286. doi: 10.1213/ANE.0000000000001992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000001992</ArticleId><ArticleId IdType="pubmed">28368940</ArticleId></ArticleIdList></Reference><Reference><Citation>Coste J., Pouchot J. A grey zone for quantitative diagnostic and screening tests. Int. J. Epidemiol. 2003;32:304&#x2013;313. doi: 10.1093/ije/dyg054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyg054</ArticleId><ArticleId IdType="pubmed">12714554</ArticleId></ArticleIdList></Reference><Reference><Citation>Green S.B. How Many Subjects Does It Take To Do A Regression Analysis. Multivar. Behav. Res. 1991;26:499&#x2013;510. doi: 10.1207/s15327906mbr2603_7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1207/s15327906mbr2603_7</ArticleId><ArticleId IdType="pubmed">26776715</ArticleId></ArticleIdList></Reference><Reference><Citation>Reese T., Kr&#xf6;ger F., Makridis G., Drexler R., Jusufi M., Schneider M., Br&#xfc;ning R., von Rittberg Y., Wagner K.C., Oldhafer K.J. Impact of acute kidney injury after extended liver resections. HPB. 2021;23:1000&#x2013;1007. doi: 10.1016/j.hpb.2020.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hpb.2020.10.015</ArticleId><ArticleId IdType="pubmed">33191106</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller T.E., Mythen M., Shaw A.D., Hwang S., Shenoy A.V., Bershad M., Hunley C. Association between perioperative fluid management and patient outcomes: A multicentre retrospective study. Br. J. Anaesth. 2021;126:720&#x2013;729. doi: 10.1016/j.bja.2020.10.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.10.031</ArticleId><ArticleId IdType="pubmed">33317803</ArticleId></ArticleIdList></Reference><Reference><Citation>Frogel J., Galusca D. Anesthetic considerations for patients with advanced valvular heart disease undergoing noncardiac surgery. Anesth. Clin. 2010;28:67&#x2013;85. doi: 10.1016/j.anclin.2010.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anclin.2010.01.008</ArticleId><ArticleId IdType="pubmed">20400041</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y., Zhang C., Zhang F., Liu C., Li H., Lou J., Xu Z., Liu Y., Cao J., Mi W. Development and validation of a risk nomogram for postoperative acute kidney injury in older patients undergoing liver resection: A pilot study. BMC Anesth. 2022;22:22. doi: 10.1186/s12871-022-01566-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-022-01566-z</ArticleId><ArticleId IdType="pmc">PMC8756684</ArticleId><ArticleId IdType="pubmed">35026992</ArticleId></ArticleIdList></Reference><Reference><Citation>Ida S., Morita Y., Matsumoto A., Muraki R., Kitajima R., Furuhashi S., Takeda M., Kikuchi H., Hiramatsu Y., Takeuchi H. Prediction of postoperative complications after hepatectomy with dynamic monitoring of central venous oxygen saturation. BMC Surg. 2023;23:343. doi: 10.1186/s12893-023-02238-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12893-023-02238-6</ArticleId><ArticleId IdType="pmc">PMC10644466</ArticleId><ArticleId IdType="pubmed">37957615</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaspari R., Teofili L., Ardito F., Adducci E., Vellone M., Mele C., Orlando N., Iacobucci T., Antonelli M., Giuliante F. High Arterial Lactate Levels after Hepatic Resection Are Associated with Low Oxygen Delivery and Predict Severe Postoperative Complications. Biomedicines. 2022;10:1108. doi: 10.3390/biomedicines10051108.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10051108</ArticleId><ArticleId IdType="pmc">PMC9138275</ArticleId><ArticleId IdType="pubmed">35625845</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemke M., Karanicolas P.J., Habashi R., Behman R., Coburn N.G., Hanna S.S., Law C.H., Hallet J. Elevated Lactate is Independently Associated with Adverse Outcomes Following Hepatectomy. World J. Surg. 2017;41:3180&#x2013;3188. doi: 10.1007/s00268-017-4118-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-017-4118-0</ArticleId><ArticleId IdType="pubmed">28717907</ArticleId></ArticleIdList></Reference><Reference><Citation>Recknagel S., Rademacher S., H&#xf6;hne C., Lederer A.A., Lange U.G., Herta T., Seehofer D., Sucher R., Scheuermann U. Prediction of the Postoperative Outcome in Liver Resection Using Perioperative Serum Lactate Levels. J. Clin. Med. 2023;12:2100. doi: 10.3390/jcm12062100.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12062100</ArticleId><ArticleId IdType="pmc">PMC10051976</ArticleId><ArticleId IdType="pubmed">36983103</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly C., St&#xe4;ttner S., Niederwieser T., Primavesi F. Systematic review on peri-operative lactate measurements to predict outcomes in patients undergoing liver resection. J. Hepatobiliary Pancreat. Sci. 2020;27:359&#x2013;370. doi: 10.1002/jhbp.727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jhbp.727</ArticleId><ArticleId IdType="pmc">PMC7496457</ArticleId><ArticleId IdType="pubmed">32065510</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32801231</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>02</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1319-2442</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Season>Jul-Aug</Season></PubDate></JournalIssue><Title>Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia</Title><ISOAbbreviation>Saudi J Kidney Dis Transpl</ISOAbbreviation></Journal><ArticleTitle>Risk Factors for the Development of Postoperative Acute Kidney Injury in Patients Undergoing Joint Replacement Surgery: A Meta-Analysis.</ArticleTitle><Pagination><StartPage>703</StartPage><EndPage>716</EndPage><MedlinePgn>703-716</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/1319-2442.292304</ELocationID><Abstract><AbstractText>A new-onset acute kidney injury (AKI) after arthroplasty impairs rehabilitation and outcome. A prior knowledge of risk factors contributes to a planned preventive management and prognostication. Although many studies have addressed the issue, our objective was to perform a meta-analysis to bring a consensus on the perioperative risk factors promoting AKI postoperatively. We conducted a systematic review and meta-analysis of observational studies reporting risk factors with odds of development of AKI according to the existing criteria after hip or knee replacement surgery. We searched the PubMed and Google Scholar databases for free English articles published until June 2018. Two authors independently screened the articles and extracted data. Discrepancies were resolved by consensus or consulting the third author. Methodological quality of the articles was assessed using the Newcastle-Ottawa Scale. A total of five studies were included in this meta-analysis. The following risk factors were found to contribute to new kidney injury: advanced age; male gender; preoperative liver, cardiac, or kidney diseases; presence of heart failure; American Society of Anesthesiologists grade &#x2265; 3; requirement of perioperative blood transfusion, revision arthroplasty, and knee arthroplasty; body mass index; and use of angiotensin-converting enzyme inhibitors. Diabetes, hypertension, duration of surgery, type of anesthesia, and preoperative serum creatinine were not found to be associated with renal injury. The key limitation was the availability of small number of studies. More longitudinal observational studies addressing the issue are the need of the hour, and, till then, a preventive strategy aimed at the identified risk factors should help.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Parnandi Bhaskar</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Neha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tripathy</LastName><ForeName>Sujit K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Saudi Arabia</Country><MedlineTA>Saudi J Kidney Dis Transpl</MedlineTA><NlmUniqueID>9436968</NlmUniqueID><ISSNLinking>1319-2442</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019643" MajorTopicYN="N">Arthroplasty, Replacement</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32801231</ArticleId><ArticleId IdType="doi">10.4103/1319-2442.292304</ArticleId><ArticleId IdType="pii">SaudiJKidneyDisTranspl_2020_31_4_703_292304</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32040627</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-198X</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Pediatric nephrology (Berlin, Germany)</Title><ISOAbbreviation>Pediatr Nephrol</ISOAbbreviation></Journal><ArticleTitle>Association of postoperative fluid overload with adverse outcomes after congenital heart surgery: a systematic review and dose-response meta-analysis.</ArticleTitle><Pagination><StartPage>1109</StartPage><EndPage>1119</EndPage><MedlinePgn>1109-1119</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00467-020-04489-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">Pediatric cardiac surgery is commonly associated with acute kidney injury (AKI) and significant fluid retention, which complicate postoperative management and lead to increased rates of morbidity. This meta-analysis aimed to accumulate current literature evidence and evaluate the correlation of fluid overload degree with adverse outcome in patients undergoing congenital heart surgery.</AbstractText><AbstractText Label="METHODS">Medline, Scopus, CENTRAL, Clinicaltrials.gov, and Google Scholar were systematically searched from inception. All studies reporting the effects of fluid overload on postoperative clinical outcomes were selected. A dose-response meta-analytic method using restricted cubic splines was implemented in R-3.6.1.</AbstractText><AbstractText Label="RESULTS">Twelve studies were included, with a total of 3111 pediatric patients. Qualitative synthesis indicated that fluid overload was linked to significantly higher risk of mortality, AKI, prolonged hospital, and intensive care unit (ICU) stay, as well as with increased duration of mechanical ventilation, inotrope need, and infection rate. Meta-analysis demonstrated a linear correlation between fluid overload and the risk of mortality (&#x3c7;<sup>2</sup>&#xa0;=&#x2009;6.22, p value&#x2009;=&#x2009;0.01) and AKI (&#x3c7;<sup>2</sup>&#xa0;=&#x2009;35.84, p value&#x2009;&lt;&#x2009;0.001), while a positive curvilinear relationship was estimated for the outcomes of hospital (&#x3c7;<sup>2</sup>&#xa0;=&#x2009;18.84, p value&#x2009;=&#x2009;0.0001) and ICU stay (&#x3c7;<sup>2</sup>&#xa0;=&#x2009;63.69, p value&#x2009;=&#x2009;0.0001).</AbstractText><AbstractText Label="CONCLUSIONS">The present meta-analysis supports that postoperative fluid overload is significantly linked to elevated risk of prolonged hospital stay, AKI development, and mortality in pediatric patients undergoing cardiac surgery. These findings warrant replication by future prospective studies, which should define the optimal cutoff values and assess the effectiveness of therapeutic strategies to limit fluid overload in the postoperative setting.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bellos</LastName><ForeName>Ioannis</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-5088-5458</Identifier><AffiliationInfo><Affiliation>Laboratory of Experimental Surgery and Surgical Research N.S. Christeas, Athens University Medical School, National and Kapodistrian University of Athens, Athens, Greece. bellosg@windowslive.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iliopoulos</LastName><ForeName>Dimitrios C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Surgery and Surgical Research N.S. Christeas, Athens University Medical School, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perrea</LastName><ForeName>Despina N</ForeName><Initials>DN</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Surgery and Surgical Research N.S. Christeas, Athens University Medical School, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Pediatr Nephrol</MedlineTA><NlmUniqueID>8708728</NlmUniqueID><ISSNLinking>0931-041X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006330" MajorTopicYN="N">Heart Defects, Congenital</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015278" MajorTopicYN="N">Intensive Care Units, Pediatric</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014883" MajorTopicYN="N">Water-Electrolyte Imbalance</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Congenital heart</Keyword><Keyword MajorTopicYN="N">Fluid overload</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Pediatric</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32040627</ArticleId><ArticleId IdType="doi">10.1007/s00467-020-04489-4</ArticleId><ArticleId IdType="pii">10.1007/s00467-020-04489-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Clin J Am Soc Nephrol. 2015 Mar 6;10(3):500-14</Citation><ArticleIdList><ArticleId IdType="pubmed">25376763</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2014 Dec;42(12):2591-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25072753</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiology. 1993 May;4(3):218-28</Citation><ArticleIdList><ArticleId IdType="pubmed">8512986</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2007 May;71(10):963-4</Citation><ArticleIdList><ArticleId IdType="pubmed">17495936</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Nephrol. 2012 Jul;27(7):1067-78</Citation><ArticleIdList><ArticleId IdType="pubmed">22012033</ArticleId></ArticleIdList></Reference><Reference><Citation>Nephron Clin Pract. 2012;120(4):c179-84</Citation><ArticleIdList><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Anaesthesiol Scand. 2018 Nov;62(10):1374-1382</Citation><ArticleIdList><ArticleId IdType="pubmed">29992550</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2016 Nov 10;11(11):e0166328</Citation><ArticleIdList><ArticleId IdType="pubmed">27832187</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Pediatr. 2016 Nov 1;170(11):1071-1078</Citation><ArticleIdList><ArticleId IdType="pubmed">27618162</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Pediatr Congenit Heart Surg. 2019 Nov;10(6):778-788</Citation><ArticleIdList><ArticleId IdType="pubmed">31701831</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Pediatr Congenit Heart Surg. 2015 Jul;6(3):401-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26180155</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Crit Care Med. 2017 Aug;18(8):770-778</Citation><ArticleIdList><ArticleId IdType="pubmed">28486386</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Crit Care Med. 2014 Feb;15(2):131-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24366508</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2017 Sep;92(3):751-756</Citation><ArticleIdList><ArticleId IdType="pubmed">28412020</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Nephrol. 2018 Mar;33(3):511-520</Citation><ArticleIdList><ArticleId IdType="pubmed">29128923</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 2008 Oct;134(4):768-74</Citation><ArticleIdList><ArticleId IdType="pubmed">18625673</ArticleId></ArticleIdList></Reference><Reference><Citation>Congenit Heart Dis. 2014 Mar-Apr;9(2):106-15</Citation><ArticleIdList><ArticleId IdType="pubmed">23647999</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Crit Care Med. 2016 May;17(5):420-7</Citation><ArticleIdList><ArticleId IdType="pubmed">27028790</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Crit Care Med. 2019 Feb;20(2):158-165</Citation><ArticleIdList><ArticleId IdType="pubmed">30399019</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2007 Apr 10;176(8):1091-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17420491</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Cardiol. 2015 Dec;36(8):1692-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26123810</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Cardiol. 2010 Nov;31(8):1166-70</Citation><ArticleIdList><ArticleId IdType="pubmed">20703453</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Nephrol. 2018 Jul;33(7):1235-1242</Citation><ArticleIdList><ArticleId IdType="pubmed">29508077</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2019 Sep;108(3):806-812</Citation><ArticleIdList><ArticleId IdType="pubmed">31026428</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Cardiol. 2017 Apr;38(4):787-793</Citation><ArticleIdList><ArticleId IdType="pubmed">28190141</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Pediatr Congenit Heart Surg. 2018 Sep;9(5):513-521</Citation><ArticleIdList><ArticleId IdType="pubmed">30157730</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Nephrol. 2019 Jun;23(6):782-791</Citation><ArticleIdList><ArticleId IdType="pubmed">30734166</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Crit Care Med. 2017 Jul;18(7):614-622</Citation><ArticleIdList><ArticleId IdType="pubmed">28492405</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Crit Care Med. 2018 Apr;19(4):310-317</Citation><ArticleIdList><ArticleId IdType="pubmed">29620706</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Pediatr. 2018 Mar 1;172(3):257-268</Citation><ArticleIdList><ArticleId IdType="pubmed">29356810</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Soc Nephrol. 2018 May;29(5):1549-1556</Citation><ArticleIdList><ArticleId IdType="pubmed">29472416</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Pediatr. 2018 Apr;14(2):134-142</Citation><ArticleIdList><ArticleId IdType="pubmed">29464581</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Res Methods. 2017 Aug;49(4):1494-1502</Citation><ArticleIdList><ArticleId IdType="pubmed">27620283</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Nephrol. 2017 Sep;32(9):1509-1517</Citation><ArticleIdList><ArticleId IdType="pubmed">28361230</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiothorac Vasc Anesth. 2019 Aug;33(8):2170-2179</Citation><ArticleIdList><ArticleId IdType="pubmed">30638918</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Methods Med Res. 2019 May;28(5):1579-1596</Citation><ArticleIdList><ArticleId IdType="pubmed">29742975</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 1995 Oct 15;92(8):2226-35</Citation><ArticleIdList><ArticleId IdType="pubmed">7554206</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Crit Care Med. 2013 Jan;14(1):44-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23249789</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2007;11(2):R31</Citation><ArticleIdList><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2009 Oct;62(10):e1-34</Citation><ArticleIdList><ArticleId IdType="pubmed">19631507</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Esp Anestesiol Reanim. 1984 Jan-Feb;31(1):30-3</Citation><ArticleIdList><ArticleId IdType="pubmed">6463297</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiothorac Vasc Anesth. 2016 Aug;30(4):1085-93</Citation><ArticleIdList><ArticleId IdType="pubmed">26944520</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2011 Jun;39(6):1493-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21336114</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Crit Care Med. 2016 Apr;17(4):307-14</Citation><ArticleIdList><ArticleId IdType="pubmed">26914622</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Pediatr. 2017 Apr 1;171(4):357-364</Citation><ArticleIdList><ArticleId IdType="pubmed">28241247</ArticleId></ArticleIdList></Reference><Reference><Citation>J Extra Corpor Technol. 2011 Dec;43(4):215-26</Citation><ArticleIdList><ArticleId IdType="pubmed">22416601</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Nephrol. 2020 Feb;24(2):167-173</Citation><ArticleIdList><ArticleId IdType="pubmed">31677063</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Neonatol. 2019 Feb;60(1):3-11</Citation><ArticleIdList><ArticleId IdType="pubmed">29891225</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Crit Care Med. 2016 Mar;17(3 Suppl 1):S35-48</Citation><ArticleIdList><ArticleId IdType="pubmed">26945328</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36536317</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2369</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>19</Day></PubDate></JournalIssue><Title>BMC nephrology</Title><ISOAbbreviation>BMC Nephrol</ISOAbbreviation></Journal><ArticleTitle>Artificial intelligence for the prediction of acute kidney injury during the perioperative period: systematic review and Meta-analysis of diagnostic test accuracy.</ArticleTitle><Pagination><StartPage>405</StartPage><MedlinePgn>405</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">405</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12882-022-03025-w</ELocationID><Abstract><AbstractText Label="BACKGROUND">Acute kidney injury (AKI) is independently associated with morbidity and mortality in a wide range of surgical settings. Nowadays, with the increasing use of electronic health records (EHR), advances in patient information retrieval, and cost reduction in clinical informatics, artificial intelligence is increasingly being used to improve early recognition and management for perioperative AKI. However, there is no quantitative synthesis of the performance of these methods. We conducted this systematic review and meta-analysis to estimate the sensitivity and specificity of artificial intelligence for the prediction of acute kidney injury during the perioperative period.</AbstractText><AbstractText Label="METHODS">Pubmed, Embase, and Cochrane Library were searched to 2nd October 2021. Studies presenting diagnostic performance of artificial intelligence in the early detection of perioperative acute kidney injury were included. True positives, false positives, true negatives and false negatives were pooled to collate specificity and sensitivity with 95% CIs and results were portrayed in forest plots. The risk of bias of eligible studies was assessed using the PROBAST tool.</AbstractText><AbstractText Label="RESULTS">Nineteen studies involving 304,076 patients were included. Quantitative random-effects meta-analysis using the Rutter and Gatsonis hierarchical summary receiver operating characteristics (HSROC) model revealed pooled sensitivity, specificity, and diagnostic odds ratio of 0.77 (95% CI: 0.73 to 0.81),0.75 (95% CI: 0.71 to 0.80), and 10.7 (95% CI 8.5 to 13.5), respectively. Threshold effect was found to be the only source of heterogeneity, and there was no evidence of publication bias.</AbstractText><AbstractText Label="CONCLUSIONS">Our review demonstrates the promising performance of artificial intelligence for early prediction of perioperative AKI. The limitations of lacking external validation performance and being conducted only at a single center should be overcome.</AbstractText><AbstractText Label="TRIAL REGISTRATION">This study was not registered with PROSPERO.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Hanfei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nephrology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Amanda Y</ForeName><Initials>AY</Initials><AffiliationInfo><Affiliation>The faculty of medicine and health sciences, Macquarie University, Sydney, NSW, Australia. Awang@georgeinstitute.org.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wu</LastName><ForeName>Shukun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nephrology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngo</LastName><ForeName>Johnathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Concord Clinical School, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Yunlin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nephrology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nephrology, Affiliated Hospital of Southwest Medical University, Luzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yingfeng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xingwei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. wuxw1998@126.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nephrology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China. wuxw1998@126.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy, Sichuan Provincial Peoples Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. wuxw1998@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Daqing</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. hongdaqing11@126.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nephrology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China. hongdaqing11@126.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Renal Department and Nephrology Institute, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. hongdaqing11@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Nephrol</MedlineTA><NlmUniqueID>100967793</NlmUniqueID><ISSNLinking>1471-2369</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003955" MajorTopicYN="N">Diagnostic Tests, Routine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney failure</Keyword><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Artificial intelligence</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Perioperative period</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>19</Day><Hour>23</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36536317</ArticleId><ArticleId IdType="pmc">PMC9761969</ArticleId><ArticleId IdType="doi">10.1186/s12882-022-03025-w</ArticleId><ArticleId IdType="pii">10.1186/s12882-022-03025-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ronco C, Bellomo R, Kellum JA. Acute kidney injury. Lancet. 2019;394(10212):1949&#x2013;1964. doi: 10.1016/s0140-6736(19)32563-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(19)32563-2</ArticleId><ArticleId IdType="pubmed">31777389</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhosale SJ, Kulkarni AP. Preventing perioperative acute kidney injury. Indian J Crit Care Med. 2020;24(Suppl 3):S126&#x2013;S128. doi: 10.5005/jp-journals-10071-23396.</Citation><ArticleIdList><ArticleId IdType="doi">10.5005/jp-journals-10071-23396</ArticleId><ArticleId IdType="pmc">PMC7347057</ArticleId><ArticleId IdType="pubmed">32704219</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson C, Ruchi R, Bihorac A. Perioperative acute kidney injury: risk factors and predictive strategies. Crit Care Clin. 2017;33(2):379&#x2013;396. doi: 10.1016/j.ccc.2016.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2016.12.008</ArticleId><ArticleId IdType="pmc">PMC5617733</ArticleId><ArticleId IdType="pubmed">28284301</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, Koyner JL, Hoste EAJ, Kellum JA. Update on perioperative acute kidney injury. Anesth Analg. 2018;127(5):1236&#x2013;1245. doi: 10.1213/ANE.0000000000003741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000003741</ArticleId><ArticleId IdType="pubmed">30138176</ArticleId></ArticleIdList></Reference><Reference><Citation>Bihorac A, Yavas S, Subbiah S, et al. Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg. 2009;249(5):851&#x2013;858. doi: 10.1097/SLA.0b013e3181a40a0b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e3181a40a0b</ArticleId><ArticleId IdType="pubmed">19387314</ArticleId></ArticleIdList></Reference><Reference><Citation>Group KDIGOAW KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl. 2012;2(4):279&#x2013;335.</Citation></Reference><Reference><Citation>Ostermann M, Joannidis M. Biomarkers for AKI improve clinical practice: no. Intensive Care Med. 2015;41(4):618&#x2013;622. doi: 10.1007/s00134-014-3540-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-014-3540-0</ArticleId><ArticleId IdType="pubmed">25387818</ArticleId></ArticleIdList></Reference><Reference><Citation>Matot I, Paskaleva R, Eid L, et al. Effect of the volume of fluids administered on intraoperative oliguria in laparoscopic bariatric surgery: a randomized controlled trial. Arch Surg. 2012;147(3):228&#x2013;234. doi: 10.1001/archsurg.2011.308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.2011.308</ArticleId><ArticleId IdType="pubmed">22106246</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodgson LE, Selby N, Huang TM, Forni LG. The role of risk prediction models in prevention and management of AKI. Semin Nephrol. 2019;39(5):421&#x2013;430. doi: 10.1016/j.semnephrol.2019.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semnephrol.2019.06.002</ArticleId><ArticleId IdType="pubmed">31514906</ArticleId></ArticleIdList></Reference><Reference><Citation>Thottakkara P, Ozrazgat-Baslanti T, Hupf BB, et al. Application of machine learning techniques to high-dimensional clinical data to forecast postoperative complications. PLoS One. 2016;11(5):e0155705. doi: 10.1371/journal.pone.0155705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0155705</ArticleId><ArticleId IdType="pmc">PMC4883761</ArticleId><ArticleId IdType="pubmed">27232332</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan L, Vaid A, Nadkarni GN. Applications of machine learning methods in kidney disease: hope or hype? Curr Opin Nephrol Hypertens. 2020;29(3):319&#x2013;326. doi: 10.1097/MNH.0000000000000604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MNH.0000000000000604</ArticleId><ArticleId IdType="pmc">PMC7770625</ArticleId><ArticleId IdType="pubmed">32235273</ArticleId></ArticleIdList></Reference><Reference><Citation>Gameiro J, Branco T, Lopes JA. Artificial intelligence in acute kidney injury risk prediction. J Clin Med. 2020;9(3). 10.3390/jcm9030678.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7141311</ArticleId><ArticleId IdType="pubmed">32138284</ArticleId></ArticleIdList></Reference><Reference><Citation>Moons KGM, Wolff RF, Riley RD, et al. PROBAST: a tool to assess risk of Bias and applicability of prediction model studies: explanation and elaboration. Ann Intern Med. 2019;170(1):W1&#x2013;W33. doi: 10.7326/M18-1377.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M18-1377</ArticleId><ArticleId IdType="pubmed">30596876</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff RF, Moons KGM, Riley RD, et al. PROBAST: a tool to assess the risk of Bias and applicability of prediction model studies. Ann Intern Med. 2019;170(1):51&#x2013;58. doi: 10.7326/M18-1376.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M18-1376</ArticleId><ArticleId IdType="pubmed">30596875</ArticleId></ArticleIdList></Reference><Reference><Citation>Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol. 2005;58(10):982&#x2013;990. doi: 10.1016/j.jclinepi.2005.02.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2005.02.022</ArticleId><ArticleId IdType="pubmed">16168343</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeks JJ, Higgins JP, Altman DG, Group CSM . Cochrane handbook for systematic reviews of interventions. 2019. Analysing data and undertaking meta-analyses; pp. 241&#x2013;284.</Citation></Reference><Reference><Citation>Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58(9):882&#x2013;893. doi: 10.1016/j.jclinepi.2005.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2005.01.016</ArticleId><ArticleId IdType="pubmed">16085191</ArticleId></ArticleIdList></Reference><Reference><Citation>Adhikari L, Ozrazgat-Baslanti T, Ruppert M, et al. Improved predictive models for acute kidney injury with IDEA: intraoperative data embedded analytics. PLoS One. 2019;14(4):e0214904. doi: 10.1371/journal.pone.0214904.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0214904</ArticleId><ArticleId IdType="pmc">PMC6448850</ArticleId><ArticleId IdType="pubmed">30947282</ArticleId></ArticleIdList></Reference><Reference><Citation>Bihorac A, Ozrazgat-Baslanti T, Ebadi A, et al. MySurgeryRisk: development and validation of a machine-learning risk algorithm for major complications and death after surgery. Ann Surg. 2019;269(4):652&#x2013;662. doi: 10.1097/sla.0000000000002706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/sla.0000000000002706</ArticleId><ArticleId IdType="pmc">PMC6110979</ArticleId><ArticleId IdType="pubmed">29489489</ArticleId></ArticleIdList></Reference><Reference><Citation>Filiberto AC, Ozrazgat-Baslanti T, Loftus TJ, et al. Optimizing predictive strategies for acute kidney injury after major vascular surgery. Surgery. 2021;170(1):298&#x2013;303. doi: 10.1016/j.surg.2021.01.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.surg.2021.01.030</ArticleId><ArticleId IdType="pmc">PMC8276529</ArticleId><ArticleId IdType="pubmed">33648766</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofer IS, Lee C, Gabel E, Baldi P, Cannesson M. Development and validation of a deep neural network model to predict postoperative mortality, acute kidney injury, and reintubation using a single feature set. npj Digit Med. 2020;3(1). 10.1038/s41746-020-0248-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7170922</ArticleId><ArticleId IdType="pubmed">32352036</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko S, Jo C, Chang CB, et al. A web-based machine-learning algorithm predicting postoperative acute kidney injury after total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2020. 10.1007/s00167-020-06258-0.</Citation><ArticleIdList><ArticleId IdType="pubmed">32880677</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HC, Yoon HK, Nam K, et al. Derivation and validation of machine learning approaches to predict acute kidney injury after cardiac surgery. J Clin Med. 2018;7(10). 10.3390/jcm7100322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6210196</ArticleId><ArticleId IdType="pubmed">30282956</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HC, Yoon SB, Yang SM, et al. Prediction of acute kidney injury after liver transplantation: machine learning approaches vs. logistic regression model. J Clin Med. 2018;7(11). 10.3390/jcm7110428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6262324</ArticleId><ArticleId IdType="pubmed">30413107</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei G, Wang G, Zhang C, Chen Y, Yang X. Using machine learning to predict acute kidney injury after aortic arch surgery. J Cardiothorac Vasc Anesth. 2020;34(12):3321&#x2013;3328. doi: 10.1053/j.jvca.2020.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2020.06.007</ArticleId><ArticleId IdType="pubmed">32636105</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei VJ, Luong T, Shan E, et al. Risk stratification for postoperative acute kidney injury in major noncardiac surgery using preoperative and intraoperative data. JAMA Netw Open. 2019;2(12):e1916921. doi: 10.1001/jamanetworkopen.2019.16921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2019.16921</ArticleId><ArticleId IdType="pmc">PMC6902769</ArticleId><ArticleId IdType="pubmed">31808922</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Xu J, Wang Y, et al. A novel machine learning algorithm, Bayesian networks model, to predict the high-risk patients with cardiac surgery-associated acute kidney injury. Clin Cardiol. 2020;43(7):752&#x2013;761. doi: 10.1002/clc.23377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.23377</ArticleId><ArticleId IdType="pmc">PMC7368305</ArticleId><ArticleId IdType="pubmed">32400109</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer A, Zverinski D, Pfahringer B, et al. Machine learning for real-time prediction of complications in critical care: a retrospective study. Lancet Respir Med. 2018;6(12):905&#x2013;914. doi: 10.1016/S2213-2600(18)30300-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(18)30300-X</ArticleId><ArticleId IdType="pubmed">30274956</ArticleId></ArticleIdList></Reference><Reference><Citation>Penny-Dimri JC, Bergmeir C, Reid CM, Williams-Spence J, Cochrane AD, Smith JA. Machine learning algorithms for predicting and risk profiling of cardiac surgery-associated acute kidney injury. Article. Semin Thorac Cardiovasc Surg. 2021;33(3):735&#x2013;745. doi: 10.1053/j.semtcvs.2020.09.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semtcvs.2020.09.028</ArticleId><ArticleId IdType="pubmed">32979479</ArticleId></ArticleIdList></Reference><Reference><Citation>Rank N, Pfahringer B, Kempfert J, et al. Deep-learning-based real-time prediction of acute kidney injury outperforms human predictive performance. npj Digit Med. 2020;3(1). 10.1038/s41746-020-00346-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7588492</ArticleId><ArticleId IdType="pubmed">33134556</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng PY, Chen YT, Wang CH, et al. Prediction of the development of acute kidney injury following cardiac surgery by machine learning. Crit Care. 2020;24(1). 10.1186/s13054-020-03179-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7395374</ArticleId><ArticleId IdType="pubmed">32736589</ArticleId></ArticleIdList></Reference><Reference><Citation>Xin W, Yi W, Liu H, et al. Early prediction of acute kidney injury after liver transplantation by scoring system and decision tree. Ren Fail. 2021;43(1):1137&#x2013;1145. doi: 10.1080/0886022x.2021.1945462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/0886022x.2021.1945462</ArticleId><ArticleId IdType="pmc">PMC8281092</ArticleId><ArticleId IdType="pubmed">34261422</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue B, Li D, Lu C, et al. Use of machine learning to develop and evaluate models using preoperative and intraoperative data to identify risks of postoperative complications. JAMA Netw Open. 2021;4(3):e212240. doi: 10.1001/jamanetworkopen.2021.2240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.2240</ArticleId><ArticleId IdType="pmc">PMC8010590</ArticleId><ArticleId IdType="pubmed">33783520</ArticleId></ArticleIdList></Reference><Reference><Citation>Yayac M, Aman ZS, Rondon AJ, Tan TL, Courtney PM, Purtill JJ. Risk factors and effect of acute kidney injury on outcomes following Total hip and knee arthroplasty. J Arthroplast. 2021;36(1):331&#x2013;338. doi: 10.1016/j.arth.2020.07.072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2020.07.072</ArticleId><ArticleId IdType="pubmed">32839060</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Yang D, Liu Z, et al. An explainable supervised machine learning predictor of acute kidney injury after adult deceased donor liver transplantation. J Transl Med. 2021;19(1). 10.1186/s12967-021-02990-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8317304</ArticleId><ArticleId IdType="pubmed">34321016</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou C, Wang R, Jiang W, et al. Machine learning for the prediction of acute kidney injury and paraplegia after thoracoabdominal aortic aneurysm repair. J Card Surg. 2020;35(1):89&#x2013;99. doi: 10.1111/jocs.14317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocs.14317</ArticleId><ArticleId IdType="pubmed">31765025</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Xing G, Wang L, et al. Acute kidney injury in China: a cross-sectional survey. Lancet. 2015;386(10002):1465&#x2013;1471. doi: 10.1016/s0140-6736(15)00344-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(15)00344-x</ArticleId><ArticleId IdType="pubmed">26466051</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox ZL, McCoy AB, Matheny ME, et al. Adverse drug events during AKI and its recovery. Clin J Am Soc Nephrol. 2013;8(7):1070&#x2013;1078. doi: 10.2215/CJN.11921112.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.11921112</ArticleId><ArticleId IdType="pmc">PMC3700703</ArticleId><ArticleId IdType="pubmed">23539228</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera-Gutierrez ME, Seller-Perez G, Sanchez-Izquierdo-Riera JA, Maynar-Moliner J, On behalf of the COFRADE investigators group Prevalence of acute kidney injury in intensive care units: the "COrte de prevalencia de disFuncion RenAl y DEpuracion en criticos" point-prevalence multicenter study. J Crit Care. 2013;28(5):687&#x2013;694. doi: 10.1016/j.jcrc.2013.05.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2013.05.019</ArticleId><ArticleId IdType="pubmed">23845794</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Bihorac A. Artificial intelligence to predict AKI: is it a breakthrough? Nat Rev Nephrol. 2019;15(11):663&#x2013;664. doi: 10.1038/s41581-019-0203-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-019-0203-y</ArticleId><ArticleId IdType="pmc">PMC6800602</ArticleId><ArticleId IdType="pubmed">31506607</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomasev N, Glorot X, Rae JW, et al. A clinically applicable approach to continuous prediction of future acute kidney injury. Nature. 2019;572(7767):116&#x2013;119. doi: 10.1038/s41586-019-1390-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1390-1</ArticleId><ArticleId IdType="pmc">PMC6722431</ArticleId><ArticleId IdType="pubmed">31367026</ArticleId></ArticleIdList></Reference><Reference><Citation>Song X, Liu X, Liu F, Wang C. Comparison of machine learning and logistic regression models in predicting acute kidney injury: a systematic review and meta-analysis. Int J Med Inform. 2021;151:104484. doi: 10.1016/j.ijmedinf.2021.104484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2021.104484</ArticleId><ArticleId IdType="pubmed">33991886</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Biesen W, Vanmassenhove J, Decruyenaere J. Prediction of acute kidney injury using artificial intelligence: are we there yet? Nephrol Dial Transplant. 2020;35(2):204&#x2013;205. doi: 10.1093/ndt/gfz226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfz226</ArticleId><ArticleId IdType="pubmed">31782793</ArticleId></ArticleIdList></Reference><Reference><Citation>Gumbert SD, Kork F, Jackson ML, et al. Perioperative acute kidney injury. Anesthesiology. 2020;132(1):180&#x2013;204. doi: 10.1097/ALN.0000000000002968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000002968</ArticleId><ArticleId IdType="pmc">PMC10924686</ArticleId><ArticleId IdType="pubmed">31687986</ArticleId></ArticleIdList></Reference><Reference><Citation>Lachance P, Villeneuve PM, Rewa OG, et al. Association between e-alert implementation for detection of acute kidney injury and outcomes: a systematic review. Nephrol Dial Transplant. 2017;32(2):265&#x2013;272. doi: 10.1093/ndt/gfw424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfw424</ArticleId><ArticleId IdType="pmc">PMC6251638</ArticleId><ArticleId IdType="pubmed">28088774</ArticleId></ArticleIdList></Reference><Reference><Citation>Rind DM, Safran C, Phillips RS, Wang Q, et al. Effect of computer-based alerts on the treatment and outcomes of hospitalized patients. Arch Intern Med. 1994;154(13):1511&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">8018007</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson FP, Shashaty M, Testani J, et al. Automated, electronic alerts for acute kidney injury: a single-blind, parallel-group, randomised controlled trial. Lancet. 2015;385(9981):1966&#x2013;1974. doi: 10.1016/s0140-6736(15)60266-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(15)60266-5</ArticleId><ArticleId IdType="pmc">PMC4475457</ArticleId><ArticleId IdType="pubmed">25726515</ArticleId></ArticleIdList></Reference><Reference><Citation>Colpaert K, Hoste EA, Steurbaut K, et al. Impact of real-time electronic alerting of acute kidney injury on therapeutic intervention and progression of RIFLE class. Crit Care Med. 2012;40(4):1164&#x2013;1170. doi: 10.1097/CCM.0b013e3182387a6b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3182387a6b</ArticleId><ArticleId IdType="pubmed">22067631</ArticleId></ArticleIdList></Reference><Reference><Citation>Flechet M, Guiza F, Schetz M, et al. AKIpredictor, an online prognostic calculator for acute kidney injury in adult critically ill patients: development, validation and comparison to serum neutrophil gelatinase-associated lipocalin. Intensive Care Med. 2017;43(6):764&#x2013;773. doi: 10.1007/s00134-017-4678-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-4678-3</ArticleId><ArticleId IdType="pubmed">28130688</ArticleId></ArticleIdList></Reference><Reference><Citation>Grieshaber P, M&#xf6;ller S, Arneth B, et al. Predicting cardiac surgery-associated acute kidney injury using a combination of clinical risk scores and urinary biomarkers. Thorac Cardiovasc Surg. 2020;68(5):389&#x2013;400. doi: 10.1055/s-0039-1678565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0039-1678565</ArticleId><ArticleId IdType="pubmed">30743275</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahim NE, McCarthy CP, Shrestha S, et al. A clinical, proteomics, and artificial intelligence-driven model to predict acute kidney injury in patients undergoing coronary angiography. Clin Cardiol. 2019;42(2):292&#x2013;298. doi: 10.1002/clc.23143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.23143</ArticleId><ArticleId IdType="pmc">PMC6712314</ArticleId><ArticleId IdType="pubmed">30582197</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JJ, Chi NH, Huang TM, et al. Urinary biomarkers predict advanced acute kidney injury after cardiovascular surgery. Crit Care. 2018;22(1):108. doi: 10.1186/s13054-018-2035-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-018-2035-8</ArticleId><ArticleId IdType="pmc">PMC5921971</ArticleId><ArticleId IdType="pubmed">29699579</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S, Lee H. Acute kidney injury prediction models: current concepts and future strategies. Curr Opin Nephrol Hypertens. 2019;28(6):552&#x2013;559. doi: 10.1097/MNH.0000000000000536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MNH.0000000000000536</ArticleId><ArticleId IdType="pubmed">31356235</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazul-Sunko B, Zarkovic N, Vrkic N, et al. Proatrial natriuretic peptide (1-98), but not cystatin C, is predictive for occurrence of acute renal insufficiency in critically ill septic patients. Nephron Clin Pract. 2004;97(3):c103&#x2013;c107. doi: 10.1159/000078638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000078638</ArticleId><ArticleId IdType="pubmed">15292687</ArticleId></ArticleIdList></Reference><Reference><Citation>Villa P, Jimenez M, Soriano MC, Manzanares J, Casasnovas P. Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients. Crit Care. 2005;9(2):R139&#x2013;R143. doi: 10.1186/cc3044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc3044</ArticleId><ArticleId IdType="pmc">PMC1175926</ArticleId><ArticleId IdType="pubmed">15774046</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Ho KM, Hong Y. Machine learning for the prediction of volume responsiveness in patients with oliguric acute kidney injury in critical care. Crit Care. 2019;23(1):112. doi: 10.1186/s13054-019-2411-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2411-z</ArticleId><ArticleId IdType="pmc">PMC6454725</ArticleId><ArticleId IdType="pubmed">30961662</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashani KB. Automated acute kidney injury alerts. Kidney Int. 2018;94(3):484&#x2013;490. doi: 10.1016/j.kint.2018.02.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2018.02.014</ArticleId><ArticleId IdType="pubmed">29728257</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Zheng X, Wang J, et al. Effect of clinical decision support systems on clinical outcome for acute kidney injury: a systematic review and meta-analysis. BMC Nephrol. 2021;22(1):271. doi: 10.1186/s12882-021-02459-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-021-02459-y</ArticleId><ArticleId IdType="pmc">PMC8335454</ArticleId><ArticleId IdType="pubmed">34348688</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilly BM, Evans AT. Translating clinical research into clinical practice: impact of using prediction rules to make decisions. Ann Intern Med. 2006;144(3):201&#x2013;209. doi: 10.7326/0003-4819-144-3-200602070-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-144-3-200602070-00009</ArticleId><ArticleId IdType="pubmed">16461965</ArticleId></ArticleIdList></Reference><Reference><Citation>Laupacis A, Sekar N, Stiell IG. Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA. 1997;277(6):488&#x2013;494. doi: 10.1001/jama.1997.03540300056034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1997.03540300056034</ArticleId><ArticleId IdType="pubmed">9020274</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastin AJ, Ostermann M, Slack AJ, Diller GP, Finney SJ, Evans TW. Acute kidney injury after cardiac surgery according to risk/injury/failure/loss/end-stage, acute kidney injury network, and kidney disease: improving global outcomes classifications. J Crit Care. 2013;28(4):389&#x2013;396. doi: 10.1016/j.jcrc.2012.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2012.12.008</ArticleId><ArticleId IdType="pubmed">23743540</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson FP. Machine learning to predict acute kidney injury. Am J Kidney Dis. 2020;75(6):965&#x2013;967. doi: 10.1053/j.ajkd.2019.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2019.08.010</ArticleId><ArticleId IdType="pmc">PMC7735021</ArticleId><ArticleId IdType="pubmed">31677894</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda-Parr S, Gibbons E. Emerging consensus on &#x2018;ethical AI&#x2019;: human rights critique of stakeholder guidelines. Glob Policy. 2021;12(S6):32&#x2013;44. doi: 10.1111/1758-5899.12965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1758-5899.12965</ArticleId></ArticleIdList></Reference><Reference><Citation>Human Rights BDaTPH. https://www.hrbdt.ac.uk/health/. Accessed 20 Nov 2021. Published Identifying opportunities and threats to the right to health in a new data-driven economy.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35440800</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>19</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Utility of plasma NGAL for the diagnosis of AKI following cardiac surgery requiring cardiopulmonary bypass: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>6436</StartPage><MedlinePgn>6436</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">6436</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-022-10477-5</ELocationID><Abstract><AbstractText>The objective of this study was to assess the diagnostic value of plasma neutrophil gelatinase-associated lipocalin (pNGAL) for the early diagnosis of acute kidney injury (AKI) in adult patients following cardiac surgery requiring cardiopulmonary bypass (CPB). Electronic databases and other resources were systematically searched for relevant studies. Risk of bias was assessed using the Quality Assessment for Diagnostic Accuracy Studies 2 (QUADAS-2) tool. Studies were assigned to a sub-group based on the timing of the pNGAL sample in relation to the cessation of CPB. These were&#x2009;&lt;&#x2009;4&#xa0;h, 4-8&#xa0;h, 12&#xa0;h or 24&#xa0;h post-cessation of CPB. Summary values for sensitivity and specificity were estimated using the hierarchical summary receiver operator characteristic (ROC) curve model. A random-effects meta-analysis of each pair of sensitivity and specificity estimates from each included study was performed. In total, 3131 patients from 16&#xa0;studies were included. When taken at 4-8&#xa0;h following CPB, pNGAL had superior performance for the diagnosis of AKI in the defined population when compared to earlier and later time points. Prediction regions and confidence intervals, however, demonstrated significant variability in pooled estimates of sensitivity and specificity. This is likely due to population and study design heterogeneity, lack of standardisation of assays and thresholds, and inability to distinguish the different molecular forms of NGAL. In conclusion, the diagnostic utility of pNGAL in this clinical setting is inconclusive and large individual studies of representative populations of cardiac surgery patients using assays that specifically detect NGAL in its monomeric form are required.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sharrod-Cole</LastName><ForeName>Hayley</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Clinical Biochemistry, Black Country Pathology Services, Wolverhampton, West Midlands, UK. Hayley.Sharrod-cole@nhs.net.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Biochemistry, New Cross Hospital, Wolverhampton, WV10 0QP, UK. Hayley.Sharrod-cole@nhs.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fenn</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Clinical Biochemistry, Black Country Pathology Services, Wolverhampton, West Midlands, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gama</LastName><ForeName>Rousseau</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Clinical Biochemistry, Black Country Pathology Services, Wolverhampton, West Midlands, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine and Clinical Practice, Wolverhampton University, Wolverhampton, West Midlands, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ford</LastName><ForeName>Clare</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Clinical Biochemistry, Black Country Pathology Services, Wolverhampton, West Midlands, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giri</LastName><ForeName>Ramesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiac Anaesthesia, Royal Wolverhampton NHS Trust, Wolverhampton, West Midlands, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luckraz</LastName><ForeName>Heyman</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Cardiac Surgery, Royal Wolverhampton NHS Trust, Wolverhampton, West Midlands, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000209">Acute-Phase Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071068">Lipocalin-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054834">Lipocalins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011518">Proto-Oncogene Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000209" MajorTopicYN="N">Acute-Phase Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071068" MajorTopicYN="N">Lipocalin-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054834" MajorTopicYN="N">Lipocalins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011518" MajorTopicYN="N">Proto-Oncogene Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>20</Day><Hour>5</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35440800</ArticleId><ArticleId IdType="pmc">PMC9018850</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-10477-5</ArticleId><ArticleId IdType="pii">10.1038/s41598-022-10477-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hoste EA, Cruz DN, Davenport A, et al. The epidemiology of cardiac surgery-associated acute kidney injury. Int. J. Artif. Organs. 2008;31(2):158&#x2013;165. doi: 10.1177/039139880803100209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/039139880803100209</ArticleId><ArticleId IdType="pubmed">18311732</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EA, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: The multinational AKI-EPI study. Intens. Care Med. 2015;41(8):1411&#x2013;1423. doi: 10.1007/s00134-015-3934-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3934-7</ArticleId><ArticleId IdType="pubmed">26162677</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra PK, Luckraz H, Nandi J, et al. Long-term quality of life postacute kidney injury in cardiac surgery patients. Ann. Card. Anaesth. 2018;21(1):41&#x2013;45. doi: 10.4103/aca.ACA_104_17.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/aca.ACA_104_17</ArticleId><ArticleId IdType="pmc">PMC5791486</ArticleId><ArticleId IdType="pubmed">29336390</ArticleId></ArticleIdList></Reference><Reference><Citation>Luckraz H, Gravenor MB, George R, et al. Long and short-term outcomes in patients requiring continuous renal replacement therapy post cardiopulmonary bypass. Eur. J. Cardiothorac. Surg. 2005;27(5):906&#x2013;909. doi: 10.1016/j.ejcts.2005.01.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2005.01.057</ArticleId><ArticleId IdType="pubmed">15848334</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J. Am. Soc. Nephrol. 2005;16(11):3365&#x2013;3370. doi: 10.1681/asn.2004090740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/asn.2004090740</ArticleId><ArticleId IdType="pubmed">16177006</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR. Long-term risk of mortality and other adverse outcomes after acute kidney injury: A systematic review and meta-analysis. Am. J. Kidney Dis. 2009;53(6):961&#x2013;973. doi: 10.1053/j.ajkd.2008.11.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2008.11.034</ArticleId><ArticleId IdType="pmc">PMC2726041</ArticleId><ArticleId IdType="pubmed">19346042</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson CE, Yavas S, Segal MS, et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation. 2009;119(18):2444&#x2013;2453. doi: 10.1161/circulationaha.108.800011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circulationaha.108.800011</ArticleId><ArticleId IdType="pubmed">19398670</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldt J, Brenner T, Lehmann A, Suttner SW, Kumle B, Isgro F. Is kidney function altered by the duration of cardiopulmonary bypass? Ann. Thorac. Surg. 2003;75(3):906&#x2013;912. doi: 10.1016/s0003-4975(02)04559-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0003-4975(02)04559-9</ArticleId><ArticleId IdType="pubmed">12645715</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranucci M, Pavesi M, Mazza E, et al. Risk factors for renal dysfunction after coronary surgery: The role of cardiopulmonary bypass technique. Perfusion. 1994;9(5):319&#x2013;326. doi: 10.1177/026765919400900503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/026765919400900503</ArticleId><ArticleId IdType="pubmed">7833539</ArticleId></ArticleIdList></Reference><Reference><Citation>Boodhwani M, Rubens FD, Wozny D, Nathan HJ. Effects of mild hypothermia and rewarming on renal function after coronary artery bypass grafting. Ann. Thorac Surg. 2009;87(2):489&#x2013;495. doi: 10.1016/j.athoracsur.2008.10.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2008.10.078</ArticleId><ArticleId IdType="pubmed">19161766</ArticleId></ArticleIdList></Reference><Reference><Citation>Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur. J. Cardiothorac. Surg. 2002;21(2):232&#x2013;244. doi: 10.1016/s1010-7940(01)01099-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1010-7940(01)01099-5</ArticleId><ArticleId IdType="pubmed">11825729</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreeram GM, Grocott HP, White WD, Newman MF, Stafford-Smith M. Transcranial Doppler emboli count predicts rise in creatinine after coronary artery bypass graft surgery. J. Cardiothorac. Vasc. Anesth. 2004;18(5):548&#x2013;551. doi: 10.1053/j.jvca.2004.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2004.07.010</ArticleId><ArticleId IdType="pubmed">15578463</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickering JW, James MT, Palmer SC. Acute kidney injury and prognosis after cardiopulmonary bypass: A meta-analysis of cohort studies. Am. J. Kidney Dis. 2015;65(2):283&#x2013;293. doi: 10.1053/j.ajkd.2014.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2014.09.008</ArticleId><ArticleId IdType="pubmed">25445101</ArticleId></ArticleIdList></Reference><Reference><Citation>Delanaye P, Cavalier E, Pottel H. Serum creatinine: Not so simple! Nephron. 2017;136(4):302&#x2013;308. doi: 10.1159/000469669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000469669</ArticleId><ArticleId IdType="pubmed">28441651</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu KD, Brakeman PR. Renal repair and recovery. Crit. Care Med. 2008;36(4 Suppl):S187&#x2013;S192. doi: 10.1097/CCM.0b013e318168ca4a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318168ca4a</ArticleId><ArticleId IdType="pubmed">18382192</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Nakao K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int. 2007;71(10):967&#x2013;970. doi: 10.1038/sj.ki.5002165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ki.5002165</ArticleId><ArticleId IdType="pubmed">17342180</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: A systematic review and meta-analysis. Am. J. Kidney Dis. 2009;54(6):1012&#x2013;1024. doi: 10.1053/j.ajkd.2009.07.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2009.07.020</ArticleId><ArticleId IdType="pubmed">19850388</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase-Fielitz A, Bellomo R, Devarajan P, et al. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery&#x2014;A prospective cohort study. Crit. Care Med. 2009;37(2):553&#x2013;560. doi: 10.1097/CCM.0b013e318195846e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318195846e</ArticleId><ArticleId IdType="pubmed">19114878</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall PS, Mitchell ED, Smith AF, et al. The future for diagnostic tests of acute kidney injury in critical care: Evidence synthesis, care pathway analysis and research prioritisation. Health Technol. Assess. 2018;22(32):1&#x2013;274. doi: 10.3310/hta22320.</Citation><ArticleIdList><ArticleId IdType="doi">10.3310/hta22320</ArticleId><ArticleId IdType="pmc">PMC6004543</ArticleId><ArticleId IdType="pubmed">29862965</ArticleId></ArticleIdList></Reference><Reference><Citation>Brazzelli, M. et al. The Architect and Alinity Urine NGAL Assays, Urine NephroCheck Test, and Urine and Plasma NGAL Tests to Help Assess the Risk of Acute Kidney Injury for People Who are Being Considered for Admission to Critical Care (2019).</Citation></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Int. J. Surg. 2021;88:105906. doi: 10.1016/j.ijsu.2021.105906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2021.105906</ArticleId><ArticleId IdType="pubmed">33789826</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin. Pract. 2012;120(4):c179&#x2013;c184. doi: 10.1159/000339789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000339789</ArticleId><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure&#x2014;Definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit. Care. 2004;8(4):R204&#x2013;R212. doi: 10.1186/cc2872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc2872</ArticleId><ArticleId IdType="pmc">PMC522841</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit. Care. 2007;2:R31. doi: 10.1186/cc5713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc5713</ArticleId><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: A revised tool for the quality assessment of diagnostic accuracy studies. Ann. Intern. Med. 2011;155(8):529&#x2013;536. doi: 10.7326/0003-4819-155-8-201110180-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-155-8-201110180-00009</ArticleId><ArticleId IdType="pubmed">22007046</ArticleId></ArticleIdList></Reference><Reference><Citation>Macaskill P, Gatsonis C, Deeks JJ, Harbord RMT. Chapter 10: Analysing and presenting results. In: Deeks JJBP, Gatsonis C, editors. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 10. The Cochrane Collaboration; 2010.</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557&#x2013;560. doi: 10.1136/bmj.327.7414.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Othman HMEDM, Hassan AEM, Elsersi MH, Soliman AKMA, Emam DF. Neutrophil gelatinase-associated lipocalin as a biomarker for predicting acute kidney injury after coronary artery bypass grafting. Ain-Shams J. Anesthesiol. 2021;13(1):5. doi: 10.1186/s42077-020-00123-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42077-020-00123-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh CR, Coca SG, Thiessen-Philbrook H, et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J. Am. Soc. Nephrol. 2011;22(9):1748&#x2013;1757. doi: 10.1681/asn.2010121302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/asn.2010121302</ArticleId><ArticleId IdType="pmc">PMC3171945</ArticleId><ArticleId IdType="pubmed">21836143</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghonemy TA, Amro GM. Plasma neutrophil gelatinase-associated lipocalin (NGAL) and plasma cystatin C (CysC) as biomarker of acute kidney injury after cardiac surgery. Saudi J. Kidney Dis. Transpl. 2014;25(3):582&#x2013;588. doi: 10.4103/1319-2442.132194.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1319-2442.132194</ArticleId><ArticleId IdType="pubmed">24821156</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakar CV, Arrigain S, Worley S, Yared JP, Paganini EP. A clinical score to predict acute renal failure after cardiac surgery. J. Am. Soc. Nephrol. 2005;16(1):162&#x2013;168. doi: 10.1681/asn.2004040331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/asn.2004040331</ArticleId><ArticleId IdType="pubmed">15563569</ArticleId></ArticleIdList></Reference><Reference><Citation>Seabra VF, Alobaidi S, Balk EM, Poon AH, Jaber BL. Off-pump coronary artery bypass surgery and acute kidney injury: A meta-analysis of randomized controlled trials. Clin. J. Am. Soc. Nephrol. 2010;5(10):1734&#x2013;1744. doi: 10.2215/cjn.02800310.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/cjn.02800310</ArticleId><ArticleId IdType="pmc">PMC2974371</ArticleId><ArticleId IdType="pubmed">20671222</ArticleId></ArticleIdList></Reference><Reference><Citation>Kjeldsen L, Johnsen AH, Sengel&#xf8;v H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J. Biol. Chem. 1993;268(14):10425&#x2013;10432. doi: 10.1016/S0021-9258(18)82217-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)82217-7</ArticleId><ArticleId IdType="pubmed">7683678</ArticleId></ArticleIdList></Reference><Reference><Citation>Kjeldsen L, Bainton DF, Sengel&#xf8;v H, Borregaard N. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood. 1994;83(3):799&#x2013;807. doi: 10.1182/blood.V83.3.799.799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V83.3.799.799</ArticleId><ArticleId IdType="pubmed">8298140</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu SY, Carlson M, Engstr&#xf6;m A, Garcia R, Peterson CG, Venge P. Purification and characterization of a human neutrophil lipocalin (HNL) from the secondary granules of human neutrophils. Scand. J. Clin. Lab Investig. 1994;54(5):365&#x2013;376. doi: 10.3109/00365519409088436.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365519409088436</ArticleId><ArticleId IdType="pubmed">7997842</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai L, Rubin J, Han W, Venge P, Xu S. The origin of multiple molecular forms in urine of HNL/NGAL. Clin. J. Am. Soc. Nephrol. 2010;5(12):2229&#x2013;2235. doi: 10.2215/cjn.00980110.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/cjn.00980110</ArticleId><ArticleId IdType="pmc">PMC2994084</ArticleId><ArticleId IdType="pubmed">20829422</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu KD, Thompson BT, Ancukiewicz M, et al. Acute kidney injury in patients with acute lung injury: Impact of fluid accumulation on classification of acute kidney injury and associated outcomes. Crit. Care Med. 2011;39(12):2665&#x2013;2671. doi: 10.1097/CCM.0b013e318228234b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318228234b</ArticleId><ArticleId IdType="pmc">PMC3220741</ArticleId><ArticleId IdType="pubmed">21785346</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase M, Devarajan P, Haase-Fielitz A, et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: A multicenter pooled analysis of prospective studies. J. Am. Coll. Cardiol. 2011;57(17):1752&#x2013;1761. doi: 10.1016/j.jacc.2010.11.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2010.11.051</ArticleId><ArticleId IdType="pmc">PMC4866647</ArticleId><ArticleId IdType="pubmed">21511111</ArticleId></ArticleIdList></Reference><Reference><Citation>Nickolas TL, Schmidt-Ott KM, Canetta P, et al. Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: A multicenter prospective cohort study. J. Am. Coll. Cardiol. 2012;59(3):246&#x2013;255. doi: 10.1016/j.jacc.2011.10.854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2011.10.854</ArticleId><ArticleId IdType="pmc">PMC3487165</ArticleId><ArticleId IdType="pubmed">22240130</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J. Clin. Epidemiol. 2005;58(9):882&#x2013;893. doi: 10.1016/j.jclinepi.2005.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2005.01.016</ArticleId><ArticleId IdType="pubmed">16085191</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE . Diagnostics Assessment Programme Manual. NICE; 2011.</Citation><ArticleIdList><ArticleId IdType="pubmed">27466648</ArticleId></ArticleIdList></Reference><Reference><Citation>Merkle J, Daka A, Deppe AC, Wahlers T, Paunel-G&#xf6;rg&#xfc;l&#xfc; A. High levels of cell-free DNA accurately predict late acute kidney injury in patients after cardiac surgery. PLoS ONE. 2019;14(6):e0218548. doi: 10.1371/journal.pone.0218548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0218548</ArticleId><ArticleId IdType="pmc">PMC6581428</ArticleId><ArticleId IdType="pubmed">31211810</ArticleId></ArticleIdList></Reference><Reference><Citation>Introcaso G, Nafi M, Bonomi A, et al. Improvement of neutrophil gelatinase-associated lipocalin sensitivity and specificity by two plasma measurements in predicting acute kidney injury after cardiac surgery. Biochem. Med. (Zagreb) 2018;28(3):030701. doi: 10.11613/bm.2018.030701.</Citation><ArticleIdList><ArticleId IdType="doi">10.11613/bm.2018.030701</ArticleId><ArticleId IdType="pmc">PMC6214698</ArticleId><ArticleId IdType="pubmed">30429668</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerci P, Claudot JL, Novy E, Settembre N, Lalot JM, Losser MR. Immediate postoperative plasma neutrophil gelatinase-associated lipocalin to predict acute kidney injury after major open abdominal aortic surgery: A prospective observational study. Anaesth. Crit. Care Pain Med. 2018;37(4):327&#x2013;334. doi: 10.1016/j.accpm.2017.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.accpm.2017.09.006</ArticleId><ArticleId IdType="pubmed">29033359</ArticleId></ArticleIdList></Reference><Reference><Citation>Schley G, K&#xf6;berle C, Manuilova E, et al. Comparison of plasma and urine biomarker performance in acute kidney injury. PLoS ONE. 2015;10(12):e0145042. doi: 10.1371/journal.pone.0145042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0145042</ArticleId><ArticleId IdType="pmc">PMC4682932</ArticleId><ArticleId IdType="pubmed">26669323</ArticleId></ArticleIdList></Reference><Reference><Citation>Park CM, Kim JS, Moon HW, et al. Usefulness of plasma neutrophil gelatinase-associated lipocalin as an early marker of acute kidney injury after cardiopulmonary bypass in Korean cardiac patients: 2 prospective observational study. Clin. Biochem. 2015;48(1&#x2013;2):44&#x2013;49. doi: 10.1016/j.clinbiochem.2014.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinbiochem.2014.09.019</ArticleId><ArticleId IdType="pubmed">25284002</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidher E, Harling L, Ashrafian H, et al. Pulse wave velocity and neutrophil gelatinase-associated lipocalin as predictors of acute kidney injury following aortic valve replacement. J Cardiothorac. Surg. 2014;9:89. doi: 10.1186/1749-8090-9-89.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-8090-9-89</ArticleId><ArticleId IdType="pmc">PMC4057558</ArticleId><ArticleId IdType="pubmed">24886694</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry TE, Muehlschlegel JD, Liu KY, et al. Plasma neutrophil gelatinase-associated lipocalin and acute postoperative kidney injury in adult cardiac surgical patients. Anesth Analg. 2010;110(6):1541&#x2013;1547. doi: 10.1213/ANE.0b013e3181da938e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e3181da938e</ArticleId><ArticleId IdType="pmc">PMC2999841</ArticleId><ArticleId IdType="pubmed">20435938</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase M, Bellomo R, Devarajan P, et al. Novel biomarkers early predict the severity of acute kidney injury after cardiac surgery in adults. Ann. Thorac. Surg. 2009;88(1):124&#x2013;130. doi: 10.1016/j.athoracsur.2009.04.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2009.04.023</ArticleId><ArticleId IdType="pubmed">19559209</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrotti A, Miltgen G, Chevet-Noel A, et al. Neutrophil gelatinase-associated lipocalin as early predictor of acute kidney injury after cardiac surgery in adults with chronic kidney failure. Ann. Thorac. Surg. 2015;99(3):864&#x2013;869. doi: 10.1016/j.athoracsur.2014.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2014.10.011</ArticleId><ArticleId IdType="pubmed">25595830</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaipov A, Solak Y, Turkmen K, et al. Serum uric acid may predict development of progressive acute kidney injury after open heart surgery. Ren. Fail. 2015;37(1):96&#x2013;102. doi: 10.3109/0886022x.2014.976130.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/0886022x.2014.976130</ArticleId><ArticleId IdType="pubmed">25347234</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabhu A, Sujatha DI, Ninan B, Vijayalakshmi MA. Neutrophil gelatinase associated lipocalin as a biomarker for acute kidney injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Ann. Vasc. Surg. 2010;24(4):525&#x2013;531. doi: 10.1016/j.avsg.2010.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2010.01.001</ArticleId><ArticleId IdType="pubmed">20363104</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuladhar SM, P&#xfc;ntmann VO, Soni M, Punjabi PP, Bogle RG. Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass. J. Cardiovasc. Pharmacol. 2009;53(3):261&#x2013;266. doi: 10.1097/FJC.0b013e31819d6139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FJC.0b013e31819d6139</ArticleId><ArticleId IdType="pubmed">19247188</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40776908</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Clinical practice guidelines for acute kidney injury: a systematic review of the methodological quality.</ArticleTitle><Pagination><StartPage>1567359</StartPage><MedlinePgn>1567359</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1567359</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2025.1567359</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">Hospitalized patients, particularly those in the ICU, face a significant risk of acute kidney injury (AKI). Clinical practice guidelines (CPGs) that outline diagnostic and therapeutic strategies for AKI can be valuable tools for healthcare professionals, but their effectiveness hinges on their quality. The research aims to conduct a systematic review focusing on the methodological and reporting quality of CPGs addressing acute kidney injury.</AbstractText><AbstractText Label="DESIGN" NlmCategory="UNASSIGNED">A systematic review of CPGs for the management of acute kidney injury in adult patients.</AbstractText><AbstractText Label="DATA RESOURCES" NlmCategory="UNASSIGNED">PubMed and other related databases were systematically searched from January 2012 to January 2023 to collect clinical guidelines and expert consensus on acute kidney injury. After summarizing the basic information, the methodological and reporting quality of the included guidelines or expert consensus was evaluated using the AGREE II and RIGHT tools.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 8 CPGs from 6 countries and regions were included in this study, and the period was 2012-2023. In terms of methodological quality, 1 guideline was a level strongly recommended, and 6 were level B, generally recommended guidelines. While the evaluated guidelines demonstrated moderate overall reporting completeness, critical deficiencies persist in contextual transparency and quality assurance protocols, necessitating prioritized remediation in future iterations.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Our appraisal identifies the 2012 KDIGO guideline as the highest-quality AKI guidance framework currently available, which has driven global standardization of diagnostic criteria and management protocols. Our analysis reveals critical gaps in the practical applicability and transparency of current clinical practice guidelines, particularly regarding implementation strategies tailored to different populations, such as aging populations. Future iterations must prioritize demographic inclusivity, with explicit recommendations addressing the diagnostic challenges and management complexities of AKI among different populations.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Li, Wu, Wu, Fu, Xu, Zhai and Chen.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Ruizhe</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Peking University Third Hospital, Beijing University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wu</LastName><ForeName>Lanxia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Psychology, Shandong Second Medical University, Weifang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wu</LastName><ForeName>Xinhui</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Shandong Electric Power Central Hospital, Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Qingyang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Mingyu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhai</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Junfei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">acute renal failure</Keyword><Keyword MajorTopicYN="N">clinical practice guidelines</Keyword><Keyword MajorTopicYN="N">evidence-based</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>8</Day><Hour>5</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40776908</ArticleId><ArticleId IdType="pmc">PMC12328445</ArticleId><ArticleId IdType="doi">10.3389/fmed.2025.1567359</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet (London, England). (2012) 380:756&#x2013;66. doi: 10.1016/S0140-6736(11)61454-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)61454-2</ArticleId><ArticleId IdType="pubmed">22617274</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, James MT. Acute kidney injury. Ann Intern Med. (2017) 167:ITC66&#x2013;80. doi: 10.7326/AITC201711070, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/AITC201711070</ArticleId><ArticleId IdType="pubmed">29114754</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco C, Bellomo R, Kellum JA. Acute kidney injury. Lancet (London, England). (2019) 394:1949&#x2013;64. doi: 10.1016/S0140-6736(19)32563-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32563-2</ArticleId><ArticleId IdType="pubmed">31777389</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Romagnani P, Ashuntantang G, Ronco C, Zarbock A, Anders H-J. Acute kidney injury. Nat Rev Dis Primers. (2021) 7:52. doi: 10.1038/s41572-021-00284-z, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-021-00284-z</ArticleId><ArticleId IdType="pubmed">34267223</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob J, Dannenhoffer J, Rutter A. Acute kidney injury. Prim Care. (2020) 47:571&#x2013;84. doi: 10.1016/j.pop.2020.08.008, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pop.2020.08.008</ArticleId><ArticleId IdType="pubmed">33121629</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostermann M, Liu K, Kashani K. Fluid management in acute kidney injury. Chest. (2019) 156:594&#x2013;603. doi: 10.1016/j.chest.2019.04.004, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2019.04.004</ArticleId><ArticleId IdType="pubmed">31002784</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito P, Cappadona F, Marengo M, Fiorentino M, Fabbrini P, Quercia AD, et al. Recognition patterns of acute kidney injury in hospitalized patients. Clin Kidney J. (2024) 17:sfae231. doi: 10.1093/ckj/sfae231, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ckj/sfae231</ArticleId><ArticleId IdType="pmc">PMC11328729</ArticleId><ArticleId IdType="pubmed">39157067</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet (London, England). (1993) 342:1317&#x2013;22. doi: 10.1016/0140-6736(93)92244-N, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0140-6736(93)92244-N</ArticleId><ArticleId IdType="pubmed">7901634</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlister FA, van Diepen S, Padwal RS, Johnson JA, Majumdar SR. How evidence-based are the recommendations in evidence-based guidelines? PLoS Med. (2007) 4:e250. doi: 10.1371/journal.pmed.0040250, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0040250</ArticleId><ArticleId IdType="pmc">PMC1939859</ArticleId><ArticleId IdType="pubmed">17683197</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner T, Misso M, Harris C, Green S. Development of evidence-based clinical practice guidelines (CPGs): comparing approaches. Implement Sci. (2008) 3:45. doi: 10.1186/1748-5908-3-45, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1748-5908-3-45</ArticleId><ArticleId IdType="pmc">PMC2584093</ArticleId><ArticleId IdType="pubmed">18954465</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;nemann HJ, Hill SR, Kakad M, Vist GE, Bellamy R, Stockman L, et al. Transparent development of the WHO rapid advice guidelines. PLoS Med. (2007) 4:e119. doi: 10.1371/journal.pmed.0040119, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0040119</ArticleId><ArticleId IdType="pmc">PMC1877972</ArticleId><ArticleId IdType="pubmed">17535099</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. Canad Med Assoc J. (2010) 182:E839&#x2013;42. doi: 10.1503/cmaj.090449, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.090449</ArticleId><ArticleId IdType="pmc">PMC3001530</ArticleId><ArticleId IdType="pubmed">20603348</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Yang K, Maru&#x161;ic A, Qaseem A, Meerpohl JJ, Flottorp S, et al. A reporting tool for practice guidelines in health care: the RIGHT statement. Ann Intern Med. (2017) 166:128&#x2013;32. doi: 10.7326/M16-1565, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M16-1565</ArticleId><ArticleId IdType="pubmed">27893062</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan MKH, Goodall R, Hughes W, Langridge B, Shalhoub J, Davies AH. A methodological assessment of diabetic foot syndrome clinical practice guidelines. Europ J Vasc Endov Surg. (2020) 60:274&#x2013;81. doi: 10.1016/j.ejvs.2020.04.028, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejvs.2020.04.028</ArticleId><ArticleId IdType="pubmed">32636064</ArticleId></ArticleIdList></Reference><Reference><Citation>Collaboration A . Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care. (2003) 12:18&#x2013;23. doi: 10.1136/qhc.12.1.18</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/qhc.12.1.18</ArticleId><ArticleId IdType="pmc">PMC1743672</ArticleId><ArticleId IdType="pubmed">12571340</ArticleId></ArticleIdList></Reference><Reference><Citation>Joly E, Desmoulin A, Tran P-L, Derancourt C, Bertolotti A. Quality and consistency of clinical practice guidelines for the local management of anogenital warts: a systematic review using AGREE II score and RIGHT checklist. J Europ Acad Dermatol Venereol. (2023) 37:e505&#x2013;e507. doi: 10.1111/jdv.18828</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdv.18828</ArticleId><ArticleId IdType="pubmed">36541253</ArticleId></ArticleIdList></Reference><Reference><Citation>Krook JE, O'Connell MJ, Wieand HS, Beart RW, Leigh JE, Kugler JW, et al. A prospective, randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer. Cancer. (1991) 67:2454&#x2013;8. doi: 10.1002/1097-0142(19910515)67:10&lt;2454::aid-cncr2820671010&gt;3.0.co;2-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1097-0142(19910515)67:10&lt;2454::aid-cncr2820671010&gt;3.0.co;2-2</ArticleId><ArticleId IdType="pubmed">2015545</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade R, Pereira R, van Cingel R, Staal JB, Espregueira-Mendes J. How should clinicians rehabilitate patients after ACL reconstruction? A systematic review of clinical practice guidelines (CPGs) with a focus on quality appraisal (AGREE II). Br J Sports Med. (2020) 54:512&#x2013;9. doi: 10.1136/bjsports-2018-100310, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjsports-2018-100310</ArticleId><ArticleId IdType="pubmed">31175108</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE) . Acute kidney injury: prevention, detection and management. London: NICE. (2019):1&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">31909927</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang SY, Chiou TT, Shiao CC, Lin HY, Chan MJ, Wu CH, et al. Nomenclature and diagnostic criteria for acute kidney injury&#x2014;2020 consensus of the Taiwan AKI-task force. J Formos Med Assoc. (2022) 121:749&#x2013;65. doi: 10.1016/j.jfma.2021.08.005, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2021.08.005</ArticleId><ArticleId IdType="pubmed">34446340</ArticleId></ArticleIdList></Reference><Reference><Citation>Doi K, Nishida O, Shigematsu T, Sadahiro T, Itami N, Iseki K, et al. The Japanese clinical practice guideline for acute kidney injury 2016. Clin Exp Nephrol. (2018) 22:985&#x2013;1045. doi: 10.1007/s10157-018-1600-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10157-018-1600-4</ArticleId><ArticleId IdType="pmc">PMC6154171</ArticleId><ArticleId IdType="pubmed">30039479</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. (2012) 120:c179&#x2013;84. doi: 10.1159/000339789, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000339789</ArticleId><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanagasundaram S, Ashley C, Bhojani S, Caldwell A, Ellam T, Kaur A, et al. Clinical Practice Guideline Acute Kidney Injury (AKI). Bristol, United Kingdom: The UK Renal Association. (2019):1&#x2013;120.</Citation></Reference><Reference><Citation>Joannidis M, Druml W, Forni LG, Groeneveld ABJ, Honore PM, Hoste E, et al. Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017: expert opinion of the working group on prevention, AKI section, European Society of Intensive Care Medicine. Intensive Care Med. (2017) 43:730&#x2013;49. doi: 10.1007/s00134-017-4832-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-4832-y</ArticleId><ArticleId IdType="pmc">PMC5487598</ArticleId><ArticleId IdType="pubmed">28577069</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichai C, Vinsonneau C, Souweine B, Armando F, Canet E, Clec'h C, et al. Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies). Ann Intensive Care. (2016) 6:48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4882312</ArticleId><ArticleId IdType="pubmed">27230984</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman M, Shad F, Smith MC. Acute kidney injury: a guide to diagnosis and management. Am Fam Physician. (2012) 86:631&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23062091</ArticleId></ArticleIdList></Reference><Reference><Citation>Varndell W, Fry M, Lutze M, Elliott D. Use of the Delphi method to generate guidance in emergency nursing practice: a systematic review. Int Emerg Nurs. (2021) 56:100867. doi: 10.1016/j.ienj.2020.100867, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ienj.2020.100867</ArticleId><ArticleId IdType="pubmed">32238322</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EAJ, Kellum JA, Selby NM, Zarbock A, Palevsky PM, Bagshaw SM, et al. Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol. (2018) 14:607&#x2013;25. doi: 10.1038/s41581-018-0052-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-018-0052-0</ArticleId><ArticleId IdType="pubmed">30135570</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowling CB, Whitson HE, Johnson TM, 2nd. The 5Ts: preliminary development of a framework to support inclusion of older adults in research. J Am Geriatr Soc. (2019) 67:342&#x2013;6. doi: 10.1111/jgs.15785, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.15785</ArticleId><ArticleId IdType="pmc">PMC6532768</ArticleId><ArticleId IdType="pubmed">30693952</ArticleId></ArticleIdList></Reference><Reference><Citation>Soysal P, Heybeli C, Koc Okudur S, Caliskan Bozyel E, Smith L, Kazancioglu R. Prevalence and co-incidence of geriatric syndromes according to glomerular filtration rate in older patients. Int Urol Nephrol. (2023) 55:469&#x2013;76. doi: 10.1007/s11255-022-03356-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11255-022-03356-5</ArticleId><ArticleId IdType="pubmed">36030356</ArticleId></ArticleIdList></Reference><Reference><Citation>Matzke GR, Aronoff GR, Atkinson AJ, Bennett WM, Decker BS, Eckardt KU, et al. Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from kidney disease: improving global outcomes (KDIGO). Kidney Int. (2011) 80:1122&#x2013;37. doi: 10.1038/ki.2011.322</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2011.322</ArticleId><ArticleId IdType="pubmed">21918498</ArticleId></ArticleIdList></Reference><Reference><Citation>Denic A, Glassock RJ, Rule AD. Structural and functional changes with the aging kidney. Adv Chronic Kidney Dis. (2016) 23:19&#x2013;28. doi: 10.1053/j.ackd.2015.08.004, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ackd.2015.08.004</ArticleId><ArticleId IdType="pmc">PMC4693148</ArticleId><ArticleId IdType="pubmed">26709059</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Parrott NJ, Lav&#xe9; T. Embracing the future of medicine with virtual patients. Drug Discov Today. (2025) 30:104322. doi: 10.1016/j.drudis.2025.104322, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2025.104322</ArticleId><ArticleId IdType="pubmed">40032136</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebert N, Schneider A, Huscher D, Mielke N, Balabanova Y, Brobert G, et al. Incidence of hospital-acquired acute kidney injury and trajectories of glomerular filtration rate in older adults. BMC Nephrol. (2023) 24:226. doi: 10.1186/s12882-023-03272-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-023-03272-5</ArticleId><ArticleId IdType="pmc">PMC10394866</ArticleId><ArticleId IdType="pubmed">37528401</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy RK, Menon S, Selewski DT. Putting the injury back into AKI: understanding AKI phenotypes and improving risk assessment in cardiac surgery-associated AKI. Pediatric Nephrology (Berlin, Germany). (2025) 40:887&#x2013;90. doi: 10.1007/s00467-024-06617-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00467-024-06617-w</ArticleId><ArticleId IdType="pubmed">39656275</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Hao W, Chen Y, Chen S, Liu W, Yu F, et al. Clinical features, risk factors, and clinical burden of acute kidney injury in older adults. Ren Fail. (2020) 42:1127&#x2013;34. doi: 10.1080/0886022X.2020.1843491, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/0886022X.2020.1843491</ArticleId><ArticleId IdType="pmc">PMC7671701</ArticleId><ArticleId IdType="pubmed">33191852</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37817430</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2765-1606</ISSN><JournalIssue CitedMedium="Print"><Volume>56</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>05</Day></PubDate></JournalIssue><Title>Journal of chest surgery</Title><ISOAbbreviation>J Chest Surg</ISOAbbreviation></Journal><ArticleTitle>Minimally Invasive Procedure versus Conventional Redo Sternotomy for Mitral Valve Surgery in Patients with Previous Cardiac Surgery: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>374</StartPage><EndPage>386</EndPage><MedlinePgn>374-386</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5090/jcs.23.038</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The heightened morbidity and mortality associated with repeat cardiac surgery are well documented. Redo median sternotomy (MS) and minimally invasive valve surgery are options for patients with prior cardiac surgery who require mitral valve surgery (MVS). We conducted a systematic review and meta-analysis comparing the outcomes of redo MS and minimally invasive MVS (MIMVS) in this population.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We searched PubMed, EMBASE, and Scopus for studies comparing outcomes of redo MS and MIMVS for MVS. To calculate risk ratios (RRs) for binary outcomes and weighted mean differences (MDs) for continuous data, we employed a random-effects model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">We included 12 retrospective observational studies, comprising 4157 participants (675 for MIMVS; 3482 for redo MS). Reductions in mortality (RR, 0.54; 95% confidence interval [CI], 0.37-0.80), length of hospital stay (MD, -4.23; 95% CI, -5.77 to -2.68), length of intensive care unit (ICU) stay (MD, -2.02; 95% CI, -3.17 to -0.88), and new-onset acute kidney injury (AKI) risk (odds ratio, 0.34; 95% CI, 0.19 to 0.61) were statistically significant and favored MIMVS (p&lt;0.05). No significant differences were observed in aortic cross-clamp time, cardiopulmonary bypass time, or risk of perioperative stroke, new-onset atrial fibrillation, surgical site infection, or reoperation for bleeding (p&gt;0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The current literature, which primarily consists of retrospective comparisons, underscores certain benefits of MIMVS over redo MS. These include decreased mortality, shorter hospital and ICU stays, and reduced AKI risk. Given the lack of high-quality evidence, prospective randomized control trials with adequate power are necessary to investigate long-term outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tariq</LastName><ForeName>Muhammad Ali</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0003-1108-0731</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Dow University Hospital, Dow University of Health Sciences, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malik</LastName><ForeName>Minhail Khalid</ForeName><Initials>MK</Initials><Identifier Source="ORCID">0000-0002-3823-2670</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Dow University Hospital, Dow University of Health Sciences, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uddin</LastName><ForeName>Qazi Shurjeel</ForeName><Initials>QS</Initials><Identifier Source="ORCID">0000-0003-4850-2125</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altaf</LastName><ForeName>Zahabia</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0003-3638-2277</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zafar</LastName><ForeName>Mariam</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4985-0009</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>J Chest Surg</MedlineTA><NlmUniqueID>101775790</NlmUniqueID><ISSNLinking>2765-1606</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Minimally invasive surgical procedures</Keyword><Keyword MajorTopicYN="N">Mitral valve</Keyword><Keyword MajorTopicYN="N">Reoperation</Keyword><Keyword MajorTopicYN="N">Sternotomy</Keyword><Keyword MajorTopicYN="N">Thoracotomy</Keyword></KeywordList><CoiStatement>
<b>Conflict of interest</b>
. No potential conflict of interest relevant to this article was reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>11</Day><Hour>1</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37817430</ArticleId><ArticleId IdType="pmc">PMC10625962</ArticleId><ArticleId IdType="doi">10.5090/jcs.23.038</ArticleId><ArticleId IdType="pii">jcs.23.038</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Marin-Cuartas M, de Waha S, Saeed D, Misfeld M, Kiefer P, Borger MA. Considerations for reoperative heart valve surgery. Struct Heart. 2022;7:100098.  doi: 10.1016/j.shj.2022.100098. 
https://doi.org/10.1016/j.shj.2022.100098. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.shj.2022.100098</ArticleId><ArticleId IdType="pmc">PMC10236806</ArticleId><ArticleId IdType="pubmed">37275309</ArticleId></ArticleIdList></Reference><Reference><Citation>Thourani VH, Weintraub WS, Guyton RA, et al.  Outcomes and long-term survival for patients undergoing mitral valve repair versus replacement: effect of age and concomitant coronary artery bypass grafting. Circulation. 2003;108:298&#x2013;304. doi: 10.1161/01.CIR.0000079169.15862.13. 
https://doi.org/10.1161/01.CIR.0000079169.15862.13. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000079169.15862.13</ArticleId><ArticleId IdType="pubmed">12835220</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilic A, Acker MA, Gleason TG, et al.  Clinical outcomes of mitral valve reoperations in the United States: an analysis of the Society of Thoracic Surgeons National Database. Ann Thorac Surg. 2019;107:754&#x2013;9. doi: 10.1016/j.athoracsur.2018.08.083. 
https://doi.org/10.1016/j.athoracsur.2018.08.083. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2018.08.083</ArticleId><ArticleId IdType="pubmed">30365952</ArticleId></ArticleIdList></Reference><Reference><Citation>Reser D, Caliskan E, Tolboom H, Guidotti A, Maisano F. Median sternotomy. Multimed Man Cardiothorac Surg. 2015;2015:mmv017.  doi: 10.1093/mmcts/mmv017. 
https://doi.org/10.1093/mmcts/mmv017. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/mmcts/mmv017</ArticleId><ArticleId IdType="pubmed">26188337</ArticleId></ArticleIdList></Reference><Reference><Citation>Elahi M, Dhannapuneni R, Firmin R, Hickey M. Direct complications of repeat median sternotomy in adults. Asian Cardiovasc Thorac Ann. 2005;13:135&#x2013;8. doi: 10.1177/021849230501300208. 
https://doi.org/10.1177/021849230501300208. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/021849230501300208</ArticleId><ArticleId IdType="pubmed">15905341</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundermann SH, Czerny M, Falk V. Open vs. minimally invasive mitral valve surgery: surgical technique, indications and results. Cardiovasc Eng Technol. 2015;6:160&#x2013;6. doi: 10.1007/s13239-015-0210-5. 
https://doi.org/10.1007/s13239-015-0210-5. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13239-015-0210-5</ArticleId><ArticleId IdType="pubmed">26577232</ArticleId></ArticleIdList></Reference><Reference><Citation>Vo AT, Nguyen DH, Van Hoang S, et al.  Learning curve in minimally invasive mitral valve surgery: a single-center experience. J Cardiothorac Surg. 2019;14:213. doi: 10.1186/s13019-019-1038-0. 
https://doi.org/10.1186/s13019-019-1038-0. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-019-1038-0</ArticleId><ArticleId IdType="pmc">PMC6896294</ArticleId><ArticleId IdType="pubmed">31806039</ArticleId></ArticleIdList></Reference><Reference><Citation>Burfeind WR, Glower DD, Davis RD, Landolfo KP, Lowe JE, Wolfe WG. Mitral surgery after prior cardiac operation: port-access versus sternotomy or thoracotomy. Ann Thorac Surg. 2002;74:S1323&#x2013;5. doi: 10.1016/S0003-4975(02)03909-7. 
https://doi.org/10.1016/s0003-4975(02)03909-7. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-4975(02)03909-7</ArticleId><ArticleId IdType="pubmed">12400809</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolotin G, Kypson AP, Reade CC, et al. Should a video-assisted mini-thoracotomy be the approach of choice for reoperative mitral valve surgery? J Heart Valve Dis. 2004;13:155&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">15086251</ArticleId></ArticleIdList></Reference><Reference><Citation>Svensson LG, Gillinov AM, Blackstone EH, et al.  Does right thoracotomy increase the risk of mitral valve reoperation? J Thorac Cardiovasc Surg. 2007;134:677&#x2013;82. doi: 10.1016/j.jtcvs.2007.04.052. 
https://doi.org/10.1016/j.jtcvs.2007.04.052. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2007.04.052</ArticleId><ArticleId IdType="pubmed">17723817</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DC, Chee HK, Song MG, et al.  Comparative analysis of thoracotomy and sternotomy approaches in cardiac reoperation. Korean J Thorac Cardiovasc Surg. 2012;45:225&#x2013;9. doi: 10.5090/kjtcs.2012.45.4.225. 
https://doi.org/10.5090/kjtcs.2012.45.4.225. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.5090/kjtcs.2012.45.4.225</ArticleId><ArticleId IdType="pmc">PMC3413826</ArticleId><ArticleId IdType="pubmed">22880166</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiraoka A, Kuinose M, Totsugawa T, Chikazawa G, Yoshitaka H. Mitral valve reoperation under ventricular fibrillation through right mini-thoracotomy using three-dimensional videoscope. J Cardiothorac Surg. 2013;8:81. doi: 10.1186/1749-8090-8-81. 
https://doi.org/10.1186/1749-8090-8-81. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-8090-8-81</ArticleId><ArticleId IdType="pmc">PMC3626926</ArticleId><ArticleId IdType="pubmed">23587412</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallabhajosyula P, Wallen T, Pulsipher A, et al.  Minimally invasive port access approach for reoperations on the mitral valve. Ann Thorac Surg. 2015;100:68&#x2013;73. doi: 10.1016/j.athoracsur.2015.02.039. 
https://doi.org/10.1016/j.athoracsur.2015.02.039. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2015.02.039</ArticleId><ArticleId IdType="pubmed">25975939</ArticleId></ArticleIdList></Reference><Reference><Citation>Losenno KL, Jones PM, Valdis M, Fox SA, Kiaii B, Chu MW. Higher-risk mitral valve operations after previous sternotomy: endoscopic, minimally invasive approach improves patient outcomes. Can J Surg. 2016;59:399&#x2013;406. doi: 10.1503/cjs.004516. 
https://doi.org/10.1503/cjs.004516. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cjs.004516</ArticleId><ArticleId IdType="pmc">PMC5125922</ArticleId><ArticleId IdType="pubmed">28234615</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghoneim A, Bouhout I, Mazine A, et al.  Beating heart minimally invasive mitral valve surgery in patients with patent coronary bypass grafts. Can J Cardiol. 2016;32:987. doi: 10.1016/j.cjca.2015.09.016. 
https://doi.org/10.1016/j.cjca.2015.09.016. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2015.09.016</ArticleId><ArticleId IdType="pubmed">26838664</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel NC, Hemli JM, Seetharam K, et al.  Reoperative mitral valve surgery via sternotomy or right thoracotomy: a propensity-matched analysis. J Card Surg. 2019;34:976&#x2013;82. doi: 10.1111/jocs.14170. 
https://doi.org/10.1111/jocs.14170. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocs.14170</ArticleId><ArticleId IdType="pubmed">31376216</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Xu HS, Wen B, Zhao WZ, Liu C. Minimally invasive beating heart technique for mitral valve surgery in patients with previous sternotomy and giant left ventricle. J Cardiothorac Surg. 2020;15:122. doi: 10.1186/s13019-020-01171-6. 
https://doi.org/10.1186/s13019-020-01171-6. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-020-01171-6</ArticleId><ArticleId IdType="pmc">PMC7268179</ArticleId><ArticleId IdType="pubmed">32493495</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon Y, Park SJ, Kim HJ, et al.  Mini-thoracotomy and full-sternotomy approach for reoperative mitral valve surgery after a previous sternotomy. Interact Cardiovasc Thorac Surg. 2022;34:354&#x2013;60. doi: 10.1093/icvts/ivab309. 
https://doi.org/10.1093/icvts/ivab309. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivab309</ArticleId><ArticleId IdType="pmc">PMC8860419</ArticleId><ArticleId IdType="pubmed">35188960</ArticleId></ArticleIdList></Reference><Reference><Citation>Monsefi N, Makkawi B, Ozturk M, Alirezai H, Alaj E, Bakhtiary F. Right minithoracotomy and resternotomy approach in patients undergoing a redo mitral valve procedure. Interact Cardiovasc Thorac Surg. 2022;34:33&#x2013;9. doi: 10.1093/icvts/ivab228. 
https://doi.org/10.1093/icvts/ivab228. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivab228</ArticleId><ArticleId IdType="pmc">PMC8743136</ArticleId><ArticleId IdType="pubmed">34999811</ArticleId></ArticleIdList></Reference><Reference><Citation>Elgharably H, Bakaeen FG, Pettersson GB. Third time mitral valve replacement-lessons learned. J Card Surg. 2017;32:571&#x2013;3. doi: 10.1111/jocs.13198. 
https://doi.org/10.1111/jocs.13198. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocs.13198</ArticleId><ArticleId IdType="pubmed">28849598</ArticleId></ArticleIdList></Reference><Reference><Citation>Heuts S, Olsthoorn JR, Hermans SM, et al.  Multidisciplinary decision-making in mitral valve disease: the mitral valve heart team. Neth Heart J. 2019;27:176&#x2013;84. doi: 10.1007/s12471-019-1238-1. 
https://doi.org/10.1007/s12471-019-1238-1. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12471-019-1238-1</ArticleId><ArticleId IdType="pmc">PMC6439106</ArticleId><ArticleId IdType="pubmed">30742250</ArticleId></ArticleIdList></Reference><Reference><Citation>Prestipino F, D'Ascoli R, Nagy &#xc1;, Paternoster G, Manzan E, Luzi G. Mini-thoracotomy in redo mitral valve surgery: safety and efficacy of a standardized procedure. J Thorac Dis. 2021;13:5363&#x2013;72. doi: 10.21037/jtd-21-667. 
https://doi.org/10.21037/jtd-21-667. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd-21-667</ArticleId><ArticleId IdType="pmc">PMC8482333</ArticleId><ArticleId IdType="pubmed">34659803</ArticleId></ArticleIdList></Reference><Reference><Citation>Speiser U, Pohling D, Tugtekin SM, Charitos E, Matschke K, Wilbring M. Redo surgery for noninfective isolated mitral valve disease: Initial outcome and further follow-up compared to primary surgery. J Card Surg. 2022;37:1990&#x2013;7. doi: 10.1111/jocs.16512. 
https://doi.org/10.1111/jocs.16512. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocs.16512</ArticleId><ArticleId IdType="pubmed">35430746</ArticleId></ArticleIdList></Reference><Reference><Citation>Gammie JS, Zhao Y, Peterson ED, O'Brien SM, Rankin JS, Griffith BP. J. Maxwell Chamberlain Memorial Paper for adult cardiac surgery: less-invasive mitral valve operations: trends and outcomes from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg. 2010;90:1401&#x2013;8. 1410. doi: 10.1016/j.athoracsur.2010.05.055. 
https://doi.org/10.1016/j.athoracsur.2010.05.055. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2010.05.055</ArticleId><ArticleId IdType="pubmed">20971230</ArticleId></ArticleIdList></Reference><Reference><Citation>Crooke GA, Schwartz CF, Ribakove GH, et al.  Retrograde arterial perfusion, not incision location, significantly increases the risk of stroke in reoperative mitral valve procedures. Ann Thorac Surg. 2010;89:723&#x2013;9. doi: 10.1016/j.athoracsur.2009.11.061. 
https://doi.org/10.1016/j.athoracsur.2009.11.061. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2009.11.061</ArticleId><ArticleId IdType="pubmed">20172117</ArticleId></ArticleIdList></Reference><Reference><Citation>Akay TH, Gultekin B, Ozkan S, et al.  Mitral valve replacements in redo patients with previous mitral valve procedures: mid-term results and risk factors for survival. J Card Surg. 2008;23:415&#x2013;21. doi: 10.1111/j.1540-8191.2008.00630.x. 
https://doi.org/10.1111/j.1540-8191.2008.00630.x. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8191.2008.00630.x</ArticleId><ArticleId IdType="pubmed">18928480</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismayl M, Abbasi MA, Mostafa MR, et al.  Meta-analysis comparing valve-in-valve transcatheter mitral valve replacement versus redo surgical mitral valve replacement in degenerated bioprosthetic mitral valve. Am J Cardiol. 2023;189:98&#x2013;107. doi: 10.1016/j.amjcard.2022.11.043. 
https://doi.org/10.1016/j.amjcard.2022.11.043. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2022.11.043</ArticleId><ArticleId IdType="pubmed">36521415</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39954384</PMID><DateCompleted><Year>2025</Year><Month>03</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>102</Volume><PubDate><Year>2025</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Perioperative goal-directed therapy with artificial intelligence to reduce the incidence of intraoperative hypotension and renal failure in patients undergoing lung surgery: A pilot study.</ArticleTitle><Pagination><StartPage>111777</StartPage><MedlinePgn>111777</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2025.111777</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(25)00037-6</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study was to investigate whether goal-directed treatment using artificial intelligence, compared to standard care, can reduce the frequency, duration, and severity of intraoperative hypotension in patients undergoing single lung ventilation, with a potential reduction of postoperative acute kidney injury (AKI).</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">single center, single-blinded randomized controlled trial.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">University hospital operating room.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">150 patients undergoing lung surgery with single lung ventilation were included.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Patients were randomly assigned to two groups: the Intervention group, where a goal-directed therapy based on the Hypotension Prediction Index (HPI) was implemented; the Control group, without a specific hemodynamic protocol.</AbstractText><AbstractText Label="MEASUREMENTS" NlmCategory="METHODS">The primary outcome measures include the frequency, duration of intraoperative hypotension, furthermore the Area under MAP 65 and the time-weighted average (TWA) of MAP of 65. Other outcome parameters are the incidence of AKI and myocardial injury after non-cardiac surgery (MINS).</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">The number of hypotensive episodes was lower in the intervention group compared to the control group (0 [0-1] vs. 1 [0-2]; p&#xa0;=&#xa0;0.01), the duration of hypotension was shorter in the intervention group (0&#xa0;min [0-3.17] vs. 2.33&#xa0;min [0-7.42]; p&#xa0;=&#xa0;0.01). The area under the MAP of 65 (0&#xa0;mmHg * min [0-12] vs. 10.67&#xa0;mmHg * min [0-44.16]; p&#xa0;&lt;&#xa0;0.01) and the TWA of MAP of 65 (0&#xa0;mmHg [0-0.08] vs. 0.07&#xa0;mmHg [0-0.25]; p&#xa0;&lt;&#xa0;0.01) were lower in the intervention group. The incidence of postoperative AKI showed no differences between the groups (6.7&#xa0;% vs.4.2&#xa0;%; p&#xa0;=&#xa0;0.72). There was a trend to lower incidence of MINS in the intervention group (17.1&#xa0;% vs. 31.8&#xa0;%; p&#xa0;=&#xa0;0.07). A tendency towards reduced postoperative infection was seen in the intervention group (16.0&#xa0;% vs. 26.8&#xa0;%; p&#xa0;=&#xa0;0.16).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The implementation of a treatment algorithm based on HPI allowed us to decrease the duration and severity of hypotension in patients undergoing lung surgery. It did not result in a significant reduction in the incidence of AKI, however we observed a tendency towards lower incidence of MINS in the intervention group, along with a slight reduction in postoperative infections.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Habicher</LastName><ForeName>Marit</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Justus Liebig University of Giessen, Rudolf-Buchheim-Street 7, 35392 Giessen, Germany. Electronic address: Marit.Habicher@chiru.med.uni-giessen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denn</LastName><ForeName>Sara Marie</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Justus Liebig University of Giessen, Rudolf-Buchheim-Street 7, 35392 Giessen, Germany. Electronic address: Sara.M.Denn@chiru.med.uni-giessen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneck</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Justus Liebig University of Giessen, Rudolf-Buchheim-Street 7, 35392 Giessen, Germany. Electronic address: Emmanuel.Schneck@chiru.med.uni-giessen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akbari</LastName><ForeName>Amir Ali</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Justus Liebig University of Giessen, Rudolf-Buchheim-Street 7, 35392 Giessen, Germany. Electronic address: Amir.Ali-Akbari@chiru.med.uni-giessen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>G&#xf6;tz</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Justus Liebig University of Giessen, Rudolf-Buchheim-Street 7, 35392 Giessen, Germany. Electronic address: Goetz.f.Schmidt@chiru.med.uni-giessen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Markmann</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Justus Liebig University of Giessen, Rudolf-Buchheim-Street 7, 35392 Giessen, Germany. Electronic address: Melanie.Markmann@chiru.med.uni-giessen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alkoudmani</LastName><ForeName>Ibrahim</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of General, Visceral, Thoracic, Transplant and Pediatric Surgery, University Hospital of Giessen, Rudolf-Buchheim Street 7, 35392 Giessen, Germany. Electronic address: Ibrahim.Alkoudmani@chiru.med.uni-giessen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koch</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Justus Liebig University of Giessen, Rudolf-Buchheim-Street 7, 35392 Giessen, Germany. Electronic address: Christian.Koch@chiru.med.uni-giessen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sander</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Justus Liebig University of Giessen, Rudolf-Buchheim-Street 7, 35392 Giessen, Germany. Electronic address: Michael.Sander@chiru.med.uni-giessen.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="Y">Intraoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="Y">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061810" MajorTopicYN="Y">One-Lung Ventilation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013510" MajorTopicYN="Y">Pulmonary Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Artificial intelligence</Keyword><Keyword MajorTopicYN="N">Hypotension prediction index</Keyword><Keyword MajorTopicYN="N">Intraoperative hypotension</Keyword><Keyword MajorTopicYN="N">Thoracic surgery</Keyword></KeywordList><CoiStatement>Declaration of competing interest SD, GS, MM, IA and CK declare that they have no conflict of interest related to this trial. MH has received honoraria for giving lectures from Edwards Lifesciences (Irvine, CA, USA). MH has received honoraria for giving lectures from Baxter (Deerfield, IL, USA). ES received an honorarium for lectures from Edwards Lifesciences (Irvine, CA, USA) and Orion Pharma (Hamburg, Germany). AA has received honoraria for giving lectures from Edwards Lifesciences (Irvine, CA, USA). MS is consultant for Edwards Lifesciences and has received institutional research funding for investigator-initiated trials and honoraria for giving lectures from Edwards Lifesciences, has received honoraria for giving lectures from AMOMED (Vienna, Austria), and has received honoraria for giving lectures from Orion Pharma (Hamburg, Germany). MS has received honoraria for giving lectures from Philips Medizin Systeme B&#xf6;blingen (B&#xf6;blingen, Germany).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>3</Day><Hour>0</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>16</Day><Hour>1</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>15</Day><Hour>18</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39954384</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2025.111777</ArticleId><ArticleId IdType="pii">S0952-8180(25)00037-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35598720</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2165</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><Issue>2-3</Issue><PubDate><Year>2022</Year><Season>Aug-Sep</Season></PubDate></JournalIssue><Title>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</Title><ISOAbbreviation>Eur J Vasc Endovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Editor's Choice - Sex Specific Outcomes After Complex Fenestrated and Branched Endovascular Aortic Repair: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>200</StartPage><EndPage>208</EndPage><MedlinePgn>200-208</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejvs.2022.05.026</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1078-5884(22)00328-8</ELocationID><Abstract><AbstractText Label="OBJECTIVE">As females are at higher mortality risk after endovascular aortic repair, this study aimed to compare the 30-day and 12-month mortality, morbidity, and re-intervention rates between the sexes, treated with fenestrated or branched endovascular aortic repair (F/BEVAR).</AbstractText><AbstractText Label="DATA SOURCES">A search of the English literature, via Ovid, using MEDLINE, Embase, and CENTRAL, up to 30 July 2021, was performed.</AbstractText><AbstractText Label="REVIEW METHODS">This meta-analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement, and its protocol was registered in PROSPERO (CRD42021273418). Observational studies (2010-21), with &#x2265; 20 patients, reporting on sex specific outcomes (mortality, acute kidney injury [AKI], spinal cord ischaemia [SCI], and re-intervention, after F/BEVAR), were considered eligible. Risk of bias in the studies was assessed using ROBINS-I, and evidence quality was assessed using GRADE. The primary outcome was the sex specific 30-day mortality rate, AKI, SCI, and re-intervention rates; secondary outcomes were survival and freedom from re-intervention at 12 months after F/BEVAR. The outcomes were summarised as odds ratio (OR) with 95% confidence intervals (CIs).</AbstractText><AbstractText Label="RESULTS">Four retrospective and one prospective study (2 421 patients; 26% females) were included. The 30-day mortality rate was 12% in females vs. 3% in males (OR 2.65, 95% CI 1.79 - 3.92; &#x399;<sup>2</sup>&#xa0;= 0%). The 30-day AKI, SCI, and re-intervention rates were similar (OR 1.45, 95% CI 1.03 - 2.03; &#x399;<sup>2</sup>&#xa0;= 0%; OR 1.86, 95% CI 1.27 - 2.74; &#x399;<sup>2</sup>&#xa0;= 38%; and OR 1.06, 95% CI 0.66 - 1.77; &#x399;<sup>2</sup>&#xa0;= 0%, respectively). The 12-month survival rate was lower in females (OR 0.95, 95% CI 0.91 - 0.99; &#x399;<sup>2</sup>&#xa0;= 38%). When excluding 30-day deaths, there was no difference in 12-month survival between sexes (OR 0.99, 95% CI 0.95 - 1.02; &#x399;<sup>2</sup>&#xa0;= 32%). The 12-month freedom from re-intervention was similar between sexes (OR 0.87, 95% CI 0.75 - 1.01; &#x399;<sup>2</sup>&#xa0;= 0%).</AbstractText><AbstractText Label="CONCLUSION">Female patients treated by F/BEVAR may present worse outcomes in terms of 30-day and 12-month survival. The high peri-operative mortality rate remains an issue. When excluding 30-day deaths, the 12-month survival rate was similar between the sexes. Early morbidity and re-intervention rates were comparable.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nana</LastName><ForeName>Petroula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Larissa University Hospital, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece. Electronic address: petr.nana7@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spanos</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Larissa University Hospital, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece; German Aortic Centre, Department of Vascular Medicine, University Heart Centre Hamburg, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Behrendt</LastName><ForeName>Christian-Alexander</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>German Aortic Centre, Department of Vascular Medicine, University Heart Centre Hamburg, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dakis</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Larissa University Hospital, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brotis</LastName><ForeName>Alexandros</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Larissa University Hospital, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kouvelos</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Larissa University Hospital, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giannoukas</LastName><ForeName>Athanasios</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Larissa University Hospital, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xf6;lbel</LastName><ForeName>Tilo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>German Aortic Centre, Department of Vascular Medicine, University Heart Centre Hamburg, Hamburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Vasc Endovasc Surg</MedlineTA><NlmUniqueID>9512728</NlmUniqueID><ISSNLinking>1078-5884</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur J Vasc Endovasc Surg. 2022 Aug-Sep;64(2-3):209. doi: 10.1016/j.ejvs.2022.05.032.</RefSource><PMID Version="1">35598722</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Branched endovascular repair</Keyword><Keyword MajorTopicYN="N">Female</Keyword><Keyword MajorTopicYN="N">Fenestrated endovascular repair</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Sex</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>22</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35598720</ArticleId><ArticleId IdType="doi">10.1016/j.ejvs.2022.05.026</ArticleId><ArticleId IdType="pii">S1078-5884(22)00328-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36434726</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>29</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>25</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Higher blood pressure versus normotension targets to prevent acute kidney injury: a systematic review and meta-regression of randomized controlled trials.</ArticleTitle><Pagination><StartPage>364</StartPage><MedlinePgn>364</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">364</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-022-04236-1</ELocationID><Abstract><AbstractText Label="BACKGROUND">Renal hypoperfusion is one of the most common causes of acute kidney injury (AKI), especially in shock and perioperative patients. An optimal blood pressure (BP) target to prevent AKI remains undetermined. We conducted a systematic review and meta-analysis of available randomized clinical trial (RCT) results to address this knowledge gap.</AbstractText><AbstractText Label="METHODS">From inception to May 13, 2022, we searched Ovid Medline, EMBASE, Cochrane Library, SCOPUS, clinicaltrials.gov, and WHO ICTRP for&#xa0;RCTs comparing higher BP target versus normotension in hemodynamically unstable patients (shock, post-cardiac arrest, or surgery patients). The outcomes of interest were post-intervention AKI rate and renal replacement therapy (RRT) rate. Two investigators independently screened the citations and reviewed the full texts for eligible studies according to a predefined form.</AbstractText><AbstractText Label="RESULTS">Twelve trials were included, enrolling a total of 5759 participants, with shock, non-cardiac, and cardiac surgery patients accounting for 3282 (57.0%), 1687 (29.3%) and 790 (13.7%) patients, respectively. Compared to lower mean arterial blood pressure (MAP) targets that served as normotension, targeting higher MAP had no significant effect on AKI rates in shock (RR [95% CI]&#x2009;=&#x2009;1.10 [0.93, 1.29]), in cardiac-surgery (RR [95% CI]&#x2009;=&#x2009;0.87 [0.73, 1.03]) and non-cardiac surgery patients (RR [95% CI]&#x2009;=&#x2009;1.25 [0.98, 1.60]) using random-effects meta-analyses. In shock patients with premorbid hypertension, however, targeting MAP above 70&#xa0;mmHg resulted in significantly lower RRT risks, RR [95%CI]&#x2009;=&#x2009;1.20 [1.03, 1.41], p&#x2009;&lt;&#x2009;0.05.</AbstractText><AbstractText Label="CONCLUSIONS">Targeting a higher MAP in shock or perioperative patients may not be superior to normotension, except in shock patients with premorbid hypertension. Further studies are needed to assess the effects of a high MAP target to preventing AKI in hypertensive patients across common settings of hemodynamic instability. Trial registration This systematic review has been registered on PROSPERO ( CRD42021286203 ) on November 19, 2021, prior to data extraction and analysis.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tran</LastName><ForeName>Phu Nguyen Trong</ForeName><Initials>PNT</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Faculty of Medicine, Can Tho University of Medicine and Pharmacy, Cantho, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kusirisin</LastName><ForeName>Prit</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence in Critical Care Nephrology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaewdoungtien</LastName><ForeName>Piyanut</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence in Critical Care Nephrology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Nephrology, Police General Hospital, Royal Thai Police Headquarters, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phannajit</LastName><ForeName>Jeerath</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Clinical Epidemiology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Srisawat</LastName><ForeName>Nattachai</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. drnattachai@yahoo.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, Bangkok, Thailand. drnattachai@yahoo.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence in Critical Care Nephrology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. drnattachai@yahoo.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Academy of Science, Royal Society of Thailand, Bangkok, Thailand. drnattachai@yahoo.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="Y">Hypertension</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Hypertension</Keyword><Keyword MajorTopicYN="N">Mean arterial blood pressure</Keyword><Keyword MajorTopicYN="N">Perioperative</Keyword><Keyword MajorTopicYN="N">Renal replacement therapy</Keyword><Keyword MajorTopicYN="N">Shock</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>26</Day><Hour>11</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36434726</ArticleId><ArticleId IdType="pmc">PMC9700976</ArticleId><ArticleId IdType="doi">10.1186/s13054-022-04236-1</ArticleId><ArticleId IdType="pii">10.1186/s13054-022-04236-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Raimann JG, Riella MC, Levin NW. International Society of Nephrology's 0by25 initiative (zero preventable deaths from acute kidney injury by 2025): focus on diagnosis of acute kidney injury in low-income countries. Clin Kidney J. 2018;11(1):12&#x2013;19. doi: 10.1093/ckj/sfw134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ckj/sfw134</ArticleId><ArticleId IdType="pmc">PMC5798075</ArticleId><ArticleId IdType="pubmed">29423195</ArticleId></ArticleIdList></Reference><Reference><Citation>Susantitaphong P, Cruz DN, Cerda J, Abulfaraj M, Alqahtani F, Koulouridis I, et al. World incidence of AKI: a meta-analysis. Clin J Am Soc Nephrol. 2013;8(9):1482&#x2013;1493. doi: 10.2215/CJN.00710113.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.00710113</ArticleId><ArticleId IdType="pmc">PMC3805065</ArticleId><ArticleId IdType="pubmed">23744003</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179&#x2013;c184. doi: 10.1159/000339789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000339789</ArticleId><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Badin J, Boulain T, Ehrmann S, Skarzynski M, Bretagnol A, Buret J, et al. Relation between mean arterial pressure and renal function in the early phase of shock: a prospective, explorative cohort study. Crit Care. 2011;15(3):R135. doi: 10.1186/cc10253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10253</ArticleId><ArticleId IdType="pmc">PMC3219004</ArticleId><ArticleId IdType="pubmed">21645384</ArticleId></ArticleIdList></Reference><Reference><Citation>Poukkanen M, Wilkman E, Vaara ST, Pettil&#xe4; V, Kaukonen K-M, Korhonen A-M, et al. Hemodynamic variables and progression of acute kidney injury in critically ill patients with severe sepsis: data from the prospective observational FINNAKI study. Crit Care. 2013;17(6):1&#x2013;11. doi: 10.1186/cc13161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13161</ArticleId><ArticleId IdType="pmc">PMC4056430</ArticleId><ArticleId IdType="pubmed">24330815</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204&#x2013;R212. doi: 10.1186/cc2872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc2872</ArticleId><ArticleId IdType="pmc">PMC522841</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31. doi: 10.1186/cc5713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc5713</ArticleId><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference><Reference><Citation>Grand J, Meyer AS, Kjaergaard J, Wiberg S, Thomsen JH, Frydland M, et al. A randomised double-blind pilot trial comparing a mean arterial pressure target of 65 mm Hg versus 72 mm Hg after out-of-hospital cardiac arrest. Eur Heart J Acute Cardiovasc Care. 2020;9(4_suppl):S100&#x2013;S109. doi: 10.1177/2048872619900095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2048872619900095</ArticleId><ArticleId IdType="pubmed">32004081</ArticleId></ArticleIdList></Reference><Reference><Citation>Asfar P, Meziani F, Hamel J-F, Grelon F, Megarbane B, Anguel N, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370(17):1583&#x2013;1593. doi: 10.1056/NEJMoa1312173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1312173</ArticleId><ArticleId IdType="pubmed">24635770</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamontagne F, Richards-Belle A, Thomas K, Harrison DA, Sadique MZ, Grieve RD, et al. Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: a randomized clinical trial. JAMA. 2020;323(10):938&#x2013;949. doi: 10.1001/jama.2020.0930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.0930</ArticleId><ArticleId IdType="pmc">PMC7064880</ArticleId><ArticleId IdType="pubmed">32049269</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Lefrant JY, Guinot PG, Godet T, Lorne E, Cuvillon P, et al. Effect of individualized vs standard blood pressure management strategies on postoperative organ dysfunction among high-risk patients undergoing major surgery: a randomized clinical trial. JAMA. 2017;318(14):1346&#x2013;1357. doi: 10.1001/jama.2017.14172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.14172</ArticleId><ArticleId IdType="pmc">PMC5710560</ArticleId><ArticleId IdType="pubmed">28973220</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu AM, Qiu Y, Zhang P, Zhao R, Li ST, Zhang YX, et al. Higher versus lower mean arterial pressure target management in older patients having non-cardiothoracic surgery: a prospective randomized controlled trial. J Clin Anesth. 2021;69:110150. doi: 10.1016/j.jclinane.2020.110150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2020.110150</ArticleId><ArticleId IdType="pubmed">33418429</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanner PM, Wulff DU, Djurdjevic M, Korte W, Schnider TW, Filipovic M. Targeting higher intraoperative blood pressures does not reduce adverse cardiovascular events following noncardiac surgery. J Am Coll Cardiol. 2021;78(18):1753&#x2013;1764. doi: 10.1016/j.jacc.2021.08.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2021.08.048</ArticleId><ArticleId IdType="pubmed">34711333</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Jiang Z, Ying J, Han Y, Chen Z. Optimal blood pressure decreases acute kidney injury after gastrointestinal surgery in elderly hypertensive patients: a randomized study: optimal blood pressure reduces acute kidney injury. J Clin Anesth. 2017;43:77&#x2013;83. doi: 10.1016/j.jclinane.2017.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2017.09.004</ArticleId><ArticleId IdType="pubmed">29055803</ArticleId></ArticleIdList></Reference><Reference><Citation>Azau A, Markowicz P, Corbeau JJ, Cottineau C, Moreau X, Baufreton C, et al. Increasing mean arterial pressure during cardiac surgery does not reduce the rate of postoperative acute kidney injury. Perfusion. 2014;29(6):496&#x2013;504. doi: 10.1177/0267659114527331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0267659114527331</ArticleId><ArticleId IdType="pubmed">24619062</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandler K, Nilsson JC, Oturai P, Jensen ME, M&#xf8;ller CH, Clemmesen JO, et al. Higher arterial pressure during cardiopulmonary bypass may not reduce the risk of acute kidney injury. J Cardiothorac Surg. 2019;14(1):107. doi: 10.1186/s13019-019-0929-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-019-0929-4</ArticleId><ArticleId IdType="pmc">PMC6567467</ArticleId><ArticleId IdType="pubmed">31196131</ArticleId></ArticleIdList></Reference><Reference><Citation>Siepe M, Pfeiffer T, Gieringer A, Zemann S, Benk C, Schlensak C, et al. Increased systemic perfusion pressure during cardiopulmonary bypass is associated with less early postoperative cognitive dysfunction and delirium. Eur J Cardiothorac Surg. 2011;40(1):200&#x2013;207. doi: 10.1016/j.ejcts.2010.11.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2010.11.024</ArticleId><ArticleId IdType="pubmed">21168339</ArticleId></ArticleIdList></Reference><Reference><Citation>Vedel AG, Holmgaard F, Rasmussen LS, Langkilde A, Paulson OB, Lange T, et al. High-target versus low-target blood pressure management during cardiopulmonary bypass to prevent cerebral injury in cardiac surgery patients: a randomized controlled trial. Circulation. 2018;137(17):1770&#x2013;1780. doi: 10.1161/CIRCULATIONAHA.117.030308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.117.030308</ArticleId><ArticleId IdType="pubmed">29339351</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirvinskas E, Benetis R, Raliene L, Andrejaitiene J. The influence of mean arterial blood pressure during cardiopulmonary bypass on postoperative renal dysfunction in elderly patients. Perfusion. 2012;27(3):193&#x2013;198. doi: 10.1177/0267659112436751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0267659112436751</ArticleId><ArticleId IdType="pubmed">22337760</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamontagne F, Day AG, Meade MO, Cook DJ, Guyatt GH, Hylands M, et al. Pooled analysis of higher versus lower blood pressure targets for vasopressor therapy septic and vasodilatory shock. Intensive Care Med. 2018;44(1):12&#x2013;21. doi: 10.1007/s00134-017-5016-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-5016-5</ArticleId><ArticleId IdType="pubmed">29260272</ArticleId></ArticleIdList></Reference><Reference><Citation>McEwen CC, Amir T, Qiu Y, Young J, Kennedy K, Grocott HP, et al. Morbidity and mortality in patients managed with high compared with low blood pressure targets during on-pump cardiac surgery: a systematic review and meta-analysis of randomized controlled trials. Can J Anaesth. 2022;69:374&#x2013;386. doi: 10.1007/s12630-021-02171-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-021-02171-3</ArticleId><ArticleId IdType="pubmed">35014001</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu MY, Hong S, Lu J, Liu YH, Deng M. Effect of strict intraoperative blood pressure management strategy on postoperative acute kidney injury in non-cardiac surgery: a meta-analysis of randomised controlled trials. Int J Clin Pract. 2021;75(11):e14570. doi: 10.1111/ijcp.14570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14570</ArticleId><ArticleId IdType="pubmed">34165855</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmid S, Blobner M, Haas B, Lucke M, Neumaier M, Anetsberger A, et al. Perioperative multi-system optimization protocol in elderly hip fracture patients: a randomized-controlled trial. Can J Anaesth. 2019;66(12):1472&#x2013;1482. doi: 10.1007/s12630-019-01475-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-019-01475-9</ArticleId><ArticleId IdType="pubmed">31531828</ArticleId></ArticleIdList></Reference><Reference><Citation>Demiselle J, Radermacher P, Asfar P. Blood pressure targets in the initial stabilization. In: Pinsky MR, Teboul J-L, Vincent J-L, editors. Hemodynamic monitoring. Cham: Springer; 2019. pp. 359&#x2013;366.</Citation></Reference><Reference><Citation>Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;47(11):1181&#x2013;1247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8486643</ArticleId><ArticleId IdType="pubmed">34599691</ArticleId></ArticleIdList></Reference><Reference><Citation>Fellahi JL, Futier E, Vaisse C, Collange O, Huet O, Loriau J, et al. Perioperative hemodynamic optimization: from guidelines to implementation-an experts' opinion paper. Ann Intensive Care. 2021;11(1):58. doi: 10.1186/s13613-021-00845-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-021-00845-1</ArticleId><ArticleId IdType="pmc">PMC8046882</ArticleId><ArticleId IdType="pubmed">33852124</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Wan L, May C. Vasoactive drugs and acute kidney injury. Crit Care Med. 2008;36(4 Suppl):S179&#x2013;S186. doi: 10.1097/CCM.0b013e318169167f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318169167f</ArticleId><ArticleId IdType="pubmed">18382191</ArticleId></ArticleIdList></Reference><Reference><Citation>Beloncle F, Piquilloud L, Asfar P. Chapter 18&#x2014;Renal blood flow and perfusion pressure. In: Ronco C, Bellomo R, Kellum JA, Ricci Z, editors. Critical care nephrology. 3. Philadelphia: Elsevier; 2019. pp. 106&#x2013;9.e2.</Citation></Reference><Reference><Citation>Almeida JB, Sarago&#xe7;a MA, Tavares A, Cezareti ML, Draibe SA, Ramos OL. Severe hypertension induces disturbances of renal autoregulation. Hypertension. 1992;19(2 Suppl):lI279-83.</Citation><ArticleIdList><ArticleId IdType="pubmed">1735593</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewitte A, Labat A, Duvignaud PA, Bouche G, Joannes-Boyau O, Ripoche J, et al. High mean arterial pressure target to improve sepsis-associated acute kidney injury in patients with prior hypertension: a feasibility study. Ann Intensive Care. 2021;11(1):139. doi: 10.1186/s13613-021-00925-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-021-00925-2</ArticleId><ArticleId IdType="pmc">PMC8458519</ArticleId><ArticleId IdType="pubmed">34553274</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecconi M, De Backer D, Antonelli M, Beale R, Bakker J, Hofer C, et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med. 2014;40(12):1795&#x2013;1815. doi: 10.1007/s00134-014-3525-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-014-3525-z</ArticleId><ArticleId IdType="pmc">PMC4239778</ArticleId><ArticleId IdType="pubmed">25392034</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Forni LG, Bell M, Chew MS, Edwards M, Grams ME, et al. Postoperative acute kidney injury in adult non-cardiac surgery: joint consensus report of the Acute Disease Quality Initiative and PeriOperative Quality Initiative. Nat Rev Nephrol. 2021;17(9):605&#x2013;618. doi: 10.1038/s41581-021-00418-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-021-00418-2</ArticleId><ArticleId IdType="pmc">PMC8367817</ArticleId><ArticleId IdType="pubmed">33976395</ArticleId></ArticleIdList></Reference><Reference><Citation>Fellahi J-L, Futier E, Vaisse C, Collange O, Huet O, Loriau J, et al. Perioperative hemodynamic optimization: from guidelines to implementation&#x2014;an experts&#x2019; opinion paper. Ann Intensive Care. 2021;11(1):1&#x2013;10. doi: 10.1186/s13613-021-00845-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-021-00845-1</ArticleId><ArticleId IdType="pmc">PMC8046882</ArticleId><ArticleId IdType="pubmed">33852124</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34854822</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>134</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Hydroxyethyl Starch for Fluid Management in Patients Undergoing Major Abdominal Surgery: A Systematic Review With Meta-analysis and Trial Sequential Analysis.</ArticleTitle><Pagination><StartPage>686</StartPage><EndPage>695</EndPage><MedlinePgn>686-695</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000005803</ELocationID><Abstract><AbstractText Label="BACKGROUND">In critically ill patients, warnings about a risk of death and acute kidney injury (AKI) with hydroxyethyl starch (HES) solutions have been raised. However, HES solutions may yet have a role to play in major abdominal surgery. This meta-analysis and trial sequential analysis (TSA) aimed to investigate the effect of HES intravascular volume replacement on the risk of AKI, intraoperative blood transfusion, and postoperative intra-abdominal complications compared to crystalloid intravascular volume replacement.</AbstractText><AbstractText Label="METHODS">In this meta-analysis and TSA, we searched for randomized controlled trials (RCTs) comparing intraoperative HES intravascular volume replacement to crystalloid intravascular volume replacement in adult patients undergoing major abdominal surgery. Primary outcome was 30-day AKI, defined as a binary outcome according to Kidney Disease Improving Global Outcomes (KDIGO) criteria, combining stages 1, 2, and 3 into an AKI category versus no AKI category (stage 0). Secondary outcomes included rates of intraoperative blood transfusion and postoperative intra-abdominal complications. We used random effects models to calculate summary estimates. We used relative risk (RR) as summary measure for dichotomous outcomes, with corresponding 95% confidence intervals (CIs) for the primary outcome (P value &lt;.05 was considered statistically significant) and 99% CI after Bonferroni correction for the secondary outcomes (P value &lt;.01 was considered statistically significant).</AbstractText><AbstractText Label="RESULTS">Seven RCTs including 2398 patients were included. HES intravascular volume replacement was not associated with an increased risk of 30-day AKI (RR = 1.22, 95% CI, 0.94-1.59; P = .13), when compared to crystalloid intravascular volume replacement. According to TSA, this analysis was underpowered. HES intravascular volume replacement was associated with higher rates of blood transfusion (RR = 1.57 99% CI, 1.10-2.25; P = .001), and similar rates of postoperative intra-abdominal complications (RR = 0.76 99% CI, 0.57-1.02; P = .02).</AbstractText><AbstractText Label="CONCLUSIONS">In this meta-analysis to focus on HES intravascular volume replacement in major abdominal surgery, HES intravascular volume replacement was not associated with a higher risk of 30-day AKI when compared to crystalloid intravascular volume replacement. However, CI and TSA do not exclude harmful effects of HES intravascular volume replacement on the renal function.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 International Anesthesia Research Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pensier</LastName><ForeName>Joris</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the Anesthesiology and Intensive Care, Anesthesia and Critical Care Department B, Saint Eloi Teaching Hospital, Montpellier Cedex 5, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement d'Anesth&#xe9;sie-R&#xe9;animation B, Centre Hospitalier Universitaire Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deffontis</LastName><ForeName>Lucas</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the Anesthesiology and Intensive Care, Anesthesia and Critical Care Department B, Saint Eloi Teaching Hospital, Montpellier Cedex 5, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement d'Anesth&#xe9;sie-R&#xe9;animation B, Centre Hospitalier Universitaire Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roll&#xe9;</LastName><ForeName>Am&#xe9;lie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Anesthesiology and Intensive Care, Anesthesia and Critical Care Department B, Saint Eloi Teaching Hospital, Montpellier Cedex 5, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement d'Anesth&#xe9;sie-R&#xe9;animation B, Centre Hospitalier Universitaire Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aarab</LastName><ForeName>Yassir</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>From the Anesthesiology and Intensive Care, Anesthesia and Critical Care Department B, Saint Eloi Teaching Hospital, Montpellier Cedex 5, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement d'Anesth&#xe9;sie-R&#xe9;animation B, Centre Hospitalier Universitaire Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capdevila</LastName><ForeName>Mathieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Anesthesiology and Intensive Care, Anesthesia and Critical Care Department B, Saint Eloi Teaching Hospital, Montpellier Cedex 5, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement d'Anesth&#xe9;sie-R&#xe9;animation B, Centre Hospitalier Universitaire Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monet</LastName><ForeName>Cl&#xe9;ment</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>From the Anesthesiology and Intensive Care, Anesthesia and Critical Care Department B, Saint Eloi Teaching Hospital, Montpellier Cedex 5, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement d'Anesth&#xe9;sie-R&#xe9;animation B, Centre Hospitalier Universitaire Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carr</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the Anesthesiology and Intensive Care, Anesthesia and Critical Care Department B, Saint Eloi Teaching Hospital, Montpellier Cedex 5, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement d'Anesth&#xe9;sie-R&#xe9;animation B, Centre Hospitalier Universitaire Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Futier</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre Hospitalier Universitaire Clermont-Ferrand, D&#xe9;partement de M&#xe9;decine P&#xe9;riop&#xe9;ratoire, Anesth&#xe9;sie et R&#xe9;animation, Clermont-Ferrand, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molinari</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Statistics, University of Montpellier Lapeyronie Hospital, UMR 729 MISTEA, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaber</LastName><ForeName>Samir</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Anesthesiology and Intensive Care, Anesthesia and Critical Care Department B, Saint Eloi Teaching Hospital, Montpellier Cedex 5, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement d'Anesth&#xe9;sie-R&#xe9;animation B, Centre Hospitalier Universitaire Montpellier, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Intensive Care, Anesthesia and Critical Care Department B, Saint Eloi Teaching Hospital, PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR 9214, Montpellier Cedex 5 Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Jong</LastName><ForeName>Audrey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Anesthesiology and Intensive Care, Anesthesia and Critical Care Department B, Saint Eloi Teaching Hospital, Montpellier Cedex 5, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement d'Anesth&#xe9;sie-R&#xe9;animation B, Centre Hospitalier Universitaire Montpellier, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Intensive Care, Anesthesia and Critical Care Department B, Saint Eloi Teaching Hospital, PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR 9214, Montpellier Cedex 5 Montpellier, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077324">Crystalloid Solutions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006895">Hydroxyethyl Starch Derivatives</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010952">Plasma Substitutes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Anesth Analg. 2022 Apr 1;134(4):683-685. doi: 10.1213/ANE.0000000000005903.</RefSource><PMID Version="1">35299209</PMID></CommentsCorrections><CommentsCorrections RefType="ErratumIn"><RefSource>Anesth Analg. 2022 Sep 1;135(3):e20. doi: 10.1213/ANE.0000000000006096.</RefSource><PMID Version="1">35981304</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="N">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077324" MajorTopicYN="N">Crystalloid Solutions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006895" MajorTopicYN="Y">Hydroxyethyl Starch Derivatives</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010952" MajorTopicYN="N">Plasma Substitutes</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Conflicts of Interest: See Disclosures at the end of the article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>2</Day><Hour>12</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34854822</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000005803</ArticleId><ArticleId IdType="pii">00000539-202204000-00008</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Corcoran T, Rhodes JE, Clarke S, Myles PS, Ho KM. Perioperative fluid management strategies in major surgery: a stratified meta-analysis. Anesth Analg. 2012;114:640&#x2013;651.</Citation></Reference><Reference><Citation>He H, Liu D, Ince C. Colloids and the microcirculation. Anesth Analg. 2018;126:1747&#x2013;1754.</Citation></Reference><Reference><Citation>Kabon B, Sessler DI, Kurz A; Crystalloid&#x2013;Colloid Study Team. Effect of intraoperative goal-directed balanced crystalloid versus colloid administration on major postoperative morbidity: a randomized trial. Anesthesiology. 2019;130:728&#x2013;744.</Citation></Reference><Reference><Citation>Chappell D, Jacob M, Hofmann-Kiefer K, Conzen P, Rehm M. A rational approach to perioperative fluid management. Anesthesiology. 2008;109:723&#x2013;740.</Citation></Reference><Reference><Citation>Hartog CS, Bauer M, Reinhart K. The efficacy and safety of colloid resuscitation in the critically ill. Anesth Analg. 2011;112:156&#x2013;164.</Citation></Reference><Reference><Citation>Dickenmann M, Oettl T, Mihatsch MJ. Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. Am J Kidney Dis. 2008;51:491&#x2013;503.</Citation></Reference><Reference><Citation>PRAC recommends suspending hydroxyethyl-starch solutions for infusion from the market EMA/4068/2018. Accessed February 2, 2020. https://www.ema.europa.eu/en/news/prac-recommends-suspending-hydroxyethyl-starch-solutions-infusion-market .</Citation></Reference><Reference><Citation>Perner A, Haase N, Guttormsen AB, et al.; 6S Trial Group; Scandinavian Critical Care Trials Group. Hydroxyethyl starch 130/0.42 versus Ringer&#x2019;s acetate in severe sepsis. N Engl J Med. 2012;367:124&#x2013;134.</Citation></Reference><Reference><Citation>Heming N, Lamothe L, Jaber S, et al. Morbidity and mortality of crystalloids compared to colloids in critically ill surgical patients: a subgroup analysis of a randomized trial. Anesthesiology. 2018;129:1149&#x2013;1158.</Citation></Reference><Reference><Citation>Joosten A, Raj Lawrence S, Colesnicenco A, et al. Personalized versus protocolized fluid management using noninvasive hemodynamic monitoring (clearsight system) in patients undergoing moderate-risk abdominal surgery. Anesth Analg. 2019;129:e8&#x2013;e12.</Citation></Reference><Reference><Citation>Joosten A, Delaporte A, Ickx B, et al. Crystalloid versus colloid for intraoperative goal-directed fluid therapy using a closed-loop system: a randomized, double-blinded, controlled trial in major abdominal surgery. Anesthesiology. 2018;128:55&#x2013;66.</Citation></Reference><Reference><Citation>Futier E, Garot M, Godet T, et al.; FLASH Trial Group. Effect of hydroxyethyl starch vs saline for volume replacement therapy on death or postoperative complications among high-risk patients undergoing major abdominal surgery: the FLASH randomized clinical trial. JAMA. 2020;323:225&#x2013;236.</Citation></Reference><Reference><Citation>Kozek-Langenecker SA, Jungheinrich C, Sauermann W, Van der Linden P. The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials. Anesth Analg. 2008;107:382&#x2013;390.</Citation></Reference><Reference><Citation>Rasmussen KC, Johansson PI, H&#xf8;jskov M, et al. Hydroxyethyl starch reduces coagulation competence and increases blood loss during major surgery: results from a randomized controlled trial. Ann Surg. 2014;259:249&#x2013;254.</Citation></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.</Citation></Reference><Reference><Citation>Kheterpal S, Tremper KK, Heung M, et al. Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set. Anesthesiology. 2009;110:505&#x2013;515.</Citation></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:c179&#x2013;c184.</Citation></Reference><Reference><Citation>Myburgh JA, Finfer S, Bellomo R, et al.; CHEST Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901&#x2013;1911.</Citation></Reference><Reference><Citation>Mascha EJ, Sessler DI. Statistical grand rounds: design and analysis of studies with binary- event composite endpoints: guidelines for anesthesia research. Anesth Analg. 2011;112:1461&#x2013;1471.</Citation></Reference><Reference><Citation>Bakker IS, Grossmann I, Henneman D, Havenga K, Wiggers T. Risk factors for anastomotic leakage and leak-related mortality after colonic cancer surgery in a nationwide audit. Br J Surg. 2014;101:424&#x2013;432.</Citation></Reference><Reference><Citation>Sartelli M, Catena F, Di Saverio S, et al. Current concept of abdominal sepsis: WSES position paper. World J Emerg Surg. 2014;9:22.</Citation></Reference><Reference><Citation>Jakobsen JC, Wetterslev J, Winkel P, Lange T, Gluud C. Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. BMC Med Res Methodol. 2014;14:120.</Citation></Reference><Reference><Citation>Pensier J, de Jong A, Hajjej Z, et al. Effect of lung recruitment maneuver on oxygenation, physiological parameters and mortality in acute respiratory distress syndrome patients: a systematic review and meta-analysis. Intensive Care Med. 2019;45:1691&#x2013;1702.</Citation></Reference><Reference><Citation>Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Med Res Methodol. 2009;9:86.</Citation></Reference><Reference><Citation>Mascha EJ. Alpha, beta, meta: guidelines for assessing power and type i error in meta-analyses. Anesth Analg. 2015;121:1430&#x2013;1433.</Citation></Reference><Reference><Citation>Barbateskovic M, Marker S, Granholm A, et al. Stress ulcer prophylaxis with proton pump inhibitors or histamin-2 receptor antagonists in adult intensive care patients: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med. 2019;45:143&#x2013;158.</Citation></Reference><Reference><Citation>Stang A, Poole C, Bender R. Common problems related to the use of number needed to treat. J Clin Epidemiol. 2010;63:820&#x2013;825.</Citation></Reference><Reference><Citation>Yates DR, Davies SJ, Milner HE, Wilson RJ. Crystalloid or colloid for goal-directed fluid therapy in colorectal surgery. Br J Anaesth. 2014;112:281&#x2013;289.</Citation></Reference><Reference><Citation>Ghodraty MR, Rokhtabnak F, Dehghan HR, et al. Crystalloid versus colloid fluids for reduction of postoperative ileus after abdominal operation under combined general and epidural anesthesia. Surgery. 2017;162:1055&#x2013;1062.</Citation></Reference><Reference><Citation>Cvetkovic A, Kalezic N, Milicic B, et al. The impact of different infusion solutions on postoperative recovery following colorectal surgery. J BUON. 2018;23:1369&#x2013;1379.</Citation></Reference><Reference><Citation>Payen D. The efficacy and safety of colloid resuscitation in the critically ill. Anesth Analg. 2011;112:17&#x2013;18.</Citation></Reference><Reference><Citation>Haase N, Perner A, Hennings LI, et al. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ. 2013;346:f839.</Citation></Reference><Reference><Citation>Zarychanski R, Abou-Setta AM, Turgeon AF, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA. 2013;309:678&#x2013;688.</Citation></Reference><Reference><Citation>Serpa Neto A, Veelo DP, Peireira VG, et al. Fluid resuscitation with hydroxyethyl starches in patients with sepsis is associated with an increased incidence of acute kidney injury and use of renal replacement therapy: a systematic review and meta-analysis of the literature. J Crit Care. 2014;29:185.e1&#x2013;185.e7.</Citation></Reference><Reference><Citation>Patel A, Laffan MA, Waheed U, Brett SJ. Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality. BMJ. 2014;349:g4561.</Citation></Reference><Reference><Citation>Mutter TC, Ruth CA, Dart AB. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev. 2013:Cd007594.</Citation></Reference><Reference><Citation>Gillies MA, Habicher M, Jhanji S, et al. Incidence of postoperative death and acute kidney injury associated with i.v. 6% hydroxyethyl starch use: systematic review and meta-analysis. Br J Anaesth. 2014;112:25&#x2013;34.</Citation></Reference><Reference><Citation>Gattas DJ, Dan A, Myburgh J, Billot L, Lo S, Finfer S; CHEST Management Committee. Fluid resuscitation with 6 % hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Med. 2013;39:558&#x2013;568.</Citation></Reference><Reference><Citation>Futier E, Constantin JM, Paugam-Burtz C, et al.; IMPROVE Study Group. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med. 2013;369:428&#x2013;437.</Citation></Reference><Reference><Citation>Montravers P, Tubach F, Lescot T, et al.; DURAPOP Trial Group. Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial. Intensive Care Med. 2018;44:300&#x2013;310.</Citation></Reference><Reference><Citation>Grocott MPW, Mythen MG, Gan TJ. Perioperative fluid management and clinical outcomes in adults. Anesth Analg. 2005;100:1093&#x2013;1106.</Citation></Reference><Reference><Citation>Dalton JE, Bolen SD, Mascha EJ. Publication bias: the elephant in the review. Anesth Analg. 2016;123:812&#x2013;813.</Citation></Reference><Reference><Citation>Semler MW, Self WH, Wanderer JP, et al.; SMART Investigators and the Pragmatic Critical Care Research Group. Balanced crystalloids versus saline in critically ill adults. N Engl J Med. 2018;378:829&#x2013;839.</Citation></Reference><Reference><Citation>Langeron O, Doelberg M, Ang ET, Bonnet F, Capdevila X, Coriat P. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg. 2001;92:855&#x2013;862.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38918723</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2318</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>25</Day></PubDate></JournalIssue><Title>BMC geriatrics</Title><ISOAbbreviation>BMC Geriatr</ISOAbbreviation></Journal><ArticleTitle>A simple machine learning model for the prediction of acute kidney injury following noncardiac surgery in geriatric patients: a prospective cohort study.</ArticleTitle><Pagination><StartPage>549</StartPage><MedlinePgn>549</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">549</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12877-024-05148-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Surgery in geriatric patients often poses risk of major postoperative complications. Acute kidney injury (AKI) is a common complication following noncardiac surgery and is associated with increased mortality. Early identification of geriatric patients at high risk of AKI could facilitate preventive measures and improve patient prognosis. This study used machine learning methods to identify important features and predict AKI following noncardiac surgery in geriatric patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The data for this study were obtained from a prospective cohort. Patients aged&#x2009;&#x2265;&#x2009;65 years who received noncardiac surgery from June 2019 to December 2021 were enrolled. Data were split into training set (from June 2019 to March 2021) and internal validation set (from April 2021 to December 2021) by time. The least absolute shrinkage and selection operator (LASSO) regularization algorithm and the random forest recursive feature elimination algorithm (RF-RFE) were used to screen important predictors. Models were trained through extreme gradient boosting (XGBoost), random forest, and LASSO. The SHapley Additive exPlanations (SHAP) package was used to interpret the machine learning model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The training set included 6753 geriatric patients. Of these, 250 (3.70%) patients developed AKI. The XGBoost model with RF-RFE selected features outperformed other models with an area under the precision-recall curve (AUPRC) of 0.505 (95% confidence interval [CI]: 0.369-0.626) and an area under the receiver operating characteristic curve (AUROC) of 0.806 (95%CI: 0.733-0.875). The model incorporated ten predictors, including operation site and hypertension. The internal validation set included 3808 geriatric patients, and 96 (2.52%) patients developed AKI. The model maintained good predictive performance with an AUPRC of 0.431 (95%CI: 0.331-0.524) and an AUROC of 0.845 (95%CI: 0.796-0.888) in the internal validation.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study developed a simple machine learning model and a web calculator for predicting AKI following noncardiac surgery in geriatric patients. This model may be a valuable tool for guiding preventive measures and improving patient prognosis.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">The protocol of this study was approved by the Committee of Ethics from West China Hospital of Sichuan University (2019-473) with a waiver of informed consent and registered at www.chictr.org.cn (ChiCTR1900025160, 15/08/2019).</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Xiran</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, 610041, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit for Perioperative Stress Assessment and Clinical Decision, Chinese Academy of Medical Sciences (2018RU012), West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, 610041, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit for Perioperative Stress Assessment and Clinical Decision, Chinese Academy of Medical Sciences (2018RU012), West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Qixu</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Center of Statistical Research, School of Statistics, Southwestern University of Finance and Economics, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint Lab of Data Science and Business Intelligence, School of Statistics, Southwestern University of Finance and Economics, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yuewen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center of Statistical Research, School of Statistics, Southwestern University of Finance and Economics, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint Lab of Data Science and Business Intelligence, School of Statistics, Southwestern University of Finance and Economics, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Ruihao</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, 610041, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit for Perioperative Stress Assessment and Clinical Decision, Chinese Academy of Medical Sciences (2018RU012), West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center of Statistical Research, School of Statistics, Southwestern University of Finance and Economics, Chengdu, China. likec@swufe.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint Lab of Data Science and Business Intelligence, School of Statistics, Southwestern University of Finance and Economics, Chengdu, China. likec@swufe.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hao</LastName><ForeName>Xuechao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, 610041, China. aneshxc@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit for Perioperative Stress Assessment and Clinical Decision, Chinese Academy of Medical Sciences (2018RU012), West China Hospital, Sichuan University, Chengdu, China. aneshxc@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Geriatr</MedlineTA><NlmUniqueID>100968548</NlmUniqueID><ISSNLinking>1471-2318</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Geriatric assessment</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Noncardiac surgery</Keyword><Keyword MajorTopicYN="N">Risk assessment</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>26</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>25</Day><Hour>23</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38918723</ArticleId><ArticleId IdType="pmc">PMC11197315</ArticleId><ArticleId IdType="doi">10.1186/s12877-024-05148-1</ArticleId><ArticleId IdType="pii">10.1186/s12877-024-05148-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nepogodiev D, Martin J, Biccard B, Makupe A, Bhangu A, Nepogodiev D, et al. Global burden of postoperative death. The Lancet. 2019;393:401. doi: 10.1016/S0140-6736(18)33139-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)33139-8</ArticleId><ArticleId IdType="pubmed">30722955</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahli Z, Shelley RM, Richard S, Jeffrey B, Sandhya LD, Mitchell TH. Preoperative Cognitive Impairment As a Predictor of Postoperative Outcomes in a Collaborative Care Model. JAGS. 2018;66:584&#x2013;589. doi: 10.1111/jgs.15261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.15261</ArticleId><ArticleId IdType="pmc">PMC5849502</ArticleId><ArticleId IdType="pubmed">29332302</ArticleId></ArticleIdList></Reference><Reference><Citation>Oresanya LB, Lyons WL, Finlayson E. Preoperative assessment of the older patient: a narrative review. JAMA. 2014;311(20):2110&#x2013;2120. doi: 10.1001/jama.2014.4573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.4573</ArticleId><ArticleId IdType="pubmed">24867014</ArticleId></ArticleIdList></Reference><Reference><Citation>Shigehiko U, John AK, Rinaldo B, Gordon SD, Hiroshi M, Stanislao M, et al. Acute Renal Failure in Critically ill Patients. JAMA. 2005;294:813&#x2013;818. doi: 10.1001/jama.294.7.813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.294.7.813</ArticleId><ArticleId IdType="pubmed">16106006</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012;81(5):442&#x2013;448. doi: 10.1038/ki.2011.379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2011.379</ArticleId><ArticleId IdType="pmc">PMC3788581</ArticleId><ArticleId IdType="pubmed">22113526</ArticleId></ArticleIdList></Reference><Reference><Citation>Bihorac A, Yavas S, Subbiah S, Hobson CE, Schold JD, Gabrielli A, et al. Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg. 2009;249(5):851&#x2013;858. doi: 10.1097/SLA.0b013e3181a40a0b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e3181a40a0b</ArticleId><ArticleId IdType="pubmed">19387314</ArticleId></ArticleIdList></Reference><Reference><Citation>Gumbert SD, Kork F, Jackson ML, Vanga N, Ghebremichael SJ, Wang CY, et al. Perioperative Acute Kidney Injury. Anesthesiology. 2020;132(1):180&#x2013;204. doi: 10.1097/ALN.0000000000002968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000002968</ArticleId><ArticleId IdType="pmc">PMC10924686</ArticleId><ArticleId IdType="pubmed">31687986</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Connor ME, Hewson RW, Kirwan CJ, Ackland GL, Pearse RM, Prowle JR. Acute kidney injury and mortality 1 year after major non-cardiac surgery. Br J Surg. 2017;104(7):868&#x2013;876. doi: 10.1002/bjs.10498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.10498</ArticleId><ArticleId IdType="pubmed">28218392</ArticleId></ArticleIdList></Reference><Reference><Citation>Steven CY, Lee HT. Acute Kidney Injury and Extrarenal Organ Dysfunction. Anesthesiology. 2012;116:1139&#x2013;1148. doi: 10.1097/ALN.0b013e31824f951b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e31824f951b</ArticleId><ArticleId IdType="pubmed">22415388</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell S, Dekker FW, Vadiveloo T, Marwick C, Deshmukh H, Donnan PT, et al. Risk of postoperative acute kidney injury in patients undergoing orthopaedic surgery&#x2013;development and validation of a risk score and effect of acute kidney injury on survival: observational cohort study. BMJ (Clinical research ed) 2015;351:h5639.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4641433</ArticleId><ArticleId IdType="pubmed">26561522</ArticleId></ArticleIdList></Reference><Reference><Citation>Duminda NW, Keyvan K, Jean YD, Vivek R, Christopher TC, John TG, et al. Derivation and Validation of a Simplified Predictive Index for Renal Replacement Therapy After Cardiac Surgery. JAMA. 2007;297:1801&#x2013;1809. doi: 10.1001/jama.297.16.1801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.297.16.1801</ArticleId><ArticleId IdType="pubmed">17456822</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JR, Cochran RP, Leavitt BJ, Dacey LJ, Ross CS, MacKenzie TA, et al. Multivariable prediction of renal insufficiency developing after cardiac surgery. Circulation. 2007;116(11 Suppl):I139&#x2013;I143.</Citation><ArticleIdList><ArticleId IdType="pubmed">17846294</ArticleId></ArticleIdList></Reference><Reference><Citation>Kate B, Veerle V, Domenico P, Moninder B, Kate T, Jonathan AS. Predictive models for kidney disease: improving global outcomes (KDIGO) defined acute kidney injury in UK cardiac surgery. Crit Care. 2014;18:606. doi: 10.1186/s13054-014-0606-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0606-x</ArticleId><ArticleId IdType="pmc">PMC4258283</ArticleId><ArticleId IdType="pubmed">25673427</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S, Cho H, Park S, Lee S, Kim K, Yoon HJ, et al. Simple Postoperative AKI Risk (SPARK) Classification before Noncardiac Surgery: A Prediction Index Development Study with External Validation. J Am Soc Nephrol. 2019;30(1):170&#x2013;181. doi: 10.1681/ASN.2018070757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2018070757</ArticleId><ArticleId IdType="pmc">PMC6317608</ArticleId><ArticleId IdType="pubmed">30563915</ArticleId></ArticleIdList></Reference><Reference><Citation>Grams ME, Sang Y, Coresh J, Ballew S, Matsushita K, Molnar MZ, et al. Acute Kidney Injury After Major Surgery: A Retrospective Analysis of Veterans Health Administration Data. Am J Kidney Dis. 2016;67(6):872&#x2013;880. doi: 10.1053/j.ajkd.2015.07.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2015.07.022</ArticleId><ArticleId IdType="pmc">PMC4775458</ArticleId><ArticleId IdType="pubmed">26337133</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Heung M, Rosenberg AL, Englesbe M, Shanks AM, et al. Development and validation of an acute kidney injury risk index for patients undergoing general surgery: Results from a national data set. Anesthesiology. 2009;110:505&#x2013;515. doi: 10.1097/ALN.0b013e3181979440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181979440</ArticleId><ArticleId IdType="pubmed">19212261</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirracchio R, Petersen ML, Carone M, Rigon MR, Chevret S, van der Laan MJ. Mortality prediction in intensive care units with the Super ICU Learner Algorithm (SICULA): a population-based study. Lancet Respir Med. 2015;3(1):42&#x2013;52. doi: 10.1016/S2213-2600(14)70239-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(14)70239-5</ArticleId><ArticleId IdType="pmc">PMC4321691</ArticleId><ArticleId IdType="pubmed">25466337</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashidi P, Bihorac A. Artificial intelligence approaches to improve kidney care. Nat Rev Nephrol. 2020;16(2):71&#x2013;72. doi: 10.1038/s41581-019-0243-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-019-0243-3</ArticleId><ArticleId IdType="pmc">PMC7591106</ArticleId><ArticleId IdType="pubmed">31873197</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei VJ, Luong T, Shan E, Chen X, Neuman MD, Eneanya ND, et al. Risk Stratification for Postoperative Acute Kidney Injury in Major Noncardiac Surgery Using Preoperative and Intraoperative Data. JAMA Netw Open. 2019;2(12):e1916921. doi: 10.1001/jamanetworkopen.2019.16921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2019.16921</ArticleId><ArticleId IdType="pmc">PMC6902769</ArticleId><ArticleId IdType="pubmed">31808922</ArticleId></ArticleIdList></Reference><Reference><Citation>Rank N, Pfahringer B, Kempfert J, Stamm C, Kuhne T, Schoenrath F, et al. Deep-learning-based real-time prediction of acute kidney injury outperforms human predictive performance. NPJ Digit Med. 2020;3:139. doi: 10.1038/s41746-020-00346-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-020-00346-8</ArticleId><ArticleId IdType="pmc">PMC7588492</ArticleId><ArticleId IdType="pubmed">33134556</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko S, Jo C, Chang CB, Lee YS, Moon YW, Youm JW, et al. A web-based machine-learning algorithm predicting postoperative acute kidney injury after total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2022;30(2):545&#x2013;554. doi: 10.1007/s00167-020-06258-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00167-020-06258-0</ArticleId><ArticleId IdType="pubmed">32880677</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q, Zhang Y, Zhang M, Li Z, Liu J. Application of Machine Learning Algorithms to Predict Acute Kidney Injury in Elderly Orthopedic Postoperative Patients. Clin Interv Aging. 2022;17:317&#x2013;330. doi: 10.2147/CIA.S349978.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S349978</ArticleId><ArticleId IdType="pmc">PMC8979591</ArticleId><ArticleId IdType="pubmed">35386749</ArticleId></ArticleIdList></Reference><Reference><Citation>Saydy N, Mazine A, Stevens LM, Jeamart H, Demers P, Page P, et al. Differences and similarities in risk factors for postoperative acute kidney injury between younger and older adults undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2018;155(1):256&#x2013;265. doi: 10.1016/j.jtcvs.2017.08.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2017.08.039</ArticleId><ArticleId IdType="pubmed">28942979</ArticleId></ArticleIdList></Reference><Reference><Citation>Alrezk R, Jackson N, Al Rezk M, Elashoff R, Weintraub N, Elashoff D, et al. Derivation and Validation of a Geriatric-Sensitive Perioperative Cardiac Risk Index. J Am Heart Assoc. 2017;6(11):1&#x2013;10. doi: 10.1161/JAHA.117.006648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.117.006648</ArticleId><ArticleId IdType="pmc">PMC5721761</ArticleId><ArticleId IdType="pubmed">29146612</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew G and Agha R for the STROCSS Group. STROCSS Strengthening the Reporting of cohort, cross-sectional and case-control studies in Surgery. Int J Surg. 2021;2021(96):106165.</Citation><ArticleIdList><ArticleId IdType="pubmed">34774726</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins GS, Moons KGM, Dhiman P, Riley RD, Beam AL, Van Calster B, et al. TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ (Clinical research ed) 2024;385:e078378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11019967</ArticleId><ArticleId IdType="pubmed">38626948</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179&#x2013;c184. doi: 10.1159/000339789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000339789</ArticleId><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Mironchyk P, Tchistiakov V. Monotone optimal binning algorithm for credit risk modeling. Financ Econ. 2017:1&#x2013;15. 10.13140/RG.2.2.31885.44003.</Citation></Reference><Reference><Citation>Saito T, Rehmsmeier M. The precision-recall plot is more informative than the ROC plot when evaluating binary classifiers on imbalanced datasets. PLoS ONE. 2015;10(3):1&#x2013;21. doi: 10.1371/journal.pone.0118432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0118432</ArticleId><ArticleId IdType="pmc">PMC4349800</ArticleId><ArticleId IdType="pubmed">25738806</ArticleId></ArticleIdList></Reference><Reference><Citation>Staffa SJ, Zurakowski D. Statistical Development and Validation of Clinical Prediction Models. Anesthesiology. 2021;135(3):396&#x2013;405. doi: 10.1097/ALN.0000000000003871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003871</ArticleId><ArticleId IdType="pubmed">34330146</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg SM, Erion G, Chen H, DeGrave A, Prutkin JM, Nair B, et al. From Local Explanations to Global Understanding with Explainable AI for Trees. Nat Mach Intell. 2020;2(1):56&#x2013;67. doi: 10.1038/s42256-019-0138-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42256-019-0138-9</ArticleId><ArticleId IdType="pmc">PMC7326367</ArticleId><ArticleId IdType="pubmed">32607472</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Z, Bo L, Xu Z, Song Y, Wang J, Wen P, et al. An explainable machine learning algorithm for risk factor analysis of in-hospital mortality in sepsis survivors with ICU readmission. Comput Methods Programs Biomed. 2021;204:106040. doi: 10.1016/j.cmpb.2021.106040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmpb.2021.106040</ArticleId><ArticleId IdType="pubmed">33780889</ArticleId></ArticleIdList></Reference><Reference><Citation>Goren O, Matot I. Perioperative acute kidney injury. Br J Anaesth. 2015;115:ii3&#x2013;ii14. doi: 10.1093/bja/aev380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aev380</ArticleId><ArticleId IdType="pubmed">26658199</ArticleId></ArticleIdList></Reference><Reference><Citation>Spahillari A, Parikh CR, Sint K, Koyner JL, Patel UD, Edelstein CL, et al. Serum Cystatin C&#x2013; Versus Creatinine-Based Definitions of Acute Kidney Injury Following Cardiac Surgery: A Prospective Cohort Study. Am J Kidney Dis. 2012;60(6):922&#x2013;929. doi: 10.1053/j.ajkd.2012.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2012.06.002</ArticleId><ArticleId IdType="pmc">PMC3496012</ArticleId><ArticleId IdType="pubmed">22809763</ArticleId></ArticleIdList></Reference><Reference><Citation>Shlipak MG, Matsushita K, &#xc4;rnl&#xf6;v J, Inker LA, Katz R, Polkinghorne KR, et al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med. 2013;369(10):932&#x2013;943. doi: 10.1056/NEJMoa1214234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1214234</ArticleId><ArticleId IdType="pmc">PMC3993094</ArticleId><ArticleId IdType="pubmed">24004120</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Yang B, Liu M, You T, Shen H, Chen Y, et al. Serum cystatin C is a potential predictor of short-term mortality and acute kidney injury in acute aortic dissection patients: a retrospective cohort study. J Thorac Dis. 2022;14(8):2977&#x2013;2986. doi: 10.21037/jtd-22-937.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd-22-937</ArticleId><ArticleId IdType="pmc">PMC9442520</ArticleId><ArticleId IdType="pubmed">36071756</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudasill SE, Liu J, Kamath AF. Revisiting the International Normalized Ratio (INR) Threshold for Complications in Primary Total Knee Arthroplasty: An Analysis of 21,239 Cases. J Bone Joint Surg Am. 2019;101(6):514&#x2013;522. doi: 10.2106/JBJS.18.00771.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.18.00771</ArticleId><ArticleId IdType="pubmed">30893232</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo M, Gao Y, Wang L, Zhang H, Liu X, Zhang H. Early Acute Kidney Injury Associated with Liver Transplantation: A Retrospective Case-Control Study. Med Sci Monit. 2020;26:e923864. doi: 10.12659/MSM.923864.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.923864</ArticleId><ArticleId IdType="pmc">PMC7387046</ArticleId><ArticleId IdType="pubmed">32681793</ArticleId></ArticleIdList></Reference><Reference><Citation>Duchnowski P, Hryniewiecki T, Ku&#x15b;mierczyk M, Szyma&#x144;ski P. Anisocytosis predicts postoperative renal replacement therapy in patients undergoing heart valve surgery. Cardiol J. 2020;27(4):362&#x2013;367. doi: 10.5603/CJ.a2019.0020.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/CJ.a2019.0020</ArticleId><ArticleId IdType="pmc">PMC8016011</ArticleId><ArticleId IdType="pubmed">30799549</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan DXH, Sim YE, Chan YH, Poopalalingam R, Abdullah HR. Development of the Combined Assessment of Risk Encountered in Surgery (CARES) surgical risk calculator for prediction of postsurgical mortality and need for intensive care unit admission risk: a single-center retrospective study. BMJ Open. 2018;8(3):e019427. doi: 10.1136/bmjopen-2017-019427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-019427</ArticleId><ArticleId IdType="pmc">PMC5875658</ArticleId><ArticleId IdType="pubmed">29574442</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalfino L, Tullo L, Donadio I, Malcangi V, Brienza N. Intra-abdominal hypertension and acute renal failure in critically ill patients. Intensive Care Med. 2008;34(4):707&#x2013;713. doi: 10.1007/s00134-007-0969-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-007-0969-4</ArticleId><ArticleId IdType="pubmed">18157662</ArticleId></ArticleIdList></Reference><Reference><Citation>Demarchi AC, de Almeida CT, Ponce D, e Castro MC, Danaga AR, Yamaguti FA, et al. Intra-abdominal pressure as a predictor of acute kidney injury in postoperative abdominal surgery. Ren Fail. 2014;36(4):557&#x2013;61. doi: 10.3109/0886022X.2013.876353.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/0886022X.2013.876353</ArticleId><ArticleId IdType="pubmed">24456177</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol. 2017;13(11):697&#x2013;711. doi: 10.1038/nrneph.2017.119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2017.119</ArticleId><ArticleId IdType="pubmed">28869251</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimoto M, Murashima M, Kokubu M, Matsui M, Eriguchi M, Samejima K-I, et al. Pre-operative proteinuria and post-operative acute kidney injury in noncardiac surgery: the NARA-Acute Kidney Injury cohort study. Nephrol Dial Transplant. 2020;35(12):2111&#x2013;2116. doi: 10.1093/ndt/gfz269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfz269</ArticleId><ArticleId IdType="pubmed">31891400</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkins J, Mpody C, Corridore M, Cambier G, Tobias JD, Nafiu OO. Risk Factors and Consequences of Acute Kidney Injury After Noncardiac Surgery in Children. Anesth Analg. 2022;135(3):625&#x2013;632. doi: 10.1213/ANE.0000000000005901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005901</ArticleId><ArticleId IdType="pubmed">35086116</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22866958</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>21</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>4</Issue><PubDate><Year>2012</Year><Month>Aug</Month><Day>07</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Clinical review: Volume of fluid resuscitation and the incidence of acute kidney injury - a systematic review.</ArticleTitle><Pagination><StartPage>230</StartPage><MedlinePgn>230</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/cc11345</ELocationID><Abstract><AbstractText>Intravenous fluids are widely administered to maintain renal perfusion and prevent acute kidney injury (AKI). However, fluid overload is of concern during AKI. Using the Pubmed database (up to October 2011) we identified all randomised controlled studies of goal-directed therapy (GDT)-based fluid resuscitation (FR) reporting renal outcomes and documenting fluid given during perioperative care. In 24 perioperative studies, GDT was associated with decreased risk of postoperative AKI (odds ratio (OR) = 0.59, 95% confidence interval (CI) = 0.39 to 0.89) but additional fluid given was limited (median: 555 ml). Moreover, the decrease in AKI was greatest (OR = 0.47, 95% CI = 0.29 to 0.76) in the 10 studies where FR was the same between GDT and control groups. Inotropic drug use in GDT patients was associated with decreased AKI (OR = 0.52, 95% CI = 0.34 to 0.80, P = 0.003), whereas studies not involving inotropic drugs found no effect (OR = 0.75, 95% CI = 0.37 to 1.53, P = 0.43). The greatest protection from AKI occurred in patients with no difference in total fluid delivery and use of inotropes (OR = 0.46, 95% CI = 0.27 to 0.76, P = 0.0036). GDT-based FR may decrease AKI in surgical patients; however, this effect requires little overall FR and appears most effective when supported by inotropic drugs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prowle</LastName><ForeName>John R</ForeName><Initials>JR</Initials></Author><Author ValidYN="Y"><LastName>Chua</LastName><ForeName>Horng-Ruey</ForeName><Initials>HR</Initials></Author><Author ValidYN="Y"><LastName>Bagshaw</LastName><ForeName>Sean M</ForeName><Initials>SM</Initials></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>08</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>8</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22866958</ArticleId><ArticleId IdType="pmc">PMC3580679</ArticleId><ArticleId IdType="doi">10.1186/cc11345</ArticleId><ArticleId IdType="pii">cc11345</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16:3365&#x2013;3370. doi: 10.1681/ASN.2004090740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2004090740</ArticleId><ArticleId IdType="pubmed">16177006</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C. Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294:813&#x2013;818. doi: 10.1001/jama.294.7.813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.294.7.813</ArticleId><ArticleId IdType="pubmed">16106006</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahbari NN, Zimmermann JB, Schmidt T, Koch M, Weigand MA, Weitz J. Meta-analysis of standard, restrictive and supplemental fluid administration in colorectal surgery. Br J Surg. 2009;96:331&#x2013;341. doi: 10.1002/bjs.6552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.6552</ArticleId><ArticleId IdType="pubmed">19283742</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandstrup B, T&#xf8;nnesen H, Beier-Holgersen R, Hjorts&#xf8; E, &#xd8;rding H, Lindorff-Larsen K, Rasmussen MS, Lanng C, Wallin L, Iversen LH, Gramkow CS, Okholm M, Blemmer T, Svendsen P-E, Rottensten HH, Thage B, Riis J, Jeppesen IS, Teilum D, Christensen AM, Graungaard B, Pott F. Danish Study Group on Perioperative Fluid Therapy. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial. Ann Surg. 2003;238:641&#x2013;648. doi: 10.1097/01.sla.0000094387.50865.23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.sla.0000094387.50865.23</ArticleId><ArticleId IdType="pmc">PMC1356139</ArticleId><ArticleId IdType="pubmed">14578723</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Echeverri JE, Ligabo EV, Ronco C, Bellomo R. Fluid balance and acute kidney injury. Nat Rev Nephrol. 2010;6:107&#x2013;115. doi: 10.1038/nrneph.2009.213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2009.213</ArticleId><ArticleId IdType="pubmed">20027192</ArticleId></ArticleIdList></Reference><Reference><Citation>Payen D, de Pont AC, Sakr Y, Spies C, Reinhart K, Vincent JL. Sepsis Occurrence in Acutely Ill Patients Investigators. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care. 2008;12:R74. doi: 10.1186/cc6916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc6916</ArticleId><ArticleId IdType="pmc">PMC2481469</ArticleId><ArticleId IdType="pubmed">18533029</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouchard J, Soroko SB, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 2009;76:422&#x2013;427. doi: 10.1038/ki.2009.159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2009.159</ArticleId><ArticleId IdType="pubmed">19436332</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalfino L, Giglio MT, Puntillo F, Marucci M, Brienza N. Haemodynamic goal-directed therapy and postoperative infections: earlier is better. a systematic review and meta-analysis. Crit Care. 2011;15:R154. doi: 10.1186/cc10284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10284</ArticleId><ArticleId IdType="pmc">PMC3219028</ArticleId><ArticleId IdType="pubmed">21702945</ArticleId></ArticleIdList></Reference><Reference><Citation>Giglio MT, Marucci M, Testini M, Brienza N. Goal-directed haemodynamic therapy and gastrointestinal complications in major surgery: a meta-analysis of randomized controlled trials. Br J Anaesth. 2009;103:637&#x2013;646. doi: 10.1093/bja/aep279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aep279</ArticleId><ArticleId IdType="pubmed">19837807</ArticleId></ArticleIdList></Reference><Reference><Citation>Brienza N, Giglio MT, Marucci M, Fiore T. Does perioperative hemodynamic optimization protect renal function in surgical patients? A meta-analytic study. Crit Care Med. 2009;37:2079&#x2013;2090. doi: 10.1097/CCM.0b013e3181a00a43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181a00a43</ArticleId><ArticleId IdType="pubmed">19384211</ArticleId></ArticleIdList></Reference><Reference><Citation>Editors-in-Chief Statement Regarding Published Clinical Trials Conducted without IRB Approval by Joachim Boldt. http://www.bja.ac.uk/wp-content/uploads/2011/02/EIC-Joint-Statement-on-Retractions.4Mar2011.pdf</Citation><ArticleIdList><ArticleId IdType="pubmed">21540815</ArticleId></ArticleIdList></Reference><Reference><Citation>Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1&#x2013;12. doi: 10.1016/0197-2456(95)00134-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(95)00134-4</ArticleId><ArticleId IdType="pubmed">8721797</ArticleId></ArticleIdList></Reference><Reference><Citation>R: A language and environment for statistical computing. http://www.r-project.org/</Citation></Reference><Reference><Citation>Fletcher J. What is heterogeneity and is it important? BMJ. 2007;334:94&#x2013;96. doi: 10.1136/bmj.39057.406644.68.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39057.406644.68</ArticleId><ArticleId IdType="pmc">PMC1767262</ArticleId><ArticleId IdType="pubmed">17218716</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539&#x2013;1558. doi: 10.1002/sim.1186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557&#x2013;560. doi: 10.1136/bmj.327.7414.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeks JJ, Higgins JPT, Altman DG.  In: Cochrane Handbook for Systematic Reviews of Interventions. Version 5-1-0. Higgins JPT, Green S, editor. London: The Cochrane Collaboration; 2011. 9.5.2 Identifying and measuring heterogeneity.http://www.cochrane-handbook.org</Citation></Reference><Reference><Citation>Galbraith RF. A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med. 1988;7:889&#x2013;894. doi: 10.1002/sim.4780070807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.4780070807</ArticleId><ArticleId IdType="pubmed">3413368</ArticleId></ArticleIdList></Reference><Reference><Citation>Deville WL, Buntinx F, Bouter LM, Montori VM, de Vet HC, van der Windt DA, Bezemer PD. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol. 2002;2:9. doi: 10.1186/1471-2288-2-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-2-9</ArticleId><ArticleId IdType="pmc">PMC117243</ArticleId><ArticleId IdType="pubmed">12097142</ArticleId></ArticleIdList></Reference><Reference><Citation>Bender JS, Smith-Meek MA, Jones CE. Routine pulmonary artery catheterization does not reduce morbidity and mortality of elective vascular surgery: results of a prospective, randomized trial. Ann Surg. 1997;226:229&#x2013;236. doi: 10.1097/00000658-199709000-00002. discussion 236-237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-199709000-00002</ArticleId><ArticleId IdType="pmc">PMC1191013</ArticleId><ArticleId IdType="pubmed">9339929</ArticleId></ArticleIdList></Reference><Reference><Citation>Benes J, Chytra I, Altmann P, Hluchy M, Kasal E, Svitak R, Pradl R, Stepan M. Intraoperative fluid optimization using stroke volume variation in high risk surgical patients: results of prospective randomized study. Crit Care. 2010;14:R118. doi: 10.1186/cc9070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9070</ArticleId><ArticleId IdType="pmc">PMC2911766</ArticleId><ArticleId IdType="pubmed">20553586</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishop MH, Shoemaker WC, Appel PL, Meade P, Ordog GJ, Wasserberger J, Wo CJ, Rimle DA, Kram HB, Umali R. et al.Prospective, randomized trial of survivor values of cardiac index, oxygen delivery, and oxygen consumption as resuscitation endpoints in severe trauma. J Trauma. 1995;38:780&#x2013;787. doi: 10.1097/00005373-199505000-00018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-199505000-00018</ArticleId><ArticleId IdType="pubmed">7760409</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonazzi M, Gentile F, Biasi GM, Migliavacca S, Esposti D, Cipolla M, Marsicano M, Prampolini F, Ornaghi M, Sternjakob S, Tshomba Y. Impact of perioperative haemodynamic monitoring on cardiac morbidity after major vascular surgery in low risk patients. A randomised pilot trial. Eur J Vasc Endovasc Surg. 2002;23:445&#x2013;451. doi: 10.1053/ejvs.2002.1617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/ejvs.2002.1617</ArticleId><ArticleId IdType="pubmed">12027474</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecconi M, Fasano N, Langiano N, Divella M, Costa MG, Rhodes A, Della Rocca G. Goal-directed haemodynamic therapy during elective total hip arthroplasty under regional anaesthesia. Crit Care. 2011;15:R132. doi: 10.1186/cc10246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10246</ArticleId><ArticleId IdType="pmc">PMC3218998</ArticleId><ArticleId IdType="pubmed">21624138</ArticleId></ArticleIdList></Reference><Reference><Citation>Challand C, Struthers R, Sneyd JR, Erasmus PD, Mellor N, Hosie KB, Minto G. Randomized controlled trial of intraoperative goal-directed fluid therapy in aerobically fit and unfit patients having major colorectal surgery. Br J Anaesth. 2012;108:53&#x2013;62. doi: 10.1093/bja/aer273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aer273</ArticleId><ArticleId IdType="pubmed">21873370</ArticleId></ArticleIdList></Reference><Reference><Citation>Chytra I, Pradl R, Bosman R, Pelnar P, Kasal E, Zidkova A. Esophageal Doppler-guided fluid management decreases blood lactate levels in multiple-trauma patients: a randomized controlled trial. Crit Care. 2007;11:R24. doi: 10.1186/cc5703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc5703</ArticleId><ArticleId IdType="pmc">PMC2151901</ArticleId><ArticleId IdType="pubmed">17313691</ArticleId></ArticleIdList></Reference><Reference><Citation>Donati A, Loggi S, Preiser JC, Orsetti G, Munch C, Gabbanelli V, Pelaia P, Pietropaoli P. Goal-directed intraoperative therapy reduces morbidity and length of hospital stay in high-risk surgical patients. Chest. 2007;132:1817&#x2013;1824. doi: 10.1378/chest.07-0621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.07-0621</ArticleId><ArticleId IdType="pubmed">17925428</ArticleId></ArticleIdList></Reference><Reference><Citation>Forget P, Lois F, de Kock M. Goal-directed fluid management based on the pulse oximeter-derived pleth variability index reduces lactate levels and improves fluid management. Anesth Analg. 2010;111:910&#x2013;914.</Citation><ArticleIdList><ArticleId IdType="pubmed">20705785</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan TJ, Soppitt A, Maroof M, el-Moalem H, Robertson KM, Moretti E, Dwane P, Glass PS. Goal-directed intraoperative fluid administration reduces length of hospital stay after major surgery. Anesthesiology. 2002;97:820&#x2013;826. doi: 10.1097/00000542-200210000-00012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200210000-00012</ArticleId><ArticleId IdType="pubmed">12357146</ArticleId></ArticleIdList></Reference><Reference><Citation>Harten J, Crozier JE, McCreath B, Hay A, McMillan DC, McArdle CS, Kinsella J. Effect of intraoperative fluid optimisation on renal function in patients undergoing emergency abdominal surgery: a randomised controlled pilot study (ISRCTN 11799696) Int J Surg. 2008;6:197&#x2013;204. doi: 10.1016/j.ijsu.2008.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2008.03.002</ArticleId><ArticleId IdType="pubmed">18424200</ArticleId></ArticleIdList></Reference><Reference><Citation>Jhanji S, Vivian-Smith A, Lucena-Amaro S, Watson D, Hinds CJ, Pearse RM. Haemodynamic optimisation improves tissue microvascular flow and oxygenation after major surgery: a randomised controlled trial. Crit Care. 2010;14:R151. doi: 10.1186/cc9220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9220</ArticleId><ArticleId IdType="pmc">PMC2945135</ArticleId><ArticleId IdType="pubmed">20698956</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapoor PM, Kakani M, Chowdhury U, Choudhury M, Kiran U. Early goal-directed therapy in moderate to high-risk cardiac surgery patients. Ann Card Anaesth. 2008;11:27&#x2013;34. doi: 10.4103/0971-9784.38446.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0971-9784.38446</ArticleId><ArticleId IdType="pubmed">18182756</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobo SM, Salgado PF, Castillo VG, Borim AA, Polachini CA, Palchetti JC, Brienzi SL, de Oliveira GG. Effects of maximizing oxygen delivery on morbidity and mortality in high-risk surgical patients. Crit Care Med. 2000;28:3396&#x2013;3404. doi: 10.1097/00003246-200010000-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200010000-00003</ArticleId><ArticleId IdType="pubmed">11057792</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes MR, Oliveira MA, Pereira VO, Lemos IP, Auler JO, Michard F. Goal-directed fluid management based on pulse pressure variation monitoring during high-risk surgery: a pilot randomized controlled trial. Crit Care. 2007;11:R100. doi: 10.1186/cc6117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc6117</ArticleId><ArticleId IdType="pmc">PMC2556743</ArticleId><ArticleId IdType="pubmed">17822565</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer J, Boldt J, Mengistu AM, Rohm KD, Suttner S. Goal-directed intraoperative therapy based on autocalibrated arterial pressure waveform analysis reduces hospital stay in high-risk surgical patients: a randomized, controlled trial. Crit Care. 2010;14:R18. doi: 10.1186/cc8875.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc8875</ArticleId><ArticleId IdType="pmc">PMC2875533</ArticleId><ArticleId IdType="pubmed">20156348</ArticleId></ArticleIdList></Reference><Reference><Citation>McKendry M, McGloin H, Saberi D, Caudwell L, Brady AR, Singer M. Randomised controlled trial assessing the impact of a nurse delivered, flow monitored protocol for optimisation of circulatory status after cardiac surgery. BMJ. 2004;329:258&#x2013;261. doi: 10.1136/bmj.38156.767118.7C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38156.767118.7C</ArticleId><ArticleId IdType="pmc">PMC498021</ArticleId><ArticleId IdType="pubmed">15242867</ArticleId></ArticleIdList></Reference><Reference><Citation>Noblett SE, Snowden CP, Shenton BK, Horgan AF. Randomized clinical trial assessing the effect of Doppler-optimized fluid management on outcome after elective colorectal resection. Br J Surg. 2006;93:1069&#x2013;1076. doi: 10.1002/bjs.5454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.5454</ArticleId><ArticleId IdType="pubmed">16888706</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearse R, Dawson D, Fawcett J, Rhodes A, Grounds RM, Bennett ED. Early goal-directed therapy after major surgery reduces complications and duration of hospital stay. A randomised, controlled trial [ISRCTN38797445] Crit Care. 2005;9:R687&#x2013;R693. doi: 10.1186/cc3887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc3887</ArticleId><ArticleId IdType="pmc">PMC1414018</ArticleId><ArticleId IdType="pubmed">16356219</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xf6;l&#xf6;nen P, Ruokonen E, Hippelainen M, Poyhonen M, Takala J. A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients. Anesth Analg. 2000;90:1052&#x2013;1059. doi: 10.1097/00000539-200005000-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-200005000-00010</ArticleId><ArticleId IdType="pubmed">10781452</ArticleId></ArticleIdList></Reference><Reference><Citation>Valentine RJ, Duke ML, Inman MH, Grayburn PA, Hagino RT, Kakish HB, Clagett GP. Effectiveness of pulmonary artery catheters in aortic surgery: a randomized trial. J Vasc Surg. 1998;27:203&#x2013;211. doi: 10.1016/S0741-5214(98)70351-9. discussion 211-212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0741-5214(98)70351-9</ArticleId><ArticleId IdType="pubmed">9510275</ArticleId></ArticleIdList></Reference><Reference><Citation>Venn R, Steele A, Richardson P, Poloniecki J, Grounds M, Newman P. Randomized controlled trial to investigate influence of the fluid challenge on duration of hospital stay and perioperative morbidity in patients with hip fractures. Br J Anaesth. 2002;88:65&#x2013;71. doi: 10.1093/bja/88.1.65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/88.1.65</ArticleId><ArticleId IdType="pubmed">11881887</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakeling HG, McFall MR, Jenkins CS, Woods WG, Miles WF, Barclay GR, Fleming SC. Intraoperative oesophageal Doppler guided fluid management shortens postoperative hospital stay after major bowel surgery. Br J Anaesth. 2005;95:634&#x2013;642. doi: 10.1093/bja/aei223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aei223</ArticleId><ArticleId IdType="pubmed">16155038</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson J, Woods I, Fawcett J, Whall R, Dibb W, Morris C, McManus E. Reducing the risk of major elective surgery: randomised controlled trial of preoperative optimisation of oxygen delivery. BMJ. 1999;318:1099&#x2013;1103. doi: 10.1136/bmj.318.7191.1099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.318.7191.1099</ArticleId><ArticleId IdType="pmc">PMC27840</ArticleId><ArticleId IdType="pubmed">10213716</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Constantin JM, Petit A, Chanques G, Kwiatkowski F, Flamein R, Slim K, Sapin V, Jaber S, Bazin JE. Conservative vs restrictive individualized goal-directed fluid replacement strategy in major abdominal surgery: a prospective randomized trial. Arch Surg. 2010;145:1193&#x2013;1200. doi: 10.1001/archsurg.2010.275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.2010.275</ArticleId><ArticleId IdType="pubmed">21173294</ArticleId></ArticleIdList></Reference><Reference><Citation>Jammer I, Ulvik A, Erichsen C, Lodemel O, Ostgaard G. Does central venous oxygen saturation-directed fluid therapy affect postoperative morbidity after colorectal surgery? A randomized assessor-blinded controlled trial. Anesthesiology. 2010;113:1072&#x2013;1080. doi: 10.1097/ALN.0b013e3181f79337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181f79337</ArticleId><ArticleId IdType="pubmed">20885291</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobo SM, Ronchi LS, Oliveira NE, Brandao PG, Froes A, Cunrath GS, Nishiyama KG, Netinho JG, Lobo FR. Restrictive strategy of intraoperative fluid maintenance during optimization of oxygen delivery decreases major complications after high-risk surgery. Crit Care. 2011;15:R226. doi: 10.1186/cc10466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10466</ArticleId><ArticleId IdType="pmc">PMC3334772</ArticleId><ArticleId IdType="pubmed">21943111</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med. 2004;351:159&#x2013;169. doi: 10.1056/NEJMra032401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra032401</ArticleId><ArticleId IdType="pubmed">15247356</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipcsey M, Bellomo R. Septic acute kidney injury: hemodynamic syndrome, inflammatory disorder, or both? Crit Care. 2011;15:1008. doi: 10.1186/cc10525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10525</ArticleId><ArticleId IdType="pmc">PMC3388644</ArticleId><ArticleId IdType="pubmed">22112533</ArticleId></ArticleIdList></Reference><Reference><Citation>Langenberg C, Bellomo R, May C, Wan L, Egi M, Morgera S. Renal blood flow in sepsis. Crit Care. 2005;9:R363&#x2013;R374. doi: 10.1186/cc3540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc3540</ArticleId><ArticleId IdType="pmc">PMC1269441</ArticleId><ArticleId IdType="pubmed">16137349</ArticleId></ArticleIdList></Reference><Reference><Citation>Saotome T, Ishikawa K, May CN, Birchall IE, Bellomo R. The impact of experimental hypoperfusion on subsequent kidney function. Intensive Care Med. 2010;36:533&#x2013;540. doi: 10.1007/s00134-009-1740-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-009-1740-9</ArticleId><ArticleId IdType="pubmed">20049587</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua HR, Glassford N, Bellomo R. Acute kidney injury after cardiac arrest. Resuscitation. 2012;83:721&#x2013;727. doi: 10.1016/j.resuscitation.2011.11.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2011.11.030</ArticleId><ArticleId IdType="pubmed">22155699</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan L, Bellomo R, May CN. A comparison of 4% succinylated gelatin solution versus normal saline in stable normovolaemic sheep: global haemodynamic, regional blood flow and oxygen delivery effects. Anaesth Intensive Care. 2007;35:924&#x2013;931.</Citation><ArticleIdList><ArticleId IdType="pubmed">18084984</ArticleId></ArticleIdList></Reference><Reference><Citation>Legrand M, Mik EG, Balestra GM, Lutter R, Pirracchio R, Payen D, Ince C. Fluid resuscitation does not improve renal oxygenation during hemorrhagic shock in rats. Anesthesiology. 2010;112:119&#x2013;127. doi: 10.1097/ALN.0b013e3181c4a5e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181c4a5e2</ArticleId><ArticleId IdType="pubmed">19996951</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyson A, Bezemer R, Legrand M, Balestra G, Singer M, Ince C. Microvascular and interstitial oxygen tension in the renal cortex and medulla studied in a 4-h rat model of LPS-induced endotoxemia. Shock. 2011;36:83&#x2013;89. doi: 10.1097/SHK.0b013e3182169d5a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e3182169d5a</ArticleId><ArticleId IdType="pubmed">21368713</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen HH, Ibels LS. Acute renal failure. Multivariate analysis of causes and risk factors. Am J Med. 1982;73:211&#x2013;218. doi: 10.1016/0002-9343(82)90181-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(82)90181-4</ArticleId><ArticleId IdType="pubmed">7114078</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YL, Prowle J, Licari E, Uchino S, Bellomo R. Changes in blood pressure before the development of nosocomial acute kidney injury. Nephrol Dial Transplant. 2009;24:504&#x2013;511.</Citation><ArticleIdList><ArticleId IdType="pubmed">18768582</ArticleId></ArticleIdList></Reference><Reference><Citation>Badin J, Boulain T, Ehrmann S, Skarzynski M, Bretagnol A, Buret J, Benzekri-Lefevre D, Mercier E, Runge I, Garot D, Mathonnet A, Dequin PF, Perrotin D. Relation between mean arterial pressure and renal function in the early phase of shock: a prospective, explorative cohort study. Crit Care. 2011;15:R135. doi: 10.1186/cc10253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10253</ArticleId><ArticleId IdType="pmc">PMC3219004</ArticleId><ArticleId IdType="pubmed">21645384</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles PS, Bellomo R. A pivotal trial of fluid therapy for major abdominal surgery: need and equipoise. Crit Care Resusc. 2011;13:278&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pubmed">22129291</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrler T, Tischer A, Meyer A, Feiler S, Guba M, Nowak S, Rentsch M, Bartenstein P, Hacker M, Jauch KW. The intrinsic renal compartment syndrome: new perspectives in kidney transplantation. Transplantation. 2010;89:40&#x2013;46. doi: 10.1097/TP.0b013e3181c40aba.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0b013e3181c40aba</ArticleId><ArticleId IdType="pubmed">20061917</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu KD, Thompson BT, Ancukiewicz M, Steingrub JS, Douglas IS, Matthay MA, Wright P, Peterson MW, Rock P, Hyzy RC, Anzueto A, Truwit JD. Acute kidney injury in patients with acute lung injury: impact of fluid accumulation on classification of acute kidney injury and associated outcomes. Crit Care Med. 2011;39:2665&#x2013;2671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3220741</ArticleId><ArticleId IdType="pubmed">21785346</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearse RM, Belsey JD, Cole JN, Bennett ED. Effect of dopexamine infusion on mortality following major surgery: individual patient data meta-regression analysis of published clinical trials. Crit Care Med. 2008;36:1323&#x2013;1329. doi: 10.1097/CCM.0b013e31816a091b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31816a091b</ArticleId><ArticleId IdType="pubmed">18379261</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A, Fumagalli R. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med. 1995;333:1025&#x2013;1032. doi: 10.1056/NEJM199510193331601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199510193331601</ArticleId><ArticleId IdType="pubmed">7675044</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds CJ, Watson D. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med. 1994;330:1717&#x2013;1722. doi: 10.1056/NEJM199406163302404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199406163302404</ArticleId><ArticleId IdType="pubmed">7993413</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368&#x2013;1377. doi: 10.1056/NEJMoa010307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa010307</ArticleId><ArticleId IdType="pubmed">11794169</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin SM, Huang CD, Lin HC, Liu CY, Wang CH, Kuo HP. A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: a randomized controlled trial. Shock. 2006;26:551&#x2013;557. doi: 10.1097/01.shk.0000232271.09440.8f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.shk.0000232271.09440.8f</ArticleId><ArticleId IdType="pubmed">17117128</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira CF, de Oliveira DS, Gottschald AF, Moura JD, Costa GA, Ventura AC, Fernandes JC, Vaz FA, Carcillo JA, Rivers EP, Troster EJ. ACCM/PALS haemodynamic support guidelines for paediatric septic shock: an outcomes comparison with and without monitoring central venous oxygen saturation. Intensive Care Med. 2008;34:1065&#x2013;1075. doi: 10.1007/s00134-008-1085-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-008-1085-9</ArticleId><ArticleId IdType="pubmed">18369591</ArticleId></ArticleIdList></Reference><Reference><Citation>Maitland K, Kiguli S, Opoka RO, Engoru C, Olupot-Olupot P, Akech SO, Nyeko R, Mtove G, Reyburn H, Lang T, Brent B, Evans JA, Tibenderana JK, Crawley J, Russell EC, Levin M, Babiker AG, Gibb DM. Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011;364:2483&#x2013;2495. doi: 10.1056/NEJMoa1101549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1101549</ArticleId><ArticleId IdType="pubmed">21615299</ArticleId></ArticleIdList></Reference><Reference><Citation>Scandinavian Starch for Severe Sepsis/Septic Shock Trial (6S) - NCT00962156. http://clinicaltrials.gov/ct2/show/NCT00962156</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3040153</ArticleId><ArticleId IdType="pubmed">21269526</ArticleId></ArticleIdList></Reference><Reference><Citation>Crystalloid Versus Hydroxyethyl Starch Trials (CHEST) - NCT00935168. http://clinicaltrials.gov/ct2/show/NCT00935168</Citation></Reference><Reference><Citation>Protocolized Care for Early Septic Shock (ProCESS) - NCT00510835. http://clinicaltrials.gov/ct2/show/NCT00510835</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4081520</ArticleId><ArticleId IdType="pubmed">24289512</ArticleId></ArticleIdList></Reference><Reference><Citation>Australasian Resuscitation in Sepsis Evaluation Randomised Controlled Trial (ARISE) - NCT00975793. http://clinicaltrials.gov/ct2/show/NCT00975793</Citation></Reference><Reference><Citation>A multicentre, randomised controlled trial of the clinical and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shock (ProMISe) - ISRCTN36307479. http://www.controlled-trials.com/ISRCTN36307479</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4781482</ArticleId><ArticleId IdType="pubmed">26597979</ArticleId></ArticleIdList></Reference><Reference><Citation>Optimisation of peri-operative cardiovascular management to improve surgical outcome (OPTIMISE) - ISRCTN04386758. http://www.controlled-trials.com/ISRCTN04386758/pearse</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35014001</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1496-8975</ISSN><JournalIssue CitedMedium="Internet"><Volume>69</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Canadian journal of anaesthesia = Journal canadien d'anesthesie</Title><ISOAbbreviation>Can J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Morbidity and mortality in patients managed with high compared with low blood pressure targets during on-pump cardiac surgery: a systematic review and meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>374</StartPage><EndPage>386</EndPage><MedlinePgn>374-386</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12630-021-02171-3</ELocationID><Abstract><AbstractText Label="PURPOSE">Many believe that blood pressure management during cardiac surgery is associated with postoperative outcomes. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) to determine the impact of high compared with low intraoperative blood pressure targets on postoperative morbidity and mortality in adults undergoing cardiac surgery on cardiopulmonary bypass (CPB). Our primary objective was to inform the design of a future large RCT.</AbstractText><AbstractText Label="SOURCE">We searched MEDLINE, EMBASE, Web of Science, CINAHL, and CENTRAL for RCTs comparing high with low intraoperative blood pressure targets in adult patients undergoing any cardiac surgical procedure on CPB. We screened reference lists, grey literature, and conference proceedings.</AbstractText><AbstractText Label="PRINCIPAL FINDINGS">We included eight RCTs (N =1,116 participants); all examined the effect of blood pressure management only during the CPB. Trial definitions of high compared with low blood pressure varied and, in some, there was a discrepancy between the target and achieved mean arterial pressure. We observed no difference in delirium, cognitive decline, stroke, acute kidney injury, or mortality between high and low blood pressure targets (very-low to low quality evidence). Higher blood pressure targets may have increased the risk of requiring a blood transfusion (three trials; n = 456 participants; relative risk, 1.4; 95% confidence interval, 1.1 to 1.9; P = 0.01; moderate quality evidence) but this finding was based on a small number of trials.</AbstractText><AbstractText Label="CONCLUSION">Individual trial definitions of high and low blood pressure targets varied, limiting inferences. The effect of high (compared with low) blood pressure targets on other morbidity and mortality after cardiac surgery remains unclear because of limitations with the body of existing evidence. Research to determine the optimal management of blood pressure during cardiac surgery is required.</AbstractText><AbstractText Label="STUDY REGISTRATION">PROSPERO (CRD42020177376); registered: 5 July 2020.</AbstractText><CopyrightInformation>&#xa9; 2022. Canadian Anesthesiologists' Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McEwen</LastName><ForeName>Charlotte C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Surgery (Cardiac Surgery), McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amir</LastName><ForeName>Takhliq</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Jack</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Health Sciences Library, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kennedy</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evaluation, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grocott</LastName><ForeName>Hilary P</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kashani</LastName><ForeName>Hessam</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazer</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brudney</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Critical Care) and Anesthesia and Perioperative Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kavosh</LastName><ForeName>Morvarid</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobsohn</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Critical Care) and Anesthesia and Perioperative Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vedel</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anesthesiology, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Eugene</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitlock</LastName><ForeName>Richard P</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Departments of Surgery (Cardiac Surgery) and Health Research Methods, Evaluation, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Perioperative Research Division, Population Health Research Institute, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belley-Cot&#xe9;</LastName><ForeName>Emilie P</ForeName><Initials>EP</Initials><AffiliationInfo><Affiliation>Perioperative Research Division, Population Health Research Institute, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Medicine (Cardiology and Critical Care) and Health Research Methods, Evaluation, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spence</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1267-9455</Identifier><AffiliationInfo><Affiliation>Perioperative Research Division, Population Health Research Institute, Hamilton, ON, Canada. jessicaspence13@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Anesthesia and Critical Care and Health Research Methods, Evaluation, and Impact, McMaster University, Hamilton, ON, Canada. jessicaspence13@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><VernacularTitle>Morbidit&#xe9; et mortalit&#xe9; des patients pris en charge avec des cibles &#xe9;lev&#xe9;es ou basses de pression art&#xe9;rielle pendant la chirurgie cardiaque sous circulation extracorporelle&#xa0;: une revue syst&#xe9;matique et une m&#xe9;ta-analyse d&#x2019;&#xe9;tudes randomis&#xe9;es contr&#xf4;l&#xe9;es.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Can J Anaesth</MedlineTA><NlmUniqueID>8701709</NlmUniqueID><ISSNLinking>0832-610X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Can J Anaesth. 2022 Jun;69(6):799-800. doi: 10.1007/s12630-022-02205-4.</RefSource><PMID Version="1">35165836</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009017" MajorTopicYN="N">Morbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="fre"><AbstractText Label="UNLABELLED">R&#xe9;SUM&#xe9;: OBJECTIF: Pour beaucoup, la prise en charge de la pression art&#xe9;rielle pendant la chirurgie cardiaque serait associ&#xe9;e aux issues postop&#xe9;ratoires. Nous avons r&#xe9;alis&#xe9; une revue syst&#xe9;matique et une m&#xe9;ta-analyse d&#x2019;&#xe9;tudes randomis&#xe9;es contr&#xf4;l&#xe9;es (ERC) afin de d&#xe9;terminer l&#x2019;impact de cibles perop&#xe9;ratoires de pression art&#xe9;rielle &#xe9;lev&#xe9;es par rapport &#xe0; des cibles basses sur la morbidit&#xe9; et la mortalit&#xe9; postop&#xe9;ratoires d&#x2019;adultes b&#xe9;n&#xe9;ficiant d&#x2019;une chirurgie cardiaque sous circulation extracorporelle (CEC). Notre objectif principal &#xe9;tait d&#x2019;orienter la conception d&#x2019;une future ERC d&#x2019;envergure.</AbstractText><AbstractText Label="SOURCES" NlmCategory="METHODS">Nous avons analys&#xe9; les bases de donn&#xe9;es MEDLINE, EMBASE, Web of Science, CINAHL et CENTRAL afin d&#x2019;en tirer les ERC comparant des cibles de pression art&#xe9;rielle perop&#xe9;ratoire &#xe9;lev&#xe9;es &#xe0; des cibles basses chez des patients adultes b&#xe9;n&#xe9;ficiant d&#x2019;une intervention chirurgicale cardiaque sous CEC. Nous avons pass&#xe9; au crible les listes de r&#xe9;f&#xe9;rences, la litt&#xe9;rature grise et les travaux de congr&#xe8;s.</AbstractText><AbstractText Label="CONSTATATIONS PRINCIPALES" NlmCategory="UNASSIGNED">Nous avons inclus huit ERC (N = 1116 participants); toutes les &#xe9;tudes ont examin&#xe9; l&#x2019;effet de la prise en charge de la pression art&#xe9;rielle uniquement pendant la CEC. Les d&#xe9;finitions d&#x2019;une pression art&#xe9;rielle &#xe9;lev&#xe9;e ou basse variaient d&#x2019;une &#xe9;tude &#xe0; l&#x2019;autre et, dans certains cas, un &#xe9;cart a &#xe9;t&#xe9; not&#xe9; entre la pression art&#xe9;rielle cible et la pression art&#xe9;rielle moyenne atteinte. Nous n&#x2019;avons observ&#xe9; aucune diff&#xe9;rence dans les taux de delirium, de d&#xe9;clin cognitif, d&#x2019;accident vasculaire c&#xe9;r&#xe9;bral, d&#x2019;insuffisance r&#xe9;nale aigu&#xeb; ou de mortalit&#xe9; entre les cibles de pression art&#xe9;rielle &#xe9;lev&#xe9;e et basse (donn&#xe9;es probantes de qualit&#xe9; tr&#xe8;s faible &#xe0; faible). Des cibles de pression art&#xe9;rielle plus &#xe9;lev&#xe9;es pourraient avoir augment&#xe9; le risque de transfusion sanguine (trois &#xe9;tudes; n = 456 participants; risque relatif, 1,4; intervalle de confiance &#xe0; 95 %, 1,1 &#xe0; 1,9; P = 0,01; donn&#xe9;es probantes de qualit&#xe9; mod&#xe9;r&#xe9;e), mais ce r&#xe9;sultat se fondait sur un petit nombre d&#x2019;&#xe9;tudes.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Les d&#xe9;finitions individuelles des cibles d&#x2019;hypertension et d&#x2019;hypotension art&#xe9;rielle variaient, ce qui a limit&#xe9; les inf&#xe9;rences. L&#x2019;effet de cibles de pression art&#xe9;rielle &#xe9;lev&#xe9;e (par rapport &#xe0; une pression art&#xe9;rielle basse) sur d&#x2019;autres mesures de la morbidit&#xe9; et de la mortalit&#xe9; apr&#xe8;s une chirurgie cardiaque demeure incertain en raison des limites de l&#x2019;ensemble des donn&#xe9;es probantes existantes. Des recherches visant &#xe0; d&#xe9;terminer la prise en charge optimale de la pression art&#xe9;rielle pendant la chirurgie cardiaque sont n&#xe9;cessaires. ENREGISTREMENT DE L&#x2019;&#xe9;TUDE: PROSPERO (CRD42020177376); enregistr&#xe9;e le 5 juillet 2020.</AbstractText><CopyrightInformation>&#xa9; 2022. Canadian Anesthesiologists' Society.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Blood pressure targets</Keyword><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">Morbidity and mortality</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>59</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35014001</ArticleId><ArticleId IdType="doi">10.1007/s12630-021-02171-3</ArticleId><ArticleId IdType="pii">10.1007/s12630-021-02171-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Murphy GS, Hessel EA 2<sup>nd</sup>, Groom RC. Optimal perfusion during cardiopulmonary bypass: an evidence-based approach. Anesth Analg 2009; 108: 1394-417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e3181875e2e</ArticleId><ArticleId IdType="pubmed">19372313</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono M, Brady K, Easley RB, et al. Duration and magnitude of blood pressure below cerebral autoregulation threshold during cardiopulmonary bypass is associated with major morbidity and operative mortality. J Thorac Cardiovasc Surg 2014; 147: 483-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2013.07.069</ArticleId><ArticleId IdType="pubmed">24075467</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudiger A, Begdeda H, Babic D, et al. Intra-operative events during cardiac surgery are risk factors for the development of delirium in the ICU. Crit Care 2016; DOI: https://doi.org/10.1186/s13054-016-1445-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1445-8</ArticleId><ArticleId IdType="pubmed">27716402</ArticleId><ArticleId IdType="pmc">5084342</ArticleId></ArticleIdList></Reference><Reference><Citation>Siepe M, Pfeiffer T, Gieringer A, et al. Increased systemic perfusion pressure during cardiopulmonary bypass is associated with less early postoperative cognitive dysfunction and delirium. Eur J Cardiothorac Surg 2011; 40: 200-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2010.11.024</ArticleId><ArticleId IdType="pubmed">21168339</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold JP, Charlson ME, Williams-Russo P, et al. Improvement of outcomes after coronary artery bypass. A randomized trial comparing intraoperative high versus low mean arterial pressure. J Thorac Cardiovasc Surg 1995; 110: 1302-11.</Citation></Reference><Reference><Citation>Vedel AG, Holmgaard F, Rasmussen LS, et al. High-target versus low-target blood pressure management during cardiopulmonary bypass to prevent cerebral injury in cardiac surgery patients: a randomized controlled trial. Circulation 2018; 137: 1770-80.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.117.030308</ArticleId><ArticleId IdType="pubmed">29339351</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronson S, Stafford-Smith M, Phillips-Bute B, et al. Intraoperative systolic blood pressure variability predicts 30-day mortality in aortocoronary bypass surgery patients. Anesthesiology 2010; 113: 305-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181e07ee9</ArticleId><ArticleId IdType="pubmed">20571360</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Peterson JC, Krieger KH, et al. Improvement of outcomes after coronary artery bypass II: a randomized trial comparing intraoperative high versus customized mean arterial pressure. J Card Surg 2007; 22: 465-72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8191.2007.00471.x</ArticleId><ArticleId IdType="pubmed">18039205</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Akiyoshi K, Nakano M, et al. Determining thresholds for three indices of autoregulation to identify the lower limit of autoregulation during cardiac surgery. Crit Care Med 2021; 49: 650-60.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004737</ArticleId><ArticleId IdType="pubmed">33278074</ArticleId><ArticleId IdType="pmc">7979429</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thomas J, Chandler J, et al. Cochrane Handbook for Systematic Reviews of Interventions&#xa0;version 6.2&#xa0;(updated February&#xa0;2021). Cochrane, 2021. Available from URL: www.training.cochrane.org/handbook (accessed November 2021).</Citation></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015; DOI: https://doi.org/10.1186/2046-4053-4-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pubmed">26693720</ArticleId><ArticleId IdType="pmc">4688988</ArticleId></ArticleIdList></Reference><Reference><Citation>Veritas Health Innovation. Covidence Systematic Review Software. Melbourne, Australia. Available from ULR: www.covidence.org (accessed November 2021).</Citation></Reference><Reference><Citation>Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; DOI: https://doi.org/10.1136/bmj.d5928 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pubmed">22096256</ArticleId><ArticleId IdType="pmc">3196245</ArticleId></ArticleIdList></Reference><Reference><Citation>The Cochrane Collaboration. Review Manager (RevMan). Computer Program, Version 5.4. 2020.</Citation></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 2014; DOI: https://doi.org/10.1186/1471-2288-14-135 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-135</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId><ArticleId IdType="pmc">4383202</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>IntHout J, Ioannidis JP, Borm GF. The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Methodol 2014; DOI: https://doi.org/10.1186/1471-2288-14-25 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-25</ArticleId><ArticleId IdType="pubmed">24548571</ArticleId><ArticleId IdType="pmc">4015721</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeks JJ, Higgins JP, Altman DG; Cochrane Statistical Methods Group. Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, et al. (Eds). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from URL: training.cochrane.org/handbook (accessed November 2021).</Citation></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId><ArticleId IdType="pmc">2335261</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirvinskas E, Benetis R, Raliene L, Andrejaitiene J. The influence of mean arterial blood pressure during cardiopulmonary bypass on postoperative renal dysfunction in elderly patients. Perfusion 2012; 27: 193-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0267659112436751</ArticleId><ArticleId IdType="pubmed">22337760</ArticleId></ArticleIdList></Reference><Reference><Citation>Urzua J, Troncoso S, Bugedo G, et al. Renal function and cardiopulmonary bypass: effect of perfusion pressure. J Cardiothorac Vasc Anesth 1992; 6: 299-303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/1053-0770(92)90144-V</ArticleId><ArticleId IdType="pubmed">1610995</ArticleId></ArticleIdList></Reference><Reference><Citation>Azau A, Markowicz P, Corbeau JJ, et al. Increasing mean arterial pressure during cardiac surgery does not reduce the rate of postoperative acute kidney injury. Perfusion 2014; 29: 496-504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0267659114527331</ArticleId><ArticleId IdType="pubmed">24619062</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagheri K, Motamedi O, Aghavoudi O, Akbari M. The effects of mean arterial pressure during cardiopulmonary bypass on clinical and paraclinical parameters during and after coronary artery bypass graft surgery. J Isfahan Med Sch 2012; 29: 1-10.</Citation></Reference><Reference><Citation>Kandler K, Nilsson JC, Oturai P, et al. Higher arterial pressure during cardiopulmonary bypass may not reduce the risk of acute kidney injury. J Cardiothorac Surg 2019; DOI: https://doi.org/10.1186/s13019-019-0929-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-019-0929-4</ArticleId><ArticleId IdType="pubmed">31196131</ArticleId><ArticleId IdType="pmc">6567467</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen MH, Draegert C, Vedel AG, et al. Long-term survival and cognitive function according to blood pressure management during cardiac surgery. A follow-up. Acta Anaesthesiol Scand 2020; 64: 936-44.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.13595</ArticleId><ArticleId IdType="pubmed">32270483</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich DL, Bodian CA, Krol M, Kuroda M, Osinski T, Thys DM. Intraoperative hemodynamic predictors of mortality, stroke, and myocardial infarction after coronary artery bypass surgery. Anesth Analg 1999; 89: 814-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/00000539-199910000-00002</ArticleId><ArticleId IdType="pubmed">10512249</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown CH 4<sup>th</sup>, Neufeld KJ, Tian J, et al. Effect of targeting mean arterial pressure during cardiopulmonary bypass by monitoring cerebral autoregulation on postsurgical delirium among older patients: a nested randomized clinical trial. JAMA Surg 2019; 154: 819-26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2019.1163</ArticleId><ArticleId IdType="pubmed">31116358</ArticleId><ArticleId IdType="pmc">6537779</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogue CW, Brown CH 4<sup>th</sup>, Hori D, et al. Personalized blood pressure management during cardiac surgery with cerebral autoregulation monitoring: a randomized trial. Semin Thorac Cardiovasc Surg 2021; 33: 429-38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semtcvs.2020.09.032</ArticleId><ArticleId IdType="pubmed">33186735</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijnberge M, Schenk J, Bulle E, et al. Association of intraoperative hypotension with postoperative morbidity and mortality: systematic review and meta-analysis. BJS Open 2021; DOI: https://doi.org/10.1093/bjsopen/zraa018 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bjsopen/zraa018</ArticleId><ArticleId IdType="pubmed">33609377</ArticleId><ArticleId IdType="pmc">7893468</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamontagne F, Day AG, Meade MO, et al. Pooled analysis of higher versus lower blood pressure targets for vasopressor therapy septic and vasodilatory shock. Intensive Care Med 2018; 44: 12-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-5016-5</ArticleId><ArticleId IdType="pubmed">29260272</ArticleId></ArticleIdList></Reference><Reference><Citation>Sessler DI, Bloomstone JA, Aronson S, et al. Perioperative Quality Initiative consensus statement on intraoperative blood pressure, risk and outcomes for elective surgery. Br J Anaesth 2019; 122: 563-74.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2019.01.013</ArticleId><ArticleId IdType="pubmed">30916004</ArticleId></ArticleIdList></Reference><Reference><Citation>Authors/Task Force Members; Kunst G, Milojevic M, et al. 2019 EACTS/EACTA/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery. Br J Anaesth 2019; 123: 713-57.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25989324</PMID><DateCompleted><Year>2016</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8191</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>7</Issue><PubDate><Year>2015</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of cardiac surgery</Title><ISOAbbreviation>J Card Surg</ISOAbbreviation></Journal><ArticleTitle>Levosimendan Reduces Mortality in Adults with Left Ventricular Dysfunction Undergoing Cardiac Surgery: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>547</StartPage><EndPage>554</EndPage><MedlinePgn>547-54</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jocs.12562</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Levosimendan is implemented in patients with low cardiac output after cardiac surgery. However, the strength of evidence is limited by randomized controlled trials enrolling a small number of patients. Hence we have conducted a systematic review to determine the role of levosimendan in adult cardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PUBMED, WoS, Cochrane database, and SCOPUS were systematically queried to identify original English language peer-reviewed literature (inception-October 2014) comparing clinical results of adult cardiac surgery between levosimendan and control. Pooled odds ratio (OR) was calculated using the Peto method; p&#x2009;&lt;&#x2009;0.05 is significant; results are presented within 95% confidence intervals. Continuous data was compared using standardized mean difference/mean difference.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fourteen studies were included in the analysis. Levosimendan reduced early mortality in patients with reduced ejection fraction (5.5% vs. 9.1%) (OR 0.48 [0.23-0.76]; p&#x2009;=&#x2009;0.004). This result was confirmed using sensitivity analysis. Postoperative acute renal failure was lower with levosimendan therapy (7.4% vs. 11.5%). Intensive care unit stay was shorter in the levosimendan cohort comparable in both groups (standardized mean difference -0.31 [-0.53, -0.09]; p&#x2009;=&#x2009;0.006; I(2) &#x2009;=&#x2009;33.6%). Levosimendan-treated patients stayed 1.01 (1.61-0.42) days shorter when compared to control (p&#x2009;=&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our meta-analysis demonstrates that Levosimendan improves clinical outcomes in patients with left ventricular dysfunction undergoing cardiac surgery. Results of the ongoing multicenter randomized controlled trial are awaited to provide more conclusive evidence regarding the benefit of this drug.</AbstractText><CopyrightInformation>&#xa9; 2015 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Ju Yong</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Asan Medical Center, Ulsan School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deo</LastName><ForeName>Salil V</ForeName><Initials>SV</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Surgery, Case Medical Center, Case Western Reserve University, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rababa'h</LastName><ForeName>Abeer</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altarabsheh</LastName><ForeName>Salah E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Queen Alia Heart Institute, Amman, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Yang Hyun</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Samsung Hospital, Sungkyunkwan School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hang</LastName><ForeName>Dustin</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Medicine, Case Western Reserve University, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGraw</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Health Sciences Library, Case Western Reserve University, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avery</LastName><ForeName>Edwin G</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Peri-operative Medicine, Case Medical Center, Case Western Reserve University, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Markowitz</LastName><ForeName>Alan H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Surgery, Case Medical Center, Case Western Reserve University, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Soon J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Surgery, Case Medical Center, Case Western Reserve University, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02025621</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>05</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Card Surg</MedlineTA><NlmUniqueID>8908809</NlmUniqueID><ISSNLinking>0886-0440</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002316">Cardiotonic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006835">Hydrazones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011724">Pyridazines</NameOfSubstance></Chemical><Chemical><RegistryNumber>349552KRHK</RegistryNumber><NameOfSubstance UI="D000077464">Simendan</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002303" MajorTopicYN="N">Cardiac Output, Low</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002316" MajorTopicYN="N">Cardiotonic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016206" MajorTopicYN="N">Databases, Bibliographic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006835" MajorTopicYN="N">Hydrazones</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011724" MajorTopicYN="N">Pyridazines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077464" MajorTopicYN="N">Simendan</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018487" MajorTopicYN="N">Ventricular Dysfunction, Left</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25989324</ArticleId><ArticleId IdType="doi">10.1111/jocs.12562</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29210843</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>23</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1365-2346</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>Apr</Month></PubDate></JournalIssue><Title>European journal of anaesthesiology</Title><ISOAbbreviation>Eur J Anaesthesiol</ISOAbbreviation></Journal><ArticleTitle>Intraoperative hypotension is associated with acute kidney injury in noncardiac surgery: An observational study.</ArticleTitle><Pagination><StartPage>273</StartPage><EndPage>279</EndPage><MedlinePgn>273-279</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/EJA.0000000000000735</ELocationID><Abstract><AbstractText Label="BACKGROUND">Perioperative acute kidney injury (AKI) is common and increases the risk of morbidity and mortality.</AbstractText><AbstractText Label="OBJECTIVES">To determine the association between intraoperative hypotension, defined as an individual decrease from baseline and the risk of perioperative AKI.</AbstractText><AbstractText Label="DESIGN">Observational cohort study.</AbstractText><AbstractText Label="SETTING">Karolinska University Hospital, Stockholm, Sweden, from October 2012 to May 2013 and October 2015 and April 2016.</AbstractText><AbstractText Label="PATIENTS">All adult patients undergoing major elective noncardiac surgery who were scheduled for an overnight admission in the postoperative unit were included. Patients undergoing phaeochromocytoma surgery were excluded.</AbstractText><AbstractText Label="DATA COLLECTION">Preoperative risk factors (comorbidities), intraoperative events (hypotension defined as a more than 40 or 50% decrease in SBP relative to each patient's baseline and lasting more than 5&#x200a;min) and postoperative data were collected from medical records.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">AKI within the first two postoperative days.</AbstractText><AbstractText Label="RESULTS">Of the final cohort of 470 patients, 127 (27%) developed AKI in the perioperative period. AKI was associated with male sex [(66 vs. 48%) P&#x200a;&lt;&#x200a;0.001], a higher preoperative creatinine (81 vs. 73&#x200a;&#x3bc;mol l, P&#x200a;=&#x200a;0.003), American Society of Anaesthesiologists class more than two (54 vs. 42%, P&#x200a;=&#x200a;0.014) and preoperative hypertension (54 vs. 40%, P&#x200a;=&#x200a;0.005). During surgery, the AKI subgroup had more hypotensive events (&gt;40%, 70 vs. 57%, P&#x200a;=&#x200a;0.013; &gt;50%, 20 vs. 12%, P&#x200a;=&#x200a;0.024) and greater blood loss (800 vs. 400&#x200a;ml, P&#x200a;&lt;&#x200a;0.001). Postoperatively, in AKI patients a positive fluid balance was more common (3123 vs. 2700&#x200a;ml, P&#x200a;&lt;&#x200a;0.001), as was 30-day mortality (4 vs. 1%, P&#x200a;&lt;&#x200a;0.005). Multivariate analyses demonstrated that an intraoperative reduction of SBP more than 50% was associated with a more than doubled risk of AKI, adjusted odds ratio 2.27; 95% CI, 1.20 to 4.30, P&#x200a;=&#x200a;0.013.</AbstractText><AbstractText Label="CONCLUSION">In patients undergoing noncardiac surgery, there was a high incidence of perioperative AKI. Intraoperative avoidance of hypotension may decrease the risk of AKI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hallqvist</LastName><ForeName>Linn</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital (LH, MB) and Clinical Epidemiology Unit, Department of Medicine, Karolinska Institute, Solna, Stockholm, Sweden (FG, EH).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Granath</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Huldt</LastName><ForeName>Elin</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Bell</LastName><ForeName>Max</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Anaesthesiol</MedlineTA><NlmUniqueID>8411711</NlmUniqueID><ISSNLinking>0265-0215</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="N">Monitoring, Intraoperative</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29210843</ArticleId><ArticleId IdType="doi">10.1097/EJA.0000000000000735</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31804347</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>26</Day></DateCompleted><DateRevised><Year>2020</Year><Month>01</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>98</Volume><Issue>49</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Perioperative outcomes in geriatric patients undergoing hip fracture surgery with different anesthesia techniques: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>e18220</StartPage><MedlinePgn>e18220</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e18220</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000018220</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Previous meta-analyses assessing anesthetic techniques in adult patients undergoing hip fractures surgery are available. However, whether the anesthetic technique is associated with risk of mortality and complications in geriatric patients with hip fractures remains unclear. This study was conducted to assess postoperative outcomes of anesthesia technique in geriatric patients undergoing hip fracture surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Cochrane Library, PubMed, EMBASE, MEDLINE, CNKI, and CBM were searched from inception up to May 25, 2018. Observational studies and randomized controlled trials (RCTs) that assessed the perioperative outcomes of technique of anesthesia (general or regional [epidural/spinal/neuraxial]) in geriatric patients (&#x2265;60 years old) undergoing hip fracture surgery were included. Two investigators independently screened studies for inclusion and performed data extraction. Heterogeneity was assessed by the I and Chi-square tests. The odds ratio (OR) of the dichotomous data, mean difference (MD) of continuous data, and 95% confidence intervals (CI) were calculated to assess the pooled data.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eleven retrospective and 2 RCTs were included. There was no difference in 30-day mortality (OR&#x200a;=&#x200a;0.96; 95% CI 0.86-1.08; P&#x200a;=&#x200a;.51) between the general and regional anesthesia groups. In-hospital mortality (OR&#x200a;=&#x200a;1.26; 95% CI 1.17-1.36; P&#x200a;&lt;&#x200a;.001), acute respiratory failure (OR&#x200a;=&#x200a;2.66; 95% CI 2.34-3.02; P&#x200a;&lt;&#x200a;.001), length of hospital stay (MD&#x200a;=&#x200a;0.33; 95% CI 0.24-0.42; P&#x200a;&lt;&#x200a;.001), and readmission (OR&#x200a;=&#x200a;1.09; 95% CI 1.01-1.18; P&#x200a;=&#x200a;.03) were significantly reduced in the regional anesthesia group. Pneumonia (OR&#x200a;=&#x200a;0.99; 95% CI 0.91-1.07; P&#x200a;=&#x200a;.79), heart failure (OR&#x200a;=&#x200a;0.97; 95% CI 0.86-1.09; P&#x200a;=&#x200a;.62), acute myocardial infraction (OR&#x200a;=&#x200a;1.07; 95% CI 0.99-1.16; P&#x200a;=&#x200a;.10), acute renal failure (OR&#x200a;=&#x200a;1.32; 95% CI 0.97-1.79; P&#x200a;=&#x200a;.07), cerebrovascular accident (OR&#x200a;=&#x200a;1.08; 95% CI 0.82-1.42; P&#x200a;=&#x200a;.58), postoperative delirium (OR&#x200a;=&#x200a;1.51; 95% CI 0.16-13.97; P&#x200a;=&#x200a;.72), and deep vein thrombosis/pulmonary embolism (OR&#x200a;=&#x200a;1.42; 95% CI 0.84-2.38; P&#x200a;=&#x200a;.19) were similar between the two anesthetic techniques.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">General anesthesia is associated with increased risk of in-hospital mortality, acute respiratory failure, longer hospital stays, and higher readmission. There is evidence to suggest that regional anesthesia is associated with improved perioperative outcomes. Large RCTs are needed to explore the most optimal anesthetic techniques for geriatric patients with hip fractures before drawing final conclusions.</AbstractText><AbstractText Label="PROSPERO REGISTRATION NUMBER" NlmCategory="UNASSIGNED">CRD42018093582.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Dong Xu</ForeName><Initials>DX</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shi Yue</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Ya Na</ForeName><Initials>YN</Initials><AffiliationInfo><Affiliation>Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="N">Hip Fractures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>12</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31804347</ArticleId><ArticleId IdType="pmc">PMC6919429</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000018220</ArticleId><ArticleId IdType="pii">00005792-201912060-00046</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int 1997;5:407&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">9425497</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes WC, Myers ER, Robinovitch SN, et al. Etiology and prevention of age-related hip fractures. Bone 1996;18:77&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">8717551</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtis EM, van der Velde R, Moon RJ, et al. Epidemiology of fractures in the United Kingdom 1988-2012: variation with age, sex, geography, ethnicity and socioeconomic status. Bone 2016;87:19&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4890652</ArticleId><ArticleId IdType="pubmed">26968752</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Waesberghe J, Stevanovic A, Rossaint R, et al. General vs. neuraxial anaesthesia in hip fracture patients: a systematic review and meta-analysis. BMC Anesthesiol 2017;17:1&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5490182</ArticleId><ArticleId IdType="pubmed">28659127</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donnell CM, McLoughlin L, Patterson CC, et al. Perioperative outcomes in the context of mode of anaesthesia for patients undergoing hip fracture surgery: systematic review and meta-analysis. Br J Anaesth 2018;120:37&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">29397135</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths R, Alper J, Beckingsale A, et al. Management of proximal femoral fractures 2011: association of anaesthetists of Great Britain and Ireland. Anaesthesia 2012;67:85&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">22150501</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen A, Boulton C, Hertz K, et al. The National Hip Fracture Database (NHFD) &#x2013; using a national clinical audit to raise standards of nursing care. Int J Orthop Trauma Nurs 2017;26:3&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">28237620</ArticleId></ArticleIdList></Reference><Reference><Citation>Brauer CA, Coca-Perraillon M, Cutler DM, et al. Incidence and mortality of hip fractures in the United States. JAMA 2009;302:1573&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4410861</ArticleId><ArticleId IdType="pubmed">19826027</ArticleId></ArticleIdList></Reference><Reference><Citation>Seitz DP, Gill SS, Bell CM, et al. Postoperative medical complications associated with anesthesia in older adults with dementia. J Am Geriatr Soc 2014;62:2102&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25370019</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai V, Chan PH, Prentice HA, et al. Is anesthesia technique associated with a higher risk of mortality or complications within 90 days of surgery for geriatric patients with hip fractures? Clin Orthop Relat Res 2018;476:1178&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6263607</ArticleId><ArticleId IdType="pubmed">29601378</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvani R, Martone AM, Marzetti E, et al. Pre-hospital dietary intake correlates with muscle mass at the time of fracture in older hip fractured patients. Front Aging Neurosci 2014;6:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4236534</ArticleId><ArticleId IdType="pubmed">25477815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Rosenbaum PR, Ludwig JM, et al. Anesthesia technique, mortality, and length of stay after hip fracture surgery. JAMA 2014;24:2508&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4344128</ArticleId><ArticleId IdType="pubmed">25058085</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MJ, Griffiths R. General versus regional anaesthesia for hip fractures. A pilot randomised controlled trial of 322 patients. Injury 2015;46:1562&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">26049662</ArticleId></ArticleIdList></Reference><Reference><Citation>Luger TJ, Kammerlander C, Gosch M, et al. Neuroaxial versus general anaesthesia in geriatric patients for hip fracture surgery: does it matter? Osteoporos Int 2010;21:555&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">21057995</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Hara DA, Duff A, Berlin JA, et al. The effect of anesthetic technique on postoperative outcomes in hip fracture repair. Anesthesiology 2000;92:947&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">10754613</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson RL, Kopp SL, Burkle CM, et al. Neuraxial vs general anaesthesia for total hip and total knee arthroplasty: a systematic review of comparative-effectiveness research. Br J Anaesth 2016;116:163&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">26787787</ArticleId></ArticleIdList></Reference><Reference><Citation>White SM, Moppett IK, Griffiths R. Outcome by mode of anaesthesia for hip fracture surgery. An observational audit of 65 535 patients in a national dataset. Anaesthesia 2014;69:224&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">24428375</ArticleId></ArticleIdList></Reference><Reference><Citation>White SM, Altermatt F, Barry J, et al. International fragility fracture network delphi consensus statement on the principles of anaesthesia for patients with hip fracture. Anaesthesia 2018;73:863&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">29508382</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015;4:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. BMJ 2009;339:b2700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714672</ArticleId><ArticleId IdType="pubmed">19622552</ArticleId></ArticleIdList></Reference><Reference><Citation> Wells GA, Shea B, O&#x2019;Connell D, et al. The Newcastle&#x2013;Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses. Available at:  http://wwwohrica/programs/clinicalepidemiology/oxfordasp. [Accessed May 5, 2012]</Citation></Reference><Reference><Citation>Higgins JP, Altman DG, G&#xf8;tzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Hekimo&#x11f;lu &#x15e;S, Heybeli N, &#xc7;olak A, et al. Comparison of different anesthetic techniques on postoperative outcomes in elderly patients with hip fracture. Turkiye Klin J Med Sci 2012;32:623&#x2013;9.</Citation></Reference><Reference><Citation>Biboulet P, Jourdan A, Van Haevre V, et al. Hemodynamic profile of target-controlled spinal anesthesia compared with 2 target-controlled general anesthesia techniques in elderly patients with cardiac comorbidities. Reg Anesth Pain Med 2012;37:433&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">22609644</ArticleId></ArticleIdList></Reference><Reference><Citation>Le-Wendling L, Bihorac A, Baslanti TO, et al. Regional anesthesia as compared with general anesthesia for surgery in geriatric patients with hip fracture: does it decrease morbidity, mortality, and health care costs? Results of a single-centered study. Pain Med 2012;13:948&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3730262</ArticleId><ArticleId IdType="pubmed">22758782</ArticleId></ArticleIdList></Reference><Reference><Citation>Basques BA, Bohl DD, Golinvaux NS, et al. General versus spinal anaesthesia for patients aged 70 years and older with a fracture of the hip. Bone Jt J 2015;97-B:689&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">25922465</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu CC, Weng SF, Chen KT, et al. Propensity score &#x2013; matched comparison of postoperative adverse outcomes between geriatric patients given a general or a neuraxial anesthetic for hip surgery: a population-based study. Anesthesiology 2015;123:136&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">25955981</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu C, Chan PH, Zohman GL, et al. Impact of anesthesia on hospital mortality and morbidities in geriatric patients following emergency hip fracture surgery. J Orthop Trauma 2018;32:116&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">29461445</ArticleId></ArticleIdList></Reference><Reference><Citation>Casati A, Aldegheri G, Vinciguerra E, et al. Randomized comparison between sevoflurane anaesthesia and unilateral spinal anaesthesia in elderly patients undergoing orthopaedic surgery. Eur J Anaesthesiol 2003;20:640&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">12932066</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda T, Imai S, Nakadera M, et al. Postoperative daily living activities of geriatric patients administered general or spinal anesthesia for hip fracture surgery: a retrospective cohort study. J Orthop Surg (Hong Kong) 2018;26:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29366390</ArticleId></ArticleIdList></Reference><Reference><Citation>Radcliff TA, Henderson WG, Stoner TJ, et al. Patient risk factors, operative care, and outcomes among older community-dwelling male veterans with hip fracture. J Bone Joint Surg Am 2008;90:34&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">18171955</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih YJ, Hsieh CH, Kang TW, et al. General versus spinal anesthesia: which is a risk factor for octogenarian hip fracture repair patients? Int J Gerontol 2010;4:37&#x2013;42.</Citation></Reference><Reference><Citation>Guay J, Parker MJ, Gajendragadkar PR, et al. Anaesthesia for hip fracture surgery in adults. Cochrane Database Syst Rev 2016;2:CD000521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6464323</ArticleId><ArticleId IdType="pubmed">26899415</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Silber JH, Elkassabany NM, et al. Comparative effectiveness of regional versus general anesthesia for hip fracture surgery in adults. Anesthesiology 2012;117:72&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">22713634</ArticleId></ArticleIdList></Reference><Reference><Citation>Sieber FE, Gottshalk A, Zakriya KJ, et al. General anesthesia occurs frequently in elderly patients during propofol-based sedation and spinal anesthesia. J Clin Anesth 2010;22:179&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">20400003</ArticleId></ArticleIdList></Reference><Reference><Citation>Memtsoudis SG, Poeran J, Zubizarreta N, et al. Do hospitals performing frequent neuraxial anesthesia for hip and knee replacements have better outcomes? Anesthesiology 2018;129:428&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">29878899</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak JC, Cameron ID, March LM. Evidence-based guidelines for the management of hip fractures in older persons: an update. Med J Aust 2010;192:37&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">20047547</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowark A, Adam C, Ahrens J, et al. Improve hip fracture outcome in the elderly patient (iHOPE): a study protocol for a pragmatic, multicentre randomised controlled trial to test the efficacy of spinal versus general anaesthesia. BMJ Open 2018;8:e023609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6196806</ArticleId><ArticleId IdType="pubmed">30341135</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32923414</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-2360</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Frontiers in pediatrics</Title><ISOAbbreviation>Front Pediatr</ISOAbbreviation></Journal><ArticleTitle>Effect of Prophylactic Levosimendan on All-Cause Mortality in Pediatric Patients Undergoing Cardiac Surgery-An Updated Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>456</StartPage><MedlinePgn>456</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">456</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fped.2020.00456</ELocationID><Abstract><AbstractText><b>Background:</b> Levosimendan, a calcium sensitizer, enhances the myocardial function by generating more energy-efficient myocardial contractility than that achieved through adrenergic stimulation with catecholamines. We conducted this meta-analysis to primarily investigate the effects of levosimendan on all-cause mortality in pediatric patients undergoing cardiac surgery under cardiopulmonary bypass. <b>Methods:</b> The databases of Pubmed, Embase, and Cochrane Library were searched till 21st March 2020. The eligible criteria were participants with age&lt;18 year and undergoing cardiac surgery for congenital heart disease (CHD), and studies of comparison between levosimendan and placebo or other inotropes. Stata version 12.0 was used to perform statistical analyses. <b>Results:</b> Six randomized controlled trials (RCTs) and 1 case-control trial (CCT) including 436 patients were included. The results showed that levosimendan did not significantly decrease all-cause mortality compared with control drugs (and placebo) in children undergoing cardiac surgery (<i>P</i> = 0.403). Perioperative prophylactic levosimendan administration strikingly decreased the low cardiac output syndrome (LCOS) incidence (<i>P</i> = 0.016) but did not significantly reduce acute kidney injury (AKI) incidence (<i>P</i> = 0.251) and shorten mechanical ventilation and ICU stay time compared with other inotropes and placebo by analyzing the included literatures [mechanical ventilation (or intubation) time: <i>P</i> = 0.188; ICU stay time: <i>P</i> = 0.620]. <b>Conclusions:</b> Compared with other inotropes and placebo, perioperative prophylactic administration of levosimendan did not decrease the rates of mortality and AKI and shorten the time of mechanical ventilation (or intubation) and ICU stay but demonstrated a significant reduction in LCOS incidence after corrective surgery in pediatric patients for CHD. Due to limited number of included studies, the current data were insufficient to make the conclusions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Wang, Luo, Li, Zhang, Wu and Yan.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hongbai</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Qipeng</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yinan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Liang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Chongqing Traditional Chinese Medicine Hospital, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xie</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Fuxia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pediatr</MedlineTA><NlmUniqueID>101615492</NlmUniqueID><ISSNLinking>2296-2360</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">levosimendan</Keyword><Keyword MajorTopicYN="N">low cardiac output syndrome</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">pediatrics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>14</Day><Hour>5</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>8</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32923414</ArticleId><ArticleId IdType="pmc">PMC7456871</ArticleId><ArticleId IdType="doi">10.3389/fped.2020.00456</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bohn D. Objective assessment of cardiac output in infants after cardiac surgery. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. (2011) 14:19&#x2013;23. 10.1053/j.pcsu.2011.01.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.pcsu.2011.01.002</ArticleId><ArticleId IdType="pubmed">21444044</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkhardt BE, R&#xfc;cker G, Stiller B. Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease. Cochrane Database Syst Rev. (2015) 3:CD009515 10.1002/14651858.CD009515.pub2</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD009515.pub2</ArticleId><ArticleId IdType="pmc">PMC11032183</ArticleId><ArticleId IdType="pubmed">25806562</ArticleId></ArticleIdList></Reference><Reference><Citation>Wernovsky G, Wypij D, Jonas RA, Mayer JE, Jr., Hanley FL, Hickey PR, et al. . Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation. (1995) 92:2226&#x2013;35. 10.1161/01.CIR.92.8.2226</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.92.8.2226</ArticleId><ArticleId IdType="pubmed">7554206</ArticleId></ArticleIdList></Reference><Reference><Citation>Du X, Chen H, Song X, Wang S, Hao Z, Yin L, et al. . Risk factors for low cardiac output syndrome in children with congenital heart disease undergoing cardiac surgery: a retrospective cohort study. BMC Pediatr. (2020) 20:87. 10.1186/s12887-020-1972-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12887-020-1972-y</ArticleId><ArticleId IdType="pmc">PMC7038550</ArticleId><ArticleId IdType="pubmed">32093619</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuerek M, Rossano JW, Mascio CE, Shaddy RE. Postoperative management of heart failure in pediatric patients. Expert Rev Cardiovasc Ther. (2016) 14:201&#x2013;15. 10.1586/14779072.2016.1117388</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14779072.2016.1117388</ArticleId><ArticleId IdType="pubmed">26560361</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan SM. Acute kidney injury after pediatric cardiac surgery. Pediatr Neonatol. (2019) 60:3&#x2013;11. 10.1016/j.pedneo.2018.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pedneo.2018.03.007</ArticleId><ArticleId IdType="pubmed">29891225</ArticleId></ArticleIdList></Reference><Reference><Citation>Parmar D, Lakhia K, Garg P, Patel K, Shah R, Surti J, et al. . Risk factors for delayed extubation after ventricular septal defect closure: a prospective observational study. Braz J Cardiovasc Surg. (2017) 32:276&#x2013;82. 10.21470/1678-9741-2017-0031</Citation><ArticleIdList><ArticleId IdType="doi">10.21470/1678-9741-2017-0031</ArticleId><ArticleId IdType="pmc">PMC5613723</ArticleId><ArticleId IdType="pubmed">28977199</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller KH. Factors influencing selected lengths of ICU stay for coronary artery bypass patients. J Cardiovasc Nurs. (1998) 12:52&#x2013;61. 10.1097/00005082-199807000-00006</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005082-199807000-00006</ArticleId><ArticleId IdType="pubmed">9645623</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel J, R&#xfc;cker G, Stiller B. Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease. Cochrane Database Syst Rev. (2017) 8:CD011312. 10.1002/14651858.CD011312.pub3</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD011312.pub3</ArticleId><ArticleId IdType="pmc">PMC6483297</ArticleId><ArticleId IdType="pubmed">28770972</ArticleId></ArticleIdList></Reference><Reference><Citation>Murni IK, Djer MM, Yanuarso PB, Putra ST, Advani N, Rachmat J, et al. . Outcome of pediatric cardiac surgery and predictors of major complication in a developing country. Ann Pediatr Cardiol. (2019) 12:38&#x2013;44. 10.4103/apc.APC_146_17</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/apc.APC_146_17</ArticleId><ArticleId IdType="pmc">PMC6343386</ArticleId><ArticleId IdType="pubmed">30745768</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillies M, Bellomo R, Doolan L, Buxton B. Bench-to-bedside review: inotropic drug therapy after adult cardiac surgery &#x2013; a systematic literature review. Crit Care. (2005) 9:266&#x2013;79. 10.1186/cc3024</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc3024</ArticleId><ArticleId IdType="pmc">PMC1175868</ArticleId><ArticleId IdType="pubmed">15987381</ArticleId></ArticleIdList></Reference><Reference><Citation>Saab G, Mindel G, Ewald G, Vijayan A. Acute renal failure secondary to milrinone in a patient with cardiac amyloidosis. Am J Kidney Dis. (2002) 40:E7. 10.1053/ajkd.2002.34552</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/ajkd.2002.34552</ArticleId><ArticleId IdType="pubmed">12148128</ArticleId></ArticleIdList></Reference><Reference><Citation>Antila S, Kivikko M, Lehtonen L, Eha J, Heikkil&#xe4; A, Pohjanjousi P, et al. . Pharmacokinetics of levosimendan and its circulating metabolites in patients with heart failure after an extended continuous infusion of levosimendan. Br J Clin Pharmacol. (2004) 57:412&#x2013;5. 10.1111/j.1365-2125.2003.02043.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2125.2003.02043.x</ArticleId><ArticleId IdType="pmc">PMC1884479</ArticleId><ArticleId IdType="pubmed">15025738</ArticleId></ArticleIdList></Reference><Reference><Citation>Parissis JT, Rafouli-Stergiou P, Paraskevaidis I, Mebazaa A. Levosimendan: from basic science to clinical practice. Heart Fail Rev. (2009) 14:265&#x2013;75. 10.1007/s10741-008-9128-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10741-008-9128-4</ArticleId><ArticleId IdType="pubmed">19101796</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathak A, Lebrin M, Vaccaro A, Senard JM, Despas F. Pharmacology of levosimendan: inotropic, vasodilatory and cardioprotective effects. J Clin Pharm Ther. (2013) 38:341&#x2013;9. 10.1111/jcpt.12067</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpt.12067</ArticleId><ArticleId IdType="pubmed">23594161</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. (2009) 62:1006&#x2013;12. 10.1016/j.jclinepi.2009.06.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2009.06.005</ArticleId><ArticleId IdType="pubmed">19631508</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien SM, Clarke DR, Jacobs JP, Jacobs ML, Lacour-Gayet FG, Pizarro C, et al. . An empirically based tool for analyzing mortality associated with congenital heart surgery. J Thorac Cardiovasc Surg. (2009) 138:1139&#x2013;53. 10.1016/j.jtcvs.2009.03.071</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2009.03.071</ArticleId><ArticleId IdType="pubmed">19837218</ArticleId></ArticleIdList></Reference><Reference><Citation>McSharry B, Straney L, Alexander J, Gentles T, Winlaw D, Beca J, et al. . Australian and New Zealand intensive care society paediatric study group and centre for outcomes and resource evaluation. RACHS - ANZ: a modified risk adjustment in congenital heart surgery model for outcome surveillance in Australia and New Zealand. J Am Heart Assoc. (2019) 8:e011390. 10.1161/JAHA.118.011390</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.118.011390</ArticleId><ArticleId IdType="pmc">PMC6512128</ArticleId><ArticleId IdType="pubmed">31039662</ArticleId></ArticleIdList></Reference><Reference><Citation>Koster G, Wetterslev J, Gluud C, Zijlstra JG, Scheeren TW, van der Horst IC, et al. . Effects of levosimendan for low cardiac output syndrome in critically ill patients: systematic review with meta-analysis and trial sequential analysis. Intensive Care Med. (2015) 41:203&#x2013;21. 10.1007/s00134-014-3604-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-014-3604-1</ArticleId><ArticleId IdType="pubmed">25518953</ArticleId></ArticleIdList></Reference><Reference><Citation>Trifan A, Stanciu C, Girleanu I, Stoica OC, Singeap AM, Maxim R, et al. . Proton pump inhibitors therapy and risk of Clostridium difficile infection: systematic review and meta-analysis. World J Gastroenterol. (2017) 23:6500&#x2013;15. 10.3748/wjg.v23.i35.6500</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v23.i35.6500</ArticleId><ArticleId IdType="pmc">PMC5643276</ArticleId><ArticleId IdType="pubmed">29085200</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng KT, Chan XL, Tan W, Wang CY. Levosimendan use in patients with preoperative low ejection fraction undergoing cardiac surgery: a systematic review with meta-analysis and trial sequential analysis. J Clin Anesth. (2019) 52:37&#x2013;47. 10.1016/j.jclinane.2018.08.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2018.08.019</ArticleId><ArticleId IdType="pubmed">30172838</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P, Wu X, Wang Z, Li Z, Tian X, Wang J, et al. . Effects of levosimendan on mortality in patients undergoing cardiac surgery: a systematic review and meta-analysis. J Card Surg. (2018) 33:322&#x2013;9. 10.1111/jocs.13716</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocs.13716</ArticleId><ArticleId IdType="pubmed">29785788</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedrich JO, Adhikari NK, Beyene J. Ratio of means for analyzing continuous outcomes in meta-analysis performed as well as mean difference methods. J Clin Epidemiol. (2011) 64:556&#x2013;64. 10.1016/j.jclinepi.2010.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.09.016</ArticleId><ArticleId IdType="pubmed">21447428</ArticleId></ArticleIdList></Reference><Reference><Citation>Momeni M, Rubay J, Matta A, Rennotte MT, Veyckemans F, Poncelet AJ, et al. . Levosimendan in congenital cardiac surgery: a randomized, double-blind clinical trial. J Cardiothorac Vasc Anesth. (2011) 25:419&#x2013;24. 10.1053/j.jvca.2010.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2010.07.004</ArticleId><ArticleId IdType="pubmed">20829069</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebade AA, Khalil MA, Mohamed AK. Levosimendan is superior to dobutamine as an inodilator in the treatment of pulmonary hypertension for children undergoing cardiac surgery. J Anesth. (2013) 27:334&#x2013;9. 10.1007/s00540-012-1537-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-012-1537-9</ArticleId><ArticleId IdType="pubmed">23223915</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechner E, Hofer A, Leitner-Peneder G, Freynschlag R, Mair R, Weinzettel R, et al. . Levosimendan versus milrinone in neonates and infants after corrective open-heart surgery: a pilot study. Pediatr Crit Care Med. (2012) 13:542&#x2013;8. 10.1097/PCC.0b013e3182455571</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0b013e3182455571</ArticleId><ArticleId IdType="pubmed">22622649</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellicer A, Riera J, Lopez-Ortego P, Bravo MC, Madero R, Perez-Rodriguez J, et al. . Phase 1 study of two inodilators in neonates undergoing cardiovascular surgery. Pediatr Res. (2013) 73:95&#x2013;103. 10.1038/pr.2012.154</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/pr.2012.154</ArticleId><ArticleId IdType="pubmed">23138399</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci Z, Garisto C, Favia I, Vitale V, Di Chiara L, Cogo PE. Levosimendan infusion in newborns after corrective surgery for congenital heart disease: randomized controlled trial. Intensive Care Med. (2012) 38:1198&#x2013;204. 10.1007/s00134-012-2564-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-012-2564-6</ArticleId><ArticleId IdType="pubmed">22527079</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Gong J, Shi S, Wang J, Gao Y, Wang S, et al. . Levosimendan for pediatric anomalous left coronary artery from the pulmonary artery undergoing repair: a single-center experience. Front Pediatr. (2018) 6:225. 10.3389/fped.2018.00225</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2018.00225</ArticleId><ArticleId IdType="pmc">PMC6102403</ArticleId><ArticleId IdType="pubmed">30155453</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang A, Cui C, Fan Y, Zi J, Zhang J, Wang G, et al. . Prophylactic use of levosimendan in pediatric patients undergoing cardiac surgery: a prospective randomized controlled trial. Crit Care. (2019) 23:428. 10.1186/s13054-019-2704-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2704-2</ArticleId><ArticleId IdType="pmc">PMC6937718</ArticleId><ArticleId IdType="pubmed">31888711</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh CR, Greenberg JH, McArthur E, Thiessen-Philbrook H, Everett AD, Wald R, et al. . Incidence of ESKD and mortality among children with congenital heart disease after cardiac surgery. Clin J Am Soc Nephrol. (2019) 14:1450&#x2013;7. 10.2215/CJN.00690119</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.00690119</ArticleId><ArticleId IdType="pmc">PMC6777584</ArticleId><ArticleId IdType="pubmed">31501090</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer HM, Thomas J, Wilson GS, de Kock M. Anesthesia-related and perioperative mortality: an audit of 8493 cases at a tertiary pediatric teaching hospital in South Africa. Paediatr Anaesth. (2017) 27:1021&#x2013;7. 10.1111/pan.13214</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.13214</ArticleId><ArticleId IdType="pubmed">28857435</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowe S, Brown KL, Pagel C, Muthialu N, Cunningham D, Gibbs J, et al. . Development of a diagnosis- and procedure-based risk model for 30-day outcome after pediatric cardiac surgery. J Thorac Cardiovasc Surg. (2013) 145:1270&#x2013;8. 10.1016/j.jtcvs.2012.06.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2012.06.023</ArticleId><ArticleId IdType="pubmed">22818122</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X, Nie S, Zhang A, Mao J, Liu HP, Xia H, et al. . Acute kidney injury among hospitalized children in China. Clin J Am Soc Nephrol. (2018) 13:1791&#x2013;800. 10.2215/CJN.00800118</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.00800118</ArticleId><ArticleId IdType="pmc">PMC6302328</ArticleId><ArticleId IdType="pubmed">30287424</ArticleId></ArticleIdList></Reference><Reference><Citation>Watkins SC, Williamson K, Davidson M, Donahue BS. Long-term mortality associated with acute kidney injury in children following congenital cardiac surgery. Paediatr Anaesth. (2014) 24:919&#x2013;26. 10.1111/pan.12419</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.12419</ArticleId><ArticleId IdType="pubmed">24823449</ArticleId></ArticleIdList></Reference><Reference><Citation>Santiago MJ, L&#xf3;pez-Herce J, Urbano J, Solana MJ, del Castillo J, S&#xe1;nchez A, et al. . Evolution and mortality risk factors in children with continuous renal replacement therapy after cardiac surgery. Rev Esp Cardiol. (2012) 65:795&#x2013;800. 10.1016/j.rec.2011.12.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rec.2011.12.010</ArticleId><ArticleId IdType="pubmed">22537666</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Abraham R, Efrati O, Mishali D, Yulia F, Vardi A, Barzilay Z, et al. . Predictors for mortality after prolonged mechanical ventilation after cardiac surgery in children. J Crit Care. (2002) 17:235&#x2013;9. 10.1053/jcrc.2002.36760</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jcrc.2002.36760</ArticleId><ArticleId IdType="pubmed">12501150</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers L, Ray S, Johnson M4, Feinstein Y, Dominguez TE, Peters MJ, et al. . The inadequate oxygen delivery index and low cardiac output syndrome score as predictors of adverse events associated with low cardiac output syndrome early after cardiac bypass. Pediatr Crit Care Med. (2019) 20:737&#x2013;43. 10.1097/PCC.0000000000001960</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000001960</ArticleId><ArticleId IdType="pubmed">31033863</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabib A, Abrishami SE1, Mahdavi M1, Mortezaeian H1, Totonchi Z. Predictors of prolonged mechanical ventilation in pediatric patients after cardiac surgery for congenital heart disease. Res Cardiovasc Med. (2016) 5:e30391. 10.5812/cardiovascmed.30391</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/cardiovascmed.30391</ArticleId><ArticleId IdType="pmc">PMC5219893</ArticleId><ArticleId IdType="pubmed">28105408</ArticleId></ArticleIdList></Reference><Reference><Citation>Truijen J, Westerhof BE, Kim YS, Stok WJ, de Mol BA, Preckel B, et al. . The effect of haemodynamic and peripheral vascular variability on cardiac output monitoring: thermodilution and non-invasive pulse contour cardiac output during cardiothoracic surgery. Anaesthesia. (2018) 73:1489&#x2013;99. 10.1111/anae.14380</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.14380</ArticleId><ArticleId IdType="pubmed">30074237</ArticleId></ArticleIdList></Reference><Reference><Citation>Milligan DJ, Fields AM. Levosimendan: calcium sensitizer and inodilator. Anesthesiol Clin. (2010) 28:753&#x2013;60. 10.1016/j.anclin.2010.08.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anclin.2010.08.003</ArticleId><ArticleId IdType="pubmed">21074750</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J, Zhang Y, Chen L, He Y, Qing X. Levosimendan in patients with low cardiac output syndrome undergoing cardiac surgery: a systematic review and meta-analysis. Anaesth Crit Care Pain Med. (2019) 38:243&#x2013;9. 10.1016/j.accpm.2018.08.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.accpm.2018.08.005</ArticleId><ArticleId IdType="pubmed">30342103</ArticleId></ArticleIdList></Reference><Reference><Citation>Tena M&#xc1;, Urso S, Gonz&#xe1;lez JM, Santana L, Sadaba R, Juarez P, et al. . Levosimendan versus placebo in cardiac surgery: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg. (2018) 27:677&#x2013;85. 10.1093/icvts/ivy133</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivy133</ArticleId><ArticleId IdType="pubmed">29718383</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno E, V&#xe1;zquez-Polo FJ, Negr&#xed;n MA. Bayesian meta-analysis: the role of the between-sample heterogeneity. Stat Methods Med Res. (2018) 27:3643&#x2013;57. 10.1177/0962280217709837</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280217709837</ArticleId><ArticleId IdType="pubmed">28511616</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L, Sun W, Zhang K, Zhou B, Kong X. Perioperative sildenafil therapy in pediatric congenital cardiac disease patients. Int Heart J. (2018) 59:1333&#x2013;9. 10.1536/ihj.17-548</Citation><ArticleIdList><ArticleId IdType="doi">10.1536/ihj.17-548</ArticleId><ArticleId IdType="pubmed">30249921</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">17276098</PMID><DateCompleted><Year>2007</Year><Month>06</Month><Day>20</Day></DateCompleted><DateRevised><Year>2014</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1078-5884</ISSN><JournalIssue CitedMedium="Print"><Volume>33</Volume><Issue>5</Issue><PubDate><Year>2007</Year><Month>May</Month></PubDate></JournalIssue><Title>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</Title><ISOAbbreviation>Eur J Vasc Endovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Acute renal injury and dysfunction following elective abdominal aortic surgery.</ArticleTitle><Pagination><StartPage>550</StartPage><EndPage>555</EndPage><MedlinePgn>550-5</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To evaluate the incidence of kidney injury and acute renal dysfunction (ARD) and associated risk factors in open abdominal aortic surgery.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">69 patients undergoing elective infrarenal aortic repair were included in a prospective study. Anaesthesia and haemodynamic management were standardised targeting a mean arterial pressure (MAP) of 70-90 mmHg, pulmonary artery occlusion pressure of 12-14 mmHg and cardiac index &gt;or=2.4 l/min/m(2). Urinary albumin-creatinine and N-acetyl-B-D-glucosaminidase-creatinine ratios were measured as indicators of kidney injury. The definition of ARD was based on the RIFLE criteria.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Kidney injury was found in most patients. ARD developed in 22% of the patients, and acute renal failure in 4%. The patients with ARD were older, and had lower plasma creatinine and estimated GFR before surgery. ARD was associated with intraoperative hypotension (MAP &lt;60 mmHg &gt;15 min), low cardiac index (&lt;2.4 l/min/m(2)), rhabdomyolysis, and early reoperation. Intraoperative hypotension and postoperative low cardiac output were independent risk factors for ARD in multivariate analysis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Kidney injury occurs in most patients undergoing infrarenal aortic surgery, but only 22% develop acute renal dysfunction. Hypotension and low cardiac output are risk factors that could be avoided by optimizing perioperative management.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tallgren</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care Medicine, Helsinki University Hospital, Helsinki, Finland. minna.tallgren@hus.fi</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niemi</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>P&#xf6;yhi&#xe4;</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Raininko</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Railo</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Salmenper&#xe4;</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Lep&#xe4;ntalo</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Hynninen</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2007</Year><Month>02</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Vasc Endovasc Surg</MedlineTA><NlmUniqueID>9512728</NlmUniqueID><ISSNLinking>1078-5884</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.1.52</RegistryNumber><NameOfSubstance UI="D000118">Acetylglucosaminidase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000118" MajorTopicYN="N">Acetylglucosaminidase</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000419" MajorTopicYN="N">Albuminuria</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017544" MajorTopicYN="N">Aortic Aneurysm, Abdominal</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002303" MajorTopicYN="N">Cardiac Output, Low</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="N">Glomerular Filtration Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014656" MajorTopicYN="N">Vascular Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2006</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2006</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>2</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>6</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>2</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17276098</ArticleId><ArticleId IdType="doi">10.1016/j.ejvs.2006.12.005</ArticleId><ArticleId IdType="pii">S1078-5884(06)00738-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27344977</PMID><DateCompleted><Year>2017</Year><Month>02</Month><Day>17</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1755-5922</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>5</Issue><PubDate><Year>2016</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Cardiovascular therapeutics</Title><ISOAbbreviation>Cardiovasc Ther</ISOAbbreviation></Journal><ArticleTitle>Impact of antioxidant supplementations on cardio-renal protection in cardiac surgery: an updated and comprehensive meta-analysis and systematic review.</ArticleTitle><Pagination><StartPage>360</StartPage><EndPage>370</EndPage><MedlinePgn>360-70</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/1755-5922.12207</ELocationID><Abstract><AbstractText>This systematic review with meta-analysis sought to determine the strength of evidence in terms of the impact of common antioxidant supplementations, such as N-acetylcysteine (NAC), vitamin C, and polyunsaturated fatty acids (PUFA) on perioperative outcomes after cardiac surgery with particular focus on the incidence of atrial fibrillation (AF) and acute kidney injury (AKI) with associated mortality. A total of 29 trials were identified that reported incidence of AF and 17 trials that reported incidence of AKI. Pooled analysis reported that NAC (OR=0.5; P=.001), vitamin C (OR=0.4; P=.001), and PUFA (OR=0.8; P=.01) administration were associated with significantly reduced incidence of AF. In terms of postoperative AKI, only NAC was shown to be a beneficial supplement that was able to significantly reduce the incidence of AKI (OR=0.7; P=.01), and NAC could also significantly decrease overall mortality (OR=0.3; P=.03) following cardiac surgery. The use of NAC in patients undergoing cardiac surgery should be strongly recommended due to its combined cardio-renal protective effects and reduced mortality. Also, PUFA and vitamin C might be able to significantly decrease the incidence of arrhythmia; however, reno-protective effects and impact on overall mortality of these supplements seem to be less impressive.</AbstractText><CopyrightInformation>&#xa9; 2016 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ali- Hasan- Al- Saegh</LastName><ForeName>Sadeq</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Mirhosseini</LastName><ForeName>Seyed Jalil</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tahernejad</LastName><ForeName>Mahbube</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahdavi</LastName><ForeName>Parisa</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shahidzadeh</LastName><ForeName>Azadeh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karimi-Bondarabadi</LastName><ForeName>Ali Akbar</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dehghan</LastName><ForeName>Ali-Mohammad</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahimizadeh</LastName><ForeName>Elham</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haddad</LastName><ForeName>Fatemeh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Physiology, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghodratipour</LastName><ForeName>Zahra</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarrafan-Chaharsoughi</LastName><ForeName>Zahra</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shahidzadeh</LastName><ForeName>Arezoo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghanei</LastName><ForeName>Azam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lotfaliani</LastName><ForeName>Mohammadreza</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeriouh</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Transplantation and Mechanical Circulatory Support, Royal Brompton &amp; Harefield NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weymann</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Transplantation and Mechanical Circulatory Support, Royal Brompton &amp; Harefield NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Thoracic and Cardiovascular Surgery, University Hospital Heidelberg, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Popov</LastName><ForeName>Aron-Frederik</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Transplantation and Mechanical Circulatory Support, Royal Brompton &amp; Harefield NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabashnikov</LastName><ForeName>Anton</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Transplantation and Mechanical Circulatory Support, Royal Brompton &amp; Harefield NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cardiovasc Ther</MedlineTA><NlmUniqueID>101319630</NlmUniqueID><ISSNLinking>1755-5914</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005231">Fatty Acids, Unsaturated</NameOfSubstance></Chemical><Chemical><RegistryNumber>PQ6CK8PD0R</RegistryNumber><NameOfSubstance UI="D001205">Ascorbic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>WYQ7N0BPYC</RegistryNumber><NameOfSubstance UI="D000111">Acetylcysteine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Cardiovasc Ther. 2017 Aug;35(4). doi: 10.1111/1755-5922.12287.</RefSource><PMID Version="1">28710826</PMID><Note>Ali-Hassan-Sayegh, Sadegh [corrected to Ali- Hasan- Al- Saegh, Sadeq]</Note></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000111" MajorTopicYN="N">Acetylcysteine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000975" MajorTopicYN="N">Antioxidants</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001205" MajorTopicYN="N">Ascorbic Acid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019587" MajorTopicYN="Y">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005231" MajorTopicYN="N">Fatty Acids, Unsaturated</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute renal injury</Keyword><Keyword MajorTopicYN="N">Atrial fibrillation</Keyword><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">N-acetylcysteine</Keyword><Keyword MajorTopicYN="N">Polyunsaturated fatty acids</Keyword><Keyword MajorTopicYN="N">Vitamin C</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27344977</ArticleId><ArticleId IdType="doi">10.1111/1755-5922.12207</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34512331</PMID><DateRevised><Year>2021</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1663-9812</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in pharmacology</Title><ISOAbbreviation>Front Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Cardio- and Cerebrovascular Outcomes of Postoperative Acute Kidney Injury in Noncardiac Surgical Patients With Hypertension.</ArticleTitle><Pagination><StartPage>696456</StartPage><MedlinePgn>696456</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">696456</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fphar.2021.696456</ELocationID><Abstract><AbstractText><b>Background:</b> The cardiovascular and cerebrovascular risk of postoperative acute kidney injury (AKI) in surgical patients is poorly described, especially in the hypertensive population. <b>Methods</b>: We conducted a retrospective cohort study among all hypertensive patients who underwent elective noncardiac surgery from January 1st, 2012 to August 1st, 2017 at the Third Xiangya Hospital. The primary outcomes were fatal stroke and fatal myocardial infarction (MI). The secondary outcomes were all-cause mortality. <b>Results:</b> The postoperative cumulative mortality within 3&#xa0;months, 6&#xa0;months, 1&#xa0;year, 2&#xa0;years, and 5&#xa0;years were 1.27, 1.48, 2.15, 2.15, and 5.36%, for fatal stroke, and 2.05, 2.27, 2.70, 3.37, and 5.61% for fatal MI, respectively, in patients with postoperative AKI. Compared with non-AKI patients, those with postoperative AKI had a significantly higher risk of fatal stroke and fatal MI within 3&#xa0;months [hazard ratio (HR): 5.49 (95% CI: 1.88-16.00) and 11.82 (95% CI: 4.56-30.62), respectively], 6&#xa0;months [HR: 3.58 (95% CI: 1.43-8.97) and 9.23 (95% CI: 3.89-21.90), respectively], 1&#xa0;year [HR: 3.64 (95% CI: 1.63-8.10) and 5.14 (95% CI: 2.50-10.57), respectively], 2&#xa0;years [HR: 2.21 (95% CI: 1.03-4.72) and 3.06 (95% CI: 1.66-5.64), respectively], and 5&#xa0;years [HR: 2.27 (95% CI: 1.30-3.98) and 1.98 (95% CI: 1.16-3.20), respectively]. In subgroup analysis of perioperative blood pressure (BP) lowering administration, postoperative AKI was significantly associated with 1-year and 5-year risk of fatal stroke [HR: 9.46 (95% CI: 2.85-31.40) and 3.88 (95% CI: 1.67-9.01), respectively] in patients with ACEI/ARB, and MI [HR: 6.62 (95% CI: 2.23-19.62) and 2.44 (95% CI: 1.22-4.90), respectively] in patients with CCB. <b>Conclusion:</b> Hypertensive patients with postoperative AKI have a significantly higher risk of fatal stroke and fatal MI, as well as all-cause mortality, within 5&#xa0;years after elective noncardiac surgery. In patients with perioperative administration of ACEI/ARB and CCB, postoperative AKI was significantly associated with higher risk of fatal stroke and MI, respectively.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Guangyu, Jingfeng, Xing, Hong and Yao.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guangyu</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center of Clinical Research, The Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General Surgery, The Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jingfeng</LastName><ForeName>Lou</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center of Clinical Research, The Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xing</LastName><ForeName>Liu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, The Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center of Clinical Research, The Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center of Clinical Research, The Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Life Science and Medicine, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Medical Information Research(Central South University), College of Hunan Province, Changsha, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pharmacol</MedlineTA><NlmUniqueID>101548923</NlmUniqueID><ISSNLinking>1663-9812</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cardiovascular and cerebrovascular outcomes</Keyword><Keyword MajorTopicYN="N">hypertension</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">noncardiac surgery</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>8</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34512331</ArticleId><ArticleId IdType="pmc">PMC8430207</ArticleId><ArticleId IdType="doi">10.3389/fphar.2021.696456</ArticleId><ArticleId IdType="pii">696456</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Anzai A., Anzai T., Naito K., Kaneko H., Mano Y., Jo Y., et al. (2010). Prognostic Significance of Acute Kidney Injury After Reperfused ST-Elevation Myocardial Infarction: Synergistic Acceleration of Renal Dysfunction and Left Ventricular Remodeling. J. Card. Fail. 16, 381&#x2013;389. 10.1016/j.cardfail.2009.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardfail.2009.12.020</ArticleId><ArticleId IdType="pubmed">20447573</ArticleId></ArticleIdList></Reference><Reference><Citation>Arias-Cabrales C., Rodr&#xed;guez E., Bermejo S., Sierra A., Burballa C., Barrios C., et al. (2018). Short- and Long-Term Outcomes after Non-severe Acute Kidney Injury. Clin. Exp. Nephrol. 22, 61&#x2013;67. 10.1007/s10157-017-1420-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10157-017-1420-y</ArticleId><ArticleId IdType="pubmed">28551821</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartekova M., Radosinska J., Jelemensky M., Dhalla N. S. (2018). Role of Cytokines and Inflammation in Heart Function during Health and Disease. Heart Fail. Rev. 23, 733&#x2013;758. 10.1007/s10741-018-9716-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10741-018-9716-x</ArticleId><ArticleId IdType="pubmed">29862462</ArticleId></ArticleIdList></Reference><Reference><Citation>Beattie W. S., Wijeysundera D. N., Karkouti K., McCluskey S., Tait G. (2008). Does Tight Heart Rate Control Improve Beta-Blocker Efficacy? An Updated Analysis of the Noncardiac Surgical Randomized Trials. Anesth. Analgesia 106, 1039&#x2013;1048. 10.1213/ane.0b013e318163f6a9</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e318163f6a9</ArticleId><ArticleId IdType="pubmed">18349171</ArticleId></ArticleIdList></Reference><Reference><Citation>Chawla L. S., Kimmel P. L. (2012). Acute Kidney Injury and Chronic Kidney Disease: an Integrated Clinical Syndrome. Kidney Int. 82, 516&#x2013;524. 10.1038/ki.2012.208</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2012.208</ArticleId><ArticleId IdType="pubmed">22673882</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xe9;pret F., Prud'homme M., Legrand M. (2017). A Role of Remote Organs Effect in Acute Kidney Injury Outcome. Nephron 137, 273&#x2013;276. 10.1159/000476077</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000476077</ArticleId><ArticleId IdType="pubmed">28586768</ArticleId></ArticleIdList></Reference><Reference><Citation>Dix P., Howell S. (2001). Survey of Cancellation Rate of Hypertensive Patients Undergoing Anaesthesia and Elective Surgery. Br. J. Anaesth. 86, 789&#x2013;793. 10.1093/bja/86.6.789</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/86.6.789</ArticleId><ArticleId IdType="pubmed">11573584</ArticleId></ArticleIdList></Reference><Reference><Citation>Gameiro J., Duarte I., Marques F., Fonseca J. A., Jorge S., Rosa R., et al. (2020). Transient and Persistent AKI and Outcomes in Patients Undergoing Major Abdominal Surgery. Nephron 144, 236&#x2013;244. 10.1159/000506397</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000506397</ArticleId><ArticleId IdType="pubmed">32316024</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas C. E., LeBlanc J. M. (2004). Acute Postoperative Hypertension: A Review of Therapeutic Options. Am. J. Health-System Pharm. 61, 1661&#x2013;1673. 10.1093/ajhp/61.16.1661</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajhp/61.16.1661</ArticleId><ArticleId IdType="pubmed">15540477</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen M. K., Gammelager H., Mikkelsen M. M., Hjortdal V. E., Layton J. B., Johnsen S. P., et al. (2013). Post-operative Acute Kidney Injury and Five-Year Risk of Death, Myocardial Infarction, and Stroke Among Elective Cardiac Surgical Patients: a Cohort Study. Crit. Care 17, R292. 10.1186/cc13158</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13158</ArticleId><ArticleId IdType="pmc">PMC4057271</ArticleId><ArticleId IdType="pubmed">24330762</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollmann C., Fernandes N. L., Biccard B. M. (2018). A Systematic Review of Outcomes Associated with Withholding or Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Before Noncardiac Surgery. Anesth. Analgesia 127, 678&#x2013;687. 10.1213/ane.0000000000002837</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0000000000002837</ArticleId><ArticleId IdType="pubmed">29381513</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikehata Y., Tanaka T., Ichihara K., Kobayashi K., Kitamura H., Takahashi S., et al. (2016). Incidence and Risk Factors for Acute Kidney Injury after Radical Cystectomy. Int. J. Urol. 23, 558&#x2013;563. 10.1111/iju.13104</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/iju.13104</ArticleId><ArticleId IdType="pubmed">27168129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishani A., Xue J. L., Himmelfarb J., Eggers P. W., Kimmel P. L., Molitoris B. A., et al. (2009). Acute Kidney Injury Increases Risk of ESRD Among Elderly. J. Am. Soc. Nephrol. 20, 223&#x2013;228. 10.1681/asn.2007080837</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/asn.2007080837</ArticleId><ArticleId IdType="pmc">PMC2615732</ArticleId><ArticleId IdType="pubmed">19020007</ArticleId></ArticleIdList></Reference><Reference><Citation>James M. T., Ghali W. A., Knudtson M. L., Ravani P., Tonelli M., Faris P., et al. (2011). Associations Between Acute Kidney Injury and Cardiovascular and Renal Outcomes After Coronary Angiography. Circulation 123, 409&#x2013;416. 10.1161/circulationaha.110.970160</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circulationaha.110.970160</ArticleId><ArticleId IdType="pubmed">21242477</ArticleId></ArticleIdList></Reference><Reference><Citation>Kline J., Rachoin J.-S. (2013). Acute Kidney Injury and Chronic Kidney Disease: It's a Two-Way Street. Ren. Fail. 35, 452&#x2013;455. 10.3109/0886022x.2013.766572</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/0886022x.2013.766572</ArticleId><ArticleId IdType="pubmed">23409917</ArticleId></ArticleIdList></Reference><Reference><Citation>Kork F., Balzer F., Spies C. D., Wernecke K.-D., Ginde A. A., Jankowski J., et al. (2015). Minor Postoperative Increases of Creatinine Are Associated with Higher Mortality and Longer Hospital Length of Stay in Surgical Patients. Anesthesiology 123, 1301&#x2013;1311. 10.1097/aln.0000000000000891</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aln.0000000000000891</ArticleId><ArticleId IdType="pmc">PMC4679549</ArticleId><ArticleId IdType="pubmed">26492475</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau D., Pannu N., James M. T., Hemmelgarn B. R., Kieser T. M., Meyer S. R., et al. (2020). Costs and Consequences of Acute Kidney Injury after Cardiac Surgery: A Cohort Study. J. Thorac. Cardiovasc. Surg. S0022-5223, 30516. 10.1016/j.jtcvs.2020.01.101</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2020.01.101</ArticleId><ArticleId IdType="pubmed">32299694</ArticleId></ArticleIdList></Reference><Reference><Citation>Legrand M., Rossignol P. (2020). Cardiovascular Consequences of Acute Kidney Injury. N. Engl. J. Med. 382, 2238&#x2013;2247. 10.1056/nejmra1916393</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmra1916393</ArticleId><ArticleId IdType="pubmed">32492305</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., Wu X., Lopez A. D., Wang L., Cai Y., Page A., et al. (2016). An Integrated National Mortality Surveillance System for Death Registration and Mortality Surveillance, China. Bull. World Health Organ. 94, 46&#x2013;57. 10.2471/blt.15.153148</Citation><ArticleIdList><ArticleId IdType="doi">10.2471/blt.15.153148</ArticleId><ArticleId IdType="pmc">PMC4709796</ArticleId><ArticleId IdType="pubmed">26769996</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Mart&#xed;nez E., Buonafine M., Boukhalfa I., Ibarrola J., Fern&#xe1;ndez-Celis A., Kolkhof P., et al. (2017). Aldosterone Target NGAL (Neutrophil Gelatinase-Associated Lipocalin) Is Involved in Cardiac Remodeling After Myocardial Infarction through NF&#x3ba;B Pathway. Hypertension 70, 1148&#x2013;1156. 10.1161/hypertensionaha.117.09791</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/hypertensionaha.117.09791</ArticleId><ArticleId IdType="pubmed">29061727</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Connor M. E., Kirwan C. J., Pearse R. M., Prowle J. R. (2016). Incidence and Associations of Acute Kidney Injury after Major Abdominal Surgery. Intensive Care Med. 42, 521&#x2013;530. 10.1007/s00134-015-4157-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-4157-7</ArticleId><ArticleId IdType="pubmed">26602784</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Connor M. E., Hewson R. W., Kirwan C. J., Ackland G. L., Pearse R. M., Prowle J. R. (2017). Acute Kidney Injury and Mortality 1 Year after Major Non-cardiac Surgery. Br. J. Surg. 104, 868&#x2013;876. 10.1002/bjs.10498</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.10498</ArticleId><ArticleId IdType="pubmed">28218392</ArticleId></ArticleIdList></Reference><Reference><Citation>Odutayo A., Wong C. X., Farkouh M., Altman D. G., Hopewell S., Emdin C. A., et al. (2017). AKI and Long-Term Risk for Cardiovascular Events and Mortality. J. Am. Soc. Nephrol. 28, 377&#x2013;387. 10.1681/asn.2016010105</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/asn.2016010105</ArticleId><ArticleId IdType="pmc">PMC5198285</ArticleId><ArticleId IdType="pubmed">27297949</ArticleId></ArticleIdList></Reference><Reference><Citation>Palevsky P. M., Liu K. D., Brophy P. D., Chawla L. S., Parikh C. R., Thakar C. V., et al. (2013). KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Acute Kidney Injury. Am. J. Kidney Dis. 61, 649&#x2013;672. 10.1053/j.ajkd.2013.02.349</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2013.02.349</ArticleId><ArticleId IdType="pubmed">23499048</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco C., Bellasi A., Di Lullo L. (2018). Cardiorenal Syndrome: An Overview. Adv. Chronic Kidney Dis. 25, 382&#x2013;390. 10.1053/j.ackd.2018.08.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ackd.2018.08.004</ArticleId><ArticleId IdType="pubmed">30309455</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco C., Haapio M., House A. A., Anavekar N., Bellomo R. (2008). Cardiorenal Syndrome. J. Am. Coll. Cardiol. 52, 1527&#x2013;1539. 10.1016/j.jacc.2008.07.051</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2008.07.051</ArticleId><ArticleId IdType="pubmed">19007588</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders R. D., Hughes F., Shaw A., Thompson A., Bader A., Hoeft A., et al. (2019). Perioperative Quality Initiative Consensus Statement on Preoperative Blood Pressure, Risk and Outcomes for Elective Surgery. Br. J. Anaesth. 122, 552&#x2013;562. 10.1016/j.bja.2019.01.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2019.01.018</ArticleId><ArticleId IdType="pubmed">30916006</ArticleId></ArticleIdList></Reference><Reference><Citation>See E. J., Jayasinghe K., Glassford N., Bailey M., Johnson D. W., Polkinghorne K. R., et al. (2019). Long-term Risk of Adverse Outcomes after Acute Kidney Injury: a Systematic Review and Meta-Analysis of Cohort Studies Using Consensus Definitions of Exposure. Kidney Int. 95, 160&#x2013;172. 10.1016/j.kint.2018.08.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2018.08.036</ArticleId><ArticleId IdType="pubmed">30473140</ArticleId></ArticleIdList></Reference><Reference><Citation>Susantitaphong P., Cruz D. N., Cerda J., Abulfaraj M., Alqahtani F., Koulouridis I., et al. (2013). World Incidence of AKI: A Meta-Analysis. Clin. J. Am. Soc. Nephrol. 8, 1482&#x2013;1493. 10.2215/cjn.00710113</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/cjn.00710113</ArticleId><ArticleId IdType="pmc">PMC3805065</ArticleId><ArticleId IdType="pubmed">23744003</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarjus A., Mart&#xed;nez-Mart&#xed;nez E., Amador C., Latouche C., El Moghrabi S., Berger T., et al. (2015). Neutrophil Gelatinase-Associated Lipocalin, a Novel Mineralocorticoid Biotarget, Mediates Vascular Profibrotic Effects of Mineralocorticoids. Hypertension 66, 158&#x2013;166. 10.1161/hypertensionaha.115.05431</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/hypertensionaha.115.05431</ArticleId><ArticleId IdType="pubmed">25987661</ArticleId></ArticleIdList></Reference><Reference><Citation>Yacoub R., Patel N., Lohr J. W., Rajagopalan S., Nader N., Arora P. (2013). Acute Kidney Injury and Death Associated with Renin Angiotensin System Blockade in Cardiothoracic Surgery: a Meta-Analysis of Observational Studies. Am. J. Kidney Dis. 62, 1077&#x2013;1086. 10.1053/j.ajkd.2013.04.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2013.04.018</ArticleId><ArticleId IdType="pubmed">23791246</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32927705</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2308-3425</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Sep</Month><Day>10</Day></PubDate></JournalIssue><Title>Journal of cardiovascular development and disease</Title><ISOAbbreviation>J Cardiovasc Dev Dis</ISOAbbreviation></Journal><ArticleTitle>Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Cardiac Surgery: Meta-Analysis and Systematic Review of the Literature.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">36</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcdd7030036</ELocationID><Abstract><AbstractText>The number of patients with severe aortic stenosis (AS) and a history of prior cardiac surgery has increased. Prior cardiac surgery increases the risk of adverse outcomes in patients undergoing aortic valve replacement. To evaluate the impact of prior cardiac surgery on clinical endpoints in patients undergoing transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR), we performed a literature search using PubMed, Embase, Google Scholar, and Scopus databases. The clinical endpoints included in our study were 30-day mortality, 1-2-year mortality, acute kidney injury (AKI), bleeding, stroke, procedural time, and duration of hospital stay. Seven studies, which included a total of 8221 patients, were selected. Our study found that TAVR was associated with a lower incidence of stroke and bleeding complications. There was no significant difference in terms of AKI, 30-day all-cause mortality, and 1-2-year all-cause mortality between the two groups. The average procedure time and duration of hospital stay were 170 min less (<i>p</i> &#x2264; 0.01) and 3.6 days shorter (<i>p</i> &lt; 0.01) in patients with TAVR, respectively. In patients with prior coronary artery bypass graft and severe AS, both TAVR and SAVR are reasonable options. However, TAVR may be associated with a lower incidence of complications like stroke and perioperative bleeding, in addition to a shorter length of stay.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Latif</LastName><ForeName>Azka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Creighton University, Omaha, NE 68124, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lateef</LastName><ForeName>Noman</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Creighton University, Omaha, NE 68124, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahsan</LastName><ForeName>Muhammad Junaid</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-2472-9379</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Creighton University, Omaha, NE 68124, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kapoor</LastName><ForeName>Vikas</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Creighton University, Omaha, NE 68124, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Usman</LastName><ForeName>Rana Mohammad</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Tennessee, Memphis, TN 38152, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cooper</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Creighton University, Omaha, NE 68124, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andukuri</LastName><ForeName>Venkata</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Creighton University, Omaha, NE 68124, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mirza</LastName><ForeName>Mohsin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Creighton University, Omaha, NE 68124, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashfaq</LastName><ForeName>Muhammad Zubair</ForeName><Initials>MZ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Creighton University, Omaha, NE 68124, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khouzam</LastName><ForeName>Rami</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University of Tennessee, Memphis, TN 38152, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Cardiovasc Dev Dis</MedlineTA><NlmUniqueID>101651414</NlmUniqueID><ISSNLinking>2308-3425</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SAVR</Keyword><Keyword MajorTopicYN="N">TAVR</Keyword><Keyword MajorTopicYN="N">in-hospital outcomes</Keyword><Keyword MajorTopicYN="N">prior CABG</Keyword><Keyword MajorTopicYN="N">redo-AVR</Keyword><Keyword MajorTopicYN="N">short-term outcomes</Keyword><Keyword MajorTopicYN="N">surgical aortic valve replacement</Keyword><Keyword MajorTopicYN="N">transcatheter aortic valve replacement</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>15</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>9</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32927705</ArticleId><ArticleId IdType="pmc">PMC7570107</ArticleId><ArticleId IdType="doi">10.3390/jcdd7030036</ArticleId><ArticleId IdType="pii">jcdd7030036</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Goldbarg S.H., Elmariah S., Miller M.A., Fuster V. Insights Into Degenerative Aortic Valve Disease. J. Am. Coll. Cardiol. 2007;50:1205&#x2013;1213. doi: 10.1016/j.jacc.2007.06.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2007.06.024</ArticleId><ArticleId IdType="pubmed">17888836</ArticleId></ArticleIdList></Reference><Reference><Citation>Nkomo V.T., Gardin J.M., Skelton T.N., Gottdiener J.S., Scott C.G., Enriquez-Sarano M. Burden of valvular heart diseases: A population-based study. Lancet. 2006;368:1005&#x2013;1011. doi: 10.1016/S0140-6736(06)69208-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(06)69208-8</ArticleId><ArticleId IdType="pubmed">16980116</ArticleId></ArticleIdList></Reference><Reference><Citation>Popma J.J., Adams D.H., Reardon M.J., Yakubov S.J., Kleiman N.S., Heimansohn D., Hermiller J., Hughes G.C., Harrison J.K., Coselli J., et al. Transcatheter Aortic Valve Replacement Using a Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis at Extreme Risk for Surgery. J. Am. Coll. Cardiol. 2014;63:1972&#x2013;1981. doi: 10.1016/j.jacc.2014.02.556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2014.02.556</ArticleId><ArticleId IdType="pubmed">24657695</ArticleId></ArticleIdList></Reference><Reference><Citation>Drews T., Pasic M., Buz S., Unbehaun A., Dreysse S., Kukucka M., Mladenow A., Hetzer R. Transapical aortic valve implantation after previous heart surgery. Eur. J. Cardio-Thoracic Surg. 2011;39:625&#x2013;630. doi: 10.1016/j.ejcts.2010.06.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2010.06.023</ArticleId><ArticleId IdType="pubmed">20691604</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilbring M., Tugtekin S.-M., Alexiou K., Simonis G., Matschke K., Kappert U. Transapical transcatheter aortic valve implantation vs conventional aortic valve replacement in high-risk patients with previous cardiac surgery: A propensity-score analysis&#x2020;. Eur. J. Cardio-Thoracic Surg. 2013;44:42&#x2013;47. doi: 10.1093/ejcts/ezs680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezs680</ArticleId><ArticleId IdType="pubmed">23345180</ArticleId></ArticleIdList></Reference><Reference><Citation>Greason K.L., Mathew V., Suri R.M., Holmes D.R., Rihal C.S., McAndrew T., Xu K., Mack M., Webb J.G., Pichard A., et al. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Graft Operation: A PARTNER Trial Subgroup Analysis. Ann. Thorac. Surg. 2014;98:1&#x2013;8. doi: 10.1016/j.athoracsur.2014.02.079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2014.02.079</ArticleId><ArticleId IdType="pubmed">24881859</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulos N., Schiller N., Fichtlscherer S., Lehmann R., Weber C.F., Moritz A., Doss M., Zierer A. Propensity matched analysis of longterm outcomes following transcatheter based aortic valve implantation versus classic aortic valve replacement in patients with previous cardiac surgery. J. Cardiothorac. Surg. 2014;9:99. doi: 10.1186/1749-8090-9-99.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-8090-9-99</ArticleId><ArticleId IdType="pmc">PMC4073508</ArticleId><ArticleId IdType="pubmed">24915763</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendt D., Al-Rashid F., Kahlert P., El-Chilali K., Demircioglu E., Neuh&#xe4;user M., Liakopoulos O., Dohle D.S., Erbel. R., Jakob H., et al. Conventional aortic valve replacement or transcatheter aortic valve implantation in patients with previous cardiac surgery. J. Cardiol. 2015;66:292&#x2013;297. doi: 10.1016/j.jjcc.2015.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jjcc.2015.04.003</ArticleId><ArticleId IdType="pubmed">25975735</ArticleId></ArticleIdList></Reference><Reference><Citation>Conte J., Gleason T.G., Resar J.R., Adams D.H., Deeb G.M., Popma J.J., Hughes G.C., Zorn G.L., Reardon M.J. Transcatheter or Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting. Ann. Thorac. Surg. 2016;101:72&#x2013;79. doi: 10.1016/j.athoracsur.2015.06.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2015.06.067</ArticleId><ArticleId IdType="pubmed">26433523</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Redfors B., Ben-Yehuda O., Crowley A., Greason K.L., Alu M.C., Finn M.T., Vahl T.P., Nazif T., Thourani V.H., et al. Transcatheter versus surgical aortic valve replacement in patients with prior cardiac surgery in the randomized PARTNER 2A trial. JACC Cardiovasc. Interv. 2018;11:2207&#x2013;2216. doi: 10.1016/j.jcin.2018.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2018.08.006</ArticleId><ArticleId IdType="pubmed">30409278</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta T., Khera S., Kolte D., Goel K., Kalra A., Villablanca P.A., Aronow H.D., Abbott J.D., Fonarow G.C., Taub C.C., et al. Transcatheter versus surgical aortic valve replacement in patients with prior coronary artery bypass grafting: Trends in utilization and propensity-matched analysis of in-hospital outcomes. Circ. Cardiovasc. Interv. 2018;11:e006179. doi: 10.1161/CIRCINTERVENTIONS.117.006179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCINTERVENTIONS.117.006179</ArticleId><ArticleId IdType="pubmed">29643130</ArticleId></ArticleIdList></Reference><Reference><Citation>Fighali S.F., Avendan&#xf1;o A., Elayda M.A., Lee V.V., Hernandez C., Siero V., Leachman R.D., Cooley D.A. Early and Late Mortality of Patients Undergoing Aortic Valve Replacement After Previous Coronary Artery Bypass Graft Surgery. Circulation. 1995;92:163&#x2013;168. doi: 10.1161/01.CIR.92.9.163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.92.9.163</ArticleId><ArticleId IdType="pubmed">7586402</ArticleId></ArticleIdList></Reference><Reference><Citation>Medtronic Transcatheter Aortic Valve Replacement in Low Risk Patients. January 16, 2018.  [(accessed on 5 July 2020)]; Available online:  https://clinicaltrials.gov/ct2/show/NCT02701283.</Citation></Reference><Reference><Citation>Mack M.C., Szerlip M., A Herbert M., Akram S., Worley C., Kim R.J., Prince B.A., Harrington K.B., Mack M.J., Holper E.M. Outcomes of Treatment of Nonagenarians With Severe Aortic Stenosis. Ann. Thorac. Surg. 2015;100:74&#x2013;80. doi: 10.1016/j.athoracsur.2015.02.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2015.02.045</ArticleId><ArticleId IdType="pubmed">26013708</ArticleId></ArticleIdList></Reference><Reference><Citation>Rein&#xf6;hl J., Kaier K., Reinecke H., Frankenstein L., Zirlik A., Zehender M., Muhlen C.V.Z., Bode C., Stachon P. Transcatheter Aortic Valve Replacement. JACC Cardiovasc. Interv. 2016;9:2137&#x2013;2143. doi: 10.1016/j.jcin.2016.07.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2016.07.035</ArticleId><ArticleId IdType="pubmed">27765308</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalluri N., Atti V., Munir A.B., Karam B., Patel N., Kumar V., Vemula P., Edla S., Asti D., Paturu A., et al. Valve in valve transcatheter aortic valve implantation (ViV-TAVI) versus redo-Surgical aortic valve replacement (redo-SAVR): A systematic review and meta-analysis. J. Interv. Cardiol. 2018;31:661&#x2013;671. doi: 10.1111/joic.12520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joic.12520</ArticleId><ArticleId IdType="pubmed">29781182</ArticleId></ArticleIdList></Reference><Reference><Citation>Holzhey D., Shi W., Rastan A., Borger M.A., Mohr F.W. Transapical versus Conventional Aortic Valve Replacement-A Propensity-Matched Comparison. Hear. Surg. Forum. 2012;15:E4&#x2013;E8. doi: 10.1532/HSF98.20111084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1532/HSF98.20111084</ArticleId><ArticleId IdType="pubmed">22360904</ArticleId></ArticleIdList></Reference><Reference><Citation>Strauch J.T., Scherner M., Haldenwang P.L., Madershahian N., Pfister R., Kuhn E.W., Liakopoulos O.J., Wippermann J., Wahlers T. Transapical minimally invasive aortic valve implantation and conventional aortic valve replacement in octogenarians. Thorac. Cardiovasc. Surg. 2012;60:335&#x2013;342. doi: 10.1055/s-0032-1304538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0032-1304538</ArticleId><ArticleId IdType="pubmed">22547302</ArticleId></ArticleIdList></Reference><Reference><Citation>Terr&#xe9; J.A., George I., Smith C.R. Pros and cons of transcatheter aortic valve implantation (TAVI) Ann. Cardiothorac. Surg. 2017;6:444&#x2013;452. doi: 10.21037/acs.2017.09.15.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/acs.2017.09.15</ArticleId><ArticleId IdType="pmc">PMC5639221</ArticleId><ArticleId IdType="pubmed">29062739</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">26700609</PMID><DateCompleted><Year>2016</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8615</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of critical care</Title><ISOAbbreviation>J Crit Care</ISOAbbreviation></Journal><ArticleTitle>Kinetic estimated glomerular filtration rate and acute kidney injury in cardiac surgery patients.</ArticleTitle><Pagination><StartPage>249</StartPage><EndPage>254</EndPage><MedlinePgn>249-54</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrc.2015.11.006</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0883-9441(15)00557-2</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To determine how a formula to estimate kinetically changing glomerular filtration rate (keGFR) relates to serum creatinine changes and to compare the discriminatory ability of keGFR to that of perioperative change in serum creatinine to predict acute kidney injury (AKI) and mortality.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Retrospective cohort study at a single-tertiary-care Midwestern university hospital of 4022 patients admitted to the intensive care unit between January 2006 and January 2012 immediately after cardiac surgery.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">Of 4022 patients, 1031 (25.6%) developed at least AKI stage 1 and 1106 (27.5%) developed AKI-min. Patients who developed AKI stage 1 or AKI-min had a greater decrease in keGFR, both by absolute amounts and by percentage. After adjusting for other factors with logistic regression, keGFR had good discrimination (c statistic = 0.787 and 0.749, respectively) in predicting AKI and operative mortality.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Despite no change in immediate perioperative serum creatinine levels, keGFR fell and this predicted subsequent AKI. Using keGFR enables identification of patients who, despite unchanged postoperative creatinine, incur clinically significant kidney injury based on reduction in GFR and increased mortality.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Seelhammer</LastName><ForeName>Troy G</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>Anesthesiology &amp; Critical Care, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maile</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>University of Michigan, Ann Arbor, MI.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heung</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Anesthesiology &amp; Critical Care, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haft</LastName><ForeName>Jonathan W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>University of Michigan, Ann Arbor, MI.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jewell</LastName><ForeName>Elizabeth S</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>University of Michigan, Ann Arbor, MI.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engoren</LastName><ForeName>Milo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Michigan, Ann Arbor, MI. Electronic address: engorenm@med.umich.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Crit Care</MedlineTA><NlmUniqueID>8610642</NlmUniqueID><ISSNLinking>0883-9441</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="N">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="Y">Glomerular Filtration Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006785" MajorTopicYN="N">Hospitals, University</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007677" MajorTopicYN="N">Kidney Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062606" MajorTopicYN="N">Tertiary Care Centers</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Creatinine clearance</Keyword><Keyword MajorTopicYN="N">Glomerular filtration rate</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Prediction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>11</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26700609</ArticleId><ArticleId IdType="doi">10.1016/j.jcrc.2015.11.006</ArticleId><ArticleId IdType="pii">S0883-9441(15)00557-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36345680</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8191</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>12</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of cardiac surgery</Title><ISOAbbreviation>J Card Surg</ISOAbbreviation></Journal><ArticleTitle>Furosemide does not reduce the incidence of postoperative acute kidney injury in adult patients undergoing cardiac surgery: A PRISMA-compliant systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>4850</StartPage><EndPage>4860</EndPage><MedlinePgn>4850-4860</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jocs.17120</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Acute kidney injury (AKI) is a common complication of cardiac surgical patients, the occurrence of which is multifactorial. Furosemide is the most common loop diuretic and widely used in cardiac surgery to reduce fluid overload, increase tubular flow and urine output. It remains unknown whether furosemide affects the incidence or prognosis of cardiac surgery-induced acute kidney injury (CS-AKI). Therefore, the current study was performed to address this question.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed, Embase, Scopus, Cochrane Library, and Web of Science databases were searched for relevant studies. Primary outcomes of interest included postoperative CS-AKI incidence, need for renal replacement therapy (RRT) rate. Secondary outcomes of interest included postoperative serum creatinine (Scr) and blood urea nitrogen (BUN) levels, postoperative mechanical ventilation duration (MVD), length of stay (LOS) in intensive care unit (ICU) and in hospital, and mortality. The odds ratio (OR) and/or the weighted mean difference (WMD) with 95% confidence interval (CI) were used to pool the data.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Database search yielded six studies including 566 adult patients, and 283 patients were allocated into Group Furosemide and 283 into Group Control (Placebo). Heterogeneity between studies was deemed acceptable, and the publication bias was low. Meta-analysis suggested that furosemide administration in adult cardiac surgical patients had no effect on CS-AKI incidence (n&#x2009;=&#x2009;4 trials; OR&#x2009;=&#x2009;0.92; 95% CI: 0.37-2.30; p&#x2009;=&#x2009;.86; I<sup>2</sup> &#x2009;=&#x2009;57%) and need for RRT rate (n&#x2009;=&#x2009;2 trials; OR&#x2009;=&#x2009;4.13; 95% CI: 0.44-38.51; p&#x2009;=&#x2009;.21; I<sup>2</sup> &#x2009;=&#x2009;0%). Diversely, furosemide administration in adult cardiac surgical patients significantly decreased postoperative BUN level (n&#x2009;=&#x2009;3 trials; WMD&#x2009;=&#x2009;0.71; 95% CI: 0.10-1.33; p&#x2009;=&#x2009;.02; I<sup>2</sup> &#x2009;=&#x2009;0%), postoperative MVD (n&#x2009;=&#x2009;2 trials; WMD&#x2009;=&#x2009;-3.13; 95% CI: -3.78 to -2.49; p&#x2009;&lt;&#x2009;.00001; I<sup>2</sup> &#x2009;=&#x2009;0%) and postoperative LOS in ICU (n&#x2009;=&#x2009;3 trials; WMD&#x2009;=&#x2009;-0.47; 95% CI:&#xa0;-0.76 to -0.18; p&#x2009;=&#x2009;.001; I<sup>2</sup> &#x2009;=&#x2009;0%). However, it had no significant impact on postoperative Scr level, postoperative LOS in hospital, and postoperative mortality.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This meta-analysis suggested that furosemide administration in adult cardiac surgical patients had no significant effect on CS-AKI incidence, need for RRT rate, postoperative Scr level, LOS in hospital and mortality, but could reduce postoperative BUN level, MVD, and LOS in ICU. As only a limited number of studies were included, these results should be interpreted carefully and cautiously. Future high-quality randomized controlled trials are needed to define the role of furosemide in CS-AKI prevention and management.</AbstractText><CopyrightInformation>&#xa9; 2022 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Chun-Mei</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0001-8821-3198</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Fuwai Yunnan Cardiovascular Hospital, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Yun-Tai</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Ke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fuwai Yunnan Cardiovascular Hospital, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Meng-Qi</ForeName><Initials>MQ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fuwai Yunnan Cardiovascular Hospital, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Li-Xian</ForeName><Initials>LX</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fuwai Yunnan Cardiovascular Hospital, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fuwai Yunnan Cardiovascular Hospital, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Evidence in Cardiovascular Anesthesia (EICA) Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>CAMS Innovation Fund for Medical Sciences (CIFMS)-2021-I2M-C&amp;T-B-038</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Card Surg</MedlineTA><NlmUniqueID>8908809</NlmUniqueID><ISSNLinking>0886-0440</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>7LXU5N7ZO5</RegistryNumber><NameOfSubstance UI="D005665">Furosemide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005665" MajorTopicYN="N">Furosemide</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute renal injury</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">furosemide</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>8</Day><Hour>3</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36345680</ArticleId><ArticleId IdType="doi">10.1111/jocs.17120</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Hobson CE, Yavas S, Segal MS, et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation. 2009;119(18):2444-2453.</Citation></Reference><Reference><Citation>Mao H, Katz N, Ariyanon W, et al. Cardiac surgery-associated acute kidney injury. Cardiorenal Med. 2013;3(3):178-199.</Citation></Reference><Reference><Citation>Ortega-Loubon C, Fern&#xe1;ndez-Molina M, Carrascal-Hinojal Y, Fulquet-Carreras E. Cardiac surgery-associated acute kidney injury. Ann Card Anaesth. 2016;19(4):687-698.</Citation></Reference><Reference><Citation>Massoudy P, Wagner S, Thielmann M, et al. Coronary artery bypass surgery and acute kidney injury-impact of the off-pump technique. Nephrol Dial Transplant. 2008;23(9):2853-2860.</Citation></Reference><Reference><Citation>Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1(1):19-32.</Citation></Reference><Reference><Citation>Shaw A. Update on acute kidney injury after cardiac surgery. J Thorac Cardiovasc Surg. 2012;143(3):676-681.</Citation></Reference><Reference><Citation>Bagshaw SM, Delaney A, Jones D, Ronco C, Bellomo R. Diuretics in the management of acute kidney injury: a multinational survey. Contrib Nephrol. 2007;156:236-249.</Citation></Reference><Reference><Citation>Aravindan N, Shaw A. Effect of furosemide infusion on renal hemodynamics and angiogenesis gene expression in acute renal ischemia/reperfusion. Ren Fail. 2006;28(1):25-35.</Citation></Reference><Reference><Citation>Aravindan N, Aravindan S, Riedel BJ, Weng HR, Shaw AD. Furosemide prevents apoptosis and associated gene expression in a rat model of surgical ischemic acute renal failure. Ren Fail. 2007;29(4):399-407.</Citation></Reference><Reference><Citation>Mehta RL. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA. 2002;288(20):2547-2553.</Citation></Reference><Reference><Citation>Uchino S, Doig GS, Bellomo R, et al. Diuretics and mortality in acute renal failure. Crit Care Med. 2004;32(8):1669-1677.</Citation></Reference><Reference><Citation>Kunt AT, Akg&#xfc;n S, Atalan N, Bitir N, Arsan S. Furosemide infusion prevents the requirement of renal replacement therapy after cardiac surgery. Anatol&#xa0;J&#xa0;Cardiol. 2009;9(6):499-504.</Citation></Reference><Reference><Citation>Fakhari S, Mirzaei Bavil F, Bilehjani E, Abolhasani S, Mirinazhad M, Naghipour B. Prophylactic furosemide infusion decreasing early major postoperative renal dysfunction in on-pump adult cardiac surgery: a randomized clinical trial. Res Rep Urol. 2017;9:5-13.</Citation></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179-c184.</Citation></Reference><Reference><Citation>Silbert BI, Ho KM, Lipman J, et al. Does furosemide increase oxidative stress in acute kidney injury? Antioxid Redox Signal. 2017;26(5):221-226.</Citation></Reference><Reference><Citation>Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol. 2000;11(1):97-104.</Citation></Reference><Reference><Citation>Zheng H, Liu L, Fan G, Liu Z, Wang Z, Chang B. Preoperative use of furosemide May increase the incidence of acute kidney injury after coronary artery bypass grafting: a propensity score-matched study. Gen Thorac Cardiovasc Surg. 2021;69(10):1392-1399.</Citation></Reference><Reference><Citation>Winther-Olesen M, M&#xf8;ller MH, Johansen KK, Aasvang EK. Effects of post-operative furosemide in adult surgical patients: a systematic review and meta-analysis of randomised clinical trials. Acta Anaesthesiol Scand. 2020;64(3):282-291.</Citation></Reference><Reference><Citation>Page MJ, Moher D. Evaluations of the uptake and impact of the preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and extensions: a scoping review. Syst Rev. 2017;6(1):263.</Citation></Reference><Reference><Citation>Higgins JPT, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.</Citation></Reference><Reference><Citation>Luo X, Jiang L, Du B, Wen Y, Wang M, Xi X. Beijing acute kidney injury trial: a comparison of different diagnostic criteria of acute kidney injury in critically ill patients. Crit Care. 2014;18(4):R144.</Citation></Reference><Reference><Citation>Cumpston M, Li T, Page MJ, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019;10:ED000142.</Citation></Reference><Reference><Citation>Lassnigg A. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004;15(6):1597-1605.</Citation></Reference><Reference><Citation>Luckraz H, Giri R, Wrigley B, et al. Reduction in acute kidney injury post cardiac surgery using balanced forced diuresis: a randomized, controlled trial. Eur J Cardiothorac Surg. 2021;59(3):562-569.</Citation></Reference><Reference><Citation>Choudhury M, Narula J, Saini K, Kapoor PM, Kiran U. Does intraoperative diuretic therapy affect the thoracic fluid content and clinical outcome in patients undergoing mitral valve surgery? J Cardiac Crit Care TSS. 2020;4(02):86-90.</Citation></Reference><Reference><Citation>Bayat F, Faritous Z, Aghdaei N, Dabbagh A. A study of the efficacy of furosemide as a prophylaxis of acute renal failure in coronary artery bypass grafting patients: a clinical trial. ARYA Atheroscler. 2015;11(3):173-178.</Citation></Reference><Reference><Citation>Mahesh B, Yim B, Robson D, Pillai R, Ratnatunga C, Pigott D. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial. Eur J Cardiothorac Surg. 2008;33(3):370-376.</Citation></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute dialysis quality initiative - acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204-R212.</Citation></Reference><Reference><Citation>Wang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nature Reviews Nephrology. 2017;13(11):697-711.</Citation></Reference><Reference><Citation>Joannidis M, Druml W, Forni LG, et al. Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017: expert opinion of the -Working Group on Prevention, AKI section, European Society of Intensive Care Medicine. Intensive Care Med. 2017;43(6):730-749.</Citation></Reference><Reference><Citation>Kellum JA, Lameire N. Group KAGW Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013;17(1):204.</Citation></Reference><Reference><Citation>Ichai C, Vinsonneau C, Souweine B, et al. Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies). Ann Intensive Care. 2016;6(1):48.</Citation></Reference><Reference><Citation>Ho KM. Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ. 2006;333(7565):420.</Citation></Reference><Reference><Citation>Krzych &#x141;J, Czempik PF. Impact of furosemide on mortality and the requirement for renal replacement therapy in acute kidney injury: a systematic review and meta-analysis of randomised trials. Ann Intensive Care. 2019;9(1):85.</Citation></Reference><Reference><Citation>Perner A, Prowle J, Joannidis M, Young P, Hjortrup PB, Pettil&#xe4; V. Fluid management in acute kidney injury. Intensive Care Med. 2017;43(6):807-815.</Citation></Reference><Reference><Citation>Prowle JR, Kirwan CJ, Bellomo R. Fluid management for the prevention and attenuation of acute kidney injury. Nature Reviews Nephrology. 2014;10(1):37-47.</Citation></Reference><Reference><Citation>Mitter N, Shah A, Yuh D, et al. Renal injury is associated with operative mortality after cardiac surgery for women and men. J Thorac Cardiovasc Surg. 2010;140(6):1367-1373.</Citation></Reference><Reference><Citation>Wen J, Cheng Q, Zhao J, et al. Hospital-acquired acute kidney injury in Chinese very elderly persons. J Nephrol. 2013;26(3):572-579.</Citation></Reference><Reference><Citation>Coleman MD, Shaefi S, Sladen RN. Preventing acute kidney injury after cardiac surgery. Curr Opin Anaesthesiol. 2011;24(1):70-76.</Citation></Reference><Reference><Citation>Haase M, Bellomo R, Story D, et al. Effect of mean arterial pressure, haemoglobin and blood transfusion during cardiopulmonary bypass on post-operative acute kidney injury. Nephrol Dial Transplant. 2012;27(1):153-160.</Citation></Reference><Reference><Citation>Cheungpasitporn W, Thongprayoon C, Kittanamongkolchai W, et al. Comparison of renal outcomes in off-pump versus on-pump coronary artery bypass grafting: a systematic review and meta-analysis of randomized controlled trials. Nephrology. 2015;20(10):727-735.</Citation></Reference><Reference><Citation>Khan UA, Coca SG, Hong K, et al. Blood transfusions are associated with urinary biomarkers of kidney injury in cardiac surgery. J Thorac Cardiovasc Surg. 2014;148(2):726-732.</Citation></Reference><Reference><Citation>Zarbock A, Milles K. Novel therapy for renal protection. Curr Opin Anaesthesiol. 2015;28(4):431-438.</Citation></Reference><Reference><Citation>Greco T, Zangrillo A, Biondi-Zoccai G, Landoni G. Meta-analysis: pitfalls and hints. Heart Lung Vessel. 2013;5(4):219-225.</Citation></Reference><Reference><Citation>Frieden TR. Evidence for health decision making - beyond randomized, controlled trials. N Engl J Med. 2017;377(5):465-475.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35736797</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>04</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8674</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Surgical infections</Title><ISOAbbreviation>Surg Infect (Larchmt)</ISOAbbreviation></Journal><ArticleTitle>Kidney Injury in Critically Ill Patients Treated with Vancomycin and Zosyn or an Alternative: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>516</StartPage><EndPage>524</EndPage><MedlinePgn>516-524</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/sur.2022.128</ELocationID><Abstract><AbstractText><b><i>Background:</i></b> Zosyn<sup>&#xae;</sup> (piperacillin-tazobactam; Pfizer Medical, New York, NY), a valuable antibiotic against gram-negative bacteria, combined with vancomycin (Z+V) is known for its high incidence of acute kidney injury (AKI), particularly in the intensive care unit (ICU), leading to the frequent use of alternatives for gram-negative coverage (Alt+V). Because there are limited data describing AKI on these alternative antibiotic agents, a systematic review and meta-analysis was conducted to determine if these regimens were indeed associated with decreased rates of AKI. <b><i>Patients and Methods:</i></b> A literature review was performed electronically from its inception to November 1, 2018, screening for relevant literature by title, abstract and full text according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines within the following databases: PubMed/Medline, CINAHL, Scopus, and Cochrane Central Register of Controlled Trials. Studies were included if they contained adults who had been admitted to the ICU for treatment and had received a combination of intravenous Z&#x2009;+&#x2009;V or Alt+V as well as had AKI measured during administration of these antibiotic agents. Studies were excluded if they represented pediatric populations, did not receive care in an ICU during their hospital admission, only received monotherapy for antibiotic treatment or received antibiotic treatment for less than 48 hours. Independent extraction was performed by two reviewers. Risk of bias was assessed using the Risk of Bias in Non-randomised Studies of Interventions (ROBINS-I) methodology for retrospective studies. Random-effects models were used to calculate any differences between rates of AKI after Z&#x2009;+&#x2009;V or Alt&#x2009;+&#x2009;V. <b><i>Results:</i></b> Fourteen articles (totaling 30,399 patients) were included. All studies available were retrospective in design. Compared with Alt&#x2009;+&#x2009;V, Z&#x2009;+&#x2009;V was associated with a higher risk ratio of AKI (1.79; 95% confidence interval [CI], 1.46-2.19; p&#x2009;&lt;&#x2009;0.001). Cefepime (C&#x2009;+&#x2009;V) was the most common alternative to Zosyn, and Z&#x2009;+&#x2009;V was associated with higher rates of kidney injury compared with C&#x2009;+&#x2009;V (1.70; 95% CI, 1.36-2.12; p&#x2009;&lt;&#x2009;0.00001). However, there was substantial heterogeneity in the data collected as well as high risk of bias. <b><i>Conclusions:</i></b> Zosyn plus vancomycin is associated with more risk of AKI compared with Alt+V coverage in ICU adult populations. However, the conclusions were limited by the retrospective nature of the studies, high bias of included articles, and heterogeneity of the included studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Blears</LastName><ForeName>Elizabeth E</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>University of Texas-Medical Branch, Galveston, Texas, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shriners Hospital for Children, Galveston, Texas, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Allegheny Health Network, Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Texas-Medical Branch, Galveston, Texas, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shriners Hospital for Children, Galveston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Popp</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of Texas-Medical Branch, Galveston, Texas, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shriners Hospital for Children, Galveston, Texas, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Hand, Plastic and Reconstructive Surgery, Department of Surgery, Medical University of Graz, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jong O</ForeName><Initials>JO</Initials><AffiliationInfo><Affiliation>University of Texas-Medical Branch, Galveston, Texas, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shriners Hospital for Children, Galveston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norbury</LastName><ForeName>William B</ForeName><Initials>WB</Initials><AffiliationInfo><Affiliation>University of Texas-Medical Branch, Galveston, Texas, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shriners Hospital for Children, Galveston, Texas, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Surg Infect (Larchmt)</MedlineTA><NlmUniqueID>9815642</NlmUniqueID><ISSNLinking>1096-2964</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>157044-21-8</RegistryNumber><NameOfSubstance UI="D000077725">Piperacillin, Tazobactam Drug Combination</NameOfSubstance></Chemical><Chemical><RegistryNumber>6Q205EH1VU</RegistryNumber><NameOfSubstance UI="D014640">Vancomycin</NameOfSubstance></Chemical><Chemical><RegistryNumber>X00B0D5O0E</RegistryNumber><NameOfSubstance UI="D010878">Piperacillin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010878" MajorTopicYN="N">Piperacillin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077725" MajorTopicYN="N">Piperacillin, Tazobactam Drug Combination</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014640" MajorTopicYN="Y">Vancomycin</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute renal failure</Keyword><Keyword MajorTopicYN="N">intensive care</Keyword><Keyword MajorTopicYN="N">piperacillin-tazobactam</Keyword><Keyword MajorTopicYN="N">vancomycin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>23</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35736797</ArticleId><ArticleId IdType="doi">10.1089/sur.2022.128</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37410103</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-8726</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>World journal of urology</Title><ISOAbbreviation>World J Urol</ISOAbbreviation></Journal><ArticleTitle>Application of a protocol for enhanced recovery after radical cystectomy: a before-and-after cohort study.</ArticleTitle><Pagination><StartPage>2273</StartPage><EndPage>2280</EndPage><MedlinePgn>2273-2280</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00345-023-04468-y</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Radical cystectomy with urinary diversion is a major urological surgery burdened both by a high rate of short- and long-term complications and by a high emotional and psychological impact. Post-operative recovery is extremely important and the application of ERAS protocols can facilitate the return to functional autonomy. The aim of the present study was to verify the efficacy of our ERAS programme on outcomes of recovery after surgery of patients undergoing radical cystectomy with various urinary diversions.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a before-after study comparing the historical group (n. 77) of radical cystectomies following a peri-operative standard of care with the prospective observational group (n. 83) following our ERAS programme. Recovery after surgery outcomes evaluated were length of stay, re-admission rate at 30-90/days and post-operative complications.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Patients treated following the ERAS protocol presented less intra-operative blood loss (p&#x2009;&lt;&#x2009;0.001) and less intra-operative fluid infusions (p&#x2009;&lt;&#x2009;0.001). Time of first flatus was shorter in the ERAS group, though no difference was found in timing of nasogastric tube removal and defecation. Removal of drainage was done significantly earlier in the ERAS group. The median length of stay decreased from 12 to 9&#xa0;days (p&#x2009;=&#x2009;0.003) with a significant reduction also in re-admission rates at 30 and long-term complications at 90&#xa0;days from surgery.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The application of an opioid-free ERAS protocol to patients undergoing open radical cystectomy was associated, as compared with prior traditional care, with significant reductions of recovery time and length of stay, number of total in-hospital complications, in particular functional ileus and re-admissions by 30 and 90&#xa0;days after surgery.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brusasco</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-6709-6172</Identifier><AffiliationInfo><Affiliation>Anaesthesia and Intensive Care Unit, E.O. Ospedali Galliera, Mura della Cappuccine 14, 16128, Genoa, Italy. claudia.brusasco@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Domenico</LastName><ForeName>Antonia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Urology Unit, E.O. Ospedali Galliera, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ennas</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Urology Unit, E.O. Ospedali Galliera, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benelli</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Urology Unit, E.O. Ospedali Galliera, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dotta</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Urology Unit, E.O. Ospedali Galliera, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tosi</LastName><ForeName>Mattia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Urology Unit, E.O. Ospedali Galliera, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manfredi</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Urology Unit, E.O. Ospedali Galliera, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calcagno</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Urology Unit, E.O. Ospedali Galliera, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campodonico</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Urology Unit, E.O. Ospedali Galliera, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Germinale</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Urology Unit, E.O. Ospedali Galliera, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montevecchi</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Unit, Giovanni Borea Hospital, Sanremo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corradi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Introini</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Urology Unit, E.O. Ospedali Galliera, Genoa, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>World J Urol</MedlineTA><NlmUniqueID>8307716</NlmUniqueID><ISSNLinking>0724-4983</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015653" MajorTopicYN="N">Cystectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001749" MajorTopicYN="Y">Urinary Bladder Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014547" MajorTopicYN="Y">Urinary Diversion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">ERAS protocol</Keyword><Keyword MajorTopicYN="N">Enhanced recovery after surgery</Keyword><Keyword MajorTopicYN="N">Functional ileus</Keyword><Keyword MajorTopicYN="N">Opioid-free anaesthesia</Keyword><Keyword MajorTopicYN="N">Urological complications</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>6</Day><Hour>13</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>6</Day><Hour>11</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37410103</ArticleId><ArticleId IdType="doi">10.1007/s00345-023-04468-y</ArticleId><ArticleId IdType="pii">10.1007/s00345-023-04468-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Witjes JA, Bruins HM, Cathomas R et al (2021) European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. Eur Urol 79:82&#x2013;104. https://doi.org/10.1016/j.eururo.2020.03.055</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eururo.2020.03.055</ArticleId><ArticleId IdType="pubmed">32360052</ArticleId></ArticleIdList></Reference><Reference><Citation>Elbadry MS, Ali AI, Hassan A et al (2020) The relationship between type of urinary diversion and quality of life after radical cystectomy: Ileal conduit versus orthotopic bladder. BJUI Compass 1:133&#x2013;138. https://doi.org/10.1002/bco2.29</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bco2.29</ArticleId><ArticleId IdType="pubmed">35474941</ArticleId><ArticleId IdType="pmc">8988837</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerantola Y, Valerio M, Persson B et al (2013) Guidelines for perioperative care after radical cystectomy for bladder cancer: Enhanced Recovery After Surgery (ERAS(&#xae;)) society recommendations. Clin Nutr 32:879&#x2013;887. https://doi.org/10.1016/j.clnu.2013.09.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2013.09.014</ArticleId><ArticleId IdType="pubmed">24189391</ArticleId></ArticleIdList></Reference><Reference><Citation>Persson B, Carringer M, Andr&#xe9;n O et al (2015) Initial experiences with the enhanced recovery after surgery (ERAS) protocol in open radical cystectomy. Scand J Urol 49:302&#x2013;307. https://doi.org/10.3109/21681805.2015.1004641</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21681805.2015.1004641</ArticleId><ArticleId IdType="pubmed">25660105</ArticleId></ArticleIdList></Reference><Reference><Citation>Karl A, Buchner A, Becker A et al (2014) A new concept for early recovery after surgery for patients undergoing radical cystectomy for bladder cancer: results of a prospective randomized study. J Urol 191:335&#x2013;340. https://doi.org/10.1016/j.juro.2013.08.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.juro.2013.08.019</ArticleId><ArticleId IdType="pubmed">23968966</ArticleId></ArticleIdList></Reference><Reference><Citation>Daneshmand S, Ahmadi H, Schuckman AK et al (2014) Enhanced recovery protocol after radical cystectomy for bladder cancer. J Urol 192:50&#x2013;55. https://doi.org/10.1016/j.juro.2014.01.097</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.juro.2014.01.097</ArticleId><ArticleId IdType="pubmed">24518775</ArticleId></ArticleIdList></Reference><Reference><Citation>Azhar RA, Bochner B, Catto J et al (2016) Enhanced recovery after urological surgery: a contemporary systematic review of outcomes, key elements, and research needs. Eur Urol 70:176&#x2013;187. https://doi.org/10.1016/j.eururo.2016.02.051</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eururo.2016.02.051</ArticleId><ArticleId IdType="pubmed">26970912</ArticleId><ArticleId IdType="pmc">5514421</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B, Domes T, Jana K (2018) Evaluation of an enhanced recovery protocol on patients having radical cystectomy for bladder cancer. Can Urol Assoc J. https://doi.org/10.5489/cuaj.5273</Citation><ArticleIdList><ArticleId IdType="doi">10.5489/cuaj.5273</ArticleId><ArticleId IdType="pubmed">30332597</ArticleId><ArticleId IdType="pmc">6261727</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang KH, Groves R, Venugopal S et al (2018) Prospective implementation of enhanced recovery after surgery protocols to radical cystectomy. Eur Urol 73:363&#x2013;371. https://doi.org/10.1016/j.eururo.2017.07.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eururo.2017.07.031</ArticleId><ArticleId IdType="pubmed">28801130</ArticleId></ArticleIdList></Reference><Reference><Citation>Frees SK, Aning J, Black P et al (2018) A prospective randomized pilot study evaluating an ERAS protocol versus a standard protocol for patients treated with radical cystectomy and urinary diversion for bladder cancer. World J Urol 36:215&#x2013;220. https://doi.org/10.1007/s00345-017-2109-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00345-017-2109-2</ArticleId><ArticleId IdType="pubmed">29116394</ArticleId></ArticleIdList></Reference><Reference><Citation>Systematic Review and Meta-Analysis of the Efficacy and Safety of Enhanced Recovery After Surgery vs. Conventional Recovery After Surgery on Perioperative Outcomes of Radical Cystectomy - PubMed. https://pubmed.ncbi.nlm.nih.gov/33072572/ . Accessed 31 Dec 2022</Citation></Reference><Reference><Citation>Patel SY, Garcia Getting RE, Alford B et al (2018) Improved outcomes of enhanced recovery after surgery (ERAS) protocol for radical cystectomy with addition of a multidisciplinary care process in a US comprehensive cancer care center. World J Surg 42:2701&#x2013;2707. https://doi.org/10.1007/s00268-018-4665-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-018-4665-z</ArticleId><ArticleId IdType="pubmed">29750321</ArticleId><ArticleId IdType="pmc">7771278</ArticleId></ArticleIdList></Reference><Reference><Citation>Peerbocus M, Wang Z-J (2021) Enhanced recovery after surgery and radical cystectomy: a systematic review and meta-analysis. Res Rep Urol 13:535&#x2013;547. https://doi.org/10.2147/RRU.S307385</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/RRU.S307385</ArticleId><ArticleId IdType="pubmed">34350137</ArticleId><ArticleId IdType="pmc">8328386</ArticleId></ArticleIdList></Reference><Reference><Citation>Lannes F, Walz J, Maubon T et al (2022) Enhanced recovery after surgery for radical cystectomy decreases postoperative complications at different times. Urol Int 106:171&#x2013;179. https://doi.org/10.1159/000518163</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000518163</ArticleId><ArticleId IdType="pubmed">34569540</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend WB, Worrilow WM, Robinson MM et al (2020) Implementation of a dedicated enhanced recovery after surgery (ERAS) program for radical cystectomy patients is associated with decreased postoperative inpatient opioid usage and pain scores. Urology 143:186&#x2013;193. https://doi.org/10.1016/j.urology.2020.04.110</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.urology.2020.04.110</ArticleId><ArticleId IdType="pubmed">32473208</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunkman WJ, Manning MW, Whittle J et al (2019) Impact of an enhanced recovery pathway on length of stay and complications in elective radical cystectomy: a before and after cohort study. Perioper Med (Lond) 8:9. https://doi.org/10.1186/s13741-019-0120-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13741-019-0120-4</ArticleId><ArticleId IdType="pubmed">31440369</ArticleId></ArticleIdList></Reference><Reference><Citation>Defining postoperative ileus and associated risk factors in patients undergoing radical cystectomy with an Enhanced Recovery After Surgery (ERAS) program&#x2014;PubMed. https://pubmed.ncbi.nlm.nih.gov/32745002/ . Accessed 4 Oct 2022</Citation></Reference><Reference><Citation>Brooks NA, Kokorovic A, McGrath JS et al (2022) Critical analysis of quality of life and cost-effectiveness of enhanced recovery after surgery (ERAS) for patient&#x2019;s undergoing urologic oncology surgery: a systematic review. World J Urol 40:1325&#x2013;1342. https://doi.org/10.1007/s00345-020-03341-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00345-020-03341-6</ArticleId><ArticleId IdType="pubmed">32648071</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Djaladat H, Schuckman AK et al (2019) Surgical approach as a determinant factor of clinical outcome following radical cystectomy: does enhanced recovery after surgery (ERAS) level the playing field? Urol Oncol 37:765&#x2013;773. https://doi.org/10.1016/j.urolonc.2019.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.urolonc.2019.06.001</ArticleId><ArticleId IdType="pubmed">31285114</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghoreifi A, Basin MF, Ghodoussipour S et al (2021) Perioperative outcomes of goal-directed versus conventional fluid therapy in radical cystectomy with enhanced recovery protocol. Int Urol Nephrol 53:1827&#x2013;1833. https://doi.org/10.1007/s11255-021-02903-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11255-021-02903-w</ArticleId><ArticleId IdType="pubmed">34089170</ArticleId></ArticleIdList></Reference><Reference><Citation>Arslan-Carlon V, Tan KS, Dalbagni G et al (2020) Goal-directed versus standard fluid therapy to decrease ileus after open radical cystectomy: a prospective randomized controlled trial. Anesthesiology 133:293&#x2013;303. https://doi.org/10.1097/ALN.0000000000003367</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003367</ArticleId><ArticleId IdType="pubmed">32472804</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna PT, Peterson M, Albersheim J et al (2020) Acute kidney injury following enhanced recovery after surgery in patients undergoing radical cystectomy. J Urol 204:982&#x2013;988. https://doi.org/10.1097/JU.0000000000001153</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JU.0000000000001153</ArticleId><ArticleId IdType="pubmed">32469268</ArticleId></ArticleIdList></Reference><Reference><Citation>Wuethrich PY, Burkhard FC, Thalmann GN et al (2014) Restrictive deferred hydration combined with preemptive norepinephrine infusion during radical cystectomy reduces postoperative complications and hospitalization time: a randomized clinical trial. Anesthesiology 120:365&#x2013;377. https://doi.org/10.1097/ALN.0b013e3182a44440</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3182a44440</ArticleId><ArticleId IdType="pubmed">23887199</ArticleId></ArticleIdList></Reference><Reference><Citation>Wuethrich PY, Burkhard FC (2015) Improved perioperative outcome with norepinephrine and a restrictive fluid administration during open radical cystectomy and urinary diversion. Urol Oncol 33:66.e21&#x2013;24. https://doi.org/10.1016/j.urolonc.2014.07.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.urolonc.2014.07.018</ArticleId><ArticleId IdType="pubmed">25192836</ArticleId></ArticleIdList></Reference><Reference><Citation>Evered LA, Chan MTV, Han R et al (2021) Anaesthetic depth and delirium after major surgery: a randomised clinical trial. Br J Anaesth 127:704&#x2013;712. https://doi.org/10.1016/j.bja.2021.07.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2021.07.021</ArticleId><ArticleId IdType="pubmed">34465469</ArticleId><ArticleId IdType="pmc">8579421</ArticleId></ArticleIdList></Reference><Reference><Citation>Zainfeld D, Chen J, Cai J et al (2018) The impact of patient-related nonmodifiable factors on perioperative outcomes following radical cystectomy with enhanced recovery protocol. Ther Adv Urol 10:393&#x2013;401. https://doi.org/10.1177/1756287218811019</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1756287218811019</ArticleId><ArticleId IdType="pubmed">30574199</ArticleId><ArticleId IdType="pmc">6295781</ArticleId></ArticleIdList></Reference><Reference><Citation>Radical cystectomy in a cohort of octogenarians managed in the ERAS era&#x2014;PubMed. https://pubmed.ncbi.nlm.nih.gov/32981848/ . Accessed 31 Dec 2022</Citation></Reference><Reference><Citation>Hanna P, Zabell J, Osman Y et al (2021) Enhanced recovery after surgery (ERAS) following radical cystectomy: is it worth implementing for all patients? World J Urol 39:1927&#x2013;1933. https://doi.org/10.1007/s00345-020-03435-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00345-020-03435-1</ArticleId><ArticleId IdType="pubmed">32918095</ArticleId></ArticleIdList></Reference><Reference><Citation>Llorente C, Guijarro A, Hern&#xe1;ndez V et al (2020) Outcomes of an enhanced recovery after radical cystectomy program in a prospective multicenter study: compliance and key components for success. World J Urol 38:3121&#x2013;3129. https://doi.org/10.1007/s00345-020-03132-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00345-020-03132-z</ArticleId><ArticleId IdType="pubmed">32140768</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghodoussipour S, Naser-Tavakolian A, Cameron B et al (2020) Internal audit of an enhanced recovery after surgery protocol for radical cystectomy. World J Urol 38:3131&#x2013;3137. https://doi.org/10.1007/s00345-020-03135-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00345-020-03135-w</ArticleId><ArticleId IdType="pubmed">32112242</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30389130</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-685X</ISSN><JournalIssue CitedMedium="Internet"><Volume>157</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>Apr</Month></PubDate></JournalIssue><Title>The Journal of thoracic and cardiovascular surgery</Title><ISOAbbreviation>J Thorac Cardiovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Intraoperative prediction of cardiac surgery-associated acute kidney injury using urinary biomarkers of cell cycle arrest.</ArticleTitle><Pagination><StartPage>1545</StartPage><EndPage>1553.e5</EndPage><MedlinePgn>1545-1553.e5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jtcvs.2018.08.090</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-5223(18)32484-X</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Tissue inhibitor of metalloproteinases 2 (TIMP-2) and insulin-like growth factor-binding protein 7 (IGFBP7) are postoperative urinary biomarkers of renal stress and acute kidney injury (AKI). We conducted this study to test the hypothesis that intraoperative concentrations of urinary [TIMP-2]&#xb7;[IGFBP7] are associated with postoperative AKI.</AbstractText><AbstractText Label="METHODS">We measured urinary [TIMP-2]&#xb7;[IGFBP7] at 8 perioperative timepoints in 400 patients who participated in a randomized controlled trial of atorvastatin for AKI in cardiac surgery. We compared [TIMP-2]&#xb7;[IGFBP7] between subjects who did and did not develop KDIGO stage 2 or 3 AKI within 48&#xa0;hours of surgery, adjusted for AKI risk factors.</AbstractText><AbstractText Label="RESULTS">Fourteen patients (3.5%) met the primary endpoint of stage 2 or 3 AKI within 48&#xa0;hours of surgery, and an additional 77 patients (19.3%) developed stage 1 AKI. Patients who developed stage 2 or 3 AKI displayed bimodal elevations of [TIMP-2]&#xb7;[IGFBP7], with a first elevation (median, 0.45 [ng/mL]<sup>2</sup>/1000) intraoperatively and a second elevation (1.45 [ng/mL]<sup>2</sup>/1000) 6&#xa0;hours postoperatively. Patients who did not develop AKI did not have any elevations in [TIMP-2]&#xb7;[IGFBP7]. Each 10-fold increase in intraoperative [TIMP-2]&#xb7;[IGFBP7] was independently associated with a 290% increase in the odds of stage 2 or 3 AKI (P&#xa0;=&#xa0;.01), and each 10-fold increase in the 6 hours postoperative [TIMP-2]&#xb7;[IGFBP7] was independently associated with a 650% increase in the odds of stage 2 or 3 AKI (P&#xa0;&lt;&#xa0;.001). The maximum [TIMP-2]&#xb7;[IGFBP7] between these 2 timepoints provided an area under the receiver operating characteristic curve of 0.82 (95% confidence interval [CI], 0.73-0.90), 100% sensitivity, and 100% negative predictive value using the &gt;0.3 cutoff to predict stage 2 or 3 AKI.</AbstractText><AbstractText Label="CONCLUSIONS">Intraoperative elevations of [TIMP-2]&#xb7;[IGFBP7] can predict moderate or severe AKI and could provide an opportunity to alter postoperative management to prevent kidney injury.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cummings</LastName><ForeName>Jared J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Division of Cardiothoracic Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tenn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Andrew D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Division of Cardiothoracic Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tenn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Statistics, Walker Bioscience, Carlsbad, Calif.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez</LastName><ForeName>Marcos G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Division of Critical Care Medicine, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tenn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Neal</LastName><ForeName>Jason B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Division of Cardiothoracic Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tenn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Billings</LastName><ForeName>Frederic T</ForeName><Initials>FT</Initials><Suffix>4th</Suffix><AffiliationInfo><Affiliation>Division of Cardiothoracic Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tenn; Division of Critical Care Medicine, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tenn. Electronic address: frederic.t.billings@vanderbilt.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR000445</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 GM102676</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002243</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM112871</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM108554</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Thorac Cardiovasc Surg</MedlineTA><NlmUniqueID>0376343</NlmUniqueID><ISSNLinking>0022-5223</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018969">Insulin-Like Growth Factor Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C560823">TIMP2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C102529">insulin-like growth factor binding protein-related protein 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>127497-59-0</RegistryNumber><NameOfSubstance UI="D019716">Tissue Inhibitor of Metalloproteinase-2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Thorac Cardiovasc Surg. 2019 Apr;157(4):1554-1555. doi: 10.1016/j.jtcvs.2018.08.119.</RefSource><PMID Version="1">30447967</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059447" MajorTopicYN="Y">Cell Cycle Checkpoints</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018969" MajorTopicYN="N">Insulin-Like Growth Factor Binding Proteins</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="Y">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007432" MajorTopicYN="N">Intraoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019716" MajorTopicYN="N">Tissue Inhibitor of Metalloproteinase-2</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="Y">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016482" MajorTopicYN="N">Urinalysis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">IGFBP7</Keyword><Keyword MajorTopicYN="N">NephroCheck, prediction</Keyword><Keyword MajorTopicYN="N">TIMP-2</Keyword><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword></KeywordList><CoiStatement>Conflict of interest: Dr. Shaw and Dr. Shi are consultants for Astute Medical, which developed the [TIMP-2]&#x2022;[IGFBP7] NephroCheck assay and performed urinary [TIMP-2]&#x2022;[IGFBP7] measurements blinded to all subject characteristics. Astute Medical did not participate in the design of the study or decision to <b>submit</b> the findings for publication. Dr. Shi completed the statistical analysis. Dr. Cummings, Shaw, Shi, and Billings wrote the manuscript. The authors declare no other conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30389130</ArticleId><ArticleId IdType="mid">NIHMS1516612</ArticleId><ArticleId IdType="pmc">PMC6431272</ArticleId><ArticleId IdType="doi">10.1016/j.jtcvs.2018.08.090</ArticleId><ArticleId IdType="pii">S0022-5223(18)32484-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hu J, Chen R, Liu S, Yu X, Zou J, Ding X. Global Incidence and Outcomes of Adult Patients With Acute Kidney Injury After Cardiac Surgery: A Systematic Review and Meta-Analysis. J Cardiothorac Vasc Anesth. 2016;30:82&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">26482484</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuhrman DY, Kellum JA. Epidemiology and pathophysiology of cardiac surgery-associated acute kidney injury. Curr Opin Anaesthesiol. 2017;30:60&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">27820742</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Agostino RS, Jacobs JP, Badhwar V, Fernandez FG, Paone G, Wormuth DW, et al. The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2018 Update on Outcomes and Quality. Ann Thorac Surg. 2018;105:15&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">29233331</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol. 2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">28869251</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakkar M, Bruno VD, Guida G, Angelini GD, Chivasso P, Suleiman MS, et al. Postoperative acute kidney injury defined by RIFLE criteria predicts early health outcome and long-term survival in patients undergoing redo coronary artery bypass graft surgery. J Thorac Cardiovasc Surg. 2016;152:235&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4915911</ArticleId><ArticleId IdType="pubmed">27016793</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neal JB, Shaw AD, Billings FTt. Acute kidney injury following cardiac surgery: current understanding and future directions. Crit Care. 2016;20:187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4931708</ArticleId><ArticleId IdType="pubmed">27373799</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Kellum JA, Ronco C. Defining acute renal failure: physiological principles. Intensive Care Med. 2004;30:33&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">14618231</ArticleId></ArticleIdList></Reference><Reference><Citation>Albert C, Albert A, Kube J, Bellomo R, Wettersten N, Kuppe H, et al. Urinary biomarkers may provide prognostic information for subclinical acute kidney injury after cardiac surgery. J Thorac Cardiovasc Surg. 2018;155:2441&#x2013;2452 e2413.</Citation><ArticleIdList><ArticleId IdType="pubmed">29366580</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyner JL, Bennett MR, Worcester EM, Ma Q, Raman J, Jeevanandam V, et al. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int. 2008;74:1059&#x2013;1069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2745082</ArticleId><ArticleId IdType="pubmed">18650797</ArticleId></ArticleIdList></Reference><Reference><Citation>Han WK, Wagener G, Zhu Y, Wang S, Lee HT. Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol. 2009;4:873&#x2013;882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2676184</ArticleId><ArticleId IdType="pubmed">19406962</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013;17:R25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057242</ArticleId><ArticleId IdType="pubmed">23388612</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrezenmeier EV, Barasch J, Budde K, Westhoff T, Schmidt-Ott KM. Biomarkers in acute kidney injury - pathophysiological basis and clinical performance. Acta Physiol (Ox&#xed;). 2017;219:554&#x2013;572.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5575831</ArticleId><ArticleId IdType="pubmed">27474473</ArticleId></ArticleIdList></Reference><Reference><Citation>Group KW. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney International Supplements. 2012;2.</Citation></Reference><Reference><Citation>Pilarczyk K, Edayadiyil-Dudasova M, Wendt D, Demircioglu E, Benedik J, Dohle DS, et al. Urinary [TIMP-2]*[IGFBP7] for early prediction of acute kidney injury after coronary artery bypass surgery. Ann Intensive Care. 2015;5:50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4679715</ArticleId><ArticleId IdType="pubmed">26669781</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M, Schmidt C, Van Aken H, Martens S, Rossaint J, Singbartl K, et al. Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery. PLoS One. 2014;9:e93460.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3968141</ArticleId><ArticleId IdType="pubmed">24675717</ArticleId></ArticleIdList></Reference><Reference><Citation>Gocze I, Jauch D, Gotz M, Kennedy P, Jung B, Zeman F, et al. Biomarker-guided Intervention to Prevent Acute Kidney Injury After Major Surgery: The Prospective Randomized BigpAK Study. Ann Surg. 2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">28857811</ArticleId></ArticleIdList></Reference><Reference><Citation>Gocze I, Koch M, Renner P, Zeman F, Graf BM, Dahlke MH, et al. Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery. PLoS One.2015;10:e0120863.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4370650</ArticleId><ArticleId IdType="pubmed">25798585</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EA, McCullough PA, Kashani K, Chawla LS, Joannidis M, Shaw AD, et al. Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers. Nephrol Dial Transplant. 2014;29:2054&#x2013;2061.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4209880</ArticleId><ArticleId IdType="pubmed">25237065</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FTt, Pretorius M, Schildcrout JS, Mercaldo ND, Byrne JG, Ikizler TA, et al. Obesity and oxidative stress predict AKI after cardiac surgery. JAm Soc Nephrol. 2012;23:1221&#x2013;1228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3380645</ArticleId><ArticleId IdType="pubmed">22626819</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FTt, Ball SK, Roberts LJ 2nd, Pretorius M. Postoperative acute kidney injury is associated with hemoglobinemia and an enhanced oxidative stress response. Free Radic Biol Med. 2011;50:1480&#x2013;1487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3090463</ArticleId><ArticleId IdType="pubmed">21334433</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FTt, Hendricks PA, Schildcrout JS, Shi Y, Petracek MR, Byrne JG, et al. High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial. JAMA. 2016;315:877&#x2013;888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4843765</ArticleId><ArticleId IdType="pubmed">26906014</ArticleId></ArticleIdList></Reference><Reference><Citation>Pohlert T The Pairwise Multiple Comparison of Mean Ranks Package (PMCMR). 2014;R package.</Citation></Reference><Reference><Citation>Thakar CV, Arrigain S, Worley S, Yared JP, Paganini EP. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol. 2005;16:162&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">15563569</ArticleId></ArticleIdList></Reference><Reference><Citation>Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011; 12:77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3068975</ArticleId><ArticleId IdType="pubmed">21414208</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrell Jr FD C; et al. Hmisc: Harrell Miscellaneous. 4.1&#x2013;1 ed2018.</Citation></Reference><Reference><Citation>Team RC. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. 2014.</Citation></Reference><Reference><Citation>Mayer T, Bolliger D, Scholz M, Reuthebuch O, Gregor M, Meier P, et al. Urine Biomarkers of Tubular Renal Cell Damage for the Prediction of Acute Kidney Injury After Cardiac Surgery-A Pilot Study. J Cardiothorac Vasc Anesth. 2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">28803769</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M, Schmidt C, Hoffmeier A, Van Aken H, Wempe C, Gerss J, et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med. 2017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5633630</ArticleId><ArticleId IdType="pubmed">28110412</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zou Z, Jin J, Teng J, Xu J, Shen B, et al. Urinary TIMP-2 and IGFBP7 for the prediction of acute kidney injury following cardiac surgery. BMC Nephrol. 2017; 18:177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5450378</ArticleId><ArticleId IdType="pubmed">28558754</ArticleId></ArticleIdList></Reference><Reference><Citation>Bihorac A, Chawla LS, Shaw AD, Al-Khafaji A, Davison DL, Demuth GE, et al. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am JRespir Crit Care Med. 2014;189:932&#x2013;939.</Citation><ArticleIdList><ArticleId IdType="pubmed">24559465</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28024933</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>06</Day></DateCompleted><DateRevised><Year>2018</Year><Month>04</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>A Preoperative Multimarker Approach to Evaluate Acute Kidney Injury After Cardiac Surgery.</ArticleTitle><Pagination><StartPage>837</StartPage><EndPage>846</EndPage><MedlinePgn>837-846</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2016.10.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(16)30455-4</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate whether a multimarker strategy combining preoperative biomarkers representing distinct pathophysiologic pathways enhances preoperative risk assessment of acute kidney injury after cardiac surgery (CSA-AKI) and increases knowledge of underlying pathogenesis.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective, cohort study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Single-center tertiary referral hospital.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">The study comprised 1,015 adults undergoing cardiac surgery with cardiopulmonary bypass.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">CSA-AKI was defined as&#x2265;50% increase in serum creatinine concentration, absolute increase&#x2265;26 &#xb5;mol/L, or new requirement for dialysis. Preoperative and perioperative information until hospital discharge was recorded. Preoperative plasma levels of C-reactive protein, terminal complement complex, neopterin, lactoferrin, N-terminal pro-brain natriuretic peptide, and cystatin C were determined using enzyme immunoassays. Biomarkers were selected based on causal hypotheses of underlying mechanisms and were related to inflammatory, hemodynamic, or renal signaling pathways.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">One hundred patients (9.9%) developed CSA-AKI. Higher baseline plasma concentrations of neopterin and N-terminal pro-brain natriuretic peptide were associated independently with CSA-AKI (p = 0.04 and p&lt;0.001, respectively). Lower baseline plasma lactoferrin concentrations were observed in patients with CSA-AKI (p = 0.05). Compared with clinical risk assessment, addition of these biomarkers provided a slight, but significant, increment in predictive utility (area under the curve 0.81-0.83, likelihood ratio test p&lt;0.001). A net of 12% of patients were reclassified correctly, and improved prediction was demonstrated, especially in patients with intermediate risk (56% correct reclassification).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Preoperative hemodynamic, renal, and immunologic function play central roles in the pathogenesis of CSA-AKI. These findings add evidence to the potential of a multimarker approach to improve preoperative prediction of CSA-AKI.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Enger</LastName><ForeName>Tone B</ForeName><Initials>TB</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Children's and Women's Health, Faculty of Medicine, NTNU-Norwegian University of Science and Technology, Trondheim, Norway; Department of Cardiothoracic Anesthesia and Intensive Care, St. Olavs University Hospital, Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pleym</LastName><ForeName>Hilde</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Circulation and Medical Imaging, Faculty of Medicine, NTNU-Norwegian University of Science and Technology, Trondheim, Norway; Clinic of Anesthesia and Intensive Care, St. Olavs University Hospital, Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stenseth</LastName><ForeName>Roar</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anesthesia and Intensive Care, St. Olavs University Hospital, Trondheim, Norway; Department of Circulation and Medical Imaging, Faculty of Medicine, NTNU-Norwegian University of Science and Technology, Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greiff</LastName><ForeName>Guri</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anesthesia and Intensive Care, St. Olavs University Hospital, Trondheim, Norway; Department of Circulation and Medical Imaging, Faculty of Medicine, NTNU-Norwegian University of Science and Technology, Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wahba</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Circulation and Medical Imaging, Faculty of Medicine, NTNU-Norwegian University of Science and Technology, Trondheim, Norway; Clinic of Cardiothoracic Surgery, St. Olavs University Hospital, Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Videm</LastName><ForeName>Vibeke</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Children's and Women's Health, Faculty of Medicine, NTNU-Norwegian University of Science and Technology, Trondheim, Norway; Department of Immunology and Transfusion Medicine, St. Olavs University Hospital, Trondheim, Norway. Electronic address: vibeke.videm@ntnu.no.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009664" MajorTopicYN="N">Norway</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">preoperative biomarkers</Keyword><Keyword MajorTopicYN="N">risk prediction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28024933</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2016.10.005</ArticleId><ArticleId IdType="pii">S1053-0770(16)30455-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>